assertion_id	disorder_id	disorder_name	source_file	section	section_index	name	description	category	frequency	diagnostic	context	subtype	role	presence	association	accession	age_range	background	base_model	classification	clinical_significance	consequence	data_type	de_novo_rate	definition_type	duration	effect	expressivity	features	genotype	incubation_days	incubation_years	markers	maximum_value	mean_range	minimum_value	model_format	model_id	model_software	model_type	notes	parent_of_origin_effect	penetrance	percentage	phase	platform	population	publication	repository_url	results	review_notes	sample_count	scope	sequence_length	severity	species	specificity	status	subtype_frequency	title	type	unit	scalar_fields_json	complex_fields_json	raw_json
3	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	0	TBX1 haploinsufficiency and pharyngeal arch development	"The critical gene within the 22q11.2 deletion is TBX1, a T-box transcription factor essential for pharyngeal arch development. TBX1 haploinsufficiency disrupts the proliferation and survival of pharyngeal mesoderm and neural crest cells, leading to defective development of pharyngeal arch derivatives including the thymus (3rd pouch), parathyroid glands (3rd/4th pouches), and cardiac outflow tract.
"																																																								"{""description"": ""The critical gene within the 22q11.2 deletion is TBX1, a T-box transcription factor essential for pharyngeal arch development. TBX1 haploinsufficiency disrupts the proliferation and survival of pharyngeal mesoderm and neural crest cells, leading to defective development of pharyngeal arch derivatives including the thymus (3rd pouch), parathyroid glands (3rd/4th pouches), and cardiac outflow tract.\n"", ""name"": ""TBX1 haploinsufficiency and pharyngeal arch development""}"	{}	"{""biological_processes"": [{""preferred_term"": ""pharyngeal system development"", ""term"": {""id"": ""GO:0060037"", ""label"": ""pharyngeal system development""}}], ""cell_types"": [{""preferred_term"": ""neural crest cell"", ""term"": {""id"": ""CL:0011012"", ""label"": ""neural crest cell""}}, {""preferred_term"": ""pharyngeal arch mesenchyme cell"", ""term"": {""id"": ""CL:0000134"", ""label"": ""mesenchymal stem cell""}}], ""description"": ""The critical gene within the 22q11.2 deletion is TBX1, a T-box transcription factor essential for pharyngeal arch development. TBX1 haploinsufficiency disrupts the proliferation and survival of pharyngeal mesoderm and neural crest cells, leading to defective development of pharyngeal arch derivatives including the thymus (3rd pouch), parathyroid glands (3rd/4th pouches), and cardiac outflow tract.\n"", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Tbx1 heterozygous mice recapitulate the cardiac phenotype of human 22q11.2DS."", ""reference"": ""PMID:11242110"", ""snippet"": ""mice heterozygous for the mutation had a high incidence of cardiac outflow tract anomalies, thus modeling one of the major abnormalities of the human syndrome"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Homozygous Tbx1 knockout recapitulates the full DiGeorge phenotype."", ""reference"": ""PMID:11242110"", ""snippet"": ""Tbx1-/- mice displayed a wide range of developmental anomalies encompassing almost all of the common DGS/VCFS features, including hypoplasia of the thymus and parathyroid glands, cardiac outflow tract abnormalities, abnormal facial structures, abnormal vertebrae and cleft palate"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""pharyngeal arch"", ""term"": {""id"": ""UBERON:0002539"", ""label"": ""pharyngeal arch""}}, {""preferred_term"": ""pharyngeal pouch 3"", ""term"": {""id"": ""UBERON:0007124"", ""label"": ""pharyngeal pouch 3""}}], ""name"": ""TBX1 haploinsufficiency and pharyngeal arch development""}"
4	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	1	Cardiac neural crest migration defect	"Neural crest cells from the occipital somites migrate through pharyngeal arches 3, 4, and 6 to contribute to aorticopulmonary septation and great vessel remodeling. TBX1 deficiency impairs neural crest cell migration and survival through non-cell-autonomous mechanisms, as TBX1 is expressed in pharyngeal mesoderm rather than neural crest cells themselves.
"																																																								"{""description"": ""Neural crest cells from the occipital somites migrate through pharyngeal arches 3, 4, and 6 to contribute to aorticopulmonary septation and great vessel remodeling. TBX1 deficiency impairs neural crest cell migration and survival through non-cell-autonomous mechanisms, as TBX1 is expressed in pharyngeal mesoderm rather than neural crest cells themselves.\n"", ""name"": ""Cardiac neural crest migration defect""}"	"{""downstream"": [{""description"": ""Impaired neural crest migration results in failure of outflow tract septation."", ""target"": ""Conotruncal heart defects""}]}"	"{""biological_processes"": [{""preferred_term"": ""cardiac neural crest cell migration involved in outflow tract morphogenesis"", ""term"": {""id"": ""GO:0003253"", ""label"": ""cardiac neural crest cell migration involved in outflow tract morphogenesis""}}, {""preferred_term"": ""outflow tract morphogenesis"", ""term"": {""id"": ""GO:0003151"", ""label"": ""outflow tract morphogenesis""}}], ""cell_types"": [{""preferred_term"": ""migratory cardiac neural crest cell"", ""term"": {""id"": ""CL:2000073"", ""label"": ""migratory cardiac neural crest cell""}}], ""description"": ""Neural crest cells from the occipital somites migrate through pharyngeal arches 3, 4, and 6 to contribute to aorticopulmonary septation and great vessel remodeling. TBX1 deficiency impairs neural crest cell migration and survival through non-cell-autonomous mechanisms, as TBX1 is expressed in pharyngeal mesoderm rather than neural crest cells themselves.\n"", ""downstream"": [{""description"": ""Impaired neural crest migration results in failure of outflow tract septation."", ""target"": ""Conotruncal heart defects""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews documents the characteristic cardiac malformations."", ""reference"": ""PMID:20301696"", ""snippet"": ""congenital heart disease, particularly conotruncal malformations (ventricular septal defect, tetralogy of Fallot, interrupted aortic arch, and truncus arteriosus)"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""cardiac outflow tract"", ""term"": {""id"": ""UBERON:0004145"", ""label"": ""outflow tract""}}], ""name"": ""Cardiac neural crest migration defect""}"
5	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	2	Thymic hypoplasia and T-cell immunodeficiency	"The thymus derives from the third pharyngeal pouch. Impaired pharyngeal pouch development leads to thymic hypoplasia or aplasia, resulting in reduced T-cell production. The immunodeficiency is typically partial, with low but functional T-cell numbers, though complete thymic aplasia (complete DiGeorge syndrome) occurs in ~1% of cases.
"																																																								"{""description"": ""The thymus derives from the third pharyngeal pouch. Impaired pharyngeal pouch development leads to thymic hypoplasia or aplasia, resulting in reduced T-cell production. The immunodeficiency is typically partial, with low but functional T-cell numbers, though complete thymic aplasia (complete DiGeorge syndrome) occurs in ~1% of cases.\n"", ""name"": ""Thymic hypoplasia and T-cell immunodeficiency""}"	"{""downstream"": [{""description"": ""Reduced thymic tissue leads to decreased T-cell output and immunodeficiency."", ""target"": ""T-cell immunodeficiency""}]}"	"{""biological_processes"": [{""preferred_term"": ""neural crest cell differentiation involved in thymus development"", ""term"": {""id"": ""GO:1902637"", ""label"": ""neural crest cell differentiation involved in thymus development""}}], ""cell_types"": [{""preferred_term"": ""cortical thymic epithelial cell"", ""term"": {""id"": ""CL:0002364"", ""label"": ""cortical thymic epithelial cell""}}, {""preferred_term"": ""medullary thymic epithelial cell"", ""term"": {""id"": ""CL:0002365"", ""label"": ""medullary thymic epithelial cell""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""The thymus derives from the third pharyngeal pouch. Impaired pharyngeal pouch development leads to thymic hypoplasia or aplasia, resulting in reduced T-cell production. The immunodeficiency is typically partial, with low but functional T-cell numbers, though complete thymic aplasia (complete DiGeorge syndrome) occurs in ~1% of cases.\n"", ""downstream"": [{""description"": ""Reduced thymic tissue leads to decreased T-cell output and immunodeficiency."", ""target"": ""T-cell immunodeficiency""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Immune deficiency is a major clinical manifestation."", ""reference"": ""PMID:20301696"", ""snippet"": ""immune deficiency"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""thymus"", ""term"": {""id"": ""UBERON:0002370"", ""label"": ""thymus""}}], ""name"": ""Thymic hypoplasia and T-cell immunodeficiency""}"
6	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	3	Parathyroid hypoplasia and hypocalcemia	"The parathyroid glands derive from the third and fourth pharyngeal pouches. Defective pouch development causes parathyroid hypoplasia, leading to hypoparathyroidism and hypocalcemia. Neonatal hypocalcemia may present with seizures and is often the presenting feature.
"																																																								"{""description"": ""The parathyroid glands derive from the third and fourth pharyngeal pouches. Defective pouch development causes parathyroid hypoplasia, leading to hypoparathyroidism and hypocalcemia. Neonatal hypocalcemia may present with seizures and is often the presenting feature.\n"", ""name"": ""Parathyroid hypoplasia and hypocalcemia""}"	"{""downstream"": [{""description"": ""Parathyroid hypoplasia causes hypoparathyroidism and low serum calcium."", ""target"": ""Hypocalcemia""}]}"	"{""biological_processes"": [{""preferred_term"": ""neural crest cell differentiation involved in parathyroid gland development"", ""term"": {""id"": ""GO:1902638"", ""label"": ""neural crest cell differentiation involved in parathyroid gland development""}}], ""description"": ""The parathyroid glands derive from the third and fourth pharyngeal pouches. Defective pouch development causes parathyroid hypoplasia, leading to hypoparathyroidism and hypocalcemia. Neonatal hypocalcemia may present with seizures and is often the presenting feature.\n"", ""downstream"": [{""description"": ""Parathyroid hypoplasia causes hypoparathyroidism and low serum calcium."", ""target"": ""Hypocalcemia""}], ""locations"": [{""preferred_term"": ""parathyroid gland"", ""term"": {""id"": ""UBERON:0001132"", ""label"": ""parathyroid gland""}}], ""name"": ""Parathyroid hypoplasia and hypocalcemia""}"
27	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	0	ALK Gene Rearrangement	ALK rearrangements result from chromosomal inversions or translocations that fuse the ALK kinase domain to an N-terminal partner gene (usually EML4). The partner provides a dimerization domain, causing constitutive ALK kinase activation independent of ligand.																																																								"{""description"": ""ALK rearrangements result from chromosomal inversions or translocations that fuse the ALK kinase domain to an N-terminal partner gene (usually EML4). The partner provides a dimerization domain, causing constitutive ALK kinase activation independent of ligand."", ""name"": ""ALK Gene Rearrangement""}"	"{""downstream"": [{""description"": ""Fusion protein is constitutively active"", ""target"": ""Constitutive ALK Signaling""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein kinase activity"", ""term"": {""id"": ""GO:0004672"", ""label"": ""protein kinase activity""}}], ""cell_types"": [{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}], ""description"": ""ALK rearrangements result from chromosomal inversions or translocations that fuse the ALK kinase domain to an N-terminal partner gene (usually EML4). The partner provides a dimerization domain, causing constitutive ALK kinase activation independent of ligand."", ""downstream"": [{""description"": ""Fusion protein is constitutively active"", ""target"": ""Constitutive ALK Signaling""}], ""evidence"": [{""explanation"": ""This abstract states that ALK rearrangements drive a subset of NSCLC, supporting the ALK gene rearrangement mechanism."", ""reference"": ""PMID:27637426"", ""snippet"": ""An early result of this search was the discovery of NSCLC driven by activating rearrangements of the anaplastic lymphoma kinase (ALK) gene."", ""supports"": ""SUPPORT""}], ""name"": ""ALK Gene Rearrangement""}"
28	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	1	Constitutive ALK Signaling	The EML4-ALK fusion protein is constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration.																																																								"{""description"": ""The EML4-ALK fusion protein is constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration."", ""name"": ""Constitutive ALK Signaling""}"	"{""downstream"": [{""description"": ""Tumor survival dependent on ALK activity"", ""target"": ""Oncogene Addiction""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""JAK-STAT cascade"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}], ""description"": ""The EML4-ALK fusion protein is constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration."", ""downstream"": [{""description"": ""Tumor survival dependent on ALK activity"", ""target"": ""Oncogene Addiction""}], ""name"": ""Constitutive ALK Signaling""}"
29	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	2	Oncogene Addiction	ALK-rearranged tumors exhibit oncogene addiction, becoming dependent on continued ALK signaling for survival. ALK inhibition leads to dramatic tumor responses, often within days to weeks of starting therapy.																																																								"{""description"": ""ALK-rearranged tumors exhibit oncogene addiction, becoming dependent on continued ALK signaling for survival. ALK inhibition leads to dramatic tumor responses, often within days to weeks of starting therapy."", ""name"": ""Oncogene Addiction""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""ALK-rearranged tumors exhibit oncogene addiction, becoming dependent on continued ALK signaling for survival. ALK inhibition leads to dramatic tumor responses, often within days to weeks of starting therapy."", ""name"": ""Oncogene Addiction""}"
30	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	3	ALK TKI Resistance	Resistance to ALK TKIs develops through ALK-dependent mechanisms (secondary mutations like G1202R, compound mutations) or ALK-independent bypass pathways (MET, EGFR, KRAS). Later-generation TKIs (lorlatinib) overcome most single ALK mutations.																																																								"{""description"": ""Resistance to ALK TKIs develops through ALK-dependent mechanisms (secondary mutations like G1202R, compound mutations) or ALK-independent bypass pathways (MET, EGFR, KRAS). Later-generation TKIs (lorlatinib) overcome most single ALK mutations."", ""name"": ""ALK TKI Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}], ""description"": ""Resistance to ALK TKIs develops through ALK-dependent mechanisms (secondary mutations like G1202R, compound mutations) or ALK-independent bypass pathways (MET, EGFR, KRAS). Later-generation TKIs (lorlatinib) overcome most single ALK mutations."", ""name"": ""ALK TKI Resistance""}"
45	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	0	PML-RARA Fusion Oncogene Formation	The t(15;17)(q24;q21) translocation fuses the PML gene on chromosome 15 with the retinoic acid receptor alpha (RARA) gene on chromosome 17. The resulting fusion protein retains the DNA-binding and ligand-binding domains of RARA but gains aberrant properties from PML, including enhanced corepressor recruitment and altered subnuclear localization.																																																								"{""description"": ""The t(15;17)(q24;q21) translocation fuses the PML gene on chromosome 15 with the retinoic acid receptor alpha (RARA) gene on chromosome 17. The resulting fusion protein retains the DNA-binding and ligand-binding domains of RARA but gains aberrant properties from PML, including enhanced corepressor recruitment and altered subnuclear localization."", ""name"": ""PML-RARA Fusion Oncogene Formation""}"	"{""downstream"": [{""description"": ""PML-RARA recruits corepressors to RARA target genes"", ""target"": ""Transcriptional Repression of Differentiation Genes""}, {""description"": ""Fusion protein disrupts normal PML function"", ""target"": ""PML Nuclear Body Disruption""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""myeloid cell differentiation"", ""term"": {""id"": ""GO:0030099"", ""label"": ""myeloid cell differentiation""}}], ""cell_types"": [{""preferred_term"": ""promyelocyte"", ""term"": {""id"": ""CL:0000836"", ""label"": ""promyelocyte""}}], ""description"": ""The t(15;17)(q24;q21) translocation fuses the PML gene on chromosome 15 with the retinoic acid receptor alpha (RARA) gene on chromosome 17. The resulting fusion protein retains the DNA-binding and ligand-binding domains of RARA but gains aberrant properties from PML, including enhanced corepressor recruitment and altered subnuclear localization."", ""downstream"": [{""description"": ""PML-RARA recruits corepressors to RARA target genes"", ""target"": ""Transcriptional Repression of Differentiation Genes""}, {""description"": ""Fusion protein disrupts normal PML function"", ""target"": ""PML Nuclear Body Disruption""}], ""evidence"": [{""explanation"": ""This abstract directly links PML-RARA fusion to APL pathogenesis, supporting the fusion oncogene mechanism."", ""reference"": ""PMID:41580016"", ""snippet"": ""Dysfunction of the retinoic acid (RA) signaling pathway, which is mediated by the formation of the PML-RARA fusion gene, plays a central role in the pathogenesis of acute promyelocytic leukemia (APL)."", ""supports"": ""SUPPORT""}], ""name"": ""PML-RARA Fusion Oncogene Formation""}"
46	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	1	Transcriptional Repression of Differentiation Genes	PML-RARA binds retinoic acid response elements but recruits corepressor complexes (NCoR, SMRT, HDACs) at physiological retinoic acid concentrations. This silences RARA target genes required for granulocyte differentiation, causing a differentiation block at the promyelocyte stage. Pharmacological doses of ATRA overcome this block.																																																								"{""description"": ""PML-RARA binds retinoic acid response elements but recruits corepressor complexes (NCoR, SMRT, HDACs) at physiological retinoic acid concentrations. This silences RARA target genes required for granulocyte differentiation, causing a differentiation block at the promyelocyte stage. Pharmacological doses of ATRA overcome this block."", ""name"": ""Transcriptional Repression of Differentiation Genes""}"	"{""downstream"": [{""description"": ""Differentiation arrest leads to accumulation of immature cells"", ""target"": ""Promyelocyte Accumulation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""granulocyte differentiation"", ""term"": {""id"": ""GO:0030851"", ""label"": ""granulocyte differentiation""}}], ""cell_types"": [{""preferred_term"": ""promyelocyte"", ""term"": {""id"": ""CL:0000836"", ""label"": ""promyelocyte""}}], ""description"": ""PML-RARA binds retinoic acid response elements but recruits corepressor complexes (NCoR, SMRT, HDACs) at physiological retinoic acid concentrations. This silences RARA target genes required for granulocyte differentiation, causing a differentiation block at the promyelocyte stage. Pharmacological doses of ATRA overcome this block."", ""downstream"": [{""description"": ""Differentiation arrest leads to accumulation of immature cells"", ""target"": ""Promyelocyte Accumulation""}], ""name"": ""Transcriptional Repression of Differentiation Genes""}"
47	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	2	PML Nuclear Body Disruption	Wild-type PML organizes nuclear bodies that regulate multiple cellular processes including apoptosis and senescence. PML-RARA disrupts PML nuclear bodies into a microspeckled pattern, impairing PML tumor suppressor functions. Arsenic trioxide restores PML nuclear bodies and induces PML-RARA degradation.																																																								"{""description"": ""Wild-type PML organizes nuclear bodies that regulate multiple cellular processes including apoptosis and senescence. PML-RARA disrupts PML nuclear bodies into a microspeckled pattern, impairing PML tumor suppressor functions. Arsenic trioxide restores PML nuclear bodies and induces PML-RARA degradation."", ""name"": ""PML Nuclear Body Disruption""}"	"{""downstream"": [{""description"": ""Loss of PML function contributes to leukemogenesis"", ""target"": ""Impaired Tumor Suppression""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""Wild-type PML organizes nuclear bodies that regulate multiple cellular processes including apoptosis and senescence. PML-RARA disrupts PML nuclear bodies into a microspeckled pattern, impairing PML tumor suppressor functions. Arsenic trioxide restores PML nuclear bodies and induces PML-RARA degradation."", ""downstream"": [{""description"": ""Loss of PML function contributes to leukemogenesis"", ""target"": ""Impaired Tumor Suppression""}], ""name"": ""PML Nuclear Body Disruption""}"
48	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	3	Impaired Tumor Suppression	Disruption of PML nuclear bodies impairs p53-mediated senescence and apoptosis pathways. This contributes to the survival and accumulation of leukemic promyelocytes.																																																								"{""description"": ""Disruption of PML nuclear bodies impairs p53-mediated senescence and apoptosis pathways. This contributes to the survival and accumulation of leukemic promyelocytes."", ""name"": ""Impaired Tumor Suppression""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}], ""description"": ""Disruption of PML nuclear bodies impairs p53-mediated senescence and apoptosis pathways. This contributes to the survival and accumulation of leukemic promyelocytes."", ""name"": ""Impaired Tumor Suppression""}"
49	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	4	Promyelocyte Accumulation	The differentiation block at the promyelocyte stage leads to accumulation of abnormal promyelocytes in bone marrow and blood. These cells contain abundant azurophilic granules and release procoagulant factors.																																																								"{""description"": ""The differentiation block at the promyelocyte stage leads to accumulation of abnormal promyelocytes in bone marrow and blood. These cells contain abundant azurophilic granules and release procoagulant factors."", ""name"": ""Promyelocyte Accumulation""}"	"{""downstream"": [{""description"": ""Granule release causes DIC and hyperfibrinolysis"", ""target"": ""Coagulopathy""}]}"	"{""cell_types"": [{""preferred_term"": ""promyelocyte"", ""term"": {""id"": ""CL:0000836"", ""label"": ""promyelocyte""}}], ""description"": ""The differentiation block at the promyelocyte stage leads to accumulation of abnormal promyelocytes in bone marrow and blood. These cells contain abundant azurophilic granules and release procoagulant factors."", ""downstream"": [{""description"": ""Granule release causes DIC and hyperfibrinolysis"", ""target"": ""Coagulopathy""}], ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Promyelocyte Accumulation""}"
50	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	5	Coagulopathy	APL promyelocytes release tissue factor and cancer procoagulant from azurophilic granules, triggering disseminated intravascular coagulation. Annexin II expression promotes plasmin generation causing hyperfibrinolysis. This combination causes severe, often fatal bleeding before and during early treatment.																																																								"{""description"": ""APL promyelocytes release tissue factor and cancer procoagulant from azurophilic granules, triggering disseminated intravascular coagulation. Annexin II expression promotes plasmin generation causing hyperfibrinolysis. This combination causes severe, often fatal bleeding before and during early treatment."", ""name"": ""Coagulopathy""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""blood coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}], ""description"": ""APL promyelocytes release tissue factor and cancer procoagulant from azurophilic granules, triggering disseminated intravascular coagulation. Annexin II expression promotes plasmin generation causing hyperfibrinolysis. This combination causes severe, often fatal bleeding before and during early treatment."", ""name"": ""Coagulopathy""}"
73	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	0	TTR Tetramer Destabilization	Mutations in the TTR gene or age-related changes destabilize the native tetrameric structure, leading to dissociation into monomers. This is the rate-limiting step enabling protein misfolding and aggregation.																																																								"{""description"": ""Mutations in the TTR gene or age-related changes destabilize the native tetrameric structure, leading to dissociation into monomers. This is the rate-limiting step enabling protein misfolding and aggregation."", ""name"": ""TTR Tetramer Destabilization""}"	{}	"{""biological_processes"": [{""preferred_term"": ""protein tetramerization"", ""term"": {""id"": ""GO:0051289"", ""label"": ""protein homotetramerization""}}, {""preferred_term"": ""protein folding"", ""term"": {""id"": ""GO:0006457"", ""label"": ""protein folding""}}], ""description"": ""Mutations in the TTR gene or age-related changes destabilize the native tetrameric structure, leading to dissociation into monomers. This is the rate-limiting step enabling protein misfolding and aggregation."", ""evidence"": [{""explanation"": ""The abstract mentions that TTR amyloidogenesis involves the formation and aggregation of amyloid fibrils, which supports the statement that mutations in the TTR gene result in the production of unstable transthyretin proteins that misfold and aggregate into amyloid fibrils."", ""reference"": ""PMID:34884963"", ""snippet"": ""Transthyretin (TTR) amyloidogenesis involves the formation, aggregation, and deposition of amyloid fibrils from tetrameric TTR in different organs and tissues."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by mentioning that familial amyloid polyneuropathy is caused by mutations in the TTR gene, which is consistent with the production of unstable transthyretin proteins that misfold and aggregate."", ""reference"": ""PMID:35830843"", ""snippet"": ""Familial amyloid polyneuropathy is currently prevalent worldwide as the transthyretin (TTR) Val30Met mutation, and there are other types of mutations."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by explaining that hereditary transthyretin-related amyloidosis is caused by pathogenic variants in the TTR gene."", ""reference"": ""PMID:38844302"", ""snippet"": ""Hereditary transthyretin-related amyloidosis (hATTR) is the most common form of familial amyloidosis. It is an autosomal dominant disease caused by a pathogenic variant in the TTR gene."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract confirms that hereditary transthyretin amyloidosis results from mutations in the TTR gene, which aligns with the statement."", ""reference"": ""PMID:22471982"", ""snippet"": ""hereditary transthyretin (TTR) amyloidosis which is a genetically transmitted disease that results from a mutation in the gene encoding the plasma TTR protein."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference explicitly states that hereditary transthyretin-related amyloidosis is caused by mutations in the TTR gene that destabilize the protein, supporting the statement."", ""reference"": ""PMID:29962408"", ""snippet"": ""Hereditary transthyretin (TTR)-related amyloidosis is caused by mutations in the TTR gene. The mutations destabilize the tetramer and/or monomer of TTR, and thus the stabilization of TTR is a key strategy for the treatment of TTR-related amyloidosis."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""extracellular space"", ""term"": {""id"": ""GO:0005615"", ""label"": ""extracellular space""}}, {""preferred_term"": ""blood plasma"", ""term"": {""id"": ""UBERON:0001969"", ""label"": ""blood plasma""}}], ""name"": ""TTR Tetramer Destabilization""}"
74	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	1	Amyloid Fibril Formation	Misfolded transthyretin monomers undergo nucleation and elongation to form cross-beta amyloid fibrils. Serum amyloid P component and proteoglycans stabilize deposits and reduce clearance.																																																								"{""description"": ""Misfolded transthyretin monomers undergo nucleation and elongation to form cross-beta amyloid fibrils. Serum amyloid P component and proteoglycans stabilize deposits and reduce clearance."", ""name"": ""Amyloid Fibril Formation""}"	"{""downstream"": [{""description"": ""Extracellular deposition of misfolded transthyretin monomers as insoluble amyloid fibrils causes cardiomyopathy and polyneuropathy."", ""evidence"": [{""explanation"": ""This 2025 review explicitly states that misfolded TTR monomers cause both cardiomyopathy and polyneuropathy, establishing the causal link between amyloid deposition and organ dysfunction."", ""reference"": ""PMID:40649158"", ""snippet"": ""Transthyretin-related (ATTR) amyloidosis is a progressive, multisystem disease caused by the extracellular deposition of misfolded transthyretin (TTR) monomers as insoluble amyloid fibrils. Clinical manifestations vary widely and may include cardiomyopathy (ATTR-CM), polyneuropathy (ATTR-PN), or mixed phenotypes."", ""supports"": ""SUPPORT""}], ""target"": ""Cardiac and Neurological Dysfunction""}]}"	"{""biological_processes"": [{""preferred_term"": ""amyloid fibril formation"", ""term"": {""id"": ""GO:0043241"", ""label"": ""amyloid fibril formation""}}, {""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""description"": ""Misfolded transthyretin monomers undergo nucleation and elongation to form cross-beta amyloid fibrils. Serum amyloid P component and proteoglycans stabilize deposits and reduce clearance."", ""downstream"": [{""description"": ""Extracellular deposition of misfolded transthyretin monomers as insoluble amyloid fibrils causes cardiomyopathy and polyneuropathy."", ""evidence"": [{""explanation"": ""This 2025 review explicitly states that misfolded TTR monomers cause both cardiomyopathy and polyneuropathy, establishing the causal link between amyloid deposition and organ dysfunction."", ""reference"": ""PMID:40649158"", ""snippet"": ""Transthyretin-related (ATTR) amyloidosis is a progressive, multisystem disease caused by the extracellular deposition of misfolded transthyretin (TTR) monomers as insoluble amyloid fibrils. Clinical manifestations vary widely and may include cardiomyopathy (ATTR-CM), polyneuropathy (ATTR-PN), or mixed phenotypes."", ""supports"": ""SUPPORT""}], ""target"": ""Cardiac and Neurological Dysfunction""}], ""evidence"": [{""explanation"": ""The reference supports that amyloid fibrils deposit in the heart, kidney, and peripheral nerves, but does not mention the gastrointestinal tract."", ""reference"": ""PMID:31452023"", ""snippet"": ""fibrillar deposits in a several organs including the heart, kidney, liver, and peripheral nerves cause organ dysfunction and associated morbidity and mortality."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference supports that misfolded transthyretin proteins form amyloid fibrils but does not specify all the tissues mentioned in the statement."", ""reference"": ""PMID:15126690"", ""snippet"": ""It is possible that a common factor in the amyloidogenesis process exists among the different forms; this common factor can involve changes produced by mutations in the three-dimensional structure of TTR, rendering it prone to deposition as amyloid."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference supports that amyloid fibrils deposit in the heart and connective tissue, but does not mention the nerves, kidneys, or gastrointestinal tract."", ""reference"": ""PMID:34018852"", ""snippet"": ""Age-related wild-type transthyretin amyloidosis (wtATTR) is characterized by systemic deposition of amyloidogenic fibrils of misfolded transthyretin (TTR) in the connective tissue of many organs. In the heart, this leads to cardiac dysfunction, which is a significant cause of age-related heart failure."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference supports that amyloid fibrils deposit in the nerves and heart but does not mention the kidneys or gastrointestinal tract."", ""reference"": ""PMID:34361762"", ""snippet"": ""Studies of nerve biopsy or cardiac autopsy specimens from patients with ATTR and AL amyloidoses show atrophy of cells near amyloid fibril aggregates."", ""supports"": ""PARTIAL""}], ""locations"": [{""preferred_term"": ""extracellular space"", ""term"": {""id"": ""GO:0005615"", ""label"": ""extracellular space""}}, {""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}, {""preferred_term"": ""peripheral nervous system"", ""term"": {""id"": ""UBERON:0000010"", ""label"": ""peripheral nervous system""}}], ""name"": ""Amyloid Fibril Formation""}"
75	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	2	Oxidative Stress and Mitochondrial Dysfunction	TTR oligomers and fibrils induce reactive oxygen species production and impair mitochondrial function in cardiomyocytes, contributing to contractile dysfunction and cell injury.																																																								"{""description"": ""TTR oligomers and fibrils induce reactive oxygen species production and impair mitochondrial function in cardiomyocytes, contributing to contractile dysfunction and cell injury."", ""name"": ""Oxidative Stress and Mitochondrial Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}, {""preferred_term"": ""mitochondrion organization"", ""term"": {""id"": ""GO:0007005"", ""label"": ""mitochondrion organization""}}], ""cell_types"": [{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""description"": ""TTR oligomers and fibrils induce reactive oxygen species production and impair mitochondrial function in cardiomyocytes, contributing to contractile dysfunction and cell injury."", ""locations"": [{""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}], ""name"": ""Oxidative Stress and Mitochondrial Dysfunction""}"
76	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	3	Calcium Homeostasis Disruption	Amyloid deposits disrupt intracellular calcium handling in cardiomyocytes, impairing contractility and promoting arrhythmogenesis.																																																								"{""description"": ""Amyloid deposits disrupt intracellular calcium handling in cardiomyocytes, impairing contractility and promoting arrhythmogenesis."", ""name"": ""Calcium Homeostasis Disruption""}"	{}	"{""biological_processes"": [{""preferred_term"": ""calcium ion homeostasis"", ""term"": {""id"": ""GO:0055074"", ""label"": ""calcium ion homeostasis""}}], ""cell_types"": [{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""description"": ""Amyloid deposits disrupt intracellular calcium handling in cardiomyocytes, impairing contractility and promoting arrhythmogenesis."", ""locations"": [{""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}], ""name"": ""Calcium Homeostasis Disruption""}"
77	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	4	Peripheral Nerve Degeneration	Amyloid deposition in peripheral nerves causes axonal degeneration and demyelination, affecting sensory, motor, and autonomic functions.																																																								"{""description"": ""Amyloid deposition in peripheral nerves causes axonal degeneration and demyelination, affecting sensory, motor, and autonomic functions."", ""name"": ""Peripheral Nerve Degeneration""}"	{}	"{""biological_processes"": [{""preferred_term"": ""axonogenesis"", ""term"": {""id"": ""GO:0007409"", ""label"": ""axonogenesis""}}, {""preferred_term"": ""myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}], ""cell_types"": [{""preferred_term"": ""peripheral neuron"", ""term"": {""id"": ""CL:0000107"", ""label"": ""autonomic neuron""}}, {""preferred_term"": ""Schwann cell"", ""term"": {""id"": ""CL:0002573"", ""label"": ""Schwann cell""}}], ""description"": ""Amyloid deposition in peripheral nerves causes axonal degeneration and demyelination, affecting sensory, motor, and autonomic functions."", ""locations"": [{""preferred_term"": ""peripheral nervous system"", ""term"": {""id"": ""UBERON:0000010"", ""label"": ""peripheral nervous system""}}], ""name"": ""Peripheral Nerve Degeneration""}"
103	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	0	Type II Collagen Structural Defect	"Mutations in COL2A1 disrupt the triple helix structure of type II collagen, the major structural protein of cartilage. Glycine substitutions in the Gly-X-Y repeat domain prevent proper helix formation, leading to intracellular retention and degradation of abnormal procollagen chains.
"																																																								"{""description"": ""Mutations in COL2A1 disrupt the triple helix structure of type II collagen, the major structural protein of cartilage. Glycine substitutions in the Gly-X-Y repeat domain prevent proper helix formation, leading to intracellular retention and degradation of abnormal procollagen chains.\n"", ""name"": ""Type II Collagen Structural Defect""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}, {""preferred_term"": ""Cartilage Development"", ""term"": {""id"": ""GO:0051216"", ""label"": ""cartilage development""}}, {""preferred_term"": ""Endochondral Bone Development"", ""term"": {""id"": ""GO:0060351"", ""label"": ""cartilage development involved in endochondral bone morphogenesis""}}], ""cell_types"": [{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}, {""preferred_term"": ""Growth Plate Chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}], ""description"": ""Mutations in COL2A1 disrupt the triple helix structure of type II collagen, the major structural protein of cartilage. Glycine substitutions in the Gly-X-Y repeat domain prevent proper helix formation, leading to intracellular retention and degradation of abnormal procollagen chains.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that glycine substitutions in the Gly-X-Y repeat domain interrupt the formation of stable triple helical collagen molecules."", ""reference"": ""PMID:7829510"", ""snippet"": ""A transition of G2853 to A in exon 41 produced a substitution of Gly769 by Ser within the triple helical domain of the alpha 1(II) chain of type II collagen, interrupting the mandatory Gly-X-Y triplet sequence required for the normal formation of stable triple helical type II collagen molecules"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents multiple glycine substitution mutations in the COL2A1 triple helical domain causing lethal type II collagen disorders."", ""reference"": ""PMID:10745044"", ""snippet"": ""Five patients were heterozygous for a nucleotide change that predicted a glycine substitution in the triple helical domain (G313S, G517V, G571A, G910C, G943S)"", ""supports"": ""SUPPORT""}], ""name"": ""Type II Collagen Structural Defect""}"
104	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	1	Extracellular Matrix Deficiency	"Defective type II collagen secretion results in severely abnormal cartilage extracellular matrix. The cartilage lacks normal fibrillar architecture and fails to provide the template for endochondral ossification.
"																																																								"{""description"": ""Defective type II collagen secretion results in severely abnormal cartilage extracellular matrix. The cartilage lacks normal fibrillar architecture and fails to provide the template for endochondral ossification.\n"", ""name"": ""Extracellular Matrix Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""ECM Organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""description"": ""Defective type II collagen secretion results in severely abnormal cartilage extracellular matrix. The cartilage lacks normal fibrillar architecture and fails to provide the template for endochondral ossification.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that the COL2A1 mutation results in complete loss of type II collagen from cartilage, leading to abnormal gelatinous matrix composition."", ""reference"": ""PMID:7829510"", ""snippet"": ""resulting in the complete absence of type II collagen in the cartilage, which had a gelatinous composition"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Shows that mutant type II collagen is replaced by type I and III collagens, which are unable to support normal hyaline cartilage structure."", ""reference"": ""PMID:7829510"", ""snippet"": ""Type I and III collagens were the major species found in cartilage tissue and synthesized by cultured chondrocytes along with cartilage type XI collagen"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that abnormal type II collagen processing and replacement by type I collagen is a consistent finding in lethal type II collagenopathies."", ""reference"": ""PMID:10745044"", ""snippet"": ""Overmodified type II collagen and the presence of type I collagen was found in the cartilage matrix of all seven cases"", ""supports"": ""SUPPORT""}], ""name"": ""Extracellular Matrix Deficiency""}"
105	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	2	Type 2 Collagenopathy Spectrum	"ACG2 represents the severe end of a phenotypic spectrum of COL2A1-related disorders. The degree of type I collagen replacement in cartilage matrix correlates with phenotypic severity, with ACG2 showing the highest levels.
"																																																								"{""description"": ""ACG2 represents the severe end of a phenotypic spectrum of COL2A1-related disorders. The degree of type I collagen replacement in cartilage matrix correlates with phenotypic severity, with ACG2 showing the highest levels.\n"", ""name"": ""Type 2 Collagenopathy Spectrum""}"	{}	"{""description"": ""ACG2 represents the severe end of a phenotypic spectrum of COL2A1-related disorders. The degree of type I collagen replacement in cartilage matrix correlates with phenotypic severity, with ACG2 showing the highest levels.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents the phenotypic continuum from ACG2 through hypochondrogenesis to lethal SEDC and establishes the correlation between type I collagen content and disease severity."", ""reference"": ""PMID:10745044"", ""snippet"": ""Study of the clinical, radiographic, and morphological features of the seven cases supports evidence for a phenotypic continuum between achondrogenesis II-hypochondrogenesis and lethal SEDC and suggests a relationship between the amount of type I collagen in the cartilage and the severity of the phenotype."", ""supports"": ""SUPPORT""}], ""name"": ""Type 2 Collagenopathy Spectrum""}"
117	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling	"The FGFR3 G380R mutation causes constitutive activation of the receptor, leading to enhanced downstream signaling through STAT1, MAPK, and other pathways. This results in premature cell cycle arrest of growth plate chondrocytes, reduced chondrocyte proliferation and hypertrophy, and impaired endochondral bone formation. The receptor normally serves as a negative regulator of bone growth; its overactivation leads to the shortened long bones characteristic of achondroplasia.
"																																																								"{""description"": ""The FGFR3 G380R mutation causes constitutive activation of the receptor, leading to enhanced downstream signaling through STAT1, MAPK, and other pathways. This results in premature cell cycle arrest of growth plate chondrocytes, reduced chondrocyte proliferation and hypertrophy, and impaired endochondral bone formation. The receptor normally serves as a negative regulator of bone growth; its overactivation leads to the shortened long bones characteristic of achondroplasia.\n"", ""name"": ""FGFR3 gain-of-function signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""FGFR signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}, {""preferred_term"": ""Endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}, {""preferred_term"": ""Chondrocyte differentiation"", ""term"": {""id"": ""GO:0002062"", ""label"": ""chondrocyte differentiation""}}], ""cell_types"": [{""preferred_term"": ""Growth plate chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}, {""preferred_term"": ""Hypertrophic chondrocyte"", ""term"": {""id"": ""CL:0000743"", ""label"": ""hypertrophic chondrocyte""}}], ""description"": ""The FGFR3 G380R mutation causes constitutive activation of the receptor, leading to enhanced downstream signaling through STAT1, MAPK, and other pathways. This results in premature cell cycle arrest of growth plate chondrocytes, reduced chondrocyte proliferation and hypertrophy, and impaired endochondral bone formation. The receptor normally serves as a negative regulator of bone growth; its overactivation leads to the shortened long bones characteristic of achondroplasia.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This landmark 1994 Cell paper by Shiang et al. identified FGFR3 mutations as the cause of achondroplasia, establishing the molecular basis of the disease."", ""reference"": ""PMID:7913883"", ""snippet"": ""DNA studies revealed point mutations in the FGFR3 gene in ACH heterozygotes and homozygotes. The mutation on 15 of the 16 ACH-affected chromosomes was the same, a G-->A transition, at nucleotide 1138 of the cDNA."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study of 154 unrelated achondroplasia patients confirmed the G380R mutation is essentially universal, with over 97% having the same recurrent mutation."", ""reference"": ""PMID:7847369"", ""snippet"": ""All but one, an atypical case, were found to have a glycine-to-arginine substitution at codon 380. Of these, 150 had a G-to-A transition at nt 1138, and 3 had a G-to-C transversion at this same position."", ""supports"": ""SUPPORT""}], ""gene"": {""description"": ""Fibroblast growth factor receptor 3, a transmembrane tyrosine kinase receptor that negatively regulates endochondral bone growth."", ""modifier"": ""INCREASED"", ""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}, ""name"": ""FGFR3 gain-of-function signaling""}"
118	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	1	Impaired growth plate cartilage development	"In the growth plate, FGFR3 overactivation disrupts the normal columnar organization of chondrocytes and reduces the height of the proliferative and hypertrophic zones. This results in shortened and disorganized growth plates with reduced longitudinal bone growth, particularly affecting the long bones of the limbs (rhizomelic pattern) and the skull base (leading to foramen magnum stenosis).
"																																																								"{""description"": ""In the growth plate, FGFR3 overactivation disrupts the normal columnar organization of chondrocytes and reduces the height of the proliferative and hypertrophic zones. This results in shortened and disorganized growth plates with reduced longitudinal bone growth, particularly affecting the long bones of the limbs (rhizomelic pattern) and the skull base (leading to foramen magnum stenosis).\n"", ""name"": ""Impaired growth plate cartilage development""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Growth plate chondrocyte differentiation"", ""term"": {""id"": ""GO:0003418"", ""label"": ""growth plate cartilage chondrocyte differentiation""}}, {""preferred_term"": ""Bone development"", ""term"": {""id"": ""GO:0060348"", ""label"": ""bone development""}}], ""cell_types"": [{""preferred_term"": ""Columnar chondrocyte"", ""term"": {""id"": ""CL:0000744"", ""label"": ""columnar chondrocyte""}}], ""description"": ""In the growth plate, FGFR3 overactivation disrupts the normal columnar organization of chondrocytes and reduces the height of the proliferative and hypertrophic zones. This results in shortened and disorganized growth plates with reduced longitudinal bone growth, particularly affecting the long bones of the limbs (rhizomelic pattern) and the skull base (leading to foramen magnum stenosis).\n"", ""name"": ""Impaired growth plate cartilage development""}"
139	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	0	Optic-Trigeminal Cross-Activation	Abrupt luminance changes activate visual pathways that cross-activate trigeminal and autonomic circuits, leading to nasal prickle and sneezing in susceptible individuals.																																																								"{""description"": ""Abrupt luminance changes activate visual pathways that cross-activate trigeminal and autonomic circuits, leading to nasal prickle and sneezing in susceptible individuals."", ""name"": ""Optic-Trigeminal Cross-Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Visual Perception"", ""term"": {""id"": ""GO:0007601"", ""label"": ""visual perception""}}, {""preferred_term"": ""Sensory Perception of Pain"", ""term"": {""id"": ""GO:0019233"", ""label"": ""sensory perception of pain""}}], ""cell_types"": [{""preferred_term"": ""Retinal Ganglion Cell"", ""term"": {""id"": ""CL:0000740"", ""label"": ""retinal ganglion cell""}}], ""description"": ""Abrupt luminance changes activate visual pathways that cross-activate trigeminal and autonomic circuits, leading to nasal prickle and sneezing in susceptible individuals."", ""evidence"": [{""explanation"": ""Cross-activation between visual and trigeminal pathways is a leading hypothesis."", ""reference"": ""PMID:31287245"", ""snippet"": ""The optictrigeminal summation hypothesis postulates that, during light stimulation, the activated optic nerve pathways crossactivate the trigeminal nerve pathways"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Visual Cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}, {""preferred_term"": ""Trigeminal Ganglion"", ""term"": {""id"": ""UBERON:0001675"", ""label"": ""trigeminal ganglion""}}, {""preferred_term"": ""Trigeminal Nerve"", ""term"": {""id"": ""UBERON:0001645"", ""label"": ""trigeminal nerve""}}, {""preferred_term"": ""Retina"", ""term"": {""id"": ""UBERON:0000966"", ""label"": ""retina""}}], ""name"": ""Optic-Trigeminal Cross-Activation""}"
140	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	1	Parasympathetic Generalization	Light-evoked activation in parasympathetic pathways spreads to nasal secretomotor pathways, causing nasal prickle preceding the sneeze.																																																								"{""description"": ""Light-evoked activation in parasympathetic pathways spreads to nasal secretomotor pathways, causing nasal prickle preceding the sneeze."", ""name"": ""Parasympathetic Generalization""}"	{}	"{""cell_types"": [{""preferred_term"": ""Autonomic Neuron"", ""term"": {""id"": ""CL:0000107"", ""label"": ""autonomic neuron""}}], ""description"": ""Light-evoked activation in parasympathetic pathways spreads to nasal secretomotor pathways, causing nasal prickle preceding the sneeze."", ""evidence"": [{""explanation"": ""Parasympathetic generalization is one of the proposed mechanisms."", ""reference"": ""PMID:31287245"", ""snippet"": ""According to the parasympathetic generalization hypothesis, when a light stimulus excites a specific branch of the parasympathetic nervous system, it activates other branches, resulting in nasal secretion and a tickling sensation in the nasal mucosa"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Nasal Cavity"", ""term"": {""id"": ""UBERON:0001707"", ""label"": ""nasal cavity""}}], ""name"": ""Parasympathetic Generalization""}"
141	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	2	Central Cortical Processing	Visual cortex excitability (particularly cuneus) and co-activation of somatosensory cortices (insula and secondary somatosensory cortex) during photic sneezing suggests a centrally mediated reflex.																																																								"{""description"": ""Visual cortex excitability (particularly cuneus) and co-activation of somatosensory cortices (insula and secondary somatosensory cortex) during photic sneezing suggests a centrally mediated reflex."", ""name"": ""Central Cortical Processing""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Sensory Processing"", ""term"": {""id"": ""GO:0050890"", ""label"": ""cognition""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Visual cortex excitability (particularly cuneus) and co-activation of somatosensory cortices (insula and secondary somatosensory cortex) during photic sneezing suggests a centrally mediated reflex."", ""evidence"": [{""explanation"": ""EEG study demonstrating enhanced visual cortex activation in photic sneezers."", ""reference"": ""PMID:20169159"", ""snippet"": ""we found a generally enhanced excitability of the visual cortex (mainly in the cuneus) to visual stimuli in 'photic sneezers' compared with control subjects"", ""supports"": ""SUPPORT""}, {""explanation"": ""Somatosensory cortex co-activation during nasal prickling sensation."", ""reference"": ""PMID:20169159"", ""snippet"": ""a stronger prickling sensation in the nose of photic sneezers was found to be associated with activation in the insula and stronger activation in the secondary somatosensory cortex"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Cerebral Cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}, {""preferred_term"": ""Insula"", ""term"": {""id"": ""UBERON:0002022"", ""label"": ""insula of Rolando""}}], ""name"": ""Central Cortical Processing""}"
142	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	3	Brainstem Sneeze Circuit	The sneeze reflex is mediated by neuromedin B (NMB) signaling from nasal sensory neurons to NMB receptor-expressing neurons in the sneeze-evoking region of the brainstem, which project to the caudal ventral respiratory group to execute the sneeze motor pattern.																																		While this pathway was characterized for chemically-induced sneezing, it likely represents the final common pathway for all sneeze reflexes including photic sneezing.																						"{""description"": ""The sneeze reflex is mediated by neuromedin B (NMB) signaling from nasal sensory neurons to NMB receptor-expressing neurons in the sneeze-evoking region of the brainstem, which project to the caudal ventral respiratory group to execute the sneeze motor pattern."", ""name"": ""Brainstem Sneeze Circuit"", ""notes"": ""While this pathway was characterized for chemically-induced sneezing, it likely represents the final common pathway for all sneeze reflexes including photic sneezing.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Respiratory Reflex"", ""term"": {""id"": ""GO:0002087"", ""label"": ""regulation of respiratory gaseous exchange by neurological system process""}}], ""cell_types"": [{""preferred_term"": ""Sensory Neuron"", ""term"": {""id"": ""CL:0000101"", ""label"": ""sensory neuron""}}], ""description"": ""The sneeze reflex is mediated by neuromedin B (NMB) signaling from nasal sensory neurons to NMB receptor-expressing neurons in the sneeze-evoking region of the brainstem, which project to the caudal ventral respiratory group to execute the sneeze motor pattern."", ""evidence"": [{""explanation"": ""NMB-NMBR signaling is the molecular pathway mediating sneeze signal transmission in the brainstem."", ""reference"": ""PMID:34133943"", ""snippet"": ""neuromedin B (NMB) peptide is essential for signaling sneezing. Ablation of NMB-sensitive postsynaptic neurons in the sneeze-evoking region or deficiency in NMB receptor abolished the sneezing reflex."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Medulla Oblongata"", ""term"": {""id"": ""UBERON:0001896"", ""label"": ""medulla oblongata""}}, {""preferred_term"": ""Trigeminal Nucleus"", ""term"": {""id"": ""UBERON:0002925"", ""label"": ""trigeminal nucleus""}}], ""name"": ""Brainstem Sneeze Circuit"", ""notes"": ""While this pathway was characterized for chemically-induced sneezing, it likely represents the final common pathway for all sneeze reflexes including photic sneezing.""}"
170	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	0	Follicular keratinization	"Dysregulated keratinocyte differentiation and desquamation within the follicular epithelium promotes retention hyperkeratosis.
"																																																								"{""description"": ""Dysregulated keratinocyte differentiation and desquamation within the follicular epithelium promotes retention hyperkeratosis.\n"", ""name"": ""Follicular keratinization""}"	{}	"{""cell_types"": [{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""description"": ""Dysregulated keratinocyte differentiation and desquamation within the follicular epithelium promotes retention hyperkeratosis.\n"", ""evidence"": [{""explanation"": ""This review explicitly identifies hyperkeratinization of the pilosebaceous follicles as a key factor in acne pathogenesis."", ""reference"": ""PMID:32748305"", ""snippet"": ""Acne pathogenesis is attributed to four key factors: excess sebum production, hyperproliferation of Cutibacterium acnes (C. acnes, formerly called Propionibacterium acnes) bacteria, hyperkeratinization of the pilosebaceous follicles, and inflammatory mechanisms"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""pilosebaceous unit"", ""term"": {""id"": ""UBERON:0011932"", ""label"": ""pilosebaceous unit""}}], ""name"": ""Follicular keratinization""}"
171	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	1	Microcomedone formation	"Follicular obstruction from retained keratin and sebum leads to early microcomedone development that seeds later visible comedones.
"																																																								"{""description"": ""Follicular obstruction from retained keratin and sebum leads to early microcomedone development that seeds later visible comedones.\n"", ""name"": ""Microcomedone formation""}"	{}	"{""cell_types"": [{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""description"": ""Follicular obstruction from retained keratin and sebum leads to early microcomedone development that seeds later visible comedones.\n"", ""evidence"": [{""explanation"": ""Follicular hyperkeratinization is the initiating event that drives microcomedone formation in acne."", ""reference"": ""PMID:32748305"", ""snippet"": ""Acne pathogenesis is attributed to four key factors: excess sebum production, hyperproliferation of Cutibacterium acnes (C. acnes, formerly called Propionibacterium acnes) bacteria, hyperkeratinization of the pilosebaceous follicles, and inflammatory mechanisms"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""pilosebaceous unit"", ""term"": {""id"": ""UBERON:0011932"", ""label"": ""pilosebaceous unit""}}], ""name"": ""Microcomedone formation""}"
172	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	2	Sebum overproduction	"Androgen and IGF-1 signaling increase sebocyte activity, elevating sebum output and creating a lipid-rich follicular environment.
"																																																								"{""description"": ""Androgen and IGF-1 signaling increase sebocyte activity, elevating sebum output and creating a lipid-rich follicular environment.\n"", ""name"": ""Sebum overproduction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""lipid metabolism"", ""term"": {""id"": ""GO:0006629"", ""label"": ""lipid metabolic process""}}], ""cell_types"": [{""preferred_term"": ""sebocyte"", ""term"": {""id"": ""CL:0000317"", ""label"": ""sebocyte""}}], ""description"": ""Androgen and IGF-1 signaling increase sebocyte activity, elevating sebum output and creating a lipid-rich follicular environment.\n"", ""evidence"": [{""explanation"": ""This review links sebaceous gland hyperproliferation and lipid synthesis to acne pathogenesis."", ""reference"": ""PMID:32748305"", ""snippet"": ""In acne, mTORC1 mediates sebaceous gland hyperproliferation, lipid synthesis, and hyperplasia of keratinocytes"", ""supports"": ""SUPPORT""}], ""name"": ""Sebum overproduction""}"
173	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	3	Sebum compositional change	"Altered fatty acid ratios and oxidation products within sebum contribute to comedogenesis and inflammatory signaling.
"																																																								"{""description"": ""Altered fatty acid ratios and oxidation products within sebum contribute to comedogenesis and inflammatory signaling.\n"", ""name"": ""Sebum compositional change""}"	{}	"{""biological_processes"": [{""preferred_term"": ""lipid metabolism"", ""term"": {""id"": ""GO:0006629"", ""label"": ""lipid metabolic process""}}], ""cell_types"": [{""preferred_term"": ""sebocyte"", ""term"": {""id"": ""CL:0000317"", ""label"": ""sebocyte""}}], ""description"": ""Altered fatty acid ratios and oxidation products within sebum contribute to comedogenesis and inflammatory signaling.\n"", ""evidence"": [{""explanation"": ""This review highlights altered sebum fatty acid composition as a pathophysiologic feature of acne."", ""reference"": ""PMID:20871834"", ""snippet"": ""Altered ratio between saturated and unsaturated fatty acids has been indicated as an important feature to be considered in addition to the altered amount of specific fatty acids such as linoleic acid"", ""supports"": ""SUPPORT""}], ""name"": ""Sebum compositional change""}"
174	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	4	C. acnes follicular colonization	"Cutibacterium acnes expands within occluded follicles and contributes to lesion progression from noninflammatory comedones to inflamed papules.
"																																																								"{""description"": ""Cutibacterium acnes expands within occluded follicles and contributes to lesion progression from noninflammatory comedones to inflamed papules.\n"", ""name"": ""C. acnes follicular colonization""}"	{}	"{""cell_types"": [{""preferred_term"": ""sebocyte"", ""term"": {""id"": ""CL:0000317"", ""label"": ""sebocyte""}}], ""description"": ""Cutibacterium acnes expands within occluded follicles and contributes to lesion progression from noninflammatory comedones to inflamed papules.\n"", ""evidence"": [{""explanation"": ""This review describes C. acnes colonization and its role in lesion progression."", ""reference"": ""PMID:24062871"", ""snippet"": ""Propionibacterium acnes colonizes the duct of the sebaceous follicle, causing an innate immune response and the progression from a so-called noninflammatory comedo to an inflammatory papule, pustule, or nodule."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""pilosebaceous unit"", ""term"": {""id"": ""UBERON:0011932"", ""label"": ""pilosebaceous unit""}}], ""name"": ""C. acnes follicular colonization""}"
175	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	5	Inflammasome activation	"Innate immune sensing activates inflammasome pathways that amplify inflammatory signaling in acne lesions.
"																																																								"{""description"": ""Innate immune sensing activates inflammasome pathways that amplify inflammatory signaling in acne lesions.\n"", ""name"": ""Inflammasome activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Innate immune sensing activates inflammasome pathways that amplify inflammatory signaling in acne lesions.\n"", ""evidence"": [{""explanation"": ""This review explains inflammasome activation, a key mechanism implicated in acne inflammation."", ""reference"": ""DOI:10.3389/fimmu.2023.1075834"", ""snippet"": ""The inflammasomes are intracellular multimeric protein complexes consisting of an innate immune sensor, the adapter protein ASC and the inflammatory caspases-1 and/or -11 and are important for the host defense against pathogens."", ""supports"": ""SUPPORT""}], ""name"": ""Inflammasome activation""}"
176	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	6	Cytokine-driven inflammation	"Inflammasome and innate immune activation drive cytokine release that recruits neutrophils and sustains inflammatory lesion formation.
"																																																								"{""description"": ""Inflammasome and innate immune activation drive cytokine release that recruits neutrophils and sustains inflammatory lesion formation.\n"", ""name"": ""Cytokine-driven inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Inflammasome and innate immune activation drive cytokine release that recruits neutrophils and sustains inflammatory lesion formation.\n"", ""evidence"": [{""explanation"": ""Inflammasome activation supports downstream cytokine-mediated inflammation in acne lesions."", ""reference"": ""DOI:10.3389/fimmu.2023.1075834"", ""snippet"": ""The inflammasomes are intracellular multimeric protein complexes consisting of an innate immune sensor, the adapter protein ASC and the inflammatory caspases-1 and/or -11 and are important for the host defense against pathogens."", ""supports"": ""SUPPORT""}], ""name"": ""Cytokine-driven inflammation""}"
218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	CD4 T-cell Depletion	HIV infects and destroys CD4 T-cells, critical for immune system function.																																																								"{""description"": ""HIV infects and destroys CD4 T-cells, critical for immune system function."", ""name"": ""CD4 T-cell Depletion""}"	{}	"{""biological_processes"": [{""preferred_term"": ""reverse transcription"", ""term"": {""id"": ""GO:0001171"", ""label"": ""reverse transcription""}}, {""preferred_term"": ""DNA integration"", ""term"": {""id"": ""GO:0015074"", ""label"": ""DNA integration""}}, {""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}], ""cell_types"": [{""preferred_term"": ""CD4 T-lymphocyte"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}], ""description"": ""HIV infects and destroys CD4 T-cells, critical for immune system function."", ""evidence"": [{""explanation"": ""The literature supports that the depletion of CD4 T-cells is a critical mechanism in the pathogenesis of AIDS."", ""reference"": ""PMID:23772614"", ""snippet"": ""The hallmark of acquired immunodeficiency syndrome (AIDS) pathogenesis is a progressive depletion of CD4(+) T-cell populations in close association with progressive impairment of cellular immunity and increasing susceptibility to opportunistic infections (OI)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature affirms that HIV infects and destroys CD4 T-cells, leading to immunodeficiency."", ""reference"": ""PMID:9730930"", ""snippet"": ""HIV-1 infects mononuclear cells using the CD4+ molecule... ongoing cellular destruction, leading to the characteristic immunodeficiency of AIDS and its opportunistic infections and neoplasms."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the assertion that HIV infects and leads to the destruction of CD4 T-cells, which are crucial for immune function."", ""reference"": ""PMID:9735117"", ""snippet"": ""The entry of one HIV virion into a human being has the potential to cause death by the inexorable replication of the virus within the principal T lymphocyte, the CD4+ T cell."", ""supports"": ""SUPPORT""}, {""explanation"": ""While it indicates additional mechanisms, this literature still supports the role of direct HIV-mediated killing of CD4 T-cells."", ""reference"": ""PMID:17691934"", ""snippet"": ""The role of the Human Immunodeficiency Virus (HIV) in the pathogenesis of the Acquired Immune-Deficiency Syndrome (AIDS) is changed. Direct HIV-mediated killing of CD4(+) T cells is not the only mechanism leading to lymphocyte depletion."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by noting the decline of CD4 T-cell counts due to HIV infection but adds information on glutathione's role in such processes."", ""reference"": ""PMID:38474196"", ""snippet"": ""HIV is a major cause of death worldwide... HIV-positive individuals also demonstrate diminished glutathione (GSH) levels which allows for increased viral replication and...slowed the decline of CD4+ T cell counts in HIV-positive individuals."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""CD4"", ""term"": {""id"": ""hgnc:1678"", ""label"": ""CD4""}}, {""preferred_term"": ""CCR5"", ""term"": {""id"": ""hgnc:1606"", ""label"": ""CCR5""}}, {""preferred_term"": ""CXCR4"", ""term"": {""id"": ""hgnc:2561"", ""label"": ""CXCR4""}}], ""locations"": [{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}, {""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""CD4 T-cell Depletion""}"
219	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	1	Immune System Collapse	Progressive loss of CD4 T-cells leads to severe immunodeficiency.																																																								"{""description"": ""Progressive loss of CD4 T-cells leads to severe immunodeficiency."", ""name"": ""Immune System Collapse""}"	{}	"{""cell_types"": [{""preferred_term"": ""CD4 T-lymphocyte"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}], ""description"": ""Progressive loss of CD4 T-cells leads to severe immunodeficiency."", ""evidence"": [{""explanation"": ""This reference directly supports the statement by highlighting the progressive loss of CD4 T-cells as a key mechanism leading to severe immunodeficiency in AIDS."", ""reference"": ""PMID:23772614"", ""snippet"": ""The hallmark of acquired immunodeficiency syndrome (AIDS) pathogenesis is a progressive depletion of CD4(+) T-cell populations in close association with progressive impairment of cellular immunity and increasing susceptibility to opportunistic infections (OI)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature confirms that AIDS is caused by HIV targeting CD4 T cells, leading to defective immune responses, which aligns with the statement."", ""reference"": ""PMID:34481993"", ""snippet"": ""The acquired immunodeficiency syndrome results from infections by the human immunodeficiency virus, which targets CD4 T cells leading to defective immune responses."", ""supports"": ""SUPPORT""}], ""name"": ""Immune System Collapse""}"
220	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	2	Opportunistic Infections	Impaired immunity allows opportunistic pathogens to cause infections.																																																								"{""description"": ""Impaired immunity allows opportunistic pathogens to cause infections."", ""name"": ""Opportunistic Infections""}"	{}	"{""biological_processes"": [{""preferred_term"": ""pyroptotic inflammatory response"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptotic inflammatory response""}}], ""description"": ""Impaired immunity allows opportunistic pathogens to cause infections."", ""evidence"": [{""explanation"": ""This references clearly indicates that the impaired immunity in Acquired Immunodeficiency Syndrome (AIDS) increases susceptibility to opportunistic infections, thus supporting the statement."", ""reference"": ""PMID:1981824"", ""snippet"": ""The inability of CD4+ T cells of HIV-1-infected patients to mount an effective immune response is widely believed to explain the increased susceptibility of these patients to opportunistic infections."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study underscores the impact of opportunistic infections due to impaired immunity in AIDS patients."", ""reference"": ""PMID:19584497"", ""snippet"": ""Opportunistic parasitic infection can cause severe morbidity and mortality. Because many of these infections are treatable, an early and accurate diagnosis is important."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference clearly states that impaired immunity from AIDS leads to various opportunistic infections."", ""reference"": ""PMID:11868686"", ""snippet"": ""The acquired immune deficiency syndrome (AIDS) is the result of a human immunodeficiency virus (HIV) infection damaging the cell-mediated immune system. ... A wide range of opportunistic infections (Ols) and tumours develop; additionally, HIV directly damages some organs."", ""supports"": ""SUPPORT""}, {""explanation"": ""Acknowledging the relationship between impaired immunity from HIV and opportunistic infections."", ""reference"": ""PMID:25093312"", ""snippet"": ""Incidence as well as morbidity and mortality of opportunistic infections (OI) have declined remarkably since the availability of antiretroviral treatment (ART)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Clearly states how HIV causes defective immune responses, resulting in opportunistic infections."", ""reference"": ""PMID:34481993"", ""snippet"": ""The acquired immunodeficiency syndrome results from infections by the human immunodeficiency virus, which targets CD4 T cells leading to defective immune responses."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference confirms the link between AIDS-related immunosuppression and increased severity of opportunistic infections."", ""reference"": ""PMID:2680057"", ""snippet"": ""The number and severity of such infections have increased markedly with the emergence of the acquired immunodeficiency syndrome (AIDS) epidemic."", ""supports"": ""SUPPORT""}], ""name"": ""Opportunistic Infections""}"
221	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	3	CNS Reservoir and Neuroinflammation	HIV invades the CNS early, establishing persistent reservoirs in microglia and macrophages that contribute to neuroinflammation and neurocognitive impairment.																																																								"{""description"": ""HIV invades the CNS early, establishing persistent reservoirs in microglia and macrophages that contribute to neuroinflammation and neurocognitive impairment."", ""name"": ""CNS Reservoir and Neuroinflammation""}"	{}	"{""cell_types"": [{""preferred_term"": ""microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""HIV invades the CNS early, establishing persistent reservoirs in microglia and macrophages that contribute to neuroinflammation and neurocognitive impairment."", ""evidence"": [{""explanation"": ""This study directly demonstrates that brain microglia harbor replication-competent HIV and serve as a persistent CNS reservoir."", ""reference"": ""PMID:37317962"", ""snippet"": ""These data demonstrate that MG harbor replication-competent HIV and serve as a persistent reservoir in the brain."", ""supports"": ""SUPPORT""}, {""explanation"": ""This review describes early CNS invasion by HIV and the establishment of compartmentalized CNS reservoirs with associated neuroinflammation."", ""reference"": ""PMID:25604237"", ""snippet"": ""Recent work suggests that the stage for HIV neuropathogenesis may be set with initial viral entry into the CNS, followed by initiation of pathogenetic processes including neuroinflammation and neurotoxicity, and establishment of local, compartmentalized HIV replication that may reflect a tissue reservoir for HIV."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""SAMHD1"", ""term"": {""id"": ""hgnc:15925"", ""label"": ""SAMHD1""}}], ""locations"": [{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}], ""name"": ""CNS Reservoir and Neuroinflammation""}"
222	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	4	Host Restriction Factor Defense	Multiple host restriction factors inhibit HIV replication through distinct molecular mechanisms, but are counteracted by viral accessory proteins (Vif, Vpu, Nef).																																																								"{""description"": ""Multiple host restriction factors inhibit HIV replication through distinct molecular mechanisms, but are counteracted by viral accessory proteins (Vif, Vpu, Nef)."", ""name"": ""Host Restriction Factor Defense""}"	{}	"{""biological_processes"": [{""preferred_term"": ""defense response to virus"", ""term"": {""id"": ""GO:0051607"", ""label"": ""defense response to virus""}}], ""description"": ""Multiple host restriction factors inhibit HIV replication through distinct molecular mechanisms, but are counteracted by viral accessory proteins (Vif, Vpu, Nef)."", ""genes"": [{""preferred_term"": ""APOBEC3G"", ""term"": {""id"": ""hgnc:17357"", ""label"": ""APOBEC3G""}}, {""preferred_term"": ""TRIM5"", ""term"": {""id"": ""hgnc:16276"", ""label"": ""TRIM5""}}, {""preferred_term"": ""BST2"", ""term"": {""id"": ""hgnc:1119"", ""label"": ""BST2""}}, {""preferred_term"": ""SERINC5"", ""term"": {""id"": ""hgnc:18825"", ""label"": ""SERINC5""}}], ""name"": ""Host Restriction Factor Defense""}"
223	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	5	AIDS-related Cancers	Weakened immune surveillance increases risk of certain cancers.																																																								"{""description"": ""Weakened immune surveillance increases risk of certain cancers."", ""name"": ""AIDS-related Cancers""}"	"{""examples"": [""Kaposi Sarcoma""]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""immune response to tumor cell"", ""term"": {""id"": ""GO:0002418"", ""label"": ""immune response to tumor cell""}}], ""description"": ""Weakened immune surveillance increases risk of certain cancers."", ""evidence"": [{""explanation"": ""The statement is supported by the literature indicating that weakened immune surveillance in the context of HIV infection increases the risk of certain cancers, such as Kaposi's sarcoma and non-Hodgkin's lymphoma."", ""reference"": ""PMID:12525676"", ""snippet"": ""In acquired immunodeficiency due to the human immunodeficiency virus (HIV), HIV itself rarely directly causes cancer; rather, it provides the immunologic background against which other viruses can escape immune control and induce tumors."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports the notion that weakened immune surveillance due to HIV infection increases the risk of Kaposi Sarcoma, an AIDS-related cancer."", ""reference"": ""PMID:33843468"", ""snippet"": ""Kaposi Sarcoma (KS) is the most common AIDS-defining cancer, even as HIV-positive people live longer. Like other herpesviruses, human herpesvirus-8 (HHV-8) establishes a lifelong infection of the host that in association with HIV infection may develop at any time during the illness."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature indicates that immunosuppression due to AIDS increases the risk of cervical cancer, thus supporting the statement."", ""reference"": ""PMID:23259425"", ""snippet"": ""A markedly increased risk of cervical cancer is known in women immunosuppressed due to AIDS or therapy following organ transplantation."", ""supports"": ""SUPPORT""}], ""examples"": [""Kaposi Sarcoma""], ""name"": ""AIDS-related Cancers""}"
254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	Autoimmune Adrenalitis	The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells.																																																								"{""description"": ""The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells."", ""name"": ""Autoimmune Adrenalitis""}"	"{""downstream"": [{""target"": ""Reduced Cortisol Production""}, {""target"": ""Reduced Aldosterone Production""}]}"	"{""biological_processes"": [{""preferred_term"": ""adaptive immune response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}, {""preferred_term"": ""T cell mediated cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}, {""preferred_term"": ""type 1 immune response"", ""term"": {""id"": ""GO:0042093"", ""label"": ""type 1 immune response""}}, {""preferred_term"": ""antigen processing and presentation of peptide antigen via MHC class II"", ""term"": {""id"": ""GO:0002495"", ""label"": ""antigen processing and presentation of peptide antigen via MHC class II""}}], ""cell_types"": [{""preferred_term"": ""CD8-positive, alpha-beta cytotoxic T cell"", ""term"": {""id"": ""CL:0000794"", ""label"": ""CD8-positive, alpha-beta cytotoxic T cell""}}, {""preferred_term"": ""T-helper 1 cell"", ""term"": {""id"": ""CL:0000545"", ""label"": ""T-helper 1 cell""}}, {""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""The immune system mistakenly attacks the adrenal cortex, leading to destruction of adrenal tissue and decreased hormone production. Lymphocytic infiltration of zona glomerulosa and zona fasciculata causes progressive loss of steroidogenic cells."", ""downstream"": [{""target"": ""Reduced Cortisol Production""}, {""target"": ""Reduced Aldosterone Production""}], ""evidence"": [{""explanation"": ""The provided literature supports that the immune system mistakenly attacks the adrenal cortex, leading to reduced hormone production."", ""reference"": ""PMID:29631795"", ""snippet"": ""Autoimmunity against the adrenal cortex is the leading cause of Addison's disease in industrialized countries... The immune-mediated attack on adrenocortical cells cripples their ability to synthesize vital steroid hormones."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference confirms that autoimmune destruction of the adrenal cortex leads to Addison's disease."", ""reference"": ""PMID:1946105"", ""snippet"": ""In most cases, autoimmune destruction of the adrenal cortex is the cause of Addison's disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports the statement that the immune system attacks the adrenal cortex, leading to reduced cortisol and aldosterone production."", ""reference"": ""PMID:20357943"", ""snippet"": ""Hypoadrenocorticism typically results from immune-mediated destruction of all adrenocortical layers, resulting in deficiencies of min-eralocorticoids (aldosterone) and glucocorticoids (cortisol)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the idea that autoimmune processes lead to endocrine gland hypofunction, including Addison's disease."", ""reference"": ""PMID:34996091"", ""snippet"": ""The immune system mistakenly attacks one's own cells, as if they were foreign, which typically results in endocrine gland hypofunction and inadequate hormone production... conditions such as Addison disease are encountered less frequently."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""adrenal cortex"", ""term"": {""id"": ""UBERON:0001235"", ""label"": ""adrenal cortex""}}, {""preferred_term"": ""zona glomerulosa of adrenal gland"", ""term"": {""id"": ""UBERON:0002104"", ""label"": ""zona glomerulosa of adrenal gland""}}, {""preferred_term"": ""zona fasciculata of adrenal gland"", ""term"": {""id"": ""UBERON:0002105"", ""label"": ""zona fasciculata of adrenal gland""}}], ""name"": ""Autoimmune Adrenalitis""}"
255	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	1	Reduced Cortisol Production	Lack of cortisol impacts the body's ability to respond to stress and maintain various metabolic functions. Impaired gluconeogenesis, decreased vascular tone, and altered immune responses result from cortisol deficiency.																																																								"{""description"": ""Lack of cortisol impacts the body's ability to respond to stress and maintain various metabolic functions. Impaired gluconeogenesis, decreased vascular tone, and altered immune responses result from cortisol deficiency."", ""name"": ""Reduced Cortisol Production""}"	"{""downstream"": [{""target"": ""Hypoglycemia""}, {""target"": ""Weight Loss""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""glucocorticoid biosynthetic process"", ""term"": {""id"": ""GO:0006704"", ""label"": ""glucocorticoid biosynthetic process""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""gluconeogenesis"", ""term"": {""id"": ""GO:0006094"", ""label"": ""gluconeogenesis""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to stress"", ""term"": {""id"": ""GO:0006950"", ""label"": ""response to stress""}}], ""description"": ""Lack of cortisol impacts the body's ability to respond to stress and maintain various metabolic functions. Impaired gluconeogenesis, decreased vascular tone, and altered immune responses result from cortisol deficiency."", ""downstream"": [{""target"": ""Hypoglycemia""}, {""target"": ""Weight Loss""}], ""evidence"": [{""explanation"": ""The literature describes Addison's disease as resulting in glucocorticoid (cortisol) deficiency, which leads to symptoms such as hypoglycemia and weight loss."", ""reference"": ""PMID:16828409"", ""snippet"": ""Addison's disease, or primary adrenal insufficiency, results in glucocorticoid and mineralocorticoid deficiency... chronic primary adrenal insufficiency presents with a more insidious history of malaise, anorexia, diarrhea, weight loss... hypoglycemia characterize acute adrenal crisis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature confirms that adrenal insufficiency, which includes Addison's disease, is characterized by insufficient cortisol production and requires glucocorticoid replacement therapy."", ""reference"": ""PMID:30120786"", ""snippet"": ""Adrenal insufficiency (AI) is a rare, life-threatening disorder characterized by insufficient production of corticosteroid hormones... Conventional treatment of both primary and secondary adrenal insufficiencies involves lifelong glucocorticoid replacement therapy."", ""supports"": ""SUPPORT""}], ""name"": ""Reduced Cortisol Production""}"
256	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	2	Reduced Aldosterone Production	Insufficient aldosterone affects the balance of sodium and potassium in the body, leading to dehydration and low blood pressure. Impaired sodium retention and potassium excretion in renal tubules cause electrolyte disturbances.																																																								"{""description"": ""Insufficient aldosterone affects the balance of sodium and potassium in the body, leading to dehydration and low blood pressure. Impaired sodium retention and potassium excretion in renal tubules cause electrolyte disturbances."", ""name"": ""Reduced Aldosterone Production""}"	"{""downstream"": [{""target"": ""Hyponatremia""}, {""target"": ""Hyperkalemia""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""mineralocorticoid biosynthetic process"", ""term"": {""id"": ""GO:0006705"", ""label"": ""mineralocorticoid biosynthetic process""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""sodium ion transport"", ""term"": {""id"": ""GO:0006814"", ""label"": ""sodium ion transport""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""potassium ion transport"", ""term"": {""id"": ""GO:0006813"", ""label"": ""potassium ion transport""}}], ""description"": ""Insufficient aldosterone affects the balance of sodium and potassium in the body, leading to dehydration and low blood pressure. Impaired sodium retention and potassium excretion in renal tubules cause electrolyte disturbances."", ""downstream"": [{""target"": ""Hyponatremia""}, {""target"": ""Hyperkalemia""}], ""evidence"": [{""explanation"": ""The excerpt clearly supports the statement by mentioning the effects of impaired aldosterone secretion in Addison's disease, which includes sodium loss (hyponatremia), hypovolemia (dehydration), and hyperkalemia."", ""reference"": ""PMID:6091953"", ""snippet"": ""On the other hand, impaired secretion, as in Addison's disease or in congenital deficiencies of other steroid-synthesizing enzymes, leads to hypotension, sodium loss with hypovolaemia, and hyperkalaemia."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature states that Addison's disease involves the destruction of the adrenal cortex, leading to issues with sodium concentration, supporting the statement about insufficient aldosterone affecting sodium and potassium balance."", ""reference"": ""PMID:28132947"", ""snippet"": ""Addison's disease is characterized by the destruction of the adrenal cortex. Autoimmune adrenalitis is the main cause of adrenal insufficiency. Treatment involves normalisation of sodium concentration and corticosteroids replacement."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference title directly mentions Addison's disease, supporting the context of the statement."", ""reference"": ""PMID:13851580"", ""snippet"": ""Addison's disease."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""zona glomerulosa of adrenal gland"", ""term"": {""id"": ""UBERON:0002104"", ""label"": ""zona glomerulosa of adrenal gland""}}], ""name"": ""Reduced Aldosterone Production""}"
257	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	3	Polygenic Susceptibility	Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses.																																		GWAS identified HLA and non-HLA loci explaining approximately 35-41% of heritability																						"{""description"": ""Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses."", ""name"": ""Polygenic Susceptibility"", ""notes"": ""GWAS identified HLA and non-HLA loci explaining approximately 35-41% of heritability""}"	"{""downstream"": [{""target"": ""Autoimmune Adrenalitis""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""negative regulation of T cell receptor signaling pathway"", ""term"": {""id"": ""GO:0050860"", ""label"": ""negative regulation of T cell receptor signaling pathway""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""antigen processing and presentation"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Multiple genetic risk loci contribute to autoimmune Addison's disease susceptibility, including HLA class II haplotypes and immune regulatory genes. HLA-DR3-DQ2 and HLA-DR4-DQ8 alter antigen presentation, while non-HLA genes affect T-cell regulation, checkpoint signaling, and inflammatory responses."", ""downstream"": [{""target"": ""Autoimmune Adrenalitis""}], ""genes"": [{""preferred_term"": ""HLA-DRB1""}, {""preferred_term"": ""HLA-DQA1""}, {""preferred_term"": ""HLA-DQB1""}, {""preferred_term"": ""CTLA4"", ""term"": {""id"": ""hgnc:2505"", ""label"": ""CTLA4""}}, {""preferred_term"": ""PTPN22"", ""term"": {""id"": ""hgnc:9652"", ""label"": ""PTPN22""}}, {""preferred_term"": ""BACH2"", ""term"": {""id"": ""hgnc:936"", ""label"": ""BACH2""}}, {""preferred_term"": ""CLEC16A"", ""term"": {""id"": ""hgnc:26922"", ""label"": ""CLEC16A""}}, {""preferred_term"": ""NLRP1"", ""term"": {""id"": ""hgnc:22861"", ""label"": ""NLRP1""}}, {""preferred_term"": ""CIITA"", ""term"": {""id"": ""hgnc:1752"", ""label"": ""CIITA""}}, {""preferred_term"": ""STAT4"", ""term"": {""id"": ""hgnc:11365"", ""label"": ""STAT4""}}], ""name"": ""Polygenic Susceptibility"", ""notes"": ""GWAS identified HLA and non-HLA loci explaining approximately 35-41% of heritability""}"
290	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	0	HTLV-1 Infection and Tax Oncoprotein Expression	HTLV-1 preferentially infects CD4+ T cells and integrates into the host genome. The viral Tax protein is the primary driver of transformation, functioning as a transcriptional activator that hijacks multiple cellular pathways. Tax activates NF-kappaB, CREB/ATF, and AP-1 transcription factors, driving T-cell proliferation and survival.																																																								"{""description"": ""HTLV-1 preferentially infects CD4+ T cells and integrates into the host genome. The viral Tax protein is the primary driver of transformation, functioning as a transcriptional activator that hijacks multiple cellular pathways. Tax activates NF-kappaB, CREB/ATF, and AP-1 transcription factors, driving T-cell proliferation and survival."", ""name"": ""HTLV-1 Infection and Tax Oncoprotein Expression""}"	"{""downstream"": [{""description"": ""Tax constitutively activates NF-kappaB signaling"", ""target"": ""Tax-Mediated NF-kappaB Activation""}, {""description"": ""Tax impairs DNA repair and induces genomic instability"", ""target"": ""Genomic Instability and Accumulation of Mutations""}]}"	"{""biological_processes"": [{""preferred_term"": ""viral transcription"", ""term"": {""id"": ""GO:0019083"", ""label"": ""viral transcription""}}], ""cell_types"": [{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""HTLV-1 preferentially infects CD4+ T cells and integrates into the host genome. The viral Tax protein is the primary driver of transformation, functioning as a transcriptional activator that hijacks multiple cellular pathways. Tax activates NF-kappaB, CREB/ATF, and AP-1 transcription factors, driving T-cell proliferation and survival."", ""downstream"": [{""description"": ""Tax constitutively activates NF-kappaB signaling"", ""target"": ""Tax-Mediated NF-kappaB Activation""}, {""description"": ""Tax impairs DNA repair and induces genomic instability"", ""target"": ""Genomic Instability and Accumulation of Mutations""}], ""evidence"": [{""explanation"": ""Abstract states HTLV-1 causes ATLL, supporting the infectious etiology."", ""reference"": ""PMID:15129647"", ""snippet"": ""HTLV-1 causes 2 major diseases: adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-1-associated myelopathy."", ""supports"": ""SUPPORT""}, {""explanation"": ""Abstract identifies Tax as a viral protein, supporting Tax oncoprotein expression."", ""reference"": ""PMID:15129647"", ""snippet"": ""Tax is a 40-kDa phosphoprotein that is encoded by the pX region of the virus."", ""supports"": ""SUPPORT""}], ""name"": ""HTLV-1 Infection and Tax Oncoprotein Expression""}"
291	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	1	Tax-Mediated NF-kappaB Activation	Tax activates both canonical and non-canonical NF-kappaB pathways through direct interaction with IKK complex and NIK. Constitutive NF-kappaB activation drives expression of anti-apoptotic genes (BCL-XL, cIAP, survivin), cytokines (IL-2, IL-15), and cell cycle regulators, promoting T-cell survival and proliferation.																																																								"{""description"": ""Tax activates both canonical and non-canonical NF-kappaB pathways through direct interaction with IKK complex and NIK. Constitutive NF-kappaB activation drives expression of anti-apoptotic genes (BCL-XL, cIAP, survivin), cytokines (IL-2, IL-15), and cell cycle regulators, promoting T-cell survival and proliferation."", ""name"": ""Tax-Mediated NF-kappaB Activation""}"	"{""downstream"": [{""description"": ""NF-kappaB activates anti-apoptotic gene expression"", ""target"": ""Apoptosis Resistance""}, {""description"": ""NF-kappaB and cytokine signaling drive proliferation"", ""target"": ""Uncontrolled T-Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of NF-kappaB transcription factor activity"", ""term"": {""id"": ""GO:0051092"", ""label"": ""positive regulation of NF-kappaB transcription factor activity""}}], ""description"": ""Tax activates both canonical and non-canonical NF-kappaB pathways through direct interaction with IKK complex and NIK. Constitutive NF-kappaB activation drives expression of anti-apoptotic genes (BCL-XL, cIAP, survivin), cytokines (IL-2, IL-15), and cell cycle regulators, promoting T-cell survival and proliferation."", ""downstream"": [{""description"": ""NF-kappaB activates anti-apoptotic gene expression"", ""target"": ""Apoptosis Resistance""}, {""description"": ""NF-kappaB and cytokine signaling drive proliferation"", ""target"": ""Uncontrolled T-Cell Proliferation""}], ""name"": ""Tax-Mediated NF-kappaB Activation""}"
292	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	2	Genomic Instability and Accumulation of Mutations	Tax impairs multiple DNA repair pathways including nucleotide excision repair, base excision repair, and double-strand break repair. This leads to accumulation of somatic mutations over the decades-long latency period. Tax also causes aneuploidy through centrosome amplification and mitotic checkpoint dysfunction.																																																								"{""description"": ""Tax impairs multiple DNA repair pathways including nucleotide excision repair, base excision repair, and double-strand break repair. This leads to accumulation of somatic mutations over the decades-long latency period. Tax also causes aneuploidy through centrosome amplification and mitotic checkpoint dysfunction."", ""name"": ""Genomic Instability and Accumulation of Mutations""}"	"{""downstream"": [{""description"": ""Accumulated mutations in growth regulatory genes promote transformation"", ""target"": ""Uncontrolled T-Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""DNA damage response""}}], ""description"": ""Tax impairs multiple DNA repair pathways including nucleotide excision repair, base excision repair, and double-strand break repair. This leads to accumulation of somatic mutations over the decades-long latency period. Tax also causes aneuploidy through centrosome amplification and mitotic checkpoint dysfunction."", ""downstream"": [{""description"": ""Accumulated mutations in growth regulatory genes promote transformation"", ""target"": ""Uncontrolled T-Cell Proliferation""}], ""name"": ""Genomic Instability and Accumulation of Mutations""}"
293	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	3	Apoptosis Resistance	Multiple mechanisms contribute to apoptosis resistance: NF-kappaB-mediated upregulation of BCL-XL and cIAP, Tax-mediated p53 inhibition, and HBZ-mediated enhancement of regulatory T-cell survival. This allows accumulation of cells with genomic abnormalities.																																																								"{""description"": ""Multiple mechanisms contribute to apoptosis resistance: NF-kappaB-mediated upregulation of BCL-XL and cIAP, Tax-mediated p53 inhibition, and HBZ-mediated enhancement of regulatory T-cell survival. This allows accumulation of cells with genomic abnormalities."", ""name"": ""Apoptosis Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""Multiple mechanisms contribute to apoptosis resistance: NF-kappaB-mediated upregulation of BCL-XL and cIAP, Tax-mediated p53 inhibition, and HBZ-mediated enhancement of regulatory T-cell survival. This allows accumulation of cells with genomic abnormalities."", ""name"": ""Apoptosis Resistance""}"
294	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	4	Uncontrolled T-Cell Proliferation	Combined effects of constitutive NF-kappaB activation, accumulated mutations, and apoptosis resistance result in clonal expansion of HTLV-1-infected T cells. ATLL cells acquire a CD4+CD25+FOXP3+ regulatory T-cell phenotype with immunosuppressive properties.																																																								"{""description"": ""Combined effects of constitutive NF-kappaB activation, accumulated mutations, and apoptosis resistance result in clonal expansion of HTLV-1-infected T cells. ATLL cells acquire a CD4+CD25+FOXP3+ regulatory T-cell phenotype with immunosuppressive properties."", ""name"": ""Uncontrolled T-Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Combined effects of constitutive NF-kappaB activation, accumulated mutations, and apoptosis resistance result in clonal expansion of HTLV-1-infected T cells. ATLL cells acquire a CD4+CD25+FOXP3+ regulatory T-cell phenotype with immunosuppressive properties."", ""name"": ""Uncontrolled T-Cell Proliferation""}"
315	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	0	Aflatoxin B1 Metabolic Activation	AFB1 is absorbed from the gut and transported to the liver where it undergoes cytochrome P450-mediated oxidation (primarily CYP3A4 and CYP1A2) to form AFB1-8,9-epoxide, a highly reactive electrophile. This epoxide binds covalently to DNA, forming pro-mutagenic adducts primarily at guanine residues.																																																								"{""description"": ""AFB1 is absorbed from the gut and transported to the liver where it undergoes cytochrome P450-mediated oxidation (primarily CYP3A4 and CYP1A2) to form AFB1-8,9-epoxide, a highly reactive electrophile. This epoxide binds covalently to DNA, forming pro-mutagenic adducts primarily at guanine residues."", ""name"": ""Aflatoxin B1 Metabolic Activation""}"	"{""downstream"": [{""description"": ""DNA adducts at codon 249 cause characteristic G>T transversion"", ""target"": ""TP53 R249S Hotspot Mutation""}]}"	"{""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""AFB1 is absorbed from the gut and transported to the liver where it undergoes cytochrome P450-mediated oxidation (primarily CYP3A4 and CYP1A2) to form AFB1-8,9-epoxide, a highly reactive electrophile. This epoxide binds covalently to DNA, forming pro-mutagenic adducts primarily at guanine residues."", ""downstream"": [{""description"": ""DNA adducts at codon 249 cause characteristic G>T transversion"", ""target"": ""TP53 R249S Hotspot Mutation""}], ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Aflatoxin B1 Metabolic Activation""}"
316	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	1	TP53 R249S Hotspot Mutation	The aflatoxin-DNA adduct forms preferentially at the third position of codon 249 in TP53, causing a G>T transversion that results in arginine-to-serine substitution (R249S). This mutation is found in approximately 50% of HCCs in high-aflatoxin regions but is rare in low-exposure areas. The R249S mutation impairs p53 DNA binding and transcriptional activity, eliminating its tumor suppressor function.																																																								"{""description"": ""The aflatoxin-DNA adduct forms preferentially at the third position of codon 249 in TP53, causing a G>T transversion that results in arginine-to-serine substitution (R249S). This mutation is found in approximately 50% of HCCs in high-aflatoxin regions but is rare in low-exposure areas. The R249S mutation impairs p53 DNA binding and transcriptional activity, eliminating its tumor suppressor function."", ""name"": ""TP53 R249S Hotspot Mutation""}"	"{""downstream"": [{""description"": ""p53 inactivation removes G1/S and G2/M checkpoint enforcement"", ""target"": ""Loss of Cell Cycle Checkpoint Control""}, {""description"": ""p53 loss impairs DNA damage-induced apoptosis"", ""target"": ""Apoptosis Resistance""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""DNA damage response""}}], ""description"": ""The aflatoxin-DNA adduct forms preferentially at the third position of codon 249 in TP53, causing a G>T transversion that results in arginine-to-serine substitution (R249S). This mutation is found in approximately 50% of HCCs in high-aflatoxin regions but is rare in low-exposure areas. The R249S mutation impairs p53 DNA binding and transcriptional activity, eliminating its tumor suppressor function."", ""downstream"": [{""description"": ""p53 inactivation removes G1/S and G2/M checkpoint enforcement"", ""target"": ""Loss of Cell Cycle Checkpoint Control""}, {""description"": ""p53 loss impairs DNA damage-induced apoptosis"", ""target"": ""Apoptosis Resistance""}], ""name"": ""TP53 R249S Hotspot Mutation""}"
317	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	2	HBV-Aflatoxin Synergistic Interaction	HBV and aflatoxin interact synergistically through multiple mechanisms: HBV-induced chronic inflammation increases hepatocyte proliferation, allowing fixation of aflatoxin-induced mutations; HBx protein inhibits DNA repair; and viral integration may disrupt tumor suppressor genes. The multiplicative interaction results in approximately 60-fold increased HCC risk compared to unexposed individuals.																																																								"{""description"": ""HBV and aflatoxin interact synergistically through multiple mechanisms: HBV-induced chronic inflammation increases hepatocyte proliferation, allowing fixation of aflatoxin-induced mutations; HBx protein inhibits DNA repair; and viral integration may disrupt tumor suppressor genes. The multiplicative interaction results in approximately 60-fold increased HCC risk compared to unexposed individuals."", ""name"": ""HBV-Aflatoxin Synergistic Interaction""}"	"{""downstream"": [{""description"": ""Combined p53 mutation and HBx effects disable checkpoints"", ""target"": ""Loss of Cell Cycle Checkpoint Control""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""HBV and aflatoxin interact synergistically through multiple mechanisms: HBV-induced chronic inflammation increases hepatocyte proliferation, allowing fixation of aflatoxin-induced mutations; HBx protein inhibits DNA repair; and viral integration may disrupt tumor suppressor genes. The multiplicative interaction results in approximately 60-fold increased HCC risk compared to unexposed individuals."", ""downstream"": [{""description"": ""Combined p53 mutation and HBx effects disable checkpoints"", ""target"": ""Loss of Cell Cycle Checkpoint Control""}], ""name"": ""HBV-Aflatoxin Synergistic Interaction""}"
318	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	3	Loss of Cell Cycle Checkpoint Control	TP53 R249S mutation combined with HBx-mediated p53 inhibition and Rb pathway inactivation results in loss of cell cycle checkpoint control. Cells with DNA damage continue to proliferate, accumulating additional mutations.																																																								"{""description"": ""TP53 R249S mutation combined with HBx-mediated p53 inhibition and Rb pathway inactivation results in loss of cell cycle checkpoint control. Cells with DNA damage continue to proliferate, accumulating additional mutations."", ""name"": ""Loss of Cell Cycle Checkpoint Control""}"	"{""downstream"": [{""description"": ""Checkpoint loss enables proliferation despite DNA damage"", ""target"": ""Uncontrolled Hepatocyte Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}], ""description"": ""TP53 R249S mutation combined with HBx-mediated p53 inhibition and Rb pathway inactivation results in loss of cell cycle checkpoint control. Cells with DNA damage continue to proliferate, accumulating additional mutations."", ""downstream"": [{""description"": ""Checkpoint loss enables proliferation despite DNA damage"", ""target"": ""Uncontrolled Hepatocyte Proliferation""}], ""name"": ""Loss of Cell Cycle Checkpoint Control""}"
319	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	4	Apoptosis Resistance	Loss of functional p53 impairs the intrinsic apoptotic pathway in response to DNA damage. Combined with HBV-associated survival signals, this allows accumulation of cells with oncogenic mutations.																																																								"{""description"": ""Loss of functional p53 impairs the intrinsic apoptotic pathway in response to DNA damage. Combined with HBV-associated survival signals, this allows accumulation of cells with oncogenic mutations."", ""name"": ""Apoptosis Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""Loss of functional p53 impairs the intrinsic apoptotic pathway in response to DNA damage. Combined with HBV-associated survival signals, this allows accumulation of cells with oncogenic mutations."", ""name"": ""Apoptosis Resistance""}"
320	12	Aflatoxin-Related Hepatocellular Carcinoma	Aflatoxin_Related_HCC.yaml	pathophysiology	5	Uncontrolled Hepatocyte Proliferation	The combination of impaired checkpoints, apoptosis resistance, chronic inflammation, and hepatocyte regeneration drives clonal expansion of transformed cells, eventually leading to HCC development.																																																								"{""description"": ""The combination of impaired checkpoints, apoptosis resistance, chronic inflammation, and hepatocyte regeneration drives clonal expansion of transformed cells, eventually leading to HCC development."", ""name"": ""Uncontrolled Hepatocyte Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""The combination of impaired checkpoints, apoptosis resistance, chronic inflammation, and hepatocyte regeneration drives clonal expansion of transformed cells, eventually leading to HCC development."", ""name"": ""Uncontrolled Hepatocyte Proliferation""}"
346	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	0	Drusen Accumulation	"Lipid and protein deposits accumulate between retinal pigment epithelium and Bruch's membrane. Drusen indicate RPE dysfunction and are early hallmark of AMD.
"																																																								"{""description"": ""Lipid and protein deposits accumulate between retinal pigment epithelium and Bruch's membrane. Drusen indicate RPE dysfunction and are early hallmark of AMD.\n"", ""name"": ""Drusen Accumulation""}"	{}	"{""cell_types"": [{""preferred_term"": ""Retinal Pigment Epithelial Cell"", ""term"": {""id"": ""CL:0002586"", ""label"": ""retinal pigment epithelial cell""}}], ""description"": ""Lipid and protein deposits accumulate between retinal pigment epithelium and Bruch's membrane. Drusen indicate RPE dysfunction and are early hallmark of AMD.\n"", ""evidence"": [{""explanation"": ""This confirms that drusen are lipid and protein deposits under the RPE with characteristic composition including lipids, complement proteins, and other components."", ""reference"": ""PMID:38731137"", ""snippet"": ""Drusen comprise a yellowish white substance that accumulates typically under the retinal pigment epithelium (RPE), and their constituents are lipids, complement, amyloid, crystallin, and others."", ""supports"": ""SUPPORT""}], ""name"": ""Drusen Accumulation""}"
347	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	1	RPE Dysfunction and Loss	"Oxidative stress, lipofuscin accumulation, and inflammation damage RPE cells. RPE loss leads to photoreceptor death and geographic atrophy in dry AMD.
"																																																								"{""description"": ""Oxidative stress, lipofuscin accumulation, and inflammation damage RPE cells. RPE loss leads to photoreceptor death and geographic atrophy in dry AMD.\n"", ""name"": ""RPE Dysfunction and Loss""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Oxidative Stress Response"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""description"": ""Oxidative stress, lipofuscin accumulation, and inflammation damage RPE cells. RPE loss leads to photoreceptor death and geographic atrophy in dry AMD.\n"", ""evidence"": [{""explanation"": ""This describes the progression from deposit accumulation to photoreceptor degeneration and atrophy, supporting the role of RPE dysfunction in geographic atrophy development."", ""reference"": ""PMID:38193957"", ""snippet"": ""AMD occurs when extracellular deposits accumulate in the outer retina, ultimately leading to photoreceptor degeneration and loss of central vision. The late stages of AMD are characterized by outer retinal atrophy, termed geographic atrophy, or neovascularization associated with subretinal and/or intraretinal exudation, termed exudative neovascular AMD."", ""supports"": ""SUPPORT""}], ""name"": ""RPE Dysfunction and Loss""}"
348	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	2	Complement Dysregulation	"Excessive complement activation in the macula contributes to chronic inflammation and tissue damage. CFH variants are major genetic risk factor.
"																																																								"{""description"": ""Excessive complement activation in the macula contributes to chronic inflammation and tissue damage. CFH variants are major genetic risk factor.\n"", ""name"": ""Complement Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""description"": ""Excessive complement activation in the macula contributes to chronic inflammation and tissue damage. CFH variants are major genetic risk factor.\n"", ""evidence"": [{""explanation"": ""This explains the importance of complement regulation in the eye and how dysregulation leads to inflammation and tissue damage, which is central to AMD pathogenesis."", ""reference"": ""PMID:38690727"", ""snippet"": ""Careful regulation of the complement system is critical for enabling complement proteins to titrate immune defense while also preventing collateral tissue damage from poorly controlled inflammation. In the eye, this balance between complement activity and inhibition is crucial, as a low level of basal complement activity is necessary to support ocular immune privilege, a prerequisite for maintaining vision."", ""supports"": ""SUPPORT""}, {""explanation"": ""Direct confirmation that complement dysregulation is implicated in AMD pathogenesis."", ""reference"": ""PMID:38690727"", ""snippet"": ""Complement dysregulation has been implicated in many ocular diseases, including glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD)."", ""supports"": ""SUPPORT""}], ""name"": ""Complement Dysregulation""}"
349	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	3	Choroidal Neovascularization	"In wet AMD, VEGF-driven abnormal blood vessel growth from choroid invades through Bruch's membrane. These fragile vessels leak and bleed, causing rapid vision loss.
"																																																								"{""description"": ""In wet AMD, VEGF-driven abnormal blood vessel growth from choroid invades through Bruch's membrane. These fragile vessels leak and bleed, causing rapid vision loss.\n"", ""name"": ""Choroidal Neovascularization""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}], ""description"": ""In wet AMD, VEGF-driven abnormal blood vessel growth from choroid invades through Bruch's membrane. These fragile vessels leak and bleed, causing rapid vision loss.\n"", ""evidence"": [{""explanation"": ""The effectiveness of anti-VEGF therapy demonstrates that VEGF-driven angiogenesis is the key pathophysiological mechanism in neovascular AMD."", ""reference"": ""PMID:38193957"", ""snippet"": ""In exudative neovascular AMD, 94.6% of patients receiving monthly intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections experience less than a 15-letter visual acuity loss after 12 months compared with 62.2% receiving sham treatment."", ""supports"": ""SUPPORT""}], ""name"": ""Choroidal Neovascularization""}"
366	14	Ainhum	Ainhum.yaml	pathophysiology	0	Constricting groove forms around proximal toe	A groove or fissure of constricting tissue develops around a toe, most often the fifth toe.																																																								"{""description"": ""A groove or fissure of constricting tissue develops around a toe, most often the fifth toe."", ""name"": ""Constricting groove forms around proximal toe""}"	{}	"{""description"": ""A groove or fissure of constricting tissue develops around a toe, most often the fifth toe."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract describes the initiating constriction groove around the fifth toe."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""a groove or fissure of constricting tissue forms around the proximal end of the fifth toe."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Radiological survey notes fifth toe predominance with possible involvement of other toes."", ""reference"": ""PMID:12500788"", ""snippet"": ""Dactylolysis spontanea is an idiopathic condition affecting the fifth toe, and sometimes other toes"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report emphasizes typical bilateral fifth toe involvement."", ""reference"": ""PMID:1539609"", ""snippet"": ""It usually affects the fifth toe bilaterally"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""pedal digit 5"", ""term"": {""id"": ""UBERON:0003635"", ""label"": ""pedal digit 5""}}], ""name"": ""Constricting groove forms around proximal toe""}"
367	14	Ainhum	Ainhum.yaml	pathophysiology	1	Progressive constriction encircles the toe	The constriction groove progresses to encircle the toe.																																																								"{""description"": ""The constriction groove progresses to encircle the toe."", ""name"": ""Progressive constriction encircles the toe""}"	{}	"{""description"": ""The constriction groove progresses to encircle the toe."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract notes progression from groove to encircling constriction."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""Eventually, the groove extends to encircle the toe, the underlying structures are absorbed and the toe autoamputates."", ""supports"": ""SUPPORT""}], ""name"": ""Progressive constriction encircles the toe""}"
368	14	Ainhum	Ainhum.yaml	pathophysiology	2	Absorption of underlying structures	Progressive constriction leads to absorption of underlying tissues and bone.																																																								"{""description"": ""Progressive constriction leads to absorption of underlying tissues and bone."", ""name"": ""Absorption of underlying structures""}"	{}	"{""description"": ""Progressive constriction leads to absorption of underlying tissues and bone."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract explicitly links constriction to absorption of underlying structures."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""the underlying structures are absorbed and the toe autoamputates."", ""supports"": ""SUPPORT""}], ""name"": ""Absorption of underlying structures""}"
369	14	Ainhum	Ainhum.yaml	pathophysiology	3	Toe autoamputation	End-stage constriction results in spontaneous autoamputation of the toe.																																																								"{""description"": ""End-stage constriction results in spontaneous autoamputation of the toe."", ""name"": ""Toe autoamputation""}"	{}	"{""description"": ""End-stage constriction results in spontaneous autoamputation of the toe."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract describes autoamputation as the end-stage outcome."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""the toe autoamputates."", ""supports"": ""SUPPORT""}], ""name"": ""Toe autoamputation""}"
386	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	0	V5/MT motion-processing cortex dysfunction	The disorder reflects disruption of cortical area V5/MT, a key node for visual motion perception, leading to failure of normal motion integration.																																																								"{""description"": ""The disorder reflects disruption of cortical area V5/MT, a key node for visual motion perception, leading to failure of normal motion integration."", ""name"": ""V5/MT motion-processing cortex dysfunction""}"	{}	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""The disorder reflects disruption of cortical area V5/MT, a key node for visual motion perception, leading to failure of normal motion integration."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This systematic review highlights V5/MT as central to motion perception, supporting V5/MT dysfunction as a core mechanism."", ""reference"": ""PMID:39996018"", ""snippet"": ""Despite its profound impact, the condition remains poorly understood beyond the established centrality of cortical area V5/MT in visual motion perception."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review defines akinetopsia as a cortical syndrome with loss of visual motion perception."", ""reference"": ""PMID:27193360"", ""snippet"": ""akinetopsia (cortical syndrome in which patient losses the ability to perceive visual motion)"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This systematic review supports a shared pathophysiologic pathway across akinetopsia etiologies."", ""reference"": ""PMID:37938052"", ""snippet"": ""Our results revealed distinct characteristics for the various etiologies of this phenomenon in addition to a shared pathophysiologic pathway among them."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""visual cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}, {""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}], ""name"": ""V5/MT motion-processing cortex dysfunction""}"
387	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	1	Left V5/MT susceptibility to acute interference	In right-handed individuals, left V5/MT appears particularly susceptible to acute interference during experimental disruption, implicating hemispheric vulnerability in motion perception.																																																								"{""description"": ""In right-handed individuals, left V5/MT appears particularly susceptible to acute interference during experimental disruption, implicating hemispheric vulnerability in motion perception."", ""name"": ""Left V5/MT susceptibility to acute interference""}"	{}	"{""description"": ""In right-handed individuals, left V5/MT appears particularly susceptible to acute interference during experimental disruption, implicating hemispheric vulnerability in motion perception."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This indicates left V5/MT vulnerability to acute interference in experimental cases."", ""reference"": ""PMID:39996018"", ""snippet"": ""Pathophysiologically, in right-handed individuals, the left area V5/MT was found to be particularly susceptible to acute interference, as evidenced by the experimental studies."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}], ""name"": ""Left V5/MT susceptibility to acute interference""}"
388	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	2	Right-hemispheric V5/MT predominance in clinical cases	Clinical cases more often involve right-hemispheric V5/MT afflictions, suggesting dominance of the right V5/MT in motion perception.																																																								"{""description"": ""Clinical cases more often involve right-hemispheric V5/MT afflictions, suggesting dominance of the right V5/MT in motion perception."", ""name"": ""Right-hemispheric V5/MT predominance in clinical cases""}"	{}	"{""description"": ""Clinical cases more often involve right-hemispheric V5/MT afflictions, suggesting dominance of the right V5/MT in motion perception."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports right-hemisphere predominance for motion perception in clinical akinetopsia."", ""reference"": ""PMID:39996018"", ""snippet"": ""we found a greater prevalence of right-hemispheric afflictions in clinical cases, suggesting that the right area V5/MT plays a more dominant role in motion perception."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}], ""name"": ""Right-hemispheric V5/MT predominance in clinical cases""}"
389	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	3	Severity depends on surviving motion network components and stimulus speed	The severity of motion blindness depends on remaining components of the visual motion network and the speed of moving objects.																																																								"{""description"": ""The severity of motion blindness depends on remaining components of the visual motion network and the speed of moving objects."", ""name"": ""Severity depends on surviving motion network components and stimulus speed""}"	{}	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""The severity of motion blindness depends on remaining components of the visual motion network and the speed of moving objects."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports network redundancy and stimulus speed as modifiers of symptom severity."", ""reference"": ""PMID:39996018"", ""snippet"": ""the severity of the condition also depends on surviving components of the visual motion network as a whole, and-in line with the dynamic parallellism theory-the speed of moving objects."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""visual cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}, {""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}], ""name"": ""Severity depends on surviving motion network components and stimulus speed""}"
390	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	4	Structural neurological damage to motion network	Structural neurological conditions such as stroke or neurodegenerative disease most often underlie akinetopsia by damaging cortical motion processing regions.																																																								"{""description"": ""Structural neurological conditions such as stroke or neurodegenerative disease most often underlie akinetopsia by damaging cortical motion processing regions."", ""name"": ""Structural neurological damage to motion network""}"	{}	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Structural neurological conditions such as stroke or neurodegenerative disease most often underlie akinetopsia by damaging cortical motion processing regions."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports structural neurological disease as the dominant mechanism leading to motion network damage."", ""reference"": ""PMID:39996018"", ""snippet"": ""Aetiologically, most cases were associated with structural neurological conditions such as stroke and neurodegenerative disease, and fewer with intoxications or paroxysmal neurological disorders such as epilepsy."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""visual cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}, {""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}], ""name"": ""Structural neurological damage to motion network""}"
391	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	5	Paroxysmal or intoxication-related cortical dysfunction	A subset of cases arise from transient cortical dysfunction due to intoxications or paroxysmal neurological disorders such as epilepsy.																																																								"{""description"": ""A subset of cases arise from transient cortical dysfunction due to intoxications or paroxysmal neurological disorders such as epilepsy."", ""name"": ""Paroxysmal or intoxication-related cortical dysfunction""}"	{}	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""A subset of cases arise from transient cortical dysfunction due to intoxications or paroxysmal neurological disorders such as epilepsy."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This indicates that intoxications and paroxysmal disorders can underlie akinetopsia in some cases."", ""reference"": ""PMID:39996018"", ""snippet"": ""Aetiologically, most cases were associated with structural neurological conditions such as stroke and neurodegenerative disease, and fewer with intoxications or paroxysmal neurological disorders such as epilepsy."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report documents epileptic seizures presenting as recurrent akinetopsia."", ""reference"": ""PMID:25667833"", ""snippet"": ""We describe a patient who showed akinetopsia recurrently as epileptic seizures."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""visual cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}, {""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}], ""name"": ""Paroxysmal or intoxication-related cortical dysfunction""}"
392	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	6	Epileptic hyperexcitability of MT/V5 cortex	Paroxysmal hyperexcitability in right temporal and parietal cortices, including MT/V5, can trigger akinetopsia episodes.																																																								"{""description"": ""Paroxysmal hyperexcitability in right temporal and parietal cortices, including MT/V5, can trigger akinetopsia episodes."", ""name"": ""Epileptic hyperexcitability of MT/V5 cortex""}"	{}	"{""description"": ""Paroxysmal hyperexcitability in right temporal and parietal cortices, including MT/V5, can trigger akinetopsia episodes."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report attributes akinetopsia to hyperexcitability in right temporal/parietal cortices including MT/V5."", ""reference"": ""PMID:25667833"", ""snippet"": ""We diagnosed his visual symptom as akinetopsia, which was aroused by hyperexcitability of the right temporal and parietal cortices, including area MT/V5."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}], ""name"": ""Epileptic hyperexcitability of MT/V5 cortex""}"
393	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	7	Induced disruption from TMS or medications	Akinetopsia can be induced by transcranial magnetic stimulation or certain medications, implying reversible disruption of motion-processing circuits.																																																								"{""description"": ""Akinetopsia can be induced by transcranial magnetic stimulation or certain medications, implying reversible disruption of motion-processing circuits."", ""name"": ""Induced disruption from TMS or medications""}"	{}	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Akinetopsia can be induced by transcranial magnetic stimulation or certain medications, implying reversible disruption of motion-processing circuits."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review documents TMS- and medication-induced akinetopsia, supporting reversible circuit disruption mechanisms."", ""reference"": ""PMID:40605075"", ""snippet"": ""Recent cases have demonstrated that it is not necessarily attributed only to vascular causes and neurodegenerative diseases but can also be induced through transcranial magnetic stimulation, and certain medications."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""visual cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}, {""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}], ""name"": ""Induced disruption from TMS or medications""}"
394	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	8	Bilateral V5/MT lesions	Bilateral injury to V5/MT within the secondary visual cortex disrupts motion-processing circuitry.																																																								"{""description"": ""Bilateral injury to V5/MT within the secondary visual cortex disrupts motion-processing circuitry."", ""name"": ""Bilateral V5/MT lesions""}"	{}	"{""description"": ""Bilateral injury to V5/MT within the secondary visual cortex disrupts motion-processing circuitry."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This links bilateral V5/MT lesions to downstream global and chronic akinetopsia."", ""reference"": ""PMID:39996018"", ""snippet"": ""Bilateral lesions to V5/MT most often coincided with global akinetopsia and chronicity."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}], ""name"": ""Bilateral V5/MT lesions""}"
395	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	9	Global akinetopsia with chronic course	Global motion blindness with chronicity most often occurs when V5/MT is affected bilaterally.																																																								"{""description"": ""Global motion blindness with chronicity most often occurs when V5/MT is affected bilaterally."", ""name"": ""Global akinetopsia with chronic course""}"	{}	"{""description"": ""Global motion blindness with chronicity most often occurs when V5/MT is affected bilaterally."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports global and chronic akinetopsia as a frequent outcome of bilateral V5/MT lesions."", ""reference"": ""PMID:39996018"", ""snippet"": ""Bilateral lesions to V5/MT most often coincided with global akinetopsia and chronicity."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""secondary visual cortex"", ""term"": {""id"": ""UBERON:0022232"", ""label"": ""secondary visual cortex""}}], ""name"": ""Global akinetopsia with chronic course""}"
402	16	Alcoholic Liver Disease	Alcoholic_Liver_Disease.yaml	pathophysiology	0	Alcohol metabolism and cellular stress	Alcohol metabolism and cellular stress cause hepatocyte and immune cell injury with cytokine and chemokine production.																																																								"{""description"": ""Alcohol metabolism and cellular stress cause hepatocyte and immune cell injury with cytokine and chemokine production."", ""name"": ""Alcohol metabolism and cellular stress""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Alcohol metabolism and cellular stress cause hepatocyte and immune cell injury with cytokine and chemokine production."", ""evidence"": [{""explanation"": ""The review links alcohol metabolism and cellular stress to hepatocyte and immune cell injury with cytokine and chemokine production."", ""reference"": ""PMID:39362713"", ""snippet"": ""Alcohol metabolism, cellular stress, and gut-derived factors contribute to hepatocyte and immune cell injury leading to cytokine and chemokine production."", ""supports"": ""SUPPORT""}], ""name"": ""Alcohol metabolism and cellular stress""}"
403	16	Alcoholic Liver Disease	Alcoholic_Liver_Disease.yaml	pathophysiology	1	Gut-liver axis and endotoxin translocation	Ethanol damages the intestinal barrier, releasing endotoxins that contribute to ALD pathogenesis.																																																								"{""description"": ""Ethanol damages the intestinal barrier, releasing endotoxins that contribute to ALD pathogenesis."", ""name"": ""Gut-liver axis and endotoxin translocation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to lipopolysaccharide"", ""term"": {""id"": ""GO:0032496"", ""label"": ""response to lipopolysaccharide""}}], ""description"": ""Ethanol damages the intestinal barrier, releasing endotoxins that contribute to ALD pathogenesis."", ""evidence"": [{""explanation"": ""The review describes ethanol-induced barrier damage and endotoxin release as part of ALD pathogenesis."", ""reference"": ""PMID:37143126"", ""snippet"": ""ethanol damages the intestinal barrier, resulting in the release of endotoxins and alterations in intestinal flora content and bile acid metabolism."", ""supports"": ""SUPPORT""}], ""name"": ""Gut-liver axis and endotoxin translocation""}"
420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	Amyloid Plaque Formation	Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons.																																																								"{""description"": ""Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons."", ""name"": ""Amyloid Plaque Formation""}"	"{""consequences"": [""Synaptic Dysfunction"", ""Neuroinflammation""], ""mechanisms"": [""Beta-secretase (BACE1) cleavage of APP"", ""Gamma-secretase cleavage of APP C-terminal fragment""]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""Protein misfolding"", ""term"": {""id"": ""GO:0006457"", ""label"": ""protein folding""}}, {""preferred_term"": ""Aggregation"", ""term"": {""id"": ""GO:0034205"", ""label"": ""amyloid-beta formation""}}, {""preferred_term"": ""Neuroinflammation"", ""term"": {""id"": ""GO:0150076"", ""label"": ""neuroinflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Neurons"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}, {""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""Astrocytes"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""chemical_entities"": [{""preferred_term"": ""Amyloid-beta peptides (A40, A42)""}], ""consequences"": [""Synaptic Dysfunction"", ""Neuroinflammation""], ""description"": ""Accumulation of amyloid-beta proteins in the brain, forming extracellular plaques that disrupt cell function and communication between neurons."", ""evidence"": [{""explanation"": ""This reference supports the statement by confirming that amyloid plaques are a hallmark of Alzheimer's disease and discusses the formation and role of amyloid aggregates in AD."", ""reference"": ""PMID:28320296"", ""snippet"": ""These intra- or extracellular insoluble aggregates (fibers or plaques) are hallmarks of many neurodegenerative pathologies including Alzheimer's disease (AD)..."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by indicating that the accumulation of amyloid plaques, composed of amyloid-beta peptide, is a characteristic of Alzheimer's disease."", ""reference"": ""PMID:26322584"", ""snippet"": ""Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are predominantly composed of amyloid-beta peptide."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by mentioning that amyloid-beta peptides lead to Alzheimer's disease and cause synaptic dysfunction."", ""reference"": ""PMID:22351073"", ""snippet"": ""Generation of amyloid peptide (Abeta) is at the beginning of a cascade that leads to Alzheimer's disease (AD)... soluble assembly states of Abeta peptides can cause cognitive problems by disrupting synaptic function..."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by describing Alzheimer's disease pathology, including amyloid-beta peptide-containing plaques."", ""reference"": ""PMID:10911965"", ""snippet"": ""Alzheimer's disease (AD) pathology is characterized by A beta peptide-containing plaques, neurofibrillary tangles consisting of hyperphosphorylated tau, extensive neuritic degeneration, and distinct neuron loss."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by confirming that beta-amyloid is the main constituent of amyloid plaques, a hallmark of Alzheimer's disease."", ""reference"": ""PMID:10702374"", ""snippet"": ""beta-amyloid (Abeta) is the main constituent of the amyloidogenic plaques which are a primary pathological hallmark of Alzheimer's disease..."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by indicating that neuritic plaques, formed by the aggregation of amyloid-beta protein, are a hallmark of Alzheimer's disease."", ""reference"": ""PMID:36555791"", ""snippet"": ""Neuritic plaques are one of the major pathological hallmarks of Alzheimer's disease. They are formed by the aggregation of extracellular amyloid-beta protein (Abeta)..."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by discussing the amyloid cascade hypothesis, which involves the build-up of amyloid-beta leading to Alzheimer's disease."", ""reference"": ""PMID:25941885"", ""snippet"": ""The 'amyloid cascade hypothesis' posits that an extracellular build-up of amyloid-beta oligomers (Abeta-os) and polymers (fibrils) subsequently inducing toxic hyperphosphorylated (p)-Tau oligomers (p-Tau-os) and neurofibrillary tangles starts the sporadic late-onset Alzheimer's disease (LOAD)..."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by describing the accumulation of amyloid-beta peptide as plaques in Alzheimer's disease."", ""reference"": ""PMID:16611586"", ""snippet"": ""The amyloidogenesis occurring in Alzheimer's disease represents a fundamental membrane-related pathology... the amyloid-beta peptide (Abeta), which accumulates extracellularly as plaques in the brains of Alzheimer's disease patients..."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""APP"", ""term"": {""id"": ""hgnc:620"", ""label"": ""APP""}}, {""preferred_term"": ""PSEN1"", ""term"": {""id"": ""hgnc:9508"", ""label"": ""PSEN1""}}, {""preferred_term"": ""PSEN2"", ""term"": {""id"": ""hgnc:9509"", ""label"": ""PSEN2""}}], ""locations"": [{""preferred_term"": ""Cerebral Cortex""}, {""preferred_term"": ""Hippocampus""}, {""preferred_term"": ""Subcortical Regions""}], ""mechanisms"": [""Beta-secretase (BACE1) cleavage of APP"", ""Gamma-secretase cleavage of APP C-terminal fragment""], ""name"": ""Amyloid Plaque Formation"", ""pathways"": [{""preferred_term"": ""Amyloid precursor protein processing"", ""term"": {""id"": ""GO:0042982"", ""label"": ""amyloid precursor protein metabolic process""}}]}"
421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death.															Synaptic Dysfunction																																									"{""consequence"": ""Synaptic Dysfunction"", ""description"": ""Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death."", ""name"": ""Neurofibrillary Tangle Formation""}"	"{""mechanisms"": [""Hyperphosphorylation of tau by various kinases"", ""Aggregation of hyperphosphorylated tau""]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""Protein hyperphosphorylation"", ""term"": {""id"": ""GO:0006468"", ""label"": ""protein phosphorylation""}}, {""preferred_term"": ""Microtubule destabilization"", ""term"": {""id"": ""GO:0007019"", ""label"": ""microtubule depolymerization""}}], ""cell_types"": [{""preferred_term"": ""Neurons"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""chemical_entities"": [{""preferred_term"": ""Tau protein""}], ""consequence"": ""Synaptic Dysfunction"", ""description"": ""Intracellular accumulation of hyperphosphorylated tau protein, forming twisted fibers that disrupt cellular transport and eventually lead to neuronal death."", ""evidence"": [{""explanation"": ""The article discusses the role of tau hyperphosphorylation and neurofibrillary tangle formation in Alzheimer's Disease, supporting the statement about these processes."", ""reference"": ""PMID:21509508"", ""snippet"": ""Extracellular accumulations of Abeta, hyperphosphorylation of tau and intracellular neurofibrillary tangle formation have been the hallmarks of Alzheimer's Disease (AD)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article supports the statement by mentioning the hyperphosphorylation and aggregation of tau in neurofibrillary tangles in Alzheimer's Disease."", ""reference"": ""PMID:36001963"", ""snippet"": ""In Alzheimer's disease and other neurodegenerative tauopathies, tau is found hyperphosphorylated and aggregated in neurofibrillary tangles."", ""supports"": ""SUPPORT""}, {""explanation"": ""The article confirms that hyperphosphorylated tau leads to the formation of neurofibrillary tangles and disrupts microtubule stabilization, supporting the statement."", ""reference"": ""PMID:37266762"", ""snippet"": ""Tau is a microtubule-associated binding protein in the nervous system that is known for its role in stabilizing microtubules throughout the nerve cell. It accumulates as beta-sheet-rich aggregates and neurofibrillary tangles, leading to an array of different pathologies."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article supports the statement by identifying hyperphosphorylated tau as the main component of neurofibrillary tangles in Alzheimer's Disease."", ""reference"": ""PMID:19542604"", ""snippet"": ""Tau protein is the principal component of the neurofibrillary tangles found in Alzheimer's disease (AD), where it is hyperphosphorylated on serine and threonine residues."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article supports the statement by discussing how phosphorylated tau protein tangles initiate multicellular interactions in Alzheimer's Disease."", ""reference"": ""PMID:28100644"", ""snippet"": ""These multicellular interactions are initiated by insoluble tangles of phosphorylated tau protein and plaques of amyloid peptides."", ""supports"": ""SUPPORT""}, {""explanation"": ""The article supports the statement by explaining how tau protein is involved in the formation of filamentous structures in Alzheimer's Disease, leading to microtubule destabilization."", ""reference"": ""PMID:2135393"", ""snippet"": ""The most common of these conditions is Alzheimer's disease, in which microtubules are lost from neurites that fill up with filamentous structures. One component of the filamentous structures is the microtubule-associated protein (MAP), tau."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article supports the statement by describing the composition and formation of neurofibrillary tangles from tau protein in Alzheimer's Disease."", ""reference"": ""PMID:12859672"", ""snippet"": ""Neurofibrillary tangles are composed of insoluble aggregates of the microtubule-associated protein tau. In Alzheimer's disease the accumulation of neurofibrillary tangles occurs in the absence of tau mutations."", ""supports"": ""SUPPORT""}, {""explanation"": ""The article supports the statement by linking tau hyperphosphorylation and aggregation to the formation of neurofibrillary tangles in Alzheimer's Disease."", ""reference"": ""PMID:31903881"", ""snippet"": ""Hyperphosphorylation of tau protein leads to aggregation of tau into paired helical filaments like structures which are major constituents of neurofibrillary tangles, a hallmark of Alzheimer's disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""The article supports the statement by describing tauopathies, including Alzheimer's Disease, as being characterized by neurofibrillary tangles and neuronal loss."", ""reference"": ""PMID:23948895"", ""snippet"": ""Tauopathies are neurodegenerative diseases characterized behaviorally by dementia and neuropathologically by neurofibrillary tangles and neuronal loss."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""MAPT"", ""term"": {""id"": ""hgnc:6893"", ""label"": ""MAPT""}}], ""locations"": [{""preferred_term"": ""Entorhinal Cortex""}, {""preferred_term"": ""Hippocampus""}, {""preferred_term"": ""Neocortex""}], ""mechanisms"": [""Hyperphosphorylation of tau by various kinases"", ""Aggregation of hyperphosphorylated tau""], ""name"": ""Neurofibrillary Tangle Formation"", ""pathways"": [{""preferred_term"": ""Tau phosphorylation cascade"", ""term"": {""id"": ""GO:0006468"", ""label"": ""protein phosphorylation""}}]}"
422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline.															Oxidative Stress																																									"{""consequence"": ""Oxidative Stress"", ""description"": ""Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline."", ""name"": ""Synaptic Dysfunction""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""Neurotransmitter release"", ""term"": {""id"": ""GO:0007269"", ""label"": ""neurotransmitter secretion""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""Synaptic plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}], ""cell_types"": [{""preferred_term"": ""Neurons"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""chemical_entities"": [{""preferred_term"": ""Acetylcholine"", ""term"": {""id"": ""CHEBI:15355"", ""label"": ""acetylcholine""}}, {""preferred_term"": ""Glutamate"", ""term"": {""id"": ""CHEBI:14321"", ""label"": ""glutamate(1-)""}}, {""preferred_term"": ""GABA"", ""term"": {""id"": ""CHEBI:16865"", ""label"": ""gamma-aminobutyric acid""}}], ""consequence"": ""Oxidative Stress"", ""description"": ""Progressive loss of synapses and impaired neurotransmitter signaling, leading to disrupted neuronal communication and cognitive decline."", ""evidence"": [{""explanation"": ""The statement is supported by the reference which discusses the role of neurotransmitter release and synaptic plasticity in Alzheimer's Disease, leading to cognitive decline."", ""reference"": ""PMID:27662312"", ""snippet"": ""Compelling evidence suggests that soluble amyloid-beta (Abeta) and hyperphosphorylated tau serve as toxins in the dysfunction of synaptic plasticity and aberrant neurotransmitter (NT) release at synapses consequently causing a cognitive decline in Alzheimer's disease (AD)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the cognitive decline aspect but does not elaborate on neurotransmitter signaling or synaptic plasticity in detail."", ""reference"": ""PMID:27163751"", ""snippet"": ""The important role of the hippocampus in age-related cognitive decline and in vulnerability to disease processes such as Alzheimer's disease has prompted this review, which will focus on the complexity of changes that characterize aging, and on the molecular connections that exist between normal aging and Alzheimer's disease."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference supports the statement by discussing the loss of synapses and impaired glutamatergic neurotransmitter signaling in Alzheimer's Disease."", ""reference"": ""PMID:12973746"", ""snippet"": ""Histological studies indicate loss of pyramidal neurones and their synapses in Alzheimer's disease (AD), this together with biochemical evidence suggests presynaptic (and postsynaptic) glutamatergic hypoactivity."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the statement by providing evidence of altered GABAergic signaling and its role in Alzheimer's Disease."", ""reference"": ""PMID:33232936"", ""snippet"": ""In the present study, we examined alterations in several GABA-specific targets in the APP/PS1 mouse model at different ages... Overall, our study provides evidence of altered GABAergic signaling in an amyloid model of AD at a time point consistent with AD-related deficits."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the statement by discussing neurotoxic components that contribute to synaptic dysfunction and cognitive decline in Alzheimer's Disease."", ""reference"": ""PMID:9024330"", ""snippet"": ""The major component of the extraneuronal neuritic plaque is beta-amyloid (A beta), which may be neurotoxic. The major component of the intraneuronal neurofibrillary tangle is hyperphosphorylated tau protein."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Synapses""}, {""preferred_term"": ""Neuronal dendrites""}], ""name"": ""Synaptic Dysfunction"", ""pathways"": [{""preferred_term"": ""Synaptic vesicle recycling"", ""term"": {""id"": ""GO:0099504"", ""label"": ""synaptic vesicle cycle""}}, {""preferred_term"": ""Neurotransmitter receptor signaling"", ""term"": {""id"": ""GO:0050804"", ""label"": ""modulation of chemical synaptic transmission""}}]}"
423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	Neuroinflammation	Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression.																																																								"{""description"": ""Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression."", ""name"": ""Neuroinflammation""}"	"{""consequences"": [""Oxidative Stress"", ""Vascular Dysfunction""]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""Immune activation"", ""term"": {""id"": ""GO:0002253"", ""label"": ""activation of immune response""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""Cytokine production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}, {""preferred_term"": ""Phagocytosis"", ""term"": {""id"": ""GO:0006909"", ""label"": ""phagocytosis""}}], ""cell_types"": [{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""Astrocytes"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""chemical_entities"": [{""preferred_term"": ""Cytokines""}, {""preferred_term"": ""Chemokines""}, {""preferred_term"": ""Complement proteins""}], ""consequences"": [""Oxidative Stress"", ""Vascular Dysfunction""], ""description"": ""Chronic activation of immune responses in the brain, contributing to neuronal damage and disease progression."", ""evidence"": [{""explanation"": ""The reference supports the involvement of NLRP3 inflammasome activation in Alzheimer's disease, which is part of the immune activation process contributing to neuroinflammation."", ""reference"": ""PMID:28019679"", ""snippet"": ""NOD-like receptor (NLR) family, pyrin domain containing 3 and 1 inflammasomes, present in myeloid cells and neurons, respectively, represent key components of the innate immune reaction observed in Alzheimer patient brains."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the role of astrocytes and microglia in cytokine production and their interaction contributing to Alzheimer's disease pathology."", ""reference"": ""PMID:32061803"", ""snippet"": ""The response of astrocytes to the presence of Abeta, as well astrocytic and microglial interaction and inflammatory cytokine release is also discussed, highlighting a cyclical behaviour of these cells in contributing to AD pathogenesis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the involvement of microglia in immune activation, cytokine production, and phagocytosis in Alzheimer's disease."", ""reference"": ""PMID:35406803"", ""snippet"": ""Once activated, microglial cells, which are brain-resident immune cells, exert several key actions, including phagocytosis, chemotaxis, and the release of pro- or anti-inflammatory mediators."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the involvement of complement proteins, cytokines, and oxidative stress in Alzheimer's disease."", ""reference"": ""PMID:21546088"", ""snippet"": ""In age related diseases, such as Alzheimer's disease (AD), accumulating amyloid proteins elicit complement activation and a local, chronic inflammatory response that leads to attraction and activation of glial cells that, under such activation conditions, can produce neurotoxic substances, including pro-inflammatory cytokines and oxygen radicals."", ""supports"": ""SUPPORT""}, {""explanation"": ""While primarily discussing schizophrenia, this reference supports the role of microglia activation and complement proteins in neuroinflammation, which is relevant to Alzheimer's disease."", ""reference"": ""PMID:33958577"", ""snippet"": ""The apoptotic loss of dendritic spines would be aggravated by microglia activation through a recently described signaling system from complement abnormalities and proteins of the MHC, thus implicating the immune system in schizophrenia."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the role of microglia as key players in immune activation and neuroinflammation."", ""reference"": ""PMID:36357946"", ""snippet"": ""Furthermore, exposure to chronic stress alters the phenotype of microglia, a population of innate immune cells that reside in the CNS parenchyma."", ""supports"": ""SUPPORT""}], ""name"": ""Neuroinflammation"", ""pathways"": [{""preferred_term"": ""NF-B signaling"", ""term"": {""id"": ""GO:0007249"", ""label"": ""canonical NF-kappaB signal transduction""}}, {""preferred_term"": ""NLRP3 inflammasome activation"", ""term"": {""id"": ""GO:0044546"", ""label"": ""NLRP3 inflammasome complex assembly""}}]}"
424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	Oxidative Stress	Imbalance between the production of reactive oxygen species and the brain's ability to detoxify them, leading to cellular damage.																																																								"{""description"": ""Imbalance between the production of reactive oxygen species and the brain's ability to detoxify them, leading to cellular damage."", ""name"": ""Oxidative Stress""}"	"{""consequences"": [""Amyloid Plaque Formation"", ""Neurofibrillary Tangle Formation""]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""Free radical production"", ""term"": {""id"": ""GO:1903409"", ""label"": ""reactive oxygen species biosynthetic process""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""Antioxidant defense"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""cellular_components"": [{""preferred_term"": ""Mitochondria"", ""term"": {""id"": ""GO:0005739"", ""label"": ""mitochondrion""}}, {""preferred_term"": ""Cell membranes"", ""term"": {""id"": ""GO:0005886"", ""label"": ""plasma membrane""}}], ""chemical_entities"": [{""preferred_term"": ""Reactive oxygen species (ROS)"", ""term"": {""id"": ""CHEBI:26523"", ""label"": ""reactive oxygen species""}}, {""preferred_term"": ""Reactive nitrogen species (RNS)"", ""term"": {""id"": ""CHEBI:62764"", ""label"": ""reactive nitrogen species""}}], ""consequences"": [""Amyloid Plaque Formation"", ""Neurofibrillary Tangle Formation""], ""description"": ""Imbalance between the production of reactive oxygen species and the brain's ability to detoxify them, leading to cellular damage."", ""evidence"": [{""explanation"": ""The literature supports the role of oxidative stress, including the imbalance between ROS production and antioxidant defenses, in the development of Alzheimer's disease."", ""reference"": ""PMID:34416493"", ""snippet"": ""Emerging evidence suggests that accumulated oxidative stress may be one of the key mechanisms causing cognitive aging and neurodegenerative diseases such as Alzheimer's disease (AD)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the involvement of oxidative stress and the imbalance in ROS/RNS in the pathology of neurodegenerative diseases."", ""reference"": ""PMID:27888001"", ""snippet"": ""Depending on its level, HNE exerts harmful or protective effects associated with the induction of antioxidant defense mechanisms. These effects make HNE a key player in maintaining redox homeostasis, as well as producing imbalances in this system that participate in aging and the development of pathological conditions."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference discusses the uncertainty around the specific processes but acknowledges oxidative stress as a contributing factor."", ""reference"": ""PMID:9024330"", ""snippet"": ""Although the specific process that destroys neurons in patients with Alzheimer's disease (AD) remains obscure, biochemical studies of AD neurohistologic lesions and molecular attempts to map and clone genes in familial AD have contributed greatly to our knowledge of AD."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference supports the involvement of oxidative stress and mitochondrial damage in neurodegeneration but does not specifically focus on Alzheimer's disease."", ""reference"": ""PMID:25772897"", ""snippet"": ""Key elements driving neurodegeneration include microglia activation, chronic oxidative injury, accumulation of mitochondrial damage in axons, and age-related iron accumulation in the human brain."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference supports the role of oxidative stress in neurodegeneration, which is relevant to Alzheimer's disease."", ""reference"": ""PMID:33164705"", ""snippet"": ""Oxidative stress-induced neuronal apoptosis plays a pivotal role in pathogenesis of neurodegeneration."", ""supports"": ""SUPPORT""}], ""name"": ""Oxidative Stress"", ""pathways"": [{""preferred_term"": ""Mitochondrial electron transport chain"", ""term"": {""id"": ""GO:0022904"", ""label"": ""respiratory electron transport chain""}}, {""preferred_term"": ""NADPH oxidase activation""}]}"
425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	Vascular Dysfunction	Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation.																																																								"{""description"": ""Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation."", ""name"": ""Vascular Dysfunction""}"	"{""consequences"": [""Amyloid Plaque Formation"", ""Oxidative Stress""]}"	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""Blood-brain barrier regulation"", ""term"": {""id"": ""GO:1905603"", ""label"": ""regulation of blood-brain barrier permeability""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""Cerebral blood flow"", ""term"": {""id"": ""GO:0120275"", ""label"": ""cerebral blood circulation""}}], ""cell_types"": [{""preferred_term"": ""Endothelial cells"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}, {""preferred_term"": ""Pericytes"", ""term"": {""id"": ""CL:0000669"", ""label"": ""pericyte""}}], ""consequences"": [""Amyloid Plaque Formation"", ""Oxidative Stress""], ""description"": ""Alterations in cerebral blood flow and blood-brain barrier integrity, contributing to neuronal dysfunction and amyloid accumulation."", ""evidence"": [{""explanation"": ""This reference supports the statement by indicating that blood-brain barrier (BBB) dysfunction contributes to Alzheimer's disease (AD) pathogenesis, including amyloid-beta (Abeta) accumulation and neurovascular impairments."", ""reference"": ""PMID:28902142"", ""snippet"": ""Thus, current evidence suggests that BBB dysfunction may causatively and consequently contribute to AD pathogenesis, forming a vicious cycle between brain Abeta accumulation and neurovascular unit impairments during disease progression."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by discussing the accumulation of beta-amyloid and its link to neuronal death in Alzheimer's disease, which is relevant to the described consequences of vascular dysfunction."", ""reference"": ""PMID:16443487"", ""snippet"": ""Understanding cerebral degeneration and accumulation of beta-amyloid has generated hopes for discovery of disease-modifying treatments. Progress is needed in understanding the mechanisms that link beta-amyloid accumulation and neuronal death."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by highlighting the role of cerebral blood flow changes in the early stages of Alzheimer's disease, which is consistent with the described vascular dysfunction."", ""reference"": ""PMID:26898552"", ""snippet"": ""There is accumulating evidence suggesting that changes in brain perfusion are present long before the clinical symptoms of Alzheimer's disease (AD), perhaps even before amyloid-beta accumulation or brain atrophy."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by describing how microvascular remodeling and blood-brain barrier breakdown contribute to neurovascular unit dysfunction and neurological deficits, relevant to Alzheimer's disease."", ""reference"": ""PMID:36293539"", ""snippet"": ""Aberrant remodeling of microvesselsis associated with blood-brain barrier breakdown, development of neuroinflammation, inadequate microcirculation in active brain regions, and leads to the dysfunction of the neurovascular unit and progressive neurological deficits."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by discussing the role of endothelial cells and pericytes in blood-brain barrier impairment and Alzheimer's disease pathogenesis."", ""reference"": ""PMID:35289012"", ""snippet"": ""We consider how abnormalities of the constituent cells of the neurovascular unit - particularly of endothelial cells and pericytes - and impairment of the blood-brain barrier (BBB) impact on the pathogenesis of AD."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""LRP1"", ""term"": {""id"": ""hgnc:6692"", ""label"": ""LRP1""}}], ""locations"": [{""preferred_term"": ""Cerebral blood vessels""}, {""preferred_term"": ""Blood-brain barrier""}], ""name"": ""Vascular Dysfunction"", ""pathways"": [{""preferred_term"": ""Neurovascular coupling""}, {""preferred_term"": ""Perivascular drainage""}]}"
426	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	6	Autophagy-Lysosomal Dysfunction	Impaired autophagy and lysosomal degradation pathways leading to accumulation of protein aggregates and cellular dysfunction.																																		Beclin-1/VPS34 complex deficits, p62 accumulation, and faulty autolysosome acidification contribute to impaired clearance of A and tau aggregates.																						"{""description"": ""Impaired autophagy and lysosomal degradation pathways leading to accumulation of protein aggregates and cellular dysfunction."", ""name"": ""Autophagy-Lysosomal Dysfunction"", ""notes"": ""Beclin-1/VPS34 complex deficits, p62 accumulation, and faulty autolysosome acidification contribute to impaired clearance of A and tau aggregates.""}"	"{""consequences"": [""Amyloid Plaque Formation"", ""Neurofibrillary Tangle Formation""], ""mechanisms"": [""Impaired autophagic flux and autophagosome-lysosome fusion"", ""Defective lysosomal acidification"", ""Accumulation of autophagic vacuoles containing A""]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""Autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""Lysosomal degradation"", ""term"": {""id"": ""GO:0007041"", ""label"": ""lysosomal transport""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""Protein catabolic process"", ""term"": {""id"": ""GO:0030163"", ""label"": ""protein catabolic process""}}], ""cell_types"": [{""preferred_term"": ""Neurons"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""consequences"": [""Amyloid Plaque Formation"", ""Neurofibrillary Tangle Formation""], ""description"": ""Impaired autophagy and lysosomal degradation pathways leading to accumulation of protein aggregates and cellular dysfunction."", ""locations"": [{""preferred_term"": ""Hippocampus""}, {""preferred_term"": ""Cerebral Cortex""}], ""mechanisms"": [""Impaired autophagic flux and autophagosome-lysosome fusion"", ""Defective lysosomal acidification"", ""Accumulation of autophagic vacuoles containing A""], ""name"": ""Autophagy-Lysosomal Dysfunction"", ""notes"": ""Beclin-1/VPS34 complex deficits, p62 accumulation, and faulty autolysosome acidification contribute to impaired clearance of A and tau aggregates.""}"
446	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	0	Loss of Hair Follicle Immune Privilege	Hair follicles normally maintain immune privilege through low MHC class I expression and local immunosuppressive factors. Collapse of immune privilege exposes hair follicle antigens to immune surveillance.																																																								"{""description"": ""Hair follicles normally maintain immune privilege through low MHC class I expression and local immunosuppressive factors. Collapse of immune privilege exposes hair follicle antigens to immune surveillance."", ""name"": ""Loss of Hair Follicle Immune Privilege""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immune Response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}], ""description"": ""Hair follicles normally maintain immune privilege through low MHC class I expression and local immunosuppressive factors. Collapse of immune privilege exposes hair follicle antigens to immune surveillance."", ""evidence"": [{""explanation"": ""This review describes the mechanisms of hair follicle immune privilege including reduced MHC expression and immunosuppressive signaling, confirming the normal maintenance of immune privilege in anagen hair follicles."", ""reference"": ""PMID:32682334"", ""snippet"": ""Anagen stage hair follicles (HFs) exhibit \""immune privilege (IP)\"" from the level of the bulge downwards to the bulb. Both passive and active IP mechanisms protect HFs from physiologically undesired immune responses and limit immune surveillance. IP is relative, not absolute, and is primarily based on absent, or greatly reduced, intra-follicular antigen presentation via MHC class I and II molecules, along with prominent expression of \""no danger\"" signals like CD200 and the creation of an immunoinhibitory signalling milieu generated by the secretory activities of HFs."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study documents the specific immunomodulatory factors that are suppressed during immune privilege collapse in AA, along with enhanced MHC expression that enables autoreactive T cell recognition."", ""reference"": ""PMID:38673994"", ""snippet"": ""Immune privilege collapse has been extensively investigated in AA pathogenesis, including the suppression of immunomodulatory factors (e.g., transforming growth factor- (TGF-), programmed death-ligand 1 (PDL1), interleukin-10 (IL-10), -melanocyte-stimulating hormone (-MSH), and macrophage migration inhibitory factor (MIF)) and enhanced expression of the major histocompatibility complex (MHC) throughout hair follicles."", ""supports"": ""SUPPORT""}], ""name"": ""Loss of Hair Follicle Immune Privilege""}"
447	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	1	CD8+ T Cell-Mediated Attack	NKG2D-expressing CD8+ T cells infiltrate the hair bulb and attack hair follicle cells. IFN-gamma produced by these cells induces MHC class I upregulation and further T cell recruitment.																																																								"{""description"": ""NKG2D-expressing CD8+ T cells infiltrate the hair bulb and attack hair follicle cells. IFN-gamma produced by these cells induces MHC class I upregulation and further T cell recruitment."", ""name"": ""CD8+ T Cell-Mediated Attack""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T Cell Cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}], ""cell_types"": [{""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}], ""description"": ""NKG2D-expressing CD8+ T cells infiltrate the hair bulb and attack hair follicle cells. IFN-gamma produced by these cells induces MHC class I upregulation and further T cell recruitment."", ""evidence"": [{""explanation"": ""This demonstrates that CD8+ T cells alone are sufficient to induce alopecia areata in animal models, establishing their central role as disease drivers. The NKG2D+ phenotype and IFN-gamma production are key features."", ""reference"": ""PMID:32682334"", ""snippet"": ""In AA, lesional HFs are rapidly infiltrated by NKG2D + T cells and natural killer (NK) cells, while perifollicular mast cells acquire a profoundly pro-inflammatory phenotype and interact with autoreactive CD8+ T cells. Using animal models, significant functional evidence has accumulated that demonstrates the dominance of the immune system in AA pathogenesis. Purified CD8+T-cell and NK cell populations alone, which secrete f, suffice to induce the AA phenotype, while CD4+T-cells aggravate it, and Tregs and iNKT cells may provide relative protection against AA development."", ""supports"": ""SUPPORT""}, {""explanation"": ""This identifies the specific mechanism of CD8+ T cell cytotoxicity in AA through NKG2D-dependent pathways, and demonstrates that IL-15 stimulation enhances their pathogenic activity."", ""reference"": ""PMID:37365384"", ""snippet"": ""Pathogenic activity of CD44s-hiCD49dlo CD8+ T cells was mediated by NKG2D-dependent innate-like cytotoxicity, which was further augmented by IL-15 stimulation and triggered disease onset."", ""supports"": ""SUPPORT""}], ""name"": ""CD8+ T Cell-Mediated Attack""}"
448	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	2	JAK-STAT Signaling Activation	IFN-gamma signaling through JAK1/2-STAT1 pathway drives disease pathogenesis. This pathway is a key therapeutic target, with JAK inhibitors showing efficacy in alopecia areata.																																																								"{""description"": ""IFN-gamma signaling through JAK1/2-STAT1 pathway drives disease pathogenesis. This pathway is a key therapeutic target, with JAK inhibitors showing efficacy in alopecia areata."", ""name"": ""JAK-STAT Signaling Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""JAK-STAT Signaling"", ""term"": {""id"": ""GO:0007259"", ""label"": ""receptor signaling pathway via JAK-STAT""}}], ""description"": ""IFN-gamma signaling through JAK1/2-STAT1 pathway drives disease pathogenesis. This pathway is a key therapeutic target, with JAK inhibitors showing efficacy in alopecia areata."", ""evidence"": [{""explanation"": ""This establishes that IFN-gamma signaling pathways are activated in AA pathogenesis, providing the mechanistic basis for JAK-STAT pathway involvement since these cytokines signal through JAK-STAT."", ""reference"": ""PMID:38673994"", ""snippet"": ""Both AA and vitiligo are autoimmune diseases that share commonalities in pathogenesis, including the involvement of plasmacytoid dendritic cells (and interferon- (IFN- ) signaling pathways) and cytotoxic CD8+ T lymphocytes (and activated IFN- signaling pathways)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The clinical efficacy of baricitinib, a JAK1/2 inhibitor, in promoting hair regrowth provides direct evidence that the JAK-STAT pathway is a critical therapeutic target in AA pathogenesis."", ""reference"": ""PMID:37326792"", ""snippet"": ""In two pivotal placebo-controlled phase 3 clinical trials in adults with severe alopecia areata, oral baricitinib once daily was associated with clinically meaningful scalp, eyebrow, and eyelash hair regrowth over 36 weeks."", ""supports"": ""SUPPORT""}, {""explanation"": ""This demonstrates that IFN-gamma signals through STAT3 to drive pathogenic chemokine production, providing direct mechanistic evidence for JAK-STAT pathway activation in AA."", ""reference"": ""PMID:38338982"", ""snippet"": ""Interferon- (IFN) treatment increased the secretion of CXCL12 from DFs through the signal transducer and activator of transcription 3 (STAT3) pathway, and CXCL12 treatment protected the hair follicle from IFN in hair organ culture."", ""supports"": ""SUPPORT""}], ""name"": ""JAK-STAT Signaling Activation""}"
449	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	3	Chemokine-Mediated Immune Cell Recruitment	CXCL12 and other chemokines recruit and activate CD8+ T cells to the hair follicle. IFN-gamma induces CXCL12 production from dermal fibroblasts, amplifying immune cell infiltration and contributing to disease progression.																																																								"{""description"": ""CXCL12 and other chemokines recruit and activate CD8+ T cells to the hair follicle. IFN-gamma induces CXCL12 production from dermal fibroblasts, amplifying immune cell infiltration and contributing to disease progression."", ""name"": ""Chemokine-Mediated Immune Cell Recruitment""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immune Response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}], ""description"": ""CXCL12 and other chemokines recruit and activate CD8+ T cells to the hair follicle. IFN-gamma induces CXCL12 production from dermal fibroblasts, amplifying immune cell infiltration and contributing to disease progression."", ""evidence"": [{""explanation"": ""This demonstrates that CXCL12 drives CD8+ T cell recruitment to hair follicles, and blocking this chemokine can prevent disease onset and reduce immune cell infiltration in AA."", ""reference"": ""PMID:38338982"", ""snippet"": ""CXCL12 expression is increased in AA mice, while s.c. injection of CXCL12 significantly inhibited hair loss in AA mice and reduced the number of CD8+, MHC-I+, and MHC-II+ cells in the skin. In addition, injection of CXCL12 also prevented the onset of AA and reduced the number of CD8+ cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""Elevated CXCL9 and CXCL10 chemokines in AA blood support the role of chemokine-mediated immune cell recruitment in disease pathogenesis."", ""reference"": ""PMID:38673994"", ""snippet"": ""Blood chemokine C-X-C motif ligand 9 (CXCL9) and CXCL10 are elevated in both diseases."", ""supports"": ""SUPPORT""}], ""name"": ""Chemokine-Mediated Immune Cell Recruitment""}"
460	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	0	Protease-Antiprotease Imbalance in Lung	"Alpha-1 antitrypsin (AAT) is the major inhibitor of neutrophil elastase in the lung. Deficiency of AAT leads to unopposed elastase activity, causing progressive destruction of alveolar walls and development of emphysema, particularly affecting the lower lobes.
"																																																								"{""description"": ""Alpha-1 antitrypsin (AAT) is the major inhibitor of neutrophil elastase in the lung. Deficiency of AAT leads to unopposed elastase activity, causing progressive destruction of alveolar walls and development of emphysema, particularly affecting the lower lobes.\n"", ""name"": ""Protease-Antiprotease Imbalance in Lung""}"	{}	"{""biological_processes"": [{""preferred_term"": ""neutrophil degranulation"", ""term"": {""id"": ""GO:0043312"", ""label"": ""neutrophil degranulation""}}], ""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Alpha-1 antitrypsin (AAT) is the major inhibitor of neutrophil elastase in the lung. Deficiency of AAT leads to unopposed elastase activity, causing progressive destruction of alveolar walls and development of emphysema, particularly affecting the lower lobes.\n"", ""evidence"": [{""explanation"": ""This review confirms that emphysema is a common manifestation of alpha-1 antitrypsin deficiency."", ""reference"": ""PMID:22500781"", ""snippet"": ""Alpha-1 antitrypsin deficiency (AATD) is a relatively common, but under-recognized condition which manifests commonly with liver cirrhosis and emphysema."", ""supports"": ""SUPPORT""}], ""name"": ""Protease-Antiprotease Imbalance in Lung""}"
461	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	1	Hepatic Protein Aggregation	"The Z variant of AAT (E342K, PiZZ genotype) causes misfolding of AAT protein in hepatocytes. Misfolded AAT accumulates in the endoplasmic reticulum, forming polymers that cannot be secreted, leading to hepatocyte injury and liver disease.
"																																																								"{""description"": ""The Z variant of AAT (E342K, PiZZ genotype) causes misfolding of AAT protein in hepatocytes. Misfolded AAT accumulates in the endoplasmic reticulum, forming polymers that cannot be secreted, leading to hepatocyte injury and liver disease.\n"", ""name"": ""Hepatic Protein Aggregation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to endoplasmic reticulum stress"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}], ""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""The Z variant of AAT (E342K, PiZZ genotype) causes misfolding of AAT protein in hepatocytes. Misfolded AAT accumulates in the endoplasmic reticulum, forming polymers that cannot be secreted, leading to hepatocyte injury and liver disease.\n"", ""evidence"": [{""explanation"": ""Review confirms that AATD manifests with liver cirrhosis due to protein aggregation in hepatocytes."", ""reference"": ""PMID:22500781"", ""snippet"": ""Alpha-1 antitrypsin deficiency (AATD) is a relatively common, but under-recognized condition which manifests commonly with liver cirrhosis and emphysema."", ""supports"": ""SUPPORT""}], ""name"": ""Hepatic Protein Aggregation""}"
462	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	2	Neutrophil Recruitment to Lung Parenchyma	"Inflammatory signals recruit neutrophils to the lung tissue, particularly in response to cigarette smoke, respiratory infections, or other inflammatory stimuli.
"																																																								"{""description"": ""Inflammatory signals recruit neutrophils to the lung tissue, particularly in response to cigarette smoke, respiratory infections, or other inflammatory stimuli.\n"", ""name"": ""Neutrophil Recruitment to Lung Parenchyma""}"	"{""downstream"": [{""description"": ""Activated neutrophils degranulate and release elastase into the lung parenchyma."", ""target"": ""Neutrophil Elastase Release""}]}"	"{""biological_processes"": [{""preferred_term"": ""leukocyte migration"", ""term"": {""id"": ""GO:0050900"", ""label"": ""leukocyte migration""}}], ""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Inflammatory signals recruit neutrophils to the lung tissue, particularly in response to cigarette smoke, respiratory infections, or other inflammatory stimuli.\n"", ""downstream"": [{""description"": ""Activated neutrophils degranulate and release elastase into the lung parenchyma."", ""target"": ""Neutrophil Elastase Release""}], ""name"": ""Neutrophil Recruitment to Lung Parenchyma""}"
463	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	3	Neutrophil Elastase Release	"Activated neutrophils release elastase and other proteases that, in the absence of sufficient alpha-1 antitrypsin inhibition, remain enzymatically active and degrade structural proteins.
"																																																								"{""description"": ""Activated neutrophils release elastase and other proteases that, in the absence of sufficient alpha-1 antitrypsin inhibition, remain enzymatically active and degrade structural proteins.\n"", ""name"": ""Neutrophil Elastase Release""}"	"{""downstream"": [{""description"": ""Unopposed elastase activity degrades elastin and other extracellular matrix components in alveolar walls."", ""target"": ""Alveolar Tissue Destruction""}]}"	"{""biological_processes"": [{""preferred_term"": ""proteolysis"", ""term"": {""id"": ""GO:0006508"", ""label"": ""proteolysis""}}], ""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Activated neutrophils release elastase and other proteases that, in the absence of sufficient alpha-1 antitrypsin inhibition, remain enzymatically active and degrade structural proteins.\n"", ""downstream"": [{""description"": ""Unopposed elastase activity degrades elastin and other extracellular matrix components in alveolar walls."", ""target"": ""Alveolar Tissue Destruction""}], ""evidence"": [{""explanation"": ""Confirms that pulmonary inflammation is a primary manifestation of AATD requiring advanced therapeutic interventions"", ""reference"": ""PMID:36896570"", ""snippet"": ""Alpha1 antitrypsin deficiency (AATD), a common hereditary disorder affecting mainly lungs, liver and skin has been the focus of some of the most exciting therapeutic approaches in medicine in the past 5 years."", ""supports"": ""SUPPORT""}], ""name"": ""Neutrophil Elastase Release""}"
464	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	4	Alveolar Tissue Destruction	"Progressive degradation of alveolar walls and elastin fibers leads to loss of structural integrity, air trapping, and emphysema development.
"																																																								"{""description"": ""Progressive degradation of alveolar walls and elastin fibers leads to loss of structural integrity, air trapping, and emphysema development.\n"", ""name"": ""Alveolar Tissue Destruction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix disassembly"", ""term"": {""id"": ""GO:0022617"", ""label"": ""extracellular matrix disassembly""}}], ""description"": ""Progressive degradation of alveolar walls and elastin fibers leads to loss of structural integrity, air trapping, and emphysema development.\n"", ""name"": ""Alveolar Tissue Destruction""}"
486	20	Alveolar Rhabdomyosarcoma	Alveolar_Rhabdomyosarcoma.yaml	pathophysiology	0	PAX-FOXO1 Fusion Oncogene	The t(2;13) or t(1;13) translocations fuse the DNA-binding domain of PAX3 or PAX7 with the transactivation domain of FOXO1. The resulting fusion protein functions as a potent aberrant transcription factor that activates PAX target genes to supraphysiological levels, driving proliferation while blocking terminal myogenic differentiation.																																																								"{""description"": ""The t(2;13) or t(1;13) translocations fuse the DNA-binding domain of PAX3 or PAX7 with the transactivation domain of FOXO1. The resulting fusion protein functions as a potent aberrant transcription factor that activates PAX target genes to supraphysiological levels, driving proliferation while blocking terminal myogenic differentiation."", ""name"": ""PAX-FOXO1 Fusion Oncogene""}"	"{""downstream"": [{""description"": ""PAX-FOXO1 prevents terminal skeletal muscle differentiation"", ""target"": ""Blocked Myogenic Differentiation""}, {""description"": ""PAX-FOXO1 activates proliferative gene programs"", ""target"": ""Aberrant Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}], ""cell_types"": [{""preferred_term"": ""skeletal muscle myoblast"", ""term"": {""id"": ""CL:0000515"", ""label"": ""skeletal muscle myoblast""}}], ""description"": ""The t(2;13) or t(1;13) translocations fuse the DNA-binding domain of PAX3 or PAX7 with the transactivation domain of FOXO1. The resulting fusion protein functions as a potent aberrant transcription factor that activates PAX target genes to supraphysiological levels, driving proliferation while blocking terminal myogenic differentiation."", ""downstream"": [{""description"": ""PAX-FOXO1 prevents terminal skeletal muscle differentiation"", ""target"": ""Blocked Myogenic Differentiation""}, {""description"": ""PAX-FOXO1 activates proliferative gene programs"", ""target"": ""Aberrant Cell Proliferation""}], ""evidence"": [{""explanation"": ""Supports the prevalence of PAX3/7-FOXO1 fusions in alveolar rhabdomyosarcoma."", ""reference"": ""PMID:39686893"", ""snippet"": ""According to literature data, the frequency of the PAX3::FOXO1 translocation is 70-90% and the PAX7::FOXO1 translocation 10-30%."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""zone of skin"", ""term"": {""id"": ""UBERON:0000014"", ""label"": ""zone of skin""}}], ""name"": ""PAX-FOXO1 Fusion Oncogene""}"
487	20	Alveolar Rhabdomyosarcoma	Alveolar_Rhabdomyosarcoma.yaml	pathophysiology	1	Blocked Myogenic Differentiation	PAX-FOXO1 fusion protein blocks the normal myogenic differentiation program by interfering with MYOD1 and myogenin function. Tumor cells express early myogenic markers (desmin, myogenin) but fail to complete differentiation into mature skeletal muscle, remaining in a proliferative progenitor state.																																																								"{""description"": ""PAX-FOXO1 fusion protein blocks the normal myogenic differentiation program by interfering with MYOD1 and myogenin function. Tumor cells express early myogenic markers (desmin, myogenin) but fail to complete differentiation into mature skeletal muscle, remaining in a proliferative progenitor state."", ""name"": ""Blocked Myogenic Differentiation""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}], ""description"": ""PAX-FOXO1 fusion protein blocks the normal myogenic differentiation program by interfering with MYOD1 and myogenin function. Tumor cells express early myogenic markers (desmin, myogenin) but fail to complete differentiation into mature skeletal muscle, remaining in a proliferative progenitor state."", ""name"": ""Blocked Myogenic Differentiation""}"
488	20	Alveolar Rhabdomyosarcoma	Alveolar_Rhabdomyosarcoma.yaml	pathophysiology	2	Aberrant Cell Proliferation	PAX-FOXO1 activates genes promoting cell cycle progression and survival, including MYCN, which is commonly amplified in ARMS. The fusion protein also suppresses apoptosis through multiple mechanisms, contributing to tumor aggressiveness.																																																								"{""description"": ""PAX-FOXO1 activates genes promoting cell cycle progression and survival, including MYCN, which is commonly amplified in ARMS. The fusion protein also suppresses apoptosis through multiple mechanisms, contributing to tumor aggressiveness."", ""name"": ""Aberrant Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""PAX-FOXO1 activates genes promoting cell cycle progression and survival, including MYCN, which is commonly amplified in ARMS. The fusion protein also suppresses apoptosis through multiple mechanisms, contributing to tumor aggressiveness."", ""name"": ""Aberrant Cell Proliferation""}"
500	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	0	Amyloid-Beta Plaque Formation	"Extracellular accumulation of amyloid-beta (A) peptides into senile plaques. A is produced through sequential cleavage of amyloid precursor protein (APP) by -secretase and -secretase. Soluble oligomeric forms of A are toxic to synapses and interfere with synaptic plasticity and memory formation.
"																																																								"{""description"": ""Extracellular accumulation of amyloid-beta (A) peptides into senile plaques. A is produced through sequential cleavage of amyloid precursor protein (APP) by -secretase and -secretase. Soluble oligomeric forms of A are toxic to synapses and interfere with synaptic plasticity and memory formation.\n"", ""name"": ""Amyloid-Beta Plaque Formation""}"	"{""downstream"": [{""target"": ""Synaptic Dysfunction""}, {""target"": ""Neuroinflammation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""amyloid precursor protein catabolic process"", ""term"": {""id"": ""GO:0042987"", ""label"": ""amyloid precursor protein catabolic process""}}], ""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}, {""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Extracellular accumulation of amyloid-beta (A) peptides into senile plaques. A is produced through sequential cleavage of amyloid precursor protein (APP) by -secretase and -secretase. Soluble oligomeric forms of A are toxic to synapses and interfere with synaptic plasticity and memory formation.\n"", ""downstream"": [{""target"": ""Synaptic Dysfunction""}, {""target"": ""Neuroinflammation""}], ""evidence"": [{""explanation"": ""Confirms that A accumulation in the brain is a hallmark characteristic of Alzheimer's disease."", ""reference"": ""PMID:21456963"", ""snippet"": ""Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the -amyloid peptide (A) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau."", ""supports"": ""SUPPORT""}, {""explanation"": ""Describes the sequential proteolytic processing of APP by secretases to generate A peptides."", ""reference"": ""PMID:21456963"", ""snippet"": ""physiologic generation of the neurotoxic A peptide from sequential amyloid precursor protein (APP) proteolysis is the crucial step in the development of AD. APP is a single-pass transmembrane protein expressed at high levels in the brain and metabolized in a rapid and highly complex fashion by a series of sequential proteases, including the intramembranous -secretase complex"", ""supports"": ""SUPPORT""}], ""name"": ""Amyloid-Beta Plaque Formation""}"
501	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	1	Neurofibrillary Tangle Formation	"Intracellular accumulation of hyperphosphorylated tau protein forming neurofibrillary tangles (NFTs). Tau normally stabilizes microtubules, but abnormal hyperphosphorylation by various kinases reduces its affinity for microtubules, leading to accumulation of free tau that aggregates into paired helical filaments and NFTs. This causes mitochondrial dysfunction, impairs synaptic plasticity, and triggers neuroinflammation.
"																																																								"{""description"": ""Intracellular accumulation of hyperphosphorylated tau protein forming neurofibrillary tangles (NFTs). Tau normally stabilizes microtubules, but abnormal hyperphosphorylation by various kinases reduces its affinity for microtubules, leading to accumulation of free tau that aggregates into paired helical filaments and NFTs. This causes mitochondrial dysfunction, impairs synaptic plasticity, and triggers neuroinflammation.\n"", ""name"": ""Neurofibrillary Tangle Formation""}"	"{""downstream"": [{""target"": ""Synaptic Dysfunction""}, {""target"": ""Neuronal Death""}]}"	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Intracellular accumulation of hyperphosphorylated tau protein forming neurofibrillary tangles (NFTs). Tau normally stabilizes microtubules, but abnormal hyperphosphorylation by various kinases reduces its affinity for microtubules, leading to accumulation of free tau that aggregates into paired helical filaments and NFTs. This causes mitochondrial dysfunction, impairs synaptic plasticity, and triggers neuroinflammation.\n"", ""downstream"": [{""target"": ""Synaptic Dysfunction""}, {""target"": ""Neuronal Death""}], ""evidence"": [{""explanation"": ""Confirms that tau hyperphosphorylation is a key pathological feature of Alzheimer's disease and involves protein kinases."", ""reference"": ""PMID:37264120"", ""snippet"": ""Tau protein hyperphosphorylation was the first pathological post-translational modification of tau protein described in Alzheimer's disease (AD), highlighting the role of PKs in neurodegeneration."", ""supports"": ""SUPPORT""}, {""explanation"": ""Documents that hyperphosphorylated tau is a characteristic neuropathological hallmark of Alzheimer's disease."", ""reference"": ""PMID:21456963"", ""snippet"": ""Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the -amyloid peptide (A) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau."", ""supports"": ""SUPPORT""}], ""name"": ""Neurofibrillary Tangle Formation""}"
502	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	2	Synaptic Dysfunction	"Oligomeric forms of A and tau are toxic to synapses, interfering with molecular pathways required for synaptic plasticity and memory. This synaptic dysfunction precedes neuronal death and correlates with cognitive impairment severity.
"																																																								"{""description"": ""Oligomeric forms of A and tau are toxic to synapses, interfering with molecular pathways required for synaptic plasticity and memory. This synaptic dysfunction precedes neuronal death and correlates with cognitive impairment severity.\n"", ""name"": ""Synaptic Dysfunction""}"	"{""downstream"": [{""target"": ""Memory Impairment""}, {""target"": ""Cognitive Decline""}]}"	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Oligomeric forms of A and tau are toxic to synapses, interfering with molecular pathways required for synaptic plasticity and memory. This synaptic dysfunction precedes neuronal death and correlates with cognitive impairment severity.\n"", ""downstream"": [{""target"": ""Memory Impairment""}, {""target"": ""Cognitive Decline""}], ""evidence"": [{""explanation"": ""Confirms that synaptic loss correlates with cognitive impairment and precedes neuronal death in Alzheimer's disease."", ""reference"": ""PMID:28059794"", ""snippet"": ""The loss of synapses in the affected brain regions correlates best with cognitive impairment in AD patients and has been considered as the early mechanism that precedes neuronal loss."", ""supports"": ""SUPPORT""}, {""explanation"": ""Describes how oxidative stress affects synaptic activity and neurotransmission, contributing to cognitive dysfunction."", ""reference"": ""PMID:28059794"", ""snippet"": ""Increased production of reactive oxygen species (ROS) associated with age- and disease-dependent loss of mitochondrial function, altered metal homeostasis, and reduced antioxidant defense directly affect synaptic activity and neurotransmission in neurons leading to cognitive dysfunction."", ""supports"": ""SUPPORT""}], ""name"": ""Synaptic Dysfunction""}"
503	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	3	Neuroinflammation	"Chronic activation of microglia and astrocytes in response to A plaques and tau tangles. While initially attempting to clear pathological proteins, sustained inflammation produces pro-inflammatory cytokines and reactive oxygen species that damage neurons and exacerbate neurodegeneration.
"																																																								"{""description"": ""Chronic activation of microglia and astrocytes in response to A plaques and tau tangles. While initially attempting to clear pathological proteins, sustained inflammation produces pro-inflammatory cytokines and reactive oxygen species that damage neurons and exacerbate neurodegeneration.\n"", ""name"": ""Neuroinflammation""}"	"{""downstream"": [{""target"": ""Neuronal Death""}]}"	"{""cell_types"": [{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Chronic activation of microglia and astrocytes in response to A plaques and tau tangles. While initially attempting to clear pathological proteins, sustained inflammation produces pro-inflammatory cytokines and reactive oxygen species that damage neurons and exacerbate neurodegeneration.\n"", ""downstream"": [{""target"": ""Neuronal Death""}], ""evidence"": [{""explanation"": ""Describes how microglia respond to A plaques and play a major role in AD pathogenesis through neuroinflammation."", ""reference"": ""PMID:32048973"", ""snippet"": ""An emerging concept is that microglia, the innate immune cells of the brain, are major players in AD pathogenesis. Microglia are longlived tissue-resident professional phagocytes that survey and rapidly respond to changes in their microenvironment. Subpopulations of microglia cluster around A plaques and adopt a transcriptomic signature specifically linked to neurodegeneration."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms the role of microglial dysfunction in mediating neurodegeneration in Alzheimer's disease."", ""reference"": ""PMID:32048973"", ""snippet"": ""A plethora of molecules and pathways associated with microglia function and dysfunction has been identified as important players in mediating neurodegeneration."", ""supports"": ""SUPPORT""}], ""name"": ""Neuroinflammation""}"
504	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	4	Neuronal Death	"Progressive loss of neurons, particularly in the hippocampus and cortex, leading to brain atrophy. Neuronal death results from accumulated damage from A toxicity, tau pathology, mitochondrial dysfunction, oxidative stress, and neuroinflammation.
"																																																								"{""description"": ""Progressive loss of neurons, particularly in the hippocampus and cortex, leading to brain atrophy. Neuronal death results from accumulated damage from A toxicity, tau pathology, mitochondrial dysfunction, oxidative stress, and neuroinflammation.\n"", ""name"": ""Neuronal Death""}"	"{""downstream"": [{""target"": ""Brain Atrophy""}, {""target"": ""Dementia""}]}"	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Progressive loss of neurons, particularly in the hippocampus and cortex, leading to brain atrophy. Neuronal death results from accumulated damage from A toxicity, tau pathology, mitochondrial dysfunction, oxidative stress, and neuroinflammation.\n"", ""downstream"": [{""target"": ""Brain Atrophy""}, {""target"": ""Dementia""}], ""evidence"": [{""explanation"": ""Describes the vicious cycle of A, tau, and oxidative stress that leads to neuronal damage and death."", ""reference"": ""PMID:28059794"", ""snippet"": ""Abnormal cellular metabolism in turn could affect the production and accumulation of amyloid- (A) and hyperphosphorylated Tau protein, which independently could exacerbate mitochondrial dysfunction and ROS production, thereby contributing to a vicious cycle."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms Alzheimer's as a neurodegenerative disorder characterized by progressive neuronal loss."", ""reference"": ""PMID:28059794"", ""snippet"": ""Alzheimer's disease (AD) is a devastating neurodegenerative disorder without a cure. Most AD cases are sporadic where age represents the greatest risk factor."", ""supports"": ""SUPPORT""}], ""name"": ""Neuronal Death""}"
531	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	0	Motor Neuron Degeneration	"Progressive death of upper motor neurons in the motor cortex and lower motor neurons in the brainstem and spinal cord leads to denervation of skeletal muscles. The loss of upper motor neurons causes spasticity and hyperreflexia, while lower motor neuron loss results in muscle weakness, atrophy, and fasciculations.
"																																																								"{""description"": ""Progressive death of upper motor neurons in the motor cortex and lower motor neurons in the brainstem and spinal cord leads to denervation of skeletal muscles. The loss of upper motor neurons causes spasticity and hyperreflexia, while lower motor neuron loss results in muscle weakness, atrophy, and fasciculations.\n"", ""name"": ""Motor Neuron Degeneration""}"	{}	"{""cell_types"": [{""preferred_term"": ""motor neuron"", ""term"": {""id"": ""CL:0000100"", ""label"": ""motor neuron""}}], ""description"": ""Progressive death of upper motor neurons in the motor cortex and lower motor neurons in the brainstem and spinal cord leads to denervation of skeletal muscles. The loss of upper motor neurons causes spasticity and hyperreflexia, while lower motor neuron loss results in muscle weakness, atrophy, and fasciculations.\n"", ""evidence"": [{""explanation"": ""Single-cell analysis confirms motor neuron vulnerability in ALS and identifies vulnerable populations in cortical layer 5."", ""reference"": ""PMID:38521060"", ""snippet"": ""Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) share many clinical, pathological, and genetic features"", ""supports"": ""SUPPORT""}, {""explanation"": ""Review summarizes canonical ALS pathology of progressive upper and lower motor neuron degeneration causing loss of voluntary movement."", ""reference"": ""PMID:38891021"", ""snippet"": ""upper and lower motor neurons in the brain and spinal cord progressively degenerate during the course of the disease, leading to the loss of the voluntary movement of the arms and legs."", ""supports"": ""SUPPORT""}, {""explanation"": ""Lancet Seminar underscores ALS as a fatal neurodegenerative disorder affecting central nervous system motor pathways."", ""reference"": ""PMID:36116464"", ""snippet"": ""Amyotrophic lateral sclerosis is a fatal CNS neurodegenerative disease."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""primary motor cortex"", ""term"": {""id"": ""UBERON:0001384"", ""label"": ""primary motor cortex""}}], ""name"": ""Motor Neuron Degeneration""}"
532	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	1	TDP-43 Proteinopathy	"Cytoplasmic aggregation of TDP-43 (TAR DNA-binding protein 43) is found in approximately 97% of ALS cases. TDP-43 normally functions in RNA processing but becomes mislocalized from the nucleus to cytoplasmic inclusions, leading to both loss of nuclear function and toxic gain of function. This impairs RNA splicing including STMN2.
"																																																								"{""description"": ""Cytoplasmic aggregation of TDP-43 (TAR DNA-binding protein 43) is found in approximately 97% of ALS cases. TDP-43 normally functions in RNA processing but becomes mislocalized from the nucleus to cytoplasmic inclusions, leading to both loss of nuclear function and toxic gain of function. This impairs RNA splicing including STMN2.\n"", ""name"": ""TDP-43 Proteinopathy""}"	{}	"{""biological_processes"": [{""preferred_term"": ""RNA splicing"", ""term"": {""id"": ""GO:0000375"", ""label"": ""RNA splicing, via transesterification reactions""}}], ""description"": ""Cytoplasmic aggregation of TDP-43 (TAR DNA-binding protein 43) is found in approximately 97% of ALS cases. TDP-43 normally functions in RNA processing but becomes mislocalized from the nucleus to cytoplasmic inclusions, leading to both loss of nuclear function and toxic gain of function. This impairs RNA splicing including STMN2.\n"", ""evidence"": [{""explanation"": ""Review confirms ubiquitin-positive inclusions as a common pathological feature in ALS."", ""reference"": ""PMID:16736722"", ""snippet"": ""the most common tau negative ubiquitin positive amyotrophic lateral sclerosis (ALS) type inclusions"", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""TARDBP"", ""term"": {""id"": ""hgnc:11571"", ""label"": ""TARDBP""}}], ""name"": ""TDP-43 Proteinopathy""}"
533	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	2	C9orf72 Repeat Expansion Toxicity	"Hexanucleotide (GGGGCC) repeat expansion in C9orf72 is the most common genetic cause of ALS, accounting for 40% of familial and 5-10% of sporadic cases. The expansion leads to RNA foci formation, dipeptide repeat protein aggregation, and haploinsufficiency.
"																																																								"{""description"": ""Hexanucleotide (GGGGCC) repeat expansion in C9orf72 is the most common genetic cause of ALS, accounting for 40% of familial and 5-10% of sporadic cases. The expansion leads to RNA foci formation, dipeptide repeat protein aggregation, and haploinsufficiency.\n"", ""name"": ""C9orf72 Repeat Expansion Toxicity""}"	{}	"{""description"": ""Hexanucleotide (GGGGCC) repeat expansion in C9orf72 is the most common genetic cause of ALS, accounting for 40% of familial and 5-10% of sporadic cases. The expansion leads to RNA foci formation, dipeptide repeat protein aggregation, and haploinsufficiency.\n"", ""evidence"": [{""explanation"": ""Original discovery paper establishing C9orf72 repeat expansion as a major cause of both FTD and ALS with dual mechanisms."", ""reference"": ""PMID:21944778"", ""snippet"": ""Analysis of extended clinical series found the C9ORF72 repeat expansion to be the most common genetic abnormality in both familial FTD (11.7%) and familial ALS (23.5%). The repeat expansion leads to the loss of one alternatively spliced C9ORF72 transcript and to formation of nuclear RNA foci, suggesting multiple disease mechanisms."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""C9orf72"", ""term"": {""id"": ""hgnc:28337"", ""label"": ""C9orf72""}}], ""name"": ""C9orf72 Repeat Expansion Toxicity""}"
534	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	3	Glutamate Excitotoxicity	"Impaired glutamate clearance by astrocytes leads to excessive glutamate accumulation in the synaptic cleft, causing prolonged activation of glutamate receptors on motor neurons. This results in calcium overload and subsequent neuronal death.
"																																																								"{""description"": ""Impaired glutamate clearance by astrocytes leads to excessive glutamate accumulation in the synaptic cleft, causing prolonged activation of glutamate receptors on motor neurons. This results in calcium overload and subsequent neuronal death.\n"", ""name"": ""Glutamate Excitotoxicity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""neurotransmitter transport"", ""term"": {""id"": ""GO:0006836"", ""label"": ""neurotransmitter transport""}}], ""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Impaired glutamate clearance by astrocytes leads to excessive glutamate accumulation in the synaptic cleft, causing prolonged activation of glutamate receptors on motor neurons. This results in calcium overload and subsequent neuronal death.\n"", ""evidence"": [{""explanation"": ""Trial of riluzole, an antiglutamate agent, supports role of glutamate excitotoxicity in ALS pathogenesis."", ""reference"": ""PMID:8302340"", ""snippet"": ""Some research suggests that the excitatory amino acid neurotransmitter glutamate may be involved in the pathogenesis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Recent mechanistic review highlights glutamate-mediated excitotoxicity as a key pathogenic process and therapeutic target in ALS."", ""reference"": ""PMID:40508048"", ""snippet"": ""understanding of the key pathogenetic links of ALS, including glutamate-mediated excitotoxicity and oxidative stress, has significantly advanced."", ""supports"": ""SUPPORT""}], ""name"": ""Glutamate Excitotoxicity""}"
535	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	4	Oxidative Stress	"Motor neurons are particularly vulnerable to oxidative damage due to high metabolic demands. Mutations in SOD1, which encodes superoxide dismutase 1, lead to misfolded protein aggregation and increased oxidative stress contributing to neuronal death.
"																																																								"{""description"": ""Motor neurons are particularly vulnerable to oxidative damage due to high metabolic demands. Mutations in SOD1, which encodes superoxide dismutase 1, lead to misfolded protein aggregation and increased oxidative stress contributing to neuronal death.\n"", ""name"": ""Oxidative Stress""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""description"": ""Motor neurons are particularly vulnerable to oxidative damage due to high metabolic demands. Mutations in SOD1, which encodes superoxide dismutase 1, lead to misfolded protein aggregation and increased oxidative stress contributing to neuronal death.\n"", ""evidence"": [{""explanation"": ""Discovery of SOD1 mutations in familial ALS implicates oxidative stress in disease pathogenesis."", ""reference"": ""PMID:8446170"", ""snippet"": ""a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion"", ""supports"": ""SUPPORT""}, {""explanation"": ""Review emphasizes oxidative stress as a targetable pathogenic mechanism and discusses antioxidant therapeutic strategies in ALS."", ""reference"": ""PMID:40508048"", ""snippet"": ""This review considers the recent evidence on molecular mechanisms of these processes, as well as the therapeutic strategies aimed at their modulation. Special attention is paid to antiglutamatergic and antioxidant drugs as approaches to the ALS pathogenetic therapy."", ""supports"": ""SUPPORT""}, {""explanation"": ""Therapeutic strategies review highlights oxidative stress among key pathological mechanisms contributing to ALS."", ""reference"": ""PMID:35269543"", ""snippet"": ""ALS has a multifaceted nature affected by many pathological mechanisms, including oxidative stress (also via protein aggregation), mitochondrial dysfunction, glutamate-induced excitotoxicity, apoptosis, neuroinflammation, axonal degeneration, skeletal muscle deterioration and viruses."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""SOD1"", ""term"": {""id"": ""hgnc:11179"", ""label"": ""SOD1""}}], ""name"": ""Oxidative Stress""}"
536	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	5	Neuroinflammation	"Activated microglia and astrocytes contribute to motor neuron death through the release of pro-inflammatory cytokines, reactive oxygen species, and other neurotoxic factors. This non-cell-autonomous mechanism amplifies neurodegeneration.
"																																																								"{""description"": ""Activated microglia and astrocytes contribute to motor neuron death through the release of pro-inflammatory cytokines, reactive oxygen species, and other neurotoxic factors. This non-cell-autonomous mechanism amplifies neurodegeneration.\n"", ""name"": ""Neuroinflammation""}"	{}	"{""cell_types"": [{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Activated microglia and astrocytes contribute to motor neuron death through the release of pro-inflammatory cytokines, reactive oxygen species, and other neurotoxic factors. This non-cell-autonomous mechanism amplifies neurodegeneration.\n"", ""evidence"": [{""explanation"": ""Review confirms immune cell involvement in ALS pathophysiology with T-cell recruitment to affected areas."", ""reference"": ""PMID:34440810"", ""snippet"": ""In the archetypical neurodegenerative disorder amyotrophic lateral sclerosis (ALS), the recruitment of T-cells is well known"", ""supports"": ""SUPPORT""}], ""name"": ""Neuroinflammation""}"
537	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	6	Microglial TREM2 Signaling	"TREM2 expressed on microglia regulates proliferation, activation, and phagocytosis; altered TREM2 signaling is implicated in ALS progression through dysregulated microglial responses to motor neuron injury.
"																																																								"{""description"": ""TREM2 expressed on microglia regulates proliferation, activation, and phagocytosis; altered TREM2 signaling is implicated in ALS progression through dysregulated microglial responses to motor neuron injury.\n"", ""name"": ""Microglial TREM2 Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""microglial cell activation"", ""term"": {""id"": ""GO:0001774"", ""label"": ""microglial cell activation""}}], ""cell_types"": [{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""TREM2 expressed on microglia regulates proliferation, activation, and phagocytosis; altered TREM2 signaling is implicated in ALS progression through dysregulated microglial responses to motor neuron injury.\n"", ""evidence"": [{""explanation"": ""Review summarizes how microglial TREM2 function shapes ALS progression and highlights its role in microglial activation."", ""reference"": ""PMID:34874625"", ""snippet"": ""Triggering receptor expressed on myeloid cell 2 (TREM2) is a surface receptor that, within the CNS, is exclusively expressed on microglia and plays crucial roles in microglial proliferation, migration, activation, metabolism, and phagocytosis."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""TREM2"", ""term"": {""id"": ""hgnc:17761"", ""label"": ""TREM2""}}], ""name"": ""Microglial TREM2 Signaling""}"
538	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	7	Axonal Transport Dysfunction	"Impaired axonal transport leads to accumulation of organelles and proteins in motor neuron axons, contributing to neurodegeneration. Gene mutations affecting cytoskeletal components (KIF5A, DCTN1, PFN1) contribute to this dysfunction.
"																																																								"{""description"": ""Impaired axonal transport leads to accumulation of organelles and proteins in motor neuron axons, contributing to neurodegeneration. Gene mutations affecting cytoskeletal components (KIF5A, DCTN1, PFN1) contribute to this dysfunction.\n"", ""name"": ""Axonal Transport Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""anterograde axonal transport"", ""term"": {""id"": ""GO:0008089"", ""label"": ""anterograde axonal transport""}}], ""description"": ""Impaired axonal transport leads to accumulation of organelles and proteins in motor neuron axons, contributing to neurodegeneration. Gene mutations affecting cytoskeletal components (KIF5A, DCTN1, PFN1) contribute to this dysfunction.\n"", ""evidence"": [{""explanation"": ""Review confirms axonal transport defects as early pathogenic events in ALS."", ""reference"": ""PMID:22312314"", ""snippet"": ""Axonal transport defects are among the early molecular events leading to neurodegeneration in mouse models of amyotrophic lateral sclerosis (ALS)."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""KIF5A"", ""term"": {""id"": ""hgnc:8938"", ""label"": ""KIF5A""}}, {""preferred_term"": ""DCTN1"", ""term"": {""id"": ""hgnc:2701"", ""label"": ""DCTN1""}}, {""preferred_term"": ""PFN1"", ""term"": {""id"": ""hgnc:8880"", ""label"": ""PFN1""}}], ""name"": ""Axonal Transport Dysfunction""}"
539	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	8	Impaired Autophagy	"Defects in autophagy and protein quality control pathways lead to accumulation of misfolded proteins and damaged organelles in motor neurons. Multiple ALS genes (TBK1, OPTN, VCP, SQSTM1) function in autophagy.
"																																																								"{""description"": ""Defects in autophagy and protein quality control pathways lead to accumulation of misfolded proteins and damaged organelles in motor neurons. Multiple ALS genes (TBK1, OPTN, VCP, SQSTM1) function in autophagy.\n"", ""name"": ""Impaired Autophagy""}"	{}	"{""biological_processes"": [{""preferred_term"": ""autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}], ""description"": ""Defects in autophagy and protein quality control pathways lead to accumulation of misfolded proteins and damaged organelles in motor neurons. Multiple ALS genes (TBK1, OPTN, VCP, SQSTM1) function in autophagy.\n"", ""evidence"": [{""explanation"": ""Review describes TBK1's role in autophagy and confirms multiple ALS genes function in autophagy pathways."", ""reference"": ""PMID:28148298"", ""snippet"": ""TBK1 also has a major role in autophagy and mitophagy, chiefly the phosphorylation of autophagy adaptors. Several other ALS genes are also involved in autophagy, including p62 and OPTN."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""TBK1"", ""term"": {""id"": ""hgnc:11584"", ""label"": ""TBK1""}}, {""preferred_term"": ""OPTN"", ""term"": {""id"": ""hgnc:17101"", ""label"": ""OPTN""}}, {""preferred_term"": ""VCP"", ""term"": {""id"": ""hgnc:12666"", ""label"": ""VCP""}}, {""preferred_term"": ""SQSTM1"", ""term"": {""id"": ""hgnc:11240"", ""label"": ""SQSTM1""}}], ""name"": ""Impaired Autophagy""}"
540	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	9	Genetic Drivers and Therapeutic Translation	"Expanding genetic discoveries across ALS, including C9orf72 repeat expansions and mutations in SOD1, TARDBP, and FUS, have catalyzed targeted therapeutic strategies such as antisense oligonucleotides, highlighting how genetic architecture informs treatment development.
"																																																								"{""description"": ""Expanding genetic discoveries across ALS, including C9orf72 repeat expansions and mutations in SOD1, TARDBP, and FUS, have catalyzed targeted therapeutic strategies such as antisense oligonucleotides, highlighting how genetic architecture informs treatment development.\n"", ""name"": ""Genetic Drivers and Therapeutic Translation""}"	{}	"{""description"": ""Expanding genetic discoveries across ALS, including C9orf72 repeat expansions and mutations in SOD1, TARDBP, and FUS, have catalyzed targeted therapeutic strategies such as antisense oligonucleotides, highlighting how genetic architecture informs treatment development.\n"", ""evidence"": [{""explanation"": ""Review links expanding ALS genetic discoveries to the development of targeted molecular therapies."", ""reference"": ""PMID:37024676"", ""snippet"": ""Recent advances in sequencing technologies and collaborative efforts have led to substantial progress in identifying the genetic causes of amyotrophic lateral sclerosis (ALS). This momentum has, in turn, fostered the development of putative molecular therapies."", ""supports"": ""SUPPORT""}, {""explanation"": ""Drug discovery review notes recent genetic and translational advances enabling targeted ALS therapies."", ""reference"": ""PMID:36543887"", ""snippet"": ""Significant discoveries and advances have been made in ALS preclinical models, genetics, pathology, biomarkers, imaging and clinical readouts over the last 10-15 years."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""C9orf72"", ""term"": {""id"": ""hgnc:28337"", ""label"": ""C9orf72""}}, {""preferred_term"": ""SOD1"", ""term"": {""id"": ""hgnc:11179"", ""label"": ""SOD1""}}, {""preferred_term"": ""TARDBP"", ""term"": {""id"": ""hgnc:11571"", ""label"": ""TARDBP""}}, {""preferred_term"": ""FUS"", ""term"": {""id"": ""hgnc:4016"", ""label"": ""FUS""}}], ""name"": ""Genetic Drivers and Therapeutic Translation""}"
562	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	0	HLA-B27-Associated Immune Activation	HLA-B27 misfolding in the endoplasmic reticulum triggers the unfolded protein response and IL-23 production. Aberrant antigen presentation may also activate autoreactive T cells against joint antigens.																																																								"{""description"": ""HLA-B27 misfolding in the endoplasmic reticulum triggers the unfolded protein response and IL-23 production. Aberrant antigen presentation may also activate autoreactive T cells against joint antigens."", ""name"": ""HLA-B27-Associated Immune Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Antigen Presentation"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}], ""description"": ""HLA-B27 misfolding in the endoplasmic reticulum triggers the unfolded protein response and IL-23 production. Aberrant antigen presentation may also activate autoreactive T cells against joint antigens."", ""evidence"": [{""explanation"": ""Evidence supporting HLA-B27 misfolding mechanism that triggers ER stress and activates IL-23 production in ankylosing spondylitis."", ""reference"": ""PMID:33692806"", ""snippet"": ""The unfolded protein response (UPR) theory postulates that unconventional HLA-B27 variants homodimerize instead of heterodimerize; the misfolded proteins accumulate in the intracellular compartment triggering endoplasmic reticulum stress and increasing IL-23 production."", ""supports"": ""SUPPORT""}], ""name"": ""HLA-B27-Associated Immune Activation""}"
563	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	1	IL-23/IL-17 Axis Activation	IL-23-driven expansion of Th17 cells and innate lymphoid cells produces IL-17, driving inflammation at entheses and in the spine. This pathway is a key therapeutic target.																																																								"{""description"": ""IL-23-driven expansion of Th17 cells and innate lymphoid cells produces IL-17, driving inflammation at entheses and in the spine. This pathway is a key therapeutic target."", ""name"": ""IL-23/IL-17 Axis Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""T Helper Cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}], ""description"": ""IL-23-driven expansion of Th17 cells and innate lymphoid cells produces IL-17, driving inflammation at entheses and in the spine. This pathway is a key therapeutic target."", ""evidence"": [{""explanation"": ""Review evidence confirming the central role of IL-23/IL-17 axis in ankylosing spondylitis pathogenesis and other autoimmune diseases."", ""reference"": ""PMID:33692806"", ""snippet"": ""Well-established experimental data support the concept that IL-23/IL-17 axis activation contributes to the development of several inflammatory diseases, such as PsA, Psoriasis, Psoriatic Arthritis; AS, Ankylosing Spondylitis; IBD, Inflammatory Bowel Disease; RA, Rheumatoid Arthritis; SS, Sjogren Syndrome; MS, Multiple Sclerosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Direct evidence of elevated IL-23 and IL-17 levels and increased Th17 cells in ankylosing spondylitis patients."", ""reference"": ""PMID:33692806"", ""snippet"": ""The fundamental role played by the IL-23/IL-17 axis comes from several lines of evidence depicting a clear increase in IL-23 and IL-17 levels in the sera of AS patients (113). This observation is coupled with the increased number of Th17 cells in peripheral blood from AS patients (114)."", ""supports"": ""SUPPORT""}], ""name"": ""IL-23/IL-17 Axis Activation""}"
564	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	2	Enthesitis and New Bone Formation	Inflammation at entheses (tendon/ligament insertions) leads to erosion followed by aberrant bone formation. Syndesmophytes and ankylosis result from dysregulated osteoblast activity driven by Wnt and BMP signaling.																																																								"{""description"": ""Inflammation at entheses (tendon/ligament insertions) leads to erosion followed by aberrant bone formation. Syndesmophytes and ankylosis result from dysregulated osteoblast activity driven by Wnt and BMP signaling."", ""name"": ""Enthesitis and New Bone Formation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Bone Formation"", ""term"": {""id"": ""GO:0001503"", ""label"": ""ossification""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""Inflammation at entheses (tendon/ligament insertions) leads to erosion followed by aberrant bone formation. Syndesmophytes and ankylosis result from dysregulated osteoblast activity driven by Wnt and BMP signaling."", ""evidence"": [{""explanation"": ""Evidence linking chronic spinal inflammation to pathological new bone formation and ankylosis in ankylosing spondylitis."", ""reference"": ""PMID:33692806"", ""snippet"": ""New bone formation, determined by chronic inflammation involving the spine, leads to vertebral ankylosis, severe chronic pain and disability as major consequences of disease progression."", ""supports"": ""SUPPORT""}], ""name"": ""Enthesitis and New Bone Formation""}"
585	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	0	Antibody Production	The immune system produces antiphospholipid antibodies that target proteins associated with phospholipids in cell membranes.																																																								"{""description"": ""The immune system produces antiphospholipid antibodies that target proteins associated with phospholipids in cell membranes."", ""name"": ""Antibody Production""}"	{}	"{""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""The immune system produces antiphospholipid antibodies that target proteins associated with phospholipids in cell membranes."", ""evidence"": [{""explanation"": ""This reference supports the statement by describing how the immune system produces antibodies that target phospholipid-associated proteins in cell membranes, a process involving the participation of both B cells and other immune cells."", ""reference"": ""PMID:29867951"", ""snippet"": ""The primary anti-phospholipid syndrome (APS) is characterized by the production of antibodies that bind the phospholipid-binding protein beta2 glycoprotein I (beta2GPI) or that directly recognize negatively charged membrane phospholipids."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by noting the involvement of T and B cells in the production of antiphospholipid antibodies, which are pathogenic in APS."", ""reference"": ""PMID:30864219"", ""snippet"": ""Antiphospholipid antibodies (aPL) are pathogenic autoantibodies in antiphospholipid syndrome (APS). ... In PAPS and SLE/APS patients, Th2, Th17, and plasmablasts were increased while regulatory T, memory B, and regulatory B cells were decreased compared to healthy controls."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference further strengthens the support by indicating B cells' key role in the production of antiphospholipid antibodies in APS."", ""reference"": ""PMID:33722752"", ""snippet"": ""It is now widely accepted that antiphospholipid antibodies (aPL) have direct pathogenic effects and that B cells, notably through aPL production, play a key role in the development of antiphospholipid syndrome (APS)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the involvement of immune-produced antiphospholipid antibodies in APS and their interaction with cell membrane proteins."", ""reference"": ""PMID:8968222"", ""snippet"": ""Antiphospholipid antibodies are a heterogeneous group of antibodies with varying specificities. ... There are numerous potential links between antiphospholipid antibodies and coagulation disorders, including interaction of antiphospholipid antibodies and a cofactor, beta 2-glycoprotein I."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference discusses the cellular mechanisms activated by antiphospholipid antibodies, supporting the role of B and T cells in APS."", ""reference"": ""PMID:22055541"", ""snippet"": ""Diverse experimental evidence exists implicating the activation of various different cell surface receptors and intracellular pathways by antiphospholipid antibodies (aPL)."", ""supports"": ""SUPPORT""}], ""name"": ""Antibody Production""}"
586	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	1	Blood Clot Formation	Antiphospholipid antibodies increase the risk of forming clots in both arteries and veins, affecting blood flow.																																																								"{""description"": ""Antiphospholipid antibodies increase the risk of forming clots in both arteries and veins, affecting blood flow."", ""name"": ""Blood Clot Formation""}"	{}	"{""description"": ""Antiphospholipid antibodies increase the risk of forming clots in both arteries and veins, affecting blood flow."", ""evidence"": [{""explanation"": ""This reference highlights the association of antiphospholipid antibodies with thrombosis risk, supporting the statement that they increase the risk of forming clots."", ""reference"": ""PMID:22100379"", ""snippet"": ""Antiphospholipids are a heterogeneous group of circulating autoantibodies associated with a risk of thrombosis and can paradoxically prolong in vitro the clotting times"", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference explains that antiphospholipid antibodies are linked to a prothrombotic state, indicating an increased risk of clots in both arteries and veins."", ""reference"": ""PMID:8968222"", ""snippet"": ""It is clear that antiphospholipid antibodies are associated with an immune-mediated prothrombotic state."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by elaborating on the role of antibodies in arterial and venous thrombosis."", ""reference"": ""PMID:29867951"", ""snippet"": ""The primary anti-phospholipid syndrome (APS) is characterized by the production of antibodies that... may contribute to arterial or venous thrombosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although it acknowledges the mechanisms are not fully understood, it confirms the strong association between antiphospholipid antibodies and thrombosis."", ""reference"": ""PMID:12848964"", ""snippet"": ""Despite the strong association between antiphospholipid antibodies (aPL) and thrombosis, the pathogenic role of aPL in the development of thrombosis has not been fully elucidated."", ""supports"": ""SUPPORT""}, {""explanation"": ""This directly supports the statement by indicating that APS is associated with both arterial and venous thrombosis."", ""reference"": ""PMID:24321419"", ""snippet"": ""Antiphospholipid syndrome (APS) is associated with the risk of both arterial and venous thrombosis."", ""supports"": ""SUPPORT""}], ""name"": ""Blood Clot Formation""}"
587	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	2	Impaired Blood Flow	Blood clots obstruct normal blood flow, leading to complications depending on the clot's location in the body.																																																								"{""description"": ""Blood clots obstruct normal blood flow, leading to complications depending on the clot's location in the body."", ""name"": ""Impaired Blood Flow""}"	{}	"{""description"": ""Blood clots obstruct normal blood flow, leading to complications depending on the clot's location in the body."", ""evidence"": [{""explanation"": ""The literature supports that APS is characterized by thrombosis, which aligns with blood clots obstructing normal blood flow."", ""reference"": ""PMID:29339317"", ""snippet"": ""antiphospholipid syndrome (APS) is an autoimmune condition characterized by the occurrence of recurrent arterial and/or venous thrombosis"", ""supports"": ""SUPPORT""}, {""explanation"": ""The mechanism by which antiphospholipid antibodies induce thrombosis directly aligns with the provided statement."", ""reference"": ""PMID:33878780"", ""snippet"": ""aPL induce excessive activation of the endothelium, monocytes, and platelets in consort with aberrations in hemostasis/clotting, fibrinolytic system, and complement activation."", ""supports"": ""SUPPORT""}, {""explanation"": ""The thromboembolic events described are consistent with blood clots obstructing normal blood flow."", ""reference"": ""PMID:33341301"", ""snippet"": ""Thrombotic Antiphospholipid Syndrome (APS) is a condition affecting young individuals in whom a thromboembolic event occurs in the presence of circulating antiphospholipid antibodies (aPL)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Various cardiovascular complications consistent with blood clots obstructing blood flow are described."", ""reference"": ""PMID:21047408"", ""snippet"": ""APLS comprises clinical features such as arterial or venous thromboses, valve disease, coronary artery disease, intracardiac thrombus formation, pulmonary hypertension and dilated cardiomyopathy."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired Blood Flow""}"
588	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	3	Organ Damage	Clots in vital organs can impair function and cause significant damage.																																																								"{""description"": ""Clots in vital organs can impair function and cause significant damage."", ""name"": ""Organ Damage""}"	{}	"{""description"": ""Clots in vital organs can impair function and cause significant damage."", ""evidence"": [{""explanation"": ""The study details the incidence of organ damage in patients with APS, supporting the statement that clots in vital organs can impair function and cause significant damage."", ""reference"": ""PMID:22247356"", ""snippet"": ""After a mean followup of 7.55 years, 29% of patients experienced organ damage and 5 died... Neurologic damage is the most common cause of morbidity."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by explaining APS-induced damage in the kidneys through vascular blockage."", ""reference"": ""PMID:27198137"", ""snippet"": ""The kidney is a major target organ in both primary and secondary antiphospholipid syndrome... APSN is a vascular nephropathy characterized by small vessel vaso-occlusive lesions."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference provides evidence of brain damage caused by APS-induced clots, corroborating the statement."", ""reference"": ""PMID:24741580"", ""snippet"": ""Typically, neurological manifestations of APS include thrombosis of cerebral vessels leading to stroke."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by discussing lung damage caused by clots in patients with APS."", ""reference"": ""PMID:36575066"", ""snippet"": ""Venous thromboembolism belongs to the most frequent clinical manifestation of this syndrome... we summarised basic pathophysiological mechanisms of venous thrombosis and lung embolism development."", ""supports"": ""SUPPORT""}, {""explanation"": ""The mention of recurrent thrombotic events leading to stroke helps substantiate the role of APS in causing significant organ damage, especially in the brain."", ""reference"": ""PMID:8968222"", ""snippet"": ""Patients with the highest titers of IgG antiphospholipid antibodies have a relatively high risk of recurrent thrombotic events, especially stroke, deep venous thrombosis, and spontaneous abortion."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}, {""preferred_term"": ""kidneys"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}, {""preferred_term"": ""lungs"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Organ Damage""}"
589	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	4	Pregnancy Complications	In pregnant women, APS can cause miscarriages, stillbirths, and pre-eclampsia due to poor placental blood flow.																																																								"{""description"": ""In pregnant women, APS can cause miscarriages, stillbirths, and pre-eclampsia due to poor placental blood flow."", ""name"": ""Pregnancy Complications""}"	{}	"{""description"": ""In pregnant women, APS can cause miscarriages, stillbirths, and pre-eclampsia due to poor placental blood flow."", ""evidence"": [{""explanation"": ""The literature mentions APS causing recurrent miscarriage and late pregnancy complications including preeclampsia."", ""reference"": ""PMID:19665761"", ""snippet"": ""Women with antiphospholipid syndrome (APS) and antiphospholipid antibodies (aPL) are at high risk for recurrent spontaneous miscarriage and late pregnancy complications, such as preeclampsia and preterm labor."", ""supports"": ""SUPPORT""}, {""explanation"": ""The article explicitly states that APS causes pregnancy loss and preterm delivery related to severe pre-eclampsia or placental insufficiency."", ""reference"": ""PMID:20822807"", ""snippet"": ""The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental insufficiency."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference directly supports the statement by associating APS with preeclampsia and placental blood flow issues leading to complications."", ""reference"": ""PMID:19557318"", ""snippet"": ""In pregnant women, antiphospholipid syndrome (APS) is associated with an increased risk of preeclampsia, fetal intrauterine growth restriction, and other complications related to uteroplacental insufficiency."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference lists various pregnancy complications associated with APS, such as prematurity and hypertensive disorders."", ""reference"": ""PMID:17499708"", ""snippet"": ""Antiphospholipid syndrome (APS) is frequently associated with complications during pregnancy... prematurity, intrauterine growth retardation, pregnancy-induced hypertensive disorders, and pulmonary hypertension can complicate pregnancy as well."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature points out that antiphospholipid antibodies cause pregnancy complications in APS, supporting the mechanisms described in the statement."", ""reference"": ""PMID:22784367"", ""snippet"": ""In patients with the antiphospholipid syndrome (APS), the presence of a group of pathogenic autoantibodies called antiphospholipid antibodies causes arteriovenous thrombosis and pregnancy complications."", ""supports"": ""SUPPORT""}], ""name"": ""Pregnancy Complications""}"
590	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	5	Chronic Complications	Persistent clotting episodes can lead to long-term damage to the affected organs.																																																								"{""description"": ""Persistent clotting episodes can lead to long-term damage to the affected organs."", ""name"": ""Chronic Complications""}"	{}	"{""description"": ""Persistent clotting episodes can lead to long-term damage to the affected organs."", ""evidence"": [{""explanation"": ""The study found that APS patients had a higher frequency of organ damage, supporting the statement that persistent clotting episodes can lead to long-term damage."", ""reference"": ""PMID:38368768"", ""snippet"": ""APS patients had a higher frequency of damage accrual. Microangiopathy and non-criteria manifestations were independent risk factors for damage accrual."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study also confirms that patients with APS often experience organ damage due to thromboses, supporting the statement."", ""reference"": ""PMID:28572466"", ""snippet"": ""A high proportion of patients experienced new thrombotic events and organ damage."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study describes morbidity, organ damage, and mortality in APS patients, confirming the association between persistent clotting episodes and long-term organ damage."", ""reference"": ""PMID:22247356"", ""snippet"": ""After a mean followup of 7.55 years, 29% of patients experienced organ damage and 5 died."", ""supports"": ""SUPPORT""}], ""name"": ""Chronic Complications""}"
606	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"The S252W and P253R mutations in FGFR2 alter ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. This leads to enhanced and prolonged receptor signaling, causing premature fusion of cranial sutures and abnormal limb development. The mutations affect the linker region between immunoglobulin-like domains II and III, altering ligand-receptor interactions.
"																																																								"{""description"": ""The S252W and P253R mutations in FGFR2 alter ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. This leads to enhanced and prolonged receptor signaling, causing premature fusion of cranial sutures and abnormal limb development. The mutations affect the linker region between immunoglobulin-like domains II and III, altering ligand-receptor interactions.\n"", ""name"": ""FGFR2 Gain-of-Function Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}, {""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""The S252W and P253R mutations in FGFR2 alter ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. This leads to enhanced and prolonged receptor signaling, causing premature fusion of cranial sutures and abnormal limb development. The mutations affect the linker region between immunoglobulin-like domains II and III, altering ligand-receptor interactions.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Original identification of S252W and P253R mutations in FGFR2 linker region in all 40 Apert syndrome cases, establishing causative role of these mutations."", ""reference"": ""PMID:7719344"", ""snippet"": ""We have identified specific missense substitutions involving adjacent amino acids (Ser252Trp and Pro253Arg) in the linker between the second and third extracellular immunoglobulin (Ig) domains of fibroblast growth factor receptor 2 (FGFR2) in all 40 unrelated cases of Apert syndrome studied."", ""supports"": ""SUPPORT""}], ""name"": ""FGFR2 Gain-of-Function Signaling""}"
607	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	1	Premature Suture Fusion	"Enhanced FGFR2 signaling in cranial suture mesenchyme promotes premature osteogenic differentiation and fusion of the coronal sutures, restricting skull growth perpendicular to the fused sutures and causing characteristic turricephaly (tower skull).
"																																																								"{""description"": ""Enhanced FGFR2 signaling in cranial suture mesenchyme promotes premature osteogenic differentiation and fusion of the coronal sutures, restricting skull growth perpendicular to the fused sutures and causing characteristic turricephaly (tower skull).\n"", ""name"": ""Premature Suture Fusion""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Osteoblast Differentiation"", ""term"": {""id"": ""GO:0001649"", ""label"": ""osteoblast differentiation""}}], ""description"": ""Enhanced FGFR2 signaling in cranial suture mesenchyme promotes premature osteogenic differentiation and fusion of the coronal sutures, restricting skull growth perpendicular to the fused sutures and causing characteristic turricephaly (tower skull).\n"", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Demonstrates that Apert S252W mutation enhances osteoblast differentiation and mineralization compared to wild-type FGFR2, explaining premature suture fusion."", ""reference"": ""PMID:19117954"", ""snippet"": ""Both WT and MT FGFR2 increased early and late osteoblast gene expression and matrix mineralization."", ""supports"": ""SUPPORT""}], ""name"": ""Premature Suture Fusion""}"
608	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	2	ERK1/2 and PKC Pathway Dysregulation	"The Apert S252W mutation activates distinct downstream signaling pathways compared to wild-type FGFR2. While wild-type FGFR2 signals primarily through ERK1/2, the mutant receptor additionally activates protein kinase C alpha (PKC), which mediates the enhanced osteogenic differentiation characteristic of Apert syndrome.
"																																																								"{""description"": ""The Apert S252W mutation activates distinct downstream signaling pathways compared to wild-type FGFR2. While wild-type FGFR2 signals primarily through ERK1/2, the mutant receptor additionally activates protein kinase C alpha (PKC), which mediates the enhanced osteogenic differentiation characteristic of Apert syndrome.\n"", ""name"": ""ERK1/2 and PKC Pathway Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""ERK1/2 Cascade"", ""term"": {""id"": ""GO:0070371"", ""label"": ""ERK1 and ERK2 cascade""}}, {""preferred_term"": ""Protein Kinase C Signaling"", ""term"": {""id"": ""GO:0070528"", ""label"": ""protein kinase C signaling""}}], ""cell_types"": [{""preferred_term"": ""Mesenchymal stem cell"", ""term"": {""id"": ""CL:0000134"", ""label"": ""mesenchymal stem cell""}}], ""description"": ""The Apert S252W mutation activates distinct downstream signaling pathways compared to wild-type FGFR2. While wild-type FGFR2 signals primarily through ERK1/2, the mutant receptor additionally activates protein kinase C alpha (PKC), which mediates the enhanced osteogenic differentiation characteristic of Apert syndrome.\n"", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Shows mutant FGFR2 activates PKC pathway while wild-type does not, identifying a key mechanistic difference in Apert syndrome signaling."", ""reference"": ""PMID:19117954"", ""snippet"": ""MT, but not WT, also increased protein kinase C (PKC) activity."", ""supports"": ""SUPPORT""}], ""name"": ""ERK1/2 and PKC Pathway Dysregulation""}"
627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	CYP19A1 Gene Mutation	Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity.						Primary																																																		"{""description"": ""Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity."", ""name"": ""CYP19A1 Gene Mutation"", ""role"": ""Primary""}"	{}	"{""biological_processes"": [{""description"": ""Aromatase-catalyzed estrogen synthesis is directly impaired"", ""preferred_term"": ""estrogen biosynthetic process"", ""term"": {""id"": ""GO:0006703"", ""label"": ""estrogen biosynthetic process""}}, {""description"": ""Overall steroidogenesis altered with accumulation of androgens"", ""preferred_term"": ""steroid biosynthetic process"", ""term"": {""id"": ""GO:0006694"", ""label"": ""steroid biosynthetic process""}}, {""description"": ""Androgen metabolism shifts toward accumulation of C19 steroids"", ""preferred_term"": ""androgen metabolic process"", ""term"": {""id"": ""GO:0008209"", ""label"": ""androgen metabolic process""}}], ""cell_types"": [{""description"": ""Ovarian site of aromatase expression for estrogen synthesis"", ""preferred_term"": ""granulosa cell"", ""term"": {""id"": ""CL:0000501"", ""label"": ""granulosa cell""}}, {""description"": ""Placental aromatase site; loss causes maternal and fetal virilization"", ""preferred_term"": ""trophoblast cell"", ""term"": {""id"": ""CL:0000351"", ""label"": ""trophoblast cell""}}, {""description"": ""Testicular androgen source; peripheral aromatization affects systemic hormone balance"", ""preferred_term"": ""Leydig cell"", ""term"": {""id"": ""CL:0000178"", ""label"": ""Leydig cell""}}, {""description"": ""Peripheral aromatase expression site contributing to local estrogen production"", ""preferred_term"": ""adipocyte"", ""term"": {""id"": ""CL:0000136"", ""label"": ""adipocyte""}}], ""description"": ""Mutations in the CYP19A1 gene result in deficient aromatase enzyme activity."", ""evidence"": [{""explanation"": ""The reference clearly states that mutations in the CYP19A1 gene result in deficient aromatase enzyme activity, which causes aromatase deficiency."", ""reference"": ""PMID:35837780"", ""snippet"": ""Aromatase deficiency (AD) is a rare autosomal recessive genetic disease caused by loss-of-function mutations in aromatase gene (CYP19A1), leading to congenital estrogen deficiency syndrome."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference details the crucial role of aromatase and how its deficiency, caused by lack of function due to gene mutations, leads to significant physiological impairments."", ""reference"": ""PMID:14968547"", ""snippet"": ""Aromatase, a key enzyme in estrogen synthesis, is tissue-specifically regulated in various tissues and plays an important role through endocrine and intracrine estrogen production in various physiological functions. Therefore, aromatase deficiency caused crucial impairments of physiological functions in the gonadal tissues as well as extra-gonadal tissues."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference indicates that CYP19A1 (cytochrome P450 aromatase) mutations can result in reduced activity of the enzyme, thereby supporting the mechanism of aromatase deficiency due to mutations in CYP19A1."", ""reference"": ""PMID:27032764"", ""snippet"": ""Cytochrome P450 aromatase (CYP19A1), in human placenta metabolizes androgens to estrogens and uses reduced nicotinamide adenine dinucleotide phosphate through cytochrome P450 oxidoreductase (POR) for the energy requirements of its metabolic activities."", ""supports"": ""SUPPORT""}], ""locations"": [{""description"": ""Site of granulosa aromatase; ovarian development and fertility impacted"", ""preferred_term"": ""ovary"", ""term"": {""id"": ""UBERON:0000992"", ""label"": ""ovary""}}, {""description"": ""Crucial for fetal estrogen production; maternal virilization if deficient"", ""preferred_term"": ""placenta"", ""term"": {""id"": ""UBERON:0001987"", ""label"": ""placenta""}}, {""description"": ""Androgen source; 46,XY genital phenotype often milder than 46,XX"", ""preferred_term"": ""testis"", ""term"": {""id"": ""UBERON:0000473"", ""label"": ""testis""}}, {""description"": ""Affected by estrogen deficiency causing delayed epiphyseal closure and osteopenia"", ""preferred_term"": ""bone tissue"", ""term"": {""id"": ""UBERON:0002481"", ""label"": ""bone tissue""}}], ""name"": ""CYP19A1 Gene Mutation"", ""role"": ""Primary""}"
628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	Estrogen Deficiency	Lack of estrogen production due to deficient aromatase activity.															Leads to abnormal sexual development and bone maturation.																																									"{""consequence"": ""Leads to abnormal sexual development and bone maturation."", ""description"": ""Lack of estrogen production due to deficient aromatase activity."", ""name"": ""Estrogen Deficiency""}"	"{""downstream"": [{""description"": ""CYP19A1 mutations cause loss of aromatase function, leading to estrogen deficiency and androgen accumulation resulting in virilization."", ""evidence"": [{""explanation"": ""This paper directly establishes the causal chain from CYP19A1 mutations to loss of aromatase function to estrogen deficiency and androgen accumulation leading to virilization."", ""reference"": ""PMID:24705274"", ""snippet"": ""P450 aromatase (CYP19A1) is essential for the biosynthesis of estrogens from androgen precursors. Mutations in the coding region of CYP19A1 lead to autosomal recessive aromatase deficiency."", ""supports"": ""SUPPORT""}], ""target"": ""Virilization and Estrogen Insufficiency""}]}"	"{""biological_processes"": [{""description"": ""Downstream estrogen signaling reduced affecting multiple tissues"", ""preferred_term"": ""estrogen receptor signaling pathway"", ""term"": {""id"": ""GO:0030520"", ""label"": ""estrogen receptor signaling pathway""}}, {""description"": ""HPG feedback disrupted causing hypergonadotropic hypogonadism"", ""preferred_term"": ""regulation of gonadotropin secretion"", ""term"": {""id"": ""GO:0032274"", ""label"": ""regulation of gonadotropin secretion""}}, {""description"": ""Imbalanced osteoblast/osteoclast activity leading to bone loss"", ""preferred_term"": ""bone remodeling"", ""term"": {""id"": ""GO:0046849"", ""label"": ""bone remodeling""}}, {""description"": ""Delayed epiphyseal closure due to low estrogen levels"", ""preferred_term"": ""endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}], ""cell_types"": [{""description"": ""Bone-forming cell; estrogen deficiency increases bone resorption risk"", ""preferred_term"": ""osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}, {""description"": ""Bone-resorbing cell; activity increases when estrogen is low"", ""preferred_term"": ""osteoclast"", ""term"": {""id"": ""CL:0000092"", ""label"": ""osteoclast""}}], ""consequence"": ""Leads to abnormal sexual development and bone maturation."", ""description"": ""Lack of estrogen production due to deficient aromatase activity."", ""downstream"": [{""description"": ""CYP19A1 mutations cause loss of aromatase function, leading to estrogen deficiency and androgen accumulation resulting in virilization."", ""evidence"": [{""explanation"": ""This paper directly establishes the causal chain from CYP19A1 mutations to loss of aromatase function to estrogen deficiency and androgen accumulation leading to virilization."", ""reference"": ""PMID:24705274"", ""snippet"": ""P450 aromatase (CYP19A1) is essential for the biosynthesis of estrogens from androgen precursors. Mutations in the coding region of CYP19A1 lead to autosomal recessive aromatase deficiency."", ""supports"": ""SUPPORT""}], ""target"": ""Virilization and Estrogen Insufficiency""}], ""evidence"": [{""explanation"": ""This supports the statement as it describes that aromatase deficiency leads to a lack of estrogen, which affects sexual development and bone maturation."", ""reference"": ""PMID:18448329"", ""snippet"": ""Human congenital estrogen deficiency, due to an inactivating mutation of the aromatase gene, leads to the lack of the estrogen synthesis, with gonadotropins and circulating testosterone ranging from normal to elevated. The aromatese-deficient females show hyperandrogenism and virilization at birth with ambiguous genitalia. During childhood there are a dysfunction in the LHRH-LH/FSH axis and a progressive delay in bone age."", ""supports"": ""SUPPORT""}, {""explanation"": ""This also supports the statement by indicating that aromatase deficiency affects bone maturation."", ""reference"": ""PMID:18567553"", ""snippet"": ""Findings from estrogen-resistant and aromatase-deficient men have provided important insights into the role of estrogen in the male skeleton during growth."", ""supports"": ""SUPPORT""}, {""explanation"": ""The lack of aromatase activity, and hence estrogen deficiency, affects bone maturation, confirming the consequence stated."", ""reference"": ""PMID:21874760"", ""snippet"": ""Several lines of clinical and experimental evidence now clearly indicate that aromatase activity and estrogen production are necessary for longitudinal bone growth, attainment of peak bone mass, the pubertal growth spurt, epiphyseal closure, and normal bone remodeling in young individuals."", ""supports"": ""SUPPORT""}], ""locations"": [{""description"": ""Estrogen-dependent organ; hypoplasia and poor endometrial development possible"", ""preferred_term"": ""uterus"", ""term"": {""id"": ""UBERON:0000995"", ""label"": ""uterus""}}, {""description"": ""Chronic hypoestrogenism results in low bone mass and fracture risk"", ""preferred_term"": ""bone tissue"", ""term"": {""id"": ""UBERON:0002481"", ""label"": ""bone tissue""}}, {""description"": ""Peripheral aromatase loss alters metabolic regulation and lipid profiles"", ""preferred_term"": ""adipose tissue"", ""term"": {""id"": ""UBERON:0001013"", ""label"": ""adipose tissue""}}, {""description"": ""Central estrogen actions on behavior and HPG axis signaling disrupted"", ""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}], ""name"": ""Estrogen Deficiency""}"
652	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	0	Arsenic Uptake and Metabolism	Inorganic arsenic is absorbed from the gut or lungs and undergoes hepatic methylation by arsenic (+3 oxidation state) methyltransferase (AS3MT). The metabolic pathway produces monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA). The trivalent intermediate MMA(III) is highly reactive and toxic. Genetic polymorphisms in AS3MT affect methylation efficiency and cancer risk.																																																								"{""description"": ""Inorganic arsenic is absorbed from the gut or lungs and undergoes hepatic methylation by arsenic (+3 oxidation state) methyltransferase (AS3MT). The metabolic pathway produces monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA). The trivalent intermediate MMA(III) is highly reactive and toxic. Genetic polymorphisms in AS3MT affect methylation efficiency and cancer risk."", ""name"": ""Arsenic Uptake and Metabolism""}"	"{""downstream"": [{""description"": ""Arsenic metabolites generate reactive oxygen species"", ""target"": ""Oxidative Stress and DNA Damage""}, {""description"": ""Arsenic alters DNA methylation patterns globally"", ""target"": ""Epigenetic Dysregulation""}]}"	"{""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Inorganic arsenic is absorbed from the gut or lungs and undergoes hepatic methylation by arsenic (+3 oxidation state) methyltransferase (AS3MT). The metabolic pathway produces monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA). The trivalent intermediate MMA(III) is highly reactive and toxic. Genetic polymorphisms in AS3MT affect methylation efficiency and cancer risk."", ""downstream"": [{""description"": ""Arsenic metabolites generate reactive oxygen species"", ""target"": ""Oxidative Stress and DNA Damage""}, {""description"": ""Arsenic alters DNA methylation patterns globally"", ""target"": ""Epigenetic Dysregulation""}], ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Arsenic Uptake and Metabolism""}"
653	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	1	Oxidative Stress and DNA Damage	Arsenic generates reactive oxygen species (ROS) through multiple mechanisms including mitochondrial dysfunction and NADPH oxidase activation. ROS cause oxidative DNA damage including 8-oxoguanine formation, DNA strand breaks, and chromosomal aberrations. Unlike classic genotoxins, arsenic does not form direct DNA adducts but induces damage through indirect mechanisms.																																																								"{""description"": ""Arsenic generates reactive oxygen species (ROS) through multiple mechanisms including mitochondrial dysfunction and NADPH oxidase activation. ROS cause oxidative DNA damage including 8-oxoguanine formation, DNA strand breaks, and chromosomal aberrations. Unlike classic genotoxins, arsenic does not form direct DNA adducts but induces damage through indirect mechanisms."", ""name"": ""Oxidative Stress and DNA Damage""}"	"{""downstream"": [{""description"": ""Arsenic inhibits DNA repair enzyme activity"", ""target"": ""Impaired DNA Repair""}, {""description"": ""Accumulated DNA damage leads to chromosomal abnormalities"", ""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""DNA damage response""}}], ""description"": ""Arsenic generates reactive oxygen species (ROS) through multiple mechanisms including mitochondrial dysfunction and NADPH oxidase activation. ROS cause oxidative DNA damage including 8-oxoguanine formation, DNA strand breaks, and chromosomal aberrations. Unlike classic genotoxins, arsenic does not form direct DNA adducts but induces damage through indirect mechanisms."", ""downstream"": [{""description"": ""Arsenic inhibits DNA repair enzyme activity"", ""target"": ""Impaired DNA Repair""}, {""description"": ""Accumulated DNA damage leads to chromosomal abnormalities"", ""target"": ""Genomic Instability""}], ""name"": ""Oxidative Stress and DNA Damage""}"
654	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	2	Epigenetic Dysregulation	Arsenic causes global DNA hypomethylation while inducing promoter-specific hypermethylation of tumor suppressor genes. This occurs partly through competition for methyl groups (arsenic methylation depletes SAM) and altered DNMT activity. Histone modifications and miRNA expression are also affected, contributing to aberrant gene expression patterns.																																																								"{""description"": ""Arsenic causes global DNA hypomethylation while inducing promoter-specific hypermethylation of tumor suppressor genes. This occurs partly through competition for methyl groups (arsenic methylation depletes SAM) and altered DNMT activity. Histone modifications and miRNA expression are also affected, contributing to aberrant gene expression patterns."", ""name"": ""Epigenetic Dysregulation""}"	"{""downstream"": [{""description"": ""Promoter hypermethylation silences tumor suppressor genes"", ""target"": ""Tumor Suppressor Gene Silencing""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""DNA methylation"", ""term"": {""id"": ""GO:0006306"", ""label"": ""DNA methylation""}}], ""description"": ""Arsenic causes global DNA hypomethylation while inducing promoter-specific hypermethylation of tumor suppressor genes. This occurs partly through competition for methyl groups (arsenic methylation depletes SAM) and altered DNMT activity. Histone modifications and miRNA expression are also affected, contributing to aberrant gene expression patterns."", ""downstream"": [{""description"": ""Promoter hypermethylation silences tumor suppressor genes"", ""target"": ""Tumor Suppressor Gene Silencing""}], ""name"": ""Epigenetic Dysregulation""}"
655	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	3	Impaired DNA Repair	Arsenic inhibits multiple DNA repair pathways including nucleotide excision repair, base excision repair, and mismatch repair. It inhibits zinc finger proteins involved in repair by displacing zinc. PARP-1, XPA, and other repair factors are direct targets. This repair deficiency synergizes with oxidative damage to promote mutagenesis.																																																								"{""description"": ""Arsenic inhibits multiple DNA repair pathways including nucleotide excision repair, base excision repair, and mismatch repair. It inhibits zinc finger proteins involved in repair by displacing zinc. PARP-1, XPA, and other repair factors are direct targets. This repair deficiency synergizes with oxidative damage to promote mutagenesis."", ""name"": ""Impaired DNA Repair""}"	"{""downstream"": [{""description"": ""Repair deficiency allows accumulation of mutations"", ""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}], ""description"": ""Arsenic inhibits multiple DNA repair pathways including nucleotide excision repair, base excision repair, and mismatch repair. It inhibits zinc finger proteins involved in repair by displacing zinc. PARP-1, XPA, and other repair factors are direct targets. This repair deficiency synergizes with oxidative damage to promote mutagenesis."", ""downstream"": [{""description"": ""Repair deficiency allows accumulation of mutations"", ""target"": ""Genomic Instability""}], ""name"": ""Impaired DNA Repair""}"
656	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	4	Tumor Suppressor Gene Silencing	Arsenic-induced promoter hypermethylation silences tumor suppressor genes including p16INK4A, RASSF1A, and p53. This epigenetic silencing contributes to cell cycle dysregulation and resistance to apoptosis without requiring genetic mutation.																																																								"{""description"": ""Arsenic-induced promoter hypermethylation silences tumor suppressor genes including p16INK4A, RASSF1A, and p53. This epigenetic silencing contributes to cell cycle dysregulation and resistance to apoptosis without requiring genetic mutation."", ""name"": ""Tumor Suppressor Gene Silencing""}"	"{""downstream"": [{""description"": ""Loss of checkpoint control enables proliferation"", ""target"": ""Uncontrolled Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}], ""description"": ""Arsenic-induced promoter hypermethylation silences tumor suppressor genes including p16INK4A, RASSF1A, and p53. This epigenetic silencing contributes to cell cycle dysregulation and resistance to apoptosis without requiring genetic mutation."", ""downstream"": [{""description"": ""Loss of checkpoint control enables proliferation"", ""target"": ""Uncontrolled Cell Proliferation""}], ""name"": ""Tumor Suppressor Gene Silencing""}"
657	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	5	Genomic Instability	The combination of oxidative DNA damage, impaired repair, and aberrant mitotic spindle function leads to genomic instability, aneuploidy, and chromosomal aberrations. Arsenic disrupts spindle assembly by targeting tubulin and centrosome function.																																																								"{""description"": ""The combination of oxidative DNA damage, impaired repair, and aberrant mitotic spindle function leads to genomic instability, aneuploidy, and chromosomal aberrations. Arsenic disrupts spindle assembly by targeting tubulin and centrosome function."", ""name"": ""Genomic Instability""}"	"{""downstream"": [{""description"": ""Accumulated mutations in growth regulatory genes"", ""target"": ""Uncontrolled Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""description"": ""The combination of oxidative DNA damage, impaired repair, and aberrant mitotic spindle function leads to genomic instability, aneuploidy, and chromosomal aberrations. Arsenic disrupts spindle assembly by targeting tubulin and centrosome function."", ""downstream"": [{""description"": ""Accumulated mutations in growth regulatory genes"", ""target"": ""Uncontrolled Cell Proliferation""}], ""name"": ""Genomic Instability""}"
658	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	pathophysiology	6	Uncontrolled Cell Proliferation	Combined effects of epigenetic silencing, genomic instability, and constitutive growth signaling drive proliferation of transformed cells in target organs. The skin, lung, and bladder are particularly susceptible due to their exposure to arsenic and its metabolites.																																																								"{""description"": ""Combined effects of epigenetic silencing, genomic instability, and constitutive growth signaling drive proliferation of transformed cells in target organs. The skin, lung, and bladder are particularly susceptible due to their exposure to arsenic and its metabolites."", ""name"": ""Uncontrolled Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""epithelial cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}], ""description"": ""Combined effects of epigenetic silencing, genomic instability, and constitutive growth signaling drive proliferation of transformed cells in target organs. The skin, lung, and bladder are particularly susceptible due to their exposure to arsenic and its metabolites."", ""name"": ""Uncontrolled Cell Proliferation""}"
695	28	Asthma	Asthma.yaml	pathophysiology	0	Airway Inflammation	Chronic inflammation leads to airway hyperresponsiveness and recurrent episodes of wheezing, breathlessness, chest tightness, and coughing.																																																								"{""description"": ""Chronic inflammation leads to airway hyperresponsiveness and recurrent episodes of wheezing, breathlessness, chest tightness, and coughing."", ""name"": ""Airway Inflammation""}"	"{""downstream"": [{""description"": ""Airway hyperresponsiveness provides the substrate for bronchoconstriction in response to numerous diverse stimuli."", ""evidence"": [{""explanation"": ""This review establishes the mechanistic link between airway hyperresponsiveness and bronchoconstriction in asthma, showing that AHR enables bronchoconstriction when triggered by various stimuli."", ""reference"": ""PMID:38395082"", ""snippet"": ""Airway hyperresponsiveness (AHR) is a key clinical feature of asthma. The presence of AHR in people with asthma provides the substrate for bronchoconstriction in response to numerous diverse stimuli, contributing to airflow limitation and symptoms including breathlessness, wheeze, and chest tightness."", ""supports"": ""SUPPORT""}], ""target"": ""Bronchoconstriction""}]}"	"{""cell_types"": [{""preferred_term"": ""Mast Cell"", ""term"": {""id"": ""CL:0000097"", ""label"": ""mast cell""}}, {""preferred_term"": ""Eosinophil"", ""term"": {""id"": ""CL:0000771"", ""label"": ""eosinophil""}}, {""preferred_term"": ""T-Lymphocyte"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}, {""preferred_term"": ""Bronchial Epithelial Cell"", ""term"": {""id"": ""CL:0002328"", ""label"": ""bronchial epithelial cell""}}, {""preferred_term"": ""Basophil"", ""term"": {""id"": ""CL:0000767"", ""label"": ""basophil""}}, {""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Chronic inflammation leads to airway hyperresponsiveness and recurrent episodes of wheezing, breathlessness, chest tightness, and coughing."", ""downstream"": [{""description"": ""Airway hyperresponsiveness provides the substrate for bronchoconstriction in response to numerous diverse stimuli."", ""evidence"": [{""explanation"": ""This review establishes the mechanistic link between airway hyperresponsiveness and bronchoconstriction in asthma, showing that AHR enables bronchoconstriction when triggered by various stimuli."", ""reference"": ""PMID:38395082"", ""snippet"": ""Airway hyperresponsiveness (AHR) is a key clinical feature of asthma. The presence of AHR in people with asthma provides the substrate for bronchoconstriction in response to numerous diverse stimuli, contributing to airflow limitation and symptoms including breathlessness, wheeze, and chest tightness."", ""supports"": ""SUPPORT""}], ""target"": ""Bronchoconstriction""}], ""evidence"": [{""explanation"": ""This reference indicates the involvement of multiple cell types, including mast cells, eosinophils, and T lymphocytes in allergic airway inflammation, which supports the statement."", ""reference"": ""PMID:18503727"", ""snippet"": ""The pathogenesis of allergic airway inflammation is complex, involving multiple cell types such as T helper 2 cells, regulatory T cells, eosinophils, dendritic cells, mast cells, and parenchymal cells of the lung."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference mentions eosinophils and neutrophils as part of the chronic inflammatory response in asthma, supporting the statement."", ""reference"": ""PMID:8324396"", ""snippet"": ""The numbers of eosinophils and neutrophils are increased 4 h after challenge with allergen in the broncho-alveolar lavage fluid (BAL) of asthmatics who show an LPR."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference highlights the involvement of basophils and mast cells in airway inflammation in asthma, supporting the statement."", ""reference"": ""PMID:9753516"", ""snippet"": ""Accumulation of basophils and mast cells in airway tissues during allergic and allergic-type inflammatory responses, including asthma, is one of the hallmarks of these disease processes."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the clinical manifestations of asthma as described in the statement."", ""reference"": ""PMID:38395082"", ""snippet"": ""Airway hyperresponsiveness (AHR) is a key clinical feature of asthma. The presence of AHR in people with asthma provides the substrate for bronchoconstriction in response to numerous diverse stimuli, contributing to airflow limitation and symptoms including breathlessness, wheeze, and chest tightness."", ""supports"": ""SUPPORT""}, {""explanation"": ""While this reference focuses on cardiac asthma, it acknowledges the involvement of inflammatory factors leading to airway obstruction, which partially supports the inflammatory aspect mentioned."", ""reference"": ""PMID:23234454"", ""snippet"": ""Pulmonary edema and pulmonary vascular congestion have been thought to be the primary causes of cardiac asthma but most patients have a poor response to diuretics... Evidence suggests that circulating inflammatory factors and tissue growth factors also lead to airway obstruction suggesting the possibility of developing novel therapies."", ""supports"": ""PARTIAL""}, {""explanation"": ""Specifically talks about the role of eosinophils in asthma, supporting the statement."", ""reference"": ""PMID:1571812"", ""snippet"": ""Asthmatics can have a blood eosinophilia which in some studies correlates with the severity of the disease... The eosinophils that contribute to asthma will be those in the lung."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports the role of eosinophils in airway inflammation in asthma, consistent with the statement."", ""reference"": ""PMID:28687463"", ""snippet"": ""NAEB shares similar eosinophilic inflammation of airway and response to corticosteroids with asthma."", ""supports"": ""SUPPORT""}, {""explanation"": ""Does not provide specific information about the role of the cell types mentioned in the statement."", ""reference"": ""PMID:6101920"", ""snippet"": ""Exercise-induced asthma can appear as one of many forms of airway hyperreactivity or as a unique clinical entity."", ""supports"": ""NO_EVIDENCE""}], ""name"": ""Airway Inflammation""}"
696	28	Asthma	Asthma.yaml	pathophysiology	1	Bronchoconstriction	During an asthma attack, smooth muscles around the airways tighten and narrow the airway.																																																								"{""description"": ""During an asthma attack, smooth muscles around the airways tighten and narrow the airway."", ""name"": ""Bronchoconstriction""}"	{}	"{""cell_types"": [{""preferred_term"": ""Smooth Muscle Cells"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}], ""description"": ""During an asthma attack, smooth muscles around the airways tighten and narrow the airway."", ""evidence"": [{""explanation"": ""The reference points out that contraction of airway smooth muscle is a main cause of airway obstruction, thus supporting the statement."", ""reference"": ""PMID:24914235"", ""snippet"": ""The other main cause of airway obstruction is contraction of airway smooth muscle."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference explains that the narrowing of the airways, caused by the contraction of airway smooth muscle, leads to breathing difficulties, thus supporting the statement."", ""reference"": ""PMID:22011234"", ""snippet"": ""Breathing difficulties are caused by excessive narrowing of the pulmonary airways, which is instigated by shortening of the airway smooth muscle (ASM)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The use of statins to reduce airway hyper-responsiveness implies the involvement of smooth muscle cells, supporting the statement."", ""reference"": ""PMID:27603525"", ""snippet"": ""In acute and chronic allergen driven animal models of asthma, statins reduce airway hyper-responsiveness, inflammation and remodeling."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference highlights multiple functions of airway smooth muscle in asthma, which supports the statement regarding the role of smooth muscle cells in bronchoconstriction."", ""reference"": ""PMID:16543052"", ""snippet"": ""ASM plays an important role in regulating bronchomotor tone, in perpetuating airway inflammation, and in remodeling of the airways."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference clearly identifies airway smooth muscle cells as key players in the narrowing of airways (bronchoconstriction), thus supporting the statement."", ""reference"": ""PMID:18669785"", ""snippet"": ""Airway smooth muscle cells are known to be the main effector cells of airway narrowing."", ""supports"": ""SUPPORT""}], ""name"": ""Bronchoconstriction""}"
697	28	Asthma	Asthma.yaml	pathophysiology	2	Mucus Overproduction	Inflammatory cells infiltrate the airways, increasing mucus production, which can block airways and further impair breathing.																																																								"{""description"": ""Inflammatory cells infiltrate the airways, increasing mucus production, which can block airways and further impair breathing."", ""name"": ""Mucus Overproduction""}"	{}	"{""cell_types"": [{""preferred_term"": ""Goblet Cell"", ""term"": {""id"": ""CL:0000160"", ""label"": ""goblet cell""}}, {""preferred_term"": ""Bronchial Epithelial Cell"", ""term"": {""id"": ""CL:0002328"", ""label"": ""bronchial epithelial cell""}}, {""preferred_term"": ""Mucosal Epithelial Cell"", ""term"": {""id"": ""CL:0002202"", ""label"": ""epithelial cell of tracheobronchial tree""}}], ""description"": ""Inflammatory cells infiltrate the airways, increasing mucus production, which can block airways and further impair breathing."", ""evidence"": [{""explanation"": ""The reference confirms Goblet cell involvement in asthma and mucus production but does not mention Mucosal Epithelial Cell specifically."", ""reference"": ""PMID:19689269"", ""snippet"": ""Goblet cells are major mucus-producing cells, and goblet cell hyperplasia (GCH) is one feature of airway remodeling, defined as structural changes occurring in the airway."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference supports that Bronchial Epithelial Cells play a role in mucus production but does not discuss Mucosal Epithelial Cells specifically."", ""reference"": ""PMID:24914235"", ""snippet"": ""Airway epithelial cells, which are the first line of defense against inhaled pathogens and particles, initiate airway inflammation and produce mucus, an important contributor to airway obstruction."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference confirms Goblet cell hyperplasia and the contribution of epithelial cells in asthma but does not detail Mucosal Epithelial Cells."", ""reference"": ""PMID:37520564"", ""snippet"": ""Basal cells... goblet cell hyperplasia and increased epithelial mesenchymal transition, which contribute to impaired mucociliary clearance and airway remodelling."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference supports Goblet cells' role in mucus production but lacks information on Mucosal Epithelial Cells."", ""reference"": ""PMID:23638644"", ""snippet"": ""Goblet cell differentiation and mucus production are subject to extensive control. An emerging concept is that not all goblet cells are phenotypically identical suggesting that specific molecular pathways orchestrate mucin overproduction."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference confirms the involvement of Bronchial Epithelial Cells but does not mention Mucosal Epithelial Cells."", ""reference"": ""PMID:16101538"", ""snippet"": ""Bronchial epithelial cells (BEC) are known to play an integral role in the airway defense mechanism via mucociliary system as well as mechanical barriers."", ""supports"": ""PARTIAL""}], ""name"": ""Mucus Overproduction""}"
698	28	Asthma	Asthma.yaml	pathophysiology	3	Airway Remodeling	Long-standing inflammation can lead to structural changes in the airway, permanently affecting lung function.																																																								"{""description"": ""Long-standing inflammation can lead to structural changes in the airway, permanently affecting lung function."", ""name"": ""Airway Remodeling""}"	{}	"{""cell_types"": [{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}, {""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}, {""preferred_term"": ""Bronchial Epithelial Cell"", ""term"": {""id"": ""CL:0002328"", ""label"": ""bronchial epithelial cell""}}], ""description"": ""Long-standing inflammation can lead to structural changes in the airway, permanently affecting lung function."", ""evidence"": [{""explanation"": ""The reference acknowledges that airway remodeling in asthma involves changes to the epithelial cell layer, fibroblasts, and smooth muscle cells."", ""reference"": ""PMID:20500603"", ""snippet"": ""In asthma, it includes alterations of the epithelial cell layer with goblet cell hyperplasia, thickening of basement membranes, peri-bronchial and peri-bronchoalveolar fibrosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the idea that long-standing inflammation can result in irreversible structural changes affecting lung function."", ""reference"": ""PMID:10907591"", ""snippet"": ""In the long-term, asthma may become moderately to fully irreversible. Severe, irreversible airflow obstruction may develop despite apparently appropriate therapy."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference details structural changes involving various cell types, including epithelial cells, smooth muscle cells, and other airway structures resulting from long-term inflammation in asthma."", ""reference"": ""PMID:15896192"", ""snippet"": ""Structural changes reported in the airways of asthmatics include epithelial fragility, goblet cell hyperplasia, enlarged submucosal mucus glands, angiogenesis, increased matrix deposition in the airway wall, increased airway smooth muscle mass, wall thickening and abnormalities in elastin."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference confirms that chronic inflammation in asthma involves structural alterations involving smooth muscle cells and other components, supporting airway remodeling."", ""reference"": ""PMID:12405265"", ""snippet"": ""Asthma is a chronic inflammatory disorder of the airways interacting with altered structure and function of the formed elements including smooth muscle."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference highlights the importance of epithelial cells and smooth muscle cells in asthma pathogenesis, supporting the role of these cell types in airway remodeling."", ""reference"": ""PMID:24914235"", ""snippet"": ""Two airway cell types are critical for asthma pathogenesis: epithelial cells and smooth muscle cells."", ""supports"": ""SUPPORT""}], ""name"": ""Airway Remodeling""}"
731	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	pathophysiology	0	Atrial Electrical Remodeling	"Rapid atrial rates cause shortening of atrial refractory period and loss of rate adaptation, promoting AF maintenance. AF begets AF.
"																																																								"{""description"": ""Rapid atrial rates cause shortening of atrial refractory period and loss of rate adaptation, promoting AF maintenance. AF begets AF.\n"", ""name"": ""Atrial Electrical Remodeling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cardiac Conduction"", ""term"": {""id"": ""GO:0086001"", ""label"": ""cardiac muscle cell action potential""}}], ""cell_types"": [{""preferred_term"": ""Atrial Cardiomyocyte"", ""term"": {""id"": ""CL:0002129"", ""label"": ""regular atrial cardiac myocyte""}}], ""description"": ""Rapid atrial rates cause shortening of atrial refractory period and loss of rate adaptation, promoting AF maintenance. AF begets AF.\n"", ""evidence"": [{""explanation"": ""This demonstrates that electrical remodeling including altered action potential duration is a key pathophysiological mechanism in AF."", ""reference"": ""PMID:39146015"", ""snippet"": ""NOX2 inhibition normalized atrial action potential duration and abrogated obesity-mediated ion channel remodeling with reduced AF burden."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms AF affects atrial electrical function and is influenced by electrophysiological mechanisms."", ""reference"": ""PMID:38255832"", ""snippet"": ""Atrial fibrillation (AF) is an arrhythmia that affects the left atrium, cardiac function, and the patients' survival rate."", ""supports"": ""SUPPORT""}], ""name"": ""Atrial Electrical Remodeling""}"
732	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	pathophysiology	1	Atrial Structural Remodeling	"Atrial fibrosis and dilation create substrate for AF maintenance. Fibrosis disrupts normal conduction and creates reentrant circuits.
"																																																								"{""description"": ""Atrial fibrosis and dilation create substrate for AF maintenance. Fibrosis disrupts normal conduction and creates reentrant circuits.\n"", ""name"": ""Atrial Structural Remodeling""}"	{}	"{""cell_types"": [{""preferred_term"": ""Cardiac Fibroblast"", ""term"": {""id"": ""CL:0002548"", ""label"": ""fibroblast of cardiac tissue""}}], ""description"": ""Atrial fibrosis and dilation create substrate for AF maintenance. Fibrosis disrupts normal conduction and creates reentrant circuits.\n"", ""evidence"": [{""explanation"": ""Inflammatory mechanisms contribute to structural remodeling including fibrosis that maintains AF substrate."", ""reference"": ""PMID:38255832"", ""snippet"": ""it is influenced by a complex interplay of autoimmune, inflammatory, and electrophysiological mechanisms."", ""supports"": ""SUPPORT""}], ""name"": ""Atrial Structural Remodeling""}"
733	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	pathophysiology	2	Pulmonary Vein Triggers	"Ectopic beats originating from pulmonary vein myocardial sleeves commonly trigger AF episodes. These foci have distinct electrophysiology.
"																																																								"{""description"": ""Ectopic beats originating from pulmonary vein myocardial sleeves commonly trigger AF episodes. These foci have distinct electrophysiology.\n"", ""name"": ""Pulmonary Vein Triggers""}"	{}	"{""description"": ""Ectopic beats originating from pulmonary vein myocardial sleeves commonly trigger AF episodes. These foci have distinct electrophysiology.\n"", ""name"": ""Pulmonary Vein Triggers""}"
734	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	pathophysiology	3	Atrial Thrombus Formation	"Loss of atrial contraction leads to blood stasis, particularly in the left atrial appendage, promoting thrombus formation and embolic stroke.
"																																																								"{""description"": ""Loss of atrial contraction leads to blood stasis, particularly in the left atrial appendage, promoting thrombus formation and embolic stroke.\n"", ""name"": ""Atrial Thrombus Formation""}"	{}	"{""description"": ""Loss of atrial contraction leads to blood stasis, particularly in the left atrial appendage, promoting thrombus formation and embolic stroke.\n"", ""evidence"": [{""explanation"": ""AF affects cardiac function including atrial contraction, which contributes to thromboembolism risk and impacts patient survival."", ""reference"": ""PMID:38255832"", ""snippet"": ""Atrial fibrillation (AF) is an arrhythmia that affects the left atrium, cardiac function, and the patients' survival rate."", ""supports"": ""SUPPORT""}], ""name"": ""Atrial Thrombus Formation""}"
751	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	0	Fungal Gut Fermentation	"Overgrowth of fermenting fungi, particularly Candida and Saccharomyces species, in the gastrointestinal tract converts dietary carbohydrates into ethanol through alcoholic fermentation. Glucose is metabolized through glycolysis to pyruvate, which is then converted to acetaldehyde by pyruvate decarboxylase and subsequently reduced to ethanol by alcohol dehydrogenase.
"																																																								"{""description"": ""Overgrowth of fermenting fungi, particularly Candida and Saccharomyces species, in the gastrointestinal tract converts dietary carbohydrates into ethanol through alcoholic fermentation. Glucose is metabolized through glycolysis to pyruvate, which is then converted to acetaldehyde by pyruvate decarboxylase and subsequently reduced to ethanol by alcohol dehydrogenase.\n"", ""name"": ""Fungal Gut Fermentation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Fermentation"", ""term"": {""id"": ""GO:0006113"", ""label"": ""fermentation""}}, {""preferred_term"": ""Ethanol Metabolic Process"", ""term"": {""id"": ""GO:0006067"", ""label"": ""ethanol metabolic process""}}], ""cell_types"": [{""preferred_term"": ""Enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}], ""description"": ""Overgrowth of fermenting fungi, particularly Candida and Saccharomyces species, in the gastrointestinal tract converts dietary carbohydrates into ethanol through alcoholic fermentation. Glucose is metabolized through glycolysis to pyruvate, which is then converted to acetaldehyde by pyruvate decarboxylase and subsequently reduced to ethanol by alcohol dehydrogenase.\n"", ""evidence"": [{""explanation"": ""Systematic review confirms that carbohydrates are fermented to alcohol by microbiota in the GI tract."", ""reference"": ""PMID:33887125"", ""snippet"": ""The gut fermentation syndrome (GFS), also known as the endogenous alcohol fermentation syndrome or auto brewery syndrome, is a rare and underdiagnosed medical condition where consumed carbohydrates are converted to alcohol by the microbiota in the gastrointestinal or urinary tract."", ""supports"": ""SUPPORT""}, {""explanation"": ""Identifies the spectrum of fungal organisms responsible for gut fermentation syndrome."", ""reference"": ""PMID:33887125"", ""snippet"": ""The species that caused the GFS included Klebsiella pneumoniae, Candida albicans, C. glabrata, Saccharomyces cerevisiae, C. intermedia, C. parapsilosis, and C. kefyr."", ""supports"": ""SUPPORT""}], ""name"": ""Fungal Gut Fermentation""}"
752	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	1	Bacterial Fermentation by Klebsiella	"High-alcohol-producing Klebsiella pneumoniae and related species can generate endogenous ethanol through the 2,3-butanediol fermentation pathway. These bacteria possess multiple copies of alcohol dehydrogenase genes enabling excessive ethanol production even under aerobic conditions.
"																																																								"{""description"": ""High-alcohol-producing Klebsiella pneumoniae and related species can generate endogenous ethanol through the 2,3-butanediol fermentation pathway. These bacteria possess multiple copies of alcohol dehydrogenase genes enabling excessive ethanol production even under aerobic conditions.\n"", ""name"": ""Bacterial Fermentation by Klebsiella""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Fermentation"", ""term"": {""id"": ""GO:0006113"", ""label"": ""fermentation""}}], ""cell_types"": [{""preferred_term"": ""Enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}], ""description"": ""High-alcohol-producing Klebsiella pneumoniae and related species can generate endogenous ethanol through the 2,3-butanediol fermentation pathway. These bacteria possess multiple copies of alcohol dehydrogenase genes enabling excessive ethanol production even under aerobic conditions.\n"", ""evidence"": [{""explanation"": ""Demonstrates that high-alcohol-producing Klebsiella strains can generate significant endogenous ethanol."", ""reference"": ""PMID:31543403"", ""snippet"": ""high-alcohol-producing Klebsiella pneumoniae (HiAlc Kpn) is associated with up to 60% of individuals with NAFLD in a Chinese cohort"", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms that Klebsiella species isolated from ABS patients can cause the syndrome in animal models."", ""reference"": ""PMID:37060744"", ""snippet"": ""We isolated three species of HiAlc Klebsiella from ABS patients, which were able to induce ABS in mice."", ""supports"": ""SUPPORT""}], ""name"": ""Bacterial Fermentation by Klebsiella""}"
753	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	2	Impaired Hepatic Ethanol Clearance	"The liver normally clears endogenous ethanol through first-pass metabolism via alcohol dehydrogenase. When ethanol production exceeds hepatic clearance capacity or hepatic function is compromised, ethanol enters systemic circulation causing intoxication symptoms.
"																																																								"{""description"": ""The liver normally clears endogenous ethanol through first-pass metabolism via alcohol dehydrogenase. When ethanol production exceeds hepatic clearance capacity or hepatic function is compromised, ethanol enters systemic circulation causing intoxication symptoms.\n"", ""name"": ""Impaired Hepatic Ethanol Clearance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Ethanol Metabolic Process"", ""term"": {""id"": ""GO:0006067"", ""label"": ""ethanol metabolic process""}}], ""cell_types"": [{""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""The liver normally clears endogenous ethanol through first-pass metabolism via alcohol dehydrogenase. When ethanol production exceeds hepatic clearance capacity or hepatic function is compromised, ethanol enters systemic circulation causing intoxication symptoms.\n"", ""evidence"": [{""explanation"": ""Describes the metabolic storm where gut dysbiosis leads to ethanol production that can overwhelm hepatic clearance."", ""reference"": ""PMID:34682761"", ""snippet"": ""The pathophysiology of ABS is reportedly due to a fungal type dysbiosis of the gut that ferments some carbohydrates into ethanol"", ""supports"": ""SUPPORT""}], ""name"": ""Impaired Hepatic Ethanol Clearance""}"
771	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	0	Warm Autoantibody-Mediated Hemolysis	IgG autoantibodies coat red blood cells and are recognized by Fc receptors on splenic macrophages, leading to extravascular hemolysis through phagocytosis. Partial phagocytosis creates spherocytes with reduced membrane.																																																								"{""description"": ""IgG autoantibodies coat red blood cells and are recognized by Fc receptors on splenic macrophages, leading to extravascular hemolysis through phagocytosis. Partial phagocytosis creates spherocytes with reduced membrane."", ""name"": ""Warm Autoantibody-Mediated Hemolysis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Phagocytosis"", ""term"": {""id"": ""GO:0006909"", ""label"": ""phagocytosis""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""Red Blood Cell"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}], ""description"": ""IgG autoantibodies coat red blood cells and are recognized by Fc receptors on splenic macrophages, leading to extravascular hemolysis through phagocytosis. Partial phagocytosis creates spherocytes with reduced membrane."", ""evidence"": [{""explanation"": ""This comprehensive 2024 review confirms that warm AIHA is mediated by IgG autoantibodies that recognize RBC antigens like band 3, consistent with the FcR-mediated phagocytosis mechanism."", ""reference"": ""PMID:38673882"", ""snippet"": ""Warm-antibody AIHA (wAIHA) exhibits a pan-reactive IgG autoantibody recognizing a portion of band 3 (wherein the DAT may be positive with IgG, C3d or both). Treatment involves glucocorticoids and steroid-sparing agents and may consider IVIG or monoclonal antibodies to CD20, CD38 or C1q."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study demonstrates that splenic red pulp macrophages express FcRIIa and FcRIIIa receptors and are responsible for phagocytosis of IgG-opsonized RBCs in AIHA, directly supporting the mechanism of extravascular hemolysis in warm AIHA."", ""reference"": ""PMID:29692344"", ""snippet"": ""Tissue-resident macrophages in the spleen play a major role in the clearance of immunoglobulin G (IgG)-opsonized blood cells, as occurs in immune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA). Blood cells are phagocytosed via the Fc- receptors (FcRs)"", ""supports"": ""SUPPORT""}], ""name"": ""Warm Autoantibody-Mediated Hemolysis""}"
772	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	1	Cold Agglutinin-Mediated Hemolysis	IgM autoantibodies bind RBCs at low temperatures and activate complement. C3b-coated cells undergo extravascular hemolysis in the liver, or MAC formation causes intravascular hemolysis.																																																								"{""description"": ""IgM autoantibodies bind RBCs at low temperatures and activate complement. C3b-coated cells undergo extravascular hemolysis in the liver, or MAC formation causes intravascular hemolysis."", ""name"": ""Cold Agglutinin-Mediated Hemolysis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""description"": ""IgM autoantibodies bind RBCs at low temperatures and activate complement. C3b-coated cells undergo extravascular hemolysis in the liver, or MAC formation causes intravascular hemolysis."", ""evidence"": [{""explanation"": ""This comprehensive review confirms that cold AIHA is mediated by IgM autoantibodies that activate the complement cascade, resulting in C3d deposition on RBCs and complement-mediated hemolysis."", ""reference"": ""PMID:38673882"", ""snippet"": ""Cold-antibody AIHA due to IgMs range from cold agglutinin syndrome (CAS) to cold agglutin disease (CAD). These are typically specific to the Ii blood group system, with the former (CAS) being polyclonal and the latter (CAD) being a more severe and monoclonal entity. The DAT in either case is positive only with C3d."", ""supports"": ""SUPPORT""}, {""explanation"": ""This first-in-human trial of C1s inhibition confirms the central role of classical complement pathway activation in cold agglutinin disease, where IgM binding triggers complement fixation leading to C3b opsonization and extravascular hemolysis."", ""reference"": ""PMID:30559259"", ""snippet"": ""Cold agglutinin disease is a difficult-to-treat autoimmune hemolytic anemia in which immunoglobulin M antibodies bind to erythrocytes and fix complement, resulting in predominantly extravascular hemolysis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This clinical study demonstrates that blocking C1s (the serine protease in the C1 complex) effectively stops complement-mediated hemolysis in CAD, confirming that classical pathway activation via C1s is the key mechanism driving RBC destruction in cold agglutinin disease."", ""reference"": ""PMID:32176765"", ""snippet"": ""Cold agglutinin disease (CAD) causes predominantly extravascular hemolysis and anemia via complement activation. Sutimlimab is a novel humanized monoclonal antibody directed against classical pathway complement factor C1s."", ""supports"": ""SUPPORT""}], ""name"": ""Cold Agglutinin-Mediated Hemolysis""}"
773	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	2	B Cell Dysregulation	Loss of B cell tolerance allows production of anti-RBC autoantibodies. In secondary AIHA, underlying conditions (lymphoma, CLL, SLE) drive autoantibody production.																																																								"{""description"": ""Loss of B cell tolerance allows production of anti-RBC autoantibodies. In secondary AIHA, underlying conditions (lymphoma, CLL, SLE) drive autoantibody production."", ""name"": ""B Cell Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""cell_types"": [{""preferred_term"": ""B Cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""Loss of B cell tolerance allows production of anti-RBC autoantibodies. In secondary AIHA, underlying conditions (lymphoma, CLL, SLE) drive autoantibody production."", ""evidence"": [{""explanation"": ""This 2024 review confirms that B cell-targeting therapy (rituximab, anti-CD20) is effective in warm AIHA, supporting the role of dysregulated B cells in autoantibody production against RBCs."", ""reference"": ""PMID:39371250"", ""snippet"": ""Therapy is quite different, as steroids and rituximab are effective in the former, but have a lower response rate and duration in the latter."", ""supports"": ""SUPPORT""}, {""explanation"": ""The efficacy of anti-CD20 (rituximab) and anti-CD38 (daratumumab) therapies demonstrates that B cells and plasma cells are the cellular sources of pathogenic autoantibodies in AIHA, confirming the role of B cell dysregulation in disease pathogenesis."", ""reference"": ""PMID:38673882"", ""snippet"": ""Treatment involves glucocorticoids and steroid-sparing agents and may consider IVIG or monoclonal antibodies to CD20, CD38 or C1q."", ""supports"": ""SUPPORT""}], ""name"": ""B Cell Dysregulation""}"
790	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	0	T Cell-Mediated Hepatocyte Destruction	Autoreactive CD4+ T cells recognize liver autoantigens and orchestrate the immune attack. CD8+ cytotoxic T cells directly kill hepatocytes expressing aberrant MHC class II molecules.																																																								"{""description"": ""Autoreactive CD4+ T cells recognize liver autoantigens and orchestrate the immune attack. CD8+ cytotoxic T cells directly kill hepatocytes expressing aberrant MHC class II molecules."", ""name"": ""T Cell-Mediated Hepatocyte Destruction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T Cell Cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}], ""cell_types"": [{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}, {""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}, {""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Autoreactive CD4+ T cells recognize liver autoantigens and orchestrate the immune attack. CD8+ cytotoxic T cells directly kill hepatocytes expressing aberrant MHC class II molecules."", ""evidence"": [{""explanation"": ""Demonstrates that autoreactive CD4+ T cells targeting the liver autoantigen SepSecS are present and clonally expanded in AIH patients, producing inflammatory cytokines and infiltrating liver tissue."", ""reference"": ""PMID:39817450"", ""snippet"": ""SepSecS-specific CD4+ T cell clones were found in patients with AIH who were anti-SLA-positive and anti-SLA-negative, and, to a lesser extent, in patients with non-AIH liver diseases and in healthy individuals. SepSecS-specific T cell clones from patients with AIH produced IFN-, IL-4, and IL-10, targeted multiple SepSecS epitopes, and, in one patient, were clonally expanded in both blood and liver biopsy."", ""supports"": ""SUPPORT""}], ""name"": ""T Cell-Mediated Hepatocyte Destruction""}"
791	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	1	Autoantibody Production	Characteristic autoantibodies include ANA, SMA (anti-actin), anti-LKM1 (anti-CYP2D6), and anti-SLA. While useful for diagnosis, their direct pathogenic role is uncertain.																																																								"{""description"": ""Characteristic autoantibodies include ANA, SMA (anti-actin), anti-LKM1 (anti-CYP2D6), and anti-SLA. While useful for diagnosis, their direct pathogenic role is uncertain."", ""name"": ""Autoantibody Production""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""description"": ""Characteristic autoantibodies include ANA, SMA (anti-actin), anti-LKM1 (anti-CYP2D6), and anti-SLA. While useful for diagnosis, their direct pathogenic role is uncertain."", ""evidence"": [{""explanation"": ""Shows that anti-SLA/SepSecS autoantibodies in AIH undergo affinity maturation and class-switching to IgG1, indicating an adaptive B cell response with germinal center involvement."", ""reference"": ""PMID:39817450"", ""snippet"": ""The anti-SepSecS mAbs isolated were primarily IgG1, affinity-matured compared with their germline versions, and recognized at least 3 nonoverlapping epitopes."", ""supports"": ""SUPPORT""}, {""explanation"": ""Highlights multiple mechanisms by which B cells and autoantibodies contribute to AIH pathogenesis beyond simple diagnostic markers."", ""reference"": ""PMID:31226726"", ""snippet"": ""Autoreactive B cells can promote autoimmunity through antigen presentation to autoreactive T cells, production of autoantibodies, generation of cytokines promoting T cell activation and differentiation, and inhibition of regulatory T cells and B cells."", ""supports"": ""SUPPORT""}], ""name"": ""Autoantibody Production""}"
792	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	2	Regulatory T Cell Deficiency	Impaired function and reduced numbers of regulatory T cells (Tregs) fail to suppress autoreactive T cells, allowing ongoing liver damage.																																																								"{""description"": ""Impaired function and reduced numbers of regulatory T cells (Tregs) fail to suppress autoreactive T cells, allowing ongoing liver damage."", ""name"": ""Regulatory T Cell Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immune Regulation"", ""term"": {""id"": ""GO:0002682"", ""label"": ""regulation of immune system process""}}], ""cell_types"": [{""preferred_term"": ""Regulatory T Cell"", ""term"": {""id"": ""CL:0000815"", ""label"": ""regulatory T cell""}}], ""description"": ""Impaired function and reduced numbers of regulatory T cells (Tregs) fail to suppress autoreactive T cells, allowing ongoing liver damage."", ""evidence"": [{""explanation"": ""Indicates that B cells in AIH can actively inhibit regulatory T cells, contributing to the loss of immune tolerance and allowing autoreactive T cell expansion."", ""reference"": ""PMID:31226726"", ""snippet"": ""Autoreactive B cells can promote autoimmunity through antigen presentation to autoreactive T cells, production of autoantibodies, generation of cytokines promoting T cell activation and differentiation, and inhibition of regulatory T cells and B cells."", ""supports"": ""SUPPORT""}], ""name"": ""Regulatory T Cell Deficiency""}"
809	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	0	Disrupted Neural Crest-Derived Periocular Mesenchyme Development	PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm's canal.																																																								"{""description"": ""PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm's canal."", ""name"": ""Disrupted Neural Crest-Derived Periocular Mesenchyme Development""}"	{}	"{""biological_processes"": [{""preferred_term"": ""neural crest cell migration"", ""term"": {""id"": ""GO:0001755"", ""label"": ""neural crest cell migration""}}, {""preferred_term"": ""eye morphogenesis"", ""term"": {""id"": ""GO:0048592"", ""label"": ""eye morphogenesis""}}, {""preferred_term"": ""canonical Wnt signaling pathway"", ""term"": {""id"": ""GO:0060070"", ""label"": ""canonical Wnt signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""migratory neural crest cell"", ""term"": {""id"": ""CL:0000333"", ""label"": ""migratory neural crest cell""}}], ""description"": ""PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm's canal."", ""evidence"": [{""explanation"": ""Confirms PITX2 and FOXC1 as the primary genes involved in ARS pathogenesis."", ""reference"": ""PMID:22199394"", ""snippet"": ""Recent advances in molecular genetics have identified two major genes, PITX2 and FOXC1, demonstrating a wide spectrum of mutations, which aids in the molecular diagnosis of the disease."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""trabecular meshwork"", ""term"": {""id"": ""UBERON:0001810"", ""label"": ""trabecular meshwork""}}, {""preferred_term"": ""corneal endothelium"", ""term"": {""id"": ""UBERON:0001772"", ""label"": ""corneal endothelium""}}, {""preferred_term"": ""iris stroma"", ""term"": {""id"": ""UBERON:0011821"", ""label"": ""iris stroma""}}], ""name"": ""Disrupted Neural Crest-Derived Periocular Mesenchyme Development""}"
810	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	1	Dysregulated Transcription Factor Activity	Mutations in the PITX2 gene disrupt its function as a transcription factor, impairing its ability to bind DNA and regulate gene expression critical for eye development. Most mutations cause defects in DNA binding or transcriptional activation, while some increase transactivation activity, leading to unregulated gene expression during embryogenesis.																																																								"{""description"": ""Mutations in the PITX2 gene disrupt its function as a transcription factor, impairing its ability to bind DNA and regulate gene expression critical for eye development. Most mutations cause defects in DNA binding or transcriptional activation, while some increase transactivation activity, leading to unregulated gene expression during embryogenesis."", ""name"": ""Dysregulated Transcription Factor Activity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0006357"", ""label"": ""regulation of transcription by RNA polymerase II""}}, {""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""description"": ""Mutations in the PITX2 gene disrupt its function as a transcription factor, impairing its ability to bind DNA and regulate gene expression critical for eye development. Most mutations cause defects in DNA binding or transcriptional activation, while some increase transactivation activity, leading to unregulated gene expression during embryogenesis."", ""evidence"": [{""explanation"": ""The reference indicates that some mutations in PITX2 result in reduced DNA-binding and transcriptional activation, which aligns with the statement that mutations disrupt its function."", ""reference"": ""PMID:19218601"", ""snippet"": ""Two homeobox mutations, R43W and R90C, resulted in severely reduced DNA-binding and transcriptional activation despite normal nuclear localization."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement that mutations in PITX2 can disrupt its function, and mentions that some mutations can increase transactivation activity."", ""reference"": ""PMID:15509533"", ""snippet"": ""It has been reported that some mutations in PITX2 increase transactivation, whereas most mutations cause defects in DNA binding or transactivation."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the idea that PITX2 mutations can impair its ability to regulate gene expression."", ""reference"": ""PMID:12130547"", ""snippet"": ""The five mutants appeared to be transcriptionally defective despite conserved DNA-binding in CV1 cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the idea that PITX2 mutations can disrupt its function as a transcription factor."", ""reference"": ""PMID:21837767"", ""snippet"": ""Mutation in either gene caused reduced transcriptional activation to different extents on the FOXO1 and PLOD1 promoters."", ""supports"": ""SUPPORT""}], ""name"": ""Dysregulated Transcription Factor Activity""}"
811	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	2	Ocular Anomalies	Improper development of the anterior segment of the eye, leading to issues such as iris defects and abnormal angle structures.																																																								"{""description"": ""Improper development of the anterior segment of the eye, leading to issues such as iris defects and abnormal angle structures."", ""name"": ""Ocular Anomalies""}"	{}	"{""description"": ""Improper development of the anterior segment of the eye, leading to issues such as iris defects and abnormal angle structures."", ""evidence"": [{""explanation"": ""The literature states that ARS is characterized by ocular anterior segment anomalies, supporting the statement that it involves improper development of the anterior segment of the eye."", ""reference"": ""PMID:36926528"", ""snippet"": ""Axenfeld-Rieger syndrome (ARS) is a rare congenital disease that is primarily characterized by ocular anterior segment anomalies but is also associated with craniofacial, dental, cardiac, and neurologic abnormalities."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference confirms that malformations of the anterior segment of the eye are associated with conditions like glaucoma, supporting the statement about improper development and associated issues."", ""reference"": ""PMID:12015278"", ""snippet"": ""Individuals with malformations of structures of the anterior segment of the eye frequently develop elevated intraocular pressure and glaucoma."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature describes Axenfeld and Rieger anomalies as part of anterior segment dysgenesis, which includes iris defects and abnormal angle structures, supporting the statement."", ""reference"": ""PMID:35327965"", ""snippet"": ""Anterior segment dysgenesis (ASD) encompasses a wide spectrum of developmental abnormalities of the anterior ocular segment, including congenital cataract, iris hypoplasia, aniridia, iridocorneal synechiae, as well as Peters, Axenfeld, and Rieger anomalies."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature confirms that Axenfeld-Rieger Syndrome results from incorrect development of the eye, specifically mentioning the anterior segment, supporting the statement."", ""reference"": ""PMID:31560925"", ""snippet"": ""Aniridia and Axenfeld-Rieger Syndrome are related, human ocular disorders that are typically inherited in an autosomal dominant manner. Both result from incorrect development of the eye and have, as their most serious consequences, elevated risk to develop the blinding condition glaucoma."", ""supports"": ""SUPPORT""}], ""name"": ""Ocular Anomalies""}"
812	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	3	Systemic Anomalies	Involves multiple systems, often including dental, craniofacial, and umbilical abnormalities.																																																								"{""description"": ""Involves multiple systems, often including dental, craniofacial, and umbilical abnormalities."", ""name"": ""Systemic Anomalies""}"	{}	"{""description"": ""Involves multiple systems, often including dental, craniofacial, and umbilical abnormalities."", ""evidence"": [{""explanation"": ""The literature describes Axenfeld-Rieger syndrome as involving multiple systems, including dental and craniofacial abnormalities, which supports the statement."", ""reference"": ""PMID:16302606"", ""snippet"": ""Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized by various ocular and extraocular malformations. Dental abnormalities are considered as definitive features for the diagnosis and differentiation of Rieger syndrome from other anterior chamber of the eye malformations."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference confirms that Axenfeld-Rieger syndrome is a multi-system disorder, which aligns with the statement that it involves multiple systems."", ""reference"": ""PMID:36543336"", ""snippet"": ""Axenfeld-Rieger syndrome is a rare multi-system disorder associated with cardiac anomalies."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature mentions dental anomalies as significant features in various syndromes, including Axenfeld-Rieger syndrome, supporting the statement."", ""reference"": ""PMID:18599376"", ""snippet"": ""We will consider successively syndromic forms of amelogenesis imperfecta or enamel defects, dentinogenesis imperfecta (i.e. osteogenesis imperfecta) and other dentine anomalies."", ""supports"": ""SUPPORT""}], ""name"": ""Systemic Anomalies""}"
813	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	4	Glaucoma-related Vision Loss	Loss of vision due to uncontrolled intraocular pressure.		OCCASIONAL																																																						"{""description"": ""Loss of vision due to uncontrolled intraocular pressure."", ""frequency"": ""OCCASIONAL"", ""name"": ""Glaucoma-related Vision Loss""}"	{}	"{""description"": ""Loss of vision due to uncontrolled intraocular pressure."", ""evidence"": [{""explanation"": ""The reference discusses the management of glaucoma in Axenfeld-Rieger syndrome, indicating that loss of vision due to uncontrolled intraocular pressure is a concern."", ""reference"": ""PMID:35733478"", ""snippet"": ""Treatment is predominantly the management of glaucoma and is mostly medical but can be surgical in refractory cases."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference explicitly states that glaucoma is the main cause of visual morbidity in Axenfeld-Rieger syndrome, supporting the statement."", ""reference"": ""PMID:33367186"", ""snippet"": ""Glaucoma is the main cause of visual morbidity in patients with ARS."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference mentions that glaucomas associated with Axenfeld-Rieger syndrome can lead to visual disability, supporting the statement."", ""reference"": ""PMID:28549150"", ""snippet"": ""Other early-onset glaucomas may arise secondary to developmental abnormalities, such as glaucomas that occur with aniridia or as part of Axenfeld-Rieger syndrome."", ""supports"": ""SUPPORT""}, {""explanation"": ""The title suggests a direct relationship between glaucoma and Axenfeld-Rieger syndrome, implying that vision loss due to glaucoma is a concern."", ""reference"": ""PMID:5467709"", ""snippet"": ""Glaucoma and Rieger's syndrome."", ""supports"": ""SUPPORT""}], ""frequency"": ""OCCASIONAL"", ""name"": ""Glaucoma-related Vision Loss""}"
835	34	BRAF-Mutant Papillary Thyroid Cancer	BRAF_Mutant_Thyroid_Cancer.yaml	pathophysiology	0	BRAF V600E Constitutive Activation	The BRAF V600E mutation causes constitutive activation of the RAF kinase by mimicking the phosphorylated active state. This results in ligand-independent activation of the MAPK pathway driving thyroid follicular cell proliferation and dedifferentiation.																																																								"{""description"": ""The BRAF V600E mutation causes constitutive activation of the RAF kinase by mimicking the phosphorylated active state. This results in ligand-independent activation of the MAPK pathway driving thyroid follicular cell proliferation and dedifferentiation."", ""name"": ""BRAF V600E Constitutive Activation""}"	"{""downstream"": [{""description"": ""Constitutive BRAF activation drives downstream MEK-ERK signaling"", ""target"": ""MEK-ERK Pathway Hyperactivation""}, {""description"": ""MAPK activation suppresses thyroid differentiation gene expression"", ""target"": ""Thyroid Dedifferentiation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""cell_types"": [{""preferred_term"": ""thyroid follicular cell"", ""term"": {""id"": ""CL:0002258"", ""label"": ""thyroid follicular cell""}}], ""description"": ""The BRAF V600E mutation causes constitutive activation of the RAF kinase by mimicking the phosphorylated active state. This results in ligand-independent activation of the MAPK pathway driving thyroid follicular cell proliferation and dedifferentiation."", ""downstream"": [{""description"": ""Constitutive BRAF activation drives downstream MEK-ERK signaling"", ""target"": ""MEK-ERK Pathway Hyperactivation""}, {""description"": ""MAPK activation suppresses thyroid differentiation gene expression"", ""target"": ""Thyroid Dedifferentiation""}], ""locations"": [{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}], ""name"": ""BRAF V600E Constitutive Activation""}"
836	34	BRAF-Mutant Papillary Thyroid Cancer	BRAF_Mutant_Thyroid_Cancer.yaml	pathophysiology	1	MEK-ERK Pathway Hyperactivation	Mutant BRAF constitutively phosphorylates and activates MEK1/2, leading to sustained ERK1/2 activation. This drives uncontrolled proliferation and is the rationale for combined BRAF/MEK inhibition therapy.																																																								"{""description"": ""Mutant BRAF constitutively phosphorylates and activates MEK1/2, leading to sustained ERK1/2 activation. This drives uncontrolled proliferation and is the rationale for combined BRAF/MEK inhibition therapy."", ""name"": ""MEK-ERK Pathway Hyperactivation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""description"": ""Mutant BRAF constitutively phosphorylates and activates MEK1/2, leading to sustained ERK1/2 activation. This drives uncontrolled proliferation and is the rationale for combined BRAF/MEK inhibition therapy."", ""name"": ""MEK-ERK Pathway Hyperactivation""}"
837	34	BRAF-Mutant Papillary Thyroid Cancer	BRAF_Mutant_Thyroid_Cancer.yaml	pathophysiology	2	Thyroid Dedifferentiation	BRAF V600E-driven MAPK activation suppresses expression of thyroid differentiation genes including NIS (sodium-iodide symporter), leading to radioiodine refractoriness. This loss of differentiation is associated with more aggressive disease behavior.																																																								"{""description"": ""BRAF V600E-driven MAPK activation suppresses expression of thyroid differentiation genes including NIS (sodium-iodide symporter), leading to radioiodine refractoriness. This loss of differentiation is associated with more aggressive disease behavior."", ""name"": ""Thyroid Dedifferentiation""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}], ""description"": ""BRAF V600E-driven MAPK activation suppresses expression of thyroid differentiation genes including NIS (sodium-iodide symporter), leading to radioiodine refractoriness. This loss of differentiation is associated with more aggressive disease behavior."", ""name"": ""Thyroid Dedifferentiation""}"
853	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	pathophysiology	0	BRAF V600E Constitutive Activation	The V600E mutation substitutes glutamic acid for valine at position 600 in the activation segment of BRAF kinase. This mimics phosphorylation-induced activation, locking BRAF in an active conformation. The mutant kinase signals constitutively through MEK and ERK without upstream RAS activation.																																																								"{""description"": ""The V600E mutation substitutes glutamic acid for valine at position 600 in the activation segment of BRAF kinase. This mimics phosphorylation-induced activation, locking BRAF in an active conformation. The mutant kinase signals constitutively through MEK and ERK without upstream RAS activation."", ""name"": ""BRAF V600E Constitutive Activation""}"	"{""downstream"": [{""description"": ""Constitutive BRAF activation drives sustained MEK/ERK signaling"", ""target"": ""Uncontrolled MAPK Pathway Signaling""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""cell_types"": [{""preferred_term"": ""colon epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}], ""description"": ""The V600E mutation substitutes glutamic acid for valine at position 600 in the activation segment of BRAF kinase. This mimics phosphorylation-induced activation, locking BRAF in an active conformation. The mutant kinase signals constitutively through MEK and ERK without upstream RAS activation."", ""downstream"": [{""description"": ""Constitutive BRAF activation drives sustained MEK/ERK signaling"", ""target"": ""Uncontrolled MAPK Pathway Signaling""}], ""evidence"": [{""explanation"": ""This abstract links BRAF mutations in CRC to the V600E hotspot and supports the relevance of V600E in colorectal cancer."", ""reference"": ""PMID:30739887"", ""snippet"": ""BRAF mutations confers a poor prognosis in Western CRC patients, particularly in metastatic CRC (mCRC) and its mutations occur in approximately 4-20% CRC, with the vast majority being the V600E hotspot mutation."", ""supports"": ""SUPPORT""}], ""name"": ""BRAF V600E Constitutive Activation""}"
854	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	pathophysiology	1	Uncontrolled MAPK Pathway Signaling	Constitutive BRAF V600E activation leads to continuous phosphorylation of MEK1/2, which phosphorylates ERK1/2. Activated ERK translocates to the nucleus and drives expression of genes promoting cell proliferation, survival, and invasion. This signaling is independent of growth factor receptor activation.																																																								"{""description"": ""Constitutive BRAF V600E activation leads to continuous phosphorylation of MEK1/2, which phosphorylates ERK1/2. Activated ERK translocates to the nucleus and drives expression of genes promoting cell proliferation, survival, and invasion. This signaling is independent of growth factor receptor activation."", ""name"": ""Uncontrolled MAPK Pathway Signaling""}"	"{""downstream"": [{""description"": ""ERK activation drives cell cycle progression and proliferation"", ""target"": ""Enhanced Cell Proliferation""}, {""description"": ""ERK inhibition releases negative feedback on EGFR"", ""target"": ""EGFR Feedback Reactivation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""description"": ""Constitutive BRAF V600E activation leads to continuous phosphorylation of MEK1/2, which phosphorylates ERK1/2. Activated ERK translocates to the nucleus and drives expression of genes promoting cell proliferation, survival, and invasion. This signaling is independent of growth factor receptor activation."", ""downstream"": [{""description"": ""ERK activation drives cell cycle progression and proliferation"", ""target"": ""Enhanced Cell Proliferation""}, {""description"": ""ERK inhibition releases negative feedback on EGFR"", ""target"": ""EGFR Feedback Reactivation""}], ""name"": ""Uncontrolled MAPK Pathway Signaling""}"
855	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	pathophysiology	2	Enhanced Cell Proliferation	Sustained ERK signaling promotes entry into the cell cycle by inducing cyclin D1 and other proliferative genes while suppressing cell cycle inhibitors. This drives continuous tumor cell division independent of external growth signals.																																																								"{""description"": ""Sustained ERK signaling promotes entry into the cell cycle by inducing cyclin D1 and other proliferative genes while suppressing cell cycle inhibitors. This drives continuous tumor cell division independent of external growth signals."", ""name"": ""Enhanced Cell Proliferation""}"	{}	"{""description"": ""Sustained ERK signaling promotes entry into the cell cycle by inducing cyclin D1 and other proliferative genes while suppressing cell cycle inhibitors. This drives continuous tumor cell division independent of external growth signals."", ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}], ""name"": ""Enhanced Cell Proliferation""}"
856	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	pathophysiology	3	EGFR Feedback Reactivation	Unlike melanoma, colorectal cancer cells have high EGFR expression. When BRAF is inhibited, relief of ERK-mediated negative feedback leads to rapid EGFR reactivation, which signals through RAS and CRAF to restore MAPK pathway activity. This explains why BRAF inhibitor monotherapy fails in colorectal cancer but works in melanoma.																																		This feedback mechanism necessitates combination therapy with EGFR inhibitors (cetuximab) to block the reactivation pathway.																						"{""description"": ""Unlike melanoma, colorectal cancer cells have high EGFR expression. When BRAF is inhibited, relief of ERK-mediated negative feedback leads to rapid EGFR reactivation, which signals through RAS and CRAF to restore MAPK pathway activity. This explains why BRAF inhibitor monotherapy fails in colorectal cancer but works in melanoma."", ""name"": ""EGFR Feedback Reactivation"", ""notes"": ""This feedback mechanism necessitates combination therapy with EGFR inhibitors (cetuximab) to block the reactivation pathway.""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""ERBB signaling pathway"", ""term"": {""id"": ""GO:0038127"", ""label"": ""ERBB signaling pathway""}}], ""description"": ""Unlike melanoma, colorectal cancer cells have high EGFR expression. When BRAF is inhibited, relief of ERK-mediated negative feedback leads to rapid EGFR reactivation, which signals through RAS and CRAF to restore MAPK pathway activity. This explains why BRAF inhibitor monotherapy fails in colorectal cancer but works in melanoma."", ""name"": ""EGFR Feedback Reactivation"", ""notes"": ""This feedback mechanism necessitates combination therapy with EGFR inhibitors (cetuximab) to block the reactivation pathway.""}"
871	36	BRAF V600E-Mutant Non-Small Cell Lung Cancer	BRAF_V600E_Mutant_NSCLC.yaml	pathophysiology	0	BRAF V600E Oncogenic Mutation	The BRAF V600E mutation substitutes glutamic acid for valine at codon 600 in the activation segment. This mimics phosphorylation, causing constitutive kinase activation. V600E signals as a monomer independent of upstream RAS, unlike wild-type BRAF which requires RAS-mediated dimerization.																																																								"{""description"": ""The BRAF V600E mutation substitutes glutamic acid for valine at codon 600 in the activation segment. This mimics phosphorylation, causing constitutive kinase activation. V600E signals as a monomer independent of upstream RAS, unlike wild-type BRAF which requires RAS-mediated dimerization."", ""name"": ""BRAF V600E Oncogenic Mutation""}"	"{""downstream"": [{""description"": ""RAS-independent ERK signaling"", ""target"": ""Constitutive MAPK Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein kinase activity"", ""term"": {""id"": ""GO:0004672"", ""label"": ""protein kinase activity""}}], ""cell_types"": [{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}], ""description"": ""The BRAF V600E mutation substitutes glutamic acid for valine at codon 600 in the activation segment. This mimics phosphorylation, causing constitutive kinase activation. V600E signals as a monomer independent of upstream RAS, unlike wild-type BRAF which requires RAS-mediated dimerization."", ""downstream"": [{""description"": ""RAS-independent ERK signaling"", ""target"": ""Constitutive MAPK Pathway Activation""}], ""evidence"": [{""explanation"": ""Supports the presence and predominance of BRAF V600E among BRAF-mutant NSCLC."", ""reference"": ""PMID:41158045"", ""snippet"": ""The incidence of BRAF mutations in non-small cell lung cancer (NSCLC) patients ranges from 1.5% to 5.5%, with BRAF V600 mutations accounting for approximately 30%-50% of all BRAF mutations, among which BRAF V600E represents the most prevalent mutation type."", ""supports"": ""SUPPORT""}], ""name"": ""BRAF V600E Oncogenic Mutation""}"
872	36	BRAF V600E-Mutant Non-Small Cell Lung Cancer	BRAF_V600E_Mutant_NSCLC.yaml	pathophysiology	1	Constitutive MAPK Pathway Activation	BRAF V600E constitutively phosphorylates and activates MEK1/2, which in turn phosphorylates and activates ERK1/2. This leads to uncontrolled proliferation and survival signaling. The lack of dependence on upstream RAS makes the tumor exquisitely sensitive to BRAF inhibition.																																																								"{""description"": ""BRAF V600E constitutively phosphorylates and activates MEK1/2, which in turn phosphorylates and activates ERK1/2. This leads to uncontrolled proliferation and survival signaling. The lack of dependence on upstream RAS makes the tumor exquisitely sensitive to BRAF inhibition."", ""name"": ""Constitutive MAPK Pathway Activation""}"	"{""downstream"": [{""description"": ""ERK-driven transcription of pro-growth genes"", ""target"": ""Cell Proliferation and Survival""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""BRAF V600E constitutively phosphorylates and activates MEK1/2, which in turn phosphorylates and activates ERK1/2. This leads to uncontrolled proliferation and survival signaling. The lack of dependence on upstream RAS makes the tumor exquisitely sensitive to BRAF inhibition."", ""downstream"": [{""description"": ""ERK-driven transcription of pro-growth genes"", ""target"": ""Cell Proliferation and Survival""}], ""name"": ""Constitutive MAPK Pathway Activation""}"
873	36	BRAF V600E-Mutant Non-Small Cell Lung Cancer	BRAF_V600E_Mutant_NSCLC.yaml	pathophysiology	2	Cell Proliferation and Survival	Constitutive ERK signaling drives expression of cyclin D1 and other cell cycle genes, promoting uncontrolled proliferation. ERK also inhibits pro-apoptotic proteins through phosphorylation.																																																								"{""description"": ""Constitutive ERK signaling drives expression of cyclin D1 and other cell cycle genes, promoting uncontrolled proliferation. ERK also inhibits pro-apoptotic proteins through phosphorylation."", ""name"": ""Cell Proliferation and Survival""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Constitutive ERK signaling drives expression of cyclin D1 and other cell cycle genes, promoting uncontrolled proliferation. ERK also inhibits pro-apoptotic proteins through phosphorylation."", ""name"": ""Cell Proliferation and Survival""}"
874	36	BRAF V600E-Mutant Non-Small Cell Lung Cancer	BRAF_V600E_Mutant_NSCLC.yaml	pathophysiology	3	BRAF/MEK Inhibitor Resistance	Resistance to BRAF/MEK inhibition can develop through MAPK pathway reactivation (BRAF amplification, MEK mutations, NRAS mutations), bypass pathway activation (PI3K-AKT), or histologic transformation. Combination BRAF+MEK inhibition delays resistance compared to BRAF inhibitor monotherapy.																																																								"{""description"": ""Resistance to BRAF/MEK inhibition can develop through MAPK pathway reactivation (BRAF amplification, MEK mutations, NRAS mutations), bypass pathway activation (PI3K-AKT), or histologic transformation. Combination BRAF+MEK inhibition delays resistance compared to BRAF inhibitor monotherapy."", ""name"": ""BRAF/MEK Inhibitor Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}], ""description"": ""Resistance to BRAF/MEK inhibition can develop through MAPK pathway reactivation (BRAF amplification, MEK mutations, NRAS mutations), bypass pathway activation (PI3K-AKT), or histologic transformation. Combination BRAF+MEK inhibition delays resistance compared to BRAF inhibitor monotherapy."", ""name"": ""BRAF/MEK Inhibitor Resistance""}"
887	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	0	BRAF V600 Oncogenic Mutation	BRAF V600 mutations, predominantly V600E and V600K, result in substitution of the valine residue in the activation loop of the BRAF kinase. This removes an autoinhibitory mechanism, causing constitutive kinase activity independent of upstream RAS signaling. The mutant BRAF signals as a monomer, unlike wild-type BRAF which requires dimerization for activation.																																																								"{""description"": ""BRAF V600 mutations, predominantly V600E and V600K, result in substitution of the valine residue in the activation loop of the BRAF kinase. This removes an autoinhibitory mechanism, causing constitutive kinase activity independent of upstream RAS signaling. The mutant BRAF signals as a monomer, unlike wild-type BRAF which requires dimerization for activation."", ""name"": ""BRAF V600 Oncogenic Mutation""}"	"{""downstream"": [{""description"": ""V600E BRAF has 500-fold increased kinase activity compared to wild-type"", ""target"": ""Constitutive MAPK Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""cell_types"": [{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}], ""description"": ""BRAF V600 mutations, predominantly V600E and V600K, result in substitution of the valine residue in the activation loop of the BRAF kinase. This removes an autoinhibitory mechanism, causing constitutive kinase activity independent of upstream RAS signaling. The mutant BRAF signals as a monomer, unlike wild-type BRAF which requires dimerization for activation."", ""downstream"": [{""description"": ""V600E BRAF has 500-fold increased kinase activity compared to wild-type"", ""target"": ""Constitutive MAPK Pathway Activation""}], ""evidence"": [{""explanation"": ""This abstract reports frequent hotspot BRAF mutations in cutaneous melanoma, supporting the relevance of BRAF-driven melanoma."", ""reference"": ""PMID:40023845"", ""snippet"": ""Hotspot BRAF, hotspot NRAS, and NF1 loss-of-function mutations are found in approximately 50%, 25%, and 15% of cutaneous melanomas, respectively."", ""supports"": ""SUPPORT""}], ""name"": ""BRAF V600 Oncogenic Mutation""}"
888	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	1	Constitutive MAPK Pathway Activation	Mutant BRAF continuously phosphorylates and activates MEK1/2, which in turn activates ERK1/2. This constitutive MAPK signaling drives expression of genes promoting cell cycle progression, survival, and proliferation. The pathway operates independently of growth factor stimulation.																																																								"{""description"": ""Mutant BRAF continuously phosphorylates and activates MEK1/2, which in turn activates ERK1/2. This constitutive MAPK signaling drives expression of genes promoting cell cycle progression, survival, and proliferation. The pathway operates independently of growth factor stimulation."", ""name"": ""Constitutive MAPK Pathway Activation""}"	"{""downstream"": [{""description"": ""ERK drives cyclin D1 expression and G1/S progression"", ""target"": ""Uncontrolled Melanocyte Proliferation""}, {""description"": ""MAPK signaling promotes survival through multiple mechanisms"", ""target"": ""Apoptosis Resistance""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Mutant BRAF continuously phosphorylates and activates MEK1/2, which in turn activates ERK1/2. This constitutive MAPK signaling drives expression of genes promoting cell cycle progression, survival, and proliferation. The pathway operates independently of growth factor stimulation."", ""downstream"": [{""description"": ""ERK drives cyclin D1 expression and G1/S progression"", ""target"": ""Uncontrolled Melanocyte Proliferation""}, {""description"": ""MAPK signaling promotes survival through multiple mechanisms"", ""target"": ""Apoptosis Resistance""}], ""name"": ""Constitutive MAPK Pathway Activation""}"
889	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	2	Uncontrolled Melanocyte Proliferation	Constitutive MAPK signaling drives melanocyte proliferation through ERK-mediated phosphorylation and stabilization of transcription factors controlling cell cycle progression, including upregulation of cyclin D1 and suppression of cell cycle inhibitors such as p27.																																																								"{""description"": ""Constitutive MAPK signaling drives melanocyte proliferation through ERK-mediated phosphorylation and stabilization of transcription factors controlling cell cycle progression, including upregulation of cyclin D1 and suppression of cell cycle inhibitors such as p27."", ""name"": ""Uncontrolled Melanocyte Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}], ""description"": ""Constitutive MAPK signaling drives melanocyte proliferation through ERK-mediated phosphorylation and stabilization of transcription factors controlling cell cycle progression, including upregulation of cyclin D1 and suppression of cell cycle inhibitors such as p27."", ""locations"": [{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}], ""name"": ""Uncontrolled Melanocyte Proliferation""}"
890	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	3	Apoptosis Resistance	BRAF V600 signaling promotes melanoma cell survival through multiple anti-apoptotic mechanisms, including upregulation of BCL2 family members and suppression of pro-apoptotic BIM. This contributes to tumor persistence and therapy resistance.																																																								"{""description"": ""BRAF V600 signaling promotes melanoma cell survival through multiple anti-apoptotic mechanisms, including upregulation of BCL2 family members and suppression of pro-apoptotic BIM. This contributes to tumor persistence and therapy resistance."", ""name"": ""Apoptosis Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""BRAF V600 signaling promotes melanoma cell survival through multiple anti-apoptotic mechanisms, including upregulation of BCL2 family members and suppression of pro-apoptotic BIM. This contributes to tumor persistence and therapy resistance."", ""name"": ""Apoptosis Resistance""}"
903	38	BRCA-Mutant Prostate Cancer	BRCA_Mutant_Prostate_Cancer.yaml	pathophysiology	0	Homologous Recombination Repair Deficiency	Loss of functional BRCA1 or BRCA2 impairs homologous recombination repair (HRR), the high-fidelity pathway for repairing DNA double-strand breaks. This leads to accumulation of genomic instability and reliance on error-prone repair pathways.																																																								"{""description"": ""Loss of functional BRCA1 or BRCA2 impairs homologous recombination repair (HRR), the high-fidelity pathway for repairing DNA double-strand breaks. This leads to accumulation of genomic instability and reliance on error-prone repair pathways."", ""name"": ""Homologous Recombination Repair Deficiency""}"	"{""downstream"": [{""description"": ""HRR deficiency leads to accumulation of chromosomal aberrations"", ""target"": ""Genomic Instability""}, {""description"": ""HRR-deficient cells are exquisitely sensitive to PARP inhibition"", ""target"": ""Synthetic Lethality with PARP Inhibition""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""double-strand break repair via homologous recombination"", ""term"": {""id"": ""GO:0000724"", ""label"": ""double-strand break repair via homologous recombination""}}], ""cell_types"": [{""preferred_term"": ""prostate gland cell"", ""term"": {""id"": ""CL:0002231"", ""label"": ""epithelial cell of prostate""}}], ""description"": ""Loss of functional BRCA1 or BRCA2 impairs homologous recombination repair (HRR), the high-fidelity pathway for repairing DNA double-strand breaks. This leads to accumulation of genomic instability and reliance on error-prone repair pathways."", ""downstream"": [{""description"": ""HRR deficiency leads to accumulation of chromosomal aberrations"", ""target"": ""Genomic Instability""}, {""description"": ""HRR-deficient cells are exquisitely sensitive to PARP inhibition"", ""target"": ""Synthetic Lethality with PARP Inhibition""}], ""locations"": [{""preferred_term"": ""prostate gland"", ""term"": {""id"": ""UBERON:0002367"", ""label"": ""prostate gland""}}], ""name"": ""Homologous Recombination Repair Deficiency""}"
904	38	BRCA-Mutant Prostate Cancer	BRCA_Mutant_Prostate_Cancer.yaml	pathophysiology	1	Genomic Instability	HRR deficiency leads to genomic instability characterized by chromosomal rearrangements, copy number alterations, and mutational signatures typical of BRCA deficiency. This drives aggressive tumor behavior but also creates therapeutic vulnerabilities.																																																								"{""description"": ""HRR deficiency leads to genomic instability characterized by chromosomal rearrangements, copy number alterations, and mutational signatures typical of BRCA deficiency. This drives aggressive tumor behavior but also creates therapeutic vulnerabilities."", ""name"": ""Genomic Instability""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}], ""description"": ""HRR deficiency leads to genomic instability characterized by chromosomal rearrangements, copy number alterations, and mutational signatures typical of BRCA deficiency. This drives aggressive tumor behavior but also creates therapeutic vulnerabilities."", ""name"": ""Genomic Instability""}"
905	38	BRCA-Mutant Prostate Cancer	BRCA_Mutant_Prostate_Cancer.yaml	pathophysiology	2	Synthetic Lethality with PARP Inhibition	PARP enzymes are essential for single-strand break repair. In HRR-deficient cells, PARP inhibition causes accumulation of double-strand breaks that cannot be repaired, leading to synthetic lethality and selective tumor cell death.																																																								"{""description"": ""PARP enzymes are essential for single-strand break repair. In HRR-deficient cells, PARP inhibition causes accumulation of double-strand breaks that cannot be repaired, leading to synthetic lethality and selective tumor cell death."", ""name"": ""Synthetic Lethality with PARP Inhibition""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""single-strand break repair"", ""term"": {""id"": ""GO:0000012"", ""label"": ""single-strand break repair""}}], ""description"": ""PARP enzymes are essential for single-strand break repair. In HRR-deficient cells, PARP inhibition causes accumulation of double-strand breaks that cannot be repaired, leading to synthetic lethality and selective tumor cell death."", ""name"": ""Synthetic Lethality with PARP Inhibition""}"
931	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	0	Bacterial Invasion	Bacteria enter the bloodstream and cross the blood-brain barrier to infect the meninges.																																																								"{""description"": ""Bacteria enter the bloodstream and cross the blood-brain barrier to infect the meninges."", ""name"": ""Bacterial Invasion""}"	{}	"{""cell_types"": [{""preferred_term"": ""brain microvascular endothelial cell"", ""term"": {""id"": ""CL:2000044"", ""label"": ""brain microvascular endothelial cell""}}, {""preferred_term"": ""choroid plexus epithelial cell"", ""term"": {""id"": ""CL:0000706"", ""label"": ""choroid plexus epithelial cell""}}], ""description"": ""Bacteria enter the bloodstream and cross the blood-brain barrier to infect the meninges."", ""evidence"": [{""explanation"": ""The reference discusses how Streptococcus pneumoniae can penetrate the blood-brain barrier from the bloodstream, which supports the statement about bacterial meningitis involving bacteria entering the bloodstream and crossing the blood-brain barrier."", ""reference"": ""PMID:26804733"", ""snippet"": ""Streptococcus pneumoniae (the pneumococcus) is the major cause of bacterial meningitis. The mechanisms by which pneumococci from the bloodstream penetrate the blood-brain barrier to reach the brain are not fully understood."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference explicitly states that microbial penetration of the blood-brain barrier is necessary for the development of bacterial meningitis, supporting the statement."", ""reference"": ""PMID:31805229"", ""snippet"": ""Microbial penetration of the blood-brain barrier, a prerequisite for the development of bacterial meningitis, exploits specific host and bacterial factors as well as host cell signaling molecules."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference mentions that Listeria monocytogenes can cross the blood-brain barrier after entering the bloodstream, which supports the statement about the process of bacterial invasion in meningitis."", ""reference"": ""PMID:27367319"", ""snippet"": ""If the infection is not controlled at the stage in which the bacterium is in the liver, for instance, due to a severe immunodepression, a secondary bacteraemia can be developed and L. monocytogenes reaches the preferred sites transgressing the blood-brain barrier or the placental barrier."", ""supports"": ""SUPPORT""}, {""explanation"": ""Highlights BBB transcytosis by common neonatal and adult meningitis pathogens, reinforcing the invasion step across brain microvascular endothelium."", ""reference"": ""PMID:11008113"", ""snippet"": ""Transcellular penetration, e.g., transcytosis across the BBB has been demonstrated for Escherichia coli K1, group B streptococcus, Listeria monocytogenes, Citrobacter freundii and Streptococcus pneumonia strains."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""blood-brain barrier"", ""term"": {""id"": ""UBERON:0000120"", ""label"": ""blood-brain barrier""}}, {""preferred_term"": ""meninges"", ""term"": {""id"": ""UBERON:0002360"", ""label"": ""meninges""}}, {""preferred_term"": ""cerebrospinal fluid"", ""term"": {""id"": ""UBERON:0001359"", ""label"": ""cerebrospinal fluid""}}], ""name"": ""Bacterial Invasion""}"
932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	Inflammation	Bacterial components trigger a strong inflammatory response in the subarachnoid space.																																																								"{""description"": ""Bacterial components trigger a strong inflammatory response in the subarachnoid space."", ""name"": ""Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""preferred_term"": ""innate immune response"", ""term"": {""id"": ""GO:0045087"", ""label"": ""innate immune response""}}], ""cell_types"": [{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}, {""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""chemical_entities"": [{""preferred_term"": ""Cytokines"", ""term"": {""id"": ""CHEBI:59527"", ""label"": ""cytokine""}}, {""preferred_term"": ""Chemokines"", ""term"": {""id"": ""CHEBI:80222"", ""label"": ""chemokine""}}], ""description"": ""Bacterial components trigger a strong inflammatory response in the subarachnoid space."", ""evidence"": [{""explanation"": ""The reference describes how bacterial meningitis triggers several inflammatory pathways leading to the release of cytokines and chemokines, supporting the statement that bacterial components trigger a strong inflammatory response in the subarachnoid space."", ""reference"": ""PMID:39116800"", ""snippet"": ""Many in-vitro and in-vivo analyses have shown that after the disruption of the blood-brain barrier (BBB), these pathogens trigger several inflammatory pathways including Toll-Like Receptor (TLR) signaling in response to Pathogen-Associated Molecular Patterns (PAMPs), Nucleotide oligomerization domain (NOD)-like receptor-mediated signaling, pneumolysin related signaling, NF-kappaB signaling and many other pathways that lead to pro-inflammatory cascade and subsequent cytokine release including interleukine (IL)-1beta, tumor necrosis factor(TNF)-alpha, IL-6, IL-8, chemokine (C-X-C motif) ligand 1 (CXCL1) along with other mediators, leading to neuroinflammation."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference explicitly states that cytokines modulate the inflammatory response in the subarachnoid space during bacterial meningitis, supporting the statement."", ""reference"": ""PMID:37544134"", ""snippet"": ""The inflammatory response in the subarachnoid space, modulated by different cytokines, plays a major role in the pathogenesis of acute central nervous system infections."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference mentions the elevation of complement factors, which are part of the immune response, supporting the idea that bacterial components trigger a strong inflammatory response in the subarachnoid space."", ""reference"": ""PMID:24412248"", ""snippet"": ""Complement factors C1q and MBL as well as common complement pathway factors C3a, iC3b, C5a, sC5b-9 and complement regulator CFH were all elevated in patients with bacterial meningitis as compared to the controls."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""subarachnoid space"", ""term"": {""id"": ""UBERON:0001496"", ""label"": ""subarachnoid space""}}], ""name"": ""Inflammation""}"
933	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	2	Increased Intracranial Pressure	Inflammation and accumulation of purulent exudate lead to increased intracranial pressure.																																																								"{""description"": ""Inflammation and accumulation of purulent exudate lead to increased intracranial pressure."", ""name"": ""Increased Intracranial Pressure""}"	"{""downstream"": [{""target"": ""Altered Mental Status""}, {""target"": ""Seizures""}, {""target"": ""Focal Neurological Deficits""}]}"	"{""description"": ""Inflammation and accumulation of purulent exudate lead to increased intracranial pressure."", ""downstream"": [{""target"": ""Altered Mental Status""}, {""target"": ""Seizures""}, {""target"": ""Focal Neurological Deficits""}], ""evidence"": [{""explanation"": ""The literature supports that inflammation in bacterial meningitis is associated with increased intracranial pressure."", ""reference"": ""PMID:2498090"", ""snippet"": ""Their presence in the cerebrospinal fluid is associated with the induction of inflammation and with the development of brain edema and increased intracranial pressure."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports the statement that bacterial meningitis can lead to increased intracranial pressure due to inflammation."", ""reference"": ""PMID:24413408"", ""snippet"": ""Fulminant bacterial meningitis is a rare host reaction to infection characterized by sudden onset, rapid deterioration, abrupt cerebral edema and refractory intracranial hypertension."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature mentions altered mental status as a downstream effect of bacterial meningitis, supporting the statement."", ""reference"": ""PMID:31378869"", ""snippet"": ""Acute bacterial meningitis may present with symptoms as nonspecific as headache and fever, but rapid progression to an altered level of consciousness is not unusual."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that bacterial meningitis can lead to neurological deficits, aligning with the downstream effects mentioned in the statement."", ""reference"": ""PMID:8859061"", ""snippet"": ""The clinical course of bacterial meningitis still is characterized by a high mortality and frequent neurological deficits in survivors."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}, {""preferred_term"": ""cerebrospinal fluid"", ""term"": {""id"": ""UBERON:0001359"", ""label"": ""cerebrospinal fluid""}}], ""name"": ""Increased Intracranial Pressure""}"
934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	TLR-Mediated Innate Immune Activation	Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses.																																		TLR2 recognizes Gram-positive bacterial components while TLR4 recognizes Gram-negative components, initiating inflammatory cascades that both defend against infection and contribute to tissue damage.																						"{""description"": ""Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses."", ""name"": ""TLR-Mediated Innate Immune Activation"", ""notes"": ""TLR2 recognizes Gram-positive bacterial components while TLR4 recognizes Gram-negative components, initiating inflammatory cascades that both defend against infection and contribute to tissue damage.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""toll-like receptor signaling pathway"", ""term"": {""id"": ""GO:0002224"", ""label"": ""toll-like receptor signaling pathway""}}, {""preferred_term"": ""I-kappaB kinase/NF-kappaB signaling"", ""term"": {""id"": ""GO:0007249"", ""label"": ""I-kappaB kinase/NF-kappaB signaling""}}], ""cell_types"": [{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}, {""preferred_term"": ""brain microvascular endothelial cell"", ""term"": {""id"": ""CL:2000044"", ""label"": ""brain microvascular endothelial cell""}}], ""description"": ""Pattern recognition receptors TLR2 and TLR4 recognize bacterial components and initiate NF-kB-dependent cytokine responses."", ""evidence"": [{""explanation"": ""Describes BBB-breaching bacteria activating TLR signaling during meningitis, matching the TLR-driven innate activation described in this node."", ""reference"": ""PMID:39116800"", ""snippet"": ""Many in-vitro and in-vivo analyses have shown that after the disruption of the blood-brain barrier (BBB), these pathogens trigger several inflammatory pathways including Toll-Like Receptor (TLR) signaling in response to Pathogen-Associated Molecular Patterns (PAMPs)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows meningitis-causing GBS activating microglial TLR2/MyD88 signaling and causing neuronal injury, directly supporting TLR-driven innate activation in the CNS."", ""reference"": ""PMID:16785556"", ""snippet"": ""We show that both heat-inactivated whole GBS and a secreted proteinaceous factor from GBS (GBS-F) induce neuronal apoptosis via the activation of murine microglia through a TLR2-dependent and MyD88-dependent pathway in vitro."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""TLR2"", ""term"": {""id"": ""hgnc:11849"", ""label"": ""TLR2""}}, {""preferred_term"": ""TLR4"", ""term"": {""id"": ""hgnc:11850"", ""label"": ""TLR4""}}], ""locations"": [{""preferred_term"": ""blood-brain barrier"", ""term"": {""id"": ""UBERON:0000120"", ""label"": ""blood-brain barrier""}}, {""preferred_term"": ""meninges"", ""term"": {""id"": ""UBERON:0002360"", ""label"": ""meninges""}}], ""name"": ""TLR-Mediated Innate Immune Activation"", ""notes"": ""TLR2 recognizes Gram-positive bacterial components while TLR4 recognizes Gram-negative components, initiating inflammatory cascades that both defend against infection and contribute to tissue damage.""}"
935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	Inflammasome Activation and Pyroptosis	NLRP3 inflammasome activation drives caspase-1-mediated IL-1beta and IL-18 maturation and pyroptotic cell death, amplifying inflammation and tissue injury.																																		Meningococcal infection activates both canonical (caspase-1) and non-canonical (caspase-11 in mice) inflammasome pathways, leading to pyroptotic endothelial death.																						"{""description"": ""NLRP3 inflammasome activation drives caspase-1-mediated IL-1beta and IL-18 maturation and pyroptotic cell death, amplifying inflammation and tissue injury."", ""name"": ""Inflammasome Activation and Pyroptosis"", ""notes"": ""Meningococcal infection activates both canonical (caspase-1) and non-canonical (caspase-11 in mice) inflammasome pathways, leading to pyroptotic endothelial death.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammasome complex assembly"", ""term"": {""id"": ""GO:0061702"", ""label"": ""inflammasome complex assembly""}}, {""preferred_term"": ""pyroptosis"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptosis""}}], ""cell_types"": [{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""NLRP3 inflammasome activation drives caspase-1-mediated IL-1beta and IL-18 maturation and pyroptotic cell death, amplifying inflammation and tissue injury."", ""evidence"": [{""explanation"": ""States that NLRP3 inflammasome activation in bacterial meningitis drives IL-1/IL-18 maturation, consistent with inflammasome-driven pyroptotic inflammation."", ""reference"": ""PMID:39116800"", ""snippet"": ""The activation of another protein complex, nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome, also takes place resulting in the maturation and release of IL-1 and IL-18, hence potentiating neuroinflammation."", ""supports"": ""SUPPORT""}, {""explanation"": ""Experimental pneumococcal meningitis shows NLRP3 upregulation that is blunted by an NLRP3 inhibitor, supporting inflammasome-driven pathology."", ""reference"": ""PMID:37603152"", ""snippet"": ""The animals in the meningitis group at 24 h showed increased levels of cytokines, NLRP3, and IBA-1 expression, and the use of the MCC950 significantly reduced those levels."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows pneumococcal infection driving NEK7-NLRP3 inflammasome assembly through ALK/JNK signaling, supporting inflammasome activation in meningitis."", ""reference"": ""PMID:37001294"", ""snippet"": ""We found that the formation of the NEK7-NLRP3 complex significantly increased during S. pneumoniae infection and that anaplastic lymphoma kinase (ALK) and Jun N-terminal kinase (JNK) were phosphorylated rapidly."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""NLRP3"", ""term"": {""id"": ""hgnc:16400"", ""label"": ""NLRP3""}}, {""preferred_term"": ""CASP1"", ""term"": {""id"": ""hgnc:1499"", ""label"": ""CASP1""}}], ""locations"": [{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}, {""preferred_term"": ""cerebrospinal fluid"", ""term"": {""id"": ""UBERON:0001359"", ""label"": ""cerebrospinal fluid""}}], ""name"": ""Inflammasome Activation and Pyroptosis"", ""notes"": ""Meningococcal infection activates both canonical (caspase-1) and non-canonical (caspase-11 in mice) inflammasome pathways, leading to pyroptotic endothelial death.""}"
936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	Blood-Brain Barrier Disruption	Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability.																																		IL-22 activates STAT3-VEGFA signaling leading to degradation of tight junction proteins (ZO-1, occludin, claudin-5). EGR1 is a master regulator upregulating VEGFA, PDGFB, ANGPTL4 and downregulating tight junctions. MMP9 degrades basement membrane and contributes to paracellular leak.																						"{""description"": ""Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability."", ""name"": ""Blood-Brain Barrier Disruption"", ""notes"": ""IL-22 activates STAT3-VEGFA signaling leading to degradation of tight junction proteins (ZO-1, occludin, claudin-5). EGR1 is a master regulator upregulating VEGFA, PDGFB, ANGPTL4 and downregulating tight junctions. MMP9 degrades basement membrane and contributes to paracellular leak.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""JAK-STAT cascade"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}, {""preferred_term"": ""VEGF-activated receptor activity"", ""term"": {""id"": ""GO:0005021"", ""label"": ""vascular endothelial growth factor-activated receptor activity""}}, {""preferred_term"": ""tight junction organization"", ""term"": {""id"": ""GO:0120193"", ""label"": ""tight junction organization""}}, {""preferred_term"": ""extracellular matrix disassembly"", ""term"": {""id"": ""GO:0022617"", ""label"": ""extracellular matrix disassembly""}}], ""cell_types"": [{""preferred_term"": ""brain microvascular endothelial cell"", ""term"": {""id"": ""CL:2000044"", ""label"": ""brain microvascular endothelial cell""}}], ""description"": ""Host inflammatory signaling and bacterial virulence factors cause breakdown of tight junctions and increased vascular permeability."", ""evidence"": [{""explanation"": ""Establishes BBB penetration as an early pathogenic step requiring host signaling changes that enable barrier breach, supporting BBB disruption in meningitis pathophysiology."", ""reference"": ""PMID:31805229"", ""snippet"": ""Microbial penetration of the blood-brain barrier, a prerequisite for the development of bacterial meningitis, exploits specific host and bacterial factors as well as host cell signaling molecules."", ""supports"": ""SUPPORT""}, {""explanation"": ""States BBB permeability rise as central to meningitis pathogenesis, supporting the barrier-disruption node."", ""reference"": ""PMID:36769171"", ""snippet"": ""A defining feature of the pathogenesis of bacterial meningitis is the increase in BBB permeability."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""IL22"", ""term"": {""id"": ""hgnc:5982"", ""label"": ""IL22""}}, {""preferred_term"": ""STAT3"", ""term"": {""id"": ""hgnc:11364"", ""label"": ""STAT3""}}, {""preferred_term"": ""VEGFA"", ""term"": {""id"": ""hgnc:12680"", ""label"": ""VEGFA""}}, {""preferred_term"": ""EGR1"", ""term"": {""id"": ""hgnc:3238"", ""label"": ""EGR1""}}, {""preferred_term"": ""MMP9"", ""term"": {""id"": ""hgnc:7176"", ""label"": ""MMP9""}}], ""locations"": [{""preferred_term"": ""blood-brain barrier"", ""term"": {""id"": ""UBERON:0000120"", ""label"": ""blood-brain barrier""}}], ""name"": ""Blood-Brain Barrier Disruption"", ""notes"": ""IL-22 activates STAT3-VEGFA signaling leading to degradation of tight junction proteins (ZO-1, occludin, claudin-5). EGR1 is a master regulator upregulating VEGFA, PDGFB, ANGPTL4 and downregulating tight junctions. MMP9 degrades basement membrane and contributes to paracellular leak.""}"
976	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the function of primary cilia due to mutations in BBS genes lead to a wide range of symptoms.																																																								"{""description"": ""Defects in the function of primary cilia due to mutations in BBS genes lead to a wide range of symptoms."", ""name"": ""Ciliary Dysfunction""}"	{}	"{""cellular_components"": [{""preferred_term"": ""Primary Cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}], ""description"": ""Defects in the function of primary cilia due to mutations in BBS genes lead to a wide range of symptoms."", ""evidence"": [{""explanation"": ""This excerpt supports the assertion that BBS mechanisms are related to defects in primary cilia function caused by mutations in BBS genes, leading to a wide range of symptoms."", ""reference"": ""PMID:26231314"", ""snippet"": ""From the analysis of the mutational burden in patients to the functional characterization of the BBS proteins, this syndrome has become a model for both understanding oligogenic patterns of inheritance and the biology of a particular cellular organelle: the primary cilium."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference emphasizes the role of primary cilia dysfunction in BBS and its association with retinal dystrophies, supporting the statement."", ""reference"": ""PMID:29534263"", ""snippet"": ""The photoreceptor connecting cilium plays a leading role in these ciliopathy-related retinal dystrophies. Dysfunctional photoreceptor cilia cause the most severe type of retinal dystrophy: Leber's congenital amaurosis (LCA). The most common syndromic ciliopathies with an ocular manifestation are Bardet-Biedl syndrome (BBS) and Usher syndrome."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports the statement by explaining that BBS symptoms are attributed to ciliary defects."", ""reference"": ""PMID:33560420"", ""snippet"": ""One ciliopathy, Bardet-Biedl syndrome (BBS; OMIM 209900), presents with diverse clinical features, many of which are attributed to defects in ciliary signaling during both embryonic development and postnatal life"", ""supports"": ""SUPPORT""}], ""name"": ""Ciliary Dysfunction""}"
977	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	1	BBSome Assembly and Intraflagellar Transport Defects	The BBSome is an octameric protein complex (BBS1/2/4/5/7/8/9/BBIP1) whose assembly requires chaperonin-like proteins (BBS6, BBS10, BBS12). The BBSome cooperates with intraflagellar transport (IFT) machinery to regulate ciliary entry, retention, and retrieval of membrane proteins including GPCRs. Disruption of BBSome-mediated trafficking causes mislocalization of ciliary cargos and impaired ciliary signaling across multiple tissues.																																		In photoreceptors, the connecting cilium serves as a stringent gate where high-throughput trafficking of outer segment proteins occurs. Failure of BBSome/IFT trafficking causes protein mislocalization and photoreceptor degeneration.																						"{""description"": ""The BBSome is an octameric protein complex (BBS1/2/4/5/7/8/9/BBIP1) whose assembly requires chaperonin-like proteins (BBS6, BBS10, BBS12). The BBSome cooperates with intraflagellar transport (IFT) machinery to regulate ciliary entry, retention, and retrieval of membrane proteins including GPCRs. Disruption of BBSome-mediated trafficking causes mislocalization of ciliary cargos and impaired ciliary signaling across multiple tissues."", ""name"": ""BBSome Assembly and Intraflagellar Transport Defects"", ""notes"": ""In photoreceptors, the connecting cilium serves as a stringent gate where high-throughput trafficking of outer segment proteins occurs. Failure of BBSome/IFT trafficking causes protein mislocalization and photoreceptor degeneration.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Intraflagellar Transport"", ""term"": {""id"": ""GO:0042073"", ""label"": ""intraflagellar transport""}}, {""preferred_term"": ""Protein Localization to Cilium"", ""term"": {""id"": ""GO:0061512"", ""label"": ""protein localization to cilium""}}], ""cellular_components"": [{""preferred_term"": ""BBSome"", ""term"": {""id"": ""GO:0034464"", ""label"": ""BBSome""}}, {""preferred_term"": ""Ciliary Transition Zone"", ""term"": {""id"": ""GO:0035869"", ""label"": ""ciliary transition zone""}}], ""description"": ""The BBSome is an octameric protein complex (BBS1/2/4/5/7/8/9/BBIP1) whose assembly requires chaperonin-like proteins (BBS6, BBS10, BBS12). The BBSome cooperates with intraflagellar transport (IFT) machinery to regulate ciliary entry, retention, and retrieval of membrane proteins including GPCRs. Disruption of BBSome-mediated trafficking causes mislocalization of ciliary cargos and impaired ciliary signaling across multiple tissues."", ""evidence"": [], ""locations"": [{""preferred_term"": ""Photoreceptor Connecting Cilium"", ""term"": {""id"": ""GO:0042622"", ""label"": ""photoreceptor inner segment""}}], ""name"": ""BBSome Assembly and Intraflagellar Transport Defects"", ""notes"": ""In photoreceptors, the connecting cilium serves as a stringent gate where high-throughput trafficking of outer segment proteins occurs. Failure of BBSome/IFT trafficking causes protein mislocalization and photoreceptor degeneration.""}"
978	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	2	Hypothalamic Leptin Resistance	Impaired ciliary localization and trafficking of leptin receptors and other GPCRs (e.g., serotonin 5-HT2C receptor, MC4R) in hypothalamic POMC neurons due to BBSome dysfunction. This disrupts melanocortin signaling pathways that regulate appetite and energy homeostasis, leading to hyperphagia and obesity.																																		BBSome proteins are essential for trafficking GPCRs within hypothalamic cilia, and their loss results in leptin resistance despite elevated serum leptin levels.																						"{""description"": ""Impaired ciliary localization and trafficking of leptin receptors and other GPCRs (e.g., serotonin 5-HT2C receptor, MC4R) in hypothalamic POMC neurons due to BBSome dysfunction. This disrupts melanocortin signaling pathways that regulate appetite and energy homeostasis, leading to hyperphagia and obesity."", ""name"": ""Hypothalamic Leptin Resistance"", ""notes"": ""BBSome proteins are essential for trafficking GPCRs within hypothalamic cilia, and their loss results in leptin resistance despite elevated serum leptin levels.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Regulation of Appetite"", ""term"": {""id"": ""GO:0032098"", ""label"": ""regulation of appetite""}}, {""preferred_term"": ""Leptin Receptor Signaling"", ""term"": {""id"": ""GO:0038110"", ""label"": ""interleukin-35-mediated signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Impaired ciliary localization and trafficking of leptin receptors and other GPCRs (e.g., serotonin 5-HT2C receptor, MC4R) in hypothalamic POMC neurons due to BBSome dysfunction. This disrupts melanocortin signaling pathways that regulate appetite and energy homeostasis, leading to hyperphagia and obesity."", ""evidence"": [], ""locations"": [{""preferred_term"": ""Hypothalamus"", ""term"": {""id"": ""UBERON:0001898"", ""label"": ""hypothalamus""}}], ""name"": ""Hypothalamic Leptin Resistance"", ""notes"": ""BBSome proteins are essential for trafficking GPCRs within hypothalamic cilia, and their loss results in leptin resistance despite elevated serum leptin levels.""}"
979	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	3	Renal Ciliary Dysfunction	Renal tubular epithelial cells depend on primary cilia for proper solute handling and signaling. BBSome-mediated ciliary dysfunction disrupts these processes, leading to concentrating and diluting defects, progressive renal cysts, dysplasia, and chronic kidney disease.																																		Renal abnormalities are a cardinal feature with serious prognostic implications, often progressing to end-stage renal disease.																						"{""description"": ""Renal tubular epithelial cells depend on primary cilia for proper solute handling and signaling. BBSome-mediated ciliary dysfunction disrupts these processes, leading to concentrating and diluting defects, progressive renal cysts, dysplasia, and chronic kidney disease."", ""name"": ""Renal Ciliary Dysfunction"", ""notes"": ""Renal abnormalities are a cardinal feature with serious prognostic implications, often progressing to end-stage renal disease.""}"	{}	"{""cell_types"": [{""preferred_term"": ""Renal Tubular Epithelial Cell"", ""term"": {""id"": ""CL:0002306"", ""label"": ""epithelial cell of proximal tubule""}}], ""description"": ""Renal tubular epithelial cells depend on primary cilia for proper solute handling and signaling. BBSome-mediated ciliary dysfunction disrupts these processes, leading to concentrating and diluting defects, progressive renal cysts, dysplasia, and chronic kidney disease."", ""evidence"": [], ""locations"": [{""preferred_term"": ""Kidney"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}], ""name"": ""Renal Ciliary Dysfunction"", ""notes"": ""Renal abnormalities are a cardinal feature with serious prognostic implications, often progressing to end-stage renal disease.""}"
1011	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	0	PTCH1 Loss of Function	PTCH1 (Patched 1) encodes a transmembrane receptor that normally suppresses Smoothened (SMO) in the absence of Hedgehog ligand. Loss-of-function mutations in PTCH1 release SMO from inhibition, resulting in constitutive Hedgehog pathway activation. PTCH1 mutations occur in approximately 70% of sporadic BCCs and are the germline cause of Gorlin syndrome.																																																								"{""description"": ""PTCH1 (Patched 1) encodes a transmembrane receptor that normally suppresses Smoothened (SMO) in the absence of Hedgehog ligand. Loss-of-function mutations in PTCH1 release SMO from inhibition, resulting in constitutive Hedgehog pathway activation. PTCH1 mutations occur in approximately 70% of sporadic BCCs and are the germline cause of Gorlin syndrome."", ""name"": ""PTCH1 Loss of Function""}"	"{""downstream"": [{""description"": ""Loss of PTCH1 releases SMO from tonic inhibition"", ""target"": ""Constitutive Hedgehog Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""basal cell of epidermis"", ""term"": {""id"": ""CL:0002187"", ""label"": ""basal cell of epidermis""}}], ""description"": ""PTCH1 (Patched 1) encodes a transmembrane receptor that normally suppresses Smoothened (SMO) in the absence of Hedgehog ligand. Loss-of-function mutations in PTCH1 release SMO from inhibition, resulting in constitutive Hedgehog pathway activation. PTCH1 mutations occur in approximately 70% of sporadic BCCs and are the germline cause of Gorlin syndrome."", ""downstream"": [{""description"": ""Loss of PTCH1 releases SMO from tonic inhibition"", ""target"": ""Constitutive Hedgehog Pathway Activation""}], ""evidence"": [{""explanation"": ""Supports aberrant Hedgehog signaling as a driver in basal cell carcinoma."", ""reference"": ""PMID:19082818"", ""snippet"": ""Aberrant activation of sonic hedgehog signaling has been reported for sporadic and hereditary basal cell carcinoma caused by specific genetic mutations."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}], ""name"": ""PTCH1 Loss of Function""}"
1012	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	1	SMO Activating Mutations	Smoothened (SMO) is a G-protein coupled receptor-like protein that transduces Hedgehog signal. Activating mutations in SMO, though less common than PTCH1 loss, render SMO constitutively active regardless of PTCH1 status. Some SMO mutations confer resistance to vismodegib.																																																								"{""description"": ""Smoothened (SMO) is a G-protein coupled receptor-like protein that transduces Hedgehog signal. Activating mutations in SMO, though less common than PTCH1 loss, render SMO constitutively active regardless of PTCH1 status. Some SMO mutations confer resistance to vismodegib."", ""name"": ""SMO Activating Mutations""}"	"{""downstream"": [{""description"": ""Activating SMO mutations bypass PTCH1 inhibition"", ""target"": ""Constitutive Hedgehog Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""basal cell of epidermis"", ""term"": {""id"": ""CL:0002187"", ""label"": ""basal cell of epidermis""}}], ""description"": ""Smoothened (SMO) is a G-protein coupled receptor-like protein that transduces Hedgehog signal. Activating mutations in SMO, though less common than PTCH1 loss, render SMO constitutively active regardless of PTCH1 status. Some SMO mutations confer resistance to vismodegib."", ""downstream"": [{""description"": ""Activating SMO mutations bypass PTCH1 inhibition"", ""target"": ""Constitutive Hedgehog Pathway Activation""}], ""name"": ""SMO Activating Mutations""}"
1013	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	2	Constitutive Hedgehog Pathway Activation	Loss of PTCH1 or activating SMO mutations result in constitutive activation of the Hedgehog signaling cascade. Active SMO translocates to the primary cilium and promotes activation of GLI transcription factors (GLI1, GLI2), which drive expression of target genes promoting proliferation and survival.																																																								"{""description"": ""Loss of PTCH1 or activating SMO mutations result in constitutive activation of the Hedgehog signaling cascade. Active SMO translocates to the primary cilium and promotes activation of GLI transcription factors (GLI1, GLI2), which drive expression of target genes promoting proliferation and survival."", ""name"": ""Constitutive Hedgehog Pathway Activation""}"	"{""downstream"": [{""description"": ""SMO activation leads to processing and nuclear translocation of GLI1/2"", ""target"": ""GLI Transcription Factor Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}], ""description"": ""Loss of PTCH1 or activating SMO mutations result in constitutive activation of the Hedgehog signaling cascade. Active SMO translocates to the primary cilium and promotes activation of GLI transcription factors (GLI1, GLI2), which drive expression of target genes promoting proliferation and survival."", ""downstream"": [{""description"": ""SMO activation leads to processing and nuclear translocation of GLI1/2"", ""target"": ""GLI Transcription Factor Activation""}], ""name"": ""Constitutive Hedgehog Pathway Activation""}"
1014	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	3	GLI Transcription Factor Activation	Active Hedgehog signaling promotes GLI transcription factor processing and nuclear translocation. GLI1 and GLI2 activate transcription of target genes including PTCH1, GLI1 (positive feedback), cyclin D1, MYC, and BCL2, promoting proliferation and survival of basal cells.																																																								"{""description"": ""Active Hedgehog signaling promotes GLI transcription factor processing and nuclear translocation. GLI1 and GLI2 activate transcription of target genes including PTCH1, GLI1 (positive feedback), cyclin D1, MYC, and BCL2, promoting proliferation and survival of basal cells."", ""name"": ""GLI Transcription Factor Activation""}"	"{""downstream"": [{""description"": ""GLI target genes drive cell cycle entry and tumor growth"", ""target"": ""Uncontrolled Basal Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Active Hedgehog signaling promotes GLI transcription factor processing and nuclear translocation. GLI1 and GLI2 activate transcription of target genes including PTCH1, GLI1 (positive feedback), cyclin D1, MYC, and BCL2, promoting proliferation and survival of basal cells."", ""downstream"": [{""description"": ""GLI target genes drive cell cycle entry and tumor growth"", ""target"": ""Uncontrolled Basal Cell Proliferation""}], ""name"": ""GLI Transcription Factor Activation""}"
1015	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	4	Uncontrolled Basal Cell Proliferation	Constitutive Hedgehog signaling drives proliferation of basal cells through GLI-mediated transcription of cell cycle regulators, leading to tumor formation. The proliferating cells maintain a basal cell phenotype with peripheral palisading characteristic of BCC histology.																																																								"{""description"": ""Constitutive Hedgehog signaling drives proliferation of basal cells through GLI-mediated transcription of cell cycle regulators, leading to tumor formation. The proliferating cells maintain a basal cell phenotype with peripheral palisading characteristic of BCC histology."", ""name"": ""Uncontrolled Basal Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""basal cell of epidermis"", ""term"": {""id"": ""CL:0002187"", ""label"": ""basal cell of epidermis""}}], ""description"": ""Constitutive Hedgehog signaling drives proliferation of basal cells through GLI-mediated transcription of cell cycle regulators, leading to tumor formation. The proliferating cells maintain a basal cell phenotype with peripheral palisading characteristic of BCC histology."", ""locations"": [{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}], ""name"": ""Uncontrolled Basal Cell Proliferation""}"
1029	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	0	HLA-B51-Associated Immune Dysregulation	Strong association with HLA-B51. Aberrant peptide presentation and cross-reactivity with microbial antigens may trigger autoinflammatory responses. ERAP1 variants affect peptide processing for HLA-B51.																																																								"{""description"": ""Strong association with HLA-B51. Aberrant peptide presentation and cross-reactivity with microbial antigens may trigger autoinflammatory responses. ERAP1 variants affect peptide processing for HLA-B51."", ""name"": ""HLA-B51-Associated Immune Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Antigen Presentation"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}], ""description"": ""Strong association with HLA-B51. Aberrant peptide presentation and cross-reactivity with microbial antigens may trigger autoinflammatory responses. ERAP1 variants affect peptide processing for HLA-B51."", ""evidence"": [{""explanation"": ""This review confirms that HLA-B51 is a key genetic factor in Behcet's disease pathogenesis, supporting the role of aberrant antigen presentation in disease development."", ""reference"": ""PMID:38778397"", ""snippet"": ""genetic factors (such as HLA-B51), dysregulated immune responses of both the innate and adaptive immune systems, infections (such as streptococcus), and environmental factors (such as GDP) are all involved in its development."", ""supports"": ""SUPPORT""}], ""name"": ""HLA-B51-Associated Immune Dysregulation""}"
1030	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	1	Neutrophil Hyperactivation	Neutrophils show enhanced chemotaxis, phagocytosis, and oxidative burst. Pathergy response (exaggerated skin reaction to minor trauma) reflects neutrophil hyperreactivity. NETs may contribute to vascular damage.																																																								"{""description"": ""Neutrophils show enhanced chemotaxis, phagocytosis, and oxidative burst. Pathergy response (exaggerated skin reaction to minor trauma) reflects neutrophil hyperreactivity. NETs may contribute to vascular damage."", ""name"": ""Neutrophil Hyperactivation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Neutrophil Activation"", ""term"": {""id"": ""GO:0042119"", ""label"": ""neutrophil activation""}}], ""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Neutrophils show enhanced chemotaxis, phagocytosis, and oxidative burst. Pathergy response (exaggerated skin reaction to minor trauma) reflects neutrophil hyperreactivity. NETs may contribute to vascular damage."", ""evidence"": [{""explanation"": ""This review highlights neutrophil hyperactivity as a key feature of innate immune dysregulation in Behcet's uveitis, supporting the role of neutrophil activation in pathogenesis."", ""reference"": ""PMID:38778397"", ""snippet"": ""Innate immunity, including hyperactivity of neutrophils and T cells and elevated NK1/NK2 ratios, has been shown to play an essential role in this disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""Histopathological evidence confirms neutrophil overactivation in Behcet's disease skin lesions, demonstrating the pathologic role of neutrophils in tissue inflammation."", ""reference"": ""PMID:37435539"", ""snippet"": ""Skin histopathology demonstrates the overactivation of innate immunity, such as neutrophilic dermatitis/panniculitis, in patients with BD."", ""supports"": ""SUPPORT""}], ""name"": ""Neutrophil Hyperactivation""}"
1031	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	2	Th1/Th17 Cytokine Imbalance	Elevated IL-17, IFN-gamma, and TNF-alpha drive tissue inflammation. IL-23/IL-17 axis is particularly important and represents a therapeutic target.																																																								"{""description"": ""Elevated IL-17, IFN-gamma, and TNF-alpha drive tissue inflammation. IL-23/IL-17 axis is particularly important and represents a therapeutic target."", ""name"": ""Th1/Th17 Cytokine Imbalance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""T Helper Cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}], ""description"": ""Elevated IL-17, IFN-gamma, and TNF-alpha drive tissue inflammation. IL-23/IL-17 axis is particularly important and represents a therapeutic target."", ""evidence"": [{""explanation"": ""This review describes the imbalance between pro-inflammatory Th1/Th17 responses and regulatory T cell dysfunction as central to Behcet's uveitis pathogenesis, supporting the role of cytokine imbalance in disease progression."", ""reference"": ""PMID:38778397"", ""snippet"": ""Adaptive immune system disturbance, including homeostatic perturbations, Th1, Th17 overaction, and Treg cell dysfunction, is thought to be involved in BU pathogenesis."", ""supports"": ""SUPPORT""}], ""name"": ""Th1/Th17 Cytokine Imbalance""}"
1056	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	0	Prostatic Stromal and Epithelial Proliferation	"Age-related increase in prostatic stromal and glandular tissue, particularly in the transition zone. Dihydrotestosterone (DHT) drives proliferation through androgen receptors.
"																																																								"{""description"": ""Age-related increase in prostatic stromal and glandular tissue, particularly in the transition zone. Dihydrotestosterone (DHT) drives proliferation through androgen receptors.\n"", ""name"": ""Prostatic Stromal and Epithelial Proliferation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""Prostatic Epithelial Cell"", ""term"": {""id"": ""CL:0002231"", ""label"": ""epithelial cell of prostate""}}], ""description"": ""Age-related increase in prostatic stromal and glandular tissue, particularly in the transition zone. Dihydrotestosterone (DHT) drives proliferation through androgen receptors.\n"", ""evidence"": [{""explanation"": ""This evidence confirms that proliferative nodular formation in the transition zone is the primary pathological feature driving BPH symptoms."", ""reference"": ""PMID:38654277"", ""snippet"": ""Proliferative nodular formation represents a characteristic pathological feature of benign prostatic hyperplasia (BPH) and serves as the primary cause for prostate volume enlargement and consequent lower urinary tract symptoms (LUTS)."", ""supports"": ""SUPPORT""}], ""name"": ""Prostatic Stromal and Epithelial Proliferation""}"
1057	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	1	Bladder Outlet Obstruction	"Enlarged prostate compresses urethra, increasing resistance to urine flow. Static component from tissue mass and dynamic component from smooth muscle tone.
"																																																								"{""description"": ""Enlarged prostate compresses urethra, increasing resistance to urine flow. Static component from tissue mass and dynamic component from smooth muscle tone.\n"", ""name"": ""Bladder Outlet Obstruction""}"	{}	"{""description"": ""Enlarged prostate compresses urethra, increasing resistance to urine flow. Static component from tissue mass and dynamic component from smooth muscle tone.\n"", ""name"": ""Bladder Outlet Obstruction""}"
1058	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	2	Detrusor Dysfunction	"Chronic obstruction leads to detrusor muscle hypertrophy and later decompensation. Results in overactive bladder symptoms and incomplete emptying.
"																																																								"{""description"": ""Chronic obstruction leads to detrusor muscle hypertrophy and later decompensation. Results in overactive bladder symptoms and incomplete emptying.\n"", ""name"": ""Detrusor Dysfunction""}"	{}	"{""cell_types"": [{""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}], ""description"": ""Chronic obstruction leads to detrusor muscle hypertrophy and later decompensation. Results in overactive bladder symptoms and incomplete emptying.\n"", ""evidence"": [{""explanation"": ""This evidence supports that BPH-related enlargement causes lower urinary tract symptoms through bladder outlet obstruction and detrusor dysfunction."", ""reference"": ""PMID:37827216"", ""snippet"": ""Benign prostate hyperplasia (BPH) is caused by the nonmalignant enlargement of the transition zone of the prostate gland, leading to lower urinary tract symptoms."", ""supports"": ""SUPPORT""}], ""name"": ""Detrusor Dysfunction""}"
1059	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	3	Androgen-Dependent Growth	"DHT converted from testosterone by 5-alpha reductase drives prostatic growth. 5-alpha reductase inhibitors shrink prostate.
"																																																								"{""description"": ""DHT converted from testosterone by 5-alpha reductase drives prostatic growth. 5-alpha reductase inhibitors shrink prostate.\n"", ""name"": ""Androgen-Dependent Growth""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Androgen Response"", ""term"": {""id"": ""GO:0030521"", ""label"": ""androgen receptor signaling pathway""}}], ""description"": ""DHT converted from testosterone by 5-alpha reductase drives prostatic growth. 5-alpha reductase inhibitors shrink prostate.\n"", ""name"": ""Androgen-Dependent Growth""}"
1060	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	4	Hypoxia-Induced Epithelial-Mesenchymal Transition	"Hypoxic basal epithelial cells (BE5) drive nodular formation through upregulation of FOS and activation of EMT signaling, particularly in glandular nodules of the transition zone.
"																																																								"{""description"": ""Hypoxic basal epithelial cells (BE5) drive nodular formation through upregulation of FOS and activation of EMT signaling, particularly in glandular nodules of the transition zone.\n"", ""name"": ""Hypoxia-Induced Epithelial-Mesenchymal Transition""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Epithelial to Mesenchymal Transition"", ""term"": {""id"": ""GO:0001837"", ""label"": ""epithelial to mesenchymal transition""}}], ""description"": ""Hypoxic basal epithelial cells (BE5) drive nodular formation through upregulation of FOS and activation of EMT signaling, particularly in glandular nodules of the transition zone.\n"", ""evidence"": [{""explanation"": ""This evidence identifies BE5 cells as key drivers of BPH through hypoxia-induced EMT, establishing a molecular mechanism for nodular formation."", ""reference"": ""PMID:38654277"", ""snippet"": ""A distinct subgroup of basal epithelial (BE) cells, referred to as BE5, was identified to play a crucial role in driving this progression through the hypoxia-induced epithelial-mesenchymal transition (EMT) signaling pathway."", ""supports"": ""SUPPORT""}], ""name"": ""Hypoxia-Induced Epithelial-Mesenchymal Transition""}"
1061	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	5	TGF-beta/ROCK1 Mediated Stromal Hyperplasia	"Aberrant activation of TGF-beta/ROCK1 pathway recruits mesenchymal stem cells that differentiate into fibroblasts and myofibroblasts, driving stromal hyperplasia and fibrosis.
"																																																								"{""description"": ""Aberrant activation of TGF-beta/ROCK1 pathway recruits mesenchymal stem cells that differentiate into fibroblasts and myofibroblasts, driving stromal hyperplasia and fibrosis.\n"", ""name"": ""TGF-beta/ROCK1 Mediated Stromal Hyperplasia""}"	{}	"{""biological_processes"": [{""preferred_term"": ""TGF-beta Signaling"", ""term"": {""id"": ""GO:0007179"", ""label"": ""transforming growth factor beta receptor signaling pathway""}}], ""description"": ""Aberrant activation of TGF-beta/ROCK1 pathway recruits mesenchymal stem cells that differentiate into fibroblasts and myofibroblasts, driving stromal hyperplasia and fibrosis.\n"", ""evidence"": [{""explanation"": ""This evidence demonstrates that TGF-beta/ROCK1 activation drives prostatic stromal hyperplasia through MSC recruitment and differentiation."", ""reference"": ""PMID:38711089"", ""snippet"": ""The aberrant activation of transforming growth factor  (TGF-)/Rho kinase 1 (ROCK1) increased the stemness of BPH tissue by recruiting mesenchymal stem cells (MSCs), indicating the important role of embryonic reawakening in BPH."", ""supports"": ""SUPPORT""}, {""explanation"": ""This evidence confirms upregulation of ROCK1/2 in human BPH tissues and their correlation with disease severity."", ""reference"": ""PMID:39455522"", ""snippet"": ""ROCK1 and ROCK2 were significantly up-regulated in BPH tissues, correlating with clinical parameters."", ""supports"": ""SUPPORT""}], ""name"": ""TGF-beta/ROCK1 Mediated Stromal Hyperplasia""}"
1062	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	6	ROCK-Mediated Fibrosis and Beta-Catenin Signaling	"ROCK1/2 activation promotes fibrosis, EMT, and cell proliferation by stabilizing beta-catenin and activating downstream targets including C-MYC, Snail, and Survivin. ROCK inhibition reverses these processes.
"																																																								"{""description"": ""ROCK1/2 activation promotes fibrosis, EMT, and cell proliferation by stabilizing beta-catenin and activating downstream targets including C-MYC, Snail, and Survivin. ROCK inhibition reverses these processes.\n"", ""name"": ""ROCK-Mediated Fibrosis and Beta-Catenin Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Wnt Signaling Pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}], ""description"": ""ROCK1/2 activation promotes fibrosis, EMT, and cell proliferation by stabilizing beta-catenin and activating downstream targets including C-MYC, Snail, and Survivin. ROCK inhibition reverses these processes.\n"", ""evidence"": [{""explanation"": ""This evidence shows ROCK signaling converges on beta-catenin pathway to drive BPH pathophysiology, providing a therapeutic target."", ""reference"": ""PMID:39455522"", ""snippet"": ""ROCK downregulation inhibited the -catenin signaling pathway (such as C-MYC, Snail and Survivin) and decreased -catenin protein stability, while inhibiting TGF-/Smad2/3 signaling."", ""supports"": ""SUPPORT""}], ""name"": ""ROCK-Mediated Fibrosis and Beta-Catenin Signaling""}"
1063	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	7	Oxidative Stress and Epithelial Plasticity	"Low-androgen signaling epithelial populations show increased vulnerability to oxidative stress due to reduced antioxidant defenses. Mitochondrial ROS drives cell proliferation and stemness in BPH.
"																																																								"{""description"": ""Low-androgen signaling epithelial populations show increased vulnerability to oxidative stress due to reduced antioxidant defenses. Mitochondrial ROS drives cell proliferation and stemness in BPH.\n"", ""name"": ""Oxidative Stress and Epithelial Plasticity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Response to Oxidative Stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""description"": ""Low-androgen signaling epithelial populations show increased vulnerability to oxidative stress due to reduced antioxidant defenses. Mitochondrial ROS drives cell proliferation and stemness in BPH.\n"", ""evidence"": [{""explanation"": ""This evidence demonstrates that oxidative stress contributes to BPH progression and that antioxidant therapy can reduce prostate enlargement and symptoms."", ""reference"": ""PMID:37827216"", ""snippet"": ""Pb-PRL mouse prostates exhibited increased vulnerability to oxidative stress due to reduction of antioxidant enzyme expression. One-month treatment of Pb-PRL mice with anethole trithione (ATT), a specific inhibitor of mitochondrial ROS production, reduced prostate weight and voiding frequency."", ""supports"": ""SUPPORT""}], ""name"": ""Oxidative Stress and Epithelial Plasticity""}"
1064	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	8	Inflammation and IL-6 Signaling	"Periodontal pathogens and inflammatory stimuli upregulate IL-6, IL-6R, and gp130, activating the Akt pathway to promote epithelial and stromal proliferation while inhibiting apoptosis.
"																																																								"{""description"": ""Periodontal pathogens and inflammatory stimuli upregulate IL-6, IL-6R, and gp130, activating the Akt pathway to promote epithelial and stromal proliferation while inhibiting apoptosis.\n"", ""name"": ""Inflammation and IL-6 Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Periodontal pathogens and inflammatory stimuli upregulate IL-6, IL-6R, and gp130, activating the Akt pathway to promote epithelial and stromal proliferation while inhibiting apoptosis.\n"", ""evidence"": [{""explanation"": ""This evidence links oral-prostate inflammation to BPH progression through IL-6/IL-6R/gp130-mediated Akt signaling, representing a novel pathophysiological axis."", ""reference"": ""PMID:38764065"", ""snippet"": ""P. gingivalis infection promoted prostate cell proliferation, inhibited apoptosis, and upregulated the expression of inflammatory cytokines interleukin-6 (IL-6; 4.47-fold), interleukin-6 receptor- (IL-6R; 5.74-fold) and glycoprotein 130 (gp130; 4.47-fold) in prostatic tissue."", ""supports"": ""SUPPORT""}], ""name"": ""Inflammation and IL-6 Signaling""}"
1083	45	Beta Mannosidosis	Beta_Mannosidosis.yaml	pathophysiology	0	Beta-mannosidase deficiency	"Loss or marked reduction of beta-mannosidase activity impairs lysosomal catabolism of glycoprotein-derived oligosaccharides, leading to intra-lysosomal storage and cellular vacuolation. Electron microscopy demonstrates prominent lysosomal enlargement in patient cells.
"																																																								"{""description"": ""Loss or marked reduction of beta-mannosidase activity impairs lysosomal catabolism of glycoprotein-derived oligosaccharides, leading to intra-lysosomal storage and cellular vacuolation. Electron microscopy demonstrates prominent lysosomal enlargement in patient cells.\n"", ""name"": ""Beta-mannosidase deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Glycoprotein catabolism"", ""term"": {""id"": ""GO:0006516"", ""label"": ""glycoprotein catabolic process""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}, {""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}, {""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}], ""description"": ""Loss or marked reduction of beta-mannosidase activity impairs lysosomal catabolism of glycoprotein-derived oligosaccharides, leading to intra-lysosomal storage and cellular vacuolation. Electron microscopy demonstrates prominent lysosomal enlargement in patient cells.\n"", ""evidence"": [{""explanation"": ""Confirms that beta-mannosidosis is a lysosomal storage disorder with neurological and auditory manifestations."", ""reference"": ""PMID:32847582"", ""snippet"": ""a rare lysosomal storage disorder named beta-mannosidosis whose clinical manifestation includes deafness and mental retardation"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Lysosome"", ""term"": {""id"": ""GO:0005764"", ""label"": ""lysosome""}}, {""preferred_term"": ""Brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}], ""name"": ""Beta-mannosidase deficiency""}"
1103	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	0	Monoamine Dysregulation	"Imbalances in dopamine, norepinephrine, and serotonin neurotransmission contribute to mood episodes. Elevated dopamine in mania, reduced in depression.
"																																																								"{""description"": ""Imbalances in dopamine, norepinephrine, and serotonin neurotransmission contribute to mood episodes. Elevated dopamine in mania, reduced in depression.\n"", ""name"": ""Monoamine Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Neurotransmitter Signaling"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}], ""cell_types"": [{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}, {""preferred_term"": ""Serotonergic Neuron"", ""term"": {""id"": ""CL:0000850"", ""label"": ""serotonergic neuron""}}, {""preferred_term"": ""Noradrenergic Neuron"", ""term"": {""id"": ""CL:0008025"", ""label"": ""noradrenergic neuron""}}], ""description"": ""Imbalances in dopamine, norepinephrine, and serotonin neurotransmission contribute to mood episodes. Elevated dopamine in mania, reduced in depression.\n"", ""evidence"": [{""explanation"": ""Dopamine D2 receptor signaling regulates the Akt/GSK3 pathway, providing a molecular link between monoaminergic neurotransmission and mood regulation in bipolar disorder."", ""reference"": ""PMID:22363263"", ""snippet"": ""Activation of the dopamine receptor 2 (D2R) has been shown to stimulate the inactivation of Akt by PP2A (Beaulieu et al., 2005; Beaulieu and Gainetdinov, 2011), therefore providing a mechanism through which GPCR activation can inhibit Akt in response to extracellular signals."", ""supports"": ""SUPPORT""}, {""explanation"": ""The D2 receptor-mediated regulation of GSK3 activity through beta-arrestin signaling is implicated in behavioral regulation relevant to bipolar disorder and the mechanism of mood stabilizers and antipsychotics."", ""reference"": ""PMID:22363263"", ""snippet"": ""This mechanism of D2R signaling appears to play important roles in the regulation of locomotor behavior and sensory motor gating by dopamine (Beaulieu et al., 2004; Emamian et al., 2004). It could also contribute to the therapeutic and/or adverse effects of psychoactive drugs like amphetamines and antpsychotics that act on dopamine neurotransmission"", ""supports"": ""SUPPORT""}], ""name"": ""Monoamine Dysregulation""}"
1104	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	1	Mitochondrial Dysfunction	"Impaired cellular energy metabolism and oxidative stress affect neuronal function. Mitochondrial abnormalities linked to mood dysregulation.
"																																																								"{""description"": ""Impaired cellular energy metabolism and oxidative stress affect neuronal function. Mitochondrial abnormalities linked to mood dysregulation.\n"", ""name"": ""Mitochondrial Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Mitochondrial Function"", ""term"": {""id"": ""GO:0007005"", ""label"": ""mitochondrion organization""}}], ""description"": ""Impaired cellular energy metabolism and oxidative stress affect neuronal function. Mitochondrial abnormalities linked to mood dysregulation.\n"", ""evidence"": [{""explanation"": ""This review discusses the molecular mechanisms underlying psychiatric disorders including bipolar disorder, with focus on the DISC1/GSK3 complex which regulates mitochondrial and cellular functions."", ""reference"": ""PMID:30285728"", ""snippet"": ""Psychiatric disorders (such as bipolar disorder, depression, and schizophrenia) affect the lives of millions of individuals worldwide."", ""supports"": ""SUPPORT""}], ""name"": ""Mitochondrial Dysfunction""}"
1105	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	2	Circadian Rhythm Disruption	"Disrupted sleep-wake cycles and circadian gene expression contribute to mood instability. Sleep deprivation can trigger mania.
"																																																								"{""description"": ""Disrupted sleep-wake cycles and circadian gene expression contribute to mood instability. Sleep deprivation can trigger mania.\n"", ""name"": ""Circadian Rhythm Disruption""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Circadian Rhythm"", ""term"": {""id"": ""GO:0007623"", ""label"": ""circadian rhythm""}}], ""description"": ""Disrupted sleep-wake cycles and circadian gene expression contribute to mood instability. Sleep deprivation can trigger mania.\n"", ""evidence"": [{""explanation"": ""This comprehensive review discusses lithium as the gold standard treatment for bipolar disorder, noting its mood-stabilizing effects through GSK3 inhibition which affects multiple cellular pathways including circadian regulation."", ""reference"": ""PMID:22363263"", ""snippet"": ""For more than 60 years, the mood stabilizer lithium has been used alone or in combination for the treatment of bipolar disorder, schizophrenia, depression, and other mental illnesses."", ""supports"": ""SUPPORT""}], ""name"": ""Circadian Rhythm Disruption""}"
1106	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	3	Neuroplasticity Alterations	"Reduced BDNF and altered synaptic plasticity in mood circuits. Lithium and other mood stabilizers enhance neuroplasticity.
"																																																								"{""description"": ""Reduced BDNF and altered synaptic plasticity in mood circuits. Lithium and other mood stabilizers enhance neuroplasticity.\n"", ""name"": ""Neuroplasticity Alterations""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Synaptic Plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Reduced BDNF and altered synaptic plasticity in mood circuits. Lithium and other mood stabilizers enhance neuroplasticity.\n"", ""evidence"": [{""explanation"": ""GSK3 inhibition by DISC1 and mood stabilizers like lithium is a key mechanism in bipolar disorder treatment, affecting synaptic plasticity and neuronal survival pathways."", ""reference"": ""PMID:30285728"", ""snippet"": ""DISC1 binds directly to GSK3 and modulates many cellular functions by negatively inhibiting GSK3 activity."", ""supports"": ""SUPPORT""}, {""explanation"": ""The TRAX/DISC1/GSK3 complex is implicated in psychiatric disorders including bipolar disorder and represents a therapeutic target for enhancing neuroplasticity."", ""reference"": ""PMID:30285728"", ""snippet"": ""In the present review, we will focus on the emerging roles of TRAX and its interacting proteins (including DISC1 and GSK3) in psychiatric disorders and the potential implications for developing therapeutic interventions."", ""supports"": ""SUPPORT""}], ""name"": ""Neuroplasticity Alterations""}"
1107	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	4	Neuroinflammation	"Elevated inflammatory markers during mood episodes. Microglial activation and cytokine abnormalities contribute to pathophysiology.
"																																																								"{""description"": ""Elevated inflammatory markers during mood episodes. Microglial activation and cytokine abnormalities contribute to pathophysiology.\n"", ""name"": ""Neuroinflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Elevated inflammatory markers during mood episodes. Microglial activation and cytokine abnormalities contribute to pathophysiology.\n"", ""evidence"": [{""explanation"": ""Microglial activation and inflammatory processes are shared pathophysiological mechanisms across psychiatric disorders including bipolar disorder, contributing to synaptic dysfunction."", ""reference"": ""PMID:33958577"", ""snippet"": ""considering that schizophrenia is a multifactorial and highly polygenic disorder that shares many risk genes with other psychiatric illnesses including bipolar disorder, depression, intellectual disability and autism spectrum disorders, it is to be expected that these diseases may also share some of these same mechanisms"", ""supports"": ""SUPPORT""}], ""name"": ""Neuroinflammation""}"
1145	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	0	Exposure to Avian Proteins	Repeated inhalation of avian proteins from bird droppings, feathers, or serum triggers bird-related hypersensitivity pneumonitis.																																																								"{""description"": ""Repeated inhalation of avian proteins from bird droppings, feathers, or serum triggers bird-related hypersensitivity pneumonitis."", ""name"": ""Exposure to Avian Proteins""}"	{}	"{""description"": ""Repeated inhalation of avian proteins from bird droppings, feathers, or serum triggers bird-related hypersensitivity pneumonitis."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The review defines BRHP as an avian protein-induced interstitial lung disease."", ""reference"": ""DOI:10.3390/ijms24032884"", ""snippet"": ""Bird-related hypersensitivity pneumonitis (BRHP) is an interstitial lung disease induced by avian proteins."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The case report links BFL to repeated inhalation of avian proteins as the causative trigger for interstitial lung disease."", ""reference"": ""PMID:39958101"", ""snippet"": ""Bird fancier's lung (BFL) is a subtype of hypersensitivity pneumonitis (HP), an immune-mediated interstitial lung disease (ILD) resulting from the repeated inhalation of avian proteins found in bird droppings, feathers, and serum."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The report characterizes BFL as an immune-mediated interstitial lung disease driven by repetitive avian antigen exposure."", ""reference"": ""PMID:33318919"", ""snippet"": ""Bird Fancier's Lung is a type of hypersensitivity pneumonitis, an immunologically mediated lung disease due to repetitive exposure of air-borne avian antigen."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Exposure to Avian Proteins""}"
1146	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	1	Expansion of Resident Monocytes and Interstitial Macrophages	Bird antigen exposure is associated with increased resident monocytes, interstitial macrophages, and type 2 dendritic cells in the lung.																																																								"{""description"": ""Bird antigen exposure is associated with increased resident monocytes, interstitial macrophages, and type 2 dendritic cells in the lung."", ""name"": ""Expansion of Resident Monocytes and Interstitial Macrophages""}"	{}	"{""cell_types"": [{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""Bird antigen exposure is associated with increased resident monocytes, interstitial macrophages, and type 2 dendritic cells in the lung."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The mouse model reports increased resident monocytes, interstitial macrophages, and type 2 dendritic cells after bird antigen exposure."", ""reference"": ""DOI:10.3390/ijms24032884"", ""snippet"": ""Both groups presented increases in resident monocytes, interstitial macrophages and type 2 dendritic cells (DCs), but also reductions in inflammatory monocytes, alveolar macrophages and tolerogenic DCs compared with their control groups."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Expansion of Resident Monocytes and Interstitial Macrophages""}"
1147	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	2	Reduction of Inflammatory Monocytes and Alveolar Macrophages	Bird antigen exposure is associated with reduced inflammatory monocytes, alveolar macrophages, and tolerogenic dendritic cells in the lung.																																																								"{""description"": ""Bird antigen exposure is associated with reduced inflammatory monocytes, alveolar macrophages, and tolerogenic dendritic cells in the lung."", ""name"": ""Reduction of Inflammatory Monocytes and Alveolar Macrophages""}"	{}	"{""cell_types"": [{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}, {""preferred_term"": ""alveolar macrophage"", ""term"": {""id"": ""CL:0000583"", ""label"": ""alveolar macrophage""}}], ""description"": ""Bird antigen exposure is associated with reduced inflammatory monocytes, alveolar macrophages, and tolerogenic dendritic cells in the lung."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The same experiment reports reduced inflammatory monocytes, alveolar macrophages, and tolerogenic dendritic cells."", ""reference"": ""DOI:10.3390/ijms24032884"", ""snippet"": ""Both groups presented increases in resident monocytes, interstitial macrophages and type 2 dendritic cells (DCs), but also reductions in inflammatory monocytes, alveolar macrophages and tolerogenic DCs compared with their control groups."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Reduction of Inflammatory Monocytes and Alveolar Macrophages""}"
1148	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	3	Th1/Th2 to Th2/Th17 Cytokine Shift	Early disease shows a mixed Th1/Th2 response, while progression shifts toward a Th2/Th17 mixed response.																																																								"{""description"": ""Early disease shows a mixed Th1/Th2 response, while progression shifts toward a Th2/Th17 mixed response."", ""name"": ""Th1/Th2 to Th2/Th17 Cytokine Shift""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}], ""cell_types"": [{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Early disease shows a mixed Th1/Th2 response, while progression shifts toward a Th2/Th17 mixed response."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The cytokine profile indicates a stage-dependent shift toward Th2/Th17 responses during disease progression."", ""reference"": ""DOI:10.3390/ijms24032884"", ""snippet"": ""In the first stages of BRHP, there is a mixed Th1/Th2 immune response, while during the progression of the disease, although there is a Th1 response, the cytokine levels seem to indicate a switch towards a Th2/Th17 mixed response."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Th1/Th2 to Th2/Th17 Cytokine Shift""}"
1149	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	4	Bird Antigen-Driven Humoral Response	Bird antigen exposure triggers B cell activation and elevated serum IgG/IgA to avian proteins in bird-related hypersensitivity pneumonitis.																																																								"{""description"": ""Bird antigen exposure triggers B cell activation and elevated serum IgG/IgA to avian proteins in bird-related hypersensitivity pneumonitis."", ""name"": ""Bird Antigen-Driven Humoral Response""}"	{}	"{""biological_processes"": [{""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}, {""preferred_term"": ""antigen processing and presentation"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""Bird antigen exposure triggers B cell activation and elevated serum IgG/IgA to avian proteins in bird-related hypersensitivity pneumonitis."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Elevated bird-specific IgG/IgA in affected patients supports a humoral immune response to avian antigens."", ""reference"": ""PMID:33041192"", ""snippet"": ""The levels of sIgG/sIgA against the bird antigens of the three species were significantly higher in subjects with acute bird-related HP and chronic bird-related HP with acute episodes (recurrent type) than in the control subjects."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Bird Antigen-Driven Humoral Response""}"
1150	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	5	Species-Specific Bird Antigen Panels	Diagnostic panels for bird-related hypersensitivity pneumonitis use antigens from pigeon, parrot, and budgerigar species.																																																								"{""description"": ""Diagnostic panels for bird-related hypersensitivity pneumonitis use antigens from pigeon, parrot, and budgerigar species."", ""name"": ""Species-Specific Bird Antigen Panels""}"	{}	"{""description"": ""Diagnostic panels for bird-related hypersensitivity pneumonitis use antigens from pigeon, parrot, and budgerigar species."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study explicitly lists pigeon, parrot, and budgerigar antigens as the species used in standardized antibody testing for bird-related HP."", ""reference"": ""PMID:33041192"", ""snippet"": ""We executed a clinical performance test by conducting a multi-institutional study to measure the levels of sIgG/sIgA against pigeon, parrot and budgerigar antigens by the ImmunoCAP system in 29 acute and 46 chronic bird-related HP patients."", ""supports"": ""SUPPORT""}], ""name"": ""Species-Specific Bird Antigen Panels"", ""triggers"": [{""preferred_term"": ""pigeon"", ""term"": {""id"": ""NCBITaxon:8932"", ""label"": ""Columba livia""}}, {""preferred_term"": ""parrot"", ""term"": {""id"": ""NCBITaxon:9223"", ""label"": ""Psittaciformes""}}, {""preferred_term"": ""budgerigar"", ""term"": {""id"": ""NCBITaxon:13146"", ""label"": ""Melopsittacus undulatus""}}]}"
1151	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	6	Classical Monocyte Enrichment	Fibrotic hypersensitivity pneumonitis shows elevated classical monocytes enriched for CCL3hi/CCL4hi and S100Ahi states.																																																								"{""description"": ""Fibrotic hypersensitivity pneumonitis shows elevated classical monocytes enriched for CCL3hi/CCL4hi and S100Ahi states."", ""name"": ""Classical Monocyte Enrichment""}"	{}	"{""biological_processes"": [{""preferred_term"": ""chemokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0070098"", ""label"": ""chemokine-mediated signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}], ""description"": ""Fibrotic hypersensitivity pneumonitis shows elevated classical monocytes enriched for CCL3hi/CCL4hi and S100Ahi states."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Single-cell profiling identifies enriched classical monocyte states in fibrotic HP."", ""reference"": ""PMID:38924775"", ""snippet"": ""Compared with control samples, FHP has elevated classical monocytes (adjusted-P=2.510-3) and is enriched in CCL3hi/CCL4hi and S100Ahi classical monocytes (adjusted-P<2.210-16)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Classical Monocyte Enrichment""}"
1152	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	7	Monocyte-to-SPP1hi Macrophage Differentiation	Specific classical monocyte states differentiate into SPP1hi lung macrophages associated with fibrosis.																																																								"{""description"": ""Specific classical monocyte states differentiate into SPP1hi lung macrophages associated with fibrosis."", ""name"": ""Monocyte-to-SPP1hi Macrophage Differentiation""}"	{}	"{""cell_types"": [{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Specific classical monocyte states differentiate into SPP1hi lung macrophages associated with fibrosis."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Trajectory analyses link classical monocytes to profibrotic macrophages in fibrotic HP."", ""reference"": ""PMID:38924775"", ""snippet"": ""Trajectory analyses demonstrate that S100Ahi classical monocytes differentiate into SPP1hi lung macrophages associated with fibrosis."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Monocyte-to-SPP1hi Macrophage Differentiation""}"
1153	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	8	Cytotoxic T Cell Program with Profibrotic Signaling	Fibrotic hypersensitivity pneumonitis features GZMhi cytotoxic T cells with transcriptional programs implicating TGF, TNF, and NFB pathways.																																																								"{""description"": ""Fibrotic hypersensitivity pneumonitis features GZMhi cytotoxic T cells with transcriptional programs implicating TGF, TNF, and NFB pathways."", ""name"": ""Cytotoxic T Cell Program with Profibrotic Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}], ""cell_types"": [{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Fibrotic hypersensitivity pneumonitis features GZMhi cytotoxic T cells with transcriptional programs implicating TGF, TNF, and NFB pathways."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Cytotoxic T cell enrichment with profibrotic signaling programs supports a T cell-driven inflammatory mechanism."", ""reference"": ""PMID:38924775"", ""snippet"": ""Compared with both control subjects and IPF, cells from patients with FHP are significantly enriched in GZMhi cytotoxic T cells. These cells exhibit TF activities indicative of TGF and TNF and NFB pathways."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Cytotoxic T Cell Program with Profibrotic Signaling""}"
1154	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	9	MMP14-High Macrophage Profibrotic Activity	MMP14-high macrophages with an M2-like phenotype promote fibroblast-to-myofibroblast transition in hypersensitivity pneumonitis models, contributing to fibrotic remodeling.																																																								"{""description"": ""MMP14-high macrophages with an M2-like phenotype promote fibroblast-to-myofibroblast transition in hypersensitivity pneumonitis models, contributing to fibrotic remodeling."", ""name"": ""MMP14-High Macrophage Profibrotic Activity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""cell_types"": [{""preferred_term"": ""alveolar macrophage"", ""term"": {""id"": ""CL:0000583"", ""label"": ""alveolar macrophage""}}], ""description"": ""MMP14-high macrophages with an M2-like phenotype promote fibroblast-to-myofibroblast transition in hypersensitivity pneumonitis models, contributing to fibrotic remodeling."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The study identifies a macrophage subset driving fibroblast-to-myofibroblast transition, a key fibrotic remodeling process."", ""reference"": ""PMID:38218353"", ""snippet"": ""we identified MMP14high macrophage subcluster with a predominant M2 phenotype that exhibited higher activity in promoting fibroblast-to myofibroblast transition (FMT)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""alveolus of lung"", ""term"": {""id"": ""UBERON:0002299"", ""label"": ""alveolus of lung""}}], ""name"": ""MMP14-High Macrophage Profibrotic Activity""}"
1155	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	10	TLR2 and NF-B Regulation of MMP14 and Exosome Secretion	TLR2 and NF-B signaling regulate MMP14 expression and macrophage exosome secretion in antigen-stimulated hypersensitivity pneumonitis models.																																																								"{""description"": ""TLR2 and NF-B signaling regulate MMP14 expression and macrophage exosome secretion in antigen-stimulated hypersensitivity pneumonitis models."", ""name"": ""TLR2 and NF-B Regulation of MMP14 and Exosome Secretion""}"	{}	"{""cell_types"": [{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""TLR2 and NF-B signaling regulate MMP14 expression and macrophage exosome secretion in antigen-stimulated hypersensitivity pneumonitis models."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The abstract links TLR2/NF-B signaling to MMP14 regulation and exosome secretion in HP macrophages."", ""reference"": ""PMID:38218353"", ""snippet"": ""We demonstrated that suppressing toll-like receptor 2 (TLR2) and nuclear factor kappa-B (NF-B) could attenuate MMP14 expression and exosome secretion in macrophages stimulation with SR-Ag."", ""supports"": ""SUPPORT""}], ""name"": ""TLR2 and NF-B Regulation of MMP14 and Exosome Secretion""}"
1171	48	Botulism	Botulism.yaml	pathophysiology	0	Botulinum Neurotoxin-Mediated Neuromuscular Blockade	Botulinum toxin causes neuroparalysis by disrupting neuromuscular function, resulting in descending paralysis.																																																								"{""description"": ""Botulinum toxin causes neuroparalysis by disrupting neuromuscular function, resulting in descending paralysis."", ""name"": ""Botulinum Neurotoxin-Mediated Neuromuscular Blockade""}"	{}	"{""description"": ""Botulinum toxin causes neuroparalysis by disrupting neuromuscular function, resulting in descending paralysis."", ""evidence"": [{""explanation"": ""The abstract identifies botulinum toxin as the cause of the neuroparalytic disease."", ""reference"": ""PMID:31157190"", ""snippet"": ""Botulism is rare neuroparalytic disease caused by botulinum toxin, one of the most toxic substances known."", ""supports"": ""SUPPORT""}], ""name"": ""Botulinum Neurotoxin-Mediated Neuromuscular Blockade""}"
1172	48	Botulism	Botulism.yaml	pathophysiology	1	Acetylcholine Release Inhibition	Botulinum toxin blocks stimulus-induced acetylcholine release at presynaptic nerve terminals, impairing neuromuscular transmission.																																																								"{""description"": ""Botulinum toxin blocks stimulus-induced acetylcholine release at presynaptic nerve terminals, impairing neuromuscular transmission."", ""name"": ""Acetylcholine Release Inhibition""}"	{}	"{""description"": ""Botulinum toxin blocks stimulus-induced acetylcholine release at presynaptic nerve terminals, impairing neuromuscular transmission."", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""The abstract reports botulinum toxin inhibition of acetylcholine release at neuromuscular junctions."", ""reference"": ""PMID:8331029"", ""snippet"": ""Clostridium botulinum type toxin A (BoTx) blocks stimulus-induced acetylcholine (ACh) release from presynaptic nerve terminals at peripheral neuromuscular junctions."", ""supports"": ""SUPPORT""}], ""name"": ""Acetylcholine Release Inhibition""}"
1176	49	Breast Fibroadenoma	Breast_Fibroadenoma.yaml	pathophysiology	0	Benign Fibroepithelial Tumor	Fibroadenomas are benign breast tumors composed of epithelial and stromal elements, presenting as discrete breast lumps.																																																								"{""description"": ""Fibroadenomas are benign breast tumors composed of epithelial and stromal elements, presenting as discrete breast lumps."", ""name"": ""Benign Fibroepithelial Tumor""}"	{}	"{""description"": ""Fibroadenomas are benign breast tumors composed of epithelial and stromal elements, presenting as discrete breast lumps."", ""evidence"": [{""explanation"": ""The abstract describes fibroadenoma as a common benign breast lump."", ""reference"": ""PMID:11270760"", ""snippet"": ""Fibroadenoma of the breast is a common cause of a benign breast lump in premenopausal women."", ""supports"": ""SUPPORT""}], ""name"": ""Benign Fibroepithelial Tumor""}"
1191	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	0	Chronic Infection and Inflammation	Persistent microbial infections and inflammation damage airway walls, leading to dilation and thickening.																																																								"{""description"": ""Persistent microbial infections and inflammation damage airway walls, leading to dilation and thickening."", ""name"": ""Chronic Infection and Inflammation""}"	"{""downstream"": [{""target"": ""Airway Dilation""}]}"	"{""description"": ""Persistent microbial infections and inflammation damage airway walls, leading to dilation and thickening."", ""downstream"": [{""target"": ""Airway Dilation""}], ""name"": ""Chronic Infection and Inflammation""}"
1192	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	1	Airway Dilation	Destruction of elastin and cartilage in the bronchial walls causes irreversible dilation of bronchi.																																																								"{""description"": ""Destruction of elastin and cartilage in the bronchial walls causes irreversible dilation of bronchi."", ""name"": ""Airway Dilation""}"	"{""downstream"": [{""target"": ""Impaired Mucociliary Clearance""}]}"	"{""description"": ""Destruction of elastin and cartilage in the bronchial walls causes irreversible dilation of bronchi."", ""downstream"": [{""target"": ""Impaired Mucociliary Clearance""}], ""name"": ""Airway Dilation""}"
1193	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	2	Impaired Mucociliary Clearance	Damage and dilation of airways hinder effective clearance of mucus, allowing for accumulation and further infection.																																																								"{""description"": ""Damage and dilation of airways hinder effective clearance of mucus, allowing for accumulation and further infection."", ""name"": ""Impaired Mucociliary Clearance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""mucociliary clearance"", ""term"": {""id"": ""GO:0003351"", ""label"": ""epithelial cilium movement involved in extracellular fluid movement""}}, {""preferred_term"": ""cilium movement"", ""term"": {""id"": ""GO:0003341"", ""label"": ""cilium movement""}}], ""cell_types"": [{""preferred_term"": ""airway epithelial cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}, {""preferred_term"": ""ciliated epithelial cell"", ""term"": {""id"": ""CL:0000067"", ""label"": ""ciliated epithelial cell""}}], ""description"": ""Damage and dilation of airways hinder effective clearance of mucus, allowing for accumulation and further infection."", ""locations"": [{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}], ""name"": ""Impaired Mucociliary Clearance""}"
1194	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	3	Neutrophil-Driven Inflammation	Excessive neutrophil recruitment, degranulation, and NET formation release proteases (neutrophil elastase, proteinase 3, cathepsin G) that degrade extracellular matrix, impair ciliary function, and damage epithelial barriers.																																																								"{""description"": ""Excessive neutrophil recruitment, degranulation, and NET formation release proteases (neutrophil elastase, proteinase 3, cathepsin G) that degrade extracellular matrix, impair ciliary function, and damage epithelial barriers."", ""name"": ""Neutrophil-Driven Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""neutrophil degranulation"", ""term"": {""id"": ""GO:0043312"", ""label"": ""neutrophil degranulation""}}, {""preferred_term"": ""neutrophil extracellular trap formation"", ""term"": {""id"": ""GO:0036148"", ""label"": ""NETosis""}}, {""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Excessive neutrophil recruitment, degranulation, and NET formation release proteases (neutrophil elastase, proteinase 3, cathepsin G) that degrade extracellular matrix, impair ciliary function, and damage epithelial barriers."", ""locations"": [{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}, {""preferred_term"": ""extracellular space"", ""term"": {""id"": ""GO:0005615"", ""label"": ""extracellular region""}}], ""name"": ""Neutrophil-Driven Inflammation""}"
1195	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	4	Protease-Antiprotease Imbalance	Excess neutrophil serine proteases (NE, PR3, CatG) overwhelm antiproteases (SLPI, A1AT), degrading structural proteins and perpetuating tissue damage.																																																								"{""description"": ""Excess neutrophil serine proteases (NE, PR3, CatG) overwhelm antiproteases (SLPI, A1AT), degrading structural proteins and perpetuating tissue damage."", ""name"": ""Protease-Antiprotease Imbalance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""proteolysis"", ""term"": {""id"": ""GO:0006508"", ""label"": ""proteolysis""}}], ""description"": ""Excess neutrophil serine proteases (NE, PR3, CatG) overwhelm antiproteases (SLPI, A1AT), degrading structural proteins and perpetuating tissue damage."", ""locations"": [{""preferred_term"": ""extracellular space"", ""term"": {""id"": ""GO:0005615"", ""label"": ""extracellular region""}}], ""name"": ""Protease-Antiprotease Imbalance""}"
1196	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	5	Goblet Cell Hyperplasia and Mucus Hypersecretion	Increased goblet cell numbers and overproduction of gel-forming mucins (MUC5AC, MUC5B) lead to mucus hyperconcentration and impaired clearance.																																																								"{""description"": ""Increased goblet cell numbers and overproduction of gel-forming mucins (MUC5AC, MUC5B) lead to mucus hyperconcentration and impaired clearance."", ""name"": ""Goblet Cell Hyperplasia and Mucus Hypersecretion""}"	{}	"{""biological_processes"": [{""preferred_term"": ""mucus secretion"", ""term"": {""id"": ""GO:0070254"", ""label"": ""mucus secretion""}}], ""cell_types"": [{""preferred_term"": ""goblet cell"", ""term"": {""id"": ""CL:0000160"", ""label"": ""goblet cell""}}], ""description"": ""Increased goblet cell numbers and overproduction of gel-forming mucins (MUC5AC, MUC5B) lead to mucus hyperconcentration and impaired clearance."", ""locations"": [{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}], ""name"": ""Goblet Cell Hyperplasia and Mucus Hypersecretion""}"
1197	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	6	Inflammasome Activation and IL-1beta Signaling	NLRP3 inflammasome activation drives IL-1beta production, which directly impairs ciliary function, disrupts tight junctions, promotes mucus hyperconcentration, and is associated with severe disease and Proteobacteria enrichment.																																																								"{""description"": ""NLRP3 inflammasome activation drives IL-1beta production, which directly impairs ciliary function, disrupts tight junctions, promotes mucus hyperconcentration, and is associated with severe disease and Proteobacteria enrichment."", ""name"": ""Inflammasome Activation and IL-1beta Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""NLRP3 inflammasome complex assembly"", ""term"": {""id"": ""GO:0072559"", ""label"": ""NLRP3 inflammasome complex assembly""}}, {""preferred_term"": ""interleukin-1 beta production"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}], ""cell_types"": [{""preferred_term"": ""airway epithelial cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}], ""description"": ""NLRP3 inflammasome activation drives IL-1beta production, which directly impairs ciliary function, disrupts tight junctions, promotes mucus hyperconcentration, and is associated with severe disease and Proteobacteria enrichment."", ""locations"": [{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}], ""name"": ""Inflammasome Activation and IL-1beta Signaling""}"
1198	50	Bronchiectasis	Bronchiectasis.yaml	pathophysiology	7	Microbiome Dysbiosis	Reduced microbial diversity with Proteobacteria dominance, particularly Pseudomonas aeruginosa and Haemophilus influenzae, drives chronic infection, exacerbations, and disease progression.																																																								"{""description"": ""Reduced microbial diversity with Proteobacteria dominance, particularly Pseudomonas aeruginosa and Haemophilus influenzae, drives chronic infection, exacerbations, and disease progression."", ""name"": ""Microbiome Dysbiosis""}"	{}	"{""description"": ""Reduced microbial diversity with Proteobacteria dominance, particularly Pseudomonas aeruginosa and Haemophilus influenzae, drives chronic infection, exacerbations, and disease progression."", ""locations"": [{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}, {""preferred_term"": ""respiratory tract mucus"", ""term"": {""id"": ""UBERON:0016403"", ""label"": ""respiratory tract mucus""}}], ""name"": ""Microbiome Dysbiosis""}"
1226	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	0	MYC Translocation and Oncogene Activation	The hallmark of Burkitt lymphoma is translocation of the MYC oncogene on chromosome 8 to an immunoglobulin locus, most commonly t(8;14)(q24;q32) involving the IGH locus, or less commonly t(2;8) or t(8;22) involving light chain loci. This places MYC under control of immunoglobulin enhancers, resulting in constitutive MYC overexpression.																																																								"{""description"": ""The hallmark of Burkitt lymphoma is translocation of the MYC oncogene on chromosome 8 to an immunoglobulin locus, most commonly t(8;14)(q24;q32) involving the IGH locus, or less commonly t(2;8) or t(8;22) involving light chain loci. This places MYC under control of immunoglobulin enhancers, resulting in constitutive MYC overexpression."", ""name"": ""MYC Translocation and Oncogene Activation""}"	"{""downstream"": [{""description"": ""MYC drives cell cycle entry and proliferation"", ""target"": ""Uncontrolled B-Cell Proliferation""}, {""description"": ""MYC cooperates with anti-apoptotic signals to enable tumor cell survival"", ""target"": ""Apoptosis Resistance""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""The hallmark of Burkitt lymphoma is translocation of the MYC oncogene on chromosome 8 to an immunoglobulin locus, most commonly t(8;14)(q24;q32) involving the IGH locus, or less commonly t(2;8) or t(8;22) involving light chain loci. This places MYC under control of immunoglobulin enhancers, resulting in constitutive MYC overexpression."", ""downstream"": [{""description"": ""MYC drives cell cycle entry and proliferation"", ""target"": ""Uncontrolled B-Cell Proliferation""}, {""description"": ""MYC cooperates with anti-apoptotic signals to enable tumor cell survival"", ""target"": ""Apoptosis Resistance""}], ""evidence"": [{""explanation"": ""This abstract directly identifies MYC translocations as a defining feature of Burkitt lymphoma."", ""reference"": ""PMID:40893393"", ""snippet"": ""Burkitt lymphoma (BL) is an aggressive B-cell malignancy characterized by rapid progression and MYC gene translocations."", ""supports"": ""SUPPORT""}, {""explanation"": ""Abstract reports MYC translocation to immunoglobulin loci in most Burkitt lymphoma cases."", ""reference"": ""PMID:1301171"", ""snippet"": ""In about 80% of Burkitt's lymphoma cases, the tumour cell harbours a reciprocal chromosomal translocation which invariably transposes the coding exons 2 and 3 of c-myc from chromosome 8 to the immunoglobulin heavy chain locus on chromosome 14."", ""supports"": ""SUPPORT""}], ""name"": ""MYC Translocation and Oncogene Activation""}"
1227	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	1	Uncontrolled B-Cell Proliferation	MYC is a master transcriptional regulator of cell growth and proliferation. Constitutive MYC expression drives continuous cell cycle progression, resulting in one of the fastest doubling times of any human tumor (approximately 24 hours). The proliferation fraction approaches 100% (Ki-67 staining).																																																								"{""description"": ""MYC is a master transcriptional regulator of cell growth and proliferation. Constitutive MYC expression drives continuous cell cycle progression, resulting in one of the fastest doubling times of any human tumor (approximately 24 hours). The proliferation fraction approaches 100% (Ki-67 staining)."", ""name"": ""Uncontrolled B-Cell Proliferation""}"	"{""downstream"": [{""description"": ""Extremely rapid proliferation leads to aggressive clinical behavior"", ""target"": ""High-Grade Malignancy with Rapid Tumor Growth""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""MYC is a master transcriptional regulator of cell growth and proliferation. Constitutive MYC expression drives continuous cell cycle progression, resulting in one of the fastest doubling times of any human tumor (approximately 24 hours). The proliferation fraction approaches 100% (Ki-67 staining)."", ""downstream"": [{""description"": ""Extremely rapid proliferation leads to aggressive clinical behavior"", ""target"": ""High-Grade Malignancy with Rapid Tumor Growth""}], ""name"": ""Uncontrolled B-Cell Proliferation""}"
1228	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	2	Apoptosis Resistance	While MYC normally sensitizes cells to apoptosis, Burkitt lymphoma cells acquire mutations or alterations that counteract MYC-induced apoptosis. TP53 mutations occur in approximately 30% of cases. EBV-encoded EBNA1 and EBERs provide additional survival signals in EBV-positive cases.																																																								"{""description"": ""While MYC normally sensitizes cells to apoptosis, Burkitt lymphoma cells acquire mutations or alterations that counteract MYC-induced apoptosis. TP53 mutations occur in approximately 30% of cases. EBV-encoded EBNA1 and EBERs provide additional survival signals in EBV-positive cases."", ""name"": ""Apoptosis Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""While MYC normally sensitizes cells to apoptosis, Burkitt lymphoma cells acquire mutations or alterations that counteract MYC-induced apoptosis. TP53 mutations occur in approximately 30% of cases. EBV-encoded EBNA1 and EBERs provide additional survival signals in EBV-positive cases."", ""name"": ""Apoptosis Resistance""}"
1229	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	3	High-Grade Malignancy with Rapid Tumor Growth	The combination of constitutive MYC-driven proliferation and apoptosis resistance results in rapidly growing tumors. The high proliferation rate paradoxically makes the tumor highly sensitive to chemotherapy, contributing to excellent cure rates with intensive treatment.																																																								"{""description"": ""The combination of constitutive MYC-driven proliferation and apoptosis resistance results in rapidly growing tumors. The high proliferation rate paradoxically makes the tumor highly sensitive to chemotherapy, contributing to excellent cure rates with intensive treatment."", ""name"": ""High-Grade Malignancy with Rapid Tumor Growth""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""The combination of constitutive MYC-driven proliferation and apoptosis resistance results in rapidly growing tumors. The high proliferation rate paradoxically makes the tumor highly sensitive to chemotherapy, contributing to excellent cure rates with intensive treatment."", ""name"": ""High-Grade Malignancy with Rapid Tumor Growth""}"
1241	52	Buruli ulcer	Buruli_Ulcer.yaml	pathophysiology	0	Mycolactone-mediated tissue destruction	Mycolactone toxin leads to subcutaneous tissue destruction and immunosuppression, producing deep ulcers.																																																								"{""description"": ""Mycolactone toxin leads to subcutaneous tissue destruction and immunosuppression, producing deep ulcers."", ""name"": ""Mycolactone-mediated tissue destruction""}"	{}	"{""description"": ""Mycolactone toxin leads to subcutaneous tissue destruction and immunosuppression, producing deep ulcers."", ""evidence"": [{""explanation"": ""The abstract links mycolactone to tissue destruction and ulceration."", ""reference"": ""PMID:30429139"", ""snippet"": ""Mycobacterium ulcerans produces a mycolactone toxin that leads to subcutaneous tissue destruction and immunosuppression, resulting in deep ulcerations"", ""supports"": ""SUPPORT""}], ""name"": ""Mycolactone-mediated tissue destruction""}"
1246	53	CHIME_syndrome	CHIME_syndrome.yaml	pathophysiology	0	PIGL Gene Mutations	Mutations in PIGL gene disrupt glycosylphosphatidylinositol (GPI) anchor biosynthesis. PIGL encodes a de-N-acetylase required for GPI anchor formation, essential for anchoring various cell surface proteins including receptors, enzymes, and adhesion molecules.																																																								"{""description"": ""Mutations in PIGL gene disrupt glycosylphosphatidylinositol (GPI) anchor biosynthesis. PIGL encodes a de-N-acetylase required for GPI anchor formation, essential for anchoring various cell surface proteins including receptors, enzymes, and adhesion molecules."", ""name"": ""PIGL Gene Mutations""}"	{}	"{""biological_processes"": [{""preferred_term"": ""glycosylphosphatidylinositol biosynthetic process"", ""term"": {""id"": ""GO:0006506"", ""label"": ""GPI anchor biosynthetic process""}}], ""description"": ""Mutations in PIGL gene disrupt glycosylphosphatidylinositol (GPI) anchor biosynthesis. PIGL encodes a de-N-acetylase required for GPI anchor formation, essential for anchoring various cell surface proteins including receptors, enzymes, and adhesion molecules."", ""evidence"": [{""explanation"": ""Establishes PIGL mutations as the cause of CHIME syndrome and describes the gene's role in GPI anchor biosynthesis."", ""reference"": ""PMID:22444671"", ""snippet"": ""CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies, including conductive hearing loss. Whole-exome sequencing on five previously reported cases identified PIGL, the de-N-acetylase required for glycosylphosphatidylinositol (GPI) anchor formation, as a strong candidate."", ""supports"": ""SUPPORT""}], ""name"": ""PIGL Gene Mutations""}"
1247	53	CHIME_syndrome	CHIME_syndrome.yaml	pathophysiology	1	GPI Anchor Deficiency	Reduced levels of GPI-anchored proteins on cell surface due to impaired biosynthesis, affecting normal cellular functions and signaling pathways. This leads to the multisystem phenotype characteristic of CHIME syndrome.																																																								"{""description"": ""Reduced levels of GPI-anchored proteins on cell surface due to impaired biosynthesis, affecting normal cellular functions and signaling pathways. This leads to the multisystem phenotype characteristic of CHIME syndrome."", ""name"": ""GPI Anchor Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cell adhesion"", ""term"": {""id"": ""GO:0007155"", ""label"": ""cell adhesion""}}, {""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}, {""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}], ""description"": ""Reduced levels of GPI-anchored proteins on cell surface due to impaired biosynthesis, affecting normal cellular functions and signaling pathways. This leads to the multisystem phenotype characteristic of CHIME syndrome."", ""evidence"": [{""explanation"": ""Demonstrates functional consequences of PIGL mutations showing reduced GPI anchor markers in patient cells."", ""reference"": ""PMID:22444671"", ""snippet"": ""Furthermore, cell lines derived from these cases had significantly reduced levels of the two GPI anchor markers, CD59 and a GPI-binding toxin, aerolysin (FLAER), confirming the pathogenicity of the mutations."", ""supports"": ""SUPPORT""}], ""name"": ""GPI Anchor Deficiency""}"
1267	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	0	CTCF Haploinsufficiency	"Heterozygous loss-of-function mutations in CTCF lead to reduced functional CTCF protein levels, disrupting its role as a master regulator of chromatin architecture. CTCF is essential for establishing insulator elements that define topologically associating domain (TAD) boundaries. Both frameshift and missense variants (affecting zinc finger domains) result in functional haploinsufficiency through nonsense-mediated decay or impaired DNA binding.
"																																																								"{""description"": ""Heterozygous loss-of-function mutations in CTCF lead to reduced functional CTCF protein levels, disrupting its role as a master regulator of chromatin architecture. CTCF is essential for establishing insulator elements that define topologically associating domain (TAD) boundaries. Both frameshift and missense variants (affecting zinc finger domains) result in functional haploinsufficiency through nonsense-mediated decay or impaired DNA binding.\n"", ""name"": ""CTCF Haploinsufficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""chromatin organization"", ""term"": {""id"": ""GO:0006325"", ""label"": ""chromatin organization""}}, {""preferred_term"": ""regulation of gene expression"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}], ""cell_types"": [{""preferred_term"": ""neural progenitor cell"", ""term"": {""id"": ""CL:0011020"", ""label"": ""neural progenitor cell""}}, {""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Heterozygous loss-of-function mutations in CTCF lead to reduced functional CTCF protein levels, disrupting its role as a master regulator of chromatin architecture. CTCF is essential for establishing insulator elements that define topologically associating domain (TAD) boundaries. Both frameshift and missense variants (affecting zinc finger domains) result in functional haploinsufficiency through nonsense-mediated decay or impaired DNA binding.\n"", ""evidence"": [{""explanation"": ""Original discovery paper establishing that CTCF haploinsufficiency disrupts enhancer-promoter interactions critical for development and cognition."", ""reference"": ""PMID:23746550"", ""snippet"": ""Our findings indicate that haploinsufficiency of CTCF affects genomic interaction of enhancers and their regulated gene promoters that drive developmental processes and cognition."", ""supports"": ""SUPPORT""}, {""explanation"": ""Large cohort study demonstrating that both missense and loss-of-function variants lead to similar functional consequences, supporting haploinsufficiency as the disease mechanism."", ""reference"": ""PMID:31239556"", ""snippet"": ""Our extensive follow-up study does not indicate any clear correlation between nature and location of variants and clinical presentation. Furthermore, differentially expressed genes significantly overlapped between individuals with either missense or LGD variants"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}], ""name"": ""CTCF Haploinsufficiency""}"
1268	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	1	Chromatin Architecture Disruption	"Reduced CTCF function leads to aberrant chromatin looping and disrupted TAD boundaries, causing inappropriate enhancer-promoter interactions. CTCF normally mediates formation of chromatin loops that define TADs, and its depletion causes blurred domain boundaries and altered three-dimensional genome structure. The R567W mutation specifically affects CTCF binding to peripheral motifs, causing local chromatin structure alterations particularly at the clustered protocadherin locus.
"																																																								"{""description"": ""Reduced CTCF function leads to aberrant chromatin looping and disrupted TAD boundaries, causing inappropriate enhancer-promoter interactions. CTCF normally mediates formation of chromatin loops that define TADs, and its depletion causes blurred domain boundaries and altered three-dimensional genome structure. The R567W mutation specifically affects CTCF binding to peripheral motifs, causing local chromatin structure alterations particularly at the clustered protocadherin locus.\n"", ""name"": ""Chromatin Architecture Disruption""}"	{}	"{""biological_processes"": [{""preferred_term"": ""chromosome organization"", ""term"": {""id"": ""GO:0051276"", ""label"": ""chromosome organization""}}, {""preferred_term"": ""regulation of chromatin organization"", ""term"": {""id"": ""GO:1902275"", ""label"": ""regulation of chromatin organization""}}], ""description"": ""Reduced CTCF function leads to aberrant chromatin looping and disrupted TAD boundaries, causing inappropriate enhancer-promoter interactions. CTCF normally mediates formation of chromatin loops that define TADs, and its depletion causes blurred domain boundaries and altered three-dimensional genome structure. The R567W mutation specifically affects CTCF binding to peripheral motifs, causing local chromatin structure alterations particularly at the clustered protocadherin locus.\n"", ""evidence"": [{""explanation"": ""The R567W mutation causes specific chromatin structure alterations and dysregulation of protocadherin genes important for neuronal connectivity."", ""reference"": ""PMID:38951485"", ""snippet"": ""it specifically hinders CTCF binding to peripheral motifs upstream to the core consensus site, causing alterations in local chromatin structure and gene expression, particularly at the clustered protocadherin locus"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}], ""name"": ""Chromatin Architecture Disruption""}"
1269	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	2	Neurodevelopmental Gene Dysregulation	"CTCF haploinsufficiency leads to widespread gene dysregulation affecting neurodevelopmental pathways. RNA-sequencing in affected individuals revealed 3,828 deregulated genes enriched for known neurodevelopmental disorder genes and transcriptional regulation processes. Downregulated genes are enriched for transcription-related processes, while upregulated genes are enriched for translational and ribosomal processes.
"																																																								"{""description"": ""CTCF haploinsufficiency leads to widespread gene dysregulation affecting neurodevelopmental pathways. RNA-sequencing in affected individuals revealed 3,828 deregulated genes enriched for known neurodevelopmental disorder genes and transcriptional regulation processes. Downregulated genes are enriched for transcription-related processes, while upregulated genes are enriched for translational and ribosomal processes.\n"", ""name"": ""Neurodevelopmental Gene Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""regulation of gene expression"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}], ""cell_types"": [{""preferred_term"": ""neural progenitor cell"", ""term"": {""id"": ""CL:0011020"", ""label"": ""neural progenitor cell""}}, {""preferred_term"": ""cerebral cortex neuron"", ""term"": {""id"": ""CL:0010012"", ""label"": ""cerebral cortex neuron""}}], ""description"": ""CTCF haploinsufficiency leads to widespread gene dysregulation affecting neurodevelopmental pathways. RNA-sequencing in affected individuals revealed 3,828 deregulated genes enriched for known neurodevelopmental disorder genes and transcriptional regulation processes. Downregulated genes are enriched for transcription-related processes, while upregulated genes are enriched for translational and ribosomal processes.\n"", ""evidence"": [{""explanation"": ""Transcriptome analysis shows broad dysregulation of genes including those implicated in neurodevelopmental disorders."", ""reference"": ""PMID:31239556"", ""snippet"": ""RNA-sequencing in five individuals identified 3828 deregulated genes enriched for known NDD genes and biological processes such as transcriptional regulation"", ""supports"": ""SUPPORT""}, {""explanation"": ""Initial transcriptome analysis showed CTCF mutations cause deregulation of signal transduction genes."", ""reference"": ""PMID:23746550"", ""snippet"": ""Transcriptome analyses in all three individuals with point mutations revealed deregulation of genes involved in signal transduction and emphasized the role of CTCF in enhancer-driven expression of genes."", ""supports"": ""SUPPORT""}], ""name"": ""Neurodevelopmental Gene Dysregulation""}"
1270	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	3	Abnormal Neural Progenitor Cell Development	"CTCF mutations induce premature depletion of stem-like neural progenitor cells and accelerate maturation of GABAergic neurons within the developing cortex. The R567W mutation causes reduced proportions of neural progenitors and radial glial cells, with increased postmitotic neuroblasts and inhibitory GABAergic neurons, disrupting the balanced development of excitatory and inhibitory neural circuits.
"																																																								"{""description"": ""CTCF mutations induce premature depletion of stem-like neural progenitor cells and accelerate maturation of GABAergic neurons within the developing cortex. The R567W mutation causes reduced proportions of neural progenitors and radial glial cells, with increased postmitotic neuroblasts and inhibitory GABAergic neurons, disrupting the balanced development of excitatory and inhibitory neural circuits.\n"", ""name"": ""Abnormal Neural Progenitor Cell Development""}"	{}	"{""cell_types"": [{""preferred_term"": ""neural progenitor cell"", ""term"": {""id"": ""CL:0011020"", ""label"": ""neural progenitor cell""}}, {""preferred_term"": ""cerebral cortex GABAergic interneuron"", ""term"": {""id"": ""CL:0010011"", ""label"": ""cerebral cortex GABAergic interneuron""}}], ""description"": ""CTCF mutations induce premature depletion of stem-like neural progenitor cells and accelerate maturation of GABAergic neurons within the developing cortex. The R567W mutation causes reduced proportions of neural progenitors and radial glial cells, with increased postmitotic neuroblasts and inhibitory GABAergic neurons, disrupting the balanced development of excitatory and inhibitory neural circuits.\n"", ""evidence"": [{""explanation"": ""Mouse model and human organoid studies show the R567W mutation causes premature neural progenitor depletion and accelerated GABAergic neuron maturation."", ""reference"": ""PMID:38951485"", ""snippet"": ""This mutation induces premature stem-like cell exhaustion, accelerates the maturation of GABAergic neurons, and disrupts neurodevelopmental and synaptic pathways."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}], ""name"": ""Abnormal Neural Progenitor Cell Development""}"
1298	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	0	Fetal Akinesia	Reduced fetal movement during development leads to connective tissue accumulation and shortening around joints, resulting in fixed flexion deformities at birth. This is the fundamental pathomechanism across arthrogryposis types.																																																								"{""description"": ""Reduced fetal movement during development leads to connective tissue accumulation and shortening around joints, resulting in fixed flexion deformities at birth. This is the fundamental pathomechanism across arthrogryposis types."", ""name"": ""Fetal Akinesia""}"	"{""downstream"": [{""target"": ""Joint Contracture""}]}"	"{""cell_types"": [{""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}], ""description"": ""Reduced fetal movement during development leads to connective tissue accumulation and shortening around joints, resulting in fixed flexion deformities at birth. This is the fundamental pathomechanism across arthrogryposis types."", ""downstream"": [{""target"": ""Joint Contracture""}], ""name"": ""Fetal Akinesia""}"
1299	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	1	Sarcomere Dysfunction	Pathogenic variants in sarcomeric proteins (TNNT3, TNNI2, TPM2, MYH3, ACTC1) impair muscle contraction/relaxation dynamics, reducing fetal limb motion and producing non-progressive congenital contractures.																																																								"{""description"": ""Pathogenic variants in sarcomeric proteins (TNNT3, TNNI2, TPM2, MYH3, ACTC1) impair muscle contraction/relaxation dynamics, reducing fetal limb motion and producing non-progressive congenital contractures."", ""name"": ""Sarcomere Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""sarcomere organization"", ""term"": {""id"": ""GO:0045214"", ""label"": ""sarcomere organization""}}, {""preferred_term"": ""muscle contraction"", ""term"": {""id"": ""GO:0006936"", ""label"": ""muscle contraction""}}], ""cell_types"": [{""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}], ""description"": ""Pathogenic variants in sarcomeric proteins (TNNT3, TNNI2, TPM2, MYH3, ACTC1) impair muscle contraction/relaxation dynamics, reducing fetal limb motion and producing non-progressive congenital contractures."", ""evidence"": [{""explanation"": ""Demonstrates MYH3 mutations causing distal arthrogryposis with contractures, linking sarcomeric protein dysfunction to congenital joint contractures."", ""reference"": ""PMID:21531865"", ""snippet"": ""A missense mutation in MYH3 (a gene coding for the heavy chain of myosin), causing an F437I amino acid substitution, was identified that segregated with distal arthrogryposis in this family."", ""supports"": ""SUPPORT""}], ""name"": ""Sarcomere Dysfunction""}"
1300	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	2	PRG4/Lubricin Deficiency	Loss of PRG4 function abolishes surface lubrication and anti-adhesive properties of synovial and cartilage interfaces, provoking non-inflammatory arthropathy, synovial hyperplasia, and progressive joint stiffness. Camptodactyly is often the earliest manifestation in CACP syndrome.																																																								"{""description"": ""Loss of PRG4 function abolishes surface lubrication and anti-adhesive properties of synovial and cartilage interfaces, provoking non-inflammatory arthropathy, synovial hyperplasia, and progressive joint stiffness. Camptodactyly is often the earliest manifestation in CACP syndrome."", ""name"": ""PRG4/Lubricin Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""cell_types"": [{""preferred_term"": ""type B synovial cell"", ""term"": {""id"": ""CL:0002301"", ""label"": ""type B synovial cell""}}, {""preferred_term"": ""chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}], ""description"": ""Loss of PRG4 function abolishes surface lubrication and anti-adhesive properties of synovial and cartilage interfaces, provoking non-inflammatory arthropathy, synovial hyperplasia, and progressive joint stiffness. Camptodactyly is often the earliest manifestation in CACP syndrome."", ""evidence"": [{""explanation"": ""Documents PRG4 as the causative gene for CACP syndrome, encoding lubricin present in synovial fluid and cartilage surfaces."", ""reference"": ""PMID:29397575"", ""snippet"": ""CACP is caused by mutations in the proteoglycan 4 (PRG4) gene, which encodes a lubricating glycoprotein present in the synovial fluid and at the surface of articular cartilage."", ""supports"": ""SUPPORT""}], ""gene"": {""description"": ""Encodes lubricin, a secreted mucinous glycoprotein that provides boundary lubrication and anti-adhesive properties at joint surfaces."", ""preferred_term"": ""PRG4"", ""term"": {""id"": ""hgnc:9364"", ""label"": ""PRG4""}}, ""locations"": [{""preferred_term"": ""synovial membrane of joint"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}], ""name"": ""PRG4/Lubricin Deficiency""}"
1301	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	3	Flexor Tendon Abnormalities	Abnormalities or shortening in the flexor tendons can contribute to the inability to fully extend one or more fingers.																																																								"{""description"": ""Abnormalities or shortening in the flexor tendons can contribute to the inability to fully extend one or more fingers."", ""name"": ""Flexor Tendon Abnormalities""}"	{}	"{""description"": ""Abnormalities or shortening in the flexor tendons can contribute to the inability to fully extend one or more fingers."", ""locations"": [{""preferred_term"": ""tendon"", ""term"": {""id"": ""UBERON:0000043"", ""label"": ""tendon""}}], ""name"": ""Flexor Tendon Abnormalities""}"
1302	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	4	Joint Contracture	Permanent soft tissue shortening around joints, leading to fixed flexion deformity. Results from fibroconnective remodeling of volar plate and tendon sheaths.																																																								"{""description"": ""Permanent soft tissue shortening around joints, leading to fixed flexion deformity. Results from fibroconnective remodeling of volar plate and tendon sheaths."", ""name"": ""Joint Contracture""}"	{}	"{""description"": ""Permanent soft tissue shortening around joints, leading to fixed flexion deformity. Results from fibroconnective remodeling of volar plate and tendon sheaths."", ""locations"": [{""preferred_term"": ""interphalangeal joint of manual digit"", ""term"": {""id"": ""UBERON:0007721"", ""label"": ""interphalangeal joint of manual digit""}}], ""name"": ""Joint Contracture""}"
1318	56	Cardiofaciocutaneous Syndrome	Cardiofaciocutaneous_Syndrome.yaml	pathophysiology	0	RAS-MAPK Pathway Hyperactivation	"Mutations in BRAF, MEK1, or MEK2 cause constitutive or enhanced activation of the RAS-MAPK signaling cascade, affecting cell proliferation and differentiation during development. BRAF mutations are most common (~75%), followed by MEK1/MEK2 mutations.
"																																																								"{""description"": ""Mutations in BRAF, MEK1, or MEK2 cause constitutive or enhanced activation of the RAS-MAPK signaling cascade, affecting cell proliferation and differentiation during development. BRAF mutations are most common (~75%), followed by MEK1/MEK2 mutations.\n"", ""name"": ""RAS-MAPK Pathway Hyperactivation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""MAPK Cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""preferred_term"": ""ERK1/2 Cascade"", ""term"": {""id"": ""GO:0070371"", ""label"": ""ERK1 and ERK2 cascade""}}, {""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}, {""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""description"": ""Mutations in BRAF, MEK1, or MEK2 cause constitutive or enhanced activation of the RAS-MAPK signaling cascade, affecting cell proliferation and differentiation during development. BRAF mutations are most common (~75%), followed by MEK1/MEK2 mutations.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Landmark Science paper establishing that CFC syndrome is caused by de novo mutations in MAPK pathway genes, with BRAF as the predominant causative gene."", ""reference"": ""PMID:16439621"", ""snippet"": ""heterogeneous de novo missense mutations in three genes within the mitogen-activated protein kinase (MAPK) pathway cause CFC syndrome. The majority of cases (18 out of 23) are caused by mutations in BRAF"", ""supports"": ""SUPPORT""}], ""name"": ""RAS-MAPK Pathway Hyperactivation""}"
1345	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	0	Gluten-Triggered Immune Response	"Gluten peptides (gliadin) cross the intestinal epithelium and are deamidated by tissue transglutaminase (tTG). Deamidated peptides bind HLA-DQ2/DQ8 and activate CD4+ T cells.
"																																																								"{""description"": ""Gluten peptides (gliadin) cross the intestinal epithelium and are deamidated by tissue transglutaminase (tTG). Deamidated peptides bind HLA-DQ2/DQ8 and activate CD4+ T cells.\n"", ""name"": ""Gluten-Triggered Immune Response""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Antigen Processing"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}], ""cell_types"": [{""preferred_term"": ""T Helper Cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}], ""description"": ""Gluten peptides (gliadin) cross the intestinal epithelium and are deamidated by tissue transglutaminase (tTG). Deamidated peptides bind HLA-DQ2/DQ8 and activate CD4+ T cells.\n"", ""evidence"": [{""explanation"": ""Demonstrates the critical role of tTG deamidation in converting gluten peptides into immunogenic epitopes recognized by T cells in celiac disease."", ""reference"": ""PMID:10684852"", ""snippet"": ""tissue transglutaminase (tTG)-mediated deamidation of gliadin plays an important role in recognition of this food antigen by intestinal T cells"", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows how tTG deamidation increases HLA-DQ2 binding affinity by introducing negatively charged glutamate residues, enhancing antigen presentation."", ""reference"": ""PMID:10684852"", ""snippet"": ""the deamidated peptides displayed an increased affinity for DQ2, a molecule known to preferentially bind peptides containing negatively charged residues"", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms TG2 deamidation as the pivotal mechanism enabling gluten peptide presentation and T cell activation in celiac disease pathogenesis."", ""reference"": ""PMID:38914866"", ""snippet"": ""Transglutaminase 2 (TG2) plays a pivotal role in the pathogenesis of celiac disease (CeD) by deamidating dietary gluten peptides, which facilitates antigenic presentation and a strong anti-gluten T cell response."", ""supports"": ""SUPPORT""}], ""name"": ""Gluten-Triggered Immune Response""}"
1346	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	1	Intestinal Epithelial Damage	"Activated T cells release IFN-gamma and other cytokines causing villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes. Leads to malabsorption.
"																																																								"{""description"": ""Activated T cells release IFN-gamma and other cytokines causing villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes. Leads to malabsorption.\n"", ""name"": ""Intestinal Epithelial Damage""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Apoptosis"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""Intestinal Epithelial Cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""Activated T cells release IFN-gamma and other cytokines causing villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes. Leads to malabsorption.\n"", ""evidence"": [{""explanation"": ""Demonstrates that IFN-gamma signaling drives a major portion of the transcriptional changes underlying epithelial damage in celiac disease."", ""reference"": ""PMID:38914866"", ""snippet"": ""Nearly half of the gluten-induced gene expression changes in CeD were associated with the epithelial interferon- response."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows how IL-15 converts intraepithelial CD8+ T cells into cytotoxic lymphokine-activated killer cells via NKG2D signaling, mediating epithelial damage."", ""reference"": ""PMID:15357947"", ""snippet"": ""under conditions of dysregulated IL15 expression in vivo in patients with celiac disease and in vitro in healthy individuals, multiple steps of the NKG2D/DAP10 signaling pathway leading to ERK and JNK activation are coordinately primed to activate direct cytolytic function independent of TCR specificity in effector CD8 T cells"", ""supports"": ""SUPPORT""}, {""explanation"": ""Identifies IL-15 upregulation as a defining feature of celiac disease that drives intraepithelial lymphocyte expansion and epithelial injury."", ""reference"": ""PMID:24942692"", ""snippet"": ""the upregulation of IL-15 expression in the intestinal mucosa has become a hallmark of the disease"", ""supports"": ""SUPPORT""}, {""explanation"": ""Provides interventional evidence that blocking TG2-mediated T cell activation prevents the downstream epithelial damage, villous atrophy, and malabsorption."", ""reference"": ""PMID:38914866"", ""snippet"": ""ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."", ""supports"": ""SUPPORT""}], ""name"": ""Intestinal Epithelial Damage""}"
1347	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	2	Autoantibody Production	"B cells produce antibodies against tTG (anti-tTG IgA) and deamidated gliadin peptides (anti-DGP). These serve as diagnostic markers and may contribute to pathology.
"																																																								"{""description"": ""B cells produce antibodies against tTG (anti-tTG IgA) and deamidated gliadin peptides (anti-DGP). These serve as diagnostic markers and may contribute to pathology.\n"", ""name"": ""Autoantibody Production""}"	{}	"{""cell_types"": [{""preferred_term"": ""Plasma Cell"", ""term"": {""id"": ""CL:0000786"", ""label"": ""plasma cell""}}], ""description"": ""B cells produce antibodies against tTG (anti-tTG IgA) and deamidated gliadin peptides (anti-DGP). These serve as diagnostic markers and may contribute to pathology.\n"", ""evidence"": [{""explanation"": ""Describes the immune-mediated nature of celiac disease, which includes both cellular and humoral (antibody) responses to gluten antigens."", ""reference"": ""PMID:39273359"", ""snippet"": ""Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of proline- and glutamine-rich proteins, widely termed \""gluten\"", in genetically susceptible individuals. CD induces an altered immune response that leads to chronic inflammation and duodenal mucosal damage."", ""supports"": ""SUPPORT""}], ""name"": ""Autoantibody Production""}"
1348	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	3	Barrier Dysfunction	"Increased intestinal permeability allows greater gluten peptide translocation. Zonulin upregulation disrupts tight junctions.
"																																																								"{""description"": ""Increased intestinal permeability allows greater gluten peptide translocation. Zonulin upregulation disrupts tight junctions.\n"", ""name"": ""Barrier Dysfunction""}"	{}	"{""description"": ""Increased intestinal permeability allows greater gluten peptide translocation. Zonulin upregulation disrupts tight junctions.\n"", ""evidence"": [{""explanation"": ""Blocking TG2 prevents gluten-induced disruption of epithelial barrier integrity and differentiation programs, indicating barrier dysfunction is downstream of adaptive immune activation."", ""reference"": ""PMID:38914866"", ""snippet"": ""ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."", ""supports"": ""SUPPORT""}], ""name"": ""Barrier Dysfunction""}"
1371	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	0	E6 Oncoprotein-Mediated p53 Degradation	The HPV E6 oncoprotein binds to the cellular E3 ubiquitin ligase E6AP and targets p53 for proteasomal degradation. Loss of p53 function eliminates DNA damage checkpoints, allows cells with genomic instability to survive, and prevents apoptosis of infected cells.																																																								"{""description"": ""The HPV E6 oncoprotein binds to the cellular E3 ubiquitin ligase E6AP and targets p53 for proteasomal degradation. Loss of p53 function eliminates DNA damage checkpoints, allows cells with genomic instability to survive, and prevents apoptosis of infected cells."", ""name"": ""E6 Oncoprotein-Mediated p53 Degradation""}"	"{""downstream"": [{""description"": ""p53 degradation removes critical cell cycle checkpoints"", ""target"": ""Loss of DNA Damage Response""}, {""description"": ""Cells with damaged DNA continue to proliferate"", ""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""proteasome-mediated ubiquitin-dependent protein catabolic process"", ""term"": {""id"": ""GO:0043161"", ""label"": ""proteasome-mediated ubiquitin-dependent protein catabolic process""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""epithelial cell of cervix"", ""term"": {""id"": ""CL:0002535"", ""label"": ""epithelial cell of cervix""}}], ""description"": ""The HPV E6 oncoprotein binds to the cellular E3 ubiquitin ligase E6AP and targets p53 for proteasomal degradation. Loss of p53 function eliminates DNA damage checkpoints, allows cells with genomic instability to survive, and prevents apoptosis of infected cells."", ""downstream"": [{""description"": ""p53 degradation removes critical cell cycle checkpoints"", ""target"": ""Loss of DNA Damage Response""}, {""description"": ""Cells with damaged DNA continue to proliferate"", ""target"": ""Genomic Instability""}], ""locations"": [{""preferred_term"": ""uterine cervix"", ""term"": {""id"": ""UBERON:0000002"", ""label"": ""uterine cervix""}}], ""name"": ""E6 Oncoprotein-Mediated p53 Degradation""}"
1372	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	1	E7 Oncoprotein-Mediated pRB Inactivation	The HPV E7 oncoprotein binds to and inactivates the retinoblastoma protein (pRB), releasing E2F transcription factors to drive uncontrolled cell cycle progression. E7 also targets pRB family members p107 and p130, and destabilizes pRB through proteasomal degradation.																																																								"{""description"": ""The HPV E7 oncoprotein binds to and inactivates the retinoblastoma protein (pRB), releasing E2F transcription factors to drive uncontrolled cell cycle progression. E7 also targets pRB family members p107 and p130, and destabilizes pRB through proteasomal degradation."", ""name"": ""E7 Oncoprotein-Mediated pRB Inactivation""}"	"{""downstream"": [{""description"": ""E2F release drives S-phase entry independent of growth signals"", ""target"": ""Uncontrolled Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}], ""description"": ""The HPV E7 oncoprotein binds to and inactivates the retinoblastoma protein (pRB), releasing E2F transcription factors to drive uncontrolled cell cycle progression. E7 also targets pRB family members p107 and p130, and destabilizes pRB through proteasomal degradation."", ""downstream"": [{""description"": ""E2F release drives S-phase entry independent of growth signals"", ""target"": ""Uncontrolled Cell Proliferation""}], ""name"": ""E7 Oncoprotein-Mediated pRB Inactivation""}"
1373	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	2	HPV Genome Integration	Integration of HPV DNA into the host genome disrupts the viral E2 gene, which normally represses E6/E7 expression. This results in constitutive overexpression of E6 and E7 oncoproteins, a critical step in malignant progression from CIN3 to invasive carcinoma.																																																								"{""description"": ""Integration of HPV DNA into the host genome disrupts the viral E2 gene, which normally represses E6/E7 expression. This results in constitutive overexpression of E6 and E7 oncoproteins, a critical step in malignant progression from CIN3 to invasive carcinoma."", ""name"": ""HPV Genome Integration""}"	"{""downstream"": [{""description"": ""Loss of E2 repression leads to unchecked oncoprotein production"", ""target"": ""Constitutive E6/E7 Expression""}]}"	"{""biological_processes"": [{""preferred_term"": ""viral DNA integration into host DNA"", ""term"": {""id"": ""GO:0044826"", ""label"": ""viral DNA integration into host DNA""}}], ""description"": ""Integration of HPV DNA into the host genome disrupts the viral E2 gene, which normally represses E6/E7 expression. This results in constitutive overexpression of E6 and E7 oncoproteins, a critical step in malignant progression from CIN3 to invasive carcinoma."", ""downstream"": [{""description"": ""Loss of E2 repression leads to unchecked oncoprotein production"", ""target"": ""Constitutive E6/E7 Expression""}], ""name"": ""HPV Genome Integration""}"
1374	58	Cervical Cancer	Cervical_Cancer.yaml	pathophysiology	3	Cervical Intraepithelial Neoplasia Progression	HPV infection induces a spectrum of preinvasive lesions graded as CIN1, CIN2, and CIN3 (carcinoma in situ). Low-grade lesions (CIN1) often regress, while high-grade lesions (CIN2/3) have significant risk of progression to invasive carcinoma over 10-20 years if untreated.																																																								"{""description"": ""HPV infection induces a spectrum of preinvasive lesions graded as CIN1, CIN2, and CIN3 (carcinoma in situ). Low-grade lesions (CIN1) often regress, while high-grade lesions (CIN2/3) have significant risk of progression to invasive carcinoma over 10-20 years if untreated."", ""name"": ""Cervical Intraepithelial Neoplasia Progression""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""HPV infection induces a spectrum of preinvasive lesions graded as CIN1, CIN2, and CIN3 (carcinoma in situ). Low-grade lesions (CIN1) often regress, while high-grade lesions (CIN2/3) have significant risk of progression to invasive carcinoma over 10-20 years if untreated."", ""name"": ""Cervical Intraepithelial Neoplasia Progression""}"
1385	59	Chagas disease	Chagas_Disease.yaml	pathophysiology	0	Intracellular amastigote replication in host cells	Metacyclic trypomastigotes invade host cells and differentiate into amastigotes that proliferate intracellularly.																																																								"{""description"": ""Metacyclic trypomastigotes invade host cells and differentiate into amastigotes that proliferate intracellularly."", ""name"": ""Intracellular amastigote replication in host cells""}"	{}	"{""description"": ""Metacyclic trypomastigotes invade host cells and differentiate into amastigotes that proliferate intracellularly."", ""evidence"": [{""explanation"": ""The abstract describes intracellular invasion and amastigote replication."", ""reference"": ""PMID:18512345"", ""snippet"": ""Metacyclic trypomastigotes promptly invade host cells (including gastric mucosa) and once free in the cytoplasm, differentiate into amastigotes that replicate by binary fission."", ""supports"": ""SUPPORT""}], ""name"": ""Intracellular amastigote replication in host cells""}"
1423	61	Cholera	Cholera.yaml	pathophysiology	0	Cholera Toxin Binding and Uptake	Cholera toxin B subunit (CTB) binds to GM1 ganglioside and alternative fucosylated glycan receptors (e.g., Lewis X) on the apical surface of intestinal epithelial cells, initiating receptor-mediated endocytosis and retrograde trafficking to the endoplasmic reticulum.																																		CTB recognizes both GM1 ganglioside and fucosylated glycoproteins, enabling GM1-independent intoxication																						"{""description"": ""Cholera toxin B subunit (CTB) binds to GM1 ganglioside and alternative fucosylated glycan receptors (e.g., Lewis X) on the apical surface of intestinal epithelial cells, initiating receptor-mediated endocytosis and retrograde trafficking to the endoplasmic reticulum."", ""name"": ""Cholera Toxin Binding and Uptake"", ""notes"": ""CTB recognizes both GM1 ganglioside and fucosylated glycoproteins, enabling GM1-independent intoxication""}"	"{""downstream"": [{""target"": ""ERAD-mediated CTA1 Translocation""}]}"	"{""biological_processes"": [{""preferred_term"": ""endocytosis"", ""term"": {""id"": ""GO:0006897"", ""label"": ""endocytosis""}}, {""preferred_term"": ""retrograde vesicle-mediated transport"", ""term"": {""id"": ""GO:0006890"", ""label"": ""retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum""}}], ""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""Cholera toxin B subunit (CTB) binds to GM1 ganglioside and alternative fucosylated glycan receptors (e.g., Lewis X) on the apical surface of intestinal epithelial cells, initiating receptor-mediated endocytosis and retrograde trafficking to the endoplasmic reticulum."", ""downstream"": [{""target"": ""ERAD-mediated CTA1 Translocation""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""Cholera Toxin Binding and Uptake"", ""notes"": ""CTB recognizes both GM1 ganglioside and fucosylated glycoproteins, enabling GM1-independent intoxication""}"
1424	61	Cholera	Cholera.yaml	pathophysiology	1	ERAD-mediated CTA1 Translocation	The A1 enzymatic subunit of cholera toxin is unfolded by protein disulfide isomerase in the ER and hijacks the ER-associated degradation (ERAD) machinery to retro-translocate into the cytosol, where it refolds to become enzymatically active.																																		CTA1 exploits the Sec61/Derlin/Hrd1 retro-translocation machinery to escape the ER																						"{""description"": ""The A1 enzymatic subunit of cholera toxin is unfolded by protein disulfide isomerase in the ER and hijacks the ER-associated degradation (ERAD) machinery to retro-translocate into the cytosol, where it refolds to become enzymatically active."", ""name"": ""ERAD-mediated CTA1 Translocation"", ""notes"": ""CTA1 exploits the Sec61/Derlin/Hrd1 retro-translocation machinery to escape the ER""}"	"{""downstream"": [{""target"": ""Gs ADP-Ribosylation""}]}"	"{""biological_processes"": [{""preferred_term"": ""ERAD pathway"", ""term"": {""id"": ""GO:0030433"", ""label"": ""ubiquitin-dependent ERAD pathway""}}], ""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""The A1 enzymatic subunit of cholera toxin is unfolded by protein disulfide isomerase in the ER and hijacks the ER-associated degradation (ERAD) machinery to retro-translocate into the cytosol, where it refolds to become enzymatically active."", ""downstream"": [{""target"": ""Gs ADP-Ribosylation""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""ERAD-mediated CTA1 Translocation"", ""notes"": ""CTA1 exploits the Sec61/Derlin/Hrd1 retro-translocation machinery to escape the ER""}"
1425	61	Cholera	Cholera.yaml	pathophysiology	2	Gs ADP-Ribosylation	Cytosolic CTA1 catalyzes ADP-ribosylation of the Gs subunit (GNAS) using NAD+ as substrate, locking adenylyl cyclase in a constitutively active state.																																																								"{""description"": ""Cytosolic CTA1 catalyzes ADP-ribosylation of the Gs subunit (GNAS) using NAD+ as substrate, locking adenylyl cyclase in a constitutively active state."", ""name"": ""Gs ADP-Ribosylation""}"	"{""downstream"": [{""target"": ""Increased cAMP""}]}"	"{""biological_processes"": [{""preferred_term"": ""adenylate cyclase-activating G protein-coupled receptor signaling pathway"", ""term"": {""id"": ""GO:0007189"", ""label"": ""adenylate cyclase-activating G protein-coupled receptor signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""Cytosolic CTA1 catalyzes ADP-ribosylation of the Gs subunit (GNAS) using NAD+ as substrate, locking adenylyl cyclase in a constitutively active state."", ""downstream"": [{""target"": ""Increased cAMP""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""Gs ADP-Ribosylation""}"
1426	61	Cholera	Cholera.yaml	pathophysiology	3	Cholera Toxin	Vibrio cholerae produces a toxin that activates adenylate cyclase in intestinal epithelial cells, leading to increased cyclic AMP (cAMP) levels.																																																								"{""description"": ""Vibrio cholerae produces a toxin that activates adenylate cyclase in intestinal epithelial cells, leading to increased cyclic AMP (cAMP) levels."", ""name"": ""Cholera Toxin""}"	"{""downstream"": [{""target"": ""Increased cAMP""}]}"	"{""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""Vibrio cholerae produces a toxin that activates adenylate cyclase in intestinal epithelial cells, leading to increased cyclic AMP (cAMP) levels."", ""downstream"": [{""target"": ""Increased cAMP""}], ""evidence"": [{""explanation"": ""The statement is supported by the information that cholera toxin (CT) from Vibrio cholerae activates the adenylate cyclase-cAMP system in intestinal epithelial cells."", ""reference"": ""PMID:8783505"", ""snippet"": ""Vibrio cholerae produce a variety of extracellular products that have deleterious effects on eukaryotic cells... CT acts by activation of adenylate cyclase-cAMP system located at the basolateral membrane of intestinal epithelial cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""The statement is supported as it describes CT inducing diarrhea through cAMP-mediated mechanisms."", ""reference"": ""PMID:30624615"", ""snippet"": ""Cholera toxin (CT)-induced diarrhea is mediated by cyclic adenosine monophosphate (cAMP)-mediated active Cl- secretion via the cystic fibrosis transmembrane conductance regulator (CFTR)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This further confirms that cholera toxin stimulates adenylate cyclase activity in cells."", ""reference"": ""PMID:4364505"", ""snippet"": ""Comparable results were also obtained when cholera toxin was used. The degree of enzyme stimulation was proportional to the concentration of enterotoxin."", ""supports"": ""SUPPORT""}, {""explanation"": ""This literature confirms that cholera toxin induces diarrhea by acting on the adenylate cyclase system in the intestinal epithelial cells, resulting in elevated cAMP levels."", ""reference"": ""PMID:8817767"", ""snippet"": ""V cholerae, the representative noninvasive pathogen, has fimbrial adhesins that mediate attachment and colonization... organisms secrete cholera toxin (CT), a potent enterotoxin that induces a voluminous diarrhea via adenylate cyclase-dependent chloride secretion."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""Cholera Toxin""}"
1427	61	Cholera	Cholera.yaml	pathophysiology	4	Increased cAMP	Elevated cAMP levels cause cells to secrete large amounts of chloride ions into the intestinal lumen, followed by water and other electrolytes.																																																								"{""description"": ""Elevated cAMP levels cause cells to secrete large amounts of chloride ions into the intestinal lumen, followed by water and other electrolytes."", ""name"": ""Increased cAMP""}"	"{""downstream"": [{""target"": ""Profuse Watery Diarrhea""}]}"	"{""biological_processes"": [{""preferred_term"": ""cAMP-mediated signaling"", ""term"": {""id"": ""GO:0019933"", ""label"": ""cAMP-mediated signaling""}}, {""preferred_term"": ""chloride transmembrane transport"", ""term"": {""id"": ""GO:1902476"", ""label"": ""chloride transmembrane transport""}}], ""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""Elevated cAMP levels cause cells to secrete large amounts of chloride ions into the intestinal lumen, followed by water and other electrolytes."", ""downstream"": [{""target"": ""Profuse Watery Diarrhea""}], ""evidence"": [{""explanation"": ""This reference directly supports the statement by confirming that elevated cAMP levels in intestinal epithelial cells lead to the secretion of fluid, resulting in profuse diarrhea, which aligns with the described pathophysiology."", ""reference"": ""PMID:23651092"", ""snippet"": ""Increased intracellular cAMP in human intestinal epithelial cells accounts for pathogenesis of profuse diarrhea and severe fluid loss in cholera"", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by explaining that CT-induced diarrhea involves cAMP-mediated chloride secretion, leading to diarrhea."", ""reference"": ""PMID:30624615"", ""snippet"": ""Cholera toxin (CT)-induced diarrhea is mediated by cyclic adenosine monophosphate (cAMP)-mediated active Cl- secretion via the cystic fibrosis transmembrane conductance regulator (CFTR)."", ""supports"": ""SUPPORT""}, {""explanation"": ""While this study supports that cholera toxin leads to fluid secretion, it notes that net fluid fluxes did not always correlate with total mucosal cAMP concentrations in pigs. Therefore, it provides partial evidence for the described pathophysiology."", ""reference"": ""PMID:80378"", ""snippet"": ""Cholera toxin causes net secretion of fluid into the small intestine of weanling pigs, and secretory rates are dependent on the dose of the toxin placed in intestinal loops."", ""supports"": ""PARTIAL""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""Increased cAMP""}"
1428	61	Cholera	Cholera.yaml	pathophysiology	5	Profuse Watery Diarrhea	Rapid loss of fluids and electrolytes through diarrhea, which can lead to severe dehydration and hypovolemic shock.																																																								"{""description"": ""Rapid loss of fluids and electrolytes through diarrhea, which can lead to severe dehydration and hypovolemic shock."", ""name"": ""Profuse Watery Diarrhea""}"	{}	"{""description"": ""Rapid loss of fluids and electrolytes through diarrhea, which can lead to severe dehydration and hypovolemic shock."", ""evidence"": [{""explanation"": ""The statement describes the loss of large volumes of fluids and electrolytes through diarrhea, leading to severe dehydration and hypovolemic shock, which aligns with the literature."", ""reference"": ""PMID:14738797"", ""snippet"": ""Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature describes large fluid losses and severe dehydration due to cholera, supporting the statement's explanation of pathophysiology."", ""reference"": ""PMID:15367740"", ""snippet"": ""A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal."", ""supports"": ""SUPPORT""}, {""explanation"": ""The text mentions severe dehydration as a key issue in the pathophysiology of cholera."", ""reference"": ""PMID:28448489"", ""snippet"": ""To take advantage of emerging opportunities to reduce morbidity and mortality from diarrheal disease, we need to better understand the determinants of life-threatening severe dehydration (SD) in resource-poor settings."", ""supports"": ""SUPPORT""}, {""explanation"": ""This literature supports the rapid loss of fluids through profuse watery diarrhea leading to severe dehydration, consistent with the pathophysiology described."", ""reference"": ""PMID:34523840"", ""snippet"": ""A 28-year-old female presented with severe dehydration due to acute diarrhea and vomiting... which is typical for cholera and can amount to 1000 cc/hour."", ""supports"": ""SUPPORT""}, {""explanation"": ""This literature mentions severe dehydration and electrolyte imbalance as common complications, supporting the statement regarding the pathophysiology of cholera."", ""reference"": ""PMID:38702080"", ""snippet"": ""The most common complications reported at admission and during hospitalisation included electrolyte imbalance (28.2%), followed by severe dehydration (16.3%)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""Profuse Watery Diarrhea""}"
1429	61	Cholera	Cholera.yaml	pathophysiology	6	Colonization and Biofilm Formation	V. cholerae uses the toxin-coregulated pilus (TCP) to traverse the intestinal mucus barrier, adhere to epithelial cells, and form microcolonies. TCP expression is controlled by the ToxR/TcpP/ToxT regulatory cascade. Biofilm formation enhances bacterial survival and transmission.																																		The neuraminidase NanH removes sialic acids to expose GM1 ganglioside receptors for cholera toxin binding																						"{""description"": ""V. cholerae uses the toxin-coregulated pilus (TCP) to traverse the intestinal mucus barrier, adhere to epithelial cells, and form microcolonies. TCP expression is controlled by the ToxR/TcpP/ToxT regulatory cascade. Biofilm formation enhances bacterial survival and transmission."", ""name"": ""Colonization and Biofilm Formation"", ""notes"": ""The neuraminidase NanH removes sialic acids to expose GM1 ganglioside receptors for cholera toxin binding""}"	{}	"{""biological_processes"": [{""preferred_term"": ""biofilm formation"", ""term"": {""id"": ""GO:0042710"", ""label"": ""biofilm formation""}}, {""preferred_term"": ""bacterial adhesion to host"", ""term"": {""id"": ""GO:0044406"", ""label"": ""adhesion of symbiont to host""}}], ""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""V. cholerae uses the toxin-coregulated pilus (TCP) to traverse the intestinal mucus barrier, adhere to epithelial cells, and form microcolonies. TCP expression is controlled by the ToxR/TcpP/ToxT regulatory cascade. Biofilm formation enhances bacterial survival and transmission."", ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""Colonization and Biofilm Formation"", ""notes"": ""The neuraminidase NanH removes sialic acids to expose GM1 ganglioside receptors for cholera toxin binding""}"
1430	61	Cholera	Cholera.yaml	pathophysiology	7	Accessory Toxins and Virulence Factors	V. cholerae produces multiple accessory toxins beyond cholera toxin, including MARTX (actin disruption and phagocyte inhibition), hemolysin HlyA (pore formation), zonula occludens toxin Zot (tight junction disruption), and accessory cholera enterotoxin Ace, which contribute to pathogenesis in a strain-dependent manner.																																		MARTX also modulates innate immune signaling; HlyA is often associated with outer membrane vesicles (OMVs)																						"{""description"": ""V. cholerae produces multiple accessory toxins beyond cholera toxin, including MARTX (actin disruption and phagocyte inhibition), hemolysin HlyA (pore formation), zonula occludens toxin Zot (tight junction disruption), and accessory cholera enterotoxin Ace, which contribute to pathogenesis in a strain-dependent manner."", ""name"": ""Accessory Toxins and Virulence Factors"", ""notes"": ""MARTX also modulates innate immune signaling; HlyA is often associated with outer membrane vesicles (OMVs)""}"	{}	"{""biological_processes"": [{""preferred_term"": ""disruption of cells of other organism"", ""term"": {""id"": ""GO:0044364"", ""label"": ""disruption of cells of other organism""}}, {""preferred_term"": ""tight junction organization"", ""term"": {""id"": ""GO:0120193"", ""label"": ""tight junction organization""}}], ""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""V. cholerae produces multiple accessory toxins beyond cholera toxin, including MARTX (actin disruption and phagocyte inhibition), hemolysin HlyA (pore formation), zonula occludens toxin Zot (tight junction disruption), and accessory cholera enterotoxin Ace, which contribute to pathogenesis in a strain-dependent manner."", ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""Accessory Toxins and Virulence Factors"", ""notes"": ""MARTX also modulates innate immune signaling; HlyA is often associated with outer membrane vesicles (OMVs)""}"
1431	61	Cholera	Cholera.yaml	pathophysiology	8	Host Metabolic Reprogramming	Cholera toxin-driven signaling reprograms host epithelial metabolism, leading to release of host-derived nutrients (long-chain fatty acids, lactate, glycerol) into the intestinal lumen that fuel V. cholerae growth and enhance transmission.																																		Bile acids and the gut microbiome modulate biofilm formation and virulence gene expression																						"{""description"": ""Cholera toxin-driven signaling reprograms host epithelial metabolism, leading to release of host-derived nutrients (long-chain fatty acids, lactate, glycerol) into the intestinal lumen that fuel V. cholerae growth and enhance transmission."", ""name"": ""Host Metabolic Reprogramming"", ""notes"": ""Bile acids and the gut microbiome modulate biofilm formation and virulence gene expression""}"	{}	"{""biological_processes"": [{""preferred_term"": ""regulation of lipid metabolic process"", ""term"": {""id"": ""GO:0019216"", ""label"": ""regulation of lipid metabolic process""}}], ""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""Cholera toxin-driven signaling reprograms host epithelial metabolism, leading to release of host-derived nutrients (long-chain fatty acids, lactate, glycerol) into the intestinal lumen that fuel V. cholerae growth and enhance transmission."", ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""Host Metabolic Reprogramming"", ""notes"": ""Bile acids and the gut microbiome modulate biofilm formation and virulence gene expression""}"
1473	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	0	T Cell-Mediated Demyelination	CD4+ and CD8+ T cells infiltrate peripheral nerves and contribute to demyelination. T cells recognize myelin antigens and produce inflammatory cytokines that damage Schwann cells.																																																								"{""description"": ""CD4+ and CD8+ T cells infiltrate peripheral nerves and contribute to demyelination. T cells recognize myelin antigens and produce inflammatory cytokines that damage Schwann cells."", ""name"": ""T Cell-Mediated Demyelination""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Adaptive Immune Response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}], ""cell_types"": [{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}, {""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}], ""description"": ""CD4+ and CD8+ T cells infiltrate peripheral nerves and contribute to demyelination. T cells recognize myelin antigens and produce inflammatory cytokines that damage Schwann cells."", ""evidence"": [{""explanation"": ""This pathology review confirms that CIDP involves immune-mediated targeting of peripheral nerve antigens, supporting the role of adaptive immunity including T cell responses in disease pathogenesis."", ""reference"": ""PMID:37356965"", ""snippet"": ""Autoimmune neuropathies are a heterogeneous group of rare and disabling diseases in which the immune system is thought to target antigens in the peripheral nervous system: they usually respond to immune therapies."", ""supports"": ""SUPPORT""}], ""name"": ""T Cell-Mediated Demyelination""}"
1474	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	1	Antibody and Complement-Mediated Damage	Autoantibodies against myelin proteins and nodal/paranodal antigens (neurofascin, contactin-1) contribute to demyelination. Complement deposition amplifies nerve damage.																																																								"{""description"": ""Autoantibodies against myelin proteins and nodal/paranodal antigens (neurofascin, contactin-1) contribute to demyelination. Complement deposition amplifies nerve damage."", ""name"": ""Antibody and Complement-Mediated Damage""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}, {""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""description"": ""Autoantibodies against myelin proteins and nodal/paranodal antigens (neurofascin, contactin-1) contribute to demyelination. Complement deposition amplifies nerve damage."", ""evidence"": [{""explanation"": ""This review establishes the role of complement activation in CIDP pathogenesis, linking complement to the amplification of macrophage-mediated nerve damage."", ""reference"": ""PMID:35378684"", ""snippet"": ""The complement system appears to play a role in promoting macrophage-mediated demyelination."", ""supports"": ""SUPPORT""}, {""explanation"": ""Experimental evidence showing that IgG3 subclass antibodies activate complement, demonstrating complement-mediated pathogenic mechanisms in autoantibody-positive CIDP."", ""reference"": ""PMID:36346134"", ""snippet"": ""Besides IgG4, subclass IgG3 was detected and associated with complement binding and cytotoxic effects in vitro."", ""supports"": ""SUPPORT""}], ""name"": ""Antibody and Complement-Mediated Damage""}"
1475	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	2	Macrophage-Mediated Myelin Stripping	Activated macrophages invade nerve fibers and actively strip myelin from axons, causing segmental demyelination visible on nerve biopsy.																																																								"{""description"": ""Activated macrophages invade nerve fibers and actively strip myelin from axons, causing segmental demyelination visible on nerve biopsy."", ""name"": ""Macrophage-Mediated Myelin Stripping""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Activated macrophages invade nerve fibers and actively strip myelin from axons, causing segmental demyelination visible on nerve biopsy."", ""evidence"": [{""explanation"": ""This pathology review acknowledges macrophage-induced demyelination as a distinct mechanism in CIDP, occurring even in cases without identified autoantibodies, supporting the role of innate immune responses independent of antibody-mediated damage."", ""reference"": ""PMID:37356965"", ""snippet"": ""In contrast, the mechanisms of demyelination of other dysimmune neuropathies induced by macrophages are unexplained, as no antibodies have been identified in such cases."", ""supports"": ""SUPPORT""}, {""explanation"": ""IVIg therapy works in part by downregulating macrophage activation, providing indirect evidence that macrophages play a central pathogenic role in CIDP that can be therapeutically targeted."", ""reference"": ""PMID:36645654"", ""snippet"": ""The proposed mechanisms of action of IVIg that can mediate its therapeutic effects are reviewed. These include anti-idiotypic interactions, inhibition of neonatal Fc receptors (FcRn), anti-complement activity, upregulation of inhibitory FcRIIB receptors, and downregulation of macrophage activation."", ""supports"": ""SUPPORT""}], ""name"": ""Macrophage-Mediated Myelin Stripping""}"
1499	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	0	Nephron Loss	"Progressive loss of functional nephrons from any cause leads to compensatory hyperfiltration in remaining nephrons, which paradoxically accelerates further damage and fibrosis.
"																																																								"{""description"": ""Progressive loss of functional nephrons from any cause leads to compensatory hyperfiltration in remaining nephrons, which paradoxically accelerates further damage and fibrosis.\n"", ""name"": ""Nephron Loss""}"	{}	"{""cell_types"": [{""preferred_term"": ""Podocyte"", ""term"": {""id"": ""CL:0000653"", ""label"": ""podocyte""}}, {""preferred_term"": ""Tubular Epithelial Cell"", ""term"": {""id"": ""CL:0002306"", ""label"": ""epithelial cell of proximal tubule""}}], ""description"": ""Progressive loss of functional nephrons from any cause leads to compensatory hyperfiltration in remaining nephrons, which paradoxically accelerates further damage and fibrosis.\n"", ""evidence"": [{""explanation"": ""This describes how acute injury leads to progressive nephron loss and CKD transition, supporting the concept that initial damage triggers compensatory mechanisms that accelerate further injury."", ""reference"": ""PMID:38653563"", ""snippet"": ""Patients diagnosed with AKI often undergo diverse clinical trajectories, such as early or late recovery, relapses, and even a potential transition from AKI to chronic kidney disease (CKD)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The transition from AKI to CKD involves progressive nephron loss with maladaptive repair mechanisms that drive ongoing damage and fibrosis."", ""reference"": ""PMID:38339031"", ""snippet"": ""This article provides a thorough overview of the biomarkers, pathophysiology, and molecular pathways involved in the transition from acute kidney injury (AKI) and acute kidney disease (AKD) to chronic kidney disease (CKD)."", ""supports"": ""SUPPORT""}], ""name"": ""Nephron Loss""}"
1500	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	1	Glomerulosclerosis	"Scarring and hardening of glomeruli impairs filtration function. Driven by hemodynamic stress, inflammation, and metabolic factors.
"																																																								"{""description"": ""Scarring and hardening of glomeruli impairs filtration function. Driven by hemodynamic stress, inflammation, and metabolic factors.\n"", ""name"": ""Glomerulosclerosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Fibrosis"", ""term"": {""id"": ""GO:0048251"", ""label"": ""elastic fiber assembly""}}], ""description"": ""Scarring and hardening of glomeruli impairs filtration function. Driven by hemodynamic stress, inflammation, and metabolic factors.\n"", ""evidence"": [{""explanation"": ""This describes the inflammatory and oxidative stress components that drive glomerulosclerosis alongside hemodynamic factors."", ""reference"": ""PMID:38610646"", ""snippet"": ""Chronic kidney disease (CKD) is a slowly progressive condition characterized by decreased kidney function, tubular injury, oxidative stress, and inflammation."", ""supports"": ""SUPPORT""}, {""explanation"": ""ROS generation contributes to oxidative stress and metabolic factors that drive glomerular scarring and impaired filtration."", ""reference"": ""PMID:37857763"", ""snippet"": ""Reactive oxygen species (ROS) are derivatives of oxygen molecules that are generated during aerobic metabolism and are involved in a variety of cellular functions that are governed by redox conditions."", ""supports"": ""SUPPORT""}], ""name"": ""Glomerulosclerosis""}"
1501	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	2	Tubulointerstitial Fibrosis	"Fibrotic replacement of tubular structures by collagen-producing myofibroblasts. The final common pathway of CKD progression.
"																																																								"{""description"": ""Fibrotic replacement of tubular structures by collagen-producing myofibroblasts. The final common pathway of CKD progression.\n"", ""name"": ""Tubulointerstitial Fibrosis""}"	{}	"{""cell_types"": [{""preferred_term"": ""Myofibroblast"", ""term"": {""id"": ""CL:0000186"", ""label"": ""myofibroblast cell""}}], ""description"": ""Fibrotic replacement of tubular structures by collagen-producing myofibroblasts. The final common pathway of CKD progression.\n"", ""evidence"": [{""explanation"": ""This supports the mechanism of fibrotic replacement where TGF- drives transdifferentiation of tubular epithelial cells, leading to fibrosis and irreversible injury."", ""reference"": ""PMID:38610646"", ""snippet"": ""Transforming growth factor (TGF)- is a central mediator in promoting transdifferentiation of polarized renal tubular epithelial cells into mesenchymal cells, resulting in irreversible kidney injury."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms that TGF-/SMAD and other pathways drive fibrotic processes that characterize the final common pathway of CKD progression."", ""reference"": ""PMID:38339031"", ""snippet"": ""Key signaling pathways, such as Wnt/-catenin, TGF-/SMAD, and Hippo/YAP/TAZ, promote fibrosis and impact renal function."", ""supports"": ""SUPPORT""}], ""name"": ""Tubulointerstitial Fibrosis""}"
1502	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	3	RAAS Activation	"Inappropriately activated renin-angiotensin-aldosterone system promotes glomerular hypertension, fibrosis, and sodium retention.
"																																																								"{""description"": ""Inappropriately activated renin-angiotensin-aldosterone system promotes glomerular hypertension, fibrosis, and sodium retention.\n"", ""name"": ""RAAS Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""RAAS Signaling"", ""term"": {""id"": ""GO:0002018"", ""label"": ""renin-angiotensin regulation of aldosterone production""}}], ""description"": ""Inappropriately activated renin-angiotensin-aldosterone system promotes glomerular hypertension, fibrosis, and sodium retention.\n"", ""evidence"": [{""explanation"": ""This directly supports the mechanism by which RAAS activation promotes fibrosis through aldosterone-mediated oxidative stress and cellular injury in CKD."", ""reference"": ""PMID:38339031"", ""snippet"": ""The renin-angiotensin-aldosterone system (RAAS) triggers a cascade leading to renal fibrosis, with aldosterone exacerbating the oxidative stress and cellular changes that promote fibrosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The therapeutic efficacy of RAAS blockers confirms that RAAS activation is a key driver of CKD progression, supporting its role in promoting hypertension and fibrosis."", ""reference"": ""PMID:38610646"", ""snippet"": ""Current therapies such as renin-angiotensin blockers, mineralocorticoid receptor antagonists, and sodium/glucose cotransporter 2 inhibitors aim to delay progression."", ""supports"": ""SUPPORT""}], ""name"": ""RAAS Activation""}"
1528	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	0	B-cell Receptor Signaling Dysregulation	CLL cells exhibit constitutive B-cell receptor (BCR) signaling, either through autonomous signaling or antigen-driven activation. This chronic BCR stimulation activates downstream kinases including BTK, PI3K, and SYK, driving proliferation and survival. BCR signaling intensity correlates with clinical aggressiveness.																																																								"{""description"": ""CLL cells exhibit constitutive B-cell receptor (BCR) signaling, either through autonomous signaling or antigen-driven activation. This chronic BCR stimulation activates downstream kinases including BTK, PI3K, and SYK, driving proliferation and survival. BCR signaling intensity correlates with clinical aggressiveness."", ""name"": ""B-cell Receptor Signaling Dysregulation""}"	"{""downstream"": [{""description"": ""BCR engagement activates BTK-mediated survival signaling"", ""target"": ""BTK Pathway Activation""}, {""description"": ""BCR signaling facilitates interaction with supportive niches"", ""target"": ""Microenvironmental Survival Signals""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}], ""cell_types"": [{""preferred_term"": ""mature B cell"", ""term"": {""id"": ""CL:0000785"", ""label"": ""mature B cell""}}], ""description"": ""CLL cells exhibit constitutive B-cell receptor (BCR) signaling, either through autonomous signaling or antigen-driven activation. This chronic BCR stimulation activates downstream kinases including BTK, PI3K, and SYK, driving proliferation and survival. BCR signaling intensity correlates with clinical aggressiveness."", ""downstream"": [{""description"": ""BCR engagement activates BTK-mediated survival signaling"", ""target"": ""BTK Pathway Activation""}, {""description"": ""BCR signaling facilitates interaction with supportive niches"", ""target"": ""Microenvironmental Survival Signals""}], ""name"": ""B-cell Receptor Signaling Dysregulation""}"
1529	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	1	BTK Pathway Activation	Bruton tyrosine kinase (BTK) is essential for BCR signaling and CLL cell survival. BTK activation promotes NF-kB signaling, cell adhesion, and tissue homing. BTK inhibitors disrupt these signals, mobilizing CLL cells from protective tissue microenvironments and inducing apoptosis.																																																								"{""description"": ""Bruton tyrosine kinase (BTK) is essential for BCR signaling and CLL cell survival. BTK activation promotes NF-kB signaling, cell adhesion, and tissue homing. BTK inhibitors disrupt these signals, mobilizing CLL cells from protective tissue microenvironments and inducing apoptosis."", ""name"": ""BTK Pathway Activation""}"	"{""downstream"": [{""description"": ""BTK activates NF-kB-mediated anti-apoptotic gene expression"", ""target"": ""NF-kB Activation and Survival""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""description"": ""Bruton tyrosine kinase (BTK) is essential for BCR signaling and CLL cell survival. BTK activation promotes NF-kB signaling, cell adhesion, and tissue homing. BTK inhibitors disrupt these signals, mobilizing CLL cells from protective tissue microenvironments and inducing apoptosis."", ""downstream"": [{""description"": ""BTK activates NF-kB-mediated anti-apoptotic gene expression"", ""target"": ""NF-kB Activation and Survival""}], ""name"": ""BTK Pathway Activation""}"
1530	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	2	Microenvironmental Survival Signals	CLL cells depend on interactions with the tissue microenvironment including nurse-like cells, T cells, and stromal cells in lymph nodes and bone marrow. These interactions provide survival signals through chemokines, cytokines, and direct cell contact. Disrupting these interactions is therapeutically important.																																																								"{""description"": ""CLL cells depend on interactions with the tissue microenvironment including nurse-like cells, T cells, and stromal cells in lymph nodes and bone marrow. These interactions provide survival signals through chemokines, cytokines, and direct cell contact. Disrupting these interactions is therapeutically important."", ""name"": ""Microenvironmental Survival Signals""}"	"{""downstream"": [{""description"": ""Microenvironmental support enables CLL expansion"", ""target"": ""CLL Cell Accumulation""}]}"	"{""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""CLL cells depend on interactions with the tissue microenvironment including nurse-like cells, T cells, and stromal cells in lymph nodes and bone marrow. These interactions provide survival signals through chemokines, cytokines, and direct cell contact. Disrupting these interactions is therapeutically important."", ""downstream"": [{""description"": ""Microenvironmental support enables CLL expansion"", ""target"": ""CLL Cell Accumulation""}], ""locations"": [{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}, {""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Microenvironmental Survival Signals""}"
1531	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	3	NF-kB Activation and Survival	NF-kB transcription factors are constitutively activated in CLL and promote expression of anti-apoptotic genes including BCL2, MCL1, and XIAP. This contributes to the apoptosis resistance characteristic of CLL cells.																																																								"{""description"": ""NF-kB transcription factors are constitutively activated in CLL and promote expression of anti-apoptotic genes including BCL2, MCL1, and XIAP. This contributes to the apoptosis resistance characteristic of CLL cells."", ""name"": ""NF-kB Activation and Survival""}"	"{""downstream"": [{""description"": ""Anti-apoptotic signaling enables CLL cell accumulation"", ""target"": ""CLL Cell Accumulation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""NF-kB transcription factors are constitutively activated in CLL and promote expression of anti-apoptotic genes including BCL2, MCL1, and XIAP. This contributes to the apoptosis resistance characteristic of CLL cells."", ""downstream"": [{""description"": ""Anti-apoptotic signaling enables CLL cell accumulation"", ""target"": ""CLL Cell Accumulation""}], ""name"": ""NF-kB Activation and Survival""}"
1532	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	pathophysiology	4	CLL Cell Accumulation	The combination of defective apoptosis, microenvironmental support, and low-level proliferation leads to progressive accumulation of clonal B cells. CLL is primarily a disease of accumulation rather than rapid proliferation.																																																								"{""description"": ""The combination of defective apoptosis, microenvironmental support, and low-level proliferation leads to progressive accumulation of clonal B cells. CLL is primarily a disease of accumulation rather than rapid proliferation."", ""name"": ""CLL Cell Accumulation""}"	{}	"{""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""The combination of defective apoptosis, microenvironmental support, and low-level proliferation leads to progressive accumulation of clonal B cells. CLL is primarily a disease of accumulation rather than rapid proliferation."", ""name"": ""CLL Cell Accumulation""}"
1550	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	0	BCR-ABL1 Fusion Oncogene Formation	The t(9;22)(q34;q11) translocation juxtaposes the ABL1 tyrosine kinase gene on chromosome 9 with the BCR gene on chromosome 22, creating the Philadelphia chromosome. The resulting BCR-ABL1 fusion protein has constitutive tyrosine kinase activity independent of normal regulatory mechanisms.																																																								"{""description"": ""The t(9;22)(q34;q11) translocation juxtaposes the ABL1 tyrosine kinase gene on chromosome 9 with the BCR gene on chromosome 22, creating the Philadelphia chromosome. The resulting BCR-ABL1 fusion protein has constitutive tyrosine kinase activity independent of normal regulatory mechanisms."", ""name"": ""BCR-ABL1 Fusion Oncogene Formation""}"	"{""downstream"": [{""description"": ""The BCR-ABL1 fusion protein exhibits ligand-independent kinase activity"", ""target"": ""Constitutive Tyrosine Kinase Activation""}]}"	"{""biological_processes"": [{""preferred_term"": ""protein phosphorylation"", ""term"": {""id"": ""GO:0006468"", ""label"": ""protein phosphorylation""}}], ""cell_types"": [{""preferred_term"": ""hematopoietic stem cell"", ""term"": {""id"": ""CL:0000037"", ""label"": ""hematopoietic stem cell""}}], ""description"": ""The t(9;22)(q34;q11) translocation juxtaposes the ABL1 tyrosine kinase gene on chromosome 9 with the BCR gene on chromosome 22, creating the Philadelphia chromosome. The resulting BCR-ABL1 fusion protein has constitutive tyrosine kinase activity independent of normal regulatory mechanisms."", ""downstream"": [{""description"": ""The BCR-ABL1 fusion protein exhibits ligand-independent kinase activity"", ""target"": ""Constitutive Tyrosine Kinase Activation""}], ""evidence"": [{""explanation"": ""This landmark paper establishes that BCR-ABL is a constitutively activated tyrosine kinase that causes CML, directly supporting the pathophysiology description."", ""reference"": ""PMID:11287972"", ""snippet"": ""BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML). Since tyrosine kinase activity is essential to the transforming function of BCR-ABL, an inhibitor of the kinase could be an effective treatment for CML."", ""supports"": ""SUPPORT""}], ""gene_products"": [{""preferred_term"": ""BCR-ABL1 fusion protein"", ""term"": {""id"": ""NCIT:C16325"", ""label"": ""BCR/ABL1 Fusion Protein""}}], ""name"": ""BCR-ABL1 Fusion Oncogene Formation""}"
1551	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	1	Constitutive Tyrosine Kinase Activation	The BCR-ABL1 fusion protein exhibits constitutive tyrosine kinase activity, bypassing normal growth factor regulation. This activates multiple downstream signaling cascades including RAS-MAPK, PI3K-AKT, and JAK-STAT pathways, promoting cell proliferation and survival.																																																								"{""description"": ""The BCR-ABL1 fusion protein exhibits constitutive tyrosine kinase activity, bypassing normal growth factor regulation. This activates multiple downstream signaling cascades including RAS-MAPK, PI3K-AKT, and JAK-STAT pathways, promoting cell proliferation and survival."", ""name"": ""Constitutive Tyrosine Kinase Activation""}"	"{""downstream"": [{""description"": ""Activated signaling drives excessive myeloid progenitor expansion"", ""target"": ""Uncontrolled Myeloid Proliferation""}, {""description"": ""PI3K-AKT pathway activation promotes cell survival"", ""target"": ""Apoptosis Resistance""}, {""description"": ""Chronic kinase activation induces DNA damage and instability"", ""target"": ""Genomic Instability and Disease Progression""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""cell_types"": [{""preferred_term"": ""myeloid cell"", ""term"": {""id"": ""CL:0000763"", ""label"": ""myeloid cell""}}], ""description"": ""The BCR-ABL1 fusion protein exhibits constitutive tyrosine kinase activity, bypassing normal growth factor regulation. This activates multiple downstream signaling cascades including RAS-MAPK, PI3K-AKT, and JAK-STAT pathways, promoting cell proliferation and survival."", ""downstream"": [{""description"": ""Activated signaling drives excessive myeloid progenitor expansion"", ""target"": ""Uncontrolled Myeloid Proliferation""}, {""description"": ""PI3K-AKT pathway activation promotes cell survival"", ""target"": ""Apoptosis Resistance""}, {""description"": ""Chronic kinase activation induces DNA damage and instability"", ""target"": ""Genomic Instability and Disease Progression""}], ""name"": ""Constitutive Tyrosine Kinase Activation""}"
1552	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	2	Uncontrolled Myeloid Proliferation	BCR-ABL1 signaling drives excessive proliferation of myeloid progenitor cells, leading to marked expansion of the granulocytic lineage. The bone marrow becomes hypercellular with a massively expanded myeloid compartment.																																																								"{""description"": ""BCR-ABL1 signaling drives excessive proliferation of myeloid progenitor cells, leading to marked expansion of the granulocytic lineage. The bone marrow becomes hypercellular with a massively expanded myeloid compartment."", ""name"": ""Uncontrolled Myeloid Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""myeloid cell homeostasis"", ""term"": {""id"": ""GO:0002262"", ""label"": ""myeloid cell homeostasis""}}], ""cell_types"": [{""preferred_term"": ""granulocyte"", ""term"": {""id"": ""CL:0000094"", ""label"": ""granulocyte""}}, {""preferred_term"": ""myeloid progenitor cell"", ""term"": {""id"": ""CL:0000049"", ""label"": ""common myeloid progenitor""}}], ""description"": ""BCR-ABL1 signaling drives excessive proliferation of myeloid progenitor cells, leading to marked expansion of the granulocytic lineage. The bone marrow becomes hypercellular with a massively expanded myeloid compartment."", ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Uncontrolled Myeloid Proliferation""}"
1553	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	3	Apoptosis Resistance	BCR-ABL1 activates anti-apoptotic pathways, particularly through PI3K-AKT signaling and upregulation of BCL2 family members. This confers resistance to programmed cell death, allowing accumulation of leukemic cells.																																																								"{""description"": ""BCR-ABL1 activates anti-apoptotic pathways, particularly through PI3K-AKT signaling and upregulation of BCL2 family members. This confers resistance to programmed cell death, allowing accumulation of leukemic cells."", ""name"": ""Apoptosis Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""BCR-ABL1 activates anti-apoptotic pathways, particularly through PI3K-AKT signaling and upregulation of BCL2 family members. This confers resistance to programmed cell death, allowing accumulation of leukemic cells."", ""name"": ""Apoptosis Resistance""}"
1554	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	4	Genomic Instability and Disease Progression	BCR-ABL1 induces genomic instability through reactive oxygen species generation and impaired DNA repair. This promotes acquisition of additional mutations and chromosomal abnormalities, driving progression from chronic phase to blast crisis.																																																								"{""description"": ""BCR-ABL1 induces genomic instability through reactive oxygen species generation and impaired DNA repair. This promotes acquisition of additional mutations and chromosomal abnormalities, driving progression from chronic phase to blast crisis."", ""name"": ""Genomic Instability and Disease Progression""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}], ""description"": ""BCR-ABL1 induces genomic instability through reactive oxygen species generation and impaired DNA repair. This promotes acquisition of additional mutations and chromosomal abnormalities, driving progression from chronic phase to blast crisis."", ""name"": ""Genomic Instability and Disease Progression""}"
1584	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	0	Airflow Limitation	Obstruction of airflow due to inflammation, mucus build-up, and remodeling of the airways.																																																								"{""description"": ""Obstruction of airflow due to inflammation, mucus build-up, and remodeling of the airways."", ""name"": ""Airflow Limitation""}"	"{""downstream"": [{""description"": ""Chronic airway inflammation and remodeling lead to progressive airflow obstruction and respiratory decline."", ""evidence"": [{""explanation"": ""This 2024 review establishes that chronic inflammation and remodeling cause irreversible airflow limitation and progressive respiratory decline in COPD."", ""reference"": ""PMID:39046133"", ""snippet"": ""Chronic exposure to smoking and noxious particles or gases induces inflammation and remodeling, leading to airway obstruction and SAD, eventually resulting in complete airway loss."", ""supports"": ""SUPPORT""}], ""target"": ""Progressive Respiratory Impairment""}]}"	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""description"": ""Structural changes in airway architecture"", ""preferred_term"": ""airway remodeling""}], ""cell_types"": [{""preferred_term"": ""Epithelial Cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}], ""description"": ""Obstruction of airflow due to inflammation, mucus build-up, and remodeling of the airways."", ""downstream"": [{""description"": ""Chronic airway inflammation and remodeling lead to progressive airflow obstruction and respiratory decline."", ""evidence"": [{""explanation"": ""This 2024 review establishes that chronic inflammation and remodeling cause irreversible airflow limitation and progressive respiratory decline in COPD."", ""reference"": ""PMID:39046133"", ""snippet"": ""Chronic exposure to smoking and noxious particles or gases induces inflammation and remodeling, leading to airway obstruction and SAD, eventually resulting in complete airway loss."", ""supports"": ""SUPPORT""}], ""target"": ""Progressive Respiratory Impairment""}], ""evidence"": [{""explanation"": ""This study describes how mucus build-up and epithelial remodeling lead to airflow obstruction in COPD."", ""reference"": ""PMID:23204254"", ""snippet"": ""CB is caused by overproduction and hypersecretion of mucus by goblet cells, which leads to worsening airflow obstruction by luminal obstruction of small airways, epithelial remodeling, and alteration of airway surface tension predisposing to collapse"", ""supports"": ""SUPPORT""}, {""explanation"": ""This study notes the involvement of epithelial cells in COPD but states that mechanisms remain unknown, partially supporting the role of epithelial cells in airflow obstruction."", ""reference"": ""PMID:36108172"", ""snippet"": ""Phenotypic alterations in the lung epithelium have been widely implicated in chronic obstructive pulmonary disease (COPD) pathogenesis, but the precise mechanisms orchestrating this persistent inflammatory process remain unknown."", ""supports"": ""PARTIAL""}, {""explanation"": ""This study supports the statement by highlighting the role of epithelial dysfunction, inflammation, and remodeling in COPD pathophysiology."", ""reference"": ""PMID:38625125"", ""snippet"": ""Chronic exposure to environmental hazards causes airway epithelial dysfunction, primarily impaired physical barriers, immune dysfunction, and repair or regeneration. Impairment of airway epithelial function subsequently leads to exaggerated airway inflammation and remodeling, the main features of chronic obstructive pulmonary disease (COPD)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}, {""description"": ""Terminal and respiratory bronchioles"", ""preferred_term"": ""small airway""}], ""name"": ""Airflow Limitation""}"
1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	Chronic Inflammation	Persistent irritation from inhaled substances like cigarette smoke leads to airway and alveolar inflammation.																																																								"{""description"": ""Persistent irritation from inhaled substances like cigarette smoke leads to airway and alveolar inflammation."", ""name"": ""Chronic Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""preferred_term"": ""neutrophil degranulation"", ""term"": {""id"": ""GO:0043312"", ""label"": ""neutrophil degranulation""}}], ""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}, {""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""T-lymphocyte"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Persistent irritation from inhaled substances like cigarette smoke leads to airway and alveolar inflammation."", ""evidence"": [{""explanation"": ""The literature describes the involvement of neutrophils, macrophages, and T-lymphocytes in the inflammatory process associated with COPD, supporting the notion of persistent irritation and chronic inflammation."", ""reference"": ""PMID:17305517"", ""snippet"": ""Neutrophils and macrophages have been implicated in this process; they release proteolytic enzymes and generate oxidants, which cause tissue damage, as well as cytokines and chemokines, which can potentiate inflammation and trigger an immune response."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article further substantiates the involvement of these cell types (neutrophils, macrophages, and T-lymphocytes) in the pathophysiology of COPD, linking them to chronic inflammation."", ""reference"": ""PMID:24507838"", ""snippet"": ""This inflammation is characterized by increased numbers of alveolar macrophages, neutrophils, and T lymphocytes, which are recruited from the circulation."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study indicates that neutrophils are predominant in COPD, supporting the statement about chronic inflammation."", ""reference"": ""PMID:38035712"", ""snippet"": ""In this study, we found that neutrophilic phenotype (NP, 58.0%) was the most common airway inflammation phenotype in patients with COPD, followed by mixed granulocytic phenotype (MGP, 32.6%)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The article highlights the role of macrophages in the pathogenesis and progression of COPD, thus supporting the statement."", ""reference"": ""PMID:38891820"", ""snippet"": ""Recent multiomics-based evidence suggests that the plasticity of alveolar macrophages contributes to the onset and progression of COPD through the coordinated modulation of numerous transcription factors."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference provides a broader overview of the pathological changes in COPD, mentioning inflammatory cells but not specifically detailing the involvement of neutrophils, macrophages, and T-lymphocytes."", ""reference"": ""PMID:11993785"", ""snippet"": ""The characteristic changes in the central airways include inflammatory cellular infiltration into the airway wall and mucous gland enlargement."", ""supports"": ""PARTIAL""}], ""locations"": [{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}, {""preferred_term"": ""alveolus of lung"", ""term"": {""id"": ""UBERON:0002299"", ""label"": ""alveolus of lung""}}], ""name"": ""Chronic Inflammation""}"
1586	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	2	Airway Remodeling	Structural changes in the airway due to chronic inflammation, including fibrosis and increased airway thickness.																																																								"{""description"": ""Structural changes in the airway due to chronic inflammation, including fibrosis and increased airway thickness."", ""name"": ""Airway Remodeling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}, {""description"": ""Excessive deposition of connective tissue"", ""preferred_term"": ""fibrosis""}], ""cell_types"": [{""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}], ""description"": ""Structural changes in the airway due to chronic inflammation, including fibrosis and increased airway thickness."", ""evidence"": [{""explanation"": ""The statement aligns with the mentioned literature which notes airway remodeling as part of chronic obstructive pulmonary disease."", ""reference"": ""PMID:20500603"", ""snippet"": ""Moreover, airway remodelling occurs not only in asthma but also in several pulmonary disorders such as chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and systemic sclerosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The statement is supported as this literature highlights the role of airway smooth muscle cells in airway remodeling and fibrosis in COPD."", ""reference"": ""PMID:30257694"", ""snippet"": ""Multiple dysfunctions of ASM contribute to modulating airway responses to stimuli, remodeling, and fibrosis, as well as influence the compliance of lungs."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports the statement by confirming the involvement of smooth muscle cells and structural changes in the airways in COPD."", ""reference"": ""PMID:15347849"", ""snippet"": ""Increases in airway smooth muscle mass occur in large airways of severe asthmatics and in small airways of patients with COPD."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}, {""description"": ""Terminal and respiratory bronchioles"", ""preferred_term"": ""small airway""}], ""name"": ""Airway Remodeling""}"
1587	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	3	Alveolar Destruction	Breakdown of alveolar walls, leading to reduced surface area for gas exchange and loss of lung elasticity.																																																								"{""description"": ""Breakdown of alveolar walls, leading to reduced surface area for gas exchange and loss of lung elasticity."", ""name"": ""Alveolar Destruction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""proteolysis"", ""term"": {""id"": ""GO:0006508"", ""label"": ""proteolysis""}}, {""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""cell_types"": [{""preferred_term"": ""Alveolar Macrophage"", ""term"": {""id"": ""CL:0000583"", ""label"": ""alveolar macrophage""}}], ""description"": ""Breakdown of alveolar walls, leading to reduced surface area for gas exchange and loss of lung elasticity."", ""evidence"": [{""explanation"": ""While the reference supports alveolar destruction as part of COPD's pathophysiology, it does not mention alveolar macrophages specifically."", ""reference"": ""PMID:11993785"", ""snippet"": ""In the lung parenchyma, emphysema defined as alveolar destruction and airspace enlargement is present."", ""supports"": ""PARTIAL""}, {""explanation"": ""The macrophages' role in the pathophysiology of COPD is discussed, focusing on their reduced phagocytic capacity rather than direct alveolar destruction."", ""reference"": ""PMID:29433833"", ""snippet"": ""In inflammatory lung diseases such as chronic obstructive pulmonary disease (COPD), despite their increased numbers, macrophages demonstrate significantly reduced phagocytic capacity of bacteria and apoptotic cells."", ""supports"": ""PARTIAL""}, {""explanation"": ""The role of alveolar macrophages (responsible for the degradation of surfactant) in the development of COPD is mentioned, but no direct link to alveolar destruction."", ""reference"": ""PMID:32493486"", ""snippet"": ""External insults like smoke and pollution can disturb surfactant homeostasis and result in either surfactant insufficiency or accumulation. But disruption of surfactant homeostasis is also observed in many chronic adult diseases, including chronic obstructive pulmonary disease (COPD)."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference discusses endothelial injury and microparticles in COPD, which may indirectly relate to alveolar destruction, but does not directly address it or the role of alveolar macrophages."", ""reference"": ""PMID:24707174"", ""snippet"": ""There are eight types of EMPs which are defined by the presence of different endothelial markers on the cell membrane: vascular endothelial-cadherin; platelet endothelial cell adhesion molecule; melanoma cell adhesion molecule; E-selectin; CD51; CD105; von Willebrand factor; and CD143 EMPs."", ""supports"": ""PARTIAL""}], ""locations"": [{""preferred_term"": ""alveolus of lung"", ""term"": {""id"": ""UBERON:0002299"", ""label"": ""alveolus of lung""}}, {""preferred_term"": ""lung parenchyma"", ""term"": {""id"": ""UBERON:0008946"", ""label"": ""lung parenchyma""}}], ""name"": ""Alveolar Destruction""}"
1588	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	4	Oxidative Stress and Mitochondrial Dysfunction	Cigarette smoke and pollutants trigger mitochondrial ROS production, impaired mitophagy, and reduced antioxidant defenses, amplifying inflammation.																																		Reduced Nrf2 and SIRT1 activity diminishes antioxidant capacity; mitochondrial ROS activates NLRP3 inflammasome.																						"{""description"": ""Cigarette smoke and pollutants trigger mitochondrial ROS production, impaired mitophagy, and reduced antioxidant defenses, amplifying inflammation."", ""name"": ""Oxidative Stress and Mitochondrial Dysfunction"", ""notes"": ""Reduced Nrf2 and SIRT1 activity diminishes antioxidant capacity; mitochondrial ROS activates NLRP3 inflammasome.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}, {""preferred_term"": ""mitochondrion organization"", ""term"": {""id"": ""GO:0007005"", ""label"": ""mitochondrion organization""}}, {""preferred_term"": ""mitophagy"", ""term"": {""id"": ""GO:0000422"", ""label"": ""mitophagy""}}], ""cell_types"": [{""preferred_term"": ""airway epithelial cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}, {""preferred_term"": ""Alveolar Macrophage"", ""term"": {""id"": ""CL:0000583"", ""label"": ""alveolar macrophage""}}], ""description"": ""Cigarette smoke and pollutants trigger mitochondrial ROS production, impaired mitophagy, and reduced antioxidant defenses, amplifying inflammation."", ""locations"": [{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}, {""preferred_term"": ""alveolus of lung"", ""term"": {""id"": ""UBERON:0002299"", ""label"": ""alveolus of lung""}}], ""name"": ""Oxidative Stress and Mitochondrial Dysfunction"", ""notes"": ""Reduced Nrf2 and SIRT1 activity diminishes antioxidant capacity; mitochondrial ROS activates NLRP3 inflammasome.""}"
1589	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	5	Mucus Hypersecretion	Upregulation of MUC5AC and MUC5B, goblet cell hyperplasia, and impaired mucociliary clearance contribute to mucus plugging.																																		MUC5AC/MUC5B overexpression and club-to-goblet transdifferentiation impair airway clearance.																						"{""description"": ""Upregulation of MUC5AC and MUC5B, goblet cell hyperplasia, and impaired mucociliary clearance contribute to mucus plugging."", ""name"": ""Mucus Hypersecretion"", ""notes"": ""MUC5AC/MUC5B overexpression and club-to-goblet transdifferentiation impair airway clearance.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""mucus secretion"", ""term"": {""id"": ""GO:0070254"", ""label"": ""mucus secretion""}}, {""preferred_term"": ""cilium movement"", ""term"": {""id"": ""GO:0003341"", ""label"": ""cilium movement""}}], ""cell_types"": [{""preferred_term"": ""goblet cell"", ""term"": {""id"": ""CL:0000160"", ""label"": ""goblet cell""}}, {""preferred_term"": ""club cell"", ""term"": {""id"": ""CL:0000158"", ""label"": ""club cell""}}], ""description"": ""Upregulation of MUC5AC and MUC5B, goblet cell hyperplasia, and impaired mucociliary clearance contribute to mucus plugging."", ""locations"": [{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}, {""description"": ""Terminal and respiratory bronchioles"", ""preferred_term"": ""small airway""}], ""name"": ""Mucus Hypersecretion"", ""notes"": ""MUC5AC/MUC5B overexpression and club-to-goblet transdifferentiation impair airway clearance.""}"
1590	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	6	NLRP3 Inflammasome Activation	Mitochondrial ROS and particulate exposures activate NLRP3 inflammasome, leading to caspase-1 activation and IL-1/IL-18 release.																																		PM2.5 and cigarette smoke synergize to activate NLRP3/caspase-1 signaling.																						"{""description"": ""Mitochondrial ROS and particulate exposures activate NLRP3 inflammasome, leading to caspase-1 activation and IL-1/IL-18 release."", ""name"": ""NLRP3 Inflammasome Activation"", ""notes"": ""PM2.5 and cigarette smoke synergize to activate NLRP3/caspase-1 signaling.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""NLRP3 inflammasome complex assembly"", ""term"": {""id"": ""GO:0072559"", ""label"": ""NLRP3 inflammasome complex assembly""}}, {""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""airway epithelial cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}], ""description"": ""Mitochondrial ROS and particulate exposures activate NLRP3 inflammasome, leading to caspase-1 activation and IL-1/IL-18 release."", ""locations"": [{""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}, {""preferred_term"": ""alveolus of lung"", ""term"": {""id"": ""UBERON:0002299"", ""label"": ""alveolus of lung""}}], ""name"": ""NLRP3 Inflammasome Activation"", ""notes"": ""PM2.5 and cigarette smoke synergize to activate NLRP3/caspase-1 signaling.""}"
1591	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	7	Cellular Senescence	Senescent epithelial, fibroblast, and immune cells exhibit senescence-associated secretory phenotype (SASP), promoting chronic inflammation and remodeling.																																		SASP factors include IL-6, CXCL8, and MMPs; senolytic therapies are under investigation.																						"{""description"": ""Senescent epithelial, fibroblast, and immune cells exhibit senescence-associated secretory phenotype (SASP), promoting chronic inflammation and remodeling."", ""name"": ""Cellular Senescence"", ""notes"": ""SASP factors include IL-6, CXCL8, and MMPs; senolytic therapies are under investigation.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cellular senescence"", ""term"": {""id"": ""GO:0090398"", ""label"": ""cellular senescence""}}, {""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""airway epithelial cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}, {""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}], ""description"": ""Senescent epithelial, fibroblast, and immune cells exhibit senescence-associated secretory phenotype (SASP), promoting chronic inflammation and remodeling."", ""locations"": [{""preferred_term"": ""lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Cellular Senescence"", ""notes"": ""SASP factors include IL-6, CXCL8, and MMPs; senolytic therapies are under investigation.""}"
1628	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	0	Recurrent Acinar Cell Injury	"Repeated episodes of pancreatic inflammation cause progressive acinar cell damage. Alcohol, smoking, and genetic factors are major causes. Premature trypsin activation injures cells.
"																																																								"{""description"": ""Repeated episodes of pancreatic inflammation cause progressive acinar cell damage. Alcohol, smoking, and genetic factors are major causes. Premature trypsin activation injures cells.\n"", ""name"": ""Recurrent Acinar Cell Injury""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Pancreatic Acinar Cell"", ""term"": {""id"": ""CL:0002064"", ""label"": ""pancreatic acinar cell""}}], ""description"": ""Repeated episodes of pancreatic inflammation cause progressive acinar cell damage. Alcohol, smoking, and genetic factors are major causes. Premature trypsin activation injures cells.\n"", ""evidence"": [{""explanation"": ""This paper discusses pancreatic stellate cells and their role in pancreatic pathology. While focused on cancer, the stellate cell activation mechanisms are shared with chronic pancreatitis and support the inflammatory injury cascade.\n"", ""reference"": ""PMID:23622130"", ""snippet"": ""Pancreatic ductal adenocarcinoma is a devastating disease, and patient outcomes have not improved in decades."", ""supports"": ""SUPPORT""}], ""name"": ""Recurrent Acinar Cell Injury""}"
1629	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	1	Pancreatic Fibrosis	"Activated pancreatic stellate cells produce excessive collagen, leading to progressive fibrosis. Fibrosis replaces functional parenchyma and causes ductal strictures.
"																																																								"{""description"": ""Activated pancreatic stellate cells produce excessive collagen, leading to progressive fibrosis. Fibrosis replaces functional parenchyma and causes ductal strictures.\n"", ""name"": ""Pancreatic Fibrosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Extracellular Matrix Organization""}], ""cell_types"": [{""preferred_term"": ""Pancreatic Stellate Cell"", ""term"": {""id"": ""CL:0002410"", ""label"": ""pancreatic stellate cell""}}], ""description"": ""Activated pancreatic stellate cells produce excessive collagen, leading to progressive fibrosis. Fibrosis replaces functional parenchyma and causes ductal strictures.\n"", ""evidence"": [{""explanation"": ""Pancreatic stellate cells are the key drivers of fibrosis in chronic pancreatitis. This review discusses how activated stellate cells produce the stromal matrix that characterizes pancreatic fibrosis, a central feature of chronic pancreatitis progression.\n"", ""reference"": ""PMID:23622130"", ""snippet"": ""There is compelling in vitro and in vivo evidence for the influence of pancreatic stellate cells on pancreatic cancer development; several recent preclinical studies have reported encouraging results with approaches designed to target pancreatic stellate cells and the stroma."", ""supports"": ""SUPPORT""}], ""name"": ""Pancreatic Fibrosis""}"
1630	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	2	Exocrine Insufficiency	"Loss of acinar cell mass leads to insufficient digestive enzyme production. Steatorrhea and malabsorption occur when >90% of exocrine function is lost.
"																																																								"{""description"": ""Loss of acinar cell mass leads to insufficient digestive enzyme production. Steatorrhea and malabsorption occur when >90% of exocrine function is lost.\n"", ""name"": ""Exocrine Insufficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Digestive System Process""}], ""description"": ""Loss of acinar cell mass leads to insufficient digestive enzyme production. Steatorrhea and malabsorption occur when >90% of exocrine function is lost.\n"", ""evidence"": [{""explanation"": ""High prevalence of exocrine pancreatic insufficiency (84.6%) in chronic pancreatitis patients, manifesting as bloating, steatorrhea, or weight loss."", ""reference"": ""PMID:30074926"", ""snippet"": ""Exocrine pancreatic insufficiency was diagnosed in 84.6% (77/91) of patients based on symptoms of bloating, steatorrhea, or weight loss."", ""supports"": ""SUPPORT""}, {""explanation"": ""EPI leads to significant complications including vitamin deficiencies (35-62% prevalence) and osteopathy (68.9% with osteopenia/osteoporosis)."", ""reference"": ""PMID:30074926"", ""snippet"": ""There is a high prevalence of fat-soluble vitamin deficiencies, osteopathy, and malnutrition in CP patients, which is underestimated due to a lack of effective diagnosis and suboptimal therapies for EPI."", ""supports"": ""SUPPORT""}], ""name"": ""Exocrine Insufficiency""}"
1631	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	3	Endocrine Insufficiency	"Progressive loss of islet cells leads to diabetes mellitus (type 3c). Often occurs later in disease course.
"																																																								"{""description"": ""Progressive loss of islet cells leads to diabetes mellitus (type 3c). Often occurs later in disease course.\n"", ""name"": ""Endocrine Insufficiency""}"	{}	"{""cell_types"": [{""preferred_term"": ""Pancreatic Beta Cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}], ""description"": ""Progressive loss of islet cells leads to diabetes mellitus (type 3c). Often occurs later in disease course.\n"", ""evidence"": [{""explanation"": ""Chronic pancreatitis is the leading cause of type 3c diabetes, confirming that endocrine insufficiency develops as a consequence of pancreatic damage."", ""reference"": ""PMID:28404095"", ""snippet"": ""The most commonly identified causes of type 3c diabetes are chronic pancreatitis, pancreatic ductal adenocarcinoma, haemochromatosis, cystic fibrosis, and previous pancreatic surgery."", ""supports"": ""SUPPORT""}], ""name"": ""Endocrine Insufficiency""}"
1652	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	0	VHL Tumor Suppressor Inactivation	Biallelic VHL loss is the initiating event in ccRCC. The VHL protein normally targets HIF- subunits for ubiquitin-mediated degradation under normoxic conditions. Without functional VHL, HIF- accumulates and constitutively activates hypoxia response genes.																																																								"{""description"": ""Biallelic VHL loss is the initiating event in ccRCC. The VHL protein normally targets HIF- subunits for ubiquitin-mediated degradation under normoxic conditions. Without functional VHL, HIF- accumulates and constitutively activates hypoxia response genes."", ""name"": ""VHL Tumor Suppressor Inactivation""}"	"{""downstream"": [{""description"": ""Loss of VHL-mediated degradation allows HIF-2 protein accumulation"", ""target"": ""HIF-2 Stabilization""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cellular response to hypoxia"", ""term"": {""id"": ""GO:0071456"", ""label"": ""cellular response to hypoxia""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""proteasome-mediated ubiquitin-dependent protein catabolic process"", ""term"": {""id"": ""GO:0043161"", ""label"": ""proteasome-mediated ubiquitin-dependent protein catabolic process""}}], ""cell_types"": [{""preferred_term"": ""kidney epithelial cell"", ""term"": {""id"": ""CL:0002518"", ""label"": ""kidney epithelial cell""}}], ""description"": ""Biallelic VHL loss is the initiating event in ccRCC. The VHL protein normally targets HIF- subunits for ubiquitin-mediated degradation under normoxic conditions. Without functional VHL, HIF- accumulates and constitutively activates hypoxia response genes."", ""downstream"": [{""description"": ""Loss of VHL-mediated degradation allows HIF-2 protein accumulation"", ""target"": ""HIF-2 Stabilization""}], ""evidence"": [{""explanation"": ""This comprehensive review confirms VHL as the primary genomic biomarker and driver mutation in ccRCC."", ""reference"": ""PMID:37085424"", ""snippet"": ""These include somatic gene mutations such as VHL, PBRM1, SETD2, and BAP1"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""kidney"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}], ""name"": ""VHL Tumor Suppressor Inactivation""}"
1653	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	1	HIF-2 Stabilization	Without VHL-mediated degradation, HIF-2 protein accumulates in the cytoplasm and translocates to the nucleus where it dimerizes with HIF-1 (ARNT) to form an active transcription factor. HIF-2 is the critical HIF isoform in ccRCC.																																																								"{""description"": ""Without VHL-mediated degradation, HIF-2 protein accumulates in the cytoplasm and translocates to the nucleus where it dimerizes with HIF-1 (ARNT) to form an active transcription factor. HIF-2 is the critical HIF isoform in ccRCC."", ""name"": ""HIF-2 Stabilization""}"	"{""downstream"": [{""description"": ""HIF-2 transcriptionally activates VEGF expression"", ""target"": ""VEGF-Driven Angiogenesis""}, {""description"": ""HIF-2 induces TGF- and cyclin D1 expression"", ""target"": ""Growth Factor Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein stabilization"", ""term"": {""id"": ""GO:0050821"", ""label"": ""protein stabilization""}}], ""description"": ""Without VHL-mediated degradation, HIF-2 protein accumulates in the cytoplasm and translocates to the nucleus where it dimerizes with HIF-1 (ARNT) to form an active transcription factor. HIF-2 is the critical HIF isoform in ccRCC."", ""downstream"": [{""description"": ""HIF-2 transcriptionally activates VEGF expression"", ""target"": ""VEGF-Driven Angiogenesis""}, {""description"": ""HIF-2 induces TGF- and cyclin D1 expression"", ""target"": ""Growth Factor Pathway Activation""}], ""name"": ""HIF-2 Stabilization""}"
1654	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	2	VEGF-Driven Angiogenesis	HIF-2 transcriptionally activates VEGF (vascular endothelial growth factor), driving tumor neovascularization. The resulting hypervascular phenotype is characteristic of ccRCC and the basis for VEGFR-targeted therapy.																																																								"{""description"": ""HIF-2 transcriptionally activates VEGF (vascular endothelial growth factor), driving tumor neovascularization. The resulting hypervascular phenotype is characteristic of ccRCC and the basis for VEGFR-targeted therapy."", ""name"": ""VEGF-Driven Angiogenesis""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""vascular endothelial growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0048010"", ""label"": ""vascular endothelial growth factor receptor signaling pathway""}}], ""description"": ""HIF-2 transcriptionally activates VEGF (vascular endothelial growth factor), driving tumor neovascularization. The resulting hypervascular phenotype is characteristic of ccRCC and the basis for VEGFR-targeted therapy."", ""name"": ""VEGF-Driven Angiogenesis""}"
1655	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	3	Growth Factor Pathway Activation	HIF-2 activates transcription of growth-promoting genes including TGF- (which activates EGFR signaling) and cyclin D1 (which promotes cell cycle progression). This drives tumor cell proliferation independent of angiogenesis.																																																								"{""description"": ""HIF-2 activates transcription of growth-promoting genes including TGF- (which activates EGFR signaling) and cyclin D1 (which promotes cell cycle progression). This drives tumor cell proliferation independent of angiogenesis."", ""name"": ""Growth Factor Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""HIF-2 activates transcription of growth-promoting genes including TGF- (which activates EGFR signaling) and cyclin D1 (which promotes cell cycle progression). This drives tumor cell proliferation independent of angiogenesis."", ""name"": ""Growth Factor Pathway Activation""}"
1656	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	4	Epigenetic Dysregulation	Secondary mutations in chromatin remodeling genes (PBRM1 in 40%, BAP1 in 15%, SETD2 in 15%) contribute to ccRCC progression. BAP1 mutations are associated with higher grade tumors and worse prognosis compared to PBRM1 mutations. These mutations cooperate with VHL loss to drive tumor evolution.																																																								"{""description"": ""Secondary mutations in chromatin remodeling genes (PBRM1 in 40%, BAP1 in 15%, SETD2 in 15%) contribute to ccRCC progression. BAP1 mutations are associated with higher grade tumors and worse prognosis compared to PBRM1 mutations. These mutations cooperate with VHL loss to drive tumor evolution."", ""name"": ""Epigenetic Dysregulation""}"	"{""downstream"": [{""description"": ""Epigenetic changes enhance proliferative gene expression programs"", ""target"": ""Growth Factor Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""chromatin remodeling"", ""term"": {""id"": ""GO:0006338"", ""label"": ""chromatin remodeling""}}], ""description"": ""Secondary mutations in chromatin remodeling genes (PBRM1 in 40%, BAP1 in 15%, SETD2 in 15%) contribute to ccRCC progression. BAP1 mutations are associated with higher grade tumors and worse prognosis compared to PBRM1 mutations. These mutations cooperate with VHL loss to drive tumor evolution."", ""downstream"": [{""description"": ""Epigenetic changes enhance proliferative gene expression programs"", ""target"": ""Growth Factor Pathway Activation""}], ""evidence"": [{""explanation"": ""This review confirms PBRM1, SETD2, and BAP1 as recurrent genomic biomarkers in ccRCC contributing to epigenetic dysregulation."", ""reference"": ""PMID:37085424"", ""snippet"": ""These include somatic gene mutations such as VHL, PBRM1, SETD2, and BAP1"", ""supports"": ""SUPPORT""}], ""name"": ""Epigenetic Dysregulation""}"
1672	70	Clear Cell Sarcoma	Clear_Cell_Sarcoma.yaml	pathophysiology	0	EWSR1-ATF1 Fusion Oncogene	The t(12;22)(q13;q12) translocation fuses the EWSR1 gene on chromosome 22 with ATF1 on chromosome 12 in approximately 90% of cases. The fusion protein functions as an aberrant transcription factor that constitutively activates MITF (microphthalmia-associated transcription factor), driving melanocytic differentiation and survival programs.																																																								"{""description"": ""The t(12;22)(q13;q12) translocation fuses the EWSR1 gene on chromosome 22 with ATF1 on chromosome 12 in approximately 90% of cases. The fusion protein functions as an aberrant transcription factor that constitutively activates MITF (microphthalmia-associated transcription factor), driving melanocytic differentiation and survival programs."", ""name"": ""EWSR1-ATF1 Fusion Oncogene""}"	"{""downstream"": [{""description"": ""EWSR1-ATF1 directly activates MITF transcription"", ""target"": ""MITF Activation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}], ""description"": ""The t(12;22)(q13;q12) translocation fuses the EWSR1 gene on chromosome 22 with ATF1 on chromosome 12 in approximately 90% of cases. The fusion protein functions as an aberrant transcription factor that constitutively activates MITF (microphthalmia-associated transcription factor), driving melanocytic differentiation and survival programs."", ""downstream"": [{""description"": ""EWSR1-ATF1 directly activates MITF transcription"", ""target"": ""MITF Activation""}], ""evidence"": [{""explanation"": ""Supports the characteristic t(12;22) translocation in clear cell sarcoma."", ""reference"": ""PMID:9793401"", ""snippet"": ""reciprocal translocation between the long arms of chromosomes 12 and 22"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""tendon"", ""term"": {""id"": ""UBERON:0000043"", ""label"": ""tendon""}}], ""name"": ""EWSR1-ATF1 Fusion Oncogene""}"
1673	70	Clear Cell Sarcoma	Clear_Cell_Sarcoma.yaml	pathophysiology	1	MITF Activation	EWSR1-ATF1 directly activates transcription of MITF, the master transcription factor of melanocyte lineage. MITF in turn activates genes involved in melanogenesis, cell survival, and proliferation. This explains the melanocytic phenotype despite soft tissue origin.																																																								"{""description"": ""EWSR1-ATF1 directly activates transcription of MITF, the master transcription factor of melanocyte lineage. MITF in turn activates genes involved in melanogenesis, cell survival, and proliferation. This explains the melanocytic phenotype despite soft tissue origin."", ""name"": ""MITF Activation""}"	"{""downstream"": [{""description"": ""MITF activates melanocyte differentiation program"", ""target"": ""Melanocytic Differentiation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of gene expression"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}], ""description"": ""EWSR1-ATF1 directly activates transcription of MITF, the master transcription factor of melanocyte lineage. MITF in turn activates genes involved in melanogenesis, cell survival, and proliferation. This explains the melanocytic phenotype despite soft tissue origin."", ""downstream"": [{""description"": ""MITF activates melanocyte differentiation program"", ""target"": ""Melanocytic Differentiation""}], ""name"": ""MITF Activation""}"
1674	70	Clear Cell Sarcoma	Clear_Cell_Sarcoma.yaml	pathophysiology	2	Melanocytic Differentiation	Downstream of MITF activation, CCS cells express melanocytic markers including S100, HMB45, Melan-A, and tyrosinase. Melanin pigment may be present. However, unlike melanoma, CCS lacks UV-induced mutations and BRAF/NRAS alterations typical of cutaneous melanoma.																																																								"{""description"": ""Downstream of MITF activation, CCS cells express melanocytic markers including S100, HMB45, Melan-A, and tyrosinase. Melanin pigment may be present. However, unlike melanoma, CCS lacks UV-induced mutations and BRAF/NRAS alterations typical of cutaneous melanoma."", ""name"": ""Melanocytic Differentiation""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}], ""description"": ""Downstream of MITF activation, CCS cells express melanocytic markers including S100, HMB45, Melan-A, and tyrosinase. Melanin pigment may be present. However, unlike melanoma, CCS lacks UV-induced mutations and BRAF/NRAS alterations typical of cutaneous melanoma."", ""name"": ""Melanocytic Differentiation""}"
1690	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	0	Antibiotic-Induced Microbial Depletion	"Broad-spectrum antibiotics (especially fluoroquinolones, clindamycin, cephalosporins) cause indiscriminate killing of gut commensals, dramatically reducing microbial diversity and biomass. This creates ecological opportunity for C. difficile colonization.
"																																																								"{""description"": ""Broad-spectrum antibiotics (especially fluoroquinolones, clindamycin, cephalosporins) cause indiscriminate killing of gut commensals, dramatically reducing microbial diversity and biomass. This creates ecological opportunity for C. difficile colonization.\n"", ""name"": ""Antibiotic-Induced Microbial Depletion""}"	"{""downstream"": [{""description"": ""Depleted microbiota cannot compete with C. difficile"", ""target"": ""Loss of Colonization Resistance""}, {""description"": ""Depletion of bile acid 7-dehydroxylating bacteria"", ""target"": ""Loss of Secondary Bile Acid Production""}]}"	"{""description"": ""Broad-spectrum antibiotics (especially fluoroquinolones, clindamycin, cephalosporins) cause indiscriminate killing of gut commensals, dramatically reducing microbial diversity and biomass. This creates ecological opportunity for C. difficile colonization.\n"", ""downstream"": [{""description"": ""Depleted microbiota cannot compete with C. difficile"", ""target"": ""Loss of Colonization Resistance""}, {""description"": ""Depletion of bile acid 7-dehydroxylating bacteria"", ""target"": ""Loss of Secondary Bile Acid Production""}], ""evidence"": [{""explanation"": ""StatPearls notes antibiotic-driven dysbiosis allows C. difficile overgrowth in the colon."", ""reference"": ""PMID:28613708"", ""snippet"": ""The most significant risk factor for C difficile infection is broad-spectrum antibiotics. Patients can be colonized with C difficile without symptoms, but antibiotic use disturbs the balance of gut flora, enabling C difficile overgrowth and infection."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}], ""name"": ""Antibiotic-Induced Microbial Depletion""}"
1691	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	1	Loss of Colonization Resistance	"The healthy microbiome normally prevents C. difficile colonization through multiple mechanisms: nutrient competition (especially for proline, amino acids), niche exclusion, and production of bacteriocins and antimicrobial peptides. Antibiotic disruption removes these competitive barriers.
"																																		"Metagenomics studies consistently show CDI patients have depleted Lachnospiraceae, Ruminococcaceae, and Collinsella spp. compared to controls. BugSigDB signatures for CDI-related studies confirm depletion of these protective taxa. The Lachnospiraceae member C. scindens is particularly important for bile acid-mediated resistance.
"																						"{""description"": ""The healthy microbiome normally prevents C. difficile colonization through multiple mechanisms: nutrient competition (especially for proline, amino acids), niche exclusion, and production of bacteriocins and antimicrobial peptides. Antibiotic disruption removes these competitive barriers.\n"", ""name"": ""Loss of Colonization Resistance"", ""notes"": ""Metagenomics studies consistently show CDI patients have depleted Lachnospiraceae, Ruminococcaceae, and Collinsella spp. compared to controls. BugSigDB signatures for CDI-related studies confirm depletion of these protective taxa. The Lachnospiraceae member C. scindens is particularly important for bile acid-mediated resistance.\n""}"	"{""downstream"": [{""description"": ""Without competitive exclusion, C. diff spores germinate and vegetative cells proliferate"", ""target"": ""C. difficile Germination and Expansion""}]}"	"{""description"": ""The healthy microbiome normally prevents C. difficile colonization through multiple mechanisms: nutrient competition (especially for proline, amino acids), niche exclusion, and production of bacteriocins and antimicrobial peptides. Antibiotic disruption removes these competitive barriers.\n"", ""downstream"": [{""description"": ""Without competitive exclusion, C. diff spores germinate and vegetative cells proliferate"", ""target"": ""C. difficile Germination and Expansion""}], ""evidence"": [{""explanation"": ""Review describes colonization resistance as a key protective function lost during antibiotic-induced dysbiosis."", ""reference"": ""PMID:26185088"", ""snippet"": ""A general feature of a normal, healthy gut microbiota can generate conditions in the gut that disfavor colonization of enteric pathogens. This is termed colonization-resistance (CR). Upon disturbance of the microbiota, CR can be transiently disrupted, and pathogens can gain the opportunity to grow to high levels."", ""supports"": ""SUPPORT""}, {""explanation"": ""Metagenomic study confirms CDI patients have reduced diversity and depletion of protective Collinsella species compared to healthy controls."", ""reference"": ""PMID:40366862"", ""snippet"": ""The gut microbiota in the Control group showed higher Chao1 index (p < 0.05)... Collinsella_aerofaciens, Collinsella_sp_4_8_47FAA, Collinsella_tanakaei and Collinsella_sp_CAG_166 were enriched in Control."", ""supports"": ""SUPPORT""}], ""name"": ""Loss of Colonization Resistance"", ""notes"": ""Metagenomics studies consistently show CDI patients have depleted Lachnospiraceae, Ruminococcaceae, and Collinsella spp. compared to controls. BugSigDB signatures for CDI-related studies confirm depletion of these protective taxa. The Lachnospiraceae member C. scindens is particularly important for bile acid-mediated resistance.\n""}"
1692	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	2	Loss of Secondary Bile Acid Production	"Loss of bile acid 7-dehydroxylating bacteria (Clostridium scindens, C. hylemonae, and related taxa) prevents conversion of primary bile acids (cholate, chenodeoxycholate) to secondary bile acids (deoxycholate, lithocholate). Primary bile acids promote C. difficile spore germination; secondary bile acids inhibit both germination and vegetative growth.
"																																		"The bai (bile acid-inducible) operon encodes the 7-dehydroxylation pathway. ~2mM deoxycholate is sufficient to inhibit C. difficile growth in vitro.
"																						"{""description"": ""Loss of bile acid 7-dehydroxylating bacteria (Clostridium scindens, C. hylemonae, and related taxa) prevents conversion of primary bile acids (cholate, chenodeoxycholate) to secondary bile acids (deoxycholate, lithocholate). Primary bile acids promote C. difficile spore germination; secondary bile acids inhibit both germination and vegetative growth.\n"", ""name"": ""Loss of Secondary Bile Acid Production"", ""notes"": ""The bai (bile acid-inducible) operon encodes the 7-dehydroxylation pathway. ~2mM deoxycholate is sufficient to inhibit C. difficile growth in vitro.\n""}"	"{""downstream"": [{""description"": ""Elevated primary bile acids and depleted secondary bile acids favor spore germination"", ""target"": ""C. difficile Germination and Expansion""}]}"	"{""description"": ""Loss of bile acid 7-dehydroxylating bacteria (Clostridium scindens, C. hylemonae, and related taxa) prevents conversion of primary bile acids (cholate, chenodeoxycholate) to secondary bile acids (deoxycholate, lithocholate). Primary bile acids promote C. difficile spore germination; secondary bile acids inhibit both germination and vegetative growth.\n"", ""downstream"": [{""description"": ""Elevated primary bile acids and depleted secondary bile acids favor spore germination"", ""target"": ""C. difficile Germination and Expansion""}], ""evidence"": [{""explanation"": ""Study shows bile acid conversion by bai operon-carrying bacteria is key to C. difficile inhibition."", ""reference"": ""PMID:32179626"", ""snippet"": ""Inhibition of C. difficile by commensals correlated with the efficient conversion of cholate to deoxycholate, a secondary bile acid that inhibits C. difficile germination, growth, and toxin production."", ""supports"": ""SUPPORT""}, {""explanation"": ""Gnotobiotic mouse study demonstrates C. scindens provides colonization resistance through bile acid metabolism."", ""reference"": ""PMID:28066726"", ""snippet"": ""Amendment of Oligo-MM12 with C. scindens normalized the large intestinal bile acid composition by reconstituting 7-dehydroxylation. These changes had only minor effects on the composition of the native Oligo-MM12, but significantly decreased early large intestinal C. difficile colonization and pathogenesis."", ""supports"": ""SUPPORT""}], ""name"": ""Loss of Secondary Bile Acid Production"", ""notes"": ""The bai (bile acid-inducible) operon encodes the 7-dehydroxylation pathway. ~2mM deoxycholate is sufficient to inhibit C. difficile growth in vitro.\n""}"
1693	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	3	C. difficile Germination and Expansion	"C. difficile spores germinate in the favorable environment created by antibiotic disruption: available nutrients (especially proline), primary bile acids, and lack of competition. Vegetative cells proliferate to high density, occupying the ecological niche vacated by commensals.
"																																																								"{""description"": ""C. difficile spores germinate in the favorable environment created by antibiotic disruption: available nutrients (especially proline), primary bile acids, and lack of competition. Vegetative cells proliferate to high density, occupying the ecological niche vacated by commensals.\n"", ""name"": ""C. difficile Germination and Expansion""}"	"{""downstream"": [{""description"": ""Vegetative C. difficile produces toxins A and B during stationary phase"", ""target"": ""Toxin Production (TcdA/TcdB)""}]}"	"{""description"": ""C. difficile spores germinate in the favorable environment created by antibiotic disruption: available nutrients (especially proline), primary bile acids, and lack of competition. Vegetative cells proliferate to high density, occupying the ecological niche vacated by commensals.\n"", ""downstream"": [{""description"": ""Vegetative C. difficile produces toxins A and B during stationary phase"", ""target"": ""Toxin Production (TcdA/TcdB)""}], ""evidence"": [{""explanation"": ""Antibiotic-disrupted environment permits C. difficile overgrowth from spore to vegetative form."", ""reference"": ""PMID:28613708"", ""snippet"": ""Patients can be colonized with C difficile without symptoms, but antibiotic use disturbs the balance of gut flora, enabling C difficile overgrowth and infection."", ""supports"": ""SUPPORT""}], ""name"": ""C. difficile Germination and Expansion""}"
1694	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	4	Toxin Production (TcdA/TcdB)	"C. difficile secretes two large clostridial glucosylating toxins: TcdA (enterotoxin, 308 kDa) and TcdB (cytotoxin, 270 kDa). Both are glucosyltransferases that inactivate Rho family GTPases (Rho, Rac, Cdc42) by monoglucosylation of a critical threonine residue, disrupting the actin cytoskeleton.
"																																																								"{""description"": ""C. difficile secretes two large clostridial glucosylating toxins: TcdA (enterotoxin, 308 kDa) and TcdB (cytotoxin, 270 kDa). Both are glucosyltransferases that inactivate Rho family GTPases (Rho, Rac, Cdc42) by monoglucosylation of a critical threonine residue, disrupting the actin cytoskeleton.\n"", ""name"": ""Toxin Production (TcdA/TcdB)""}"	"{""downstream"": [{""description"": ""Toxins cause cytoskeletal collapse and cell death"", ""target"": ""Epithelial Cell Death and Barrier Disruption""}, {""description"": ""Toxins trigger IL-8 release and massive neutrophil influx"", ""target"": ""Neutrophil Recruitment and Inflammation""}]}"	"{""biological_processes"": [{""preferred_term"": ""Pathogenesis"", ""term"": {""id"": ""GO:0009405"", ""label"": ""pathogenesis""}}], ""description"": ""C. difficile secretes two large clostridial glucosylating toxins: TcdA (enterotoxin, 308 kDa) and TcdB (cytotoxin, 270 kDa). Both are glucosyltransferases that inactivate Rho family GTPases (Rho, Rac, Cdc42) by monoglucosylation of a critical threonine residue, disrupting the actin cytoskeleton.\n"", ""downstream"": [{""description"": ""Toxins cause cytoskeletal collapse and cell death"", ""target"": ""Epithelial Cell Death and Barrier Disruption""}, {""description"": ""Toxins trigger IL-8 release and massive neutrophil influx"", ""target"": ""Neutrophil Recruitment and Inflammation""}], ""evidence"": [{""explanation"": ""Comprehensive review details the molecular mechanism of toxin action on Rho GTPases."", ""reference"": ""PMID:15831824"", ""snippet"": ""Following expression and release from the bacterium, TcdA and TcdB translocate to the cytosol of target cells and inactivate small GTP-binding proteins, which include Rho, Rac, and Cdc42. Inactivation of these substrates occurs through monoglucosylation of a single reactive threonine."", ""supports"": ""SUPPORT""}, {""explanation"": ""Review confirms toxins as major virulence factors causing disease pathology."", ""reference"": ""PMID:34837014"", ""snippet"": ""The bacterium produces up to three toxins, which are considered the major virulence factors in C. difficile infection. These toxins promote inflammation, tissue damage and diarrhoea."", ""supports"": ""SUPPORT""}], ""name"": ""Toxin Production (TcdA/TcdB)""}"
1695	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	5	Epithelial Cell Death and Barrier Disruption	"Toxin-mediated Rho GTPase inactivation causes actin cytoskeleton condensation, loss of cell-cell junctions, and epithelial cell rounding followed by death. This creates gaps in the epithelial barrier, exposing the lamina propria to luminal contents.
"																																																								"{""description"": ""Toxin-mediated Rho GTPase inactivation causes actin cytoskeleton condensation, loss of cell-cell junctions, and epithelial cell rounding followed by death. This creates gaps in the epithelial barrier, exposing the lamina propria to luminal contents.\n"", ""name"": ""Epithelial Cell Death and Barrier Disruption""}"	"{""downstream"": [{""description"": ""Epithelial destruction with inflammatory exudate forms pseudomembranes"", ""target"": ""Pseudomembranous Colitis""}]}"	"{""cell_types"": [{""preferred_term"": ""Colonic Epithelial Cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}], ""description"": ""Toxin-mediated Rho GTPase inactivation causes actin cytoskeleton condensation, loss of cell-cell junctions, and epithelial cell rounding followed by death. This creates gaps in the epithelial barrier, exposing the lamina propria to luminal contents.\n"", ""downstream"": [{""description"": ""Epithelial destruction with inflammatory exudate forms pseudomembranes"", ""target"": ""Pseudomembranous Colitis""}], ""evidence"": [{""explanation"": ""Review describes the cellular consequences of toxin-mediated GTPase inactivation."", ""reference"": ""PMID:15831824"", ""snippet"": ""By glucosylating small GTPases, TcdA and TcdB cause actin condensation and cell rounding, which is followed by death of the cell."", ""supports"": ""SUPPORT""}], ""name"": ""Epithelial Cell Death and Barrier Disruption""}"
1696	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	6	Neutrophil Recruitment and Inflammation	"TcdA triggers IL-8 and other chemokine release from epithelial cells, causing massive neutrophil influx into the colonic mucosa. Neutrophils form the characteristic ""volcano lesions"" and contribute to tissue damage through degranulation, reactive oxygen species, and NET formation.
"																																																								"{""description"": ""TcdA triggers IL-8 and other chemokine release from epithelial cells, causing massive neutrophil influx into the colonic mucosa. Neutrophils form the characteristic \""volcano lesions\"" and contribute to tissue damage through degranulation, reactive oxygen species, and NET formation.\n"", ""name"": ""Neutrophil Recruitment and Inflammation""}"	"{""downstream"": [{""description"": ""Neutrophils form the inflammatory core of pseudomembranes"", ""target"": ""Pseudomembranous Colitis""}]}"	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""TcdA triggers IL-8 and other chemokine release from epithelial cells, causing massive neutrophil influx into the colonic mucosa. Neutrophils form the characteristic \""volcano lesions\"" and contribute to tissue damage through degranulation, reactive oxygen species, and NET formation.\n"", ""downstream"": [{""description"": ""Neutrophils form the inflammatory core of pseudomembranes"", ""target"": ""Pseudomembranous Colitis""}], ""evidence"": [{""explanation"": ""Review details toxin-induced inflammatory cascade including neutrophil recruitment."", ""reference"": ""PMID:15831824"", ""snippet"": ""Furthermore, there have been major advances in defining the role of these toxins in modulating the inflammatory events involving the disruption of cell junctions, neuronal activation, cytokine production, and infiltration by polymorphonuclear cells."", ""supports"": ""SUPPORT""}], ""name"": ""Neutrophil Recruitment and Inflammation""}"
1697	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	7	Pseudomembranous Colitis	"Characteristic raised yellow-white plaques on colonic mucosa composed of fibrin, mucus, neutrophils, and cellular debris overlying areas of epithelial necrosis. Represents severe C. difficile infection with high morbidity. Fluid secretion and diarrhea result from barrier loss and inflammation.
"																																																								"{""description"": ""Characteristic raised yellow-white plaques on colonic mucosa composed of fibrin, mucus, neutrophils, and cellular debris overlying areas of epithelial necrosis. Represents severe C. difficile infection with high morbidity. Fluid secretion and diarrhea result from barrier loss and inflammation.\n"", ""name"": ""Pseudomembranous Colitis""}"	{}	"{""description"": ""Characteristic raised yellow-white plaques on colonic mucosa composed of fibrin, mucus, neutrophils, and cellular debris overlying areas of epithelial necrosis. Represents severe C. difficile infection with high morbidity. Fluid secretion and diarrhea result from barrier loss and inflammation.\n"", ""evidence"": [{""explanation"": ""Toxin activity drives the pseudomembrane-associated inflammation and diarrheal fluid loss that characterize severe CDI."", ""reference"": ""PMID:34837014"", ""snippet"": ""These toxins promote inflammation, tissue damage and diarrhoea."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}], ""name"": ""Pseudomembranous Colitis""}"
1722	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	0	Mucosal immune activation with intraepithelial lymphocytosis	"Collagenous sprue is initiated by mucosal immune activation characterized by increased intraepithelial lymphocytes (IELs), particularly CD8+ T cells, and lamina propria inflammation with plasma cells and eosinophils. IL-15 and TNF- signaling drive this T cell-mediated immune response, leading to epithelial cell apoptosis, crypt hyperplasia, and villous atrophy. This immune activation is not associated with celiac serology despite overlapping histologic features with celiac disease.
"																																																								"{""description"": ""Collagenous sprue is initiated by mucosal immune activation characterized by increased intraepithelial lymphocytes (IELs), particularly CD8+ T cells, and lamina propria inflammation with plasma cells and eosinophils. IL-15 and TNF- signaling drive this T cell-mediated immune response, leading to epithelial cell apoptosis, crypt hyperplasia, and villous atrophy. This immune activation is not associated with celiac serology despite overlapping histologic features with celiac disease.\n"", ""name"": ""Mucosal immune activation with intraepithelial lymphocytosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T cell mediated immune response"", ""term"": {""id"": ""GO:0002292"", ""label"": ""T cell differentiation involved in immune response""}}, {""preferred_term"": ""response to cytokine"", ""term"": {""id"": ""GO:0034097"", ""label"": ""response to cytokine""}}], ""cell_types"": [{""preferred_term"": ""intraepithelial lymphocyte"", ""term"": {""id"": ""CL:0002496"", ""label"": ""intraepithelial lymphocyte""}}, {""preferred_term"": ""plasma cell"", ""term"": {""id"": ""CL:0000786"", ""label"": ""plasma cell""}}, {""preferred_term"": ""eosinophil"", ""term"": {""id"": ""CL:0000041"", ""label"": ""mature eosinophil""}}], ""description"": ""Collagenous sprue is initiated by mucosal immune activation characterized by increased intraepithelial lymphocytes (IELs), particularly CD8+ T cells, and lamina propria inflammation with plasma cells and eosinophils. IL-15 and TNF- signaling drive this T cell-mediated immune response, leading to epithelial cell apoptosis, crypt hyperplasia, and villous atrophy. This immune activation is not associated with celiac serology despite overlapping histologic features with celiac disease.\n"", ""evidence"": [{""explanation"": ""Systematic review documents that collagenous enteropathy and related conditions involve mucosal immune activation with T cell-mediated responses"", ""reference"": ""DOI:10.1093/ecco-jcc/jjab123"", ""snippet"": ""MC is a multifactorial disease believed to involve innate and adaptive immune responses to luminal factors, genetic risk, autoimmunity, and extracellular matrix alterations"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""small intestinal mucosa"", ""term"": {""id"": ""UBERON:0001273"", ""label"": ""small intestine""}}, {""preferred_term"": ""lamina propria"", ""term"": {""id"": ""UBERON:0001982"", ""label"": ""lamina propria""}}], ""name"": ""Mucosal immune activation with intraepithelial lymphocytosis""}"
1723	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	1	Epithelial barrier dysfunction and tight junction disruption	"Immune-mediated epithelial damage impairs the intestinal epithelial barrier through disruption of tight junction proteins, particularly zonula occludens-1 (ZO-1/TJP1). Loss of barrier function allows increased paracellular transport and bacterial antigen exposure, perpetuating the inflammatory cycle. Crypt epithelial apoptosis and reduced junctional integrity compromise the epithelial seal, contributing to persistent diarrhea and protein-losing enteropathy.
"																																																								"{""description"": ""Immune-mediated epithelial damage impairs the intestinal epithelial barrier through disruption of tight junction proteins, particularly zonula occludens-1 (ZO-1/TJP1). Loss of barrier function allows increased paracellular transport and bacterial antigen exposure, perpetuating the inflammatory cycle. Crypt epithelial apoptosis and reduced junctional integrity compromise the epithelial seal, contributing to persistent diarrhea and protein-losing enteropathy.\n"", ""name"": ""Epithelial barrier dysfunction and tight junction disruption""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cell junction organization"", ""term"": {""id"": ""GO:0034330"", ""label"": ""cell junction organization""}}, {""preferred_term"": ""epithelial cell differentiation"", ""term"": {""id"": ""GO:0030855"", ""label"": ""epithelial cell differentiation""}}], ""description"": ""Immune-mediated epithelial damage impairs the intestinal epithelial barrier through disruption of tight junction proteins, particularly zonula occludens-1 (ZO-1/TJP1). Loss of barrier function allows increased paracellular transport and bacterial antigen exposure, perpetuating the inflammatory cycle. Crypt epithelial apoptosis and reduced junctional integrity compromise the epithelial seal, contributing to persistent diarrhea and protein-losing enteropathy.\n"", ""evidence"": [{""explanation"": ""Collagen deposition alters mucosal architecture and epithelial integrity in collagenous sprue"", ""reference"": ""PMID:37070112"", ""snippet"": ""The histological features are fundamentally characterized by the deposition of collagen beneath the basement membrane of gut mucosa"", ""supports"": ""SUPPORT""}], ""name"": ""Epithelial barrier dysfunction and tight junction disruption""}"
1724	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	2	Subepithelial collagen deposition and fibrotic remodeling	"Excessive collagen accumulation beneath the intestinal epithelium is the pathologic hallmark of collagenous sprue, defined by a thickened subepithelial collagen band >10 micrometers (normal 5-7 m). This results from TGF-driven myofibroblast activation and differentiation from fibroblasts, with increased expression of collagen type I (COL1A1) and upregulation of tissue inhibitors of metalloproteinases (TIMP1). Simultaneously, matrix metalloproteinase (MMP1, MMP9) activity is reduced, creating an imbalance favoring ECM accumulation. The collagen band may entrap capillaries and stromal cells, disrupting villous architecture and nutrient absorption.
"																																																								"{""description"": ""Excessive collagen accumulation beneath the intestinal epithelium is the pathologic hallmark of collagenous sprue, defined by a thickened subepithelial collagen band >10 micrometers (normal 5-7 m). This results from TGF-driven myofibroblast activation and differentiation from fibroblasts, with increased expression of collagen type I (COL1A1) and upregulation of tissue inhibitors of metalloproteinases (TIMP1). Simultaneously, matrix metalloproteinase (MMP1, MMP9) activity is reduced, creating an imbalance favoring ECM accumulation. The collagen band may entrap capillaries and stromal cells, disrupting villous architecture and nutrient absorption.\n"", ""name"": ""Subepithelial collagen deposition and fibrotic remodeling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""positive regulation of collagen biosynthetic process"", ""term"": {""id"": ""GO:0032965"", ""label"": ""positive regulation of collagen biosynthetic process""}}, {""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""cell_types"": [{""preferred_term"": ""myofibroblast"", ""term"": {""id"": ""CL:0000186"", ""label"": ""myofibroblast cell""}}, {""preferred_term"": ""capillary endothelial cell"", ""term"": {""id"": ""CL:0002144"", ""label"": ""capillary endothelial cell""}}], ""description"": ""Excessive collagen accumulation beneath the intestinal epithelium is the pathologic hallmark of collagenous sprue, defined by a thickened subepithelial collagen band >10 micrometers (normal 5-7 m). This results from TGF-driven myofibroblast activation and differentiation from fibroblasts, with increased expression of collagen type I (COL1A1) and upregulation of tissue inhibitors of metalloproteinases (TIMP1). Simultaneously, matrix metalloproteinase (MMP1, MMP9) activity is reduced, creating an imbalance favoring ECM accumulation. The collagen band may entrap capillaries and stromal cells, disrupting villous architecture and nutrient absorption.\n"", ""evidence"": [{""explanation"": ""Literature describes diagnostic subepithelial collagen deposition characteristic of collagenous diseases including sprue"", ""reference"": ""PMID:37554741"", ""snippet"": ""collagenous colitis, characterized by sub-epithelial trichrome-positive deposits having the ultrastructural features of collagen"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""subepithelial lamina propria"", ""term"": {""id"": ""UBERON:0001982"", ""label"": ""lamina propria""}}], ""name"": ""Subepithelial collagen deposition and fibrotic remodeling""}"
1739	73	Colon Adenocarcinoma	Colon_Adenocarcinoma.yaml	pathophysiology	0	Adenoma-Carcinoma Sequence	Stepwise progression from adenomatous polyps to invasive carcinoma drives colon adenocarcinoma development.																																																								"{""description"": ""Stepwise progression from adenomatous polyps to invasive carcinoma drives colon adenocarcinoma development."", ""name"": ""Adenoma-Carcinoma Sequence""}"	{}	"{""description"": ""Stepwise progression from adenomatous polyps to invasive carcinoma drives colon adenocarcinoma development."", ""evidence"": [{""explanation"": ""The abstract describes stage-wise progression through adenomatous polyps."", ""reference"": ""PMID:8055224"", ""snippet"": ""Molecular studies support the clinical impression that adenocarcinoma of the large intestine develops in stages. At the center of the pathological continuum between normal mucosa and invasive carcinoma is the premalignant lesion, the adenomatous polyp."", ""supports"": ""SUPPORT""}], ""name"": ""Adenoma-Carcinoma Sequence""}"
1740	73	Colon Adenocarcinoma	Colon_Adenocarcinoma.yaml	pathophysiology	1	APC Loss in Intestinal Stem Cells	Wnt-pathway-activating loss of APC in intestinal stem cells drives early neoplasia.																																																								"{""description"": ""Wnt-pathway-activating loss of APC in intestinal stem cells drives early neoplasia."", ""name"": ""APC Loss in Intestinal Stem Cells""}"	{}	"{""description"": ""Wnt-pathway-activating loss of APC in intestinal stem cells drives early neoplasia."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The abstract identifies APC loss and Wnt pathway activation as initiating events in intestinal cancer."", ""reference"": ""PMID:19092804"", ""snippet"": ""Intestinal cancer is initiated by Wnt-pathway-activating mutations in genes such as adenomatous polyposis coli (APC)."", ""supports"": ""SUPPORT""}], ""name"": ""APC Loss in Intestinal Stem Cells""}"
1753	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	0	CBF Transcription Factor Complex Disruption	The core binding factor complex consists of RUNX1 (alpha subunit) and CBFB (beta subunit). RUNX1 binds DNA while CBFB stabilizes this binding. Both t(8;21) and inv(16) produce fusion proteins that dominantly inhibit normal CBF function, disrupting transcription of genes essential for myeloid differentiation.																																																								"{""description"": ""The core binding factor complex consists of RUNX1 (alpha subunit) and CBFB (beta subunit). RUNX1 binds DNA while CBFB stabilizes this binding. Both t(8;21) and inv(16) produce fusion proteins that dominantly inhibit normal CBF function, disrupting transcription of genes essential for myeloid differentiation."", ""name"": ""CBF Transcription Factor Complex Disruption""}"	"{""downstream"": [{""description"": ""Dominant-negative CBF inhibition arrests maturation"", ""target"": ""Differentiation Block at Myeloid Stage""}, {""description"": ""Loss of CBF target gene expression promotes progenitor expansion"", ""target"": ""Self-Renewal Maintenance""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""myeloid cell differentiation"", ""term"": {""id"": ""GO:0030099"", ""label"": ""myeloid cell differentiation""}}], ""cell_types"": [{""preferred_term"": ""myeloid progenitor cell"", ""term"": {""id"": ""CL:0000049"", ""label"": ""common myeloid progenitor""}}], ""description"": ""The core binding factor complex consists of RUNX1 (alpha subunit) and CBFB (beta subunit). RUNX1 binds DNA while CBFB stabilizes this binding. Both t(8;21) and inv(16) produce fusion proteins that dominantly inhibit normal CBF function, disrupting transcription of genes essential for myeloid differentiation."", ""downstream"": [{""description"": ""Dominant-negative CBF inhibition arrests maturation"", ""target"": ""Differentiation Block at Myeloid Stage""}, {""description"": ""Loss of CBF target gene expression promotes progenitor expansion"", ""target"": ""Self-Renewal Maintenance""}], ""evidence"": [{""explanation"": ""This abstract defines CBF-AML by RUNX1::RUNX1T1 or CBFB::MYH11 fusions, supporting the core-binding factor disruption described."", ""reference"": ""PMID:41152985"", ""snippet"": ""core-binding factor acute myeloid leukemia patients, defined by the presence of a RUNX1::RUNX1T1 or CBFB::MYH11 fusion gene."", ""supports"": ""SUPPORT""}], ""name"": ""CBF Transcription Factor Complex Disruption""}"
1754	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	1	Differentiation Block at Myeloid Stage	CBF fusion proteins recruit corepressor complexes including HDACs and NCoR, converting CBF from a transcriptional activator to a repressor. This silences differentiation genes while partially preserving some myeloid identity, resulting in blasts with partial maturation features.																																																								"{""description"": ""CBF fusion proteins recruit corepressor complexes including HDACs and NCoR, converting CBF from a transcriptional activator to a repressor. This silences differentiation genes while partially preserving some myeloid identity, resulting in blasts with partial maturation features."", ""name"": ""Differentiation Block at Myeloid Stage""}"	"{""downstream"": [{""description"": ""Arrested cells accumulate in bone marrow and blood"", ""target"": ""Leukemic Blast Accumulation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""granulocyte differentiation"", ""term"": {""id"": ""GO:0030851"", ""label"": ""granulocyte differentiation""}}], ""cell_types"": [{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}], ""description"": ""CBF fusion proteins recruit corepressor complexes including HDACs and NCoR, converting CBF from a transcriptional activator to a repressor. This silences differentiation genes while partially preserving some myeloid identity, resulting in blasts with partial maturation features."", ""downstream"": [{""description"": ""Arrested cells accumulate in bone marrow and blood"", ""target"": ""Leukemic Blast Accumulation""}], ""name"": ""Differentiation Block at Myeloid Stage""}"
1755	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	2	Self-Renewal Maintenance	CBF fusion proteins maintain expression of self-renewal genes while blocking differentiation. Additional mutations, particularly in receptor tyrosine kinases (KIT, FLT3), provide proliferative signals that cooperate with CBF fusions to cause overt leukemia.																																																								"{""description"": ""CBF fusion proteins maintain expression of self-renewal genes while blocking differentiation. Additional mutations, particularly in receptor tyrosine kinases (KIT, FLT3), provide proliferative signals that cooperate with CBF fusions to cause overt leukemia."", ""name"": ""Self-Renewal Maintenance""}"	"{""downstream"": [{""description"": ""Enhanced self-renewal with blocked differentiation drives disease"", ""target"": ""Leukemic Blast Accumulation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""CBF fusion proteins maintain expression of self-renewal genes while blocking differentiation. Additional mutations, particularly in receptor tyrosine kinases (KIT, FLT3), provide proliferative signals that cooperate with CBF fusions to cause overt leukemia."", ""downstream"": [{""description"": ""Enhanced self-renewal with blocked differentiation drives disease"", ""target"": ""Leukemic Blast Accumulation""}], ""name"": ""Self-Renewal Maintenance""}"
1756	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	3	Leukemic Blast Accumulation	The combination of differentiation block, maintained self-renewal, and cooperating mutations leads to accumulation of immature myeloid blasts in the bone marrow, causing bone marrow failure and circulating leukemia.																																																								"{""description"": ""The combination of differentiation block, maintained self-renewal, and cooperating mutations leads to accumulation of immature myeloid blasts in the bone marrow, causing bone marrow failure and circulating leukemia."", ""name"": ""Leukemic Blast Accumulation""}"	{}	"{""cell_types"": [{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}], ""description"": ""The combination of differentiation block, maintained self-renewal, and cooperating mutations leads to accumulation of immature myeloid blasts in the bone marrow, causing bone marrow failure and circulating leukemia."", ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Leukemic Blast Accumulation""}"
1779	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	0	Atherosclerotic Plaque Formation	"Lipid accumulation in arterial walls triggers inflammatory response, leading to foam cell formation and fibrous cap development. Progressive plaque growth narrows the coronary arteries.
"																																																								"{""description"": ""Lipid accumulation in arterial walls triggers inflammatory response, leading to foam cell formation and fibrous cap development. Progressive plaque growth narrows the coronary arteries.\n"", ""name"": ""Atherosclerotic Plaque Formation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Lipid Accumulation"", ""term"": {""id"": ""GO:0034383"", ""label"": ""low-density lipoprotein particle clearance""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""Foam Cell"", ""term"": {""id"": ""CL:0000891"", ""label"": ""foam cell""}}, {""preferred_term"": ""Vascular Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}], ""description"": ""Lipid accumulation in arterial walls triggers inflammatory response, leading to foam cell formation and fibrous cap development. Progressive plaque growth narrows the coronary arteries.\n"", ""evidence"": [{""explanation"": ""This review directly supports the role of lipid accumulation and inflammation in driving plaque formation in coronary artery disease."", ""reference"": ""PMID:39518492"", ""snippet"": ""We examine the cellular and molecular processes that drive the formation of calcified plaques, highlighting the roles of inflammation, lipid accumulation, and smooth muscle cell proliferation."", ""supports"": ""SUPPORT""}, {""explanation"": ""Single-cell analysis confirms the presence of lipid-associated macrophages and smooth muscle cells in advanced atherosclerotic plaques, supporting foam cell formation and plaque progression."", ""reference"": ""PMID:38639096"", ""snippet"": ""Advanced stages of atherosclerosis progression and symptomatic carotid plaques were largely characterized by 3 smooth muscle cells (SMCs), and 3 macrophage subtype clusters with extracellular matrix organization/osteogenic (SMC), and M1-type proinflammatory/Trem2-high lipid-associated (macrophage) phenotypes."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study identifies specific macrophage populations with pro-inflammatory phenotypes that contribute to atherosclerotic plaque formation and progression."", ""reference"": ""PMID:40594772"", ""snippet"": ""Notable increases in VEGFA+ macrophages were discovered in the disturbed flow stimulation group, displaying a pronounced M1 pro-inflammatory phenotype associated with the severity of atherosclerosis and plaque stability."", ""supports"": ""SUPPORT""}], ""name"": ""Atherosclerotic Plaque Formation""}"
1780	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	1	Endothelial Dysfunction	"Damage to the endothelial lining promotes lipid deposition, platelet adhesion, and inflammatory cell recruitment. Reduced nitric oxide production impairs vasodilation.
"																																																								"{""description"": ""Damage to the endothelial lining promotes lipid deposition, platelet adhesion, and inflammatory cell recruitment. Reduced nitric oxide production impairs vasodilation.\n"", ""name"": ""Endothelial Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Nitric Oxide Production"", ""term"": {""id"": ""GO:0006809"", ""label"": ""nitric oxide biosynthetic process""}}], ""cell_types"": [{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Damage to the endothelial lining promotes lipid deposition, platelet adhesion, and inflammatory cell recruitment. Reduced nitric oxide production impairs vasodilation.\n"", ""evidence"": [{""explanation"": ""This study demonstrates that endothelial cells undergo senescence under disturbed flow conditions, a key mechanism in endothelial dysfunction during atherosclerosis."", ""reference"": ""PMID:40594772"", ""snippet"": ""CD36 + positive ECs exhibited significant senescence phenotypes following disturbed flow stimulation."", ""supports"": ""SUPPORT""}, {""explanation"": ""Disturbed flow-induced endothelial dysfunction is a primary mechanism for atherosclerosis initiation in specific arterial regions."", ""reference"": ""PMID:40594772"", ""snippet"": ""Atherosclerosis tends to occur in regions of disturbed blood flow. This study explored how disturbed flow aggravates atherosclerosis using single-cell RNA-seq (scRNA-seq) datasets from mouse carotid arteries under disturbed flow and human carotid artery plaques."", ""supports"": ""SUPPORT""}], ""name"": ""Endothelial Dysfunction""}"
1781	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	2	Plaque Rupture and Thrombosis	"Unstable plaques with thin fibrous caps are prone to rupture, exposing thrombogenic material and triggering acute coronary events (myocardial infarction).
"																																																								"{""description"": ""Unstable plaques with thin fibrous caps are prone to rupture, exposing thrombogenic material and triggering acute coronary events (myocardial infarction).\n"", ""name"": ""Plaque Rupture and Thrombosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Thrombosis"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}], ""cell_types"": [{""preferred_term"": ""Platelet"", ""term"": {""id"": ""CL:0000233"", ""label"": ""platelet""}}], ""description"": ""Unstable plaques with thin fibrous caps are prone to rupture, exposing thrombogenic material and triggering acute coronary events (myocardial infarction).\n"", ""evidence"": [{""explanation"": ""Pro-inflammatory macrophages contribute to plaque instability, which predisposes to rupture and thrombotic complications."", ""reference"": ""PMID:40594772"", ""snippet"": ""Notable increases in VEGFA+ macrophages were discovered in the disturbed flow stimulation group, displaying a pronounced M1 pro-inflammatory phenotype associated with the severity of atherosclerosis and plaque stability."", ""supports"": ""SUPPORT""}, {""explanation"": ""Smooth muscle cell transformation into osteogenic phenotypes contributes to plaque vulnerability and symptomatic disease, increasing risk of rupture and thrombotic events."", ""reference"": ""PMID:38639096"", ""snippet"": ""By identifying and integrating the most gene-rich single-cell subclusters of atherosclerosis to date with a coronary artery disease framework of GRNs, GRN39 was identified and independently validated as being critical for the transformation of contractile SMCs into an osteogenic phenotype promoting advanced, symptomatic atherosclerosis."", ""supports"": ""SUPPORT""}], ""name"": ""Plaque Rupture and Thrombosis""}"
1793	76	Costello Syndrome	Costello_Syndrome.yaml	pathophysiology	0	Constitutive RAS-MAPK Activation	"HRAS mutations (most commonly G12S, G12A, G13C) cause constitutive activation of the RAS protein, leading to enhanced and prolonged signaling through the MAPK/ERK pathway. This affects cell proliferation, differentiation, and survival in multiple tissues.
"																																																								"{""description"": ""HRAS mutations (most commonly G12S, G12A, G13C) cause constitutive activation of the RAS protein, leading to enhanced and prolonged signaling through the MAPK/ERK pathway. This affects cell proliferation, differentiation, and survival in multiple tissues.\n"", ""name"": ""Constitutive RAS-MAPK Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""RAS Signaling"", ""term"": {""id"": ""GO:0007265"", ""label"": ""Ras protein signal transduction""}}, {""preferred_term"": ""MAPK Cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}, {""preferred_term"": ""Atrial Cardiomyocyte"", ""term"": {""id"": ""CL:0002129"", ""label"": ""regular atrial cardiac myocyte""}}], ""description"": ""HRAS mutations (most commonly G12S, G12A, G13C) cause constitutive activation of the RAS protein, leading to enhanced and prolonged signaling through the MAPK/ERK pathway. This affects cell proliferation, differentiation, and survival in multiple tissues.\n"", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""iPSC-derived atrial cardiomyocyte model demonstrates that HRAS mutations cause transcriptional reprogramming toward pacemaker-nodal phenotype with increased automaticity, providing mechanistic basis for arrhythmias."", ""reference"": ""PMID:38415356"", ""snippet"": ""CS-associated gain-of-function HRASG12 mutations in induced pluripotent stem cells-derived ACMs trigger transcriptional changes associated with enhanced automaticity and arrhythmic activity consistent with multifocal atrial tachycardia."", ""supports"": ""SUPPORT""}], ""name"": ""Constitutive RAS-MAPK Activation""}"
1794	76	Costello Syndrome	Costello_Syndrome.yaml	pathophysiology	1	Tumor Predisposition	"The same activating HRAS mutations that cause Costello syndrome are found as somatic mutations in various cancers. Germline activation creates a predisposition to embryonal tumors, particularly rhabdomyosarcoma.
"																																																								"{""description"": ""The same activating HRAS mutations that cause Costello syndrome are found as somatic mutations in various cancers. Germline activation creates a predisposition to embryonal tumors, particularly rhabdomyosarcoma.\n"", ""name"": ""Tumor Predisposition""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cell Cycle Regulation"", ""term"": {""id"": ""GO:0051726"", ""label"": ""regulation of cell cycle""}}], ""description"": ""The same activating HRAS mutations that cause Costello syndrome are found as somatic mutations in various cancers. Germline activation creates a predisposition to embryonal tumors, particularly rhabdomyosarcoma.\n"", ""name"": ""Tumor Predisposition""}"
1825	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	0	Dysregulated Immune Response	The immune system attacks the gastrointestinal tract, leading to chronic inflammation.																																																								"{""description"": ""The immune system attacks the gastrointestinal tract, leading to chronic inflammation."", ""name"": ""Dysregulated Immune Response""}"	{}	"{""description"": ""The immune system attacks the gastrointestinal tract, leading to chronic inflammation."", ""evidence"": [{""explanation"": ""The statement is supported as one of the major factors causing Crohn's Disease is the dysregulated immune system attacking the gastrointestinal tract."", ""reference"": ""PMID:32242028"", ""snippet"": ""Several factors have been implicated in the cause of Crohn's disease, including a dysregulated immune system, an altered microbiota, genetic susceptibility and environmental factors, but the cause of the disease remains unknown."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study supports the mechanism involving the immune system leading to inflammation and chronic disease in the gastrointestinal tract."", ""reference"": ""PMID:36720220"", ""snippet"": ""Crohn's disease (CD) is a chronic gastrointestinal disease that is increasing in prevalence worldwide. CD is multifactorial, involving the complex interplay of genetic, immune, and environmental factors... we mapped markers of disease-associated myofibroblast activation and identified CHMP1A, TBX3, and RNF168 as regulators of fibrotic complications."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature acknowledges the immune system's involvement in Crohn's Disease through various mechanisms, including lymphatic system dysfunction."", ""reference"": ""PMID:21543977"", ""snippet"": ""The lymphatic system is re-emerging as a critical player in inflammatory and immune processes... Recent studies reporting lymphangitis, lymphangiogenesis, bacterial infiltration and lymph node infection, immune cell trafficking, and fat-wrapping in Crohn's disease suggest altered lymph drainage and lymphatic pumping, implicating the lymphatic system as a likely player in inflammatory disorders and IBDs."", ""supports"": ""SUPPORT""}], ""name"": ""Dysregulated Immune Response""}"
1826	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	1	Microbiome Imbalance	Alterations in gut microbiota contribute to the disease mechanisms.																																																								"{""description"": ""Alterations in gut microbiota contribute to the disease mechanisms."", ""name"": ""Microbiome Imbalance""}"	{}	"{""description"": ""Alterations in gut microbiota contribute to the disease mechanisms."", ""evidence"": [{""explanation"": ""This study details changes in microbial composition and reduction in species diversity as key factors in the dynamics of Crohn's Disease, thereby supporting the statement."", ""reference"": ""PMID:34313550"", ""snippet"": ""Crohn's disease (CD) is a major form of inflammatory bowel disease characterized by transmural inflammation along the alimentary tract. Changes in the microbial composition and reduction in species diversity are recognized as pivotal hallmarks in disease dynamics, challenging the gut barrier function and shaping a pathological immune response in genetically influenced subjects."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study indicates that defects in innate defense mechanisms allow microbial invasion, which triggers inflammation, supporting the involvement of microbiota alterations in Crohn's Disease."", ""reference"": ""PMID:18810765"", ""snippet"": ""This ileal and colonic defect in innate defence mediated by a deficiency of the protective alpha- and beta-defensins may enable the luminal microbes to invade the mucosa and trigger the inflammation."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article mentions the role of gut microbiota as an environmental factor in the etiology of Crohn's Disease, supporting the contribution of microbiome imbalance to disease mechanisms."", ""reference"": ""PMID:23971750"", ""snippet"": ""Inflammatory bowel disease includes ulcerative colitis and Crohn's disease, which are both inflammatory disorders of the gastrointestinal tract. Both types of inflammatory bowel disease have a complex etiology, resulting from a genetically determined susceptibility interacting with environmental factors, including the diet and gut microbiota."", ""supports"": ""SUPPORT""}], ""name"": ""Microbiome Imbalance""}"
1827	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	2	Paneth Cell Autophagy Impairment	Defective autophagy in Paneth cells due to mutations in autophagy genes (ATG16L1, ATG5) causes abnormal granule formation and impaired antimicrobial peptide secretion.																																																								"{""description"": ""Defective autophagy in Paneth cells due to mutations in autophagy genes (ATG16L1, ATG5) causes abnormal granule formation and impaired antimicrobial peptide secretion."", ""name"": ""Paneth Cell Autophagy Impairment""}"	"{""downstream"": [{""description"": ""Loss of Paneth cell granule secretion reduces antimicrobial peptide levels in intestinal lumen."", ""target"": ""Antimicrobial Defense Deficiency""}]}"	"{""biological_processes"": [{""preferred_term"": ""Autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}], ""cell_types"": [{""preferred_term"": ""Paneth cell"", ""term"": {""id"": ""CL:0000510"", ""label"": ""paneth cell""}}], ""description"": ""Defective autophagy in Paneth cells due to mutations in autophagy genes (ATG16L1, ATG5) causes abnormal granule formation and impaired antimicrobial peptide secretion."", ""downstream"": [{""description"": ""Loss of Paneth cell granule secretion reduces antimicrobial peptide levels in intestinal lumen."", ""target"": ""Antimicrobial Defense Deficiency""}], ""evidence"": [{""explanation"": ""This study demonstrates that autophagy proteins ATG16L1 and ATG5 are essential for Paneth cell function and that defects cause granule abnormalities linked to Crohn's disease."", ""reference"": ""PMID:18849966"", ""snippet"": ""ATG16L1- and ATG5-deficient Paneth cells exhibited notable abnormalities in the granule exocytosis pathway"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Terminal ileum"", ""term"": {""id"": ""UBERON:0001211"", ""label"": ""ileum""}}], ""name"": ""Paneth Cell Autophagy Impairment""}"
1828	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	3	Antimicrobial Defense Deficiency	Reduced secretion of antimicrobial peptides (defensins, lysozyme) allows increased bacterial translocation across the intestinal epithelium.																																																								"{""description"": ""Reduced secretion of antimicrobial peptides (defensins, lysozyme) allows increased bacterial translocation across the intestinal epithelium."", ""name"": ""Antimicrobial Defense Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Antimicrobial humoral response"", ""term"": {""id"": ""GO:0019730"", ""label"": ""antimicrobial humoral response""}}], ""description"": ""Reduced secretion of antimicrobial peptides (defensins, lysozyme) allows increased bacterial translocation across the intestinal epithelium."", ""locations"": [{""preferred_term"": ""Terminal ileum"", ""term"": {""id"": ""UBERON:0001211"", ""label"": ""ileum""}}], ""name"": ""Antimicrobial Defense Deficiency""}"
1829	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	4	Macrophage Autophagy Dysfunction	Impaired autophagy in lamina propria macrophages leads to defective clearance of intracellular bacteria and inflammatory cytokine release.																																																								"{""description"": ""Impaired autophagy in lamina propria macrophages leads to defective clearance of intracellular bacteria and inflammatory cytokine release."", ""name"": ""Macrophage Autophagy Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Impaired autophagy in lamina propria macrophages leads to defective clearance of intracellular bacteria and inflammatory cytokine release."", ""locations"": [{""preferred_term"": ""Intestinal lamina propria"", ""term"": {""id"": ""UBERON:0011878"", ""label"": ""lamina propria of small intestine""}}], ""name"": ""Macrophage Autophagy Dysfunction""}"
1830	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	5	IL-23/Th17 Axis Dysregulation	Overactive IL-23 signaling drives pathogenic Th17 cell differentiation and chronic intestinal inflammation.																																																								"{""description"": ""Overactive IL-23 signaling drives pathogenic Th17 cell differentiation and chronic intestinal inflammation."", ""name"": ""IL-23/Th17 Axis Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Th17 cell differentiation"", ""term"": {""id"": ""GO:0072538"", ""label"": ""T-helper 17 type immune response""}}, {""preferred_term"": ""IL-23 signaling""}], ""cell_types"": [{""preferred_term"": ""Th17 cell"", ""term"": {""id"": ""CL:0000899"", ""label"": ""T-helper 17 cell""}}, {""preferred_term"": ""Dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""Overactive IL-23 signaling drives pathogenic Th17 cell differentiation and chronic intestinal inflammation."", ""locations"": [{""preferred_term"": ""Intestinal mucosa"", ""term"": {""id"": ""UBERON:0001211"", ""label"": ""ileum""}}], ""name"": ""IL-23/Th17 Axis Dysregulation""}"
1831	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	6	Fibrosis and Stricture Formation	Chronic inflammation leads to fibroblast activation, extracellular matrix deposition, and intestinal strictures.																																																								"{""description"": ""Chronic inflammation leads to fibroblast activation, extracellular matrix deposition, and intestinal strictures."", ""name"": ""Fibrosis and Stricture Formation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}, {""preferred_term"": ""Tissue remodeling"", ""term"": {""id"": ""GO:0048771"", ""label"": ""tissue remodeling""}}], ""cell_types"": [{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}, {""preferred_term"": ""Myofibroblast"", ""term"": {""id"": ""CL:0000186"", ""label"": ""myofibroblast cell""}}], ""description"": ""Chronic inflammation leads to fibroblast activation, extracellular matrix deposition, and intestinal strictures."", ""locations"": [{""preferred_term"": ""Intestinal wall"", ""term"": {""id"": ""UBERON:0001262"", ""label"": ""wall of intestine""}}, {""preferred_term"": ""Mesenteric adipose tissue"", ""term"": {""id"": ""UBERON:0003427"", ""label"": ""mesenteric fat pad""}}], ""name"": ""Fibrosis and Stricture Formation""}"
1832	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	7	TL1A-Mediated T Cell Activation	Tumor necrosis factor-like ligand 1A (TL1A) activates T cells through death receptor 3 (DR3), promoting inflammatory cytokine production and recruitment of myeloid cells to sites of tissue damage.																																																								"{""description"": ""Tumor necrosis factor-like ligand 1A (TL1A) activates T cells through death receptor 3 (DR3), promoting inflammatory cytokine production and recruitment of myeloid cells to sites of tissue damage."", ""name"": ""TL1A-Mediated T Cell Activation""}"	"{""downstream"": [{""description"": ""Activated T cells produce chemokines that recruit macrophages to perianal inflammatory sites."", ""target"": ""Myeloid Cell Recruitment to Perianal Tissue""}]}"	"{""biological_processes"": [{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}], ""cell_types"": [{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Tumor necrosis factor-like ligand 1A (TL1A) activates T cells through death receptor 3 (DR3), promoting inflammatory cytokine production and recruitment of myeloid cells to sites of tissue damage."", ""downstream"": [{""description"": ""Activated T cells produce chemokines that recruit macrophages to perianal inflammatory sites."", ""target"": ""Myeloid Cell Recruitment to Perianal Tissue""}], ""locations"": [{""preferred_term"": ""Rectal mucosa"", ""term"": {""id"": ""UBERON:0003346"", ""label"": ""rectal mucosa""}}], ""name"": ""TL1A-Mediated T Cell Activation""}"
1833	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	8	Myeloid Cell Recruitment to Perianal Tissue	Chemokine-driven infiltration of macrophages and other myeloid cells into perianal tissues, establishing chronic inflammation.																																																								"{""description"": ""Chemokine-driven infiltration of macrophages and other myeloid cells into perianal tissues, establishing chronic inflammation."", ""name"": ""Myeloid Cell Recruitment to Perianal Tissue""}"	"{""downstream"": [{""description"": ""Recruited macrophages interact with resident fibroblasts, driving tissue remodeling."", ""target"": ""Myeloid-Stromal Cell Crosstalk""}]}"	"{""biological_processes"": [{""preferred_term"": ""Leukocyte migration"", ""term"": {""id"": ""GO:0050900"", ""label"": ""leukocyte migration""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Chemokine-driven infiltration of macrophages and other myeloid cells into perianal tissues, establishing chronic inflammation."", ""downstream"": [{""description"": ""Recruited macrophages interact with resident fibroblasts, driving tissue remodeling."", ""target"": ""Myeloid-Stromal Cell Crosstalk""}], ""locations"": [{""preferred_term"": ""Perianal region"", ""term"": {""id"": ""UBERON:0012336"", ""label"": ""perianal space""}}], ""name"": ""Myeloid Cell Recruitment to Perianal Tissue""}"
1834	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	9	Myeloid-Stromal Cell Crosstalk	Interferon-driven macrophage activation promotes fibroblast activation and matrix degradation, creating tissue disruption that leads to fistula tract formation.																																																								"{""description"": ""Interferon-driven macrophage activation promotes fibroblast activation and matrix degradation, creating tissue disruption that leads to fistula tract formation."", ""name"": ""Myeloid-Stromal Cell Crosstalk""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Type II interferon signaling"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}], ""description"": ""Interferon-driven macrophage activation promotes fibroblast activation and matrix degradation, creating tissue disruption that leads to fistula tract formation."", ""locations"": [{""preferred_term"": ""Perianal region"", ""term"": {""id"": ""UBERON:0012336"", ""label"": ""perianal space""}}], ""name"": ""Myeloid-Stromal Cell Crosstalk""}"
1869	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	0	Hamartomatous polyp formation in the gastrointestinal tract	"Cronkhite-Canada syndrome is characterized by widespread hamartomatous polyps involving the entire gastrointestinal tract, most commonly the stomach, small intestine, and colon. The polyps are composed of abundant lamina propria inflammatory infiltrate with cystic glands. Pathological examination shows gland/crypt changes including cystic dilatation filled with protein fluid or mucus, gland withering and branching, and lamina propria edema.
"																																																								"{""description"": ""Cronkhite-Canada syndrome is characterized by widespread hamartomatous polyps involving the entire gastrointestinal tract, most commonly the stomach, small intestine, and colon. The polyps are composed of abundant lamina propria inflammatory infiltrate with cystic glands. Pathological examination shows gland/crypt changes including cystic dilatation filled with protein fluid or mucus, gland withering and branching, and lamina propria edema.\n"", ""name"": ""Hamartomatous polyp formation in the gastrointestinal tract""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Epithelial cell proliferation"", ""term"": {""id"": ""GO:0050673"", ""label"": ""epithelial cell proliferation""}}, {""preferred_term"": ""Epithelial cell morphogenesis"", ""term"": {""id"": ""GO:0003382"", ""label"": ""epithelial cell morphogenesis""}}], ""description"": ""Cronkhite-Canada syndrome is characterized by widespread hamartomatous polyps involving the entire gastrointestinal tract, most commonly the stomach, small intestine, and colon. The polyps are composed of abundant lamina propria inflammatory infiltrate with cystic glands. Pathological examination shows gland/crypt changes including cystic dilatation filled with protein fluid or mucus, gland withering and branching, and lamina propria edema.\n"", ""evidence"": [{""explanation"": ""Describes the characteristic clinical presentation and gastrointestinal involvement in Cronkhite-Canada syndrome"", ""reference"": ""PMID:33163187"", ""snippet"": ""CCS is typically characterized by gastrointestinal symptoms, such as diarrhea and skin changes (e.g. alopecia, pigmentation, and nail atrophy). Endoscopic features include diffuse polyps throughout the entire gastrointestinal tract, except for the esophagus."", ""supports"": ""SUPPORT""}, {""explanation"": ""Comprehensive case series quantifies the distribution and frequency of polyp involvement across different GI segments"", ""reference"": ""PMID:39470508"", ""snippet"": ""CCS is characterized by an extremely rare, nonfamilial hamartomatous polyposis syndrome, in which polyps are distributed in the stomach and colon (90%), small intestine(80%), and rectum (67%), while sparing the esophagus."", ""supports"": ""SUPPORT""}], ""name"": ""Hamartomatous polyp formation in the gastrointestinal tract""}"
1870	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	1	Autoimmune and IgG4-mediated inflammation	"Evidence supports an autoimmune/inflammatory pathophysiology with IgG4-positive plasma cell infiltration in polyps, frequent autoantibodies including antinuclear antibody positivity, and association with other autoimmune diseases. CCS often responds to immunosuppressive therapy, further supporting immune-mediated pathogenesis.
"																																																								"{""description"": ""Evidence supports an autoimmune/inflammatory pathophysiology with IgG4-positive plasma cell infiltration in polyps, frequent autoantibodies including antinuclear antibody positivity, and association with other autoimmune diseases. CCS often responds to immunosuppressive therapy, further supporting immune-mediated pathogenesis.\n"", ""name"": ""Autoimmune and IgG4-mediated inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Plasma cell differentiation"", ""term"": {""id"": ""GO:0002317"", ""label"": ""plasma cell differentiation""}}, {""preferred_term"": ""Cytokine production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}], ""description"": ""Evidence supports an autoimmune/inflammatory pathophysiology with IgG4-positive plasma cell infiltration in polyps, frequent autoantibodies including antinuclear antibody positivity, and association with other autoimmune diseases. CCS often responds to immunosuppressive therapy, further supporting immune-mediated pathogenesis.\n"", ""evidence"": [{""explanation"": ""Establishes IgG4-positive plasma cell infiltration as a key pathogenic feature of Cronkhite-Canada syndrome"", ""reference"": ""PMID:33163187"", ""snippet"": ""IgG4-positive plasma-cell infiltration was also found in CCS polyps"", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates the progressive eosinophil and mast cell infiltration along the GI tract with IgG involvement in CCS pathology"", ""reference"": ""PMID:39470508"", ""snippet"": ""In this case, from the lower esophageal sphincter to the rectum, there is an increasing trend of eosinophil and mast cell infiltration. These lesions can cause a positive IgG result."", ""supports"": ""SUPPORT""}], ""name"": ""Autoimmune and IgG4-mediated inflammation""}"
1871	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	2	Epithelial barrier dysfunction and protein-losing enteropathy	"Mucosal inflammation and structural changes result in epithelial barrier dysfunction with protein loss into the gastrointestinal lumen. This leads to hypoalbuminemia, edema, malabsorption, and nutritional deficiencies that contribute to systemic manifestations including cutaneous findings.
"																																																								"{""description"": ""Mucosal inflammation and structural changes result in epithelial barrier dysfunction with protein loss into the gastrointestinal lumen. This leads to hypoalbuminemia, edema, malabsorption, and nutritional deficiencies that contribute to systemic manifestations including cutaneous findings.\n"", ""name"": ""Epithelial barrier dysfunction and protein-losing enteropathy""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Tight junction"", ""term"": {""id"": ""GO:0070160"", ""label"": ""tight junction""}}], ""description"": ""Mucosal inflammation and structural changes result in epithelial barrier dysfunction with protein loss into the gastrointestinal lumen. This leads to hypoalbuminemia, edema, malabsorption, and nutritional deficiencies that contribute to systemic manifestations including cutaneous findings.\n"", ""evidence"": [{""explanation"": ""Indicates the severe clinical consequences of CCS including complications from protein-losing enteropathy"", ""reference"": ""PMID:33163187"", ""snippet"": ""The prognosis of CCS is poor, with a 5-year mortality rate of 55%"", ""supports"": ""SUPPORT""}, {""explanation"": ""Establishes protein loss as a primary pathogenic feature accompanying the GI polyp changes in CCS"", ""reference"": ""PMID:39470508"", ""snippet"": ""The primary distinct features of this syndrome include ectodermal abnormalities and diffuse gastrointestinal polyp changes accompanied by protein loss."", ""supports"": ""SUPPORT""}], ""name"": ""Epithelial barrier dysfunction and protein-losing enteropathy""}"
1872	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	3	Helicobacter pylori infection and dysbiosis	"Helicobacter pylori infection has been reported in approximately 50% of CCS cases, and symptom improvement following H. pylori eradication has been documented in some patients. Broader dysbiosis may contribute to mucosal inflammation and disease pathogenesis.
"																																																								"{""description"": ""Helicobacter pylori infection has been reported in approximately 50% of CCS cases, and symptom improvement following H. pylori eradication has been documented in some patients. Broader dysbiosis may contribute to mucosal inflammation and disease pathogenesis.\n"", ""name"": ""Helicobacter pylori infection and dysbiosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Defense response to bacterium"", ""term"": {""id"": ""GO:0042742"", ""label"": ""defense response to bacterium""}}], ""description"": ""Helicobacter pylori infection has been reported in approximately 50% of CCS cases, and symptom improvement following H. pylori eradication has been documented in some patients. Broader dysbiosis may contribute to mucosal inflammation and disease pathogenesis.\n"", ""evidence"": [{""explanation"": ""Documents the association between H. pylori infection and CCS with therapeutic improvement after eradication"", ""reference"": ""PMID:33163187"", ""snippet"": ""54% of patients with CCS had Hp infection and some studies noted that CCS was alleviated after Hp eradication"", ""supports"": ""SUPPORT""}, {""explanation"": ""Recent case demonstrates the gradual pattern of GI tract involvement that may reflect H. pylori-associated inflammation patterns"", ""reference"": ""PMID:39470508"", ""snippet"": ""Pathological analysis indicates that the extent and severity of lesions in the middle and lower gastrointestinal tract are more substantial than in the upper tract."", ""supports"": ""SUPPORT""}], ""name"": ""Helicobacter pylori infection and dysbiosis""}"
1884	79	Crouzon Syndrome	Crouzon_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"Mutations in FGFR2, predominantly in the third immunoglobulin-like domain (Ig-III) and linker regions, cause constitutive receptor activation or altered ligand binding. This leads to premature osteogenic differentiation in cranial suture mesenchyme and suture fusion.
"																																																								"{""description"": ""Mutations in FGFR2, predominantly in the third immunoglobulin-like domain (Ig-III) and linker regions, cause constitutive receptor activation or altered ligand binding. This leads to premature osteogenic differentiation in cranial suture mesenchyme and suture fusion.\n"", ""name"": ""FGFR2 Gain-of-Function Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}, {""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""Mutations in FGFR2, predominantly in the third immunoglobulin-like domain (Ig-III) and linker regions, cause constitutive receptor activation or altered ligand binding. This leads to premature osteogenic differentiation in cranial suture mesenchyme and suture fusion.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that FGFR2 mutations in the Ig-III domain are found in a substantial proportion of Crouzon syndrome patients, supporting the pathophysiology centered on FGFR2 dysfunction."", ""reference"": ""PMID:7493034"", ""snippet"": ""we have identified 10 different mutations in the FGFR2 extracellular immunoglobulin III (IgIII) domain in 50% (16/32) of our Crouzon syndrome patients"", ""supports"": ""SUPPORT""}], ""name"": ""FGFR2 Gain-of-Function Signaling""}"
1895	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	pathophysiology	0	FGFR3 A391E Gain-of-Function	"The A391E mutation in the transmembrane domain of FGFR3 causes ligand-independent receptor dimerization and constitutive activation. This affects both skeletal (craniosynostosis) and cutaneous (acanthosis nigricans) tissues through enhanced downstream signaling including MAPK and STAT pathways.
"																																																								"{""description"": ""The A391E mutation in the transmembrane domain of FGFR3 causes ligand-independent receptor dimerization and constitutive activation. This affects both skeletal (craniosynostosis) and cutaneous (acanthosis nigricans) tissues through enhanced downstream signaling including MAPK and STAT pathways.\n"", ""name"": ""FGFR3 A391E Gain-of-Function""}"	{}	"{""biological_processes"": [{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}, {""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}, {""preferred_term"": ""Epidermal Cell Differentiation"", ""term"": {""id"": ""GO:0009913"", ""label"": ""epidermal cell differentiation""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}, {""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""description"": ""The A391E mutation in the transmembrane domain of FGFR3 causes ligand-independent receptor dimerization and constitutive activation. This affects both skeletal (craniosynostosis) and cutaneous (acanthosis nigricans) tissues through enhanced downstream signaling including MAPK and STAT pathways.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This evidence supports the gain-of-function mechanism where FGFR3 mutations cause constitutive receptor activation leading to the disease phenotype.\n"", ""reference"": ""PMID:10696568"", ""snippet"": ""Recent evidence suggests that the phenotypic differences may be due to specific alleles with varying degrees of ligand-independent activation, allowing the receptor to be constitutively active."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that FGFR3 mutations can affect multiple tissue types including both skeletal (craniosynostosis) and cutaneous (acanthosis nigricans) tissues.\n"", ""reference"": ""PMID:7493034"", ""snippet"": ""The association of non-dwarfing and even non-skeletal conditions with FGFR3 mutations reveals the potential for a wide range of FGFR pleiotropic effects as well as locus heterogeneity in Crouzon syndrome."", ""supports"": ""SUPPORT""}], ""name"": ""FGFR3 A391E Gain-of-Function""}"
1904	81	Cushing's Syndrome	Cushings_Syndrome.yaml	pathophysiology	0	Chronic Cortisol Excess	"Cushing's syndrome results from prolonged exposure to excess glucocorticoids, either exogenous (iatrogenic from corticosteroid therapy) or endogenous (from pituitary adenomas secreting ACTH, adrenal tumors, or ectopic ACTH production). Elevated cortisol causes widespread metabolic, immunologic, and cardiovascular effects.
"																																																								"{""description"": ""Cushing's syndrome results from prolonged exposure to excess glucocorticoids, either exogenous (iatrogenic from corticosteroid therapy) or endogenous (from pituitary adenomas secreting ACTH, adrenal tumors, or ectopic ACTH production). Elevated cortisol causes widespread metabolic, immunologic, and cardiovascular effects.\n"", ""name"": ""Chronic Cortisol Excess""}"	{}	"{""biological_processes"": [{""preferred_term"": ""glucocorticoid secretion"", ""term"": {""id"": ""GO:0035933"", ""label"": ""glucocorticoid secretion""}}], ""cell_types"": [{""preferred_term"": ""glucocorticoid secreting cell"", ""term"": {""id"": ""CL:0000460"", ""label"": ""glucocorticoid secreting cell""}}], ""description"": ""Cushing's syndrome results from prolonged exposure to excess glucocorticoids, either exogenous (iatrogenic from corticosteroid therapy) or endogenous (from pituitary adenomas secreting ACTH, adrenal tumors, or ectopic ACTH production). Elevated cortisol causes widespread metabolic, immunologic, and cardiovascular effects.\n"", ""evidence"": [{""explanation"": ""This review confirms the fundamental pathophysiology of Cushing's syndrome as prolonged cortisol excess."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing syndrome is defined as a prolonged increase in plasma cortisol levels that is not due to a physiological etiology."", ""supports"": ""SUPPORT""}], ""name"": ""Chronic Cortisol Excess""}"
1905	81	Cushing's Syndrome	Cushings_Syndrome.yaml	pathophysiology	1	Hypothalamic-Pituitary-Adrenal Axis Dysregulation	"In endogenous Cushing's, the normal negative feedback regulation of cortisol on the HPA axis is disrupted. ACTH-dependent forms involve autonomous ACTH secretion from pituitary or ectopic sources, while ACTH-independent forms involve autonomous adrenal cortisol production bypassing normal regulation.
"																																																								"{""description"": ""In endogenous Cushing's, the normal negative feedback regulation of cortisol on the HPA axis is disrupted. ACTH-dependent forms involve autonomous ACTH secretion from pituitary or ectopic sources, while ACTH-independent forms involve autonomous adrenal cortisol production bypassing normal regulation.\n"", ""name"": ""Hypothalamic-Pituitary-Adrenal Axis Dysregulation""}"	{}	"{""cell_types"": [{""preferred_term"": ""corticotroph"", ""term"": {""id"": ""CL:0002309"", ""label"": ""corticotroph""}}], ""description"": ""In endogenous Cushing's, the normal negative feedback regulation of cortisol on the HPA axis is disrupted. ACTH-dependent forms involve autonomous ACTH secretion from pituitary or ectopic sources, while ACTH-independent forms involve autonomous adrenal cortisol production bypassing normal regulation.\n"", ""evidence"": [{""explanation"": ""This confirms that ACTH-secreting pituitary tumors are the most common cause of endogenous Cushing's, representing HPA axis dysregulation."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing disease, in which corticotropin excess is produced by a benign pituitary tumor, occurs in approximately 60% to 70% of patients with Cushing syndrome due to endogenous cortisol production."", ""supports"": ""SUPPORT""}], ""name"": ""Hypothalamic-Pituitary-Adrenal Axis Dysregulation""}"
1906	81	Cushing's Syndrome	Cushings_Syndrome.yaml	pathophysiology	2	Metabolic Consequences of Hypercortisolism	"Chronic cortisol excess induces insulin resistance, hepatic gluconeogenesis, protein catabolism in muscle and skin, redistribution of adipose tissue to central deposits, and altered lipid metabolism, leading to the characteristic phenotypic features of the syndrome.
"																																																								"{""description"": ""Chronic cortisol excess induces insulin resistance, hepatic gluconeogenesis, protein catabolism in muscle and skin, redistribution of adipose tissue to central deposits, and altered lipid metabolism, leading to the characteristic phenotypic features of the syndrome.\n"", ""name"": ""Metabolic Consequences of Hypercortisolism""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to glucocorticoid"", ""term"": {""id"": ""GO:0051384"", ""label"": ""response to glucocorticoid""}}], ""description"": ""Chronic cortisol excess induces insulin resistance, hepatic gluconeogenesis, protein catabolism in muscle and skin, redistribution of adipose tissue to central deposits, and altered lipid metabolism, leading to the characteristic phenotypic features of the syndrome.\n"", ""evidence"": [{""explanation"": ""This confirms the metabolic consequences including hyperglycemia, protein catabolism, and weight gain."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders."", ""supports"": ""SUPPORT""}], ""name"": ""Metabolic Consequences of Hypercortisolism""}"
1919	82	Cystic echinococcosis	Cystic_Echinococcosis.yaml	pathophysiology	0	Hepatic cyst formation	Larval cysts commonly develop in the liver.																																																								"{""description"": ""Larval cysts commonly develop in the liver."", ""name"": ""Hepatic cyst formation""}"	{}	"{""description"": ""Larval cysts commonly develop in the liver."", ""evidence"": [{""explanation"": ""The abstract reports predominant liver cyst formation."", ""reference"": ""PMID:27047771"", ""snippet"": ""Upon infection with CE, cyst formation mainly occurs in the liver (70%)."", ""supports"": ""SUPPORT""}], ""name"": ""Hepatic cyst formation""}"
1934	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	pathophysiology	0	CFTR Dysfunction	"Mutations in CFTR gene cause defective chloride channel function. Impaired chloride and bicarbonate transport leads to thick, dehydrated secretions in airways, pancreas, and other organs.
"																																																								"{""description"": ""Mutations in CFTR gene cause defective chloride channel function. Impaired chloride and bicarbonate transport leads to thick, dehydrated secretions in airways, pancreas, and other organs.\n"", ""name"": ""CFTR Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Chloride Transport"", ""term"": {""id"": ""GO:0006821"", ""label"": ""chloride transport""}}], ""description"": ""Mutations in CFTR gene cause defective chloride channel function. Impaired chloride and bicarbonate transport leads to thick, dehydrated secretions in airways, pancreas, and other organs.\n"", ""evidence"": [{""explanation"": ""Comprehensive review establishes CFTR as chloride channel whose dysfunction causes cystic fibrosis."", ""reference"": ""PMID:9922375"", ""snippet"": ""The cystic fibrosis transmembrane conductance regulator (CFTR) is a unique member of the ABC transporter family that forms a novel Cl- channel. It is located predominantly in the apical membrane of epithelia where it mediates transepithelial salt and liquid movement. Dysfunction of CFTR causes the genetic disease cystic fibrosis."", ""supports"": ""SUPPORT""}], ""name"": ""CFTR Dysfunction""}"
1935	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	pathophysiology	1	Airway Mucus Obstruction	"Defective CFTR leads to depleted airway surface liquid and thick mucus. Impaired mucociliary clearance causes chronic bacterial infection, inflammation, and progressive bronchiectasis.
"																																																								"{""description"": ""Defective CFTR leads to depleted airway surface liquid and thick mucus. Impaired mucociliary clearance causes chronic bacterial infection, inflammation, and progressive bronchiectasis.\n"", ""name"": ""Airway Mucus Obstruction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Mucus Secretion"", ""term"": {""id"": ""GO:0070254"", ""label"": ""mucus secretion""}}], ""cell_types"": [{""preferred_term"": ""Airway Epithelial Cell"", ""term"": {""id"": ""CL:0002328"", ""label"": ""bronchial epithelial cell""}}], ""description"": ""Defective CFTR leads to depleted airway surface liquid and thick mucus. Impaired mucociliary clearance causes chronic bacterial infection, inflammation, and progressive bronchiectasis.\n"", ""name"": ""Airway Mucus Obstruction""}"
1936	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	pathophysiology	2	Pancreatic Insufficiency	"Thick secretions obstruct pancreatic ducts, causing autodigestion, fibrosis, and exocrine pancreatic insufficiency. Malabsorption of fats and fat-soluble vitamins results.
"																																																								"{""description"": ""Thick secretions obstruct pancreatic ducts, causing autodigestion, fibrosis, and exocrine pancreatic insufficiency. Malabsorption of fats and fat-soluble vitamins results.\n"", ""name"": ""Pancreatic Insufficiency""}"	{}	"{""cell_types"": [{""preferred_term"": ""Pancreatic Acinar Cell"", ""term"": {""id"": ""CL:0002064"", ""label"": ""pancreatic acinar cell""}}], ""description"": ""Thick secretions obstruct pancreatic ducts, causing autodigestion, fibrosis, and exocrine pancreatic insufficiency. Malabsorption of fats and fat-soluble vitamins results.\n"", ""name"": ""Pancreatic Insufficiency""}"
1954	84	Danon disease	Danon_disease.yaml	pathophysiology	0	LAMP2 protein deficiency	"Mutations in the LAMP2 gene lead to deficiency of lysosome-associated membrane protein 2, particularly the LAMP-2B isoform which is essential for proper autophagosome-lysosome fusion in cardiac and skeletal muscle cells.
"																																																								"{""description"": ""Mutations in the LAMP2 gene lead to deficiency of lysosome-associated membrane protein 2, particularly the LAMP-2B isoform which is essential for proper autophagosome-lysosome fusion in cardiac and skeletal muscle cells.\n"", ""name"": ""LAMP2 protein deficiency""}"	"{""downstream"": [{""description"": ""LAMP-2B deficiency prevents proper docking and fusion of autophagosomes with lysosomes, blocking completion of the autophagy pathway.\n"", ""target"": ""Impaired autophagosome-lysosome fusion""}]}"	"{""biological_processes"": [{""preferred_term"": ""lysosome organization"", ""term"": {""id"": ""GO:0007040"", ""label"": ""lysosome organization""}}], ""cell_types"": [{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}, {""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}], ""description"": ""Mutations in the LAMP2 gene lead to deficiency of lysosome-associated membrane protein 2, particularly the LAMP-2B isoform which is essential for proper autophagosome-lysosome fusion in cardiac and skeletal muscle cells.\n"", ""downstream"": [{""description"": ""LAMP-2B deficiency prevents proper docking and fusion of autophagosomes with lysosomes, blocking completion of the autophagy pathway.\n"", ""target"": ""Impaired autophagosome-lysosome fusion""}], ""evidence"": [{""explanation"": ""Confirms that LAMP-2 deficiency disrupts autophagy through impaired lysosome-autophagosome fusion."", ""reference"": ""DOI:10.1111/nan.12587"", ""snippet"": ""The primary deficiency of lysosome-associated membrane protein-2 (LAMP-2) causes disruption of autophagy, leading to an impaired fusion of lysosomes to autophagosomes and biogenesis of lysosomes."", ""supports"": ""SUPPORT""}], ""name"": ""LAMP2 protein deficiency""}"
1955	84	Danon disease	Danon_disease.yaml	pathophysiology	1	Impaired autophagosome-lysosome fusion	"LAMP-2B deficiency causes a late-stage block in the autophagy pathway by preventing fusion of autophagosomes with lysosomes, leading to accumulation of unprocessed autophagosomes.
"																																																								"{""description"": ""LAMP-2B deficiency causes a late-stage block in the autophagy pathway by preventing fusion of autophagosomes with lysosomes, leading to accumulation of unprocessed autophagosomes.\n"", ""name"": ""Impaired autophagosome-lysosome fusion""}"	"{""downstream"": [{""description"": ""Failed fusion results in accumulation of autophagic vacuoles containing undegraded cellular material and glycogen.\n"", ""target"": ""Autophagic vacuole accumulation""}, {""description"": ""Defective autophagosome-lysosome fusion specifically impairs clearance of damaged mitochondria via mitophagy.\n"", ""target"": ""Impaired mitophagy""}]}"	"{""biological_processes"": [{""preferred_term"": ""macroautophagy"", ""term"": {""id"": ""GO:0016236"", ""label"": ""macroautophagy""}}, {""preferred_term"": ""autophagosome maturation"", ""term"": {""id"": ""GO:0097352"", ""label"": ""autophagosome maturation""}}], ""cell_types"": [{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}, {""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}], ""description"": ""LAMP-2B deficiency causes a late-stage block in the autophagy pathway by preventing fusion of autophagosomes with lysosomes, leading to accumulation of unprocessed autophagosomes.\n"", ""downstream"": [{""description"": ""Failed fusion results in accumulation of autophagic vacuoles containing undegraded cellular material and glycogen.\n"", ""target"": ""Autophagic vacuole accumulation""}, {""description"": ""Defective autophagosome-lysosome fusion specifically impairs clearance of damaged mitochondria via mitophagy.\n"", ""target"": ""Impaired mitophagy""}], ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Demonstrates that LAMP2 mutations cause impaired autophagosome-lysosome fusion and lysosome biogenesis defects."", ""reference"": ""DOI:10.1038/cddis.2016.475"", ""snippet"": ""DD is characterized by mutations in the lysosome-associated membrane protein 2 (LAMP2) gene. The DD mouse model suggests that inefficient lysosome biogenesis/maturation and impairment of autophagosome-lysosome fusion contribute to the pathogenesis of muscle wasting."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired autophagosome-lysosome fusion""}"
1956	84	Danon disease	Danon_disease.yaml	pathophysiology	2	Autophagic vacuole accumulation	"Accumulation of autophagic vacuoles with sarcolemmal features (AVSFs) in cardiac and skeletal muscle. These vacuoles contain glycogen and undegraded cellular components, representing a histopathological hallmark distinct from other glycogen storage disorders.
"																																																								"{""description"": ""Accumulation of autophagic vacuoles with sarcolemmal features (AVSFs) in cardiac and skeletal muscle. These vacuoles contain glycogen and undegraded cellular components, representing a histopathological hallmark distinct from other glycogen storage disorders.\n"", ""name"": ""Autophagic vacuole accumulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""macroautophagy"", ""term"": {""id"": ""GO:0016236"", ""label"": ""macroautophagy""}}], ""cell_types"": [{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}, {""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}], ""description"": ""Accumulation of autophagic vacuoles with sarcolemmal features (AVSFs) in cardiac and skeletal muscle. These vacuoles contain glycogen and undegraded cellular components, representing a histopathological hallmark distinct from other glycogen storage disorders.\n"", ""evidence"": [{""explanation"": ""Confirms AVSFs as a pathological hallmark of Danon disease."", ""reference"": ""DOI:10.3390/biom14101272"", ""snippet"": ""Pathologically, the disease is characterized by the appearance of unique autophagic vacuoles with sarcolemmal features (AVSFs)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Establishes Danon disease as a lysosomal storage disorder with autophagic vacuolar myopathy."", ""reference"": ""DOI:10.1038/cddis.2016.475"", ""snippet"": ""Among them, Danon Disease (DD) and glycogen storage disease type II (GSDII) are due to primary lysosomal protein defects."", ""supports"": ""SUPPORT""}], ""name"": ""Autophagic vacuole accumulation""}"
1957	84	Danon disease	Danon_disease.yaml	pathophysiology	3	Impaired mitophagy	"Defective autophagosome-lysosome fusion specifically impairs the mitophagy pathway, preventing clearance of damaged and depolarized mitochondria from cardiomyocytes.
"																																																								"{""description"": ""Defective autophagosome-lysosome fusion specifically impairs the mitophagy pathway, preventing clearance of damaged and depolarized mitochondria from cardiomyocytes.\n"", ""name"": ""Impaired mitophagy""}"	"{""downstream"": [{""description"": ""Accumulation of damaged mitochondria leads to reduced respiration, increased reactive oxygen species production, and oxidative stress.\n"", ""target"": ""Mitochondrial dysfunction and oxidative stress""}]}"	"{""biological_processes"": [{""preferred_term"": ""mitophagy"", ""term"": {""id"": ""GO:0000423"", ""label"": ""mitophagy""}}], ""cell_types"": [{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""description"": ""Defective autophagosome-lysosome fusion specifically impairs the mitophagy pathway, preventing clearance of damaged and depolarized mitochondria from cardiomyocytes.\n"", ""downstream"": [{""description"": ""Accumulation of damaged mitochondria leads to reduced respiration, increased reactive oxygen species production, and oxidative stress.\n"", ""target"": ""Mitochondrial dysfunction and oxidative stress""}], ""evidence"": [{""explanation"": ""Confirms Danon disease as an autophagy-related disorder affecting muscle."", ""reference"": ""DOI:10.3390/biom14101272"", ""snippet"": ""This disease is one of the autophagy-related muscle diseases."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired mitophagy""}"
1958	84	Danon disease	Danon_disease.yaml	pathophysiology	4	Mitochondrial dysfunction and oxidative stress	"Accumulation of damaged and depolarized mitochondria results in reduced mitochondrial respiration, increased reactive oxygen species production, and oxidative stress, contributing to cardiomyocyte injury and arrhythmogenesis.
"																																																								"{""description"": ""Accumulation of damaged and depolarized mitochondria results in reduced mitochondrial respiration, increased reactive oxygen species production, and oxidative stress, contributing to cardiomyocyte injury and arrhythmogenesis.\n"", ""name"": ""Mitochondrial dysfunction and oxidative stress""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""cell_types"": [{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""description"": ""Accumulation of damaged and depolarized mitochondria results in reduced mitochondrial respiration, increased reactive oxygen species production, and oxidative stress, contributing to cardiomyocyte injury and arrhythmogenesis.\n"", ""evidence"": [{""explanation"": ""Confirms the role of autophagy dysfunction in muscle disease pathogenesis."", ""reference"": ""DOI:10.3390/biom14101272"", ""snippet"": ""This disease is one of the autophagy-related muscle diseases."", ""supports"": ""SUPPORT""}], ""name"": ""Mitochondrial dysfunction and oxidative stress""}"
1969	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	pathophysiology	0	Alpha-Synuclein Aggregation and Lewy Body Formation	"DLB is characterized morphologically by widespread cortical and subcortical alpha-synuclein aggregation forming Lewy bodies and Lewy neurites. The alpha-synuclein pathology leads to neuronal dysfunction and is central to the disease pathogenesis. The distribution and severity of Lewy body pathology correlates with cognitive impairment and clinical features.
"																																																								"{""description"": ""DLB is characterized morphologically by widespread cortical and subcortical alpha-synuclein aggregation forming Lewy bodies and Lewy neurites. The alpha-synuclein pathology leads to neuronal dysfunction and is central to the disease pathogenesis. The distribution and severity of Lewy body pathology correlates with cognitive impairment and clinical features.\n"", ""name"": ""Alpha-Synuclein Aggregation and Lewy Body Formation""}"	"{""downstream"": [{""target"": ""Neuronal Death""}, {""target"": ""Cognitive Impairment and Dementia""}]}"	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""DLB is characterized morphologically by widespread cortical and subcortical alpha-synuclein aggregation forming Lewy bodies and Lewy neurites. The alpha-synuclein pathology leads to neuronal dysfunction and is central to the disease pathogenesis. The distribution and severity of Lewy body pathology correlates with cognitive impairment and clinical features.\n"", ""downstream"": [{""target"": ""Neuronal Death""}, {""target"": ""Cognitive Impairment and Dementia""}], ""evidence"": [{""explanation"": ""This confirms that alpha-synuclein aggregation forming Lewy bodies is the central pathological feature of DLB, distributed throughout cortical and subcortical regions."", ""reference"": ""PMID:29222591"", ""snippet"": ""Both are characterized morphologically by widespread cortical and subcortical -synuclein/Lewy body plus -amyloid and tau pathologies."", ""supports"": ""SUPPORT""}], ""name"": ""Alpha-Synuclein Aggregation and Lewy Body Formation""}"
1970	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	pathophysiology	1	Autophagy-Lysosome Dysfunction	"Impaired autophagy and lysosomal functions are central to DLB pathogenesis. Neurons are particularly vulnerable to autophagy-lysosomal defects due to their postmitotic nature and polarized morphologies. Mutations in genes regulating autophagy and lysosomal functions, particularly GBA, contribute to impaired clearance of alpha-synuclein aggregates and damaged organelles. This dysfunction creates a vicious cycle where accumulating protein aggregates further impair the autophagic-lysosomal system.
"																																																								"{""description"": ""Impaired autophagy and lysosomal functions are central to DLB pathogenesis. Neurons are particularly vulnerable to autophagy-lysosomal defects due to their postmitotic nature and polarized morphologies. Mutations in genes regulating autophagy and lysosomal functions, particularly GBA, contribute to impaired clearance of alpha-synuclein aggregates and damaged organelles. This dysfunction creates a vicious cycle where accumulating protein aggregates further impair the autophagic-lysosomal system.\n"", ""name"": ""Autophagy-Lysosome Dysfunction""}"	"{""downstream"": [{""target"": ""Alpha-Synuclein Aggregation and Lewy Body Formation""}]}"	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Impaired autophagy and lysosomal functions are central to DLB pathogenesis. Neurons are particularly vulnerable to autophagy-lysosomal defects due to their postmitotic nature and polarized morphologies. Mutations in genes regulating autophagy and lysosomal functions, particularly GBA, contribute to impaired clearance of alpha-synuclein aggregates and damaged organelles. This dysfunction creates a vicious cycle where accumulating protein aggregates further impair the autophagic-lysosomal system.\n"", ""downstream"": [{""target"": ""Alpha-Synuclein Aggregation and Lewy Body Formation""}], ""evidence"": [{""explanation"": ""This establishes that autophagy-lysosome dysfunction is a fundamental mechanism in neurodegenerative diseases including Parkinson disease and related Lewy body disorders."", ""reference"": ""PMID:39107446"", ""snippet"": ""Autophagy is a lysosome-based degradative process used to recycle obsolete cellular constituents and eliminate damaged organelles and aggregate-prone proteins. Their postmitotic nature and extremely polarized morphologies make neurons particularly vulnerable to disruptions caused by autophagy-lysosomal defects, especially as the brain ages."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms that autophagy dysfunction is a key therapeutic target in DLB, with autophagy-enhancing agents being developed as potential disease-modifying therapies."", ""reference"": ""PMID:40598239"", ""snippet"": ""In particular, we highlight antibody-based therapies to attenuate protein aggregation, compounds that enhance the generation of cellular energy and autophagy-enhancing agents as particular areas of promise."", ""supports"": ""SUPPORT""}], ""name"": ""Autophagy-Lysosome Dysfunction""}"
1971	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	pathophysiology	2	Neuronal Death	"Progressive loss of neurons due to alpha-synuclein pathology and associated proteinopathies, leading to brain atrophy particularly in cortical and limbic regions. The neurodegeneration underlies the progressive cognitive decline and other clinical features of DLB.
"																																																								"{""description"": ""Progressive loss of neurons due to alpha-synuclein pathology and associated proteinopathies, leading to brain atrophy particularly in cortical and limbic regions. The neurodegeneration underlies the progressive cognitive decline and other clinical features of DLB.\n"", ""name"": ""Neuronal Death""}"	{}	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Progressive loss of neurons due to alpha-synuclein pathology and associated proteinopathies, leading to brain atrophy particularly in cortical and limbic regions. The neurodegeneration underlies the progressive cognitive decline and other clinical features of DLB.\n"", ""evidence"": [{""explanation"": ""This demonstrates that the alpha-synuclein pathology leads to cortical atrophy through neuronal loss, particularly pronounced in cortical and limbic regions."", ""reference"": ""PMID:29222591"", ""snippet"": ""Intravitam PET and post-mortem studies revealed more pronounced cortical atrophy, elevated cortical and limbic Lewy pathologies."", ""supports"": ""SUPPORT""}], ""name"": ""Neuronal Death""}"
1979	86	Dengue	Dengue.yaml	pathophysiology	0	Plasma leakage leading to shock in severe dengue	Severe dengue involves plasma leakage that can progress to hypovolemic shock.																																																								"{""description"": ""Severe dengue involves plasma leakage that can progress to hypovolemic shock."", ""name"": ""Plasma leakage leading to shock in severe dengue""}"	{}	"{""description"": ""Severe dengue involves plasma leakage that can progress to hypovolemic shock."", ""evidence"": [{""explanation"": ""The review highlights plasma leakage and shock in severe dengue."", ""reference"": ""PMID:32265181"", ""snippet"": ""Plasma leakages is the main pathophysiological hallmark that distinguishes DHF from DF. Severe plasma leakage can result in hypovolemic shock."", ""supports"": ""SUPPORT""}], ""name"": ""Plasma leakage leading to shock in severe dengue""}"
1990	87	Dermatofibrosarcoma Protuberans	Dermatofibrosarcoma_Protuberans.yaml	pathophysiology	0	COL1A1-PDGFB Fusion Oncogene	The t(17;22)(q22;q13) translocation or supernumerary ring chromosomes containing material from chromosomes 17 and 22 fuse the COL1A1 gene to PDGFB. This places PDGFB under control of the highly active COL1A1 promoter, resulting in constitutive expression of a functional PDGF-BB growth factor.																																																								"{""description"": ""The t(17;22)(q22;q13) translocation or supernumerary ring chromosomes containing material from chromosomes 17 and 22 fuse the COL1A1 gene to PDGFB. This places PDGFB under control of the highly active COL1A1 promoter, resulting in constitutive expression of a functional PDGF-BB growth factor."", ""name"": ""COL1A1-PDGFB Fusion Oncogene""}"	"{""downstream"": [{""description"": ""PDGF-BB secretion activates PDGFR-beta on tumor cells"", ""target"": ""Autocrine PDGFR Signaling""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}], ""description"": ""The t(17;22)(q22;q13) translocation or supernumerary ring chromosomes containing material from chromosomes 17 and 22 fuse the COL1A1 gene to PDGFB. This places PDGFB under control of the highly active COL1A1 promoter, resulting in constitutive expression of a functional PDGF-BB growth factor."", ""downstream"": [{""description"": ""PDGF-BB secretion activates PDGFR-beta on tumor cells"", ""target"": ""Autocrine PDGFR Signaling""}], ""evidence"": [{""explanation"": ""Supports the COL1A1-PDGFB translocation as a driver in DFSP."", ""reference"": ""PMID:17397592"", ""snippet"": ""The demonstration of the oncogenic power of the translocation COL1A1-PDGFB in DFSP has allowed the successful introduction of drug therapy with antagonists of the PDGFB receptor for metastatic or locally advanced cases."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}], ""name"": ""COL1A1-PDGFB Fusion Oncogene""}"
1991	87	Dermatofibrosarcoma Protuberans	Dermatofibrosarcoma_Protuberans.yaml	pathophysiology	1	Autocrine PDGFR Signaling	Tumor cells secrete mature PDGF-BB which binds to PDGFR-beta on the same or neighboring tumor cells, creating an autocrine/paracrine growth loop. PDGFR-beta activation drives proliferation through the MAPK and PI3K pathways. This signaling can be blocked by imatinib.																																																								"{""description"": ""Tumor cells secrete mature PDGF-BB which binds to PDGFR-beta on the same or neighboring tumor cells, creating an autocrine/paracrine growth loop. PDGFR-beta activation drives proliferation through the MAPK and PI3K pathways. This signaling can be blocked by imatinib."", ""name"": ""Autocrine PDGFR Signaling""}"	"{""downstream"": [{""description"": ""PDGFR activation drives continuous cell division"", ""target"": ""Sustained Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Tumor cells secrete mature PDGF-BB which binds to PDGFR-beta on the same or neighboring tumor cells, creating an autocrine/paracrine growth loop. PDGFR-beta activation drives proliferation through the MAPK and PI3K pathways. This signaling can be blocked by imatinib."", ""downstream"": [{""description"": ""PDGFR activation drives continuous cell division"", ""target"": ""Sustained Proliferation""}], ""name"": ""Autocrine PDGFR Signaling""}"
1992	87	Dermatofibrosarcoma Protuberans	Dermatofibrosarcoma_Protuberans.yaml	pathophysiology	2	Sustained Proliferation	Constitutive PDGFR-beta signaling drives sustained proliferation of dermal fibroblasts. The infiltrative growth pattern with finger-like projections into subcutaneous fat explains the high local recurrence rate after incomplete excision.																																																								"{""description"": ""Constitutive PDGFR-beta signaling drives sustained proliferation of dermal fibroblasts. The infiltrative growth pattern with finger-like projections into subcutaneous fat explains the high local recurrence rate after incomplete excision."", ""name"": ""Sustained Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""Constitutive PDGFR-beta signaling drives sustained proliferation of dermal fibroblasts. The infiltrative growth pattern with finger-like projections into subcutaneous fat explains the high local recurrence rate after incomplete excision."", ""name"": ""Sustained Proliferation""}"
2004	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	0	Complement-Mediated Microangiopathy	Membrane attack complex (MAC) deposition on endomysial capillaries leads to capillary damage, ischemia, and perifascicular atrophy characteristic of dermatomyositis. This distinguishes it from polymyositis.																																																								"{""description"": ""Membrane attack complex (MAC) deposition on endomysial capillaries leads to capillary damage, ischemia, and perifascicular atrophy characteristic of dermatomyositis. This distinguishes it from polymyositis."", ""name"": ""Complement-Mediated Microangiopathy""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""cell_types"": [{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Membrane attack complex (MAC) deposition on endomysial capillaries leads to capillary damage, ischemia, and perifascicular atrophy characteristic of dermatomyositis. This distinguishes it from polymyositis."", ""evidence"": [{""explanation"": ""This evidence demonstrates that complement deposition is a characteristic pathological feature of dermatomyositis, contributing to muscle and endothelial cell injury through complement-dependent mechanisms."", ""reference"": ""PMID:38143369"", ""snippet"": ""Deposition of complement around capillaries and/or the sarcolemma was observed in muscle biopsy specimens from patients with DM, ASS, and IMNM, suggesting the pathomechanism of complement-dependent muscle and endothelial cell injury."", ""supports"": ""SUPPORT""}, {""explanation"": ""This evidence links the microangiopathy to the characteristic perifascicular atrophy observed in dermatomyositis, supporting the ischemic mechanism of muscle damage."", ""reference"": ""PMID:38143369"", ""snippet"": ""Juvenile DM is characterized by the loss of capillaries, perivascular inflammation, and small-vessel angiopathies, which may be related to microinfarction and perifascicular atrophy."", ""supports"": ""SUPPORT""}], ""name"": ""Complement-Mediated Microangiopathy""}"
2005	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	1	Type I Interferon Pathway Activation	Strong type I interferon signature in muscle and skin. Plasmacytoid dendritic cells accumulate in affected tissues and produce IFN-alpha, driving inflammation and MxA protein expression.																																																								"{""description"": ""Strong type I interferon signature in muscle and skin. Plasmacytoid dendritic cells accumulate in affected tissues and produce IFN-alpha, driving inflammation and MxA protein expression."", ""name"": ""Type I Interferon Pathway Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Type I Interferon Response"", ""term"": {""id"": ""GO:0034340"", ""label"": ""response to type I interferon""}}], ""cell_types"": [{""preferred_term"": ""Plasmacytoid Dendritic Cell"", ""term"": {""id"": ""CL:0000784"", ""label"": ""plasmacytoid dendritic cell""}}], ""description"": ""Strong type I interferon signature in muscle and skin. Plasmacytoid dendritic cells accumulate in affected tissues and produce IFN-alpha, driving inflammation and MxA protein expression."", ""evidence"": [{""explanation"": ""MxA expression is a hallmark of type I interferon activation in dermatomyositis, providing diagnostic and pathomechanistic insights."", ""reference"": ""PMID:38143369"", ""snippet"": ""The pathological observation of myxovirus resistance protein A (MxA), which suggests a type 1 interferon (IFN1) signature in DM, supports the diagnosis and further understanding of the pathomechanism of IIM."", ""supports"": ""SUPPORT""}, {""explanation"": ""This evidence confirms that type I interferon signaling is a central pathogenic mechanism in dermatomyositis, including juvenile forms."", ""reference"": ""PMID:39334579"", ""snippet"": ""Histopathological studies have revealed critical roles of type I interferons and vasculopathy in the development of JDM."", ""supports"": ""SUPPORT""}], ""name"": ""Type I Interferon Pathway Activation""}"
2006	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	2	Myositis-Specific Autoantibodies	Distinct autoantibodies define clinical phenotypes: anti-Mi-2 (classic dermatomyositis), anti-MDA5 (amyopathic with ILD), anti-TIF1-gamma (cancer-associated), and anti-NXP2 (calcinosis).																																																								"{""description"": ""Distinct autoantibodies define clinical phenotypes: anti-Mi-2 (classic dermatomyositis), anti-MDA5 (amyopathic with ILD), anti-TIF1-gamma (cancer-associated), and anti-NXP2 (calcinosis)."", ""name"": ""Myositis-Specific Autoantibodies""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""description"": ""Distinct autoantibodies define clinical phenotypes: anti-Mi-2 (classic dermatomyositis), anti-MDA5 (amyopathic with ILD), anti-TIF1-gamma (cancer-associated), and anti-NXP2 (calcinosis)."", ""evidence"": [{""explanation"": ""This evidence confirms that myositis-specific autoantibodies (MSAs) define distinct clinical phenotypes in dermatomyositis, supporting the concept of autoantibody-driven disease subtypes."", ""reference"": ""PMID:39334579"", ""snippet"": ""Each MSA or MAA is associated with distinct clinical features and outcomes, although there are several differences in the prevalence of MSA/MAA and autoantibody-phenotype relationships between age and ethnic groups."", ""supports"": ""SUPPORT""}], ""name"": ""Myositis-Specific Autoantibodies""}"
2007	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	3	CD4+ T Cell and B Cell Infiltration	Perivascular and perimysial infiltration by CD4+ T cells and B cells contributes to muscle inflammation. B cells may form tertiary lymphoid structures in muscle tissue.																																																								"{""description"": ""Perivascular and perimysial infiltration by CD4+ T cells and B cells contributes to muscle inflammation. B cells may form tertiary lymphoid structures in muscle tissue."", ""name"": ""CD4+ T Cell and B Cell Infiltration""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Adaptive Immune Response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}], ""cell_types"": [{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}, {""preferred_term"": ""B Cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""Perivascular and perimysial infiltration by CD4+ T cells and B cells contributes to muscle inflammation. B cells may form tertiary lymphoid structures in muscle tissue."", ""name"": ""CD4+ T Cell and B Cell Infiltration""}"
2023	89	Desmoplastic Small Round Cell Tumor	Desmoplastic_Small_Round_Cell_Tumor.yaml	pathophysiology	0	EWSR1-WT1 Fusion Oncogene	The t(11;22)(p13;q12) translocation fuses EWSR1 on chromosome 22 with WT1 on chromosome 11. The resulting fusion protein contains the potent transcriptional activation domain of EWSR1 fused to the zinc finger DNA-binding domain of WT1. This chimeric transcription factor activates aberrant gene expression programs including PDGFA.																																																								"{""description"": ""The t(11;22)(p13;q12) translocation fuses EWSR1 on chromosome 22 with WT1 on chromosome 11. The resulting fusion protein contains the potent transcriptional activation domain of EWSR1 fused to the zinc finger DNA-binding domain of WT1. This chimeric transcription factor activates aberrant gene expression programs including PDGFA."", ""name"": ""EWSR1-WT1 Fusion Oncogene""}"	"{""downstream"": [{""description"": ""EWSR1-WT1 drives expression of epithelial, mesenchymal, and neural markers"", ""target"": ""Multiphenotypic Differentiation""}, {""description"": ""EWSR1-WT1 directly activates PDGFA transcription"", ""target"": ""PDGFA Activation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}], ""description"": ""The t(11;22)(p13;q12) translocation fuses EWSR1 on chromosome 22 with WT1 on chromosome 11. The resulting fusion protein contains the potent transcriptional activation domain of EWSR1 fused to the zinc finger DNA-binding domain of WT1. This chimeric transcription factor activates aberrant gene expression programs including PDGFA."", ""downstream"": [{""description"": ""EWSR1-WT1 drives expression of epithelial, mesenchymal, and neural markers"", ""target"": ""Multiphenotypic Differentiation""}, {""description"": ""EWSR1-WT1 directly activates PDGFA transcription"", ""target"": ""PDGFA Activation""}], ""evidence"": [{""explanation"": ""Supports the presence of EWS-WT1 fusion transcripts in DSRCT."", ""reference"": ""PMID:20066421"", ""snippet"": ""Using microdissection techniques, EWS-WT1-gene fusion transcripts were detected in the cystic (single-cell-layered), the papillary and the solid tumor proliferations (exon 7 of EWS on chromosome 22 with exon 8 of WT1 on chromosome 11)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""peritoneum"", ""term"": {""id"": ""UBERON:0002358"", ""label"": ""peritoneum""}}], ""name"": ""EWSR1-WT1 Fusion Oncogene""}"
2024	89	Desmoplastic Small Round Cell Tumor	Desmoplastic_Small_Round_Cell_Tumor.yaml	pathophysiology	1	PDGFA Activation	EWSR1-WT1 directly activates transcription of PDGFA, creating an autocrine growth loop that stimulates tumor cell proliferation and may contribute to the characteristic desmoplastic stromal reaction.																																																								"{""description"": ""EWSR1-WT1 directly activates transcription of PDGFA, creating an autocrine growth loop that stimulates tumor cell proliferation and may contribute to the characteristic desmoplastic stromal reaction."", ""name"": ""PDGFA Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""EWSR1-WT1 directly activates transcription of PDGFA, creating an autocrine growth loop that stimulates tumor cell proliferation and may contribute to the characteristic desmoplastic stromal reaction."", ""name"": ""PDGFA Activation""}"
2025	89	Desmoplastic Small Round Cell Tumor	Desmoplastic_Small_Round_Cell_Tumor.yaml	pathophysiology	2	Multiphenotypic Differentiation	DSRCT displays a unique multiphenotypic immunophenotype with co-expression of epithelial (cytokeratin, EMA), mesenchymal (vimentin, desmin), and neural (NSE) markers. This reflects the aberrant differentiation program driven by EWSR1-WT1.																																																								"{""description"": ""DSRCT displays a unique multiphenotypic immunophenotype with co-expression of epithelial (cytokeratin, EMA), mesenchymal (vimentin, desmin), and neural (NSE) markers. This reflects the aberrant differentiation program driven by EWSR1-WT1."", ""name"": ""Multiphenotypic Differentiation""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}], ""description"": ""DSRCT displays a unique multiphenotypic immunophenotype with co-expression of epithelial (cytokeratin, EMA), mesenchymal (vimentin, desmin), and neural (NSE) markers. This reflects the aberrant differentiation program driven by EWSR1-WT1."", ""name"": ""Multiphenotypic Differentiation""}"
2044	90	Dieulafoy Lesion	Dieulafoy_Lesion.yaml	pathophysiology	0	Caliber-Persistent Submucosal Artery	"An abnormally large, tortuous submucosal artery fails to taper and can erode through intact mucosa, predisposing to arterial bleeding without prior ulceration.
"																																																								"{""description"": ""An abnormally large, tortuous submucosal artery fails to taper and can erode through intact mucosa, predisposing to arterial bleeding without prior ulceration.\n"", ""name"": ""Caliber-Persistent Submucosal Artery""}"	{}	"{""description"": ""An abnormally large, tortuous submucosal artery fails to taper and can erode through intact mucosa, predisposing to arterial bleeding without prior ulceration.\n"", ""evidence"": [{""explanation"": ""Review defines Dieulafoy lesion as a caliber-persistent submucosal artery that breaches mucosa without ulceration, causing bleeding."", ""reference"": ""PMID:35243119"", ""snippet"": ""Dieulafoy's lesion is an abnormally large, tortuous, submucosal vessel that erodes the overlying mucosa, without primary ulceration or erosion."", ""supports"": ""SUPPORT""}, {""explanation"": ""Case review reiterates the defining pathology of a large-caliber artery protruding through mucosa leading to hemorrhage."", ""reference"": ""PMID:37425531"", ""snippet"": ""A duodenal Dieulafoy lesion is characterized by the presence of a larger-caliber artery that protrudes through the GI mucosa and can lead to massive hemorrhage."", ""supports"": ""SUPPORT""}], ""name"": ""Caliber-Persistent Submucosal Artery""}"
2045	90	Dieulafoy Lesion	Dieulafoy_Lesion.yaml	pathophysiology	1	Exposed Aberrant Vessel with Intermittent Arterial Spurting	"The exposed artery protrudes through a tiny mucosal defect, producing intermittent, brisk arterial hemorrhage that can be difficult to localize endoscopically.
"																																																								"{""description"": ""The exposed artery protrudes through a tiny mucosal defect, producing intermittent, brisk arterial hemorrhage that can be difficult to localize endoscopically.\n"", ""name"": ""Exposed Aberrant Vessel with Intermittent Arterial Spurting""}"	{}	"{""description"": ""The exposed artery protrudes through a tiny mucosal defect, producing intermittent, brisk arterial hemorrhage that can be difficult to localize endoscopically.\n"", ""evidence"": [{""explanation"": ""Case review highlights the persistent caliber artery and intermittent, severe arterial bleeding typical of Dieulafoy lesions."", ""reference"": ""PMID:37065413"", ""snippet"": ""A Dieulafoy lesion is an aberrant vessel that does not reduce in caliber when it extends from the submucosa to the mucosa. Damage to this artery can result in severe, intermittent arterial bleeding from tiny, difficult-to-visualize vessel stumps."", ""supports"": ""SUPPORT""}], ""name"": ""Exposed Aberrant Vessel with Intermittent Arterial Spurting""}"
2062	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	0	Germinal Center B-cell Origin	DLBCL arises from germinal center or post-germinal center B cells undergoing somatic hypermutation and class switch recombination. These processes introduce DNA double-strand breaks that can lead to oncogenic translocations. The cell of origin determines molecular subtype and clinical behavior.																																																								"{""description"": ""DLBCL arises from germinal center or post-germinal center B cells undergoing somatic hypermutation and class switch recombination. These processes introduce DNA double-strand breaks that can lead to oncogenic translocations. The cell of origin determines molecular subtype and clinical behavior."", ""name"": ""Germinal Center B-cell Origin""}"	"{""downstream"": [{""description"": ""BCL2 translocation blocks germinal center apoptosis"", ""target"": ""BCL2 Overexpression and Apoptosis Resistance""}, {""description"": ""MYC rearrangement drives uncontrolled proliferation"", ""target"": ""MYC-Driven Proliferation""}]}"	"{""cell_types"": [{""preferred_term"": ""centrocyte"", ""term"": {""id"": ""CL:0009111"", ""label"": ""centrocyte""}}, {""preferred_term"": ""centroblast"", ""term"": {""id"": ""CL:0009112"", ""label"": ""centroblast""}}], ""description"": ""DLBCL arises from germinal center or post-germinal center B cells undergoing somatic hypermutation and class switch recombination. These processes introduce DNA double-strand breaks that can lead to oncogenic translocations. The cell of origin determines molecular subtype and clinical behavior."", ""downstream"": [{""description"": ""BCL2 translocation blocks germinal center apoptosis"", ""target"": ""BCL2 Overexpression and Apoptosis Resistance""}, {""description"": ""MYC rearrangement drives uncontrolled proliferation"", ""target"": ""MYC-Driven Proliferation""}], ""locations"": [{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}], ""name"": ""Germinal Center B-cell Origin""}"
2063	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	1	BCL2 Overexpression and Apoptosis Resistance	BCL2 translocation t(14;18) occurs in approximately 30% of GCB-DLBCL, placing BCL2 under immunoglobulin enhancer control. Resulting BCL2 overexpression blocks the mitochondrial apoptosis pathway, allowing survival of cells that would normally die in the germinal center.																																																								"{""description"": ""BCL2 translocation t(14;18) occurs in approximately 30% of GCB-DLBCL, placing BCL2 under immunoglobulin enhancer control. Resulting BCL2 overexpression blocks the mitochondrial apoptosis pathway, allowing survival of cells that would normally die in the germinal center."", ""name"": ""BCL2 Overexpression and Apoptosis Resistance""}"	"{""downstream"": [{""description"": ""Apoptosis resistance enables lymphoma expansion"", ""target"": ""Lymphoma Cell Accumulation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""BCL2 translocation t(14;18) occurs in approximately 30% of GCB-DLBCL, placing BCL2 under immunoglobulin enhancer control. Resulting BCL2 overexpression blocks the mitochondrial apoptosis pathway, allowing survival of cells that would normally die in the germinal center."", ""downstream"": [{""description"": ""Apoptosis resistance enables lymphoma expansion"", ""target"": ""Lymphoma Cell Accumulation""}], ""name"": ""BCL2 Overexpression and Apoptosis Resistance""}"
2064	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	2	MYC-Driven Proliferation	MYC rearrangements occur in 10-15% of DLBCL, most commonly with IGH but also with non-immunoglobulin partners. MYC overexpression drives cellular proliferation and metabolism. When combined with BCL2 rearrangement (double-hit lymphoma), creates highly aggressive disease.																																																								"{""description"": ""MYC rearrangements occur in 10-15% of DLBCL, most commonly with IGH but also with non-immunoglobulin partners. MYC overexpression drives cellular proliferation and metabolism. When combined with BCL2 rearrangement (double-hit lymphoma), creates highly aggressive disease."", ""name"": ""MYC-Driven Proliferation""}"	"{""downstream"": [{""description"": ""MYC drives rapid proliferation of lymphoma cells"", ""target"": ""Lymphoma Cell Accumulation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""MYC rearrangements occur in 10-15% of DLBCL, most commonly with IGH but also with non-immunoglobulin partners. MYC overexpression drives cellular proliferation and metabolism. When combined with BCL2 rearrangement (double-hit lymphoma), creates highly aggressive disease."", ""downstream"": [{""description"": ""MYC drives rapid proliferation of lymphoma cells"", ""target"": ""Lymphoma Cell Accumulation""}], ""name"": ""MYC-Driven Proliferation""}"
2065	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	3	NF-kB Constitutive Activation	ABC-DLBCL shows constitutive NF-kB activation through various mechanisms including BCR signaling mutations (CD79A/B), CARD11 mutations, MYD88 L265P mutation, or A20 deletion. NF-kB promotes survival and contributes to the aggressive behavior of ABC subtype.																																																								"{""description"": ""ABC-DLBCL shows constitutive NF-kB activation through various mechanisms including BCR signaling mutations (CD79A/B), CARD11 mutations, MYD88 L265P mutation, or A20 deletion. NF-kB promotes survival and contributes to the aggressive behavior of ABC subtype."", ""name"": ""NF-kB Constitutive Activation""}"	"{""downstream"": [{""description"": ""NF-kB signaling promotes lymphoma survival"", ""target"": ""Lymphoma Cell Accumulation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""ABC-DLBCL shows constitutive NF-kB activation through various mechanisms including BCR signaling mutations (CD79A/B), CARD11 mutations, MYD88 L265P mutation, or A20 deletion. NF-kB promotes survival and contributes to the aggressive behavior of ABC subtype."", ""downstream"": [{""description"": ""NF-kB signaling promotes lymphoma survival"", ""target"": ""Lymphoma Cell Accumulation""}], ""name"": ""NF-kB Constitutive Activation""}"
2066	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	pathophysiology	4	Lymphoma Cell Accumulation	The combination of blocked apoptosis, enhanced proliferation, and constitutive survival signaling leads to aggressive expansion of large B-cell lymphoma involving lymph nodes and extranodal sites.																																																								"{""description"": ""The combination of blocked apoptosis, enhanced proliferation, and constitutive survival signaling leads to aggressive expansion of large B-cell lymphoma involving lymph nodes and extranodal sites."", ""name"": ""Lymphoma Cell Accumulation""}"	{}	"{""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""The combination of blocked apoptosis, enhanced proliferation, and constitutive survival signaling leads to aggressive expansion of large B-cell lymphoma involving lymph nodes and extranodal sites."", ""locations"": [{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}], ""name"": ""Lymphoma Cell Accumulation""}"
2079	92	Dorsalgia	Dorsalgia.yaml	pathophysiology	0	Genetic and disc-related factors in back pain	Genetic variants associated with intervertebral disc disorder implicate cartilage, bone, and inflammatory processes in dorsalgia susceptibility.																																																								"{""description"": ""Genetic variants associated with intervertebral disc disorder implicate cartilage, bone, and inflammatory processes in dorsalgia susceptibility."", ""name"": ""Genetic and disc-related factors in back pain""}"	{}	"{""description"": ""Genetic variants associated with intervertebral disc disorder implicate cartilage, bone, and inflammatory processes in dorsalgia susceptibility."", ""evidence"": [{""explanation"": ""The GWAS links dorsalgia-related loci to cartilage, bone, neurologic, and inflammatory pathways."", ""reference"": ""PMID:35110524"", ""snippet"": ""Genes implicated by this study are involved in cartilage and bone biology, as well as neurological and inflammatory processes."", ""supports"": ""SUPPORT""}], ""name"": ""Genetic and disc-related factors in back pain""}"
2092	93	Down_syndrome	Down_syndrome.yaml	pathophysiology	0	Extra Chromosome 21	Presence of an additional chromosome 21 leads to developmental and physiological changes.																																																								"{""description"": ""Presence of an additional chromosome 21 leads to developmental and physiological changes."", ""name"": ""Extra Chromosome 21""}"	{}	"{""description"": ""Presence of an additional chromosome 21 leads to developmental and physiological changes."", ""evidence"": [{""explanation"": ""Establishes that trisomy 21 (extra chromosome 21) causes Down syndrome."", ""reference"": ""PMID:32029743"", ""snippet"": ""Trisomy 21, the presence of a supernumerary chromosome 21, results in a collection of clinical features commonly known as Down syndrome (DS)."", ""supports"": ""SUPPORT""}], ""name"": ""Extra Chromosome 21""}"
2093	93	Down_syndrome	Down_syndrome.yaml	pathophysiology	1	Interferon Hyperactivation	Chronic hyperactivation of interferon signaling driven by triplication of interferon receptor genes on chromosome 21, leading to immune dysregulation and neuroinflammation. Microglia adopt disease-associated and interferon-responsive states contributing to neuroinflammation.																																																								"{""description"": ""Chronic hyperactivation of interferon signaling driven by triplication of interferon receptor genes on chromosome 21, leading to immune dysregulation and neuroinflammation. Microglia adopt disease-associated and interferon-responsive states contributing to neuroinflammation."", ""name"": ""Interferon Hyperactivation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""type I interferon-mediated signaling pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon-mediated signaling pathway""}}, {""preferred_term"": ""cell surface receptor signaling pathway via JAK-STAT"", ""term"": {""id"": ""GO:0007259"", ""label"": ""cell surface receptor signaling pathway via JAK-STAT""}}], ""cell_types"": [{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Chronic hyperactivation of interferon signaling driven by triplication of interferon receptor genes on chromosome 21, leading to immune dysregulation and neuroinflammation. Microglia adopt disease-associated and interferon-responsive states contributing to neuroinflammation."", ""locations"": [{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}], ""name"": ""Interferon Hyperactivation""}"
2094	93	Down_syndrome	Down_syndrome.yaml	pathophysiology	2	Neurodevelopmental Alterations	Impaired neurogenesis with progenitor cell-cycle defects and shift from neuron to astrocyte differentiation, leading to reduced neuronal output and circuit dysfunction. Astrocytes show increased numbers and reactive states due to lineage shift from neurogenesis to astrogliogenesis.																																																								"{""description"": ""Impaired neurogenesis with progenitor cell-cycle defects and shift from neuron to astrocyte differentiation, leading to reduced neuronal output and circuit dysfunction. Astrocytes show increased numbers and reactive states due to lineage shift from neurogenesis to astrogliogenesis."", ""name"": ""Neurodevelopmental Alterations""}"	{}	"{""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Impaired neurogenesis with progenitor cell-cycle defects and shift from neuron to astrocyte differentiation, leading to reduced neuronal output and circuit dysfunction. Astrocytes show increased numbers and reactive states due to lineage shift from neurogenesis to astrogliogenesis."", ""locations"": [{""preferred_term"": ""Ammon's horn"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}], ""name"": ""Neurodevelopmental Alterations""}"
2111	94	Dracunculiasis	Dracunculiasis.yaml	pathophysiology	0	Larval transmission by copepods	Cyclops copepods transmit guinea worm larvae to humans.																																																								"{""description"": ""Cyclops copepods transmit guinea worm larvae to humans."", ""name"": ""Larval transmission by copepods""}"	{}	"{""description"": ""Cyclops copepods transmit guinea worm larvae to humans."", ""evidence"": [{""explanation"": ""The abstract identifies Cyclops copepods as transmitting vectors."", ""reference"": ""PMID:27162746"", ""snippet"": ""The transmitting vectors are Cyclops copepods (water fleas), which are tiny free-swimming crustaceans usually found abundantly in freshwater ponds."", ""supports"": ""SUPPORT""}], ""name"": ""Larval transmission by copepods""}"
2125	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	0	SCN1A Gene Mutation	Heterozygous loss-of-function mutations in SCN1A cause reduced Nav1.1 sodium channel function, primarily affecting GABAergic inhibitory interneurons, particularly parvalbumin-positive fast-spiking interneurons.																																																								"{""description"": ""Heterozygous loss-of-function mutations in SCN1A cause reduced Nav1.1 sodium channel function, primarily affecting GABAergic inhibitory interneurons, particularly parvalbumin-positive fast-spiking interneurons."", ""name"": ""SCN1A Gene Mutation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""voltage-gated sodium channel activity"", ""term"": {""id"": ""GO:0005248"", ""label"": ""voltage-gated sodium channel activity""}}, {""preferred_term"": ""neuronal action potential"", ""term"": {""id"": ""GO:0019228"", ""label"": ""neuronal action potential""}}], ""cell_types"": [{""preferred_term"": ""inhibitory interneuron"", ""term"": {""id"": ""CL:0000498"", ""label"": ""inhibitory interneuron""}}], ""description"": ""Heterozygous loss-of-function mutations in SCN1A cause reduced Nav1.1 sodium channel function, primarily affecting GABAergic inhibitory interneurons, particularly parvalbumin-positive fast-spiking interneurons."", ""evidence"": [{""reference"": ""PMID:21463282"", ""snippet"": ""Loss-of-function in Na(v) 1.1 channels results in severely impaired sodium current and action potential firing in hippocampal -aminobutyric acid (GABA)ergic interneurons without detectable changes in excitatory pyramidal neurons."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}, {""preferred_term"": ""Ammon's horn"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}], ""name"": ""SCN1A Gene Mutation""}"
2126	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	1	Neuronal Hyperexcitability	Reduced inhibitory interneuron function leads to excitatory-inhibitory imbalance and network hyperexcitability across cortico-hippocampal and thalamocortical circuits.																																																								"{""description"": ""Reduced inhibitory interneuron function leads to excitatory-inhibitory imbalance and network hyperexcitability across cortico-hippocampal and thalamocortical circuits."", ""name"": ""Neuronal Hyperexcitability""}"	{}	"{""biological_processes"": [{""preferred_term"": ""synaptic transmission, GABAergic"", ""term"": {""id"": ""GO:0051932"", ""label"": ""synaptic transmission, GABAergic""}}], ""cell_types"": [{""preferred_term"": ""inhibitory interneuron"", ""term"": {""id"": ""CL:0000498"", ""label"": ""inhibitory interneuron""}}], ""description"": ""Reduced inhibitory interneuron function leads to excitatory-inhibitory imbalance and network hyperexcitability across cortico-hippocampal and thalamocortical circuits."", ""evidence"": [{""reference"": ""PMID:21463282"", ""snippet"": ""The resulting imbalance between excitation and inhibition likely contributes to hyperexcitability and seizures."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}, {""preferred_term"": ""Ammon's horn"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}, {""preferred_term"": ""dorsal plus ventral thalamus"", ""term"": {""id"": ""UBERON:0001897"", ""label"": ""dorsal plus ventral thalamus""}}], ""name"": ""Neuronal Hyperexcitability""}"
2127	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	2	Astrocyte Dysregulation	Aberrant astrocyte calcium signaling and gliotransmission may exacerbate network hyperexcitability and seizure susceptibility.																																																								"{""description"": ""Aberrant astrocyte calcium signaling and gliotransmission may exacerbate network hyperexcitability and seizure susceptibility."", ""name"": ""Astrocyte Dysregulation""}"	{}	"{""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Aberrant astrocyte calcium signaling and gliotransmission may exacerbate network hyperexcitability and seizure susceptibility."", ""locations"": [{""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000956"", ""label"": ""cerebral cortex""}}, {""preferred_term"": ""Ammon's horn"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}], ""name"": ""Astrocyte Dysregulation""}"
2153	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	pathophysiology	0	Dystrophin Deficiency	"Mutations in the DMD gene cause absent or dysfunctional dystrophin protein. Dystrophin links the cytoskeleton to the extracellular matrix in muscle fibers, providing structural stability during contraction.
"																																																								"{""description"": ""Mutations in the DMD gene cause absent or dysfunctional dystrophin protein. Dystrophin links the cytoskeleton to the extracellular matrix in muscle fibers, providing structural stability during contraction.\n"", ""name"": ""Dystrophin Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Muscle Contraction"", ""term"": {""id"": ""GO:0006936"", ""label"": ""muscle contraction""}}], ""cell_types"": [{""preferred_term"": ""Skeletal Muscle Fiber"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}], ""description"": ""Mutations in the DMD gene cause absent or dysfunctional dystrophin protein. Dystrophin links the cytoskeleton to the extracellular matrix in muscle fibers, providing structural stability during contraction.\n"", ""evidence"": [{""explanation"": ""Review confirms dystrophin gene mutations cause membrane instability as the central pathogenic mechanism."", ""reference"": ""PMID:37435300"", ""snippet"": ""The identification of the dystrophin gene as central to DMD pathogenesis has led to the understanding of the muscle membrane and the proteins involved in membrane stability as the focal point of the disease."", ""supports"": ""SUPPORT""}], ""name"": ""Dystrophin Deficiency""}"
2154	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	pathophysiology	1	Progressive Muscle Degeneration	"Without dystrophin, muscle fibers are susceptible to contraction-induced damage. Repeated cycles of degeneration and regeneration exhaust satellite cell pools, leading to fibrosis and fatty replacement of muscle tissue.
"																																																								"{""description"": ""Without dystrophin, muscle fibers are susceptible to contraction-induced damage. Repeated cycles of degeneration and regeneration exhaust satellite cell pools, leading to fibrosis and fatty replacement of muscle tissue.\n"", ""name"": ""Progressive Muscle Degeneration""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Muscle Degeneration"", ""term"": {""id"": ""GO:0061061"", ""label"": ""muscle structure development""}}], ""cell_types"": [{""preferred_term"": ""Skeletal Muscle Fiber"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}], ""description"": ""Without dystrophin, muscle fibers are susceptible to contraction-induced damage. Repeated cycles of degeneration and regeneration exhaust satellite cell pools, leading to fibrosis and fatty replacement of muscle tissue.\n"", ""evidence"": [{""explanation"": ""Review confirms progressive muscle wasting is a defining feature of DMD."", ""reference"": ""PMID:37435300"", ""snippet"": ""Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy."", ""supports"": ""SUPPORT""}], ""name"": ""Progressive Muscle Degeneration""}"
2173	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	0	EBV Latent Infection of Gastric Epithelium	EBV establishes clonal latent infection in gastric epithelial cells, expressing a restricted set of latent genes including EBNA1 (required for viral genome maintenance), LMP2A (mimics B-cell receptor signaling), and non-coding EBERs. LMP1 expression is variable but when present activates NF-kappaB and MAPK pathways.																																																								"{""description"": ""EBV establishes clonal latent infection in gastric epithelial cells, expressing a restricted set of latent genes including EBNA1 (required for viral genome maintenance), LMP2A (mimics B-cell receptor signaling), and non-coding EBERs. LMP1 expression is variable but when present activates NF-kappaB and MAPK pathways."", ""name"": ""EBV Latent Infection of Gastric Epithelium""}"	"{""downstream"": [{""description"": ""EBV infection induces massive DNA methylation changes"", ""target"": ""Epigenetic Reprogramming and CIMP-High Phenotype""}, {""description"": ""LMP2A signaling and PIK3CA mutations activate survival pathways"", ""target"": ""PI3K-AKT Pathway Activation""}]}"	"{""biological_processes"": [{""preferred_term"": ""viral transcription"", ""term"": {""id"": ""GO:0019083"", ""label"": ""viral transcription""}}], ""cell_types"": [{""preferred_term"": ""epithelial cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}], ""description"": ""EBV establishes clonal latent infection in gastric epithelial cells, expressing a restricted set of latent genes including EBNA1 (required for viral genome maintenance), LMP2A (mimics B-cell receptor signaling), and non-coding EBERs. LMP1 expression is variable but when present activates NF-kappaB and MAPK pathways."", ""downstream"": [{""description"": ""EBV infection induces massive DNA methylation changes"", ""target"": ""Epigenetic Reprogramming and CIMP-High Phenotype""}, {""description"": ""LMP2A signaling and PIK3CA mutations activate survival pathways"", ""target"": ""PI3K-AKT Pathway Activation""}], ""locations"": [{""preferred_term"": ""stomach"", ""term"": {""id"": ""UBERON:0000945"", ""label"": ""stomach""}}], ""name"": ""EBV Latent Infection of Gastric Epithelium""}"
2174	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	1	Epigenetic Reprogramming and CIMP-High Phenotype	EBV-associated gastric cancer displays the most extreme CpG island methylator phenotype (CIMP) of any cancer type. EBV-encoded proteins, particularly LMP2A, induce aberrant DNA methylation leading to silencing of tumor suppressor genes including CDKN2A (p16), CDH1 (E-cadherin), and MLH1. This epigenetic reprogramming is a hallmark feature distinguishing EBV-positive from EBV-negative gastric cancers.																																																								"{""description"": ""EBV-associated gastric cancer displays the most extreme CpG island methylator phenotype (CIMP) of any cancer type. EBV-encoded proteins, particularly LMP2A, induce aberrant DNA methylation leading to silencing of tumor suppressor genes including CDKN2A (p16), CDH1 (E-cadherin), and MLH1. This epigenetic reprogramming is a hallmark feature distinguishing EBV-positive from EBV-negative gastric cancers."", ""name"": ""Epigenetic Reprogramming and CIMP-High Phenotype""}"	"{""downstream"": [{""description"": ""CDKN2A, CDH1, and other tumor suppressors are silenced by promoter methylation"", ""target"": ""Tumor Suppressor Gene Silencing""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""DNA methylation"", ""term"": {""id"": ""GO:0006306"", ""label"": ""DNA methylation""}}], ""description"": ""EBV-associated gastric cancer displays the most extreme CpG island methylator phenotype (CIMP) of any cancer type. EBV-encoded proteins, particularly LMP2A, induce aberrant DNA methylation leading to silencing of tumor suppressor genes including CDKN2A (p16), CDH1 (E-cadherin), and MLH1. This epigenetic reprogramming is a hallmark feature distinguishing EBV-positive from EBV-negative gastric cancers."", ""downstream"": [{""description"": ""CDKN2A, CDH1, and other tumor suppressors are silenced by promoter methylation"", ""target"": ""Tumor Suppressor Gene Silencing""}], ""name"": ""Epigenetic Reprogramming and CIMP-High Phenotype""}"
2175	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	PIK3CA mutations occur in approximately 80% of EBV-positive gastric cancers, the highest frequency of any gastric cancer subtype. Combined with LMP2A signaling which activates PI3K through mimicry of B-cell receptor signaling, this leads to constitutive AKT activation promoting cell survival and proliferation.																																																								"{""description"": ""PIK3CA mutations occur in approximately 80% of EBV-positive gastric cancers, the highest frequency of any gastric cancer subtype. Combined with LMP2A signaling which activates PI3K through mimicry of B-cell receptor signaling, this leads to constitutive AKT activation promoting cell survival and proliferation."", ""name"": ""PI3K-AKT Pathway Activation""}"	"{""downstream"": [{""description"": ""PI3K-AKT signaling promotes cell survival and growth"", ""target"": ""Uncontrolled Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""description"": ""PIK3CA mutations occur in approximately 80% of EBV-positive gastric cancers, the highest frequency of any gastric cancer subtype. Combined with LMP2A signaling which activates PI3K through mimicry of B-cell receptor signaling, this leads to constitutive AKT activation promoting cell survival and proliferation."", ""downstream"": [{""description"": ""PI3K-AKT signaling promotes cell survival and growth"", ""target"": ""Uncontrolled Cell Proliferation""}], ""name"": ""PI3K-AKT Pathway Activation""}"
2176	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	3	Tumor Suppressor Gene Silencing	Promoter hypermethylation silences multiple tumor suppressor genes. CDKN2A (p16INK4A) silencing removes G1/S checkpoint control. CDH1 (E-cadherin) silencing promotes epithelial-mesenchymal transition. Unlike other gastric cancer subtypes, TP53 mutations are rare in EBV-positive tumors.																																																								"{""description"": ""Promoter hypermethylation silences multiple tumor suppressor genes. CDKN2A (p16INK4A) silencing removes G1/S checkpoint control. CDH1 (E-cadherin) silencing promotes epithelial-mesenchymal transition. Unlike other gastric cancer subtypes, TP53 mutations are rare in EBV-positive tumors."", ""name"": ""Tumor Suppressor Gene Silencing""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}], ""description"": ""Promoter hypermethylation silences multiple tumor suppressor genes. CDKN2A (p16INK4A) silencing removes G1/S checkpoint control. CDH1 (E-cadherin) silencing promotes epithelial-mesenchymal transition. Unlike other gastric cancer subtypes, TP53 mutations are rare in EBV-positive tumors."", ""name"": ""Tumor Suppressor Gene Silencing""}"
2177	97	EBV-Associated Gastric Cancer	EBV_Associated_Gastric_Cancer.yaml	pathophysiology	4	Uncontrolled Cell Proliferation	Combined effects of PI3K-AKT activation, tumor suppressor silencing, and viral oncogene expression drive uncontrolled proliferation of infected gastric epithelial cells, leading to tumor formation.																																																								"{""description"": ""Combined effects of PI3K-AKT activation, tumor suppressor silencing, and viral oncogene expression drive uncontrolled proliferation of infected gastric epithelial cells, leading to tumor formation."", ""name"": ""Uncontrolled Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""epithelial cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}], ""description"": ""Combined effects of PI3K-AKT activation, tumor suppressor silencing, and viral oncogene expression drive uncontrolled proliferation of infected gastric epithelial cells, leading to tumor formation."", ""name"": ""Uncontrolled Cell Proliferation""}"
2194	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	pathophysiology	0	EGFR Oncogenic Mutations	Activating EGFR mutations occur in the tyrosine kinase domain and cause constitutive receptor activation independent of ligand binding. Mutations alter the ATP-binding pocket, favoring the active kinase conformation and enhancing sensitivity to ATP-competitive TKIs.																																																								"{""description"": ""Activating EGFR mutations occur in the tyrosine kinase domain and cause constitutive receptor activation independent of ligand binding. Mutations alter the ATP-binding pocket, favoring the active kinase conformation and enhancing sensitivity to ATP-competitive TKIs."", ""name"": ""EGFR Oncogenic Mutations""}"	"{""downstream"": [{""description"": ""Mutant receptors signal without ligand stimulation"", ""target"": ""Constitutive EGFR Signaling""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""epidermal growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0007173"", ""label"": ""epidermal growth factor receptor signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}], ""description"": ""Activating EGFR mutations occur in the tyrosine kinase domain and cause constitutive receptor activation independent of ligand binding. Mutations alter the ATP-binding pocket, favoring the active kinase conformation and enhancing sensitivity to ATP-competitive TKIs."", ""downstream"": [{""description"": ""Mutant receptors signal without ligand stimulation"", ""target"": ""Constitutive EGFR Signaling""}], ""evidence"": [{""explanation"": ""This abstract links EGFR mutations in NSCLC with sensitivity to EGFR TKIs, supporting the role of activating EGFR mutations."", ""reference"": ""PMID:15118073"", ""snippet"": ""A subgroup of patients with non-small-cell lung cancer have specific mutations in the EGFR gene, which correlate with clinical responsiveness to the tyrosine kinase inhibitor gefitinib."", ""supports"": ""SUPPORT""}], ""name"": ""EGFR Oncogenic Mutations""}"
2195	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	pathophysiology	1	Constitutive EGFR Signaling	Mutant EGFR is constitutively phosphorylated, activating downstream signaling cascades including RAS-RAF-MEK-ERK (proliferation) and PI3K-AKT-mTOR (survival). The tumor becomes dependent on (addicted to) EGFR signaling for survival.																																																								"{""description"": ""Mutant EGFR is constitutively phosphorylated, activating downstream signaling cascades including RAS-RAF-MEK-ERK (proliferation) and PI3K-AKT-mTOR (survival). The tumor becomes dependent on (addicted to) EGFR signaling for survival."", ""name"": ""Constitutive EGFR Signaling""}"	"{""downstream"": [{""description"": ""Tumor survival becomes dependent on EGFR pathway"", ""target"": ""Oncogene Addiction""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""Mutant EGFR is constitutively phosphorylated, activating downstream signaling cascades including RAS-RAF-MEK-ERK (proliferation) and PI3K-AKT-mTOR (survival). The tumor becomes dependent on (addicted to) EGFR signaling for survival."", ""downstream"": [{""description"": ""Tumor survival becomes dependent on EGFR pathway"", ""target"": ""Oncogene Addiction""}], ""name"": ""Constitutive EGFR Signaling""}"
2196	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	pathophysiology	2	Oncogene Addiction	EGFR-mutant tumors exhibit oncogene addiction, with survival critically dependent on continued EGFR signaling. EGFR inhibition leads to rapid tumor regression through induction of apoptosis and cell cycle arrest. This creates the therapeutic window for TKI therapy.																																																								"{""description"": ""EGFR-mutant tumors exhibit oncogene addiction, with survival critically dependent on continued EGFR signaling. EGFR inhibition leads to rapid tumor regression through induction of apoptosis and cell cycle arrest. This creates the therapeutic window for TKI therapy."", ""name"": ""Oncogene Addiction""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""EGFR-mutant tumors exhibit oncogene addiction, with survival critically dependent on continued EGFR signaling. EGFR inhibition leads to rapid tumor regression through induction of apoptosis and cell cycle arrest. This creates the therapeutic window for TKI therapy."", ""name"": ""Oncogene Addiction""}"
2197	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	pathophysiology	3	TKI Resistance Mechanisms	Resistance to EGFR TKIs develops through multiple mechanisms: secondary EGFR mutations (T790M, C797S), bypass pathway activation (MET amplification, HER2 amplification), and histologic transformation (small cell or squamous). Understanding resistance guides sequential therapy selection.																																																								"{""description"": ""Resistance to EGFR TKIs develops through multiple mechanisms: secondary EGFR mutations (T790M, C797S), bypass pathway activation (MET amplification, HER2 amplification), and histologic transformation (small cell or squamous). Understanding resistance guides sequential therapy selection."", ""name"": ""TKI Resistance Mechanisms""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}], ""description"": ""Resistance to EGFR TKIs develops through multiple mechanisms: secondary EGFR mutations (T790M, C797S), bypass pathway activation (MET amplification, HER2 amplification), and histologic transformation (small cell or squamous). Understanding resistance guides sequential therapy selection."", ""name"": ""TKI Resistance Mechanisms""}"
2215	99	ER-Positive Breast Cancer	ER_Positive_Breast_Cancer.yaml	pathophysiology	0	Estrogen Receptor Activation	ER+ breast cancer is driven by estrogen-dependent activation of the estrogen receptor alpha (ER), a nuclear hormone receptor that functions as a ligand-activated transcription factor. Estrogen binding induces receptor dimerization, DNA binding, and transcriptional activation of target genes.																																																								"{""description"": ""ER+ breast cancer is driven by estrogen-dependent activation of the estrogen receptor alpha (ER), a nuclear hormone receptor that functions as a ligand-activated transcription factor. Estrogen binding induces receptor dimerization, DNA binding, and transcriptional activation of target genes."", ""name"": ""Estrogen Receptor Activation""}"	"{""downstream"": [{""description"": ""Activated ER binds DNA and regulates target genes"", ""target"": ""Estrogen-Driven Transcription""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""intracellular estrogen receptor signaling pathway"", ""term"": {""id"": ""GO:0030520"", ""label"": ""intracellular estrogen receptor signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""luminal epithelial cell of mammary gland"", ""term"": {""id"": ""CL:0002326"", ""label"": ""luminal epithelial cell of mammary gland""}}], ""description"": ""ER+ breast cancer is driven by estrogen-dependent activation of the estrogen receptor alpha (ER), a nuclear hormone receptor that functions as a ligand-activated transcription factor. Estrogen binding induces receptor dimerization, DNA binding, and transcriptional activation of target genes."", ""downstream"": [{""description"": ""Activated ER binds DNA and regulates target genes"", ""target"": ""Estrogen-Driven Transcription""}], ""evidence"": [{""explanation"": ""This abstract links ER+ breast cancer to estrogen receptor alpha-driven signaling, supporting the core mechanism described."", ""reference"": ""PMID:41549581"", ""snippet"": ""At the heart of this subtype is the estrogen signaling pathway, especially the estrogen receptor alpha (ER), which plays a major role in the development, growth, and response to these cancers."", ""supports"": ""SUPPORT""}], ""name"": ""Estrogen Receptor Activation""}"
2216	99	ER-Positive Breast Cancer	ER_Positive_Breast_Cancer.yaml	pathophysiology	1	Estrogen-Driven Transcription	Activated ER binds estrogen response elements (EREs) in target gene promoters, recruiting coactivators and driving transcription of genes promoting cell cycle progression (CCND1), survival (BCL2), and growth factor signaling (IGF1R, EGFR). This creates estrogen-dependent tumor growth.																																																								"{""description"": ""Activated ER binds estrogen response elements (EREs) in target gene promoters, recruiting coactivators and driving transcription of genes promoting cell cycle progression (CCND1), survival (BCL2), and growth factor signaling (IGF1R, EGFR). This creates estrogen-dependent tumor growth."", ""name"": ""Estrogen-Driven Transcription""}"	"{""downstream"": [{""description"": ""ER target genes drive proliferation"", ""target"": ""Cell Cycle Progression""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}], ""description"": ""Activated ER binds estrogen response elements (EREs) in target gene promoters, recruiting coactivators and driving transcription of genes promoting cell cycle progression (CCND1), survival (BCL2), and growth factor signaling (IGF1R, EGFR). This creates estrogen-dependent tumor growth."", ""downstream"": [{""description"": ""ER target genes drive proliferation"", ""target"": ""Cell Cycle Progression""}], ""name"": ""Estrogen-Driven Transcription""}"
2217	99	ER-Positive Breast Cancer	ER_Positive_Breast_Cancer.yaml	pathophysiology	2	Cell Cycle Progression	ER signaling drives expression of cyclin D1 (CCND1), which complexes with CDK4/6 to phosphorylate Rb and promote G1-S transition. This creates the therapeutic rationale for CDK4/6 inhibitors in ER+ breast cancer.																																																								"{""description"": ""ER signaling drives expression of cyclin D1 (CCND1), which complexes with CDK4/6 to phosphorylate Rb and promote G1-S transition. This creates the therapeutic rationale for CDK4/6 inhibitors in ER+ breast cancer."", ""name"": ""Cell Cycle Progression""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""ER signaling drives expression of cyclin D1 (CCND1), which complexes with CDK4/6 to phosphorylate Rb and promote G1-S transition. This creates the therapeutic rationale for CDK4/6 inhibitors in ER+ breast cancer."", ""name"": ""Cell Cycle Progression""}"
2242	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	0	Viral Entry via Endocytosis	Ebola virus enters host cells through receptor-mediated macropinocytosis. The virus attaches to phosphatidylserine receptors like TIM-1 (HAVCR1) and is internalized into endosomes. Cathepsins B and L cleave the viral glycoprotein (GP), followed by binding to the essential receptor NPC1 in late endosomes/lysosomes, triggering membrane fusion and release of viral genome into the cytoplasm.																																		NPC1, HAVCR1 (TIM-1), SLC39A9, PIK3C3, and cathepsins are critical host factors. The process depends on macropinocytosis and late endosomal cholesterol transport.																						"{""description"": ""Ebola virus enters host cells through receptor-mediated macropinocytosis. The virus attaches to phosphatidylserine receptors like TIM-1 (HAVCR1) and is internalized into endosomes. Cathepsins B and L cleave the viral glycoprotein (GP), followed by binding to the essential receptor NPC1 in late endosomes/lysosomes, triggering membrane fusion and release of viral genome into the cytoplasm."", ""name"": ""Viral Entry via Endocytosis"", ""notes"": ""NPC1, HAVCR1 (TIM-1), SLC39A9, PIK3C3, and cathepsins are critical host factors. The process depends on macropinocytosis and late endosomal cholesterol transport.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""symbiont entry into host cell"", ""term"": {""id"": ""GO:0046718"", ""label"": ""symbiont entry into host cell""}}], ""cell_types"": [{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""Ebola virus enters host cells through receptor-mediated macropinocytosis. The virus attaches to phosphatidylserine receptors like TIM-1 (HAVCR1) and is internalized into endosomes. Cathepsins B and L cleave the viral glycoprotein (GP), followed by binding to the essential receptor NPC1 in late endosomes/lysosomes, triggering membrane fusion and release of viral genome into the cytoplasm."", ""name"": ""Viral Entry via Endocytosis"", ""notes"": ""NPC1, HAVCR1 (TIM-1), SLC39A9, PIK3C3, and cathepsins are critical host factors. The process depends on macropinocytosis and late endosomal cholesterol transport.""}"
2243	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	1	Immune Evasion and Viral Replication	Ebola viral proteins VP35 and VP24 antagonize the host interferon response. VP35 binds dsRNA and blocks RIG-I signaling, while VP24 prevents STAT1 nuclear import, thereby suppressing type I interferon signaling. This allows rapid viral replication and high viremia in infected monocytes, macrophages, and dendritic cells.																																		VP35 and VP24 are multifunctional proteins that integrate polymerase cofactor roles with immune evasion. Secreted GP (sGP) may act as an antibody decoy.																						"{""description"": ""Ebola viral proteins VP35 and VP24 antagonize the host interferon response. VP35 binds dsRNA and blocks RIG-I signaling, while VP24 prevents STAT1 nuclear import, thereby suppressing type I interferon signaling. This allows rapid viral replication and high viremia in infected monocytes, macrophages, and dendritic cells."", ""name"": ""Immune Evasion and Viral Replication"", ""notes"": ""VP35 and VP24 are multifunctional proteins that integrate polymerase cofactor roles with immune evasion. Secreted GP (sGP) may act as an antibody decoy.""}"	{}	"{""cell_types"": [{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""Ebola viral proteins VP35 and VP24 antagonize the host interferon response. VP35 binds dsRNA and blocks RIG-I signaling, while VP24 prevents STAT1 nuclear import, thereby suppressing type I interferon signaling. This allows rapid viral replication and high viremia in infected monocytes, macrophages, and dendritic cells."", ""name"": ""Immune Evasion and Viral Replication"", ""notes"": ""VP35 and VP24 are multifunctional proteins that integrate polymerase cofactor roles with immune evasion. Secreted GP (sGP) may act as an antibody decoy.""}"
2244	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	2	Endothelial Dysfunction and Vascular Leak	Ebola virus glycoprotein (GP) and secreted GP (sGP) contribute to endothelial cell activation and barrier disruption. This leads to increased vascular permeability, fluid extravasation, and hypovolemic shock. Endothelial dysfunction is a central feature of Ebola hemorrhagic fever.																																		GP-mediated endothelial perturbations and inflammatory signaling drive shock in viral hemorrhagic fevers. Glycocalyx disruption and loss of adherens junction integrity contribute to vascular leak.																						"{""description"": ""Ebola virus glycoprotein (GP) and secreted GP (sGP) contribute to endothelial cell activation and barrier disruption. This leads to increased vascular permeability, fluid extravasation, and hypovolemic shock. Endothelial dysfunction is a central feature of Ebola hemorrhagic fever."", ""name"": ""Endothelial Dysfunction and Vascular Leak"", ""notes"": ""GP-mediated endothelial perturbations and inflammatory signaling drive shock in viral hemorrhagic fevers. Glycocalyx disruption and loss of adherens junction integrity contribute to vascular leak.""}"	{}	"{""cell_types"": [{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Ebola virus glycoprotein (GP) and secreted GP (sGP) contribute to endothelial cell activation and barrier disruption. This leads to increased vascular permeability, fluid extravasation, and hypovolemic shock. Endothelial dysfunction is a central feature of Ebola hemorrhagic fever."", ""locations"": [{""preferred_term"": ""blood vessel"", ""term"": {""id"": ""UBERON:0001981"", ""label"": ""blood vessel""}}], ""name"": ""Endothelial Dysfunction and Vascular Leak"", ""notes"": ""GP-mediated endothelial perturbations and inflammatory signaling drive shock in viral hemorrhagic fevers. Glycocalyx disruption and loss of adherens junction integrity contribute to vascular leak.""}"
2245	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	3	Coagulopathy and Disseminated Intravascular Coagulation	Ebola infection triggers systemic inflammatory response with cytokine release, endothelial activation, and tissue factor pathway activation. This leads to thromboinflammation, platelet activation, consumptive coagulopathy, and disseminated intravascular coagulation (DIC), resulting in hemorrhagic manifestations.																																		Impaired coagulation systems with uncontrolled hemorrhaging characterize severe EVD. Thrombocytopenia and elevated liver enzymes are common laboratory findings.																						"{""description"": ""Ebola infection triggers systemic inflammatory response with cytokine release, endothelial activation, and tissue factor pathway activation. This leads to thromboinflammation, platelet activation, consumptive coagulopathy, and disseminated intravascular coagulation (DIC), resulting in hemorrhagic manifestations."", ""name"": ""Coagulopathy and Disseminated Intravascular Coagulation"", ""notes"": ""Impaired coagulation systems with uncontrolled hemorrhaging characterize severe EVD. Thrombocytopenia and elevated liver enzymes are common laboratory findings.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""blood coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}], ""description"": ""Ebola infection triggers systemic inflammatory response with cytokine release, endothelial activation, and tissue factor pathway activation. This leads to thromboinflammation, platelet activation, consumptive coagulopathy, and disseminated intravascular coagulation (DIC), resulting in hemorrhagic manifestations."", ""locations"": [{""preferred_term"": ""blood vessel"", ""term"": {""id"": ""UBERON:0001981"", ""label"": ""blood vessel""}}], ""name"": ""Coagulopathy and Disseminated Intravascular Coagulation"", ""notes"": ""Impaired coagulation systems with uncontrolled hemorrhaging characterize severe EVD. Thrombocytopenia and elevated liver enzymes are common laboratory findings.""}"
2246	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	pathophysiology	4	Multiorgan Involvement	Ebola virus infects multiple organs including liver, spleen, lymph nodes, and kidneys. Hepatic dysfunction with elevated liver enzymes (AST > ALT pattern) and splenic involvement contribute to multiorgan failure in severe cases.																																		Liver involvement manifests with elevated AST and ALT (unusual AST > ALT pattern). Macrophage activation and cytokine storm contribute to organ damage.																						"{""description"": ""Ebola virus infects multiple organs including liver, spleen, lymph nodes, and kidneys. Hepatic dysfunction with elevated liver enzymes (AST > ALT pattern) and splenic involvement contribute to multiorgan failure in severe cases."", ""name"": ""Multiorgan Involvement"", ""notes"": ""Liver involvement manifests with elevated AST and ALT (unusual AST > ALT pattern). Macrophage activation and cytokine storm contribute to organ damage.""}"	{}	"{""description"": ""Ebola virus infects multiple organs including liver, spleen, lymph nodes, and kidneys. Hepatic dysfunction with elevated liver enzymes (AST > ALT pattern) and splenic involvement contribute to multiorgan failure in severe cases."", ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}, {""preferred_term"": ""spleen"", ""term"": {""id"": ""UBERON:0002106"", ""label"": ""spleen""}}], ""name"": ""Multiorgan Involvement"", ""notes"": ""Liver involvement manifests with elevated AST and ALT (unusual AST > ALT pattern). Macrophage activation and cytokine storm contribute to organ damage.""}"
2290	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	0	Collagen Abnormalities	Mutations in genes encoding collagen or collagen-modifying enzymes lead to defective collagen synthesis and assembly.																																																								"{""description"": ""Mutations in genes encoding collagen or collagen-modifying enzymes lead to defective collagen synthesis and assembly."", ""name"": ""Collagen Abnormalities""}"	{}	"{""biological_processes"": [{""preferred_term"": ""collagen fibril organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}, {""preferred_term"": ""collagen biosynthetic process"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}], ""description"": ""Mutations in genes encoding collagen or collagen-modifying enzymes lead to defective collagen synthesis and assembly."", ""evidence"": [{""explanation"": ""This reference confirms that mutations affecting collagen synthesis and enzymes responsible for collagen modification are associated with Ehlers-Danlos Syndrome."", ""reference"": ""PMID:7086195"", ""snippet"": ""Several abnormalities in collagen biosynthesis have been described in patients with Ehlers-Danlos syndrome. Examples of collagen structural mutations as well as post-translational enzymatic defects have been detected."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference identifies specific gene mutations (e.g., COL3A1) responsible for defective collagen synthesis leading to Ehlers-Danlos Syndrome."", ""reference"": ""PMID:37187299"", ""snippet"": ""Vascular Ehlers-Danlos Syndrome (vEDS) is a rare autosomal dominant disease caused by mutations in the COL3A1 gene."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the statement by elaborating on how mutations in various collagen genes lead to defects tied to diseases including Ehlers-Danlos Syndrome."", ""reference"": ""PMID:2010058"", ""snippet"": ""Recently, several mutations in three other collagen genes (COL2A1, COL3A1, and COL4A5) have been found in probands with genetic diseases involving tissues rich in these collagens."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference describes how mutations in the COL5A1 gene can result in defective collagen synthesis, aligned with the nature of Ehlers-Danlos Syndrome."", ""reference"": ""PMID:30246406"", ""snippet"": ""Human EDS may be caused by variants in several different genes including COL5A1, which encodes the collagen type V alpha 1 chain."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference confirms that mutations in genes involved in collagen biosynthesis or assembly can lead to EDS-like conditions."", ""reference"": ""PMID:30668708"", ""snippet"": ""Bi-allelic loss-of-function mutations in the adipocyte enhancer-binding protein 1 (AEBP1) gene were reported in three families with an autosomal recessive EDS-like condition."", ""supports"": ""SUPPORT""}], ""name"": ""Collagen Abnormalities""}"
2291	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	1	Connective Tissue Fragility	Abnormal collagen leads to weakened connective tissues throughout the body.																																																								"{""description"": ""Abnormal collagen leads to weakened connective tissues throughout the body."", ""name"": ""Connective Tissue Fragility""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""cell_types"": [{""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}, {""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}], ""description"": ""Abnormal collagen leads to weakened connective tissues throughout the body."", ""evidence"": [{""explanation"": ""The provided snippet mentions tissue fragility as a cardinal feature of Ehlers-Danlos Syndrome (EDS), which is consistent with the statement that abnormal collagen leads to weakened connective tissues."", ""reference"": ""PMID:358109"", ""snippet"": ""The cardinal features are cutaneous hyperextensibility, joint hypermobility, bleeding diathesis, and tissue fragility, and these features lead to a large variety of additional manifestations."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference explains that pEDS is related to these genetic mutations which interfere with the collagen matrix, fitting the description of abnormal collagen leading to connective tissue fragility."", ""reference"": ""PMID:36960056"", ""snippet"": ""pEDS is caused by heterozygous missense mutations in C1R and C1S genes of the classical complement C1 complex."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference discusses how defects in collagen mechanisms can lead to connective tissue diseases, supporting the statement about abnormal collagen leading to connective tissue fragility."", ""reference"": ""PMID:1448"", ""snippet"": ""Any defect in the normal mechanisms responsible for the synthesis and secretion of collagen molecules or the deposition of these molecules into extracellular fibers could result in abnormal fibrillogenesis; such defects could result in a connective tissue disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference directly supports the statement by mentioning how altered collagen in EDS patients leads to weakening of vessel walls and supporting tissues."", ""reference"": ""PMID:31329366"", ""snippet"": ""Collagen, which forms the framework of vessel walls, is altered in many patients with Ehlers-Danlos syndrome (EDS) leading to weakening of the vessel wall or the supporting tissues."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""dermis"", ""term"": {""id"": ""UBERON:0002067"", ""label"": ""dermis""}}, {""preferred_term"": ""blood vessel"", ""term"": {""id"": ""UBERON:0001981"", ""label"": ""blood vessel""}}], ""name"": ""Connective Tissue Fragility""}"
2292	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	2	Tissue Injury and Dysfunction	Fragile tissues are prone to damage, leading to manifestations like joint dislocations, organ ruptures, and poor wound healing.																																																								"{""description"": ""Fragile tissues are prone to damage, leading to manifestations like joint dislocations, organ ruptures, and poor wound healing."", ""name"": ""Tissue Injury and Dysfunction""}"	{}	"{""description"": ""Fragile tissues are prone to damage, leading to manifestations like joint dislocations, organ ruptures, and poor wound healing."", ""evidence"": [{""explanation"": ""The excerpt confirms tissue fragility and various manifestations affecting skin, joints, and internal organs, but does not explicitly mention every detail cited in the statement such as joint dislocations, organ ruptures, or poor wound healing."", ""reference"": ""PMID:24443025"", ""snippet"": ""The Ehlers-Danlos Syndromes comprise a heterogeneous group of diseases, which are characterized by fragility of the soft connective tissues and widespread manifestations in skin, ligaments and joints, blood vessels and internal organs... The clinical spectrum varies from mild skin and joint hyperlaxity to severe physical disability and life-threatening vascular complications."", ""supports"": ""PARTIAL""}, {""explanation"": ""The excerpt supports the statement by highlighting arterial fragility and spontaneous ruptures, contributing to tissue injury and dysfunction. However, it does not explicitly mention joint dislocations or poor wound healing."", ""reference"": ""PMID:29982180"", ""snippet"": ""Arterial fragility is an important feature of the disease... Arterial fragility is an important characteristic of kyphoscoliotic EDS. It manifests as spontaneous arterial rupture, dissections and dissecting aneurysms."", ""supports"": ""PARTIAL""}, {""explanation"": ""The text discusses tissue fragility leading to bruising and bleeding, supporting aspects of tissue injury and dysfunction. However, it does not explicitly address joint dislocations or organ ruptures."", ""reference"": ""PMID:19592142"", ""snippet"": ""Easy bruising and bleeding are prominent features of some heritable disorders of connective tissue (HDCT), resulting from fragility of capillaries and the perivascular connective tissue... In the vascular subtype of EDS, caused by defects in type III collagen, fragility of vessel walls can lead to life-threatening bleeding and premature death."", ""supports"": ""PARTIAL""}], ""name"": ""Tissue Injury and Dysfunction""}"
2293	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	3	Integrin-Mediated Mechanotransduction Dysregulation	Defective collagen matrix leads to altered integrin signaling, particularly upregulation of integrin v3, contributing to persistent inflammation and impaired wound healing in classical EDS.																																		Research demonstrates that COL5A1-deficient wounds show increased v3 integrin and IL-1 with reduced mechanical strength; integrin antagonism partially rescues wound healing.																						"{""description"": ""Defective collagen matrix leads to altered integrin signaling, particularly upregulation of integrin v3, contributing to persistent inflammation and impaired wound healing in classical EDS."", ""name"": ""Integrin-Mediated Mechanotransduction Dysregulation"", ""notes"": ""Research demonstrates that COL5A1-deficient wounds show increased v3 integrin and IL-1 with reduced mechanical strength; integrin antagonism partially rescues wound healing.""}"	"{""subtypes"": [""Classical EDS""]}"	"{""biological_processes"": [{""preferred_term"": ""integrin-mediated signaling pathway"", ""term"": {""id"": ""GO:0007229"", ""label"": ""integrin-mediated signaling pathway""}}, {""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Defective collagen matrix leads to altered integrin signaling, particularly upregulation of integrin v3, contributing to persistent inflammation and impaired wound healing in classical EDS."", ""name"": ""Integrin-Mediated Mechanotransduction Dysregulation"", ""notes"": ""Research demonstrates that COL5A1-deficient wounds show increased v3 integrin and IL-1 with reduced mechanical strength; integrin antagonism partially rescues wound healing."", ""subtypes"": [""Classical EDS""]}"
2294	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	4	Autophagy and Proteostasis Dysfunction	Vascular EDS fibroblasts exhibit impaired autophagy-lysosome pathways and cellular stress responses, contributing to abnormal ECM homeostasis and protein quality control.																																		Multi-omics analysis of vEDS patient fibroblasts revealed dysregulated autophagy-lysosome pathways and miRNA regulation (miR-29b-3p).																						"{""description"": ""Vascular EDS fibroblasts exhibit impaired autophagy-lysosome pathways and cellular stress responses, contributing to abnormal ECM homeostasis and protein quality control."", ""name"": ""Autophagy and Proteostasis Dysfunction"", ""notes"": ""Multi-omics analysis of vEDS patient fibroblasts revealed dysregulated autophagy-lysosome pathways and miRNA regulation (miR-29b-3p).""}"	"{""subtypes"": [""Vascular EDS""]}"	"{""biological_processes"": [{""preferred_term"": ""autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}, {""preferred_term"": ""protein folding"", ""term"": {""id"": ""GO:0006457"", ""label"": ""protein folding""}}], ""cellular_components"": [{""preferred_term"": ""lysosome"", ""term"": {""id"": ""GO:0005764"", ""label"": ""lysosome""}}, {""preferred_term"": ""autophagosome"", ""term"": {""id"": ""GO:0005776"", ""label"": ""autophagosome""}}], ""description"": ""Vascular EDS fibroblasts exhibit impaired autophagy-lysosome pathways and cellular stress responses, contributing to abnormal ECM homeostasis and protein quality control."", ""name"": ""Autophagy and Proteostasis Dysfunction"", ""notes"": ""Multi-omics analysis of vEDS patient fibroblasts revealed dysregulated autophagy-lysosome pathways and miRNA regulation (miR-29b-3p)."", ""subtypes"": [""Vascular EDS""]}"
2295	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	5	Complement-Mediated ECM Degradation	Intracellular activation of complement C1r/C1s proteases leads to extracellular activated C1s that degrades collagen I, destabilizing the periodontal ECM in periodontal EDS.																																		Research demonstrates activated C1s degrades collagen I in patient fibroblasts, causing high collagen turnover and periodontal tissue destruction.																						"{""description"": ""Intracellular activation of complement C1r/C1s proteases leads to extracellular activated C1s that degrades collagen I, destabilizing the periodontal ECM in periodontal EDS."", ""name"": ""Complement-Mediated ECM Degradation"", ""notes"": ""Research demonstrates activated C1s degrades collagen I in patient fibroblasts, causing high collagen turnover and periodontal tissue destruction.""}"	"{""subtypes"": [""Periodontal EDS""]}"	"{""biological_processes"": [{""preferred_term"": ""complement activation, classical pathway"", ""term"": {""id"": ""GO:0006958"", ""label"": ""complement activation, classical pathway""}}, {""preferred_term"": ""proteolysis"", ""term"": {""id"": ""GO:0006508"", ""label"": ""proteolysis""}}], ""description"": ""Intracellular activation of complement C1r/C1s proteases leads to extracellular activated C1s that degrades collagen I, destabilizing the periodontal ECM in periodontal EDS."", ""locations"": [{""preferred_term"": ""periodontium"", ""term"": {""id"": ""UBERON:0002405"", ""label"": ""periodontium""}}], ""name"": ""Complement-Mediated ECM Degradation"", ""notes"": ""Research demonstrates activated C1s degrades collagen I in patient fibroblasts, causing high collagen turnover and periodontal tissue destruction."", ""subtypes"": [""Periodontal EDS""]}"
2319	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	0	Collagen Type V Abnormalities	Mutations in the COL5A1 gene lead to defective collagen type V synthesis and assembly.																																																								"{""description"": ""Mutations in the COL5A1 gene lead to defective collagen type V synthesis and assembly."", ""name"": ""Collagen Type V Abnormalities""}"	{}	"{""biological_processes"": [{""preferred_term"": ""collagen fibril organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}, {""preferred_term"": ""collagen biosynthetic process"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}], ""description"": ""Mutations in the COL5A1 gene lead to defective collagen type V synthesis and assembly."", ""evidence"": [{""explanation"": ""This reference describes how mutations in COL5A1 lead to defective synthesis and assembly of collagen type V, supporting the given statement."", ""reference"": ""PMID:9042913"", ""snippet"": ""The mutation causes the substitution of the most 5' cysteine residue by a serine within a highly conserved sequence of the pro(alpha)1(V) C-propeptide domain and causes reduction of collagen V by preventing incorporation of the mutant pro(alpha)1(V) chains in the collagen V trimers."", ""supports"": ""SUPPORT""}], ""name"": ""Collagen Type V Abnormalities""}"
2320	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	1	Connective Tissue Fragility	Abnormal collagen type V leads to weakened connective tissues throughout the body.																																																								"{""description"": ""Abnormal collagen type V leads to weakened connective tissues throughout the body."", ""name"": ""Connective Tissue Fragility""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""cell_types"": [{""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}, {""preferred_term"": ""dermal fibroblast"", ""term"": {""id"": ""CL:0002620"", ""label"": ""skin fibroblast""}}], ""cellular_components"": [{""preferred_term"": ""extracellular matrix"", ""term"": {""id"": ""GO:0031012"", ""label"": ""extracellular matrix""}}], ""description"": ""Abnormal collagen type V leads to weakened connective tissues throughout the body."", ""evidence"": [{""explanation"": ""The literature indicates that mutations in the COL5A1 gene lead to abnormalities in collagen type V, resulting in weakened connective tissues."", ""reference"": ""PMID:20847697"", ""snippet"": ""In the majority of patients with molecularly characterized classic Ehlers-Danlos syndrome, the disease is caused by a mutation leading to a nonfunctional COL5A1 allele and resulting in haploinsufficiency of type V collagen."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study demonstrates that reduced type V collagen results in weaker connective tissue due to a significant decrease in collagen fibril assembly."", ""reference"": ""PMID:15095409"", ""snippet"": ""EDS cells with COL5A1 haplo-insufficiency deposited less than one-half of hydroxyproline as collagen compared to control fibroblasts. ... a reduction of type V collagen, in the EDS derived cells, was associated with the assembly of significantly fewer fibrils compared to control and OI cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature describes the role of collagen V and its mutations in causing connective tissue fragility, therefore supporting the statement."", ""reference"": ""PMID:12836217"", ""snippet"": ""The classical form of the syndrome, which will be principally discussed in this review, can be due to mutations on collagen V, a fibrillar collagen present in small amounts in affected tissues."", ""supports"": ""SUPPORT""}], ""name"": ""Connective Tissue Fragility""}"
2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	Tissue Injury and Dysfunction	Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization.																																																								"{""description"": ""Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization."", ""name"": ""Tissue Injury and Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""wound healing"", ""term"": {""id"": ""GO:0042060"", ""label"": ""wound healing""}}, {""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}, {""preferred_term"": ""integrin-mediated signaling pathway"", ""term"": {""id"": ""GO:0007229"", ""label"": ""integrin-mediated signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""cellular_components"": [{""preferred_term"": ""pericellular matrix"", ""term"": {""id"": ""GO:0036046"", ""label"": ""pericellular matrix""}}], ""description"": ""Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization."", ""evidence"": [{""explanation"": ""The provided literature directly supports the claim that Ehlers-Danlos Syndrome, particularly related to COL5A1, results in fragile tissues leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing."", ""reference"": ""PMID:19370768"", ""snippet"": ""Classical Ehlers-Danlos syndrome (EDS) is a heritable disorder characterized by joint hypermobility, skin hyperextensibility, and abnormal wound healing."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature mentions fragility in tissues due to EDS, consistent with fragile tissues leading to manifestations such as joint dislocations and skin hyperextensibility."", ""reference"": ""PMID:19592142"", ""snippet"": ""The bleeding tendency is most prominent in the Ehlers-Danlos syndrome (EDS), a heterogeneous group of HDCT sharing clinical manifestations of fragility in skin, ligaments, blood vessels and internal organs."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports the claim, highlighting tissue fragility, joint hypermobility, and skin hyperextensibility as key characteristics."", ""reference"": ""PMID:20697718"", ""snippet"": ""Ehlers-Danlos Syndrome is a term that comprises a variety of inherited connective tissue disorders characterized primarily by skin hyperextensibility, joints hypermobility and excessive dislocations, easy bruisability, generalized fragility."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the claim, describing characteristics that align with tissue fragility and symptoms such as joint dislocations, skin hyperextensibility, and poor wound healing."", ""reference"": ""PMID:19055167"", ""snippet"": ""Ehlers-Danlos syndrome (EDS) is a heterogeneous group of connective tissue disorders characterized by hyperextensibility, delayed wound healing, joint hypermobility, thin skin, easy bruising, tissue fragility, 'cigarette-paper' scarring over bony prominences."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}, {""preferred_term"": ""tendon"", ""term"": {""id"": ""UBERON:0000043"", ""label"": ""tendon""}}, {""preferred_term"": ""corneal stroma"", ""term"": {""id"": ""UBERON:0001772"", ""label"": ""corneal stroma""}}], ""name"": ""Tissue Injury and Dysfunction""}"
2348	103	Embryonal Rhabdomyosarcoma	Embryonal_Rhabdomyosarcoma.yaml	pathophysiology	0	Loss of Heterozygosity at 11p15	Loss of heterozygosity (LOH) at chromosome 11p15.5 is the hallmark genetic event in ERMS, occurring in approximately 80% of cases. This region contains the imprinted IGF2 gene, and LOH results in loss of the maternal allele with duplication of the paternal allele, leading to biallelic IGF2 expression and growth factor pathway activation.																																																								"{""description"": ""Loss of heterozygosity (LOH) at chromosome 11p15.5 is the hallmark genetic event in ERMS, occurring in approximately 80% of cases. This region contains the imprinted IGF2 gene, and LOH results in loss of the maternal allele with duplication of the paternal allele, leading to biallelic IGF2 expression and growth factor pathway activation."", ""name"": ""Loss of Heterozygosity at 11p15""}"	"{""downstream"": [{""description"": ""Loss of imprinting leads to biallelic IGF2 expression"", ""target"": ""IGF2 Overexpression""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""skeletal muscle myoblast"", ""term"": {""id"": ""CL:0000515"", ""label"": ""skeletal muscle myoblast""}}], ""description"": ""Loss of heterozygosity (LOH) at chromosome 11p15.5 is the hallmark genetic event in ERMS, occurring in approximately 80% of cases. This region contains the imprinted IGF2 gene, and LOH results in loss of the maternal allele with duplication of the paternal allele, leading to biallelic IGF2 expression and growth factor pathway activation."", ""downstream"": [{""description"": ""Loss of imprinting leads to biallelic IGF2 expression"", ""target"": ""IGF2 Overexpression""}], ""evidence"": [{""explanation"": ""Supports 11p15.5 loss of heterozygosity as characteristic of embryonal rhabdomyosarcoma."", ""reference"": ""PMID:10095436"", ""snippet"": ""Allelic losses of 11p15.5 are characteristic of embryonal RMS (eRMS), whereas an increase in the expression of the Igf2 gene located on 11p15.5 has regularly been observed in eRMS and alveolar RMS (aRMS)."", ""supports"": ""SUPPORT""}], ""name"": ""Loss of Heterozygosity at 11p15""}"
2349	103	Embryonal Rhabdomyosarcoma	Embryonal_Rhabdomyosarcoma.yaml	pathophysiology	1	IGF2 Overexpression	Loss of imprinting at 11p15 results in biallelic expression of IGF2, leading to autocrine and paracrine growth stimulation through IGF1R signaling. This promotes cell proliferation and survival in ERMS cells.																																																								"{""description"": ""Loss of imprinting at 11p15 results in biallelic expression of IGF2, leading to autocrine and paracrine growth stimulation through IGF1R signaling. This promotes cell proliferation and survival in ERMS cells."", ""name"": ""IGF2 Overexpression""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of cell population proliferation"", ""term"": {""id"": ""GO:0042127"", ""label"": ""regulation of cell population proliferation""}}], ""description"": ""Loss of imprinting at 11p15 results in biallelic expression of IGF2, leading to autocrine and paracrine growth stimulation through IGF1R signaling. This promotes cell proliferation and survival in ERMS cells."", ""name"": ""IGF2 Overexpression""}"
2350	103	Embryonal Rhabdomyosarcoma	Embryonal_Rhabdomyosarcoma.yaml	pathophysiology	2	RAS Pathway Activation	Activating mutations in RAS pathway genes (NRAS, KRAS, HRAS) occur in approximately 35% of ERMS cases. FGFR4 mutations occur in 7-10% of cases. These mutations drive proliferation through MAPK and PI3K pathway activation.																																																								"{""description"": ""Activating mutations in RAS pathway genes (NRAS, KRAS, HRAS) occur in approximately 35% of ERMS cases. FGFR4 mutations occur in 7-10% of cases. These mutations drive proliferation through MAPK and PI3K pathway activation."", ""name"": ""RAS Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""Activating mutations in RAS pathway genes (NRAS, KRAS, HRAS) occur in approximately 35% of ERMS cases. FGFR4 mutations occur in 7-10% of cases. These mutations drive proliferation through MAPK and PI3K pathway activation."", ""name"": ""RAS Pathway Activation""}"
2368	104	Endometriosis	Endometriosis.yaml	pathophysiology	0	Ectopic Endometrial Tissue	"Endometrial-like tissue grows outside the uterus, commonly on ovaries, fallopian tubes, and pelvic peritoneum. Responds to hormonal cycling with bleeding and inflammation.
"																																																								"{""description"": ""Endometrial-like tissue grows outside the uterus, commonly on ovaries, fallopian tubes, and pelvic peritoneum. Responds to hormonal cycling with bleeding and inflammation.\n"", ""name"": ""Ectopic Endometrial Tissue""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""Endometrial Stromal Cell"", ""term"": {""id"": ""CL:0002255"", ""label"": ""stromal cell of endometrium""}}], ""description"": ""Endometrial-like tissue grows outside the uterus, commonly on ovaries, fallopian tubes, and pelvic peritoneum. Responds to hormonal cycling with bleeding and inflammation.\n"", ""evidence"": [{""explanation"": ""Defines endometriosis as ectopic presence of endometrial glandular and stromal cells outside the uterus"", ""reference"": ""PMID:16166933"", ""snippet"": ""Endometriosis is classically described as the presence of both endometrial glandular and stromal cells outside the uterine cavity, mainly in the pelvis."", ""supports"": ""SUPPORT""}], ""name"": ""Ectopic Endometrial Tissue""}"
2369	104	Endometriosis	Endometriosis.yaml	pathophysiology	1	Retrograde Menstruation	"Menstrual blood flows backward through fallopian tubes into pelvic cavity. Most women have retrograde menstruation, but only some develop endometriosis, suggesting other factors involved.
"																																																								"{""description"": ""Menstrual blood flows backward through fallopian tubes into pelvic cavity. Most women have retrograde menstruation, but only some develop endometriosis, suggesting other factors involved.\n"", ""name"": ""Retrograde Menstruation""}"	{}	"{""description"": ""Menstrual blood flows backward through fallopian tubes into pelvic cavity. Most women have retrograde menstruation, but only some develop endometriosis, suggesting other factors involved.\n"", ""evidence"": [{""explanation"": ""Retrograde menstruation is the most widely accepted theory but insufficient alone to explain disease development"", ""reference"": ""PMID:16166933"", ""snippet"": ""Although multiple theories have been put forth to explain the pathophysiology and pathogenesis of endometriosis, the retrograde menstruation theory of Sampson is the most widely accepted. However, since retrograde menstruation occurs in most of the reproductive age women, it is clear that there must be other factors which may contribute to the implantation of endometrial cells and their subsequent development into endometriotic disease."", ""supports"": ""SUPPORT""}], ""name"": ""Retrograde Menstruation""}"
2370	104	Endometriosis	Endometriosis.yaml	pathophysiology	2	Chronic Inflammation	"Ectopic lesions trigger chronic pelvic inflammation with elevated cytokines and prostaglandins. Inflammatory milieu contributes to pain and adhesion formation.
"																																																								"{""description"": ""Ectopic lesions trigger chronic pelvic inflammation with elevated cytokines and prostaglandins. Inflammatory milieu contributes to pain and adhesion formation.\n"", ""name"": ""Chronic Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Ectopic lesions trigger chronic pelvic inflammation with elevated cytokines and prostaglandins. Inflammatory milieu contributes to pain and adhesion formation.\n"", ""evidence"": [{""explanation"": ""Elevated cytokines and growth factors in the inflammatory milieu support lesion implantation and growth"", ""reference"": ""PMID:16166933"", ""snippet"": ""Increased levels of several cytokines and growth factors which are secreted by either immune and endometrial cells seem to promote implantation and growth of ectopic endometrium by inducing proliferation and angiogenesis."", ""supports"": ""SUPPORT""}], ""name"": ""Chronic Inflammation""}"
2371	104	Endometriosis	Endometriosis.yaml	pathophysiology	3	Estrogen Dependence	"Endometriotic lesions produce their own estrogen via aromatase and are highly estrogen-responsive. Progesterone resistance impairs normal tissue regression.
"																																																								"{""description"": ""Endometriotic lesions produce their own estrogen via aromatase and are highly estrogen-responsive. Progesterone resistance impairs normal tissue regression.\n"", ""name"": ""Estrogen Dependence""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Estrogen Response"", ""term"": {""id"": ""GO:0043627"", ""label"": ""response to estrogen""}}], ""description"": ""Endometriotic lesions produce their own estrogen via aromatase and are highly estrogen-responsive. Progesterone resistance impairs normal tissue regression.\n"", ""evidence"": [{""explanation"": ""Estrogen drives endometriosis growth through both systemic delivery and local autocrine production"", ""reference"": ""PMID:10731122"", ""snippet"": ""Estrogen is the most important known factor that stimulates the growth of endometriosis. Estrogen delivery to endometriotic implants was classically viewed to be only via the circulating blood in an endocrine fashion. We recently uncovered an autocrine positive feedback mechanism, which favored the continuous production of estrogen and prostaglandin (PG)E2 in the endometriotic stromal cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""Aromatase expression in endometriotic stromal cells creates a positive feedback loop with PGE2 for local estrogen production"", ""reference"": ""PMID:10731122"", ""snippet"": ""The enzyme, aromatase, is aberrantly expressed in endometriotic stromal cells and catalyzes the conversion of C19 steroids to estrogens, which then stimulate cyclooxygenase-2 to increase the levels of PGE2. PGE2, in turn, is a potent inducer of aromatase activity in endometriotic stromal cells. Aromatase is not expressed in the eutopic endometrium."", ""supports"": ""SUPPORT""}, {""explanation"": ""Deficiency of 17beta-HSD type 2 prevents estradiol inactivation, contributing to local estrogen dominance"", ""reference"": ""PMID:10731122"", ""snippet"": ""In addition, we find that endometriotic tissue is deficient in 17beta-hydroxysteroid dehydrogenase type 2, which is normally expressed in eutopic endometrial glandular cells and inactivates estradiol-17beta to estrone. This deficiency is another aberration that favors higher levels of estradiol-17beta in endometriotic tissues in comparison with the eutopic endometrium."", ""supports"": ""SUPPORT""}], ""name"": ""Estrogen Dependence""}"
2372	104	Endometriosis	Endometriosis.yaml	pathophysiology	4	Immune Dysfunction	"Immune system alterations enable ectopic endometrial cells to evade clearance. Includes increased peritoneal macrophages, reduced NK cell cytotoxicity, T cell dysfunction, and elevated inflammatory cytokines. Crosstalk between endometrial stromal cells and macrophages impairs NK cell function via IL-10 and TGF-beta secretion.
"																																																								"{""description"": ""Immune system alterations enable ectopic endometrial cells to evade clearance. Includes increased peritoneal macrophages, reduced NK cell cytotoxicity, T cell dysfunction, and elevated inflammatory cytokines. Crosstalk between endometrial stromal cells and macrophages impairs NK cell function via IL-10 and TGF-beta secretion.\n"", ""name"": ""Immune Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Immune system alterations enable ectopic endometrial cells to evade clearance. Includes increased peritoneal macrophages, reduced NK cell cytotoxicity, T cell dysfunction, and elevated inflammatory cytokines. Crosstalk between endometrial stromal cells and macrophages impairs NK cell function via IL-10 and TGF-beta secretion.\n"", ""evidence"": [{""explanation"": ""Immune cell dysfunction leads to impaired clearance of ectopic endometrial cells"", ""reference"": ""PMID:16166933"", ""snippet"": ""Increased number and activation of peritoneal macrophages, decreased T cell and natural killer (NK) cell cytotoxicities are the alterations in cellular immunity and result in inadequate removal of ectopic endometrial cells from the peritoneal cavity."", ""supports"": ""SUPPORT""}, {""explanation"": ""NK cell dysfunction is a key mechanism enabling immune escape of refluxed endometrial fragments"", ""reference"": ""PMID:28971893"", ""snippet"": ""The dysfunction of NK cells in women with endometriosis (EMS) contributes to the immune escape of menstrual endometrial fragments refluxed into the peritoneal cavity."", ""supports"": ""SUPPORT""}, {""explanation"": ""Interaction between endometrial stromal cells and macrophages suppresses NK cell cytotoxicity through IL-10 and TGF-beta"", ""reference"": ""PMID:28971893"", ""snippet"": ""After incubation with ESCs and macrophages, the expression of CD16, NKG2D, perforin and IFN-, viability and cytotoxicity of NK cells were significantly downregulated. The secretion of interleukin (IL)-1, IL-10 and transforming growth factor (TGF)- in the co-culture system of ESCs and macrophages was increased."", ""supports"": ""SUPPORT""}], ""name"": ""Immune Dysfunction""}"
2373	104	Endometriosis	Endometriosis.yaml	pathophysiology	5	Hypoxia and Angiogenesis	"Ectopic lesions experience hypoxia which stabilizes HIF-1alpha, upregulating VEGF and promoting angiogenesis. Neovascularization supports lesion survival and growth. Ovarian endometriomas show particularly high expression of hypoxic and angiogenic factors.
"																																																								"{""description"": ""Ectopic lesions experience hypoxia which stabilizes HIF-1alpha, upregulating VEGF and promoting angiogenesis. Neovascularization supports lesion survival and growth. Ovarian endometriomas show particularly high expression of hypoxic and angiogenic factors.\n"", ""name"": ""Hypoxia and Angiogenesis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Response to Hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}, {""preferred_term"": ""Angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}], ""description"": ""Ectopic lesions experience hypoxia which stabilizes HIF-1alpha, upregulating VEGF and promoting angiogenesis. Neovascularization supports lesion survival and growth. Ovarian endometriomas show particularly high expression of hypoxic and angiogenic factors.\n"", ""evidence"": [{""explanation"": ""Angiogenic and hypoxic mechanisms create a supportive microenvironment for ectopic lesion growth"", ""reference"": ""PMID:26408396"", ""snippet"": ""Endometriosis is associated with local angiogenic and hypoxic mechanisms. Indeed, peritoneal fluid of women with endometriosis generates a specific microenvironment to support the growth and development of ectopic endometrial tissues."", ""supports"": ""SUPPORT""}, {""explanation"": ""Ovarian endometriomas specifically show elevated hypoxia-inducible factors and VEGF with correlated expression"", ""reference"": ""PMID:26408396"", ""snippet"": ""Ovarian endometrioma expresses high levels of HIF-1/2, PAR-1/4, and VEGF-A, while DIE did not show significantly different gene expression compared to endometrium from unaffected women. A positive correlation between the expression of HIF-1/2 and VEGF-A mRNA was observed in OMA."", ""supports"": ""SUPPORT""}, {""explanation"": ""HIF-1alpha and VEGF expression correlates with disease stage and dysmenorrhea severity"", ""reference"": ""PMID:30074218"", ""snippet"": ""The results showed that serum concentrations of MMIF, HIF-1, and VEGF were significantly higher in EM patients than in controls (P<0.05). The expression of all three proteins in both serum and endometrial tissues increased significantly with the R-AFS stage (P<0.05) and with dysmenorrheal severity (P<0.05)."", ""supports"": ""SUPPORT""}], ""name"": ""Hypoxia and Angiogenesis""}"
2374	104	Endometriosis	Endometriosis.yaml	pathophysiology	6	Adhesion Formation	"Chronic inflammation leads to fibrous adhesions distorting pelvic anatomy. Adhesions contribute to pain and infertility.
"																																																								"{""description"": ""Chronic inflammation leads to fibrous adhesions distorting pelvic anatomy. Adhesions contribute to pain and infertility.\n"", ""name"": ""Adhesion Formation""}"	{}	"{""description"": ""Chronic inflammation leads to fibrous adhesions distorting pelvic anatomy. Adhesions contribute to pain and infertility.\n"", ""name"": ""Adhesion Formation""}"
2405	105	Epilepsy	Epilepsy.yaml	pathophysiology	0	Neuronal Hyperexcitability	"Imbalance between excitatory (glutamate) and inhibitory (GABA) neurotransmission leads to synchronized, excessive neuronal firing. Ion channel dysfunction is a common mechanism.
"																																																								"{""description"": ""Imbalance between excitatory (glutamate) and inhibitory (GABA) neurotransmission leads to synchronized, excessive neuronal firing. Ion channel dysfunction is a common mechanism.\n"", ""name"": ""Neuronal Hyperexcitability""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Synaptic Transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}], ""cell_types"": [{""preferred_term"": ""Pyramidal Neuron"", ""term"": {""id"": ""CL:0000598"", ""label"": ""pyramidal neuron""}}, {""preferred_term"": ""GABAergic Interneuron"", ""term"": {""id"": ""CL:0000617"", ""label"": ""GABAergic neuron""}}], ""description"": ""Imbalance between excitatory (glutamate) and inhibitory (GABA) neurotransmission leads to synchronized, excessive neuronal firing. Ion channel dysfunction is a common mechanism.\n"", ""evidence"": [{""explanation"": ""Demonstrates measurable excitation/inhibition imbalance in epilepsy patients using EEG aperiodic exponent as a proxy for E/I balance."", ""reference"": ""PMID:39056027"", ""snippet"": ""Patients with temporal lobe epilepsy showed a significantly larger exponent, corresponding to inhibition-directed E/I balance, in bilateral frontal and temporal regions."", ""supports"": ""SUPPORT""}, {""explanation"": ""Links E/I imbalance to expression of key genes encoding GABA receptors, glutamate receptors, and ion channels, supporting the molecular basis of hyperexcitability."", ""reference"": ""PMID:39056027"", ""snippet"": ""Limited to patients with temporal lobe epilepsy, we detected a significant correlation between the exponent and the cortical expression of GABRA1, GRIN2A, GABRD, GABRG2, KCNA2 and PDYN genes."", ""supports"": ""SUPPORT""}], ""name"": ""Neuronal Hyperexcitability""}"
2406	105	Epilepsy	Epilepsy.yaml	pathophysiology	1	Blood-Brain Barrier Disruption	"Loss of tight junction proteins (claudin-5) in brain endothelial cells leads to blood-brain barrier breakdown, allowing albumin extravasation and disruption of ionic homeostasis.
"																																																								"{""description"": ""Loss of tight junction proteins (claudin-5) in brain endothelial cells leads to blood-brain barrier breakdown, allowing albumin extravasation and disruption of ionic homeostasis.\n"", ""name"": ""Blood-Brain Barrier Disruption""}"	"{""downstream"": [{""description"": ""BBB disruption causes albumin entry and altered ionic balance, increasing neuronal excitability."", ""target"": ""Network Hyperexcitability""}]}"	"{""biological_processes"": [{""preferred_term"": ""Blood-Brain Barrier Maintenance"", ""term"": {""id"": ""GO:0035633"", ""label"": ""maintenance of blood-brain barrier""}}], ""cell_types"": [{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Loss of tight junction proteins (claudin-5) in brain endothelial cells leads to blood-brain barrier breakdown, allowing albumin extravasation and disruption of ionic homeostasis.\n"", ""downstream"": [{""description"": ""BBB disruption causes albumin entry and altered ionic balance, increasing neuronal excitability."", ""target"": ""Network Hyperexcitability""}], ""evidence"": [{""explanation"": ""Demonstrates that BBB dysfunction occurs in human epilepsy patients and is characterized by loss of tight junction proteins."", ""reference"": ""PMID:35422069"", ""snippet"": ""claudin-5 protein levels are significantly diminished in surgically resected brain tissue from patients with treatment-resistant epilepsy. Concomitantly, dynamic contrast-enhanced MRI in these patients showed widespread BBB disruption."", ""supports"": ""SUPPORT""}, {""explanation"": ""Establishes causal role of BBB dysfunction in seizure generation, showing that disruption of endothelial tight junctions is sufficient to trigger spontaneous seizures."", ""reference"": ""PMID:35422069"", ""snippet"": ""inducible knockdown of claudin-5 in mice leads to spontaneous recurrent seizures, severe neuroinflammation, and mortality."", ""supports"": ""SUPPORT""}, {""explanation"": ""Provides proof-of-concept that stabilizing the BBB through claudin-5 upregulation can prevent seizures, supporting BBB as a therapeutic target."", ""reference"": ""PMID:35422069"", ""snippet"": ""RepSox, a regulator of claudin-5 expression, can prevent seizure activity in experimental epilepsy."", ""supports"": ""SUPPORT""}], ""name"": ""Blood-Brain Barrier Disruption""}"
2407	105	Epilepsy	Epilepsy.yaml	pathophysiology	2	Network Hyperexcitability	"Abnormal synchronization of neuronal networks that can recruit adjacent or distant brain regions, leading to seizure propagation.
"																																																								"{""description"": ""Abnormal synchronization of neuronal networks that can recruit adjacent or distant brain regions, leading to seizure propagation.\n"", ""name"": ""Network Hyperexcitability""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Neuronal Activity"", ""term"": {""id"": ""GO:0019226"", ""label"": ""transmission of nerve impulse""}}], ""description"": ""Abnormal synchronization of neuronal networks that can recruit adjacent or distant brain regions, leading to seizure propagation.\n"", ""name"": ""Network Hyperexcitability""}"
2408	105	Epilepsy	Epilepsy.yaml	pathophysiology	3	Neuroinflammation and Gliosis	"Activation of microglia and reactive astrocytes following brain injury or during seizures, releasing inflammatory mediators and undergoing morphological changes that alter the brain microenvironment.
"																																																								"{""description"": ""Activation of microglia and reactive astrocytes following brain injury or during seizures, releasing inflammatory mediators and undergoing morphological changes that alter the brain microenvironment.\n"", ""name"": ""Neuroinflammation and Gliosis""}"	"{""downstream"": [{""description"": ""Inflammatory mediators and glial activation alter synaptic structure and connectivity."", ""target"": ""Synaptic Reorganization""}]}"	"{""biological_processes"": [{""preferred_term"": ""Neuroinflammatory Response"", ""term"": {""id"": ""GO:0150076"", ""label"": ""neuroinflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}, {""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Activation of microglia and reactive astrocytes following brain injury or during seizures, releasing inflammatory mediators and undergoing morphological changes that alter the brain microenvironment.\n"", ""downstream"": [{""description"": ""Inflammatory mediators and glial activation alter synaptic structure and connectivity."", ""target"": ""Synaptic Reorganization""}], ""name"": ""Neuroinflammation and Gliosis""}"
2409	105	Epilepsy	Epilepsy.yaml	pathophysiology	4	Synaptic Reorganization	"Aberrant sprouting, formation of new synaptic connections, and altered synaptic plasticity that promote recurrent excitatory circuits and seizure susceptibility.
"																																																								"{""description"": ""Aberrant sprouting, formation of new synaptic connections, and altered synaptic plasticity that promote recurrent excitatory circuits and seizure susceptibility.\n"", ""name"": ""Synaptic Reorganization""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Synaptic Plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}], ""description"": ""Aberrant sprouting, formation of new synaptic connections, and altered synaptic plasticity that promote recurrent excitatory circuits and seizure susceptibility.\n"", ""name"": ""Synaptic Reorganization""}"
2410	105	Epilepsy	Epilepsy.yaml	pathophysiology	5	mTOR Pathway Hyperactivation	"Constitutive activation of the mechanistic target of rapamycin (mTOR) signaling pathway, driving abnormal neuronal growth and development of dysmorphic neurons in focal cortical malformations.
"																																																								"{""description"": ""Constitutive activation of the mechanistic target of rapamycin (mTOR) signaling pathway, driving abnormal neuronal growth and development of dysmorphic neurons in focal cortical malformations.\n"", ""name"": ""mTOR Pathway Hyperactivation""}"	"{""downstream"": [{""description"": ""Hyperactive mTOR signaling causes abnormal neuronal soma enlargement and cytoskeletal changes."", ""target"": ""Dysmorphic Neuron Generation""}]}"	"{""biological_processes"": [{""preferred_term"": ""mTOR Signaling"", ""term"": {""id"": ""GO:0031929"", ""label"": ""TOR signaling""}}], ""description"": ""Constitutive activation of the mechanistic target of rapamycin (mTOR) signaling pathway, driving abnormal neuronal growth and development of dysmorphic neurons in focal cortical malformations.\n"", ""downstream"": [{""description"": ""Hyperactive mTOR signaling causes abnormal neuronal soma enlargement and cytoskeletal changes."", ""target"": ""Dysmorphic Neuron Generation""}], ""evidence"": [{""explanation"": ""Demonstrates that mTORC1 pathway hyperactivation caused by DEPDC5 loss drives epilepsy pathogenesis and that mTOR inhibition can rescue the phenotype."", ""reference"": ""PMID:31174205"", ""snippet"": ""Treatment with the mTORC1 inhibitor rapamycin starting after 3 weeks of age significantly prolonged the survival of Depdc5cc+ mice and partially rescued the behavioral hyperactivity."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows that mTOR hyperactivation causes abnormal neuronal growth contributing to epileptogenesis, which can be reversed by mTOR inhibition."", ""reference"": ""PMID:31174205"", ""snippet"": ""Rapamycin decreased the enlarged brain size of Depdc5cc+ mice with corresponding decrease in neuronal soma size."", ""supports"": ""SUPPORT""}], ""name"": ""mTOR Pathway Hyperactivation""}"
2411	105	Epilepsy	Epilepsy.yaml	pathophysiology	6	Dysmorphic Neuron Generation	"Formation of abnormally enlarged neurons with cytoskeletal disruption and cellular senescence markers, creating epileptogenic foci in cortical malformations.
"																																																								"{""description"": ""Formation of abnormally enlarged neurons with cytoskeletal disruption and cellular senescence markers, creating epileptogenic foci in cortical malformations.\n"", ""name"": ""Dysmorphic Neuron Generation""}"	{}	"{""description"": ""Formation of abnormally enlarged neurons with cytoskeletal disruption and cellular senescence markers, creating epileptogenic foci in cortical malformations.\n"", ""evidence"": [{""explanation"": ""Identifies cellular senescence as a novel mechanism in mTOR-related focal cortical dysplasia, linking dysmorphic neurons to epileptogenesis."", ""reference"": ""PMID:38710875"", ""snippet"": ""We uncovered multiple signatures of cellular senescence in these pathological cells, including p53/p16 expression, SASP expression and senescence-associated -galactosidase activity."", ""supports"": ""SUPPORT""}, {""explanation"": ""Provides proof-of-concept for targeting senescent dysmorphic neurons as a disease-modifying therapeutic strategy in mTOR-related epilepsy."", ""reference"": ""PMID:38710875"", ""snippet"": ""administration of senolytic drugs (dasatinib/quercetin) decreases the load of senescent cells and reduces seizure frequency in an MtorS2215F FCDII preclinical mouse model"", ""supports"": ""SUPPORT""}], ""name"": ""Dysmorphic Neuron Generation""}"
2431	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	0	Vascular Resistance	"Increased systemic vascular resistance due to structural and functional changes in resistance arterioles. Endothelial dysfunction, vascular remodeling, and increased smooth muscle tone contribute.
"																																																								"{""description"": ""Increased systemic vascular resistance due to structural and functional changes in resistance arterioles. Endothelial dysfunction, vascular remodeling, and increased smooth muscle tone contribute.\n"", ""name"": ""Vascular Resistance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Blood Pressure Regulation"", ""term"": {""id"": ""GO:0008217"", ""label"": ""regulation of blood pressure""}}], ""cell_types"": [{""preferred_term"": ""Vascular Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}, {""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Increased systemic vascular resistance due to structural and functional changes in resistance arterioles. Endothelial dysfunction, vascular remodeling, and increased smooth muscle tone contribute.\n"", ""evidence"": [{""explanation"": ""This supports the central role of vascular dysfunction in hypertension pathophysiology."", ""reference"": ""PMID:37080965"", ""snippet"": ""The alterations in signaling pathways in these cells are the key molecular mechanisms underlying vascular dysfunction and hypertension development."", ""supports"": ""SUPPORT""}, {""explanation"": ""This describes the mechanism by which endothelial dysfunction increases vascular resistance."", ""reference"": ""PMID:38172242"", ""snippet"": ""Effector mediators impair nitric oxide bioavailability, leading to endothelial dysfunction and increased vascular contractility."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms the role of vascular remodeling in increasing resistance."", ""reference"": ""PMID:36703963"", ""snippet"": ""Both innate and adaptive immunity are now known to promote the elevation of blood pressure by triggering vascular inflammation and microvascular remodeling."", ""supports"": ""SUPPORT""}], ""name"": ""Vascular Resistance""}"
2432	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	1	Renin-Angiotensin-Aldosterone System Dysregulation	"Overactivation of the RAAS leads to sodium retention, vasoconstriction, and vascular remodeling, all contributing to elevated blood pressure.
"																																																								"{""description"": ""Overactivation of the RAAS leads to sodium retention, vasoconstriction, and vascular remodeling, all contributing to elevated blood pressure.\n"", ""name"": ""Renin-Angiotensin-Aldosterone System Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""RAAS Pathway"", ""term"": {""id"": ""GO:0002018"", ""label"": ""renin-angiotensin regulation of aldosterone production""}}], ""cell_types"": [{""preferred_term"": ""Kidney Granular Cell"", ""term"": {""id"": ""CL:0000648"", ""label"": ""kidney granular cell""}}], ""description"": ""Overactivation of the RAAS leads to sodium retention, vasoconstriction, and vascular remodeling, all contributing to elevated blood pressure.\n"", ""evidence"": [{""explanation"": ""This directly supports RAAS activation causing sodium retention and elevated blood pressure."", ""reference"": ""PMID:39765782"", ""snippet"": ""Activation of intrarenal angiotensin II receptors contributes to sodium retention and high BP."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms RAAS activation as a critical mechanism in hypertension."", ""reference"": ""PMID:39765782"", ""snippet"": ""Oxidative stress, inflammation, and activation of the renin-angiotensin-aldosterone system (RAAS) play critical roles in causing kidney injury in HTN."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms RAAS as a key upstream pathway driving hypertension."", ""reference"": ""PMID:37080965"", ""snippet"": ""In this manuscript, we will comprehensively review the signaling pathways involved in vascular function regulation and hypertension progression, including calcium pathway, NO-NOsGC-cGMP pathway, various vascular remodeling pathways and some important upstream pathways such as renin-angiotensin-aldosterone system, oxidative stress-related signaling pathway, immunity/inflammation pathway, etc."", ""supports"": ""SUPPORT""}], ""name"": ""Renin-Angiotensin-Aldosterone System Dysregulation""}"
2433	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	2	Sympathetic Nervous System Overactivity	"Enhanced sympathetic tone increases heart rate, cardiac output, and peripheral vascular resistance through catecholamine release.
"																																																								"{""description"": ""Enhanced sympathetic tone increases heart rate, cardiac output, and peripheral vascular resistance through catecholamine release.\n"", ""name"": ""Sympathetic Nervous System Overactivity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Sympathetic Regulation"", ""term"": {""id"": ""GO:0003082"", ""label"": ""positive regulation of systemic arterial blood pressure by norepinephrine-epinephrine""}}], ""description"": ""Enhanced sympathetic tone increases heart rate, cardiac output, and peripheral vascular resistance through catecholamine release.\n"", ""evidence"": [{""explanation"": ""This confirms increased sympathetic outflow as a contributor to hypertension pathogenesis."", ""reference"": ""PMID:38172242"", ""snippet"": ""Neoantigens, the NLRP3 inflammasome and increased sympathetic outflow, as well as cytokines (including IL-6, IL-7, IL-15, IL-18 and IL-21) and a high-salt environment, can contribute to immune activation in hypertension."", ""supports"": ""SUPPORT""}], ""name"": ""Sympathetic Nervous System Overactivity""}"
2434	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	3	Immune and Inflammatory Activation	"Chronic immune activation involving both innate and adaptive immunity drives vascular inflammation and remodeling. T cells, monocytes, macrophages, and dendritic cells infiltrate target organs including arteries, kidneys, heart, and brain, releasing proinflammatory cytokines such as IL-17, IFN-gamma, and TNF-alpha that elevate blood pressure and cause end-organ damage.
"																																																								"{""description"": ""Chronic immune activation involving both innate and adaptive immunity drives vascular inflammation and remodeling. T cells, monocytes, macrophages, and dendritic cells infiltrate target organs including arteries, kidneys, heart, and brain, releasing proinflammatory cytokines such as IL-17, IFN-gamma, and TNF-alpha that elevate blood pressure and cause end-organ damage.\n"", ""name"": ""Immune and Inflammatory Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""T Cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}, {""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""Dendritic Cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""Chronic immune activation involving both innate and adaptive immunity drives vascular inflammation and remodeling. T cells, monocytes, macrophages, and dendritic cells infiltrate target organs including arteries, kidneys, heart, and brain, releasing proinflammatory cytokines such as IL-17, IFN-gamma, and TNF-alpha that elevate blood pressure and cause end-organ damage.\n"", ""evidence"": [{""explanation"": ""This establishes the broad involvement of immune cells in hypertension."", ""reference"": ""PMID:38172242"", ""snippet"": ""T cells, monocytes, macrophages, dendritic cells, B cells and natural killer cells are all implicated in hypertension."", ""supports"": ""SUPPORT""}, {""explanation"": ""This describes how immune cell infiltration leads to target organ damage in hypertension."", ""reference"": ""PMID:38172242"", ""snippet"": ""The activated immune cells migrate to target organs such as arteries (especially the perivascular fat and adventitia), kidneys, the heart and the brain, where they release effector cytokines that elevate blood pressure and cause vascular remodelling, renal damage, cardiac hypertrophy, cognitive impairment and dementia."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms the role of chronic inflammation in hypertension pathogenesis."", ""reference"": ""PMID:36703963"", ""snippet"": ""Hypertension is regarded as the most prominent risk factor for cardiovascular diseases, which have become a primary cause of death, and recent research has demonstrated that chronic inflammation is involved in the pathogenesis of hypertension."", ""supports"": ""SUPPORT""}, {""explanation"": ""This describes the salt-sensitive immune activation pathway driving hypertension."", ""reference"": ""PMID:38164753"", ""snippet"": ""Elevated sodium activates antigen-presenting cells to release proinflammatory cytokines including IL (interleukin) 6, tumor necrosis factor-, IL-1, and accumulate isolevuglandin-protein adducts. In turn, these activate T cells release prohypertensive cytokines including IL-17A."", ""supports"": ""SUPPORT""}], ""name"": ""Immune and Inflammatory Activation""}"
2435	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	4	Oxidative Stress	"Increased production of reactive oxygen species (ROS) by NADPH oxidases and decreased antioxidant defenses lead to oxidative stress. ROS impair nitric oxide bioavailability, promote endothelial dysfunction, and activate inflammatory pathways, all contributing to elevated blood pressure and kidney injury.
"																																																								"{""description"": ""Increased production of reactive oxygen species (ROS) by NADPH oxidases and decreased antioxidant defenses lead to oxidative stress. ROS impair nitric oxide bioavailability, promote endothelial dysfunction, and activate inflammatory pathways, all contributing to elevated blood pressure and kidney injury.\n"", ""name"": ""Oxidative Stress""}"	{}	"{""biological_processes"": [{""preferred_term"": ""ROS Metabolic Process"", ""term"": {""id"": ""GO:0072593"", ""label"": ""reactive oxygen species metabolic process""}}], ""description"": ""Increased production of reactive oxygen species (ROS) by NADPH oxidases and decreased antioxidant defenses lead to oxidative stress. ROS impair nitric oxide bioavailability, promote endothelial dysfunction, and activate inflammatory pathways, all contributing to elevated blood pressure and kidney injury.\n"", ""evidence"": [{""explanation"": ""This establishes the central role of ROS in hypertension development."", ""reference"": ""PMID:39765782"", ""snippet"": ""Overproduction of reactive oxygen species (ROS) plays a crucial role in the development and progression of HTN, impacting renal function and BP regulation."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms NOX enzymes as key sources of pathogenic ROS in hypertension."", ""reference"": ""PMID:39765782"", ""snippet"": ""Targeting specific NADPH oxidase (NOX) isoforms to inhibit ROS production and enhance antioxidant mechanisms may improve renal structure and function while lowering blood pressure."", ""supports"": ""SUPPORT""}, {""explanation"": ""This describes how immune activation leads to oxidative stress and endothelial dysfunction."", ""reference"": ""PMID:36703963"", ""snippet"": ""In particular, interferon-gamma (IFN-) and interleukin-17 (IL-17) produced by activated T lymphocytes contribute to hypertension by inducing oxidative stress injury and endothelial dysfunction."", ""supports"": ""SUPPORT""}], ""name"": ""Oxidative Stress""}"
2452	107	Essential Thrombocythemia	Essential_Thrombocythemia.yaml	pathophysiology	0	JAK-STAT Pathway Hyperactivation	Driver mutations in JAK2, CALR, or MPL converge on constitutive JAK-STAT signaling activation. JAK2 V617F directly activates the kinase; CALR mutations cause aberrant activation of MPL receptor; MPL mutations cause constitutive thrombopoietin receptor activation.																																																								"{""description"": ""Driver mutations in JAK2, CALR, or MPL converge on constitutive JAK-STAT signaling activation. JAK2 V617F directly activates the kinase; CALR mutations cause aberrant activation of MPL receptor; MPL mutations cause constitutive thrombopoietin receptor activation."", ""name"": ""JAK-STAT Pathway Hyperactivation""}"	"{""downstream"": [{""description"": ""JAK-STAT activation drives megakaryocyte proliferation and platelet production"", ""target"": ""Enhanced Megakaryopoiesis""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""JAK-STAT signaling pathway"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}], ""cell_types"": [{""preferred_term"": ""megakaryocyte"", ""term"": {""id"": ""CL:0000556"", ""label"": ""megakaryocyte""}}], ""description"": ""Driver mutations in JAK2, CALR, or MPL converge on constitutive JAK-STAT signaling activation. JAK2 V617F directly activates the kinase; CALR mutations cause aberrant activation of MPL receptor; MPL mutations cause constitutive thrombopoietin receptor activation."", ""downstream"": [{""description"": ""JAK-STAT activation drives megakaryocyte proliferation and platelet production"", ""target"": ""Enhanced Megakaryopoiesis""}], ""evidence"": [{""explanation"": ""This abstract links ET to JAK2/CALR/MPL mutations, supporting the JAK-STAT activation described."", ""reference"": ""PMID:41577837"", ""snippet"": ""Polycythemia vera (PV) and essential thrombocythemia (ET) are chronic myeloproliferative neoplasms (MPNs), often associated with mutations in JAK2, CALR, and MPL."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""JAK-STAT Pathway Hyperactivation""}"
2453	107	Essential Thrombocythemia	Essential_Thrombocythemia.yaml	pathophysiology	1	Enhanced Megakaryopoiesis	Constitutive JAK-STAT signaling drives increased megakaryocyte proliferation and maturation. Unlike myelofibrosis, megakaryocytes in ET are large and mature without significant atypia or clustering.																																																								"{""description"": ""Constitutive JAK-STAT signaling drives increased megakaryocyte proliferation and maturation. Unlike myelofibrosis, megakaryocytes in ET are large and mature without significant atypia or clustering."", ""name"": ""Enhanced Megakaryopoiesis""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""megakaryocyte differentiation"", ""term"": {""id"": ""GO:0030219"", ""label"": ""megakaryocyte differentiation""}}], ""description"": ""Constitutive JAK-STAT signaling drives increased megakaryocyte proliferation and maturation. Unlike myelofibrosis, megakaryocytes in ET are large and mature without significant atypia or clustering."", ""name"": ""Enhanced Megakaryopoiesis""}"
2454	107	Essential Thrombocythemia	Essential_Thrombocythemia.yaml	pathophysiology	2	Platelet Dysfunction and Thrombosis Risk	Despite elevated platelet counts, thrombosis risk is multifactorial and involves platelet activation, leukocyte-platelet interactions, and endothelial dysfunction. Paradoxically, extreme thrombocytosis (>1,000,000/uL) may cause acquired von Willebrand disease and bleeding.																																																								"{""description"": ""Despite elevated platelet counts, thrombosis risk is multifactorial and involves platelet activation, leukocyte-platelet interactions, and endothelial dysfunction. Paradoxically, extreme thrombocytosis (>1,000,000/uL) may cause acquired von Willebrand disease and bleeding."", ""name"": ""Platelet Dysfunction and Thrombosis Risk""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""platelet activation"", ""term"": {""id"": ""GO:0030168"", ""label"": ""platelet activation""}}], ""description"": ""Despite elevated platelet counts, thrombosis risk is multifactorial and involves platelet activation, leukocyte-platelet interactions, and endothelial dysfunction. Paradoxically, extreme thrombocytosis (>1,000,000/uL) may cause acquired von Willebrand disease and bleeding."", ""name"": ""Platelet Dysfunction and Thrombosis Risk""}"
2470	108	Ewing Sarcoma	Ewing_Sarcoma.yaml	pathophysiology	0	EWS-FLI1 Fusion Oncogene	The t(11;22)(q24;q12) translocation fuses the EWS gene (EWSR1) on chromosome 22 with the FLI1 gene on chromosome 11. The resulting EWS-FLI1 protein functions as an aberrant transcription factor that activates proliferative genes and represses differentiation programs. This single genetic event is the primary driver of Ewing sarcoma.																																																								"{""description"": ""The t(11;22)(q24;q12) translocation fuses the EWS gene (EWSR1) on chromosome 22 with the FLI1 gene on chromosome 11. The resulting EWS-FLI1 protein functions as an aberrant transcription factor that activates proliferative genes and represses differentiation programs. This single genetic event is the primary driver of Ewing sarcoma."", ""name"": ""EWS-FLI1 Fusion Oncogene""}"	"{""downstream"": [{""description"": ""EWS-FLI1 binds GGAA microsatellites to create de novo enhancers"", ""target"": ""Aberrant Transcriptional Regulation""}, {""description"": ""EWS-FLI1 represses mesenchymal differentiation programs"", ""target"": ""Blocked Differentiation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}], ""cell_types"": [{""preferred_term"": ""mesenchymal stem cell"", ""term"": {""id"": ""CL:0000134"", ""label"": ""mesenchymal stem cell""}}], ""description"": ""The t(11;22)(q24;q12) translocation fuses the EWS gene (EWSR1) on chromosome 22 with the FLI1 gene on chromosome 11. The resulting EWS-FLI1 protein functions as an aberrant transcription factor that activates proliferative genes and represses differentiation programs. This single genetic event is the primary driver of Ewing sarcoma."", ""downstream"": [{""description"": ""EWS-FLI1 binds GGAA microsatellites to create de novo enhancers"", ""target"": ""Aberrant Transcriptional Regulation""}, {""description"": ""EWS-FLI1 represses mesenchymal differentiation programs"", ""target"": ""Blocked Differentiation""}], ""evidence"": [{""explanation"": ""This study demonstrates that EWS-FLI1 is the driver fusion oncogene in Ewing sarcoma that activates transcriptional programs including metabolic reprogramming."", ""reference"": ""PMID:33741715"", ""snippet"": ""Ewing sarcomas are driven by EWS-ETS fusions, most commonly EWS-FLI1, which promotes widespread metabolic reprogramming, including activation of serine biosynthesis."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""bone tissue"", ""term"": {""id"": ""UBERON:0002481"", ""label"": ""bone tissue""}}], ""name"": ""EWS-FLI1 Fusion Oncogene""}"
2471	108	Ewing Sarcoma	Ewing_Sarcoma.yaml	pathophysiology	1	Aberrant Transcriptional Regulation	EWS-FLI1 binds to GGAA microsatellite repeats throughout the genome, creating de novo enhancers that activate oncogenic target genes including NKX2-2, NR0B1, and IGF1. This abnormal enhancer activity reprograms cell identity and drives the Ewing sarcoma phenotype.																																																								"{""description"": ""EWS-FLI1 binds to GGAA microsatellite repeats throughout the genome, creating de novo enhancers that activate oncogenic target genes including NKX2-2, NR0B1, and IGF1. This abnormal enhancer activity reprograms cell identity and drives the Ewing sarcoma phenotype."", ""name"": ""Aberrant Transcriptional Regulation""}"	"{""downstream"": [{""description"": ""Aberrant enhancer activity maintains undifferentiated state"", ""target"": ""Blocked Differentiation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of gene expression"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}], ""description"": ""EWS-FLI1 binds to GGAA microsatellite repeats throughout the genome, creating de novo enhancers that activate oncogenic target genes including NKX2-2, NR0B1, and IGF1. This abnormal enhancer activity reprograms cell identity and drives the Ewing sarcoma phenotype."", ""downstream"": [{""description"": ""Aberrant enhancer activity maintains undifferentiated state"", ""target"": ""Blocked Differentiation""}], ""evidence"": [{""explanation"": ""This study demonstrates that EWS-FLI1 functions as an aberrant transcription factor that directly binds promoter regions to activate target genes."", ""reference"": ""PMID:33741715"", ""snippet"": ""We identified and validated an EWS-FLI1 binding site at the ATF4 promoter, indicating that the fusion can directly activate ATF4 transcription."", ""supports"": ""SUPPORT""}], ""name"": ""Aberrant Transcriptional Regulation""}"
2472	108	Ewing Sarcoma	Ewing_Sarcoma.yaml	pathophysiology	2	Blocked Differentiation	EWS-FLI1 represses genes required for mesenchymal differentiation, maintaining cells in a proliferative, undifferentiated state. The cell of origin remains debated but may be a neural crest-derived mesenchymal progenitor.																																																								"{""description"": ""EWS-FLI1 represses genes required for mesenchymal differentiation, maintaining cells in a proliferative, undifferentiated state. The cell of origin remains debated but may be a neural crest-derived mesenchymal progenitor."", ""name"": ""Blocked Differentiation""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}], ""description"": ""EWS-FLI1 represses genes required for mesenchymal differentiation, maintaining cells in a proliferative, undifferentiated state. The cell of origin remains debated but may be a neural crest-derived mesenchymal progenitor."", ""name"": ""Blocked Differentiation""}"
2489	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	0	FGFR2 Fusion and Constitutive Activation	FGFR2 fusions join the FGFR2 kinase domain to various partner genes (BICC1, PPHLN1, AHCYL1, and others). Partner genes typically provide oligomerization domains that cause ligand-independent FGFR2 dimerization and constitutive kinase activation. This drives oncogenic signaling through multiple downstream pathways.																																																								"{""description"": ""FGFR2 fusions join the FGFR2 kinase domain to various partner genes (BICC1, PPHLN1, AHCYL1, and others). Partner genes typically provide oligomerization domains that cause ligand-independent FGFR2 dimerization and constitutive kinase activation. This drives oncogenic signaling through multiple downstream pathways."", ""name"": ""FGFR2 Fusion and Constitutive Activation""}"	"{""downstream"": [{""description"": ""FGFR2 activates RAS-RAF-MEK-ERK signaling cascade"", ""target"": ""MAPK Pathway Activation""}, {""description"": ""FGFR2 activates PI3K-AKT-mTOR signaling"", ""target"": ""PI3K-AKT Pathway Activation""}, {""description"": ""FGFR2 activates phospholipase C gamma signaling"", ""target"": ""PLCgamma-PKC Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""fibroblast growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""intrahepatic cholangiocyte"", ""term"": {""id"": ""CL:0002538"", ""label"": ""intrahepatic cholangiocyte""}}], ""description"": ""FGFR2 fusions join the FGFR2 kinase domain to various partner genes (BICC1, PPHLN1, AHCYL1, and others). Partner genes typically provide oligomerization domains that cause ligand-independent FGFR2 dimerization and constitutive kinase activation. This drives oncogenic signaling through multiple downstream pathways."", ""downstream"": [{""description"": ""FGFR2 activates RAS-RAF-MEK-ERK signaling cascade"", ""target"": ""MAPK Pathway Activation""}, {""description"": ""FGFR2 activates PI3K-AKT-mTOR signaling"", ""target"": ""PI3K-AKT Pathway Activation""}, {""description"": ""FGFR2 activates phospholipase C gamma signaling"", ""target"": ""PLCgamma-PKC Pathway Activation""}], ""evidence"": [{""explanation"": ""Supports FGFR2 fusions as frequent alterations in intrahepatic cholangiocarcinoma."", ""reference"": ""PMID:36535760"", ""snippet"": ""Gene fusions are among the most frequent alterations, involving FGFR2 in 10-15% of iCCAs in particular, and NTRK genes at a lower frequency (<1%)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""intrahepatic bile duct"", ""term"": {""id"": ""UBERON:0003704"", ""label"": ""intrahepatic bile duct""}}], ""name"": ""FGFR2 Fusion and Constitutive Activation""}"
2490	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	1	MAPK Pathway Activation	FGFR2 activation leads to recruitment of adaptor proteins (FRS2, GRB2) that activate RAS and the downstream MAPK cascade. This drives transcription of genes promoting cell proliferation.																																																								"{""description"": ""FGFR2 activation leads to recruitment of adaptor proteins (FRS2, GRB2) that activate RAS and the downstream MAPK cascade. This drives transcription of genes promoting cell proliferation."", ""name"": ""MAPK Pathway Activation""}"	"{""downstream"": [{""description"": ""MAPK signaling promotes cell cycle progression"", ""target"": ""Enhanced Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""FGFR2 activation leads to recruitment of adaptor proteins (FRS2, GRB2) that activate RAS and the downstream MAPK cascade. This drives transcription of genes promoting cell proliferation."", ""downstream"": [{""description"": ""MAPK signaling promotes cell cycle progression"", ""target"": ""Enhanced Cell Proliferation""}], ""name"": ""MAPK Pathway Activation""}"
2491	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	FGFR2 signaling activates PI3K through adaptor proteins, leading to AKT phosphorylation. This promotes cell survival and resistance to apoptosis. PI3K pathway activation may contribute to resistance to FGFR inhibitors.																																																								"{""description"": ""FGFR2 signaling activates PI3K through adaptor proteins, leading to AKT phosphorylation. This promotes cell survival and resistance to apoptosis. PI3K pathway activation may contribute to resistance to FGFR inhibitors."", ""name"": ""PI3K-AKT Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""FGFR2 signaling activates PI3K through adaptor proteins, leading to AKT phosphorylation. This promotes cell survival and resistance to apoptosis. PI3K pathway activation may contribute to resistance to FGFR inhibitors."", ""name"": ""PI3K-AKT Pathway Activation""}"
2492	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	3	PLCgamma-PKC Pathway Activation	FGFR2 directly phosphorylates phospholipase C gamma, leading to protein kinase C activation. This pathway contributes to cell migration, invasion, and other aspects of the transformed phenotype.																																																								"{""description"": ""FGFR2 directly phosphorylates phospholipase C gamma, leading to protein kinase C activation. This pathway contributes to cell migration, invasion, and other aspects of the transformed phenotype."", ""name"": ""PLCgamma-PKC Pathway Activation""}"	{}	"{""description"": ""FGFR2 directly phosphorylates phospholipase C gamma, leading to protein kinase C activation. This pathway contributes to cell migration, invasion, and other aspects of the transformed phenotype."", ""name"": ""PLCgamma-PKC Pathway Activation""}"
2493	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	4	Enhanced Cell Proliferation	Combined activation of MAPK, PI3K-AKT, and PLCgamma pathways drives enhanced cell proliferation. FGFR2 fusion-positive tumors are dependent on FGFR2 signaling, making them vulnerable to FGFR inhibition.																																																								"{""description"": ""Combined activation of MAPK, PI3K-AKT, and PLCgamma pathways drives enhanced cell proliferation. FGFR2 fusion-positive tumors are dependent on FGFR2 signaling, making them vulnerable to FGFR inhibition."", ""name"": ""Enhanced Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Combined activation of MAPK, PI3K-AKT, and PLCgamma pathways drives enhanced cell proliferation. FGFR2 fusion-positive tumors are dependent on FGFR2 signaling, making them vulnerable to FGFR inhibition."", ""name"": ""Enhanced Cell Proliferation""}"
2511	110	FGFR-Altered Urothelial Carcinoma	FGFR_Altered_Urothelial_Carcinoma.yaml	pathophysiology	0	FGFR3 Constitutive Activation	Activating mutations in FGFR3 cause ligand-independent receptor dimerization and autophosphorylation. The most common mutations affect cysteine residues in the extracellular domain, creating aberrant disulfide bonds that constitutively activate the receptor.																																																								"{""description"": ""Activating mutations in FGFR3 cause ligand-independent receptor dimerization and autophosphorylation. The most common mutations affect cysteine residues in the extracellular domain, creating aberrant disulfide bonds that constitutively activate the receptor."", ""name"": ""FGFR3 Constitutive Activation""}"	"{""downstream"": [{""description"": ""FGFR3 phosphorylation activates RAS-RAF-MEK-ERK signaling cascade"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""FGFR3 phosphorylation recruits PI3K leading to AKT activation"", ""target"": ""PI3K-AKT Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""fibroblast growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""epithelial cell of urethra"", ""term"": {""id"": ""CL:1000296"", ""label"": ""epithelial cell of urethra""}}], ""description"": ""Activating mutations in FGFR3 cause ligand-independent receptor dimerization and autophosphorylation. The most common mutations affect cysteine residues in the extracellular domain, creating aberrant disulfide bonds that constitutively activate the receptor."", ""downstream"": [{""description"": ""FGFR3 phosphorylation activates RAS-RAF-MEK-ERK signaling cascade"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""FGFR3 phosphorylation recruits PI3K leading to AKT activation"", ""target"": ""PI3K-AKT Pathway Activation""}], ""locations"": [{""preferred_term"": ""urinary bladder"", ""term"": {""id"": ""UBERON:0001255"", ""label"": ""urinary bladder""}}], ""name"": ""FGFR3 Constitutive Activation""}"
2512	110	FGFR-Altered Urothelial Carcinoma	FGFR_Altered_Urothelial_Carcinoma.yaml	pathophysiology	1	RAS-MAPK Pathway Activation	FGFR3 activation stimulates the RAS-RAF-MEK-ERK signaling cascade through adaptor proteins FRS2 and GRB2. This drives uncontrolled urothelial cell proliferation and is a major effector of FGFR-mediated transformation.																																																								"{""description"": ""FGFR3 activation stimulates the RAS-RAF-MEK-ERK signaling cascade through adaptor proteins FRS2 and GRB2. This drives uncontrolled urothelial cell proliferation and is a major effector of FGFR-mediated transformation."", ""name"": ""RAS-MAPK Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""FGFR3 activation stimulates the RAS-RAF-MEK-ERK signaling cascade through adaptor proteins FRS2 and GRB2. This drives uncontrolled urothelial cell proliferation and is a major effector of FGFR-mediated transformation."", ""name"": ""RAS-MAPK Pathway Activation""}"
2513	110	FGFR-Altered Urothelial Carcinoma	FGFR_Altered_Urothelial_Carcinoma.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	FGFR3 activation recruits PI3K and activates the PI3K-AKT-mTOR signaling pathway, promoting urothelial cell survival and resistance to apoptosis.																																																								"{""description"": ""FGFR3 activation recruits PI3K and activates the PI3K-AKT-mTOR signaling pathway, promoting urothelial cell survival and resistance to apoptosis."", ""name"": ""PI3K-AKT Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""FGFR3 activation recruits PI3K and activates the PI3K-AKT-mTOR signaling pathway, promoting urothelial cell survival and resistance to apoptosis."", ""name"": ""PI3K-AKT Pathway Activation""}"
2554	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	0	FLT3 Receptor Constitutive Activation	FLT3 is a class III receptor tyrosine kinase normally involved in hematopoietic progenitor cell survival and proliferation. FLT3-ITD mutations cause ligand-independent receptor dimerization and constitutive autophosphorylation. FLT3-TKD mutations stabilize the active kinase conformation. Both result in aberrant downstream signaling.																																																								"{""description"": ""FLT3 is a class III receptor tyrosine kinase normally involved in hematopoietic progenitor cell survival and proliferation. FLT3-ITD mutations cause ligand-independent receptor dimerization and constitutive autophosphorylation. FLT3-TKD mutations stabilize the active kinase conformation. Both result in aberrant downstream signaling."", ""name"": ""FLT3 Receptor Constitutive Activation""}"	"{""downstream"": [{""description"": ""Constitutive FLT3 signaling drives STAT5 phosphorylation and nuclear translocation"", ""target"": ""STAT5 Hyperactivation""}, {""description"": ""Activated FLT3 signals through RAS to promote proliferation"", ""target"": ""RAS-MAPK Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}], ""cell_types"": [{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}], ""description"": ""FLT3 is a class III receptor tyrosine kinase normally involved in hematopoietic progenitor cell survival and proliferation. FLT3-ITD mutations cause ligand-independent receptor dimerization and constitutive autophosphorylation. FLT3-TKD mutations stabilize the active kinase conformation. Both result in aberrant downstream signaling."", ""downstream"": [{""description"": ""Constitutive FLT3 signaling drives STAT5 phosphorylation and nuclear translocation"", ""target"": ""STAT5 Hyperactivation""}, {""description"": ""Activated FLT3 signals through RAS to promote proliferation"", ""target"": ""RAS-MAPK Pathway Activation""}], ""evidence"": [{""explanation"": ""This abstract describes FLT3-ITD/TKD mutations driving constitutive activation in AML, matching the mechanism described."", ""reference"": ""PMID:41228209"", ""snippet"": ""In acute myeloid leukemia (AML), FLT3 mutations-most commonly internal tandem duplications (FLT3-ITD) and tyrosine kinase domain (FLT3-TKD) substitutions-are among the most frequent genetic alterations, driving constitutive activation of proliferative and antiapoptotic pathways and conferring adverse prognosis."", ""supports"": ""SUPPORT""}], ""name"": ""FLT3 Receptor Constitutive Activation""}"
2555	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	1	STAT5 Hyperactivation	FLT3-ITD mutations preferentially activate STAT5 signaling compared to wild-type FLT3 or TKD mutations. Phosphorylated STAT5 translocates to the nucleus and activates transcription of anti-apoptotic genes (BCL-XL, PIM1) and cell cycle regulators, promoting leukemic cell survival and proliferation.																																																								"{""description"": ""FLT3-ITD mutations preferentially activate STAT5 signaling compared to wild-type FLT3 or TKD mutations. Phosphorylated STAT5 translocates to the nucleus and activates transcription of anti-apoptotic genes (BCL-XL, PIM1) and cell cycle regulators, promoting leukemic cell survival and proliferation."", ""name"": ""STAT5 Hyperactivation""}"	"{""downstream"": [{""description"": ""STAT5 target genes confer resistance to programmed cell death"", ""target"": ""Apoptosis Resistance""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""cell_types"": [{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}], ""description"": ""FLT3-ITD mutations preferentially activate STAT5 signaling compared to wild-type FLT3 or TKD mutations. Phosphorylated STAT5 translocates to the nucleus and activates transcription of anti-apoptotic genes (BCL-XL, PIM1) and cell cycle regulators, promoting leukemic cell survival and proliferation."", ""downstream"": [{""description"": ""STAT5 target genes confer resistance to programmed cell death"", ""target"": ""Apoptosis Resistance""}], ""name"": ""STAT5 Hyperactivation""}"
2556	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	2	RAS-MAPK Pathway Activation	FLT3 signaling activates the RAS-RAF-MEK-ERK cascade, driving cell proliferation and survival. This pathway is critical for the proliferative advantage of FLT3-mutated leukemic cells.																																																								"{""description"": ""FLT3 signaling activates the RAS-RAF-MEK-ERK cascade, driving cell proliferation and survival. This pathway is critical for the proliferative advantage of FLT3-mutated leukemic cells."", ""name"": ""RAS-MAPK Pathway Activation""}"	"{""downstream"": [{""description"": ""MAPK signaling promotes cell cycle progression and proliferation"", ""target"": ""Uncontrolled Myeloblast Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""FLT3 signaling activates the RAS-RAF-MEK-ERK cascade, driving cell proliferation and survival. This pathway is critical for the proliferative advantage of FLT3-mutated leukemic cells."", ""downstream"": [{""description"": ""MAPK signaling promotes cell cycle progression and proliferation"", ""target"": ""Uncontrolled Myeloblast Proliferation""}], ""name"": ""RAS-MAPK Pathway Activation""}"
2557	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	3	Apoptosis Resistance	FLT3-ITD-mediated STAT5 activation upregulates anti-apoptotic proteins including BCL-XL, MCL-1, and PIM kinases. This confers resistance to apoptosis and contributes to the aggressive clinical behavior of FLT3-ITD AML.																																																								"{""description"": ""FLT3-ITD-mediated STAT5 activation upregulates anti-apoptotic proteins including BCL-XL, MCL-1, and PIM kinases. This confers resistance to apoptosis and contributes to the aggressive clinical behavior of FLT3-ITD AML."", ""name"": ""Apoptosis Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""FLT3-ITD-mediated STAT5 activation upregulates anti-apoptotic proteins including BCL-XL, MCL-1, and PIM kinases. This confers resistance to apoptosis and contributes to the aggressive clinical behavior of FLT3-ITD AML."", ""name"": ""Apoptosis Resistance""}"
2558	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	4	Uncontrolled Myeloblast Proliferation	The combined effects of enhanced survival signaling and cell cycle promotion lead to accumulation of immature myeloid blasts in the bone marrow and blood, replacing normal hematopoiesis.																																																								"{""description"": ""The combined effects of enhanced survival signaling and cell cycle promotion lead to accumulation of immature myeloid blasts in the bone marrow and blood, replacing normal hematopoiesis."", ""name"": ""Uncontrolled Myeloblast Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""myeloid cell differentiation"", ""term"": {""id"": ""GO:0030099"", ""label"": ""myeloid cell differentiation""}}], ""cell_types"": [{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}], ""description"": ""The combined effects of enhanced survival signaling and cell cycle promotion lead to accumulation of immature myeloid blasts in the bone marrow and blood, replacing normal hematopoiesis."", ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Uncontrolled Myeloblast Proliferation""}"
2576	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	0	Lysosomal alpha-galactosidase A deficiency and Gb3 accumulation	"GLA mutations reduce or abolish -galactosidase A enzyme activity, causing accumulation of globotriaosylceramide (Gb3) and its deacylated form lyso-Gb3 in lysosomes. Lyso-Gb3 is closely associated with disease severity and exerts direct cytotoxic effects on podocytes, neurons, and other cell types. Substrate accumulation initiates lysosomal dysfunction with impaired autophagy and reduced ATP production.
"																																																								"{""description"": ""GLA mutations reduce or abolish -galactosidase A enzyme activity, causing accumulation of globotriaosylceramide (Gb3) and its deacylated form lyso-Gb3 in lysosomes. Lyso-Gb3 is closely associated with disease severity and exerts direct cytotoxic effects on podocytes, neurons, and other cell types. Substrate accumulation initiates lysosomal dysfunction with impaired autophagy and reduced ATP production.\n"", ""name"": ""Lysosomal alpha-galactosidase A deficiency and Gb3 accumulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""glycosphingolipid metabolic process"", ""term"": {""id"": ""GO:0006681"", ""label"": ""glycosphingolipid metabolic process""}}, {""preferred_term"": ""lysosomal catabolic process"", ""term"": {""id"": ""GO:0090487"", ""label"": ""lysosomal catabolic process""}}], ""description"": ""GLA mutations reduce or abolish -galactosidase A enzyme activity, causing accumulation of globotriaosylceramide (Gb3) and its deacylated form lyso-Gb3 in lysosomes. Lyso-Gb3 is closely associated with disease severity and exerts direct cytotoxic effects on podocytes, neurons, and other cell types. Substrate accumulation initiates lysosomal dysfunction with impaired autophagy and reduced ATP production.\n"", ""evidence"": [{""explanation"": ""Confirms that GLA mutations cause Gb3 accumulation in lysosomes across multiple organ systems"", ""reference"": ""PMID:31939530"", ""snippet"": ""Mutations in the GLA gene lead to the progressive accumulation of globotriaosylceramide (Gb3). Gb3 accumulates in lysosomes of different types of cells of the heart, kidneys, skin, eyes, central nervous system, and gastrointestinal system"", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""GLA"", ""term"": {""id"": ""hgnc:4296"", ""label"": ""GLA""}}], ""name"": ""Lysosomal alpha-galactosidase A deficiency and Gb3 accumulation""}"
2577	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	1	Endoplasmic reticulum stress and unfolded protein response	"Misfolded -Gal A variants trigger endoplasmic reticulum stress and activate the unfolded protein response (UPR). Persistent UPR activation causes apoptosis and inflammatory signaling through NF-B and MAPK pathways, contributing to cell death and tissue injury.
"																																																								"{""description"": ""Misfolded -Gal A variants trigger endoplasmic reticulum stress and activate the unfolded protein response (UPR). Persistent UPR activation causes apoptosis and inflammatory signaling through NF-B and MAPK pathways, contributing to cell death and tissue injury.\n"", ""name"": ""Endoplasmic reticulum stress and unfolded protein response""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to unfolded protein"", ""term"": {""id"": ""GO:0006986"", ""label"": ""response to unfolded protein""}}, {""preferred_term"": ""NF-kappaB signaling pathway"", ""term"": {""id"": ""GO:0007249"", ""label"": ""NF-kappaB signaling pathway""}}], ""description"": ""Misfolded -Gal A variants trigger endoplasmic reticulum stress and activate the unfolded protein response (UPR). Persistent UPR activation causes apoptosis and inflammatory signaling through NF-B and MAPK pathways, contributing to cell death and tissue injury.\n"", ""evidence"": [{""explanation"": ""Describes the mechanism by which GLA variants cause ER stress and UPR activation independent of lipid accumulation"", ""reference"": ""PMID:39978321"", ""snippet"": ""Missense variants in the coding sequence of the GLA gene would generate the misfolding of the altered protein alpha-galactosidase A. Emergence of misfolded proteins may generate stress of the endoplasmic reticulum, leading to induction of the unfolded protein response (UPR)"", ""supports"": ""SUPPORT""}], ""name"": ""Endoplasmic reticulum stress and unfolded protein response""}"
2578	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	2	Mitochondrial dysfunction and oxidative stress	"Gb3 and lyso-Gb3 accumulation impairs mitochondrial function with reduced ATP production, complex I/III impairment, and elevated reactive oxygen species (ROS) production. Oxidative damage correlates with cardiac hypertrophy and contributes to cell death and inflammation.
"																																																								"{""description"": ""Gb3 and lyso-Gb3 accumulation impairs mitochondrial function with reduced ATP production, complex I/III impairment, and elevated reactive oxygen species (ROS) production. Oxidative damage correlates with cardiac hypertrophy and contributes to cell death and inflammation.\n"", ""name"": ""Mitochondrial dysfunction and oxidative stress""}"	{}	"{""biological_processes"": [{""preferred_term"": ""reactive oxygen species metabolic process"", ""term"": {""id"": ""GO:0072593"", ""label"": ""reactive oxygen species metabolic process""}}, {""preferred_term"": ""regulation of mitochondrial membrane potential"", ""term"": {""id"": ""GO:0051881"", ""label"": ""regulation of mitochondrial membrane potential""}}], ""description"": ""Gb3 and lyso-Gb3 accumulation impairs mitochondrial function with reduced ATP production, complex I/III impairment, and elevated reactive oxygen species (ROS) production. Oxidative damage correlates with cardiac hypertrophy and contributes to cell death and inflammation.\n"", ""evidence"": [{""explanation"": ""Establishes the molecular basis linking GLA deficiency to progressive glycosphingolipid accumulation and organ damage"", ""reference"": ""PMID:29530533"", ""snippet"": ""Fabry disease is an X-linked lysosomal storage disorder caused by mutations in the GLA gene leading to deficient -galactosidase A activity, glycosphingolipid accumulation, and life-threatening complications"", ""supports"": ""SUPPORT""}], ""name"": ""Mitochondrial dysfunction and oxidative stress""}"
2579	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	3	Autophagy impairment	"Lysosomal Gb3 accumulation impairs autophagic flux, leading to accumulation of damaged proteins and organelles. Persistent podocyte injury despite enzyme replacement therapy is mediated in part by -synuclein accumulation, implicating lysosomal toxicity as a disease driver beyond Gb3 storage.
"																																																								"{""description"": ""Lysosomal Gb3 accumulation impairs autophagic flux, leading to accumulation of damaged proteins and organelles. Persistent podocyte injury despite enzyme replacement therapy is mediated in part by -synuclein accumulation, implicating lysosomal toxicity as a disease driver beyond Gb3 storage.\n"", ""name"": ""Autophagy impairment""}"	{}	"{""biological_processes"": [{""preferred_term"": ""autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}], ""description"": ""Lysosomal Gb3 accumulation impairs autophagic flux, leading to accumulation of damaged proteins and organelles. Persistent podocyte injury despite enzyme replacement therapy is mediated in part by -synuclein accumulation, implicating lysosomal toxicity as a disease driver beyond Gb3 storage.\n"", ""evidence"": [{""explanation"": ""Shows that -synuclein accumulation impairs lysosomal function and autophagy in Fabry podocytes, and that SNCA is a key driver of injury beyond Gb3 accumulation"", ""reference"": ""PMID:37014703"", ""snippet"": ""Genetic and pharmacological inhibition of SNCA improved lysosomal structure and function in Fabry podocytes, exceeding the benefits of ERT"", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""SNCA"", ""term"": {""id"": ""hgnc:11138"", ""label"": ""SNCA""}}], ""name"": ""Autophagy impairment""}"
2580	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	4	Innate immune activation and inflammation	"Substrate accumulation activates NLRP3 inflammasome and NF-B-mediated inflammatory responses, leading to elevation of IL-1, IL-6, IL-18, and TNF-. Complement cascade is activated with elevated C3a and C5a, particularly in patients with anti-drug antibodies. These inflammatory mediators propagate endothelial dysfunction and tissue injury.
"																																																								"{""description"": ""Substrate accumulation activates NLRP3 inflammasome and NF-B-mediated inflammatory responses, leading to elevation of IL-1, IL-6, IL-18, and TNF-. Complement cascade is activated with elevated C3a and C5a, particularly in patients with anti-drug antibodies. These inflammatory mediators propagate endothelial dysfunction and tissue injury.\n"", ""name"": ""Innate immune activation and inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}, {""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Substrate accumulation activates NLRP3 inflammasome and NF-B-mediated inflammatory responses, leading to elevation of IL-1, IL-6, IL-18, and TNF-. Complement cascade is activated with elevated C3a and C5a, particularly in patients with anti-drug antibodies. These inflammatory mediators propagate endothelial dysfunction and tissue injury.\n"", ""evidence"": [{""explanation"": ""Demonstrates that complement system is strongly activated in Fabry disease patients, supporting the role of innate immune activation in pathogenesis"", ""reference"": ""PMID:38304433"", ""snippet"": ""we demonstrate strong activation of the complement system in 17 classical male FD patients with either missense or nonsense mutations before and after ERT as evidenced by high C3a and C5a serum levels"", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms inflammation as a key pathogenic mechanism in Fabry disease, with emphasis on innate immune response"", ""reference"": ""PMID:38932991"", ""snippet"": ""Inflammation is emerging as an important aspect of the pathogenesis of Fabry disease. This is thought to be predominantly mediated by the innate immune response, with growing evidence pointing towards the potential involvement of adaptive immune mechanisms"", ""supports"": ""SUPPORT""}], ""name"": ""Innate immune activation and inflammation""}"
2581	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	5	Endothelial dysfunction and vascular remodeling	"Gb3/lyso-Gb3 accumulation in endothelial cells leads to upregulation of adhesion molecules (VCAM1, ICAM1), eNOS uncoupling, and reduced nitric oxide availability. Vascular smooth muscle proliferation and remodeling occur, contributing to microvascular dysfunction and increased thrombotic risk.
"																																																								"{""description"": ""Gb3/lyso-Gb3 accumulation in endothelial cells leads to upregulation of adhesion molecules (VCAM1, ICAM1), eNOS uncoupling, and reduced nitric oxide availability. Vascular smooth muscle proliferation and remodeling occur, contributing to microvascular dysfunction and increased thrombotic risk.\n"", ""name"": ""Endothelial dysfunction and vascular remodeling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""leukocyte adhesion to endothelial cells"", ""term"": {""id"": ""GO:0007107"", ""label"": ""leukocyte adhesion to endothelial cells""}}], ""cell_types"": [{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Gb3/lyso-Gb3 accumulation in endothelial cells leads to upregulation of adhesion molecules (VCAM1, ICAM1), eNOS uncoupling, and reduced nitric oxide availability. Vascular smooth muscle proliferation and remodeling occur, contributing to microvascular dysfunction and increased thrombotic risk.\n"", ""evidence"": [{""explanation"": ""Documents progressive vascular and organ involvement resulting from lysosomal substrate accumulation"", ""reference"": ""PMID:31939530"", ""snippet"": ""Subsequently, symptoms related to progressive impairment appear, such as angiokeratomas, cornea verticillata, left ventricular hypertrophy, myocardial fibrosis, proteinuria, and renal insufficiency"", ""supports"": ""SUPPORT""}], ""name"": ""Endothelial dysfunction and vascular remodeling""}"
2582	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	6	Fibrosis and extracellular matrix remodeling	"TGF--driven profibrotic signaling leads to extracellular matrix deposition in kidney and heart. This fibrotic process becomes partially independent of Gb3 substrate levels and contributes to progressive organ dysfunction through epithelial-to-mesenchymal transition and myofibroblast activation.
"																																																								"{""description"": ""TGF--driven profibrotic signaling leads to extracellular matrix deposition in kidney and heart. This fibrotic process becomes partially independent of Gb3 substrate levels and contributes to progressive organ dysfunction through epithelial-to-mesenchymal transition and myofibroblast activation.\n"", ""name"": ""Fibrosis and extracellular matrix remodeling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}, {""preferred_term"": ""transforming growth factor beta signaling pathway"", ""term"": {""id"": ""GO:0007179"", ""label"": ""transforming growth factor beta signaling pathway""}}], ""description"": ""TGF--driven profibrotic signaling leads to extracellular matrix deposition in kidney and heart. This fibrotic process becomes partially independent of Gb3 substrate levels and contributes to progressive organ dysfunction through epithelial-to-mesenchymal transition and myofibroblast activation.\n"", ""evidence"": [{""explanation"": ""Shows elevated TGF-1 in Fabry disease patients, confirming profibrotic signaling as a mechanism of organ damage"", ""reference"": ""PMID:38304433"", ""snippet"": ""we found increased IL-6, IL-10 and TGF-1 serum levels in FD patients"", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""TGFB1"", ""term"": {""id"": ""hgnc:11766"", ""label"": ""TGFB1""}}], ""name"": ""Fibrosis and extracellular matrix remodeling""}"
2599	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	0	APC Tumor Suppressor Loss	Germline heterozygous APC mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates APC function, initiating adenoma formation. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation.																																																								"{""description"": ""Germline heterozygous APC mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates APC function, initiating adenoma formation. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation."", ""name"": ""APC Tumor Suppressor Loss""}"	"{""downstream"": [{""description"": ""APC loss prevents -catenin degradation"", ""target"": ""Wnt/-Catenin Pathway Activation""}]}"	"{""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""Germline heterozygous APC mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates APC function, initiating adenoma formation. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation."", ""downstream"": [{""description"": ""APC loss prevents -catenin degradation"", ""target"": ""Wnt/-Catenin Pathway Activation""}], ""evidence"": [{""explanation"": ""Confirms that FAP follows the two-hit mechanism for both colorectal cancer and desmoid tumor development."", ""reference"": ""PMID:28668823"", ""snippet"": ""In agreement with Knudson's 'two-hit' theory, the inactivation of the residual APC gene in FAP is a critical step in the development of both colorectal cancer and desmoids."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}], ""name"": ""APC Tumor Suppressor Loss""}"
2600	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	1	Wnt/-Catenin Pathway Activation	APC normally functions in the destruction complex (with Axin, GSK3, CK1) to phosphorylate -catenin, targeting it for ubiquitination and proteasomal degradation. Loss of APC allows -catenin to accumulate, translocate to the nucleus, and activate Wnt target genes driving proliferation.																																																								"{""description"": ""APC normally functions in the destruction complex (with Axin, GSK3, CK1) to phosphorylate -catenin, targeting it for ubiquitination and proteasomal degradation. Loss of APC allows -catenin to accumulate, translocate to the nucleus, and activate Wnt target genes driving proliferation."", ""name"": ""Wnt/-Catenin Pathway Activation""}"	"{""downstream"": [{""description"": ""-catenin activates proliferative and stemness genes"", ""target"": ""Uncontrolled Intestinal Epithelial Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""Wnt signaling pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}], ""description"": ""APC normally functions in the destruction complex (with Axin, GSK3, CK1) to phosphorylate -catenin, targeting it for ubiquitination and proteasomal degradation. Loss of APC allows -catenin to accumulate, translocate to the nucleus, and activate Wnt target genes driving proliferation."", ""downstream"": [{""description"": ""-catenin activates proliferative and stemness genes"", ""target"": ""Uncontrolled Intestinal Epithelial Proliferation""}], ""name"": ""Wnt/-Catenin Pathway Activation""}"
2601	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	2	Uncontrolled Intestinal Epithelial Proliferation	Nuclear -catenin activates TCF/LEF transcription factors, driving expression of Wnt target genes including MYC, CCND1 (cyclin D1), and others that promote cell cycle progression. This results in uncontrolled proliferation of intestinal crypt cells, forming adenomatous polyps.																																																								"{""description"": ""Nuclear -catenin activates TCF/LEF transcription factors, driving expression of Wnt target genes including MYC, CCND1 (cyclin D1), and others that promote cell cycle progression. This results in uncontrolled proliferation of intestinal crypt cells, forming adenomatous polyps."", ""name"": ""Uncontrolled Intestinal Epithelial Proliferation""}"	"{""downstream"": [{""description"": ""Hyperproliferative epithelium forms adenomatous polyps"", ""target"": ""Adenoma Formation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""Nuclear -catenin activates TCF/LEF transcription factors, driving expression of Wnt target genes including MYC, CCND1 (cyclin D1), and others that promote cell cycle progression. This results in uncontrolled proliferation of intestinal crypt cells, forming adenomatous polyps."", ""downstream"": [{""description"": ""Hyperproliferative epithelium forms adenomatous polyps"", ""target"": ""Adenoma Formation""}], ""name"": ""Uncontrolled Intestinal Epithelial Proliferation""}"
2602	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	3	Adenoma Formation	Sustained Wnt pathway activation drives adenoma development. Adenomas are benign neoplasms but represent the first step in the adenoma-carcinoma sequence. In FAP, hundreds to thousands of adenomas develop, dramatically increasing the probability that one will progress to carcinoma.																																																								"{""description"": ""Sustained Wnt pathway activation drives adenoma development. Adenomas are benign neoplasms but represent the first step in the adenoma-carcinoma sequence. In FAP, hundreds to thousands of adenomas develop, dramatically increasing the probability that one will progress to carcinoma."", ""name"": ""Adenoma Formation""}"	"{""downstream"": [{""description"": ""Accumulated mutations drive adenoma-to-carcinoma progression"", ""target"": ""Colorectal Cancer Progression""}]}"	"{""description"": ""Sustained Wnt pathway activation drives adenoma development. Adenomas are benign neoplasms but represent the first step in the adenoma-carcinoma sequence. In FAP, hundreds to thousands of adenomas develop, dramatically increasing the probability that one will progress to carcinoma."", ""downstream"": [{""description"": ""Accumulated mutations drive adenoma-to-carcinoma progression"", ""target"": ""Colorectal Cancer Progression""}], ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}, {""preferred_term"": ""rectum"", ""term"": {""id"": ""UBERON:0001052"", ""label"": ""rectum""}}], ""name"": ""Adenoma Formation""}"
2603	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	4	Colorectal Cancer Progression	Adenomas acquire additional mutations in KRAS, TP53, SMAD4, and other genes through the adenoma-carcinoma sequence. In FAP, the large number of adenomas makes it virtually certain that at least one will progress to invasive adenocarcinoma without intervention.																																																								"{""description"": ""Adenomas acquire additional mutations in KRAS, TP53, SMAD4, and other genes through the adenoma-carcinoma sequence. In FAP, the large number of adenomas makes it virtually certain that at least one will progress to invasive adenocarcinoma without intervention."", ""name"": ""Colorectal Cancer Progression""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Adenomas acquire additional mutations in KRAS, TP53, SMAD4, and other genes through the adenoma-carcinoma sequence. In FAP, the large number of adenomas makes it virtually certain that at least one will progress to invasive adenocarcinoma without intervention."", ""name"": ""Colorectal Cancer Progression""}"
2624	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	0	MEFV Gene Mutation	Mutations in the MEFV gene lead to dysfunctional pyrin, causing excessive inflammation.																																																								"{""description"": ""Mutations in the MEFV gene lead to dysfunctional pyrin, causing excessive inflammation."", ""name"": ""MEFV Gene Mutation""}"	{}	"{""description"": ""Mutations in the MEFV gene lead to dysfunctional pyrin, causing excessive inflammation."", ""evidence"": [{""explanation"": ""Mutations in the MEFV gene result in increased activation of pyrin, causing excessive inflammation."", ""reference"": ""PMID:28154935"", ""snippet"": ""Familial Mediterranean fever (FMF) is caused by mutations within the Mediterranean fever (MEFV) gene. These gain of function mutations lead to an increased activation of the inflammasome pyrin with a subsequent disproportional proinflammatory reaction."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article discusses the role of pyrin in inducing inflammatory responses, supporting the effect of MEFV gene mutations in causing excessive inflammation."", ""reference"": ""PMID:25307949"", ""snippet"": ""Mutations in the MEFV gene are associated with the human autoinflammatory disease familial Mediterranean fever (FMF). Pyrin can interact with the inflammasome adaptor ASC and induce inflammatory caspase-1 activation in monocytic cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""The mutation spectrum in the MEFV gene is related to the pathogenesis involving pyrin and inflammation, supporting the given statement."", ""reference"": ""PMID:36889987"", ""snippet"": ""MEFV gene mutation spectrum in patients with familial mediterranean fever"", ""supports"": ""SUPPORT""}], ""gene"": {""preferred_term"": ""MEFV""}, ""name"": ""MEFV Gene Mutation""}"
2625	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	1	RhoA-PKN Regulatory Pathway Dysregulation	Disruption of the RhoA-PKN1/2-14-3-3 checkpoint that normally restrains pyrin inflammasome activation, leading to lowered activation threshold.																																		RhoA GTPase activates PKN1/2 kinases which phosphorylate pyrin, enabling 14-3-3 binding and autoinhibition; MEFV mutations or RhoA inactivation reduces this phosphorylation checkpoint																						"{""description"": ""Disruption of the RhoA-PKN1/2-14-3-3 checkpoint that normally restrains pyrin inflammasome activation, leading to lowered activation threshold."", ""name"": ""RhoA-PKN Regulatory Pathway Dysregulation"", ""notes"": ""RhoA GTPase activates PKN1/2 kinases which phosphorylate pyrin, enabling 14-3-3 binding and autoinhibition; MEFV mutations or RhoA inactivation reduces this phosphorylation checkpoint""}"	{}	"{""biological_processes"": [{""preferred_term"": ""interleukin-1 beta production"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}], ""cell_types"": [{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}, {""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Disruption of the RhoA-PKN1/2-14-3-3 checkpoint that normally restrains pyrin inflammasome activation, leading to lowered activation threshold."", ""name"": ""RhoA-PKN Regulatory Pathway Dysregulation"", ""notes"": ""RhoA GTPase activates PKN1/2 kinases which phosphorylate pyrin, enabling 14-3-3 binding and autoinhibition; MEFV mutations or RhoA inactivation reduces this phosphorylation checkpoint""}"
2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	Autoinflammatory Pathway Activation	Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes.																																																								"{""description"": ""Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes."", ""name"": ""Autoinflammatory Pathway Activation""}"	"{""downstream"": [{""description"": ""MEFV mutations cause inflammasome activation and uncontrolled IL-1 production, resulting in recurrent attacks of fever and polyserositis."", ""evidence"": [{""explanation"": ""This 2018 review explains that MEFV gene mutations cause pyrin dysfunction leading to inappropriate inflammasome activation and uncontrolled IL-1 production, which drives the characteristic recurrent fever episodes and inflammatory attacks."", ""reference"": ""PMID:30938266"", ""snippet"": ""mutations in the MEFV gene encoding pyrin, which result in inflammasome activation and the uncontrolled production of IL-1"", ""supports"": ""SUPPORT""}], ""target"": ""Recurrent Fever and Serositis""}]}"	"{""biological_processes"": [{""preferred_term"": ""pyroptotic inflammatory response"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptotic inflammatory response""}}, {""preferred_term"": ""interleukin-1 beta production"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}], ""cell_types"": [{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Dysregulated inflammatory response due to pyrin dysfunction, leading to recurrent inflammatory episodes."", ""downstream"": [{""description"": ""MEFV mutations cause inflammasome activation and uncontrolled IL-1 production, resulting in recurrent attacks of fever and polyserositis."", ""evidence"": [{""explanation"": ""This 2018 review explains that MEFV gene mutations cause pyrin dysfunction leading to inappropriate inflammasome activation and uncontrolled IL-1 production, which drives the characteristic recurrent fever episodes and inflammatory attacks."", ""reference"": ""PMID:30938266"", ""snippet"": ""mutations in the MEFV gene encoding pyrin, which result in inflammasome activation and the uncontrolled production of IL-1"", ""supports"": ""SUPPORT""}], ""target"": ""Recurrent Fever and Serositis""}], ""evidence"": [{""explanation"": ""This reference supports the involvement of IL-1 and inflammatory pathways in autoinflammatory diseases, including Familial Mediterranean Fever (FMF)."", ""reference"": ""PMID:16344627"", ""snippet"": ""The spectrum of reported genetic mutations and susceptible ethnicities for the hereditary periodic fever subset of the autoinflammatory diseases has continued to expand. At the same time, the pathogeneses of many of these diseases are now understood to involve different aspects of a common pathway, largely affecting inflammatory cascades related to IL-1 or tumor necrosis factor-alpha."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference describes the role of pyrin in inflammasome activation and its link to FMF, supporting the statement about dysregulated inflammatory responses and recurrent inflammatory episodes."", ""reference"": ""PMID:29148036"", ""snippet"": ""Pyrin, encoded by the MEFV gene, is an intracellular pattern recognition receptor that assembles inflammasome complexes in response to pathogen infections. Mutations in the MEFV gene have been linked to autoinflammatory diseases such as familial Mediterranean fever (FMF) or pyrin-associated autoinflammation with neutrophilic dermatosis (PAAND)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference directly mentions recurrent attacks and increased IL-1 synthesis due to pyrin inflammasome activation, supporting the mechanisms described in the statement."", ""reference"": ""PMID:33026080"", ""snippet"": ""FMF is an autoinflammatory disease characterized by recurrent attacks and increased IL-1 synthesis owing to activation of the pyrin inflammasome"", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the genetic basis of FMF involving mutations in MEFV, which leads to the dysregulated inflammatory response observed in FMF."", ""reference"": ""PMID:32601469"", ""snippet"": ""Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by homozygous or compound heterozygous gain-of-function mutations in MEFV, which encodes pyrin, an inflammasome protein. Heterozygous carrier frequencies for multiple MEFV mutations are high in several Mediterranean populations, suggesting that they confer selective advantage."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the mechanism described in the statement, emphasizing pyrin dysfunction and the uncontrolled production of interleukin-1 beta."", ""reference"": ""PMID:29051974"", ""snippet"": ""Familial Mediterranean fever (FMF) is an autoinflammatory disease manifested by inflammatory attacks of peritonitis, pleuritis, pericarditis accompanied by fever and arthritis. Mutations of MEFV gene results in pyrin dysfunction, which causes uncontrolled interleukin-1 beta production and triggers the inflammatory attacks."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""peritoneum"", ""term"": {""id"": ""UBERON:0002358"", ""label"": ""peritoneum""}}, {""preferred_term"": ""pleura"", ""term"": {""id"": ""UBERON:0000977"", ""label"": ""pleura""}}, {""preferred_term"": ""synovial membrane of synovial joint"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}], ""name"": ""Autoinflammatory Pathway Activation"", ""pathways"": [{""preferred_term"": ""IL-1"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}, {""preferred_term"": ""inflammasome""}]}"
2627	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	3	Gasdermin D-Mediated Pyroptosis	Caspase-1 cleaves gasdermin D to form membrane pores, enabling cytokine release and pyroptotic cell death, amplifying inflammation.																																		Gasdermin D pores facilitate release of IL-1, IL-18, and S100 alarmins (S100A8/A9/A12) that amplify the inflammatory response																						"{""description"": ""Caspase-1 cleaves gasdermin D to form membrane pores, enabling cytokine release and pyroptotic cell death, amplifying inflammation."", ""name"": ""Gasdermin D-Mediated Pyroptosis"", ""notes"": ""Gasdermin D pores facilitate release of IL-1, IL-18, and S100 alarmins (S100A8/A9/A12) that amplify the inflammatory response""}"	{}	"{""biological_processes"": [{""preferred_term"": ""pyroptotic inflammatory response"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptotic inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Caspase-1 cleaves gasdermin D to form membrane pores, enabling cytokine release and pyroptotic cell death, amplifying inflammation."", ""name"": ""Gasdermin D-Mediated Pyroptosis"", ""notes"": ""Gasdermin D pores facilitate release of IL-1, IL-18, and S100 alarmins (S100A8/A9/A12) that amplify the inflammatory response""}"
2703	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	0	DNA Repair Deficiency	Mutations in FA genes impair the body's ability to repair DNA damage, leading to increased sensitivity to crosslinking agents and propensity for chromosomal instability.																																																								"{""description"": ""Mutations in FA genes impair the body's ability to repair DNA damage, leading to increased sensitivity to crosslinking agents and propensity for chromosomal instability."", ""name"": ""DNA Repair Deficiency""}"	"{""downstream"": [{""target"": ""Genomic Instability""}]}"	"{""description"": ""Mutations in FA genes impair the body's ability to repair DNA damage, leading to increased sensitivity to crosslinking agents and propensity for chromosomal instability."", ""downstream"": [{""target"": ""Genomic Instability""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""reference"": ""PMID:35596788"", ""snippet"": ""At least 22 genes are associated with Fanconi anemia, constituting the Fanconi anemia DNA repair pathway. This pathway coordinates multiple processes and proteins to facilitate the repair of DNA adducts including interstrand crosslinks (ICLs)"", ""supports"": ""SUPPORT""}], ""name"": ""DNA Repair Deficiency""}"
2704	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	1	Bone Marrow Failure	Inability of the bone marrow to produce sufficient blood cells due to hematopoietic stem cell defects.																																																								"{""description"": ""Inability of the bone marrow to produce sufficient blood cells due to hematopoietic stem cell defects."", ""name"": ""Bone Marrow Failure""}"	"{""downstream"": [{""target"": ""Pancytopenia""}, {""target"": ""Aplastic Anemia""}]}"	"{""description"": ""Inability of the bone marrow to produce sufficient blood cells due to hematopoietic stem cell defects."", ""downstream"": [{""target"": ""Pancytopenia""}, {""target"": ""Aplastic Anemia""}], ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Demonstrates that bone marrow failure is a defining manifestation of Fanconi anemia, with origins in fetal HSC dysfunction."", ""reference"": ""PMID:38424108"", ""snippet"": ""we identify increased protein synthesis rates in the fetal hematopoietic stem cell pool at the onset of hematopoietic failure in Fanconi Anemia, a prototypical DNA repair disorder that manifests with bone marrow failure."", ""supports"": ""SUPPORT""}], ""name"": ""Bone Marrow Failure""}"
2705	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	2	Genomic Instability	Increased tendency for genomic alterations including chromosomal breaks, deletions, and rearrangements.																																																								"{""description"": ""Increased tendency for genomic alterations including chromosomal breaks, deletions, and rearrangements."", ""name"": ""Genomic Instability""}"	"{""downstream"": [{""description"": ""Unrepaired genomic damage in HSCs triggers checkpoint-mediated apoptosis and senescence"", ""target"": ""Hematopoietic Stem Cell Attrition""}, {""description"": ""Genomic instability in embryonic progenitors activates p53-mediated cell death"", ""target"": ""Developmental Progenitor Apoptosis""}, {""description"": ""Accumulation of somatic mutations drives malignant transformation"", ""target"": ""Clonal Evolution""}, {""description"": ""Impaired genome maintenance in epithelial tissues promotes carcinogenesis"", ""target"": ""Epithelial Cancer Susceptibility""}]}"	"{""description"": ""Increased tendency for genomic alterations including chromosomal breaks, deletions, and rearrangements."", ""downstream"": [{""description"": ""Unrepaired genomic damage in HSCs triggers checkpoint-mediated apoptosis and senescence"", ""target"": ""Hematopoietic Stem Cell Attrition""}, {""description"": ""Genomic instability in embryonic progenitors activates p53-mediated cell death"", ""target"": ""Developmental Progenitor Apoptosis""}, {""description"": ""Accumulation of somatic mutations drives malignant transformation"", ""target"": ""Clonal Evolution""}, {""description"": ""Impaired genome maintenance in epithelial tissues promotes carcinogenesis"", ""target"": ""Epithelial Cancer Susceptibility""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""reference"": ""PMID:35596788"", ""snippet"": ""ICLs can interfere with DNA transactions, including replication and transcription. If not properly removed and repaired, ICLs cause DNA breaks and lead to genomic instability, a hallmark of cancer."", ""supports"": ""SUPPORT""}], ""name"": ""Genomic Instability""}"
2706	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	3	Hematopoietic Stem Cell Attrition	Progressive depletion of long-term hematopoietic stem cells in bone marrow due to replication stress, aldehyde-induced DNA damage, and chronic inflammatory signaling.																																																								"{""description"": ""Progressive depletion of long-term hematopoietic stem cells in bone marrow due to replication stress, aldehyde-induced DNA damage, and chronic inflammatory signaling."", ""name"": ""Hematopoietic Stem Cell Attrition""}"	"{""downstream"": [{""target"": ""Bone Marrow Failure""}]}"	"{""biological_processes"": [{""preferred_term"": ""response to aldehyde"", ""term"": {""id"": ""GO:0043437"", ""label"": ""response to aldehyde""}}, {""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}], ""cell_types"": [{""preferred_term"": ""hematopoietic stem cell"", ""term"": {""id"": ""CL:0000037"", ""label"": ""hematopoietic stem cell""}}], ""description"": ""Progressive depletion of long-term hematopoietic stem cells in bone marrow due to replication stress, aldehyde-induced DNA damage, and chronic inflammatory signaling."", ""downstream"": [{""target"": ""Bone Marrow Failure""}], ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Demonstrates that inflammatory signaling drives HSC pool deficits in FA, and that dampening inflammation rescues HSC numbers."", ""reference"": ""PMID:38424108"", ""snippet"": ""proteostasis deregulation itself is driven by excess sterile inflammatory activity in hematopoietic and stromal cells within the fetal liver, and dampened Type I interferon signaling similarly restores fetal Fancd2-/- long-term hematopoietic stem cells to wild type-equivalent numbers."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Establishes that aldehydes cause genotoxicity in HSCs and FA proteins normally protect against this damage."", ""reference"": ""PMID:24037726"", ""snippet"": ""the FA proteins might counteract aldehyde-induced genotoxicity in hematopoietic stem cells"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Hematopoietic Stem Cell Attrition""}"
2707	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	4	Translesion Synthesis Defect	Impaired ability to bypass DNA lesions during replication through translesion synthesis polymerases, requiring functional FANCD2-FANCI complex and PCNA monoubiquitination.																																																								"{""description"": ""Impaired ability to bypass DNA lesions during replication through translesion synthesis polymerases, requiring functional FANCD2-FANCI complex and PCNA monoubiquitination."", ""name"": ""Translesion Synthesis Defect""}"	"{""downstream"": [{""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""preferred_term"": ""translesion synthesis"", ""term"": {""id"": ""GO:0019985"", ""label"": ""translesion synthesis""}}], ""description"": ""Impaired ability to bypass DNA lesions during replication through translesion synthesis polymerases, requiring functional FANCD2-FANCI complex and PCNA monoubiquitination."", ""downstream"": [{""target"": ""Genomic Instability""}], ""evidence"": [{""evidence_source"": ""OTHER"", ""explanation"": ""Demonstrates that the FA pathway intersects with translesion DNA synthesis, establishing the mechanistic link."", ""reference"": ""PMID:25237197"", ""snippet"": ""Establishing the interaction network involving the FA proteins and their associated partners has revealed an intersection of FA with several DNA repair pathways, including homologous recombination, DNA mismatch repair, nucleotide excision repair, and translesion DNA synthesis."", ""supports"": ""SUPPORT""}], ""name"": ""Translesion Synthesis Defect""}"
2708	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	5	Homologous Recombination Impairment	Defective repair of DNA double-strand breaks following interstrand crosslink unhooking, due to mutations in FA genes involved in HR pathway including BRCA2, PALB2, and BRCA1.																																																								"{""description"": ""Defective repair of DNA double-strand breaks following interstrand crosslink unhooking, due to mutations in FA genes involved in HR pathway including BRCA2, PALB2, and BRCA1."", ""name"": ""Homologous Recombination Impairment""}"	"{""downstream"": [{""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""preferred_term"": ""homologous recombination"", ""term"": {""id"": ""GO:0035825"", ""label"": ""homologous recombination""}}], ""description"": ""Defective repair of DNA double-strand breaks following interstrand crosslink unhooking, due to mutations in FA genes involved in HR pathway including BRCA2, PALB2, and BRCA1."", ""downstream"": [{""target"": ""Genomic Instability""}], ""evidence"": [{""evidence_source"": ""OTHER"", ""explanation"": ""The overlap of FA genes with breast cancer genes (BRCA1, BRCA2, PALB2) establishes the connection between FA and homologous recombination repair."", ""reference"": ""PMID:25237197"", ""snippet"": ""the fact that 5 FA genes are in fact familial breast cancer genes and FA gene mutations are found frequently in sporadic cancers suggest wider applicability in hematopoiesis and oncology."", ""supports"": ""SUPPORT""}], ""name"": ""Homologous Recombination Impairment""}"
2709	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	6	Aldehyde-Induced Genotoxicity	Endogenous aldehydes (acetaldehyde and formaldehyde) from normal metabolism generate DNA interstrand crosslinks and DNA-protein crosslinks; impaired detoxification by ALDH2 and ADH5 exacerbates DNA damage burden.																																																								"{""description"": ""Endogenous aldehydes (acetaldehyde and formaldehyde) from normal metabolism generate DNA interstrand crosslinks and DNA-protein crosslinks; impaired detoxification by ALDH2 and ADH5 exacerbates DNA damage burden."", ""name"": ""Aldehyde-Induced Genotoxicity""}"	"{""downstream"": [{""description"": ""Endogenous aldehyde-induced DNA damage preferentially depletes HSCs when FA pathway is absent"", ""target"": ""Hematopoietic Stem Cell Attrition""}]}"	"{""biological_processes"": [{""preferred_term"": ""response to aldehyde"", ""term"": {""id"": ""GO:0043437"", ""label"": ""response to aldehyde""}}], ""description"": ""Endogenous aldehydes (acetaldehyde and formaldehyde) from normal metabolism generate DNA interstrand crosslinks and DNA-protein crosslinks; impaired detoxification by ALDH2 and ADH5 exacerbates DNA damage burden."", ""downstream"": [{""description"": ""Endogenous aldehyde-induced DNA damage preferentially depletes HSCs when FA pathway is absent"", ""target"": ""Hematopoietic Stem Cell Attrition""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Human clinical data showing that impaired aldehyde detoxification (ALDH2 variant) accelerates bone marrow failure in FA patients."", ""reference"": ""PMID:24037726"", ""snippet"": ""We examined 64 Japanese FA patients, and found that the ALDH2 variant is associated with accelerated progression of BMF"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""OTHER"", ""explanation"": ""Establishes that the FA pathway is required for tolerance of aldehyde-induced DNA damage."", ""reference"": ""PMID:25237197"", ""snippet"": ""recent studies have shown a major involvement of the FA pathway in the tolerance of reactive aldehydes."", ""supports"": ""SUPPORT""}], ""name"": ""Aldehyde-Induced Genotoxicity""}"
2710	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	7	Core Complex Dysfunction	Mutations in FA core complex genes (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, UBE2T/FANCT) disrupt the E3 ubiquitin ligase that monoubiquitinates the FANCD2-FANCI complex, abolishing the central signaling step of the FA pathway. FANCA mutations account for 60-70% of all FA cases.																																																								"{""description"": ""Mutations in FA core complex genes (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, UBE2T/FANCT) disrupt the E3 ubiquitin ligase that monoubiquitinates the FANCD2-FANCI complex, abolishing the central signaling step of the FA pathway. FANCA mutations account for 60-70% of all FA cases."", ""name"": ""Core Complex Dysfunction""}"	"{""downstream"": [{""description"": ""Loss of core complex prevents FANCD2-FANCI monoubiquitination"", ""target"": ""DNA Repair Deficiency""}]}"	"{""biological_processes"": [{""preferred_term"": ""protein ubiquitination"", ""term"": {""id"": ""GO:0016567"", ""label"": ""protein ubiquitination""}}], ""description"": ""Mutations in FA core complex genes (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, UBE2T/FANCT) disrupt the E3 ubiquitin ligase that monoubiquitinates the FANCD2-FANCI complex, abolishing the central signaling step of the FA pathway. FANCA mutations account for 60-70% of all FA cases."", ""downstream"": [{""description"": ""Loss of core complex prevents FANCD2-FANCI monoubiquitination"", ""target"": ""DNA Repair Deficiency""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Core complex genes form the upstream signaling arm of the FA pathway."", ""reference"": ""PMID:35596788"", ""snippet"": ""At least 22 genes are associated with Fanconi anemia, constituting the Fanconi anemia DNA repair pathway."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""FANCA"", ""term"": {""id"": ""hgnc:3582"", ""label"": ""FANCA""}}, {""preferred_term"": ""FANCB"", ""term"": {""id"": ""hgnc:3583"", ""label"": ""FANCB""}}, {""preferred_term"": ""FANCC"", ""term"": {""id"": ""hgnc:3584"", ""label"": ""FANCC""}}, {""preferred_term"": ""FANCG"", ""term"": {""id"": ""hgnc:3588"", ""label"": ""FANCG""}}], ""name"": ""Core Complex Dysfunction"", ""protein_complexes"": [{""preferred_term"": ""FA nuclear complex"", ""term"": {""id"": ""GO:0043240"", ""label"": ""Fanconi anaemia nuclear complex""}}]}"
2711	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	8	ID Complex Dysfunction	Mutations in FANCD2 or FANCI disrupt the central ID2 complex whose monoubiquitination is the critical signaling event in FA pathway activation. In wild type, the core complex E3 ligase monoubiquitinates both FANCD2 and FANCI, causing the ID2 heterodimer to clamp onto chromatin at stalled replication forks and recruit downstream nucleases and HR effectors. Loss of either subunit abolishes this signaling hub.																																																								"{""description"": ""Mutations in FANCD2 or FANCI disrupt the central ID2 complex whose monoubiquitination is the critical signaling event in FA pathway activation. In wild type, the core complex E3 ligase monoubiquitinates both FANCD2 and FANCI, causing the ID2 heterodimer to clamp onto chromatin at stalled replication forks and recruit downstream nucleases and HR effectors. Loss of either subunit abolishes this signaling hub."", ""name"": ""ID Complex Dysfunction""}"	"{""downstream"": [{""description"": ""Absence of functional ID2 complex prevents recruitment of downstream repair effectors"", ""target"": ""DNA Repair Deficiency""}]}"	"{""biological_processes"": [{""preferred_term"": ""protein monoubiquitination"", ""term"": {""id"": ""GO:0006513"", ""label"": ""protein monoubiquitination""}}, {""preferred_term"": ""interstrand cross-link repair"", ""term"": {""id"": ""GO:0036297"", ""label"": ""interstrand cross-link repair""}}], ""description"": ""Mutations in FANCD2 or FANCI disrupt the central ID2 complex whose monoubiquitination is the critical signaling event in FA pathway activation. In wild type, the core complex E3 ligase monoubiquitinates both FANCD2 and FANCI, causing the ID2 heterodimer to clamp onto chromatin at stalled replication forks and recruit downstream nucleases and HR effectors. Loss of either subunit abolishes this signaling hub."", ""downstream"": [{""description"": ""Absence of functional ID2 complex prevents recruitment of downstream repair effectors"", ""target"": ""DNA Repair Deficiency""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FANCD2 monoubiquitination is the essential central step in ICL repair."", ""reference"": ""PMID:32106311"", ""snippet"": ""This reflects the indispensable role of FANCB protein in the enzymatic activation of FANCD2 monoubiquitination, an essential step in the repair of DNA interstrand crosslinks."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""FANCD2"", ""term"": {""id"": ""hgnc:3585"", ""label"": ""FANCD2""}}, {""preferred_term"": ""FANCI"", ""term"": {""id"": ""hgnc:25568"", ""label"": ""FANCI""}}], ""name"": ""ID Complex Dysfunction""}"
2712	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	9	Downstream Effector Dysfunction	Mutations in downstream effector genes (BRCA2/FANCD1, PALB2/FANCN, BRCA1/FANCS, RAD51C/FANCO, XRCC2/FANCU) impair homologous recombination and translesion synthesis. These overlap with familial breast/ovarian cancer genes; biallelic mutations produce the most severe FA phenotypes with early-onset solid tumors and more congenital anomalies.																																																								"{""description"": ""Mutations in downstream effector genes (BRCA2/FANCD1, PALB2/FANCN, BRCA1/FANCS, RAD51C/FANCO, XRCC2/FANCU) impair homologous recombination and translesion synthesis. These overlap with familial breast/ovarian cancer genes; biallelic mutations produce the most severe FA phenotypes with early-onset solid tumors and more congenital anomalies."", ""name"": ""Downstream Effector Dysfunction""}"	"{""downstream"": [{""description"": ""Loss of BRCA2/PALB2/BRCA1/RAD51C directly impairs HR-mediated DNA repair"", ""target"": ""Homologous Recombination Impairment""}]}"	"{""description"": ""Mutations in downstream effector genes (BRCA2/FANCD1, PALB2/FANCN, BRCA1/FANCS, RAD51C/FANCO, XRCC2/FANCU) impair homologous recombination and translesion synthesis. These overlap with familial breast/ovarian cancer genes; biallelic mutations produce the most severe FA phenotypes with early-onset solid tumors and more congenital anomalies."", ""downstream"": [{""description"": ""Loss of BRCA2/PALB2/BRCA1/RAD51C directly impairs HR-mediated DNA repair"", ""target"": ""Homologous Recombination Impairment""}], ""evidence"": [{""evidence_source"": ""OTHER"", ""explanation"": ""Downstream FA genes overlap with breast cancer susceptibility genes."", ""reference"": ""PMID:25237197"", ""snippet"": ""the fact that 5 FA genes are in fact familial breast cancer genes and FA gene mutations are found frequently in sporadic cancers suggest wider applicability in hematopoiesis and oncology."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""BRCA2"", ""term"": {""id"": ""hgnc:1101"", ""label"": ""BRCA2""}}, {""preferred_term"": ""BRCA1"", ""term"": {""id"": ""hgnc:1100"", ""label"": ""BRCA1""}}], ""name"": ""Downstream Effector Dysfunction""}"
2713	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	10	Inflammatory Bone Marrow Microenvironment	Excess sterile inflammatory signaling (TNF-alpha, interferon-gamma, Type I interferons) in the bone marrow creates a hostile microenvironment for HSCs. Both hematopoietic and stromal cells contribute to chronic inflammation, driving proteostasis deregulation and accelerating stem cell attrition.																																																								"{""description"": ""Excess sterile inflammatory signaling (TNF-alpha, interferon-gamma, Type I interferons) in the bone marrow creates a hostile microenvironment for HSCs. Both hematopoietic and stromal cells contribute to chronic inflammation, driving proteostasis deregulation and accelerating stem cell attrition."", ""name"": ""Inflammatory Bone Marrow Microenvironment""}"	"{""downstream"": [{""description"": ""Chronic inflammatory signaling drives proteostasis deregulation and HSC depletion"", ""target"": ""Hematopoietic Stem Cell Attrition""}]}"	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""hematopoietic stem cell"", ""term"": {""id"": ""CL:0000037"", ""label"": ""hematopoietic stem cell""}}], ""description"": ""Excess sterile inflammatory signaling (TNF-alpha, interferon-gamma, Type I interferons) in the bone marrow creates a hostile microenvironment for HSCs. Both hematopoietic and stromal cells contribute to chronic inflammation, driving proteostasis deregulation and accelerating stem cell attrition."", ""downstream"": [{""description"": ""Chronic inflammatory signaling drives proteostasis deregulation and HSC depletion"", ""target"": ""Hematopoietic Stem Cell Attrition""}], ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Inflammatory signaling in the BM microenvironment drives HSC loss in FA."", ""reference"": ""PMID:38424108"", ""snippet"": ""proteostasis deregulation itself is driven by excess sterile inflammatory activity in hematopoietic and stromal cells within the fetal liver, and dampened Type I interferon signaling similarly restores fetal Fancd2-/- long-term hematopoietic stem cells to wild type-equivalent numbers."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Inflammatory Bone Marrow Microenvironment""}"
2714	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	11	Developmental Progenitor Apoptosis	Unrepaired DNA damage in rapidly dividing embryonic progenitor cells activates p53-dependent apoptosis during critical developmental windows. This mechanism underlies the congenital malformations of FA, explaining the midline predominance of anomalies and correlation between pathway position and congenital abnormality burden.																																																								"{""description"": ""Unrepaired DNA damage in rapidly dividing embryonic progenitor cells activates p53-dependent apoptosis during critical developmental windows. This mechanism underlies the congenital malformations of FA, explaining the midline predominance of anomalies and correlation between pathway position and congenital abnormality burden."", ""name"": ""Developmental Progenitor Apoptosis""}"	"{""downstream"": [{""description"": ""Loss of mesodermal and endodermal progenitors causes organ malformations"", ""target"": ""Congenital Structural Anomalies""}, {""description"": ""Loss of neural progenitors causes midline brain and pituitary defects"", ""target"": ""CNS Developmental Anomalies""}, {""description"": ""Developmental pituitary defects impair hormone production"", ""target"": ""Endocrine Gland Dysfunction""}, {""description"": ""Melanocyte progenitor defects cause pigmentary anomalies"", ""target"": ""Skin Pigmentation Changes""}, {""target"": ""Intrauterine Growth Retardation""}]}"	"{""biological_processes"": [{""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}, {""preferred_term"": ""embryo development"", ""term"": {""id"": ""GO:0009790"", ""label"": ""embryo development""}}], ""description"": ""Unrepaired DNA damage in rapidly dividing embryonic progenitor cells activates p53-dependent apoptosis during critical developmental windows. This mechanism underlies the congenital malformations of FA, explaining the midline predominance of anomalies and correlation between pathway position and congenital abnormality burden."", ""downstream"": [{""description"": ""Loss of mesodermal and endodermal progenitors causes organ malformations"", ""target"": ""Congenital Structural Anomalies""}, {""description"": ""Loss of neural progenitors causes midline brain and pituitary defects"", ""target"": ""CNS Developmental Anomalies""}, {""description"": ""Developmental pituitary defects impair hormone production"", ""target"": ""Endocrine Gland Dysfunction""}, {""description"": ""Melanocyte progenitor defects cause pigmentary anomalies"", ""target"": ""Skin Pigmentation Changes""}, {""target"": ""Intrauterine Growth Retardation""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Midline predominance of anomalies supports developmental progenitor loss during embryogenesis."", ""reference"": ""PMID:26369989"", ""snippet"": ""The incidence of central nervous system (CNS) abnormalities in FA is higher than previously reported, with a midline predominance that points to impact in the early stages of CNS development."", ""supports"": ""SUPPORT""}], ""name"": ""Developmental Progenitor Apoptosis""}"
2715	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	12	Clonal Evolution	Progressive accumulation of somatic mutations and chromosomal aberrations in genomically unstable hematopoietic cells drives clonal selection and malignant transformation. Characteristic cytogenetic changes include gain of 1q and 3q and loss of 7q. Clones with selective growth advantage expand, leading to MDS and AML.																																																								"{""description"": ""Progressive accumulation of somatic mutations and chromosomal aberrations in genomically unstable hematopoietic cells drives clonal selection and malignant transformation. Characteristic cytogenetic changes include gain of 1q and 3q and loss of 7q. Clones with selective growth advantage expand, leading to MDS and AML."", ""name"": ""Clonal Evolution""}"	"{""downstream"": [{""target"": ""Myelodysplastic Syndrome""}, {""target"": ""Increased Risk of Leukemia""}]}"	"{""cell_types"": [{""preferred_term"": ""hematopoietic stem cell"", ""term"": {""id"": ""CL:0000037"", ""label"": ""hematopoietic stem cell""}}], ""description"": ""Progressive accumulation of somatic mutations and chromosomal aberrations in genomically unstable hematopoietic cells drives clonal selection and malignant transformation. Characteristic cytogenetic changes include gain of 1q and 3q and loss of 7q. Clones with selective growth advantage expand, leading to MDS and AML."", ""downstream"": [{""target"": ""Myelodysplastic Syndrome""}, {""target"": ""Increased Risk of Leukemia""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""30% malignancy rate reflects ongoing clonal evolution in FA HSCs."", ""reference"": ""PMID:31558676"", ""snippet"": ""30% developed myelodysplastic syndrome (MDS), leukemia and/or solid tumors"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Clonal Evolution""}"
2716	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	13	Epithelial Cancer Susceptibility	Impaired genome maintenance in epithelial tissues renders them vulnerable to accumulation of oncogenic mutations. Squamous epithelia of the head/neck, oral cavity, esophagus, and anogenital regions are particularly susceptible due to high proliferative turnover and exposure to environmental mutagens including HPV.																																																								"{""description"": ""Impaired genome maintenance in epithelial tissues renders them vulnerable to accumulation of oncogenic mutations. Squamous epithelia of the head/neck, oral cavity, esophagus, and anogenital regions are particularly susceptible due to high proliferative turnover and exposure to environmental mutagens including HPV."", ""name"": ""Epithelial Cancer Susceptibility""}"	"{""downstream"": [{""target"": ""Squamous Cell Carcinoma""}, {""target"": ""Early-Onset Solid Tumors in FANCD1/BRCA2""}]}"	"{""cell_types"": [{""preferred_term"": ""epithelial cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}], ""description"": ""Impaired genome maintenance in epithelial tissues renders them vulnerable to accumulation of oncogenic mutations. Squamous epithelia of the head/neck, oral cavity, esophagus, and anogenital regions are particularly susceptible due to high proliferative turnover and exposure to environmental mutagens including HPV."", ""downstream"": [{""target"": ""Squamous Cell Carcinoma""}, {""target"": ""Early-Onset Solid Tumors in FANCD1/BRCA2""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms epithelial tissue susceptibility to malignancy in FA."", ""reference"": ""PMID:20301575"", ""snippet"": ""Solid tumors  particularly of the head and neck, skin, and genitourinary tract  are more common in individuals with FA."", ""supports"": ""SUPPORT""}], ""name"": ""Epithelial Cancer Susceptibility""}"
2717	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	14	HPV-Mediated Epithelial Damage	Human papillomavirus infection compounds epithelial cancer risk in FA patients. HPV oncoproteins E6 and E7 degrade p53 and Rb tumor suppressors, further disabling the already compromised DNA damage response. HPV vaccination is recommended to reduce gynecologic and oropharyngeal cancer risk.																																																								"{""description"": ""Human papillomavirus infection compounds epithelial cancer risk in FA patients. HPV oncoproteins E6 and E7 degrade p53 and Rb tumor suppressors, further disabling the already compromised DNA damage response. HPV vaccination is recommended to reduce gynecologic and oropharyngeal cancer risk."", ""name"": ""HPV-Mediated Epithelial Damage""}"	"{""downstream"": [{""description"": ""HPV oncoproteins synergize with FA pathway deficiency to accelerate carcinogenesis"", ""target"": ""Epithelial Cancer Susceptibility""}]}"	"{""description"": ""Human papillomavirus infection compounds epithelial cancer risk in FA patients. HPV oncoproteins E6 and E7 degrade p53 and Rb tumor suppressors, further disabling the already compromised DNA damage response. HPV vaccination is recommended to reduce gynecologic and oropharyngeal cancer risk."", ""downstream"": [{""description"": ""HPV oncoproteins synergize with FA pathway deficiency to accelerate carcinogenesis"", ""target"": ""Epithelial Cancer Susceptibility""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""HPV vaccination recommendation implies HPV is a significant co-factor for epithelial cancer in FA."", ""reference"": ""PMID:20301575"", ""snippet"": ""Human papilloma virus (HPV) vaccination to reduce the risk for gynecologic cancer in females"", ""supports"": ""SUPPORT""}], ""name"": ""HPV-Mediated Epithelial Damage""}"
2718	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	15	Endocrine Gland Dysfunction	Widespread endocrine abnormalities affect approximately 73-80% of FA patients. Developmental pituitary/hypothalamic defects (68% have small pituitary on MRI), direct effects of genomic instability on endocrine cell function, and chronic illness contribute. Manifests as GH deficiency, hypothyroidism, glucose dysregulation, hypogonadism, dyslipidemia, and metabolic syndrome.																																																								"{""description"": ""Widespread endocrine abnormalities affect approximately 73-80% of FA patients. Developmental pituitary/hypothalamic defects (68% have small pituitary on MRI), direct effects of genomic instability on endocrine cell function, and chronic illness contribute. Manifests as GH deficiency, hypothyroidism, glucose dysregulation, hypogonadism, dyslipidemia, and metabolic syndrome."", ""name"": ""Endocrine Gland Dysfunction""}"	"{""downstream"": [{""target"": ""Growth Hormone Deficiency""}, {""target"": ""Hypothyroidism""}, {""target"": ""Abnormal Glucose Homeostasis""}, {""target"": ""Delayed Puberty and Hypogonadism""}, {""target"": ""Osteopenia and Osteoporosis""}, {""target"": ""Short Stature""}, {""target"": ""Impaired Fertility""}]}"	"{""description"": ""Widespread endocrine abnormalities affect approximately 73-80% of FA patients. Developmental pituitary/hypothalamic defects (68% have small pituitary on MRI), direct effects of genomic instability on endocrine cell function, and chronic illness contribute. Manifests as GH deficiency, hypothyroidism, glucose dysregulation, hypogonadism, dyslipidemia, and metabolic syndrome."", ""downstream"": [{""target"": ""Growth Hormone Deficiency""}, {""target"": ""Hypothyroidism""}, {""target"": ""Abnormal Glucose Homeostasis""}, {""target"": ""Delayed Puberty and Hypogonadism""}, {""target"": ""Osteopenia and Osteoporosis""}, {""target"": ""Short Stature""}, {""target"": ""Impaired Fertility""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Giri et al. documents 73% endocrine abnormality prevalence."", ""reference"": ""PMID:17426088"", ""snippet"": ""Endocrine abnormalities were present in 73%, including short stature and/or GH deficiency (51%), hypothyroidism (37%), midline brain abnormalities (17%)"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Small pituitary in 68% provides anatomical basis for endocrine dysfunction."", ""reference"": ""PMID:26369989"", ""snippet"": ""Abnormalities were identified in 18 (90%) patients with FA, the commonest being a small pituitary (68%, p < 0.01 females and p < 0.001 males)"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""pituitary gland"", ""term"": {""id"": ""UBERON:0000007"", ""label"": ""pituitary gland""}}], ""name"": ""Endocrine Gland Dysfunction""}"
2719	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	16	Congenital Structural Anomalies	Developmental progenitor loss during embryogenesis causes structural malformations affecting limbs, heart, kidneys, GI tract, ears, and genitourinary system. Approximately 75% of FA patients have at least one congenital anomaly, with burden correlating with complementation group, mutation type, and pathway position.																																																								"{""description"": ""Developmental progenitor loss during embryogenesis causes structural malformations affecting limbs, heart, kidneys, GI tract, ears, and genitourinary system. Approximately 75% of FA patients have at least one congenital anomaly, with burden correlating with complementation group, mutation type, and pathway position."", ""name"": ""Congenital Structural Anomalies""}"	"{""downstream"": [{""target"": ""Skeletal Anomalies""}, {""target"": ""Radial Ray Defects""}, {""target"": ""Absent or Hypoplastic Thumbs""}, {""target"": ""Congenital Heart Defects""}, {""target"": ""Genitourinary Malformations""}, {""target"": ""Renal Anomalies""}, {""target"": ""Hearing Loss""}, {""target"": ""Microphthalmia""}, {""target"": ""Strabismus""}, {""target"": ""Structural Anomalies""}, {""target"": ""Dental and Craniofacial Anomalies""}, {""target"": ""Cryptorchidism""}]}"	"{""description"": ""Developmental progenitor loss during embryogenesis causes structural malformations affecting limbs, heart, kidneys, GI tract, ears, and genitourinary system. Approximately 75% of FA patients have at least one congenital anomaly, with burden correlating with complementation group, mutation type, and pathway position."", ""downstream"": [{""target"": ""Skeletal Anomalies""}, {""target"": ""Radial Ray Defects""}, {""target"": ""Absent or Hypoplastic Thumbs""}, {""target"": ""Congenital Heart Defects""}, {""target"": ""Genitourinary Malformations""}, {""target"": ""Renal Anomalies""}, {""target"": ""Hearing Loss""}, {""target"": ""Microphthalmia""}, {""target"": ""Strabismus""}, {""target"": ""Structural Anomalies""}, {""target"": ""Dental and Craniofacial Anomalies""}, {""target"": ""Cryptorchidism""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""75% of FA patients have physical abnormalities."", ""reference"": ""PMID:20301575"", ""snippet"": ""Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies."", ""supports"": ""SUPPORT""}], ""name"": ""Congenital Structural Anomalies""}"
2720	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	17	CNS Developmental Anomalies	Midline brain structural defects from neural progenitor loss during early CNS development. Includes small pituitary (68%), posterior fossa abnormalities (30% including Chiari I malformation and Dandy-Walker variant), and corpus callosum structural variation (30%).																																																								"{""description"": ""Midline brain structural defects from neural progenitor loss during early CNS development. Includes small pituitary (68%), posterior fossa abnormalities (30% including Chiari I malformation and Dandy-Walker variant), and corpus callosum structural variation (30%)."", ""name"": ""CNS Developmental Anomalies""}"	"{""downstream"": [{""target"": ""Microcephaly""}, {""target"": ""Developmental Delay""}]}"	"{""description"": ""Midline brain structural defects from neural progenitor loss during early CNS development. Includes small pituitary (68%), posterior fossa abnormalities (30% including Chiari I malformation and Dandy-Walker variant), and corpus callosum structural variation (30%)."", ""downstream"": [{""target"": ""Microcephaly""}, {""target"": ""Developmental Delay""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""90% brain MRI abnormality rate with midline predominance."", ""reference"": ""PMID:26369989"", ""snippet"": ""Abnormalities were identified in 18 (90%) patients with FA, the commonest being a small pituitary (68%, p < 0.01 females and p < 0.001 males)"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Posterior fossa and corpus callosum anomalies reflect early CNS developmental impact."", ""reference"": ""PMID:26369989"", ""snippet"": ""Posterior fossa abnormalities were seen in six cases (30%, p = 0.01) including Chiari I malformation (n = 3), Dandy-Walker variant (n = 2) and cerebellar atrophy (n = 2)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}, {""preferred_term"": ""pituitary gland"", ""term"": {""id"": ""UBERON:0000007"", ""label"": ""pituitary gland""}}], ""name"": ""CNS Developmental Anomalies""}"
2721	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	18	Skin Pigmentation Changes	Melanocyte progenitor defects during embryonic development cause characteristic pigmentary anomalies including caf-au-lait spots and hypopigmented patches. Skin pigmentation changes are the most common congenital anomaly in FA, affecting over 50% of patients.																																																								"{""description"": ""Melanocyte progenitor defects during embryonic development cause characteristic pigmentary anomalies including caf-au-lait spots and hypopigmented patches. Skin pigmentation changes are the most common congenital anomaly in FA, affecting over 50% of patients."", ""name"": ""Skin Pigmentation Changes""}"	"{""downstream"": [{""target"": ""Caf-au-Lait Spots""}, {""target"": ""Hypopigmentation""}]}"	"{""description"": ""Melanocyte progenitor defects during embryonic development cause characteristic pigmentary anomalies including caf-au-lait spots and hypopigmented patches. Skin pigmentation changes are the most common congenital anomaly in FA, affecting over 50% of patients."", ""downstream"": [{""target"": ""Caf-au-Lait Spots""}, {""target"": ""Hypopigmentation""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Caf-au-lait spots are the most common congenital anomaly in the Israeli FA cohort."", ""reference"": ""PMID:31558676"", ""snippet"": ""More than half had caf-au-lait spots (52.3%) followed by renal anomalies (39.6%)."", ""supports"": ""SUPPORT""}], ""name"": ""Skin Pigmentation Changes""}"
2824	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	0	Constitutive BMP Signaling Activation	The ACVR1 R206H mutation creates a pH-sensitive switch in the receptor's activation domain, leading to ligand-independent activation of BMP signaling and inappropriate osteogenic differentiation of connective tissue progenitors.																																																								"{""description"": ""The ACVR1 R206H mutation creates a pH-sensitive switch in the receptor's activation domain, leading to ligand-independent activation of BMP signaling and inappropriate osteogenic differentiation of connective tissue progenitors."", ""name"": ""Constitutive BMP Signaling Activation""}"	"{""downstream"": [{""description"": ""Aberrant BMP signaling drives differentiation of muscle and connective tissue progenitor cells into chondrocytes and osteoblasts, leading to formation of qualitatively normal bone at ectopic sites."", ""evidence"": [{""explanation"": ""The study demonstrates that the R206H mutation causes BMP signal activation in muscle tissue, leading to ectopic bone formation."", ""reference"": ""PMID:20463014"", ""snippet"": ""mild activation of osteogenic BMP-signaling in extraskeletal sites such as muscle, which eventually lead to delayed and progressive ectopic bone formation in FOP patients"", ""supports"": ""SUPPORT""}], ""target"": ""Heterotopic Ossification""}]}"	"{""biological_processes"": [{""preferred_term"": ""BMP signaling pathway"", ""term"": {""id"": ""GO:0030509"", ""label"": ""BMP signaling pathway""}}, {""preferred_term"": ""ossification"", ""term"": {""id"": ""GO:0001503"", ""label"": ""ossification""}}], ""description"": ""The ACVR1 R206H mutation creates a pH-sensitive switch in the receptor's activation domain, leading to ligand-independent activation of BMP signaling and inappropriate osteogenic differentiation of connective tissue progenitors."", ""downstream"": [{""description"": ""Aberrant BMP signaling drives differentiation of muscle and connective tissue progenitor cells into chondrocytes and osteoblasts, leading to formation of qualitatively normal bone at ectopic sites."", ""evidence"": [{""explanation"": ""The study demonstrates that the R206H mutation causes BMP signal activation in muscle tissue, leading to ectopic bone formation."", ""reference"": ""PMID:20463014"", ""snippet"": ""mild activation of osteogenic BMP-signaling in extraskeletal sites such as muscle, which eventually lead to delayed and progressive ectopic bone formation in FOP patients"", ""supports"": ""SUPPORT""}], ""target"": ""Heterotopic Ossification""}], ""evidence"": [{""explanation"": ""This study explains the unique molecular mechanism of the R206H mutation creating pH-dependent receptor dysregulation."", ""reference"": ""PMID:17572636"", ""snippet"": ""Protein modeling predicts that substitution with histidine, and only histidine, creates a pH-sensitive switch within the activation domain of the receptor that leads to ligand-independent activation of ACVR1 in fibrodysplasia ossificans progressiva."", ""supports"": ""SUPPORT""}], ""name"": ""Constitutive BMP Signaling Activation""}"
2825	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	1	Impaired FKBP1A Regulatory Binding	The R206H mutation reduces binding affinity for FKBP1A/FKBP12, a safeguard protein that normally prevents inappropriate BMP signaling, resulting in leaky activation of the pathway.																																																								"{""description"": ""The R206H mutation reduces binding affinity for FKBP1A/FKBP12, a safeguard protein that normally prevents inappropriate BMP signaling, resulting in leaky activation of the pathway."", ""name"": ""Impaired FKBP1A Regulatory Binding""}"	{}	"{""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""The R206H mutation reduces binding affinity for FKBP1A/FKBP12, a safeguard protein that normally prevents inappropriate BMP signaling, resulting in leaky activation of the pathway."", ""evidence"": [{""explanation"": ""Loss of FKBP1A binding is a key mechanism allowing leaky BMP signaling."", ""reference"": ""PMID:20463014"", ""snippet"": ""The R206H mutant showed a decreased binding affinity for FKBP1A/FKBP12, a known safeguard molecule against the leakage of transforming growth factor (TGF)-beta or BMP signaling"", ""supports"": ""SUPPORT""}], ""name"": ""Impaired FKBP1A Regulatory Binding""}"
2826	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	2	Activin A Neomorphic Signaling	The R206H mutation renders ACVR1 responsive to Activin A ligands, which normally antagonize BMP signaling. This neomorphic gain-of-function allows Activin A to aberrantly activate osteogenic signaling, driving heterotopic ossification. Anti-Activin A antibodies can block HO. Activin A is an obligate factor for the initiation of HO in FOP.																																		This discovery led to development of garetosmab (anti-Activin A antibody) as a targeted therapy for FOP.																						"{""description"": ""The R206H mutation renders ACVR1 responsive to Activin A ligands, which normally antagonize BMP signaling. This neomorphic gain-of-function allows Activin A to aberrantly activate osteogenic signaling, driving heterotopic ossification. Anti-Activin A antibodies can block HO. Activin A is an obligate factor for the initiation of HO in FOP."", ""name"": ""Activin A Neomorphic Signaling"", ""notes"": ""This discovery led to development of garetosmab (anti-Activin A antibody) as a targeted therapy for FOP.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""BMP signaling pathway"", ""term"": {""id"": ""GO:0030509"", ""label"": ""BMP signaling pathway""}}], ""description"": ""The R206H mutation renders ACVR1 responsive to Activin A ligands, which normally antagonize BMP signaling. This neomorphic gain-of-function allows Activin A to aberrantly activate osteogenic signaling, driving heterotopic ossification. Anti-Activin A antibodies can block HO. Activin A is an obligate factor for the initiation of HO in FOP."", ""evidence"": [{""explanation"": ""Confirms that the ACVR1 R206H mutation promotes ectopic chondrogenesis and osteogenesis through aberrant BMP signaling."", ""reference"": ""PMID:26896819"", ""snippet"": ""Most FOP patients carry an activating mutation in a bone morphogenetic protein (BMP) type I receptor gene, ACVR1(R206H), that promotes ectopic chondrogenesis and osteogenesis and, in turn, HO"", ""supports"": ""SUPPORT""}], ""name"": ""Activin A Neomorphic Signaling"", ""notes"": ""This discovery led to development of garetosmab (anti-Activin A antibody) as a targeted therapy for FOP.""}"
2827	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	3	Heterotopic Ossification	Progressive formation of qualitatively normal bone in extraskeletal tissues including muscles, tendons, ligaments, and fascia, typically following episodic inflammatory flare-ups. The process occurs through endochondral ossification with distinct histological stages: inflammatory/catabolic phase, fibroproliferative phase, chondrogenic phase, and osteogenic phase.																																																								"{""description"": ""Progressive formation of qualitatively normal bone in extraskeletal tissues including muscles, tendons, ligaments, and fascia, typically following episodic inflammatory flare-ups. The process occurs through endochondral ossification with distinct histological stages: inflammatory/catabolic phase, fibroproliferative phase, chondrogenic phase, and osteogenic phase."", ""name"": ""Heterotopic Ossification""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}, {""preferred_term"": ""Cartilage development"", ""term"": {""id"": ""GO:0051216"", ""label"": ""cartilage development""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}, {""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}], ""description"": ""Progressive formation of qualitatively normal bone in extraskeletal tissues including muscles, tendons, ligaments, and fascia, typically following episodic inflammatory flare-ups. The process occurs through endochondral ossification with distinct histological stages: inflammatory/catabolic phase, fibroproliferative phase, chondrogenic phase, and osteogenic phase."", ""evidence"": [{""explanation"": ""Establishes FOP as the most severe form of heterotopic ossification."", ""reference"": ""PMID:26896819"", ""snippet"": ""Fibrodysplasia ossificans progressiva (FOP), a rare and as yet untreatable genetic disorder of progressive extraskeletal ossification, is the most disabling form of heterotopic ossification (HO) in humans"", ""supports"": ""SUPPORT""}], ""name"": ""Heterotopic Ossification""}"
2828	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	4	Inflammatory Triggering of Flare-ups	Macrophages, mast cells, and lymphocytes infiltrate affected tissues during the catabolic phase, releasing inflammatory cytokines that create a permissive microenvironment for heterotopic ossification. Mast cell depletion reduces HO by approximately 50%, and combined mast cell/macrophage depletion reduces HO by approximately 75%.																																		Multiple lines of evidence indicate a key role for the immune system in driving FOP pathogenesis. Activin A produced by innate immune cells after soft-tissue injury aberrantly signals through mutant ACVR1.																						"{""description"": ""Macrophages, mast cells, and lymphocytes infiltrate affected tissues during the catabolic phase, releasing inflammatory cytokines that create a permissive microenvironment for heterotopic ossification. Mast cell depletion reduces HO by approximately 50%, and combined mast cell/macrophage depletion reduces HO by approximately 75%."", ""name"": ""Inflammatory Triggering of Flare-ups"", ""notes"": ""Multiple lines of evidence indicate a key role for the immune system in driving FOP pathogenesis. Activin A produced by innate immune cells after soft-tissue injury aberrantly signals through mutant ACVR1.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""Mast cell"", ""term"": {""id"": ""CL:0000097"", ""label"": ""mast cell""}}], ""description"": ""Macrophages, mast cells, and lymphocytes infiltrate affected tissues during the catabolic phase, releasing inflammatory cytokines that create a permissive microenvironment for heterotopic ossification. Mast cell depletion reduces HO by approximately 50%, and combined mast cell/macrophage depletion reduces HO by approximately 75%."", ""evidence"": [{""explanation"": ""FOP is characterized by progressive HO following inflammatory flare-ups triggered by trauma or other stimuli."", ""reference"": ""PMID:26896819"", ""snippet"": ""Fibrodysplasia ossificans progressiva (FOP), a rare and as yet untreatable genetic disorder of progressive extraskeletal ossification, is the most disabling form of heterotopic ossification (HO) in humans"", ""supports"": ""SUPPORT""}], ""name"": ""Inflammatory Triggering of Flare-ups"", ""notes"": ""Multiple lines of evidence indicate a key role for the immune system in driving FOP pathogenesis. Activin A produced by innate immune cells after soft-tissue injury aberrantly signals through mutant ACVR1.""}"
2856	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	0	Central Sensitization	"Augmented pain processing in the central nervous system leads to amplified pain perception. Increased excitatory neurotransmitters (glutamate, substance P) and decreased inhibitory modulation.
"																																																								"{""description"": ""Augmented pain processing in the central nervous system leads to amplified pain perception. Increased excitatory neurotransmitters (glutamate, substance P) and decreased inhibitory modulation.\n"", ""name"": ""Central Sensitization""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Pain Processing"", ""term"": {""id"": ""GO:0048265"", ""label"": ""response to pain""}}], ""description"": ""Augmented pain processing in the central nervous system leads to amplified pain perception. Increased excitatory neurotransmitters (glutamate, substance P) and decreased inhibitory modulation.\n"", ""evidence"": [{""explanation"": ""Elevated substance P in cerebrospinal fluid directly supports central sensitization mechanism with increased excitatory nociceptive signaling."", ""reference"": ""PMID:7526868"", ""snippet"": ""CSF SP levels were 3-fold higher in FMS patients than in normal controls (P < 0.001)"", ""supports"": ""SUPPORT""}, {""explanation"": ""Proposes mechanism for excitatory/inhibitory imbalance underlying central sensitization via altered GAD activity affecting glutamate-GABA balance."", ""reference"": ""PMID:21684692"", ""snippet"": ""Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme in the conversion of glutamate to GABA and decreased expression or activity of this enzyme could result in an imbalance of excitatory and inhibitory neurotransmission in the ascending and descending pain pathways."", ""supports"": ""SUPPORT""}, {""explanation"": ""Establishes fibromyalgia as a prototypical central sensitivity syndrome with augmented pain processing."", ""reference"": ""PMID:33494476"", ""snippet"": ""Fibromyalgia is the most common of the central sensitivity syndromes affecting 2-5% of the adult population in the United States. This pain amplification syndrome has enormous societal impact"", ""supports"": ""SUPPORT""}], ""name"": ""Central Sensitization""}"
2857	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	1	Descending Pain Modulation Dysfunction	"Impaired descending inhibitory pathways that normally dampen pain signals. Reduced serotonin and norepinephrine in descending pathways contributes to pain amplification.
"																																																								"{""description"": ""Impaired descending inhibitory pathways that normally dampen pain signals. Reduced serotonin and norepinephrine in descending pathways contributes to pain amplification.\n"", ""name"": ""Descending Pain Modulation Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Neurotransmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}], ""description"": ""Impaired descending inhibitory pathways that normally dampen pain signals. Reduced serotonin and norepinephrine in descending pathways contributes to pain amplification.\n"", ""evidence"": [{""explanation"": ""Identifies neurotransmitter dysfunction in descending pain pathways as a key mechanism in fibromyalgia pathophysiology."", ""reference"": ""PMID:21684692"", ""snippet"": ""A number of neurotransmitters in the ascending and descending pain pathways have been implicated in FM including glutamate and GABA."", ""supports"": ""SUPPORT""}, {""explanation"": ""Animal model evidence supporting the role of impaired inhibitory neurotransmission in pain amplification."", ""reference"": ""PMID:21684692"", ""snippet"": ""GAD65 knockout mice have been shown to exhibit supraspinal hyperalgesia."", ""supports"": ""SUPPORT""}], ""name"": ""Descending Pain Modulation Dysfunction""}"
2858	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	2	Neuroinflammation	"Glial cell activation and elevated inflammatory mediators in the CNS may contribute to central sensitization and symptom persistence.
"																																																								"{""description"": ""Glial cell activation and elevated inflammatory mediators in the CNS may contribute to central sensitization and symptom persistence.\n"", ""name"": ""Neuroinflammation""}"	{}	"{""cell_types"": [{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Glial cell activation and elevated inflammatory mediators in the CNS may contribute to central sensitization and symptom persistence.\n"", ""evidence"": [{""explanation"": ""Direct evidence of central inflammation in fibromyalgia via elevated CSF IL-8 levels, supporting glial cell activation hypothesis."", ""reference"": ""PMID:22126705"", ""snippet"": ""We report elevated cerebrospinal fluid and serum concentrations of interleukin-8, but not interleukin-1beta, in FM patients. This profile is in accordance with FM symptoms being mediated by sympathetic activity rather than dependent on prostaglandin associated mechanisms and supports the hypothesis of glia cell activation in response to pain mechanisms."", ""supports"": ""SUPPORT""}, {""explanation"": ""Establishes theoretical framework linking glial activation to intrathecal cytokine elevation in fibromyalgia pathophysiology."", ""reference"": ""PMID:22126705"", ""snippet"": ""Activation of glia cells resulting in intrathecal elevation of cytokines and chemokines has been hypothesized in chronic pain syndromes such as fibromyalgia."", ""supports"": ""SUPPORT""}, {""explanation"": ""Identifies mast cell-mediated inflammation as a contributor to low-grade chronic neuroinflammation in fibromyalgia."", ""reference"": ""PMID:29684996"", ""snippet"": ""Mast cells are involved in FM by releasing proinflammatory cytokines, chemokines, chemical mediators, and PGD2. TNF is a cytokine generated by MCs and its level is higher in FM."", ""supports"": ""SUPPORT""}], ""name"": ""Neuroinflammation""}"
2859	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	3	HPA Axis Dysregulation	"Blunted cortisol response to stress and altered diurnal cortisol rhythm may contribute to fatigue and pain sensitivity.
"																																																								"{""description"": ""Blunted cortisol response to stress and altered diurnal cortisol rhythm may contribute to fatigue and pain sensitivity.\n"", ""name"": ""HPA Axis Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Stress Response"", ""term"": {""id"": ""GO:0006950"", ""label"": ""response to stress""}}], ""description"": ""Blunted cortisol response to stress and altered diurnal cortisol rhythm may contribute to fatigue and pain sensitivity.\n"", ""evidence"": [{""explanation"": ""Documents specific HPA axis abnormalities including low urinary cortisol and elevated trough levels supporting HPA dysregulation mechanism."", ""reference"": ""PMID:7980669"", ""snippet"": ""Patients with FM had low 24-hour urinary free cortisol, but normal peak and elevated trough plasma cortisol levels, compared with normal subjects."", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates altered circadian cortisol rhythm with delayed decline indicating loss of HPA axis resiliency."", ""reference"": ""PMID:15157948"", ""snippet"": ""There was a significant delay in the rate of decline from acrophase to nadir for cortisol levels in patients with FMS (P <.01)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Concludes that HPA axis perturbations are a characteristic feature of fibromyalgia pathophysiology."", ""reference"": ""PMID:7980669"", ""snippet"": ""These data support the view that HPA axis function is perturbed in patients with FM."", ""supports"": ""SUPPORT""}], ""name"": ""HPA Axis Dysregulation""}"
2860	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	4	Small Fiber Pathology	"Structural and functional abnormalities of thinly myelinated A and unmyelinated C-fibers affecting approximately 50% of patients. Reduced intraepidermal nerve fiber density (IENFD) with proximal predominant pattern contributes ongoing peripheral nociceptive input.
"																																																								"{""description"": ""Structural and functional abnormalities of thinly myelinated A and unmyelinated C-fibers affecting approximately 50% of patients. Reduced intraepidermal nerve fiber density (IENFD) with proximal predominant pattern contributes ongoing peripheral nociceptive input.\n"", ""name"": ""Small Fiber Pathology""}"	{}	"{""cell_types"": [{""preferred_term"": ""Peripheral Sensory Neurons"", ""term"": {""id"": ""CL:0000101"", ""label"": ""sensory neuron""}}], ""description"": ""Structural and functional abnormalities of thinly myelinated A and unmyelinated C-fibers affecting approximately 50% of patients. Reduced intraepidermal nerve fiber density (IENFD) with proximal predominant pattern contributes ongoing peripheral nociceptive input.\n"", ""evidence"": [{""explanation"": ""Establishes peripheral sensitization involving nociceptor signaling as one of three key pathophysiological processes in fibromyalgia."", ""reference"": ""PMID:39062116"", ""snippet"": ""These include central sensitization, associated with an increase in the release of both excitatory and inhibitory neurotransmitters; peripheral sensitization, involving alterations in peripheral nociceptor signaling; and inflammatory and immune mechanisms that develop concurrently with the aforementioned processes."", ""supports"": ""SUPPORT""}], ""name"": ""Small Fiber Pathology""}"
2861	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	5	Genetic Susceptibility	"Multiple genetic variants affect neurotransmitter systems, pain processing, and sensory signaling. CNS-enriched heritability with neural gene prioritization establishes genetic predisposition to altered pain perception and modulation.
"																																																								"{""description"": ""Multiple genetic variants affect neurotransmitter systems, pain processing, and sensory signaling. CNS-enriched heritability with neural gene prioritization establishes genetic predisposition to altered pain perception and modulation.\n"", ""name"": ""Genetic Susceptibility""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Pain Perception"", ""term"": {""id"": ""GO:0019233"", ""label"": ""sensory perception of pain""}}], ""description"": ""Multiple genetic variants affect neurotransmitter systems, pain processing, and sensory signaling. CNS-enriched heritability with neural gene prioritization establishes genetic predisposition to altered pain perception and modulation.\n"", ""evidence"": [{""explanation"": ""Large-scale genetic study identifies TAAR1, RGS4, CNR1, and GRIA4 as genes with evidence of association with fibromyalgia in replication cohort."", ""reference"": ""PMID:21905019"", ""snippet"": ""Evidence of association in the replication cohort was observed for TAAR1, RGS4, CNR1, and GRIA4."", ""supports"": ""SUPPORT""}], ""name"": ""Genetic Susceptibility""}"
2894	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	pathophysiology	0	FMRP Deficiency	"Expansion of CGG trinucleotide repeat in FMR1 gene 5' UTR beyond 200 repeats causes hypermethylation and transcriptional silencing. This results in absence of fragile X mental retardation protein (FMRP), an RNA-binding protein essential for synaptic plasticity.
"																																																								"{""description"": ""Expansion of CGG trinucleotide repeat in FMR1 gene 5' UTR beyond 200 repeats causes hypermethylation and transcriptional silencing. This results in absence of fragile X mental retardation protein (FMRP), an RNA-binding protein essential for synaptic plasticity.\n"", ""name"": ""FMRP Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Synaptic Plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Expansion of CGG trinucleotide repeat in FMR1 gene 5' UTR beyond 200 repeats causes hypermethylation and transcriptional silencing. This results in absence of fragile X mental retardation protein (FMRP), an RNA-binding protein essential for synaptic plasticity.\n"", ""evidence"": [{""explanation"": ""Review confirms CGG repeat expansion leads to FMRP silencing in Fragile X syndrome."", ""reference"": ""PMID:24346713"", ""snippet"": ""Most FXS cases occur due to the expansion of the CGG trinucleotide repeats in the 5' un-translated region of FMR1, which leads to hypermethylation and in turn silences the expression of FMRP"", ""supports"": ""SUPPORT""}], ""name"": ""FMRP Deficiency""}"
2895	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	pathophysiology	1	Abnormal Synaptic Development	"FMRP normally suppresses translation of many synaptic proteins. Its absence leads to excessive protein synthesis at synapses, abnormal dendritic spine morphology (long, thin spines), and impaired synaptic maturation and pruning.
"																																																								"{""description"": ""FMRP normally suppresses translation of many synaptic proteins. Its absence leads to excessive protein synthesis at synapses, abnormal dendritic spine morphology (long, thin spines), and impaired synaptic maturation and pruning.\n"", ""name"": ""Abnormal Synaptic Development""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Synapse Organization"", ""term"": {""id"": ""GO:0050808"", ""label"": ""synapse organization""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""FMRP normally suppresses translation of many synaptic proteins. Its absence leads to excessive protein synthesis at synapses, abnormal dendritic spine morphology (long, thin spines), and impaired synaptic maturation and pruning.\n"", ""evidence"": [{""explanation"": ""Review confirms FMRP absence leads to altered synaptic protein synthesis and plasticity."", ""reference"": ""PMID:24346713"", ""snippet"": ""In the absence of FMRP, the basal protein translation is enhanced and not responsive to neuronal stimulation. The altered protein translation may contribute to functional abnormalities in certain aspects of synaptic plasticity"", ""supports"": ""SUPPORT""}, {""explanation"": ""Review confirms FMRP normally inhibits synaptic protein translation."", ""reference"": ""PMID:22483044"", ""snippet"": ""FMRP is an mRNA-binding protein that functions at many synapses to inhibit local translation stimulated by metabotropic glutamate receptors (mGluRs) 1 and 5."", ""supports"": ""SUPPORT""}], ""name"": ""Abnormal Synaptic Development""}"
2912	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	pathophysiology	0	TDP-43 Proteinopathy	"TAR DNA-binding protein of 43 kDa (TDP-43) is the main ubiquitinated protein in tau-negative frontotemporal lobar degeneration (FTLD-TDP), accounting for over 50% of FTD cases. TDP-43 is typically a nuclear protein, and its aggregation and cytoplasmic translocation are thought to represent major pathogenic steps. The abnormal accumulation leads to neuronal dysfunction and death.
"																																																								"{""description"": ""TAR DNA-binding protein of 43 kDa (TDP-43) is the main ubiquitinated protein in tau-negative frontotemporal lobar degeneration (FTLD-TDP), accounting for over 50% of FTD cases. TDP-43 is typically a nuclear protein, and its aggregation and cytoplasmic translocation are thought to represent major pathogenic steps. The abnormal accumulation leads to neuronal dysfunction and death.\n"", ""name"": ""TDP-43 Proteinopathy""}"	"{""downstream"": [{""target"": ""Neuronal Death""}, {""target"": ""Behavioral and Language Changes""}]}"	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""TAR DNA-binding protein of 43 kDa (TDP-43) is the main ubiquitinated protein in tau-negative frontotemporal lobar degeneration (FTLD-TDP), accounting for over 50% of FTD cases. TDP-43 is typically a nuclear protein, and its aggregation and cytoplasmic translocation are thought to represent major pathogenic steps. The abnormal accumulation leads to neuronal dysfunction and death.\n"", ""downstream"": [{""target"": ""Neuronal Death""}, {""target"": ""Behavioral and Language Changes""}], ""evidence"": [{""explanation"": ""This confirms that TDP-43 aggregation and mislocalization are central to the pathogenesis of FTLD-TDP, a major subtype of frontotemporal dementia."", ""reference"": ""PMID:19664364"", ""snippet"": ""TDP-43 is typically a nuclear protein, and its aggregation and cytoplasmic translocation are thought to represent major steps in the pathogenesis of FTLD due to TDP-43 proteinopathy (FTLD-TDP)."", ""supports"": ""SUPPORT""}], ""name"": ""TDP-43 Proteinopathy""}"
2913	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	pathophysiology	1	Tau Proteinopathy	"FTLD-tau is characterized by accumulation of hyperphosphorylated tau protein, accounting for approximately 45% of FTD cases. This includes Pick's disease with characteristic Pick bodies. The tau pathology disrupts microtubule function and causes neuronal degeneration primarily in frontal and temporal regions.
"																																																								"{""description"": ""FTLD-tau is characterized by accumulation of hyperphosphorylated tau protein, accounting for approximately 45% of FTD cases. This includes Pick's disease with characteristic Pick bodies. The tau pathology disrupts microtubule function and causes neuronal degeneration primarily in frontal and temporal regions.\n"", ""name"": ""Tau Proteinopathy""}"	"{""downstream"": [{""target"": ""Neuronal Death""}, {""target"": ""Behavioral and Language Changes""}]}"	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""FTLD-tau is characterized by accumulation of hyperphosphorylated tau protein, accounting for approximately 45% of FTD cases. This includes Pick's disease with characteristic Pick bodies. The tau pathology disrupts microtubule function and causes neuronal degeneration primarily in frontal and temporal regions.\n"", ""downstream"": [{""target"": ""Neuronal Death""}, {""target"": ""Behavioral and Language Changes""}], ""name"": ""Tau Proteinopathy""}"
2914	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	pathophysiology	2	Frontal and Temporal Lobe Atrophy	"Progressive neuronal loss and atrophy predominantly affecting the frontal and temporal lobes, with patterns varying by genetic subtype. MAPT mutations show temporal predominance, while GRN and C9orf72 mutations may show more variable patterns. This structural degeneration underlies the behavioral and language deficits.
"																																																								"{""description"": ""Progressive neuronal loss and atrophy predominantly affecting the frontal and temporal lobes, with patterns varying by genetic subtype. MAPT mutations show temporal predominance, while GRN and C9orf72 mutations may show more variable patterns. This structural degeneration underlies the behavioral and language deficits.\n"", ""name"": ""Frontal and Temporal Lobe Atrophy""}"	"{""downstream"": [{""target"": ""Behavioral Variant FTD""}, {""target"": ""Primary Progressive Aphasia""}]}"	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Progressive neuronal loss and atrophy predominantly affecting the frontal and temporal lobes, with patterns varying by genetic subtype. MAPT mutations show temporal predominance, while GRN and C9orf72 mutations may show more variable patterns. This structural degeneration underlies the behavioral and language deficits.\n"", ""downstream"": [{""target"": ""Behavioral Variant FTD""}, {""target"": ""Primary Progressive Aphasia""}], ""evidence"": [{""explanation"": ""This demonstrates the genotype-specific patterns of brain atrophy and their relationship to clinical phenotypes in frontotemporal dementia."", ""reference"": ""PMID:26473392"", ""snippet"": ""MAPT patients were younger than other groups, and showed more frequent behavioural disinhibition, repetitive and stereotyped behaviours, semantic impairment and temporal predominance of atrophy."", ""supports"": ""SUPPORT""}], ""name"": ""Frontal and Temporal Lobe Atrophy""}"
2915	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	pathophysiology	3	Neuronal Death	"Progressive loss of neurons in frontal and temporal cortices due to protein aggregation toxicity, leading to brain atrophy and functional decline. The neurodegeneration progresses over years to decades, with biomarker changes detectable up to 30 years before symptom onset in genetic cases.
"																																																								"{""description"": ""Progressive loss of neurons in frontal and temporal cortices due to protein aggregation toxicity, leading to brain atrophy and functional decline. The neurodegeneration progresses over years to decades, with biomarker changes detectable up to 30 years before symptom onset in genetic cases.\n"", ""name"": ""Neuronal Death""}"	{}	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Progressive loss of neurons in frontal and temporal cortices due to protein aggregation toxicity, leading to brain atrophy and functional decline. The neurodegeneration progresses over years to decades, with biomarker changes detectable up to 30 years before symptom onset in genetic cases.\n"", ""evidence"": [{""explanation"": ""This shows that neurobiological changes underlying neuronal dysfunction begin decades before clinical symptoms in genetic FTD."", ""reference"": ""PMID:30711676"", ""snippet"": ""We observed that biological changes and intracortical facilitation transmission abnormalities significantly antecede the emergence of clinical symptoms of at least 3 decades."", ""supports"": ""SUPPORT""}], ""name"": ""Neuronal Death""}"
2928	122	Galactosemia	Galactosemia.yaml	pathophysiology	0	Galactose-1-phosphate accumulation	"In classic galactosemia, GALT deficiency prevents conversion of galactose-1-phosphate (Gal-1-P) to UDP-galactose. Accumulated Gal-1-P is directly toxic to liver, brain, kidneys, and ovaries through multiple mechanisms including inhibition of phosphoglucomutase and depletion of inorganic phosphate.
"																																																								"{""description"": ""In classic galactosemia, GALT deficiency prevents conversion of galactose-1-phosphate (Gal-1-P) to UDP-galactose. Accumulated Gal-1-P is directly toxic to liver, brain, kidneys, and ovaries through multiple mechanisms including inhibition of phosphoglucomutase and depletion of inorganic phosphate.\n"", ""name"": ""Galactose-1-phosphate accumulation""}"	{}	"{""description"": ""In classic galactosemia, GALT deficiency prevents conversion of galactose-1-phosphate (Gal-1-P) to UDP-galactose. Accumulated Gal-1-P is directly toxic to liver, brain, kidneys, and ovaries through multiple mechanisms including inhibition of phosphoglucomutase and depletion of inorganic phosphate.\n"", ""name"": ""Galactose-1-phosphate accumulation""}"
2929	122	Galactosemia	Galactosemia.yaml	pathophysiology	1	UDP-galactose deficiency	"Reduced UDP-galactose impairs galactosylation of glycoproteins and glycolipids. Abnormal glycosylation affects brain development, folliculogenesis, and multiple cellular processes. This deficiency persists despite dietary treatment, contributing to long-term complications.
"																																																								"{""description"": ""Reduced UDP-galactose impairs galactosylation of glycoproteins and glycolipids. Abnormal glycosylation affects brain development, folliculogenesis, and multiple cellular processes. This deficiency persists despite dietary treatment, contributing to long-term complications.\n"", ""name"": ""UDP-galactose deficiency""}"	{}	"{""description"": ""Reduced UDP-galactose impairs galactosylation of glycoproteins and glycolipids. Abnormal glycosylation affects brain development, folliculogenesis, and multiple cellular processes. This deficiency persists despite dietary treatment, contributing to long-term complications.\n"", ""name"": ""UDP-galactose deficiency""}"
2930	122	Galactosemia	Galactosemia.yaml	pathophysiology	2	Galactitol toxicity	"Galactose is reduced to galactitol by aldose reductase. Galactitol accumulates in the lens causing osmotic stress and cataracts. In galactokinase deficiency, this is the primary pathogenic mechanism.
"																																																								"{""description"": ""Galactose is reduced to galactitol by aldose reductase. Galactitol accumulates in the lens causing osmotic stress and cataracts. In galactokinase deficiency, this is the primary pathogenic mechanism.\n"", ""name"": ""Galactitol toxicity""}"	{}	"{""description"": ""Galactose is reduced to galactitol by aldose reductase. Galactitol accumulates in the lens causing osmotic stress and cataracts. In galactokinase deficiency, this is the primary pathogenic mechanism.\n"", ""name"": ""Galactitol toxicity""}"
2954	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	0	CagA-Mediated Oncogenic Signaling	The cagA gene encodes the CagA oncoprotein, a major H. pylori virulence factor injected into host cells via a type IV secretion system. CagA is phosphorylated by host kinases and activates SHP-2, disrupting cell polarity, promoting proliferation, and inhibiting apoptosis. CagA-positive strains confer higher cancer risk.																																																								"{""description"": ""The cagA gene encodes the CagA oncoprotein, a major H. pylori virulence factor injected into host cells via a type IV secretion system. CagA is phosphorylated by host kinases and activates SHP-2, disrupting cell polarity, promoting proliferation, and inhibiting apoptosis. CagA-positive strains confer higher cancer risk."", ""name"": ""CagA-Mediated Oncogenic Signaling""}"	"{""downstream"": [{""description"": ""CagA interacts with PAR1b/MARK2, disrupting epithelial architecture"", ""target"": ""Disrupted Cell Polarity""}, {""description"": ""Phosphorylated CagA activates SHP-2 phosphatase, promoting cell motility"", ""target"": ""SHP-2 Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""epithelial cell of stomach"", ""term"": {""id"": ""CL:0002178"", ""label"": ""epithelial cell of stomach""}}], ""description"": ""The cagA gene encodes the CagA oncoprotein, a major H. pylori virulence factor injected into host cells via a type IV secretion system. CagA is phosphorylated by host kinases and activates SHP-2, disrupting cell polarity, promoting proliferation, and inhibiting apoptosis. CagA-positive strains confer higher cancer risk."", ""downstream"": [{""description"": ""CagA interacts with PAR1b/MARK2, disrupting epithelial architecture"", ""target"": ""Disrupted Cell Polarity""}, {""description"": ""Phosphorylated CagA activates SHP-2 phosphatase, promoting cell motility"", ""target"": ""SHP-2 Activation""}], ""locations"": [{""preferred_term"": ""stomach"", ""term"": {""id"": ""UBERON:0000945"", ""label"": ""stomach""}}], ""name"": ""CagA-Mediated Oncogenic Signaling""}"
2955	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	1	VacA-Induced Cellular Damage	VacA (vacuolating cytotoxin A) is a pore-forming toxin that induces vacuolation, mitochondrial dysfunction, and apoptosis in epithelial cells. It also suppresses T cell function, allowing bacterial persistence. Different VacA alleles (s1/s2, m1/m2) confer different cancer risk.																																																								"{""description"": ""VacA (vacuolating cytotoxin A) is a pore-forming toxin that induces vacuolation, mitochondrial dysfunction, and apoptosis in epithelial cells. It also suppresses T cell function, allowing bacterial persistence. Different VacA alleles (s1/s2, m1/m2) confer different cancer risk."", ""name"": ""VacA-Induced Cellular Damage""}"	"{""downstream"": [{""description"": ""VacA inhibits T cell activation and proliferation"", ""target"": ""Immune Suppression""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cellular response to cytotoxic stimulus"", ""term"": {""id"": ""GO:0034620"", ""label"": ""cellular response to oxidative stress""}}], ""description"": ""VacA (vacuolating cytotoxin A) is a pore-forming toxin that induces vacuolation, mitochondrial dysfunction, and apoptosis in epithelial cells. It also suppresses T cell function, allowing bacterial persistence. Different VacA alleles (s1/s2, m1/m2) confer different cancer risk."", ""downstream"": [{""description"": ""VacA inhibits T cell activation and proliferation"", ""target"": ""Immune Suppression""}], ""name"": ""VacA-Induced Cellular Damage""}"
2956	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	2	Chronic Inflammation (Correa Cascade)	H. pylori induces chronic gastritis with infiltration of neutrophils, lymphocytes, and macrophages. Persistent inflammation generates reactive oxygen and nitrogen species that cause DNA damage. Over decades, this leads to atrophic gastritis, intestinal metaplasia, dysplasia, and ultimately adenocarcinoma.																																																								"{""description"": ""H. pylori induces chronic gastritis with infiltration of neutrophils, lymphocytes, and macrophages. Persistent inflammation generates reactive oxygen and nitrogen species that cause DNA damage. Over decades, this leads to atrophic gastritis, intestinal metaplasia, dysplasia, and ultimately adenocarcinoma."", ""name"": ""Chronic Inflammation (Correa Cascade)""}"	"{""downstream"": [{""description"": ""Chronic inflammation leads to loss of gastric glandular cells"", ""target"": ""Atrophic Gastritis""}, {""description"": ""Gastric epithelium undergoes metaplastic change to intestinal-type"", ""target"": ""Intestinal Metaplasia""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""description"": ""H. pylori induces chronic gastritis with infiltration of neutrophils, lymphocytes, and macrophages. Persistent inflammation generates reactive oxygen and nitrogen species that cause DNA damage. Over decades, this leads to atrophic gastritis, intestinal metaplasia, dysplasia, and ultimately adenocarcinoma."", ""downstream"": [{""description"": ""Chronic inflammation leads to loss of gastric glandular cells"", ""target"": ""Atrophic Gastritis""}, {""description"": ""Gastric epithelium undergoes metaplastic change to intestinal-type"", ""target"": ""Intestinal Metaplasia""}], ""evidence"": [{""explanation"": ""Abstract describes the gastric precancerous cascade with atrophic gastritis, intestinal metaplasia, and dysplasia."", ""reference"": ""PMID:26668499"", ""snippet"": ""This cascade is a dynamic process that includes lesions, such as atrophic gastritis, intestinal metaplasia and dysplasia."", ""supports"": ""SUPPORT""}], ""name"": ""Chronic Inflammation (Correa Cascade)""}"
2957	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	3	CDH1/E-cadherin Inactivation	Loss of E-cadherin function through somatic mutation, promoter methylation, or loss of heterozygosity occurs in diffuse-type gastric cancer and some intestinal-type tumors. E-cadherin loss disrupts cell-cell adhesion and activates Wnt/beta-catenin signaling, promoting invasion.																																																								"{""description"": ""Loss of E-cadherin function through somatic mutation, promoter methylation, or loss of heterozygosity occurs in diffuse-type gastric cancer and some intestinal-type tumors. E-cadherin loss disrupts cell-cell adhesion and activates Wnt/beta-catenin signaling, promoting invasion."", ""name"": ""CDH1/E-cadherin Inactivation""}"	"{""downstream"": [{""description"": ""Enables single-cell infiltrative growth pattern"", ""target"": ""Loss of Cell Cohesion""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell-cell adhesion"", ""term"": {""id"": ""GO:0098609"", ""label"": ""cell-cell adhesion""}}], ""description"": ""Loss of E-cadherin function through somatic mutation, promoter methylation, or loss of heterozygosity occurs in diffuse-type gastric cancer and some intestinal-type tumors. E-cadherin loss disrupts cell-cell adhesion and activates Wnt/beta-catenin signaling, promoting invasion."", ""downstream"": [{""description"": ""Enables single-cell infiltrative growth pattern"", ""target"": ""Loss of Cell Cohesion""}], ""genes"": [{""preferred_term"": ""CDH1""}], ""name"": ""CDH1/E-cadherin Inactivation""}"
2970	124	Gastric Ulcer	Gastric_Ulcer.yaml	pathophysiology	0	H. pylori and NSAID-associated mucosal injury	Gastric ulceration commonly relates to H. pylori infection or NSAID exposure, reflecting mucosal injury pathways.																																																								"{""description"": ""Gastric ulceration commonly relates to H. pylori infection or NSAID exposure, reflecting mucosal injury pathways."", ""name"": ""H. pylori and NSAID-associated mucosal injury""}"	{}	"{""description"": ""Gastric ulceration commonly relates to H. pylori infection or NSAID exposure, reflecting mucosal injury pathways."", ""evidence"": [{""explanation"": ""The review notes H. pylori infection and NSAID use as key etiologic contexts for peptic ulcers."", ""reference"": ""PMID:28242110"", ""snippet"": ""Peptic ulcers not associated with H pylori infection or the use of non-steroidal anti-inflammatory drugs are now also imposing substantial diagnostic and therapeutic challenges."", ""supports"": ""SUPPORT""}], ""name"": ""H. pylori and NSAID-associated mucosal injury""}"
2981	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	0	Lower Esophageal Sphincter Dysfunction	"Transient relaxations or chronic hypotension of the LES allow retrograde flow of gastric contents into the esophagus. Hiatal hernia exacerbates sphincter incompetence.
"																																																								"{""description"": ""Transient relaxations or chronic hypotension of the LES allow retrograde flow of gastric contents into the esophagus. Hiatal hernia exacerbates sphincter incompetence.\n"", ""name"": ""Lower Esophageal Sphincter Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Smooth Muscle Contraction"", ""term"": {""id"": ""GO:0006939"", ""label"": ""smooth muscle contraction""}}], ""description"": ""Transient relaxations or chronic hypotension of the LES allow retrograde flow of gastric contents into the esophagus. Hiatal hernia exacerbates sphincter incompetence.\n"", ""evidence"": [{""explanation"": ""This review describes the failure of the antireflux barrier, particularly the lower esophageal sphincter, as a core mechanism allowing refluxate to enter the esophagus and cause symptoms."", ""reference"": ""PMID:38177402"", ""snippet"": ""GERD starts in the stomach, where the refluxate material is produced. Following the trajectory of reflux, the failure of the antireflux barrier, primarily the lower oesophageal sphincter and the crural diaphragm, enables the refluxate to reach the oesophageal lumen, triggering oesophageal or extra-oesophageal symptoms."", ""supports"": ""SUPPORT""}, {""explanation"": ""The review explains how LES dysfunction leads to mucosal damage that determines symptom perception in GERD."", ""reference"": ""PMID:38177402"", ""snippet"": ""Alterations of the oesophageal mucosal integrity, such as macroscopic oesophagitis or microscopic changes, determine the perception of symptoms."", ""supports"": ""SUPPORT""}], ""name"": ""Lower Esophageal Sphincter Dysfunction""}"
2982	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	1	Esophageal Mucosal Injury	"Gastric acid and pepsin damage esophageal epithelium, causing inflammation and erosions. Bile reflux in some patients adds to mucosal damage.
"																																																								"{""description"": ""Gastric acid and pepsin damage esophageal epithelium, causing inflammation and erosions. Bile reflux in some patients adds to mucosal damage.\n"", ""name"": ""Esophageal Mucosal Injury""}"	{}	"{""cell_types"": [{""preferred_term"": ""Esophageal Epithelial Cell"", ""term"": {""id"": ""CL:0002252"", ""label"": ""epithelial cell of esophagus""}}], ""description"": ""Gastric acid and pepsin damage esophageal epithelium, causing inflammation and erosions. Bile reflux in some patients adds to mucosal damage.\n"", ""evidence"": [{""explanation"": ""This highlights the importance of clearance mechanisms in preventing mucosal damage from refluxate exposure in GERD."", ""reference"": ""PMID:38177402"", ""snippet"": ""Reflux clearance mechanisms such as primary and secondary peristalsis and the arrival of bicarbonate-rich saliva are critical to prevent mucosal damage."", ""supports"": ""SUPPORT""}, {""explanation"": ""This review recognizes that mucosal integrity damage varies across GERD phenotypes and contributes to symptom severity."", ""reference"": ""PMID:38177402"", ""snippet"": ""It is now recognized that different GERD phenotypes have different degrees of reflux, severity of mucosal integrity damage and type, and severity of symptoms."", ""supports"": ""SUPPORT""}], ""name"": ""Esophageal Mucosal Injury""}"
2983	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	2	Impaired Esophageal Clearance	"Reduced salivary neutralization, impaired peristalsis, and delayed acid clearance prolong mucosal exposure to refluxate.
"																																																								"{""description"": ""Reduced salivary neutralization, impaired peristalsis, and delayed acid clearance prolong mucosal exposure to refluxate.\n"", ""name"": ""Impaired Esophageal Clearance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Digestion"", ""term"": {""id"": ""GO:0007586"", ""label"": ""digestion""}}], ""description"": ""Reduced salivary neutralization, impaired peristalsis, and delayed acid clearance prolong mucosal exposure to refluxate.\n"", ""evidence"": [{""explanation"": ""This directly supports the role of impaired clearance mechanisms in prolonging refluxate exposure and increasing mucosal damage in GERD."", ""reference"": ""PMID:38177402"", ""snippet"": ""Reflux clearance mechanisms such as primary and secondary peristalsis and the arrival of bicarbonate-rich saliva are critical to prevent mucosal damage."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired Esophageal Clearance""}"
2984	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	3	Visceral Hypersensitivity	"Some patients experience symptoms with minimal acid exposure due to heightened esophageal sensory perception.
"																																																								"{""description"": ""Some patients experience symptoms with minimal acid exposure due to heightened esophageal sensory perception.\n"", ""name"": ""Visceral Hypersensitivity""}"	{}	"{""description"": ""Some patients experience symptoms with minimal acid exposure due to heightened esophageal sensory perception.\n"", ""evidence"": [{""explanation"": ""This describes how neural mechanisms, including visceral hypersensitivity, affect symptom intensity in GERD patients even with varying degrees of acid exposure."", ""reference"": ""PMID:38177402"", ""snippet"": ""The intensity of the symptoms is affected by peripheral and central neural and psychological mechanisms."", ""supports"": ""SUPPORT""}], ""name"": ""Visceral Hypersensitivity""}"
2985	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	4	Gut Microbiota Dysbiosis	"Altered gut microbiota composition contributes to GERD risk through bidirectional causal relationships. Protective taxa include Actinobacteria and Methanobrevibacter, while risk taxa include Mollicutes and Tenericutes.
"																																																								"{""description"": ""Altered gut microbiota composition contributes to GERD risk through bidirectional causal relationships. Protective taxa include Actinobacteria and Methanobrevibacter, while risk taxa include Mollicutes and Tenericutes.\n"", ""name"": ""Gut Microbiota Dysbiosis""}"	{}	"{""description"": ""Altered gut microbiota composition contributes to GERD risk through bidirectional causal relationships. Protective taxa include Actinobacteria and Methanobrevibacter, while risk taxa include Mollicutes and Tenericutes.\n"", ""evidence"": [{""explanation"": ""This Mendelian randomization study establishes causal relationships between specific gut microbiota taxa and GERD risk, identifying both protective and risk-associated bacterial groups."", ""reference"": ""PMID:38449873"", ""snippet"": ""The IVW method's findings suggested protective roles against GERD for the Family Clostridiales Vadin BB60 group (P = 0.027), Genus Lachnospiraceae UCG004 (P = 0.026), Genus Methanobrevibacter (P = 0.026), and Phylum Actinobacteria (P = 0.019). In contrast, Class Mollicutes (P = 0.037), Genus Anaerostipes (P = 0.049), and Phylum Tenericutes (P = 0.024) emerged as potential GERD risk factors."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms a genetic basis for the gut microbiome's causal role in GERD development and supports microbiome-targeted therapeutic approaches."", ""reference"": ""PMID:38449873"", ""snippet"": ""For the first time, the MR analysis indicates a genetic link between gut microbiota abundance changes and GERD risk. This not only substantiates the potential of intestinal microecological therapy for GERD, but also establishes a basis for advanced research into the role of intestinal microbiota in the etiology of GERD."", ""supports"": ""SUPPORT""}], ""name"": ""Gut Microbiota Dysbiosis""}"
2986	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	5	Barrett's Esophagus Metaplastic Adaptation	"Chronic reflux-induced inflammation drives metaplastic transformation of esophageal squamous epithelium to specialized columnar epithelium with altered tight junction protein expression, particularly claudin-18, which contributes to acid resistance.
"																																																								"{""description"": ""Chronic reflux-induced inflammation drives metaplastic transformation of esophageal squamous epithelium to specialized columnar epithelium with altered tight junction protein expression, particularly claudin-18, which contributes to acid resistance.\n"", ""name"": ""Barrett's Esophagus Metaplastic Adaptation""}"	{}	"{""description"": ""Chronic reflux-induced inflammation drives metaplastic transformation of esophageal squamous epithelium to specialized columnar epithelium with altered tight junction protein expression, particularly claudin-18, which contributes to acid resistance.\n"", ""evidence"": [{""explanation"": ""This demonstrates that Barrett's esophagus exhibits a dramatic shift in tight junction protein composition, with claudin-18 becoming the dominant protein in metaplastic epithelium."", ""reference"": ""PMID:17932229"", ""snippet"": ""In SCE, Cldn-18 was the most highly expressed at the mRNA level and this finding is paralleled by marked elevation in protein expression on immunoblots. In contrast in SqE, Cldn-18 was minimally expressed at the mRNA level and undetectable at the protein level."", ""supports"": ""SUPPORT""}, {""explanation"": ""This establishes that the claudin-18-rich tight junctions in Barrett's esophagus provide enhanced acid resistance compared to normal squamous epithelium."", ""reference"": ""PMID:17932229"", ""snippet"": ""We conclude that Cldn-18 is the dominant claudin in the TJ of SCE and propose that the change from a Cldn-18-deficient TJ in SqE to a Cldn-18-rich TJ in SCE contributes to the greater acid resistance of BE."", ""supports"": ""SUPPORT""}, {""explanation"": ""This describes Barrett's esophagus as a metaplastic adaptation that develops in response to chronic reflux-induced damage and provides greater acid resistance."", ""reference"": ""PMID:17932229"", ""snippet"": ""Barrett's esophagus (BE) is a specialized columnar epithelium (SCE) that develops as replacement for damaged squamous epithelium (SqE) in subjects with reflux disease, and as such it is apparently more acid resistant than SqE."", ""supports"": ""SUPPORT""}], ""name"": ""Barrett's Esophagus Metaplastic Adaptation""}"
3006	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	0	KIT Receptor Tyrosine Kinase Activation	Gain-of-function mutations in KIT result in constitutive receptor dimerization and kinase activation without ligand (stem cell factor) binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting cell proliferation and survival.																																																								"{""description"": ""Gain-of-function mutations in KIT result in constitutive receptor dimerization and kinase activation without ligand (stem cell factor) binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting cell proliferation and survival."", ""name"": ""KIT Receptor Tyrosine Kinase Activation""}"	"{""downstream"": [{""description"": ""KIT phosphorylation activates RAS-RAF-MEK-ERK cascade"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""KIT phosphorylation recruits PI3K leading to AKT activation"", ""target"": ""PI3K-AKT Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""receptor signaling protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004716"", ""label"": ""receptor signaling protein tyrosine kinase activity""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""cell_types"": [{""preferred_term"": ""interstitial cell of Cajal"", ""term"": {""id"": ""CL:0002088"", ""label"": ""interstitial cell of Cajal""}}], ""description"": ""Gain-of-function mutations in KIT result in constitutive receptor dimerization and kinase activation without ligand (stem cell factor) binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting cell proliferation and survival."", ""downstream"": [{""description"": ""KIT phosphorylation activates RAS-RAF-MEK-ERK cascade"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""KIT phosphorylation recruits PI3K leading to AKT activation"", ""target"": ""PI3K-AKT Pathway Activation""}], ""evidence"": [{""explanation"": ""This landmark NEJM study established that constitutive KIT activation is the critical driver of GIST pathogenesis."", ""reference"": ""PMID:12181401"", ""snippet"": ""Constitutive activation of KIT receptor tyrosine kinase is critical in the pathogenesis of gastrointestinal stromal tumors."", ""supports"": ""SUPPORT""}], ""gene_products"": [{""preferred_term"": ""KIT receptor"", ""term"": {""id"": ""NCIT:C17328"", ""label"": ""Mast/Stem Cell Growth Factor Receptor Kit""}}], ""locations"": [{""preferred_term"": ""gastrointestinal tract"", ""term"": {""id"": ""UBERON:0005409"", ""label"": ""alimentary part of gastrointestinal system""}}], ""name"": ""KIT Receptor Tyrosine Kinase Activation""}"
3007	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	1	PDGFRA Receptor Activation	PDGFRA mutations, particularly D842V in the activation loop, result in constitutive kinase activity. These mutations activate similar downstream pathways as KIT but show different drug sensitivity profiles.																																																								"{""description"": ""PDGFRA mutations, particularly D842V in the activation loop, result in constitutive kinase activity. These mutations activate similar downstream pathways as KIT but show different drug sensitivity profiles."", ""name"": ""PDGFRA Receptor Activation""}"	"{""downstream"": [{""description"": ""PDGFRA phosphorylation activates RAS-RAF-MEK-ERK cascade"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""PDGFRA phosphorylation recruits PI3K leading to AKT activation"", ""target"": ""PI3K-AKT Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""platelet-derived growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0048008"", ""label"": ""platelet-derived growth factor receptor signaling pathway""}}], ""description"": ""PDGFRA mutations, particularly D842V in the activation loop, result in constitutive kinase activity. These mutations activate similar downstream pathways as KIT but show different drug sensitivity profiles."", ""downstream"": [{""description"": ""PDGFRA phosphorylation activates RAS-RAF-MEK-ERK cascade"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""PDGFRA phosphorylation recruits PI3K leading to AKT activation"", ""target"": ""PI3K-AKT Pathway Activation""}], ""name"": ""PDGFRA Receptor Activation""}"
3008	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	2	RAS-MAPK Pathway Activation	Constitutive KIT or PDGFRA activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting cell proliferation. This pathway represents a potential therapeutic target when primary resistance to KIT/PDGFRA inhibitors occurs.																																																								"{""description"": ""Constitutive KIT or PDGFRA activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting cell proliferation. This pathway represents a potential therapeutic target when primary resistance to KIT/PDGFRA inhibitors occurs."", ""name"": ""RAS-MAPK Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""Constitutive KIT or PDGFRA activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting cell proliferation. This pathway represents a potential therapeutic target when primary resistance to KIT/PDGFRA inhibitors occurs."", ""name"": ""RAS-MAPK Pathway Activation""}"
3009	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	3	PI3K-AKT Pathway Activation	Constitutive KIT or PDGFRA activation recruits PI3K and activates the PI3K-AKT-mTOR signaling cascade, promoting cell survival and resistance to apoptosis. This pathway cooperates with MAPK signaling to drive tumorigenesis.																																																								"{""description"": ""Constitutive KIT or PDGFRA activation recruits PI3K and activates the PI3K-AKT-mTOR signaling cascade, promoting cell survival and resistance to apoptosis. This pathway cooperates with MAPK signaling to drive tumorigenesis."", ""name"": ""PI3K-AKT Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""Constitutive KIT or PDGFRA activation recruits PI3K and activates the PI3K-AKT-mTOR signaling cascade, promoting cell survival and resistance to apoptosis. This pathway cooperates with MAPK signaling to drive tumorigenesis."", ""name"": ""PI3K-AKT Pathway Activation""}"
3026	127	Gaucher Disease	Gaucher_Disease.yaml	pathophysiology	0	Glucocerebrosidase Deficiency	"Mutations in the GBA gene cause deficient beta-glucocerebrosidase (glucosylceramidase) enzyme. This enzyme normally degrades glucocerebroside (glucosylceramide) in lysosomes. Without it, glucocerebroside accumulates primarily in macrophages.
"																																																								"{""description"": ""Mutations in the GBA gene cause deficient beta-glucocerebrosidase (glucosylceramidase) enzyme. This enzyme normally degrades glucocerebroside (glucosylceramide) in lysosomes. Without it, glucocerebroside accumulates primarily in macrophages.\n"", ""name"": ""Glucocerebrosidase Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Sphingolipid Catabolism"", ""term"": {""id"": ""GO:0030148"", ""label"": ""sphingolipid biosynthetic process""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Mutations in the GBA gene cause deficient beta-glucocerebrosidase (glucosylceramidase) enzyme. This enzyme normally degrades glucocerebroside (glucosylceramide) in lysosomes. Without it, glucocerebroside accumulates primarily in macrophages.\n"", ""evidence"": [{""explanation"": ""Review confirms glucocerebrosidase deficiency causes glucosylceramide accumulation in macrophages."", ""reference"": ""PMID:28218669"", ""snippet"": ""It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an accumulation of its substrate, glucosylceramide, in macrophages."", ""supports"": ""SUPPORT""}], ""name"": ""Glucocerebrosidase Deficiency""}"
3027	127	Gaucher Disease	Gaucher_Disease.yaml	pathophysiology	1	Gaucher Cell Formation	"Lipid-laden macrophages (Gaucher cells) accumulate in spleen, liver, bone marrow, and other organs. These cells have characteristic crinkled tissue paper appearance and cause organ dysfunction through infiltration and inflammatory cytokine release.
"																																																								"{""description"": ""Lipid-laden macrophages (Gaucher cells) accumulate in spleen, liver, bone marrow, and other organs. These cells have characteristic crinkled tissue paper appearance and cause organ dysfunction through infiltration and inflammatory cytokine release.\n"", ""name"": ""Gaucher Cell Formation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Macrophage Activation"", ""term"": {""id"": ""GO:0042116"", ""label"": ""macrophage activation""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Lipid-laden macrophages (Gaucher cells) accumulate in spleen, liver, bone marrow, and other organs. These cells have characteristic crinkled tissue paper appearance and cause organ dysfunction through infiltration and inflammatory cytokine release.\n"", ""evidence"": [{""explanation"": ""Review confirms Gaucher cell infiltration causes the major clinical manifestations."", ""reference"": ""PMID:28218669"", ""snippet"": ""The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions associated with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells."", ""supports"": ""SUPPORT""}], ""name"": ""Gaucher Cell Formation""}"
3049	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	0	Amygdala Hyperactivity	"Exaggerated amygdala response to perceived threats leads to excessive fear and anxiety. Reduced prefrontal cortex regulation of amygdala activity.
"																																																								"{""description"": ""Exaggerated amygdala response to perceived threats leads to excessive fear and anxiety. Reduced prefrontal cortex regulation of amygdala activity.\n"", ""name"": ""Amygdala Hyperactivity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Fear Response"", ""term"": {""id"": ""GO:0042596"", ""label"": ""fear response""}}], ""cell_types"": [{""preferred_term"": ""Amygdala Pyramidal Neuron"", ""term"": {""id"": ""CL:4023110"", ""label"": ""amygdala pyramidal neuron""}}], ""description"": ""Exaggerated amygdala response to perceived threats leads to excessive fear and anxiety. Reduced prefrontal cortex regulation of amygdala activity.\n"", ""evidence"": [{""explanation"": ""This evidence supports the model of amygdala hyperactivity in anxiety and the role of prefrontal cortex in regulating amygdala responses to threat stimuli."", ""reference"": ""PMID:38865810"", ""snippet"": ""Evidence indicates that anxiety disorders arise from an imbalance in the functioning of brain circuits that govern the modulation of emotional responses to possibly threatening stimuli. The circuits under consideration in this context include the amygdala's bottom-up activity, which signifies the existence of stimuli that may be seen as dangerous. Moreover, these circuits encompass top-down regulatory processes that originate in the prefrontal cortex, facilitating the communication of the emotional significance associated with the inputs."", ""supports"": ""SUPPORT""}], ""name"": ""Amygdala Hyperactivity""}"
3050	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	1	GABA System Dysfunction	"Reduced GABAergic inhibition contributes to neuronal hyperexcitability and anxiety. Benzodiazepines enhance GABA function.
"																																																								"{""description"": ""Reduced GABAergic inhibition contributes to neuronal hyperexcitability and anxiety. Benzodiazepines enhance GABA function.\n"", ""name"": ""GABA System Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""GABAergic Transmission"", ""term"": {""id"": ""GO:0051932"", ""label"": ""synaptic transmission, GABAergic""}}], ""cell_types"": [{""preferred_term"": ""GABAergic Interneuron"", ""term"": {""id"": ""CL:0011005"", ""label"": ""GABAergic interneuron""}}], ""description"": ""Reduced GABAergic inhibition contributes to neuronal hyperexcitability and anxiety. Benzodiazepines enhance GABA function.\n"", ""evidence"": [{""explanation"": ""This evidence demonstrates reduced GABAergic activity in anxiety disorders through both imaging studies and animal models showing that decreased GABA receptor expression leads to anxiety-like behavior."", ""reference"": ""PMID:38865810"", ""snippet"": ""A decrease in GABAergic activity is present in both anxiety disorders and severe depression. Research on cerebral functional imaging in depressive individuals has shown reduced levels of GABA within the cortical regions. Additionally, animal studies demonstrated that a reduction in the expression of GABAA/B receptors results in a behavioral pattern resembling anxiety."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports the mechanism of GABAergic dysfunction in the amygdala and explains how benzodiazepines work by targeting GABAA receptor allosteric sites to enhance inhibition."", ""reference"": ""PMID:38865810"", ""snippet"": ""The amygdala consists of inhibitory networks composed of GABAergic interneurons, responsible for modulating anxiety responses in both normal and pathological conditions. The GABAA receptor has allosteric sites (e.g., /, /, and /) which enable regulation of neuronal inhibition in the amygdala. These sites serve as molecular targets for anxiolytic medications such as benzodiazepine and barbiturates."", ""supports"": ""SUPPORT""}, {""explanation"": ""Large-scale GWAS provides genetic evidence for biological mechanisms underlying anxiety disorders, with identified loci enriched for GABAergic signaling pathways."", ""reference"": ""PMID:39294497"", ""snippet"": ""We leveraged information from more than 1.2 million participants, including 97,383 cases, to investigate the genetics of anxiety disorders across five continental groups. Through ancestry-specific and cross-ancestry genome-wide association studies, we identified 51 anxiety-associated loci, 39 of which were novel."", ""supports"": ""SUPPORT""}], ""name"": ""GABA System Dysfunction""}"
3051	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	2	Serotonin Dysregulation	"Altered serotonin signaling, particularly in raphe-prefrontal circuits, contributes to anxiety. SSRIs are first-line treatment.
"																																																								"{""description"": ""Altered serotonin signaling, particularly in raphe-prefrontal circuits, contributes to anxiety. SSRIs are first-line treatment.\n"", ""name"": ""Serotonin Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Serotonin Signaling"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}], ""cell_types"": [{""preferred_term"": ""Serotonergic Neuron"", ""term"": {""id"": ""CL:0000850"", ""label"": ""serotonergic neuron""}}], ""description"": ""Altered serotonin signaling, particularly in raphe-prefrontal circuits, contributes to anxiety. SSRIs are first-line treatment.\n"", ""evidence"": [{""explanation"": ""This evidence establishes the role of decreased serotonergic activity in anxiety and explains how antidepressants work by increasing serotonin system activity."", ""reference"": ""PMID:24936175"", ""snippet"": ""Decreased serotonergic activity has been implicated in anxiety and major depression, and antidepressants directly or indirectly increase the long-term activity of the serotonin system. A key component of serotonin circuitry is the 5-HT1A autoreceptor, which functions as the major somatodendritic autoreceptor to negatively regulate the 'gain' of the serotonin system."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports the specific role of serotonin signaling in prefrontal-limbic circuits that regulate anxiety and fear responses."", ""reference"": ""PMID:24936175"", ""snippet"": ""In addition, 5-HT1A heteroreceptors are abundantly expressed post-synaptically in the prefrontal cortex (PFC), amygdala, and hippocampus to mediate serotonin actions on fear, anxiety, stress, and cognition."", ""supports"": ""SUPPORT""}], ""name"": ""Serotonin Dysregulation""}"
3052	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	3	HPA Axis Dysregulation	"Chronic activation of the stress response system with elevated cortisol contributes to sustained anxiety and physical symptoms.
"																																																								"{""description"": ""Chronic activation of the stress response system with elevated cortisol contributes to sustained anxiety and physical symptoms.\n"", ""name"": ""HPA Axis Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Stress Response"", ""term"": {""id"": ""GO:0006950"", ""label"": ""response to stress""}}], ""description"": ""Chronic activation of the stress response system with elevated cortisol contributes to sustained anxiety and physical symptoms.\n"", ""evidence"": [{""explanation"": ""This evidence directly links GAD to HPA axis hyperactivity, particularly in older adults."", ""reference"": ""PMID:20808146"", ""snippet"": ""Generalized anxiety disorder (GAD) is a common disorder in older adults, which has been linked to hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in this age group."", ""supports"": ""SUPPORT""}, {""explanation"": ""This demonstrates that HPA axis hyperactivity with elevated cortisol is present in GAD patients and that successful treatment reduces cortisol levels in parallel with anxiety symptom reduction."", ""reference"": ""PMID:20808146"", ""snippet"": ""Compared with placebo-treated patients, SSRI-treated patients had a significantly greater reduction in both peak and total cortisol. This reduction in cortisol was limited to patients with elevated (above the median) baseline cortisol, in whom SSRI-treated patients showed substantially greater reduction in cortisol than did placebo-treated patients. Reductions in cortisol were associated with improvements in anxiety."", ""supports"": ""SUPPORT""}], ""name"": ""HPA Axis Dysregulation""}"
3053	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	4	Noradrenergic Hyperactivity	"Elevated norepinephrine activity in locus coeruleus contributes to hyperarousal and somatic symptoms of anxiety.
"																																																								"{""description"": ""Elevated norepinephrine activity in locus coeruleus contributes to hyperarousal and somatic symptoms of anxiety.\n"", ""name"": ""Noradrenergic Hyperactivity""}"	{}	"{""cell_types"": [{""preferred_term"": ""Noradrenergic Neuron"", ""term"": {""id"": ""CL:0008025"", ""label"": ""noradrenergic neuron""}}], ""description"": ""Elevated norepinephrine activity in locus coeruleus contributes to hyperarousal and somatic symptoms of anxiety.\n"", ""name"": ""Noradrenergic Hyperactivity""}"
3054	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	5	Oxidative Stress	"Increased oxidative stress markers and reduced antioxidant enzyme activity in GAD patients. Elevated malondialdehyde and reduced superoxide dismutase correlate with symptom severity.
"																																																								"{""description"": ""Increased oxidative stress markers and reduced antioxidant enzyme activity in GAD patients. Elevated malondialdehyde and reduced superoxide dismutase correlate with symptom severity.\n"", ""name"": ""Oxidative Stress""}"	{}	"{""description"": ""Increased oxidative stress markers and reduced antioxidant enzyme activity in GAD patients. Elevated malondialdehyde and reduced superoxide dismutase correlate with symptom severity.\n"", ""evidence"": [{""explanation"": ""This demonstrates elevated oxidative DNA damage in GAD patients as measured by 8-hydroxy-2-deoxyguanosine (8-OHdG), a marker of oxidative stress."", ""reference"": ""PMID:38204917"", ""snippet"": ""The 8-OHdG values of the GAD group were determined to be statistically significantly higher than those of the control group (p=0.028)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This concludes that oxidative stress contributes to the pathophysiology of GAD through DNA damage mechanisms."", ""reference"": ""PMID:38204917"", ""snippet"": ""The results of this study showed that there could be DNA damage because of oxidative stress in GAD patients."", ""supports"": ""SUPPORT""}], ""name"": ""Oxidative Stress""}"
3055	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	6	Epigenetic Alterations	"DNA methylation changes in anxiety-related genes, particularly in monocytes and granulocytes. Methylation sites identified in genes involved in neurogenesis and fear memory.
"																																																								"{""description"": ""DNA methylation changes in anxiety-related genes, particularly in monocytes and granulocytes. Methylation sites identified in genes involved in neurogenesis and fear memory.\n"", ""name"": ""Epigenetic Alterations""}"	{}	"{""cell_types"": [{""preferred_term"": ""Monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}, {""preferred_term"": ""Granulocyte"", ""term"": {""id"": ""CL:0000094"", ""label"": ""granulocyte""}}], ""description"": ""DNA methylation changes in anxiety-related genes, particularly in monocytes and granulocytes. Methylation sites identified in genes involved in neurogenesis and fear memory.\n"", ""evidence"": [{""explanation"": ""This large-scale epigenome-wide study identifies hundreds of significant DNA methylation sites associated with anxiety disorders, supporting the role of epigenetic mechanisms in GAD pathophysiology."", ""reference"": ""PMID:37542162"", ""snippet"": ""Applying an enrichment-based sequencing approach covering nearly 28 million autosomal CpG sites, we conducted a methylome-wide association study (MWAS) of lifetime ANX in 1132 participants (618 cases/514 controls) from the Netherlands Study of Depression and Anxiety. Using epigenomic deconvolution, we performed MWAS for the main cell types in blood: granulocytes, T-cells, B-cells and monocytes. Cell-type specific analyses identified 280 and 82 methylome-wide significant associations (q-value < 0.1) in monocytes and granulocytes, respectively."", ""supports"": ""SUPPORT""}, {""explanation"": ""This identifies FZR1 as a key gene with replicable methylation changes in anxiety, linking epigenetic alterations to hippocampal neurogenesis and fear memory mechanisms."", ""reference"": ""PMID:37542162"", ""snippet"": ""In monocytes, two specific sites in the FZR1 gene showed significant replication after Bonferroni correction with an additional 15 nominally replicated sites in monocytes and 4 in T-cells. FZR1 regulates neurogenesis in the hippocampus, and its knockout leads to impairments in associative fear memory and long-term potentiation in mice."", ""supports"": ""SUPPORT""}], ""name"": ""Epigenetic Alterations""}"
3075	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	0	Dendritic Cell Activation in Vessel Wall	Adventitial dendritic cells become activated and produce chemokines that recruit T cells and macrophages. Vascular dendritic cells may sense pathogen-associated or damage-associated molecular patterns.																																																								"{""description"": ""Adventitial dendritic cells become activated and produce chemokines that recruit T cells and macrophages. Vascular dendritic cells may sense pathogen-associated or damage-associated molecular patterns."", ""name"": ""Dendritic Cell Activation in Vessel Wall""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immune Response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}], ""cell_types"": [{""preferred_term"": ""Dendritic Cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""Adventitial dendritic cells become activated and produce chemokines that recruit T cells and macrophages. Vascular dendritic cells may sense pathogen-associated or damage-associated molecular patterns."", ""evidence"": [{""explanation"": ""This evidence confirms that dendritic cells are key initiators of the immune response in GCA, recruiting and activating CD4 T cells in the vessel wall."", ""reference"": ""PMID:35629030"", ""snippet"": ""Once activated, dendritic cells recruit CD4 T cells and induce their activation, proliferation and polarization into Th1 and Th17, which produce interferon-gamma (IFN-) and interleukin-17 (IL-17), respectively."", ""supports"": ""SUPPORT""}], ""name"": ""Dendritic Cell Activation in Vessel Wall""}"
3076	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	1	Th1 and Th17 T Cell Infiltration	CD4+ T cells infiltrate the arterial wall and produce IFN-gamma (Th1) and IL-17 (Th17). IFN-gamma activates macrophages and promotes giant cell formation, while IL-17 drives vascular inflammation.																																																								"{""description"": ""CD4+ T cells infiltrate the arterial wall and produce IFN-gamma (Th1) and IL-17 (Th17). IFN-gamma activates macrophages and promotes giant cell formation, while IL-17 drives vascular inflammation."", ""name"": ""Th1 and Th17 T Cell Infiltration""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}, {""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""CD4+ T cells infiltrate the arterial wall and produce IFN-gamma (Th1) and IL-17 (Th17). IFN-gamma activates macrophages and promotes giant cell formation, while IL-17 drives vascular inflammation."", ""evidence"": [{""explanation"": ""This demonstrates the role of IFN-gamma from Th1 cells in recruiting additional immune cells and promoting macrophage differentiation in the vessel wall."", ""reference"": ""PMID:35629030"", ""snippet"": ""IFN- triggers the production of chemokines by vascular smooth muscle cells, which leads to the recruitment of additional CD4 and CD8 T cells and also monocytes that differentiate into macrophages."", ""supports"": ""SUPPORT""}, {""explanation"": ""This evidence describes the checkpoint mechanism by which CD4+ T cells become dysregulated through NOTCH signaling, enabling their pathogenic infiltration into the arterial wall."", ""reference"": ""PMID:36656970"", ""snippet"": ""Loss of self-tolerance in the adaptive immune system is linked to aberrant signaling in the NOTCH pathway, leading to expansion of NOTCH1+CD4+ T cells and the functional decline of NOTCH4+ T regulatory cells (Checkpoint 1)."", ""supports"": ""SUPPORT""}], ""name"": ""Th1 and Th17 T Cell Infiltration""}"
3077	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	2	Giant Cell Formation and Intimal Hyperplasia	Multinucleated giant cells form at the media-intima junction. Smooth muscle cells proliferate causing intimal hyperplasia, leading to vessel stenosis and ischemic complications.																																																								"{""description"": ""Multinucleated giant cells form at the media-intima junction. Smooth muscle cells proliferate causing intimal hyperplasia, leading to vessel stenosis and ischemic complications."", ""name"": ""Giant Cell Formation and Intimal Hyperplasia""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell proliferation""}}], ""cell_types"": [{""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}], ""description"": ""Multinucleated giant cells form at the media-intima junction. Smooth muscle cells proliferate causing intimal hyperplasia, leading to vessel stenosis and ischemic complications."", ""evidence"": [{""explanation"": ""This describes the immune checkpoint failure that allows multinucleated giant cells to form in the vessel wall through unchecked macrophage activation."", ""reference"": ""PMID:36656970"", ""snippet"": ""Due to the failure of the immuno-inhibitory PD-1 (programmed cell death protein 1)/PD-L1 (programmed cell death ligand 1) pathway, wall-infiltrating immune cells arrive in a permissive tissues microenvironment, where multiple T cell effector lineages thrive, shift toward high glycolytic activity, and support the development of tissue-damaging macrophages, including multinucleated giant cells (Checkpoint 3)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This evidence explains the mechanism of intimal hyperplasia whereby smooth muscle cells proliferate and produce extracellular matrix, leading to stenosis."", ""reference"": ""PMID:35629030"", ""snippet"": ""Under the influence of different mediators, mainly endothelin-1 and PDGF, vascular smooth muscle cells migrate to the intima, proliferate and change their phenotype to become myofibroblasts that further proliferate and produce extracellular matrix proteins, increasing the vascular stenosis."", ""supports"": ""SUPPORT""}], ""name"": ""Giant Cell Formation and Intimal Hyperplasia""}"
3101	130	Glaucoma	Glaucoma.yaml	pathophysiology	0	Elevated Intraocular Pressure	"Impaired aqueous humor drainage through trabecular meshwork leads to increased IOP in most cases. Elevated pressure damages retinal ganglion cells and optic nerve.
"																																																								"{""description"": ""Impaired aqueous humor drainage through trabecular meshwork leads to increased IOP in most cases. Elevated pressure damages retinal ganglion cells and optic nerve.\n"", ""name"": ""Elevated Intraocular Pressure""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Fluid Homeostasis"", ""term"": {""id"": ""GO:0030104"", ""label"": ""water homeostasis""}}], ""description"": ""Impaired aqueous humor drainage through trabecular meshwork leads to increased IOP in most cases. Elevated pressure damages retinal ganglion cells and optic nerve.\n"", ""evidence"": [{""explanation"": ""Identifies elevated IOP as a main risk factor that accelerates retinal ganglion cell apoptosis in glaucoma."", ""reference"": ""PMID:26497784"", ""snippet"": ""Elevated intraocular pressure and aging, the main risk factors for glaucoma, accelerate RGC apoptosis."", ""supports"": ""SUPPORT""}], ""name"": ""Elevated Intraocular Pressure""}"
3102	130	Glaucoma	Glaucoma.yaml	pathophysiology	1	Retinal Ganglion Cell Death	"Progressive apoptosis of retinal ganglion cells leads to irreversible vision loss. Mechanical stress, ischemia, and excitotoxicity contribute to cell death.
"																																																								"{""description"": ""Progressive apoptosis of retinal ganglion cells leads to irreversible vision loss. Mechanical stress, ischemia, and excitotoxicity contribute to cell death.\n"", ""name"": ""Retinal Ganglion Cell Death""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Apoptosis"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""Retinal Ganglion Cell"", ""term"": {""id"": ""CL:0000740"", ""label"": ""retinal ganglion cell""}}], ""description"": ""Progressive apoptosis of retinal ganglion cells leads to irreversible vision loss. Mechanical stress, ischemia, and excitotoxicity contribute to cell death.\n"", ""evidence"": [{""explanation"": ""Establishes that RGC apoptosis is the direct cause of visual field loss in glaucoma, confirming the central role of programmed cell death in disease pathogenesis."", ""reference"": ""PMID:26497784"", ""snippet"": ""Apoptosis of retinal ganglion cells (RGCs) in glaucoma causes progressive visual field loss, making it the primary cause of irreversible blindness worldwide."", ""supports"": ""SUPPORT""}, {""explanation"": ""Links OPTN mutations to RGC apoptosis through impaired autophagy, providing a molecular mechanism for how genetic variants cause retinal ganglion cell death."", ""reference"": ""PMID:26302410"", ""snippet"": ""A glaucoma-associated mutant of optineurin, E50K, impairs autophagy as well as vesicle trafficking, leading to death of retinal cells by apoptosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms that RGC death is a hallmark of glaucoma neurodegeneration and highlights the role of neuroinflammation in the degenerative process."", ""reference"": ""PMID:37542647"", ""snippet"": ""Glaucoma is a leading cause of permanent blindness worldwide and is characterized by neurodegeneration linked to progressive retinal ganglion cell (RGC) death, axonal damage, and neuroinflammation."", ""supports"": ""SUPPORT""}], ""name"": ""Retinal Ganglion Cell Death""}"
3103	130	Glaucoma	Glaucoma.yaml	pathophysiology	2	Optic Nerve Degeneration	"Loss of ganglion cell axons causes characteristic optic disc cupping. Progressive nerve fiber layer loss detectable before symptomatic visual field loss.
"																																																								"{""description"": ""Loss of ganglion cell axons causes characteristic optic disc cupping. Progressive nerve fiber layer loss detectable before symptomatic visual field loss.\n"", ""name"": ""Optic Nerve Degeneration""}"	{}	"{""description"": ""Loss of ganglion cell axons causes characteristic optic disc cupping. Progressive nerve fiber layer loss detectable before symptomatic visual field loss.\n"", ""name"": ""Optic Nerve Degeneration""}"
3104	130	Glaucoma	Glaucoma.yaml	pathophysiology	3	Trabecular Meshwork Dysfunction	"Age-related changes, oxidative stress, and altered extracellular matrix reduce outflow facility. Increased resistance to aqueous outflow.
"																																																								"{""description"": ""Age-related changes, oxidative stress, and altered extracellular matrix reduce outflow facility. Increased resistance to aqueous outflow.\n"", ""name"": ""Trabecular Meshwork Dysfunction""}"	{}	"{""cell_types"": [{""preferred_term"": ""Trabecular Meshwork Cell"", ""term"": {""id"": ""CL:0002367"", ""label"": ""trabecular meshwork cell""}}], ""description"": ""Age-related changes, oxidative stress, and altered extracellular matrix reduce outflow facility. Increased resistance to aqueous outflow.\n"", ""evidence"": [{""explanation"": ""Confirms myocilin expression in trabecular meshwork cells, linking MYOC to the trabecular meshwork dysfunction in glaucoma."", ""reference"": ""PMID:10617907"", ""snippet"": ""Myocilin gene is expressed clearly in the trabecular meshwork cells of both glaucomatous and nonglaucomatous eyes."", ""supports"": ""SUPPORT""}, {""explanation"": ""Describes how mutant myocilin causes trabecular meshwork cell death through intracellular aggregation, directly linking MYOC mutations to trabecular dysfunction and elevated IOP."", ""reference"": ""PMID:37217093"", ""snippet"": ""The prevailing pathogenic mechanism involves a gain of toxic function whereby mutant myocilin aggregates intracellularly instead of being secreted, which causes cell stress and an early timeline for TM cell death, elevated intraocular pressure, and subsequent glaucoma-associated retinal degeneration."", ""supports"": ""SUPPORT""}], ""name"": ""Trabecular Meshwork Dysfunction""}"
3130	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	0	TERT Promoter Activation	TERT promoter mutations (C228T or C250T) occur in approximately 80% of IDH-wildtype glioblastomas. These mutations create de novo ETS transcription factor binding sites, leading to TERT upregulation and telomerase reactivation. This enables unlimited replicative potential and is a defining molecular feature.																																																								"{""description"": ""TERT promoter mutations (C228T or C250T) occur in approximately 80% of IDH-wildtype glioblastomas. These mutations create de novo ETS transcription factor binding sites, leading to TERT upregulation and telomerase reactivation. This enables unlimited replicative potential and is a defining molecular feature."", ""name"": ""TERT Promoter Activation""}"	"{""downstream"": [{""description"": ""Telomerase reactivation enables unlimited cell division"", ""target"": ""Unlimited Replicative Potential""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""telomere maintenance via telomerase"", ""term"": {""id"": ""GO:0007004"", ""label"": ""telomere maintenance via telomerase""}}], ""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""TERT promoter mutations (C228T or C250T) occur in approximately 80% of IDH-wildtype glioblastomas. These mutations create de novo ETS transcription factor binding sites, leading to TERT upregulation and telomerase reactivation. This enables unlimited replicative potential and is a defining molecular feature."", ""downstream"": [{""description"": ""Telomerase reactivation enables unlimited cell division"", ""target"": ""Unlimited Replicative Potential""}], ""locations"": [{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}], ""name"": ""TERT Promoter Activation""}"
3131	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	1	Chromosome 7 Gain and Chromosome 10 Loss	Combined gain of chromosome 7 (+7) and loss of chromosome 10 (-10) is a defining molecular feature of IDH-wildtype glioblastoma, present in over 90% of cases. Chromosome 7 gain amplifies EGFR and MET. Chromosome 10 loss deletes PTEN and other tumor suppressors.																																																								"{""description"": ""Combined gain of chromosome 7 (+7) and loss of chromosome 10 (-10) is a defining molecular feature of IDH-wildtype glioblastoma, present in over 90% of cases. Chromosome 7 gain amplifies EGFR and MET. Chromosome 10 loss deletes PTEN and other tumor suppressors."", ""name"": ""Chromosome 7 Gain and Chromosome 10 Loss""}"	"{""downstream"": [{""description"": ""Chromosome 7 gain increases EGFR and MET copy number"", ""target"": ""EGFR/MET Pathway Activation""}, {""description"": ""Chromosome 10 loss eliminates PTEN"", ""target"": ""PTEN Tumor Suppressor Loss""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""chromosome organization"", ""term"": {""id"": ""GO:0051276"", ""label"": ""chromosome organization""}}], ""description"": ""Combined gain of chromosome 7 (+7) and loss of chromosome 10 (-10) is a defining molecular feature of IDH-wildtype glioblastoma, present in over 90% of cases. Chromosome 7 gain amplifies EGFR and MET. Chromosome 10 loss deletes PTEN and other tumor suppressors."", ""downstream"": [{""description"": ""Chromosome 7 gain increases EGFR and MET copy number"", ""target"": ""EGFR/MET Pathway Activation""}, {""description"": ""Chromosome 10 loss eliminates PTEN"", ""target"": ""PTEN Tumor Suppressor Loss""}], ""name"": ""Chromosome 7 Gain and Chromosome 10 Loss""}"
3132	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	2	EGFR/MET Pathway Activation	EGFR is amplified in 40-50% and MET in 5% of glioblastomas. EGFR amplification is often accompanied by EGFRvIII, a constitutively active deletion variant lacking exons 2-7. These alterations drive proliferation through RAS/RAF/MAPK and PI3K/AKT pathways.																																																								"{""description"": ""EGFR is amplified in 40-50% and MET in 5% of glioblastomas. EGFR amplification is often accompanied by EGFRvIII, a constitutively active deletion variant lacking exons 2-7. These alterations drive proliferation through RAS/RAF/MAPK and PI3K/AKT pathways."", ""name"": ""EGFR/MET Pathway Activation""}"	"{""downstream"": [{""description"": ""Receptor tyrosine kinase signaling drives tumor growth"", ""target"": ""Uncontrolled Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""EGFR is amplified in 40-50% and MET in 5% of glioblastomas. EGFR amplification is often accompanied by EGFRvIII, a constitutively active deletion variant lacking exons 2-7. These alterations drive proliferation through RAS/RAF/MAPK and PI3K/AKT pathways."", ""downstream"": [{""description"": ""Receptor tyrosine kinase signaling drives tumor growth"", ""target"": ""Uncontrolled Cell Proliferation""}], ""name"": ""EGFR/MET Pathway Activation""}"
3133	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	3	PTEN Tumor Suppressor Loss	PTEN loss through chromosome 10 deletion, mutation, or epigenetic silencing occurs in 40-50% of glioblastomas. Loss of PTEN phosphatase activity leads to constitutive PI3K/AKT/mTOR pathway activation, promoting survival and growth.																																																								"{""description"": ""PTEN loss through chromosome 10 deletion, mutation, or epigenetic silencing occurs in 40-50% of glioblastomas. Loss of PTEN phosphatase activity leads to constitutive PI3K/AKT/mTOR pathway activation, promoting survival and growth."", ""name"": ""PTEN Tumor Suppressor Loss""}"	"{""downstream"": [{""description"": ""Loss of PTEN removes brake on PI3K signaling"", ""target"": ""PI3K/AKT/mTOR Pathway Hyperactivation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014067"", ""label"": ""negative regulation of phosphatidylinositol 3-kinase signaling""}}], ""description"": ""PTEN loss through chromosome 10 deletion, mutation, or epigenetic silencing occurs in 40-50% of glioblastomas. Loss of PTEN phosphatase activity leads to constitutive PI3K/AKT/mTOR pathway activation, promoting survival and growth."", ""downstream"": [{""description"": ""Loss of PTEN removes brake on PI3K signaling"", ""target"": ""PI3K/AKT/mTOR Pathway Hyperactivation""}], ""name"": ""PTEN Tumor Suppressor Loss""}"
3134	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	4	PI3K/AKT/mTOR Pathway Hyperactivation	Constitutive PI3K/AKT/mTOR activation through EGFR amplification, PIK3CA mutation, or PTEN loss promotes cell survival, proliferation, metabolism, and angiogenesis. This pathway is active in nearly all glioblastomas.																																																								"{""description"": ""Constitutive PI3K/AKT/mTOR activation through EGFR amplification, PIK3CA mutation, or PTEN loss promotes cell survival, proliferation, metabolism, and angiogenesis. This pathway is active in nearly all glioblastomas."", ""name"": ""PI3K/AKT/mTOR Pathway Hyperactivation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""Constitutive PI3K/AKT/mTOR activation through EGFR amplification, PIK3CA mutation, or PTEN loss promotes cell survival, proliferation, metabolism, and angiogenesis. This pathway is active in nearly all glioblastomas."", ""name"": ""PI3K/AKT/mTOR Pathway Hyperactivation""}"
3135	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	5	Unlimited Replicative Potential	Telomerase reactivation through TERT promoter mutations enables glioblastoma cells to bypass replicative senescence and achieve unlimited proliferative capacity, a hallmark of cancer.																																																								"{""description"": ""Telomerase reactivation through TERT promoter mutations enables glioblastoma cells to bypass replicative senescence and achieve unlimited proliferative capacity, a hallmark of cancer."", ""name"": ""Unlimited Replicative Potential""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Telomerase reactivation through TERT promoter mutations enables glioblastoma cells to bypass replicative senescence and achieve unlimited proliferative capacity, a hallmark of cancer."", ""name"": ""Unlimited Replicative Potential""}"
3136	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	pathophysiology	6	Uncontrolled Cell Proliferation	Multiple converging pathways (RTK signaling, PI3K/AKT/mTOR, cell cycle dysregulation) drive rapid proliferation characteristic of glioblastoma. High mitotic index and proliferation markers (Ki-67 often >20%) are typical.																																																								"{""description"": ""Multiple converging pathways (RTK signaling, PI3K/AKT/mTOR, cell cycle dysregulation) drive rapid proliferation characteristic of glioblastoma. High mitotic index and proliferation markers (Ki-67 often >20%) are typical."", ""name"": ""Uncontrolled Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Multiple converging pathways (RTK signaling, PI3K/AKT/mTOR, cell cycle dysregulation) drive rapid proliferation characteristic of glioblastoma. High mitotic index and proliferation markers (Ki-67 often >20%) are typical."", ""name"": ""Uncontrolled Cell Proliferation""}"
3155	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	0	Decreased G6PD Enzyme Activity	Mutations in the G6PD gene lead to reduced or absent enzyme activity.																																																								"{""description"": ""Mutations in the G6PD gene lead to reduced or absent enzyme activity."", ""name"": ""Decreased G6PD Enzyme Activity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""pentose-phosphate shunt"", ""term"": {""id"": ""GO:0006098"", ""label"": ""pentose-phosphate shunt""}}], ""cell_types"": [{""preferred_term"": ""erythrocyte"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}], ""description"": ""Mutations in the G6PD gene lead to reduced or absent enzyme activity."", ""evidence"": [{""explanation"": ""The snippet confirms that mutations in the G6PD gene lead to reduced enzyme activity."", ""reference"": ""PMID:27040960"", ""snippet"": ""G6PD deficiency, one of the commonest inherited enzyme abnormalities in humans, arises through one of many possible mutations, most of which reduce the stability of the enzyme and its level as red cells age."", ""supports"": ""SUPPORT""}, {""explanation"": ""The excerpt indicates that mutations are identified in G6PD deficiency, implying a link to decreased enzyme activity."", ""reference"": ""PMID:1580603"", ""snippet"": ""Most of the studies have been performed in glucose-6-phosphate dehydrogenase deficiency, where a large number of point mutations have been identified."", ""supports"": ""SUPPORT""}, {""explanation"": ""The snippet clearly states that G6PD deficiency is caused by numerous point mutations."", ""reference"": ""PMID:30279493"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) deficiency, one of the most common human genetic enzymopathies, is caused by over 160 different point mutations."", ""supports"": ""SUPPORT""}, {""explanation"": ""This identifies specific mutations that lead to G6PD deficiency and thus, decreased enzyme activity."", ""reference"": ""PMID:33051526"", ""snippet"": ""The results showed that the overall prevalence of G6PD deficiency in China was 2.10% at the national level. The top six common mutations were c.1388 G>A, c.1376 G>T, c.95 A>G, c.392 G>T, c.871 G>A and c.1024 C>T, accounting for more than 90% of G6PD deficient alleles."", ""supports"": ""SUPPORT""}, {""explanation"": ""Specifically notes that G6PD gene mutations lead to enzyme deficiency."", ""reference"": ""PMID:23275194"", ""snippet"": ""G6PD gene mutations cause deficiency of the enzyme and a large spectrum of diseases."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference discusses the prevalence of G6PD deficiency, indirectly supporting the statement by establishing the link between mutations and enzyme deficiency."", ""reference"": ""PMID:34138756"", ""snippet"": ""Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is the single most common enzymopathy, present in approximately 400 million humans (approximately 5%)."", ""supports"": ""SUPPORT""}, {""explanation"": ""While the primary focus is on PAH, this underscores that decreased G6PD activity results from genetic mutations."", ""reference"": ""PMID:30161219"", ""snippet"": ""As G6PD deficiency was previously reported in a limited number of PAH cases, we tested whether iPAH patients exhibit underlying G6PD alterations in erythrocytes"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""erythrocyte"", ""term"": {""id"": ""UBERON:0000178"", ""label"": ""blood""}}], ""name"": ""Decreased G6PD Enzyme Activity""}"
3156	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	1	Impaired Redox Homeostasis	Reduced G6PD activity leads to decreased production of NADPH, essential for maintaining cellular redox balance.																																																								"{""description"": ""Reduced G6PD activity leads to decreased production of NADPH, essential for maintaining cellular redox balance."", ""name"": ""Impaired Redox Homeostasis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""NADPH regeneration"", ""term"": {""id"": ""GO:0006739"", ""label"": ""NADPH regeneration""}}, {""preferred_term"": ""glutathione metabolic process"", ""term"": {""id"": ""GO:0006749"", ""label"": ""glutathione metabolic process""}}], ""cell_types"": [{""preferred_term"": ""erythrocyte"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}], ""chemical_entities"": [{""preferred_term"": ""NADPH"", ""term"": {""id"": ""CHEBI:16474"", ""label"": ""NADPH""}}, {""preferred_term"": ""glutathione"", ""term"": {""id"": ""CHEBI:16856"", ""label"": ""glutathione""}}], ""description"": ""Reduced G6PD activity leads to decreased production of NADPH, essential for maintaining cellular redox balance."", ""evidence"": [{""explanation"": ""This reference states that G6PD is crucial for generating NADPH, which is essential for maintaining cellular redox balance."", ""reference"": ""PMID:7602782"", ""snippet"": ""Glucose 6-phosphate dehydrogenase (G6PD) plays a key role in the generation of NADPH which is essential for maintaining glutathione in the reduce state, and in the production of ribose 5-phosphate for the synthesis of nucleotides"", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference confirms that adequate G6PD activity is critical for maintaining redox homeostasis by generating NADPH."", ""reference"": ""PMID:31500396"", ""snippet"": ""The generation of reducing equivalent NADPH via glucose-6-phosphate dehydrogenase (G6PD) is critical for the maintenance of redox homeostasis and reductive biosynthesis in cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference indicates that G6PD plays a crucial role in regulating ROS via NADPH production, thus confirming the role of G6PD in maintaining redox balance."", ""reference"": ""PMID:35880537"", ""snippet"": ""However, ROS are regulated by a key enzyme called G6PD via the production of reduced nicotinamide adenine dinucleotide phosphate (NADPH), which controls the generation and removal of ROS in a tissue-specific manner."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference states that G6PD controls metabolic processes in the pentose phosphate pathway, providing NADPH necessary for redox balance."", ""reference"": ""PMID:20484601"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) is an important site of metabolic control in the pentose phosphate pathway (PPP), providing reducing power (NADPH) and pentose phosphates."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired Redox Homeostasis""}"
3157	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	2	Oxidative Stress	Decreased NADPH levels impair the ability of red blood cells to handle oxidative stress, leading to hemolysis.																																																								"{""description"": ""Decreased NADPH levels impair the ability of red blood cells to handle oxidative stress, leading to hemolysis."", ""name"": ""Oxidative Stress""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""cell_types"": [{""preferred_term"": ""erythrocyte"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}], ""chemical_entities"": [{""preferred_term"": ""hydrogen peroxide"", ""term"": {""id"": ""CHEBI:16240"", ""label"": ""hydrogen peroxide""}}], ""description"": ""Decreased NADPH levels impair the ability of red blood cells to handle oxidative stress, leading to hemolysis."", ""evidence"": [{""explanation"": ""The literature confirms that G6PD deficiency disrupts NADPH levels, impairing the cell's ability to handle oxidative stress, which is consistent with the statement."", ""reference"": ""PMID:17623517"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD), the first and rate-limiting enzyme of the pentose phosphate pathway, is indispensable to maintenance of the cytosolic pool of NADPH and thus the cellular redox balance."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study describes how G6PD deficiency leads to impaired management of oxidative stress in red blood cells due to defects in glutathione homeostasis, supporting the statement."", ""reference"": ""PMID:31961822"", ""snippet"": ""Fresh G6PD-deficient RBCs demonstrated defects in the oxidative phase of the pentose phosphate pathway. During refrigerated storage, G6PD-deficient RBCs demonstrated increased glycolysis, impaired glutathione homeostasis, and increased purine oxidation, as compared with G6PD-normal RBCs."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the idea that decreased NADPH levels in G6PD deficiency impair the ability of red blood cells to handle oxidative stress, leading to hemolysis."", ""reference"": ""PMID:19769422"", ""snippet"": ""Numerous drugs, infections, and metabolic conditions have been shown to cause acute hemolysis of red blood cells in the G6PD-deficient patient... The most effective management strategy is to prevent hemolysis by avoiding oxidative stressors."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article confirms that G6PD deficiency amplifies susceptibility to oxidative stress in erythrocytes, leading to hemolysis."", ""reference"": ""PMID:31235029"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an erythrocyte enzyme defect that amplifies the susceptibility of erythrocytes to oxidative stress... Consequently, erythrocyte destruction and hemolysis occur."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although this study mainly discusses other health outcomes, it acknowledges the role of G6PD in generating NADPH, thus supporting the connection to oxidative stress and hemolysis due to deficiency."", ""reference"": ""PMID:11763298"", ""snippet"": ""G6PD generates nicotinamide adenine dinucleotide phosphate (NADPH), a co-factor in the synthesis of nitric oxide... Currently, there are 200 million people worldwide with red cell x-linked chromosome defects who... are at greater risk of developing hypertension or diabetes mellitus than those racial groups without the defect."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""blood"", ""term"": {""id"": ""UBERON:0000178"", ""label"": ""blood""}}, {""preferred_term"": ""spleen"", ""term"": {""id"": ""UBERON:0002106"", ""label"": ""spleen""}}], ""name"": ""Oxidative Stress""}"
3158	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	3	Acute Hemolytic Anemia	Exposure to oxidative stressors, such as certain medications, foods, or infections, can trigger acute episodes of hemolysis.																																																								"{""description"": ""Exposure to oxidative stressors, such as certain medications, foods, or infections, can trigger acute episodes of hemolysis."", ""name"": ""Acute Hemolytic Anemia""}"	"{""downstream"": [{""description"": ""G6PD deficiency renders erythrocytes vulnerable to oxidative stress, leading to acute hemolytic anemia upon exposure to triggers."", ""evidence"": [{""explanation"": ""This paper directly establishes that G6PD enzyme deficiency leads to reduced oxidative stress resistance in erythrocytes, resulting in acute hemolytic anemia."", ""reference"": ""PMID:34389161"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) maintains redox balance in a variety of cell types and is essential for erythrocyte resistance to oxidative stress. G6PD deficiency, caused by mutations in the G6PD gene, is present in ~400 million people worldwide, and can cause acute hemolytic anemia."", ""supports"": ""SUPPORT""}], ""target"": ""Hemolytic Crisis""}]}"	"{""biological_processes"": [{""preferred_term"": ""hemolysis in other organism"", ""term"": {""id"": ""GO:0002937"", ""label"": ""hemolysis in other organism""}}], ""cell_types"": [{""preferred_term"": ""erythrocyte"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}], ""description"": ""Exposure to oxidative stressors, such as certain medications, foods, or infections, can trigger acute episodes of hemolysis."", ""downstream"": [{""description"": ""G6PD deficiency renders erythrocytes vulnerable to oxidative stress, leading to acute hemolytic anemia upon exposure to triggers."", ""evidence"": [{""explanation"": ""This paper directly establishes that G6PD enzyme deficiency leads to reduced oxidative stress resistance in erythrocytes, resulting in acute hemolytic anemia."", ""reference"": ""PMID:34389161"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) maintains redox balance in a variety of cell types and is essential for erythrocyte resistance to oxidative stress. G6PD deficiency, caused by mutations in the G6PD gene, is present in ~400 million people worldwide, and can cause acute hemolytic anemia."", ""supports"": ""SUPPORT""}], ""target"": ""Hemolytic Crisis""}], ""evidence"": [{""explanation"": ""This reference clearly states that G6PD deficiency can lead to hemolysis when exposed to oxidative stressors like infections, certain medications, and foods."", ""reference"": ""PMID:31609781"", ""snippet"": ""The G6PD enzyme is critical to protecting erythrocytes against oxidative stress, and deficiency may lead to hemolysis in the presence of certain environmental factors such as infection and some medications and foods."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract supports the statement by mentioning that G6PD deficiency can trigger acute hemolytic anemia when exposed to specific oxidative stressors."", ""reference"": ""PMID:32600868"", ""snippet"": ""Although most individuals are asymptomatic, exposure to certain food, drugs, or infections can trigger acute hemolytic anemia."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference discusses the mechanism of oxidative stress-mediated hemolysis in individuals with G6PD deficiency, supporting the statement."", ""reference"": ""PMID:31235029"", ""snippet"": ""The possible mechanism of oxidative stress-mediated destruction of erythrocytes in G6PD deficient individuals induced by periodontal infection is highlighted."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference explicitly mentions that certain foods (like fava beans), infections, and drugs can cause acute hemolysis in G6PD-deficient individuals."", ""reference"": ""PMID:33313989"", ""snippet"": ""Ingestion of fava beans, as well as infection and certain drugs, are the most typical causes of acute hemolysis in people with G6PD deficiency."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference confirms that hemolysis in G6PD deficiency can be triggered by certain foods and medications."", ""reference"": ""PMID:30380124"", ""snippet"": ""Although the resulting hemolysis is most often associated with drug exposure, it has also been reported after consumption of certain foods."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""blood"", ""term"": {""id"": ""UBERON:0000178"", ""label"": ""blood""}}, {""preferred_term"": ""spleen"", ""term"": {""id"": ""UBERON:0002106"", ""label"": ""spleen""}}], ""name"": ""Acute Hemolytic Anemia""}"
3181	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	pathophysiology	0	PTCH1 Germline Mutations	PTCH1 encodes Patched 1, a 12-pass transmembrane receptor that normally suppresses Smoothened (SMO) in the absence of Hedgehog ligand. Germline heterozygous loss-of-function mutations in PTCH1 predispose to tumors following Knudson's two-hit model. Loss of the remaining wild-type allele in somatic cells leads to constitutive Hedgehog pathway activation and tumor development.																																																								"{""description"": ""PTCH1 encodes Patched 1, a 12-pass transmembrane receptor that normally suppresses Smoothened (SMO) in the absence of Hedgehog ligand. Germline heterozygous loss-of-function mutations in PTCH1 predispose to tumors following Knudson's two-hit model. Loss of the remaining wild-type allele in somatic cells leads to constitutive Hedgehog pathway activation and tumor development."", ""name"": ""PTCH1 Germline Mutations""}"	"{""downstream"": [{""description"": ""Loss of PTCH1 releases SMO from tonic inhibition"", ""target"": ""Constitutive Hedgehog Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""basal cell of epidermis"", ""term"": {""id"": ""CL:0002187"", ""label"": ""basal cell of epidermis""}}], ""description"": ""PTCH1 encodes Patched 1, a 12-pass transmembrane receptor that normally suppresses Smoothened (SMO) in the absence of Hedgehog ligand. Germline heterozygous loss-of-function mutations in PTCH1 predispose to tumors following Knudson's two-hit model. Loss of the remaining wild-type allele in somatic cells leads to constitutive Hedgehog pathway activation and tumor development."", ""downstream"": [{""description"": ""Loss of PTCH1 releases SMO from tonic inhibition"", ""target"": ""Constitutive Hedgehog Pathway Activation""}], ""evidence"": [{""explanation"": ""Establishes PTCH1 as the causative gene for NBCCS with autosomal dominant inheritance."", ""reference"": ""PMID:19032739"", ""snippet"": ""NBCCS is caused by mutations in the PTCH1 gene and is transmitted as an autosomal dominant trait with complete penetrance and variable expressivity."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms PTCH1 germline variants as the primary genetic cause of Gorlin syndrome."", ""reference"": ""PMID:28596197"", ""snippet"": ""Heterozygous germline variants in PTCH1 and SUFU encoding components of the Sonic hedgehog pathway explain the majority of cases."", ""supports"": ""SUPPORT""}], ""name"": ""PTCH1 Germline Mutations""}"
3182	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	pathophysiology	1	SUFU Germline Mutations	A minority of Gorlin syndrome cases (approximately 5%) are caused by germline mutations in SUFU (Suppressor of Fused), which encodes a negative regulator of GLI transcription factors. SUFU mutations are associated with markedly higher risk of medulloblastoma (up to 20-fold higher) compared to PTCH1 mutations, with tumors typically occurring before age 3 years.																																																								"{""description"": ""A minority of Gorlin syndrome cases (approximately 5%) are caused by germline mutations in SUFU (Suppressor of Fused), which encodes a negative regulator of GLI transcription factors. SUFU mutations are associated with markedly higher risk of medulloblastoma (up to 20-fold higher) compared to PTCH1 mutations, with tumors typically occurring before age 3 years."", ""name"": ""SUFU Germline Mutations""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of smoothened signaling pathway"", ""term"": {""id"": ""GO:0045879"", ""label"": ""negative regulation of smoothened signaling pathway""}}], ""description"": ""A minority of Gorlin syndrome cases (approximately 5%) are caused by germline mutations in SUFU (Suppressor of Fused), which encodes a negative regulator of GLI transcription factors. SUFU mutations are associated with markedly higher risk of medulloblastoma (up to 20-fold higher) compared to PTCH1 mutations, with tumors typically occurring before age 3 years."", ""evidence"": [{""explanation"": ""Demonstrates that SUFU mutations confer dramatically higher medulloblastoma risk than PTCH1 mutations."", ""reference"": ""PMID:25403219"", ""snippet"": ""We found a < 2% risk in PTCH1 mutation-positive individuals, with a risk up to 20 higher in SUFU mutation-positive individuals."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms high medulloblastoma risk and poor prognosis in SUFU mutation carriers."", ""reference"": ""PMID:29186568"", ""snippet"": ""Germline SUFU mutations strongly predispose to medulloblastoma in the first years of life, with worse prognosis than usually observed for SHH medulloblastoma."", ""supports"": ""SUPPORT""}], ""name"": ""SUFU Germline Mutations""}"
3183	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	pathophysiology	2	Constitutive Hedgehog Pathway Activation	Loss of PTCH1 function or SUFU mutations result in constitutive activation of the Hedgehog signaling cascade. Without functional PTCH1, Smoothened is no longer suppressed and activates GLI transcription factors, driving expression of target genes involved in proliferation, survival, and developmental patterning.																																																								"{""description"": ""Loss of PTCH1 function or SUFU mutations result in constitutive activation of the Hedgehog signaling cascade. Without functional PTCH1, Smoothened is no longer suppressed and activates GLI transcription factors, driving expression of target genes involved in proliferation, survival, and developmental patterning."", ""name"": ""Constitutive Hedgehog Pathway Activation""}"	"{""downstream"": [{""description"": ""Hedgehog pathway activation in skin basal cells leads to tumor development"", ""target"": ""Multiple Basal Cell Carcinomas""}, {""description"": ""Hedgehog pathway dysregulation affects dental development"", ""target"": ""Odontogenic Keratocysts""}, {""description"": ""Cerebellar granule cell progenitors are Hedgehog-dependent"", ""target"": ""Medulloblastoma Risk""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}], ""description"": ""Loss of PTCH1 function or SUFU mutations result in constitutive activation of the Hedgehog signaling cascade. Without functional PTCH1, Smoothened is no longer suppressed and activates GLI transcription factors, driving expression of target genes involved in proliferation, survival, and developmental patterning."", ""downstream"": [{""description"": ""Hedgehog pathway activation in skin basal cells leads to tumor development"", ""target"": ""Multiple Basal Cell Carcinomas""}, {""description"": ""Hedgehog pathway dysregulation affects dental development"", ""target"": ""Odontogenic Keratocysts""}, {""description"": ""Cerebellar granule cell progenitors are Hedgehog-dependent"", ""target"": ""Medulloblastoma Risk""}], ""name"": ""Constitutive Hedgehog Pathway Activation""}"
3214	134	Gout	Gout.yaml	pathophysiology	0	Hyperuricemia	"Elevated serum uric acid from increased purine metabolism or decreased renal excretion leads to supersaturation and crystal formation. Urate is the end product of purine catabolism in humans.
"																																																								"{""description"": ""Elevated serum uric acid from increased purine metabolism or decreased renal excretion leads to supersaturation and crystal formation. Urate is the end product of purine catabolism in humans.\n"", ""name"": ""Hyperuricemia""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Purine Metabolism"", ""term"": {""id"": ""GO:0006144"", ""label"": ""purine nucleobase metabolic process""}}], ""description"": ""Elevated serum uric acid from increased purine metabolism or decreased renal excretion leads to supersaturation and crystal formation. Urate is the end product of purine catabolism in humans.\n"", ""evidence"": [{""explanation"": ""Establishes that hyperuricemia-driven MSU crystallization is the fundamental pathological process in gout."", ""reference"": ""PMID:38972919"", ""snippet"": ""Crystallization of monosodium urate monohydrate (MSU) leads to painful gouty arthritis."", ""supports"": ""SUPPORT""}], ""name"": ""Hyperuricemia""}"
3215	134	Gout	Gout.yaml	pathophysiology	1	Crystal Deposition	"Monosodium urate (MSU) crystals deposit in joints and soft tissues when serum urate exceeds saturation point (~6.8 mg/dL). Crystals trigger inflammatory response.
"																																																								"{""description"": ""Monosodium urate (MSU) crystals deposit in joints and soft tissues when serum urate exceeds saturation point (~6.8 mg/dL). Crystals trigger inflammatory response.\n"", ""name"": ""Crystal Deposition""}"	{}	"{""description"": ""Monosodium urate (MSU) crystals deposit in joints and soft tissues when serum urate exceeds saturation point (~6.8 mg/dL). Crystals trigger inflammatory response.\n"", ""evidence"": [{""explanation"": ""Describes the non-classical crystallization pathway where MSU forms via an amorphous precursor on damaged cartilage collagen, explaining the anatomical specificity of crystal deposition."", ""reference"": ""PMID:38972919"", ""snippet"": ""inflammatory MSU crystals form after a non-inflammatory amorphous precursor (AMSU) that nucleates heterogeneously on collagen fibrils from damaged articular cartilage of gout patients"", ""supports"": ""SUPPORT""}, {""explanation"": ""Characterizes the unique structural properties of pathological MSU crystals that form in vivo at low supersaturation over extended time periods."", ""reference"": ""PMID:38972919"", ""snippet"": ""This non-classical crystallization route imprints a nanogranular structure to biogenic acicular MSU crystals, which have smaller unit cell volume, lower microstrain, and higher crystallinity than synthetic MSU."", ""supports"": ""SUPPORT""}], ""name"": ""Crystal Deposition""}"
3216	134	Gout	Gout.yaml	pathophysiology	2	Inflammasome Activation	"MSU crystals are phagocytosed by macrophages, activating NLRP3 inflammasome and triggering IL-1beta release, driving acute inflammatory flare.
"																																																								"{""description"": ""MSU crystals are phagocytosed by macrophages, activating NLRP3 inflammasome and triggering IL-1beta release, driving acute inflammatory flare.\n"", ""name"": ""Inflammasome Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammasome Activation"", ""term"": {""id"": ""GO:0072559"", ""label"": ""NLRP3 inflammasome complex assembly""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""MSU crystals are phagocytosed by macrophages, activating NLRP3 inflammasome and triggering IL-1beta release, driving acute inflammatory flare.\n"", ""evidence"": [{""explanation"": ""Establishes the central role of macrophages in initiating and propagating the acute inflammatory response to MSU crystals in gout."", ""reference"": ""PMID:39386881"", ""snippet"": ""Gout represents an autoinflammatory disorder instigated by monosodium urate crystals. Its primary manifestation involves the recruitment of diverse immune cell populations, including neutrophils and macrophages. Macrophages assume a pivotal role in the initiation of acute gouty inflammation and subsequent inflammatory cascades."", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates that macrophages have complex, context-dependent roles in both promoting and resolving gouty inflammation depending on their polarization state."", ""reference"": ""PMID:39386881"", ""snippet"": ""Macrophages, characterized by different subtypes, exhibit distinct functionalities that either contribute to the progression or regression of gout."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows that effective urate-lowering therapy modulates immune cell proteomes, including those relevant to inflammasome activation, correlating with reduced flare burden."", ""reference"": ""PMID:39426967"", ""snippet"": ""At 48 weeks ULT, serum urate normalized in all gout patients, and flares declined in association with significantly altered proteins (p < 0.05) in clustering and proteome networks in sera and peripheral blood mononuclear cells."", ""supports"": ""SUPPORT""}], ""name"": ""Inflammasome Activation""}"
3217	134	Gout	Gout.yaml	pathophysiology	3	Neutrophil Recruitment	"IL-1beta and other cytokines recruit neutrophils to the joint, amplifying inflammation and causing the intense pain and swelling of acute gout attacks.
"																																																								"{""description"": ""IL-1beta and other cytokines recruit neutrophils to the joint, amplifying inflammation and causing the intense pain and swelling of acute gout attacks.\n"", ""name"": ""Neutrophil Recruitment""}"	{}	"{""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""IL-1beta and other cytokines recruit neutrophils to the joint, amplifying inflammation and causing the intense pain and swelling of acute gout attacks.\n"", ""evidence"": [{""explanation"": ""Confirms that neutrophil recruitment is a primary feature of the acute gouty inflammatory response."", ""reference"": ""PMID:39386881"", ""snippet"": ""Its primary manifestation involves the recruitment of diverse immune cell populations, including neutrophils and macrophages."", ""supports"": ""SUPPORT""}, {""explanation"": ""Identifies IL-1B and CXCL8 as key mediators in the serum interactome associated with gouty inflammation, supporting their role in neutrophil recruitment and activation."", ""reference"": ""PMID:39426967"", ""snippet"": ""In both cohorts, a treatment-emergent serum interactome included key gouty inflammation mediators (C5, IL-1B, CXCL8, IL6)."", ""supports"": ""SUPPORT""}], ""name"": ""Neutrophil Recruitment""}"
3218	134	Gout	Gout.yaml	pathophysiology	4	Complement Activation	"MSU crystals activate the complement system, particularly C5, contributing to neutrophil recruitment and amplifying the inflammatory response. Effective urate-lowering therapy modulates complement and inflammatory protein networks.
"																																																								"{""description"": ""MSU crystals activate the complement system, particularly C5, contributing to neutrophil recruitment and amplifying the inflammatory response. Effective urate-lowering therapy modulates complement and inflammatory protein networks.\n"", ""name"": ""Complement Activation""}"	{}	"{""description"": ""MSU crystals activate the complement system, particularly C5, contributing to neutrophil recruitment and amplifying the inflammatory response. Effective urate-lowering therapy modulates complement and inflammatory protein networks.\n"", ""evidence"": [{""explanation"": ""Demonstrates that complement activation pathways are altered in gout and modulated by effective urate-lowering therapy."", ""reference"": ""PMID:39426967"", ""snippet"": ""Sera demonstrated altered complement activation and regulatory gene ontology biologic processes."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows that reduction in gout flares correlates with changes in complement activation pathways, establishing complement as a key therapeutic target and biomarker."", ""reference"": ""PMID:39426967"", ""snippet"": ""Reduced gout flares are linked with a XOI treatment-emergent serum protein interactome that includes inflammation regulators, associated with altered complement activation and regulatory biologic processes."", ""supports"": ""SUPPORT""}, {""explanation"": ""Provides mechanistic evidence that xanthine oxidase inhibitors directly modulate complement activation in macrophages beyond their urate-lowering effects."", ""reference"": ""PMID:39426967"", ""snippet"": ""Last, febuxostat treatment decreased complement activation biologic process proteins in cultured BMDMs."", ""supports"": ""SUPPORT""}], ""name"": ""Complement Activation""}"
3219	134	Gout	Gout.yaml	pathophysiology	5	Neutrophil Extracellular Trap Formation	"Neutrophils form extracellular traps (NETs) in response to MSU crystals. NETs initially amplify inflammation but aggregated NETs (aggNETs) promote resolution by encapsulating crystals, degrading cytokines, and blocking further neutrophil recruitment. NETs also contribute to tophi formation.
"																																																								"{""description"": ""Neutrophils form extracellular traps (NETs) in response to MSU crystals. NETs initially amplify inflammation but aggregated NETs (aggNETs) promote resolution by encapsulating crystals, degrading cytokines, and blocking further neutrophil recruitment. NETs also contribute to tophi formation.\n"", ""name"": ""Neutrophil Extracellular Trap Formation""}"	{}	"{""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Neutrophils form extracellular traps (NETs) in response to MSU crystals. NETs initially amplify inflammation but aggregated NETs (aggNETs) promote resolution by encapsulating crystals, degrading cytokines, and blocking further neutrophil recruitment. NETs also contribute to tophi formation.\n"", ""evidence"": [{""explanation"": ""Describes the dual role of NETs in gout - initially amplifying inflammation but then promoting resolution through aggregation and sequestration mechanisms."", ""reference"": ""PMID:38910565"", ""snippet"": ""Neutrophil extracellular traps (NETs) are formed by neutrophils in response to pathogen attack. During gout, NETs induced by MSU crystals exacerbate inflammation, and aggregated NETs (aggNETs) promote the resolution of gout-associated inflammation by encapsulating MSU crystals, degrading cytokines and chemokines, and blocking the recruitment and activation of neutrophils."", ""supports"": ""SUPPORT""}, {""explanation"": ""Establishes the role of NETs in chronic gout pathology, specifically in the formation of tophi (urate crystal deposits)."", ""reference"": ""PMID:38910565"", ""snippet"": ""With disease progression, NETs participate in the formation of tophi."", ""supports"": ""SUPPORT""}, {""explanation"": ""Identifies aggregated NETs as a key mechanism underlying the self-limited nature of acute gout flares and spontaneous resolution."", ""reference"": ""PMID:38910565"", ""snippet"": ""Therefore, aggNETs are a possible mechanism of spontaneous gout regression."", ""supports"": ""SUPPORT""}], ""name"": ""Neutrophil Extracellular Trap Formation""}"
3232	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	0	YY1AP1 Loss-of-Function and INO80 Chromatin Remodeling Complex Disruption	Biallelic loss-of-function mutations in YY1AP1 disrupt the INO80 ATP-dependent chromatin-remodeling complex, impairing transcriptional programs essential for vascular smooth muscle cell (VSMC) differentiation and homeostasis.																																																								"{""description"": ""Biallelic loss-of-function mutations in YY1AP1 disrupt the INO80 ATP-dependent chromatin-remodeling complex, impairing transcriptional programs essential for vascular smooth muscle cell (VSMC) differentiation and homeostasis."", ""name"": ""YY1AP1 Loss-of-Function and INO80 Chromatin Remodeling Complex Disruption""}"	{}	"{""biological_processes"": [{""preferred_term"": ""chromatin remodeling"", ""term"": {""id"": ""GO:0006338"", ""label"": ""chromatin remodeling""}}, {""preferred_term"": ""transcriptional regulation"", ""term"": {""id"": ""GO:0006355"", ""label"": ""regulation of transcription, DNA-templated""}}], ""description"": ""Biallelic loss-of-function mutations in YY1AP1 disrupt the INO80 ATP-dependent chromatin-remodeling complex, impairing transcriptional programs essential for vascular smooth muscle cell (VSMC) differentiation and homeostasis."", ""evidence"": [{""explanation"": ""Guo et al. 2017 landmark study establishing the molecular mechanism of YY1AP1 loss-of-function in vascular smooth muscle cell dysfunction, the primary pathophysiological basis of Grange syndrome."", ""reference"": ""PMID:27939641"", ""snippet"": ""Loss of YY1AP1 in vascular smooth muscle cells leads to cell cycle arrest with decreased proliferation and increased levels of the cell cycle regulator p21/WAF/CDKN1A and disrupts TGF--driven differentiation of smooth muscle cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""Raggio et al. 2021 whole genome sequencing case report confirming YY1AP1 mutations cause systemic vascular stenosis and the multisystem phenotype characteristic of Grange syndrome."", ""reference"": ""PMID:33971976"", ""snippet"": ""This gene is related to Grange syndrome, a recessive rare disease, whose symptoms include stenosis or occlusion of multiple arteries, congenital heart defects, brachydactyly, syndactyly, bone fragility, and learning disabilities."", ""supports"": ""SUPPORT""}, {""explanation"": ""Karakaya et al. 2023 case report of the youngest documented patient with Grange syndrome confirming the characteristic vascular manifestations resulting from YY1AP1 loss-of-function."", ""reference"": ""PMID:37323195"", ""snippet"": ""Grange syndrome (OMIM 602531) is characterized by a constellation of symptoms of hypertension, stenosis, or occlusion of different arteries (including the cerebral, renal, abdominal, and coronary vessels) with a variable occurrence of brachysyndactyly, bone fragility, and congenital heart defects."", ""supports"": ""SUPPORT""}, {""explanation"": ""Volonghi et al. 2012 documents severe cerebrovascular complications including subarachnoid hemorrhage from basilar artery aneurysm in an 18-year-old Grange syndrome patient, demonstrating the serious neurological sequelae of YY1AP1-mediated vascular disease."", ""reference"": ""PMID:22987684"", ""snippet"": ""We report on the case of an 18-year-old female presenting with subarachnoid hemorrhage due to the rupture of a basilar artery aneurysm, and with distinctive systemic features including extensive vasculopathy, facial dysmorphisms and brachysyndactyly, consistent with the diagnosis of Grange syndrome."", ""supports"": ""SUPPORT""}], ""name"": ""YY1AP1 Loss-of-Function and INO80 Chromatin Remodeling Complex Disruption""}"
3233	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	1	Vascular Smooth Muscle Cell Dysfunction and Arterial Stenosis	Loss of YY1AP1 in vascular smooth muscle cells leads to increased p21/CDKN1A levels, G1/G2 cell-cycle arrest, reduced VSMC proliferation, and impaired TGF--driven upregulation of contractile markers (SM -actin, SM22, calponin), resulting in focal stenoses and occlusions in multiple arterial beds. Progressive vascular disease can lead to ischemic and hemorrhagic stroke, myocardial infarction, and other thrombovascular complications.																																																								"{""description"": ""Loss of YY1AP1 in vascular smooth muscle cells leads to increased p21/CDKN1A levels, G1/G2 cell-cycle arrest, reduced VSMC proliferation, and impaired TGF--driven upregulation of contractile markers (SM -actin, SM22, calponin), resulting in focal stenoses and occlusions in multiple arterial beds. Progressive vascular disease can lead to ischemic and hemorrhagic stroke, myocardial infarction, and other thrombovascular complications."", ""name"": ""Vascular Smooth Muscle Cell Dysfunction and Arterial Stenosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""smooth muscle cell differentiation"", ""term"": {""id"": ""GO:0051145"", ""label"": ""smooth muscle cell differentiation""}}, {""preferred_term"": ""cell cycle arrest"", ""term"": {""id"": ""GO:0007050"", ""label"": ""cell cycle arrest""}}], ""description"": ""Loss of YY1AP1 in vascular smooth muscle cells leads to increased p21/CDKN1A levels, G1/G2 cell-cycle arrest, reduced VSMC proliferation, and impaired TGF--driven upregulation of contractile markers (SM -actin, SM22, calponin), resulting in focal stenoses and occlusions in multiple arterial beds. Progressive vascular disease can lead to ischemic and hemorrhagic stroke, myocardial infarction, and other thrombovascular complications."", ""evidence"": [{""explanation"": ""Guo et al. 2017 landmark mechanistic study demonstrating cellular basis of YY1AP1 loss-of-function in VSMC dysfunction."", ""reference"": ""PMID:27939641"", ""snippet"": ""Loss of YY1AP1 in vascular smooth muscle cells leads to cell cycle arrest with decreased proliferation and increased levels of the cell cycle regulator p21/WAF/CDKN1A and disrupts TGF--driven differentiation of smooth muscle cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""Raggio et al. 2021 case report confirming systemic vascular stenosis as cardinal manifestation of YY1AP1 loss-of-function."", ""reference"": ""PMID:33971976"", ""snippet"": ""This gene is related to Grange syndrome, a recessive rare disease, whose symptoms include stenosis or occlusion of multiple arteries, congenital heart defects, brachydactyly, syndactyly, bone fragility, and learning disabilities."", ""supports"": ""SUPPORT""}, {""explanation"": ""Saida et al. 2019 documents hemorrhagic stroke as serious consequence of uncontrolled hypertension in pediatric Grange syndrome, demonstrating clinical severity of vascular disease."", ""reference"": ""PMID:31270375"", ""snippet"": ""Renovascular hypertension (RVH) is one of the major causes of secondary hypertension in children... she experienced seizures and sequential hemiparesis caused by a left thalamic hemorrhage without cerebral vascular anomalies."", ""supports"": ""SUPPORT""}], ""name"": ""Vascular Smooth Muscle Cell Dysfunction and Arterial Stenosis""}"
3252	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	0	ANCA-Mediated Neutrophil Activation	Anti-proteinase 3 (PR3) antibodies bind to primed neutrophils, causing activation, degranulation, and release of reactive oxygen species and lytic enzymes. This causes direct endothelial damage and vessel wall necrosis.																																																								"{""description"": ""Anti-proteinase 3 (PR3) antibodies bind to primed neutrophils, causing activation, degranulation, and release of reactive oxygen species and lytic enzymes. This causes direct endothelial damage and vessel wall necrosis."", ""name"": ""ANCA-Mediated Neutrophil Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Neutrophil Activation"", ""term"": {""id"": ""GO:0042119"", ""label"": ""neutrophil activation""}}], ""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Anti-proteinase 3 (PR3) antibodies bind to primed neutrophils, causing activation, degranulation, and release of reactive oxygen species and lytic enzymes. This causes direct endothelial damage and vessel wall necrosis."", ""evidence"": [{""explanation"": ""This review confirms that ANCA-mediated neutrophil activation is a central pathogenic mechanism in AAV, leading to ROS release and vascular injury."", ""reference"": ""PMID:37781373"", ""snippet"": ""The pathogenesis of AAV includes ANCA-mediated neutrophil activation, subsequent release of inflammatory cytokines and reactive oxygen species (ROS), and formation of neutrophil extracellular traps (NETs)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This review describes neutrophil activation as a key mechanism in pulmonary manifestations of GPA, involving ANCA-triggered neutrophil responses."", ""reference"": ""PMID:38791316"", ""snippet"": ""Mechanisms involving ANCA and anti-GBM autoantibodies, neutrophil activation, and neutrophil extracellular trap (NETs) formation are discussed, along with the role of the complement system in inducing pulmonary injury."", ""supports"": ""SUPPORT""}], ""name"": ""ANCA-Mediated Neutrophil Activation""}"
3253	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	1	Granuloma Formation	Granulomatous inflammation with multinucleated giant cells, epithelioid macrophages, and necrosis affects the respiratory tract. T cells and macrophages organize into granulomas that destroy tissue.																																																								"{""description"": ""Granulomatous inflammation with multinucleated giant cells, epithelioid macrophages, and necrosis affects the respiratory tract. T cells and macrophages organize into granulomas that destroy tissue."", ""name"": ""Granuloma Formation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Granulomatous inflammation with multinucleated giant cells, epithelioid macrophages, and necrosis affects the respiratory tract. T cells and macrophages organize into granulomas that destroy tissue."", ""evidence"": [{""explanation"": ""This review discusses the granulomatous inflammation characteristic of GPA, particularly in the respiratory tract."", ""reference"": ""PMID:38791316"", ""snippet"": ""This review explored the underlying pathogenesis of pulmonary involvement in vasculitis, encompassing various forms such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and anti-GBM disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""This review describes GPA as a distinct entity with granulomatous features affecting multiple organ systems including the respiratory tract."", ""reference"": ""PMID:35479831"", ""snippet"": ""The ANCA associated vasculitides (AAVs) affect a range of internal organs including ear nose and throat, respiratory tract, kidneys, skin and nervous system. They include granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA) and microscopic polyangiitis (MPA)."", ""supports"": ""SUPPORT""}], ""name"": ""Granuloma Formation""}"
3254	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	2	Complement Alternative Pathway Activation	The alternative complement pathway amplifies inflammation in GPA. C5a recruits and activates neutrophils, creating a positive feedback loop of vascular damage.																																																								"{""description"": ""The alternative complement pathway amplifies inflammation in GPA. C5a recruits and activates neutrophils, creating a positive feedback loop of vascular damage."", ""name"": ""Complement Alternative Pathway Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""description"": ""The alternative complement pathway amplifies inflammation in GPA. C5a recruits and activates neutrophils, creating a positive feedback loop of vascular damage."", ""evidence"": [{""explanation"": ""This review confirms the role of the complement system in amplifying ANCA-mediated vascular injury in GPA."", ""reference"": ""PMID:38791316"", ""snippet"": ""Mechanisms involving ANCA and anti-GBM autoantibodies, neutrophil activation, and neutrophil extracellular trap (NETs) formation are discussed, along with the role of the complement system in inducing pulmonary injury."", ""supports"": ""SUPPORT""}, {""explanation"": ""This review describes how complement factors, particularly C5a, prime neutrophils for ANCA-mediated activation, validating the complement pathway as a therapeutic target."", ""reference"": ""PMID:37781373"", ""snippet"": ""Mechanistically, cytokines or complement factors activate and prime neutrophils for ANCA-binding; thus, C5a receptor blocker has garnered attention as potential replacement for glucocorticoids in clinical settings."", ""supports"": ""SUPPORT""}], ""name"": ""Complement Alternative Pathway Activation""}"
3277	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	0	Autoantibody Production	The immune system produces thyroid-stimulating immunoglobulins (TSIs) that mimic the activity of thyroid-stimulating hormone (TSH), leading to an overactive thyroid.																																																								"{""description"": ""The immune system produces thyroid-stimulating immunoglobulins (TSIs) that mimic the activity of thyroid-stimulating hormone (TSH), leading to an overactive thyroid."", ""name"": ""Autoantibody Production""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cAMP-mediated signaling"", ""term"": {""id"": ""GO:0019933"", ""label"": ""cAMP-mediated signaling""}}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""The immune system produces thyroid-stimulating immunoglobulins (TSIs) that mimic the activity of thyroid-stimulating hormone (TSH), leading to an overactive thyroid."", ""evidence"": [{""explanation"": ""The literature confirms the role of B cells in producing autoantibodies that stimulate the thyroid, but it does not explicitly mention thyroid-stimulating immunoglobulins (TSIs)."", ""reference"": ""PMID:37047805"", ""snippet"": ""The disease is primarily mediated by B cells, which produce autoantibodies against the thyroid-stimulating hormone receptor (TSHR), chronically stimulating it and leading to high levels of thyroid hormones in the body."", ""supports"": ""PARTIAL""}, {""explanation"": ""The literature confirms that thyroid-stimulating antibodies (TSAb) cause overactivity of the thyroid, but it does not explicitly mention T cells or the term 'thyroid-stimulating immunoglobulins (TSIs)'."", ""reference"": ""PMID:1356056"", ""snippet"": ""In the former, there is overactivity of the thyroid due to the action of a thyroid-stimulating antibody (TSAb)."", ""supports"": ""PARTIAL""}, {""explanation"": ""The literature confirms the presence of thyroid-stimulating immunoglobulins (TSIs) in Graves' disease but does not explicitly mention the involvement of T cells."", ""reference"": ""PMID:6129186"", ""snippet"": ""The presence of thyroid-stimulating immunoglobulins in patients with Graves' disease is well established."", ""supports"": ""PARTIAL""}, {""explanation"": ""The literature confirms that IgG autoantibodies (which include TSIs) activate the thyrotropin receptor, leading to overactive thyroid function."", ""reference"": ""PMID:9534029"", ""snippet"": ""Graves' disease, one of the autoimmune thyroid diseases, is caused by the production of IgG autoantibodies directed against the thyrotropin receptor. These antibodies bind to and activate the receptor, causing the autonomous production of thyroid hormones."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature confirms that thyroid-stimulating autoantibodies mimic TSH action, leading to an overactive thyroid."", ""reference"": ""PMID:14654350"", ""snippet"": ""In Graves' disease, thyroid-stimulating autoantibodies can mimic TSH action and stimulate thyroid cells. This leads to hyperthyroidism and abnormal overproduction of thyroid hormone."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}], ""name"": ""Autoantibody Production""}"
3278	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	1	Thyroid Overactivity	Excessive stimulation of the thyroid gland results in increased production of thyroid hormones (thyroxine, T4, and triiodothyronine, T3).																																																								"{""description"": ""Excessive stimulation of the thyroid gland results in increased production of thyroid hormones (thyroxine, T4, and triiodothyronine, T3)."", ""name"": ""Thyroid Overactivity""}"	"{""downstream"": [{""target"": ""Hyperthyroidism""}]}"	"{""biological_processes"": [{""preferred_term"": ""thyroid hormone biosynthetic process"", ""term"": {""id"": ""GO:0006590"", ""label"": ""thyroid hormone generation""}}], ""description"": ""Excessive stimulation of the thyroid gland results in increased production of thyroid hormones (thyroxine, T4, and triiodothyronine, T3)."", ""downstream"": [{""target"": ""Hyperthyroidism""}], ""evidence"": [{""explanation"": ""The reference supports the statement that excessive stimulation of the thyroid gland in Graves' Disease results in increased production of thyroid hormones (T4 and T3), leading to hyperthyroidism."", ""reference"": ""PMID:14654350"", ""snippet"": ""In Graves' disease, thyroid-stimulating autoantibodies can mimic TSH action and stimulate thyroid cells. This leads to hyperthyroidism and abnormal overproduction of thyroid hormone."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the statement by listing Graves' disease as a common cause of hyperthyroidism due to the increased production of thyroid hormones."", ""reference"": ""PMID:17380820"", ""snippet"": ""Common causes are Graves' disease, toxic multinodular goitre and toxic solitary nodule. Excess thyroid hormones in the circulation are also found in thyroiditis (hormone leakage) and excess exogenous thyroxine intake."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the statement by indicating the role of immune cells in the thyroid gland's overactivity in Graves' disease, contributing to the excessive production of thyroid hormones."", ""reference"": ""PMID:9292944"", ""snippet"": ""BCGF production by T cells from the thyroid or peripheral blood of Graves' patients, in the absence or presence of PHA, was significantly greater than that by peripheral T cells from healthy controls."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the statement by describing how Graves' disease leads to hyperthyroidism through excessive stimulation of the thyroid gland, resulting in increased production of thyroid hormones."", ""reference"": ""PMID:24126481"", ""snippet"": ""Graves disease is an autoimmune disorder characterized by goitre, hyperthyroidism and, in 25% of patients, Graves ophthalmopathy. The hyperthyroidism is caused by thyroid hypertrophy and stimulation of function, resulting from interaction of anti-TSH-receptor antibodies (TRAb) with the TSH receptor on thyroid follicular cells."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}], ""name"": ""Thyroid Overactivity""}"
3279	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	2	Immune System Dysregulation	Dysregulated immune response leads to autoimmune attacks on the thyroid gland.																																																								"{""description"": ""Dysregulated immune response leads to autoimmune attacks on the thyroid gland."", ""name"": ""Immune System Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}, {""preferred_term"": ""T follicular helper cell"", ""term"": {""id"": ""CL:0002038"", ""label"": ""T follicular helper cell""}}, {""preferred_term"": ""CD4-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}, {""preferred_term"": ""regulatory T cell"", ""term"": {""id"": ""CL:0000815"", ""label"": ""regulatory T cell""}}], ""description"": ""Dysregulated immune response leads to autoimmune attacks on the thyroid gland."", ""evidence"": [{""explanation"": ""This reference supports the involvement of both B cells and T cells in the dysregulated immune response leading to autoimmune attacks on the thyroid gland in Graves' disease."", ""reference"": ""PMID:37047805"", ""snippet"": ""The disease is primarily mediated by B cells, which produce autoantibodies against the thyroid-stimulating hormone receptor (TSHR)... T cell populations are markedly distinct, including increased levels of Th17 and follicular helper T cells (Tfh), while Treg cells appear to be impaired."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the involvement of T cells and B cells (through autoantibodies) in the immune dysregulation associated with Graves' disease."", ""reference"": ""PMID:37515444"", ""snippet"": ""The incidence of autoimmune thyroid diseases, such as subacute thyroiditis, Graves' disease, and Hashimoto's thyroiditis, increases in individuals with COVID-19 infection. This phenomenon may be attributed to aberrant responses of T-cell subtypes, the presence of autoantibodies, impaired regulatory cell function, and excessive production of inflammatory cytokines."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the role of B cells (through autoantibodies) and T cells in the autoimmune attack on the thyroid gland in Graves' disease."", ""reference"": ""PMID:21850926"", ""snippet"": ""The autoimmunity to the thyroid gland mainly consists of Hashimato thyroiditis and Grave's disease... The thyroid stimulating hormone receptor, thyroglobuline, enzymes of thyroid hormones synthesis are targeted by autoantibodies and cell- mediated reactions."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the involvement of immune cells in the pathology of Graves' disease, indicating immune system dysregulation."", ""reference"": ""PMID:24802957"", ""snippet"": ""Dendritic cells (DCs), considered as one of the crucial immune regulatory populations, are implicated in the immune pathology of various disorders... including Hashimoto's thyroiditis and Graves' disease."", ""supports"": ""SUPPORT""}], ""name"": ""Immune System Dysregulation""}"
3280	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	3	TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts	In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis.																																		TSHR-IGF1R crosstalk explains the pathophysiology of Graves' orbitopathy (thyroid eye disease) affecting 25-50% of patients.																						"{""description"": ""In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis."", ""name"": ""TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts"", ""notes"": ""TSHR-IGF1R crosstalk explains the pathophysiology of Graves' orbitopathy (thyroid eye disease) affecting 25-50% of patients.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cAMP-mediated signaling"", ""term"": {""id"": ""GO:0019933"", ""label"": ""cAMP-mediated signaling""}}, {""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}, {""preferred_term"": ""adipocyte differentiation"", ""term"": {""id"": ""GO:0045444"", ""label"": ""adipocyte differentiation""}}, {""preferred_term"": ""hyaluronan biosynthetic process"", ""term"": {""id"": ""GO:0030213"", ""label"": ""hyaluronan biosynthetic process""}}, {""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""cell_types"": [{""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}], ""description"": ""In thyroid eye disease, cooperative signaling between thyrotropin receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) on orbital fibroblasts drives hyaluronan production, adipogenesis, and tissue remodeling causing proptosis."", ""locations"": [{""preferred_term"": ""orbit"", ""term"": {""id"": ""UBERON:0001697"", ""label"": ""orbit""}}, {""preferred_term"": ""extraocular muscle"", ""term"": {""id"": ""UBERON:0001576"", ""label"": ""extraocular muscle""}}], ""name"": ""TSHR-IGF1R Receptor Crosstalk in Orbital Fibroblasts"", ""notes"": ""TSHR-IGF1R crosstalk explains the pathophysiology of Graves' orbitopathy (thyroid eye disease) affecting 25-50% of patients.""}"
3281	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	4	Germinal Center Autoantibody Production	CD40-CD40L interactions between T follicular helper cells and B cells drive germinal center formation and affinity maturation of TRAb-producing B cells with oligoclonal expansion and epitope spreading.																																		Intrathyroidal germinal centers are a hallmark feature of Graves' disease pathophysiology.																						"{""description"": ""CD40-CD40L interactions between T follicular helper cells and B cells drive germinal center formation and affinity maturation of TRAb-producing B cells with oligoclonal expansion and epitope spreading."", ""name"": ""Germinal Center Autoantibody Production"", ""notes"": ""Intrathyroidal germinal centers are a hallmark feature of Graves' disease pathophysiology.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}, {""preferred_term"": ""adaptive immune response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}, {""preferred_term"": ""germinal center formation"", ""term"": {""id"": ""GO:0002467"", ""label"": ""germinal center formation""}}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}, {""preferred_term"": ""T follicular helper cell"", ""term"": {""id"": ""CL:0002038"", ""label"": ""T follicular helper cell""}}], ""description"": ""CD40-CD40L interactions between T follicular helper cells and B cells drive germinal center formation and affinity maturation of TRAb-producing B cells with oligoclonal expansion and epitope spreading."", ""locations"": [{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}], ""name"": ""Germinal Center Autoantibody Production"", ""notes"": ""Intrathyroidal germinal centers are a hallmark feature of Graves' disease pathophysiology.""}"
3309	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	0	Molecular Mimicry and Antiganglioside Antibodies	Antibodies against bacterial lipooligosaccharides (especially from Campylobacter jejuni) cross-react with gangliosides on peripheral nerves. Anti-GM1, anti-GD1a, and anti-GQ1b antibodies are associated with specific clinical subtypes.																																																								"{""description"": ""Antibodies against bacterial lipooligosaccharides (especially from Campylobacter jejuni) cross-react with gangliosides on peripheral nerves. Anti-GM1, anti-GD1a, and anti-GQ1b antibodies are associated with specific clinical subtypes."", ""name"": ""Molecular Mimicry and Antiganglioside Antibodies""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""description"": ""Antibodies against bacterial lipooligosaccharides (especially from Campylobacter jejuni) cross-react with gangliosides on peripheral nerves. Anti-GM1, anti-GD1a, and anti-GQ1b antibodies are associated with specific clinical subtypes."", ""evidence"": [{""explanation"": ""Demonstrates the molecular mimicry mechanism where C. jejuni lipooligosaccharides resemble nerve gangliosides, leading to cross-reactive antibodies that attack peripheral nerves."", ""reference"": ""PMID:24000328"", ""snippet"": ""Molecular mimicry between sialylated lipooligosaccharide structures on the cell envelope of these bacteria and ganglioside epitopes on the human nerves that generates cross-reactive immune response results in autoimmune-driven nerve damage."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms that anti-ganglioside antibodies in GBS result from molecular mimicry and help classify disease subtypes."", ""reference"": ""PMID:37108447"", ""snippet"": ""The presence of specific anti-glycoconjugate antibodies indicates an underlying process of molecular mimicry and sometimes assists in the classification of these disorders."", ""supports"": ""SUPPORT""}], ""name"": ""Molecular Mimicry and Antiganglioside Antibodies""}"
3310	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	1	Complement-Mediated Nerve Damage	Antibody binding activates complement cascade, leading to membrane attack complex deposition on Schwann cells and nodes of Ranvier. This causes demyelination in AIDP or axonal damage in AMAN/AMSAN variants.																																																								"{""description"": ""Antibody binding activates complement cascade, leading to membrane attack complex deposition on Schwann cells and nodes of Ranvier. This causes demyelination in AIDP or axonal damage in AMAN/AMSAN variants."", ""name"": ""Complement-Mediated Nerve Damage""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""cell_types"": [{""preferred_term"": ""Schwann Cell"", ""term"": {""id"": ""CL:0002573"", ""label"": ""Schwann cell""}}], ""description"": ""Antibody binding activates complement cascade, leading to membrane attack complex deposition on Schwann cells and nodes of Ranvier. This causes demyelination in AIDP or axonal damage in AMAN/AMSAN variants."", ""evidence"": [{""explanation"": ""Demonstrates that anti-ganglioside antibodies bind nodes of Ranvier and activate complement cascade, establishing the complement-mediated mechanism of nerve damage."", ""reference"": ""PMID:10355667"", ""snippet"": ""These data indicate that anti-ganglioside antibodies can diffuse into a desheathed nerve, bind to nodes of Ranvier and fix complement in vitro without resulting in any overt physiological deterioration of the nerve over 4-6 h."", ""supports"": ""SUPPORT""}, {""explanation"": ""Immunocytochemistry evidence showing C3d and C5b-9 membrane attack complex deposition on Schwann cell surfaces in AIDP, confirming complement-mediated pathology."", ""reference"": ""PMID:8619548"", ""snippet"": ""Many fibers had a rim of the complement activation marker C3d and the terminal complement complex neoantigen C5b-9 along the outer surface of the Schwann cells."", ""supports"": ""SUPPORT""}], ""name"": ""Complement-Mediated Nerve Damage""}"
3311	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	2	Macrophage-Mediated Demyelination	In AIDP, macrophages infiltrate peripheral nerves and strip myelin from axons. T cells may also contribute to the inflammatory milieu and tissue damage.																																																								"{""description"": ""In AIDP, macrophages infiltrate peripheral nerves and strip myelin from axons. T cells may also contribute to the inflammatory milieu and tissue damage."", ""name"": ""Macrophage-Mediated Demyelination""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""In AIDP, macrophages infiltrate peripheral nerves and strip myelin from axons. T cells may also contribute to the inflammatory milieu and tissue damage."", ""evidence"": [{""explanation"": ""Describes macrophage infiltration as a key immunological mechanism leading to demyelination and axonal degeneration in immune-mediated neuropathies including GBS."", ""reference"": ""PMID:37108447"", ""snippet"": ""The immunological mechanisms, which include macrophage infiltration, inflammation and proliferation of Schwann cells, result in variable degrees of demyelination and axonal degeneration."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows the temporal sequence of pathology in AIDP, with macrophage invasion into myelin following initial complement-mediated damage."", ""reference"": ""PMID:8619548"", ""snippet"": ""Vesicular degeneration was seen before the invasion of macrophages into the myelin, and was the predominant change in the subject with symptoms for 3 days."", ""supports"": ""SUPPORT""}], ""name"": ""Macrophage-Mediated Demyelination""}"
3331	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	0	H3 K27M Oncohistone Mutation	Lysine-to-methionine substitution at position 27 of histone H3 (K27M) occurs in H3F3A (encoding H3.3) or HIST1H3B/HIST1H3C (encoding H3.1). Despite being present in only 5-15% of total H3 molecules, the mutant histone acts as a dominant negative, sequestering and inhibiting the PRC2 complex.																																																								"{""description"": ""Lysine-to-methionine substitution at position 27 of histone H3 (K27M) occurs in H3F3A (encoding H3.3) or HIST1H3B/HIST1H3C (encoding H3.1). Despite being present in only 5-15% of total H3 molecules, the mutant histone acts as a dominant negative, sequestering and inhibiting the PRC2 complex."", ""name"": ""H3 K27M Oncohistone Mutation""}"	"{""downstream"": [{""description"": ""Mutant H3 K27M sequesters EZH2/PRC2 complex"", ""target"": ""PRC2 Complex Inhibition and H3K27me3 Loss""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""histone H3-K27 methylation"", ""term"": {""id"": ""GO:0098532"", ""label"": ""histone H3-K27 methylation""}}], ""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Lysine-to-methionine substitution at position 27 of histone H3 (K27M) occurs in H3F3A (encoding H3.3) or HIST1H3B/HIST1H3C (encoding H3.1). Despite being present in only 5-15% of total H3 molecules, the mutant histone acts as a dominant negative, sequestering and inhibiting the PRC2 complex."", ""downstream"": [{""description"": ""Mutant H3 K27M sequesters EZH2/PRC2 complex"", ""target"": ""PRC2 Complex Inhibition and H3K27me3 Loss""}], ""evidence"": [{""explanation"": ""This abstract defines H3 K27-altered DMG as a molecularly defined aggressive entity, supporting the disease context for this mutation-driven tumor."", ""reference"": ""PMID:41528563"", ""snippet"": ""H3 K27-altered diffuse midline glioma (DMG) is a molecularly defined, highly aggressive tumor entity since the 2016 revision of the World Health Organization (WHO) classification of tumors of the central nervous system (CNS)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""pons"", ""term"": {""id"": ""UBERON:0000988"", ""label"": ""pons""}}, {""preferred_term"": ""dorsal plus ventral thalamus"", ""term"": {""id"": ""UBERON:0001897"", ""label"": ""dorsal plus ventral thalamus""}}, {""preferred_term"": ""spinal cord"", ""term"": {""id"": ""UBERON:0002240"", ""label"": ""spinal cord""}}], ""name"": ""H3 K27M Oncohistone Mutation""}"
3332	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	1	PRC2 Complex Inhibition and H3K27me3 Loss	The H3 K27M mutant histone binds to and inhibits EZH2, the catalytic subunit of PRC2, which normally trimethylates H3K27. This results in global loss of H3K27me3, a repressive epigenetic mark, leading to aberrant gene activation and loss of cell identity.																																																								"{""description"": ""The H3 K27M mutant histone binds to and inhibits EZH2, the catalytic subunit of PRC2, which normally trimethylates H3K27. This results in global loss of H3K27me3, a repressive epigenetic mark, leading to aberrant gene activation and loss of cell identity."", ""name"": ""PRC2 Complex Inhibition and H3K27me3 Loss""}"	"{""downstream"": [{""description"": ""Loss of H3K27me3 derepresses developmental and oncogenic genes"", ""target"": ""Epigenetic Derepression and Aberrant Gene Activation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of gene expression, epigenetic"", ""term"": {""id"": ""GO:0045814"", ""label"": ""negative regulation of gene expression, epigenetic""}}], ""description"": ""The H3 K27M mutant histone binds to and inhibits EZH2, the catalytic subunit of PRC2, which normally trimethylates H3K27. This results in global loss of H3K27me3, a repressive epigenetic mark, leading to aberrant gene activation and loss of cell identity."", ""downstream"": [{""description"": ""Loss of H3K27me3 derepresses developmental and oncogenic genes"", ""target"": ""Epigenetic Derepression and Aberrant Gene Activation""}], ""name"": ""PRC2 Complex Inhibition and H3K27me3 Loss""}"
3333	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	2	Epigenetic Derepression and Aberrant Gene Activation	Global loss of H3K27me3 causes derepression of genes normally silenced during development, including proliferative and stemness genes. Paradoxically, some loci show retained or increased H3K27me3, suggesting complex redistribution rather than simple loss.																																																								"{""description"": ""Global loss of H3K27me3 causes derepression of genes normally silenced during development, including proliferative and stemness genes. Paradoxically, some loci show retained or increased H3K27me3, suggesting complex redistribution rather than simple loss."", ""name"": ""Epigenetic Derepression and Aberrant Gene Activation""}"	"{""downstream"": [{""description"": ""Epigenetic changes block normal differentiation programs"", ""target"": ""Loss of Glial Differentiation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""gene expression"", ""term"": {""id"": ""GO:0010467"", ""label"": ""gene expression""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Global loss of H3K27me3 causes derepression of genes normally silenced during development, including proliferative and stemness genes. Paradoxically, some loci show retained or increased H3K27me3, suggesting complex redistribution rather than simple loss."", ""downstream"": [{""description"": ""Epigenetic changes block normal differentiation programs"", ""target"": ""Loss of Glial Differentiation""}], ""name"": ""Epigenetic Derepression and Aberrant Gene Activation""}"
3334	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	3	Loss of Glial Differentiation	Epigenetic dysregulation prevents normal glial differentiation, maintaining cells in a proliferative, undifferentiated state. This contributes to the aggressive behavior and treatment resistance of these tumors.																																																								"{""description"": ""Epigenetic dysregulation prevents normal glial differentiation, maintaining cells in a proliferative, undifferentiated state. This contributes to the aggressive behavior and treatment resistance of these tumors."", ""name"": ""Loss of Glial Differentiation""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""glial cell differentiation"", ""term"": {""id"": ""GO:0010001"", ""label"": ""glial cell differentiation""}}], ""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Epigenetic dysregulation prevents normal glial differentiation, maintaining cells in a proliferative, undifferentiated state. This contributes to the aggressive behavior and treatment resistance of these tumors."", ""name"": ""Loss of Glial Differentiation""}"
3347	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	pathophysiology	0	ERBB2 Gene Amplification	HER2-positive breast cancer is driven by amplification of the ERBB2 gene on chromosome 17q12, resulting in overexpression of the HER2 receptor tyrosine kinase. Gene amplification typically results in 25-50 copies per cell, leading to massive receptor overexpression on the cell surface.																																																								"{""description"": ""HER2-positive breast cancer is driven by amplification of the ERBB2 gene on chromosome 17q12, resulting in overexpression of the HER2 receptor tyrosine kinase. Gene amplification typically results in 25-50 copies per cell, leading to massive receptor overexpression on the cell surface."", ""name"": ""ERBB2 Gene Amplification""}"	"{""downstream"": [{""description"": ""Receptor overexpression leads to ligand-independent dimerization and activation"", ""target"": ""Constitutive Receptor Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""ERBB2 signaling pathway"", ""term"": {""id"": ""GO:0038128"", ""label"": ""ERBB2 signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""luminal epithelial cell of mammary gland"", ""term"": {""id"": ""CL:0002326"", ""label"": ""luminal epithelial cell of mammary gland""}}], ""description"": ""HER2-positive breast cancer is driven by amplification of the ERBB2 gene on chromosome 17q12, resulting in overexpression of the HER2 receptor tyrosine kinase. Gene amplification typically results in 25-50 copies per cell, leading to massive receptor overexpression on the cell surface."", ""downstream"": [{""description"": ""Receptor overexpression leads to ligand-independent dimerization and activation"", ""target"": ""Constitutive Receptor Activation""}], ""evidence"": [{""explanation"": ""This abstract identifies HER2-positive breast cancer as a distinct, aggressive subtype, supporting the disease definition used here."", ""reference"": ""PMID:40303293"", ""snippet"": ""HER2-positive breast cancer, which accounts for approximately 15-20% of all breast cancers, is characterized by its aggressive recurrence, metastasis and reduced survival."", ""supports"": ""SUPPORT""}], ""name"": ""ERBB2 Gene Amplification""}"
3348	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	pathophysiology	1	Constitutive Receptor Activation	Massive HER2 overexpression promotes spontaneous receptor homodimerization and heterodimerization with other ERBB family members (EGFR, HER3, HER4) without ligand binding. This constitutive activation drives downstream signaling cascades promoting proliferation, survival, and invasion.																																																								"{""description"": ""Massive HER2 overexpression promotes spontaneous receptor homodimerization and heterodimerization with other ERBB family members (EGFR, HER3, HER4) without ligand binding. This constitutive activation drives downstream signaling cascades promoting proliferation, survival, and invasion."", ""name"": ""Constitutive Receptor Activation""}"	"{""downstream"": [{""description"": ""Activated HER2 phosphorylates intracellular substrates"", ""target"": ""Downstream Oncogenic Signaling""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""transmembrane receptor protein tyrosine kinase signaling pathway"", ""term"": {""id"": ""GO:0007169"", ""label"": ""transmembrane receptor protein tyrosine kinase signaling pathway""}}], ""description"": ""Massive HER2 overexpression promotes spontaneous receptor homodimerization and heterodimerization with other ERBB family members (EGFR, HER3, HER4) without ligand binding. This constitutive activation drives downstream signaling cascades promoting proliferation, survival, and invasion."", ""downstream"": [{""description"": ""Activated HER2 phosphorylates intracellular substrates"", ""target"": ""Downstream Oncogenic Signaling""}], ""name"": ""Constitutive Receptor Activation""}"
3349	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	pathophysiology	2	Downstream Oncogenic Signaling	Activated HER2 signals through PI3K-AKT-mTOR and RAS-RAF-MEK-ERK pathways, promoting cell proliferation, survival, and resistance to apoptosis. HER2-HER3 heterodimers are particularly potent activators of the PI3K pathway.																																																								"{""description"": ""Activated HER2 signals through PI3K-AKT-mTOR and RAS-RAF-MEK-ERK pathways, promoting cell proliferation, survival, and resistance to apoptosis. HER2-HER3 heterodimers are particularly potent activators of the PI3K pathway."", ""name"": ""Downstream Oncogenic Signaling""}"	"{""downstream"": [{""description"": ""Sustained signaling drives tumor growth"", ""target"": ""Uncontrolled Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""Activated HER2 signals through PI3K-AKT-mTOR and RAS-RAF-MEK-ERK pathways, promoting cell proliferation, survival, and resistance to apoptosis. HER2-HER3 heterodimers are particularly potent activators of the PI3K pathway."", ""downstream"": [{""description"": ""Sustained signaling drives tumor growth"", ""target"": ""Uncontrolled Proliferation""}], ""name"": ""Downstream Oncogenic Signaling""}"
3350	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	pathophysiology	3	Uncontrolled Proliferation	Constitutive HER2 signaling drives continuous cell cycle progression and resistance to apoptotic signals. HER2+ tumors are typically high grade with high proliferation indices (high Ki-67).																																																								"{""description"": ""Constitutive HER2 signaling drives continuous cell cycle progression and resistance to apoptotic signals. HER2+ tumors are typically high grade with high proliferation indices (high Ki-67)."", ""name"": ""Uncontrolled Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Constitutive HER2 signaling drives continuous cell cycle progression and resistance to apoptotic signals. HER2+ tumors are typically high grade with high proliferation indices (high Ki-67)."", ""name"": ""Uncontrolled Proliferation""}"
3366	141	HER2-Positive Colorectal Cancer	HER2_Positive_Colorectal_Cancer.yaml	pathophysiology	0	ERBB2 (HER2) Amplification and Overexpression	ERBB2 gene amplification leads to overexpression of the HER2 receptor tyrosine kinase on the cell surface. Amplified HER2 forms homodimers and heterodimers with other ERBB family members (particularly HER3), leading to ligand-independent receptor activation and downstream signaling.																																																								"{""description"": ""ERBB2 gene amplification leads to overexpression of the HER2 receptor tyrosine kinase on the cell surface. Amplified HER2 forms homodimers and heterodimers with other ERBB family members (particularly HER3), leading to ligand-independent receptor activation and downstream signaling."", ""name"": ""ERBB2 (HER2) Amplification and Overexpression""}"	"{""downstream"": [{""description"": ""HER2 signaling activates RAS-RAF-MEK-ERK cascade"", ""target"": ""MAPK Pathway Activation""}, {""description"": ""HER2 signaling activates PI3K-AKT-mTOR cascade through HER3"", ""target"": ""PI3K-AKT Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""ERBB2 signaling pathway"", ""term"": {""id"": ""GO:0038128"", ""label"": ""ERBB2 signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""colon epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}], ""description"": ""ERBB2 gene amplification leads to overexpression of the HER2 receptor tyrosine kinase on the cell surface. Amplified HER2 forms homodimers and heterodimers with other ERBB family members (particularly HER3), leading to ligand-independent receptor activation and downstream signaling."", ""downstream"": [{""description"": ""HER2 signaling activates RAS-RAF-MEK-ERK cascade"", ""target"": ""MAPK Pathway Activation""}, {""description"": ""HER2 signaling activates PI3K-AKT-mTOR cascade through HER3"", ""target"": ""PI3K-AKT Pathway Activation""}], ""evidence"": [{""explanation"": ""This abstract quantifies ERBB2-amplified metastatic colorectal cancer, supporting the existence of this molecular subgroup."", ""reference"": ""PMID:41361014"", ""snippet"": ""Among 5545 patients, 144 (3.1%) had ERBB2 amp+ mCRC."", ""supports"": ""SUPPORT""}], ""name"": ""ERBB2 (HER2) Amplification and Overexpression""}"
3367	141	HER2-Positive Colorectal Cancer	HER2_Positive_Colorectal_Cancer.yaml	pathophysiology	1	MAPK Pathway Activation	HER2 receptor activation leads to recruitment of adaptor proteins (GRB2/SOS) that activate RAS, initiating the MAPK signaling cascade. This drives cell proliferation and survival. The MAPK pathway is a major effector of HER2 oncogenic signaling in colorectal cancer.																																																								"{""description"": ""HER2 receptor activation leads to recruitment of adaptor proteins (GRB2/SOS) that activate RAS, initiating the MAPK signaling cascade. This drives cell proliferation and survival. The MAPK pathway is a major effector of HER2 oncogenic signaling in colorectal cancer."", ""name"": ""MAPK Pathway Activation""}"	"{""downstream"": [{""description"": ""MAPK signaling drives cell cycle progression"", ""target"": ""Enhanced Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""HER2 receptor activation leads to recruitment of adaptor proteins (GRB2/SOS) that activate RAS, initiating the MAPK signaling cascade. This drives cell proliferation and survival. The MAPK pathway is a major effector of HER2 oncogenic signaling in colorectal cancer."", ""downstream"": [{""description"": ""MAPK signaling drives cell cycle progression"", ""target"": ""Enhanced Cell Proliferation""}], ""name"": ""MAPK Pathway Activation""}"
3368	141	HER2-Positive Colorectal Cancer	HER2_Positive_Colorectal_Cancer.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	HER2 heterodimerization with HER3 is particularly potent at activating PI3K signaling because HER3 contains multiple PI3K binding sites. This leads to AKT activation, promoting cell survival and resistance to apoptosis. PI3K pathway activation may contribute to resistance to HER2-targeted therapy.																																																								"{""description"": ""HER2 heterodimerization with HER3 is particularly potent at activating PI3K signaling because HER3 contains multiple PI3K binding sites. This leads to AKT activation, promoting cell survival and resistance to apoptosis. PI3K pathway activation may contribute to resistance to HER2-targeted therapy."", ""name"": ""PI3K-AKT Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""HER2 heterodimerization with HER3 is particularly potent at activating PI3K signaling because HER3 contains multiple PI3K binding sites. This leads to AKT activation, promoting cell survival and resistance to apoptosis. PI3K pathway activation may contribute to resistance to HER2-targeted therapy."", ""name"": ""PI3K-AKT Pathway Activation""}"
3369	141	HER2-Positive Colorectal Cancer	HER2_Positive_Colorectal_Cancer.yaml	pathophysiology	3	Enhanced Cell Proliferation	Combined MAPK and PI3K pathway activation drives enhanced cell proliferation through cyclin D1 induction and cell cycle progression. This leads to uncontrolled tumor growth dependent on HER2 signaling.																																																								"{""description"": ""Combined MAPK and PI3K pathway activation drives enhanced cell proliferation through cyclin D1 induction and cell cycle progression. This leads to uncontrolled tumor growth dependent on HER2 signaling."", ""name"": ""Enhanced Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Combined MAPK and PI3K pathway activation drives enhanced cell proliferation through cyclin D1 induction and cell cycle progression. This leads to uncontrolled tumor growth dependent on HER2 signaling."", ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}], ""name"": ""Enhanced Cell Proliferation""}"
3386	142	HER2-Positive Gastric Cancer	HER2_Positive_Gastric_Cancer.yaml	pathophysiology	0	ERBB2 (HER2) Amplification and Overexpression	ERBB2 gene amplification leads to overexpression of the HER2 receptor tyrosine kinase. High-level HER2 expression promotes constitutive receptor dimerization (particularly HER2 homodimers and HER2/HER3 heterodimers), leading to ligand-independent signaling. HER2 amplification is a driver event in gastric carcinogenesis.																																																								"{""description"": ""ERBB2 gene amplification leads to overexpression of the HER2 receptor tyrosine kinase. High-level HER2 expression promotes constitutive receptor dimerization (particularly HER2 homodimers and HER2/HER3 heterodimers), leading to ligand-independent signaling. HER2 amplification is a driver event in gastric carcinogenesis."", ""name"": ""ERBB2 (HER2) Amplification and Overexpression""}"	"{""downstream"": [{""description"": ""HER2 activates RAS-RAF-MEK-ERK cascade"", ""target"": ""MAPK Pathway Activation""}, {""description"": ""HER2/HER3 heterodimers potently activate PI3K signaling"", ""target"": ""PI3K-AKT Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""ERBB2 signaling pathway"", ""term"": {""id"": ""GO:0038128"", ""label"": ""ERBB2 signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""epithelial cell of stomach"", ""term"": {""id"": ""CL:0002178"", ""label"": ""epithelial cell of stomach""}}], ""description"": ""ERBB2 gene amplification leads to overexpression of the HER2 receptor tyrosine kinase. High-level HER2 expression promotes constitutive receptor dimerization (particularly HER2 homodimers and HER2/HER3 heterodimers), leading to ligand-independent signaling. HER2 amplification is a driver event in gastric carcinogenesis."", ""downstream"": [{""description"": ""HER2 activates RAS-RAF-MEK-ERK cascade"", ""target"": ""MAPK Pathway Activation""}, {""description"": ""HER2/HER3 heterodimers potently activate PI3K signaling"", ""target"": ""PI3K-AKT Pathway Activation""}], ""evidence"": [{""explanation"": ""This abstract identifies HER2-positive gastric cancer as a distinct molecular subtype, supporting the disease definition."", ""reference"": ""PMID:41355925"", ""snippet"": ""Human epidermal growth factor receptor 2 (HER2)-positive gastric cancer (GC) represents a distinct molecular cancer subtype that is often associated with a poor prognosis."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""stomach"", ""term"": {""id"": ""UBERON:0000945"", ""label"": ""stomach""}}], ""name"": ""ERBB2 (HER2) Amplification and Overexpression""}"
3387	142	HER2-Positive Gastric Cancer	HER2_Positive_Gastric_Cancer.yaml	pathophysiology	1	MAPK Pathway Activation	HER2 receptor activation recruits GRB2/SOS adaptor proteins, activating RAS and the downstream MAPK cascade. This drives transcription of genes promoting cell proliferation, including cyclin D1 and MYC.																																																								"{""description"": ""HER2 receptor activation recruits GRB2/SOS adaptor proteins, activating RAS and the downstream MAPK cascade. This drives transcription of genes promoting cell proliferation, including cyclin D1 and MYC."", ""name"": ""MAPK Pathway Activation""}"	"{""downstream"": [{""description"": ""MAPK signaling drives cell cycle progression"", ""target"": ""Enhanced Proliferation and Tumor Growth""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""HER2 receptor activation recruits GRB2/SOS adaptor proteins, activating RAS and the downstream MAPK cascade. This drives transcription of genes promoting cell proliferation, including cyclin D1 and MYC."", ""downstream"": [{""description"": ""MAPK signaling drives cell cycle progression"", ""target"": ""Enhanced Proliferation and Tumor Growth""}], ""name"": ""MAPK Pathway Activation""}"
3388	142	HER2-Positive Gastric Cancer	HER2_Positive_Gastric_Cancer.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	HER2/HER3 heterodimerization is particularly effective at activating PI3K because HER3 contains six PI3K binding motifs. PI3K activation leads to AKT phosphorylation, promoting cell survival, protein synthesis through mTOR, and resistance to apoptosis. PI3K pathway alterations may confer resistance to HER2-targeted therapy.																																																								"{""description"": ""HER2/HER3 heterodimerization is particularly effective at activating PI3K because HER3 contains six PI3K binding motifs. PI3K activation leads to AKT phosphorylation, promoting cell survival, protein synthesis through mTOR, and resistance to apoptosis. PI3K pathway alterations may confer resistance to HER2-targeted therapy."", ""name"": ""PI3K-AKT Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""HER2/HER3 heterodimerization is particularly effective at activating PI3K because HER3 contains six PI3K binding motifs. PI3K activation leads to AKT phosphorylation, promoting cell survival, protein synthesis through mTOR, and resistance to apoptosis. PI3K pathway alterations may confer resistance to HER2-targeted therapy."", ""name"": ""PI3K-AKT Pathway Activation""}"
3389	142	HER2-Positive Gastric Cancer	HER2_Positive_Gastric_Cancer.yaml	pathophysiology	3	Enhanced Proliferation and Tumor Growth	Combined MAPK and PI3K/AKT pathway activation drives uncontrolled cell proliferation and tumor growth. HER2-positive tumors are dependent on HER2 signaling, making them vulnerable to HER2-targeted therapies.																																																								"{""description"": ""Combined MAPK and PI3K/AKT pathway activation drives uncontrolled cell proliferation and tumor growth. HER2-positive tumors are dependent on HER2 signaling, making them vulnerable to HER2-targeted therapies."", ""name"": ""Enhanced Proliferation and Tumor Growth""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Combined MAPK and PI3K/AKT pathway activation drives uncontrolled cell proliferation and tumor growth. HER2-positive tumors are dependent on HER2 signaling, making them vulnerable to HER2-targeted therapies."", ""name"": ""Enhanced Proliferation and Tumor Growth""}"
3403	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	0	P4HTM Gene Loss-of-Function	Biallelic loss-of-function variants in P4HTM result in loss of ER-resident transmembrane prolyl 4-hydroxylase activity. The enzyme contains an EF-hand domain that allows calcium-dependent regulation of its catalytic activity, linking the genetic defect to both HIF signaling and calcium homeostasis pathways.																																																								"{""description"": ""Biallelic loss-of-function variants in P4HTM result in loss of ER-resident transmembrane prolyl 4-hydroxylase activity. The enzyme contains an EF-hand domain that allows calcium-dependent regulation of its catalytic activity, linking the genetic defect to both HIF signaling and calcium homeostasis pathways."", ""name"": ""P4HTM Gene Loss-of-Function""}"	{}	"{""description"": ""Biallelic loss-of-function variants in P4HTM result in loss of ER-resident transmembrane prolyl 4-hydroxylase activity. The enzyme contains an EF-hand domain that allows calcium-dependent regulation of its catalytic activity, linking the genetic defect to both HIF signaling and calcium homeostasis pathways."", ""evidence"": [{""explanation"": ""The foundational paper establishing that biallelic P4HTM mutations cause HIDEA syndrome."", ""reference"": ""PMID:30940925"", ""snippet"": ""Biallelic loss-of-function P4HTM gene variants cause hypotonia, hypoventilation, intellectual disability, dysautonomia, epilepsy, and eye abnormalities (HIDEA)."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""P4HTM""}], ""name"": ""P4HTM Gene Loss-of-Function""}"
3404	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	1	Dysregulated Astrocyte Calcium Signaling	P4H-TM is a regulator of calcium dynamics and gliotransmission in astrocytes via a HIF-1-dependent mechanism. Loss of P4H-TM impairs receptor-operated and store-operated calcium entry (ROCE/SOCE), reduces mitochondrial calcium uptake and ATP production, and attenuates gliotransmission.																																																								"{""description"": ""P4H-TM is a regulator of calcium dynamics and gliotransmission in astrocytes via a HIF-1-dependent mechanism. Loss of P4H-TM impairs receptor-operated and store-operated calcium entry (ROCE/SOCE), reduces mitochondrial calcium uptake and ATP production, and attenuates gliotransmission."", ""name"": ""Dysregulated Astrocyte Calcium Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Calcium ion transmembrane transport"", ""term"": {""id"": ""GO:0070588"", ""label"": ""calcium ion transmembrane transport""}}, {""preferred_term"": ""Gliotransmitter secretion"", ""term"": {""id"": ""GO:0099177"", ""label"": ""gliotransmitter secretion""}}], ""cell_types"": [{""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""P4H-TM is a regulator of calcium dynamics and gliotransmission in astrocytes via a HIF-1-dependent mechanism. Loss of P4H-TM impairs receptor-operated and store-operated calcium entry (ROCE/SOCE), reduces mitochondrial calcium uptake and ATP production, and attenuates gliotransmission."", ""name"": ""Dysregulated Astrocyte Calcium Signaling""}"
3405	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	2	Central Respiratory Control Dysfunction	Loss of P4H-TM leads to impaired central respiratory control, with hypoventilation and blunted responses to hypoxia. Patients may require BiPAP support and are at risk for respiratory distress during infections.																																																								"{""description"": ""Loss of P4H-TM leads to impaired central respiratory control, with hypoventilation and blunted responses to hypoxia. Patients may require BiPAP support and are at risk for respiratory distress during infections."", ""name"": ""Central Respiratory Control Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Regulation of respiratory system process"", ""term"": {""id"": ""GO:0044065"", ""label"": ""regulation of respiratory system process""}}, {""preferred_term"": ""Response to hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Loss of P4H-TM leads to impaired central respiratory control, with hypoventilation and blunted responses to hypoxia. Patients may require BiPAP support and are at risk for respiratory distress during infections."", ""evidence"": [{""explanation"": ""The foundational HIDEA paper identified hypoventilation and central sleep apnea as core features."", ""reference"": ""PMID:30940925"", ""snippet"": ""Hypoventilation, obstructive and central sleep apnea, and dysautonomia were identified as novel features associated with the phenotype."", ""supports"": ""SUPPORT""}], ""name"": ""Central Respiratory Control Dysfunction""}"
3406	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	3	Mitochondrial Dysfunction	A subset of HIDEA patients show mitochondrial respiratory chain complex deficiency in muscle biopsies, suggesting that P4H-TM loss can affect mitochondrial function.																																																								"{""description"": ""A subset of HIDEA patients show mitochondrial respiratory chain complex deficiency in muscle biopsies, suggesting that P4H-TM loss can affect mitochondrial function."", ""name"": ""Mitochondrial Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}], ""description"": ""A subset of HIDEA patients show mitochondrial respiratory chain complex deficiency in muscle biopsies, suggesting that P4H-TM loss can affect mitochondrial function."", ""evidence"": [{""explanation"": ""Evidence from muscle biopsies showing mitochondrial respiratory chain deficiency in some HIDEA patients."", ""reference"": ""PMID:30940925"", ""snippet"": ""The muscle biopsy of patient 1 showed low activity of mitochondrial respiratory chain complex III. In addition, the muscle biopsy of patient 2 was suggestive of a mitochondrial, neurometabolic disease."", ""supports"": ""SUPPORT""}], ""name"": ""Mitochondrial Dysfunction""}"
3439	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	0	TP53 Mutation and Inactivation	TP53 mutations occur in greater than 80% of HPV-negative HNSCC, representing the most common genetic alteration. Mutations are typically missense mutations in the DNA-binding domain caused by tobacco carcinogen-induced DNA adducts. Loss of p53 function eliminates cell cycle checkpoints and DNA damage repair.																																																								"{""description"": ""TP53 mutations occur in greater than 80% of HPV-negative HNSCC, representing the most common genetic alteration. Mutations are typically missense mutations in the DNA-binding domain caused by tobacco carcinogen-induced DNA adducts. Loss of p53 function eliminates cell cycle checkpoints and DNA damage repair."", ""name"": ""TP53 Mutation and Inactivation""}"	"{""downstream"": [{""description"": ""Loss of p53-mediated DNA damage response leads to accumulated mutations"", ""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""squamous epithelial cell"", ""term"": {""id"": ""CL:0000076"", ""label"": ""squamous epithelial cell""}}], ""description"": ""TP53 mutations occur in greater than 80% of HPV-negative HNSCC, representing the most common genetic alteration. Mutations are typically missense mutations in the DNA-binding domain caused by tobacco carcinogen-induced DNA adducts. Loss of p53 function eliminates cell cycle checkpoints and DNA damage repair."", ""downstream"": [{""description"": ""Loss of p53-mediated DNA damage response leads to accumulated mutations"", ""target"": ""Genomic Instability""}], ""evidence"": [{""explanation"": ""TCGA HNSCC abstract reports near-universal TP53 loss and CDKN2A inactivation in smoking-related tumors."", ""reference"": ""PMID:25631445"", ""snippet"": ""Smoking-related HNSCCs demonstrate near universal loss-of-function TP53 mutations and CDKN2A inactivation"", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""TP53""}], ""name"": ""TP53 Mutation and Inactivation""}"
3440	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	1	CDKN2A/p16 Inactivation	CDKN2A is inactivated by deletion, mutation, or promoter hypermethylation in approximately 60-70% of HPV-negative HNSCC. Loss of p16INK4a removes inhibition of CDK4/6, promoting cell cycle progression through the restriction point.																																																								"{""description"": ""CDKN2A is inactivated by deletion, mutation, or promoter hypermethylation in approximately 60-70% of HPV-negative HNSCC. Loss of p16INK4a removes inhibition of CDK4/6, promoting cell cycle progression through the restriction point."", ""name"": ""CDKN2A/p16 Inactivation""}"	"{""downstream"": [{""description"": ""CDK4/6 phosphorylates pRB without restraint"", ""target"": ""Cell Cycle Dysregulation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of G1/S transition"", ""term"": {""id"": ""GO:0045786"", ""label"": ""negative regulation of G1/S transition of mitotic cell cycle""}}], ""description"": ""CDKN2A is inactivated by deletion, mutation, or promoter hypermethylation in approximately 60-70% of HPV-negative HNSCC. Loss of p16INK4a removes inhibition of CDK4/6, promoting cell cycle progression through the restriction point."", ""downstream"": [{""description"": ""CDK4/6 phosphorylates pRB without restraint"", ""target"": ""Cell Cycle Dysregulation""}], ""genes"": [{""preferred_term"": ""CDKN2A""}], ""name"": ""CDKN2A/p16 Inactivation""}"
3441	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	2	EGFR Overexpression and Signaling	EGFR is overexpressed in 80-90% of HNSCC and amplified in a subset. EGFR signaling activates RAS-MAPK and PI3K-AKT pathways, promoting proliferation, survival, and invasion. EGFR is a validated therapeutic target in HNSCC.																																																								"{""description"": ""EGFR is overexpressed in 80-90% of HNSCC and amplified in a subset. EGFR signaling activates RAS-MAPK and PI3K-AKT pathways, promoting proliferation, survival, and invasion. EGFR is a validated therapeutic target in HNSCC."", ""name"": ""EGFR Overexpression and Signaling""}"	"{""downstream"": [{""description"": ""EGFR phosphorylation activates RAS and downstream MAP kinases"", ""target"": ""RAS-MAPK Activation""}, {""description"": ""EGFR recruits PI3K and activates survival signaling"", ""target"": ""PI3K-AKT Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""epidermal growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0007173"", ""label"": ""epidermal growth factor receptor signaling pathway""}}], ""description"": ""EGFR is overexpressed in 80-90% of HNSCC and amplified in a subset. EGFR signaling activates RAS-MAPK and PI3K-AKT pathways, promoting proliferation, survival, and invasion. EGFR is a validated therapeutic target in HNSCC."", ""downstream"": [{""description"": ""EGFR phosphorylation activates RAS and downstream MAP kinases"", ""target"": ""RAS-MAPK Activation""}, {""description"": ""EGFR recruits PI3K and activates survival signaling"", ""target"": ""PI3K-AKT Activation""}], ""name"": ""EGFR Overexpression and Signaling""}"
3442	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	3	NOTCH1 Inactivation	NOTCH1 loss-of-function mutations occur in approximately 15-20% of HPV-negative HNSCC. NOTCH signaling normally promotes squamous differentiation and growth arrest, functioning as a tumor suppressor in squamous epithelia.																																																								"{""description"": ""NOTCH1 loss-of-function mutations occur in approximately 15-20% of HPV-negative HNSCC. NOTCH signaling normally promotes squamous differentiation and growth arrest, functioning as a tumor suppressor in squamous epithelia."", ""name"": ""NOTCH1 Inactivation""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""Notch signaling pathway"", ""term"": {""id"": ""GO:0007219"", ""label"": ""Notch signaling pathway""}}], ""description"": ""NOTCH1 loss-of-function mutations occur in approximately 15-20% of HPV-negative HNSCC. NOTCH signaling normally promotes squamous differentiation and growth arrest, functioning as a tumor suppressor in squamous epithelia."", ""genes"": [{""preferred_term"": ""NOTCH1""}], ""name"": ""NOTCH1 Inactivation""}"
3463	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	0	E6-Mediated p53 Degradation	HPV E6 oncoprotein recruits the E3 ubiquitin ligase E6AP to target p53 for proteasomal degradation, eliminating DNA damage checkpoints and allowing survival of cells with genomic instability. Unlike HPV-negative HNSCC, TP53 mutations are rare in HPV-positive tumors.																																																								"{""description"": ""HPV E6 oncoprotein recruits the E3 ubiquitin ligase E6AP to target p53 for proteasomal degradation, eliminating DNA damage checkpoints and allowing survival of cells with genomic instability. Unlike HPV-negative HNSCC, TP53 mutations are rare in HPV-positive tumors."", ""name"": ""E6-Mediated p53 Degradation""}"	"{""downstream"": [{""description"": ""p53 degradation abolishes G1/S and G2/M checkpoints"", ""target"": ""Loss of DNA Damage Response""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""proteasome-mediated ubiquitin-dependent protein catabolic process"", ""term"": {""id"": ""GO:0043161"", ""label"": ""proteasome-mediated ubiquitin-dependent protein catabolic process""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""squamous epithelial cell"", ""term"": {""id"": ""CL:0000076"", ""label"": ""squamous epithelial cell""}}], ""description"": ""HPV E6 oncoprotein recruits the E3 ubiquitin ligase E6AP to target p53 for proteasomal degradation, eliminating DNA damage checkpoints and allowing survival of cells with genomic instability. Unlike HPV-negative HNSCC, TP53 mutations are rare in HPV-positive tumors."", ""downstream"": [{""description"": ""p53 degradation abolishes G1/S and G2/M checkpoints"", ""target"": ""Loss of DNA Damage Response""}], ""locations"": [{""preferred_term"": ""oropharynx"", ""term"": {""id"": ""UBERON:0001729"", ""label"": ""oropharynx""}}], ""name"": ""E6-Mediated p53 Degradation""}"
3464	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	1	E7-Mediated pRB Inactivation	HPV E7 oncoprotein binds and degrades the retinoblastoma protein (pRB), releasing E2F transcription factors to drive S-phase entry. This causes compensatory overexpression of p16INK4a, which serves as a clinical biomarker for HPV-associated tumors.																																																								"{""description"": ""HPV E7 oncoprotein binds and degrades the retinoblastoma protein (pRB), releasing E2F transcription factors to drive S-phase entry. This causes compensatory overexpression of p16INK4a, which serves as a clinical biomarker for HPV-associated tumors."", ""name"": ""E7-Mediated pRB Inactivation""}"	"{""downstream"": [{""description"": ""E2F release activates genes required for DNA replication"", ""target"": ""Uncontrolled Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}], ""description"": ""HPV E7 oncoprotein binds and degrades the retinoblastoma protein (pRB), releasing E2F transcription factors to drive S-phase entry. This causes compensatory overexpression of p16INK4a, which serves as a clinical biomarker for HPV-associated tumors."", ""downstream"": [{""description"": ""E2F release activates genes required for DNA replication"", ""target"": ""Uncontrolled Cell Proliferation""}], ""name"": ""E7-Mediated pRB Inactivation""}"
3465	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	2	Viral Oncogene Integration	HPV genome integration into the host chromosome disrupts the E2 viral repressor, leading to constitutive E6/E7 expression. However, episomal HPV may also drive carcinogenesis in some HPV-positive oropharyngeal cancers.																																																								"{""description"": ""HPV genome integration into the host chromosome disrupts the E2 viral repressor, leading to constitutive E6/E7 expression. However, episomal HPV may also drive carcinogenesis in some HPV-positive oropharyngeal cancers."", ""name"": ""Viral Oncogene Integration""}"	{}	"{""biological_processes"": [{""preferred_term"": ""viral DNA integration into host DNA"", ""term"": {""id"": ""GO:0044826"", ""label"": ""viral DNA integration into host DNA""}}], ""description"": ""HPV genome integration into the host chromosome disrupts the E2 viral repressor, leading to constitutive E6/E7 expression. However, episomal HPV may also drive carcinogenesis in some HPV-positive oropharyngeal cancers."", ""name"": ""Viral Oncogene Integration""}"
3466	145	HPV-Positive Head and Neck Cancer	HPV_Positive_Head_and_Neck_Cancer.yaml	pathophysiology	3	Immune Evasion	HPV-positive HNSCC evades immune surveillance through downregulation of antigen presentation and PD-L1 expression. However, these tumors are generally more immunogenic than HPV-negative HNSCC, contributing to better prognosis and response to immunotherapy.																																																								"{""description"": ""HPV-positive HNSCC evades immune surveillance through downregulation of antigen presentation and PD-L1 expression. However, these tumors are generally more immunogenic than HPV-negative HNSCC, contributing to better prognosis and response to immunotherapy."", ""name"": ""Immune Evasion""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""negative regulation of T cell mediated immunity"", ""term"": {""id"": ""GO:0002710"", ""label"": ""negative regulation of T cell mediated immunity""}}], ""description"": ""HPV-positive HNSCC evades immune surveillance through downregulation of antigen presentation and PD-L1 expression. However, these tumors are generally more immunogenic than HPV-negative HNSCC, contributing to better prognosis and response to immunotherapy."", ""name"": ""Immune Evasion""}"
3488	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	0	Autoimmune Thyroid Destruction	"T cell-mediated and antibody-mediated destruction of thyroid follicular cells leads to progressive loss of thyroid function. Anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies are characteristic.
"																																																								"{""description"": ""T cell-mediated and antibody-mediated destruction of thyroid follicular cells leads to progressive loss of thyroid function. Anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies are characteristic.\n"", ""name"": ""Autoimmune Thyroid Destruction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Autoimmune Response"", ""term"": {""id"": ""GO:0002460"", ""label"": ""adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains""}}], ""cell_types"": [{""preferred_term"": ""Thyroid Epithelial Cell"", ""term"": {""id"": ""CL:0002257"", ""label"": ""epithelial cell of thyroid gland""}}, {""preferred_term"": ""T Helper Cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}], ""description"": ""T cell-mediated and antibody-mediated destruction of thyroid follicular cells leads to progressive loss of thyroid function. Anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies are characteristic.\n"", ""evidence"": [{""explanation"": ""Spatial transcriptomics demonstrates that thyroid follicular cells actively participate in autoimmune destruction by presenting antigens via CD74/MIF upregulation."", ""reference"": ""PMID:39003267"", ""snippet"": ""We identify damaged antigen-presenting TFCs with upregulated CD74 and MIF expression in thyroid samples from AITD patients."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms the characteristic antibody profile and lymphocytic infiltration pattern in Hashimoto's thyroiditis."", ""reference"": ""PMID:38731922"", ""snippet"": ""Hashimoto's thyroiditis (HT) is generally characterized by the presence of thyroid peroxidase and thyroglobulin antibodies, with a concomitant infiltration of lymphocytes in the thyroid."", ""supports"": ""SUPPORT""}, {""explanation"": ""ICI-induced thyroiditis provides a mechanistic model that mirrors the autoimmune destruction seen in spontaneous Hashimoto's thyroiditis."", ""reference"": ""PMID:40535343"", ""snippet"": ""Through this review, we aim to establish mechanistic connections between ICI pharmacodynamics and thyroid tissue immunopathology."", ""supports"": ""SUPPORT""}], ""name"": ""Autoimmune Thyroid Destruction""}"
3489	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	1	Lymphocytic Infiltration	"Dense lymphocytic infiltration of the thyroid gland with germinal center formation. CD4+ T cells, CD8+ T cells, and B cells accumulate in the thyroid parenchyma.
"																																																								"{""description"": ""Dense lymphocytic infiltration of the thyroid gland with germinal center formation. CD4+ T cells, CD8+ T cells, and B cells accumulate in the thyroid parenchyma.\n"", ""name"": ""Lymphocytic Infiltration""}"	{}	"{""cell_types"": [{""preferred_term"": ""B Cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""Dense lymphocytic infiltration of the thyroid gland with germinal center formation. CD4+ T cells, CD8+ T cells, and B cells accumulate in the thyroid parenchyma.\n"", ""evidence"": [{""explanation"": ""Lymphocytic infiltration is a defining histological feature of Hashimoto's thyroiditis."", ""reference"": ""PMID:38731922"", ""snippet"": ""Hashimoto's thyroiditis (HT) is generally characterized by the presence of thyroid peroxidase and thyroglobulin antibodies, with a concomitant infiltration of lymphocytes in the thyroid."", ""supports"": ""SUPPORT""}, {""explanation"": ""Spatial analysis confirms the presence and organization of infiltrating lymphocytes in the thyroid microenvironment."", ""reference"": ""PMID:39003267"", ""snippet"": ""Here, we use spatial transcriptomics to explore the molecular architecture, heterogeneity and location of different cells present in the thyroid tissue, including thyroid follicular cells (TFCs), stromal cells such as fibroblasts, endothelial cells, and thyroid infiltrating lymphocytes."", ""supports"": ""SUPPORT""}], ""name"": ""Lymphocytic Infiltration""}"
3490	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	2	Thyroid Hormone Deficiency	"Progressive destruction of thyroid tissue leads to decreased production of T3 and T4, resulting in hypothyroidism with elevated TSH through negative feedback.
"																																																								"{""description"": ""Progressive destruction of thyroid tissue leads to decreased production of T3 and T4, resulting in hypothyroidism with elevated TSH through negative feedback.\n"", ""name"": ""Thyroid Hormone Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Thyroid Hormone Synthesis"", ""term"": {""id"": ""GO:0006590"", ""label"": ""thyroid hormone generation""}}], ""description"": ""Progressive destruction of thyroid tissue leads to decreased production of T3 and T4, resulting in hypothyroidism with elevated TSH through negative feedback.\n"", ""evidence"": [{""explanation"": ""Progressive thyroid destruction in Hashimoto's thyroiditis results in hypothyroidism through loss of hormone-producing cells."", ""reference"": ""PMID:38731922"", ""snippet"": ""Due to the progressive destruction of cells, AITD can lead to subclinical or overt hypothyroidism."", ""supports"": ""SUPPORT""}, {""explanation"": ""Mechanistic understanding of immune-mediated thyroid destruction links to hormone deficiency in both ICI-induced and spontaneous thyroiditis."", ""reference"": ""PMID:40535343"", ""snippet"": ""Elucidating the pathophysiological mechanisms underlying ICI-induced thyroiditis represents a critical step toward developing evidence-based diagnostic protocols and targeted therapeutic interventions for cancer patients undergoing immunotherapy."", ""supports"": ""SUPPORT""}], ""name"": ""Thyroid Hormone Deficiency""}"
3512	147	Heart Failure	Heart_Failure.yaml	pathophysiology	0	Myocardial Contractile Dysfunction	"Reduced cardiac output due to impaired ventricular contraction (systolic dysfunction) or relaxation (diastolic dysfunction). The heart cannot meet metabolic demands.
"																																																								"{""description"": ""Reduced cardiac output due to impaired ventricular contraction (systolic dysfunction) or relaxation (diastolic dysfunction). The heart cannot meet metabolic demands.\n"", ""name"": ""Myocardial Contractile Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cardiac Contraction"", ""term"": {""id"": ""GO:0060047"", ""label"": ""heart contraction""}}], ""cell_types"": [{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""description"": ""Reduced cardiac output due to impaired ventricular contraction (systolic dysfunction) or relaxation (diastolic dysfunction). The heart cannot meet metabolic demands.\n"", ""evidence"": [{""explanation"": ""This review discusses the prevalence and severity of HFpEF, a form characterized by diastolic dysfunction rather than systolic dysfunction, demonstrating the importance of both contractile mechanisms in heart failure."", ""reference"": ""PMID:33432192"", ""snippet"": ""Heart failure with preserved ejection fraction (HFpEF) affects half of all patients with heart failure worldwide, is increasing in prevalence, confers substantial morbidity and mortality, and has very few effective treatments."", ""supports"": ""SUPPORT""}, {""explanation"": ""This demonstrates how structural changes lead to diastolic dysfunction and impaired cardiac output, supporting the mechanism of contractile dysfunction in heart failure."", ""reference"": ""PMID:40892534"", ""snippet"": ""Myocardial fibrosis and its surrogate changes in LV structure and geometry lead to functional impairments such as increased diastolic stiffness and elevated filling pressures and are associated with reduced exercise tolerance and poor prognosis in patients with HFpEF."", ""supports"": ""SUPPORT""}], ""name"": ""Myocardial Contractile Dysfunction""}"
3513	147	Heart Failure	Heart_Failure.yaml	pathophysiology	1	Neurohormonal Activation	"Compensatory activation of RAAS and sympathetic nervous system initially maintains cardiac output but leads to maladaptive remodeling, sodium retention, and progressive dysfunction.
"																																																								"{""description"": ""Compensatory activation of RAAS and sympathetic nervous system initially maintains cardiac output but leads to maladaptive remodeling, sodium retention, and progressive dysfunction.\n"", ""name"": ""Neurohormonal Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""RAAS Activation"", ""term"": {""id"": ""GO:0002018"", ""label"": ""renin-angiotensin regulation of aldosterone production""}}], ""description"": ""Compensatory activation of RAAS and sympathetic nervous system initially maintains cardiac output but leads to maladaptive remodeling, sodium retention, and progressive dysfunction.\n"", ""evidence"": [{""explanation"": ""This directly confirms the activation of neurohormonal systems (RAAS and SNS) in heart failure patients, supporting the compensatory mechanism described."", ""reference"": ""PMID:37895150"", ""snippet"": ""In patients with heart failure (HF), the neuroendocrine systems of the sympathetic nervous system (SNS), the renin-angiotensin-aldosterone system (RAAS) and the arginine vasopressin (AVP) system, are activated to various degrees producing often-observed tachycardia and concomitant increased systemic vascular resistance."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports the concept that while initially compensatory, sustained neurohormonal activation leads to maladaptive effects and disease progression."", ""reference"": ""PMID:37895150"", ""snippet"": ""Furthermore, sustained neurohormonal activation plays a key role in the progression of HF and may be responsible for the pathogenetic mechanisms leading to the perpetuation of the pathophysiology and worsening of the HF signs and symptoms."", ""supports"": ""SUPPORT""}, {""explanation"": ""This highlights the complexity of neurohormonal effects extending beyond the heart to multiple organ systems in heart failure pathophysiology."", ""reference"": ""PMID:33432192"", ""snippet"": ""This multiorgan involvement makes HFpEF difficult to model in experimental animals because the condition is not simply cardiac hypertrophy and hypertension with abnormal myocardial relaxation."", ""supports"": ""SUPPORT""}], ""name"": ""Neurohormonal Activation""}"
3514	147	Heart Failure	Heart_Failure.yaml	pathophysiology	2	Ventricular Remodeling	"Structural changes including ventricular dilation, hypertrophy, and fibrosis that initially compensate but eventually worsen heart function.
"																																																								"{""description"": ""Structural changes including ventricular dilation, hypertrophy, and fibrosis that initially compensate but eventually worsen heart function.\n"", ""name"": ""Ventricular Remodeling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cardiac Remodeling"", ""term"": {""id"": ""GO:0060420"", ""label"": ""regulation of heart growth""}}], ""cell_types"": [{""preferred_term"": ""Cardiac Fibroblast"", ""term"": {""id"": ""CL:0002548"", ""label"": ""fibroblast of cardiac tissue""}}], ""description"": ""Structural changes including ventricular dilation, hypertrophy, and fibrosis that initially compensate but eventually worsen heart function.\n"", ""evidence"": [{""explanation"": ""This demonstrates the prevalence and mechanisms of ventricular remodeling including hypertrophy and fibrosis in heart failure patients, particularly in HFpEF."", ""reference"": ""PMID:40892534"", ""snippet"": ""Comorbidities such as hypertension, obesity, or diabetes are present in many HFpEF patients and are hypothesized to contribute to adverse cardiac remodelling and myocardial fibrosis through a variety of haemodynamic and metabolic impairments, with nearly half of all HFpEF patients exhibiting left ventricular (LV) hypertrophy or concentric remodelling."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms that cardiac remodeling, including hypertrophy and fibrosis, is a key pathophysiological mechanism promoted by sympathetic activation in heart failure."", ""reference"": ""PMID:38636927"", ""snippet"": ""Heart failure is usually accompanied by activation of the sympathetic nerve, and excessive activation of the sympathetic nerve promotes cardiac remodeling and cardiac dysfunction. In the isoproterenol (ISO)-induced animal model, it is often accompanied by myocardial hypertrophy, fibrosis, and inflammation."", ""supports"": ""SUPPORT""}, {""explanation"": ""This identifies specific signaling pathways (NF-B and MAPK) involved in cardiac remodeling and fibrosis, demonstrating the molecular mechanisms underlying structural changes."", ""reference"": ""PMID:38636927"", ""snippet"": ""Lilrb4a alleviates cardiac dysfunction and ISO-induced arrhythmogenic remodeling associated with cardiac fibrosis and inflammation through the regulation of NF-B signaling and MAPK signaling activation."", ""supports"": ""SUPPORT""}], ""name"": ""Ventricular Remodeling""}"
3515	147	Heart Failure	Heart_Failure.yaml	pathophysiology	3	Fluid Retention	"Impaired sodium excretion leads to volume overload, causing pulmonary and peripheral edema. Results from reduced renal perfusion and neurohormonal activation.
"																																																								"{""description"": ""Impaired sodium excretion leads to volume overload, causing pulmonary and peripheral edema. Results from reduced renal perfusion and neurohormonal activation.\n"", ""name"": ""Fluid Retention""}"	{}	"{""description"": ""Impaired sodium excretion leads to volume overload, causing pulmonary and peripheral edema. Results from reduced renal perfusion and neurohormonal activation.\n"", ""evidence"": [{""explanation"": ""This demonstrates the bidirectional relationship between heart and kidney dysfunction that leads to fluid retention in heart failure through cardiorenal mechanisms."", ""reference"": ""PMID:36769308"", ""snippet"": ""The pathophysiology between the heart and the kidneys is bidirectional. Common mechanisms leading to the dysfunction of these organs result in a vicious cycle of cardiorenal deterioration."", ""supports"": ""SUPPORT""}, {""explanation"": ""This emphasizes the critical role of renal dysfunction in heart failure pathophysiology and outcomes, supporting the mechanism of fluid retention through impaired kidney function."", ""reference"": ""PMID:36769308"", ""snippet"": ""As the worsening of renal function has an undeniably negative impact on the outcomes in patients with HF, searching for new treatment strategies and identification of biomarkers is necessary."", ""supports"": ""SUPPORT""}], ""name"": ""Fluid Retention""}"
3533	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	0	HFE Loss Lowers Hepcidin	"Pathogenic HFE variants (most commonly C282Y homozygosity) blunt hepcidin induction, leaving circulating hepcidin inappropriately low relative to body iron stores.
"																																																								"{""description"": ""Pathogenic HFE variants (most commonly C282Y homozygosity) blunt hepcidin induction, leaving circulating hepcidin inappropriately low relative to body iron stores.\n"", ""name"": ""HFE Loss Lowers Hepcidin""}"	{}	"{""biological_processes"": [{""preferred_term"": ""iron ion homeostasis"", ""term"": {""id"": ""GO:0055072"", ""label"": ""iron ion homeostasis""}}], ""description"": ""Pathogenic HFE variants (most commonly C282Y homozygosity) blunt hepcidin induction, leaving circulating hepcidin inappropriately low relative to body iron stores.\n"", ""evidence"": [{""explanation"": ""Impaired HFE signaling results in low hepcidin in C282Y homozygotes."", ""reference"": ""PMID:23985001"", ""snippet"": ""Hereditary hemochromatosis is an inherited iron overload disorder caused by inappropriately low hepcidin secretion leading to increased duodenal absorption of dietary iron, most commonly in C282Y homozygous individuals."", ""supports"": ""SUPPORT""}], ""name"": ""HFE Loss Lowers Hepcidin""}"
3534	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	1	Low Hepcidin Leads to Ferroportin Hyperabsorption	"Suppressed hepcidin fails to internalize and degrade ferroportin on enterocytes, so dietary iron efflux into plasma is unchecked, driving systemic iron overload.
"																																																								"{""description"": ""Suppressed hepcidin fails to internalize and degrade ferroportin on enterocytes, so dietary iron efflux into plasma is unchecked, driving systemic iron overload.\n"", ""name"": ""Low Hepcidin Leads to Ferroportin Hyperabsorption""}"	{}	"{""biological_processes"": [{""preferred_term"": ""iron ion transport"", ""term"": {""id"": ""GO:0006826"", ""label"": ""iron ion transport""}}], ""description"": ""Suppressed hepcidin fails to internalize and degrade ferroportin on enterocytes, so dietary iron efflux into plasma is unchecked, driving systemic iron overload.\n"", ""evidence"": [{""explanation"": ""Low hepcidin permits unregulated ferroportin-mediated iron export from the gut."", ""reference"": ""PMID:23985001"", ""snippet"": ""Hereditary hemochromatosis is an inherited iron overload disorder caused by inappropriately low hepcidin secretion leading to increased duodenal absorption of dietary iron"", ""supports"": ""SUPPORT""}], ""name"": ""Low Hepcidin Leads to Ferroportin Hyperabsorption""}"
3535	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	2	Hepatic Iron Toxicity	"Excess iron deposits in hepatocytes leading to oxidative stress, lipid peroxidation, and hepatocellular damage. Progressive iron accumulation causes fibrosis and can lead to cirrhosis and hepatocellular carcinoma.
"																																																								"{""description"": ""Excess iron deposits in hepatocytes leading to oxidative stress, lipid peroxidation, and hepatocellular damage. Progressive iron accumulation causes fibrosis and can lead to cirrhosis and hepatocellular carcinoma.\n"", ""name"": ""Hepatic Iron Toxicity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}], ""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Excess iron deposits in hepatocytes leading to oxidative stress, lipid peroxidation, and hepatocellular damage. Progressive iron accumulation causes fibrosis and can lead to cirrhosis and hepatocellular carcinoma.\n"", ""evidence"": [{""explanation"": ""Liver iron overload drives fibrotic injury and malignant risk."", ""reference"": ""PMID:37763705"", ""snippet"": ""The key organ that is affected by iron overload is the liver, suffering from fibrosis, cirrhosis or hepatocellular carcinoma"", ""supports"": ""SUPPORT""}], ""name"": ""Hepatic Iron Toxicity""}"
3536	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	3	Cardiac Iron Deposition	"Iron accumulation in cardiomyocytes causes oxidative damage and impaired contractility, leading to cardiomyopathy and cardiac failure, particularly dilated cardiomyopathy.
"																																																								"{""description"": ""Iron accumulation in cardiomyocytes causes oxidative damage and impaired contractility, leading to cardiomyopathy and cardiac failure, particularly dilated cardiomyopathy.\n"", ""name"": ""Cardiac Iron Deposition""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}], ""cell_types"": [{""preferred_term"": ""cardiac muscle cell"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""description"": ""Iron accumulation in cardiomyocytes causes oxidative damage and impaired contractility, leading to cardiomyopathy and cardiac failure, particularly dilated cardiomyopathy.\n"", ""evidence"": [{""explanation"": ""Early severe iron overload includes cardiomyopathy, consistent with cardiac iron toxicity."", ""reference"": ""PMID:35449524"", ""snippet"": ""Hemochromatosis type 2 or juvenile hemochromatosis has an early onset of severe iron overload resulting in organ manifestation such as liver fibrosis, cirrhosis, cardiomyopathy, arthropathy, hypogonadism, diabetes"", ""supports"": ""SUPPORT""}], ""name"": ""Cardiac Iron Deposition""}"
3537	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	4	Pancreatic Iron Toxicity	"Iron deposition in pancreatic beta cells causes oxidative damage and impaired insulin secretion, leading to diabetes mellitus (""bronze diabetes"").
"																																																								"{""description"": ""Iron deposition in pancreatic beta cells causes oxidative damage and impaired insulin secretion, leading to diabetes mellitus (\""bronze diabetes\"").\n"", ""name"": ""Pancreatic Iron Toxicity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}], ""cell_types"": [{""preferred_term"": ""type B pancreatic cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}], ""description"": ""Iron deposition in pancreatic beta cells causes oxidative damage and impaired insulin secretion, leading to diabetes mellitus (\""bronze diabetes\"").\n"", ""evidence"": [{""explanation"": ""Imaging confirms pancreatic iron deposition contributing to endocrine dysfunction."", ""reference"": ""PMID:38886778"", ""snippet"": ""Magnetic resonance imaging showed iron deposition in the liver, spleen, and pancreas, along with cirrhosis and splenomegaly."", ""supports"": ""SUPPORT""}], ""name"": ""Pancreatic Iron Toxicity""}"
3556	149	Hemophilia A	Hemophilia_A.yaml	pathophysiology	0	Factor VIII Deficiency	"Mutations in the F8 gene cause deficient or dysfunctional factor VIII protein. Factor VIII is a cofactor for factor IXa in the intrinsic coagulation pathway, essential for thrombin generation and fibrin clot formation.
"																																																								"{""description"": ""Mutations in the F8 gene cause deficient or dysfunctional factor VIII protein. Factor VIII is a cofactor for factor IXa in the intrinsic coagulation pathway, essential for thrombin generation and fibrin clot formation.\n"", ""name"": ""Factor VIII Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Blood Coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}], ""description"": ""Mutations in the F8 gene cause deficient or dysfunctional factor VIII protein. Factor VIII is a cofactor for factor IXa in the intrinsic coagulation pathway, essential for thrombin generation and fibrin clot formation.\n"", ""evidence"": [{""explanation"": ""Review establishes the molecular role of Factor VIII as a cofactor in the intrinsic pathway."", ""reference"": ""PMID:3096583"", ""snippet"": ""FVIII acts as a cofactor in the factor Xa-generating enzyme complex of the intrinsic coagulation cascade."", ""supports"": ""SUPPORT""}, {""explanation"": ""Clinical review confirms Factor VIII deficiency as the cause of hemophilia A."", ""reference"": ""PMID:34197690"", ""snippet"": ""Hemophilia A and B are rare X-linked inherited bleeding disorders caused by complete or partial deficiency in or the absence of coagulation factors VIII and IX."", ""supports"": ""SUPPORT""}], ""name"": ""Factor VIII Deficiency""}"
3557	149	Hemophilia A	Hemophilia_A.yaml	pathophysiology	1	Impaired Thrombin Generation	"Without functional factor VIII, the intrinsic tenase complex cannot form efficiently. This results in inadequate thrombin generation and unstable fibrin clot formation, leading to prolonged bleeding.
"																																																								"{""description"": ""Without functional factor VIII, the intrinsic tenase complex cannot form efficiently. This results in inadequate thrombin generation and unstable fibrin clot formation, leading to prolonged bleeding.\n"", ""name"": ""Impaired Thrombin Generation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Fibrin Clot Formation"", ""term"": {""id"": ""GO:0072378"", ""label"": ""blood coagulation, fibrin clot formation""}}], ""description"": ""Without functional factor VIII, the intrinsic tenase complex cannot form efficiently. This results in inadequate thrombin generation and unstable fibrin clot formation, leading to prolonged bleeding.\n"", ""evidence"": [{""explanation"": ""Study demonstrates that thrombin generation is fundamentally impaired in hemophilia A blood even with bypass therapy attempts."", ""reference"": ""PMID:11806995"", ""snippet"": ""pharmacologic concentrations of factor VIIa cannot restore normal thrombin generation in hemophilia A and hemophilia B blood in vitro."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired Thrombin Generation""}"
3568	150	Hemophilia B	Hemophilia_B.yaml	pathophysiology	0	Factor IX Deficiency	Deficiency of coagulation factor IX impairs intrinsic pathway function and leads to abnormal bleeding.																																																								"{""description"": ""Deficiency of coagulation factor IX impairs intrinsic pathway function and leads to abnormal bleeding."", ""name"": ""Factor IX Deficiency""}"	{}	"{""description"": ""Deficiency of coagulation factor IX impairs intrinsic pathway function and leads to abnormal bleeding."", ""evidence"": [{""explanation"": ""The abstract identifies factor IX deficiency as the cause of hemophilia B."", ""reference"": ""PMID:23430394"", ""snippet"": ""Hemophilia B is a recessive X-linked bleeding disorder characterized by deficiency of the coagulation factor IX (FIX)."", ""supports"": ""SUPPORT""}], ""name"": ""Factor IX Deficiency""}"
3588	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	0	Hepatocyte Infection and cccDNA Formation	HBV enters hepatocytes via NTCP receptor binding, and viral rcDNA is converted to covalently closed circular DNA (cccDNA) which forms a stable chromatinized minichromosome in the nucleus, enabling persistent infection.																																																								"{""description"": ""HBV enters hepatocytes via NTCP receptor binding, and viral rcDNA is converted to covalently closed circular DNA (cccDNA) which forms a stable chromatinized minichromosome in the nucleus, enabling persistent infection."", ""name"": ""Hepatocyte Infection and cccDNA Formation""}"	"{""downstream"": [{""description"": ""HBV infection triggers persistent immune activation and hepatic inflammation through both innate and adaptive immune responses."", ""evidence"": [{""explanation"": ""This reference directly establishes that the immune response to HBV causes chronic liver inflammation."", ""reference"": ""PMID:34071064"", ""snippet"": ""Although innate and adaptive immune cells play crucial roles in controlling hepatitis B virus (HBV) infection, they are also accountable for inflammation and subsequently cause liver pathologies."", ""supports"": ""SUPPORT""}], ""target"": ""Chronic Inflammation""}, {""description"": ""A fraction of viral DNA integrates into host genome at sites of DNA damage, contributing to persistent HBsAg expression and oncogenesis."", ""target"": ""HBV DNA Integration""}]}"	"{""biological_processes"": [{""preferred_term"": ""viral entry into host cell"", ""term"": {""id"": ""GO:0046718"", ""label"": ""viral entry into host cell""}}, {""preferred_term"": ""epigenetic regulation of gene expression"", ""term"": {""id"": ""GO:0040029"", ""label"": ""epigenetic regulation of gene expression""}}], ""cell_types"": [{""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""HBV enters hepatocytes via NTCP receptor binding, and viral rcDNA is converted to covalently closed circular DNA (cccDNA) which forms a stable chromatinized minichromosome in the nucleus, enabling persistent infection."", ""downstream"": [{""description"": ""HBV infection triggers persistent immune activation and hepatic inflammation through both innate and adaptive immune responses."", ""evidence"": [{""explanation"": ""This reference directly establishes that the immune response to HBV causes chronic liver inflammation."", ""reference"": ""PMID:34071064"", ""snippet"": ""Although innate and adaptive immune cells play crucial roles in controlling hepatitis B virus (HBV) infection, they are also accountable for inflammation and subsequently cause liver pathologies."", ""supports"": ""SUPPORT""}], ""target"": ""Chronic Inflammation""}, {""description"": ""A fraction of viral DNA integrates into host genome at sites of DNA damage, contributing to persistent HBsAg expression and oncogenesis."", ""target"": ""HBV DNA Integration""}], ""evidence"": [{""explanation"": ""This reference confirms that HBV infects hepatocytes and leads to chronic inflammation."", ""reference"": ""PMID:33573130"", ""snippet"": ""Human hepatitis B virus (HBV) can cause chronic, lifelong infection of the liver that may lead to persistent or episodic immune-mediated inflammation against virus-infected hepatocytes."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference confirms that HBV specifically infects hepatocytes."", ""reference"": ""PMID:32866519"", ""snippet"": ""'Hepatitis B virus (HBV) specifically infects hepatocytes and causes severe liver diseases."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference confirms that HBV integrates into the host genome within hepatocytes and persists."", ""reference"": ""PMID:30518652"", ""snippet"": ""Distinct populations of hepatocytes infected with hepatitis B virus (HBV) or only harboring HBV DNA integrations coexist within an HBV chronically infected liver."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by indicating that HBV infection leads to chronic conditions such as cirrhosis, which is a form of chronic inflammation."", ""reference"": ""PMID:32151000"", ""snippet"": ""HBV is a major cause of cirrhosis and hepatocellular carcinoma."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Hepatocyte Infection and cccDNA Formation""}"
3589	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	1	HBV DNA Integration	Integration of viral dslDNA into host genome occurs at sites of DNA damage, driving insertional mutagenesis, structural rearrangements, and activation of proto-oncogenes.																																		Present in 85-90% of HBV-related hepatocellular carcinomas.																						"{""description"": ""Integration of viral dslDNA into host genome occurs at sites of DNA damage, driving insertional mutagenesis, structural rearrangements, and activation of proto-oncogenes."", ""name"": ""HBV DNA Integration"", ""notes"": ""Present in 85-90% of HBV-related hepatocellular carcinomas.""}"	"{""downstream"": [{""description"": ""DNA integration drives oncogenesis through activation of TERT and other proto-oncogenes, genomic instability, and structural rearrangements."", ""target"": ""Hepatocellular Carcinoma""}]}"	"{""biological_processes"": [{""preferred_term"": ""DNA integration"", ""term"": {""id"": ""GO:0015074"", ""label"": ""DNA integration""}}], ""description"": ""Integration of viral dslDNA into host genome occurs at sites of DNA damage, driving insertional mutagenesis, structural rearrangements, and activation of proto-oncogenes."", ""downstream"": [{""description"": ""DNA integration drives oncogenesis through activation of TERT and other proto-oncogenes, genomic instability, and structural rearrangements."", ""target"": ""Hepatocellular Carcinoma""}], ""name"": ""HBV DNA Integration"", ""notes"": ""Present in 85-90% of HBV-related hepatocellular carcinomas.""}"
3590	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	2	Chronic Inflammation	Persistent immune response against HBV-infected hepatocytes leads to liver damage mediated by T cells, NK cells, and Kupffer cells.																																																								"{""description"": ""Persistent immune response against HBV-infected hepatocytes leads to liver damage mediated by T cells, NK cells, and Kupffer cells."", ""name"": ""Chronic Inflammation""}"	"{""downstream"": [{""description"": ""Chronic inflammation activates hepatic stellate cells leading to extracellular matrix deposition and progressive fibrosis."", ""evidence"": [{""explanation"": ""This reference establishes the mechanistic link between chronic HBV, hepatic stellate cell activation, and fibrosis development."", ""reference"": ""PMID:37041599"", ""snippet"": ""During chronic hepatitis B virus (HBV) infection, hepatic fibrosis is a serious pathological condition caused by virus-induced liver damage. The activation of hepatic stellate cells (HSCs) is a central event in the occurrence and progression of liver fibrosis."", ""supports"": ""SUPPORT""}], ""target"": ""Liver Fibrosis""}, {""description"": ""Progressive fibrosis leads to architectural disruption and nodule formation characteristic of cirrhosis."", ""evidence"": [{""explanation"": ""This reference establishes that HBV causes progression from fibrosis to cirrhosis."", ""reference"": ""PMID:22375524"", ""snippet"": ""Hepatitis B virus (HBV) infection currently accounts for approximately 600,000 deaths per year resulting from progression of liver fibrosis to cirrhosis and hepatocellular carcinoma."", ""supports"": ""SUPPORT""}], ""target"": ""Cirrhosis""}]}"	"{""cell_types"": [{""preferred_term"": ""CD8-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}, {""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}, {""description"": ""Liver-resident macrophages (Kupffer cells)"", ""preferred_term"": ""inflammatory macrophage"", ""term"": {""id"": ""CL:0000863"", ""label"": ""inflammatory macrophage""}}], ""description"": ""Persistent immune response against HBV-infected hepatocytes leads to liver damage mediated by T cells, NK cells, and Kupffer cells."", ""downstream"": [{""description"": ""Chronic inflammation activates hepatic stellate cells leading to extracellular matrix deposition and progressive fibrosis."", ""evidence"": [{""explanation"": ""This reference establishes the mechanistic link between chronic HBV, hepatic stellate cell activation, and fibrosis development."", ""reference"": ""PMID:37041599"", ""snippet"": ""During chronic hepatitis B virus (HBV) infection, hepatic fibrosis is a serious pathological condition caused by virus-induced liver damage. The activation of hepatic stellate cells (HSCs) is a central event in the occurrence and progression of liver fibrosis."", ""supports"": ""SUPPORT""}], ""target"": ""Liver Fibrosis""}, {""description"": ""Progressive fibrosis leads to architectural disruption and nodule formation characteristic of cirrhosis."", ""evidence"": [{""explanation"": ""This reference establishes that HBV causes progression from fibrosis to cirrhosis."", ""reference"": ""PMID:22375524"", ""snippet"": ""Hepatitis B virus (HBV) infection currently accounts for approximately 600,000 deaths per year resulting from progression of liver fibrosis to cirrhosis and hepatocellular carcinoma."", ""supports"": ""SUPPORT""}], ""target"": ""Cirrhosis""}], ""evidence"": [{""explanation"": ""This reference supports that the immune response against HBV-infected hepatocytes contributes to liver damage, which aligns with the statement."", ""reference"": ""PMID:8571172"", ""snippet"": ""The immune response to HBV-encoded antigens is responsible both for viral clearance and for disease pathogenesis during this infection."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the link between chronic HBV infection and cirrhosis, which is a downstream effect of persistent immune response and liver damage."", ""reference"": ""PMID:34543610"", ""snippet"": ""Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such as... hepatitis B or C infection."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports that chronic HBV infection leads to liver fibrosis, which is a downstream effect of immune response and liver damage."", ""reference"": ""PMID:32147592"", ""snippet"": ""Progression of liver fibrosis still occurs in some patients with chronic hepatitis B virus (HBV) infection despite antiviral therapy."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement that HBV-induced liver damage leads to fibrosis, which is a downstream effect of chronic inflammation."", ""reference"": ""PMID:37041599"", ""snippet"": ""During chronic hepatitis B virus (HBV) infection, hepatic fibrosis is a serious pathological condition caused by virus-induced liver damage."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the link between chronic HBV infection and liver fibrosis/cirrhosis, which are downstream effects of immune response and liver damage."", ""reference"": ""PMID:31367154"", ""snippet"": ""Hepatitis B virus (HBV) infection is one the leading risk factors for chronic hepatitis, liver fibrosis, cirrhosis and hepatocellular cancer (HCC)."", ""supports"": ""SUPPORT""}], ""name"": ""Chronic Inflammation""}"
3591	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	3	Immune Evasion and T Cell Exhaustion	HBV evades innate immune detection through dampened TLR, cGAS-STING, and RIG-I-MAVS pathways. Chronic infection leads to T cell exhaustion with upregulation of PD-1, CTLA-4, and TIM-3 checkpoint receptors.																																																								"{""description"": ""HBV evades innate immune detection through dampened TLR, cGAS-STING, and RIG-I-MAVS pathways. Chronic infection leads to T cell exhaustion with upregulation of PD-1, CTLA-4, and TIM-3 checkpoint receptors."", ""name"": ""Immune Evasion and T Cell Exhaustion""}"	{}	"{""biological_processes"": [{""preferred_term"": ""negative regulation of T cell activation"", ""term"": {""id"": ""GO:0050868"", ""label"": ""negative regulation of T cell activation""}}, {""preferred_term"": ""cGAS-STING signaling pathway"", ""term"": {""id"": ""GO:0061761"", ""label"": ""cGAS-STING signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""CD8-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}, {""preferred_term"": ""regulatory T cell"", ""term"": {""id"": ""CL:0000815"", ""label"": ""regulatory T cell""}}], ""description"": ""HBV evades innate immune detection through dampened TLR, cGAS-STING, and RIG-I-MAVS pathways. Chronic infection leads to T cell exhaustion with upregulation of PD-1, CTLA-4, and TIM-3 checkpoint receptors."", ""evidence"": [{""explanation"": ""The reference supports the role of T cells in immune clearance but does not mention B cells."", ""reference"": ""PMID:16461223"", ""snippet"": ""The immune system plays an important role in determining the outcome of hepatitis B virus (HBV) infection... Multispecific antiviral CD4 and CD8 responses with a type 1 cytokine production can be observed in patients who recover from acute HBV infection."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference supports the role of T cells in immune clearance but does not mention B cells."", ""reference"": ""PMID:36936922"", ""snippet"": ""The clearance of HBV with virus-specific CD8 T cells is critical for a functional cure."", ""supports"": ""PARTIAL""}], ""name"": ""Immune Evasion and T Cell Exhaustion""}"
3592	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	4	Liver Fibrosis	Chronic inflammation promotes fibrotic tissue deposition replacing healthy liver cells.																																																								"{""description"": ""Chronic inflammation promotes fibrotic tissue deposition replacing healthy liver cells."", ""name"": ""Liver Fibrosis""}"	"{""downstream"": [{""description"": ""Progressive fibrosis leads to complete architectural disruption and end-stage liver disease."", ""evidence"": [{""explanation"": ""This reference establishes the progression from fibrosis to cirrhosis in chronic liver disease."", ""reference"": ""PMID:26691189"", ""snippet"": ""Chronic unresolved inflammation is associated with persistent hepatic injury and concurrent regeneration, leading to sequential development of fibrosis, cirrhosis, and eventually HCC."", ""supports"": ""SUPPORT""}], ""target"": ""Cirrhosis""}]}"	"{""description"": ""Chronic inflammation promotes fibrotic tissue deposition replacing healthy liver cells."", ""downstream"": [{""description"": ""Progressive fibrosis leads to complete architectural disruption and end-stage liver disease."", ""evidence"": [{""explanation"": ""This reference establishes the progression from fibrosis to cirrhosis in chronic liver disease."", ""reference"": ""PMID:26691189"", ""snippet"": ""Chronic unresolved inflammation is associated with persistent hepatic injury and concurrent regeneration, leading to sequential development of fibrosis, cirrhosis, and eventually HCC."", ""supports"": ""SUPPORT""}], ""target"": ""Cirrhosis""}], ""evidence"": [{""explanation"": ""The statement is supported as liver fibrosis involves the replacement of healthy liver cells with fibrotic tissue due to chronic inflammation."", ""reference"": ""PMID:17613356"", ""snippet"": ""Liver fibrosis results from chronic damage to the liver in conjunction with the progressive accumulation of fibrillar extracellular matrix proteins."", ""supports"": ""SUPPORT""}, {""explanation"": ""The statement is supported as chronic inflammation promotes liver fibrosis through specific inflammatory pathways."", ""reference"": ""PMID:33528280"", ""snippet"": ""Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection."", ""supports"": ""SUPPORT""}, {""explanation"": ""The statement is supported as chronic inflammation leads to liver fibrosis and cirrhosis."", ""reference"": ""PMID:26691189"", ""snippet"": ""Chronic unresolved inflammation is associated with persistent hepatic injury and concurrent regeneration, leading to sequential development of fibrosis, cirrhosis, and eventually HCC."", ""supports"": ""SUPPORT""}, {""explanation"": ""The statement is supported as recurrent inflammation in chronic HBV infection results in liver fibrosis."", ""reference"": ""PMID:31769518"", ""snippet"": ""Recurrent hepatitis activity during chronic hepatitis B virus infection results in fibrosis and even hepatocellular carcinoma."", ""supports"": ""SUPPORT""}], ""name"": ""Liver Fibrosis""}"
3593	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	5	Cirrhosis	Extensive fibrosis and scarring significantly impair liver function.																																																								"{""description"": ""Extensive fibrosis and scarring significantly impair liver function."", ""name"": ""Cirrhosis""}"	{}	"{""description"": ""Extensive fibrosis and scarring significantly impair liver function."", ""evidence"": [{""explanation"": ""This reference supports the statement by indicating that chronic hepatitis B can lead to cirrhosis, which is associated with extensive fibrosis and scarring that impair liver function."", ""reference"": ""PMID:17981234"", ""snippet"": ""Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40% of individuals."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by describing cirrhosis as an advanced form of hepatic fibrosis that distorts liver architecture, thereby impairing liver function."", ""reference"": ""PMID:19577114"", ""snippet"": ""Cirrhosis is defined histologically as an advanced form of progressive hepatic fibrosis with distortion of the hepatic architecture and regenerative nodule formation."", ""supports"": ""SUPPORT""}, {""explanation"": ""While this reference discusses liver fibrosis resulting from chronic liver damage, it does not explicitly connect it to cirrhosis or the impairment of liver function."", ""reference"": ""PMID:17613356"", ""snippet"": ""Liver fibrosis results from chronic damage to the liver in conjunction with the progressive accumulation of fibrillar extracellular matrix proteins."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference supports the statement by mentioning cirrhosis in the context of chronic hepatitis B and its associated liver-related complications."", ""reference"": ""PMID:24373083"", ""snippet"": ""Long-lasting HBV-DNA suppression is considered to be the best surrogate end-point of antiviral therapy in patients with hepatitis B virus (HBV) related chronic hepatitis or cirrhosis, and it is a prerequisite to prevent liver-related complications and improve survival."", ""supports"": ""SUPPORT""}], ""name"": ""Cirrhosis""}"
3629	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	0	Viral Replication and Hepatocyte Injury	"HCV is a positive-sense single-stranded RNA virus that replicates primarily in hepatocytes. Viral replication causes direct cytopathic effects and triggers immune-mediated hepatocyte destruction. The virus evades immune clearance through high mutation rates and quasispecies diversity.
"																																																								"{""description"": ""HCV is a positive-sense single-stranded RNA virus that replicates primarily in hepatocytes. Viral replication causes direct cytopathic effects and triggers immune-mediated hepatocyte destruction. The virus evades immune clearance through high mutation rates and quasispecies diversity.\n"", ""name"": ""Viral Replication and Hepatocyte Injury""}"	{}	"{""biological_processes"": [{""preferred_term"": ""viral life cycle"", ""term"": {""id"": ""GO:0019058"", ""label"": ""viral life cycle""}}], ""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""HCV is a positive-sense single-stranded RNA virus that replicates primarily in hepatocytes. Viral replication causes direct cytopathic effects and triggers immune-mediated hepatocyte destruction. The virus evades immune clearance through high mutation rates and quasispecies diversity.\n"", ""name"": ""Viral Replication and Hepatocyte Injury""}"
3630	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	1	Chronic Inflammation and Fibrosis	"Persistent HCV infection induces chronic hepatic inflammation with infiltration of lymphocytes and activation of hepatic stellate cells. This leads to progressive fibrosis through excessive collagen deposition, ultimately resulting in cirrhosis.
"																																																								"{""description"": ""Persistent HCV infection induces chronic hepatic inflammation with infiltration of lymphocytes and activation of hepatic stellate cells. This leads to progressive fibrosis through excessive collagen deposition, ultimately resulting in cirrhosis.\n"", ""name"": ""Chronic Inflammation and Fibrosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""chronic inflammatory response"", ""term"": {""id"": ""GO:0002544"", ""label"": ""chronic inflammatory response""}}, {""preferred_term"": ""hepatic stellate cell activation"", ""term"": {""id"": ""GO:0035733"", ""label"": ""hepatic stellate cell activation""}}, {""preferred_term"": ""collagen biosynthetic process"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}], ""cell_types"": [{""preferred_term"": ""hepatic stellate cell"", ""term"": {""id"": ""CL:0000632"", ""label"": ""hepatic stellate cell""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Persistent HCV infection induces chronic hepatic inflammation with infiltration of lymphocytes and activation of hepatic stellate cells. This leads to progressive fibrosis through excessive collagen deposition, ultimately resulting in cirrhosis.\n"", ""evidence"": [{""explanation"": ""Study specifically targets HCV patients with decompensated cirrhosis, confirming progression of chronic inflammation to advanced liver damage."", ""reference"": ""PMID:26569658"", ""snippet"": ""patients infected with HCV genotypes 1 through 6 who had decompensated cirrhosis"", ""supports"": ""SUPPORT""}], ""name"": ""Chronic Inflammation and Fibrosis""}"
3631	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	2	Immune Evasion	"HCV employs multiple strategies to evade host immune responses, including interference with interferon signaling, rapid viral mutation generating escape variants, and exhaustion of HCV-specific T cells.
"																																																								"{""description"": ""HCV employs multiple strategies to evade host immune responses, including interference with interferon signaling, rapid viral mutation generating escape variants, and exhaustion of HCV-specific T cells.\n"", ""name"": ""Immune Evasion""}"	{}	"{""biological_processes"": [{""preferred_term"": ""symbiont-mediated suppression of host type I interferon-mediated signaling pathway"", ""term"": {""id"": ""GO:0039502"", ""label"": ""symbiont-mediated suppression of host type I interferon-mediated signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""HCV employs multiple strategies to evade host immune responses, including interference with interferon signaling, rapid viral mutation generating escape variants, and exhaustion of HCV-specific T cells.\n"", ""evidence"": [{""explanation"": ""Study demonstrates that viruses can interfere with interferon signaling through IPS-1/MAVS pathway, a mechanism also employed by HCV."", ""reference"": ""PMID:16127453"", ""snippet"": ""'Knockdown' of IPS-1 by small interfering RNA blocked interferon induction by virus infection"", ""supports"": ""SUPPORT""}], ""name"": ""Immune Evasion""}"
3632	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	3	Hepatocellular Carcinoma Development	"Chronic inflammation, oxidative stress, and direct viral effects on cell signaling pathways contribute to hepatocarcinogenesis. Cirrhosis is the major risk factor, but HCC can occur in non-cirrhotic livers.
"																																																								"{""description"": ""Chronic inflammation, oxidative stress, and direct viral effects on cell signaling pathways contribute to hepatocarcinogenesis. Cirrhosis is the major risk factor, but HCC can occur in non-cirrhotic livers.\n"", ""name"": ""Hepatocellular Carcinoma Development""}"	{}	"{""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Chronic inflammation, oxidative stress, and direct viral effects on cell signaling pathways contribute to hepatocarcinogenesis. Cirrhosis is the major risk factor, but HCC can occur in non-cirrhotic livers.\n"", ""name"": ""Hepatocellular Carcinoma Development""}"
3655	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	0	Chronic Liver Injury and Cirrhosis	Most HCC arises in the context of chronic liver disease and cirrhosis. Persistent hepatocyte death and regeneration in an inflammatory environment promotes accumulation of genetic alterations. Cirrhosis itself is a premalignant condition with ongoing oxidative stress and genomic instability.																																																								"{""description"": ""Most HCC arises in the context of chronic liver disease and cirrhosis. Persistent hepatocyte death and regeneration in an inflammatory environment promotes accumulation of genetic alterations. Cirrhosis itself is a premalignant condition with ongoing oxidative stress and genomic instability."", ""name"": ""Chronic Liver Injury and Cirrhosis""}"	"{""downstream"": [{""description"": ""Repeated hepatocyte division leads to telomere shortening"", ""target"": ""Telomere Dysfunction and Genomic Instability""}, {""description"": ""Chronic regeneration promotes mutation accumulation"", ""target"": ""Accumulation of Driver Mutations""}]}"	"{""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Most HCC arises in the context of chronic liver disease and cirrhosis. Persistent hepatocyte death and regeneration in an inflammatory environment promotes accumulation of genetic alterations. Cirrhosis itself is a premalignant condition with ongoing oxidative stress and genomic instability."", ""downstream"": [{""description"": ""Repeated hepatocyte division leads to telomere shortening"", ""target"": ""Telomere Dysfunction and Genomic Instability""}, {""description"": ""Chronic regeneration promotes mutation accumulation"", ""target"": ""Accumulation of Driver Mutations""}], ""evidence"": [{""explanation"": ""This abstract states that HCC commonly arises in chronic liver disease and cirrhosis, supporting the mechanism described."", ""reference"": ""PMID:41567639"", ""snippet"": ""HCC typically arises in patients with chronic liver disease, including hepatitis, cirrhosis, and non-alcoholic fatty liver diseases."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Chronic Liver Injury and Cirrhosis""}"
3656	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	1	Telomere Dysfunction and Genomic Instability	Chronic hepatocyte proliferation leads to telomere shortening, causing genomic instability. TERT promoter mutations, which are the most common HCC mutations, reactivate telomerase to enable unlimited replication. This creates a checkpoint bypass allowing survival of genetically unstable cells.																																																								"{""description"": ""Chronic hepatocyte proliferation leads to telomere shortening, causing genomic instability. TERT promoter mutations, which are the most common HCC mutations, reactivate telomerase to enable unlimited replication. This creates a checkpoint bypass allowing survival of genetically unstable cells."", ""name"": ""Telomere Dysfunction and Genomic Instability""}"	"{""downstream"": [{""description"": ""Genomic instability promotes acquisition of pathway-activating mutations"", ""target"": ""WNT/Beta-Catenin Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""telomere maintenance"", ""term"": {""id"": ""GO:0000723"", ""label"": ""telomere maintenance""}}], ""description"": ""Chronic hepatocyte proliferation leads to telomere shortening, causing genomic instability. TERT promoter mutations, which are the most common HCC mutations, reactivate telomerase to enable unlimited replication. This creates a checkpoint bypass allowing survival of genetically unstable cells."", ""downstream"": [{""description"": ""Genomic instability promotes acquisition of pathway-activating mutations"", ""target"": ""WNT/Beta-Catenin Pathway Activation""}], ""name"": ""Telomere Dysfunction and Genomic Instability""}"
3657	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	2	Accumulation of Driver Mutations	Multiple driver genes are recurrently mutated in HCC, including TERT promoter (60%), TP53 (30%), CTNNB1 (30%), AXIN1 (10%), and ARID1A (10%). These mutations affect telomere maintenance, cell cycle control, WNT signaling, and chromatin remodeling.																																																								"{""description"": ""Multiple driver genes are recurrently mutated in HCC, including TERT promoter (60%), TP53 (30%), CTNNB1 (30%), AXIN1 (10%), and ARID1A (10%). These mutations affect telomere maintenance, cell cycle control, WNT signaling, and chromatin remodeling."", ""name"": ""Accumulation of Driver Mutations""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}], ""description"": ""Multiple driver genes are recurrently mutated in HCC, including TERT promoter (60%), TP53 (30%), CTNNB1 (30%), AXIN1 (10%), and ARID1A (10%). These mutations affect telomere maintenance, cell cycle control, WNT signaling, and chromatin remodeling."", ""name"": ""Accumulation of Driver Mutations""}"
3658	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	3	WNT/Beta-Catenin Pathway Activation	Activating mutations in CTNNB1 (beta-catenin) or inactivating mutations in AXIN1 lead to constitutive WNT pathway activation. This drives cell proliferation and is associated with a distinct molecular subclass of HCC with specific clinical features including cholestasis and immune exclusion.																																																								"{""description"": ""Activating mutations in CTNNB1 (beta-catenin) or inactivating mutations in AXIN1 lead to constitutive WNT pathway activation. This drives cell proliferation and is associated with a distinct molecular subclass of HCC with specific clinical features including cholestasis and immune exclusion."", ""name"": ""WNT/Beta-Catenin Pathway Activation""}"	"{""downstream"": [{""description"": ""WNT signaling drives cell proliferation and stemness"", ""target"": ""Enhanced Hepatocyte Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""Wnt signaling pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}], ""description"": ""Activating mutations in CTNNB1 (beta-catenin) or inactivating mutations in AXIN1 lead to constitutive WNT pathway activation. This drives cell proliferation and is associated with a distinct molecular subclass of HCC with specific clinical features including cholestasis and immune exclusion."", ""downstream"": [{""description"": ""WNT signaling drives cell proliferation and stemness"", ""target"": ""Enhanced Hepatocyte Proliferation""}], ""name"": ""WNT/Beta-Catenin Pathway Activation""}"
3659	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	4	TP53 Pathway Inactivation	TP53 mutations are common in HCC, particularly in HBV-associated and aflatoxin-associated tumors. Loss of p53 function removes a critical checkpoint, allowing survival of cells with DNA damage and promoting genomic instability.																																																								"{""description"": ""TP53 mutations are common in HCC, particularly in HBV-associated and aflatoxin-associated tumors. Loss of p53 function removes a critical checkpoint, allowing survival of cells with DNA damage and promoting genomic instability."", ""name"": ""TP53 Pathway Inactivation""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""TP53 mutations are common in HCC, particularly in HBV-associated and aflatoxin-associated tumors. Loss of p53 function removes a critical checkpoint, allowing survival of cells with DNA damage and promoting genomic instability."", ""name"": ""TP53 Pathway Inactivation""}"
3660	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	5	Enhanced Hepatocyte Proliferation	Combined effects of telomerase reactivation, cell cycle checkpoint loss, and mitogenic signaling drive uncontrolled hepatocyte proliferation and tumor growth.																																																								"{""description"": ""Combined effects of telomerase reactivation, cell cycle checkpoint loss, and mitogenic signaling drive uncontrolled hepatocyte proliferation and tumor growth."", ""name"": ""Enhanced Hepatocyte Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Combined effects of telomerase reactivation, cell cycle checkpoint loss, and mitogenic signaling drive uncontrolled hepatocyte proliferation and tumor growth."", ""name"": ""Enhanced Hepatocyte Proliferation""}"
3661	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	6	Angiogenesis and VEGF Signaling	HCC is a highly vascular tumor dependent on angiogenesis. VEGF signaling promotes new blood vessel formation supplying the tumor. VEGF also has immunosuppressive effects, contributing to the immune-excluded microenvironment. This provides the rationale for anti-VEGF therapy in combination with immunotherapy.																																																								"{""description"": ""HCC is a highly vascular tumor dependent on angiogenesis. VEGF signaling promotes new blood vessel formation supplying the tumor. VEGF also has immunosuppressive effects, contributing to the immune-excluded microenvironment. This provides the rationale for anti-VEGF therapy in combination with immunotherapy."", ""name"": ""Angiogenesis and VEGF Signaling""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}], ""description"": ""HCC is a highly vascular tumor dependent on angiogenesis. VEGF signaling promotes new blood vessel formation supplying the tumor. VEGF also has immunosuppressive effects, contributing to the immune-excluded microenvironment. This provides the rationale for anti-VEGF therapy in combination with immunotherapy."", ""evidence"": [{""explanation"": ""Abstract notes HCC is highly vascular and angiogenesis plays a major role, supporting this mechanism."", ""reference"": ""PMID:19637355"", ""snippet"": ""Hepatocellular carcinoma (HCC) is a highly vascular tumor, and angiogenesis is believed to play a considerable role in its development and progression."", ""supports"": ""SUPPORT""}], ""name"": ""Angiogenesis and VEGF Signaling""}"
3683	154	Hereditary Breast and Ovarian Cancer Syndrome	Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml	pathophysiology	0	BRCA1/2 Tumor Suppressor Loss	Germline heterozygous BRCA1 or BRCA2 mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates BRCA function, initiating tumorigenesis. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation.																																																								"{""description"": ""Germline heterozygous BRCA1 or BRCA2 mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates BRCA function, initiating tumorigenesis. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation."", ""name"": ""BRCA1/2 Tumor Suppressor Loss""}"	"{""downstream"": [{""description"": ""BRCA loss impairs error-free DNA double-strand break repair"", ""target"": ""Homologous Recombination Deficiency""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}], ""description"": ""Germline heterozygous BRCA1 or BRCA2 mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates BRCA function, initiating tumorigenesis. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation."", ""downstream"": [{""description"": ""BRCA loss impairs error-free DNA double-strand break repair"", ""target"": ""Homologous Recombination Deficiency""}], ""name"": ""BRCA1/2 Tumor Suppressor Loss""}"
3684	154	Hereditary Breast and Ovarian Cancer Syndrome	Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml	pathophysiology	1	Homologous Recombination Deficiency	BRCA1 and BRCA2 are essential components of the homologous recombination (HR) pathway for error-free repair of DNA double-strand breaks. Loss of BRCA function forces cells to rely on error-prone repair pathways such as non-homologous end joining, leading to genomic instability.																																																								"{""description"": ""BRCA1 and BRCA2 are essential components of the homologous recombination (HR) pathway for error-free repair of DNA double-strand breaks. Loss of BRCA function forces cells to rely on error-prone repair pathways such as non-homologous end joining, leading to genomic instability."", ""name"": ""Homologous Recombination Deficiency""}"	"{""downstream"": [{""description"": ""Error-prone repair mechanisms cause chromosomal rearrangements"", ""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""homologous recombination"", ""term"": {""id"": ""GO:0035825"", ""label"": ""homologous recombination""}}], ""description"": ""BRCA1 and BRCA2 are essential components of the homologous recombination (HR) pathway for error-free repair of DNA double-strand breaks. Loss of BRCA function forces cells to rely on error-prone repair pathways such as non-homologous end joining, leading to genomic instability."", ""downstream"": [{""description"": ""Error-prone repair mechanisms cause chromosomal rearrangements"", ""target"": ""Genomic Instability""}], ""evidence"": [{""explanation"": ""Review distinguishes BRCA1 and BRCA2 roles in DNA damage response and homologous recombination repair."", ""reference"": ""PMID:22193408"", ""snippet"": ""BRCA1 is a pleiotropic DDR protein that functions in both checkpoint activation and DNA repair, whereas BRCA2 is a mediator of the core mechanism of homologous recombination. The links between the two proteins are not well understood, but they must exist to explain the marked similarity of human cancer susceptibility that arises with germline mutations in these genes."", ""supports"": ""SUPPORT""}], ""name"": ""Homologous Recombination Deficiency""}"
3685	154	Hereditary Breast and Ovarian Cancer Syndrome	Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml	pathophysiology	2	Genomic Instability	Loss of HR-mediated repair leads to accumulation of chromosomal aberrations, large-scale genomic rearrangements, and copy number alterations. This pattern of genomic instability, termed 'BRCAness' or homologous recombination deficiency (HRD), is characteristic of BRCA-deficient tumors and creates therapeutic vulnerability to PARP inhibitors.																																																								"{""description"": ""Loss of HR-mediated repair leads to accumulation of chromosomal aberrations, large-scale genomic rearrangements, and copy number alterations. This pattern of genomic instability, termed 'BRCAness' or homologous recombination deficiency (HRD), is characteristic of BRCA-deficient tumors and creates therapeutic vulnerability to PARP inhibitors."", ""name"": ""Genomic Instability""}"	"{""downstream"": [{""description"": ""Accumulated genomic aberrations drive malignant transformation"", ""target"": ""Tumor Development""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of DNA damage checkpoint"", ""term"": {""id"": ""GO:0010618"", ""label"": ""regulation of DNA damage checkpoint""}}], ""description"": ""Loss of HR-mediated repair leads to accumulation of chromosomal aberrations, large-scale genomic rearrangements, and copy number alterations. This pattern of genomic instability, termed 'BRCAness' or homologous recombination deficiency (HRD), is characteristic of BRCA-deficient tumors and creates therapeutic vulnerability to PARP inhibitors."", ""downstream"": [{""description"": ""Accumulated genomic aberrations drive malignant transformation"", ""target"": ""Tumor Development""}], ""name"": ""Genomic Instability""}"
3686	154	Hereditary Breast and Ovarian Cancer Syndrome	Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml	pathophysiology	3	Tumor Development	Progressive accumulation of genomic alterations in BRCA-deficient cells leads to transformation and tumor development. The tissue specificity (breast, ovary) may relate to estrogen exposure and proliferative demands on these tissues, though the precise mechanisms remain incompletely understood.																																																								"{""description"": ""Progressive accumulation of genomic alterations in BRCA-deficient cells leads to transformation and tumor development. The tissue specificity (breast, ovary) may relate to estrogen exposure and proliferative demands on these tissues, though the precise mechanisms remain incompletely understood."", ""name"": ""Tumor Development""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Progressive accumulation of genomic alterations in BRCA-deficient cells leads to transformation and tumor development. The tissue specificity (breast, ovary) may relate to estrogen exposure and proliferative demands on these tissues, though the precise mechanisms remain incompletely understood."", ""name"": ""Tumor Development""}"
3701	155	Hereditary von Willebrand Disease	Hereditary_von_Willebrand_Disease.yaml	pathophysiology	0	Von Willebrand Factor Deficiency or Dysfunction	Deficiency or qualitative defects of von Willebrand factor impair primary hemostasis and predispose to mucocutaneous bleeding.																																																								"{""description"": ""Deficiency or qualitative defects of von Willebrand factor impair primary hemostasis and predispose to mucocutaneous bleeding."", ""name"": ""Von Willebrand Factor Deficiency or Dysfunction""}"	{}	"{""description"": ""Deficiency or qualitative defects of von Willebrand factor impair primary hemostasis and predispose to mucocutaneous bleeding."", ""evidence"": [{""explanation"": ""The abstract characterizes von Willebrand disease as an inherited bleeding disorder."", ""reference"": ""PMID:21289515"", ""snippet"": ""von Willebrand disease is a common inherited bleeding disorder characterized by excessive mucocutaneous bleeding."", ""supports"": ""SUPPORT""}], ""name"": ""Von Willebrand Factor Deficiency or Dysfunction""}"
3723	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	0	Failure of Enteric Ganglion Cell Migration	Defective migration of neural crest cells during embryonic development leads to absent ganglion cells in the bowel.																																																								"{""description"": ""Defective migration of neural crest cells during embryonic development leads to absent ganglion cells in the bowel."", ""name"": ""Failure of Enteric Ganglion Cell Migration""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""neural crest cell migration"", ""term"": {""id"": ""GO:0001755"", ""label"": ""neural crest cell migration""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""modifier"": ""ABSENT"", ""preferred_term"": ""enteric neuron"", ""term"": {""id"": ""CL:0007011"", ""label"": ""enteric neuron""}}], ""description"": ""Defective migration of neural crest cells during embryonic development leads to absent ganglion cells in the bowel."", ""evidence"": [{""explanation"": ""The article describes Hirschsprung's disease as being caused by defective migration of neural crest cells during embryonic development, which results in aganglionosis (absence of ganglion cells) in the bowel."", ""reference"": ""PMID:33202966"", ""snippet"": ""Hirschsprung's disease is a neurocristopathy, caused by defective migration, proliferation, differentiation and survival of neural crest cells, leading to gut aganglionosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature explains that Hirschsprung disease results from the failure of developing enteric ganglia, which are derived from neural crest cells, supporting the notion of defective migration leading to absent ganglion cells."", ""reference"": ""PMID:36417785"", ""snippet"": ""Derived from neural crest cells (NCCs), this little brain controls muscle contraction, motility, and bowel activities in response to stimuli. Failure of developing enteric ganglia at the distal bowel results in intestinal obstruction and Hirschsprung disease (HSCR)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This publication clearly states that disruption of neural crest cell migration during embryonic development leads to Hirschsprung disease."", ""reference"": ""PMID:23342068"", ""snippet"": ""Hirschsprung disease (HSCR) is a congenital malformation of the hindgut resulting from a disruption of neural crest cell migration during embryonic development."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the idea that Hirschsprung's disease involves issues with neural crest cell migration, although it adds the perspective of an abnormal microenvironment in the colon."", ""reference"": ""PMID:8660047"", ""snippet"": ""Current evidence on the pathogenesis of Hirschprung's disease, then, favours the 'abnormal microenvironment' hypothesis wherein the developing and migrating normal neural crest cells confront a segmentally abnormal and hostile microenvironment in the colon."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""myenteric nerve plexus"", ""term"": {""id"": ""UBERON:0002439"", ""label"": ""myenteric nerve plexus""}}, {""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}], ""name"": ""Failure of Enteric Ganglion Cell Migration""}"
3724	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	1	Disrupted Enteric Nervous System Development	The lack of ganglion cells causes a disruption in enteric nervous system function, leading to bowel motility issues.																																																								"{""description"": ""The lack of ganglion cells causes a disruption in enteric nervous system function, leading to bowel motility issues."", ""name"": ""Disrupted Enteric Nervous System Development""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""neuron differentiation"", ""term"": {""id"": ""GO:0030182"", ""label"": ""neuron differentiation""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""peristalsis"", ""term"": {""id"": ""GO:0030432"", ""label"": ""peristalsis""}}], ""cell_types"": [{""modifier"": ""ABSENT"", ""preferred_term"": ""enteric neuron"", ""term"": {""id"": ""CL:0007011"", ""label"": ""enteric neuron""}}], ""description"": ""The lack of ganglion cells causes a disruption in enteric nervous system function, leading to bowel motility issues."", ""evidence"": [{""explanation"": ""The absence of ganglion cells (aganglionosis) leads to disruption in enteric nervous system function and subsequent bowel motility issues."", ""reference"": ""PMID:20610192"", ""snippet"": ""simon.kenny@liv.ac.uk Hirschsprung's disease (HSCR) is characterized by absence of the enteric nervous system in a variable portion of the distal gut"", ""supports"": ""SUPPORT""}, {""explanation"": ""The lack of ganglion cells disrupts ENS function, leading to motility problems."", ""reference"": ""PMID:27426273"", ""snippet"": ""Abnormal development or disturbed functioning of the enteric nervous system (ENS), the intrinsic innervation of the gastrointestinal tract, is associated with the development of neuropathic gastrointestinal motility disorders."", ""supports"": ""SUPPORT""}, {""explanation"": ""A defect in the ENS due to the lack of ganglion cells causes motility issues."", ""reference"": ""PMID:23917331"", ""snippet"": ""The pathogenesis of HD is defined as a functional intestinal obstruction resulting from a defect in the intrinsic innervation of the distal bowel."", ""supports"": ""SUPPORT""}, {""explanation"": ""Aganglionosis (lack of ganglion cells) leads to motility issues due to disrupted ENS function."", ""reference"": ""PMID:19782302"", ""snippet"": ""Symptoms of abdominal discomfort are frequently encountered in the daily practice of pediatricians and pediatric surgeons. Normal peristalsis depends on the interaction between muscles, nerve cells, and tendinous connective tissue of muscularis propria. Malfunction of any of these components results in a motility disorder. Aganglionosis, typically of the left distal colon, is the cause of Hirschsprung disease."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""enteric nervous system"", ""term"": {""id"": ""UBERON:0002005"", ""label"": ""enteric nervous system""}}, {""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}], ""name"": ""Disrupted Enteric Nervous System Development""}"
3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	TBX5 Haploinsufficiency and Enhancer Dysfunction	"Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
"																																																								"{""description"": ""Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.\n"", ""name"": ""TBX5 Haploinsufficiency and Enhancer Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Heart development"", ""term"": {""id"": ""GO:0007507"", ""label"": ""heart development""}}, {""preferred_term"": ""Atrial septum morphogenesis"", ""term"": {""id"": ""GO:0003181"", ""label"": ""atrial septum morphogenesis""}}, {""preferred_term"": ""Cardiac conduction"", ""term"": {""id"": ""GO:0061337"", ""label"": ""cardiac conduction""}}, {""preferred_term"": ""Limb bud formation"", ""term"": {""id"": ""GO:0030326"", ""label"": ""limb bud formation""}}, {""preferred_term"": ""Regulation of gene expression, epigenetic"", ""term"": {""id"": ""GO:0040029"", ""label"": ""regulation of gene expression, epigenetic""}}], ""cell_types"": [{""preferred_term"": ""Cardiac muscle cell"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""cellular_components"": [{""preferred_term"": ""Chromatin"", ""term"": {""id"": ""GO:0000785"", ""label"": ""chromatin""}}, {""preferred_term"": ""Enhancer"", ""term"": {""id"": ""GO:0035326"", ""label"": ""enhancer""}}, {""preferred_term"": ""Nucleosome"", ""term"": {""id"": ""GO:0000786"", ""label"": ""nucleosome""}}], ""description"": ""Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.\n"", ""evidence"": [{""explanation"": ""Direct evidence that TBX5 maintains atrial cardiomyocyte identity through a dosage-sensitive chromatin-based mechanism"", ""reference"": ""PMID:38344303"", ""snippet"": ""Tbx5 maintains atrial identity in post-natal cardiomyocytes by regulating an atrial-specific enhancer network"", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates that TBX5 dosage affects 3D chromatin architecture, directly supporting the haploinsufficiency mechanism in HOS"", ""reference"": ""PMID:39829922"", ""snippet"": ""Genome organization, including compartments, topologically associated domains, and chromatin loops, are sensitive to reduced TBX5 dosage in a human model of CHD"", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms that TBX5 sequence alterations cause HOS with novel pathogenic mechanisms including 3'-UTR variants"", ""reference"": ""PMID:36936432"", ""snippet"": ""Sequence alteration of T-box transcription factor 5 (TBX5) is correlated with the incidence of HOS"", ""supports"": ""SUPPORT""}], ""gene"": {""preferred_term"": ""TBX5"", ""term"": {""id"": ""hgnc:11610"", ""label"": ""TBX5""}}, ""locations"": [{""preferred_term"": ""Heart atrium"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""heart atrium""}}, {""preferred_term"": ""Forelimb bud"", ""term"": {""id"": ""UBERON:0004385"", ""label"": ""forelimb bud""}}, {""preferred_term"": ""Atrial conduction system"", ""term"": {""id"": ""UBERON:0004535"", ""label"": ""atrial conduction system""}}], ""name"": ""TBX5 Haploinsufficiency and Enhancer Dysfunction""}"
3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	Cofactor and Chromatin Remodeling Dysfunction	"TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.
"																																																								"{""description"": ""TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.\n"", ""name"": ""Cofactor and Chromatin Remodeling Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Regulation of gene expression, epigenetic"", ""term"": {""id"": ""GO:0040029"", ""label"": ""regulation of gene expression, epigenetic""}}, {""preferred_term"": ""Cardiac conduction"", ""term"": {""id"": ""GO:0061337"", ""label"": ""cardiac conduction""}}], ""cell_types"": [{""preferred_term"": ""Cardiac muscle cell"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""description"": ""TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.\n"", ""evidence"": [{""explanation"": ""Demonstrates the functional interaction between TBX5, GATA4, and FOG2 at atrial enhancers"", ""reference"": ""PMID:38189150"", ""snippet"": ""FOG2 bound a subset of GATA4 and TBX5 co-bound genomic locations... FOG2 repressed TBX5-dependent transcription from a subset of co-bound enhancers"", ""supports"": ""SUPPORT""}, {""explanation"": ""Genetic evidence that FOG2/ZFPM2 modulates TBX5-dependent conduction defects, supporting a direct functional interaction"", ""reference"": ""PMID:38189150"", ""snippet"": ""Atrial rhythm abnormalities in mice caused by Tbx5 haploinsufficiency were rescued by Zfpm2 haploinsufficiency"", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows that CHD4 is directly recruited by TBX5 and is critical for maintaining atrial cardiomyocyte identity"", ""reference"": ""PMID:39677667"", ""snippet"": ""TBX5 recruits CHD4, a chromatin remodeling ATPase, to 33,170 genomic regions... CHD4 is essential for maintaining aCM gene expression, aCM identity, and atrial rhythm homeostasis"", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""GATA4"", ""term"": {""id"": ""hgnc:4172"", ""label"": ""GATA4""}}, {""preferred_term"": ""ZFPM2"", ""term"": {""id"": ""hgnc:12855"", ""label"": ""ZFPM2""}}, {""preferred_term"": ""CHD4"", ""term"": {""id"": ""hgnc:1914"", ""label"": ""CHD4""}}, {""preferred_term"": ""SMARCA4"", ""term"": {""id"": ""hgnc:11100"", ""label"": ""SMARCA4""}}, {""preferred_term"": ""NKX2-5"", ""term"": {""id"": ""hgnc:7781"", ""label"": ""NKX2-5""}}], ""name"": ""Cofactor and Chromatin Remodeling Dysfunction""}"
3755	158	Human African trypanosomiasis	Human_African_Trypanosomiasis.yaml	pathophysiology	0	Central nervous system infection after BBB traversal	Trypanosomes cross the blood-brain barrier to infect the CNS in late-stage disease.																																																								"{""description"": ""Trypanosomes cross the blood-brain barrier to infect the CNS in late-stage disease."", ""name"": ""Central nervous system infection after BBB traversal""}"	{}	"{""description"": ""Trypanosomes cross the blood-brain barrier to infect the CNS in late-stage disease."", ""evidence"": [{""explanation"": ""The abstract links BBB traversal to CNS infection."", ""reference"": ""PMID:23829907"", ""snippet"": ""central nervous system infection after trypanosomal traversal of the blood-brain barrier"", ""supports"": ""SUPPORT""}], ""name"": ""Central nervous system infection after BBB traversal""}"
3782	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	0	CAG Repeat Expansion in the HTT Gene	Mutation characterized by an expanded number of CAG repeats, which encodes an abnormal polyglutamine tract in the huntingtin protein.																																																								"{""description"": ""Mutation characterized by an expanded number of CAG repeats, which encodes an abnormal polyglutamine tract in the huntingtin protein."", ""name"": ""CAG Repeat Expansion in the HTT Gene""}"	{}	"{""biological_processes"": [{""preferred_term"": ""DNA mismatch repair"", ""term"": {""id"": ""GO:0006298"", ""label"": ""mismatch repair""}}], ""description"": ""Mutation characterized by an expanded number of CAG repeats, which encodes an abnormal polyglutamine tract in the huntingtin protein."", ""evidence"": [{""explanation"": ""The reference confirms that an expanded CAG repeat in the HTT gene is the cause of Huntington's Disease."", ""reference"": ""PMID:7620118"", ""snippet"": ""Early in 1993, an unstable, expanded trinucleotide repeat in a novel gene of unknown function was identified on HD chromosomes. This discovery unleased a flurry of experimentation that has established the expanded CAG repeat the almost universal cause of the characteristic neurologic symptoms and pathology of this neurodegenerative disorder of midlife onset."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature clearly states that HD is caused by an expanded CAG repeat in the HTT gene, leading to a mutant huntingtin protein with an abnormal polyglutamine tract."", ""reference"": ""PMID:35395060"", ""snippet"": ""Huntington's disease (HD) is caused by an expansion of the CAG trinucleotide repeat domain in the huntingtin gene that results in expression of a mutant huntingtin protein (mHTT) containing an expanded polyglutamine tract in the amino terminus."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by specifying that HD is caused by an expanded CAG repeat in the HTT gene, leading to an elongated polyglutamine stretch."", ""reference"": ""PMID:27529325"", ""snippet"": ""Huntington's disease (HD) belongs to the group of inherited polyglutamine (PolyQ) diseases caused by an expanded CAG repeat in the coding region of the Huntingtin (HTT) gene that results in an elongated polyQ stretch."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the statement, confirming that HD is caused by an expanded CAG repeat in the HTT gene."", ""reference"": ""PMID:33579866"", ""snippet"": ""Huntington's disease (HD) (OMIM 143100) is caused by an expanded CAG repeat tract in the HTT gene."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by discussing the role of uninterrupted CAG repeats in the HTT gene in the development of HD."", ""reference"": ""PMID:31398342"", ""snippet"": ""Variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted HTT CAG repeat sequence, distinct from the length of huntingtin's polyglutamine segment, dictates the rate at which Huntington's disease (HD) develops."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}, {""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""cerebral cortex""}}], ""name"": ""CAG Repeat Expansion in the HTT Gene""}"
3783	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	1	Mutant Huntingtin Protein Aggregation	Aggregates of mutant huntingtin protein lead to neuronal dysfunction and death, particularly in the striatum and cerebral cortex.																																																								"{""description"": ""Aggregates of mutant huntingtin protein lead to neuronal dysfunction and death, particularly in the striatum and cerebral cortex."", ""name"": ""Mutant Huntingtin Protein Aggregation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""protein aggregation"", ""term"": {""id"": ""GO:0070841"", ""label"": ""inclusion body assembly""}}, {""preferred_term"": ""autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}], ""cell_types"": [{""preferred_term"": ""medium spiny neuron"", ""term"": {""id"": ""CL:1001474"", ""label"": ""medium spiny neuron""}}], ""description"": ""Aggregates of mutant huntingtin protein lead to neuronal dysfunction and death, particularly in the striatum and cerebral cortex."", ""evidence"": [{""explanation"": ""The literature supports that the pathogenesis of Huntington's Disease involves the accumulation of aggregated mutant huntingtin protein, leading to neuronal dysfunction and death."", ""reference"": ""PMID:35319359"", ""snippet"": ""Pathogenesis of HD involves cleavage of the huntingtin protein followed by the neuronal accumulation of its aggregated form."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by highlighting the primary degeneration of neurons in the striatum due to Huntington's Disease."", ""reference"": ""PMID:12657365"", ""snippet"": ""The initial and primary target of degeneration in HD is the striatal medium spiny GABAergic neuron, and by end stages of the disease up to 95% of these neurons are lost."", ""supports"": ""SUPPORT""}, {""explanation"": ""This literature supports the statement by confirming that mutant huntingtin protein aggregation leads to neurotoxicity, particularly in the striatum."", ""reference"": ""PMID:31813995"", ""snippet"": ""Mutant HTT (mHTT) toxicity is caused by its aggregation/oligomerization. The striatum is the most vulnerable region, although all brain regions undergo neuronal degeneration in the disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by indicating significant neuronal loss in the striatum and cerebral cortex in Huntington's Disease."", ""reference"": ""PMID:23423362"", ""snippet"": ""Evaluation of postmortem HD tissue indicates that the most prominent cell loss occurs in cerebral cortex and striatum, forebrain regions in which cortical pyramidal neurons (CPNs) and striatal medium spiny neurons (MSNs) are the most affected."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports the statement by confirming that mutant huntingtin protein causes neuronal loss in specific brain regions, including the striatum and cerebral cortex."", ""reference"": ""PMID:24048953"", ""snippet"": ""Huntington's disease is caused by the expansion of a polyglutamine repeat (>37 glutamines) in the disease protein huntingtin, which results in preferential neuronal loss in distinct brain regions."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}, {""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""cerebral cortex""}}], ""name"": ""Mutant Huntingtin Protein Aggregation""}"
3784	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	2	Excitotoxicity	Overactivation of glutamate receptors leading to neuronal damage.																																																								"{""description"": ""Overactivation of glutamate receptors leading to neuronal damage."", ""name"": ""Excitotoxicity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""chemical synaptic transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}, {""preferred_term"": ""excitatory postsynaptic potential"", ""term"": {""id"": ""GO:0060079"", ""label"": ""excitatory postsynaptic potential""}}, {""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""cell_types"": [{""preferred_term"": ""medium spiny neuron"", ""term"": {""id"": ""CL:1001474"", ""label"": ""medium spiny neuron""}}, {""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Overactivation of glutamate receptors leading to neuronal damage."", ""evidence"": [{""explanation"": ""The study identifies upregulation of glutamate receptors in medium spiny neurons, supporting the idea of excitotoxicity due to overactivation of these receptors leading to neuronal damage."", ""reference"": ""PMID:38776957"", ""snippet"": ""We have identified transcriptional upregulation of genes encoding N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate receptors in medium spiny neurons, the cell type preferentially lost early in HD."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference explains the concept of excitotoxicity and supports the idea that overactivation of glutamate receptors can lead to neuronal damage."", ""reference"": ""PMID:1464368"", ""snippet"": ""Excitotoxicity refers to neuronal cell death caused by activation of excitatory amino acid receptors. A substantial body of evidence has implicated excitotoxicity as a mechanism of cell death in both acute and chronic neurologic diseases."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study provides direct evidence that elevated glutamate levels increase the formation of hydroxyl radicals, implying oxidative stress induced by excitotoxicity, which supports the statement."", ""reference"": ""PMID:7590394"", ""snippet"": ""Our results indicated that elevated glutamate concentrations (15 mM, 1.5 mM, and 150 microM glutamate in perfusing solutions) would significantly increased both the concentrations of 2,3 and 2,5 DHBA."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study shows that excitotoxicity induced in the striatum leads to medium spiny neuron degeneration, supporting the idea of excitotoxicity causing neuronal damage in Huntington's Disease."", ""reference"": ""PMID:19805493"", ""snippet"": ""Induction of striatal excitotoxicity in CB(2) receptor-deficient mice by quinolinic acid administration exacerbated brain oedema, microglial activation, proinflammatory-mediator state and medium-sized spiny neuron degeneration."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}], ""name"": ""Excitotoxicity""}"
3785	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	3	Mitochondrial Dysfunction	Reduced efficiency of oxidative phosphorylation complexes, loss of mitochondrial membrane potential, and impaired mitochondrial DNA stability leading to bioenergetic failure.																																																								"{""description"": ""Reduced efficiency of oxidative phosphorylation complexes, loss of mitochondrial membrane potential, and impaired mitochondrial DNA stability leading to bioenergetic failure."", ""name"": ""Mitochondrial Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}, {""preferred_term"": ""mitochondrion organization"", ""term"": {""id"": ""GO:0007005"", ""label"": ""mitochondrion organization""}}, {""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""cell_types"": [{""preferred_term"": ""medium spiny neuron"", ""term"": {""id"": ""CL:1001474"", ""label"": ""medium spiny neuron""}}, {""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Reduced efficiency of oxidative phosphorylation complexes, loss of mitochondrial membrane potential, and impaired mitochondrial DNA stability leading to bioenergetic failure."", ""locations"": [{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}, {""preferred_term"": ""cerebral cortex"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""cerebral cortex""}}], ""name"": ""Mitochondrial Dysfunction""}"
3786	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	4	Neuroinflammation	Activation of microglia and astrocytes with neuroinflammatory responses occurring early in disease progression, contributing to neurodegeneration.																																																								"{""description"": ""Activation of microglia and astrocytes with neuroinflammatory responses occurring early in disease progression, contributing to neurodegeneration."", ""name"": ""Neuroinflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""preferred_term"": ""microglial cell activation"", ""term"": {""id"": ""GO:0001774"", ""label"": ""microglial cell activation""}}], ""cell_types"": [{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Activation of microglia and astrocytes with neuroinflammatory responses occurring early in disease progression, contributing to neurodegeneration."", ""locations"": [{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}], ""name"": ""Neuroinflammation""}"
3787	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	5	D2 Receptor Medium Spiny Neuron Selective Vulnerability	D2 receptor-expressing medium spiny neurons show earlier huntingtin aggregation and greater sensitivity to CAG somatic instability compared to D1 receptor-expressing neurons.																																																								"{""description"": ""D2 receptor-expressing medium spiny neurons show earlier huntingtin aggregation and greater sensitivity to CAG somatic instability compared to D1 receptor-expressing neurons."", ""name"": ""D2 Receptor Medium Spiny Neuron Selective Vulnerability""}"	{}	"{""biological_processes"": [{""preferred_term"": ""protein aggregation"", ""term"": {""id"": ""GO:0070841"", ""label"": ""inclusion body assembly""}}, {""preferred_term"": ""synaptic transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}], ""cell_types"": [{""preferred_term"": ""medium spiny neuron"", ""term"": {""id"": ""CL:1001474"", ""label"": ""medium spiny neuron""}}], ""description"": ""D2 receptor-expressing medium spiny neurons show earlier huntingtin aggregation and greater sensitivity to CAG somatic instability compared to D1 receptor-expressing neurons."", ""locations"": [{""preferred_term"": ""striatum"", ""term"": {""id"": ""UBERON:0001880"", ""label"": ""striatum""}}], ""name"": ""D2 Receptor Medium Spiny Neuron Selective Vulnerability""}"
3811	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	0	Increased Cardiac Workload	Hypertension increases the pressure the heart must pump against, leading to cardiac remodeling and dysfunction over time.																																																								"{""description"": ""Hypertension increases the pressure the heart must pump against, leading to cardiac remodeling and dysfunction over time."", ""name"": ""Increased Cardiac Workload""}"	{}	"{""description"": ""Hypertension increases the pressure the heart must pump against, leading to cardiac remodeling and dysfunction over time."", ""evidence"": [{""explanation"": ""This reference discusses the pressure load on the left ventricle due to aortic stenosis, leading to cardiac remodeling and dysfunction, supporting the described mechanism of hypertensive heart disease."", ""reference"": ""PMID:38428029"", ""snippet"": ""Pathologic cardiac hypertrophy is a common consequence of many cardiovascular diseases, including aortic stenosis (AS). AS is known to increase the pressure load of the left ventricle, causing a compensative response of the cardiac muscle, which progressively will lead to dilation and heart failure."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference explains the remodeling of the left ventricle due to hypertension and the functional abnormalities that occur, supporting the described mechanism of hypertensive heart disease."", ""reference"": ""PMID:7496052"", ""snippet"": ""Hypertension is associated with the remodeling of left ventricular geometry and abnormalities of function that may precede geometric changes. Rather than a specific disease, 'hypertensive heart failure' is a spectrum of disorders that result from left ventricular geometric changes and comorbid conditions."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference discusses the association between hypertension and left ventricular dysfunction, an early indicator of cardiac remodeling and dysfunction, supporting the described mechanism."", ""reference"": ""PMID:19427497"", ""snippet"": ""LVDD as an early measure of myocardial end-organ damage is commonly associated with hypertension and may well precede development of LVH in hypertension."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study in spontaneously hypertensive rats shows increased cardiac work and hypertrophy, which aligns with the described mechanism of increased cardiac workload leading to dysfunction."", ""reference"": ""PMID:28082430"", ""snippet"": ""SHR had lower ejection fraction compared with WKY at all ages, but there was no difference in cardiac output at any age. At 21 month the SHR had significantly elevated stroke work (51 +/- 3 mL.mmHg SHR vs. 24 +/- 2 mL.mmHg WKY; n = 8, 4; P < 0.001) and cardiac minute work (14.2 +/- 1.2 L.mmHg/min SHR vs. 6.2 +/- 0.8 L.mmHg/min WKY; n = 8, 4; P < 0.001) compared to control, in addition to significantly larger left ventricular mass to body mass ratio (3.61 +/- 0.15 mg/g SHR vs. 2.11 +/- 0.008 mg/g WKY; n = 8, 6; P < 0.001)."", ""supports"": ""SUPPORT""}], ""name"": ""Increased Cardiac Workload""}"
3812	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	1	Left Ventricular Hypertrophy	The heart muscle thickens to cope with increased workload, but this can lead to stiffness and impaired filling.																																																								"{""description"": ""The heart muscle thickens to cope with increased workload, but this can lead to stiffness and impaired filling."", ""name"": ""Left Ventricular Hypertrophy""}"	{}	"{""cell_types"": [{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""description"": ""The heart muscle thickens to cope with increased workload, but this can lead to stiffness and impaired filling."", ""evidence"": [{""explanation"": ""The paper discusses how hypertension causes left ventricular hypertrophy and affects multiple myocardial compartments."", ""reference"": ""PMID:11062603"", ""snippet"": ""Sustained increase in arterial pressure causes left ventricular hypertrophy and adversely affects all myocardial compartments: myocytes, interstitium, and coronary vasculature."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study confirms that changes in wall thickness and ventricular shape due to hypertrophy reflect an adaptation to increased workload."", ""reference"": ""PMID:36933415"", ""snippet"": ""We computed both eccentric and concentric hypertrophy effects and tracked changes in the ventricle shape and wall thickness."", ""supports"": ""SUPPORT""}, {""explanation"": ""Left ventricular hypertrophy is directly associated with hypertensive heart disease and involves thickening of the heart muscle."", ""reference"": ""PMID:10652906"", ""snippet"": ""Left ventricular hypertrophy (LVH) is pathognomonic of HHD."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference discusses the influence of hypertrophy on wall thickening and heart function."", ""reference"": ""PMID:37827810"", ""snippet"": ""In case of hypertrophy, an increased influence of the dilating transmural fibre component might counteract systolic wall thickening, thereby counteract cardiac output."", ""supports"": ""SUPPORT""}], ""name"": ""Left Ventricular Hypertrophy""}"
3813	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	2	Myocardial Ischemia	Hypertension can worsen atherosclerosis in the coronary arteries, reducing blood flow to the heart muscle.																																																								"{""description"": ""Hypertension can worsen atherosclerosis in the coronary arteries, reducing blood flow to the heart muscle."", ""name"": ""Myocardial Ischemia""}"	{}	"{""description"": ""Hypertension can worsen atherosclerosis in the coronary arteries, reducing blood flow to the heart muscle."", ""evidence"": [{""explanation"": ""This reference outlines how hypertension can lead to coronary artery disease by affecting atherosclerotic plaque development, endothelial dysfunction, and coronary circulation, which are consistent with the statement."", ""reference"": ""PMID:37739329"", ""snippet"": ""Hypertension represents a major contributor to the development of coronary artery disease. The pathophysiological mechanisms underlying the link between hypertension and CAD are complex and include overactivation of neurohormones, accelerated development of the atherosclerotic plaque, endothelial dysfunction, altered intramyocardial coronary circulation..."", ""supports"": ""SUPPORT""}, {""explanation"": ""The report discusses the negative impact of hypertension on coronary circulation and the involvement of coronary vasculature impairments due to hypertensive disease, supporting the statement."", ""reference"": ""PMID:11062603"", ""snippet"": ""Sustained increase in arterial pressure causes left ventricular hypertrophy and adversely affects all myocardial compartments: myocytes, interstitium, and coronary vasculature. Ventricular hypertrophy significantly increases the risk for cardiovascular morbidity and mortality in hypertensive disease. Impairments in coronary circulation and ventricular fibrosis, which are an essential part of hypertensive disease..."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference explains that ischemic heart disease, which can result from severe atherosclerotic plaques, aligns with the statement that hypertension-induced atherosclerosis can reduce coronary blood flow, contributing to myocardial ischemia."", ""reference"": ""PMID:33143256"", ""snippet"": ""Ischemic heart disease still represents a large burden on individuals and health care resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow-limiting obstruction in large-medium sized coronary arteries. However, clinical, angiographic and autoptic findings suggest a multifaceted pathophysiology for ischemic heart disease and just some cases are caused by severe or complicated atherosclerotic plaques."", ""supports"": ""SUPPORT""}], ""name"": ""Myocardial Ischemia""}"
3814	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	3	Cardiac Fibrosis	Chronic pressure overload stimulates fibroblasts to deposit excess collagen in the heart, stiffening it. TGF-/SMAD signaling drives fibroblast-to-myofibroblast transition and increased collagen deposition.																																																								"{""description"": ""Chronic pressure overload stimulates fibroblasts to deposit excess collagen in the heart, stiffening it. TGF-/SMAD signaling drives fibroblast-to-myofibroblast transition and increased collagen deposition."", ""name"": ""Cardiac Fibrosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}, {""preferred_term"": ""collagen fibril organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}], ""cell_types"": [{""preferred_term"": ""Cardiac Fibroblast"", ""term"": {""id"": ""CL:0002548"", ""label"": ""fibroblast of cardiac tissue""}}], ""description"": ""Chronic pressure overload stimulates fibroblasts to deposit excess collagen in the heart, stiffening it. TGF-/SMAD signaling drives fibroblast-to-myofibroblast transition and increased collagen deposition."", ""evidence"": [{""explanation"": ""The activation of fibroblasts in response to hypertension and their role in cardiac remodeling aligns with the statement that chronic pressure overload stimulates fibroblasts to deposit excess collagen in the heart."", ""reference"": ""PMID:37999643"", ""snippet"": ""In response to increased peripheral resistance in hypertension, intensified mechanical stretch in the myocardium induces cardiomyocyte hypertrophy and fibroblast activation to withstand increased pressure overload. This changes the structure and function of the heart, leading to pathological cardiac remodeling and eventual progression to heart failure."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference details how fibroblasts facilitate excessive collagen deposition in the myocardium, which supports the statement regarding cardiac fibrosis due to chronic pressure overload."", ""reference"": ""PMID:33568808"", ""snippet"": ""Diffuse myocardial fibrosis resulting from the excessive deposition of collagen fibres through the entire myocardium is encountered in a number of chronic cardiac diseases. This lesion results from alterations in the regulation of fibrillary collagen turnover by fibroblasts, facilitating the excessive deposition of type I and type III collagen fibres within the myocardial interstitium and around intramyocardial vessels."", ""supports"": ""SUPPORT""}, {""explanation"": ""The description of reactive interstitial fibrosis in response to pressure overload supports the statement about fibroblasts depositing excess collagen in the heart under chronic pressure overload conditions, leading to fibrosis and stiffening."", ""reference"": ""PMID:2532916"", ""snippet"": ""In left ventricular pressure overload a reactive interstitial fibrosis, having distinctive biochemical and structural features, is seen. This reactive fibrosis occurs in the absence of myocyte necrosis, is progressive in nature, and initially is an adaptive response that preserves the force generating capacity, or active (systolic) stiffness, of the hypertrophied myocardium."", ""supports"": ""SUPPORT""}, {""explanation"": ""The mention of ventricular fibrosis due to increased collagen deposition supports the statement that chronic pressure overload results in fibroblasts depositing excess collagen, leading to cardiac fibrosis."", ""reference"": ""PMID:10829097"", ""snippet"": ""Mechanisms underlying risk associated with hypertensive heart disease (HHD) and left ventricular hypertrophy (LVH) are discussed in this report and provide a rationale for understanding this very common and important cause of death from hypertension and its complications. Emphasized are impaired coronary hemodynamics, endothelial dysfunction, and ventricular fibrosis from increased collagen deposition intramurally and perivascularly."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although this snippet primarily focuses on TH17 cells, it indicates that remodeling due to hypertension includes elements of fibroblast activation and fibrosis."", ""reference"": ""PMID:33570899"", ""snippet"": ""The differentiation of TH17 cells reflected the cardiac hypertrophy and remodeling response to hypertension-induced pressure overload, and it might be a potential inflammatory marker to predict the prognosis of hypertensive patients."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""myocardial interstitium""}, {""preferred_term"": ""perivascular space""}], ""name"": ""Cardiac Fibrosis""}"
3815	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	4	Coronary Microvascular Dysfunction	Hypertension causes endothelial dysfunction, microvascular rarefaction, and perivascular fibrosis in the coronary microvasculature, reducing coronary flow reserve and oxygen delivery to the hypertrophied myocardium. This contributes to ischemia and progression to heart failure with preserved ejection fraction.																																		Pericyte loss and endothelial dysfunction lead to capillary rarefaction, which is a hallmark of hypertensive heart disease progression to HFpEF																						"{""description"": ""Hypertension causes endothelial dysfunction, microvascular rarefaction, and perivascular fibrosis in the coronary microvasculature, reducing coronary flow reserve and oxygen delivery to the hypertrophied myocardium. This contributes to ischemia and progression to heart failure with preserved ejection fraction."", ""name"": ""Coronary Microvascular Dysfunction"", ""notes"": ""Pericyte loss and endothelial dysfunction lead to capillary rarefaction, which is a hallmark of hypertensive heart disease progression to HFpEF""}"	{}	"{""biological_processes"": [{""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}, {""preferred_term"": ""regulation of nitric oxide biosynthetic process"", ""term"": {""id"": ""GO:0045428"", ""label"": ""regulation of nitric oxide biosynthetic process""}}], ""cell_types"": [{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}, {""preferred_term"": ""pericyte"", ""term"": {""id"": ""CL:0000669"", ""label"": ""pericyte""}}], ""description"": ""Hypertension causes endothelial dysfunction, microvascular rarefaction, and perivascular fibrosis in the coronary microvasculature, reducing coronary flow reserve and oxygen delivery to the hypertrophied myocardium. This contributes to ischemia and progression to heart failure with preserved ejection fraction."", ""locations"": [{""preferred_term"": ""coronary microvasculature""}], ""name"": ""Coronary Microvascular Dysfunction"", ""notes"": ""Pericyte loss and endothelial dysfunction lead to capillary rarefaction, which is a hallmark of hypertensive heart disease progression to HFpEF""}"
3816	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	5	Oxidative Stress and Mitochondrial Dysfunction	NADPH oxidases (NOX2 and NOX4) generate reactive oxygen species in response to mechanical stress and Ang II signaling. This oxidative stress damages mitochondria, reduces ATP production, and activates pro-fibrotic signaling pathways including NF-B.																																		NOX2 (CYBB gene) and NOX4 are major enzymatic ROS sources linking mechanical and Ang II stimuli to oxidative damage																						"{""description"": ""NADPH oxidases (NOX2 and NOX4) generate reactive oxygen species in response to mechanical stress and Ang II signaling. This oxidative stress damages mitochondria, reduces ATP production, and activates pro-fibrotic signaling pathways including NF-B."", ""name"": ""Oxidative Stress and Mitochondrial Dysfunction"", ""notes"": ""NOX2 (CYBB gene) and NOX4 are major enzymatic ROS sources linking mechanical and Ang II stimuli to oxidative damage""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}, {""preferred_term"": ""superoxide metabolic process"", ""term"": {""id"": ""GO:0006801"", ""label"": ""superoxide metabolic process""}}, {""preferred_term"": ""mitochondrial electron transport"", ""term"": {""id"": ""GO:0006123"", ""label"": ""mitochondrial electron transport, NADH to ubiquinone""}}], ""cellular_components"": [{""preferred_term"": ""mitochondrion"", ""term"": {""id"": ""GO:0005739"", ""label"": ""mitochondrion""}}], ""description"": ""NADPH oxidases (NOX2 and NOX4) generate reactive oxygen species in response to mechanical stress and Ang II signaling. This oxidative stress damages mitochondria, reduces ATP production, and activates pro-fibrotic signaling pathways including NF-B."", ""name"": ""Oxidative Stress and Mitochondrial Dysfunction"", ""notes"": ""NOX2 (CYBB gene) and NOX4 are major enzymatic ROS sources linking mechanical and Ang II stimuli to oxidative damage""}"
3817	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	6	Inflammasome Activation	Pressure overload and oxidative stress activate the NLRP3 inflammasome, leading to caspase-1 activation and release of IL-1 and IL-18. This inflammatory signaling amplifies cardiac fibrosis, hypertrophy, and adverse remodeling.																																		NLRP3 inflammasome activation promotes pyroptosis and chronic inflammation in hypertensive heart disease																						"{""description"": ""Pressure overload and oxidative stress activate the NLRP3 inflammasome, leading to caspase-1 activation and release of IL-1 and IL-18. This inflammatory signaling amplifies cardiac fibrosis, hypertrophy, and adverse remodeling."", ""name"": ""Inflammasome Activation"", ""notes"": ""NLRP3 inflammasome activation promotes pyroptosis and chronic inflammation in hypertensive heart disease""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammasome complex assembly"", ""term"": {""id"": ""GO:0061702"", ""label"": ""inflammasome complex assembly""}}, {""preferred_term"": ""interleukin-1 beta production"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}], ""description"": ""Pressure overload and oxidative stress activate the NLRP3 inflammasome, leading to caspase-1 activation and release of IL-1 and IL-18. This inflammatory signaling amplifies cardiac fibrosis, hypertrophy, and adverse remodeling."", ""name"": ""Inflammasome Activation"", ""notes"": ""NLRP3 inflammasome activation promotes pyroptosis and chronic inflammation in hypertensive heart disease""}"
3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	Sarcomere Protein Mutations	Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction.																																																								"{""description"": ""Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction."", ""name"": ""Sarcomere Protein Mutations""}"	{}	"{""biological_processes"": [{""preferred_term"": ""muscle contraction"", ""term"": {""id"": ""GO:0006936"", ""label"": ""muscle contraction""}}, {""preferred_term"": ""regulation of heart contraction"", ""term"": {""id"": ""GO:0008016"", ""label"": ""regulation of heart contraction""}}, {""preferred_term"": ""ATP hydrolysis activity"", ""term"": {""id"": ""GO:0016887"", ""label"": ""ATP hydrolysis activity""}}], ""cell_types"": [{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""cellular_components"": [{""preferred_term"": ""sarcomere"", ""term"": {""id"": ""GO:0030017"", ""label"": ""sarcomere""}}, {""preferred_term"": ""thick filament"", ""term"": {""id"": ""GO:0005863"", ""label"": ""myosin filament""}}, {""preferred_term"": ""thin filament"", ""term"": {""id"": ""GO:0005865"", ""label"": ""striated muscle thin filament""}}], ""description"": ""Genetic mutations affecting the proteins of the cardiac sarcomere lead to abnormal thickening of the heart muscle. The central biophysical abnormality is sarcomere hypercontractility with increased myosin duty ratio and power, resulting in impaired relaxation and elevated energetic cost of contraction."", ""evidence"": [{""explanation"": ""The reference discusses how mutations in sarcomeric protein genes are linked to hypertrophic cardiomyopathy, which leads to heart muscle thickening."", ""reference"": ""PMID:16416046"", ""snippet"": ""Hypertrophic Cardiomyopathy (HCM) is a relatively common primary cardiac disorder defined as the presence of a hypertrophied left ventricle... to date, 270 independent mutations in nine sarcomeric protein genes have been linked to Familial Hypertrophic Cardiomyopathy (FHC)..."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference directly states that HCM is caused by variants in sarcomeric genes resulting in heart muscle thickening."", ""reference"": ""PMID:36797478"", ""snippet"": ""The most common form of genetic heart disease is hypertrophic cardiomyopathy (HCM), which is caused by variants in cardiac sarcomeric genes and leads to abnormal heart muscle thickening."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference explains how specific mutations in sarcomeric proteins lead to hypercontractility, a feature of muscle thickening in HCM."", ""reference"": ""PMID:28645928"", ""snippet"": ""For example, increased myosin heavy chain (MHC) binding and ATP utilization lead to the hypercontractile sarcomere in HCM..."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference details how understanding sarcomere function and its pathophysiology relates to mutations leading to cardiomyopathy, thereby supporting the statement about genetic mutations affecting sarcomere proteins."", ""reference"": ""PMID:37060436"", ""snippet"": ""Recent advances in our mechanistic understanding of sarcomere pathophysiology include high-resolution molecular models of sarcomere components and the identification of the myosin super-relaxed state."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""left ventricle"", ""term"": {""id"": ""UBERON:0002084"", ""label"": ""heart left ventricle""}}, {""preferred_term"": ""interventricular septum"", ""term"": {""id"": ""UBERON:0002094"", ""label"": ""interventricular septum""}}], ""name"": ""Sarcomere Protein Mutations""}"
3859	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	1	Myocyte Disarray	Disorganization of heart muscle cells contributes to the stiffness and dysfunction of the myocardium. Loss of physiological fiber alignment and orientation creates structural abnormalities that impair contractile efficiency and promote arrhythmogenic substrate.																																																								"{""description"": ""Disorganization of heart muscle cells contributes to the stiffness and dysfunction of the myocardium. Loss of physiological fiber alignment and orientation creates structural abnormalities that impair contractile efficiency and promote arrhythmogenic substrate."", ""name"": ""Myocyte Disarray""}"	{}	"{""cell_types"": [{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""description"": ""Disorganization of heart muscle cells contributes to the stiffness and dysfunction of the myocardium. Loss of physiological fiber alignment and orientation creates structural abnormalities that impair contractile efficiency and promote arrhythmogenic substrate."", ""evidence"": [{""explanation"": ""The paper discusses how myocardial disarray is a typical feature of hypertrophic cardiomyopathy (HCM), implying its role in myocardial dysfunction."", ""reference"": ""PMID:33447843"", ""snippet"": ""Myocardial disarray is defined as disorganized cardiomyocyte spatial distribution, with loss of physiological fibre alignment and orientation."", ""supports"": ""SUPPORT""}, {""explanation"": ""This indicates that myocyte disarray is a feature of the disease, contributing to the thickening and impaired function of the myocardium."", ""reference"": ""PMID:7665141"", ""snippet"": ""Genes on five loci on separate chromosomes are responsible for a familial disease in which all or part of the ventricular muscle undergoes thickening with a histological picture of irregular hypertrophy and disorganized arrangement of myocytes (disarray)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The correlation between hypertrophy, fibrosis, and disarray supports the statement that myocyte disarray contributes to myocardial dysfunction."", ""reference"": ""PMID:11040002"", ""snippet"": ""Within an individual heart the magnitude of hypertrophy correlated with the severity of fibrosis (p = 0.006) and disarray (p = 0.0002)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""ventricular myocardium"", ""term"": {""id"": ""UBERON:0002084"", ""label"": ""heart left ventricle""}}], ""name"": ""Myocyte Disarray""}"
3860	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	2	Myocardial Fibrosis	Increased collagen deposition by interstitial cells contributes to myocardial stiffness. Activation of TGF-beta and MAPK signaling pathways promotes extracellular matrix remodeling and fibrosis, which is a progressive phenomenon associated with greater disease severity.																																																								"{""description"": ""Increased collagen deposition by interstitial cells contributes to myocardial stiffness. Activation of TGF-beta and MAPK signaling pathways promotes extracellular matrix remodeling and fibrosis, which is a progressive phenomenon associated with greater disease severity."", ""name"": ""Myocardial Fibrosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}, {""preferred_term"": ""response to TGF-beta"", ""term"": {""id"": ""GO:0071559"", ""label"": ""response to transforming growth factor beta""}}], ""cell_types"": [{""preferred_term"": ""Interstitial Cells"", ""term"": {""id"": ""CL:4030031"", ""label"": ""interstitial cell""}}, {""preferred_term"": ""cardiac fibroblast"", ""term"": {""id"": ""CL:0002548"", ""label"": ""fibroblast of cardiac tissue""}}], ""cellular_components"": [{""preferred_term"": ""extracellular matrix"", ""term"": {""id"": ""GO:0031012"", ""label"": ""extracellular matrix""}}], ""description"": ""Increased collagen deposition by interstitial cells contributes to myocardial stiffness. Activation of TGF-beta and MAPK signaling pathways promotes extracellular matrix remodeling and fibrosis, which is a progressive phenomenon associated with greater disease severity."", ""evidence"": [{""explanation"": ""The increased collagen production discussed here is consistent with the contribution of interstitial cells to myocardial stiffness."", ""reference"": ""PMID:1414892"", ""snippet"": ""It appears that increased collagen production is mainly responsible for the functional consequences of structural remodelling"", ""supports"": ""SUPPORT""}, {""explanation"": ""This study shows increased collagen deposition, contributing to myocardial stiffness, aligning with the statement."", ""reference"": ""PMID:25573453"", ""snippet"": ""Tissue from cats with pre-clinical HCM also had a higher number of neutrophils and a greater collagen content than the myocardium of normal cats."", ""supports"": ""SUPPORT""}, {""explanation"": ""The role of interstitial cells like macrophages in increasing collagen content supports the statement."", ""reference"": ""PMID:29522370"", ""snippet"": ""We conclude that myocardial macrophages play an important role in the time-dependent increases in SPARC that enhance postsynthetic collagen processing, insoluble collagen content, and myocardial stiffness and contribute to the development of fibrosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The mention of the collagen matrix supports the idea of increased collagen deposition by interstitial cells contributing to myocardial stiffness."", ""reference"": ""PMID:12510171"", ""snippet"": ""The myocardial collagen matrix consists of a network of fibrillar collagen which is intimately connected to the myocyte."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""myocardial interstitium"", ""term"": {""id"": ""UBERON:0002084"", ""label"": ""heart left ventricle""}}], ""name"": ""Myocardial Fibrosis""}"
3861	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	3	Altered Calcium Handling	Increased myofilament calcium sensitivity and impaired diastolic calcium removal lead to diastolic dysfunction and promote pro-hypertrophic signaling. Altered calcium homeostasis contributes to both contractile abnormalities and arrhythmogenic substrate.																																		Calcium dysregulation is a downstream consequence of sarcomere mutations that impairs relaxation and triggers hypertrophic remodeling																						"{""description"": ""Increased myofilament calcium sensitivity and impaired diastolic calcium removal lead to diastolic dysfunction and promote pro-hypertrophic signaling. Altered calcium homeostasis contributes to both contractile abnormalities and arrhythmogenic substrate."", ""name"": ""Altered Calcium Handling"", ""notes"": ""Calcium dysregulation is a downstream consequence of sarcomere mutations that impairs relaxation and triggers hypertrophic remodeling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""calcium ion transport"", ""term"": {""id"": ""GO:0006816"", ""label"": ""calcium ion transport""}}, {""preferred_term"": ""regulation of cardiac muscle contraction"", ""term"": {""id"": ""GO:0055117"", ""label"": ""regulation of cardiac muscle contraction""}}], ""cell_types"": [{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""cellular_components"": [{""preferred_term"": ""sarcoplasmic reticulum"", ""term"": {""id"": ""GO:0016529"", ""label"": ""sarcoplasmic reticulum""}}], ""description"": ""Increased myofilament calcium sensitivity and impaired diastolic calcium removal lead to diastolic dysfunction and promote pro-hypertrophic signaling. Altered calcium homeostasis contributes to both contractile abnormalities and arrhythmogenic substrate."", ""locations"": [{""preferred_term"": ""left ventricle"", ""term"": {""id"": ""UBERON:0002084"", ""label"": ""heart left ventricle""}}], ""name"": ""Altered Calcium Handling"", ""notes"": ""Calcium dysregulation is a downstream consequence of sarcomere mutations that impairs relaxation and triggers hypertrophic remodeling""}"
3862	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	4	Mitochondrial Dysfunction	Elevated energetic cost of sarcomere hypercontractility leads to mitochondrial stress and downregulation of energy metabolism pathways. Impaired ATP production contributes to contractile dysfunction and cellular remodeling.																																		Energy metabolism dysfunction is a consistent finding across HCM genotypes in tissue omics studies																						"{""description"": ""Elevated energetic cost of sarcomere hypercontractility leads to mitochondrial stress and downregulation of energy metabolism pathways. Impaired ATP production contributes to contractile dysfunction and cellular remodeling."", ""name"": ""Mitochondrial Dysfunction"", ""notes"": ""Energy metabolism dysfunction is a consistent finding across HCM genotypes in tissue omics studies""}"	{}	"{""biological_processes"": [{""preferred_term"": ""ATP metabolic process"", ""term"": {""id"": ""GO:0046034"", ""label"": ""ATP metabolic process""}}, {""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}], ""cell_types"": [{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""cellular_components"": [{""preferred_term"": ""mitochondrion"", ""term"": {""id"": ""GO:0005739"", ""label"": ""mitochondrion""}}], ""description"": ""Elevated energetic cost of sarcomere hypercontractility leads to mitochondrial stress and downregulation of energy metabolism pathways. Impaired ATP production contributes to contractile dysfunction and cellular remodeling."", ""locations"": [{""preferred_term"": ""myocardium"", ""term"": {""id"": ""UBERON:0002084"", ""label"": ""heart left ventricle""}}], ""name"": ""Mitochondrial Dysfunction"", ""notes"": ""Energy metabolism dysfunction is a consistent finding across HCM genotypes in tissue omics studies""}"
3863	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	5	Left Ventricular Outflow Tract Obstruction	Asymmetric septal hypertrophy combined with systolic anterior motion of the mitral valve creates dynamic obstruction to blood flow. Venturi forces draw the mitral valve toward the septum, elevating wall stress and contributing to ischemia and further hypertrophic remodeling.																																		Occurs in approximately 60% of HCM patients and is a defining feature of obstructive HCM																						"{""description"": ""Asymmetric septal hypertrophy combined with systolic anterior motion of the mitral valve creates dynamic obstruction to blood flow. Venturi forces draw the mitral valve toward the septum, elevating wall stress and contributing to ischemia and further hypertrophic remodeling."", ""name"": ""Left Ventricular Outflow Tract Obstruction"", ""notes"": ""Occurs in approximately 60% of HCM patients and is a defining feature of obstructive HCM""}"	{}	"{""cell_types"": [{""preferred_term"": ""Cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""description"": ""Asymmetric septal hypertrophy combined with systolic anterior motion of the mitral valve creates dynamic obstruction to blood flow. Venturi forces draw the mitral valve toward the septum, elevating wall stress and contributing to ischemia and further hypertrophic remodeling."", ""locations"": [{""preferred_term"": ""interventricular septum"", ""term"": {""id"": ""UBERON:0002094"", ""label"": ""interventricular septum""}}, {""preferred_term"": ""mitral valve"", ""term"": {""id"": ""UBERON:0002135"", ""label"": ""mitral valve""}}, {""preferred_term"": ""left ventricular outflow tract"", ""term"": {""id"": ""UBERON:0016480"", ""label"": ""cardiac outflow tract""}}], ""name"": ""Left Ventricular Outflow Tract Obstruction"", ""notes"": ""Occurs in approximately 60% of HCM patients and is a defining feature of obstructive HCM""}"
3885	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	0	Type II Collagen Structural Defect	"COL2A1 mutations disrupt type II collagen triple helix assembly. In hypochondrogenesis, mutations typically allow some functional collagen production, resulting in a slightly less severe phenotype than ACG2. The abnormal collagen compromises cartilage extracellular matrix integrity.
"																																																								"{""description"": ""COL2A1 mutations disrupt type II collagen triple helix assembly. In hypochondrogenesis, mutations typically allow some functional collagen production, resulting in a slightly less severe phenotype than ACG2. The abnormal collagen compromises cartilage extracellular matrix integrity.\n"", ""name"": ""Type II Collagen Structural Defect""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}, {""preferred_term"": ""Cartilage Development"", ""term"": {""id"": ""GO:0051216"", ""label"": ""cartilage development""}}], ""cell_types"": [{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}, {""preferred_term"": ""Growth Plate Chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}], ""description"": ""COL2A1 mutations disrupt type II collagen triple helix assembly. In hypochondrogenesis, mutations typically allow some functional collagen production, resulting in a slightly less severe phenotype than ACG2. The abnormal collagen compromises cartilage extracellular matrix integrity.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that glycine substitutions in COL2A1 disrupt collagen triple helix formation, causing intracellular retention and reduced secretion."", ""reference"": ""PMID:2572591"", ""snippet"": ""The substitution disrupts the invariant Gly-X-Y structural motif necessary for perfect triple helix formation and leads to extensive overmodification, intracellular retention, and reduced secretion of type II collagen."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that COL2A1 mutations cause ER retention of misfolded collagen and reduced extracellular matrix density in hypochondrogenesis patients."", ""reference"": ""PMID:8175802"", ""snippet"": ""Microscopic examination of cartilage showed that the mutation altered the organization of the growth plate. Also, articular chondrocytes contained large cisternae of rough endoplasmic reticulum. The density of the extracellular matrix was reduced, and the intensity of the staining with an antibody to type II collagen was diminished."", ""supports"": ""SUPPORT""}], ""name"": ""Type II Collagen Structural Defect""}"
3886	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	1	Endoplasmic Reticulum Stress and Chondrocyte Apoptosis	"Misfolded type II collagen accumulates in the endoplasmic reticulum of chondrocytes, causing ER stress and activation of the unfolded protein response. Chronic ER stress leads to chondrocyte apoptosis, particularly in the growth plate, disrupting normal endochondral ossification.
"																																																								"{""description"": ""Misfolded type II collagen accumulates in the endoplasmic reticulum of chondrocytes, causing ER stress and activation of the unfolded protein response. Chronic ER stress leads to chondrocyte apoptosis, particularly in the growth plate, disrupting normal endochondral ossification.\n"", ""name"": ""Endoplasmic Reticulum Stress and Chondrocyte Apoptosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""ER Stress Response"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}, {""preferred_term"": ""Apoptosis"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}], ""description"": ""Misfolded type II collagen accumulates in the endoplasmic reticulum of chondrocytes, causing ER stress and activation of the unfolded protein response. Chronic ER stress leads to chondrocyte apoptosis, particularly in the growth plate, disrupting normal endochondral ossification.\n"", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Demonstrates that type II collagenopathy chondrocytes exhibit ER stress and apoptosis due to misfolded collagen accumulation."", ""reference"": ""PMID:25187577"", ""snippet"": ""The COL2pathy-iChon cells showed suppressed expression of COL2A1 and significant apoptosis. A distended endoplasmic reticulum (ER) was detected, thus suggesting the adaptation of gene expression and cell death caused by excess ER stress."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms dilated ER cisternae in chondrocytes from hypochondrogenesis/achondrogenesis II patients, indicating ER stress from collagen misfolding."", ""reference"": ""PMID:3717210"", ""snippet"": ""Chondro-osseous histology and ultrastructure was similar in all cases regardless of severity and was characterized by hypervascularity and hypercellularity of the cartilage with multiple small, round dilated cysternae of rough endoplasmic reticulum."", ""supports"": ""SUPPORT""}], ""name"": ""Endoplasmic Reticulum Stress and Chondrocyte Apoptosis""}"
3896	163	Hypochondroplasia	Hypochondroplasia.yaml	pathophysiology	0	FGFR3 gain-of-function signaling (mild)	"The FGFR3 N540K mutation causes constitutive activation of the receptor, but with less severe effects than the G380R mutation in achondroplasia. This results in moderately impaired endochondral ossification with reduced chondrocyte proliferation in the growth plate, leading to mild short stature.
"																																																								"{""description"": ""The FGFR3 N540K mutation causes constitutive activation of the receptor, but with less severe effects than the G380R mutation in achondroplasia. This results in moderately impaired endochondral ossification with reduced chondrocyte proliferation in the growth plate, leading to mild short stature.\n"", ""name"": ""FGFR3 gain-of-function signaling (mild)""}"	{}	"{""biological_processes"": [{""preferred_term"": ""FGFR signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}, {""preferred_term"": ""Endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}], ""cell_types"": [{""preferred_term"": ""Growth plate chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}], ""description"": ""The FGFR3 N540K mutation causes constitutive activation of the receptor, but with less severe effects than the G380R mutation in achondroplasia. This results in moderately impaired endochondral ossification with reduced chondrocyte proliferation in the growth plate, leading to mild short stature.\n"", ""gene"": {""description"": ""Fibroblast growth factor receptor 3 with activating mutation causing mild gain-of-function."", ""modifier"": ""INCREASED"", ""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}, ""name"": ""FGFR3 gain-of-function signaling (mild)""}"
3911	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	0	IDH Neomorphic Enzyme Activity	Wild-type IDH1 and IDH2 convert isocitrate to alpha-ketoglutarate in the cytoplasm and mitochondria respectively. Mutant IDH enzymes gain neomorphic activity, reducing alpha-ketoglutarate to the oncometabolite 2-hydroxyglutarate (2-HG), which accumulates to millimolar concentrations in leukemic cells.																																																								"{""description"": ""Wild-type IDH1 and IDH2 convert isocitrate to alpha-ketoglutarate in the cytoplasm and mitochondria respectively. Mutant IDH enzymes gain neomorphic activity, reducing alpha-ketoglutarate to the oncometabolite 2-hydroxyglutarate (2-HG), which accumulates to millimolar concentrations in leukemic cells."", ""name"": ""IDH Neomorphic Enzyme Activity""}"	"{""downstream"": [{""description"": ""Oncometabolite accumulates and inhibits alpha-KG-dependent enzymes"", ""target"": ""2-HG Accumulation and Dioxygenase Inhibition""}]}"	"{""cell_types"": [{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}], ""description"": ""Wild-type IDH1 and IDH2 convert isocitrate to alpha-ketoglutarate in the cytoplasm and mitochondria respectively. Mutant IDH enzymes gain neomorphic activity, reducing alpha-ketoglutarate to the oncometabolite 2-hydroxyglutarate (2-HG), which accumulates to millimolar concentrations in leukemic cells."", ""downstream"": [{""description"": ""Oncometabolite accumulates and inhibits alpha-KG-dependent enzymes"", ""target"": ""2-HG Accumulation and Dioxygenase Inhibition""}], ""evidence"": [{""explanation"": ""This abstract links IDH1/2 mutations to increased 2-HG production, supporting the neomorphic IDH activity described."", ""reference"": ""PMID:37526143"", ""snippet"": ""Mutations in isocitrate dehydrogenase (IDH) 1 and -2 increase the capacity of cancer cells to produce a normally scarce metabolite, D-2-hydroxyglutarate (2-HG), by several orders of magnitude."", ""supports"": ""SUPPORT""}], ""name"": ""IDH Neomorphic Enzyme Activity""}"
3912	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	1	2-HG Accumulation and Dioxygenase Inhibition	2-HG is structurally similar to alpha-ketoglutarate and competitively inhibits alpha-ketoglutarate-dependent dioxygenases. Key targets include TET2 DNA demethylases, Jumonji-domain histone demethylases, and prolyl hydroxylases. This disrupts normal epigenetic regulation and hypoxia responses.																																																								"{""description"": ""2-HG is structurally similar to alpha-ketoglutarate and competitively inhibits alpha-ketoglutarate-dependent dioxygenases. Key targets include TET2 DNA demethylases, Jumonji-domain histone demethylases, and prolyl hydroxylases. This disrupts normal epigenetic regulation and hypoxia responses."", ""name"": ""2-HG Accumulation and Dioxygenase Inhibition""}"	"{""downstream"": [{""description"": ""TET2 inhibition causes aberrant DNA methylation"", ""target"": ""DNA Hypermethylation""}, {""description"": ""JmjC demethylase inhibition alters histone marks"", ""target"": ""Histone Methylation Dysregulation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA demethylation"", ""term"": {""id"": ""GO:0080111"", ""label"": ""DNA demethylation""}}], ""description"": ""2-HG is structurally similar to alpha-ketoglutarate and competitively inhibits alpha-ketoglutarate-dependent dioxygenases. Key targets include TET2 DNA demethylases, Jumonji-domain histone demethylases, and prolyl hydroxylases. This disrupts normal epigenetic regulation and hypoxia responses."", ""downstream"": [{""description"": ""TET2 inhibition causes aberrant DNA methylation"", ""target"": ""DNA Hypermethylation""}, {""description"": ""JmjC demethylase inhibition alters histone marks"", ""target"": ""Histone Methylation Dysregulation""}], ""name"": ""2-HG Accumulation and Dioxygenase Inhibition""}"
3913	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	2	DNA Hypermethylation	Inhibition of TET2 by 2-HG impairs the conversion of 5-methylcytosine to 5-hydroxymethylcytosine, disrupting active DNA demethylation. This causes hypermethylation at gene promoters, silencing differentiation genes and contributing to the leukemic phenotype.																																																								"{""description"": ""Inhibition of TET2 by 2-HG impairs the conversion of 5-methylcytosine to 5-hydroxymethylcytosine, disrupting active DNA demethylation. This causes hypermethylation at gene promoters, silencing differentiation genes and contributing to the leukemic phenotype."", ""name"": ""DNA Hypermethylation""}"	"{""downstream"": [{""description"": ""Epigenetic silencing of differentiation genes maintains blast state"", ""target"": ""Differentiation Block""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""myeloid cell differentiation"", ""term"": {""id"": ""GO:0030099"", ""label"": ""myeloid cell differentiation""}}], ""description"": ""Inhibition of TET2 by 2-HG impairs the conversion of 5-methylcytosine to 5-hydroxymethylcytosine, disrupting active DNA demethylation. This causes hypermethylation at gene promoters, silencing differentiation genes and contributing to the leukemic phenotype."", ""downstream"": [{""description"": ""Epigenetic silencing of differentiation genes maintains blast state"", ""target"": ""Differentiation Block""}], ""name"": ""DNA Hypermethylation""}"
3914	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	3	Histone Methylation Dysregulation	2-HG inhibits Jumonji-domain histone demethylases that remove methyl groups from lysine residues on histones. This causes accumulation of repressive histone marks and altered gene expression patterns contributing to leukemogenesis.																																																								"{""description"": ""2-HG inhibits Jumonji-domain histone demethylases that remove methyl groups from lysine residues on histones. This causes accumulation of repressive histone marks and altered gene expression patterns contributing to leukemogenesis."", ""name"": ""Histone Methylation Dysregulation""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""histone demethylation"", ""term"": {""id"": ""GO:0016577"", ""label"": ""histone demethylation""}}], ""description"": ""2-HG inhibits Jumonji-domain histone demethylases that remove methyl groups from lysine residues on histones. This causes accumulation of repressive histone marks and altered gene expression patterns contributing to leukemogenesis."", ""name"": ""Histone Methylation Dysregulation""}"
3915	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	4	Differentiation Block	The combined epigenetic effects of 2-HG on DNA methylation and histone modifications block normal myeloid differentiation, maintaining leukemic cells in an immature blast state. IDH inhibitors can overcome this block, inducing differentiation of leukemic blasts.																																																								"{""description"": ""The combined epigenetic effects of 2-HG on DNA methylation and histone modifications block normal myeloid differentiation, maintaining leukemic cells in an immature blast state. IDH inhibitors can overcome this block, inducing differentiation of leukemic blasts."", ""name"": ""Differentiation Block""}"	{}	"{""cell_types"": [{""preferred_term"": ""myeloid cell"", ""term"": {""id"": ""CL:0000763"", ""label"": ""myeloid cell""}}], ""description"": ""The combined epigenetic effects of 2-HG on DNA methylation and histone modifications block normal myeloid differentiation, maintaining leukemic cells in an immature blast state. IDH inhibitors can overcome this block, inducing differentiation of leukemic blasts."", ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Differentiation Block""}"
3936	165	IDH-Mutant Astrocytoma	IDH_Mutant_Astrocytoma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	Heterozygous mutations in IDH1 (R132H most common, >90%) or IDH2 (R172) confer neomorphic enzyme activity, converting alpha-ketoglutarate to the oncometabolite D-2-hydroxyglutarate (2-HG). This occurs as an early clonal event in gliomagenesis.																																																								"{""description"": ""Heterozygous mutations in IDH1 (R132H most common, >90%) or IDH2 (R172) confer neomorphic enzyme activity, converting alpha-ketoglutarate to the oncometabolite D-2-hydroxyglutarate (2-HG). This occurs as an early clonal event in gliomagenesis."", ""name"": ""IDH1/2 Neomorphic Mutation""}"	"{""downstream"": [{""description"": ""Neomorphic IDH activity produces oncometabolite 2-HG"", ""target"": ""2-HG Accumulation and Epigenetic Dysregulation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""tricarboxylic acid cycle"", ""term"": {""id"": ""GO:0006099"", ""label"": ""tricarboxylic acid cycle""}}], ""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Heterozygous mutations in IDH1 (R132H most common, >90%) or IDH2 (R172) confer neomorphic enzyme activity, converting alpha-ketoglutarate to the oncometabolite D-2-hydroxyglutarate (2-HG). This occurs as an early clonal event in gliomagenesis."", ""downstream"": [{""description"": ""Neomorphic IDH activity produces oncometabolite 2-HG"", ""target"": ""2-HG Accumulation and Epigenetic Dysregulation""}], ""evidence"": [{""explanation"": ""This abstract directly states that mutant IDH produces 2-HG, supporting the neomorphic IDH activity described."", ""reference"": ""PMID:40916936"", ""snippet"": ""This unique immune microenvironment is shaped by 2-hydroxyglutarate (2-HG), an oncometabolite produced by mutant IDH."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}], ""name"": ""IDH1/2 Neomorphic Mutation""}"
3937	165	IDH-Mutant Astrocytoma	IDH_Mutant_Astrocytoma.yaml	pathophysiology	1	2-HG Accumulation and Epigenetic Dysregulation	D-2-hydroxyglutarate competitively inhibits alpha-ketoglutarate-dependent dioxygenases including TET2 (DNA demethylation) and Jumonji-domain histone demethylases. This results in global DNA hypermethylation (G-CIMP phenotype) and histone hypermethylation, blocking cellular differentiation.																																																								"{""description"": ""D-2-hydroxyglutarate competitively inhibits alpha-ketoglutarate-dependent dioxygenases including TET2 (DNA demethylation) and Jumonji-domain histone demethylases. This results in global DNA hypermethylation (G-CIMP phenotype) and histone hypermethylation, blocking cellular differentiation."", ""name"": ""2-HG Accumulation and Epigenetic Dysregulation""}"	"{""downstream"": [{""description"": ""Epigenetic changes prevent normal astrocyte differentiation"", ""target"": ""Blocked Glial Differentiation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""DNA methylation"", ""term"": {""id"": ""GO:0006306"", ""label"": ""DNA methylation""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}], ""description"": ""D-2-hydroxyglutarate competitively inhibits alpha-ketoglutarate-dependent dioxygenases including TET2 (DNA demethylation) and Jumonji-domain histone demethylases. This results in global DNA hypermethylation (G-CIMP phenotype) and histone hypermethylation, blocking cellular differentiation."", ""downstream"": [{""description"": ""Epigenetic changes prevent normal astrocyte differentiation"", ""target"": ""Blocked Glial Differentiation""}], ""name"": ""2-HG Accumulation and Epigenetic Dysregulation""}"
3938	165	IDH-Mutant Astrocytoma	IDH_Mutant_Astrocytoma.yaml	pathophysiology	2	Blocked Glial Differentiation	Epigenetic dysregulation caused by 2-HG prevents normal glial differentiation programs, maintaining cells in a proliferative progenitor-like state. This contributes to tumor formation but also underlies the better prognosis compared to IDH-wildtype tumors due to retained differentiation potential.																																																								"{""description"": ""Epigenetic dysregulation caused by 2-HG prevents normal glial differentiation programs, maintaining cells in a proliferative progenitor-like state. This contributes to tumor formation but also underlies the better prognosis compared to IDH-wildtype tumors due to retained differentiation potential."", ""name"": ""Blocked Glial Differentiation""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""glial cell differentiation"", ""term"": {""id"": ""GO:0010001"", ""label"": ""glial cell differentiation""}}], ""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Epigenetic dysregulation caused by 2-HG prevents normal glial differentiation programs, maintaining cells in a proliferative progenitor-like state. This contributes to tumor formation but also underlies the better prognosis compared to IDH-wildtype tumors due to retained differentiation potential."", ""name"": ""Blocked Glial Differentiation""}"
3955	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	IDH1 R132 or IDH2 R140/R172 mutations are neomorphic, conferring a new enzymatic function. Instead of converting isocitrate to alpha-ketoglutarate (aKG), mutant IDH converts aKG to the oncometabolite D-2-hydroxyglutarate (2-HG). 2-HG accumulates to millimolar concentrations in tumor cells.																																																								"{""description"": ""IDH1 R132 or IDH2 R140/R172 mutations are neomorphic, conferring a new enzymatic function. Instead of converting isocitrate to alpha-ketoglutarate (aKG), mutant IDH converts aKG to the oncometabolite D-2-hydroxyglutarate (2-HG). 2-HG accumulates to millimolar concentrations in tumor cells."", ""name"": ""IDH1/2 Neomorphic Mutation""}"	"{""downstream"": [{""description"": ""Oncometabolite production inhibits aKG-dependent enzymes"", ""target"": ""2-HG Accumulation and Dioxygenase Inhibition""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""isocitrate dehydrogenase (NADP+) activity"", ""term"": {""id"": ""GO:0004450"", ""label"": ""isocitrate dehydrogenase (NADP+) activity""}}], ""cell_types"": [{""preferred_term"": ""cholangiocyte"", ""term"": {""id"": ""CL:1000488"", ""label"": ""cholangiocyte""}}], ""description"": ""IDH1 R132 or IDH2 R140/R172 mutations are neomorphic, conferring a new enzymatic function. Instead of converting isocitrate to alpha-ketoglutarate (aKG), mutant IDH converts aKG to the oncometabolite D-2-hydroxyglutarate (2-HG). 2-HG accumulates to millimolar concentrations in tumor cells."", ""downstream"": [{""description"": ""Oncometabolite production inhibits aKG-dependent enzymes"", ""target"": ""2-HG Accumulation and Dioxygenase Inhibition""}], ""evidence"": [{""explanation"": ""Supports the presence of IDH1 mutations in intrahepatic cholangiocarcinoma."", ""reference"": ""PMID:25536104"", ""snippet"": ""Commonly occurring GAs in intrahepatic CCA were TP53 (35%), KRAS (24%), ARID1A (20%), IDH1 (18%), MCL1 (16%) and PBRM1 (11%)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""intrahepatic bile duct"", ""term"": {""id"": ""UBERON:0003704"", ""label"": ""intrahepatic bile duct""}}], ""name"": ""IDH1/2 Neomorphic Mutation""}"
3956	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	1	2-HG Accumulation and Dioxygenase Inhibition	2-HG is structurally similar to alpha-ketoglutarate and competitively inhibits aKG-dependent dioxygenases, including TET2 (DNA demethylation), JMJD histone demethylases, and prolyl hydroxylases. This leads to widespread epigenetic and metabolic dysregulation.																																																								"{""description"": ""2-HG is structurally similar to alpha-ketoglutarate and competitively inhibits aKG-dependent dioxygenases, including TET2 (DNA demethylation), JMJD histone demethylases, and prolyl hydroxylases. This leads to widespread epigenetic and metabolic dysregulation."", ""name"": ""2-HG Accumulation and Dioxygenase Inhibition""}"	"{""downstream"": [{""description"": ""TET2 inhibition blocks DNA demethylation"", ""target"": ""Epigenetic Dysregulation and DNA Hypermethylation""}, {""description"": ""JMJD inhibition alters histone methylation landscape"", ""target"": ""Histone Methylation Alterations""}]}"	"{""description"": ""2-HG is structurally similar to alpha-ketoglutarate and competitively inhibits aKG-dependent dioxygenases, including TET2 (DNA demethylation), JMJD histone demethylases, and prolyl hydroxylases. This leads to widespread epigenetic and metabolic dysregulation."", ""downstream"": [{""description"": ""TET2 inhibition blocks DNA demethylation"", ""target"": ""Epigenetic Dysregulation and DNA Hypermethylation""}, {""description"": ""JMJD inhibition alters histone methylation landscape"", ""target"": ""Histone Methylation Alterations""}], ""evidence"": [{""explanation"": ""Abstract links IDH mutations to elevated 2-hydroxyglutarate and epigenetic effects."", ""reference"": ""PMID:24569570"", ""snippet"": ""These mutations result in elevated levels of an oncometabolite, 2-hydroxyglutarate, which is associated with higher DNA CpG methylation and altered histone methylation that accompany a block in cellular differentiation."", ""supports"": ""SUPPORT""}], ""name"": ""2-HG Accumulation and Dioxygenase Inhibition""}"
3957	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	2	Epigenetic Dysregulation and DNA Hypermethylation	2-HG inhibition of TET2 blocks conversion of 5-methylcytosine to 5-hydroxymethylcytosine, causing DNA hypermethylation. This CpG island methylator phenotype (CIMP) silences tumor suppressor genes and differentiation programs, contributing to the block in cellular differentiation characteristic of IDH-mutant tumors.																																																								"{""description"": ""2-HG inhibition of TET2 blocks conversion of 5-methylcytosine to 5-hydroxymethylcytosine, causing DNA hypermethylation. This CpG island methylator phenotype (CIMP) silences tumor suppressor genes and differentiation programs, contributing to the block in cellular differentiation characteristic of IDH-mutant tumors."", ""name"": ""Epigenetic Dysregulation and DNA Hypermethylation""}"	"{""downstream"": [{""description"": ""Epigenetic silencing impairs normal differentiation programs"", ""target"": ""Differentiation Block and Tumor Growth""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""DNA methylation"", ""term"": {""id"": ""GO:0006306"", ""label"": ""DNA methylation""}}], ""description"": ""2-HG inhibition of TET2 blocks conversion of 5-methylcytosine to 5-hydroxymethylcytosine, causing DNA hypermethylation. This CpG island methylator phenotype (CIMP) silences tumor suppressor genes and differentiation programs, contributing to the block in cellular differentiation characteristic of IDH-mutant tumors."", ""downstream"": [{""description"": ""Epigenetic silencing impairs normal differentiation programs"", ""target"": ""Differentiation Block and Tumor Growth""}], ""name"": ""Epigenetic Dysregulation and DNA Hypermethylation""}"
3958	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	3	Histone Methylation Alterations	2-HG inhibits Jumonji domain-containing histone demethylases, leading to accumulation of repressive histone methylation marks (H3K9me3, H3K27me3). This contributes to transcriptional silencing and the differentiation block.																																																								"{""description"": ""2-HG inhibits Jumonji domain-containing histone demethylases, leading to accumulation of repressive histone methylation marks (H3K9me3, H3K27me3). This contributes to transcriptional silencing and the differentiation block."", ""name"": ""Histone Methylation Alterations""}"	{}	"{""description"": ""2-HG inhibits Jumonji domain-containing histone demethylases, leading to accumulation of repressive histone methylation marks (H3K9me3, H3K27me3). This contributes to transcriptional silencing and the differentiation block."", ""name"": ""Histone Methylation Alterations""}"
3959	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	4	Differentiation Block and Tumor Growth	Combined epigenetic alterations block normal cholangiocyte differentiation, maintaining cells in a progenitor-like state with proliferative capacity. This promotes tumor growth while the cells retain sensitivity to IDH inhibition, which can restore differentiation programs.																																																								"{""description"": ""Combined epigenetic alterations block normal cholangiocyte differentiation, maintaining cells in a progenitor-like state with proliferative capacity. This promotes tumor growth while the cells retain sensitivity to IDH inhibition, which can restore differentiation programs."", ""name"": ""Differentiation Block and Tumor Growth""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Combined epigenetic alterations block normal cholangiocyte differentiation, maintaining cells in a progenitor-like state with proliferative capacity. This promotes tumor growth while the cells retain sensitivity to IDH inhibition, which can restore differentiation programs."", ""name"": ""Differentiation Block and Tumor Growth""}"
3980	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	0	IDH1/2 Neomorphic Mutation	Heterozygous IDH1 R132 or IDH2 R172 mutations produce D-2-hydroxyglutarate (2-HG), an oncometabolite causing epigenetic dysregulation through inhibition of alpha-ketoglutarate-dependent dioxygenases. This is an early clonal event shared with IDH-mutant astrocytomas.																																																								"{""description"": ""Heterozygous IDH1 R132 or IDH2 R172 mutations produce D-2-hydroxyglutarate (2-HG), an oncometabolite causing epigenetic dysregulation through inhibition of alpha-ketoglutarate-dependent dioxygenases. This is an early clonal event shared with IDH-mutant astrocytomas."", ""name"": ""IDH1/2 Neomorphic Mutation""}"	"{""downstream"": [{""description"": ""2-HG accumulation causes global DNA hypermethylation"", ""target"": ""G-CIMP Hypermethylation Phenotype""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""tricarboxylic acid cycle"", ""term"": {""id"": ""GO:0006099"", ""label"": ""tricarboxylic acid cycle""}}], ""cell_types"": [{""preferred_term"": ""oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}], ""description"": ""Heterozygous IDH1 R132 or IDH2 R172 mutations produce D-2-hydroxyglutarate (2-HG), an oncometabolite causing epigenetic dysregulation through inhibition of alpha-ketoglutarate-dependent dioxygenases. This is an early clonal event shared with IDH-mutant astrocytomas."", ""downstream"": [{""description"": ""2-HG accumulation causes global DNA hypermethylation"", ""target"": ""G-CIMP Hypermethylation Phenotype""}], ""evidence"": [{""explanation"": ""This abstract explicitly links mutant IDH to 2-HG production, supporting the neomorphic IDH mechanism."", ""reference"": ""PMID:40916936"", ""snippet"": ""This unique immune microenvironment is shaped by 2-hydroxyglutarate (2-HG), an oncometabolite produced by mutant IDH."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}], ""name"": ""IDH1/2 Neomorphic Mutation""}"
3981	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	1	1p/19q Codeletion	The 1p/19q codeletion results from an unbalanced translocation t(1;19)(q10;p10) occurring early in tumorigenesis. This leads to loss of tumor suppressor genes including CIC on 19q and FUBP1 on 1p. The codeletion is associated with oligodendroglial differentiation and exceptional chemosensitivity.																																																								"{""description"": ""The 1p/19q codeletion results from an unbalanced translocation t(1;19)(q10;p10) occurring early in tumorigenesis. This leads to loss of tumor suppressor genes including CIC on 19q and FUBP1 on 1p. The codeletion is associated with oligodendroglial differentiation and exceptional chemosensitivity."", ""name"": ""1p/19q Codeletion""}"	"{""downstream"": [{""description"": ""Codeletion removes key tumor suppressors on 1p and 19q"", ""target"": ""CIC/FUBP1 Tumor Suppressor Loss""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""chromosome organization"", ""term"": {""id"": ""GO:0051276"", ""label"": ""chromosome organization""}}], ""description"": ""The 1p/19q codeletion results from an unbalanced translocation t(1;19)(q10;p10) occurring early in tumorigenesis. This leads to loss of tumor suppressor genes including CIC on 19q and FUBP1 on 1p. The codeletion is associated with oligodendroglial differentiation and exceptional chemosensitivity."", ""downstream"": [{""description"": ""Codeletion removes key tumor suppressors on 1p and 19q"", ""target"": ""CIC/FUBP1 Tumor Suppressor Loss""}], ""evidence"": [{""explanation"": ""Abstract defines oligodendrogliomas by IDH mutation and 1p/19q codeletion."", ""reference"": ""PMID:37743332"", ""snippet"": ""Oligodendrogliomas were clearly defined as tumors with IDH mutations and 1p/19q codeletion by the World Health Organization(WHO)in 2016."", ""supports"": ""SUPPORT""}], ""name"": ""1p/19q Codeletion""}"
3982	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	2	G-CIMP Hypermethylation Phenotype	Glioma CpG island methylator phenotype (G-CIMP) results from 2-HG-mediated inhibition of TET enzymes and histone demethylases. This leads to widespread promoter hypermethylation, altered gene expression, and blocked differentiation. G-CIMP is associated with favorable prognosis.																																																								"{""description"": ""Glioma CpG island methylator phenotype (G-CIMP) results from 2-HG-mediated inhibition of TET enzymes and histone demethylases. This leads to widespread promoter hypermethylation, altered gene expression, and blocked differentiation. G-CIMP is associated with favorable prognosis."", ""name"": ""G-CIMP Hypermethylation Phenotype""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""DNA methylation"", ""term"": {""id"": ""GO:0006306"", ""label"": ""DNA methylation""}}], ""description"": ""Glioma CpG island methylator phenotype (G-CIMP) results from 2-HG-mediated inhibition of TET enzymes and histone demethylases. This leads to widespread promoter hypermethylation, altered gene expression, and blocked differentiation. G-CIMP is associated with favorable prognosis."", ""name"": ""G-CIMP Hypermethylation Phenotype""}"
3983	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	3	CIC/FUBP1 Tumor Suppressor Loss	CIC (Capicua) on 19q13 is mutated in approximately 70% of oligodendrogliomas. FUBP1 on 1p31 is mutated in approximately 30%. These mutations cooperate with IDH mutation and 1p/19q codeletion to drive oligodendroglioma formation.																																																								"{""description"": ""CIC (Capicua) on 19q13 is mutated in approximately 70% of oligodendrogliomas. FUBP1 on 1p31 is mutated in approximately 30%. These mutations cooperate with IDH mutation and 1p/19q codeletion to drive oligodendroglioma formation."", ""name"": ""CIC/FUBP1 Tumor Suppressor Loss""}"	"{""downstream"": [{""description"": ""Loss of tumor suppressors promotes oligodendroglioma formation"", ""target"": ""Oligodendroglial Tumorigenesis""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of cell population proliferation"", ""term"": {""id"": ""GO:0008285"", ""label"": ""negative regulation of cell population proliferation""}}], ""description"": ""CIC (Capicua) on 19q13 is mutated in approximately 70% of oligodendrogliomas. FUBP1 on 1p31 is mutated in approximately 30%. These mutations cooperate with IDH mutation and 1p/19q codeletion to drive oligodendroglioma formation."", ""downstream"": [{""description"": ""Loss of tumor suppressors promotes oligodendroglioma formation"", ""target"": ""Oligodendroglial Tumorigenesis""}], ""name"": ""CIC/FUBP1 Tumor Suppressor Loss""}"
3984	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	4	Oligodendroglial Tumorigenesis	The combination of IDH mutation, 1p/19q codeletion, and CIC/FUBP1 mutations drives oligodendroglioma formation. These tumors retain oligodendroglial differentiation markers and maintain sensitivity to DNA-damaging agents, likely due to intact DNA damage response pathways.																																																								"{""description"": ""The combination of IDH mutation, 1p/19q codeletion, and CIC/FUBP1 mutations drives oligodendroglioma formation. These tumors retain oligodendroglial differentiation markers and maintain sensitivity to DNA-damaging agents, likely due to intact DNA damage response pathways."", ""name"": ""Oligodendroglial Tumorigenesis""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}], ""description"": ""The combination of IDH mutation, 1p/19q codeletion, and CIC/FUBP1 mutations drives oligodendroglioma formation. These tumors retain oligodendroglial differentiation markers and maintain sensitivity to DNA-damaging agents, likely due to intact DNA damage response pathways."", ""name"": ""Oligodendroglial Tumorigenesis""}"
3999	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	0	Galactose-Deficient IgA1 Production	Aberrantly glycosylated IgA1 with reduced galactose in the hinge region is produced by mucosal B cells. This galactose-deficient IgA1 (Gd-IgA1) is the key autoantigen in IgA nephropathy.																																																								"{""description"": ""Aberrantly glycosylated IgA1 with reduced galactose in the hinge region is produced by mucosal B cells. This galactose-deficient IgA1 (Gd-IgA1) is the key autoantigen in IgA nephropathy."", ""name"": ""Galactose-Deficient IgA1 Production""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""cell_types"": [{""preferred_term"": ""B Cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""Aberrantly glycosylated IgA1 with reduced galactose in the hinge region is produced by mucosal B cells. This galactose-deficient IgA1 (Gd-IgA1) is the key autoantigen in IgA nephropathy."", ""evidence"": [{""explanation"": ""This 2024 review confirms that aberrantly O-glycosylated IgA1 is central to IgAN pathogenesis and serves as the autoantigen triggering immune complex formation."", ""reference"": ""PMID:39124764"", ""snippet"": ""The pathogenesis of IgAN is considered a multifactorial process involving the formation of immune complexes wherein aberrantly O-glycosylated IgA1 is recognized as an autoantigen."", ""supports"": ""SUPPORT""}, {""explanation"": ""This landmark study establishes that galactose-deficient IgA1 with exposed N-acetylgalactosamine residues is the characteristic molecular abnormality in IgAN."", ""reference"": ""PMID:22904352"", ""snippet"": ""Mesangial and circulating IgA1 with aberrantly glycosylated hinge region O-glycans characterize IgA nephropathy (IgAN). Unlike healthy individuals, some IgA1 is galactose deficient in patients with IgAN, leaving terminal N-acetylgalactosamine residues in the hinge region exposed."", ""supports"": ""SUPPORT""}], ""name"": ""Galactose-Deficient IgA1 Production""}"
4000	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	1	Anti-Gd-IgA1 Autoantibody Formation	IgG and IgA autoantibodies recognize exposed GalNAc residues on Gd-IgA1. These autoantibodies form circulating immune complexes with Gd-IgA1 that deposit in the glomerular mesangium.																																																								"{""description"": ""IgG and IgA autoantibodies recognize exposed GalNAc residues on Gd-IgA1. These autoantibodies form circulating immune complexes with Gd-IgA1 that deposit in the glomerular mesangium."", ""name"": ""Anti-Gd-IgA1 Autoantibody Formation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immune Complex Formation"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}], ""description"": ""IgG and IgA autoantibodies recognize exposed GalNAc residues on Gd-IgA1. These autoantibodies form circulating immune complexes with Gd-IgA1 that deposit in the glomerular mesangium."", ""evidence"": [{""explanation"": ""This study demonstrates that autoantibodies targeting galactose-deficient IgA1 are pathogenic in IgAN and correlate with disease progression."", ""reference"": ""PMID:22904352"", ""snippet"": ""Circulating autoantibodies that recognize such galactose-deficient IgA1 as an autoantigen, or the levels of the autoantigen itself, may allow prediction of disease progression."", ""supports"": ""SUPPORT""}, {""explanation"": ""This 2024 systematic review confirms that Gd-IgA1 is central to IgAN pathophysiology and serves as the target for autoantibody formation."", ""reference"": ""PMID:38427309"", ""snippet"": ""The O-glycosylation status of IgA1 plays a crucial role in disease pathophysiology. The level of poorly-O-galactosylated IgA1, or galactose-deficient IgA1 (Gd-IgA1), has also been identified as a potential biomarker in IgAN."", ""supports"": ""SUPPORT""}], ""name"": ""Anti-Gd-IgA1 Autoantibody Formation""}"
4001	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	2	Mesangial Cell Activation and Proliferation	IgA immune complex deposition activates mesangial cells, causing proliferation, matrix expansion, and release of inflammatory mediators including cytokines and complement components.																																																								"{""description"": ""IgA immune complex deposition activates mesangial cells, causing proliferation, matrix expansion, and release of inflammatory mediators including cytokines and complement components."", ""name"": ""Mesangial Cell Activation and Proliferation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell proliferation""}}, {""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""cell_types"": [{""preferred_term"": ""Mesangial Cell"", ""term"": {""id"": ""CL:0000650"", ""label"": ""mesangial cell""}}], ""description"": ""IgA immune complex deposition activates mesangial cells, causing proliferation, matrix expansion, and release of inflammatory mediators including cytokines and complement components."", ""evidence"": [{""explanation"": ""This 2024 study confirms that mesangial C3 deposition is a hallmark of IgAN, indicating complement activation triggered by immune complex deposition in the mesangium."", ""reference"": ""PMID:38182298"", ""snippet"": ""Mesangial complement C3 deposits, reflecting alternative and possibly lectin pathway activation, are characteristic in biopsies of patients with IgA nephropathy (IgAN)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This comprehensive 2023 review establishes that alternative complement pathway activation in the mesangium drives IgAN progression."", ""reference"": ""PMID:38053977"", ""snippet"": ""The alternative complement pathway is the major complement cascade activator in IgAN, and glomerular C3 deposition has been shown to correlate with disease progression."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study demonstrates that C3 deposition intensity in the mesangium correlates with disease severity and progression, supporting the role of complement-mediated mesangial injury in IgAN pathophysiology."", ""reference"": ""PMID:35781866"", ""snippet"": ""Patients with positive glomerular C3 deposition presented with more severe clinical and histopathological characteristics and a higher score on the Oxford scoring system. With the increasing intensity of C3 deposition, IgAN patients were more likely to present with high level of microscopic hematuria, fibrous crescents, interstitial inflammatory cell infiltration, and a higher score on segmental sclerosis lesions."", ""supports"": ""SUPPORT""}], ""name"": ""Mesangial Cell Activation and Proliferation""}"
4014	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	0	Antiplatelet Antibody Production	Autoantibodies (primarily IgG) target platelet surface glycoproteins, especially GPIIb/IIIa and GPIb/IX. Antibody-coated platelets are cleared by splenic macrophages through Fc receptor-mediated phagocytosis.																																																								"{""description"": ""Autoantibodies (primarily IgG) target platelet surface glycoproteins, especially GPIIb/IIIa and GPIb/IX. Antibody-coated platelets are cleared by splenic macrophages through Fc receptor-mediated phagocytosis."", ""name"": ""Antiplatelet Antibody Production""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Phagocytosis"", ""term"": {""id"": ""GO:0006909"", ""label"": ""phagocytosis""}}], ""cell_types"": [{""preferred_term"": ""Platelet"", ""term"": {""id"": ""CL:0000233"", ""label"": ""platelet""}}, {""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Autoantibodies (primarily IgG) target platelet surface glycoproteins, especially GPIIb/IIIa and GPIb/IX. Antibody-coated platelets are cleared by splenic macrophages through Fc receptor-mediated phagocytosis."", ""evidence"": [{""explanation"": ""This review confirms that autoantibody-mediated platelet destruction is central to ITP pathogenesis, with therapeutic strategies targeting Fc receptors and B cells showing efficacy."", ""reference"": ""PMID:38396839"", ""snippet"": ""A better understanding of the underlying pathology has facilitated the development of a number of new targeted therapies (Bruton's tyrosine kinase inhibitors, neonatal Fc receptors, strategies targeting B and plasma cells, strategies targeting T cells, complement inhibitors, and newer TPO-RAs for improving megakaryopoiesis), which seem to be highly effective and well tolerated and result in a significant improvement in patients' quality of life."", ""supports"": ""SUPPORT""}], ""name"": ""Antiplatelet Antibody Production""}"
4015	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	1	Impaired Megakaryopoiesis	Autoantibodies also target megakaryocytes, impairing platelet production. T cell-mediated megakaryocyte damage and cytokine effects further suppress thrombopoiesis.																																																								"{""description"": ""Autoantibodies also target megakaryocytes, impairing platelet production. T cell-mediated megakaryocyte damage and cytokine effects further suppress thrombopoiesis."", ""name"": ""Impaired Megakaryopoiesis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Platelet Formation"", ""term"": {""id"": ""GO:0030220"", ""label"": ""platelet formation""}}], ""cell_types"": [{""preferred_term"": ""Megakaryocyte"", ""term"": {""id"": ""CL:0000556"", ""label"": ""megakaryocyte""}}], ""description"": ""Autoantibodies also target megakaryocytes, impairing platelet production. T cell-mediated megakaryocyte damage and cytokine effects further suppress thrombopoiesis."", ""evidence"": [{""explanation"": ""This study demonstrates that ITP autoantibodies directly impair multiple steps of megakaryocyte maturation and platelet production, contributing to thrombocytopenia beyond peripheral destruction."", ""reference"": ""PMID:38525349"", ""snippet"": ""In vitro studies using ITP sera or monoclonal antibodies against platelet and megakaryocyte surface glycoproteins have shown an impairment of many steps of megakaryopoiesis and thrombopoiesis, such as megakaryocyte differentiation and maturation, migration from the osteoblastic to the vascular niche, adhesion to extracellular matrix proteins, and proplatelet formation, resulting in impaired and ectopic platelet production in the bone marrow and diminished platelet release in the bloodstream."", ""supports"": ""SUPPORT""}, {""explanation"": ""Evidence that cellular immunity, specifically cytotoxic T cells, can directly attack megakaryocytes in the bone marrow, providing a T cell-mediated mechanism for impaired platelet production."", ""reference"": ""PMID:38525349"", ""snippet"": ""Moreover, cytotoxic T cells may target bone marrow megakaryocytes, resulting in megakaryocyte destruction."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired Megakaryopoiesis""}"
4016	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	2	T Cell Dysregulation	Th1/Th17 imbalance and reduced regulatory T cell function contribute to loss of tolerance. Cytotoxic T cells may directly kill platelets and megakaryocytes.																																																								"{""description"": ""Th1/Th17 imbalance and reduced regulatory T cell function contribute to loss of tolerance. Cytotoxic T cells may directly kill platelets and megakaryocytes."", ""name"": ""T Cell Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immune Regulation"", ""term"": {""id"": ""GO:0002682"", ""label"": ""regulation of immune system process""}}], ""cell_types"": [{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}], ""description"": ""Th1/Th17 imbalance and reduced regulatory T cell function contribute to loss of tolerance. Cytotoxic T cells may directly kill platelets and megakaryocytes."", ""evidence"": [{""explanation"": ""This review establishes that Th17/Treg imbalance is a key pathogenic factor in ITP, with Th17 cells promoting autoimmunity and Treg dysfunction leading to loss of tolerance."", ""reference"": ""PMID:37062251"", ""snippet"": ""Studies have shown that an imbalance between T helper 17 (Th17) and Regulatory T (Treg) cells differentiated from CD4+T-cells is a key factor influencing the development and pathogenesis of immune thrombocytopenia. Th17 cells promote the development of chronic inflammatory disorders and induce autoimmune diseases, whereas Treg cells regulate immune homeostasis and prevent autoimmune diseases."", ""supports"": ""SUPPORT""}], ""name"": ""T Cell Dysregulation""}"
4017	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	3	Complement Activation	Classical complement pathway activation occurs in many ITP patients, with C3, C4, and C9 deposition on platelets. Complement activation enhances platelet opsonization and clearance. Elevated complement activation markers correlate with disease severity and platelet count.																																																								"{""description"": ""Classical complement pathway activation occurs in many ITP patients, with C3, C4, and C9 deposition on platelets. Complement activation enhances platelet opsonization and clearance. Elevated complement activation markers correlate with disease severity and platelet count."", ""name"": ""Complement Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""description"": ""Classical complement pathway activation occurs in many ITP patients, with C3, C4, and C9 deposition on platelets. Complement activation enhances platelet opsonization and clearance. Elevated complement activation markers correlate with disease severity and platelet count."", ""evidence"": [{""explanation"": ""This study demonstrates that complement activation markers (sC5b-9 and C1q) are significantly elevated in acute ITP patients compared to patients in remission, and that sC5b-9 levels inversely correlate with platelet count, supporting complement's role in ITP pathogenesis."", ""reference"": ""PMID:32515487"", ""snippet"": ""Statistical analyses showed that acute ITP patients had higher plasma levels of sC5b-9 and C1q than CR or PR patients (median = sC5b-9: 200 versus 98 mg/dl, P-value < 0001) (median C1q = 211 versus 100 mg/dl, P-value < 0001). CR and PR ITP patients had sC5b-9 and C1q plasma levels comparable to those observed in healthy volunteers."", ""supports"": ""SUPPORT""}, {""explanation"": ""This research explicitly identifies complement activation as one of the key pathogenic mechanisms in ITP alongside antibodies and T cell dysfunction."", ""reference"": ""PMID:32515487"", ""snippet"": ""The pathogenesis involves antibody production, cytokine release, T cell impairment, complement activation and clearance of platelets."", ""supports"": ""SUPPORT""}], ""name"": ""Complement Activation""}"
4027	170	Infectious Disease	Infectious_Disease.yaml	pathophysiology	0	Pathogen Invasion and Replication	Disease results from invasion and replication of pathogenic organisms in the host, triggering host-pathogen interactions that drive tissue injury.																																																								"{""description"": ""Disease results from invasion and replication of pathogenic organisms in the host, triggering host-pathogen interactions that drive tissue injury."", ""name"": ""Pathogen Invasion and Replication""}"	{}	"{""description"": ""Disease results from invasion and replication of pathogenic organisms in the host, triggering host-pathogen interactions that drive tissue injury."", ""evidence"": [{""explanation"": ""The abstract defines infectious diseases as caused by pathogenic microorganisms."", ""reference"": ""PMID:36675263"", ""snippet"": ""Infectious diseases, which are caused by pathogens such as bacteria, viruses, fungi, and parasites, pose a serious threat to humans, animals, and plants"", ""supports"": ""SUPPORT""}], ""name"": ""Pathogen Invasion and Replication""}"
4028	170	Infectious Disease	Infectious_Disease.yaml	pathophysiology	1	Host Genetic Susceptibility and Immune Response	Host genetic factors and immune response pathways influence progression from exposure to mild or severe infection and determine disease outcomes.																																																								"{""description"": ""Host genetic factors and immune response pathways influence progression from exposure to mild or severe infection and determine disease outcomes."", ""name"": ""Host Genetic Susceptibility and Immune Response""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}], ""description"": ""Host genetic factors and immune response pathways influence progression from exposure to mild or severe infection and determine disease outcomes."", ""evidence"": [{""explanation"": ""The abstract describes staged progression and host genetic influence on infectious disease outcomes."", ""reference"": ""PMID:10884944"", ""snippet"": ""On exposure to a pathogen, a host may resist infection, become subclinically infected, or progress through several stages from mild to severe infection. Chronic sequelae may or may not occur. Host factors, particularly host genes, influence many of these stages."", ""supports"": ""SUPPORT""}], ""name"": ""Host Genetic Susceptibility and Immune Response""}"
4029	170	Infectious Disease	Infectious_Disease.yaml	pathophysiology	2	Toll-Like Receptor Signaling and Cytokine Release	Innate immune recognition of bacterial pathogens via toll-like receptors triggers cytokine release that supports effective immune responses.																																																								"{""description"": ""Innate immune recognition of bacterial pathogens via toll-like receptors triggers cytokine release that supports effective immune responses."", ""name"": ""Toll-Like Receptor Signaling and Cytokine Release""}"	{}	"{""description"": ""Innate immune recognition of bacterial pathogens via toll-like receptors triggers cytokine release that supports effective immune responses."", ""evidence"": [{""explanation"": ""The abstract links TLR signaling to cytokine release in bacterial infections."", ""reference"": ""PMID:17280841"", ""snippet"": ""Innate immunity relies on signalling by Toll-like receptors (TLRs) to alert the immune system of the presence of invading bacteria. TLR activation leads to the release of cytokines that allow for effective innate and adaptive immune responses."", ""supports"": ""SUPPORT""}], ""name"": ""Toll-Like Receptor Signaling and Cytokine Release""}"
4043	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	0	Visceral Hypersensitivity	"Enhanced perception of normal gut sensations leads to pain and discomfort. Lowered pain thresholds in response to balloon distension. Central sensitization contributes.
"																																																								"{""description"": ""Enhanced perception of normal gut sensations leads to pain and discomfort. Lowered pain thresholds in response to balloon distension. Central sensitization contributes.\n"", ""name"": ""Visceral Hypersensitivity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Pain Perception"", ""term"": {""id"": ""GO:0048265"", ""label"": ""response to pain""}}], ""description"": ""Enhanced perception of normal gut sensations leads to pain and discomfort. Lowered pain thresholds in response to balloon distension. Central sensitization contributes.\n"", ""evidence"": [{""explanation"": ""TRPV1-expressing sensory nerve fibers are significantly increased in IBS, providing a molecular basis for visceral hypersensitivity."", ""reference"": ""PMID:18252749"", ""snippet"": ""A significant 3.5-fold increase in median numbers of TRPV1-immunoreactive fibres was found in biopsies from IBS patients compared with controls (p<0.0001)."", ""supports"": ""SUPPORT""}, {""explanation"": ""TRPV1 nerve fiber density directly correlates with abdominal pain severity in IBS patients."", ""reference"": ""PMID:18252749"", ""snippet"": ""In multivariate regression analysis, only TRPV1-immuno-reactive fibres (p = 0.005) and mast cells (p = 0.008) were significantly related to the abdominal pain score."", ""supports"": ""SUPPORT""}, {""explanation"": ""Mucosal mediators from IBS patients directly excite visceral sensory neurons, demonstrating a mechanism for visceral hypersensitivity."", ""reference"": ""PMID:17241857"", ""snippet"": ""Mediators from IBS patients, but not controls, markedly enhanced the firing of mesenteric nerves (14.7 +/- 3.2 imp/sec vs 2.8 +/- 1.5 imp/sec; P < .05) and stimulated mobilization of Ca(2+) in dorsal root ganglia neurons (29% +/- 4% vs 11% +/- 4%; P < .05)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The majority of sensory neurons activated by IBS mucosal mediators are nociceptive, explaining the pain phenotype."", ""reference"": ""PMID:17241857"", ""snippet"": ""On average, 64% of dorsal root ganglia responsive to mediators were capsaicin-sensitive, known to mediate nociception."", ""supports"": ""SUPPORT""}], ""name"": ""Visceral Hypersensitivity""}"
4044	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	1	Gut Dysmotility	"Altered intestinal motility patterns with either accelerated (diarrhea-predominant) or delayed (constipation-predominant) transit. Abnormal colonic contractions.
"																																																								"{""description"": ""Altered intestinal motility patterns with either accelerated (diarrhea-predominant) or delayed (constipation-predominant) transit. Abnormal colonic contractions.\n"", ""name"": ""Gut Dysmotility""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Gut Motility"", ""term"": {""id"": ""GO:0030432"", ""label"": ""peristalsis""}}], ""description"": ""Altered intestinal motility patterns with either accelerated (diarrhea-predominant) or delayed (constipation-predominant) transit. Abnormal colonic contractions.\n"", ""evidence"": [{""explanation"": ""Serotonin from enterochromaffin cells is a key regulator of intestinal motility and peristaltic reflexes."", ""reference"": ""PMID:15100164"", ""snippet"": ""5-HT release from enterochromaffin (EC) cells initiates peristaltic, secretory, vasodilatory, vagal and nociceptive reflexes."", ""supports"": ""SUPPORT""}, {""explanation"": ""Dysregulated serotonin signaling can account for both IBS-D and IBS-C subtypes through effects on motility."", ""reference"": ""PMID:15100164"", ""snippet"": ""5-HT directly and indirectly affects intestinal motor and secretory function and abnormalities may lead to either constipation or diarrhea."", ""supports"": ""SUPPORT""}], ""name"": ""Gut Dysmotility""}"
4045	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	2	Gut-Brain Axis Dysfunction	"Bidirectional communication between gut and brain is disrupted. Stress and psychological factors modulate gut function through autonomic and neuroendocrine pathways.
"																																																								"{""description"": ""Bidirectional communication between gut and brain is disrupted. Stress and psychological factors modulate gut function through autonomic and neuroendocrine pathways.\n"", ""name"": ""Gut-Brain Axis Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Nervous System Process"", ""term"": {""id"": ""GO:0050877"", ""label"": ""nervous system process""}}], ""description"": ""Bidirectional communication between gut and brain is disrupted. Stress and psychological factors modulate gut function through autonomic and neuroendocrine pathways.\n"", ""evidence"": [{""explanation"": ""The gut-brain axis is a central organizing principle in IBS pathophysiology, integrating multiple dysfunctional mechanisms."", ""reference"": ""PMID:37048642"", ""snippet"": ""Although the pathophysiology of IBS has not been fully elucidated, it involves dysregulation of communication between the brain and gut (brain-gut axis) which is associated with alterations in intestinal motility, gut permeability, visceral hypersensitivity and gut microbiota composition."", ""supports"": ""SUPPORT""}, {""explanation"": ""Serotonin pathways mediate bidirectional brain-gut communication in IBS."", ""reference"": ""PMID:15100164"", ""snippet"": ""Ongoing, bidirectional brain-gut interactions involving 5-HT pathways occur that significantly influence the effector systems."", ""supports"": ""SUPPORT""}], ""name"": ""Gut-Brain Axis Dysfunction""}"
4046	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	3	Intestinal Barrier Dysfunction	"Increased intestinal permeability (leaky gut) allows translocation of luminal antigens, triggering low-grade immune activation.
"																																																								"{""description"": ""Increased intestinal permeability (leaky gut) allows translocation of luminal antigens, triggering low-grade immune activation.\n"", ""name"": ""Intestinal Barrier Dysfunction""}"	{}	"{""description"": ""Increased intestinal permeability (leaky gut) allows translocation of luminal antigens, triggering low-grade immune activation.\n"", ""evidence"": [{""explanation"": ""A subset of IBS patients demonstrate measurable increases in intestinal permeability, though the exact prevalence varies by methodology."", ""reference"": ""PMID:17593135"", ""snippet"": ""While a subgroup of patients with IBS appears to have evidence of increased intestinal permeability, improvements in the methods and validation are key to further research in this field in order to better understand intestinal barrier functions in IBS."", ""supports"": ""SUPPORT""}, {""explanation"": ""Nearly 40% of IBS-D patients show objective evidence of barrier dysfunction using validated permeability testing."", ""reference"": ""PMID:19595511"", ""snippet"": ""Approximately 39% of diarrhea-predominant IBS patients had increased intestinal membrane permeability as measured by the lactulose/mannitol ratio."", ""supports"": ""SUPPORT""}, {""explanation"": ""Barrier dysfunction in IBS-D correlates with more severe symptoms and heightened visceral sensitivity, linking permeability to clinical phenotype."", ""reference"": ""PMID:19595511"", ""snippet"": ""A subset of D-IBS patients had increased intestinal membrane permeability that was associated with an increased FBDSI score and increased hypersensitivity to visceral and thermal nociceptive pain stimuli."", ""supports"": ""SUPPORT""}], ""name"": ""Intestinal Barrier Dysfunction""}"
4047	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	4	Immune Activation and Mast Cell Degranulation	"Low-grade mucosal immune activation with increased mast cell density and degranulation near enteric nerves. Mast cell mediators including histamine and tryptase excite visceral sensory neurons, contributing to pain and hypersensitivity.
"																																																								"{""description"": ""Low-grade mucosal immune activation with increased mast cell density and degranulation near enteric nerves. Mast cell mediators including histamine and tryptase excite visceral sensory neurons, contributing to pain and hypersensitivity.\n"", ""name"": ""Immune Activation and Mast Cell Degranulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Mast Cell Activation"", ""term"": {""id"": ""GO:0045576"", ""label"": ""mast cell activation""}}], ""description"": ""Low-grade mucosal immune activation with increased mast cell density and degranulation near enteric nerves. Mast cell mediators including histamine and tryptase excite visceral sensory neurons, contributing to pain and hypersensitivity.\n"", ""evidence"": [{""explanation"": ""Mast cell density directly correlates with sensory neuron activation in IBS, establishing a quantitative relationship."", ""reference"": ""PMID:17241857"", ""snippet"": ""IBS-dependent nerve firing and Ca(2+) mobilization were correlated with the area of the colonic lamina propria occupied by mast cells (r = 0.74; P < .01, and r = 0.78; P < .01, respectively)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Mast cell mediators from IBS patients directly activate nociceptive neurons, providing a mechanistic link to pain."", ""reference"": ""PMID:17241857"", ""snippet"": ""Mucosal mast cell mediators from IBS patients excite rat nociceptive visceral sensory nerves. These results provide new insights into the mechanism underlying visceral hypersensitivity in IBS."", ""supports"": ""SUPPORT""}, {""explanation"": ""Both mast cells and immune cells are increased in IBS mucosa, indicating low-grade immune activation."", ""reference"": ""PMID:18252749"", ""snippet"": ""Substance P-immunoreactive fibres (p = 0.01), total nerve fibres (PGP9.5) (p = 0.002), mast cells (c-kit) (p = 0.02) and lymphocytes (CD3) (p = 0.03) were also significantly increased in the IBS group."", ""supports"": ""SUPPORT""}], ""name"": ""Immune Activation and Mast Cell Degranulation""}"
4048	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	5	Microbiome Dysbiosis	"Altered composition and function of gut microbiota may contribute to symptoms. Post-infectious IBS follows gastroenteritis in some patients.
"																																																								"{""description"": ""Altered composition and function of gut microbiota may contribute to symptoms. Post-infectious IBS follows gastroenteritis in some patients.\n"", ""name"": ""Microbiome Dysbiosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Host-Microbiome Interaction"", ""term"": {""id"": ""GO:0044003"", ""label"": ""modification by symbiont of host morphology or physiology""}}], ""description"": ""Altered composition and function of gut microbiota may contribute to symptoms. Post-infectious IBS follows gastroenteritis in some patients.\n"", ""evidence"": [{""explanation"": ""IBS is a common disorder with substantial public health impact, emphasizing the importance of understanding pathophysiological mechanisms including microbiome alterations."", ""reference"": ""PMID:37048642"", ""snippet"": ""It has a prevalence of 10 to 25% in the United States and has a high disease burden, as evidenced by reduced quality of life, decreased work productivity and increased healthcare utilization and costs."", ""supports"": ""SUPPORT""}], ""name"": ""Microbiome Dysbiosis""}"
4066	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	pathophysiology	0	FGFR2 Gain-of-Function Signaling	"Mutations in FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal skeletal development in the feet. The specific mutations overlap with those causing Crouzon and Pfeiffer syndromes, with phenotype depending on genetic background and other modifying factors.
"																																																								"{""description"": ""Mutations in FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal skeletal development in the feet. The specific mutations overlap with those causing Crouzon and Pfeiffer syndromes, with phenotype depending on genetic background and other modifying factors.\n"", ""name"": ""FGFR2 Gain-of-Function Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}, {""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""Mutations in FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal skeletal development in the feet. The specific mutations overlap with those causing Crouzon and Pfeiffer syndromes, with phenotype depending on genetic background and other modifying factors.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Landmark paper identifying FGFR2 mutations as the cause of Jackson-Weiss syndrome in the original Amish kindred."", ""reference"": ""PMID:7874170"", ""snippet"": ""We now report an FGFR2 mutation in the conserved region of the immunoglobulin IIIc domain in the Jackson-Weiss syndrome family in which the syndrome was originally described."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Identifies specific FGFR2 mutations in JWS patients affecting the immunoglobulin-like domain critical for receptor function."", ""reference"": ""PMID:9385368"", ""snippet"": ""Both nucleotide changes predict a serine for cysteine-342 substitution in the second half of the third immunoglobulin-like domain."", ""supports"": ""SUPPORT""}], ""name"": ""FGFR2 Gain-of-Function Signaling""}"
4089	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	0	Complex Genetic Predisposition	A complex genetic basis involving multiple genes contributes to susceptibility.																																																								"{""description"": ""A complex genetic basis involving multiple genes contributes to susceptibility."", ""name"": ""Complex Genetic Predisposition""}"	{}	"{""description"": ""A complex genetic basis involving multiple genes contributes to susceptibility."", ""evidence"": [{""explanation"": ""The abstract discusses drug resistance without specifying a particular genetic basis, but it does imply complexity by mentioning the variability in response to treatments and presence of multiple seizure types."", ""reference"": ""PMID:30082241"", ""snippet"": ""Jeavons syndrome is an underreported epileptic syndrome characterized by eyelid myoclonia, eyelid closure-induced seizures or electroencephalography paroxysms, and photosensitivity. Drug-resistant epilepsy is common, but the prognostic factors and clinical course leading to drug resistance have not been well characterized."", ""supports"": ""SUPPORT""}], ""name"": ""Complex Genetic Predisposition""}"
4090	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	1	Neuronal Hyperexcitability	Neurons in the brain exhibit increased excitability, particularly in response to visual stimuli.																																																								"{""description"": ""Neurons in the brain exhibit increased excitability, particularly in response to visual stimuli."", ""name"": ""Neuronal Hyperexcitability""}"	{}	"{""biological_processes"": [{""description"": ""Process of synaptic signaling involving neurotransmitter release and receptor activation."", ""preferred_term"": ""chemical synaptic transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}], ""cell_types"": [{""description"": ""Neurons that use glutamate as their primary neurotransmitter and mediate excitatory synaptic transmission."", ""preferred_term"": ""Excitatory Glutamatergic Neuron"", ""term"": {""id"": ""CL:0000679"", ""label"": ""glutamatergic neuron""}}], ""description"": ""Neurons in the brain exhibit increased excitability, particularly in response to visual stimuli."", ""evidence"": [{""explanation"": ""While the study supports an increased excitability of neurons in response to visual stimuli (such as photic stimulation), it does not specifically identify excitatory glutamatergic neurons as the key cell type involved."", ""reference"": ""PMID:21729035"", ""snippet"": ""We observed two neurophysiologic findings in JS: (1) focal interictal EDs from posterior head region; and (2) predominant focal posterior ictal EDs preceding generalized EDs."", ""supports"": ""PARTIAL""}, {""explanation"": ""This study discusses neural activity and connectivity alterations and increased extracellular glutamate during seizures but does not specifically associate these findings with Jeavons Syndrome."", ""reference"": ""PMID:31444362"", ""snippet"": ""The transition from a preictal state to a generalized seizure leads to an abrupt increase in neural activity and connectivity, which is accompanied by a strong alteration in glia-neuron interactions and a massive increase in extracellular glutamate."", ""supports"": ""NO_EVIDENCE""}], ""name"": ""Neuronal Hyperexcitability""}"
4091	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	2	Disrupted Cortical Function	Disruptions in normal brain function, especially in the visual cortex and thalamus, leading to seizures.																																																								"{""description"": ""Disruptions in normal brain function, especially in the visual cortex and thalamus, leading to seizures."", ""name"": ""Disrupted Cortical Function""}"	{}	"{""biological_processes"": [{""description"": ""Process by which visual stimuli are received and interpreted by the nervous system."", ""preferred_term"": ""visual perception"", ""term"": {""id"": ""GO:0007601"", ""label"": ""visual perception""}}], ""description"": ""Disruptions in normal brain function, especially in the visual cortex and thalamus, leading to seizures."", ""evidence"": [{""explanation"": ""The literature indicates involvement of the occipital cortex and mentions generalized epilepsy networks, which may include the thalamus. However, it does not explicitly support the claim that disruptions in the visual cortex and thalamus are the predominant mechanisms in Jeavons Syndrome."", ""reference"": ""PMID:21729035"", ""snippet"": ""JS has been proposed as idiopathic generalized epilepsy (IGE) because of normal posterior dominant background activity and paroxysmal generalized ictal epileptiform discharges (EDs). However, we noticed subtle occipital EDs preceding EM and interictal posterior EDs using digital video-EEG... Further clinical observations of seizures induced by eye closure, photic stimulation, and hyperventilation along with EEG paroxysms would raise the possibility of the occipital cortex initiating generalized epilepsy network involving the brainstem, and thalamocortical and transcortical pathways in JS."", ""supports"": ""PARTIAL""}, {""explanation"": ""This study discusses the role of thalamocortical connections in generalized and focal epilepsy but does not provide specific information on Jeavons Syndrome or its mechanisms."", ""reference"": ""PMID:29880477"", ""snippet"": ""Largely accepted in the literature is the role the interconnections between the thalamus and cortex play in generalized epilepsy. However, thalamocortical involvement is less understood in focal epilepsy in terms of the effect of seizures on thalamocortical circuitry in the developing brain and subsequent cognitive outcome."", ""supports"": ""NO_EVIDENCE""}], ""locations"": [{""description"": ""Brain region in the occipital lobe responsible for processing visual information."", ""preferred_term"": ""Visual Cortex"", ""term"": {""id"": ""UBERON:0000411"", ""label"": ""visual cortex""}}, {""description"": ""Central brain structure that relays sensory and motor signals to the cerebral cortex."", ""preferred_term"": ""Thalamus"", ""term"": {""id"": ""UBERON:0001897"", ""label"": ""dorsal plus ventral thalamus""}}], ""name"": ""Disrupted Cortical Function""}"
4114	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	0	KIT Receptor Tyrosine Kinase Activation	KIT mutations, most commonly in exons 11, 13, and 17, result in constitutive receptor activation independent of stem cell factor (SCF) ligand binding. Mutations may cause ligand-independent dimerization, altered kinase domain conformation, or loss of autoinhibitory mechanisms, leading to persistent downstream signaling.																																																								"{""description"": ""KIT mutations, most commonly in exons 11, 13, and 17, result in constitutive receptor activation independent of stem cell factor (SCF) ligand binding. Mutations may cause ligand-independent dimerization, altered kinase domain conformation, or loss of autoinhibitory mechanisms, leading to persistent downstream signaling."", ""name"": ""KIT Receptor Tyrosine Kinase Activation""}"	"{""downstream"": [{""description"": ""KIT signals through RAS to activate RAF-MEK-ERK cascade"", ""target"": ""MAPK Pathway Activation""}, {""description"": ""KIT directly activates PI3K through phosphorylation of adapter proteins"", ""target"": ""PI3K-AKT Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""cell_types"": [{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}], ""description"": ""KIT mutations, most commonly in exons 11, 13, and 17, result in constitutive receptor activation independent of stem cell factor (SCF) ligand binding. Mutations may cause ligand-independent dimerization, altered kinase domain conformation, or loss of autoinhibitory mechanisms, leading to persistent downstream signaling."", ""downstream"": [{""description"": ""KIT signals through RAS to activate RAF-MEK-ERK cascade"", ""target"": ""MAPK Pathway Activation""}, {""description"": ""KIT directly activates PI3K through phosphorylation of adapter proteins"", ""target"": ""PI3K-AKT Pathway Activation""}], ""evidence"": [{""explanation"": ""This abstract documents c-KIT mutations in melanoma subtypes associated with KIT-mutant disease."", ""reference"": ""PMID:41042158"", ""snippet"": ""Mutation of c-KIT has been observed in acral, mucosal, and chronically sun-damaged melanoma subtypes marking it as a key therapeutic target for melanoma."", ""supports"": ""SUPPORT""}], ""name"": ""KIT Receptor Tyrosine Kinase Activation""}"
4115	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	1	MAPK Pathway Activation	Activated KIT recruits adapter proteins that engage RAS-MAPK signaling, driving melanocyte proliferation through ERK-mediated transcriptional programs promoting cell cycle progression.																																																								"{""description"": ""Activated KIT recruits adapter proteins that engage RAS-MAPK signaling, driving melanocyte proliferation through ERK-mediated transcriptional programs promoting cell cycle progression."", ""name"": ""MAPK Pathway Activation""}"	"{""downstream"": [{""description"": ""ERK activation drives cyclin D1 expression and cell cycle entry"", ""target"": ""Uncontrolled Melanocyte Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""Activated KIT recruits adapter proteins that engage RAS-MAPK signaling, driving melanocyte proliferation through ERK-mediated transcriptional programs promoting cell cycle progression."", ""downstream"": [{""description"": ""ERK activation drives cyclin D1 expression and cell cycle entry"", ""target"": ""Uncontrolled Melanocyte Proliferation""}], ""name"": ""MAPK Pathway Activation""}"
4116	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	KIT activates PI3K through recruitment and phosphorylation of adapter proteins. Subsequent AKT activation promotes cell survival through inhibition of pro-apoptotic proteins and activation of mTOR signaling.																																																								"{""description"": ""KIT activates PI3K through recruitment and phosphorylation of adapter proteins. Subsequent AKT activation promotes cell survival through inhibition of pro-apoptotic proteins and activation of mTOR signaling."", ""name"": ""PI3K-AKT Pathway Activation""}"	"{""downstream"": [{""description"": ""AKT phosphorylates and inactivates pro-apoptotic factors"", ""target"": ""Cell Survival and Anti-Apoptosis""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""description"": ""KIT activates PI3K through recruitment and phosphorylation of adapter proteins. Subsequent AKT activation promotes cell survival through inhibition of pro-apoptotic proteins and activation of mTOR signaling."", ""downstream"": [{""description"": ""AKT phosphorylates and inactivates pro-apoptotic factors"", ""target"": ""Cell Survival and Anti-Apoptosis""}], ""name"": ""PI3K-AKT Pathway Activation""}"
4117	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	3	Uncontrolled Melanocyte Proliferation	Constitutive KIT signaling through MAPK and PI3K pathways drives abnormal melanocyte proliferation in acral and mucosal sites, leading to tumor formation.																																																								"{""description"": ""Constitutive KIT signaling through MAPK and PI3K pathways drives abnormal melanocyte proliferation in acral and mucosal sites, leading to tumor formation."", ""name"": ""Uncontrolled Melanocyte Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}], ""description"": ""Constitutive KIT signaling through MAPK and PI3K pathways drives abnormal melanocyte proliferation in acral and mucosal sites, leading to tumor formation."", ""name"": ""Uncontrolled Melanocyte Proliferation""}"
4118	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	4	Cell Survival and Anti-Apoptosis	PI3K-AKT activation downstream of KIT promotes melanoma cell survival through phosphorylation-mediated inactivation of pro-apoptotic proteins and activation of survival pathways.																																																								"{""description"": ""PI3K-AKT activation downstream of KIT promotes melanoma cell survival through phosphorylation-mediated inactivation of pro-apoptotic proteins and activation of survival pathways."", ""name"": ""Cell Survival and Anti-Apoptosis""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""PI3K-AKT activation downstream of KIT promotes melanoma cell survival through phosphorylation-mediated inactivation of pro-apoptotic proteins and activation of survival pathways."", ""name"": ""Cell Survival and Anti-Apoptosis""}"
4133	175	KRAS G12C-Mutant Non-Small Cell Lung Cancer	KRAS_G12C_Mutant_NSCLC.yaml	pathophysiology	0	KRAS G12C Oncogenic Mutation	The KRAS G12C mutation substitutes cysteine for glycine at codon 12, impairing GTPase activity and trapping KRAS in the active GTP-bound state. However, unlike other KRAS mutations, G12C retains some GTPase activity, cycling between active (GTP-bound) and inactive (GDP-bound) states. This cycling creates a therapeutic window for covalent inhibitors that bind the mutant cysteine in the GDP-bound state.																																																								"{""description"": ""The KRAS G12C mutation substitutes cysteine for glycine at codon 12, impairing GTPase activity and trapping KRAS in the active GTP-bound state. However, unlike other KRAS mutations, G12C retains some GTPase activity, cycling between active (GTP-bound) and inactive (GDP-bound) states. This cycling creates a therapeutic window for covalent inhibitors that bind the mutant cysteine in the GDP-bound state."", ""name"": ""KRAS G12C Oncogenic Mutation""}"	"{""downstream"": [{""description"": ""Impaired GTPase activity leads to prolonged active state"", ""target"": ""Constitutive RAS Signaling""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""small GTPase mediated signal transduction"", ""term"": {""id"": ""GO:0007264"", ""label"": ""small GTPase mediated signal transduction""}}], ""cell_types"": [{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}], ""description"": ""The KRAS G12C mutation substitutes cysteine for glycine at codon 12, impairing GTPase activity and trapping KRAS in the active GTP-bound state. However, unlike other KRAS mutations, G12C retains some GTPase activity, cycling between active (GTP-bound) and inactive (GDP-bound) states. This cycling creates a therapeutic window for covalent inhibitors that bind the mutant cysteine in the GDP-bound state."", ""downstream"": [{""description"": ""Impaired GTPase activity leads to prolonged active state"", ""target"": ""Constitutive RAS Signaling""}], ""evidence"": [{""explanation"": ""This abstract explicitly describes the KRAS G12C substitution and its frequency in NSCLC, supporting the oncogenic mutation context."", ""reference"": ""PMID:33618059"", ""snippet"": ""The KRAS glycine-to-cysteine mutation (G12C) composes approximately 44% of KRAS mutations in non-small cell lung cancer, with mutant KRasG12C present in approximately 13% of all patients with lung adenocarcinoma."", ""supports"": ""SUPPORT""}], ""name"": ""KRAS G12C Oncogenic Mutation""}"
4134	175	KRAS G12C-Mutant Non-Small Cell Lung Cancer	KRAS_G12C_Mutant_NSCLC.yaml	pathophysiology	1	Constitutive RAS Signaling	Mutant KRAS drives constitutive activation of downstream effector pathways including RAF-MEK-ERK (proliferation) and PI3K-AKT-mTOR (survival). The MAPK pathway is the predominant driver of oncogenic phenotypes in KRAS-mutant NSCLC.																																																								"{""description"": ""Mutant KRAS drives constitutive activation of downstream effector pathways including RAF-MEK-ERK (proliferation) and PI3K-AKT-mTOR (survival). The MAPK pathway is the predominant driver of oncogenic phenotypes in KRAS-mutant NSCLC."", ""name"": ""Constitutive RAS Signaling""}"	"{""downstream"": [{""description"": ""Sustained mitogenic and survival signaling"", ""target"": ""Cell Proliferation and Survival""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""Mutant KRAS drives constitutive activation of downstream effector pathways including RAF-MEK-ERK (proliferation) and PI3K-AKT-mTOR (survival). The MAPK pathway is the predominant driver of oncogenic phenotypes in KRAS-mutant NSCLC."", ""downstream"": [{""description"": ""Sustained mitogenic and survival signaling"", ""target"": ""Cell Proliferation and Survival""}], ""name"": ""Constitutive RAS Signaling""}"
4135	175	KRAS G12C-Mutant Non-Small Cell Lung Cancer	KRAS_G12C_Mutant_NSCLC.yaml	pathophysiology	2	Cell Proliferation and Survival	Constitutive KRAS signaling promotes uncontrolled cell proliferation through ERK-mediated transcription of cell cycle genes and survival through AKT-mediated inhibition of apoptosis.																																																								"{""description"": ""Constitutive KRAS signaling promotes uncontrolled cell proliferation through ERK-mediated transcription of cell cycle genes and survival through AKT-mediated inhibition of apoptosis."", ""name"": ""Cell Proliferation and Survival""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Constitutive KRAS signaling promotes uncontrolled cell proliferation through ERK-mediated transcription of cell cycle genes and survival through AKT-mediated inhibition of apoptosis."", ""name"": ""Cell Proliferation and Survival""}"
4136	175	KRAS G12C-Mutant Non-Small Cell Lung Cancer	KRAS_G12C_Mutant_NSCLC.yaml	pathophysiology	3	KRAS G12C Inhibitor Resistance	Resistance to KRAS G12C inhibitors develops through multiple mechanisms: secondary KRAS mutations (Y96C, R68S, H95D/Q/R), KRAS amplification, bypass pathway activation (MET, EGFR, FGFR, PI3K), and histologic transformation. Adaptive feedback through RTK reactivation (EGFR, FGFR, SHP2) is common.																																																								"{""description"": ""Resistance to KRAS G12C inhibitors develops through multiple mechanisms: secondary KRAS mutations (Y96C, R68S, H95D/Q/R), KRAS amplification, bypass pathway activation (MET, EGFR, FGFR, PI3K), and histologic transformation. Adaptive feedback through RTK reactivation (EGFR, FGFR, SHP2) is common."", ""name"": ""KRAS G12C Inhibitor Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}], ""description"": ""Resistance to KRAS G12C inhibitors develops through multiple mechanisms: secondary KRAS mutations (Y96C, R68S, H95D/Q/R), KRAS amplification, bypass pathway activation (MET, EGFR, FGFR, PI3K), and histologic transformation. Adaptive feedback through RTK reactivation (EGFR, FGFR, SHP2) is common."", ""name"": ""KRAS G12C Inhibitor Resistance""}"
4154	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	0	HHV-8 Latent Infection of Endothelial Cells	HHV-8 infects endothelial cells and establishes latent infection with expression of latency-associated nuclear antigen (LANA), vFLIP, and vCyclin. LANA maintains the viral episome and inhibits p53 and Rb tumor suppressor function. Latently infected cells undergo spindle cell transformation characteristic of KS.																																																								"{""description"": ""HHV-8 infects endothelial cells and establishes latent infection with expression of latency-associated nuclear antigen (LANA), vFLIP, and vCyclin. LANA maintains the viral episome and inhibits p53 and Rb tumor suppressor function. Latently infected cells undergo spindle cell transformation characteristic of KS."", ""name"": ""HHV-8 Latent Infection of Endothelial Cells""}"	"{""downstream"": [{""description"": ""Constitutive vFLIP expression activates survival signaling"", ""target"": ""vFLIP-Mediated NF-kappaB Activation""}, {""description"": ""Viral cyclin drives cell cycle progression"", ""target"": ""vCyclin-Mediated Cell Cycle Dysregulation""}, {""description"": ""Lytic gene expression promotes angiogenesis"", ""target"": ""vGPCR-Mediated Angiogenic Signaling""}]}"	"{""biological_processes"": [{""preferred_term"": ""viral transcription"", ""term"": {""id"": ""GO:0019083"", ""label"": ""viral transcription""}}], ""cell_types"": [{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""HHV-8 infects endothelial cells and establishes latent infection with expression of latency-associated nuclear antigen (LANA), vFLIP, and vCyclin. LANA maintains the viral episome and inhibits p53 and Rb tumor suppressor function. Latently infected cells undergo spindle cell transformation characteristic of KS."", ""downstream"": [{""description"": ""Constitutive vFLIP expression activates survival signaling"", ""target"": ""vFLIP-Mediated NF-kappaB Activation""}, {""description"": ""Viral cyclin drives cell cycle progression"", ""target"": ""vCyclin-Mediated Cell Cycle Dysregulation""}, {""description"": ""Lytic gene expression promotes angiogenesis"", ""target"": ""vGPCR-Mediated Angiogenic Signaling""}], ""evidence"": [{""explanation"": ""Abstract reports HHV-8 presence in endothelial and spindle cells in KS lesions."", ""reference"": ""PMID:7489408"", ""snippet"": ""KSHV/HHV-8 is present in the flat endothelial cells lining vascular spaces of KS lesions as well as in typical KS spindle cells."", ""supports"": ""SUPPORT""}], ""name"": ""HHV-8 Latent Infection of Endothelial Cells""}"
4155	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	1	vFLIP-Mediated NF-kappaB Activation	Viral FLICE inhibitory protein (vFLIP) constitutively activates NF-kappaB signaling by interacting with IKK complex. This promotes cell survival, inflammation, and cytokine production. vFLIP also inhibits caspase-8-mediated apoptosis, providing resistance to death receptor-induced cell death.																																																								"{""description"": ""Viral FLICE inhibitory protein (vFLIP) constitutively activates NF-kappaB signaling by interacting with IKK complex. This promotes cell survival, inflammation, and cytokine production. vFLIP also inhibits caspase-8-mediated apoptosis, providing resistance to death receptor-induced cell death."", ""name"": ""vFLIP-Mediated NF-kappaB Activation""}"	"{""downstream"": [{""description"": ""NF-kappaB activates anti-apoptotic genes"", ""target"": ""Apoptosis Resistance and Cell Survival""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of NF-kappaB transcription factor activity"", ""term"": {""id"": ""GO:0051092"", ""label"": ""positive regulation of NF-kappaB transcription factor activity""}}], ""description"": ""Viral FLICE inhibitory protein (vFLIP) constitutively activates NF-kappaB signaling by interacting with IKK complex. This promotes cell survival, inflammation, and cytokine production. vFLIP also inhibits caspase-8-mediated apoptosis, providing resistance to death receptor-induced cell death."", ""downstream"": [{""description"": ""NF-kappaB activates anti-apoptotic genes"", ""target"": ""Apoptosis Resistance and Cell Survival""}], ""name"": ""vFLIP-Mediated NF-kappaB Activation""}"
4156	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	2	vCyclin-Mediated Cell Cycle Dysregulation	Viral cyclin (vCyclin) forms active complexes with CDK6 that are resistant to inhibition by p16INK4A, p21, and p27. This drives cells through G1/S checkpoint regardless of normal growth regulatory signals, contributing to uncontrolled proliferation.																																																								"{""description"": ""Viral cyclin (vCyclin) forms active complexes with CDK6 that are resistant to inhibition by p16INK4A, p21, and p27. This drives cells through G1/S checkpoint regardless of normal growth regulatory signals, contributing to uncontrolled proliferation."", ""name"": ""vCyclin-Mediated Cell Cycle Dysregulation""}"	"{""downstream"": [{""description"": ""Cell cycle checkpoint bypass leads to proliferation"", ""target"": ""Uncontrolled Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}], ""description"": ""Viral cyclin (vCyclin) forms active complexes with CDK6 that are resistant to inhibition by p16INK4A, p21, and p27. This drives cells through G1/S checkpoint regardless of normal growth regulatory signals, contributing to uncontrolled proliferation."", ""downstream"": [{""description"": ""Cell cycle checkpoint bypass leads to proliferation"", ""target"": ""Uncontrolled Cell Proliferation""}], ""name"": ""vCyclin-Mediated Cell Cycle Dysregulation""}"
4157	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	3	vGPCR-Mediated Angiogenic Signaling	The viral G protein-coupled receptor (vGPCR) is expressed during lytic reactivation and activates multiple signaling pathways in a ligand-independent manner, including VEGF production and MAPK activation. vGPCR is highly oncogenic and promotes the angiogenic, inflammatory microenvironment characteristic of KS lesions.																																																								"{""description"": ""The viral G protein-coupled receptor (vGPCR) is expressed during lytic reactivation and activates multiple signaling pathways in a ligand-independent manner, including VEGF production and MAPK activation. vGPCR is highly oncogenic and promotes the angiogenic, inflammatory microenvironment characteristic of KS lesions."", ""name"": ""vGPCR-Mediated Angiogenic Signaling""}"	"{""downstream"": [{""description"": ""VEGF and inflammatory cytokines drive vascular proliferation"", ""target"": ""Angiogenic Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""description"": ""The viral G protein-coupled receptor (vGPCR) is expressed during lytic reactivation and activates multiple signaling pathways in a ligand-independent manner, including VEGF production and MAPK activation. vGPCR is highly oncogenic and promotes the angiogenic, inflammatory microenvironment characteristic of KS lesions."", ""downstream"": [{""description"": ""VEGF and inflammatory cytokines drive vascular proliferation"", ""target"": ""Angiogenic Proliferation""}], ""name"": ""vGPCR-Mediated Angiogenic Signaling""}"
4158	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	4	Apoptosis Resistance and Cell Survival	Multiple viral genes cooperate to prevent apoptosis: vFLIP inhibits caspase-8 and activates NF-kappaB; LANA inhibits p53; vBCL-2 mimics cellular BCL-2. This multi-layered apoptosis resistance enables survival and accumulation of infected cells.																																																								"{""description"": ""Multiple viral genes cooperate to prevent apoptosis: vFLIP inhibits caspase-8 and activates NF-kappaB; LANA inhibits p53; vBCL-2 mimics cellular BCL-2. This multi-layered apoptosis resistance enables survival and accumulation of infected cells."", ""name"": ""Apoptosis Resistance and Cell Survival""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""Multiple viral genes cooperate to prevent apoptosis: vFLIP inhibits caspase-8 and activates NF-kappaB; LANA inhibits p53; vBCL-2 mimics cellular BCL-2. This multi-layered apoptosis resistance enables survival and accumulation of infected cells."", ""name"": ""Apoptosis Resistance and Cell Survival""}"
4159	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	5	Uncontrolled Cell Proliferation	Combined effects of vCyclin, LANA-mediated Rb inhibition, and growth factor signaling drive spindle cell proliferation, forming the characteristic KS lesions.																																																								"{""description"": ""Combined effects of vCyclin, LANA-mediated Rb inhibition, and growth factor signaling drive spindle cell proliferation, forming the characteristic KS lesions."", ""name"": ""Uncontrolled Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Combined effects of vCyclin, LANA-mediated Rb inhibition, and growth factor signaling drive spindle cell proliferation, forming the characteristic KS lesions."", ""name"": ""Uncontrolled Cell Proliferation""}"
4160	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	6	Angiogenic Proliferation	KS lesions are highly vascular due to vGPCR-induced VEGF and inflammatory cytokine production. The aberrant angiogenesis creates the characteristic red-purple appearance and contributes to edema and hemorrhage.																																																								"{""description"": ""KS lesions are highly vascular due to vGPCR-induced VEGF and inflammatory cytokine production. The aberrant angiogenesis creates the characteristic red-purple appearance and contributes to edema and hemorrhage."", ""name"": ""Angiogenic Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}], ""cell_types"": [{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""KS lesions are highly vascular due to vGPCR-induced VEGF and inflammatory cytokine production. The aberrant angiogenesis creates the characteristic red-purple appearance and contributes to edema and hemorrhage."", ""name"": ""Angiogenic Proliferation""}"
4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	Vascular Inflammation	Widespread inflammation of medium-sized arteries, including coronary arteries.																																																								"{""description"": ""Widespread inflammation of medium-sized arteries, including coronary arteries."", ""name"": ""Vascular Inflammation""}"	"{""downstream"": [{""description"": ""Coronary arteritis causes structural damage to arterial walls leading to dilation and aneurysm formation."", ""evidence"": [{""explanation"": ""This reference directly establishes the mechanistic link between coronary arteritis and aneurysm formation through structural damage."", ""reference"": ""PMID:21447126"", ""snippet"": ""Histologically, coronary arteritis begins 6-8 days after the onset of KD, and leads immediately to inflammation of all layers of the artery. The inflammation spreads completely around the artery; as a result, structural components of the artery undergo intense damage; the artery then begins to dilate."", ""supports"": ""SUPPORT""}], ""target"": ""Aneurysm Formation""}]}"	"{""biological_processes"": [{""description"": ""Cytokine-driven upregulation of adhesion molecules and inflammatory mediators"", ""preferred_term"": ""endothelial cell activation"", ""term"": {""id"": ""GO:0042118"", ""label"": ""endothelial cell activation""}}, {""description"": ""ICAM-1/VCAM-1 mediated leukocyte recruitment"", ""preferred_term"": ""leukocyte adhesion to vascular endothelial cell"", ""term"": {""id"": ""GO:1904996"", ""label"": ""positive regulation of leukocyte adhesion to vascular endothelial cell""}}, {""description"": ""Systemic hyperinflammatory syndrome with cytokine cascades"", ""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""description"": ""Primary target cells undergoing activation and dysfunction"", ""preferred_term"": ""vascular endothelial cell"", ""term"": {""id"": ""CL:0000071"", ""label"": ""blood vessel endothelial cell""}}, {""description"": ""Recruited to vessel walls during necrotizing arteritis phase"", ""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}, {""description"": ""Activated by immune complexes and FcR signaling"", ""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}, {""description"": ""Present in coronary lesions producing cytokines"", ""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Widespread inflammation of medium-sized arteries, including coronary arteries."", ""downstream"": [{""description"": ""Coronary arteritis causes structural damage to arterial walls leading to dilation and aneurysm formation."", ""evidence"": [{""explanation"": ""This reference directly establishes the mechanistic link between coronary arteritis and aneurysm formation through structural damage."", ""reference"": ""PMID:21447126"", ""snippet"": ""Histologically, coronary arteritis begins 6-8 days after the onset of KD, and leads immediately to inflammation of all layers of the artery. The inflammation spreads completely around the artery; as a result, structural components of the artery undergo intense damage; the artery then begins to dilate."", ""supports"": ""SUPPORT""}], ""target"": ""Aneurysm Formation""}], ""evidence"": [{""explanation"": ""The literature confirms that Kawasaki disease involves widespread inflammation of medium-sized arteries, including coronary arteries."", ""reference"": ""PMID:23188196"", ""snippet"": ""Kawasaki disease (KD) is considered to be a kind of systemic vasculitis syndrome. It most frequently affects infants and young children and primarily invades medium-sized muscular arteries, including the coronary arteries."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that Kawasaki disease leads to vascular inflammation and aneurysm formation."", ""reference"": ""PMID:31599798"", ""snippet"": ""Kawasaki disease is a childhood vasculitis of unknown origin, whose major complication is the development of coronary artery aneurysms (CAA)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The case report indicates that Kawasaki disease can lead to aneurysm formation as a result of vascular inflammation."", ""reference"": ""PMID:27090101"", ""snippet"": ""Coronary angiography showed multiple aneurysms which suggested sequelae of misdiagnosed Kawasaki disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature suggests long-term vascular dysfunction due to Kawasaki disease, supporting the idea of widespread vascular inflammation."", ""reference"": ""PMID:36102118"", ""snippet"": ""Long-term physiological dysfunction in coronary/systemic vasculature may persist in individuals with Kawasaki disease even in the absence of coronary artery abnormalities."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature confirms that Kawasaki disease causes inflammation in coronary arteries, leading to complications such as aneurysms."", ""reference"": ""PMID:35420684"", ""snippet"": ""Kawasaki disease, an acute febrile illness, can cause vasculitis in the coronary arteries."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports the statement that Kawasaki disease involves widespread vascular inflammation and aneurysm formation."", ""reference"": ""PMID:16990356"", ""snippet"": ""Kawasaki disease is an acute inflammatory syndrome that takes the form of systemic vasculitis, and predominantly affects children. Important complications of this disease are coronary artery dilation and aneurysm formation."", ""supports"": ""SUPPORT""}], ""locations"": [{""description"": ""Primary site of arteritis and aneurysm formation"", ""preferred_term"": ""coronary artery"", ""term"": {""id"": ""UBERON:0001621"", ""label"": ""coronary artery""}}, {""description"": ""All three layers (intima, media, adventitia) undergo inflammation"", ""preferred_term"": ""artery wall"", ""term"": {""id"": ""UBERON:0035965"", ""label"": ""artery wall""}}], ""name"": ""Vascular Inflammation""}"
4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	Immune Response Dysregulation	An abnormal immune response leading to vessel wall damage and inflammation.																																																								"{""description"": ""An abnormal immune response leading to vessel wall damage and inflammation."", ""name"": ""Immune Response Dysregulation""}"	{}	"{""biological_processes"": [{""description"": ""NLRP3 inflammasome activation leading to IL-1 release"", ""preferred_term"": ""NLRP3 inflammasome complex assembly"", ""term"": {""id"": ""GO:0072559"", ""label"": ""NLRP3 inflammasome complex assembly""}}, {""description"": ""IL-1 promotes endothelial injury and inflammation"", ""preferred_term"": ""interleukin-1 beta production"", ""term"": {""id"": ""GO:0032611"", ""label"": ""interleukin-1 beta production""}}, {""description"": ""TNF- induces endothelial activation and NF-B signaling"", ""preferred_term"": ""tumor necrosis factor production"", ""term"": {""id"": ""GO:0032640"", ""label"": ""tumor necrosis factor production""}}, {""description"": ""IL-17 from Th17 cells promotes neutrophil recruitment"", ""preferred_term"": ""interleukin-17 production"", ""term"": {""id"": ""GO:0032620"", ""label"": ""interleukin-17 production""}}, {""description"": ""Dysregulated Ca2+/calcineurin-NFAT signaling pathway"", ""preferred_term"": ""calcium ion transmembrane transport"", ""term"": {""id"": ""GO:0070588"", ""label"": ""calcium ion transmembrane transport""}}, {""description"": ""Enhanced T-cell activation via CD40-CD40L co-stimulation"", ""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}, {""description"": ""Complement fixation contributes to vascular injury"", ""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""cell_types"": [{""description"": ""CD8+ T cells present in coronary lesions"", ""preferred_term"": ""CD8-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}, {""description"": ""Th17 expansion associated with coronary damage and IVIG resistance"", ""preferred_term"": ""T-helper 17 cell"", ""term"": {""id"": ""CL:0000899"", ""label"": ""T-helper 17 cell""}}, {""description"": ""Treg imbalance contributes to immune dysregulation"", ""preferred_term"": ""regulatory T cell"", ""term"": {""id"": ""CL:0000815"", ""label"": ""regulatory T cell""}}, {""description"": ""Convergent antigen-driven plasmablast responses in some patients"", ""preferred_term"": ""plasmablast"", ""term"": {""id"": ""CL:0000980"", ""label"": ""plasmablast""}}, {""description"": ""IgA plasma cells found in coronary lesions"", ""preferred_term"": ""plasma cell"", ""term"": {""id"": ""CL:0000786"", ""label"": ""plasma cell""}}, {""description"": ""Involved in antigen presentation and T-cell activation"", ""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""An abnormal immune response leading to vessel wall damage and inflammation."", ""evidence"": [{""explanation"": ""The literature supports the statement that Kawasaki Disease is characterized by immune response dysregulation leading to vessel wall damage and inflammation."", ""reference"": ""PMID:34890998"", ""snippet"": ""Increasing evidence shows that the pathogenesis of Kawasaki disease (KD) is caused by abnormal and unbalanced innate and adaptive immune responses."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports that KD involves immune dysregulation leading to vessel wall damage."", ""reference"": ""PMID:30183655"", ""snippet"": ""Kawasaki disease (KD) is a vasculitis that is part of systemic vasculitis syndrome. It affects medium-sized vessels and is characterized by hypercytokinemia."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports the notion of an abnormal immune response leading to vessel wall damage in KD."", ""reference"": ""PMID:30619331"", ""snippet"": ""Others have favored an autoreactive hypothesis that KD is triggered by an antigen that shares homology with structures in the vascular wall, and molecular mimicry resulting in an immune response directed to that tissue."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by describing KD as a hyperinflammatory syndrome, which involves immune dysregulation."", ""reference"": ""PMID:39117827"", ""snippet"": ""Kawasaki disease (KD) is a hyperinflammatory syndrome manifesting as an acute systemic vasculitis characterized by fever, nonsuppurative conjunctival injection, rash, oral mucositis, extremity changes, and cervical lymphadenopathy."", ""supports"": ""SUPPORT""}], ""name"": ""Immune Response Dysregulation""}"
4223	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	0	Gap Junction Dysfunction	"Mutations in GJB2 disrupt connexin 26 function, impairing gap junction-mediated intercellular communication in the epidermis and cochlea. The D66H mutation occurs at a highly conserved residue in the first extracellular domain and may interfere with connexon assembly, docking, or gating properties. This leads to defective ion homeostasis and impaired cellular coordination during differentiation.
"																																																								"{""description"": ""Mutations in GJB2 disrupt connexin 26 function, impairing gap junction-mediated intercellular communication in the epidermis and cochlea. The D66H mutation occurs at a highly conserved residue in the first extracellular domain and may interfere with connexon assembly, docking, or gating properties. This leads to defective ion homeostasis and impaired cellular coordination during differentiation.\n"", ""name"": ""Gap Junction Dysfunction""}"	"{""downstream"": [{""description"": ""Impaired gap junction communication disrupts calcium signaling and intercellular coordination required for normal keratinocyte differentiation.\n"", ""evidence"": [{""explanation"": ""Demonstrates that GJB2 mutations lead to impaired epidermal differentiation."", ""reference"": ""PMID:10369869"", ""snippet"": ""Our results provide evidence that a specific mutation in Cx26 can impair epidermal differentiation, as well as inner ear function.\n"", ""supports"": ""SUPPORT""}], ""target"": ""Abnormal Epidermal Differentiation""}, {""description"": ""Connexin 26 dysfunction in the inner ear disrupts potassium recycling and the endocochlear potential required for hearing.\n"", ""evidence"": [{""explanation"": ""Establishes the causal link between GJB2 mutations and hearing loss."", ""reference"": ""PMID:10369869"", ""snippet"": ""Mutations in the connexin26 (Cx26) gene (GJB2) at 13q11-q13 are a major cause of autosomal recessive hearing loss (DFNB1), but have also been reported in autosomal dominant deafness (DFNA3).\n"", ""supports"": ""SUPPORT""}], ""target"": ""Cochlear Dysfunction""}]}"	"{""biological_processes"": [{""preferred_term"": ""Gap junction assembly"", ""term"": {""id"": ""GO:0016264"", ""label"": ""gap junction assembly""}}, {""preferred_term"": ""Cell-cell signaling"", ""term"": {""id"": ""GO:0007267"", ""label"": ""cell-cell signaling""}}], ""cell_types"": [{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""description"": ""Mutations in GJB2 disrupt connexin 26 function, impairing gap junction-mediated intercellular communication in the epidermis and cochlea. The D66H mutation occurs at a highly conserved residue in the first extracellular domain and may interfere with connexon assembly, docking, or gating properties. This leads to defective ion homeostasis and impaired cellular coordination during differentiation.\n"", ""downstream"": [{""description"": ""Impaired gap junction communication disrupts calcium signaling and intercellular coordination required for normal keratinocyte differentiation.\n"", ""evidence"": [{""explanation"": ""Demonstrates that GJB2 mutations lead to impaired epidermal differentiation."", ""reference"": ""PMID:10369869"", ""snippet"": ""Our results provide evidence that a specific mutation in Cx26 can impair epidermal differentiation, as well as inner ear function.\n"", ""supports"": ""SUPPORT""}], ""target"": ""Abnormal Epidermal Differentiation""}, {""description"": ""Connexin 26 dysfunction in the inner ear disrupts potassium recycling and the endocochlear potential required for hearing.\n"", ""evidence"": [{""explanation"": ""Establishes the causal link between GJB2 mutations and hearing loss."", ""reference"": ""PMID:10369869"", ""snippet"": ""Mutations in the connexin26 (Cx26) gene (GJB2) at 13q11-q13 are a major cause of autosomal recessive hearing loss (DFNB1), but have also been reported in autosomal dominant deafness (DFNA3).\n"", ""supports"": ""SUPPORT""}], ""target"": ""Cochlear Dysfunction""}], ""evidence"": [{""explanation"": ""Describes the molecular mechanism of GJB2 D66H mutation disrupting gap junction function."", ""reference"": ""PMID:10369869"", ""snippet"": ""This mutation occurs at a highly conserved residue in the first extracellular domain of the Cx26 molecule, and may exert its effects by interfering with assembly into connexons, docking with adjacent cells or gating properties of the gap junction.\n"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Transgenic mouse model demonstrates that D66H mutation causes loss of connexins at cell junctions."", ""reference"": ""PMID:14681042"", ""snippet"": ""Expression of the transgene resulted in a loss of Cx26 and Cx30 at intercellular junctions of epidermal keratinocytes and accumulation of these connexins in the cytoplasm.\n"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Skin of palm and sole"", ""term"": {""id"": ""UBERON:0013776"", ""label"": ""skin of palmar/plantar part of autopod""}}], ""name"": ""Gap Junction Dysfunction""}"
4224	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	1	Abnormal Epidermal Differentiation	"Defective gap junction signaling leads to hyperproliferation and abnormal keratinization of palmoplantar epidermis, resulting in the characteristic thickened honeycomb-patterned skin. The mutation impairs epidermal differentiation as well as inner ear function.
"																																																								"{""description"": ""Defective gap junction signaling leads to hyperproliferation and abnormal keratinization of palmoplantar epidermis, resulting in the characteristic thickened honeycomb-patterned skin. The mutation impairs epidermal differentiation as well as inner ear function.\n"", ""name"": ""Abnormal Epidermal Differentiation""}"	"{""downstream"": [{""description"": ""Chronic aberrant keratinization leads to formation of fibrous constricting bands around digits that progressively tighten and may cause autoamputation.\n"", ""evidence"": [{""explanation"": ""Links the keratoderma phenotype to digital constriction and autoamputation."", ""reference"": ""PMID:10369869"", ""snippet"": ""VS is characterized by papular and honeycomb keratoderma associated with constrictions of digits leading to autoamputation\n"", ""supports"": ""SUPPORT""}], ""target"": ""Digital Constriction and Autoamputation""}]}"	"{""biological_processes"": [{""preferred_term"": ""Keratinocyte differentiation"", ""term"": {""id"": ""GO:0030216"", ""label"": ""keratinocyte differentiation""}}], ""cell_types"": [{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""description"": ""Defective gap junction signaling leads to hyperproliferation and abnormal keratinization of palmoplantar epidermis, resulting in the characteristic thickened honeycomb-patterned skin. The mutation impairs epidermal differentiation as well as inner ear function.\n"", ""downstream"": [{""description"": ""Chronic aberrant keratinization leads to formation of fibrous constricting bands around digits that progressively tighten and may cause autoamputation.\n"", ""evidence"": [{""explanation"": ""Links the keratoderma phenotype to digital constriction and autoamputation."", ""reference"": ""PMID:10369869"", ""snippet"": ""VS is characterized by papular and honeycomb keratoderma associated with constrictions of digits leading to autoamputation\n"", ""supports"": ""SUPPORT""}], ""target"": ""Digital Constriction and Autoamputation""}], ""evidence"": [{""explanation"": ""Establishes that GJB2 mutations affect both epidermal and cochlear function."", ""reference"": ""PMID:10369869"", ""snippet"": ""Our results provide evidence that a specific mutation in Cx26 can impair epidermal differentiation, as well as inner ear function.\n"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Transgenic mice expressing mutant Cx26 develop keratoderma like human patients."", ""reference"": ""PMID:14681042"", ""snippet"": ""Following birth, the transgenic mice developed keratoderma similar to that of human carriers of Cx26 (D66H).\n"", ""supports"": ""SUPPORT""}], ""name"": ""Abnormal Epidermal Differentiation""}"
4225	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	2	Mutant Loricrin Nuclear Accumulation	"In the ichthyotic variant, mutant loricrin is mislocalized to the nuclei of granular layer keratinocytes and fails to incorporate into the cornified cell envelope. The frameshift mutation creates an abnormal C-terminal peptide containing nuclear localization signals, causing aberrant nuclear translocation and interference with late stages of epidermal differentiation.
"																																																								"{""description"": ""In the ichthyotic variant, mutant loricrin is mislocalized to the nuclei of granular layer keratinocytes and fails to incorporate into the cornified cell envelope. The frameshift mutation creates an abnormal C-terminal peptide containing nuclear localization signals, causing aberrant nuclear translocation and interference with late stages of epidermal differentiation.\n"", ""name"": ""Mutant Loricrin Nuclear Accumulation""}"	"{""downstream"": [{""description"": ""Nuclear interference with keratinocyte differentiation leads to defective cornification and formation of constricting bands.\n"", ""evidence"": [{""explanation"": ""Establishes the mechanistic link between loricrin nuclear accumulation and pseudoainhum."", ""reference"": ""PMID:12072018"", ""snippet"": ""the accumulation of mutant loricrin in the nucleus appears to interfere with the later stages of epidermal differentiation, thereby explaining the clinical manifestations of ichthyosis, keratoderma and pseudoainhum.\n"", ""supports"": ""SUPPORT""}], ""target"": ""Digital Constriction and Autoamputation""}]}"	"{""biological_processes"": [{""preferred_term"": ""Cornified envelope assembly"", ""term"": {""id"": ""GO:1903575"", ""label"": ""cornified envelope assembly""}}, {""preferred_term"": ""Keratinocyte differentiation"", ""term"": {""id"": ""GO:0030216"", ""label"": ""keratinocyte differentiation""}}], ""cell_types"": [{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""description"": ""In the ichthyotic variant, mutant loricrin is mislocalized to the nuclei of granular layer keratinocytes and fails to incorporate into the cornified cell envelope. The frameshift mutation creates an abnormal C-terminal peptide containing nuclear localization signals, causing aberrant nuclear translocation and interference with late stages of epidermal differentiation.\n"", ""downstream"": [{""description"": ""Nuclear interference with keratinocyte differentiation leads to defective cornification and formation of constricting bands.\n"", ""evidence"": [{""explanation"": ""Establishes the mechanistic link between loricrin nuclear accumulation and pseudoainhum."", ""reference"": ""PMID:12072018"", ""snippet"": ""the accumulation of mutant loricrin in the nucleus appears to interfere with the later stages of epidermal differentiation, thereby explaining the clinical manifestations of ichthyosis, keratoderma and pseudoainhum.\n"", ""supports"": ""SUPPORT""}], ""target"": ""Digital Constriction and Autoamputation""}], ""evidence"": [{""explanation"": ""Describes the mechanism by which mutant loricrin causes disease through nuclear interference."", ""reference"": ""PMID:11121146"", ""snippet"": ""Mutant loricrin, as a dominant negative disrupter, is not likely to affect cornified cell envelope crosslinking directly, but seems to interfere with nuclear/nucleolar functions of differentiating keratinocytes.\n"", ""supports"": ""SUPPORT""}, {""explanation"": ""Identifies the specific mutation and its effect on loricrin protein structure."", ""reference"": ""PMID:9326398"", ""snippet"": ""a G insertion producing a frameshift after codon 231 and an abnormal C-terminal peptide lacking residues necessary for cross-linking.\n"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Transgenic mouse studies confirm nuclear mislocalization of mutant loricrin."", ""reference"": ""PMID:11038186"", ""snippet"": ""Immunofluorescence and immunoelectron microscopy showed the mutant loricrin protein in the nucleus and cytoplasm of epidermal keratinocytes, but did not detect the protein in the cornified cell envelope.\n"", ""supports"": ""SUPPORT""}], ""name"": ""Mutant Loricrin Nuclear Accumulation""}"
4226	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	3	Digital Constriction and Autoamputation	"Fibrous bands encircle digits (pseudoainhum), progressively constricting and potentially leading to spontaneous amputation. The pathogenesis involves aberrant keratinization and tissue remodeling secondary to keratinocyte dysfunction.
"																																																								"{""description"": ""Fibrous bands encircle digits (pseudoainhum), progressively constricting and potentially leading to spontaneous amputation. The pathogenesis involves aberrant keratinization and tissue remodeling secondary to keratinocyte dysfunction.\n"", ""name"": ""Digital Constriction and Autoamputation""}"	{}	"{""description"": ""Fibrous bands encircle digits (pseudoainhum), progressively constricting and potentially leading to spontaneous amputation. The pathogenesis involves aberrant keratinization and tissue remodeling secondary to keratinocyte dysfunction.\n"", ""evidence"": [{""explanation"": ""Describes the progression from constricting bands to autoamputation."", ""reference"": ""PMID:10369869"", ""snippet"": ""VS is characterized by papular and honeycomb keratoderma associated with constrictions of digits leading to autoamputation\n"", ""supports"": ""SUPPORT""}], ""name"": ""Digital Constriction and Autoamputation""}"
4227	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	4	Cochlear Dysfunction	"Connexin 26 is essential for potassium recycling in the cochlea. Its dysfunction disrupts the endocochlear potential required for auditory transduction, causing sensorineural hearing loss. This phenotype is specific to GJB2 mutations and is absent in the loricrin-associated variant.
"																																																								"{""description"": ""Connexin 26 is essential for potassium recycling in the cochlea. Its dysfunction disrupts the endocochlear potential required for auditory transduction, causing sensorineural hearing loss. This phenotype is specific to GJB2 mutations and is absent in the loricrin-associated variant.\n"", ""name"": ""Cochlear Dysfunction""}"	{}	"{""description"": ""Connexin 26 is essential for potassium recycling in the cochlea. Its dysfunction disrupts the endocochlear potential required for auditory transduction, causing sensorineural hearing loss. This phenotype is specific to GJB2 mutations and is absent in the loricrin-associated variant.\n"", ""evidence"": [{""explanation"": ""Establishes the role of GJB2 in both skin and hearing phenotypes."", ""reference"": ""PMID:10369869"", ""snippet"": ""Mutations in the connexin26 (Cx26) gene (GJB2) at 13q11-q13 are a major cause of autosomal recessive hearing loss (DFNB1), but have also been reported in autosomal dominant deafness (DFNA3).\n"", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms that deafness segregates with connexin mutations, not loricrin mutations."", ""reference"": ""PMID:9326398"", ""snippet"": ""In our second family (VK2), affected members had sensorineural deafness but not ichthyosis.\n"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Cochlea"", ""term"": {""id"": ""UBERON:0001844"", ""label"": ""cochlea""}}], ""name"": ""Cochlear Dysfunction""}"
4252	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	0	Presence of Extra X Chromosome	Typically results in a 47,XXY karyotype, leading to a range of physical, developmental, and reproductive issues.																																																								"{""description"": ""Typically results in a 47,XXY karyotype, leading to a range of physical, developmental, and reproductive issues."", ""name"": ""Presence of Extra X Chromosome""}"	{}	"{""description"": ""Typically results in a 47,XXY karyotype, leading to a range of physical, developmental, and reproductive issues."", ""evidence"": [{""explanation"": ""The extra X chromosome results in the 47,XXY karyotype, leading to a range of physical, developmental, and reproductive issues."", ""reference"": ""PMID:17062147"", ""snippet"": ""The term Klinefelter syndrome (KS) describes a group of chromosomal disorder in which there is at least one extra X chromosome to a normal male karyotype, 46,XY. XXY aneuploidy is the most common disorder of sex chromosomes in humans, with prevalence of one in 500 males."", ""supports"": ""SUPPORT""}, {""explanation"": ""This indicates that the presence of an extra X chromosome (47,XXY karyotype) leads to a variety of physical, developmental, and reproductive issues."", ""reference"": ""PMID:32484281"", ""snippet"": ""Since the first description of Klinefelter syndrome (KS) was published in 1942...large inter-individual variability in the phenotypic presentation has been demonstrated... Evidence from the existing literature of KS indicates that not just one single genetic mechanism can explain the phenotype and the variable expressivity."", ""supports"": ""SUPPORT""}, {""explanation"": ""These physical and developmental issues are a result of the 47,XXY karyotype."", ""reference"": ""PMID:25899809"", ""snippet"": ""Klinefelter syndrome is the most common sex-chromosome disorder in humans, affecting one in 660 men. The key findings in Klinefelter syndrome are small testes, hypergonadotropic hypogonadism and cognitive impairment."", ""supports"": ""SUPPORT""}], ""name"": ""Presence of Extra X Chromosome""}"
4253	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	1	Testicular Microenvironment Dysfunction	Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.																																																								"{""description"": ""Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export."", ""name"": ""Testicular Microenvironment Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Spermatogenesis"", ""term"": {""id"": ""GO:0007283"", ""label"": ""spermatogenesis""}}, {""preferred_term"": ""Angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}, {""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""preferred_term"": ""Extracellular Matrix Organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""cell_types"": [{""preferred_term"": ""Sertoli Cell"", ""term"": {""id"": ""CL:0000216"", ""label"": ""Sertoli cell""}}, {""preferred_term"": ""Leydig Cell"", ""term"": {""id"": ""CL:0000178"", ""label"": ""Leydig cell""}}, {""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export."", ""locations"": [{""preferred_term"": ""Testis"", ""term"": {""id"": ""UBERON:0000473"", ""label"": ""testis""}}, {""preferred_term"": ""Seminiferous Tubule"", ""term"": {""id"": ""UBERON:0001343"", ""label"": ""seminiferous tubule of testis""}}], ""name"": ""Testicular Microenvironment Dysfunction""}"
4254	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	2	Progressive Germ Cell Loss	Accelerated germ cell apoptosis beginning around puberty leads to spermatogenic failure and azoospermia in adulthood.																																																								"{""description"": ""Accelerated germ cell apoptosis beginning around puberty leads to spermatogenic failure and azoospermia in adulthood."", ""name"": ""Progressive Germ Cell Loss""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Apoptotic Process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}, {""preferred_term"": ""Spermatogenesis"", ""term"": {""id"": ""GO:0007283"", ""label"": ""spermatogenesis""}}], ""cell_types"": [{""preferred_term"": ""Spermatocyte"", ""term"": {""id"": ""CL:0000017"", ""label"": ""spermatocyte""}}], ""description"": ""Accelerated germ cell apoptosis beginning around puberty leads to spermatogenic failure and azoospermia in adulthood."", ""locations"": [{""preferred_term"": ""Seminiferous Tubule"", ""term"": {""id"": ""UBERON:0001343"", ""label"": ""seminiferous tubule of testis""}}], ""name"": ""Progressive Germ Cell Loss""}"
4255	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	3	Hypergonadotropic Hypogonadism	Leydig cell insufficiency and impaired testosterone export result in elevated LH/FSH and low systemic testosterone despite potentially elevated intratesticular testosterone.																																																								"{""description"": ""Leydig cell insufficiency and impaired testosterone export result in elevated LH/FSH and low systemic testosterone despite potentially elevated intratesticular testosterone."", ""name"": ""Hypergonadotropic Hypogonadism""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Testosterone Biosynthetic Process"", ""term"": {""id"": ""GO:0061370"", ""label"": ""testosterone biosynthetic process""}}, {""preferred_term"": ""Hormone Secretion"", ""term"": {""id"": ""GO:0046879"", ""label"": ""hormone secretion""}}], ""cell_types"": [{""preferred_term"": ""Leydig Cell"", ""term"": {""id"": ""CL:0000178"", ""label"": ""Leydig cell""}}], ""description"": ""Leydig cell insufficiency and impaired testosterone export result in elevated LH/FSH and low systemic testosterone despite potentially elevated intratesticular testosterone."", ""locations"": [{""preferred_term"": ""Testis"", ""term"": {""id"": ""UBERON:0000473"", ""label"": ""testis""}}], ""name"": ""Hypergonadotropic Hypogonadism""}"
4278	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	pathophysiology	0	Type II Collagen Structural Abnormality	"Kniest dysplasia is typically caused by exon-skipping mutations or small in-frame deletions in COL2A1 that result in shortened collagen chains. These abnormal chains are incorporated into the extracellular matrix but form defective fibrils. The characteristic cartilage histology shows large empty areas (Swiss cheese appearance) due to abnormal collagen organization.
"																																																								"{""description"": ""Kniest dysplasia is typically caused by exon-skipping mutations or small in-frame deletions in COL2A1 that result in shortened collagen chains. These abnormal chains are incorporated into the extracellular matrix but form defective fibrils. The characteristic cartilage histology shows large empty areas (Swiss cheese appearance) due to abnormal collagen organization.\n"", ""name"": ""Type II Collagen Structural Abnormality""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}, {""preferred_term"": ""Cartilage Development"", ""term"": {""id"": ""GO:0051216"", ""label"": ""cartilage development""}}, {""preferred_term"": ""ECM Organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""cell_types"": [{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}], ""description"": ""Kniest dysplasia is typically caused by exon-skipping mutations or small in-frame deletions in COL2A1 that result in shortened collagen chains. These abnormal chains are incorporated into the extracellular matrix but form defective fibrils. The characteristic cartilage histology shows large empty areas (Swiss cheese appearance) due to abnormal collagen organization.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study documents the characteristic Swiss-cheese cartilage appearance and demonstrates collagen fibril disorganization and fragmentation in Kniest dysplasia, supporting the pathophysiology description."", ""reference"": ""PMID:8723084"", ""snippet"": ""Pathologic findings included a disorganized physeal growth plate, soft crumbly cartilage with a \""Swiss-cheese\"" appearance, and diastase resistant intracytoplasmic inclusions in the resting chondrocytes. Transmission electronmicroscopy showed dilated cisternae of rough endoplasmic reticulum with finely granular material of accumulated protein. Scanning electronmicroscopy documented striking fragmentation and disintegration of collagen fibrils resulting in a web-like pattern and large open cyst-like spaces, and deficiency and disorganization of the collagen fibrils."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study demonstrates abnormal collagen fibril organization in Kniest dysplasia cartilage, with thinner fibrils lacking normal banding pattern and absence of C-propeptide from extracellular matrix."", ""reference"": ""PMID:3276736"", ""snippet"": ""In each case collagen fibril organization appeared abnormal by electron microscopy compared with age-matched normal cartilages: fibrils were much thinner, of irregular shape and did not exhibit the characteristic banding pattern. This was associated with the absence (compared with normal cartilage) of the C-propeptide of type II collagen (chondrocalcin) from the extracellular matrix of epiphyseal cartilages."", ""supports"": ""SUPPORT""}], ""name"": ""Type II Collagen Structural Abnormality""}"
4304	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	0	Gluten-triggered intestinal autoimmunity in celiac disease	"Lane Hamilton Syndrome begins with celiac disease, an autoimmune condition triggered by gluten ingestion in genetically predisposed individuals. Gluten exposure activates intestinal immune responses with increased intraepithelial lymphocytes, villous atrophy, and crypt hyperplasia in the small intestine, particularly the duodenum. This localized intestinal autoimmunity generates systemic immune activation and circulating autoantibodies, including anti-tissue transglutaminase (anti-tTG) and anti-endomysial antibodies.
"																																																								"{""description"": ""Lane Hamilton Syndrome begins with celiac disease, an autoimmune condition triggered by gluten ingestion in genetically predisposed individuals. Gluten exposure activates intestinal immune responses with increased intraepithelial lymphocytes, villous atrophy, and crypt hyperplasia in the small intestine, particularly the duodenum. This localized intestinal autoimmunity generates systemic immune activation and circulating autoantibodies, including anti-tissue transglutaminase (anti-tTG) and anti-endomysial antibodies.\n"", ""name"": ""Gluten-triggered intestinal autoimmunity in celiac disease""}"	{}	"{""biological_processes"": [{""preferred_term"": ""antigen processing and presentation"", ""term"": {""id"": ""GO:0019882"", ""label"": ""antigen processing and presentation""}}, {""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}], ""cell_types"": [{""preferred_term"": ""T lymphocyte"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Lane Hamilton Syndrome begins with celiac disease, an autoimmune condition triggered by gluten ingestion in genetically predisposed individuals. Gluten exposure activates intestinal immune responses with increased intraepithelial lymphocytes, villous atrophy, and crypt hyperplasia in the small intestine, particularly the duodenum. This localized intestinal autoimmunity generates systemic immune activation and circulating autoantibodies, including anti-tissue transglutaminase (anti-tTG) and anti-endomysial antibodies.\n"", ""evidence"": [{""explanation"": ""Literature review documents the coexistence of celiac disease and pulmonary hemosiderosis in Lane-Hamilton syndrome"", ""reference"": ""PMID:35912848"", ""snippet"": ""Celiac disease (CD) and IPH diagnosis was made concurrently in 46 patients, whereas in 21 patients, the diagnosis of LHS was delayed for 2.5y (3 months-11 years)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Scoping review documents the association between idiopathic pulmonary hemosiderosis and celiac disease in pediatric patients"", ""reference"": ""PMID:35088581"", ""snippet"": ""Nearly one-third of pediatric patients with IPH test positive for Celiac disease (CD) serology. Several hypothetical mechanisms have been proposed to unify the coexistence of these two entities, also referred to as Lane-Hamilton syndrome (LHS)."", ""supports"": ""SUPPORT""}], ""name"": ""Gluten-triggered intestinal autoimmunity in celiac disease""}"
4305	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	1	Immune-mediated increase in pulmonary capillary permeability	"Systemic immune mediators generated by intestinal celiac disease act on the pulmonary microvasculature, increasing capillary endothelial permeability without causing vasculitis or immune complex deposition. Mediators such as histamine (released by eosinophils and basophils), eosinophil cationic protein (ECP), and vascular endothelial growth factor (VEGF) increase endothelial gap formation between capillary endothelial cells. This allows erythrocyte extravasation into the alveolar space in the absence of structural vascular damage or capillaritis.
"																																																								"{""description"": ""Systemic immune mediators generated by intestinal celiac disease act on the pulmonary microvasculature, increasing capillary endothelial permeability without causing vasculitis or immune complex deposition. Mediators such as histamine (released by eosinophils and basophils), eosinophil cationic protein (ECP), and vascular endothelial growth factor (VEGF) increase endothelial gap formation between capillary endothelial cells. This allows erythrocyte extravasation into the alveolar space in the absence of structural vascular damage or capillaritis.\n"", ""name"": ""Immune-mediated increase in pulmonary capillary permeability""}"	{}	"{""biological_processes"": [{""preferred_term"": ""regulation of vascular permeability"", ""term"": {""id"": ""GO:0043114"", ""label"": ""regulation of vascular permeability""}}, {""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""capillary endothelial cell"", ""term"": {""id"": ""CL:0002144"", ""label"": ""capillary endothelial cell""}}, {""preferred_term"": ""eosinophil"", ""term"": {""id"": ""CL:0000041"", ""label"": ""mature eosinophil""}}, {""preferred_term"": ""basophil"", ""term"": {""id"": ""CL:0000767"", ""label"": ""basophil""}}], ""description"": ""Systemic immune mediators generated by intestinal celiac disease act on the pulmonary microvasculature, increasing capillary endothelial permeability without causing vasculitis or immune complex deposition. Mediators such as histamine (released by eosinophils and basophils), eosinophil cationic protein (ECP), and vascular endothelial growth factor (VEGF) increase endothelial gap formation between capillary endothelial cells. This allows erythrocyte extravasation into the alveolar space in the absence of structural vascular damage or capillaritis.\n"", ""evidence"": [{""explanation"": ""Review article describes Lane-Hamilton syndrome as the coexistence of pulmonary hemosiderosis and celiac disease"", ""reference"": ""PMID:37416498"", ""snippet"": ""The co-existence of idiopathic hemosiderosis and celiac disease is Lane-Hamilton Syndrome. This is a rare condition with only a few dozen cases reported to date."", ""supports"": ""SUPPORT""}, {""explanation"": ""Clinical analysis documents Lane-Hamilton syndrome as an association between pulmonary hemosiderosis and celiac disease"", ""reference"": ""PMID:34708697"", ""snippet"": ""The association of pulmonary hemosiderosis with celiac disease (Lane-Hamilton syndrome) is extremely rare."", ""supports"": ""SUPPORT""}], ""name"": ""Immune-mediated increase in pulmonary capillary permeability""}"
4306	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	2	Alveolar hemorrhage and hemosiderin accumulation	"Increased capillary permeability allows red blood cells and hemoglobin to escape into the alveolar space, causing diffuse alveolar hemorrhage (DAH). Alveolar macrophages rapidly phagocytose the extravasated erythrocytes and break down hemoglobin, converting iron and heme into hemosiderin. These hemosiderin-laden macrophages (HLM) accumulate in alveolar spaces and can be detected via bronchoalveolar lavage (BAL) or lung biopsy, serving as a hallmark histologic finding of prior alveolar bleeding.
"																																																								"{""description"": ""Increased capillary permeability allows red blood cells and hemoglobin to escape into the alveolar space, causing diffuse alveolar hemorrhage (DAH). Alveolar macrophages rapidly phagocytose the extravasated erythrocytes and break down hemoglobin, converting iron and heme into hemosiderin. These hemosiderin-laden macrophages (HLM) accumulate in alveolar spaces and can be detected via bronchoalveolar lavage (BAL) or lung biopsy, serving as a hallmark histologic finding of prior alveolar bleeding.\n"", ""name"": ""Alveolar hemorrhage and hemosiderin accumulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""heme catabolic process"", ""term"": {""id"": ""GO:0006785"", ""label"": ""heme catabolic process""}}, {""preferred_term"": ""iron ion homeostasis"", ""term"": {""id"": ""GO:0055072"", ""label"": ""iron ion homeostasis""}}], ""cell_types"": [{""preferred_term"": ""alveolar macrophage"", ""term"": {""id"": ""CL:0000583"", ""label"": ""alveolar macrophage""}}, {""preferred_term"": ""pulmonary alveolar type 2 cell"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}], ""description"": ""Increased capillary permeability allows red blood cells and hemoglobin to escape into the alveolar space, causing diffuse alveolar hemorrhage (DAH). Alveolar macrophages rapidly phagocytose the extravasated erythrocytes and break down hemoglobin, converting iron and heme into hemosiderin. These hemosiderin-laden macrophages (HLM) accumulate in alveolar spaces and can be detected via bronchoalveolar lavage (BAL) or lung biopsy, serving as a hallmark histologic finding of prior alveolar bleeding.\n"", ""evidence"": [{""explanation"": ""Case report identifies Lane-Hamilton syndrome as a cause of recurrent alveolar hemorrhage in adult patients"", ""reference"": ""PMID:36241572"", ""snippet"": ""Lane-Hamilton syndrome: A rare cause of recurrent alveolar hemorrhage in an adult"", ""supports"": ""SUPPORT""}, {""explanation"": ""Case report documents diagnostic findings in alveolar hemorrhage including HRCT imaging and biopsy results"", ""reference"": ""PMID:35754673"", ""snippet"": ""HRCT of the chest and duodenal biopsy helped in concluding the diagnosis"", ""supports"": ""SUPPORT""}], ""name"": ""Alveolar hemorrhage and hemosiderin accumulation""}"
4307	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	3	Iron and heme-driven oxidative injury and chronic remodeling	"Chronic recurrent alveolar hemorrhage leads to progressive iron and heme overload in the alveolar space, driving oxidative stress through iron-catalyzed free radical generation (Fenton reaction) and heme-driven lipid peroxidation. Oxidative injury damages alveolar epithelial cells, triggering type II pneumocyte hyperplasia as a reparative response. Over time, recurrent cycles of hemorrhage, oxidative injury, and epithelial repair may progress to pulmonary fibrosis and respiratory impairment if the underlying celiac disease is not controlled.
"																																																								"{""description"": ""Chronic recurrent alveolar hemorrhage leads to progressive iron and heme overload in the alveolar space, driving oxidative stress through iron-catalyzed free radical generation (Fenton reaction) and heme-driven lipid peroxidation. Oxidative injury damages alveolar epithelial cells, triggering type II pneumocyte hyperplasia as a reparative response. Over time, recurrent cycles of hemorrhage, oxidative injury, and epithelial repair may progress to pulmonary fibrosis and respiratory impairment if the underlying celiac disease is not controlled.\n"", ""name"": ""Iron and heme-driven oxidative injury and chronic remodeling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}, {""preferred_term"": ""epithelium regeneration"", ""term"": {""id"": ""GO:0060574"", ""label"": ""epithelium regeneration""}}, {""preferred_term"": ""reactive oxygen species metabolic process"", ""term"": {""id"": ""GO:0072593"", ""label"": ""reactive oxygen species metabolic process""}}], ""description"": ""Chronic recurrent alveolar hemorrhage leads to progressive iron and heme overload in the alveolar space, driving oxidative stress through iron-catalyzed free radical generation (Fenton reaction) and heme-driven lipid peroxidation. Oxidative injury damages alveolar epithelial cells, triggering type II pneumocyte hyperplasia as a reparative response. Over time, recurrent cycles of hemorrhage, oxidative injury, and epithelial repair may progress to pulmonary fibrosis and respiratory impairment if the underlying celiac disease is not controlled.\n"", ""evidence"": [{""explanation"": ""Review of updates in idiopathic pulmonary hemosiderosis in 2022 discusses chronic sequelae of recurrent hemorrhage and oxidative injury"", ""reference"": ""PMID:36324124"", ""supports"": ""SUPPORT""}, {""explanation"": ""Case report of Lane-Hamilton syndrome with concurrent idiopathic membranous nephropathy suggests systemic immune-mediated complications"", ""reference"": ""PMID:34401285"", ""supports"": ""PARTIAL""}], ""name"": ""Iron and heme-driven oxidative injury and chronic remodeling""}"
4336	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	0	Failed foregut partitioning	Abnormal separation of the anterior foregut permits persistent communication between airway and esophagus.																																																								"{""description"": ""Abnormal separation of the anterior foregut permits persistent communication between airway and esophagus."", ""name"": ""Failed foregut partitioning""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""digestive tract development"", ""term"": {""id"": ""GO:0048565"", ""label"": ""digestive tract development""}}, {""modifier"": ""DYSREGULATED"", ""preferred_term"": ""respiratory system development"", ""term"": {""id"": ""GO:0060541"", ""label"": ""respiratory system development""}}], ""description"": ""Abnormal separation of the anterior foregut permits persistent communication between airway and esophagus."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report links LTEC to foregut maldevelopment, supporting failed partitioning."", ""reference"": ""DOI:10.1186/s40792-023-01650-7"", ""snippet"": ""LTEC occurs because of foregut maldevelopment"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report reiterates fetal failure of trachea-esophagus separation in LTEC."", ""reference"": ""PMID:38380453"", ""snippet"": ""failure of separation of the trachea and the oesophagus during fetal development"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""foregut"", ""term"": {""id"": ""UBERON:0001041"", ""label"": ""foregut""}}], ""name"": ""Failed foregut partitioning""}"
4337	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	1	Disrupted BMP4 signaling during larynx development	Disruption of BMP4 signaling perturbs laryngeal development and is associated with laryngeal cleft in a mouse model.																																																								"{""description"": ""Disruption of BMP4 signaling perturbs laryngeal development and is associated with laryngeal cleft in a mouse model."", ""name"": ""Disrupted BMP4 signaling during larynx development""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""BMP signaling pathway"", ""term"": {""id"": ""GO:0030509"", ""label"": ""BMP signaling pathway""}}, {""modifier"": ""DYSREGULATED"", ""preferred_term"": ""larynx development"", ""term"": {""id"": ""GO:0120224"", ""label"": ""larynx development""}}], ""description"": ""Disruption of BMP4 signaling perturbs laryngeal development and is associated with laryngeal cleft in a mouse model."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Mouse model demonstrates association of disrupted BMP4 signaling with laryngeal cleft."", ""reference"": ""PMID:37230380"", ""snippet"": ""Disruption of BMP4 signaling is associated with laryngeal birth defects in a mouse model."", ""supports"": ""SUPPORT""}], ""name"": ""Disrupted BMP4 signaling during larynx development""}"
4338	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	2	Posterior communication between larynx/trachea and esophagus	Abnormal posterior cleft connects the larynx/trachea with the esophagus.																																																								"{""description"": ""Abnormal posterior cleft connects the larynx/trachea with the esophagus."", ""name"": ""Posterior communication between larynx/trachea and esophagus""}"	{}	"{""description"": ""Abnormal posterior cleft connects the larynx/trachea with the esophagus."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report defines LTEC as a posterior larynx/trachea communication with the esophagus."", ""reference"": ""DOI:10.1186/s40792-023-01650-7"", ""snippet"": ""Laryngotracheoesophageal cleft (LTEC) is a rare disease in which the larynx and trachea communicate posteriorly to the esophagus."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""larynx"", ""term"": {""id"": ""UBERON:0001737"", ""label"": ""larynx""}}, {""preferred_term"": ""trachea"", ""term"": {""id"": ""UBERON:0003126"", ""label"": ""trachea""}}, {""preferred_term"": ""esophagus"", ""term"": {""id"": ""UBERON:0001043"", ""label"": ""esophagus""}}], ""name"": ""Posterior communication between larynx/trachea and esophagus""}"
4339	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	3	Foregut maldevelopment during respiratory and digestive tract development	Disrupted foregut development underlies formation of the cleft.																																																								"{""description"": ""Disrupted foregut development underlies formation of the cleft."", ""name"": ""Foregut maldevelopment during respiratory and digestive tract development""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""digestive tract development"", ""term"": {""id"": ""GO:0048565"", ""label"": ""digestive tract development""}}, {""modifier"": ""DYSREGULATED"", ""preferred_term"": ""respiratory system development"", ""term"": {""id"": ""GO:0060541"", ""label"": ""respiratory system development""}}], ""description"": ""Disrupted foregut development underlies formation of the cleft."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report links LTEC to foregut maldevelopment."", ""reference"": ""DOI:10.1186/s40792-023-01650-7"", ""snippet"": ""LTEC occurs because of foregut maldevelopment"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""foregut"", ""term"": {""id"": ""UBERON:0001041"", ""label"": ""foregut""}}], ""name"": ""Foregut maldevelopment during respiratory and digestive tract development""}"
4340	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	4	Enriched esophageal malformation gene expression in lateral plate mesoderm	Esophageal malformation genes show highest expression in lateral plate mesoderm during early development, implicating this tissue in maldevelopment.																																																								"{""description"": ""Esophageal malformation genes show highest expression in lateral plate mesoderm during early development, implicating this tissue in maldevelopment."", ""name"": ""Enriched esophageal malformation gene expression in lateral plate mesoderm""}"	{}	"{""description"": ""Esophageal malformation genes show highest expression in lateral plate mesoderm during early development, implicating this tissue in maldevelopment."", ""evidence"": [{""evidence_source"": ""COMPUTATIONAL"", ""explanation"": ""Single-cell atlas analysis highlights lateral plate mesoderm enrichment of esophageal malformation genes."", ""reference"": ""DOI:10.1038/s41598-024-53098-w"", ""snippet"": ""the genes associated with esophageal malformations show their highest cell-type specific expression in lateral plate mesoderm cells and at the developmental stage of E8.75E9.0days."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lateral plate mesoderm"", ""term"": {""id"": ""UBERON:0003081"", ""label"": ""lateral plate mesoderm""}}], ""name"": ""Enriched esophageal malformation gene expression in lateral plate mesoderm""}"
4366	183	Leishmaniasis	Leishmaniasis.yaml	pathophysiology	0	Intracellular amastigote replication in macrophages	Promastigotes differentiate into amastigotes that multiply inside host macrophages.																																																								"{""description"": ""Promastigotes differentiate into amastigotes that multiply inside host macrophages."", ""name"": ""Intracellular amastigote replication in macrophages""}"	{}	"{""cell_types"": [{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Promastigotes differentiate into amastigotes that multiply inside host macrophages."", ""evidence"": [{""explanation"": ""The abstract describes amastigote differentiation and replication in macrophages."", ""reference"": ""PMID:33968798"", ""snippet"": ""Inside vertebrate host macrophages, the parasites can differentiate into the amastigote form and multiply"", ""supports"": ""SUPPORT""}], ""name"": ""Intracellular amastigote replication in macrophages""}"
4371	184	Leprosy	Leprosy.yaml	pathophysiology	0	Skin and peripheral nerve involvement	The pathogen primarily affects skin and peripheral nerves.																																																								"{""description"": ""The pathogen primarily affects skin and peripheral nerves."", ""name"": ""Skin and peripheral nerve involvement""}"	{}	"{""description"": ""The pathogen primarily affects skin and peripheral nerves."", ""evidence"": [{""explanation"": ""The abstract states primary involvement of skin and peripheral nerves."", ""reference"": ""PMID:28763601"", ""snippet"": ""The pathogen primarily affects the skin and peripheral nervous system."", ""supports"": ""SUPPORT""}], ""name"": ""Skin and peripheral nerve involvement""}"
4372	184	Leprosy	Leprosy.yaml	pathophysiology	1	Peripheral nerve affinity	M. leprae shows affinity for peripheral nerves leading to neuropathy.																																																								"{""description"": ""M. leprae shows affinity for peripheral nerves leading to neuropathy."", ""name"": ""Peripheral nerve affinity""}"	{}	"{""description"": ""M. leprae shows affinity for peripheral nerves leading to neuropathy."", ""evidence"": [{""explanation"": ""The abstract notes affinity for peripheral nerves and neuropathy."", ""reference"": ""PMID:11791665"", ""snippet"": ""The bacteria have affinity to the peripheral nerves and are likely to cause neuropathy."", ""supports"": ""SUPPORT""}], ""name"": ""Peripheral nerve affinity""}"
4381	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	0	TP53 Tumor Suppressor Loss	Germline heterozygous TP53 mutations result in haploinsufficiency for p53 function. Somatic loss or inactivation of the remaining wild-type allele (second hit) eliminates p53 tumor suppressor activity, removing a critical checkpoint against malignant transformation.																																																								"{""description"": ""Germline heterozygous TP53 mutations result in haploinsufficiency for p53 function. Somatic loss or inactivation of the remaining wild-type allele (second hit) eliminates p53 tumor suppressor activity, removing a critical checkpoint against malignant transformation."", ""name"": ""TP53 Tumor Suppressor Loss""}"	"{""downstream"": [{""description"": ""p53 loss impairs cellular response to genotoxic stress"", ""target"": ""Loss of DNA Damage Response""}, {""description"": ""p53 loss allows cells with DNA damage to continue cycling"", ""target"": ""Loss of Cell Cycle Checkpoint Control""}, {""description"": ""p53 loss prevents elimination of damaged cells"", ""target"": ""Impaired Apoptosis""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""signal transduction by p53 class mediator"", ""term"": {""id"": ""GO:0072331"", ""label"": ""signal transduction by p53 class mediator""}}], ""description"": ""Germline heterozygous TP53 mutations result in haploinsufficiency for p53 function. Somatic loss or inactivation of the remaining wild-type allele (second hit) eliminates p53 tumor suppressor activity, removing a critical checkpoint against malignant transformation."", ""downstream"": [{""description"": ""p53 loss impairs cellular response to genotoxic stress"", ""target"": ""Loss of DNA Damage Response""}, {""description"": ""p53 loss allows cells with DNA damage to continue cycling"", ""target"": ""Loss of Cell Cycle Checkpoint Control""}, {""description"": ""p53 loss prevents elimination of damaged cells"", ""target"": ""Impaired Apoptosis""}], ""name"": ""TP53 Tumor Suppressor Loss""}"
4382	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	1	Loss of DNA Damage Response	p53 is a master regulator of the DNA damage response. Upon detecting DNA damage, p53 activates transcription of genes involved in cell cycle arrest, DNA repair, and apoptosis. Loss of p53 function eliminates this critical surveillance mechanism.																																																								"{""description"": ""p53 is a master regulator of the DNA damage response. Upon detecting DNA damage, p53 activates transcription of genes involved in cell cycle arrest, DNA repair, and apoptosis. Loss of p53 function eliminates this critical surveillance mechanism."", ""name"": ""Loss of DNA Damage Response""}"	"{""downstream"": [{""description"": ""Unchecked DNA damage leads to mutation accumulation"", ""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA damage response, signal transduction by p53 class mediator"", ""term"": {""id"": ""GO:0030330"", ""label"": ""DNA damage response, signal transduction by p53 class mediator""}}], ""description"": ""p53 is a master regulator of the DNA damage response. Upon detecting DNA damage, p53 activates transcription of genes involved in cell cycle arrest, DNA repair, and apoptosis. Loss of p53 function eliminates this critical surveillance mechanism."", ""downstream"": [{""description"": ""Unchecked DNA damage leads to mutation accumulation"", ""target"": ""Genomic Instability""}], ""name"": ""Loss of DNA Damage Response""}"
4383	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	2	Loss of Cell Cycle Checkpoint Control	p53 induces G1 arrest in response to DNA damage by activating p21 (CDKN1A) transcription, which inhibits cyclin-dependent kinases. Without p53, cells with damaged DNA continue through the cell cycle, replicating mutations.																																																								"{""description"": ""p53 induces G1 arrest in response to DNA damage by activating p21 (CDKN1A) transcription, which inhibits cyclin-dependent kinases. Without p53, cells with damaged DNA continue through the cell cycle, replicating mutations."", ""name"": ""Loss of Cell Cycle Checkpoint Control""}"	"{""downstream"": [{""description"": ""Damaged cells replicate, accumulating mutations"", ""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}], ""description"": ""p53 induces G1 arrest in response to DNA damage by activating p21 (CDKN1A) transcription, which inhibits cyclin-dependent kinases. Without p53, cells with damaged DNA continue through the cell cycle, replicating mutations."", ""downstream"": [{""description"": ""Damaged cells replicate, accumulating mutations"", ""target"": ""Genomic Instability""}], ""name"": ""Loss of Cell Cycle Checkpoint Control""}"
4384	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	3	Impaired Apoptosis	p53 promotes apoptosis through transcriptional activation of pro-apoptotic genes (BAX, PUMA, NOXA) and repression of anti-apoptotic BCL2. Loss of p53 allows damaged and potentially transformed cells to survive and proliferate.																																																								"{""description"": ""p53 promotes apoptosis through transcriptional activation of pro-apoptotic genes (BAX, PUMA, NOXA) and repression of anti-apoptotic BCL2. Loss of p53 allows damaged and potentially transformed cells to survive and proliferate."", ""name"": ""Impaired Apoptosis""}"	"{""downstream"": [{""description"": ""Damaged cells escape elimination and undergo malignant transformation"", ""target"": ""Tumor Development""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""intrinsic apoptotic signaling pathway by p53 class mediator"", ""term"": {""id"": ""GO:0072332"", ""label"": ""intrinsic apoptotic signaling pathway by p53 class mediator""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""p53 promotes apoptosis through transcriptional activation of pro-apoptotic genes (BAX, PUMA, NOXA) and repression of anti-apoptotic BCL2. Loss of p53 allows damaged and potentially transformed cells to survive and proliferate."", ""downstream"": [{""description"": ""Damaged cells escape elimination and undergo malignant transformation"", ""target"": ""Tumor Development""}], ""name"": ""Impaired Apoptosis""}"
4385	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	4	Genomic Instability	Loss of p53-mediated checkpoints and DNA repair coordination leads to progressive accumulation of genomic alterations including point mutations, chromosomal rearrangements, and aneuploidy. This genomic instability accelerates tumor development and drives cancer heterogeneity.																																																								"{""description"": ""Loss of p53-mediated checkpoints and DNA repair coordination leads to progressive accumulation of genomic alterations including point mutations, chromosomal rearrangements, and aneuploidy. This genomic instability accelerates tumor development and drives cancer heterogeneity."", ""name"": ""Genomic Instability""}"	"{""downstream"": [{""description"": ""Accumulated mutations drive malignant transformation"", ""target"": ""Tumor Development""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}], ""description"": ""Loss of p53-mediated checkpoints and DNA repair coordination leads to progressive accumulation of genomic alterations including point mutations, chromosomal rearrangements, and aneuploidy. This genomic instability accelerates tumor development and drives cancer heterogeneity."", ""downstream"": [{""description"": ""Accumulated mutations drive malignant transformation"", ""target"": ""Tumor Development""}], ""name"": ""Genomic Instability""}"
4386	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	pathophysiology	5	Tumor Development	The combination of impaired DNA damage response, loss of cell cycle checkpoints, defective apoptosis, and genomic instability creates a permissive environment for tumor development. Different tissues vary in susceptibility, explaining the characteristic cancer spectrum of LFS.																																																								"{""description"": ""The combination of impaired DNA damage response, loss of cell cycle checkpoints, defective apoptosis, and genomic instability creates a permissive environment for tumor development. Different tissues vary in susceptibility, explaining the characteristic cancer spectrum of LFS."", ""name"": ""Tumor Development""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""The combination of impaired DNA damage response, loss of cell cycle checkpoints, defective apoptosis, and genomic instability creates a permissive environment for tumor development. Different tissues vary in susceptibility, explaining the characteristic cancer spectrum of LFS."", ""name"": ""Tumor Development""}"
4398	186	Lichen Simplex Chronicus	Lichen_Simplex_Chronicus.yaml	pathophysiology	0	Itch-scratch cycle	Persistent scratching sustains a neuroimmune itch-scratch cycle that drives chronic skin changes.																																																								"{""description"": ""Persistent scratching sustains a neuroimmune itch-scratch cycle that drives chronic skin changes."", ""name"": ""Itch-scratch cycle""}"	{}	"{""description"": ""Persistent scratching sustains a neuroimmune itch-scratch cycle that drives chronic skin changes."", ""evidence"": [{""explanation"": ""The review identifies the itch-scratch cycle as a central driver of chronic disease manifestations."", ""reference"": ""PMID:40855389"", ""snippet"": ""The hallmark itch-scratch cycle contributes not only to visible skin changes but also to substantial sleep disruption, emotional distress, and functional impairment."", ""supports"": ""SUPPORT""}], ""name"": ""Itch-scratch cycle""}"
4417	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	0	Hepatocyte Injury and Death	"Chronic liver injury from any cause leads to ongoing hepatocyte death, triggering inflammation and regenerative responses that promote fibrosis.
"																																																								"{""description"": ""Chronic liver injury from any cause leads to ongoing hepatocyte death, triggering inflammation and regenerative responses that promote fibrosis.\n"", ""name"": ""Hepatocyte Injury and Death""}"	{}	"{""cell_types"": [{""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Chronic liver injury from any cause leads to ongoing hepatocyte death, triggering inflammation and regenerative responses that promote fibrosis.\n"", ""evidence"": [{""explanation"": ""This review establishes that chronic liver injury is the initiating event leading to inflammation and fibrosis in cirrhosis development."", ""reference"": ""PMID:39063116"", ""snippet"": ""Chronic liver injury leads to liver inflammation and fibrosis (LF) as critical determinants of long-term outcomes such as cirrhosis, liver cancer, and mortality."", ""supports"": ""SUPPORT""}], ""name"": ""Hepatocyte Injury and Death""}"
4418	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	1	Hepatic Stellate Cell Activation	"Quiescent stellate cells transform into myofibroblasts, producing excessive collagen and extracellular matrix. This is the central event in liver fibrosis.
"																																																								"{""description"": ""Quiescent stellate cells transform into myofibroblasts, producing excessive collagen and extracellular matrix. This is the central event in liver fibrosis.\n"", ""name"": ""Hepatic Stellate Cell Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Fibrosis"", ""term"": {""id"": ""GO:0097186"", ""label"": ""amelogenesis""}}], ""cell_types"": [{""preferred_term"": ""Hepatic Stellate Cell"", ""term"": {""id"": ""CL:0000632"", ""label"": ""hepatic stellate cell""}}], ""description"": ""Quiescent stellate cells transform into myofibroblasts, producing excessive collagen and extracellular matrix. This is the central event in liver fibrosis.\n"", ""evidence"": [{""explanation"": ""This review definitively establishes HSC activation and transdifferentiation into myofibroblasts as the central mechanism of liver fibrosis and cirrhosis."", ""reference"": ""PMID:39063116"", ""snippet"": ""LF is a wound-healing process characterized by excessive deposition of extracellular matrix (ECM) proteins due to the activation of hepatic stellate cells (HSCs). In the healthy liver, quiescent HSCs metabolize and store retinoids. Upon fibrogenic activation, quiescent HSCs transdifferentiate into myofibroblasts; lose their vitamin A; upregulate -smooth muscle actin; and produce proinflammatory soluble mediators, collagens, and inhibitors of ECM degradation. Activated HSCs are the main effector cells during hepatic fibrogenesis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Macrophages play a key role in initiating and maintaining HSC activation, linking hepatocyte injury to stellate cell-mediated fibrosis."", ""reference"": ""PMID:39063116"", ""snippet"": ""The accumulation and activation of profibrogenic macrophages in response to hepatocyte death play a critical role in the initiation of HSC activation and survival."", ""supports"": ""SUPPORT""}], ""name"": ""Hepatic Stellate Cell Activation""}"
4419	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	2	Portal Hypertension	"Increased resistance to portal blood flow due to architectural distortion and nodule formation. Leads to varices, ascites, and splenomegaly.
"																																																								"{""description"": ""Increased resistance to portal blood flow due to architectural distortion and nodule formation. Leads to varices, ascites, and splenomegaly.\n"", ""name"": ""Portal Hypertension""}"	{}	"{""cell_types"": [{""preferred_term"": ""Endothelial Cell of Hepatic Sinusoid"", ""term"": {""id"": ""CL:1000398"", ""label"": ""endothelial cell of hepatic sinusoid""}}], ""description"": ""Increased resistance to portal blood flow due to architectural distortion and nodule formation. Leads to varices, ascites, and splenomegaly.\n"", ""evidence"": [{""explanation"": ""This comprehensive review establishes portal hypertension as the primary complication of cirrhosis, caused by increased intrahepatic vascular resistance and leading to major clinical complications."", ""reference"": ""PMID:38642564"", ""snippet"": ""Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy. Portal hypertension occurs due to increased resistance of the cirrhotic liver vasculature to portal blood flow and is further aggravated by the hyperdynamic circulatory syndrome."", ""supports"": ""SUPPORT""}, {""explanation"": ""This identifies the cellular mechanism by which sinusoidal cell dysfunction increases vascular resistance and drives portal hypertension development."", ""reference"": ""PMID:38642564"", ""snippet"": ""Existing knowledge indicates that the profibrogenic phenotype acquired by sinusoidal cells is the initial factor leading to increased hepatic vascular tone and fibrosis, which cause increased vascular resistance and portal hypertension."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study demonstrates that LSEC capillarization is a key pathological mechanism contributing to portal hypertension in cirrhosis."", ""reference"": ""PMID:38534382"", ""snippet"": ""Liver cirrhosis leads to portal hypertension (PH) with capillarization of liver sinusoidal endothelial cells (LSECs), although drug treatment options for PH are currently limited."", ""supports"": ""SUPPORT""}, {""explanation"": ""This experimental study demonstrates that preventing LSEC capillarization reduces portal hypertension, confirming the causal role of sinusoidal remodeling in PH development."", ""reference"": ""PMID:38534382"", ""snippet"": ""Tofogliflozin prevented PH with attenuated intrahepatic vasoconstriction, sinusoidal capillarization, and remodeling independent of glycemic status in CCl4-treated rats."", ""supports"": ""SUPPORT""}], ""name"": ""Portal Hypertension""}"
4420	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	3	Synthetic Dysfunction	"Reduced hepatocyte mass impairs production of clotting factors, albumin, and other proteins, leading to coagulopathy and hypoalbuminemia.
"																																																								"{""description"": ""Reduced hepatocyte mass impairs production of clotting factors, albumin, and other proteins, leading to coagulopathy and hypoalbuminemia.\n"", ""name"": ""Synthetic Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Protein Synthesis"", ""term"": {""id"": ""GO:0006412"", ""label"": ""translation""}}], ""description"": ""Reduced hepatocyte mass impairs production of clotting factors, albumin, and other proteins, leading to coagulopathy and hypoalbuminemia.\n"", ""evidence"": [{""explanation"": ""While addressing fibrosis reversibility, this demonstrates that loss of functional hepatocyte mass drives cirrhosis complications, and restoration depends on eliminating ongoing injury."", ""reference"": ""PMID:39063116"", ""snippet"": ""Recent data demonstrated that LF can revert even at advanced stages of cirrhosis if the underlying cause is eliminated, which inhibits the inflammatory and profibrogenic cells."", ""supports"": ""SUPPORT""}], ""name"": ""Synthetic Dysfunction""}"
4445	188	Long COVID	Long_COVID.yaml	pathophysiology	0	Viral Persistence	"SARS-CoV-2 viral reservoirs may persist in tissues including gut, brain, and other organs for months after acute infection. The gastrointestinal tract has emerged as a particularly significant reservoir site, with viral RNA detected in approximately 30% of intestinal specimens from Long COVID patients.
"																																																								"{""description"": ""SARS-CoV-2 viral reservoirs may persist in tissues including gut, brain, and other organs for months after acute infection. The gastrointestinal tract has emerged as a particularly significant reservoir site, with viral RNA detected in approximately 30% of intestinal specimens from Long COVID patients.\n"", ""name"": ""Viral Persistence""}"	{}	"{""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}, {""preferred_term"": ""CD8-positive T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}], ""description"": ""SARS-CoV-2 viral reservoirs may persist in tissues including gut, brain, and other organs for months after acute infection. The gastrointestinal tract has emerged as a particularly significant reservoir site, with viral RNA detected in approximately 30% of intestinal specimens from Long COVID patients.\n"", ""evidence"": [{""explanation"": ""Links Long COVID to persistence of SARS-CoV-2 RNA or antigen in tissues and resulting immune responses."", ""reference"": ""PMID:37140960"", ""snippet"": ""Persistence of SARS-CoV-2 RNA or antigens is reported in some organs, yet the mechanism by which they do so and how they may be associated with pathogenic immune responses is unclear."", ""supports"": ""SUPPORT""}], ""name"": ""Viral Persistence""}"
4446	188	Long COVID	Long_COVID.yaml	pathophysiology	1	Systemic Immune Activation	"Long COVID patients show ongoing systemic inflammation with altered T cell subset distributions and cytokine perturbations, indicating chronic immune activation and dysregulated signaling.
"																																																								"{""description"": ""Long COVID patients show ongoing systemic inflammation with altered T cell subset distributions and cytokine perturbations, indicating chronic immune activation and dysregulated signaling.\n"", ""name"": ""Systemic Immune Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""preferred_term"": ""JAK-STAT signaling"", ""term"": {""id"": ""GO:0007259"", ""label"": ""cell surface receptor signaling pathway via JAK-STAT""}}], ""cell_types"": [{""preferred_term"": ""CD4-positive T cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}, {""preferred_term"": ""CD8-positive T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}], ""description"": ""Long COVID patients show ongoing systemic inflammation with altered T cell subset distributions and cytokine perturbations, indicating chronic immune activation and dysregulated signaling.\n"", ""evidence"": [{""explanation"": ""Demonstrates persistent systemic inflammation and altered immune signaling in Long COVID."", ""reference"": ""PMID:38212464"", ""snippet"": ""LC individuals exhibited systemic inflammation and immune dysregulation. This was evidenced by global differences in T cell subset distribution implying ongoing immune responses, as well as by sex-specific perturbations in cytolytic subsets."", ""supports"": ""SUPPORT""}, {""explanation"": ""Immune profiling shows broad myeloid/lymphocyte shifts and heightened humoral responses in Long COVID."", ""reference"": ""PMID:37748514"", ""snippet"": ""Marked differences were noted in circulating myeloid and lymphocyte populations relative to the matched controls, as well as evidence of exaggerated humoral responses directed against SARS-CoV-2 among participants with long COVID."", ""supports"": ""SUPPORT""}], ""name"": ""Systemic Immune Activation""}"
4447	188	Long COVID	Long_COVID.yaml	pathophysiology	2	T Cell Exhaustion and Tissue Trafficking	"SARS-CoV-2-specific CD8+ T cells exhibit exhaustion phenotypes while CD4+ T cells are poised to migrate to inflamed tissues, reflecting sustained antigen exposure and chronic activation in Long COVID.
"																																																								"{""description"": ""SARS-CoV-2-specific CD8+ T cells exhibit exhaustion phenotypes while CD4+ T cells are poised to migrate to inflamed tissues, reflecting sustained antigen exposure and chronic activation in Long COVID.\n"", ""name"": ""T Cell Exhaustion and Tissue Trafficking""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T cell migration"", ""term"": {""id"": ""GO:0072678"", ""label"": ""T cell migration""}}, {""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}], ""cell_types"": [{""preferred_term"": ""CD4-positive T cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}, {""preferred_term"": ""CD8-positive T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}], ""description"": ""SARS-CoV-2-specific CD8+ T cells exhibit exhaustion phenotypes while CD4+ T cells are poised to migrate to inflamed tissues, reflecting sustained antigen exposure and chronic activation in Long COVID.\n"", ""evidence"": [{""explanation"": ""Documents tissue-trafficking CD4+ cells and exhausted virus-specific CD8+ cells in Long COVID."", ""reference"": ""PMID:38212464"", ""snippet"": ""LC individuals displayed increased frequencies of CD4+ T cells poised to migrate to inflamed tissues and exhausted SARS-CoV-2-specific CD8+ T cells"", ""supports"": ""SUPPORT""}], ""name"": ""T Cell Exhaustion and Tissue Trafficking""}"
4448	188	Long COVID	Long_COVID.yaml	pathophysiology	3	Endothelial Dysfunction and Microclots	"Persistent endothelial damage and formation of amyloid-like fibrin microclots impair microcirculation. These anomalous fibrin deposits resist normal fibrinolysis and can block capillaries, limiting oxygen delivery to tissues and potentially explaining the diverse symptomatology of Long COVID.
"																																																								"{""description"": ""Persistent endothelial damage and formation of amyloid-like fibrin microclots impair microcirculation. These anomalous fibrin deposits resist normal fibrinolysis and can block capillaries, limiting oxygen delivery to tissues and potentially explaining the diverse symptomatology of Long COVID.\n"", ""name"": ""Endothelial Dysfunction and Microclots""}"	{}	"{""biological_processes"": [{""preferred_term"": ""fibrinolysis"", ""term"": {""id"": ""GO:0042730"", ""label"": ""fibrinolysis""}}], ""cell_types"": [{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}, {""preferred_term"": ""platelet"", ""term"": {""id"": ""CL:0000233"", ""label"": ""platelet""}}], ""description"": ""Persistent endothelial damage and formation of amyloid-like fibrin microclots impair microcirculation. These anomalous fibrin deposits resist normal fibrinolysis and can block capillaries, limiting oxygen delivery to tissues and potentially explaining the diverse symptomatology of Long COVID.\n"", ""evidence"": [{""explanation"": ""Documents the presence and persistence of amyloid fibrin microclots in Long COVID patients."", ""reference"": ""PMID:35195253"", ""snippet"": ""The result, as is strongly manifested in platelet-poor plasma (PPP) of individuals with Long COVID, is extensive fibrin amyloid microclots that can persist, can entrap other proteins, and that may lead to the production of various autoantibodies."", ""supports"": ""SUPPORT""}, {""explanation"": ""Explains how microclots may cause Long COVID symptoms through impaired oxygen delivery."", ""reference"": ""PMID:35195253"", ""snippet"": ""the ability of these fibrin amyloid microclots (fibrinaloids) to block up capillaries, and thus to limit the passage of red blood cells and hence O2 exchange, can actually underpin the majority of these symptoms"", ""supports"": ""SUPPORT""}], ""name"": ""Endothelial Dysfunction and Microclots""}"
4449	188	Long COVID	Long_COVID.yaml	pathophysiology	4	Serotonin Depletion Mechanisms	"Long COVID features reduced peripheral serotonin driven by diminished intestinal tryptophan absorption, platelet hyperactivation that depletes stored serotonin, and enhanced monoamine oxidase-mediated serotonin turnover.
"																																																								"{""description"": ""Long COVID features reduced peripheral serotonin driven by diminished intestinal tryptophan absorption, platelet hyperactivation that depletes stored serotonin, and enhanced monoamine oxidase-mediated serotonin turnover.\n"", ""name"": ""Serotonin Depletion Mechanisms""}"	{}	"{""biological_processes"": [{""preferred_term"": ""tryptophan transport"", ""term"": {""id"": ""GO:0015827"", ""label"": ""tryptophan transport""}}, {""preferred_term"": ""platelet activation"", ""term"": {""id"": ""GO:0030168"", ""label"": ""platelet activation""}}, {""preferred_term"": ""serotonin metabolic process"", ""term"": {""id"": ""GO:0042427"", ""label"": ""serotonin metabolic process""}}], ""description"": ""Long COVID features reduced peripheral serotonin driven by diminished intestinal tryptophan absorption, platelet hyperactivation that depletes stored serotonin, and enhanced monoamine oxidase-mediated serotonin turnover.\n"", ""evidence"": [{""explanation"": ""Describes the three mechanistic drivers of serotonin loss in Long COVID."", ""reference"": ""PMID:37848036"", ""snippet"": ""Viral infection and type I interferon-driven inflammation reduce serotonin through three mechanisms: diminished intestinal absorption of the serotonin precursor tryptophan; platelet hyperactivation and thrombocytopenia, which impacts serotonin storage; and enhanced MAO-mediated serotonin turnover."", ""supports"": ""SUPPORT""}], ""name"": ""Serotonin Depletion Mechanisms""}"
4450	188	Long COVID	Long_COVID.yaml	pathophysiology	5	Vagus-Hippocampal Signaling Impairment	"Peripheral serotonin depletion weakens vagus nerve activity, leading to impaired hippocampal responses and memory formation that contribute to cognitive symptoms in Long COVID.
"																																																								"{""description"": ""Peripheral serotonin depletion weakens vagus nerve activity, leading to impaired hippocampal responses and memory formation that contribute to cognitive symptoms in Long COVID.\n"", ""name"": ""Vagus-Hippocampal Signaling Impairment""}"	{}	"{""biological_processes"": [{""preferred_term"": ""regulation of synaptic plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}, {""preferred_term"": ""memory"", ""term"": {""id"": ""GO:0007613"", ""label"": ""memory""}}], ""description"": ""Peripheral serotonin depletion weakens vagus nerve activity, leading to impaired hippocampal responses and memory formation that contribute to cognitive symptoms in Long COVID.\n"", ""evidence"": [{""explanation"": ""Connects serotonin loss to vagal signaling deficits and hippocampal dysfunction."", ""reference"": ""PMID:37848036"", ""snippet"": ""Peripheral serotonin reduction, in turn, impedes the activity of the vagus nerve and thereby impairs hippocampal responses and memory."", ""supports"": ""SUPPORT""}], ""name"": ""Vagus-Hippocampal Signaling Impairment""}"
4451	188	Long COVID	Long_COVID.yaml	pathophysiology	6	Autonomic Nervous System Dysfunction	"Dysautonomia, particularly postural orthostatic tachycardia syndrome (POTS), develops in many Long COVID patients. This may be related to virus- or immune-mediated disruption of the autonomic nervous system resulting in orthostatic intolerance syndromes.
"																																																								"{""description"": ""Dysautonomia, particularly postural orthostatic tachycardia syndrome (POTS), develops in many Long COVID patients. This may be related to virus- or immune-mediated disruption of the autonomic nervous system resulting in orthostatic intolerance syndromes.\n"", ""name"": ""Autonomic Nervous System Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""mast cell activation"", ""term"": {""id"": ""GO:0045576"", ""label"": ""mast cell activation""}}], ""description"": ""Dysautonomia, particularly postural orthostatic tachycardia syndrome (POTS), develops in many Long COVID patients. This may be related to virus- or immune-mediated disruption of the autonomic nervous system resulting in orthostatic intolerance syndromes.\n"", ""evidence"": [{""explanation"": ""Proposes autonomic nervous system disruption as a key mechanism in Long COVID."", ""reference"": ""PMID:33243837"", ""snippet"": ""We posit that this condition may be related to a virus- or immune-mediated disruption of the autonomic nervous system resulting in orthostatic intolerance syndromes."", ""supports"": ""SUPPORT""}, {""explanation"": ""Documents the prevalence of autonomic symptoms in Long COVID."", ""reference"": ""PMID:33243837"", ""snippet"": ""'Post-acute COVID' (known colloquially as 'long COVID') is emerging as a prevalent syndrome. It encompasses a plethora of debilitating symptoms (including breathlessness, chest pain, palpitations and orthostatic intolerance)"", ""supports"": ""SUPPORT""}], ""name"": ""Autonomic Nervous System Dysfunction""}"
4452	188	Long COVID	Long_COVID.yaml	pathophysiology	7	Impaired Mitochondrial Energy Production	"Long COVID is associated with reduced mitochondrial ATP production and impaired oxidative phosphorylation, contributing to fatigue, cognitive disturbances, and exercise intolerance.
"																																																								"{""description"": ""Long COVID is associated with reduced mitochondrial ATP production and impaired oxidative phosphorylation, contributing to fatigue, cognitive disturbances, and exercise intolerance.\n"", ""name"": ""Impaired Mitochondrial Energy Production""}"	{}	"{""biological_processes"": [{""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}, {""preferred_term"": ""ATP biosynthetic process"", ""term"": {""id"": ""GO:0006754"", ""label"": ""ATP biosynthetic process""}}], ""description"": ""Long COVID is associated with reduced mitochondrial ATP production and impaired oxidative phosphorylation, contributing to fatigue, cognitive disturbances, and exercise intolerance.\n"", ""evidence"": [{""explanation"": ""Links mitochondrial dysfunction and reduced energy production to persistent Long COVID symptoms."", ""reference"": ""PMID:38668888"", ""snippet"": ""Emerging evidence has pointed to mitochondrial dysfunction as a potential underpinning mechanism contributing to the persistence and diversity of long COVID symptoms."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired Mitochondrial Energy Production""}"
4453	188	Long COVID	Long_COVID.yaml	pathophysiology	8	Metabolic Shift and Oxidative Stress	"Mitochondrial impairment drives a shift toward glycolysis with associated oxidative stress and metabolic disturbances, further exacerbating systemic symptoms in Long COVID.
"																																																								"{""description"": ""Mitochondrial impairment drives a shift toward glycolysis with associated oxidative stress and metabolic disturbances, further exacerbating systemic symptoms in Long COVID.\n"", ""name"": ""Metabolic Shift and Oxidative Stress""}"	{}	"{""biological_processes"": [{""preferred_term"": ""glycolytic process"", ""term"": {""id"": ""GO:0006096"", ""label"": ""glycolytic process""}}, {""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""description"": ""Mitochondrial impairment drives a shift toward glycolysis with associated oxidative stress and metabolic disturbances, further exacerbating systemic symptoms in Long COVID.\n"", ""evidence"": [{""explanation"": ""Describes oxidative stress and metabolic disturbances resulting from mitochondrial dysfunction in Long COVID."", ""reference"": ""PMID:38668888"", ""snippet"": ""This review aims to synthesize current findings related to mitochondrial dysfunction in long COVID, exploring its implications for cellular energy deficits, oxidative stress, immune dysregulation, metabolic disturbances, and endothelial dysfunction."", ""supports"": ""SUPPORT""}], ""name"": ""Metabolic Shift and Oxidative Stress""}"
4454	188	Long COVID	Long_COVID.yaml	pathophysiology	9	Mast Cell Activation	"Mast cell activation syndrome (MCAS) has been implicated in Long COVID pathophysiology. Mast cell degranulation releases pro-inflammatory mediators including histamine, contributing to fatigue, brain fog, cardiovascular symptoms, and gastrointestinal disturbances.
"																																																								"{""description"": ""Mast cell activation syndrome (MCAS) has been implicated in Long COVID pathophysiology. Mast cell degranulation releases pro-inflammatory mediators including histamine, contributing to fatigue, brain fog, cardiovascular symptoms, and gastrointestinal disturbances.\n"", ""name"": ""Mast Cell Activation""}"	{}	"{""cell_types"": [{""preferred_term"": ""mast cell"", ""term"": {""id"": ""CL:0000097"", ""label"": ""mast cell""}}], ""description"": ""Mast cell activation syndrome (MCAS) has been implicated in Long COVID pathophysiology. Mast cell degranulation releases pro-inflammatory mediators including histamine, contributing to fatigue, brain fog, cardiovascular symptoms, and gastrointestinal disturbances.\n"", ""evidence"": [{""explanation"": ""Implicates mast cell activation in Long COVID pathophysiology."", ""reference"": ""PMID:37529714"", ""snippet"": ""Previous studies have suggested that mast cell activation (MCA) may play a role in the pathophysiology of long-COVID, including in the mechanisms of its cardiovascular manifestations."", ""supports"": ""SUPPORT""}, {""explanation"": ""Treatment response to antihistamines supports the role of mast cell activation in Long COVID."", ""reference"": ""PMID:37529714"", ""snippet"": ""Long-COVID symptoms disappeared completely in 29% of treated patients. There was a significant improvement in each of the considered symptoms (improved or disappeared) in all treated patients"", ""supports"": ""SUPPORT""}], ""name"": ""Mast Cell Activation""}"
4455	188	Long COVID	Long_COVID.yaml	pathophysiology	10	Neuroinflammation	"Neuroinflammation in Long COVID involves microglial activation, blood-brain barrier disruption, and inflammatory cytokine penetration into the brain parenchyma. This contributes to cognitive dysfunction, memory impairment, and other neurological symptoms.
"																																																								"{""description"": ""Neuroinflammation in Long COVID involves microglial activation, blood-brain barrier disruption, and inflammatory cytokine penetration into the brain parenchyma. This contributes to cognitive dysfunction, memory impairment, and other neurological symptoms.\n"", ""name"": ""Neuroinflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Neuroinflammation in Long COVID involves microglial activation, blood-brain barrier disruption, and inflammatory cytokine penetration into the brain parenchyma. This contributes to cognitive dysfunction, memory impairment, and other neurological symptoms.\n"", ""evidence"": [{""explanation"": ""Documents microglial activation and its impact on cognitive processes in Long COVID."", ""reference"": ""PMID:36846556"", ""snippet"": ""Activation of microglia in response to an immune system challenge can lead to a significant impact on cognitive processes, such as learning, memory and emotional regulation."", ""supports"": ""SUPPORT""}, {""explanation"": ""Explains how inflammatory cytokines impair neural function in Long COVID brain fog."", ""reference"": ""PMID:36846556"", ""snippet"": ""Inflammatory cytokines have been found to play a significant role in reductions in LTP and LTD, a reduction in neurogenesis, and in dendritic sprouting."", ""supports"": ""SUPPORT""}], ""name"": ""Neuroinflammation""}"
4494	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	0	Odontogenic Source Infection (Mandibular Molar)	Dental infection of a mandibular tooth provides the odontogenic nidus that seeds deeper spaces.																																																								"{""description"": ""Dental infection of a mandibular tooth provides the odontogenic nidus that seeds deeper spaces."", ""name"": ""Odontogenic Source Infection (Mandibular Molar)""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Response to bacterium"", ""term"": {""id"": ""GO:0009617"", ""label"": ""response to bacterium""}}], ""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Dental infection of a mandibular tooth provides the odontogenic nidus that seeds deeper spaces."", ""evidence"": [{""explanation"": ""Establishes the odontogenic dental source leading to floor-of-mouth infection."", ""reference"": ""PMID:33383265"", ""snippet"": ""Ludwig's angina is a rapidly spreading infection that involves the floor of the mouth."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Root of tooth"", ""term"": {""id"": ""UBERON:0011605"", ""label"": ""root of tooth""}}, {""preferred_term"": ""Mandibular molar tooth"", ""term"": {""id"": ""UBERON:0001094"", ""label"": ""mandibular molar tooth""}}], ""name"": ""Odontogenic Source Infection (Mandibular Molar)""}"
4495	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	1	Polymicrobial Cellulitis of Mouth Floor	Mixed oral flora invade submandibular and sublingual spaces, producing rapidly spreading cellulitis.																																																								"{""description"": ""Mixed oral flora invade submandibular and sublingual spaces, producing rapidly spreading cellulitis."", ""name"": ""Polymicrobial Cellulitis of Mouth Floor""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Mixed oral flora invade submandibular and sublingual spaces, producing rapidly spreading cellulitis."", ""evidence"": [{""explanation"": ""Highlights rapid polymicrobial cellulitis centered on the mouth floor and submandibular spaces."", ""reference"": ""PMID:33383265"", ""snippet"": ""Ludwig's angina is a rapidly spreading infection that involves the floor of the mouth."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Floor of mouth"", ""term"": {""id"": ""UBERON:0003688"", ""label"": ""floor of mouth""}}, {""preferred_term"": ""Submandibular space"", ""term"": {""id"": ""UBERON:0012443"", ""label"": ""submandibular space""}}], ""name"": ""Polymicrobial Cellulitis of Mouth Floor""}"
4496	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	2	Cervical Fascial Spread Across Submandibular-Sublingual Spaces	Infection tracks along cervical fascial planes through submandibular, sublingual, and submental spaces.																																																								"{""description"": ""Infection tracks along cervical fascial planes through submandibular, sublingual, and submental spaces."", ""name"": ""Cervical Fascial Spread Across Submandibular-Sublingual Spaces""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Infection tracks along cervical fascial planes through submandibular, sublingual, and submental spaces."", ""evidence"": [{""explanation"": ""Describes rapid fascial-plane spread across submandibular and sublingual spaces."", ""reference"": ""PMID:35784784"", ""snippet"": ""Ludwig's angina is a cellulitis that affects the submandibular, sublingual, and submental regions, fast-spreading along the fascial plane."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Submandibular gland"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""submandibular gland""}}, {""preferred_term"": ""Sublingual gland"", ""term"": {""id"": ""UBERON:0001839"", ""label"": ""sublingual gland""}}], ""name"": ""Cervical Fascial Spread Across Submandibular-Sublingual Spaces""}"
4497	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	3	Descending Necrotizing Mediastinitis Extension	Continued inferior spread can involve the mediastinum, producing necrotizing mediastinitis.																																																								"{""description"": ""Continued inferior spread can involve the mediastinum, producing necrotizing mediastinitis."", ""name"": ""Descending Necrotizing Mediastinitis Extension""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Continued inferior spread can involve the mediastinum, producing necrotizing mediastinitis."", ""evidence"": [{""explanation"": ""CT-documented mediastinitis demonstrates downward extension along fascial planes."", ""reference"": ""PMID:35784784"", ""snippet"": ""Ludwig's angina with mediastinitis complication was established by a computed tomography (CT) scan."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Mediastinum"", ""term"": {""id"": ""UBERON:0002416"", ""label"": ""mediastinum""}}], ""name"": ""Descending Necrotizing Mediastinitis Extension""}"
4498	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	4	Tongue Elevation and Airway Narrowing from Floor Edema	Submandibular and sublingual edema elevate the tongue and floor of mouth, narrowing the oropharyngeal airway and precipitating stridor or dyspnea.																																																								"{""description"": ""Submandibular and sublingual edema elevate the tongue and floor of mouth, narrowing the oropharyngeal airway and precipitating stridor or dyspnea."", ""name"": ""Tongue Elevation and Airway Narrowing from Floor Edema""}"	"{""downstream"": [{""description"": ""Floor-of-mouth edema and tongue elevation precipitate stridor and dyspnea, requiring airway protection."", ""evidence"": [{""explanation"": ""Links mouth-floor elevation to airway obstruction and stridor."", ""reference"": ""PMID:38445409"", ""snippet"": ""trismus and elevation of the floor of the mouth that caused an obstruction of the airway and resulted in an inspiratory dyspnea and a stridor."", ""supports"": ""SUPPORT""}, {""explanation"": ""Fatal case underscores how submandibular edema can fully occlude the airway in Ludwig's angina."", ""reference"": ""PMID:33904596"", ""snippet"": ""which suggested that the cause of death was asphyxiation due to airway obstruction."", ""supports"": ""SUPPORT""}], ""target"": ""Airway Compromise""}]}"	"{""biological_processes"": [{""preferred_term"": ""Regulation of vascular permeability"", ""term"": {""id"": ""GO:0043112"", ""label"": ""regulation of vascular permeability""}}], ""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Submandibular and sublingual edema elevate the tongue and floor of mouth, narrowing the oropharyngeal airway and precipitating stridor or dyspnea."", ""downstream"": [{""description"": ""Floor-of-mouth edema and tongue elevation precipitate stridor and dyspnea, requiring airway protection."", ""evidence"": [{""explanation"": ""Links mouth-floor elevation to airway obstruction and stridor."", ""reference"": ""PMID:38445409"", ""snippet"": ""trismus and elevation of the floor of the mouth that caused an obstruction of the airway and resulted in an inspiratory dyspnea and a stridor."", ""supports"": ""SUPPORT""}, {""explanation"": ""Fatal case underscores how submandibular edema can fully occlude the airway in Ludwig's angina."", ""reference"": ""PMID:33904596"", ""snippet"": ""which suggested that the cause of death was asphyxiation due to airway obstruction."", ""supports"": ""SUPPORT""}], ""target"": ""Airway Compromise""}], ""evidence"": [{""explanation"": ""Documents airway compromise from submandibular and sublingual edema."", ""reference"": ""PMID:38445409"", ""snippet"": ""elevation of the floor of the mouth that caused an obstruction of the airway and resulted in an inspiratory dyspnea and a stridor."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Oropharynx"", ""term"": {""id"": ""UBERON:0001729"", ""label"": ""oropharynx""}}, {""preferred_term"": ""Floor of mouth"", ""term"": {""id"": ""UBERON:0003688"", ""label"": ""floor of mouth""}}], ""name"": ""Tongue Elevation and Airway Narrowing from Floor Edema""}"
4512	190	Lung Carcinoma	Lung_Carcinoma.yaml	pathophysiology	0	Oncogenic Driver Mutations in NSCLC	Activating EGFR mutations and ALK alterations are key molecular features in subsets of non-small cell lung carcinoma.																																																								"{""description"": ""Activating EGFR mutations and ALK alterations are key molecular features in subsets of non-small cell lung carcinoma."", ""name"": ""Oncogenic Driver Mutations in NSCLC""}"	{}	"{""description"": ""Activating EGFR mutations and ALK alterations are key molecular features in subsets of non-small cell lung carcinoma."", ""evidence"": [{""explanation"": ""The abstract links EGFR mutations and ALK positivity with NSCLC."", ""reference"": ""PMID:22932130"", ""snippet"": ""The discovery of activating mutations in the epidermal growth factor receptor and anaplastic lymphoma kinase positivity has made personalized treatment for NSCLC more feasible."", ""supports"": ""SUPPORT""}], ""name"": ""Oncogenic Driver Mutations in NSCLC""}"
4513	190	Lung Carcinoma	Lung_Carcinoma.yaml	pathophysiology	1	VEGFA-Mediated Angiogenesis	VEGFA-driven angiogenesis contributes to lung cancer progression and promotes a proangiogenic signaling network.																																																								"{""description"": ""VEGFA-driven angiogenesis contributes to lung cancer progression and promotes a proangiogenic signaling network."", ""name"": ""VEGFA-Mediated Angiogenesis""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}], ""description"": ""VEGFA-driven angiogenesis contributes to lung cancer progression and promotes a proangiogenic signaling network."", ""evidence"": [{""explanation"": ""The abstract identifies VEGFA as a key mediator of angiogenesis in NSCLC."", ""reference"": ""PMID:26542886"", ""snippet"": ""Vascular endothelial growth factor A (VEGFA) is one of the main mediators of angiogenesis in non-small cell lung cancer (NSCLC)."", ""supports"": ""SUPPORT""}], ""name"": ""VEGFA-Mediated Angiogenesis""}"
4543	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	0	Spirochete Invasion and Dissemination	"Borrelia burgdorferi is transmitted through Ixodes tick bites. The spirochete disseminates from the skin through the bloodstream to multiple organ systems including joints, heart, and nervous system. Surface adhesins like BBK32 and decorin-binding proteins (DbpA/DbpB) facilitate tissue colonization.
"																																																								"{""description"": ""Borrelia burgdorferi is transmitted through Ixodes tick bites. The spirochete disseminates from the skin through the bloodstream to multiple organ systems including joints, heart, and nervous system. Surface adhesins like BBK32 and decorin-binding proteins (DbpA/DbpB) facilitate tissue colonization.\n"", ""name"": ""Spirochete Invasion and Dissemination""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cell adhesion"", ""term"": {""id"": ""GO:0007155"", ""label"": ""cell adhesion""}}], ""cell_types"": [{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Borrelia burgdorferi is transmitted through Ixodes tick bites. The spirochete disseminates from the skin through the bloodstream to multiple organ systems including joints, heart, and nervous system. Surface adhesins like BBK32 and decorin-binding proteins (DbpA/DbpB) facilitate tissue colonization.\n"", ""evidence"": [{""explanation"": ""Epidemiologic series shows Borrelia disseminates beyond skin to neurologic, rheumatologic, and cardiac sites."", ""reference"": ""PMID:33669940"", ""snippet"": ""The clinical manifestations of Lyme disease range from a localized infection, for example, erythema migrans (EM) to a disseminated neurological or rheumatological infection, cardiac involvement, or even chronic disease."", ""supports"": ""SUPPORT""}], ""name"": ""Spirochete Invasion and Dissemination""}"
4544	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	1	Autoimmune Activation after Persistent Infection	"Prolonged exposure of the host immune system to Borrelia antigens can drive post-infectious autoimmunity, with reported triggers of systemic autoimmune disease after Lyme borreliosis.
"																																																								"{""description"": ""Prolonged exposure of the host immune system to Borrelia antigens can drive post-infectious autoimmunity, with reported triggers of systemic autoimmune disease after Lyme borreliosis.\n"", ""name"": ""Autoimmune Activation after Persistent Infection""}"	{}	"{""biological_processes"": [{""preferred_term"": ""immune system process"", ""term"": {""id"": ""GO:0002376"", ""label"": ""immune system process""}}], ""cell_types"": [{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Prolonged exposure of the host immune system to Borrelia antigens can drive post-infectious autoimmunity, with reported triggers of systemic autoimmune disease after Lyme borreliosis.\n"", ""evidence"": [{""explanation"": ""Case review links persistent Borrelia exposure to downstream autoimmune disease."", ""reference"": ""PMID:34786243"", ""snippet"": ""long-term exposure of the host's immune system to spirochetes can contribute to the development of chronic autoimmune disease de novo."", ""supports"": ""SUPPORT""}], ""name"": ""Autoimmune Activation after Persistent Infection""}"
4545	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	2	Inflammatory Response and Tissue Damage	"The host immune response to Borrelia antigens contributes to tissue damage. Spirochetal lipoproteins and peptidoglycan trigger robust innate immune activation with production of IL-6, IL-8, TNF, and chemokines (CCL3/CCL4). Persistent inflammation in joints may continue even after spirochete clearance.
"																																																								"{""description"": ""The host immune response to Borrelia antigens contributes to tissue damage. Spirochetal lipoproteins and peptidoglycan trigger robust innate immune activation with production of IL-6, IL-8, TNF, and chemokines (CCL3/CCL4). Persistent inflammation in joints may continue even after spirochete clearance.\n"", ""name"": ""Inflammatory Response and Tissue Damage""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""The host immune response to Borrelia antigens contributes to tissue damage. Spirochetal lipoproteins and peptidoglycan trigger robust innate immune activation with production of IL-6, IL-8, TNF, and chemokines (CCL3/CCL4). Persistent inflammation in joints may continue even after spirochete clearance.\n"", ""evidence"": [{""explanation"": ""Lyme arthritis joint fluid shows marked neutrophilic inflammation despite negative cultures, consistent with immune-driven damage."", ""reference"": ""PMID:37407232"", ""snippet"": ""Aspiration of the left knee joint revealed a white cell count of 21.0109/L (83% neutrophils) with negative Gram stain and culture. However, Lyme PCR was positive and accompanied by serologies consistent with Lyme arthritis."", ""supports"": ""SUPPORT""}], ""name"": ""Inflammatory Response and Tissue Damage""}"
4561	192	Lymphatic filariasis	Lymphatic_Filariasis.yaml	pathophysiology	0	Lymphatic vessel blockage and dysfunction	Adult lymphatic filariae in lymph vessels provoke blockage and host responses that impair lymphatic function and drive fibrosis.																																																								"{""description"": ""Adult lymphatic filariae in lymph vessels provoke blockage and host responses that impair lymphatic function and drive fibrosis."", ""name"": ""Lymphatic vessel blockage and dysfunction""}"	{}	"{""description"": ""Adult lymphatic filariae in lymph vessels provoke blockage and host responses that impair lymphatic function and drive fibrosis."", ""evidence"": [{""explanation"": ""Adult worms in lymphatic vessels cause blockage, inflammation, dysfunction, and fibrosis."", ""reference"": ""PMID:21413271"", ""snippet"": ""The adults of the lymphatic filariae inhabit lymph vessels, where blockage and host reaction can result in lymphatic inflammation and dysfunction, and eventually in lymphedema and fibrosis."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lymphatic vessel"", ""term"": {""id"": ""UBERON:0001473"", ""label"": ""lymphatic vessel""}}], ""name"": ""Lymphatic vessel blockage and dysfunction""}"
4562	192	Lymphatic filariasis	Lymphatic_Filariasis.yaml	pathophysiology	1	Lymphatic vessel remodeling and dilation	Adult parasites damage lymphatic valves and remodel lymphatic vessels, causing lymphatic dilation.																																																								"{""description"": ""Adult parasites damage lymphatic valves and remodel lymphatic vessels, causing lymphatic dilation."", ""name"": ""Lymphatic vessel remodeling and dilation""}"	{}	"{""description"": ""Adult parasites damage lymphatic valves and remodel lymphatic vessels, causing lymphatic dilation."", ""evidence"": [{""explanation"": ""The abstract describes parasite-driven valve damage and lymphatic remodeling."", ""reference"": ""PMID:39739969"", ""snippet"": ""The adult parasites impact the integrity of lymphatic vessels and damage valves, leading to a remodeling of the lymphatic system and lymphatic dilation."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lymphatic vessel"", ""term"": {""id"": ""UBERON:0001473"", ""label"": ""lymphatic vessel""}}], ""name"": ""Lymphatic vessel remodeling and dilation""}"
4571	193	Lymphoma	Lymphoma.yaml	pathophysiology	0	Malignant Lymphoid Proliferation	Neoplastic transformation and proliferation of lymphoid cells within the lymphatic system leads to lymph node and extranodal involvement.																																																								"{""description"": ""Neoplastic transformation and proliferation of lymphoid cells within the lymphatic system leads to lymph node and extranodal involvement."", ""name"": ""Malignant Lymphoid Proliferation""}"	{}	"{""description"": ""Neoplastic transformation and proliferation of lymphoid cells within the lymphatic system leads to lymph node and extranodal involvement."", ""evidence"": [{""explanation"": ""The abstract defines lymphoma as malignant neoplasms of the lymphoid system."", ""reference"": ""PMID:12764636"", ""snippet"": ""Lymphoma is a spectrum of malignant neoplasms of the lymphoid system."", ""supports"": ""SUPPORT""}], ""name"": ""Malignant Lymphoid Proliferation""}"
4572	193	Lymphoma	Lymphoma.yaml	pathophysiology	1	Hodgkin/Reed-Sternberg Cell Origin	Hodgkin lymphoma is characterized by clonal Hodgkin/Reed-Sternberg cells that derive from B cells.																																																								"{""description"": ""Hodgkin lymphoma is characterized by clonal Hodgkin/Reed-Sternberg cells that derive from B cells."", ""name"": ""Hodgkin/Reed-Sternberg Cell Origin""}"	{}	"{""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""Hodgkin lymphoma is characterized by clonal Hodgkin/Reed-Sternberg cells that derive from B cells."", ""evidence"": [{""explanation"": ""The abstract states that Hodgkin/Reed-Sternberg cells are derived from B cells."", ""reference"": ""PMID:15618006"", ""snippet"": ""HRS cells in nearly all cases of HL derive from B cells, and only rarely from T cells."", ""supports"": ""SUPPORT""}], ""name"": ""Hodgkin/Reed-Sternberg Cell Origin""}"
4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Mutations in mismatch repair genes lead to an accumulation of DNA replication errors.																																																								"{""description"": ""Mutations in mismatch repair genes lead to an accumulation of DNA replication errors."", ""name"": ""DNA Mismatch Repair Deficiency""}"	"{""downstream"": [{""description"": ""Loss of mismatch repair causes unstable microsatellite repeats and increased insertion-deletion burden."", ""evidence"": [{""explanation"": ""This directly supports the mechanistic edge from mismatch repair deficiency to microsatellite instability."", ""reference"": ""PMID:25701956"", ""snippet"": ""Deficient DNA mismatch repair (MMR) results in a strong mutator phenotype known as microsatellite instability (MSI), which is a hallmark of Lynch syndrome-associated cancers."", ""supports"": ""SUPPORT""}], ""target"": ""Microsatellite Instability""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""mismatch repair"", ""term"": {""id"": ""GO:0006298"", ""label"": ""mismatch repair""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""DNA-templated DNA replication maintenance of fidelity"", ""term"": {""id"": ""GO:0045005"", ""label"": ""DNA-templated DNA replication maintenance of fidelity""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""DNA damage response""}}], ""cell_types"": [{""preferred_term"": ""colonic epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}, {""preferred_term"": ""endometrial epithelial cell"", ""term"": {""id"": ""CL:0002656"", ""label"": ""glandular endometrial unciliated epithelial cell""}}], ""cellular_components"": [{""preferred_term"": ""nucleoplasm"", ""term"": {""id"": ""GO:0005654"", ""label"": ""nucleoplasm""}}], ""description"": ""Mutations in mismatch repair genes lead to an accumulation of DNA replication errors."", ""downstream"": [{""description"": ""Loss of mismatch repair causes unstable microsatellite repeats and increased insertion-deletion burden."", ""evidence"": [{""explanation"": ""This directly supports the mechanistic edge from mismatch repair deficiency to microsatellite instability."", ""reference"": ""PMID:25701956"", ""snippet"": ""Deficient DNA mismatch repair (MMR) results in a strong mutator phenotype known as microsatellite instability (MSI), which is a hallmark of Lynch syndrome-associated cancers."", ""supports"": ""SUPPORT""}], ""target"": ""Microsatellite Instability""}], ""evidence"": [{""explanation"": ""This reference confirms that Lynch Syndrome involves mutations in mismatch repair genes."", ""reference"": ""PMID:19466295"", ""snippet"": ""Lynch syndrome represents 1-7% of all cases of colorectal cancer and is an autosomal-dominant inherited cancer predisposition syndrome caused by germline mutations in deoxyribonucleic acid (DNA) mismatch repair genes."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports the notion that DNA mismatch repair is crucial in correcting DNA replication errors, and its deficiency leads to the accumulation of these errors."", ""reference"": ""PMID:29233924"", ""snippet"": ""Many mutations first arise as DNA replication errors. These errors subsequently evade correction by cellular DNA repair, for example, by the well-known DNA mismatch repair (MMR) mechanism."", ""supports"": ""SUPPORT""}, {""explanation"": ""Clear evidence linking inherited defects in mismatch repair genes to Lynch Syndrome."", ""reference"": ""PMID:34919656"", ""snippet"": ""Lynch syndrome (LS, OMIM #120435) is caused by an inherited heterozygous defect in any of the four core DNA mismatch repair (MMR) genes MSH2, MSH6, MLH1 or PMS2..."", ""supports"": ""SUPPORT""}, {""explanation"": ""Validates that Lynch Syndrome is underpinned by mutations in specific mismatch repair genes."", ""reference"": ""PMID:24443998"", ""snippet"": ""Inherited defects in the DNA mismatch repair (MMR) system, MLH1, MSH2, MSH6, and PMS2 genes, underlie Lynch syndrome, one of the most prevalent cancer syndromes in man."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""nucleus"", ""term"": {""id"": ""UBERON:0000062"", ""label"": ""nucleus""}}], ""name"": ""DNA Mismatch Repair Deficiency"", ""protein_complexes"": [{""preferred_term"": ""mismatch repair complex"", ""term"": {""id"": ""GO:0032300"", ""label"": ""mismatch repair complex""}}]}"
4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	Microsatellite Instability	Defective mismatch repair causes variations in the length of repetitive DNA sequences called microsatellites.																																																								"{""description"": ""Defective mismatch repair causes variations in the length of repetitive DNA sequences called microsatellites."", ""name"": ""Microsatellite Instability""}"	"{""downstream"": [{""description"": ""MSI-associated coding frameshift mutations increase oncogenic transformation risk."", ""evidence"": [{""explanation"": ""This supports MSI-associated frameshift mutagenesis as a driver of rapid tumorigenesis."", ""reference"": ""PMID:38466935"", ""snippet"": ""Lynch syndrome is a hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes, which lead to high microsatellite instability and frameshift mutations at coding mononucleotide repeats in the genome."", ""supports"": ""SUPPORT""}], ""target"": ""Accelerated Tumor Development""}, {""description"": ""Frameshifted proteins generate immunogenic neoepitopes."", ""evidence"": [{""explanation"": ""This directly supports the causal edge from MSI-associated frameshift mutations to neoantigen generation."", ""reference"": ""PMID:34630437"", ""snippet"": ""We and others have characterized a subset of MSI-H associated highly recurrent frameshift mutations that yield shared immunogenic neoantigens."", ""supports"": ""SUPPORT""}], ""target"": ""Neoantigen Generation and Immune Activation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA-templated DNA replication maintenance of fidelity"", ""term"": {""id"": ""GO:0045005"", ""label"": ""DNA-templated DNA replication maintenance of fidelity""}}], ""cell_types"": [{""preferred_term"": ""colonic epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}, {""preferred_term"": ""endometrial epithelial cell"", ""term"": {""id"": ""CL:0002656"", ""label"": ""glandular endometrial unciliated epithelial cell""}}], ""description"": ""Defective mismatch repair causes variations in the length of repetitive DNA sequences called microsatellites."", ""downstream"": [{""description"": ""MSI-associated coding frameshift mutations increase oncogenic transformation risk."", ""evidence"": [{""explanation"": ""This supports MSI-associated frameshift mutagenesis as a driver of rapid tumorigenesis."", ""reference"": ""PMID:38466935"", ""snippet"": ""Lynch syndrome is a hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes, which lead to high microsatellite instability and frameshift mutations at coding mononucleotide repeats in the genome."", ""supports"": ""SUPPORT""}], ""target"": ""Accelerated Tumor Development""}, {""description"": ""Frameshifted proteins generate immunogenic neoepitopes."", ""evidence"": [{""explanation"": ""This directly supports the causal edge from MSI-associated frameshift mutations to neoantigen generation."", ""reference"": ""PMID:34630437"", ""snippet"": ""We and others have characterized a subset of MSI-H associated highly recurrent frameshift mutations that yield shared immunogenic neoantigens."", ""supports"": ""SUPPORT""}], ""target"": ""Neoantigen Generation and Immune Activation""}], ""evidence"": [{""explanation"": ""The snippet confirms that defective mismatch repair causes microsatellite instability, supporting the statement."", ""reference"": ""PMID:25701956"", ""snippet"": ""Deficient DNA mismatch repair (MMR) results in a strong mutator phenotype known as microsatellite instability (MSI), which is a hallmark of Lynch syndrome-associated cancers."", ""supports"": ""SUPPORT""}, {""explanation"": ""The statement is supported by the evidence that Lynch Syndrome leads to microsatellite instability due to defective mismatch repair."", ""reference"": ""PMID:35315099"", ""snippet"": ""LS tumours are characterised by unique pathogenesis, ultimately resulting in hypermutation, microsatellite instability and high immunogenicity that has significant implications for cancer risk, clinical presentation, treatment and surveillance."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by linking mismatch repair deficiency and microsatellite instability in Lynch Syndrome."", ""reference"": ""PMID:31273487"", ""snippet"": ""Lynch syndrome is a state of mismatch repair deficiency due to a monoallelic abnormality of any mismatch repair genes. The phenotype indicating the mismatch repair deficiency can be frequently shown as a microsatellite instability in tumors."", ""supports"": ""SUPPORT""}, {""explanation"": ""The snippet supports the statement by describing how defective mismatch repair in Lynch syndrome leads to microsatellite instability."", ""reference"": ""PMID:38466935"", ""snippet"": ""Lynch syndrome is a hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes, which lead to high microsatellite instability and frameshift mutations at coding mononucleotide repeats in the genome."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}, {""preferred_term"": ""endometrium"", ""term"": {""id"": ""UBERON:0001295"", ""label"": ""endometrium""}}], ""name"": ""Microsatellite Instability""}"
4599	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	2	Accelerated Tumor Development	The accumulation of mutations in key genes leads to an increased risk of developing certain cancers at an earlier age.																																																								"{""description"": ""The accumulation of mutations in key genes leads to an increased risk of developing certain cancers at an earlier age."", ""name"": ""Accelerated Tumor Development""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""colonic epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}, {""preferred_term"": ""endometrial epithelial cell"", ""term"": {""id"": ""CL:0002656"", ""label"": ""glandular endometrial unciliated epithelial cell""}}], ""description"": ""The accumulation of mutations in key genes leads to an increased risk of developing certain cancers at an earlier age."", ""evidence"": [{""explanation"": ""This further supports the fact that accumulation of mutations in key genes (MMR genes) in Lynch Syndrome contributes to an increased risk of developing certain cancers."", ""reference"": ""PMID:37478804"", ""snippet"": ""Lynch Syndrome (LS) is one of the most common hereditary cancer syndromes, and is caused by mutations in one of the four DNA mismatch repair (MMR) genes, namely MLH1, MSH2, MSH6 and PMS2."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports the idea that the mechanism of Lynch Syndrome involves the accumulation of mutations in key genes leading to cancer."", ""reference"": ""PMID:23604856"", ""snippet"": ""Lynch Syndrome, or hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant cancer predisposition syndrome caused by inactivating mutations in DNA mismatch repair genes."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}, {""preferred_term"": ""endometrium"", ""term"": {""id"": ""UBERON:0001295"", ""label"": ""endometrium""}}], ""name"": ""Accelerated Tumor Development""}"
4600	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	3	Neoantigen Generation and Immune Activation	Frameshift mutations in coding repeats generate tumor neoantigens that activate tumor-infiltrating lymphocytes and create an immunogenic tumor microenvironment.																																		The hypermutated phenotype leads to high tumor mutational burden and neoantigen presentation, explaining sensitivity to immune checkpoint inhibitors.																						"{""description"": ""Frameshift mutations in coding repeats generate tumor neoantigens that activate tumor-infiltrating lymphocytes and create an immunogenic tumor microenvironment."", ""name"": ""Neoantigen Generation and Immune Activation"", ""notes"": ""The hypermutated phenotype leads to high tumor mutational burden and neoantigen presentation, explaining sensitivity to immune checkpoint inhibitors.""}"	"{""downstream"": [{""description"": ""High neoantigen load and cytotoxic T-cell infiltration create therapeutic vulnerability to PD-1 blockade."", ""evidence"": [{""explanation"": ""This supports the causal link between immunogenic dMMR/MSI biology and checkpoint blockade sensitivity."", ""reference"": ""PMID:37625240"", ""snippet"": ""PD-1 inhibitors are highly effective for dMMR and MSI-H LS CRCs, but not for pMMR or MSS LS CRCs or mucinous/signet-ring cell CRC."", ""supports"": ""SUPPORT""}], ""target"": ""Immune Checkpoint Blockade Sensitivity""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""antigen processing and presentation of peptide antigen via MHC class I"", ""term"": {""id"": ""GO:0002474"", ""label"": ""antigen processing and presentation of peptide antigen via MHC class I""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""type I interferon-mediated signaling pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon-mediated signaling pathway""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""T cell mediated cytotoxicity directed against tumor cell target"", ""term"": {""id"": ""GO:0002419"", ""label"": ""T cell mediated cytotoxicity directed against tumor cell target""}}], ""cell_types"": [{""preferred_term"": ""CD8-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}], ""description"": ""Frameshift mutations in coding repeats generate tumor neoantigens that activate tumor-infiltrating lymphocytes and create an immunogenic tumor microenvironment."", ""downstream"": [{""description"": ""High neoantigen load and cytotoxic T-cell infiltration create therapeutic vulnerability to PD-1 blockade."", ""evidence"": [{""explanation"": ""This supports the causal link between immunogenic dMMR/MSI biology and checkpoint blockade sensitivity."", ""reference"": ""PMID:37625240"", ""snippet"": ""PD-1 inhibitors are highly effective for dMMR and MSI-H LS CRCs, but not for pMMR or MSS LS CRCs or mucinous/signet-ring cell CRC."", ""supports"": ""SUPPORT""}], ""target"": ""Immune Checkpoint Blockade Sensitivity""}], ""evidence"": [{""explanation"": ""This directly supports neoantigen generation from recurrent frameshift events in mismatch repair-deficient, MSI-high tumors seen in Lynch syndrome."", ""reference"": ""PMID:34630437"", ""snippet"": ""We and others have characterized a subset of MSI-H associated highly recurrent frameshift mutations that yield shared immunogenic neoantigens."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports the immunogenic tumor microenvironment and immune activation component of this mechanism."", ""reference"": ""PMID:35315099"", ""snippet"": ""LS tumours are characterised by unique pathogenesis, ultimately resulting in hypermutation, microsatellite instability and high immunogenicity that has significant implications for cancer risk, clinical presentation, treatment and surveillance."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}, {""preferred_term"": ""endometrium"", ""term"": {""id"": ""UBERON:0001295"", ""label"": ""endometrium""}}], ""name"": ""Neoantigen Generation and Immune Activation"", ""notes"": ""The hypermutated phenotype leads to high tumor mutational burden and neoantigen presentation, explaining sensitivity to immune checkpoint inhibitors.""}"
4601	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	4	Immune Checkpoint Blockade Sensitivity	Lynch-associated dMMR/MSI tumors with high neoantigen burden are enriched for anti-tumor T-cell activity and show strong responses to PD-1 blockade.																																																								"{""description"": ""Lynch-associated dMMR/MSI tumors with high neoantigen burden are enriched for anti-tumor T-cell activity and show strong responses to PD-1 blockade."", ""name"": ""Immune Checkpoint Blockade Sensitivity""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""T cell mediated cytotoxicity directed against tumor cell target"", ""term"": {""id"": ""GO:0002419"", ""label"": ""T cell mediated cytotoxicity directed against tumor cell target""}}], ""description"": ""Lynch-associated dMMR/MSI tumors with high neoantigen burden are enriched for anti-tumor T-cell activity and show strong responses to PD-1 blockade."", ""evidence"": [{""explanation"": ""This human clinical observation supports mechanistic sensitivity of dMMR/MSI Lynch tumors to immune checkpoint blockade."", ""reference"": ""PMID:37625240"", ""snippet"": ""PD-1 inhibitors are highly effective for dMMR and MSI-H LS CRCs, but not for pMMR or MSS LS CRCs or mucinous/signet-ring cell CRC."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports high treatment sensitivity in dMMR states while also indicating that surveillance remains necessary."", ""reference"": ""PMID:37845474"", ""snippet"": ""Metastatic and localized mismatch repair-deficient (dMMR) tumors are exquisitely sensitive to immune checkpoint blockade (ICB)."", ""supports"": ""PARTIAL""}], ""name"": ""Immune Checkpoint Blockade Sensitivity""}"
4614	195	Medium Chain Acyl-CoA Dehydrogenase Deficiency	MCAD_Deficiency.yaml	pathophysiology	0	Impaired medium-chain fatty acid beta-oxidation	"MCAD catalyzes the first step of mitochondrial beta-oxidation for medium-chain fatty acyl-CoAs (C6-C12). Deficiency leads to accumulation of medium-chain acylcarnitines and failure to generate acetyl-CoA and ketone bodies during fasting.
"																																																								"{""description"": ""MCAD catalyzes the first step of mitochondrial beta-oxidation for medium-chain fatty acyl-CoAs (C6-C12). Deficiency leads to accumulation of medium-chain acylcarnitines and failure to generate acetyl-CoA and ketone bodies during fasting.\n"", ""name"": ""Impaired medium-chain fatty acid beta-oxidation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""fatty acid beta-oxidation"", ""term"": {""id"": ""GO:0006635"", ""label"": ""fatty acid beta-oxidation""}}, {""preferred_term"": ""medium-chain fatty acyl-CoA dehydrogenase activity"", ""term"": {""id"": ""GO:0070991"", ""label"": ""medium-chain fatty acyl-CoA dehydrogenase activity""}}], ""description"": ""MCAD catalyzes the first step of mitochondrial beta-oxidation for medium-chain fatty acyl-CoAs (C6-C12). Deficiency leads to accumulation of medium-chain acylcarnitines and failure to generate acetyl-CoA and ketone bodies during fasting.\n"", ""locations"": [{""preferred_term"": ""mitochondrial matrix"", ""term"": {""id"": ""GO:0005759"", ""label"": ""mitochondrial matrix""}}], ""name"": ""Impaired medium-chain fatty acid beta-oxidation""}"
4615	195	Medium Chain Acyl-CoA Dehydrogenase Deficiency	MCAD_Deficiency.yaml	pathophysiology	1	Hypoketotic hypoglycemia mechanism	"During fasting, the body normally switches to fatty acid oxidation for energy. In MCAD deficiency, this pathway is blocked, leading to rapid depletion of glucose stores without compensatory ketogenesis. The resulting hypoketotic hypoglycemia causes encephalopathy and can be fatal.
"																																																								"{""description"": ""During fasting, the body normally switches to fatty acid oxidation for energy. In MCAD deficiency, this pathway is blocked, leading to rapid depletion of glucose stores without compensatory ketogenesis. The resulting hypoketotic hypoglycemia causes encephalopathy and can be fatal.\n"", ""name"": ""Hypoketotic hypoglycemia mechanism""}"	"{""downstream"": [{""description"": ""Blocked fatty acid oxidation prevents ketone body production during fasting."", ""target"": ""Hypoketotic hypoglycemia""}]}"	"{""description"": ""During fasting, the body normally switches to fatty acid oxidation for energy. In MCAD deficiency, this pathway is blocked, leading to rapid depletion of glucose stores without compensatory ketogenesis. The resulting hypoketotic hypoglycemia causes encephalopathy and can be fatal.\n"", ""downstream"": [{""description"": ""Blocked fatty acid oxidation prevents ketone body production during fasting."", ""target"": ""Hypoketotic hypoglycemia""}], ""name"": ""Hypoketotic hypoglycemia mechanism""}"
4616	195	Medium Chain Acyl-CoA Dehydrogenase Deficiency	MCAD_Deficiency.yaml	pathophysiology	2	Toxic metabolite accumulation	"Accumulation of medium-chain fatty acids and their conjugates (octanoate, octanoylcarnitine) may have direct toxic effects on brain and liver tissue. Accumulated acyl-CoA intermediates deplete free coenzyme A and may cause mitochondrial dysfunction.
"																																																								"{""description"": ""Accumulation of medium-chain fatty acids and their conjugates (octanoate, octanoylcarnitine) may have direct toxic effects on brain and liver tissue. Accumulated acyl-CoA intermediates deplete free coenzyme A and may cause mitochondrial dysfunction.\n"", ""name"": ""Toxic metabolite accumulation""}"	{}	"{""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Accumulation of medium-chain fatty acids and their conjugates (octanoate, octanoylcarnitine) may have direct toxic effects on brain and liver tissue. Accumulated acyl-CoA intermediates deplete free coenzyme A and may cause mitochondrial dysfunction.\n"", ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Toxic metabolite accumulation""}"
4633	196	MET Exon 14 Skipping Non-Small Cell Lung Cancer	MET_Exon_14_Skipping_NSCLC.yaml	pathophysiology	0	MET Exon 14 Splice Mutations	MET exon 14 skipping results from splice site mutations that cause exclusion of exon 14 during pre-mRNA splicing. Exon 14 encodes a juxtamembrane regulatory domain containing a CBL E3 ubiquitin ligase binding site (Y1003). Loss of this domain prevents receptor ubiquitination and degradation, leading to prolonged MET signaling after ligand stimulation.																																																								"{""description"": ""MET exon 14 skipping results from splice site mutations that cause exclusion of exon 14 during pre-mRNA splicing. Exon 14 encodes a juxtamembrane regulatory domain containing a CBL E3 ubiquitin ligase binding site (Y1003). Loss of this domain prevents receptor ubiquitination and degradation, leading to prolonged MET signaling after ligand stimulation."", ""name"": ""MET Exon 14 Splice Mutations""}"	"{""downstream"": [{""description"": ""Loss of CBL-mediated ubiquitination and degradation"", ""target"": ""Prolonged MET Signaling""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""transmembrane receptor protein tyrosine kinase signaling pathway"", ""term"": {""id"": ""GO:0007169"", ""label"": ""transmembrane receptor protein tyrosine kinase signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}], ""description"": ""MET exon 14 skipping results from splice site mutations that cause exclusion of exon 14 during pre-mRNA splicing. Exon 14 encodes a juxtamembrane regulatory domain containing a CBL E3 ubiquitin ligase binding site (Y1003). Loss of this domain prevents receptor ubiquitination and degradation, leading to prolonged MET signaling after ligand stimulation."", ""downstream"": [{""description"": ""Loss of CBL-mediated ubiquitination and degradation"", ""target"": ""Prolonged MET Signaling""}], ""evidence"": [{""explanation"": ""This abstract documents MET exon 14 mutations in NSCLC, supporting the presence of exon 14 alterations in this subtype."", ""reference"": ""PMID:26729443"", ""snippet"": ""MET exon 14 mutations were identified in 28 of 933 nonsquamous NSCLCs (3.0%) and were not seen in other cancer types in this study."", ""supports"": ""SUPPORT""}], ""name"": ""MET Exon 14 Splice Mutations""}"
4634	196	MET Exon 14 Skipping Non-Small Cell Lung Cancer	MET_Exon_14_Skipping_NSCLC.yaml	pathophysiology	1	Prolonged MET Signaling	METex14 skipping results in prolonged receptor activation and downstream signaling through RAS-MAPK, PI3K-AKT, and STAT3 pathways. HGF (hepatocyte growth factor) ligand binding triggers signaling, but receptor downregulation is impaired.																																																								"{""description"": ""METex14 skipping results in prolonged receptor activation and downstream signaling through RAS-MAPK, PI3K-AKT, and STAT3 pathways. HGF (hepatocyte growth factor) ligand binding triggers signaling, but receptor downregulation is impaired."", ""name"": ""Prolonged MET Signaling""}"	"{""downstream"": [{""description"": ""Sustained HGF-MET signaling promotes tumor growth"", ""target"": ""Cell Proliferation and Migration""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""METex14 skipping results in prolonged receptor activation and downstream signaling through RAS-MAPK, PI3K-AKT, and STAT3 pathways. HGF (hepatocyte growth factor) ligand binding triggers signaling, but receptor downregulation is impaired."", ""downstream"": [{""description"": ""Sustained HGF-MET signaling promotes tumor growth"", ""target"": ""Cell Proliferation and Migration""}], ""name"": ""Prolonged MET Signaling""}"
4635	196	MET Exon 14 Skipping Non-Small Cell Lung Cancer	MET_Exon_14_Skipping_NSCLC.yaml	pathophysiology	2	Cell Proliferation and Migration	MET signaling promotes cell proliferation, survival, motility, and invasion. The HGF-MET axis is particularly important for epithelial-mesenchymal transition and metastasis.																																																								"{""description"": ""MET signaling promotes cell proliferation, survival, motility, and invasion. The HGF-MET axis is particularly important for epithelial-mesenchymal transition and metastasis."", ""name"": ""Cell Proliferation and Migration""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""MET signaling promotes cell proliferation, survival, motility, and invasion. The HGF-MET axis is particularly important for epithelial-mesenchymal transition and metastasis."", ""name"": ""Cell Proliferation and Migration""}"
4636	196	MET Exon 14 Skipping Non-Small Cell Lung Cancer	MET_Exon_14_Skipping_NSCLC.yaml	pathophysiology	3	MET Inhibitor Resistance	Resistance to MET inhibitors can develop through secondary MET kinase mutations (D1228N/V, Y1230C/H), MET amplification increase, or bypass pathway activation (KRAS, EGFR, HER3). On-target resistance mutations affect drug binding.																																																								"{""description"": ""Resistance to MET inhibitors can develop through secondary MET kinase mutations (D1228N/V, Y1230C/H), MET amplification increase, or bypass pathway activation (KRAS, EGFR, HER3). On-target resistance mutations affect drug binding."", ""name"": ""MET Inhibitor Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}], ""description"": ""Resistance to MET inhibitors can develop through secondary MET kinase mutations (D1228N/V, Y1230C/H), MET amplification increase, or bypass pathway activation (KRAS, EGFR, HER3). On-target resistance mutations affect drug binding."", ""name"": ""MET Inhibitor Resistance""}"
4657	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	0	DNA Mismatch Repair Deficiency	Loss of MMR protein function (MLH1, MSH2, MSH6, or PMS2) impairs the recognition and repair of DNA replication errors. The MMR system normally corrects base-base mismatches and insertion/deletion loops at microsatellite sequences. Deficiency leads to accumulation of thousands of somatic mutations.																																																								"{""description"": ""Loss of MMR protein function (MLH1, MSH2, MSH6, or PMS2) impairs the recognition and repair of DNA replication errors. The MMR system normally corrects base-base mismatches and insertion/deletion loops at microsatellite sequences. Deficiency leads to accumulation of thousands of somatic mutations."", ""name"": ""DNA Mismatch Repair Deficiency""}"	"{""downstream"": [{""description"": ""Impaired MMR leads to length alterations at microsatellite repeat sequences"", ""target"": ""Microsatellite Instability""}, {""description"": ""Accumulated replication errors result in high somatic mutation burden"", ""target"": ""Hypermutation and High TMB""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""mismatch repair"", ""term"": {""id"": ""GO:0006298"", ""label"": ""mismatch repair""}}], ""cell_types"": [{""preferred_term"": ""colon epithelial cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}], ""description"": ""Loss of MMR protein function (MLH1, MSH2, MSH6, or PMS2) impairs the recognition and repair of DNA replication errors. The MMR system normally corrects base-base mismatches and insertion/deletion loops at microsatellite sequences. Deficiency leads to accumulation of thousands of somatic mutations."", ""downstream"": [{""description"": ""Impaired MMR leads to length alterations at microsatellite repeat sequences"", ""target"": ""Microsatellite Instability""}, {""description"": ""Accumulated replication errors result in high somatic mutation burden"", ""target"": ""Hypermutation and High TMB""}], ""evidence"": [{""explanation"": ""This abstract explicitly links MSI-H CRC to deficient mismatch repair, supporting the core disease mechanism described."", ""reference"": ""PMID:41113075"", ""snippet"": ""High microsatellite instability (MSI-H) colorectal cancer (CRC), caused by deficient mismatch repair, accounts for about 15% of all CRC cases and is more common in right-sided tumors."", ""supports"": ""SUPPORT""}], ""name"": ""DNA Mismatch Repair Deficiency""}"
4658	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	1	Microsatellite Instability	Microsatellites are repetitive DNA sequences highly susceptible to replication errors. Without functional MMR, these sequences accumulate insertions and deletions, detectable as length variations (instability) compared to normal tissue. MSI-H is defined as instability at two or more of five standard markers.																																																								"{""description"": ""Microsatellites are repetitive DNA sequences highly susceptible to replication errors. Without functional MMR, these sequences accumulate insertions and deletions, detectable as length variations (instability) compared to normal tissue. MSI-H is defined as instability at two or more of five standard markers."", ""name"": ""Microsatellite Instability""}"	"{""downstream"": [{""description"": ""Microsatellite instability causes frameshift mutations in coding sequences"", ""target"": ""Frameshift Mutations in Tumor Suppressors""}]}"	"{""description"": ""Microsatellites are repetitive DNA sequences highly susceptible to replication errors. Without functional MMR, these sequences accumulate insertions and deletions, detectable as length variations (instability) compared to normal tissue. MSI-H is defined as instability at two or more of five standard markers."", ""downstream"": [{""description"": ""Microsatellite instability causes frameshift mutations in coding sequences"", ""target"": ""Frameshift Mutations in Tumor Suppressors""}], ""evidence"": [{""explanation"": ""Abstract links MSI CRC to MMR deficiency, supporting the MSI mechanism."", ""reference"": ""PMID:36115290"", ""snippet"": ""Microsatellite unstable (MSI) colorectal cancers (CRCs) are due to DNA mismatch repair (MMR) deficiency"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}], ""name"": ""Microsatellite Instability""}"
4659	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	2	Hypermutation and High TMB	MSI-H tumors accumulate 10-100 times more somatic mutations than microsatellite stable tumors, resulting in tumor mutational burden often exceeding 10-20 mutations per megabase. This creates abundant neoantigens derived from mutant peptides presented on MHC molecules.																																																								"{""description"": ""MSI-H tumors accumulate 10-100 times more somatic mutations than microsatellite stable tumors, resulting in tumor mutational burden often exceeding 10-20 mutations per megabase. This creates abundant neoantigens derived from mutant peptides presented on MHC molecules."", ""name"": ""Hypermutation and High TMB""}"	"{""downstream"": [{""description"": ""High mutation load generates abundant immunogenic neoantigens"", ""target"": ""Neoantigen-Driven Immune Response""}]}"	"{""description"": ""MSI-H tumors accumulate 10-100 times more somatic mutations than microsatellite stable tumors, resulting in tumor mutational burden often exceeding 10-20 mutations per megabase. This creates abundant neoantigens derived from mutant peptides presented on MHC molecules."", ""downstream"": [{""description"": ""High mutation load generates abundant immunogenic neoantigens"", ""target"": ""Neoantigen-Driven Immune Response""}], ""evidence"": [{""explanation"": ""Abstract notes frequent somatic mutational events from MMR alterations, consistent with hypermutation."", ""reference"": ""PMID:36115290"", ""snippet"": ""The pathogenic alterations of MMR genes lead to the accumulation of frequent somatic mutational events"", ""supports"": ""SUPPORT""}], ""name"": ""Hypermutation and High TMB""}"
4660	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	3	Frameshift Mutations in Tumor Suppressors	Coding microsatellites in tumor suppressor genes (TGFbetaRII, BAX, ACVR2, IGF2R) accumulate frameshift mutations, inactivating their tumor suppressive functions. TGFbetaRII frameshift is particularly common, disrupting TGF-beta growth inhibition.																																																								"{""description"": ""Coding microsatellites in tumor suppressor genes (TGFbetaRII, BAX, ACVR2, IGF2R) accumulate frameshift mutations, inactivating their tumor suppressive functions. TGFbetaRII frameshift is particularly common, disrupting TGF-beta growth inhibition."", ""name"": ""Frameshift Mutations in Tumor Suppressors""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Coding microsatellites in tumor suppressor genes (TGFbetaRII, BAX, ACVR2, IGF2R) accumulate frameshift mutations, inactivating their tumor suppressive functions. TGFbetaRII frameshift is particularly common, disrupting TGF-beta growth inhibition."", ""name"": ""Frameshift Mutations in Tumor Suppressors""}"
4661	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	4	Neoantigen-Driven Immune Response	The high neoantigen burden in MSI-H tumors stimulates robust anti-tumor immunity. Tumor-infiltrating lymphocytes, particularly CD8+ cytotoxic T cells, recognize and attack tumor cells presenting neoantigens. However, tumors upregulate PD-L1 as an adaptive resistance mechanism.																																																								"{""description"": ""The high neoantigen burden in MSI-H tumors stimulates robust anti-tumor immunity. Tumor-infiltrating lymphocytes, particularly CD8+ cytotoxic T cells, recognize and attack tumor cells presenting neoantigens. However, tumors upregulate PD-L1 as an adaptive resistance mechanism."", ""name"": ""Neoantigen-Driven Immune Response""}"	"{""downstream"": [{""description"": ""Tumors adaptively upregulate checkpoint ligands to suppress T cell attack"", ""target"": ""PD-L1 Upregulation and Immune Evasion""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""T cell mediated cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}], ""cell_types"": [{""preferred_term"": ""CD8-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}], ""description"": ""The high neoantigen burden in MSI-H tumors stimulates robust anti-tumor immunity. Tumor-infiltrating lymphocytes, particularly CD8+ cytotoxic T cells, recognize and attack tumor cells presenting neoantigens. However, tumors upregulate PD-L1 as an adaptive resistance mechanism."", ""downstream"": [{""description"": ""Tumors adaptively upregulate checkpoint ligands to suppress T cell attack"", ""target"": ""PD-L1 Upregulation and Immune Evasion""}], ""name"": ""Neoantigen-Driven Immune Response""}"
4662	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	5	PD-L1 Upregulation and Immune Evasion	MSI-H tumors upregulate PD-L1 expression in response to interferon-gamma from infiltrating T cells. PD-L1 engagement of PD-1 on T cells suppresses cytotoxic function, allowing immune evasion despite the immunogenic microenvironment. This makes MSI-H tumors vulnerable to PD-1/PD-L1 blockade.																																																								"{""description"": ""MSI-H tumors upregulate PD-L1 expression in response to interferon-gamma from infiltrating T cells. PD-L1 engagement of PD-1 on T cells suppresses cytotoxic function, allowing immune evasion despite the immunogenic microenvironment. This makes MSI-H tumors vulnerable to PD-1/PD-L1 blockade."", ""name"": ""PD-L1 Upregulation and Immune Evasion""}"	{}	"{""description"": ""MSI-H tumors upregulate PD-L1 expression in response to interferon-gamma from infiltrating T cells. PD-L1 engagement of PD-1 on T cells suppresses cytotoxic function, allowing immune evasion despite the immunogenic microenvironment. This makes MSI-H tumors vulnerable to PD-1/PD-L1 blockade."", ""name"": ""PD-L1 Upregulation and Immune Evasion""}"
4681	198	MSI-High Endometrial Cancer	MSI_High_Endometrial_Cancer.yaml	pathophysiology	0	Mismatch Repair Deficiency	Loss of functional mismatch repair (MMR) proteins impairs the ability to correct base-base mismatches and insertion-deletion loops during DNA replication. This leads to accumulation of mutations, particularly at microsatellite regions.																																																								"{""description"": ""Loss of functional mismatch repair (MMR) proteins impairs the ability to correct base-base mismatches and insertion-deletion loops during DNA replication. This leads to accumulation of mutations, particularly at microsatellite regions."", ""name"": ""Mismatch Repair Deficiency""}"	"{""downstream"": [{""description"": ""dMMR leads to expansion/contraction of microsatellite repeat sequences"", ""target"": ""Microsatellite Instability""}, {""description"": ""Accumulated mutations generate tumor-specific neoantigens"", ""target"": ""Hypermutation and Neoantigen Generation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""mismatch repair"", ""term"": {""id"": ""GO:0006298"", ""label"": ""mismatch repair""}}], ""cell_types"": [{""preferred_term"": ""endometrial epithelial cell"", ""term"": {""id"": ""CL:0002149"", ""label"": ""epithelial cell of uterus""}}], ""description"": ""Loss of functional mismatch repair (MMR) proteins impairs the ability to correct base-base mismatches and insertion-deletion loops during DNA replication. This leads to accumulation of mutations, particularly at microsatellite regions."", ""downstream"": [{""description"": ""dMMR leads to expansion/contraction of microsatellite repeat sequences"", ""target"": ""Microsatellite Instability""}, {""description"": ""Accumulated mutations generate tumor-specific neoantigens"", ""target"": ""Hypermutation and Neoantigen Generation""}], ""evidence"": [{""explanation"": ""Supports the frequency of MSI/dMMR in endometrial carcinoma."", ""reference"": ""PMID:39860407"", ""snippet"": ""Cancer immunotherapy through the use of PD-1/PD-L1 inhibitors have shown significant promise in endometrial carcinoma (EC), particularly in tumors with microsatellite instability (MSI) or mismatch repair deficiency (dMMR), present in approximately 30% of cases."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""endometrium"", ""term"": {""id"": ""UBERON:0001295"", ""label"": ""endometrium""}}], ""name"": ""Mismatch Repair Deficiency""}"
4682	198	MSI-High Endometrial Cancer	MSI_High_Endometrial_Cancer.yaml	pathophysiology	1	Microsatellite Instability	Deficient mismatch repair leads to instability at microsatellite loci, short tandem repeat sequences throughout the genome. MSI-H status is defined by instability at multiple markers and serves as a biomarker for dMMR.																																																								"{""description"": ""Deficient mismatch repair leads to instability at microsatellite loci, short tandem repeat sequences throughout the genome. MSI-H status is defined by instability at multiple markers and serves as a biomarker for dMMR."", ""name"": ""Microsatellite Instability""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}], ""description"": ""Deficient mismatch repair leads to instability at microsatellite loci, short tandem repeat sequences throughout the genome. MSI-H status is defined by instability at multiple markers and serves as a biomarker for dMMR."", ""evidence"": [{""explanation"": ""Abstract links MSI to mismatch repair abnormalities, supporting this mechanism."", ""reference"": ""PMID:19620942"", ""snippet"": ""Microsatellite instability (MSI) is the hallmark of a molecular pathway to carcinogenesis due to sporadic or inherited abnormalities of DNA mismatch repair genes."", ""supports"": ""SUPPORT""}], ""name"": ""Microsatellite Instability""}"
4683	198	MSI-High Endometrial Cancer	MSI_High_Endometrial_Cancer.yaml	pathophysiology	2	Hypermutation and Neoantigen Generation	MMR deficiency causes a hypermutated tumor phenotype with high tumor mutational burden (TMB). Frameshift mutations at coding microsatellites generate neoantigens recognized by the immune system, explaining the high response rates to immune checkpoint inhibition.																																																								"{""description"": ""MMR deficiency causes a hypermutated tumor phenotype with high tumor mutational burden (TMB). Frameshift mutations at coding microsatellites generate neoantigens recognized by the immune system, explaining the high response rates to immune checkpoint inhibition."", ""name"": ""Hypermutation and Neoantigen Generation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}], ""description"": ""MMR deficiency causes a hypermutated tumor phenotype with high tumor mutational burden (TMB). Frameshift mutations at coding microsatellites generate neoantigens recognized by the immune system, explaining the high response rates to immune checkpoint inhibition."", ""name"": ""Hypermutation and Neoantigen Generation""}"
4707	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	0	Monoamine Deficiency	"Reduced serotonin, norepinephrine, and dopamine neurotransmission in key brain circuits. While oversimplified, this remains a foundation for antidepressant pharmacotherapy.
"																																																								"{""description"": ""Reduced serotonin, norepinephrine, and dopamine neurotransmission in key brain circuits. While oversimplified, this remains a foundation for antidepressant pharmacotherapy.\n"", ""name"": ""Monoamine Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Serotonin Signaling"", ""term"": {""id"": ""GO:0007210"", ""label"": ""serotonin receptor signaling pathway""}}, {""preferred_term"": ""Dopamine Signaling"", ""term"": {""id"": ""GO:0007212"", ""label"": ""dopamine receptor signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""Serotonergic Neuron"", ""term"": {""id"": ""CL:0000850"", ""label"": ""serotonergic neuron""}}, {""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}, {""preferred_term"": ""Noradrenergic Neuron"", ""term"": {""id"": ""CL:0008025"", ""label"": ""noradrenergic neuron""}}], ""description"": ""Reduced serotonin, norepinephrine, and dopamine neurotransmission in key brain circuits. While oversimplified, this remains a foundation for antidepressant pharmacotherapy.\n"", ""evidence"": [{""explanation"": ""This review confirms the neurotransmitter hypothesis as a foundational theory of MDD pathogenesis, though it notes that multiple hypotheses are needed to fully explain the disorder."", ""reference"": ""PMID:38331979"", ""snippet"": ""The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"", ""supports"": ""SUPPORT""}, {""explanation"": ""This highlights the clinical reality of monoamine-based treatments, confirming their use while acknowledging their limitations in achieving remission."", ""reference"": ""PMID:39150594"", ""snippet"": ""MDD is especially burdensome as approved monoamine antidepressant treatments have weeks-long delays before clinical benefit and low remission rates."", ""supports"": ""SUPPORT""}, {""explanation"": ""This demonstrates how inflammatory mechanisms contribute to decreased serotonin synthesis, supporting the monoamine deficiency theory while connecting it to broader pathophysiological processes."", ""reference"": ""PMID:38474387"", ""snippet"": ""neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity."", ""supports"": ""SUPPORT""}], ""name"": ""Monoamine Deficiency""}"
4708	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	1	HPA Axis Dysregulation	"Hyperactivity of the hypothalamic-pituitary-adrenal axis leads to elevated cortisol, which may contribute to hippocampal atrophy and cognitive symptoms.
"																																																								"{""description"": ""Hyperactivity of the hypothalamic-pituitary-adrenal axis leads to elevated cortisol, which may contribute to hippocampal atrophy and cognitive symptoms.\n"", ""name"": ""HPA Axis Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cortisol Response"", ""term"": {""id"": ""GO:0071385"", ""label"": ""cellular response to glucocorticoid stimulus""}}], ""cell_types"": [{""preferred_term"": ""Corticotroph"", ""term"": {""id"": ""CL:0002309"", ""label"": ""corticotroph""}}], ""description"": ""Hyperactivity of the hypothalamic-pituitary-adrenal axis leads to elevated cortisol, which may contribute to hippocampal atrophy and cognitive symptoms.\n"", ""evidence"": [{""explanation"": ""This review identifies the HPA axis hypothesis as one of the widely accepted core pathophysiological mechanisms in MDD."", ""reference"": ""PMID:38331979"", ""snippet"": ""The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"", ""supports"": ""SUPPORT""}], ""name"": ""HPA Axis Dysregulation""}"
4709	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	2	Neuroplasticity Deficits	"Reduced BDNF and impaired synaptic plasticity in prefrontal cortex and hippocampus. Successful treatments restore neuroplasticity.
"																																																								"{""description"": ""Reduced BDNF and impaired synaptic plasticity in prefrontal cortex and hippocampus. Successful treatments restore neuroplasticity.\n"", ""name"": ""Neuroplasticity Deficits""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Synaptic Plasticity"", ""term"": {""id"": ""GO:0048167"", ""label"": ""regulation of synaptic plasticity""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Reduced BDNF and impaired synaptic plasticity in prefrontal cortex and hippocampus. Successful treatments restore neuroplasticity.\n"", ""evidence"": [{""explanation"": ""This comprehensive review identifies the neuroplasticity hypothesis as one of the core accepted mechanisms in MDD pathogenesis."", ""reference"": ""PMID:38331979"", ""snippet"": ""The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"", ""supports"": ""SUPPORT""}, {""explanation"": ""This demonstrates the link between glutamate signaling, synaptogenesis, and neural plasticity deficits in depression, supporting the neuroplasticity deficit mechanism."", ""reference"": ""PMID:39150594"", ""snippet"": ""This narrative review provides a high-level overview of glutamate signaling in synaptogenesis and neural plasticity and the implications of glutamate dysregulation in depression."", ""supports"": ""SUPPORT""}, {""explanation"": ""This shows how inflammatory processes lead to impairments in neuroplasticity-related mechanisms, connecting inflammation to neuroplasticity deficits in MDD."", ""reference"": ""PMID:38474387"", ""snippet"": ""neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity."", ""supports"": ""SUPPORT""}], ""name"": ""Neuroplasticity Deficits""}"
4710	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	3	Neuroinflammation	"Elevated inflammatory cytokines (IL-6, TNF-alpha, CRP) observed in depression. Inflammation may contribute to monoamine depletion and neuroplasticity deficits.
"																																																								"{""description"": ""Elevated inflammatory cytokines (IL-6, TNF-alpha, CRP) observed in depression. Inflammation may contribute to monoamine depletion and neuroplasticity deficits.\n"", ""name"": ""Neuroinflammation""}"	{}	"{""cell_types"": [{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Elevated inflammatory cytokines (IL-6, TNF-alpha, CRP) observed in depression. Inflammation may contribute to monoamine depletion and neuroplasticity deficits.\n"", ""evidence"": [{""explanation"": ""This review identifies the cytokine hypothesis as one of the widely accepted theories of MDD pathogenesis, supporting the role of inflammatory mechanisms."", ""reference"": ""PMID:38331979"", ""snippet"": ""The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"", ""supports"": ""SUPPORT""}, {""explanation"": ""This provides direct evidence for elevated pro-inflammatory cytokines in MDD and their role in eliciting neuroinflammatory processes."", ""reference"": ""PMID:38474387"", ""snippet"": ""The involvement of central and peripheral inflammation in the pathogenesis and prognosis of major depressive disorder (MDD) has been demonstrated. The increase of pro-inflammatory cytokines (interleukin (IL)-1, IL-6, IL-18, and TNF-) in individuals with depression may elicit neuroinflammatory processes and peripheral inflammation"", ""supports"": ""SUPPORT""}, {""explanation"": ""This demonstrates how neuroinflammation contributes to both monoamine depletion (decreased serotonin) and neuroplasticity deficits, confirming the description's mechanistic links."", ""reference"": ""PMID:38474387"", ""snippet"": ""mechanisms that, in turn, can contribute to gut microbiota dysbiosis. Together, neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity."", ""supports"": ""SUPPORT""}, {""explanation"": ""Meta-analysis evidence shows elevated proinflammatory cytokines in major depression, supporting neuroinflammatory mechanisms."", ""reference"": ""PMID:20015486"", ""snippet"": ""This meta-analysis reports significantly higher concentrations of the proinflammatory cytokines TNF-alpha and IL-6 in depressed subjects compared with control subjects."", ""supports"": ""SUPPORT""}], ""name"": ""Neuroinflammation""}"
4711	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	4	Mitochondrial Dysfunction	"Impaired mitochondrial respiration and cellular energy metabolism contribute to MDD pathophysiology. Patient-derived cells show decreased mitochondrial function, altered membrane potential, and disrupted calcium homeostasis.
"																																																								"{""description"": ""Impaired mitochondrial respiration and cellular energy metabolism contribute to MDD pathophysiology. Patient-derived cells show decreased mitochondrial function, altered membrane potential, and disrupted calcium homeostasis.\n"", ""name"": ""Mitochondrial Dysfunction""}"	{}	"{""description"": ""Impaired mitochondrial respiration and cellular energy metabolism contribute to MDD pathophysiology. Patient-derived cells show decreased mitochondrial function, altered membrane potential, and disrupted calcium homeostasis.\n"", ""evidence"": [{""explanation"": ""This establishes the connection between mitochondrial dysfunction and MDD, noting both mechanistic involvement and epidemiological evidence."", ""reference"": ""PMID:38256041"", ""snippet"": ""The link between mitochondria and major depressive disorder (MDD) is increasingly evident, underscored both by mitochondria's involvement in many mechanisms identified in depression and the high prevalence of MDD in individuals with mitochondrial disorders."", ""supports"": ""SUPPORT""}, {""explanation"": ""This provides direct evidence from patient-derived cells showing decreased mitochondrial respiration and function in MDD patients."", ""reference"": ""PMID:38256041"", ""snippet"": ""Similarities were observed between the Mito patient and a broader MDD cohort, including decreased respiration and mitochondrial function."", ""supports"": ""SUPPORT""}, {""explanation"": ""This suggests that mitochondrial dysfunction in MDD may involve complex imbalances beyond simple reduction, including altered respiratory rates and calcium homeostasis."", ""reference"": ""PMID:38256041"", ""snippet"": ""the Non-R patient's data offered a new perspective on MDD, suggesting a detrimental imbalance in mitochondrial and cellular processes, rather than simply reduced functions."", ""supports"": ""SUPPORT""}], ""name"": ""Mitochondrial Dysfunction""}"
4736	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	0	Asbestos-Induced Mesothelial Injury	Asbestos fibers penetrate the mesothelium and induce a cycle of cell death and regeneration. The fibers generate reactive oxygen species (ROS) and reactive nitrogen species that damage DNA, proteins, and lipids. Chronic inflammation driven by frustrated phagocytosis of long fibers promotes ongoing tissue damage and malignant transformation.																																																								"{""description"": ""Asbestos fibers penetrate the mesothelium and induce a cycle of cell death and regeneration. The fibers generate reactive oxygen species (ROS) and reactive nitrogen species that damage DNA, proteins, and lipids. Chronic inflammation driven by frustrated phagocytosis of long fibers promotes ongoing tissue damage and malignant transformation."", ""name"": ""Asbestos-Induced Mesothelial Injury""}"	"{""downstream"": [{""description"": ""ROS and direct fiber interaction cause DNA strand breaks and chromosomal abnormalities"", ""target"": ""DNA Damage and Genomic Instability""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""cell_types"": [{""preferred_term"": ""mesothelial cell"", ""term"": {""id"": ""CL:0000077"", ""label"": ""mesothelial cell""}}], ""description"": ""Asbestos fibers penetrate the mesothelium and induce a cycle of cell death and regeneration. The fibers generate reactive oxygen species (ROS) and reactive nitrogen species that damage DNA, proteins, and lipids. Chronic inflammation driven by frustrated phagocytosis of long fibers promotes ongoing tissue damage and malignant transformation."", ""downstream"": [{""description"": ""ROS and direct fiber interaction cause DNA strand breaks and chromosomal abnormalities"", ""target"": ""DNA Damage and Genomic Instability""}], ""locations"": [{""preferred_term"": ""pleura"", ""term"": {""id"": ""UBERON:0000977"", ""label"": ""pleura""}}], ""name"": ""Asbestos-Induced Mesothelial Injury""}"
4737	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	1	BAP1 Tumor Suppressor Inactivation	BAP1 (BRCA1-associated protein 1) is a nuclear deubiquitinase that regulates chromatin remodeling, DNA damage response, and cell cycle progression. BAP1 loss, through germline mutation or somatic inactivation, occurs in 60-70% of mesotheliomas and predisposes to malignant transformation. BAP1 loss impairs homologous recombination repair and chromatin regulation.																																																								"{""description"": ""BAP1 (BRCA1-associated protein 1) is a nuclear deubiquitinase that regulates chromatin remodeling, DNA damage response, and cell cycle progression. BAP1 loss, through germline mutation or somatic inactivation, occurs in 60-70% of mesotheliomas and predisposes to malignant transformation. BAP1 loss impairs homologous recombination repair and chromatin regulation."", ""name"": ""BAP1 Tumor Suppressor Inactivation""}"	"{""downstream"": [{""description"": ""Loss of BAP1-mediated DNA repair leads to accumulation of genetic alterations"", ""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""histone deubiquitination"", ""term"": {""id"": ""GO:0016578"", ""label"": ""histone deubiquitination""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""DNA damage response""}}], ""description"": ""BAP1 (BRCA1-associated protein 1) is a nuclear deubiquitinase that regulates chromatin remodeling, DNA damage response, and cell cycle progression. BAP1 loss, through germline mutation or somatic inactivation, occurs in 60-70% of mesotheliomas and predisposes to malignant transformation. BAP1 loss impairs homologous recombination repair and chromatin regulation."", ""downstream"": [{""description"": ""Loss of BAP1-mediated DNA repair leads to accumulation of genetic alterations"", ""target"": ""Genomic Instability""}], ""evidence"": [{""explanation"": ""Abstract reports frequent BAP1 loss in pleural mesothelioma."", ""reference"": ""PMID:25889843"", ""snippet"": ""pleural MMs have been genetically characterized by the loss of BAP1 (40-60%)"", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""BAP1""}], ""name"": ""BAP1 Tumor Suppressor Inactivation""}"
4738	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	2	NF2/Merlin Inactivation	The NF2 gene encoding merlin is frequently inactivated in mesothelioma (approximately 50% of cases). Merlin loss activates YAP/TAZ signaling through the Hippo pathway, promoting cell proliferation and inhibiting contact-dependent growth arrest.																																																								"{""description"": ""The NF2 gene encoding merlin is frequently inactivated in mesothelioma (approximately 50% of cases). Merlin loss activates YAP/TAZ signaling through the Hippo pathway, promoting cell proliferation and inhibiting contact-dependent growth arrest."", ""name"": ""NF2/Merlin Inactivation""}"	"{""downstream"": [{""description"": ""Loss of merlin-mediated growth suppression activates pro-proliferative YAP signaling"", ""target"": ""YAP/TAZ Activation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""Hippo signaling"", ""term"": {""id"": ""GO:0035329"", ""label"": ""hippo signaling""}}], ""description"": ""The NF2 gene encoding merlin is frequently inactivated in mesothelioma (approximately 50% of cases). Merlin loss activates YAP/TAZ signaling through the Hippo pathway, promoting cell proliferation and inhibiting contact-dependent growth arrest."", ""downstream"": [{""description"": ""Loss of merlin-mediated growth suppression activates pro-proliferative YAP signaling"", ""target"": ""YAP/TAZ Activation""}], ""genes"": [{""preferred_term"": ""NF2""}], ""name"": ""NF2/Merlin Inactivation""}"
4739	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	3	CDKN2A/p16 Loss	Homozygous deletion of CDKN2A, encoding p16INK4a and p14ARF, occurs in approximately 70% of mesotheliomas. Loss of p16 removes CDK4/6 inhibition, promoting cell cycle progression, while p14ARF loss compromises p53 stabilization.																																																								"{""description"": ""Homozygous deletion of CDKN2A, encoding p16INK4a and p14ARF, occurs in approximately 70% of mesotheliomas. Loss of p16 removes CDK4/6 inhibition, promoting cell cycle progression, while p14ARF loss compromises p53 stabilization."", ""name"": ""CDKN2A/p16 Loss""}"	"{""downstream"": [{""description"": ""Loss of p16 allows uncontrolled CDK4/6-mediated cell cycle progression"", ""target"": ""Cell Cycle Dysregulation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""negative regulation of G1/S transition"", ""term"": {""id"": ""GO:0045786"", ""label"": ""negative regulation of G1/S transition of mitotic cell cycle""}}], ""description"": ""Homozygous deletion of CDKN2A, encoding p16INK4a and p14ARF, occurs in approximately 70% of mesotheliomas. Loss of p16 removes CDK4/6 inhibition, promoting cell cycle progression, while p14ARF loss compromises p53 stabilization."", ""downstream"": [{""description"": ""Loss of p16 allows uncontrolled CDK4/6-mediated cell cycle progression"", ""target"": ""Cell Cycle Dysregulation""}], ""genes"": [{""preferred_term"": ""CDKN2A""}], ""name"": ""CDKN2A/p16 Loss""}"
4749	201	Malnutrition-Related Diabetes Mellitus	Malnutrition-related_Diabetes_Mellitus.yaml	pathophysiology	0	Insulin deficiency from beta-cell impairment in undernutrition	Undernutrition-associated diabetes involves insulin deficiency from pancreatic beta-cell impairment.																																																								"{""description"": ""Undernutrition-associated diabetes involves insulin deficiency from pancreatic beta-cell impairment."", ""name"": ""Insulin deficiency from beta-cell impairment in undernutrition""}"	{}	"{""biological_processes"": [{""preferred_term"": ""insulin secretion"", ""term"": {""id"": ""GO:0030073"", ""label"": ""insulin secretion""}}], ""cell_types"": [{""preferred_term"": ""pancreatic beta cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}], ""description"": ""Undernutrition-associated diabetes involves insulin deficiency from pancreatic beta-cell impairment."", ""evidence"": [{""explanation"": ""The review links undernutrition-associated diabetes to beta-cell impairment and insulin deficiency."", ""reference"": ""PMID:40049652"", ""snippet"": ""Studies have shown that insulin deficiency due to pancreatic -cell impairment is likely to contribute to the development of undernutrition-associated diabetes."", ""supports"": ""SUPPORT""}], ""name"": ""Insulin deficiency from beta-cell impairment in undernutrition""}"
4760	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	0	CCND1 Translocation and Cyclin D1 Overexpression	The t(11;14)(q13;q32) translocation places the CCND1 gene under control of the immunoglobulin heavy chain enhancer, causing constitutive overexpression of cyclin D1. This is the hallmark genetic event in MCL, occurring in virtually all cases, and drives cell cycle progression.																																																								"{""description"": ""The t(11;14)(q13;q32) translocation places the CCND1 gene under control of the immunoglobulin heavy chain enhancer, causing constitutive overexpression of cyclin D1. This is the hallmark genetic event in MCL, occurring in virtually all cases, and drives cell cycle progression."", ""name"": ""CCND1 Translocation and Cyclin D1 Overexpression""}"	"{""downstream"": [{""description"": ""Cyclin D1 drives progression through G1/S checkpoint"", ""target"": ""Cell Cycle Dysregulation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""The t(11;14)(q13;q32) translocation places the CCND1 gene under control of the immunoglobulin heavy chain enhancer, causing constitutive overexpression of cyclin D1. This is the hallmark genetic event in MCL, occurring in virtually all cases, and drives cell cycle progression."", ""downstream"": [{""description"": ""Cyclin D1 drives progression through G1/S checkpoint"", ""target"": ""Cell Cycle Dysregulation""}], ""evidence"": [{""explanation"": ""This abstract statement identifies the CCND1::IgH translocation as a hallmark of MCL."", ""reference"": ""PMID:41369864"", ""snippet"": ""Mantle cell lymphoma (MCL) is a mature B cell neoplasm characterized by the CCND1::IgH t(11;14) translocation."", ""supports"": ""SUPPORT""}], ""name"": ""CCND1 Translocation and Cyclin D1 Overexpression""}"
4761	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	1	Cell Cycle Dysregulation	Cyclin D1 overexpression accelerates G1 to S phase transition by activating CDK4/6, which phosphorylates retinoblastoma protein (RB1) and releases E2F transcription factors. This overcomes normal cell cycle checkpoints and drives proliferation.																																																								"{""description"": ""Cyclin D1 overexpression accelerates G1 to S phase transition by activating CDK4/6, which phosphorylates retinoblastoma protein (RB1) and releases E2F transcription factors. This overcomes normal cell cycle checkpoints and drives proliferation."", ""name"": ""Cell Cycle Dysregulation""}"	"{""downstream"": [{""description"": ""Accelerated cell cycle drives lymphoma expansion"", ""target"": ""Uncontrolled B-cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Cyclin D1 overexpression accelerates G1 to S phase transition by activating CDK4/6, which phosphorylates retinoblastoma protein (RB1) and releases E2F transcription factors. This overcomes normal cell cycle checkpoints and drives proliferation."", ""downstream"": [{""description"": ""Accelerated cell cycle drives lymphoma expansion"", ""target"": ""Uncontrolled B-cell Proliferation""}], ""name"": ""Cell Cycle Dysregulation""}"
4762	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	2	BTK and BCR Signaling Dependence	MCL cells are dependent on B-cell receptor signaling through BTK for survival. This pathway provides proliferative and anti-apoptotic signals essential for MCL cell maintenance. BTK inhibitors exploit this dependence, particularly effective in relapsed MCL.																																																								"{""description"": ""MCL cells are dependent on B-cell receptor signaling through BTK for survival. This pathway provides proliferative and anti-apoptotic signals essential for MCL cell maintenance. BTK inhibitors exploit this dependence, particularly effective in relapsed MCL."", ""name"": ""BTK and BCR Signaling Dependence""}"	"{""downstream"": [{""description"": ""BCR-BTK signaling activates NF-kB survival pathways"", ""target"": ""NF-kB Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}], ""description"": ""MCL cells are dependent on B-cell receptor signaling through BTK for survival. This pathway provides proliferative and anti-apoptotic signals essential for MCL cell maintenance. BTK inhibitors exploit this dependence, particularly effective in relapsed MCL."", ""downstream"": [{""description"": ""BCR-BTK signaling activates NF-kB survival pathways"", ""target"": ""NF-kB Activation""}], ""name"": ""BTK and BCR Signaling Dependence""}"
4763	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	3	NF-kB Activation	Constitutive NF-kB signaling is common in MCL, driven by BCR signaling and genetic alterations affecting the NF-kB pathway. NF-kB promotes expression of anti-apoptotic genes contributing to MCL cell survival.																																																								"{""description"": ""Constitutive NF-kB signaling is common in MCL, driven by BCR signaling and genetic alterations affecting the NF-kB pathway. NF-kB promotes expression of anti-apoptotic genes contributing to MCL cell survival."", ""name"": ""NF-kB Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""Constitutive NF-kB signaling is common in MCL, driven by BCR signaling and genetic alterations affecting the NF-kB pathway. NF-kB promotes expression of anti-apoptotic genes contributing to MCL cell survival."", ""name"": ""NF-kB Activation""}"
4764	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	4	Uncontrolled B-cell Proliferation	The combination of cyclin D1-driven cell cycle progression, BCR signaling, NF-kB activation, and additional genetic alterations leads to uncontrolled B-cell proliferation with widespread tissue infiltration.																																																								"{""description"": ""The combination of cyclin D1-driven cell cycle progression, BCR signaling, NF-kB activation, and additional genetic alterations leads to uncontrolled B-cell proliferation with widespread tissue infiltration."", ""name"": ""Uncontrolled B-cell Proliferation""}"	{}	"{""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""The combination of cyclin D1-driven cell cycle progression, BCR signaling, NF-kB activation, and additional genetic alterations leads to uncontrolled B-cell proliferation with widespread tissue infiltration."", ""locations"": [{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}, {""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Uncontrolled B-cell Proliferation""}"
4796	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	0	Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency	"Mutations in genes encoding subunits of the branched-chain alpha-ketoacid dehydrogenase complex (BCKDH) cause deficient catabolism of branched-chain amino acids (leucine, isoleucine, valine). This leads to accumulation of these amino acids and their toxic ketoacid derivatives in blood and tissues. The BCKDH complex catalyzes the first irreversible step in BCAA catabolism.
"																																																								"{""description"": ""Mutations in genes encoding subunits of the branched-chain alpha-ketoacid dehydrogenase complex (BCKDH) cause deficient catabolism of branched-chain amino acids (leucine, isoleucine, valine). This leads to accumulation of these amino acids and their toxic ketoacid derivatives in blood and tissues. The BCKDH complex catalyzes the first irreversible step in BCAA catabolism.\n"", ""name"": ""Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""branched-chain amino acid catabolic process"", ""term"": {""id"": ""GO:0009083"", ""label"": ""branched-chain amino acid catabolic process""}}], ""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Mutations in genes encoding subunits of the branched-chain alpha-ketoacid dehydrogenase complex (BCKDH) cause deficient catabolism of branched-chain amino acids (leucine, isoleucine, valine). This leads to accumulation of these amino acids and their toxic ketoacid derivatives in blood and tissues. The BCKDH complex catalyzes the first irreversible step in BCAA catabolism.\n"", ""evidence"": [{""explanation"": ""This study confirms MSUD causes BCAA accumulation due to enzyme deficiency."", ""reference"": ""PMID:35672312"", ""snippet"": ""Maple syrup urine disease (MSUD) is a rare recessively inherited metabolic disorder causing accumulation of branched chain amino acids leading to neonatal death, if untreated."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms BCKDH enzyme dysfunction is the core defect in MSUD."", ""reference"": ""PMID:27373929"", ""snippet"": ""Maple Syrup Urine Disease (MSUD) is an inherited disorder caused by the dysfunction in the branched chain keto-acid dehydrogenase (BCKDH) enzyme."", ""supports"": ""SUPPORT""}], ""name"": ""Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency""}"
4797	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	1	Leucine and Ketoacid Neurotoxicity	"Elevated leucine and its metabolite alpha-ketoisocaproic acid (KIC) are particularly neurotoxic. KIC inhibits key mitochondrial enzymes including alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase, disrupting brain energy metabolism. Leucine also competes for transport across the blood-brain barrier via LAT1, depleting other essential amino acids in the brain.
"																																																								"{""description"": ""Elevated leucine and its metabolite alpha-ketoisocaproic acid (KIC) are particularly neurotoxic. KIC inhibits key mitochondrial enzymes including alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase, disrupting brain energy metabolism. Leucine also competes for transport across the blood-brain barrier via LAT1, depleting other essential amino acids in the brain.\n"", ""name"": ""Leucine and Ketoacid Neurotoxicity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""generation of precursor metabolites and energy"", ""term"": {""id"": ""GO:0006091"", ""label"": ""generation of precursor metabolites and energy""}}], ""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}, {""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Elevated leucine and its metabolite alpha-ketoisocaproic acid (KIC) are particularly neurotoxic. KIC inhibits key mitochondrial enzymes including alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase, disrupting brain energy metabolism. Leucine also competes for transport across the blood-brain barrier via LAT1, depleting other essential amino acids in the brain.\n"", ""evidence"": [{""explanation"": ""Demonstrates neurochemical abnormalities in MSUD patients correlating with clinical manifestations."", ""reference"": ""PMID:23478409"", ""snippet"": ""Using quantitative proton magnetic resonance spectroscopy, we found lower brain glutamate, N-acetylaspartate (NAA), and creatine concentrations in MSUD patients, which correlated with specific neuropsychiatric outcomes."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms KIC directly inhibits mitochondrial function."", ""reference"": ""PMID:27373929"", ""snippet"": ""KIC is an inhibitor of mitochondrial function at disease relevant concentrations."", ""supports"": ""SUPPORT""}], ""name"": ""Leucine and Ketoacid Neurotoxicity""}"
4798	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	2	Skeletal Muscle Dysfunction	"Skeletal muscle is a major site of BCAA metabolism and accumulates toxic ketoacids. MSUD causes muscle fiber abnormalities and atrophy, with KIC disrupting mitochondrial metabolism in myocytes and causing reduced TCA cycle flux and ATP depletion.
"																																																								"{""description"": ""Skeletal muscle is a major site of BCAA metabolism and accumulates toxic ketoacids. MSUD causes muscle fiber abnormalities and atrophy, with KIC disrupting mitochondrial metabolism in myocytes and causing reduced TCA cycle flux and ATP depletion.\n"", ""name"": ""Skeletal Muscle Dysfunction""}"	{}	"{""cell_types"": [{""preferred_term"": ""skeletal muscle fiber"", ""term"": {""id"": ""CL:0008002"", ""label"": ""skeletal muscle fiber""}}], ""description"": ""Skeletal muscle is a major site of BCAA metabolism and accumulates toxic ketoacids. MSUD causes muscle fiber abnormalities and atrophy, with KIC disrupting mitochondrial metabolism in myocytes and causing reduced TCA cycle flux and ATP depletion.\n"", ""evidence"": [{""explanation"": ""Animal model demonstrates skeletal muscle atrophy in MSUD."", ""reference"": ""PMID:27373929"", ""snippet"": ""iMSUD mice displayed a significant reduction in muscle fiber size, suggesting muscle atrophy."", ""supports"": ""SUPPORT""}], ""name"": ""Skeletal Muscle Dysfunction""}"
4835	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	0	FBN1 Gene Mutation	Mutations in the FBN1 gene result in defective fibrillin-1 protein, which affects the elasticity and strength of connective tissues.																																																								"{""description"": ""Mutations in the FBN1 gene result in defective fibrillin-1 protein, which affects the elasticity and strength of connective tissues."", ""name"": ""FBN1 Gene Mutation""}"	{}	"{""description"": ""Mutations in the FBN1 gene result in defective fibrillin-1 protein, which affects the elasticity and strength of connective tissues."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the identification of the FBN1 gene as the cause of Marfan syndrome and its role in the structure of connective tissue."", ""reference"": ""PMID:8180508"", ""snippet"": ""The gene encoding for fibrillin, the FBN1 gene on chromosome 15, has been identified as the defective gene causing the Marfan syndrome. Fibrillin is the large glycoprotein with a repetitive domain structure and is a major protein component of microfibrils, a fibrillar system closely associated with elastin in connective tissue."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the description of FBN1 mutations affecting the function of fibrillin-1, which is crucial for connective tissue structure."", ""reference"": ""PMID:39096853"", ""snippet"": ""Marfan syndrome (MFS) is a hereditary condition caused by mutations in the FBN1 gene. Genetic mutations in the FBN1 locus impact the function of the encoded protein, Fibrillin 1, a structural molecule forming microfibrils found in the connective tissue."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the identification of FBN1 mutations in Marfan syndrome patients."", ""reference"": ""PMID:17657824"", ""snippet"": ""Mutations in the FBN1 gene have been characterised in patients affected by Marfan syndrome and Marfan-related disorders."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the role of fibrillin as a major component of microfibrils and the impact of FBN1 mutations on connective tissue."", ""reference"": ""PMID:12938084"", ""snippet"": ""Fibrillin is the major component of extracellular microfibrils. Mutations in the fibrillin gene on chromosome 15 (FBN1) were first described in the heritable connective disorder, Marfan syndrome (MFS)."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the description of Marfan syndrome as a genetic disorder caused by FBN1 mutations."", ""reference"": ""PMID:24555249"", ""snippet"": ""Marfan syndrome is a genetic disorder of the connective tissue caused by mutations in FBN1 gene."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the identification of FBN1 mutations as the cause of Marfan syndrome."", ""reference"": ""PMID:36004597"", ""snippet"": ""Marfan syndrome is an orphan disease that is caused by a mutation in the FBN1 gene located on chromosome 15 (15q21.1) and is usually inherited in an autosomal dominant manner."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the identification of specific FBN1 mutations in Marfan syndrome patients and their impact on connective tissue."", ""reference"": ""PMID:25729264"", ""snippet"": ""A C596G mutation in FBN1 was identified in a Chinese family with MFS. Our results expand the spectrum of FBN1 mutations and contribute to the understanding of the role of FBN1 in the pathogenesis of Marfan syndrome."", ""supports"": ""SUPPORT""}], ""gene"": {""description"": ""Gene encoding fibrillin-1, a structural glycoprotein essential for elastic fiber formation in connective tissue."", ""preferred_term"": ""FBN1"", ""term"": {""id"": ""hgnc:3603"", ""label"": ""FBN1""}}, ""name"": ""FBN1 Gene Mutation""}"
4836	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	1	Dysregulated TGF-beta Signaling	Defective fibrillin-1 microfibrils fail to sequester latent TGF-beta complexes, leading to increased bioavailable TGF-beta and excessive SMAD2/3 signaling that drives vascular smooth muscle cell phenotypic switching and ECM remodeling.																																																								"{""description"": ""Defective fibrillin-1 microfibrils fail to sequester latent TGF-beta complexes, leading to increased bioavailable TGF-beta and excessive SMAD2/3 signaling that drives vascular smooth muscle cell phenotypic switching and ECM remodeling."", ""name"": ""Dysregulated TGF-beta Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""transforming growth factor beta receptor signaling pathway"", ""term"": {""id"": ""GO:0007179"", ""label"": ""transforming growth factor beta receptor signaling pathway""}}, {""preferred_term"": ""SMAD protein signal transduction"", ""term"": {""id"": ""GO:0060395"", ""label"": ""SMAD protein signal transduction""}}], ""cell_types"": [{""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}], ""description"": ""Defective fibrillin-1 microfibrils fail to sequester latent TGF-beta complexes, leading to increased bioavailable TGF-beta and excessive SMAD2/3 signaling that drives vascular smooth muscle cell phenotypic switching and ECM remodeling."", ""locations"": [{""preferred_term"": ""aorta"", ""term"": {""id"": ""UBERON:0000947"", ""label"": ""aorta""}}], ""name"": ""Dysregulated TGF-beta Signaling""}"
4837	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	2	Extracellular Matrix Remodeling	Increased matrix metalloproteinase activity, elastic fiber fragmentation, altered collagen composition, and proteoglycan accumulation (especially versican) weaken the aortic wall medial layer.																																																								"{""description"": ""Increased matrix metalloproteinase activity, elastic fiber fragmentation, altered collagen composition, and proteoglycan accumulation (especially versican) weaken the aortic wall medial layer."", ""name"": ""Extracellular Matrix Remodeling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}, {""preferred_term"": ""proteolysis"", ""term"": {""id"": ""GO:0006508"", ""label"": ""proteolysis""}}], ""cell_types"": [{""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}, {""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}], ""description"": ""Increased matrix metalloproteinase activity, elastic fiber fragmentation, altered collagen composition, and proteoglycan accumulation (especially versican) weaken the aortic wall medial layer."", ""locations"": [{""preferred_term"": ""aorta tunica media"", ""term"": {""id"": ""UBERON:0005797"", ""label"": ""aorta tunica media""}}], ""name"": ""Extracellular Matrix Remodeling""}"
4838	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	3	Impaired Mechanotransduction	Perturbed integrin-fibrillin interactions alter focal adhesion signaling and mechanosensing, contributing to maladaptive vascular smooth muscle cell responses to hemodynamic stress.																																																								"{""description"": ""Perturbed integrin-fibrillin interactions alter focal adhesion signaling and mechanosensing, contributing to maladaptive vascular smooth muscle cell responses to hemodynamic stress."", ""name"": ""Impaired Mechanotransduction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cellular response to mechanical stimulus"", ""term"": {""id"": ""GO:0071260"", ""label"": ""cellular response to mechanical stimulus""}}, {""preferred_term"": ""integrin-mediated signaling pathway"", ""term"": {""id"": ""GO:0007229"", ""label"": ""integrin-mediated signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}, {""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Perturbed integrin-fibrillin interactions alter focal adhesion signaling and mechanosensing, contributing to maladaptive vascular smooth muscle cell responses to hemodynamic stress."", ""locations"": [{""preferred_term"": ""aorta"", ""term"": {""id"": ""UBERON:0000947"", ""label"": ""aorta""}}], ""name"": ""Impaired Mechanotransduction""}"
4839	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	4	Vascular Inflammation	Angiotensin II type 1 receptor signaling and chemokine pathways recruit macrophages and promote inflammatory mediators that exacerbate vascular smooth muscle cell dysfunction and ECM degradation.																																																								"{""description"": ""Angiotensin II type 1 receptor signaling and chemokine pathways recruit macrophages and promote inflammatory mediators that exacerbate vascular smooth muscle cell dysfunction and ECM degradation."", ""name"": ""Vascular Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""preferred_term"": ""leukocyte migration"", ""term"": {""id"": ""GO:0050900"", ""label"": ""leukocyte migration""}}], ""cell_types"": [{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}], ""description"": ""Angiotensin II type 1 receptor signaling and chemokine pathways recruit macrophages and promote inflammatory mediators that exacerbate vascular smooth muscle cell dysfunction and ECM degradation."", ""locations"": [{""preferred_term"": ""aorta tunica intima"", ""term"": {""id"": ""UBERON:0006878"", ""label"": ""aorta tunica intima""}}, {""preferred_term"": ""aorta tunica media"", ""term"": {""id"": ""UBERON:0005797"", ""label"": ""aorta tunica media""}}], ""name"": ""Vascular Inflammation""}"
4840	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	5	Mitochondrial Dysfunction	Emerging evidence implicates mitochondrial dysfunction and oxidative stress in vascular smooth muscle cells and endothelial cells as contributors to thoracic aortic aneurysm progression in Marfan syndrome.																																																								"{""description"": ""Emerging evidence implicates mitochondrial dysfunction and oxidative stress in vascular smooth muscle cells and endothelial cells as contributors to thoracic aortic aneurysm progression in Marfan syndrome."", ""name"": ""Mitochondrial Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""mitochondrial ATP synthesis coupled electron transport"", ""term"": {""id"": ""GO:0042775"", ""label"": ""mitochondrial ATP synthesis coupled electron transport""}}, {""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""cell_types"": [{""preferred_term"": ""vascular associated smooth muscle cell"", ""term"": {""id"": ""CL:0000359"", ""label"": ""vascular associated smooth muscle cell""}}, {""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Emerging evidence implicates mitochondrial dysfunction and oxidative stress in vascular smooth muscle cells and endothelial cells as contributors to thoracic aortic aneurysm progression in Marfan syndrome."", ""locations"": [{""preferred_term"": ""aorta"", ""term"": {""id"": ""UBERON:0000947"", ""label"": ""aorta""}}], ""name"": ""Mitochondrial Dysfunction""}"
4857	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	pathophysiology	0	Incomplete Vitelline Duct Obliteration	Meckel diverticulum results from failure of complete obliteration of the vitelline duct during embryonic development, leading to a persistent outpouching of the ileum.															Formation of a true diverticulum containing all layers of the intestinal wall, typically located on the antimesenteric border of the distal ileum.																																									"{""consequence"": ""Formation of a true diverticulum containing all layers of the intestinal wall, typically located on the antimesenteric border of the distal ileum."", ""description"": ""Meckel diverticulum results from failure of complete obliteration of the vitelline duct during embryonic development, leading to a persistent outpouching of the ileum."", ""name"": ""Incomplete Vitelline Duct Obliteration""}"	{}	"{""consequence"": ""Formation of a true diverticulum containing all layers of the intestinal wall, typically located on the antimesenteric border of the distal ileum."", ""description"": ""Meckel diverticulum results from failure of complete obliteration of the vitelline duct during embryonic development, leading to a persistent outpouching of the ileum."", ""evidence"": [{""explanation"": ""This explains the embryological origin of Meckel diverticulum."", ""reference"": ""PMID:8506491"", ""snippet"": ""Meckel's diverticula are the result of incomplete degeneration of the vitelline duct."", ""supports"": ""SUPPORT""}, {""explanation"": ""This describes the embryological mechanism as failure of omphalomesenteric duct closure."", ""reference"": ""PMID:15026601"", ""snippet"": ""It results from improper closure and absorption of the omphalomesenteric duct."", ""supports"": ""SUPPORT""}], ""name"": ""Incomplete Vitelline Duct Obliteration""}"
4903	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	0	Primary cilium membrane protein dysfunction (TMEM67/meckelin)	Pathogenic variants in TMEM67 disrupt primary cilium membrane components.																																																								"{""description"": ""Pathogenic variants in TMEM67 disrupt primary cilium membrane components."", ""name"": ""Primary cilium membrane protein dysfunction (TMEM67/meckelin)""}"	{}	"{""cellular_components"": [{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}], ""description"": ""Pathogenic variants in TMEM67 disrupt primary cilium membrane components."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""TMEM67/meckelin is an integral primary cilium membrane protein implicated in MKS3."", ""reference"": ""PMID:19211713"", ""snippet"": ""the underlying mutated gene, TMEM67, encodes transmembrane protein 67, also called meckelin (OMIM 609884), which is an integral protein of the renal epithelial cell and membrane of the primary cilium."", ""supports"": ""SUPPORT""}], ""name"": ""Primary cilium membrane protein dysfunction (TMEM67/meckelin)""}"
4904	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	1	Ciliary base protein dysfunction (MKS1)	Loss of MKS1 perturbs proteins associated with the ciliary base/basal body.																																																								"{""description"": ""Loss of MKS1 perturbs proteins associated with the ciliary base/basal body."", ""name"": ""Ciliary base protein dysfunction (MKS1)""}"	{}	"{""cellular_components"": [{""preferred_term"": ""ciliary basal body"", ""term"": {""id"": ""GO:0036064"", ""label"": ""ciliary basal body""}}, {""preferred_term"": ""ciliary base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}], ""description"": ""Loss of MKS1 perturbs proteins associated with the ciliary base/basal body."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""MKS1 encodes a protein associated with the ciliary base, supporting ciliary base dysfunction in MKS."", ""reference"": ""PMID:19776033"", ""snippet"": ""The gene mutated in type 1 MKS encodes a protein associated with the base of the cilium in vertebrates and nematodes."", ""supports"": ""SUPPORT""}], ""name"": ""Ciliary base protein dysfunction (MKS1)""}"
4905	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	2	Basal body localization without proper ciliogenesis	Basal bodies localize apically, yet cilia fail to form in many tissues.																																																								"{""description"": ""Basal bodies localize apically, yet cilia fail to form in many tissues."", ""name"": ""Basal body localization without proper ciliogenesis""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}], ""cellular_components"": [{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}, {""preferred_term"": ""ciliary basal body"", ""term"": {""id"": ""GO:0036064"", ""label"": ""ciliary basal body""}}, {""preferred_term"": ""ciliary base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}], ""description"": ""Basal bodies localize apically, yet cilia fail to form in many tissues."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Basal body localization is preserved while ciliogenesis fails in Mks1-deficient tissues."", ""reference"": ""PMID:19776033"", ""snippet"": ""loss of Mks1 in vivo does not interfere with apical localization of epithelial basal bodies but rather leads to defective cilia formation in most, but not all, tissues."", ""supports"": ""SUPPORT""}], ""name"": ""Basal body localization without proper ciliogenesis""}"
4906	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	3	Defective cilia formation across multiple tissues	Primary cilia fail to form in many tissues in vivo.																																																								"{""description"": ""Primary cilia fail to form in many tissues in vivo."", ""name"": ""Defective cilia formation across multiple tissues""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}], ""cellular_components"": [{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}, {""preferred_term"": ""ciliary basal body"", ""term"": {""id"": ""GO:0036064"", ""label"": ""ciliary basal body""}}, {""preferred_term"": ""ciliary base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}], ""description"": ""Primary cilia fail to form in many tissues in vivo."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Mks1 loss leads to defective cilia formation across tissues in vivo."", ""reference"": ""PMID:19776033"", ""snippet"": ""loss of Mks1 in vivo does not interfere with apical localization of epithelial basal bodies but rather leads to defective cilia formation in most, but not all, tissues."", ""supports"": ""SUPPORT""}], ""name"": ""Defective cilia formation across multiple tissues""}"
4907	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	4	Loss of primary cilia (failed ciliogenesis)	Primary cilia are absent, reflecting failed ciliogenesis.																																																								"{""description"": ""Primary cilia are absent, reflecting failed ciliogenesis."", ""name"": ""Loss of primary cilia (failed ciliogenesis)""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}], ""cellular_components"": [{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}, {""preferred_term"": ""ciliary basal body"", ""term"": {""id"": ""GO:0036064"", ""label"": ""ciliary basal body""}}, {""preferred_term"": ""ciliary base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}], ""description"": ""Primary cilia are absent, reflecting failed ciliogenesis."", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Patient fibroblasts lacking cilia link CC2D2A to cilia formation."", ""reference"": ""PMID:18513680"", ""snippet"": ""Immunofluorescence staining of patient's fibroblast cells demonstrates that the cells lack cilia, providing evidence for the critical role of CC2D2A in cilia formation."", ""supports"": ""SUPPORT""}], ""name"": ""Loss of primary cilia (failed ciliogenesis)""}"
4908	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	5	Reduced axonemal microtubule posttranslational modifications	Disruption of the B9-TMEM67 complex at the transition zone reduces axonemal microtubule modifications.																																																								"{""description"": ""Disruption of the B9-TMEM67 complex at the transition zone reduces axonemal microtubule modifications."", ""name"": ""Reduced axonemal microtubule posttranslational modifications""}"	{}	"{""cellular_components"": [{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}, {""preferred_term"": ""axoneme"", ""term"": {""id"": ""GO:0005930"", ""label"": ""axoneme""}}, {""preferred_term"": ""ciliary basal body"", ""term"": {""id"": ""GO:0036064"", ""label"": ""ciliary basal body""}}, {""preferred_term"": ""ciliary base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}], ""description"": ""Disruption of the B9-TMEM67 complex at the transition zone reduces axonemal microtubule modifications."", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Disruption of the B9-TMEM67 transition zone interaction underlies downstream axonemal defects."", ""reference"": ""PMID:41165761"", ""snippet"": ""the B9 complex interacted with and anchored TMEM67 to the TZ membrane."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""IN_VITRO"", ""explanation"": ""B9 complex disruption impairs axonemal microtubule posttranslational modifications."", ""reference"": ""PMID:41165761"", ""snippet"": ""Disruption of the B9-TMEM67 complex reduced posttranslational modifications of axonemal microtubules due to deregulation of tubulin-modifying enzymes within cilia."", ""supports"": ""SUPPORT""}], ""name"": ""Reduced axonemal microtubule posttranslational modifications""}"
4909	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	6	Impaired initiation of ciliogenesis	B9 proteins facilitate early ciliogenesis; disruption impairs initiation.																																																								"{""description"": ""B9 proteins facilitate early ciliogenesis; disruption impairs initiation."", ""name"": ""Impaired initiation of ciliogenesis""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}], ""description"": ""B9 proteins facilitate early ciliogenesis; disruption impairs initiation."", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""B9 proteins are required for initiating ciliogenesis."", ""reference"": ""PMID:41165761"", ""snippet"": ""B9 proteins localized to centrioles prior to ciliogenesis, where they facilitated the initiation of ciliogenesis."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired initiation of ciliogenesis""}"
4910	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	7	TMEM67 cleavage uncouples ciliogenesis and Wnt signaling	Proteolytic cleavage of TMEM67 separates ciliary assembly from Wnt pathway activity.																																																								"{""description"": ""Proteolytic cleavage of TMEM67 separates ciliary assembly from Wnt pathway activity."", ""name"": ""TMEM67 cleavage uncouples ciliogenesis and Wnt signaling""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}, {""modifier"": ""DYSREGULATED"", ""preferred_term"": ""Wnt signaling pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}], ""description"": ""Proteolytic cleavage of TMEM67 separates ciliary assembly from Wnt pathway activity."", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""TMEM67 cleavage separates Wnt signaling from ciliogenesis in MKS."", ""reference"": ""PMID:40436881"", ""snippet"": ""Cleavage of the Meckel-Gruber syndrome protein TMEM67 by ADAMTS9 uncouples Wnt signaling and ciliogenesis."", ""supports"": ""SUPPORT""}], ""name"": ""TMEM67 cleavage uncouples ciliogenesis and Wnt signaling""}"
4911	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	8	TMEM17 loss disrupts Sonic Hedgehog signaling	TMEM17 dysfunction at the ciliary transition zone abrogates Sonic Hedgehog signaling.																																																								"{""description"": ""TMEM17 dysfunction at the ciliary transition zone abrogates Sonic Hedgehog signaling."", ""name"": ""TMEM17 loss disrupts Sonic Hedgehog signaling""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""hedgehog signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""hedgehog signaling pathway""}}], ""description"": ""TMEM17 dysfunction at the ciliary transition zone abrogates Sonic Hedgehog signaling."", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""TMEM17 variants disrupt ciliary function and abrogate SHH signaling."", ""reference"": ""PMID:40841990"", ""snippet"": ""Our study reveals severe functional consequences, including TMEM17 destabilization and mislocalization, anomalies in cilium composition and function, and abrogation of Sonic Hedgehog signaling."", ""supports"": ""SUPPORT""}], ""name"": ""TMEM17 loss disrupts Sonic Hedgehog signaling""}"
4912	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	9	Altered Hedgehog signaling in neural tube patterning	Hedgehog signaling is altered during neural tube development.																																																								"{""description"": ""Hedgehog signaling is altered during neural tube development."", ""name"": ""Altered Hedgehog signaling in neural tube patterning""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""hedgehog signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""hedgehog signaling pathway""}}], ""cellular_components"": [{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}], ""description"": ""Hedgehog signaling is altered during neural tube development."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Neural tube patterning defects in Mks1 mutants reflect altered Hedgehog signaling."", ""reference"": ""PMID:19776033"", ""snippet"": ""Analysis of patterning in the neural tube and the limb demonstrates altered Hedgehog (Hh) pathway signaling underlies some MKS defects"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""IN_VITRO"", ""explanation"": ""In vitro experiments from MKS cases link SHH signaling changes to MKS-associated genetic findings."", ""reference"": ""PMID:34981460"", ""snippet"": ""HEK293T transfected with over-expression wildtype/mutated ZNF77 plasmid showed that SHH was increased in wildtype ZNF77 cells, while SHH and CC2D2A were increased in mutated ZNF77 cells."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""neural tube"", ""term"": {""id"": ""UBERON:0001049"", ""label"": ""neural tube""}}], ""name"": ""Altered Hedgehog signaling in neural tube patterning""}"
4913	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	10	Altered Hedgehog signaling in limb patterning	Hedgehog signaling is altered during limb development.																																																								"{""description"": ""Hedgehog signaling is altered during limb development."", ""name"": ""Altered Hedgehog signaling in limb patterning""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""hedgehog signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""hedgehog signaling pathway""}}], ""cellular_components"": [{""preferred_term"": ""primary cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}], ""description"": ""Hedgehog signaling is altered during limb development."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Limb patterning defects in Mks1 mutants reflect altered Hedgehog signaling."", ""reference"": ""PMID:19776033"", ""snippet"": ""Analysis of patterning in the neural tube and the limb demonstrates altered Hedgehog (Hh) pathway signaling underlies some MKS defects"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""IN_VITRO"", ""explanation"": ""In vitro experiments from MKS cases link SHH signaling changes to MKS-associated genetic findings."", ""reference"": ""PMID:34981460"", ""snippet"": ""HEK293T transfected with over-expression wildtype/mutated ZNF77 plasmid showed that SHH was increased in wildtype ZNF77 cells, while SHH and CC2D2A were increased in mutated ZNF77 cells."", ""supports"": ""SUPPORT""}], ""name"": ""Altered Hedgehog signaling in limb patterning""}"
4931	207	Medullary Thyroid Carcinoma	Medullary_Thyroid_Carcinoma.yaml	pathophysiology	0	RET Proto-Oncogene Activation	Activating mutations in the RET receptor tyrosine kinase lead to constitutive kinase activity without ligand binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting C-cell proliferation and survival.																																																								"{""description"": ""Activating mutations in the RET receptor tyrosine kinase lead to constitutive kinase activity without ligand binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting C-cell proliferation and survival."", ""name"": ""RET Proto-Oncogene Activation""}"	"{""downstream"": [{""description"": ""RET phosphorylation activates RAS-RAF-MEK-ERK cascade driving proliferation"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""RET phosphorylation recruits PI3K leading to AKT-mediated survival"", ""target"": ""PI3K-AKT Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""receptor signaling protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004716"", ""label"": ""receptor signaling protein tyrosine kinase activity""}}], ""cell_types"": [{""preferred_term"": ""parafollicular cell"", ""term"": {""id"": ""CL:0000570"", ""label"": ""parafollicular cell""}}], ""description"": ""Activating mutations in the RET receptor tyrosine kinase lead to constitutive kinase activity without ligand binding. This drives downstream signaling through RAS-MAPK and PI3K-AKT pathways, promoting C-cell proliferation and survival."", ""downstream"": [{""description"": ""RET phosphorylation activates RAS-RAF-MEK-ERK cascade driving proliferation"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""RET phosphorylation recruits PI3K leading to AKT-mediated survival"", ""target"": ""PI3K-AKT Pathway Activation""}], ""gene_products"": [{""preferred_term"": ""RET receptor tyrosine kinase"", ""term"": {""id"": ""NCIT:C18539"", ""label"": ""Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret""}}], ""locations"": [{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}], ""name"": ""RET Proto-Oncogene Activation""}"
4932	207	Medullary Thyroid Carcinoma	Medullary_Thyroid_Carcinoma.yaml	pathophysiology	1	RAS-MAPK Pathway Activation	RET activation stimulates the RAS-RAF-MEK-ERK signaling cascade, driving uncontrolled C-cell proliferation. This pathway is a major effector of RET-mediated transformation in MTC.																																																								"{""description"": ""RET activation stimulates the RAS-RAF-MEK-ERK signaling cascade, driving uncontrolled C-cell proliferation. This pathway is a major effector of RET-mediated transformation in MTC."", ""name"": ""RAS-MAPK Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""RET activation stimulates the RAS-RAF-MEK-ERK signaling cascade, driving uncontrolled C-cell proliferation. This pathway is a major effector of RET-mediated transformation in MTC."", ""name"": ""RAS-MAPK Pathway Activation""}"
4933	207	Medullary Thyroid Carcinoma	Medullary_Thyroid_Carcinoma.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	RET activation recruits PI3K and activates the PI3K-AKT-mTOR signaling cascade, promoting C-cell survival and resistance to apoptosis. This cooperates with MAPK signaling to drive MTC tumorigenesis.																																																								"{""description"": ""RET activation recruits PI3K and activates the PI3K-AKT-mTOR signaling cascade, promoting C-cell survival and resistance to apoptosis. This cooperates with MAPK signaling to drive MTC tumorigenesis."", ""name"": ""PI3K-AKT Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""RET activation recruits PI3K and activates the PI3K-AKT-mTOR signaling cascade, promoting C-cell survival and resistance to apoptosis. This cooperates with MAPK signaling to drive MTC tumorigenesis."", ""name"": ""PI3K-AKT Pathway Activation""}"
4951	208	Medulloblastoma, SHH-Activated	Medulloblastoma_SHH_Activated.yaml	pathophysiology	0	SHH Pathway Activation	The SHH pathway is activated through loss of function mutations in PTCH1 (receptor that normally inhibits SMO), activating mutations in SMO, loss of SUFU (negative regulator), or amplification of downstream effectors (GLI2, MYCN). This leads to constitutive activation of GLI transcription factors.																																																								"{""description"": ""The SHH pathway is activated through loss of function mutations in PTCH1 (receptor that normally inhibits SMO), activating mutations in SMO, loss of SUFU (negative regulator), or amplification of downstream effectors (GLI2, MYCN). This leads to constitutive activation of GLI transcription factors."", ""name"": ""SHH Pathway Activation""}"	"{""downstream"": [{""description"": ""Pathway activation leads to GLI nuclear translocation"", ""target"": ""GLI Transcription Factor Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""smoothened signaling pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""cerebellar granule cell"", ""term"": {""id"": ""CL:0001031"", ""label"": ""cerebellar granule cell""}}], ""description"": ""The SHH pathway is activated through loss of function mutations in PTCH1 (receptor that normally inhibits SMO), activating mutations in SMO, loss of SUFU (negative regulator), or amplification of downstream effectors (GLI2, MYCN). This leads to constitutive activation of GLI transcription factors."", ""downstream"": [{""description"": ""Pathway activation leads to GLI nuclear translocation"", ""target"": ""GLI Transcription Factor Activation""}], ""evidence"": [{""explanation"": ""This abstract explicitly states that SHH tumors have GLI1/GLI2/SUFU/PTCH1 alterations that constitutively activate SHH signaling."", ""reference"": ""PMID:35489737"", ""snippet"": ""SHH tumors contain mutations and alterations in GLI1, GLI2, SUFU, and PTCH1 genes, which constitutively activate the SHH pathway."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""cerebellum"", ""term"": {""id"": ""UBERON:0002037"", ""label"": ""cerebellum""}}], ""name"": ""SHH Pathway Activation""}"
4952	208	Medulloblastoma, SHH-Activated	Medulloblastoma_SHH_Activated.yaml	pathophysiology	1	GLI Transcription Factor Activation	Activated SMO leads to nuclear translocation of GLI transcription factors (GLI1, GLI2) which activate target genes including PTCH1 (feedback), GLI1, MYCN, CCND1, and BCL2. GLI2 amplification can drive pathway activation independently of upstream components.																																																								"{""description"": ""Activated SMO leads to nuclear translocation of GLI transcription factors (GLI1, GLI2) which activate target genes including PTCH1 (feedback), GLI1, MYCN, CCND1, and BCL2. GLI2 amplification can drive pathway activation independently of upstream components."", ""name"": ""GLI Transcription Factor Activation""}"	"{""downstream"": [{""description"": ""GLI targets drive proliferation of cerebellar progenitors"", ""target"": ""Cerebellar Granule Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of gene expression"", ""term"": {""id"": ""GO:0010628"", ""label"": ""positive regulation of gene expression""}}], ""description"": ""Activated SMO leads to nuclear translocation of GLI transcription factors (GLI1, GLI2) which activate target genes including PTCH1 (feedback), GLI1, MYCN, CCND1, and BCL2. GLI2 amplification can drive pathway activation independently of upstream components."", ""downstream"": [{""description"": ""GLI targets drive proliferation of cerebellar progenitors"", ""target"": ""Cerebellar Granule Cell Proliferation""}], ""name"": ""GLI Transcription Factor Activation""}"
4953	208	Medulloblastoma, SHH-Activated	Medulloblastoma_SHH_Activated.yaml	pathophysiology	2	Cerebellar Granule Cell Proliferation	SHH signaling normally controls proliferation of granule neuron precursors in the external granule layer during cerebellar development. Constitutive pathway activation leads to unchecked proliferation of these precursors, resulting in tumor formation.																																																								"{""description"": ""SHH signaling normally controls proliferation of granule neuron precursors in the external granule layer during cerebellar development. Constitutive pathway activation leads to unchecked proliferation of these precursors, resulting in tumor formation."", ""name"": ""Cerebellar Granule Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""cerebellum development"", ""term"": {""id"": ""GO:0021549"", ""label"": ""cerebellum development""}}], ""cell_types"": [{""preferred_term"": ""cerebellar granule cell"", ""term"": {""id"": ""CL:0001031"", ""label"": ""cerebellar granule cell""}}], ""description"": ""SHH signaling normally controls proliferation of granule neuron precursors in the external granule layer during cerebellar development. Constitutive pathway activation leads to unchecked proliferation of these precursors, resulting in tumor formation."", ""name"": ""Cerebellar Granule Cell Proliferation""}"
4971	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	0	WNT/Beta-Catenin Pathway Activation	Activating mutations in CTNNB1 (beta-catenin) prevent phosphorylation at serine/threonine residues in exon 3, blocking proteasomal degradation. This leads to nuclear accumulation of beta-catenin, which complexes with TCF/LEF transcription factors to activate WNT target genes.																																																								"{""description"": ""Activating mutations in CTNNB1 (beta-catenin) prevent phosphorylation at serine/threonine residues in exon 3, blocking proteasomal degradation. This leads to nuclear accumulation of beta-catenin, which complexes with TCF/LEF transcription factors to activate WNT target genes."", ""name"": ""WNT/Beta-Catenin Pathway Activation""}"	"{""downstream"": [{""description"": ""Stabilized beta-catenin translocates to nucleus"", ""target"": ""Nuclear Beta-Catenin Accumulation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""Wnt signaling pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""cerebellar granule cell"", ""term"": {""id"": ""CL:0001031"", ""label"": ""cerebellar granule cell""}}], ""description"": ""Activating mutations in CTNNB1 (beta-catenin) prevent phosphorylation at serine/threonine residues in exon 3, blocking proteasomal degradation. This leads to nuclear accumulation of beta-catenin, which complexes with TCF/LEF transcription factors to activate WNT target genes."", ""downstream"": [{""description"": ""Stabilized beta-catenin translocates to nucleus"", ""target"": ""Nuclear Beta-Catenin Accumulation""}], ""evidence"": [{""explanation"": ""This abstract sentence supports that WNT-activated medulloblastomas are driven by CTNNB1 or APC mutations."", ""reference"": ""PMID:40967259"", ""snippet"": ""nearly all cases harbor either somatic CTNNB1 mutations or germline APC mutations."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""cerebellum"", ""term"": {""id"": ""UBERON:0002037"", ""label"": ""cerebellum""}}], ""name"": ""WNT/Beta-Catenin Pathway Activation""}"
4972	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	1	Nuclear Beta-Catenin Accumulation	Stabilized beta-catenin accumulates in the nucleus where it acts as a transcriptional coactivator with TCF/LEF family transcription factors. Nuclear beta-catenin immunostaining is a diagnostic hallmark of WNT-activated medulloblastoma.																																																								"{""description"": ""Stabilized beta-catenin accumulates in the nucleus where it acts as a transcriptional coactivator with TCF/LEF family transcription factors. Nuclear beta-catenin immunostaining is a diagnostic hallmark of WNT-activated medulloblastoma."", ""name"": ""Nuclear Beta-Catenin Accumulation""}"	"{""downstream"": [{""description"": ""Beta-catenin/TCF complex activates transcription of WNT targets"", ""target"": ""WNT Target Gene Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""canonical Wnt signaling pathway"", ""term"": {""id"": ""GO:0060070"", ""label"": ""canonical Wnt signaling pathway""}}], ""description"": ""Stabilized beta-catenin accumulates in the nucleus where it acts as a transcriptional coactivator with TCF/LEF family transcription factors. Nuclear beta-catenin immunostaining is a diagnostic hallmark of WNT-activated medulloblastoma."", ""downstream"": [{""description"": ""Beta-catenin/TCF complex activates transcription of WNT targets"", ""target"": ""WNT Target Gene Activation""}], ""name"": ""Nuclear Beta-Catenin Accumulation""}"
4973	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	2	WNT Target Gene Activation	Nuclear beta-catenin/TCF complexes drive expression of WNT target genes including MYC, CCND1 (cyclin D1), AXIN2, and DKK1. These genes promote proliferation and can serve as biomarkers of WNT pathway activation.																																																								"{""description"": ""Nuclear beta-catenin/TCF complexes drive expression of WNT target genes including MYC, CCND1 (cyclin D1), AXIN2, and DKK1. These genes promote proliferation and can serve as biomarkers of WNT pathway activation."", ""name"": ""WNT Target Gene Activation""}"	"{""downstream"": [{""description"": ""WNT target genes drive proliferation of cerebellar progenitors"", ""target"": ""Cell Proliferation and Tumor Formation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of gene expression"", ""term"": {""id"": ""GO:0010628"", ""label"": ""positive regulation of gene expression""}}], ""description"": ""Nuclear beta-catenin/TCF complexes drive expression of WNT target genes including MYC, CCND1 (cyclin D1), AXIN2, and DKK1. These genes promote proliferation and can serve as biomarkers of WNT pathway activation."", ""downstream"": [{""description"": ""WNT target genes drive proliferation of cerebellar progenitors"", ""target"": ""Cell Proliferation and Tumor Formation""}], ""name"": ""WNT Target Gene Activation""}"
4974	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	3	Cell Proliferation and Tumor Formation	WNT pathway activation drives proliferation of cerebellar progenitor cells, likely from the lower rhombic lip region. Despite constitutive pathway activation, these tumors have favorable biology, possibly due to their differentiation state or immunological features.																																																								"{""description"": ""WNT pathway activation drives proliferation of cerebellar progenitor cells, likely from the lower rhombic lip region. Despite constitutive pathway activation, these tumors have favorable biology, possibly due to their differentiation state or immunological features."", ""name"": ""Cell Proliferation and Tumor Formation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""cerebellar granule cell"", ""term"": {""id"": ""CL:0001031"", ""label"": ""cerebellar granule cell""}}], ""description"": ""WNT pathway activation drives proliferation of cerebellar progenitor cells, likely from the lower rhombic lip region. Despite constitutive pathway activation, these tumors have favorable biology, possibly due to their differentiation state or immunological features."", ""name"": ""Cell Proliferation and Tumor Formation""}"
4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	Genetic Mutations	Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.																																																								"{""description"": ""Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation."", ""name"": ""Genetic Mutations""}"	"{""downstream"": [{""target"": ""Uncontrolled Cell Growth""}, {""description"": ""NRAS mutations drive malignant transformation in congenital melanocytic nevi, with NRAS being the predominant genetic driver in large-giant CMNs."", ""evidence"": [{""explanation"": ""This study establishes NRAS mutations as the predominant genetic driver in large congenital melanocytic nevi, occurring in nearly 95% of cases, supporting the role of NRAS in the pathogenesis of lesions with malignant potential."", ""reference"": ""PMID:24129063"", ""snippet"": ""Large-giant CMNs displayed NRAS mutations in 94.7% of cases (18/19). ... The results showed that NRAS mutation was the sole recurrent somatic event found in such melanocytic proliferations."", ""supports"": ""SUPPORT""}], ""target"": ""Malignant Transformation""}]}"	"{""biological_processes"": [{""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""preferred_term"": ""cellular senescence"", ""term"": {""id"": ""GO:0090398"", ""label"": ""cellular senescence""}}, {""preferred_term"": ""telomere maintenance"", ""term"": {""id"": ""GO:0000723"", ""label"": ""telomere maintenance""}}], ""cell_types"": [{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}, {""preferred_term"": ""neural crest cell"", ""term"": {""id"": ""CL:0011012"", ""label"": ""neural crest cell""}}], ""description"": ""Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation."", ""downstream"": [{""target"": ""Uncontrolled Cell Growth""}, {""description"": ""NRAS mutations drive malignant transformation in congenital melanocytic nevi, with NRAS being the predominant genetic driver in large-giant CMNs."", ""evidence"": [{""explanation"": ""This study establishes NRAS mutations as the predominant genetic driver in large congenital melanocytic nevi, occurring in nearly 95% of cases, supporting the role of NRAS in the pathogenesis of lesions with malignant potential."", ""reference"": ""PMID:24129063"", ""snippet"": ""Large-giant CMNs displayed NRAS mutations in 94.7% of cases (18/19). ... The results showed that NRAS mutation was the sole recurrent somatic event found in such melanocytic proliferations."", ""supports"": ""SUPPORT""}], ""target"": ""Malignant Transformation""}], ""evidence"": [{""explanation"": ""This study supports the role of BRAF mutations in the pathophysiology of melanoma in melanocytic nevi, including congenital cases."", ""reference"": ""PMID:16750612"", ""snippet"": ""The most exciting finding is the discovery of oncogenic BRAF mutations in both malignant melanoma and melanocytic nevi. This finding indicates that activation of the mitogen-activated protein kinase pathway may be a critical initiating step of melanocytic neoplasia."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference covers NRAS mutations in congenital melanocytic nevus syndrome but does not mention BRAF mutations."", ""reference"": ""PMID:28110826"", ""snippet"": ""Congenital melanocytic nevus syndrome (CMNS) is the result of an abnormal proliferation of melanocytes in the skin and central nervous system caused by progenitor-cell mutations during embryonic development. Mutations in the NRAS gene have been detected in many of these cells."", ""supports"": ""PARTIAL""}, {""explanation"": ""This study supports the presence of BRAF mutations in melanomas associated with congenital melanocytic nevi."", ""reference"": ""PMID:32100974"", ""snippet"": ""Melanomas developing on pre-existing congenital or acquired nevi are usually of the superficial spreading subtype and harbor the BRAFV600E mutation."", ""supports"": ""SUPPORT""}, {""explanation"": ""This comprehensive review provides evidence of both NRAS and BRAF mutations in congenital melanocytic nevi, which supports their role in the development of melanoma."", ""reference"": ""PMID:31111470"", ""snippet"": ""NRAS mosaicism was found in 68%, BRAF in 7% and double wild-type in 25% of cases of CMN. NRAS was the commonest mutation in all sizes of CMN."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""BRAF"", ""term"": {""id"": ""hgnc:1097"", ""label"": ""BRAF""}}, {""preferred_term"": ""NRAS"", ""term"": {""id"": ""hgnc:7989"", ""label"": ""NRAS""}}], ""locations"": [{""preferred_term"": ""skin"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin""}}, {""preferred_term"": ""leptomeninx"", ""term"": {""id"": ""UBERON:0000391"", ""label"": ""leptomeninx""}}], ""name"": ""Genetic Mutations""}"
4996	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	1	UV Exposure	Ultraviolet (UV) radiation can damage the DNA in skin cells, contributing to mutations and the development of melanoma.																																		Exacerbating Factor																						"{""description"": ""Ultraviolet (UV) radiation can damage the DNA in skin cells, contributing to mutations and the development of melanoma."", ""name"": ""UV Exposure"", ""notes"": ""Exacerbating Factor""}"	"{""downstream"": [{""target"": ""DNA Damage""}]}"	"{""description"": ""Ultraviolet (UV) radiation can damage the DNA in skin cells, contributing to mutations and the development of melanoma."", ""downstream"": [{""target"": ""DNA Damage""}], ""evidence"": [{""explanation"": ""While the study does not explicitly link UV radiation to melanoma in congenital melanocytic nevus (CNM), it differentiates the mutational spectrum of CNMs from other types of melanoma, suggesting a distinct pathogenesis. Thus, the connection between UV radiation and CNM-related melanoma remains implicit and not clearly defined."", ""reference"": ""PMID:25268584"", ""snippet"": ""the three CNMs contained an activating NRAS Q61 mutation and no TERT-p mutations."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference confirms the role of UV-induced DNA mutations in melanoma formation but does not specifically address melanoma developing from congenital melanocytic nevi."", ""reference"": ""PMID:33759772"", ""snippet"": ""validated the role of ultraviolet-induced DNA mutations in melanoma formation"", ""supports"": ""NO_EVIDENCE""}], ""name"": ""UV Exposure"", ""notes"": ""Exacerbating Factor""}"
4997	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	2	PI3K-AKT-mTOR Pathway Activation	Compensatory activation of the PI3K-AKT-mTOR pathway occurs alongside MAPK signaling, often driven by PTEN loss. This pathway cross-talk promotes cell survival, invasion, and resistance to MEK inhibition. Combined targeting of both MAPK and PI3K pathways represents a rational therapeutic strategy.																																																								"{""description"": ""Compensatory activation of the PI3K-AKT-mTOR pathway occurs alongside MAPK signaling, often driven by PTEN loss. This pathway cross-talk promotes cell survival, invasion, and resistance to MEK inhibition. Combined targeting of both MAPK and PI3K pathways represents a rational therapeutic strategy."", ""name"": ""PI3K-AKT-mTOR Pathway Activation""}"	"{""downstream"": [{""target"": ""Malignant Transformation""}]}"	"{""biological_processes"": [{""preferred_term"": ""phosphatidylinositol-mediated signaling"", ""term"": {""id"": ""GO:0048015"", ""label"": ""phosphatidylinositol-mediated signaling""}}, {""preferred_term"": ""TOR signaling"", ""term"": {""id"": ""GO:0031929"", ""label"": ""TOR signaling""}}], ""description"": ""Compensatory activation of the PI3K-AKT-mTOR pathway occurs alongside MAPK signaling, often driven by PTEN loss. This pathway cross-talk promotes cell survival, invasion, and resistance to MEK inhibition. Combined targeting of both MAPK and PI3K pathways represents a rational therapeutic strategy."", ""downstream"": [{""target"": ""Malignant Transformation""}], ""genes"": [{""preferred_term"": ""PTEN"", ""term"": {""id"": ""hgnc:9588"", ""label"": ""PTEN""}}], ""name"": ""PI3K-AKT-mTOR Pathway Activation""}"
4998	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	3	DNA Damage	Damage to DNA structure from various causes																																																								"{""description"": ""Damage to DNA structure from various causes"", ""name"": ""DNA Damage""}"	{}	"{""description"": ""Damage to DNA structure from various causes"", ""name"": ""DNA Damage""}"
4999	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	4	Uncontrolled Cell Growth	Dysregulated cellular proliferation																																																								"{""description"": ""Dysregulated cellular proliferation"", ""name"": ""Uncontrolled Cell Growth""}"	{}	"{""description"": ""Dysregulated cellular proliferation"", ""name"": ""Uncontrolled Cell Growth""}"
5029	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	0	Non-caseating granulomatous inflammation with epithelioid histiocytes	"Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous inflammation of orofacial tissues with epithelioid macrophages, multinucleated giant cells, and perivascular/perineural lymphocytic infiltration. This represents the histologic hallmark and primary pathologic process affecting the lips, oral mucosa, and tongue.
"																																																								"{""description"": ""Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous inflammation of orofacial tissues with epithelioid macrophages, multinucleated giant cells, and perivascular/perineural lymphocytic infiltration. This represents the histologic hallmark and primary pathologic process affecting the lips, oral mucosa, and tongue.\n"", ""name"": ""Non-caseating granulomatous inflammation with epithelioid histiocytes""}"	{}	"{""biological_processes"": [{""preferred_term"": ""granuloma formation"", ""term"": {""id"": ""GO:0034612"", ""label"": ""response to tumor necrosis factor""}}, {""preferred_term"": ""leukocyte migration"", ""term"": {""id"": ""GO:0050900"", ""label"": ""leukocyte migration""}}], ""cell_types"": [{""preferred_term"": ""epithelioid macrophage"", ""term"": {""id"": ""CL:0002150"", ""label"": ""epithelioid macrophage""}}, {""preferred_term"": ""T lymphocyte"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous inflammation of orofacial tissues with epithelioid macrophages, multinucleated giant cells, and perivascular/perineural lymphocytic infiltration. This represents the histologic hallmark and primary pathologic process affecting the lips, oral mucosa, and tongue.\n"", ""evidence"": [{""explanation"": ""Establishes the clinical phenotype and neuromucocutaneous involvement characteristic of MRS"", ""reference"": ""PMID:39135018"", ""snippet"": ""Melkersson-Rosenthal syndrome (MRS) is a rare neuro-mucocutaneous disorder characterized by recurrent edema, facial palsies, and nerve dysfunctions often associated with the plicata tongue."", ""supports"": ""SUPPORT""}, {""explanation"": ""Provides context for the granulomatous nature of orofacial pathology including MRS"", ""reference"": ""PMID:30627963"", ""snippet"": ""Granulomatous lesions of the orofacial region are a heterogeneous group of disorders characterized by a granulomatous reaction to a variety of stimuli."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lip"", ""term"": {""id"": ""UBERON:0000953"", ""label"": ""lip""}}, {""preferred_term"": ""oral mucosa"", ""term"": {""id"": ""UBERON:0001830"", ""label"": ""oral mucosa""}}, {""preferred_term"": ""tongue"", ""term"": {""id"": ""UBERON:0001723"", ""label"": ""tongue""}}], ""name"": ""Non-caseating granulomatous inflammation with epithelioid histiocytes""}"
5030	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	1	Dysregulated Th1/Th17 cytokine signaling with IL-12/23 and TNF- involvement	"The granulomatous inflammation in MRS is driven by dysregulated Th1/Th17 cytokine axes involving TNF-, IFN-, and IL-12/23 signaling. These cytokines promote macrophage activation and granuloma formation and maintenance, with therapeutic response to IL-12/23 blockade and anti-TNF agents validating this mechanistic pathway in orofacial tissue inflammation.
"																																																								"{""description"": ""The granulomatous inflammation in MRS is driven by dysregulated Th1/Th17 cytokine axes involving TNF-, IFN-, and IL-12/23 signaling. These cytokines promote macrophage activation and granuloma formation and maintenance, with therapeutic response to IL-12/23 blockade and anti-TNF agents validating this mechanistic pathway in orofacial tissue inflammation.\n"", ""name"": ""Dysregulated Th1/Th17 cytokine signaling with IL-12/23 and TNF- involvement""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to tumor necrosis factor"", ""term"": {""id"": ""GO:0034612"", ""label"": ""response to tumor necrosis factor""}}, {""preferred_term"": ""interferon-gamma-mediated signaling pathway"", ""term"": {""id"": ""GO:0060333"", ""label"": ""interferon-gamma-mediated signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""epithelioid macrophage"", ""term"": {""id"": ""CL:0002150"", ""label"": ""epithelioid macrophage""}}], ""description"": ""The granulomatous inflammation in MRS is driven by dysregulated Th1/Th17 cytokine axes involving TNF-, IFN-, and IL-12/23 signaling. These cytokines promote macrophage activation and granuloma formation and maintenance, with therapeutic response to IL-12/23 blockade and anti-TNF agents validating this mechanistic pathway in orofacial tissue inflammation.\n"", ""evidence"": [{""explanation"": ""Identifies the IL-12/23 and IFN- cytokine pathways implicated in orofacial granulomatous inflammation"", ""reference"": ""PMID:32782477"", ""snippet"": ""IL-12 and IL-23 are linked to the production of IFN-, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""oral mucosa"", ""term"": {""id"": ""UBERON:0001830"", ""label"": ""oral mucosa""}}], ""name"": ""Dysregulated Th1/Th17 cytokine signaling with IL-12/23 and TNF- involvement""}"
5031	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	2	Lymphatic dysfunction with intralymphatic histiocytosis and persistent edema	"Lymphatic dysfunction with intralymphatic histiocytosis characterized by dilated lymphatic channels with D2-40/podoplanin-positive endothelium and intraluminal CD68-positive histiocytes contributes to sustained edema. This lymphatic pathology is associated with chronic inflammation and lymphatic stasis, providing a mechanism for persistent facial and labial swelling in MRS.
"																																																								"{""description"": ""Lymphatic dysfunction with intralymphatic histiocytosis characterized by dilated lymphatic channels with D2-40/podoplanin-positive endothelium and intraluminal CD68-positive histiocytes contributes to sustained edema. This lymphatic pathology is associated with chronic inflammation and lymphatic stasis, providing a mechanism for persistent facial and labial swelling in MRS.\n"", ""name"": ""Lymphatic dysfunction with intralymphatic histiocytosis and persistent edema""}"	{}	"{""biological_processes"": [{""preferred_term"": ""lymphatic vessel development"", ""term"": {""id"": ""GO:0001945"", ""label"": ""lymphatic vessel development""}}], ""cell_types"": [{""preferred_term"": ""endothelial cell of lymphatic vessel"", ""term"": {""id"": ""CL:0002138"", ""label"": ""endothelial cell of lymphatic vessel""}}], ""description"": ""Lymphatic dysfunction with intralymphatic histiocytosis characterized by dilated lymphatic channels with D2-40/podoplanin-positive endothelium and intraluminal CD68-positive histiocytes contributes to sustained edema. This lymphatic pathology is associated with chronic inflammation and lymphatic stasis, providing a mechanism for persistent facial and labial swelling in MRS.\n"", ""evidence"": [{""explanation"": ""Supports the lymphatic dysfunction mechanism through inflammatory cytokine effects on endothelial function"", ""reference"": ""PMID:32782477"", ""snippet"": ""IL-12 and IL-23 are linked to the production of IFN-, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""lymphatic vessel"", ""term"": {""id"": ""UBERON:0001473"", ""label"": ""lymphatic vessel""}}], ""name"": ""Lymphatic dysfunction with intralymphatic histiocytosis and persistent edema""}"
5041	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	0	Endolymphatic Hydrops	"Meniere's disease is characterized by distension of the endolymphatic space (endolymphatic hydrops) due to impaired reabsorption of endolymph or excess production. This results in rupture of the membranous labyrinth and mixing of endolymph and perilymph, leading to vestibular and cochlear dysfunction.
"																																																								"{""description"": ""Meniere's disease is characterized by distension of the endolymphatic space (endolymphatic hydrops) due to impaired reabsorption of endolymph or excess production. This results in rupture of the membranous labyrinth and mixing of endolymph and perilymph, leading to vestibular and cochlear dysfunction.\n"", ""name"": ""Endolymphatic Hydrops""}"	{}	"{""description"": ""Meniere's disease is characterized by distension of the endolymphatic space (endolymphatic hydrops) due to impaired reabsorption of endolymph or excess production. This results in rupture of the membranous labyrinth and mixing of endolymph and perilymph, leading to vestibular and cochlear dysfunction.\n"", ""evidence"": [{""explanation"": ""This review confirms endolymphatic hydrops as the pathologic correlate of Meniere's disease."", ""reference"": ""PMID:27083887"", ""snippet"": ""Over 75 years ago, endolymphatic hydrops was discovered as the pathologic correlate of Menire's disease."", ""supports"": ""SUPPORT""}], ""name"": ""Endolymphatic Hydrops""}"
5042	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	1	Ion Transport Dysfunction	"Abnormal regulation of fluid and ion homeostasis in the inner ear, particularly involving potassium transport in the stria vascularis and endolymphatic sac, contributes to endolymph accumulation and hydrops formation. Dysregulation of Na+/K+-ATPase, NKCC1, and K+ channels disrupts the electrochemical gradients required for normal endolymphatic fluid balance.
"																																																								"{""description"": ""Abnormal regulation of fluid and ion homeostasis in the inner ear, particularly involving potassium transport in the stria vascularis and endolymphatic sac, contributes to endolymph accumulation and hydrops formation. Dysregulation of Na+/K+-ATPase, NKCC1, and K+ channels disrupts the electrochemical gradients required for normal endolymphatic fluid balance.\n"", ""name"": ""Ion Transport Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""potassium ion transport"", ""term"": {""id"": ""GO:0006813"", ""label"": ""potassium ion transport""}}, {""preferred_term"": ""sodium ion transport"", ""term"": {""id"": ""GO:0006814"", ""label"": ""sodium ion transport""}}, {""preferred_term"": ""water homeostasis"", ""term"": {""id"": ""GO:0030104"", ""label"": ""water homeostasis""}}], ""description"": ""Abnormal regulation of fluid and ion homeostasis in the inner ear, particularly involving potassium transport in the stria vascularis and endolymphatic sac, contributes to endolymph accumulation and hydrops formation. Dysregulation of Na+/K+-ATPase, NKCC1, and K+ channels disrupts the electrochemical gradients required for normal endolymphatic fluid balance.\n"", ""evidence"": [{""explanation"": ""Immunohistochemical study identifies AQP2 upregulation as a key molecular abnormality in MD endolymphatic sac"", ""reference"": ""PMID:29436285"", ""snippet"": ""on ELS epithelium. AQP2 expression density was significantly elevated in MD"", ""supports"": ""SUPPORT""}], ""name"": ""Ion Transport Dysfunction""}"
5043	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	2	Autoimmune and Inflammatory Mechanisms	"Elevated inflammatory markers and autoantibodies have been found in some patients, suggesting that immune-mediated inner ear damage may contribute to disease pathogenesis in a subset of cases. Local (inner ear/endolymphatic sac) and systemic immune activation includes cytokine signaling and NF-B pathway engagement. TWEAK-FN14 receptor signaling and dysregulated Fc receptor polymorphisms contribute to immune complex-mediated injury.
"																																																								"{""description"": ""Elevated inflammatory markers and autoantibodies have been found in some patients, suggesting that immune-mediated inner ear damage may contribute to disease pathogenesis in a subset of cases. Local (inner ear/endolymphatic sac) and systemic immune activation includes cytokine signaling and NF-B pathway engagement. TWEAK-FN14 receptor signaling and dysregulated Fc receptor polymorphisms contribute to immune complex-mediated injury.\n"", ""name"": ""Autoimmune and Inflammatory Mechanisms""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""preferred_term"": ""NF-kB signaling"", ""term"": {""id"": ""GO:0038123"", ""label"": ""nuclear factor-kappa B signaling""}}, {""preferred_term"": ""response to cytokine"", ""term"": {""id"": ""GO:0071345"", ""label"": ""cellular response to cytokine stimulus""}}], ""description"": ""Elevated inflammatory markers and autoantibodies have been found in some patients, suggesting that immune-mediated inner ear damage may contribute to disease pathogenesis in a subset of cases. Local (inner ear/endolymphatic sac) and systemic immune activation includes cytokine signaling and NF-B pathway engagement. TWEAK-FN14 receptor signaling and dysregulated Fc receptor polymorphisms contribute to immune complex-mediated injury.\n"", ""evidence"": [{""explanation"": ""Study documents elevated pro-inflammatory cytokines (IFN-, IL-6, TNF-) in MD endolymphatic sac tissue"", ""reference"": ""PMID:35280304"", ""snippet"": ""Up-regulated expression of interferon-, interleukin-6 and tumor necrosis factor- in the endolymphatic sac."", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates TWEAK-FN14-NF-B pathway activation as key inflammatory mechanism in MD"", ""reference"": ""PMID:29326686"", ""snippet"": ""Carriers of the risk genotype may develop an NF-B-mediated inflammatory response in MD."", ""supports"": ""SUPPORT""}, {""explanation"": ""Large case-control study establishes association between MD and systemic autoimmune disease"", ""reference"": ""PMID:22053211"", ""snippet"": ""MD displays an elevated prevalence of systemic AD such as RA, SLE and AS."", ""supports"": ""SUPPORT""}, {""explanation"": ""Case-control study identifies Fc receptor polymorphisms and immune complex dysregulation in MD"", ""reference"": ""PMID:21208440"", ""snippet"": ""Polymorphisms of CD16A and CD32 Fc receptors and circulating immune complexes in Mnire's disease."", ""supports"": ""SUPPORT""}], ""name"": ""Autoimmune and Inflammatory Mechanisms""}"
5044	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	3	Blood-Labyrinth Barrier Dysfunction and Oxidative Stress	"The blood-labyrinth barrier (BLB) maintains inner-ear homeostasis through tight junctions between endothelial cells and pericytes. In MD, increased vascular permeability and oxidative/nitrosative stress damage the BLB, leading to edema and epithelial dysfunction. Elevated iNOS and nitrotyrosine levels indicate oxidative stress-mediated cascading cellular injury.
"																																																								"{""description"": ""The blood-labyrinth barrier (BLB) maintains inner-ear homeostasis through tight junctions between endothelial cells and pericytes. In MD, increased vascular permeability and oxidative/nitrosative stress damage the BLB, leading to edema and epithelial dysfunction. Elevated iNOS and nitrotyrosine levels indicate oxidative stress-mediated cascading cellular injury.\n"", ""name"": ""Blood-Labyrinth Barrier Dysfunction and Oxidative Stress""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""description"": ""The blood-labyrinth barrier (BLB) maintains inner-ear homeostasis through tight junctions between endothelial cells and pericytes. In MD, increased vascular permeability and oxidative/nitrosative stress damage the BLB, leading to edema and epithelial dysfunction. Elevated iNOS and nitrotyrosine levels indicate oxidative stress-mediated cascading cellular injury.\n"", ""evidence"": [{""explanation"": ""Ultrastructural study documents pathological BLB changes including endothelial and pericyte damage in MD"", ""reference"": ""PMID:28325925"", ""snippet"": ""Meniere's disease specimens revealed differential ultrastructural pathological changes in the cellular elements of the microvasculature."", ""supports"": ""SUPPORT""}, {""explanation"": ""Documents oxidative stress as key pathogenic mechanism in MD blood-labyrinth barrier dysfunction"", ""reference"": ""PMID:30233382"", ""snippet"": ""We proposed that oxidative stress mediated the damage to the vestibular endorgan and the BLB in MD."", ""supports"": ""SUPPORT""}], ""name"": ""Blood-Labyrinth Barrier Dysfunction and Oxidative Stress""}"
5065	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	0	Viral T Antigen Oncogenesis	In MCPyV-positive MCC, clonally integrated virus expresses truncated large T antigen (LT) that binds and inactivates RB tumor suppressor protein, releasing E2F transcription factors and driving cell cycle progression. Small T antigen (sT) promotes proliferation through multiple mechanisms including 4E-BP1 hyperphosphorylation and cap-dependent translation.																																																								"{""description"": ""In MCPyV-positive MCC, clonally integrated virus expresses truncated large T antigen (LT) that binds and inactivates RB tumor suppressor protein, releasing E2F transcription factors and driving cell cycle progression. Small T antigen (sT) promotes proliferation through multiple mechanisms including 4E-BP1 hyperphosphorylation and cap-dependent translation."", ""name"": ""Viral T Antigen Oncogenesis""}"	"{""downstream"": [{""description"": ""Viral LT antigen sequesters and inactivates pRB protein"", ""target"": ""RB1 Pathway Inactivation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""Merkel cell"", ""term"": {""id"": ""CL:0000242"", ""label"": ""Merkel cell""}}], ""description"": ""In MCPyV-positive MCC, clonally integrated virus expresses truncated large T antigen (LT) that binds and inactivates RB tumor suppressor protein, releasing E2F transcription factors and driving cell cycle progression. Small T antigen (sT) promotes proliferation through multiple mechanisms including 4E-BP1 hyperphosphorylation and cap-dependent translation."", ""downstream"": [{""description"": ""Viral LT antigen sequesters and inactivates pRB protein"", ""target"": ""RB1 Pathway Inactivation""}], ""locations"": [{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}], ""name"": ""Viral T Antigen Oncogenesis""}"
5066	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	1	RB1 Pathway Inactivation	In virus-positive MCC, viral large T antigen binds and inactivates RB1 protein. In virus-negative MCC, RB1 is frequently inactivated by somatic mutations. In both cases, loss of RB1 function releases E2F transcription factors to drive cell cycle progression and proliferation.																																																								"{""description"": ""In virus-positive MCC, viral large T antigen binds and inactivates RB1 protein. In virus-negative MCC, RB1 is frequently inactivated by somatic mutations. In both cases, loss of RB1 function releases E2F transcription factors to drive cell cycle progression and proliferation."", ""name"": ""RB1 Pathway Inactivation""}"	"{""downstream"": [{""description"": ""E2F activation drives expression of cell cycle genes"", ""target"": ""Uncontrolled Merkel Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""In virus-positive MCC, viral large T antigen binds and inactivates RB1 protein. In virus-negative MCC, RB1 is frequently inactivated by somatic mutations. In both cases, loss of RB1 function releases E2F transcription factors to drive cell cycle progression and proliferation."", ""downstream"": [{""description"": ""E2F activation drives expression of cell cycle genes"", ""target"": ""Uncontrolled Merkel Cell Proliferation""}], ""name"": ""RB1 Pathway Inactivation""}"
5067	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	2	UV-Induced Mutagenesis	In virus-negative MCC (approximately 20%), high levels of UV-induced mutations (C>T transitions at dipyrimidine sites) drive oncogenesis. These tumors have among the highest tumor mutational burdens of any cancer and frequently harbor mutations in TP53, RB1, and other tumor suppressors.																																																								"{""description"": ""In virus-negative MCC (approximately 20%), high levels of UV-induced mutations (C>T transitions at dipyrimidine sites) drive oncogenesis. These tumors have among the highest tumor mutational burdens of any cancer and frequently harbor mutations in TP53, RB1, and other tumor suppressors."", ""name"": ""UV-Induced Mutagenesis""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""Merkel cell"", ""term"": {""id"": ""CL:0000242"", ""label"": ""Merkel cell""}}], ""description"": ""In virus-negative MCC (approximately 20%), high levels of UV-induced mutations (C>T transitions at dipyrimidine sites) drive oncogenesis. These tumors have among the highest tumor mutational burdens of any cancer and frequently harbor mutations in TP53, RB1, and other tumor suppressors."", ""locations"": [{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}], ""name"": ""UV-Induced Mutagenesis""}"
5068	213	Merkel Cell Carcinoma	Merkel_Cell_Carcinoma.yaml	pathophysiology	3	Uncontrolled Merkel Cell Proliferation	Whether driven by viral T antigens or UV-induced mutations, MCC cells exhibit uncontrolled proliferation. The neuroendocrine differentiation is retained, with expression of characteristic markers including CK20, chromogranin, and synaptophysin.																																																								"{""description"": ""Whether driven by viral T antigens or UV-induced mutations, MCC cells exhibit uncontrolled proliferation. The neuroendocrine differentiation is retained, with expression of characteristic markers including CK20, chromogranin, and synaptophysin."", ""name"": ""Uncontrolled Merkel Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""Merkel cell"", ""term"": {""id"": ""CL:0000242"", ""label"": ""Merkel cell""}}], ""description"": ""Whether driven by viral T antigens or UV-induced mutations, MCC cells exhibit uncontrolled proliferation. The neuroendocrine differentiation is retained, with expression of characteristic markers including CK20, chromogranin, and synaptophysin."", ""name"": ""Uncontrolled Merkel Cell Proliferation""}"
5096	214	Migraine	Migraine.yaml	pathophysiology	0	Cortical Spreading Depression	"Wave of neuronal depolarization spreading across cortex underlies aura. Triggers activation of trigeminal pathways and may initiate headache phase.
"																																																								"{""description"": ""Wave of neuronal depolarization spreading across cortex underlies aura. Triggers activation of trigeminal pathways and may initiate headache phase.\n"", ""name"": ""Cortical Spreading Depression""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Neural Signaling"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}], ""description"": ""Wave of neuronal depolarization spreading across cortex underlies aura. Triggers activation of trigeminal pathways and may initiate headache phase.\n"", ""evidence"": [{""explanation"": ""Establishes CSD as the neurophysiological basis of migraine aura and its role in activating trigeminal pain pathways."", ""reference"": ""PMID:37495957"", ""snippet"": ""Cortical spreading depolarization (CSD), the neurophysiological correlate of the migraine aura, can activate trigeminal pain pathways, but the neurobiological mechanisms and behavioural consequences remain unclear."", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates that CSDs directly induce headache-related behaviors in animal models, supporting CSD's role in headache initiation."", ""reference"": ""PMID:37495957"", ""snippet"": ""In both WT and FHM1 mutant mice, CSDs induced headache-related behaviour, as evidenced by increased MGS scores and the occurrence of oculotemporal strokes, at 30 min."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows that pannexin-1 channels mediate CSD-induced neuroinflammatory signaling and headache behaviors, identifying a key mechanism linking CSD to pain."", ""reference"": ""PMID:37495957"", ""snippet"": ""Blocking Panx1 channels by TAT-Panx308 inhibited CSD-induced headache related behaviour and HMGB1 release."", ""supports"": ""SUPPORT""}, {""explanation"": ""Explains the molecular mechanism by which CSD triggers neuroinflammation through pannexin-1 channels and HMGB1 release."", ""reference"": ""PMID:39080518"", ""snippet"": ""Neuronal pannexin-1 channels act as stress sensors, initiating the inflammatory signaling by inflammasome formation and high-mobility group box-1 release in response to transient perturbations such as cortical spreading depolarization (CSD)"", ""supports"": ""SUPPORT""}], ""name"": ""Cortical Spreading Depression""}"
5097	214	Migraine	Migraine.yaml	pathophysiology	1	Trigeminovascular Activation	"Activation of trigeminal nerve fibers innervating meningeal blood vessels releases CGRP and other neuropeptides, causing neurogenic inflammation and pain.
"																																																								"{""description"": ""Activation of trigeminal nerve fibers innervating meningeal blood vessels releases CGRP and other neuropeptides, causing neurogenic inflammation and pain.\n"", ""name"": ""Trigeminovascular Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Pain Signaling"", ""term"": {""id"": ""GO:0048265"", ""label"": ""response to pain""}}], ""description"": ""Activation of trigeminal nerve fibers innervating meningeal blood vessels releases CGRP and other neuropeptides, causing neurogenic inflammation and pain.\n"", ""evidence"": [{""explanation"": ""Confirms that CSD drives trigeminovascular activation leading to headache phase in migraine."", ""reference"": ""PMID:37487740"", ""snippet"": ""CSD is also thought to drive the headache phase in migraine by promoting the activation and mechanical sensitization of trigeminal primary afferent nociceptive neurons that innervate the cranial meninges."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows that meningeal inflammation activates and sensitizes trigeminal nociceptors, producing headache."", ""reference"": ""PMID:39080518"", ""snippet"": ""Studies in rodents have demonstrated that sterile meningeal inflammation can stimulate and sensitize meningeal nociceptors, culminating in headaches."", ""supports"": ""SUPPORT""}, {""explanation"": ""Describes the pathway by which brain parenchymal inflammation extends to activate pain-sensitive meningeal structures and trigeminal afferents."", ""reference"": ""PMID:39080518"", ""snippet"": ""The parenchymal neuroinflammatory signaling involving neurons, astrocytes, and microglia, which eventually extends to the meninges, can link non-homeostatic perturbations in the insensate brain to pain-sensitive meninges."", ""supports"": ""SUPPORT""}], ""name"": ""Trigeminovascular Activation""}"
5098	214	Migraine	Migraine.yaml	pathophysiology	2	Central Sensitization	"Repeated activation leads to sensitization of trigeminal nucleus and thalamic neurons, producing allodynia and enhanced pain perception.
"																																																								"{""description"": ""Repeated activation leads to sensitization of trigeminal nucleus and thalamic neurons, producing allodynia and enhanced pain perception.\n"", ""name"": ""Central Sensitization""}"	{}	"{""description"": ""Repeated activation leads to sensitization of trigeminal nucleus and thalamic neurons, producing allodynia and enhanced pain perception.\n"", ""evidence"": [{""explanation"": ""Demonstrates that P2X7 and Pannexin 1 signaling specifically mediate mechanical sensitization (allodynia) of meningeal afferents, a key component of central sensitization."", ""reference"": ""PMID:37487740"", ""snippet"": ""Broad-spectrum P2X receptor inhibition, selective blockade of the P2X7 receptor, and its related Pannexin 1 channel suppressed CSD-evoked afferent mechanical sensitization but did not affect the accompanying afferent activation response."", ""supports"": ""SUPPORT""}, {""explanation"": ""Explains how sensitization leads to allodynia where normally innocuous stimuli become painful during migraine attacks."", ""reference"": ""PMID:37487740"", ""snippet"": ""We propose that meningeal P2X7 and Pannexin 1 signaling, potentially in meningeal macrophages or neutrophils, mediates the mechanical sensitization of meningeal afferents, which contributes to migraine pain by exacerbating the headache during normally innocuous physical activities."", ""supports"": ""SUPPORT""}], ""name"": ""Central Sensitization""}"
5099	214	Migraine	Migraine.yaml	pathophysiology	3	CGRP Pathway	"Calcitonin gene-related peptide (CGRP) release from trigeminal neurons causes vasodilation and neurogenic inflammation. CGRP blockers are effective treatments.
"																																																								"{""description"": ""Calcitonin gene-related peptide (CGRP) release from trigeminal neurons causes vasodilation and neurogenic inflammation. CGRP blockers are effective treatments.\n"", ""name"": ""CGRP Pathway""}"	{}	"{""description"": ""Calcitonin gene-related peptide (CGRP) release from trigeminal neurons causes vasodilation and neurogenic inflammation. CGRP blockers are effective treatments.\n"", ""evidence"": [{""explanation"": ""Clinical efficacy of CGRP-targeting therapies validates the central role of the CGRP pathway in migraine pathophysiology."", ""reference"": ""PMID:39080518"", ""snippet"": ""The efficacy of relatively blood-brain barrier-impermeable anti-calcitonin gene-related peptide antibodies and triptans in treating migraine attacks, both with and without aura, supports the concept of migraine pain originating in meninges."", ""supports"": ""SUPPORT""}, {""explanation"": ""Identifies CGRP as a key validated target in migraine treatment based on understanding of disease pathophysiology."", ""reference"": ""PMID:37569648"", ""snippet"": ""However, the progresses in unravelling the migraine pathophysiology allowed identifying novel putative targets as calcitonin gene-related peptide (CGRP)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Notes that while CGRP pathway is important, treatment resistance in some patients indicates involvement of additional pathways beyond CGRP."", ""reference"": ""PMID:37569648"", ""snippet"": ""Nevertheless, despite the revolution brought by CGRP monoclonal antibodies and gepants, a significant percentage of patients still remains burdened by an unsatisfactory response, suggesting that other pathways may play a critical role"", ""supports"": ""SUPPORT""}], ""name"": ""CGRP Pathway""}"
5118	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	0	Anti-U1 RNP Autoimmunity	High-titer antibodies against U1 small nuclear ribonucleoprotein (U1 RNP) are the serological hallmark. These antibodies may directly contribute to disease through immune complex formation and cellular dysfunction.																																																								"{""description"": ""High-titer antibodies against U1 small nuclear ribonucleoprotein (U1 RNP) are the serological hallmark. These antibodies may directly contribute to disease through immune complex formation and cellular dysfunction."", ""name"": ""Anti-U1 RNP Autoimmunity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""description"": ""High-titer antibodies against U1 small nuclear ribonucleoprotein (U1 RNP) are the serological hallmark. These antibodies may directly contribute to disease through immune complex formation and cellular dysfunction."", ""evidence"": [{""explanation"": ""This epigenome-wide study confirms anti-U1-RNP antibodies as the defining serological feature of MCTD, with pervasive hypomethylation at interferon-related genes (MX1, PARP9, DDX60, IFI44L) supporting the central role of this autoimmune response in disease pathogenesis."", ""reference"": ""PMID:31440254"", ""snippet"": ""Mixed Connective Tissue Disease (MCTD) is a rare complex systemic autoimmune disease (SAD) characterized by the presence of increased levels of anti-U1 ribonucleoprotein autoantibodies and signs and symptoms that resemble other SADs such as systemic sclerosis (SSc), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE)."", ""supports"": ""SUPPORT""}], ""name"": ""Anti-U1 RNP Autoimmunity""}"
5119	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	1	T Cell-Mediated Inflammation	CD4+ T cells recognizing U1 RNP antigens drive the autoimmune response. Th1 and Th17 cytokines contribute to tissue inflammation and damage across multiple organ systems.																																																								"{""description"": ""CD4+ T cells recognizing U1 RNP antigens drive the autoimmune response. Th1 and Th17 cytokines contribute to tissue inflammation and damage across multiple organ systems."", ""name"": ""T Cell-Mediated Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Adaptive Immune Response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}], ""cell_types"": [{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}], ""description"": ""CD4+ T cells recognizing U1 RNP antigens drive the autoimmune response. Th1 and Th17 cytokines contribute to tissue inflammation and damage across multiple organ systems."", ""evidence"": [{""explanation"": ""Machine learning-based immunophenotyping revealed that MCTD patients with SLE-like features show significantly elevated Th1 cells (2.85% vs 1.33%, P=0.027) and plasmablasts, with enhanced interferon-alpha and interferon-gamma responses in central memory CD8+ T cells, demonstrating the central role of T cell-driven inflammation in disease heterogeneity."", ""reference"": ""PMID:38479808"", ""snippet"": ""Among the MCTD patients, patients with the SLE immunophenotype had higher proportions of Th1 cells"", ""supports"": ""SUPPORT""}], ""name"": ""T Cell-Mediated Inflammation""}"
5120	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	2	Vascular Dysfunction	Endothelial injury and proliferative vasculopathy similar to systemic sclerosis contribute to Raynaud's phenomenon and may lead to pulmonary arterial hypertension in some patients.																																																								"{""description"": ""Endothelial injury and proliferative vasculopathy similar to systemic sclerosis contribute to Raynaud's phenomenon and may lead to pulmonary arterial hypertension in some patients."", ""name"": ""Vascular Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Blood Vessel Development"", ""term"": {""id"": ""GO:0001568"", ""label"": ""blood vessel development""}}], ""cell_types"": [{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Endothelial injury and proliferative vasculopathy similar to systemic sclerosis contribute to Raynaud's phenomenon and may lead to pulmonary arterial hypertension in some patients."", ""evidence"": [{""explanation"": ""Raynaud phenomenon in MCTD reflects an underlying systemic vasculopathy with intimal fibrosis and vascular obliteration, providing the mechanistic link between endothelial dysfunction and pulmonary arterial hypertension development."", ""reference"": ""PMID:16084319"", ""snippet"": ""It is the cutaneous symptom of a systemic vasculopathy that is characterized by intimal fibrosis and blood vessel obliteration that frequently leads to visceral involvement, particularly pulmonary hypertension."", ""supports"": ""SUPPORT""}, {""explanation"": ""This systematic review and meta-analysis of 983 MCTD patients establishes pulmonary arterial hypertension as a significant vascular complication, occurring in approximately 12.5% of patients, with mortality rates reaching up to 81.8% in affected individuals."", ""reference"": ""PMID:37497727"", ""snippet"": ""Pooled prevalence of PAH in MCTD patients was 12.53% [95% CI 8.30-18.48%]"", ""supports"": ""SUPPORT""}], ""name"": ""Vascular Dysfunction""}"
5121	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	3	Muscle Inflammation	Inflammatory myopathy with lymphocytic infiltration of skeletal muscle leads to proximal muscle weakness, similar to polymyositis.																																																								"{""description"": ""Inflammatory myopathy with lymphocytic infiltration of skeletal muscle leads to proximal muscle weakness, similar to polymyositis."", ""name"": ""Muscle Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Skeletal Muscle Cell"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}], ""description"": ""Inflammatory myopathy with lymphocytic infiltration of skeletal muscle leads to proximal muscle weakness, similar to polymyositis."", ""evidence"": [{""explanation"": ""This 2025 case series of nine MCTD myositis patients demonstrates the characteristic inflammatory myopathy with perivascular lymphocytic infiltration, muscle fiber necrosis and regeneration, and atypical weakness patterns affecting proximal and axial muscles, reflecting the heterogeneity of MCTD-associated muscle involvement."", ""reference"": ""PMID:39876825"", ""snippet"": ""In biopsied muscle specimens, common findings were mild myogenic change, increased necrotic and regenerating fibers, and inflammatory infiltrates predominating in the perivascular region."", ""supports"": ""SUPPORT""}], ""name"": ""Muscle Inflammation""}"
5122	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	4	Type I Interferon Signature	Pervasive DNA hypomethylation at interferon-inducible genes drives constitutive type I interferon pathway activation. This epigenetic signature is shared with SLE and Sjogren syndrome but is particularly pronounced in MCTD, contributing to immune dysregulation and disease heterogeneity.																																																								"{""description"": ""Pervasive DNA hypomethylation at interferon-inducible genes drives constitutive type I interferon pathway activation. This epigenetic signature is shared with SLE and Sjogren syndrome but is particularly pronounced in MCTD, contributing to immune dysregulation and disease heterogeneity."", ""name"": ""Type I Interferon Signature""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Type I Interferon Signaling Pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon signaling pathway""}}], ""description"": ""Pervasive DNA hypomethylation at interferon-inducible genes drives constitutive type I interferon pathway activation. This epigenetic signature is shared with SLE and Sjogren syndrome but is particularly pronounced in MCTD, contributing to immune dysregulation and disease heterogeneity."", ""evidence"": [{""explanation"": ""The first epigenome-wide association study in MCTD revealed widespread DNA hypomethylation at interferon-related genes (MX1, PARP9, DDX60, IFI44L) with evidence that genetic variants at IRF7 and IFI44 may exert disease risk through DNA methylation changes, establishing type I interferon pathway activation as a central molecular mechanism shared with SLE and Sjogren syndrome."", ""reference"": ""PMID:31440254"", ""snippet"": ""We observed a pervasive hypomethylation involving 170 genes enriched for immune-related function such as those involved in type I interferon signaling pathways or in negative regulation of viral genome replication."", ""supports"": ""SUPPORT""}], ""name"": ""Type I Interferon Signature""}"
5147	216	Monkeypox	Monkeypox.yaml	pathophysiology	0	Viral Entry and Initial Replication	MPXV enters through skin or mucosa via fusion or endocytic pathways, initially infecting keratinocytes and skin-resident antigen-presenting cells. The virus replicates in cytoplasmic factories (Guarnieri bodies) associated with ER.																																																								"{""description"": ""MPXV enters through skin or mucosa via fusion or endocytic pathways, initially infecting keratinocytes and skin-resident antigen-presenting cells. The virus replicates in cytoplasmic factories (Guarnieri bodies) associated with ER."", ""name"": ""Viral Entry and Initial Replication""}"	{}	"{""biological_processes"": [{""preferred_term"": ""viral entry into host cell"", ""term"": {""id"": ""GO:0046718"", ""label"": ""viral entry into host cell""}}, {""preferred_term"": ""viral genome replication"", ""term"": {""id"": ""GO:0019079"", ""label"": ""viral genome replication""}}], ""cell_types"": [{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}, {""preferred_term"": ""Langerhans cell"", ""term"": {""id"": ""CL:0000453"", ""label"": ""Langerhans cell""}}, {""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""MPXV enters through skin or mucosa via fusion or endocytic pathways, initially infecting keratinocytes and skin-resident antigen-presenting cells. The virus replicates in cytoplasmic factories (Guarnieri bodies) associated with ER."", ""locations"": [{""preferred_term"": ""skin epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}, {""preferred_term"": ""mucosa"", ""term"": {""id"": ""UBERON:0000344"", ""label"": ""mucosa""}}], ""name"": ""Viral Entry and Initial Replication""}"
5148	216	Monkeypox	Monkeypox.yaml	pathophysiology	1	Lymphatic Dissemination	Infected antigen-presenting cells (Langerhans cells, dendritic cells) migrate to draining lymph nodes where early viral amplification occurs, producing characteristic lymphadenopathy.																																																								"{""description"": ""Infected antigen-presenting cells (Langerhans cells, dendritic cells) migrate to draining lymph nodes where early viral amplification occurs, producing characteristic lymphadenopathy."", ""name"": ""Lymphatic Dissemination""}"	{}	"{""biological_processes"": [{""preferred_term"": ""leukocyte migration"", ""term"": {""id"": ""GO:0050900"", ""label"": ""leukocyte migration""}}], ""cell_types"": [{""preferred_term"": ""Langerhans cell"", ""term"": {""id"": ""CL:0000453"", ""label"": ""Langerhans cell""}}, {""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""Infected antigen-presenting cells (Langerhans cells, dendritic cells) migrate to draining lymph nodes where early viral amplification occurs, producing characteristic lymphadenopathy."", ""locations"": [{""preferred_term"": ""lymph node"", ""term"": {""id"": ""UBERON:0000029"", ""label"": ""lymph node""}}], ""name"": ""Lymphatic Dissemination""}"
5149	216	Monkeypox	Monkeypox.yaml	pathophysiology	2	Hematogenous Spread and Viremia	From lymph nodes, virus disseminates via bloodstream to lymphoid organs, liver, and other tissues. Monocytes can be productively infected, potentially mediating systemic spread.																																																								"{""description"": ""From lymph nodes, virus disseminates via bloodstream to lymphoid organs, liver, and other tissues. Monocytes can be productively infected, potentially mediating systemic spread."", ""name"": ""Hematogenous Spread and Viremia""}"	{}	"{""biological_processes"": [{""preferred_term"": ""virion attachment to host cell"", ""term"": {""id"": ""GO:0019062"", ""label"": ""virion attachment to host cell""}}], ""cell_types"": [{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}], ""description"": ""From lymph nodes, virus disseminates via bloodstream to lymphoid organs, liver, and other tissues. Monocytes can be productively infected, potentially mediating systemic spread."", ""evidence"": [{""explanation"": ""This snippet confirms that monkeypox virus multiplies at the site of entry and spreads into the bloodstream."", ""reference"": ""PMID:37026012"", ""snippet"": ""Once inoculated, the viruses multiply rapidly and spread into the bloodstream to cause viremia, which then affect multiple organs."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""blood"", ""term"": {""id"": ""UBERON:0000178"", ""label"": ""blood""}}, {""preferred_term"": ""spleen"", ""term"": {""id"": ""UBERON:0002106"", ""label"": ""spleen""}}, {""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Hematogenous Spread and Viremia""}"
5150	216	Monkeypox	Monkeypox.yaml	pathophysiology	3	Viral Factory Formation	MPXV replicates entirely in the host cytoplasm, forming ER-associated viral factories (Guarnieri bodies) where genome replication and virion assembly occur.																																		Cytoplasmic inclusions visible histologically as Guarnieri bodies																						"{""description"": ""MPXV replicates entirely in the host cytoplasm, forming ER-associated viral factories (Guarnieri bodies) where genome replication and virion assembly occur."", ""name"": ""Viral Factory Formation"", ""notes"": ""Cytoplasmic inclusions visible histologically as Guarnieri bodies""}"	{}	"{""biological_processes"": [{""preferred_term"": ""viral genome replication"", ""term"": {""id"": ""GO:0019079"", ""label"": ""viral genome replication""}}, {""preferred_term"": ""virion assembly"", ""term"": {""id"": ""GO:0019068"", ""label"": ""virion assembly""}}], ""description"": ""MPXV replicates entirely in the host cytoplasm, forming ER-associated viral factories (Guarnieri bodies) where genome replication and virion assembly occur."", ""name"": ""Viral Factory Formation"", ""notes"": ""Cytoplasmic inclusions visible histologically as Guarnieri bodies""}"
5151	216	Monkeypox	Monkeypox.yaml	pathophysiology	4	Extracellular Enveloped Virion Formation	The virus produces two infectious forms - intracellular mature virions (IMV) released by cell lysis, and extracellular enveloped virions (EEV) that acquire additional membrane for efficient cell-to-cell spread. Viral proteins F13L, B5R, A34R, and A36R orchestrate EEV formation and actin-based motility.																																		F13L is target of tecovirimat antiviral; A36R drives actin tail formation for directed spread																						"{""description"": ""The virus produces two infectious forms - intracellular mature virions (IMV) released by cell lysis, and extracellular enveloped virions (EEV) that acquire additional membrane for efficient cell-to-cell spread. Viral proteins F13L, B5R, A34R, and A36R orchestrate EEV formation and actin-based motility."", ""name"": ""Extracellular Enveloped Virion Formation"", ""notes"": ""F13L is target of tecovirimat antiviral; A36R drives actin tail formation for directed spread""}"	{}	"{""biological_processes"": [{""preferred_term"": ""viral budding via host ESCRT complex"", ""term"": {""id"": ""GO:0039702"", ""label"": ""viral budding via host ESCRT complex""}}, {""preferred_term"": ""viral release from host cell"", ""term"": {""id"": ""GO:0019076"", ""label"": ""viral release from host cell""}}], ""description"": ""The virus produces two infectious forms - intracellular mature virions (IMV) released by cell lysis, and extracellular enveloped virions (EEV) that acquire additional membrane for efficient cell-to-cell spread. Viral proteins F13L, B5R, A34R, and A36R orchestrate EEV formation and actin-based motility."", ""name"": ""Extracellular Enveloped Virion Formation"", ""notes"": ""F13L is target of tecovirimat antiviral; A36R drives actin tail formation for directed spread""}"
5152	216	Monkeypox	Monkeypox.yaml	pathophysiology	5	Immune Evasion	MPXV encodes multiple immunomodulatory proteins that antagonize innate sensing (TLR, cGAS-STING), block interferon signaling (downregulation of STAT1, JAK2, IRF3), inhibit NF-B activation, and impair dendritic cell maturation. NK cells expand but become functionally impaired.																																		Viral antagonism of PRR pathways and IFN responses enables immune evasion																						"{""description"": ""MPXV encodes multiple immunomodulatory proteins that antagonize innate sensing (TLR, cGAS-STING), block interferon signaling (downregulation of STAT1, JAK2, IRF3), inhibit NF-B activation, and impair dendritic cell maturation. NK cells expand but become functionally impaired."", ""name"": ""Immune Evasion"", ""notes"": ""Viral antagonism of PRR pathways and IFN responses enables immune evasion""}"	{}	"{""biological_processes"": [{""preferred_term"": ""type I interferon signaling pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon signaling pathway""}}, {""preferred_term"": ""innate immune response"", ""term"": {""id"": ""GO:0045087"", ""label"": ""innate immune response""}}, {""preferred_term"": ""I-kappaB kinase/NF-kappaB signaling"", ""term"": {""id"": ""GO:0007249"", ""label"": ""I-kappaB kinase/NF-kappaB signaling""}}], ""cell_types"": [{""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}, {""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""MPXV encodes multiple immunomodulatory proteins that antagonize innate sensing (TLR, cGAS-STING), block interferon signaling (downregulation of STAT1, JAK2, IRF3), inhibit NF-B activation, and impair dendritic cell maturation. NK cells expand but become functionally impaired."", ""name"": ""Immune Evasion"", ""notes"": ""Viral antagonism of PRR pathways and IFN responses enables immune evasion""}"
5153	216	Monkeypox	Monkeypox.yaml	pathophysiology	6	Skin Lesion Pathogenesis	Epidermal keratinocytes undergo ballooning degeneration with cytoplasmic viral inclusions. Lesions evolve through characteristic stages - macule, papule, vesicle, pustule, and crust formation over approximately 3 weeks.																																																								"{""description"": ""Epidermal keratinocytes undergo ballooning degeneration with cytoplasmic viral inclusions. Lesions evolve through characteristic stages - macule, papule, vesicle, pustule, and crust formation over approximately 3 weeks."", ""name"": ""Skin Lesion Pathogenesis""}"	{}	"{""cell_types"": [{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""description"": ""Epidermal keratinocytes undergo ballooning degeneration with cytoplasmic viral inclusions. Lesions evolve through characteristic stages - macule, papule, vesicle, pustule, and crust formation over approximately 3 weeks."", ""evidence"": [{""explanation"": ""This reference mentions that the virus is found in specific tissues after initial replication, which supports the idea that it spreads systemically."", ""reference"": ""PMID:36253513"", ""snippet"": ""We detected MPXV in interstitial cells and seminiferous tubules of testes as well as epididymal lumina, which are the sites of sperm production and maturation."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""skin epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}], ""name"": ""Skin Lesion Pathogenesis""}"
5183	217	Muenke Syndrome	Muenke_Syndrome.yaml	pathophysiology	0	FGFR3 Gain-of-Function in Cranial Sutures	"The P250R mutation in FGFR3 causes altered ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. In cranial sutures, this leads to premature osteogenic differentiation and suture fusion. The mechanism differs from achondroplasia-type mutations that affect growth plate chondrocytes.
"																																																								"{""description"": ""The P250R mutation in FGFR3 causes altered ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. In cranial sutures, this leads to premature osteogenic differentiation and suture fusion. The mechanism differs from achondroplasia-type mutations that affect growth plate chondrocytes.\n"", ""name"": ""FGFR3 Gain-of-Function in Cranial Sutures""}"	{}	"{""biological_processes"": [{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}, {""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""The P250R mutation in FGFR3 causes altered ligand binding specificity, allowing aberrant activation by non-cognate FGF ligands. In cranial sutures, this leads to premature osteogenic differentiation and suture fusion. The mechanism differs from achondroplasia-type mutations that affect growth plate chondrocytes.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review explains that FGFR3 mutations cause varying degrees of constitutive receptor activation, which underlies the pathophysiology of Muenke syndrome and related FGFR3 disorders."", ""reference"": ""PMID:10696568"", ""snippet"": ""Recent evidence suggests that the phenotypic differences may be due to specific alleles with varying degrees of ligand-independent activation, allowing the receptor to be constitutively active."", ""supports"": ""SUPPORT""}], ""name"": ""FGFR3 Gain-of-Function in Cranial Sutures""}"
5199	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	pathophysiology	0	RET Oncogene Activation	Germline activating mutations in RET cause ligand-independent receptor dimerization and constitutive tyrosine kinase activation. Unlike tumor suppressor syndromes, only one mutant allele is required (no second hit). This represents a gain-of-function oncogene mechanism.																																																								"{""description"": ""Germline activating mutations in RET cause ligand-independent receptor dimerization and constitutive tyrosine kinase activation. Unlike tumor suppressor syndromes, only one mutant allele is required (no second hit). This represents a gain-of-function oncogene mechanism."", ""name"": ""RET Oncogene Activation""}"	"{""downstream"": [{""description"": ""Constitutive RET phosphorylation activates multiple signaling pathways"", ""target"": ""Downstream Signaling Cascade Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""transmembrane receptor protein tyrosine kinase signaling pathway"", ""term"": {""id"": ""GO:0007169"", ""label"": ""transmembrane receptor protein tyrosine kinase signaling pathway""}}], ""description"": ""Germline activating mutations in RET cause ligand-independent receptor dimerization and constitutive tyrosine kinase activation. Unlike tumor suppressor syndromes, only one mutant allele is required (no second hit). This represents a gain-of-function oncogene mechanism."", ""downstream"": [{""description"": ""Constitutive RET phosphorylation activates multiple signaling pathways"", ""target"": ""Downstream Signaling Cascade Activation""}], ""gene_products"": [{""preferred_term"": ""RET receptor"", ""term"": {""id"": ""NCIT:C18539"", ""label"": ""Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret""}}], ""name"": ""RET Oncogene Activation""}"
5200	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	pathophysiology	1	Downstream Signaling Cascade Activation	Constitutively active RET phosphorylates intracellular substrates and activates RAS-MAPK, PI3K-AKT, and JAK-STAT signaling pathways. These promote cell proliferation, survival, and transformation of neuroendocrine cell populations.																																																								"{""description"": ""Constitutively active RET phosphorylates intracellular substrates and activates RAS-MAPK, PI3K-AKT, and JAK-STAT signaling pathways. These promote cell proliferation, survival, and transformation of neuroendocrine cell populations."", ""name"": ""Downstream Signaling Cascade Activation""}"	"{""downstream"": [{""description"": ""Sustained signaling drives transformation of thyroid C-cells and chromaffin cells"", ""target"": ""Neuroendocrine Cell Transformation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""Constitutively active RET phosphorylates intracellular substrates and activates RAS-MAPK, PI3K-AKT, and JAK-STAT signaling pathways. These promote cell proliferation, survival, and transformation of neuroendocrine cell populations."", ""downstream"": [{""description"": ""Sustained signaling drives transformation of thyroid C-cells and chromaffin cells"", ""target"": ""Neuroendocrine Cell Transformation""}], ""name"": ""Downstream Signaling Cascade Activation""}"
5201	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	pathophysiology	2	Neuroendocrine Cell Transformation	Constitutive RET signaling drives transformation of neuroendocrine cell populations. C-cell hyperplasia precedes MTC development and serves as a preneoplastic lesion. Similar processes affect adrenal chromaffin cells leading to pheochromocytoma.																																																								"{""description"": ""Constitutive RET signaling drives transformation of neuroendocrine cell populations. C-cell hyperplasia precedes MTC development and serves as a preneoplastic lesion. Similar processes affect adrenal chromaffin cells leading to pheochromocytoma."", ""name"": ""Neuroendocrine Cell Transformation""}"	"{""downstream"": [{""description"": ""Progressive transformation leads to carcinoma"", ""target"": ""Tumor Development""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""parafollicular cell"", ""term"": {""id"": ""CL:0000570"", ""label"": ""parafollicular cell""}}, {""preferred_term"": ""chromaffin cell"", ""term"": {""id"": ""CL:0000166"", ""label"": ""chromaffin cell""}}], ""description"": ""Constitutive RET signaling drives transformation of neuroendocrine cell populations. C-cell hyperplasia precedes MTC development and serves as a preneoplastic lesion. Similar processes affect adrenal chromaffin cells leading to pheochromocytoma."", ""downstream"": [{""description"": ""Progressive transformation leads to carcinoma"", ""target"": ""Tumor Development""}], ""name"": ""Neuroendocrine Cell Transformation""}"
5202	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	pathophysiology	3	Tumor Development	C-cell hyperplasia progresses to medullary thyroid carcinoma. The age of MTC onset correlates with mutation location and aggressiveness. MEN2B mutations (M918T) cause earliest onset, often in infancy, while some FMTC mutations may not cause MTC until adulthood.																																																								"{""description"": ""C-cell hyperplasia progresses to medullary thyroid carcinoma. The age of MTC onset correlates with mutation location and aggressiveness. MEN2B mutations (M918T) cause earliest onset, often in infancy, while some FMTC mutations may not cause MTC until adulthood."", ""name"": ""Tumor Development""}"	{}	"{""description"": ""C-cell hyperplasia progresses to medullary thyroid carcinoma. The age of MTC onset correlates with mutation location and aggressiveness. MEN2B mutations (M918T) cause earliest onset, often in infancy, while some FMTC mutations may not cause MTC until adulthood."", ""name"": ""Tumor Development""}"
5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	Demyelination	The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission.																																																								"{""description"": ""The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission."", ""name"": ""Demyelination""}"	"{""downstream"": [{""description"": ""Autoimmune demyelination and neuronal loss lead to progressive neurological disability."", ""evidence"": [{""explanation"": ""This 2024 review explicitly states the causal relationship between the immune-mediated (autoimmune) nature of MS and neurological disability."", ""reference"": ""PMID:40636815"", ""snippet"": ""Multiple sclerosis (MS) is a complex immune-mediated disease that leads to neurological disability"", ""supports"": ""SUPPORT""}], ""target"": ""Neurological Disability""}]}"	"{""biological_processes"": [{""preferred_term"": ""Antigen processing and presentation of peptide antigen via MHC class II"", ""term"": {""id"": ""GO:0002495"", ""label"": ""antigen processing and presentation of peptide antigen via MHC class II""}}, {""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}, {""preferred_term"": ""Cytokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}, {""preferred_term"": ""Complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}, {""preferred_term"": ""Myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}], ""cell_types"": [{""preferred_term"": ""Oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}, {""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}, {""preferred_term"": ""Microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}, {""preferred_term"": ""CD4-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}], ""description"": ""The immune system attacks and destroys myelin, the protective sheath around nerve fibers, disrupting nerve signal transmission."", ""downstream"": [{""description"": ""Autoimmune demyelination and neuronal loss lead to progressive neurological disability."", ""evidence"": [{""explanation"": ""This 2024 review explicitly states the causal relationship between the immune-mediated (autoimmune) nature of MS and neurological disability."", ""reference"": ""PMID:40636815"", ""snippet"": ""Multiple sclerosis (MS) is a complex immune-mediated disease that leads to neurological disability"", ""supports"": ""SUPPORT""}], ""target"": ""Neurological Disability""}], ""evidence"": [{""explanation"": ""The literature supports that MS involves the immune system attacking myelin in the CNS, leading to demyelination. It specifically mentions the role of autoreactive lymphocytes, which include T and B lymphocytes."", ""reference"": ""PMID:24507511"", ""snippet"": ""Multiple sclerosis (MS) is considered a prototype inflammatory autoimmune disorder of the central nervous system (CNS)... These autoreactive lymphocytes can migrate to the CNS where they become reactivated upon encountering their target antigen, initiating an autoimmune inflammatory attack. This ultimately leads to demyelination and axonal damage."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports the involvement of oligodendrocytes in myelination and their loss in CNS diseases like MS, which leads to demyelination."", ""reference"": ""PMID:19847447"", ""snippet"": ""Oligodendrocytes are the myelinating cells of the central nervous system (CNS)... we will lay out the different pathways leading to oligodendrocyte and myelin loss in human CNS diseases..."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that MS is a demyelinating disease affecting the CNS, with oligodendrocytes being the cells responsible for myelin production."", ""reference"": ""PMID:36889543"", ""snippet"": ""Multiple sclerosis (MS) is a central nervous system (CNS) demyelinating disease... CNS myelin is normally produced by oligodendroglial cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that MS involves demyelination and neurodegeneration in the CNS, with oligodendrocytes playing a crucial role in this process."", ""reference"": ""PMID:37629092"", ""snippet"": ""Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system (CNS), characterized by demyelination and neurodegeneration. Oligodendrocytes play a vital role in maintaining the integrity of myelin... However, in MS, oligodendrocytes become dysfunctional, leading to myelin damage and axonal degeneration."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that MS involves demyelination in the CNS and mentions the role of T-cells and oligodendrocytes in this process."", ""reference"": ""PMID:15727225"", ""snippet"": ""Multiple sclerosis (MS) is characterized by multiple demyelinated inflammatory lesions disseminated in the central nervous system (CNS)... different mechanisms of demyelination, such as T-cell/macrophage-mediated demyelination, antibody/complement-mediated demyelination, and primary damage of the oligodendrocyte have been observed in individual MS patients."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that MS is an autoimmune disease causing demyelination in the CNS, involving oligodendrocytes."", ""reference"": ""PMID:21425268"", ""snippet"": ""Multiple sclerosis is an inflammatory demyelinating disease of the brain and spinal cord with a presumed autoimmune etiology... Approaches that directly protect myelin-producing oligodendrocytes and enhance remyelination may improve long-term outcomes..."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that MS involves immune activation leading to damage of myelin sheaths in the CNS."", ""reference"": ""PMID:28674983"", ""snippet"": ""MS is a chronic inflammatory disease of the central nervous system caused by aberrant immune activation resulting in damage to myelin sheaths within the brain and spinal cord and axonal loss"", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that MS is an autoimmune disease involving the immune system's attack on myelin and oligodendrocytes in the CNS."", ""reference"": ""PMID:17548563"", ""snippet"": ""Substantial evidence supports autoimmune activity as the etiologic mechanism underlying multiple sclerosis (MS)... Both the innate and the adaptive arms of the immune system are involved in the aberrant response to several antigens associated with the myelin sheath and oligodendrocytes (OGCs)..."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that MS involves immune responses against myelin antigens leading to demyelination in the CNS."", ""reference"": ""PMID:24507514"", ""snippet"": ""This review, focused on demyelination in multiple sclerosis, is divided in two parts. The first part addresses the many and not exclusive mechanisms leading to demyelination in the central nervous system... the influence of a primary immune response against myelin antigen(s), with a diversity of potential targets."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Central nervous system"", ""term"": {""id"": ""UBERON:0001017"", ""label"": ""central nervous system""}}, {""preferred_term"": ""Meninges"", ""term"": {""id"": ""UBERON:0002303"", ""label"": ""meninges""}}, {""preferred_term"": ""White matter"", ""term"": {""id"": ""UBERON:0002316"", ""label"": ""white matter""}}, {""preferred_term"": ""Gray matter"", ""term"": {""id"": ""UBERON:0002020"", ""label"": ""gray matter""}}, {""preferred_term"": ""Brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}, {""preferred_term"": ""Spinal cord"", ""term"": {""id"": ""UBERON:0002240"", ""label"": ""spinal cord""}}], ""name"": ""Demyelination""}"
5226	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	1	Axonal Damage	Along with demyelination, damage to the axons themselves contributes to the permanent neurological deficits.																																																								"{""description"": ""Along with demyelination, damage to the axons themselves contributes to the permanent neurological deficits."", ""name"": ""Axonal Damage""}"	{}	"{""description"": ""Along with demyelination, damage to the axons themselves contributes to the permanent neurological deficits."", ""evidence"": [{""explanation"": ""The article discusses axonal damage as a significant factor in the pathogenesis of multiple sclerosis, supporting the statement that axonal damage contributes to permanent neurological deficits."", ""reference"": ""PMID:21425267"", ""snippet"": ""Here, we review distinct, but not mutually exclusive, mechanisms of pathogenesis of axonal damage in multiple sclerosis patients that are either consequent to long-term demyelination or independent from it."", ""supports"": ""SUPPORT""}, {""explanation"": ""The article mentions axonal degeneration as part of the pathophysiology of MS, supporting the statement that axonal damage contributes to permanent neurological deficits."", ""reference"": ""PMID:17115075"", ""snippet"": ""Recent studies have implicated specific sodium channel isoforms as having an important role in several aspects of the pathophysiology of MS, including the restoration of impulse conduction after demyelination, axonal degeneration and the mistuning of Purkinje neurons that leads to cerebellar dysfunction."", ""supports"": ""SUPPORT""}, {""explanation"": ""The article directly states that axonal degeneration is a major determinant of permanent neurological impairment in MS, which supports the statement."", ""reference"": ""PMID:25159125"", ""snippet"": ""Axonal degeneration is a major determinant of permanent neurological impairment during multiple sclerosis (MS)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The article explicitly mentions that both demyelination and axonal damage are responsible for neurological deficits in MS, supporting the statement."", ""reference"": ""PMID:31760649"", ""snippet"": ""Demyelination and axonal damage are responsible for neurological deficits in demyelinating diseases including multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system."", ""supports"": ""SUPPORT""}, {""explanation"": ""The article discusses neuroaxonal degeneration as underlying primary-progressive multiple sclerosis (PPMS), which supports the statement."", ""reference"": ""PMID:17884680"", ""snippet"": ""Although neuroaxonal degeneration seems to underlie PPMS, the pathogenesis and the extent to which immune-mediated mechanisms operate is unclear."", ""supports"": ""SUPPORT""}], ""name"": ""Axonal Damage""}"
5227	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	2	Inflammatory Lesions	Immune cells crossing the blood-brain barrier create focal areas of inflammation in the central nervous system.																																																								"{""description"": ""Immune cells crossing the blood-brain barrier create focal areas of inflammation in the central nervous system."", ""name"": ""Inflammatory Lesions""}"	{}	"{""description"": ""Immune cells crossing the blood-brain barrier create focal areas of inflammation in the central nervous system."", ""evidence"": [{""explanation"": ""This reference supports the statement that immune cells cross the blood-brain barrier and create inflammation in the central nervous system."", ""reference"": ""PMID:21550344"", ""snippet"": ""Leukocyte entry into the CNS is nonetheless an early event in multiple sclerosis (MS), an inflammatory disorder of the CNS... Immune cells of MS subjects express inflammatory cytokines, reactive oxygen species (ROS) and enzymes that can facilitate their migration to the CNS by influencing BBB function, either directly or indirectly."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference directly supports the statement by mentioning that leukocytes cross the blood-brain barrier and drive the formation of focal demyelinating plaques, which are inflammatory lesions."", ""reference"": ""PMID:34440810"", ""snippet"": ""During this early stage of the disease, leukocytes cross the blood-brain barrier to drive the formation of focal demyelinating plaques."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by explaining that peripheral leukocytes migrate to the CNS and trigger neuroinflammation."", ""reference"": ""PMID:30407467"", ""snippet"": ""Neuroinflammation is triggered when peripheral leukocytes migrate to the central nervous system and release cytokines such as interleukins 1 and 6 (IL-1 and 6) and tumor necrosis factor (TNF), which act on dwelling cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by mentioning the role of astrocytes in providing access for peripheral immune cells to the CNS, contributing to lesion formation."", ""reference"": ""PMID:29515568"", ""snippet"": ""Astrocytes are now recognized to be early and highly active players during lesion formation and key for providing peripheral immune cells access to the central nervous system."", ""supports"": ""SUPPORT""}], ""name"": ""Inflammatory Lesions""}"
5270	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	0	Post-Infectious Hyperinflammatory Response	Abnormally heightened immune response following COVID-19 infection.																																																								"{""description"": ""Abnormally heightened immune response following COVID-19 infection."", ""name"": ""Post-Infectious Hyperinflammatory Response""}"	{}	"{""description"": ""Abnormally heightened immune response following COVID-19 infection."", ""evidence"": [{""explanation"": ""The literature describes MIS-C as a postinfection hyperinflammatory response, supporting the statement."", ""reference"": ""PMID:36881797"", ""snippet"": ""Believed to be a postinfection hyperinflammatory response, the clinical manifestation of this viral sequelae can vary significantly in severity and symptomatic presentation."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature indicates an abnormally heightened immune response following COVID-19 infection, which aligns with the statement."", ""reference"": ""PMID:33341814"", ""snippet"": ""The inflammatory response generated after infection by increased proinflammatory cytokines and chemokines, and complement proteins activation may likely contribute to disease severity."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that MIS-C is a post-infection condition characterized by an inflammatory response."", ""reference"": ""PMID:36879079"", ""snippet"": ""On the other hand, the presence of a wide range of inflammatory manifestations, including multisystem inflammatory syndrome in children (MIS-C), in the period after infection suggests a particular susceptibility of some children toward severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature describes MIS-C as associated with a hyperinflammatory state post-COVID-19 infection, supporting the statement."", ""reference"": ""PMID:35183528"", ""snippet"": ""Since the COVID-19 pandemic began, a cohort of Multisystem inflammatory syndrome in children (MIS-C) patients has been described. Cardiac involvement is found in 80-85% patients, typically with cardiac dysfunction with or without cardiogenic shock."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature describes PIMS-TS (another term for MIS-C) as a hyperinflammatory response following COVID-19 infection, supporting the statement."", ""reference"": ""PMID:38864099"", ""snippet"": ""PIMS-TS is a rare hyperinflammatory immune response syndrome, usually occurring two to six weeks after SARS-CoV-2 infection, which mainly affects schoolchildren and is often associated with the need for intensive care."", ""supports"": ""SUPPORT""}], ""name"": ""Post-Infectious Hyperinflammatory Response""}"
5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	Cytokine Storm	Excessive production of pro-inflammatory cytokines, leading to widespread inflammation.																																																								"{""description"": ""Excessive production of pro-inflammatory cytokines, leading to widespread inflammation."", ""name"": ""Cytokine Storm""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""preferred_term"": ""cytokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}, {""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}, {""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Excessive production of pro-inflammatory cytokines, leading to widespread inflammation."", ""evidence"": [{""explanation"": ""The abstract indicates that MIS-C is characterized by unique inflammatory signatures involving cytokines, which supports the description of excessive production of pro-inflammatory cytokines leading to widespread inflammation."", ""reference"": ""PMID:34463724"", ""snippet"": ""MIS-C has unique inflammatory signatures involving both adaptive and innate systems. Certain cytokines, inflammatory markers, and cardiac markers assist in the differentiation of MIS-C from other hyperinflammatory conditions."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract describes the hyperinflammatory response and cytokine storm syndrome associated with COVID-19, which is related to MIS-C, supporting the statement about excessive production of pro-inflammatory cytokines."", ""reference"": ""PMID:32961074"", ""snippet"": ""The COVID-19 disease pathology is plausibly linked to the hyperinflammatory response of the body characterized by pathological cytokine levels. The term 'cytokine storm syndrome' is perhaps one of the critical hallmarks of COVID-19 disease severity."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract links MIS-C to a range of inflammatory symptoms, supporting the idea of widespread inflammation due to excessive cytokine production."", ""reference"": ""PMID:33023287"", ""snippet"": ""These symptoms include malaise, myalgias, chest tightness, brain fog and other neuropsychiatric symptoms that were originally reported in children and named Multisystem Inflammatory Syndrome (MIS-C)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract describes MIS-C as a hyperinflammatory state, which aligns with the statement about excessive production of pro-inflammatory cytokines leading to widespread inflammation."", ""reference"": ""PMID:35275051"", ""snippet"": ""Multisystem inflammatory syndrome in children (MIS-C) is a hyperinflammatory state that occurs after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""IL6"", ""term"": {""id"": ""hgnc:6018"", ""label"": ""IL6""}}, {""preferred_term"": ""IL10"", ""term"": {""id"": ""hgnc:5962"", ""label"": ""IL10""}}, {""preferred_term"": ""TNF"", ""term"": {""id"": ""hgnc:11892"", ""label"": ""TNF""}}, {""preferred_term"": ""IL18"", ""term"": {""id"": ""hgnc:5973"", ""label"": ""IL18""}}, {""preferred_term"": ""IL1B"", ""term"": {""id"": ""hgnc:5992"", ""label"": ""IL1B""}}, {""preferred_term"": ""IL17A"", ""term"": {""id"": ""hgnc:5981"", ""label"": ""IL17A""}}, {""preferred_term"": ""IFNG"", ""term"": {""id"": ""hgnc:5438"", ""label"": ""IFNG""}}, {""preferred_term"": ""CXCL9"", ""term"": {""id"": ""hgnc:10563"", ""label"": ""CXCL9""}}, {""preferred_term"": ""CXCL10"", ""term"": {""id"": ""hgnc:10637"", ""label"": ""CXCL10""}}], ""locations"": [{""preferred_term"": ""blood"", ""term"": {""id"": ""UBERON:0000178"", ""label"": ""blood""}}], ""name"": ""Cytokine Storm""}"
5272	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	2	T-Cell Receptor V21.3 Skewing and IL-18-FAS Activation	Expansion of TRBV11-2 (V21.3+) T cells with skewed differentiation accompanied by elevated IL-18 and CD95/FAS signaling in NK cells and monocytes, creating an innate-adaptive immune activation axis.																																		Superantigen-like TCR V skewing observed in acute MIS-C cases with innate immune amplification																						"{""description"": ""Expansion of TRBV11-2 (V21.3+) T cells with skewed differentiation accompanied by elevated IL-18 and CD95/FAS signaling in NK cells and monocytes, creating an innate-adaptive immune activation axis."", ""name"": ""T-Cell Receptor V21.3 Skewing and IL-18-FAS Activation"", ""notes"": ""Superantigen-like TCR V skewing observed in acute MIS-C cases with innate immune amplification""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}, {""preferred_term"": ""immune response-activating signal transduction"", ""term"": {""id"": ""GO:0002757"", ""label"": ""immune response-activating signal transduction""}}], ""cell_types"": [{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}, {""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}, {""preferred_term"": ""monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}], ""description"": ""Expansion of TRBV11-2 (V21.3+) T cells with skewed differentiation accompanied by elevated IL-18 and CD95/FAS signaling in NK cells and monocytes, creating an innate-adaptive immune activation axis."", ""genes"": [{""preferred_term"": ""TRBV11-2"", ""term"": {""id"": ""hgnc:12262"", ""label"": ""TRBV11-2""}}, {""preferred_term"": ""IL18"", ""term"": {""id"": ""hgnc:5973"", ""label"": ""IL18""}}, {""preferred_term"": ""FAS"", ""term"": {""id"": ""hgnc:11920"", ""label"": ""FAS""}}], ""name"": ""T-Cell Receptor V21.3 Skewing and IL-18-FAS Activation"", ""notes"": ""Superantigen-like TCR V skewing observed in acute MIS-C cases with innate immune amplification""}"
5273	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	3	Molecular Mimicry and SNX8 Autoimmunity	Cross-reactive immune responses targeting both SARS-CoV-2 nucleocapsid protein and host protein SNX8, with autoantibodies and T cells engaging both epitopes, linking viral infection to autoimmune pathology.																																		Proteome-wide screens identify SNX8 autoantibodies with sequence similarity to SARS-CoV-2 nucleocapsid epitope																						"{""description"": ""Cross-reactive immune responses targeting both SARS-CoV-2 nucleocapsid protein and host protein SNX8, with autoantibodies and T cells engaging both epitopes, linking viral infection to autoimmune pathology."", ""name"": ""Molecular Mimicry and SNX8 Autoimmunity"", ""notes"": ""Proteome-wide screens identify SNX8 autoantibodies with sequence similarity to SARS-CoV-2 nucleocapsid epitope""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to virus"", ""term"": {""id"": ""GO:0009615"", ""label"": ""response to virus""}}, {""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}, {""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""Cross-reactive immune responses targeting both SARS-CoV-2 nucleocapsid protein and host protein SNX8, with autoantibodies and T cells engaging both epitopes, linking viral infection to autoimmune pathology."", ""genes"": [{""preferred_term"": ""SNX8"", ""term"": {""id"": ""hgnc:14972"", ""label"": ""SNX8""}}, {""preferred_term"": ""MAVS"", ""term"": {""id"": ""hgnc:29233"", ""label"": ""MAVS""}}], ""name"": ""Molecular Mimicry and SNX8 Autoimmunity"", ""notes"": ""Proteome-wide screens identify SNX8 autoantibodies with sequence similarity to SARS-CoV-2 nucleocapsid epitope""}"
5274	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	4	Endothelial Injury and Complement Activation	Vascular endothelial damage with activation of the complement cascade, elevated soluble C5b-9, and occasional autoantibodies to complement regulators (e.g., Factor H), contributing to thrombotic microangiopathy and vasculopathy.																																		Elevated soluble C5b-9 and PLA2G2A link complement activation to TMA-like features																						"{""description"": ""Vascular endothelial damage with activation of the complement cascade, elevated soluble C5b-9, and occasional autoantibodies to complement regulators (e.g., Factor H), contributing to thrombotic microangiopathy and vasculopathy."", ""name"": ""Endothelial Injury and Complement Activation"", ""notes"": ""Elevated soluble C5b-9 and PLA2G2A link complement activation to TMA-like features""}"	{}	"{""biological_processes"": [{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}, {""preferred_term"": ""blood coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}], ""cell_types"": [{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Vascular endothelial damage with activation of the complement cascade, elevated soluble C5b-9, and occasional autoantibodies to complement regulators (e.g., Factor H), contributing to thrombotic microangiopathy and vasculopathy."", ""genes"": [{""preferred_term"": ""CFH"", ""term"": {""id"": ""hgnc:4883"", ""label"": ""CFH""}}, {""preferred_term"": ""C5"", ""term"": {""id"": ""hgnc:1331"", ""label"": ""C5""}}, {""preferred_term"": ""PLA2G2A"", ""term"": {""id"": ""hgnc:9031"", ""label"": ""PLA2G2A""}}], ""locations"": [{""preferred_term"": ""blood vessel"", ""term"": {""id"": ""UBERON:0001981"", ""label"": ""blood vessel""}}, {""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}], ""name"": ""Endothelial Injury and Complement Activation"", ""notes"": ""Elevated soluble C5b-9 and PLA2G2A link complement activation to TMA-like features""}"
5275	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	5	Intestinal Barrier Dysfunction and Antigen Persistence	Persistent SARS-CoV-2 viral antigens in intestinal tissue with increased gut permeability, elevated zonulin and lipopolysaccharide-binding protein (LBP), leading to antigen translocation and elevated mucosal IgA responses.																																		Gut-to-systemic antigen leak model supported by elevated IgA and gastrointestinal symptoms																						"{""description"": ""Persistent SARS-CoV-2 viral antigens in intestinal tissue with increased gut permeability, elevated zonulin and lipopolysaccharide-binding protein (LBP), leading to antigen translocation and elevated mucosal IgA responses."", ""name"": ""Intestinal Barrier Dysfunction and Antigen Persistence"", ""notes"": ""Gut-to-systemic antigen leak model supported by elevated IgA and gastrointestinal symptoms""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}, {""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""Persistent SARS-CoV-2 viral antigens in intestinal tissue with increased gut permeability, elevated zonulin and lipopolysaccharide-binding protein (LBP), leading to antigen translocation and elevated mucosal IgA responses."", ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""Intestinal Barrier Dysfunction and Antigen Persistence"", ""notes"": ""Gut-to-systemic antigen leak model supported by elevated IgA and gastrointestinal symptoms""}"
5276	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	6	Cardiac Involvement and Myocardial Dysfunction	Direct cardiac involvement with myocarditis, ventricular dysfunction, and occasional coronary artery changes, correlating with T-cell activation signatures and inflammatory markers.																																		Cardiac dysfunction with myocarditis observed in 80-85% of MIS-C patients																						"{""description"": ""Direct cardiac involvement with myocarditis, ventricular dysfunction, and occasional coronary artery changes, correlating with T-cell activation signatures and inflammatory markers."", ""name"": ""Cardiac Involvement and Myocardial Dysfunction"", ""notes"": ""Cardiac dysfunction with myocarditis observed in 80-85% of MIS-C patients""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""cardiac muscle cell"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Direct cardiac involvement with myocarditis, ventricular dysfunction, and occasional coronary artery changes, correlating with T-cell activation signatures and inflammatory markers."", ""locations"": [{""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}], ""name"": ""Cardiac Involvement and Myocardial Dysfunction"", ""notes"": ""Cardiac dysfunction with myocarditis observed in 80-85% of MIS-C patients""}"
5301	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	0	Innate Immune Hyperreactivity	Exaggerated innate immune responses to microbial ligands, with exercise-triggered increases in proinflammatory signals, complement activation, and oxidative stress that contribute to post-exertional malaise.																																																								"{""description"": ""Exaggerated innate immune responses to microbial ligands, with exercise-triggered increases in proinflammatory signals, complement activation, and oxidative stress that contribute to post-exertional malaise."", ""name"": ""Innate Immune Hyperreactivity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Innate Immune Response"", ""term"": {""id"": ""GO:0045087"", ""label"": ""innate immune response""}}, {""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""cell_types"": [{""preferred_term"": ""Natural Killer Cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}, {""preferred_term"": ""Monocyte"", ""term"": {""id"": ""CL:0000576"", ""label"": ""monocyte""}}], ""description"": ""Exaggerated innate immune responses to microbial ligands, with exercise-triggered increases in proinflammatory signals, complement activation, and oxidative stress that contribute to post-exertional malaise."", ""evidence"": [{""explanation"": ""The BMC Medicine systematic review identifies immune dysfunction as the most reproducible finding in ME/CFS."", ""reference"": ""PMID:37226227"", ""snippet"": ""several studies validated the involvement of immune dysfunction in the pathology of ME/CFS and the use of lymphocytes as a model to investigate the pathomechanism of illness"", ""supports"": ""SUPPORT""}], ""name"": ""Innate Immune Hyperreactivity""}"
5302	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	1	Natural Killer Cell Dysfunction	Reproducible deficits in natural killer cell cytotoxicity and phenotype abnormalities, representing one of the most consistent biological findings in ME/CFS.																																																								"{""description"": ""Reproducible deficits in natural killer cell cytotoxicity and phenotype abnormalities, representing one of the most consistent biological findings in ME/CFS."", ""name"": ""Natural Killer Cell Dysfunction""}"	{}	"{""cell_types"": [{""preferred_term"": ""Natural Killer Cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}], ""description"": ""Reproducible deficits in natural killer cell cytotoxicity and phenotype abnormalities, representing one of the most consistent biological findings in ME/CFS."", ""evidence"": [{""explanation"": ""Systematic review of 17 studies confirms NK cell dysfunction as the most reproducible immunological finding in ME/CFS."", ""reference"": ""PMID:31727160"", ""snippet"": ""Impaired NK cell cytotoxicity remained the most consistent immunological report across all publications"", ""supports"": ""SUPPORT""}, {""explanation"": ""This study demonstrates reduced TRPM3 expression on NK cells in ME/CFS."", ""reference"": ""PMID:27245705"", ""snippet"": ""There was a significant reduction of TRPM3 surface expression on CD19(+) B cells (1.56  0.191) and CD56(bright) NK cells (17.37 %  5.34) in CFS/ME compared with healthy controls"", ""supports"": ""SUPPORT""}], ""name"": ""Natural Killer Cell Dysfunction""}"
5303	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	2	T-Cell Immunometabolic Dysfunction	CD8+ T cells exhibit reduced mitochondrial membrane potential and both CD4+ and CD8+ T cells show impaired glycolysis at rest and after activation, consistent with chronic immune stress and exhaustion.																																																								"{""description"": ""CD8+ T cells exhibit reduced mitochondrial membrane potential and both CD4+ and CD8+ T cells show impaired glycolysis at rest and after activation, consistent with chronic immune stress and exhaustion."", ""name"": ""T-Cell Immunometabolic Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T Cell Activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}, {""preferred_term"": ""Glycolysis"", ""term"": {""id"": ""GO:0006096"", ""label"": ""glycolytic process""}}], ""cell_types"": [{""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}, {""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}], ""description"": ""CD8+ T cells exhibit reduced mitochondrial membrane potential and both CD4+ and CD8+ T cells show impaired glycolysis at rest and after activation, consistent with chronic immune stress and exhaustion."", ""evidence"": [{""explanation"": ""Systematic review documents diverse biomarker categories including immune and metabolic dysfunction in ME/CFS."", ""reference"": ""PMID:37226227"", ""snippet"": ""Potential biomarkers ranged from genetic/epigenetic (19.8%), immunological (29.7%), metabolomics/mitochondrial/microbiome (14.85%)"", ""supports"": ""SUPPORT""}], ""name"": ""T-Cell Immunometabolic Dysfunction""}"
5304	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	3	Endothelial Dysfunction and Coagulopathy	Dysregulated endothelial function with coagulation abnormalities, platelet hyperactivation, and microcirculatory impairment leading to tissue hypoperfusion.																																																								"{""description"": ""Dysregulated endothelial function with coagulation abnormalities, platelet hyperactivation, and microcirculatory impairment leading to tissue hypoperfusion."", ""name"": ""Endothelial Dysfunction and Coagulopathy""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Blood Coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}, {""preferred_term"": ""Platelet Activation"", ""term"": {""id"": ""GO:0030168"", ""label"": ""platelet activation""}}], ""cell_types"": [{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}, {""preferred_term"": ""Platelet"", ""term"": {""id"": ""CL:0000233"", ""label"": ""platelet""}}], ""description"": ""Dysregulated endothelial function with coagulation abnormalities, platelet hyperactivation, and microcirculatory impairment leading to tissue hypoperfusion."", ""evidence"": [{""explanation"": ""Clinical study demonstrates impaired flow-mediated dilation indicating vascular dysfunction in ME/CFS."", ""reference"": ""PMID:36730360"", ""snippet"": ""ME/CFS patients had markedly reduced FMD compared to healthy controls at baseline (5.1% vs. 8.2%)"", ""supports"": ""SUPPORT""}], ""name"": ""Endothelial Dysfunction and Coagulopathy""}"
5305	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	4	TRPM3 Ion Channel Dysfunction	Impaired TRPM3 calcium channel function in natural killer cells leads to reduced calcium flux, affecting immune and autonomic signaling pathways.																																																								"{""description"": ""Impaired TRPM3 calcium channel function in natural killer cells leads to reduced calcium flux, affecting immune and autonomic signaling pathways."", ""name"": ""TRPM3 Ion Channel Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Calcium Ion Transmembrane Transport"", ""term"": {""id"": ""GO:0070588"", ""label"": ""calcium ion transmembrane transport""}}], ""cell_types"": [{""preferred_term"": ""Natural Killer Cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}], ""description"": ""Impaired TRPM3 calcium channel function in natural killer cells leads to reduced calcium flux, affecting immune and autonomic signaling pathways."", ""evidence"": [{""explanation"": ""Research demonstrates impaired TRPM3 function in ME/CFS NK cells and potential for pharmacological restoration."", ""reference"": ""PMID:31736966"", ""snippet"": ""TRPM3 channel activity was restored in IL-2 stimulated NK cells isolated from ME/CFS patients after incubation for 24 h with NTX"", ""supports"": ""SUPPORT""}], ""name"": ""TRPM3 Ion Channel Dysfunction""}"
5306	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	5	Neuroinflammation and Cerebral Hypoperfusion	Brainstem involvement, reduced cerebral blood flow, and neuroinflammatory signaling contribute to cognitive dysfunction and dysautonomia.																																																								"{""description"": ""Brainstem involvement, reduced cerebral blood flow, and neuroinflammatory signaling contribute to cognitive dysfunction and dysautonomia."", ""name"": ""Neuroinflammation and Cerebral Hypoperfusion""}"	{}	"{""description"": ""Brainstem involvement, reduced cerebral blood flow, and neuroinflammatory signaling contribute to cognitive dysfunction and dysautonomia."", ""evidence"": [{""explanation"": ""Systematic review of 63 neuroimaging studies supports CNS involvement in ME/CFS."", ""reference"": ""PMID:32873297"", ""snippet"": ""Additional brain area recruitment for cognitive tasks and abnormalities in the brain stem are frequent observations"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}, {""preferred_term"": ""Brainstem"", ""term"": {""id"": ""UBERON:0002298"", ""label"": ""brainstem""}}], ""name"": ""Neuroinflammation and Cerebral Hypoperfusion""}"
5307	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	6	Mitochondrial Dysfunction	Impaired mitochondrial function and metabolic inflexibility that worsen with exertion, contributing to fatigue and post-exertional malaise.																																																								"{""description"": ""Impaired mitochondrial function and metabolic inflexibility that worsen with exertion, contributing to fatigue and post-exertional malaise."", ""name"": ""Mitochondrial Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Fatty Acid Beta-Oxidation"", ""term"": {""id"": ""GO:0006635"", ""label"": ""fatty acid beta-oxidation""}}, {""preferred_term"": ""Response to Oxidative Stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}], ""cellular_components"": [{""preferred_term"": ""Mitochondrion"", ""term"": {""id"": ""GO:0005739"", ""label"": ""mitochondrion""}}], ""description"": ""Impaired mitochondrial function and metabolic inflexibility that worsen with exertion, contributing to fatigue and post-exertional malaise."", ""evidence"": [{""explanation"": ""ATP Profile testing demonstrates mitochondrial dysfunction in ME/CFS patients correlating with disease severity."", ""reference"": ""PMID:22837795"", ""snippet"": ""all patients tested have measureable mitochondrial dysfunction which correlates with the severity of the illness"", ""supports"": ""SUPPORT""}], ""name"": ""Mitochondrial Dysfunction""}"
5336	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	0	Autoantibody-Mediated NMJ Dysfunction	"Autoantibodies (primarily anti-AChR) target the postsynaptic membrane at neuromuscular junctions. Antibodies cause receptor internalization, complement-mediated destruction, and functional blockade, reducing acetylcholine signaling efficiency.
"																																																								"{""description"": ""Autoantibodies (primarily anti-AChR) target the postsynaptic membrane at neuromuscular junctions. Antibodies cause receptor internalization, complement-mediated destruction, and functional blockade, reducing acetylcholine signaling efficiency.\n"", ""name"": ""Autoantibody-Mediated NMJ Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Neuromuscular Transmission"", ""term"": {""id"": ""GO:0007274"", ""label"": ""neuromuscular synaptic transmission""}}], ""cell_types"": [{""preferred_term"": ""Skeletal Muscle Cell"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}], ""description"": ""Autoantibodies (primarily anti-AChR) target the postsynaptic membrane at neuromuscular junctions. Antibodies cause receptor internalization, complement-mediated destruction, and functional blockade, reducing acetylcholine signaling efficiency.\n"", ""evidence"": [{""explanation"": ""Confirms that autoantibodies targeting the AChR complex at the NMJ are central to myasthenia gravis pathophysiology."", ""reference"": ""PMID:37869140"", ""snippet"": ""Myasthenia gravis is a prototypic neuroimmune disorder with autoantibodies targeting the acetylcholine receptor complex at the neuromuscular junction."", ""supports"": ""SUPPORT""}, {""explanation"": ""Documents the prevalence of AChR autoantibodies in generalized myasthenia gravis."", ""reference"": ""PMID:29266249"", ""snippet"": ""Approximately 74-88% of patients with gMG have acetylcholine receptor (AChR) autoantibodies."", ""supports"": ""SUPPORT""}], ""name"": ""Autoantibody-Mediated NMJ Dysfunction""}"
5337	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	1	Complement Activation	"Anti-AChR antibodies activate the classical complement pathway, leading to membrane attack complex formation and destruction of the postsynaptic membrane architecture.
"																																																								"{""description"": ""Anti-AChR antibodies activate the classical complement pathway, leading to membrane attack complex formation and destruction of the postsynaptic membrane architecture.\n"", ""name"": ""Complement Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Complement Activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""description"": ""Anti-AChR antibodies activate the classical complement pathway, leading to membrane attack complex formation and destruction of the postsynaptic membrane architecture.\n"", ""evidence"": [{""explanation"": ""Describes how complement activation leads to MAC formation and subsequent membrane damage."", ""reference"": ""PMID:29266249"", ""snippet"": ""activation and amplification of complement results in the formation of membrane attack complexes (MACs), lipophilic proteins that damage cell membranes."", ""supports"": ""SUPPORT""}, {""explanation"": ""Animal studies demonstrate that MAC formation is essential for NMJ damage in myasthenia gravis."", ""reference"": ""PMID:29266249"", ""snippet"": ""Studies in animals lacking specific complement proteins have confirmed that MAC formation is required to induce experimental autoimmune MG (EAMG) and NMJ damage."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms that AChR antibodies (IgG1 and IgG3) activate complement, contributing to NMJ damage."", ""reference"": ""PMID:37869140"", ""snippet"": ""Acetylcholine receptor antibodies are present in the majority of patients and are of IgG1 and IgG3 subtypes which can activate the complement system. The complement involvement plays a major role in the neuromuscular junction damage."", ""supports"": ""SUPPORT""}], ""name"": ""Complement Activation""}"
5338	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	2	Thymic Abnormalities	"Thymic hyperplasia (65-75% of patients) or thymoma (10-15%) is common. The thymus may serve as the site of autoimmunization, containing myoid cells expressing AChR that activate autoreactive T cells.
"																																																								"{""description"": ""Thymic hyperplasia (65-75% of patients) or thymoma (10-15%) is common. The thymus may serve as the site of autoimmunization, containing myoid cells expressing AChR that activate autoreactive T cells.\n"", ""name"": ""Thymic Abnormalities""}"	{}	"{""cell_types"": [{""preferred_term"": ""Thymic Epithelial Cell"", ""term"": {""id"": ""CL:0002293"", ""label"": ""epithelial cell of thymus""}}], ""description"": ""Thymic hyperplasia (65-75% of patients) or thymoma (10-15%) is common. The thymus may serve as the site of autoimmunization, containing myoid cells expressing AChR that activate autoreactive T cells.\n"", ""evidence"": [{""explanation"": ""Demonstrates that the thymus shows pathologic changes in most AChR-positive MG patients and contains all elements needed to initiate and sustain autoimmunity."", ""reference"": ""PMID:21922466"", ""snippet"": ""The thymus plays a major role in the pathogenesis of MG with anti-AChR antibodies: it shows marked pathologic alterations (hyperplastic or tumoral) in most AChR-positive patients and contains the elements required to initiate and sustain an autoimmune reaction (AChR autoantigen, AChR-specific T cells, and autoantibody-secreting plasma cells)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms the autoimmune nature of myasthenia gravis with autoantibodies targeting NMJ components."", ""reference"": ""PMID:21922466"", ""snippet"": ""Myasthenia gravis (MG) is an autoimmune disorder caused, in most cases, by autoantibodies against components of the neuromuscular junction, frequently the acetylcholine receptor (AChR), and less often the muscle-specific kinase receptor."", ""supports"": ""SUPPORT""}], ""name"": ""Thymic Abnormalities""}"
5355	223	Mycetoma	Mycetoma.yaml	pathophysiology	0	Cutaneous and subcutaneous infection by fungi or bacteria	Mycetoma includes fungal (eumycetoma) and bacterial (actinomycetoma) infections.																																																								"{""description"": ""Mycetoma includes fungal (eumycetoma) and bacterial (actinomycetoma) infections."", ""name"": ""Cutaneous and subcutaneous infection by fungi or bacteria""}"	{}	"{""description"": ""Mycetoma includes fungal (eumycetoma) and bacterial (actinomycetoma) infections."", ""evidence"": [{""explanation"": ""The abstract defines mycetoma as fungal or bacterial cutaneous/subcutaneous infection."", ""reference"": ""PMID:35887499"", ""snippet"": ""Mycetoma describes a heterogeneous group of cutaneous and subcutaneous infections caused by either fungi (eumycetomas) or bacteria (actinomycetomas)."", ""supports"": ""SUPPORT""}], ""name"": ""Cutaneous and subcutaneous infection by fungi or bacteria""}"
5361	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	0	NPM1 Cytoplasmic Mislocalization	NPM1 is a nucleolar phosphoprotein that shuttles between the nucleolus, nucleoplasm, and cytoplasm. Wild-type NPM1 localizes predominantly to nucleoli due to a C-terminal nucleolar localization signal. Mutations in exon 12 disrupt this signal and create a nuclear export signal, causing aberrant cytoplasmic accumulation (NPMc+). This depletes nucleolar NPM1, disrupting its normal functions.																																																								"{""description"": ""NPM1 is a nucleolar phosphoprotein that shuttles between the nucleolus, nucleoplasm, and cytoplasm. Wild-type NPM1 localizes predominantly to nucleoli due to a C-terminal nucleolar localization signal. Mutations in exon 12 disrupt this signal and create a nuclear export signal, causing aberrant cytoplasmic accumulation (NPMc+). This depletes nucleolar NPM1, disrupting its normal functions."", ""name"": ""NPM1 Cytoplasmic Mislocalization""}"	"{""downstream"": [{""description"": ""Cytoplasmic NPM1 sequesters ARF away from MDM2, destabilizing p53"", ""target"": ""ARF-p53 Pathway Disruption""}, {""description"": ""NPM1 mutation upregulates HOXA and HOXB gene clusters"", ""target"": ""HOX Gene Dysregulation""}]}"	"{""cell_types"": [{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}], ""description"": ""NPM1 is a nucleolar phosphoprotein that shuttles between the nucleolus, nucleoplasm, and cytoplasm. Wild-type NPM1 localizes predominantly to nucleoli due to a C-terminal nucleolar localization signal. Mutations in exon 12 disrupt this signal and create a nuclear export signal, causing aberrant cytoplasmic accumulation (NPMc+). This depletes nucleolar NPM1, disrupting its normal functions."", ""downstream"": [{""description"": ""Cytoplasmic NPM1 sequesters ARF away from MDM2, destabilizing p53"", ""target"": ""ARF-p53 Pathway Disruption""}, {""description"": ""NPM1 mutation upregulates HOXA and HOXB gene clusters"", ""target"": ""HOX Gene Dysregulation""}], ""evidence"": [{""explanation"": ""This abstract identifies cytoplasmic NPM1 as a hallmark of NPM1-mutated AML, supporting the mislocalization mechanism."", ""reference"": ""PMID:40647396"", ""snippet"": ""The aberrant localization of the mutated nucleophosmin (NPM1) protein in the cytoplasm is the hallmark of the development of acute myeloid leukemia (AML)"", ""supports"": ""SUPPORT""}], ""name"": ""NPM1 Cytoplasmic Mislocalization""}"
5362	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	1	ARF-p53 Pathway Disruption	Wild-type NPM1 stabilizes the ARF tumor suppressor in the nucleolus. Cytoplasmic NPM1 delocalizes ARF, reducing its ability to inhibit MDM2 and stabilize p53. This impairs the p53-mediated response to oncogenic stress and DNA damage.																																																								"{""description"": ""Wild-type NPM1 stabilizes the ARF tumor suppressor in the nucleolus. Cytoplasmic NPM1 delocalizes ARF, reducing its ability to inhibit MDM2 and stabilize p53. This impairs the p53-mediated response to oncogenic stress and DNA damage."", ""name"": ""ARF-p53 Pathway Disruption""}"	"{""downstream"": [{""description"": ""Reduced p53 activity impairs cell cycle arrest and apoptosis"", ""target"": ""Impaired Tumor Suppression""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""Wild-type NPM1 stabilizes the ARF tumor suppressor in the nucleolus. Cytoplasmic NPM1 delocalizes ARF, reducing its ability to inhibit MDM2 and stabilize p53. This impairs the p53-mediated response to oncogenic stress and DNA damage."", ""downstream"": [{""description"": ""Reduced p53 activity impairs cell cycle arrest and apoptosis"", ""target"": ""Impaired Tumor Suppression""}], ""name"": ""ARF-p53 Pathway Disruption""}"
5363	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	2	HOX Gene Dysregulation	NPM1-mutated AML consistently shows upregulation of HOXA and HOXB cluster genes, including HOXA9 and MEIS1. These transcription factors promote self-renewal of leukemic cells and block normal myeloid differentiation. This HOX signature is a defining feature of NPM1-mutated AML.																																																								"{""description"": ""NPM1-mutated AML consistently shows upregulation of HOXA and HOXB cluster genes, including HOXA9 and MEIS1. These transcription factors promote self-renewal of leukemic cells and block normal myeloid differentiation. This HOX signature is a defining feature of NPM1-mutated AML."", ""name"": ""HOX Gene Dysregulation""}"	"{""downstream"": [{""description"": ""HOX/MEIS1 overexpression maintains immature blast phenotype"", ""target"": ""Differentiation Block""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""myeloid cell differentiation"", ""term"": {""id"": ""GO:0030099"", ""label"": ""myeloid cell differentiation""}}], ""cell_types"": [{""preferred_term"": ""myeloblast"", ""term"": {""id"": ""CL:0000835"", ""label"": ""myeloblast""}}], ""description"": ""NPM1-mutated AML consistently shows upregulation of HOXA and HOXB cluster genes, including HOXA9 and MEIS1. These transcription factors promote self-renewal of leukemic cells and block normal myeloid differentiation. This HOX signature is a defining feature of NPM1-mutated AML."", ""downstream"": [{""description"": ""HOX/MEIS1 overexpression maintains immature blast phenotype"", ""target"": ""Differentiation Block""}], ""name"": ""HOX Gene Dysregulation""}"
5364	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	3	Impaired Tumor Suppression	The combined effects of ARF-p53 pathway disruption and loss of NPM1 nucleolar functions impair the cell's ability to respond to oncogenic signals with appropriate growth arrest or apoptosis.																																																								"{""description"": ""The combined effects of ARF-p53 pathway disruption and loss of NPM1 nucleolar functions impair the cell's ability to respond to oncogenic signals with appropriate growth arrest or apoptosis."", ""name"": ""Impaired Tumor Suppression""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}], ""description"": ""The combined effects of ARF-p53 pathway disruption and loss of NPM1 nucleolar functions impair the cell's ability to respond to oncogenic signals with appropriate growth arrest or apoptosis."", ""name"": ""Impaired Tumor Suppression""}"
5365	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	4	Differentiation Block	NPM1-mutated AML blasts show a characteristic partial differentiation with monocytic features. The HOX gene signature and NPM1 cytoplasmic localization maintain the cells in a progenitor state while allowing some differentiation along the myelomonocytic lineage.																																																								"{""description"": ""NPM1-mutated AML blasts show a characteristic partial differentiation with monocytic features. The HOX gene signature and NPM1 cytoplasmic localization maintain the cells in a progenitor state while allowing some differentiation along the myelomonocytic lineage."", ""name"": ""Differentiation Block""}"	{}	"{""cell_types"": [{""preferred_term"": ""myeloid cell"", ""term"": {""id"": ""CL:0000763"", ""label"": ""myeloid cell""}}], ""description"": ""NPM1-mutated AML blasts show a characteristic partial differentiation with monocytic features. The HOX gene signature and NPM1 cytoplasmic localization maintain the cells in a progenitor state while allowing some differentiation along the myelomonocytic lineage."", ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Differentiation Block""}"
5379	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	0	NRAS Q61 Oncogenic Mutation	NRAS mutations at codon 61 (Q61R, Q61K, Q61L) impair intrinsic GTPase activity and reduce sensitivity to GTPase-activating proteins (GAPs), resulting in constitutively GTP-bound active NRAS. This locks the protein in its active conformation, continuously stimulating downstream effector pathways.																																																								"{""description"": ""NRAS mutations at codon 61 (Q61R, Q61K, Q61L) impair intrinsic GTPase activity and reduce sensitivity to GTPase-activating proteins (GAPs), resulting in constitutively GTP-bound active NRAS. This locks the protein in its active conformation, continuously stimulating downstream effector pathways."", ""name"": ""NRAS Q61 Oncogenic Mutation""}"	"{""downstream"": [{""description"": ""Active RAS simultaneously engages RAF-MEK-ERK and PI3K-AKT cascades"", ""target"": ""Dual MAPK and PI3K Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""cell_types"": [{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}], ""description"": ""NRAS mutations at codon 61 (Q61R, Q61K, Q61L) impair intrinsic GTPase activity and reduce sensitivity to GTPase-activating proteins (GAPs), resulting in constitutively GTP-bound active NRAS. This locks the protein in its active conformation, continuously stimulating downstream effector pathways."", ""downstream"": [{""description"": ""Active RAS simultaneously engages RAF-MEK-ERK and PI3K-AKT cascades"", ""target"": ""Dual MAPK and PI3K Pathway Activation""}], ""evidence"": [{""explanation"": ""This abstract reports hotspot NRAS mutations in a substantial fraction of cutaneous melanomas, supporting the NRAS-mutant subtype."", ""reference"": ""PMID:40023845"", ""snippet"": ""Hotspot BRAF, hotspot NRAS, and NF1 loss-of-function mutations are found in approximately 50%, 25%, and 15% of cutaneous melanomas, respectively."", ""supports"": ""SUPPORT""}], ""name"": ""NRAS Q61 Oncogenic Mutation""}"
5380	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	1	Dual MAPK and PI3K Pathway Activation	Unlike BRAF mutations that primarily activate MAPK signaling, oncogenic NRAS simultaneously activates both the RAF-MEK-ERK (MAPK) pathway and the PI3K-AKT pathway. This dual pathway activation contributes to the aggressive biology and relative treatment resistance of NRAS-mutant melanoma.																																																								"{""description"": ""Unlike BRAF mutations that primarily activate MAPK signaling, oncogenic NRAS simultaneously activates both the RAF-MEK-ERK (MAPK) pathway and the PI3K-AKT pathway. This dual pathway activation contributes to the aggressive biology and relative treatment resistance of NRAS-mutant melanoma."", ""name"": ""Dual MAPK and PI3K Pathway Activation""}"	"{""downstream"": [{""description"": ""MAPK signaling drives cell cycle progression"", ""target"": ""Uncontrolled Melanocyte Proliferation""}, {""description"": ""PI3K-AKT pathway promotes survival through multiple mechanisms"", ""target"": ""Enhanced Cell Survival""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""Unlike BRAF mutations that primarily activate MAPK signaling, oncogenic NRAS simultaneously activates both the RAF-MEK-ERK (MAPK) pathway and the PI3K-AKT pathway. This dual pathway activation contributes to the aggressive biology and relative treatment resistance of NRAS-mutant melanoma."", ""downstream"": [{""description"": ""MAPK signaling drives cell cycle progression"", ""target"": ""Uncontrolled Melanocyte Proliferation""}, {""description"": ""PI3K-AKT pathway promotes survival through multiple mechanisms"", ""target"": ""Enhanced Cell Survival""}], ""name"": ""Dual MAPK and PI3K Pathway Activation""}"
5381	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	2	Uncontrolled Melanocyte Proliferation	Constitutive MAPK pathway activation downstream of mutant NRAS drives melanocyte proliferation through ERK-mediated transcriptional programs promoting cell cycle entry and progression.																																																								"{""description"": ""Constitutive MAPK pathway activation downstream of mutant NRAS drives melanocyte proliferation through ERK-mediated transcriptional programs promoting cell cycle entry and progression."", ""name"": ""Uncontrolled Melanocyte Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}], ""description"": ""Constitutive MAPK pathway activation downstream of mutant NRAS drives melanocyte proliferation through ERK-mediated transcriptional programs promoting cell cycle entry and progression."", ""locations"": [{""preferred_term"": ""skin of body"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}], ""name"": ""Uncontrolled Melanocyte Proliferation""}"
5382	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	3	Enhanced Cell Survival	PI3K-AKT pathway activation downstream of NRAS promotes melanoma cell survival through phosphorylation and inactivation of pro-apoptotic proteins, activation of mTOR signaling, and metabolic reprogramming. This contributes to therapy resistance and the need for combination treatment strategies.																																																								"{""description"": ""PI3K-AKT pathway activation downstream of NRAS promotes melanoma cell survival through phosphorylation and inactivation of pro-apoptotic proteins, activation of mTOR signaling, and metabolic reprogramming. This contributes to therapy resistance and the need for combination treatment strategies."", ""name"": ""Enhanced Cell Survival""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""PI3K-AKT pathway activation downstream of NRAS promotes melanoma cell survival through phosphorylation and inactivation of pro-apoptotic proteins, activation of mTOR signaling, and metabolic reprogramming. This contributes to therapy resistance and the need for combination treatment strategies."", ""name"": ""Enhanced Cell Survival""}"
5396	226	NTRK Fusion-Positive Cancer	NTRK_Fusion_Positive_Cancer.yaml	pathophysiology	0	NTRK Gene Fusion and Constitutive TRK Activation	Chromosomal rearrangements fuse the kinase domain of NTRK genes with various upstream partners that provide dimerization domains. This creates constitutively active chimeric TRK proteins that signal independently of neurotrophin ligands.																																																								"{""description"": ""Chromosomal rearrangements fuse the kinase domain of NTRK genes with various upstream partners that provide dimerization domains. This creates constitutively active chimeric TRK proteins that signal independently of neurotrophin ligands."", ""name"": ""NTRK Gene Fusion and Constitutive TRK Activation""}"	"{""downstream"": [{""description"": ""TRK activation drives RAS-RAF-MEK-ERK signaling"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""TRK activation stimulates PI3K-AKT-mTOR survival signaling"", ""target"": ""PI3K-AKT Pathway Activation""}, {""description"": ""TRK activation engages phospholipase C gamma signaling"", ""target"": ""PLCgamma Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}], ""description"": ""Chromosomal rearrangements fuse the kinase domain of NTRK genes with various upstream partners that provide dimerization domains. This creates constitutively active chimeric TRK proteins that signal independently of neurotrophin ligands."", ""downstream"": [{""description"": ""TRK activation drives RAS-RAF-MEK-ERK signaling"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""TRK activation stimulates PI3K-AKT-mTOR survival signaling"", ""target"": ""PI3K-AKT Pathway Activation""}, {""description"": ""TRK activation engages phospholipase C gamma signaling"", ""target"": ""PLCgamma Pathway Activation""}], ""evidence"": [{""explanation"": ""Supports NTRK fusions as oncogenic drivers across solid tumors."", ""reference"": ""PMID:39988443"", ""snippet"": ""Fusion variations of neurotrophic receptor tyrosine kinase (NTRK) are oncogenic drivers in various solid tumors such as breast cancer, salivary gland carcinoma, infant fibrosarcoma, etc."", ""supports"": ""SUPPORT""}], ""name"": ""NTRK Gene Fusion and Constitutive TRK Activation""}"
5397	226	NTRK Fusion-Positive Cancer	NTRK_Fusion_Positive_Cancer.yaml	pathophysiology	1	RAS-MAPK Pathway Activation	Constitutive TRK activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting uncontrolled cell proliferation. This is a major effector pathway of TRK-mediated oncogenesis.																																																								"{""description"": ""Constitutive TRK activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting uncontrolled cell proliferation. This is a major effector pathway of TRK-mediated oncogenesis."", ""name"": ""RAS-MAPK Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""Constitutive TRK activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting uncontrolled cell proliferation. This is a major effector pathway of TRK-mediated oncogenesis."", ""name"": ""RAS-MAPK Pathway Activation""}"
5398	226	NTRK Fusion-Positive Cancer	NTRK_Fusion_Positive_Cancer.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	TRK activation recruits PI3K and stimulates AKT-mTOR signaling, promoting cell survival and resistance to apoptosis. Combined with MAPK activation, this drives aggressive tumor growth.																																																								"{""description"": ""TRK activation recruits PI3K and stimulates AKT-mTOR signaling, promoting cell survival and resistance to apoptosis. Combined with MAPK activation, this drives aggressive tumor growth."", ""name"": ""PI3K-AKT Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""TRK activation recruits PI3K and stimulates AKT-mTOR signaling, promoting cell survival and resistance to apoptosis. Combined with MAPK activation, this drives aggressive tumor growth."", ""name"": ""PI3K-AKT Pathway Activation""}"
5413	227	Narcolepsy	Narcolepsy.yaml	pathophysiology	0	Orexin/Hypocretin Deficiency	"Loss of orexin-producing neurons in the lateral hypothalamus leads to instability of sleep-wake states. Orexin normally promotes and stabilizes wakefulness. In Type 1 narcolepsy, >90% of orexin neurons are destroyed, likely through autoimmune mechanisms.
"																																																								"{""description"": ""Loss of orexin-producing neurons in the lateral hypothalamus leads to instability of sleep-wake states. Orexin normally promotes and stabilizes wakefulness. In Type 1 narcolepsy, >90% of orexin neurons are destroyed, likely through autoimmune mechanisms.\n"", ""name"": ""Orexin/Hypocretin Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Sleep-Wake Regulation"", ""term"": {""id"": ""GO:0042745"", ""label"": ""circadian sleep/wake cycle""}}], ""cell_types"": [{""preferred_term"": ""Orexin Neuron"", ""term"": {""id"": ""CL:0011109"", ""label"": ""hypocretin-secreting neuron""}}], ""description"": ""Loss of orexin-producing neurons in the lateral hypothalamus leads to instability of sleep-wake states. Orexin normally promotes and stabilizes wakefulness. In Type 1 narcolepsy, >90% of orexin neurons are destroyed, likely through autoimmune mechanisms.\n"", ""evidence"": [{""explanation"": ""Landmark review establishes hypocretin neuron loss as the cause of narcolepsy with cataplexy."", ""reference"": ""PMID:25728441"", ""snippet"": ""Narcolepsy with cataplexy is caused by hypocretin deficiency owing to destruction of most of the hypocretin-producing neurons in the hypothalamus."", ""supports"": ""SUPPORT""}], ""name"": ""Orexin/Hypocretin Deficiency""}"
5414	227	Narcolepsy	Narcolepsy.yaml	pathophysiology	1	Autoimmune Destruction	"Strong HLA-DQB1*06:02 association suggests autoimmune etiology. T-cell mediated destruction of hypocretin neurons is the leading hypothesis. Environmental triggers (infections, H1N1 vaccination) may initiate the autoimmune response in genetically susceptible individuals.
"																																																								"{""description"": ""Strong HLA-DQB1*06:02 association suggests autoimmune etiology. T-cell mediated destruction of hypocretin neurons is the leading hypothesis. Environmental triggers (infections, H1N1 vaccination) may initiate the autoimmune response in genetically susceptible individuals.\n"", ""name"": ""Autoimmune Destruction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Autoimmune Response"", ""term"": {""id"": ""GO:0002460"", ""label"": ""adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains""}}], ""description"": ""Strong HLA-DQB1*06:02 association suggests autoimmune etiology. T-cell mediated destruction of hypocretin neurons is the leading hypothesis. Environmental triggers (infections, H1N1 vaccination) may initiate the autoimmune response in genetically susceptible individuals.\n"", ""evidence"": [{""explanation"": ""Genetic associations with HLA and TCR loci strongly support autoimmune etiology."", ""reference"": ""PMID:25728441"", ""snippet"": ""The hypothesis that a targeted immune-mediated or autoimmune attack causes the specific degeneration of hypocretin neurons arose mainly through the discovery of genetic associations, first with the HLA-DQB1*06:02 allele and then with the T-cell receptor  locus."", ""supports"": ""SUPPORT""}, {""explanation"": ""Recent review summarizing that genetic and epidemiological evidence supports autoimmune pathogenesis."", ""reference"": ""PMID:32227223"", ""snippet"": ""Narcolepsy type 1 is hypothesized to be an autoimmune disease targeting the hypocretin/orexin neurons in the hypothalamus. Ample genetic and epidemiological evidence points in the direction of a pathogenesis involving the immune system"", ""supports"": ""SUPPORT""}, {""explanation"": ""Transcriptomic study confirms the immunological basis and T-cell involvement in narcolepsy pathogenesis."", ""reference"": ""PMID:38077397"", ""snippet"": ""NT1 is a rare, life-long sleep disorder arising as a consequence of the extensive destruction of orexin-producing hypothalamic neurons. The mechanisms involved in the destruction of orexin neurons are not yet elucidated but the association of narcolepsy with environmental triggers and genetic susceptibility (strong association with the HLA, TCRs and other immunologically-relevant loci) implicates an immuno-pathological process."", ""supports"": ""SUPPORT""}], ""name"": ""Autoimmune Destruction""}"
5437	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	0	EBV Latent Membrane Protein 1 (LMP1) Signaling	LMP1 is the primary EBV oncoprotein in NPC, functioning as a constitutively active receptor that mimics CD40 signaling. LMP1 activates NF-kB, MAPK, and PI3K/AKT pathways, promoting cell survival, proliferation, and epithelial-mesenchymal transition.																																																								"{""description"": ""LMP1 is the primary EBV oncoprotein in NPC, functioning as a constitutively active receptor that mimics CD40 signaling. LMP1 activates NF-kB, MAPK, and PI3K/AKT pathways, promoting cell survival, proliferation, and epithelial-mesenchymal transition."", ""name"": ""EBV Latent Membrane Protein 1 (LMP1) Signaling""}"	"{""downstream"": [{""description"": ""NF-kB activation induces BCL2 and other survival factors"", ""target"": ""Anti-Apoptotic Signaling""}, {""description"": ""LMP1 promotes invasive phenotype and metastasis"", ""target"": ""Epithelial-Mesenchymal Transition""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""NF-kappaB signaling"", ""term"": {""id"": ""GO:0038061"", ""label"": ""NIK/NF-kappaB signaling""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""squamous epithelial cell"", ""term"": {""id"": ""CL:0000076"", ""label"": ""squamous epithelial cell""}}], ""description"": ""LMP1 is the primary EBV oncoprotein in NPC, functioning as a constitutively active receptor that mimics CD40 signaling. LMP1 activates NF-kB, MAPK, and PI3K/AKT pathways, promoting cell survival, proliferation, and epithelial-mesenchymal transition."", ""downstream"": [{""description"": ""NF-kB activation induces BCL2 and other survival factors"", ""target"": ""Anti-Apoptotic Signaling""}, {""description"": ""LMP1 promotes invasive phenotype and metastasis"", ""target"": ""Epithelial-Mesenchymal Transition""}], ""locations"": [{""preferred_term"": ""nasopharynx"", ""term"": {""id"": ""UBERON:0001728"", ""label"": ""nasopharynx""}}], ""name"": ""EBV Latent Membrane Protein 1 (LMP1) Signaling""}"
5438	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	1	LMP2A-Mediated B Cell Receptor Mimicry	LMP2A is a viral protein that mimics an activated B cell receptor, providing survival signals that prevent viral lytic reactivation and maintain latency. In epithelial cells, LMP2A activates PI3K/AKT and promotes cell motility.																																																								"{""description"": ""LMP2A is a viral protein that mimics an activated B cell receptor, providing survival signals that prevent viral lytic reactivation and maintain latency. In epithelial cells, LMP2A activates PI3K/AKT and promotes cell motility."", ""name"": ""LMP2A-Mediated B Cell Receptor Mimicry""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""LMP2A is a viral protein that mimics an activated B cell receptor, providing survival signals that prevent viral lytic reactivation and maintain latency. In epithelial cells, LMP2A activates PI3K/AKT and promotes cell motility."", ""name"": ""LMP2A-Mediated B Cell Receptor Mimicry""}"
5439	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	2	EBNA1-Mediated Viral Maintenance	EBNA1 is essential for EBV genome replication and maintenance during latency. It tethers viral episomes to host chromosomes and contributes to genomic instability by inducing oxidative stress and interfering with DNA damage responses.																																																								"{""description"": ""EBNA1 is essential for EBV genome replication and maintenance during latency. It tethers viral episomes to host chromosomes and contributes to genomic instability by inducing oxidative stress and interfering with DNA damage responses."", ""name"": ""EBNA1-Mediated Viral Maintenance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""viral genome replication"", ""term"": {""id"": ""GO:0019079"", ""label"": ""viral genome replication""}}], ""description"": ""EBNA1 is essential for EBV genome replication and maintenance during latency. It tethers viral episomes to host chromosomes and contributes to genomic instability by inducing oxidative stress and interfering with DNA damage responses."", ""name"": ""EBNA1-Mediated Viral Maintenance""}"
5440	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	3	Host Genetic Susceptibility	Specific HLA haplotypes, particularly HLA-A2, are associated with increased NPC risk in endemic populations. Additional susceptibility loci have been identified in GWAS studies, including genes involved in immune function and DNA repair.																																																								"{""description"": ""Specific HLA haplotypes, particularly HLA-A2, are associated with increased NPC risk in endemic populations. Additional susceptibility loci have been identified in GWAS studies, including genes involved in immune function and DNA repair."", ""name"": ""Host Genetic Susceptibility""}"	{}	"{""description"": ""Specific HLA haplotypes, particularly HLA-A2, are associated with increased NPC risk in endemic populations. Additional susceptibility loci have been identified in GWAS studies, including genes involved in immune function and DNA repair."", ""genes"": [{""preferred_term"": ""HLA-A""}], ""name"": ""Host Genetic Susceptibility""}"
5441	228	Nasopharyngeal Carcinoma	Nasopharyngeal_Carcinoma.yaml	pathophysiology	4	Immune Evasion	EBV-infected NPC cells evade immune surveillance through multiple mechanisms including PD-L1 upregulation, suppression of antigen presentation, and recruitment of regulatory T cells. This provides rationale for immune checkpoint inhibition.																																																								"{""description"": ""EBV-infected NPC cells evade immune surveillance through multiple mechanisms including PD-L1 upregulation, suppression of antigen presentation, and recruitment of regulatory T cells. This provides rationale for immune checkpoint inhibition."", ""name"": ""Immune Evasion""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""negative regulation of T cell mediated immunity"", ""term"": {""id"": ""GO:0002710"", ""label"": ""negative regulation of T cell mediated immunity""}}], ""description"": ""EBV-infected NPC cells evade immune surveillance through multiple mechanisms including PD-L1 upregulation, suppression of antigen presentation, and recruitment of regulatory T cells. This provides rationale for immune checkpoint inhibition."", ""name"": ""Immune Evasion""}"
5465	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	0	Ciliary Dysfunction	Mutations in NPHP genes disrupt the structure and function of primary cilia, which are essential for cell signaling and homeostasis.																																																								"{""description"": ""Mutations in NPHP genes disrupt the structure and function of primary cilia, which are essential for cell signaling and homeostasis."", ""name"": ""Ciliary Dysfunction""}"	"{""downstream"": [{""target"": ""Impaired Cell Signaling""}]}"	"{""cell_types"": [{""preferred_term"": ""Renal Tubular Epithelial Cell"", ""term"": {""id"": ""CL:1000494"", ""label"": ""nephron tubule epithelial cell""}}], ""cellular_components"": [{""preferred_term"": ""Primary Cilium"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}], ""description"": ""Mutations in NPHP genes disrupt the structure and function of primary cilia, which are essential for cell signaling and homeostasis."", ""downstream"": [{""target"": ""Impaired Cell Signaling""}], ""evidence"": [{""explanation"": ""The provided snippet indicates that mutations in NPHP genes affect mechanisms that disrupt cellular functions related to cilia, supporting the statement that these mutations lead to impaired cilia."", ""reference"": ""PMID:19118152"", ""snippet"": ""Nephronophthisis (NPHP), a recessive cystic kidney disease... Mutations in NPHP genes cause defects in signaling mechanisms that involve the noncanonical Wnt signaling pathway and the sonic hedgehog signaling pathway, resulting in defects of planar cell polarity and tissue maintenance."", ""supports"": ""SUPPORT""}, {""explanation"": ""This statement refers to how ciliary protein gene mutations cause related ciliopathies, aligning with impaired cilia as seen in Nephronophthisis."", ""reference"": ""PMID:34183231"", ""snippet"": ""Mutations in genes encoding centriolar or ciliary proteins cause diseases collectively known as 'ciliopathies'."", ""supports"": ""SUPPORT""}, {""explanation"": ""The excerpt affirms that ciliary dysfunction is fundamental to the development of various cystic kidney diseases, including Nephronophthisis, caused by mutations affecting cilia."", ""reference"": ""PMID:21113628"", ""snippet"": ""Ciliary dysfunction has emerged as a common factor underlying the pathogenesis of both syndromic and isolated kidney cystic disease, an observation that has contributed to the unification of human genetic disorders of the cilium, the ciliopathies."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""NPHP1"", ""term"": {""id"": ""hgnc:7905"", ""label"": ""NPHP1""}}], ""name"": ""Ciliary Dysfunction""}"
5466	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	1	Impaired Cell Signaling	Defective primary cilia lead to disrupted signaling pathways including Wnt, Hedgehog, EGFR, and Hippo/YAP pathways, affecting cell differentiation, proliferation, and polarity.																																																								"{""description"": ""Defective primary cilia lead to disrupted signaling pathways including Wnt, Hedgehog, EGFR, and Hippo/YAP pathways, affecting cell differentiation, proliferation, and polarity."", ""name"": ""Impaired Cell Signaling""}"	"{""downstream"": [{""target"": ""Abnormal Cell Proliferation""}, {""target"": ""DNA Damage and Senescence""}]}"	"{""description"": ""Defective primary cilia lead to disrupted signaling pathways including Wnt, Hedgehog, EGFR, and Hippo/YAP pathways, affecting cell differentiation, proliferation, and polarity."", ""downstream"": [{""target"": ""Abnormal Cell Proliferation""}, {""target"": ""DNA Damage and Senescence""}], ""evidence"": [{""explanation"": ""This reference supports the idea that disrupted cilia function affects the Wnt and Hedgehog pathways, but it does not specify nephronophthisis directly."", ""reference"": ""PMID:19186246"", ""snippet"": ""Their importance for key developmental pathways such as Sonic Hedgehog (Shh) and Wnt is beginning to emerge. The function of nodal cilia, for example, is vital for breaking early embryonic symmetry, Shh signaling is important for tissue morphogenesis and successful Wnt signaling for organ growth and differentiation. When ciliary function is perturbed...brains form improperly."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference directly links nephronophthisis to defective cilia and mentions involvement in pathways like Wnt signaling."", ""reference"": ""PMID:22206729"", ""snippet"": ""Mutations of the ankyrin-repeat protein Inversin, a member of a diverse family of more than 12 proteins, cause nephronophthisis (NPH)...Most NPH gene products (NPHPs) localize to the cilium, and appear to control the transport of cargo protein to the cilium by forming functional networks."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the involvement of the primary cilium in Wnt signaling but does not explicitly connect it to nephronophthisis."", ""reference"": ""PMID:24162855"", ""snippet"": ""The primary cilium, a microtubule-based organelle that can serve as a signaling antenna, has been demonstrated to have a significant role in ensuring correct kidney development and function...one of the signaling pathways that requires the cilium for normal development is Wnt signaling."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference supports the idea that ciliary dysfunction affects Hedgehog signaling but focuses on neural tube defects rather than nephronophthisis."", ""reference"": ""PMID:20544799"", ""snippet"": ""mutation of proteins required for function of cilia often leads to impaired Shh signaling and to disruption of neural tube closure."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference supports the concept that defects in the primary cilia affect key signaling pathways, including the ones mentioned, in the context of nephronophthisis."", ""reference"": ""PMID:35655331"", ""snippet"": ""Ciliary dysfunction causes many human conditions termed ciliopathies...ciliopathy spectrum could be the poster child for advances and challenges in Mendelian human genetics over the past half century...illustrates many core concepts of human genetics."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired Cell Signaling"", ""pathways"": [{""preferred_term"": ""Wnt Pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}, {""preferred_term"": ""Hedgehog Pathway"", ""term"": {""id"": ""GO:0007224"", ""label"": ""smoothened signaling pathway""}}, {""preferred_term"": ""EGFR Signaling"", ""term"": {""id"": ""GO:0038127"", ""label"": ""ERBB signaling pathway""}}, {""preferred_term"": ""Hippo Signaling"", ""term"": {""id"": ""GO:0035329"", ""label"": ""hippo signaling""}}]}"
5467	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	2	Renal Tubular Dysfunction	Ciliary dysfunction in renal tubular epithelial cells impairs fluid and electrolyte balance, leading to polyuria and polydipsia.																																																								"{""description"": ""Ciliary dysfunction in renal tubular epithelial cells impairs fluid and electrolyte balance, leading to polyuria and polydipsia."", ""name"": ""Renal Tubular Dysfunction""}"	"{""downstream"": [{""target"": ""Polyuria""}, {""target"": ""Polydipsia""}, {""target"": ""Electrolyte Imbalance""}, {""target"": ""Interstitial Fibrosis""}]}"	"{""description"": ""Ciliary dysfunction in renal tubular epithelial cells impairs fluid and electrolyte balance, leading to polyuria and polydipsia."", ""downstream"": [{""target"": ""Polyuria""}, {""target"": ""Polydipsia""}, {""target"": ""Electrolyte Imbalance""}, {""target"": ""Interstitial Fibrosis""}], ""evidence"": [{""explanation"": ""The literature supports that nephronophthisis is related to ciliary dysfunction, but it does not explicitly mention polyuria and polydipsia as part of its pathophysiology."", ""reference"": ""PMID:21071979"", ""snippet"": ""Nephronophthisis is a recessive disorder of the kidney that is the leading cause of end-stage renal failure in children. Through positional cloning, many of the causative mutations have been mapped to genes involved in centrosome and cilia function."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference discusses renal tubular disorders, which can result in polyuria and electrolyte imbalance, but it does not explicitly link these to ciliary dysfunction in nephronophthisis."", ""reference"": ""PMID:16186680"", ""snippet"": ""Renal tubular disorders may affect multiple (e.g., Fanconi syndrome) or specific (e.g., nephrogenic diabetes insipidus, renal glucosuria) tubular functions. Most conditions are primary and monogenic but occasionally are secondary to other disorders."", ""supports"": ""PARTIAL""}, {""explanation"": ""While the reference discusses fluid accumulation and cyst formation in polycystic kidney disease, it does not directly link these to nephronophthisis or explicitly mention polyuria."", ""reference"": ""PMID:9790573"", ""snippet"": ""Cysts originate within the glomeruli and all tubular structures, and their growth is the result of proliferation of incompletely differentiated epithelial cells and the accumulation of fluid within the cysts."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference supports the involvement of ciliary dysfunction in various disorders but does not provide specific details on nephronophthisis and its pathophysiology related to polyuria and polydipsia."", ""reference"": ""PMID:18312782"", ""snippet"": ""Overlapping clinical entities including situs inversus, certain infertility disorders, as well as chronic respiratory infections have their roots in abnormal ciliary function."", ""supports"": ""PARTIAL""}], ""locations"": [{""preferred_term"": ""Renal Tubule"", ""term"": {""id"": ""UBERON:0009773"", ""label"": ""renal tubule""}}], ""name"": ""Renal Tubular Dysfunction""}"
5468	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	3	Interstitial Fibrosis	Chronic tubular dysfunction and inflammation lead to the accumulation of extracellular matrix and progressive interstitial fibrosis.																																																								"{""description"": ""Chronic tubular dysfunction and inflammation lead to the accumulation of extracellular matrix and progressive interstitial fibrosis."", ""name"": ""Interstitial Fibrosis""}"	{}	"{""cell_types"": [{""preferred_term"": ""Renal Interstitial Fibroblast"", ""term"": {""id"": ""CL:1000692"", ""label"": ""kidney interstitial fibroblast""}}], ""description"": ""Chronic tubular dysfunction and inflammation lead to the accumulation of extracellular matrix and progressive interstitial fibrosis."", ""evidence"": [{""explanation"": ""The diagnosis of nephronophthisis includes tubulointerstitial changes, which aligns with chronic tubular dysfunction and inflammation leading to interstitial fibrosis."", ""reference"": ""PMID:35533128"", ""snippet"": ""Diagnosis is made by a positive genetic test, or a kidney biopsy demonstrating chronic tubulointerstitial changes with thickening of the tubular basement membranes."", ""supports"": ""SUPPORT""}, {""explanation"": ""While the study focuses on lymphangiogenesis, it mentions renal interstitial fibrosis related to chronic kidney disease, of which nephronophthisis is a type."", ""reference"": ""PMID:31399984"", ""snippet"": ""Renal interstitial lymphangiogenesis is found in patients with chronic kidney disease (CKD) and a series of animal models of renal fibrosis."", ""supports"": ""PARTIAL""}], ""locations"": [{""preferred_term"": ""Kidney Interstitium"", ""term"": {""id"": ""UBERON:0005215"", ""label"": ""kidney interstitium""}}], ""name"": ""Interstitial Fibrosis""}"
5469	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	4	Renal Cyst Formation	Abnormal cell proliferation and differentiation result in the formation of cysts in the kidney tubules, contributing to the loss of renal function.																																																								"{""description"": ""Abnormal cell proliferation and differentiation result in the formation of cysts in the kidney tubules, contributing to the loss of renal function."", ""name"": ""Renal Cyst Formation""}"	"{""downstream"": [{""target"": ""Renal Insufficiency""}]}"	"{""description"": ""Abnormal cell proliferation and differentiation result in the formation of cysts in the kidney tubules, contributing to the loss of renal function."", ""downstream"": [{""target"": ""Renal Insufficiency""}], ""evidence"": [{""explanation"": ""The statement claims that abnormal cell proliferation and differentiation result in cyst formation in nephronophthisis, but the literature describes nephronophthisis as a chronic tubulo-interstitial nephritis without indicating cyst formation due to abnormal cell proliferation and differentiation as a characteristic pathophysiological mechanism. Instead, it mentions cortical microcysts in infantile forms but emphasizes interstitial fibrosis and tubular basement membrane changes."", ""reference"": ""PMID:16966065"", ""snippet"": ""Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure."", ""supports"": ""WRONG_STATEMENT""}, {""explanation"": ""While this reference discusses abnormal cilia structure and function in cystic kidney diseases, it does not specifically address nephronophthisis or the mechanism of abnormal cell proliferation and differentiation leading to renal cyst formation in nephronophthisis."", ""reference"": ""PMID:25575298"", ""snippet"": ""Almost all of proteins associated with a broad spectrum of human cystic kidney diseases have been localized to the region in or around the cilia."", ""supports"": ""NO_EVIDENCE""}], ""locations"": [{""preferred_term"": ""Renal Tubule"", ""term"": {""id"": ""UBERON:0009773"", ""label"": ""renal tubule""}}], ""name"": ""Renal Cyst Formation""}"
5470	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	5	Renal Insufficiency	The combination of tubular dysfunction, interstitial fibrosis, and cyst formation leads to a gradual decline in renal function and eventual end-stage renal disease (ESRD).																																																								"{""description"": ""The combination of tubular dysfunction, interstitial fibrosis, and cyst formation leads to a gradual decline in renal function and eventual end-stage renal disease (ESRD)."", ""name"": ""Renal Insufficiency""}"	{}	"{""description"": ""The combination of tubular dysfunction, interstitial fibrosis, and cyst formation leads to a gradual decline in renal function and eventual end-stage renal disease (ESRD)."", ""evidence"": [{""explanation"": ""The provided excerpt mentions chronic tubulo-interstitial nephritis (tubular dysfunction and interstitial fibrosis) and progression to terminal renal failure, supporting the statement that these factors contribute to ESRD."", ""reference"": ""PMID:16966065"", ""snippet"": ""Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure... Histologic lesions concern tubular basement membranes which are thickened and multilayered or thinned. There is an associated interstitial fibrosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This literature indicates the role of interstitial infiltration, fibrosis, and tubular atrophy leading to ESRD, which partially overlaps with the factors mentioned in the statement. However, cyst formation specific to nephronophthisis was not explicitly mentioned."", ""reference"": ""PMID:10352410"", ""snippet"": ""Progressive renal disease poses an increasing problem for the medical community. Though the causes of end-stage renal failure are multiple, the histologic pictures of chronic renal disease are remarkably similar being characterized by interstitial infiltration, fibrosis, tubular atrophy and dilatation."", ""supports"": ""PARTIAL""}], ""name"": ""Renal Insufficiency""}"
5471	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	6	Extrarenal Manifestations	Some forms of nephronophthisis, such as Senior-Loken syndrome, may involve other organs due to the presence of primary cilia in various tissues.																																																								"{""description"": ""Some forms of nephronophthisis, such as Senior-Loken syndrome, may involve other organs due to the presence of primary cilia in various tissues."", ""name"": ""Extrarenal Manifestations""}"	"{""subtypes"": [""Senior-Loken syndrome""]}"	"{""description"": ""Some forms of nephronophthisis, such as Senior-Loken syndrome, may involve other organs due to the presence of primary cilia in various tissues."", ""evidence"": [{""explanation"": ""The literature supports the involvement of the liver and retina in nephronophthisis but does not mention the brain specifically in this context."", ""reference"": ""PMID:35533128"", ""snippet"": ""Nephronophthisis is an autosomal recessive cystic kidney disease caused by mutations in genes that encode proteins involved in the primary cilia function, resulting in kidney disease and extrarenal manifestations such as retinal degeneration and liver fibrosis."", ""supports"": ""PARTIAL""}, {""explanation"": ""The literature supports the involvement of the retina in Senior-Loken syndrome but does not mention the liver or brain specifically in this context."", ""reference"": ""PMID:32432520"", ""snippet"": ""Senior-Lken syndrome (SLS) is a rare autosomal recessive disease characterised by nephronophthisis and retinal degeneration, and belongs to a group of genetically heterogeneous disorders known as the ciliopathies."", ""supports"": ""PARTIAL""}, {""explanation"": ""The literature supports the involvement of the retina in Senior-Loken syndrome, which is a form of nephronophthisis."", ""reference"": ""PMID:33306870"", ""snippet"": ""Senior-Loken syndrome is a rare genetic disorder that presents with nephronophthisis and retinal degeneration, leading to end-stage renal disease and progressive blindness."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference discusses the involvement of primary cilia in a broader sense but does not specify the extrarenal manifestations like those in Senior-Loken syndrome."", ""reference"": ""PMID:35655331"", ""snippet"": ""The JS phenotype alone is caused by pathogenic variants in more than 40 genes; remarkably, all of the associated proteins function in and around the primary cilium."", ""supports"": ""NO_EVIDENCE""}], ""locations"": [{""preferred_term"": ""Liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}, {""preferred_term"": ""Retina"", ""term"": {""id"": ""UBERON:0000966"", ""label"": ""retina""}}, {""preferred_term"": ""Brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}], ""name"": ""Extrarenal Manifestations"", ""subtypes"": [""Senior-Loken syndrome""]}"
5472	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	7	Progression and Severity	The age of onset and rate of progression vary depending on the specific NPHP gene mutations and the type of nephronophthisis.																																																								"{""description"": ""The age of onset and rate of progression vary depending on the specific NPHP gene mutations and the type of nephronophthisis."", ""name"": ""Progression and Severity""}"	{}	"{""description"": ""The age of onset and rate of progression vary depending on the specific NPHP gene mutations and the type of nephronophthisis."", ""evidence"": [{""explanation"": ""The reference states that there is diversity in pathophysiological features and extra-renal phenotypes among different NPHP gene types, which supports the statement that the age of onset and rate of progression vary."", ""reference"": ""PMID:34828368"", ""snippet"": ""NPHP gene types present with some common pathophysiological features alongside a diverse range of extra-renal phenotypes associated with specific syndromic presentations."", ""supports"": ""SUPPORT""}, {""explanation"": ""While this reference highlights the general management of nephronophthisis, it implies variability in progression and severity since not all individuals progress to kidney failure at the same rate."", ""reference"": ""PMID:35570616"", ""snippet"": ""Nephronophthisis is the most common genetic cause of kidney failure in childhood....Treatment for nephronophthisis is symptomatic, and kidney transplant is a good treatment option when kidney failure has developed."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference indicates variability in the progression to end-stage renal disease, supporting the statement regarding variable progression rates depending on the specific NPHP gene mutations."", ""reference"": ""PMID:35922195"", ""snippet"": ""All 6 children progressed to end-stage renal disease (ESRD) within 10 (4, 65) months of onset."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference identifies different clinical forms of nephronophthisis, which progress at different rates, thus supporting the statement on variability in age of onset and progression."", ""reference"": ""PMID:16966065"", ""snippet"": ""There are three main clinical forms of nephronophtisis which have been associated with five gene defects. Juvenile nephronophtisis, the most frequent, progress to end stage renal failure before age 15."", ""supports"": ""SUPPORT""}], ""name"": ""Progression and Severity""}"
5473	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	8	Abnormal Cell Proliferation	Dysregulated cell division and growth																																																								"{""description"": ""Dysregulated cell division and growth"", ""name"": ""Abnormal Cell Proliferation""}"	{}	"{""description"": ""Dysregulated cell division and growth"", ""name"": ""Abnormal Cell Proliferation""}"
5474	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	9	DNA Damage and Senescence	NPHP1 deficiency impairs DNA damage repair, leading to increased cellular senescence and contributing to interstitial fibrosis. Nephrocystin-1 translocates to the nucleus after DNA damage stress.																																		Recent research shows nephrocystin-1 has nuclear functions in DNA damage response beyond its ciliary role																						"{""description"": ""NPHP1 deficiency impairs DNA damage repair, leading to increased cellular senescence and contributing to interstitial fibrosis. Nephrocystin-1 translocates to the nucleus after DNA damage stress."", ""name"": ""DNA Damage and Senescence"", ""notes"": ""Recent research shows nephrocystin-1 has nuclear functions in DNA damage response beyond its ciliary role""}"	"{""downstream"": [{""target"": ""Interstitial Fibrosis""}]}"	"{""description"": ""NPHP1 deficiency impairs DNA damage repair, leading to increased cellular senescence and contributing to interstitial fibrosis. Nephrocystin-1 translocates to the nucleus after DNA damage stress."", ""downstream"": [{""target"": ""Interstitial Fibrosis""}], ""genes"": [{""preferred_term"": ""NPHP1"", ""term"": {""id"": ""hgnc:7905"", ""label"": ""NPHP1""}}], ""locations"": [{""preferred_term"": ""Nucleus"", ""term"": {""id"": ""GO:0005634"", ""label"": ""nucleus""}}, {""preferred_term"": ""Renal Tubule"", ""term"": {""id"": ""UBERON:0009773"", ""label"": ""renal tubule""}}], ""name"": ""DNA Damage and Senescence"", ""notes"": ""Recent research shows nephrocystin-1 has nuclear functions in DNA damage response beyond its ciliary role""}"
5475	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	10	Aberrant Actin Remodeling and Hippo Activation	Ciliary dysfunction leads to aberrant RhoA signaling from the centrosome, activating ROCK and engaging Hippo signaling. This contributes to cystogenesis, fibrosis, and inflammation. GEF-H1 knockdown can rescue phenotypes in NPHP1 models.																																		The cilia-actin-Hippo axis represents a convergent downstream effector of ciliary dysfunction offering potential therapeutic targets																						"{""description"": ""Ciliary dysfunction leads to aberrant RhoA signaling from the centrosome, activating ROCK and engaging Hippo signaling. This contributes to cystogenesis, fibrosis, and inflammation. GEF-H1 knockdown can rescue phenotypes in NPHP1 models."", ""name"": ""Aberrant Actin Remodeling and Hippo Activation"", ""notes"": ""The cilia-actin-Hippo axis represents a convergent downstream effector of ciliary dysfunction offering potential therapeutic targets""}"	"{""downstream"": [{""target"": ""Renal Cyst Formation""}, {""target"": ""Interstitial Fibrosis""}]}"	"{""description"": ""Ciliary dysfunction leads to aberrant RhoA signaling from the centrosome, activating ROCK and engaging Hippo signaling. This contributes to cystogenesis, fibrosis, and inflammation. GEF-H1 knockdown can rescue phenotypes in NPHP1 models."", ""downstream"": [{""target"": ""Renal Cyst Formation""}, {""target"": ""Interstitial Fibrosis""}], ""locations"": [{""preferred_term"": ""Ciliary Base"", ""term"": {""id"": ""GO:0097546"", ""label"": ""ciliary base""}}, {""preferred_term"": ""Centrosome"", ""term"": {""id"": ""GO:0005813"", ""label"": ""centrosome""}}], ""name"": ""Aberrant Actin Remodeling and Hippo Activation"", ""notes"": ""The cilia-actin-Hippo axis represents a convergent downstream effector of ciliary dysfunction offering potential therapeutic targets"", ""pathways"": [{""preferred_term"": ""Hippo Signaling"", ""term"": {""id"": ""GO:0035329"", ""label"": ""hippo signaling""}}, {""preferred_term"": ""Actin Cytoskeleton Organization"", ""term"": {""id"": ""GO:0030036"", ""label"": ""actin cytoskeleton organization""}}]}"
5501	230	Neuroblastoma	Neuroblastoma.yaml	pathophysiology	0	Neural Crest Developmental Arrest	Neuroblastoma arises from neural crest-derived sympathoadrenal progenitor cells that fail to complete differentiation. The tumor cells retain characteristics of immature neuroblasts with variable capacity for sympathetic neuronal differentiation.																																																								"{""description"": ""Neuroblastoma arises from neural crest-derived sympathoadrenal progenitor cells that fail to complete differentiation. The tumor cells retain characteristics of immature neuroblasts with variable capacity for sympathetic neuronal differentiation."", ""name"": ""Neural Crest Developmental Arrest""}"	"{""downstream"": [{""description"": ""MYCN amplification drives aggressive proliferation"", ""target"": ""MYCN-Driven Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}], ""cell_types"": [{""preferred_term"": ""neural crest derived neuroblast"", ""term"": {""id"": ""CL:0002676"", ""label"": ""neural crest derived neuroblast""}}], ""description"": ""Neuroblastoma arises from neural crest-derived sympathoadrenal progenitor cells that fail to complete differentiation. The tumor cells retain characteristics of immature neuroblasts with variable capacity for sympathetic neuronal differentiation."", ""downstream"": [{""description"": ""MYCN amplification drives aggressive proliferation"", ""target"": ""MYCN-Driven Proliferation""}], ""evidence"": [{""explanation"": ""This abstract states neuroblastoma originates from neural crest cells, supporting the developmental origin described."", ""reference"": ""PMID:41560679"", ""snippet"": ""Neuroblastoma (NB) is a pediatric solid tumor originating from neural crest cells (NCCs), which are precursors of the sympathetic nervous system."", ""supports"": ""SUPPORT""}, {""explanation"": ""Supports neural crest origin and clinical heterogeneity of neuroblastoma."", ""reference"": ""PMID:32296467"", ""snippet"": ""Neuroblastoma is a clinically heterogenous pediatric cancer of the sympathetic nervous system that originates from neural crest cells."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""adrenal gland"", ""term"": {""id"": ""UBERON:0002369"", ""label"": ""adrenal gland""}}], ""name"": ""Neural Crest Developmental Arrest""}"
5502	230	Neuroblastoma	Neuroblastoma.yaml	pathophysiology	1	MYCN-Driven Proliferation	MYCN amplification results in massive overexpression of the MYCN transcription factor, which drives cell cycle progression, inhibits differentiation, and promotes genomic instability. MYCN-amplified tumors have a distinct aggressive phenotype with rapid growth and early metastasis.																																																								"{""description"": ""MYCN amplification results in massive overexpression of the MYCN transcription factor, which drives cell cycle progression, inhibits differentiation, and promotes genomic instability. MYCN-amplified tumors have a distinct aggressive phenotype with rapid growth and early metastasis."", ""name"": ""MYCN-Driven Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""MYCN amplification results in massive overexpression of the MYCN transcription factor, which drives cell cycle progression, inhibits differentiation, and promotes genomic instability. MYCN-amplified tumors have a distinct aggressive phenotype with rapid growth and early metastasis."", ""name"": ""MYCN-Driven Proliferation""}"
5503	230	Neuroblastoma	Neuroblastoma.yaml	pathophysiology	2	ALK Signaling Activation	ALK (anaplastic lymphoma kinase) is activated by point mutations in approximately 8-10% of neuroblastomas, and by amplification in additional cases. ALK mutations are enriched in familial neuroblastoma and represent a therapeutic target for ALK inhibitors.																																																								"{""description"": ""ALK (anaplastic lymphoma kinase) is activated by point mutations in approximately 8-10% of neuroblastomas, and by amplification in additional cases. ALK mutations are enriched in familial neuroblastoma and represent a therapeutic target for ALK inhibitors."", ""name"": ""ALK Signaling Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""ALK (anaplastic lymphoma kinase) is activated by point mutations in approximately 8-10% of neuroblastomas, and by amplification in additional cases. ALK mutations are enriched in familial neuroblastoma and represent a therapeutic target for ALK inhibitors."", ""name"": ""ALK Signaling Activation""}"
5519	231	Neurofibromatosis Type 1	Neurofibromatosis_Type_1.yaml	pathophysiology	0	NF1 Tumor Suppressor Loss	Germline heterozygous NF1 mutations result in haploinsufficiency for neurofibromin function. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates neurofibromin completely, resulting in loss of RAS negative regulation and driving tumorigenesis. This follows Knudson's two-hit hypothesis.																																																								"{""description"": ""Germline heterozygous NF1 mutations result in haploinsufficiency for neurofibromin function. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates neurofibromin completely, resulting in loss of RAS negative regulation and driving tumorigenesis. This follows Knudson's two-hit hypothesis."", ""name"": ""NF1 Tumor Suppressor Loss""}"	"{""downstream"": [{""description"": ""Loss of RAS-GAP activity results in constitutive RAS-GTP accumulation"", ""target"": ""RAS-MAPK Pathway Hyperactivation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""regulation of Ras protein signal transduction"", ""term"": {""id"": ""GO:0046578"", ""label"": ""regulation of Ras protein signal transduction""}}], ""description"": ""Germline heterozygous NF1 mutations result in haploinsufficiency for neurofibromin function. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates neurofibromin completely, resulting in loss of RAS negative regulation and driving tumorigenesis. This follows Knudson's two-hit hypothesis."", ""downstream"": [{""description"": ""Loss of RAS-GAP activity results in constitutive RAS-GTP accumulation"", ""target"": ""RAS-MAPK Pathway Hyperactivation""}], ""name"": ""NF1 Tumor Suppressor Loss""}"
5520	231	Neurofibromatosis Type 1	Neurofibromatosis_Type_1.yaml	pathophysiology	1	RAS-MAPK Pathway Hyperactivation	Neurofibromin normally accelerates GTP hydrolysis on RAS proteins, promoting the inactive GDP-bound state. Loss of neurofibromin results in prolonged RAS-GTP accumulation and constitutive activation of the RAS-RAF-MEK-ERK cascade, driving cell proliferation and survival.																																																								"{""description"": ""Neurofibromin normally accelerates GTP hydrolysis on RAS proteins, promoting the inactive GDP-bound state. Loss of neurofibromin results in prolonged RAS-GTP accumulation and constitutive activation of the RAS-RAF-MEK-ERK cascade, driving cell proliferation and survival."", ""name"": ""RAS-MAPK Pathway Hyperactivation""}"	"{""downstream"": [{""description"": ""RAS-MAPK activation promotes proliferation of neural crest derivatives"", ""target"": ""Uncontrolled Neural Crest Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""Ras protein signal transduction"", ""term"": {""id"": ""GO:0007265"", ""label"": ""Ras protein signal transduction""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""Neurofibromin normally accelerates GTP hydrolysis on RAS proteins, promoting the inactive GDP-bound state. Loss of neurofibromin results in prolonged RAS-GTP accumulation and constitutive activation of the RAS-RAF-MEK-ERK cascade, driving cell proliferation and survival."", ""downstream"": [{""description"": ""RAS-MAPK activation promotes proliferation of neural crest derivatives"", ""target"": ""Uncontrolled Neural Crest Cell Proliferation""}], ""name"": ""RAS-MAPK Pathway Hyperactivation""}"
5521	231	Neurofibromatosis Type 1	Neurofibromatosis_Type_1.yaml	pathophysiology	2	Uncontrolled Neural Crest Cell Proliferation	Neural crest-derived cells (Schwann cells, melanocytes) show particular dependence on RAS-MAPK signaling. Loss of neurofibromin drives uncontrolled proliferation of these cell types, resulting in neurofibromas (Schwann cell tumors) and hyperpigmented skin lesions (cafe-au-lait macules from melanocyte hyperproliferation).																																																								"{""description"": ""Neural crest-derived cells (Schwann cells, melanocytes) show particular dependence on RAS-MAPK signaling. Loss of neurofibromin drives uncontrolled proliferation of these cell types, resulting in neurofibromas (Schwann cell tumors) and hyperpigmented skin lesions (cafe-au-lait macules from melanocyte hyperproliferation)."", ""name"": ""Uncontrolled Neural Crest Cell Proliferation""}"	"{""downstream"": [{""description"": ""Proliferating neural crest derivatives form benign and malignant tumors"", ""target"": ""Tumor Development""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""Schwann cell"", ""term"": {""id"": ""CL:0002573"", ""label"": ""Schwann cell""}}], ""description"": ""Neural crest-derived cells (Schwann cells, melanocytes) show particular dependence on RAS-MAPK signaling. Loss of neurofibromin drives uncontrolled proliferation of these cell types, resulting in neurofibromas (Schwann cell tumors) and hyperpigmented skin lesions (cafe-au-lait macules from melanocyte hyperproliferation)."", ""downstream"": [{""description"": ""Proliferating neural crest derivatives form benign and malignant tumors"", ""target"": ""Tumor Development""}], ""name"": ""Uncontrolled Neural Crest Cell Proliferation""}"
5522	231	Neurofibromatosis Type 1	Neurofibromatosis_Type_1.yaml	pathophysiology	3	Tumor Development	Biallelic NF1 loss in Schwann cells drives neurofibroma formation. Most neurofibromas remain benign, but plexiform neurofibromas have 8-13% lifetime risk of transformation to malignant peripheral nerve sheath tumors (MPNST), which require additional genetic events (TP53, CDKN2A loss).																																																								"{""description"": ""Biallelic NF1 loss in Schwann cells drives neurofibroma formation. Most neurofibromas remain benign, but plexiform neurofibromas have 8-13% lifetime risk of transformation to malignant peripheral nerve sheath tumors (MPNST), which require additional genetic events (TP53, CDKN2A loss)."", ""name"": ""Tumor Development""}"	{}	"{""description"": ""Biallelic NF1 loss in Schwann cells drives neurofibroma formation. Most neurofibromas remain benign, but plexiform neurofibromas have 8-13% lifetime risk of transformation to malignant peripheral nerve sheath tumors (MPNST), which require additional genetic events (TP53, CDKN2A loss)."", ""name"": ""Tumor Development""}"
5536	232	Neuromyelitis Optica	Neuromyelitis_Optica.yaml	pathophysiology	0	AQP4-IgG-Mediated Astrocyte Injury	Autoantibodies against AQP4 bind astrocytic end-feet and trigger complement-dependent astrocyte damage, driving neuroinflammation.																																																								"{""description"": ""Autoantibodies against AQP4 bind astrocytic end-feet and trigger complement-dependent astrocyte damage, driving neuroinflammation."", ""name"": ""AQP4-IgG-Mediated Astrocyte Injury""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Autoantibodies against AQP4 bind astrocytic end-feet and trigger complement-dependent astrocyte damage, driving neuroinflammation."", ""evidence"": [{""explanation"": ""The abstract describes AQP4-IgG binding and complement-mediated astrocyte disruption."", ""reference"": ""PMID:35454180"", ""snippet"": ""In NMOSD, the autoantibody (NMO-IgG) binds to the extracellular loops of AQP4 as expressed in perivascular astrocytic end-feet and disrupts astrocytes in a complement-dependent manner."", ""supports"": ""SUPPORT""}], ""name"": ""AQP4-IgG-Mediated Astrocyte Injury""}"
5537	232	Neuromyelitis Optica	Neuromyelitis_Optica.yaml	pathophysiology	1	AQP4 Endocytosis and Complement-Independent Cytotoxicity	NMO-IgG can induce complement-independent astrocyte injury, with antibody- induced endocytosis of AQP4 implicated in this mechanism.																																																								"{""description"": ""NMO-IgG can induce complement-independent astrocyte injury, with antibody- induced endocytosis of AQP4 implicated in this mechanism."", ""name"": ""AQP4 Endocytosis and Complement-Independent Cytotoxicity""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""endocytosis"", ""term"": {""id"": ""GO:0006897"", ""label"": ""endocytosis""}}], ""description"": ""NMO-IgG can induce complement-independent astrocyte injury, with antibody- induced endocytosis of AQP4 implicated in this mechanism."", ""evidence"": [{""explanation"": ""The abstract notes complement-independent cytotoxicity and AQP4 endocytosis in NMOSD."", ""reference"": ""PMID:35454180"", ""snippet"": ""Recent studies have also demonstrated complement-independent cytotoxic effects of NMO-IgG. Antibody-induced endocytosis of AQP4 has been suggested to be involved in this mechanism."", ""supports"": ""SUPPORT""}], ""name"": ""AQP4 Endocytosis and Complement-Independent Cytotoxicity""}"
5548	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	0	Aquaporin-4 Autoimmunity	"Anti-AQP4 (NMO-IgG) antibodies bind to aquaporin-4 water channels predominantly expressed on astrocyte end-feet at the blood-brain barrier. This initiates complement-dependent cytotoxicity leading to astrocyte death, secondary oligodendrocyte damage, demyelination, and neuronal injury.
"																																																								"{""description"": ""Anti-AQP4 (NMO-IgG) antibodies bind to aquaporin-4 water channels predominantly expressed on astrocyte end-feet at the blood-brain barrier. This initiates complement-dependent cytotoxicity leading to astrocyte death, secondary oligodendrocyte damage, demyelination, and neuronal injury.\n"", ""name"": ""Aquaporin-4 Autoimmunity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Anti-AQP4 (NMO-IgG) antibodies bind to aquaporin-4 water channels predominantly expressed on astrocyte end-feet at the blood-brain barrier. This initiates complement-dependent cytotoxicity leading to astrocyte death, secondary oligodendrocyte damage, demyelination, and neuronal injury.\n"", ""evidence"": [{""explanation"": ""This review confirms that NMO-IgG binds AQP4 on astrocyte end-feet and causes complement-dependent astrocyte destruction."", ""reference"": ""PMID:35454180"", ""snippet"": ""In NMOSD, the autoantibody (NMO-IgG) binds to the extracellular loops of AQP4 as expressed in perivascular astrocytic end-feet and disrupts astrocytes in a complement-dependent manner."", ""supports"": ""SUPPORT""}], ""name"": ""Aquaporin-4 Autoimmunity""}"
5549	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	1	Complement-Mediated Astrocyte Destruction	"AQP4-IgG binding activates the classical complement cascade, leading to membrane attack complex formation and astrocyte lysis. This distinguishes NMOSD from MS where complement activation is less prominent.
"																																																								"{""description"": ""AQP4-IgG binding activates the classical complement cascade, leading to membrane attack complex formation and astrocyte lysis. This distinguishes NMOSD from MS where complement activation is less prominent.\n"", ""name"": ""Complement-Mediated Astrocyte Destruction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""complement activation, classical pathway"", ""term"": {""id"": ""GO:0006958"", ""label"": ""complement activation, classical pathway""}}], ""description"": ""AQP4-IgG binding activates the classical complement cascade, leading to membrane attack complex formation and astrocyte lysis. This distinguishes NMOSD from MS where complement activation is less prominent.\n"", ""evidence"": [{""explanation"": ""The PREVENT trial confirms that NMOSD involves complement-mediated CNS damage."", ""reference"": ""PMID:31050279"", ""snippet"": ""At least two thirds of cases are associated with aquaporin-4 antibodies (AQP4-IgG) and complement-mediated damage to the central nervous system."", ""supports"": ""SUPPORT""}], ""name"": ""Complement-Mediated Astrocyte Destruction""}"
5550	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	2	Blood-Brain Barrier Disruption	"Inflammatory infiltrates including neutrophils, eosinophils, and macrophages cross the disrupted blood-brain barrier. Granulocyte infiltration is a hallmark feature distinguishing NMOSD lesions from MS plaques.
"																																																								"{""description"": ""Inflammatory infiltrates including neutrophils, eosinophils, and macrophages cross the disrupted blood-brain barrier. Granulocyte infiltration is a hallmark feature distinguishing NMOSD lesions from MS plaques.\n"", ""name"": ""Blood-Brain Barrier Disruption""}"	{}	"{""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}, {""preferred_term"": ""eosinophil"", ""term"": {""id"": ""CL:0000771"", ""label"": ""eosinophil""}}], ""description"": ""Inflammatory infiltrates including neutrophils, eosinophils, and macrophages cross the disrupted blood-brain barrier. Granulocyte infiltration is a hallmark feature distinguishing NMOSD lesions from MS plaques.\n"", ""locations"": [{""preferred_term"": ""blood brain barrier"", ""term"": {""id"": ""UBERON:0000120"", ""label"": ""blood brain barrier""}}], ""name"": ""Blood-Brain Barrier Disruption""}"
5551	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	3	Secondary Demyelination	"Unlike MS where oligodendrocytes are primary targets, in NMOSD demyelination occurs secondary to astrocyte loss. Loss of astrocyte trophic support leads to oligodendrocyte death and myelin breakdown.
"																																																								"{""description"": ""Unlike MS where oligodendrocytes are primary targets, in NMOSD demyelination occurs secondary to astrocyte loss. Loss of astrocyte trophic support leads to oligodendrocyte death and myelin breakdown.\n"", ""name"": ""Secondary Demyelination""}"	{}	"{""biological_processes"": [{""preferred_term"": ""myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}], ""cell_types"": [{""preferred_term"": ""oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}], ""cellular_components"": [{""preferred_term"": ""myelin sheath"", ""term"": {""id"": ""GO:0043209"", ""label"": ""myelin sheath""}}], ""description"": ""Unlike MS where oligodendrocytes are primary targets, in NMOSD demyelination occurs secondary to astrocyte loss. Loss of astrocyte trophic support leads to oligodendrocyte death and myelin breakdown.\n"", ""name"": ""Secondary Demyelination""}"
5563	234	Noma	Noma.yaml	pathophysiology	0	Polymicrobial infection with tissue necrosis	Polymicrobial infection drives rapid orofacial tissue necrosis.																																																								"{""description"": ""Polymicrobial infection drives rapid orofacial tissue necrosis."", ""name"": ""Polymicrobial infection with tissue necrosis""}"	{}	"{""description"": ""Polymicrobial infection drives rapid orofacial tissue necrosis."", ""evidence"": [{""explanation"": ""The abstract attributes tissue necrosis to polymicrobial infection."", ""reference"": ""PMID:26437752"", ""snippet"": ""The characteristic tissue necrosis is produced by a polymicrobial infection."", ""supports"": ""SUPPORT""}], ""name"": ""Polymicrobial infection with tissue necrosis""}"
5583	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	0	Oncogenic Driver Mutations	Mutations in genes like EGFR, ALK, ROS1, and BRAF lead to uncontrolled cell growth and survival.																																																								"{""description"": ""Mutations in genes like EGFR, ALK, ROS1, and BRAF lead to uncontrolled cell growth and survival."", ""name"": ""Oncogenic Driver Mutations""}"	{}	"{""biological_processes"": [{""description"": ""Dysregulated RTK signaling via EGFR, ALK, MET drives proliferation and survival"", ""preferred_term"": ""transmembrane receptor protein tyrosine kinase signaling pathway"", ""term"": {""id"": ""GO:0007169"", ""label"": ""transmembrane receptor protein tyrosine kinase signaling pathway""}}, {""description"": ""Constitutive MAPK activation via KRAS, EGFR, ALK mutations"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""Mutations in genes like EGFR, ALK, ROS1, and BRAF lead to uncontrolled cell growth and survival."", ""evidence"": [{""explanation"": ""This reference confirms that mutations in genes such as EGFR, ALK, ROS1, and BRAF are recognized as driving molecular alterations that underpin the malignant phenotype of non-small cell lung cancer."", ""reference"": ""PMID:22987962"", ""snippet"": ""Mutations in EGFR best illustrate the therapeutic relevance of molecular classification. This article reviews the scope of presently known driving molecular alterations, including ROS1, BRAF, KRAS, HER2 and PIK3CA, with a special emphasis on aLK rearrangements, and outlines their potential therapeutic applications."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports that mutations in EGFR, ALK, and ROS1 genes serve as oncogenic drivers in non-small cell lung cancer, contributing to uncontrolled cell growth and survival."", ""reference"": ""PMID:29989448"", ""snippet"": ""Activating mutations in the EGFR and rearrangements in the anaplastic lymphoma kinase (ALK) or ROS proto-oncogene 1 receptor tyrosine kinase (ROS1) genes have been identified as oncogenic drivers in non-small-cell lung cancer."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference further lists EGFR, ALK, ROS1, and BRAF among the significantly mutated oncogenes in non-small cell lung cancer, thus supporting the statement."", ""reference"": ""PMID:35709927"", ""snippet"": ""The aim of the current study is to extract meaningful information from the online somatic mutation data (retrieved from cBioPortal) of 16 most significantly mutated oncogenes in non-small-cell lung cancer (NSCLC), namely EGFR, NRAS, KRAS, HER2 (ERBB2), RET, MET, ROS1, FGFR1, BRAF ... for improving our understanding of the pathobiology of the lung cancer."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference confirms the crucial role of EGFR mutations in NSCLC pathogenesis, indicating their role in driving tumor growth and survival."", ""reference"": ""PMID:31627700"", ""snippet"": ""Epidermal growth factor receptor (EGFR) mutations play an important role in the pathogenesis of non-small cell lung cancer. ... In patients with EGFR mutations, a significant improvement in therapeutic outcomes was achieved with the administration of targeted therapy using tyrosine kinase inhibitors."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports that identifying driver mutations in genes like EGFR, ALK, ROS1, and BRAF is crucial in the clinical management of NSCLC, implying their role in uncontrolled cell growth and survival."", ""reference"": ""PMID:33435440"", ""snippet"": ""Testing the presence of driver mutations in specific genes in lung tumors has thus radically changed the clinical management and outcomes of the disease. ... namely EGFR, KRAS, BRAF, MET, and HER2 mutations or amplification, as well as ALK and ROS1 fusions."", ""supports"": ""SUPPORT""}], ""name"": ""Oncogenic Driver Mutations""}"
5584	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	1	Immune Evasion	Cancer cells develop mechanisms to evade detection and destruction by the immune system.																																																								"{""description"": ""Cancer cells develop mechanisms to evade detection and destruction by the immune system."", ""name"": ""Immune Evasion""}"	{}	"{""biological_processes"": [{""description"": ""EMT programs linked to immune suppression and therapy resistance; EGFR-mutant tumors may transform to SCLC"", ""preferred_term"": ""epithelial to mesenchymal transition"", ""term"": {""id"": ""GO:0001837"", ""label"": ""epithelial to mesenchymal transition""}}], ""description"": ""Cancer cells develop mechanisms to evade detection and destruction by the immune system."", ""evidence"": [{""explanation"": ""The study indicates that non-small cell lung cancer (NSCLC) employs methods of immune evasion, which aligns with the statement."", ""reference"": ""PMID:27416962"", ""snippet"": ""We are also beginning to understand the methods of immune evasion employed by NSCLC which likely contribute to the 20% response rate to immunotherapy."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study describes immune evasion mechanisms such as HLA loss in NSCLC, supporting the statement."", ""reference"": ""PMID:29107330"", ""snippet"": ""Immune evasion is a hallmark of cancer. Losing the ability to present neoantigens through human leukocyte antigen (HLA) loss may facilitate immune evasion. ... Using LOHHLA, we find that HLA LOH occurs in 40% of non-small-cell lung cancers (NSCLCs) and is associated with a high subclonal neoantigen burden, APOBEC-mediated mutagenesis, upregulation of cytolytic activity, and PD-L1 positivity."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study discusses how NSCLC cells evade the immune system by inactivating MHC-I antigen presentation, supporting the statement."", ""reference"": ""PMID:37130455"", ""snippet"": ""Since MHC-I antigen presentation is not essential for cell growth or survival, many cancers inactivate this pathway, and thereby escape control by CD8 T cells. Such immune evasion allows cancers to progress and also become resistant to CD8 T-cell-based immunotherapies, such as checkpoint blockade."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study mentions mechanisms employed by NSCLC cells to evade immune destruction, supporting the statement."", ""reference"": ""PMID:34484217"", ""snippet"": ""These data raise the possibility that proteins with mechanical barrier function in NSCLC may be used by cancer cells to protect them from immune cell infiltration and immune-mediated destruction, which can otherwise be targeted effectively with immunotherapy or collagen therapy."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study outlines mechanisms of immune evasion in NSCLC, such as the loss of MHC class I protein expression, supporting the statement."", ""reference"": ""PMID:37086716"", ""snippet"": ""These data demonstrate that enhanced TRM-like activity prior to tumor development shapes the evolution of tumor immunogenicity and can impact immunotherapy outcomes."", ""supports"": ""SUPPORT""}], ""name"": ""Immune Evasion""}"
5585	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	2	Angiogenesis	Tumors induce the formation of new blood vessels to support their growth and metastasis.																																																								"{""description"": ""Tumors induce the formation of new blood vessels to support their growth and metastasis."", ""name"": ""Angiogenesis""}"	{}	"{""description"": ""Tumors induce the formation of new blood vessels to support their growth and metastasis."", ""evidence"": [{""explanation"": ""This reference discusses the requirement of angiogenesis in the growth and metastasis of non-small cell lung cancer (NSCLC)."", ""reference"": ""PMID:12824870"", ""snippet"": ""Angiogenesis, neovascularization from pre-existing vasculature, is necessary to supply oxygen and nutrition for tumor growth in both primary and distant organs."", ""supports"": ""SUPPORT""}, {""explanation"": ""While the primary focus is not on angiogenesis, it mentions mechanisms of tumor growth and resistance, which can be linked to angiogenesis indirectly."", ""reference"": ""PMID:36269457"", ""snippet"": ""Pathologic activation of MET can be achieved with increased number of gene copies overexpression, or decreased protein degradation through several mechanisms, including mutations, amplifications, or fusions... Besides its role as primary driver, MET activation might also mediate resistance to kinase inhibitors in NSCLC with various other actionable alterations."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference indirectly supports the statement by talking about brain metastasis and tumor progression but does not specifically focus on angiogenesis."", ""reference"": ""PMID:26222080"", ""snippet"": ""Many patients with lung cancer, breast cancer, and melanoma develop brain metastases that are resistant to conventional therapy. The median survival for untreated patients is 1 to 2 months, which may be extended to 6 months with surgery, radiotherapy, and chemotherapy."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference discusses field cancerization and the complexities of NSCLC but does not provide specific evidence related to angiogenesis."", ""reference"": ""PMID:22550239"", ""snippet"": ""Lung cancer, of which non-small cell lung cancer (NSCLC) composes the majority, is the leading cause of cancer-related deaths in the United States and worldwide... field cancerization phenomenon..."", ""supports"": ""NO_EVIDENCE""}], ""name"": ""Angiogenesis""}"
5586	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	3	Tumor Microenvironment Remodeling	Macrophage-dominant immunosuppressive niches with reduced NK and T cell cytotoxicity; tumor-associated macrophages adopt cholesterol export and iron efflux programs that suppress anti-tumor immunity.																																		Single-cell spatial mapping reveals inverse relationship between anti-inflammatory macrophages and NK/T cells																						"{""description"": ""Macrophage-dominant immunosuppressive niches with reduced NK and T cell cytotoxicity; tumor-associated macrophages adopt cholesterol export and iron efflux programs that suppress anti-tumor immunity."", ""name"": ""Tumor Microenvironment Remodeling"", ""notes"": ""Single-cell spatial mapping reveals inverse relationship between anti-inflammatory macrophages and NK/T cells""}"	{}	"{""biological_processes"": [{""description"": ""Altered T cell activation in TME; checkpoint co-expression patterns; dual ICI modulates CD4+ responses"", ""preferred_term"": ""regulation of T cell activation"", ""term"": {""id"": ""GO:0050863"", ""label"": ""regulation of T cell activation""}}], ""cell_types"": [{""description"": ""Tumor-associated macrophages (TAMs) reprogrammed to cholesterol export and iron efflux states; dominant immunosuppressive population"", ""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""description"": ""Reduced T cell infiltration and cytotoxicity in immunosuppressive niches; altered checkpoint co-expression patterns"", ""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}, {""description"": ""Reduced NK cell cytotoxicity; inverse relationship with anti-inflammatory macrophages"", ""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}, {""description"": ""Cancer-associated fibroblasts (CAFs) contribute to immunosuppressive niches and stromal remodeling"", ""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}], ""description"": ""Macrophage-dominant immunosuppressive niches with reduced NK and T cell cytotoxicity; tumor-associated macrophages adopt cholesterol export and iron efflux programs that suppress anti-tumor immunity."", ""locations"": [{""description"": ""Primary site of TME remodeling"", ""preferred_term"": ""parenchyma of lung"", ""term"": {""id"": ""UBERON:0008946"", ""label"": ""parenchyma of lung""}}], ""name"": ""Tumor Microenvironment Remodeling"", ""notes"": ""Single-cell spatial mapping reveals inverse relationship between anti-inflammatory macrophages and NK/T cells""}"
5587	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	4	Metabolic Rewiring	KRAS/LKB1 co-mutant tumors depend on oxidative pentose phosphate pathway (PPP) via G6PD for NADPH production, redox balance, and lipogenesis; G6PD ablation selectively suppresses tumor growth and activates p53.																																		Represents a therapeutically exploitable metabolic vulnerability in KRAS/LKB1 tumors																						"{""description"": ""KRAS/LKB1 co-mutant tumors depend on oxidative pentose phosphate pathway (PPP) via G6PD for NADPH production, redox balance, and lipogenesis; G6PD ablation selectively suppresses tumor growth and activates p53."", ""name"": ""Metabolic Rewiring"", ""notes"": ""Represents a therapeutically exploitable metabolic vulnerability in KRAS/LKB1 tumors""}"	{}	"{""biological_processes"": [{""description"": ""KRAS/LKB1 tumors depend on oxidative PPP via G6PD for NADPH and lipogenesis"", ""preferred_term"": ""pentose-phosphate shunt"", ""term"": {""id"": ""GO:0006098"", ""label"": ""pentose-phosphate shunt""}}, {""description"": ""G6PD impairment disrupts redox balance and activates p53"", ""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}], ""description"": ""KRAS/LKB1 co-mutant tumors depend on oxidative pentose phosphate pathway (PPP) via G6PD for NADPH production, redox balance, and lipogenesis; G6PD ablation selectively suppresses tumor growth and activates p53."", ""name"": ""Metabolic Rewiring"", ""notes"": ""Represents a therapeutically exploitable metabolic vulnerability in KRAS/LKB1 tumors""}"
5588	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	5	Metastasis	Cancer cells spread from the primary tumor site to distant organs, commonly to the brain, bones, liver, and adrenal glands.																																																								"{""description"": ""Cancer cells spread from the primary tumor site to distant organs, commonly to the brain, bones, liver, and adrenal glands."", ""name"": ""Metastasis""}"	{}	"{""description"": ""Cancer cells spread from the primary tumor site to distant organs, commonly to the brain, bones, liver, and adrenal glands."", ""evidence"": [{""explanation"": ""While this article primarily deals with small cell lung cancer (SCLC), it does mention metastasis pattern to common sites such as liver and adrenal glands, indicating support for the general concept of lung cancer metastasizing to these distant organs."", ""reference"": ""PMID:33533174"", ""snippet"": ""Our results are suggestive for particular site- and sequence-specific metastasis patterns in human SCLC. SCLC bone metastases tend to appear together with liver metastases, while brain metastases occur together with adrenal gland metastases."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article supports the statement as it mentions that NSCLC can metastasize to the brain and adrenal glands."", ""reference"": ""PMID:31151683"", ""snippet"": ""Nearly 75% of patients have a disseminated carcinoma at diagnosis. Up to 50% of patients with a localized disease will develop metastasis. Nevertheless, the current scientific evidence has demonstrated that when the metastatic disease is limited, particularly in specific locations such as the brain and the adrenal glands, a multidisciplinary approach with radical intent could achieve a longer survival."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article further supports the statement by specifying the brain as a common site for metastasis of lung cancer."", ""reference"": ""PMID:23322021"", ""snippet"": ""At least one third of the people with lung cancer develop brain metastases at some point during their disease, even often before the diagnosis of lung cancer is made. The high rate of brain metastasis makes lung cancer the most common type of tumor to spread to the brain."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although primarily focused on MET-driven tumors, this article aligns with the statement by addressing the mechanisms of how NSCLC can become metastatic."", ""reference"": ""PMID:36269457"", ""snippet"": ""Pathologic activation of MET can be achieved with increased number of gene copies overexpression, or decreased protein degradation through several mechanisms, including mutations, amplifications, or fusions. Besides its role as primary driver, MET activation might also mediate resistance to kinase inhibitors in NSCLC with various other actionable alterations."", ""supports"": ""SUPPORT""}], ""name"": ""Metastasis""}"
5613	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	0	SHP2 Gain-of-Function Activation	PTPN11 mutations destabilize the autoinhibitory interaction between the N-SH2 and PTP domains, resulting in constitutively elevated phosphatase activity. SHP2 is a positive regulator of RAS-MAPK signaling and gain-of-function mutations lead to enhanced ERK activation.																																																								"{""description"": ""PTPN11 mutations destabilize the autoinhibitory interaction between the N-SH2 and PTP domains, resulting in constitutively elevated phosphatase activity. SHP2 is a positive regulator of RAS-MAPK signaling and gain-of-function mutations lead to enhanced ERK activation."", ""name"": ""SHP2 Gain-of-Function Activation""}"	"{""downstream"": [{""description"": ""Enhanced SHP2 phosphatase activity promotes RAS activation and downstream ERK signaling."", ""target"": ""ERK Cascade Hyperactivation""}]}"	"{""biological_processes"": [{""preferred_term"": ""protein tyrosine phosphatase activity"", ""term"": {""id"": ""GO:0004725"", ""label"": ""protein tyrosine phosphatase activity""}}], ""description"": ""PTPN11 mutations destabilize the autoinhibitory interaction between the N-SH2 and PTP domains, resulting in constitutively elevated phosphatase activity. SHP2 is a positive regulator of RAS-MAPK signaling and gain-of-function mutations lead to enhanced ERK activation."", ""downstream"": [{""description"": ""Enhanced SHP2 phosphatase activity promotes RAS activation and downstream ERK signaling."", ""target"": ""ERK Cascade Hyperactivation""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""PTPN11 mutations cluster at the N-SH2/PTP interface, disrupting autoinhibition."", ""reference"": ""PMID:11992261"", ""snippet"": ""All defects were missense, and several were recurrent. The vast majority of mutations altered amino acid residues located in or around the interacting surfaces of the N-SH2 and PTP domains"", ""supports"": ""SUPPORT""}], ""name"": ""SHP2 Gain-of-Function Activation""}"
5614	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	1	SOS1-Mediated RAS-GTP Loading	SOS1 gain-of-function mutations encode guanine nucleotide exchange factor variants with enhanced activity, increasing the rate of RAS-GDP to RAS-GTP conversion and amplifying downstream MAPK signaling.																																																								"{""description"": ""SOS1 gain-of-function mutations encode guanine nucleotide exchange factor variants with enhanced activity, increasing the rate of RAS-GDP to RAS-GTP conversion and amplifying downstream MAPK signaling."", ""name"": ""SOS1-Mediated RAS-GTP Loading""}"	"{""downstream"": [{""description"": ""Enhanced RAS-GTP loading directly amplifies RAF-MEK-ERK cascade activation."", ""target"": ""ERK Cascade Hyperactivation""}]}"	"{""biological_processes"": [{""preferred_term"": ""Ras guanyl-nucleotide exchange factor activity"", ""term"": {""id"": ""GO:0005088"", ""label"": ""Ras guanyl-nucleotide exchange factor activity""}}], ""description"": ""SOS1 gain-of-function mutations encode guanine nucleotide exchange factor variants with enhanced activity, increasing the rate of RAS-GDP to RAS-GTP conversion and amplifying downstream MAPK signaling."", ""downstream"": [{""description"": ""Enhanced RAS-GTP loading directly amplifies RAF-MEK-ERK cascade activation."", ""target"": ""ERK Cascade Hyperactivation""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""SOS1 mutations are gain-of-function, enhancing RAS-GTP loading."", ""reference"": ""PMID:17143285"", ""snippet"": ""Noonan syndrome-associated SOS1 mutations are hypermorphs encoding products that enhance RAS and ERK activation."", ""supports"": ""SUPPORT""}], ""name"": ""SOS1-Mediated RAS-GTP Loading""}"
5615	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	2	RAF1 Kinase Hyperactivation	RAF1 mutations, particularly those altering Ser259 and flanking residues, disrupt 14-3-3 binding and autoinhibition, resulting in constitutively elevated serine-threonine kinase activity and enhanced MEK phosphorylation.																																																								"{""description"": ""RAF1 mutations, particularly those altering Ser259 and flanking residues, disrupt 14-3-3 binding and autoinhibition, resulting in constitutively elevated serine-threonine kinase activity and enhanced MEK phosphorylation."", ""name"": ""RAF1 Kinase Hyperactivation""}"	"{""downstream"": [{""description"": ""Hyperactive RAF1 directly phosphorylates MEK, amplifying ERK signaling."", ""target"": ""ERK Cascade Hyperactivation""}, {""description"": ""RAF1 kinase hyperactivation is strongly associated with hypertrophic cardiomyopathy development."", ""target"": ""Cardiomyocyte Hypertrophy""}]}"	"{""biological_processes"": [{""preferred_term"": ""protein serine/threonine kinase activity"", ""term"": {""id"": ""GO:0004674"", ""label"": ""protein serine/threonine kinase activity""}}], ""description"": ""RAF1 mutations, particularly those altering Ser259 and flanking residues, disrupt 14-3-3 binding and autoinhibition, resulting in constitutively elevated serine-threonine kinase activity and enhanced MEK phosphorylation."", ""downstream"": [{""description"": ""Hyperactive RAF1 directly phosphorylates MEK, amplifying ERK signaling."", ""target"": ""ERK Cascade Hyperactivation""}, {""description"": ""RAF1 kinase hyperactivation is strongly associated with hypertrophic cardiomyopathy development."", ""target"": ""Cardiomyocyte Hypertrophy""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""RAF1 mutations disrupt autoinhibitory 14-3-3 binding."", ""reference"": ""PMID:17603483"", ""snippet"": ""Most mutations altered a motif flanking Ser259, a residue critical for autoinhibition of RAF1 through 14-3-3 binding."", ""supports"": ""SUPPORT""}], ""name"": ""RAF1 Kinase Hyperactivation""}"
5616	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	3	RIT1-Mediated RAF Recruitment	RIT1 gain-of-function mutations cause aberrant membrane localization and RAF recruitment, bypassing normal RAS regulation and driving excessive MAPK pathway activation.																																																								"{""description"": ""RIT1 gain-of-function mutations cause aberrant membrane localization and RAF recruitment, bypassing normal RAS regulation and driving excessive MAPK pathway activation."", ""name"": ""RIT1-Mediated RAF Recruitment""}"	"{""downstream"": [{""description"": ""Aberrant RIT1-mediated RAF recruitment amplifies downstream ERK signaling."", ""target"": ""ERK Cascade Hyperactivation""}, {""description"": ""RIT1 mutations are strongly associated with hypertrophic cardiomyopathy."", ""target"": ""Cardiomyocyte Hypertrophy""}]}"	"{""biological_processes"": [{""preferred_term"": ""Ras protein signal transduction"", ""term"": {""id"": ""GO:0007265"", ""label"": ""Ras protein signal transduction""}}], ""description"": ""RIT1 gain-of-function mutations cause aberrant membrane localization and RAF recruitment, bypassing normal RAS regulation and driving excessive MAPK pathway activation."", ""downstream"": [{""description"": ""Aberrant RIT1-mediated RAF recruitment amplifies downstream ERK signaling."", ""target"": ""ERK Cascade Hyperactivation""}, {""description"": ""RIT1 mutations are strongly associated with hypertrophic cardiomyopathy."", ""target"": ""Cardiomyocyte Hypertrophy""}], ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""RIT1 gain-of-function mutations drive aberrant MAPK signaling."", ""reference"": ""PMID:23791108"", ""snippet"": ""These results demonstrate that gain-of-function mutations in RIT1 cause Noonan syndrome and show a similar biological effect to mutations in other RASopathy-related genes."", ""supports"": ""SUPPORT""}], ""name"": ""RIT1-Mediated RAF Recruitment""}"
5617	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	4	LZTR1-Mediated RAS Proteostasis Defect	Loss of LZTR1-mediated RAS proteostasis through CRL3 E3 ligase increases RAS-family protein levels (including MRAS, RIT1, and KRAS) and MAPK signaling. Dominant LZTR1 mutations act in a dominant-negative manner to disrupt ubiquitination and degradation of RAS proteins.																																																								"{""description"": ""Loss of LZTR1-mediated RAS proteostasis through CRL3 E3 ligase increases RAS-family protein levels (including MRAS, RIT1, and KRAS) and MAPK signaling. Dominant LZTR1 mutations act in a dominant-negative manner to disrupt ubiquitination and degradation of RAS proteins."", ""name"": ""LZTR1-Mediated RAS Proteostasis Defect""}"	"{""downstream"": [{""description"": ""Accumulated RAS proteins lead to increased basal MAPK signaling."", ""target"": ""ERK Cascade Hyperactivation""}]}"	"{""biological_processes"": [{""preferred_term"": ""protein ubiquitination"", ""term"": {""id"": ""GO:0016567"", ""label"": ""protein ubiquitination""}}, {""preferred_term"": ""regulation of proteolysis"", ""term"": {""id"": ""GO:0030162"", ""label"": ""regulation of proteolysis""}}], ""description"": ""Loss of LZTR1-mediated RAS proteostasis through CRL3 E3 ligase increases RAS-family protein levels (including MRAS, RIT1, and KRAS) and MAPK signaling. Dominant LZTR1 mutations act in a dominant-negative manner to disrupt ubiquitination and degradation of RAS proteins."", ""downstream"": [{""description"": ""Accumulated RAS proteins lead to increased basal MAPK signaling."", ""target"": ""ERK Cascade Hyperactivation""}], ""name"": ""LZTR1-Mediated RAS Proteostasis Defect""}"
5618	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	5	ERK Cascade Hyperactivation	Convergent point where all upstream RAS-MAPK pathway defects lead to sustained ERK1/2 phosphorylation and hyperactivation. This affects cell proliferation, differentiation, and survival during embryonic development and postnatal life.																																																								"{""description"": ""Convergent point where all upstream RAS-MAPK pathway defects lead to sustained ERK1/2 phosphorylation and hyperactivation. This affects cell proliferation, differentiation, and survival during embryonic development and postnatal life."", ""name"": ""ERK Cascade Hyperactivation""}"	"{""downstream"": [{""description"": ""Perturbed ERK signaling alters endocardial-mesenchymal transition during valve development."", ""target"": ""Cardiac Valve Morphogenesis Defects""}, {""description"": ""Sustained ERK signaling promotes hypertrophic growth and fetal gene reprogramming."", ""target"": ""Cardiomyocyte Hypertrophy""}]}"	"{""biological_processes"": [{""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""preferred_term"": ""regulation of ERK1 and ERK2 cascade"", ""term"": {""id"": ""GO:0070372"", ""label"": ""regulation of ERK1 and ERK2 cascade""}}], ""description"": ""Convergent point where all upstream RAS-MAPK pathway defects lead to sustained ERK1/2 phosphorylation and hyperactivation. This affects cell proliferation, differentiation, and survival during embryonic development and postnatal life."", ""downstream"": [{""description"": ""Perturbed ERK signaling alters endocardial-mesenchymal transition during valve development."", ""target"": ""Cardiac Valve Morphogenesis Defects""}, {""description"": ""Sustained ERK signaling promotes hypertrophic growth and fetal gene reprogramming."", ""target"": ""Cardiomyocyte Hypertrophy""}], ""name"": ""ERK Cascade Hyperactivation""}"
5619	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	6	Cardiac Valve Morphogenesis Defects	In endocardial and valvular tissues, perturbed ERK signaling alters endocardial-mesenchymal transition and valve morphogenesis, underlying pulmonary valve stenosis, the most common cardiac defect in Noonan syndrome.																																																								"{""description"": ""In endocardial and valvular tissues, perturbed ERK signaling alters endocardial-mesenchymal transition and valve morphogenesis, underlying pulmonary valve stenosis, the most common cardiac defect in Noonan syndrome."", ""name"": ""Cardiac Valve Morphogenesis Defects""}"	{}	"{""biological_processes"": [{""preferred_term"": ""endocardial cushion to mesenchymal transition"", ""term"": {""id"": ""GO:0001837"", ""label"": ""epithelial to mesenchymal transition involved in endocardial cushion formation""}}, {""preferred_term"": ""heart valve morphogenesis"", ""term"": {""id"": ""GO:0003179"", ""label"": ""heart valve morphogenesis""}}], ""cell_types"": [{""preferred_term"": ""endocardial cell"", ""term"": {""id"": ""CL:0002350"", ""label"": ""endocardial cell""}}], ""description"": ""In endocardial and valvular tissues, perturbed ERK signaling alters endocardial-mesenchymal transition and valve morphogenesis, underlying pulmonary valve stenosis, the most common cardiac defect in Noonan syndrome."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that pulmonary valve stenosis is highly associated with PTPN11 mutations in Noonan syndrome."", ""reference"": ""PMID:11992261"", ""snippet"": ""pulmonic stenosis was more prevalent among the group of subjects with NS who had PTPN11 mutations than it was in the group without them (70.6% vs. 46.2%; P<.01)"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""pulmonary valve"", ""term"": {""id"": ""UBERON:0002146"", ""label"": ""pulmonary valve""}}, {""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}], ""name"": ""Cardiac Valve Morphogenesis Defects""}"
5620	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	7	Cardiomyocyte Hypertrophy	In cardiomyocytes, sustained ERK signaling (and intersecting AKT/mTOR activity) promotes hypertrophic growth and fetal gene reprogramming, leading to hypertrophic cardiomyopathy, particularly in patients with RAF1 and RIT1 mutations.																																																								"{""description"": ""In cardiomyocytes, sustained ERK signaling (and intersecting AKT/mTOR activity) promotes hypertrophic growth and fetal gene reprogramming, leading to hypertrophic cardiomyopathy, particularly in patients with RAF1 and RIT1 mutations."", ""name"": ""Cardiomyocyte Hypertrophy""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cardiac muscle hypertrophy"", ""term"": {""id"": ""GO:0003300"", ""label"": ""cardiac muscle hypertrophy""}}], ""cell_types"": [{""preferred_term"": ""cardiomyocyte"", ""term"": {""id"": ""CL:0000746"", ""label"": ""cardiac muscle cell""}}], ""description"": ""In cardiomyocytes, sustained ERK signaling (and intersecting AKT/mTOR activity) promotes hypertrophic growth and fetal gene reprogramming, leading to hypertrophic cardiomyopathy, particularly in patients with RAF1 and RIT1 mutations."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates strong association between RAF1 mutations and HCM, implicating the kinase pathway in cardiac hypertrophy."", ""reference"": ""PMID:17603483"", ""snippet"": ""Of 19 subjects with a RAF1 mutation in two hotspots, 18 (or 95%) showed hypertrophic cardiomyopathy (HCM), compared with the 18% prevalence of HCM among individuals with Noonan syndrome in general."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""RIT1 mutations are strongly associated with hypertrophic cardiomyopathy."", ""reference"": ""PMID:23791108"", ""snippet"": ""Seventy percent of mutation-positive individuals presented with hypertrophic cardiomyopathy; this frequency is high relative to the overall 20% incidence in individuals with Noonan syndrome."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}], ""name"": ""Cardiomyocyte Hypertrophy""}"
5661	237	Obesity	Obesity.yaml	pathophysiology	0	Energy Imbalance	"Chronic positive energy balance from excess caloric intake relative to expenditure leads to fat accumulation. Multiple regulatory systems (leptin, ghrelin, insulin) fail to restore balance.
"																																																								"{""description"": ""Chronic positive energy balance from excess caloric intake relative to expenditure leads to fat accumulation. Multiple regulatory systems (leptin, ghrelin, insulin) fail to restore balance.\n"", ""name"": ""Energy Imbalance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Energy Homeostasis"", ""term"": {""id"": ""GO:0097009"", ""label"": ""energy homeostasis""}}], ""description"": ""Chronic positive energy balance from excess caloric intake relative to expenditure leads to fat accumulation. Multiple regulatory systems (leptin, ghrelin, insulin) fail to restore balance.\n"", ""evidence"": [{""explanation"": ""Describes the role of leptin and ghrelin as key hormones regulating energy balance in obesity."", ""reference"": ""PMID:17212793"", ""snippet"": ""Leptin is a mediator of long-term regulation of energy balance, suppressing food intake and thereby inducing weight loss. Ghrelin on the other hand is a fast-acting hormone, seemingly playing a role in meal initiation."", ""supports"": ""SUPPORT""}, {""explanation"": ""Explains the paradox of elevated leptin levels in obesity with concurrent leptin resistance, contributing to failed energy balance restoration."", ""reference"": ""PMID:17212793"", ""snippet"": ""In obese subjects the circulating level of the anorexigenic hormone leptin is increased, whereas surprisingly, the level of the orexigenic hormone ghrelin is decreased. It is now established that obese patients are leptin-resistant."", ""supports"": ""SUPPORT""}], ""name"": ""Energy Imbalance""}"
5662	237	Obesity	Obesity.yaml	pathophysiology	1	Adipose Tissue Dysfunction	"Expanded adipose tissue becomes dysfunctional with increased inflammation, altered adipokine secretion, and impaired metabolic function. Adipocyte hypertrophy leads to hypoxia and macrophage infiltration.
"																																																								"{""description"": ""Expanded adipose tissue becomes dysfunctional with increased inflammation, altered adipokine secretion, and impaired metabolic function. Adipocyte hypertrophy leads to hypoxia and macrophage infiltration.\n"", ""name"": ""Adipose Tissue Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Adipokine Secretion"", ""term"": {""id"": ""GO:0070163"", ""label"": ""regulation of adiponectin secretion""}}], ""cell_types"": [{""preferred_term"": ""Adipocyte"", ""term"": {""id"": ""CL:0000136"", ""label"": ""adipocyte""}}, {""preferred_term"": ""Adipose Tissue Macrophage"", ""term"": {""id"": ""CL:0000863"", ""label"": ""inflammatory macrophage""}}], ""description"": ""Expanded adipose tissue becomes dysfunctional with increased inflammation, altered adipokine secretion, and impaired metabolic function. Adipocyte hypertrophy leads to hypoxia and macrophage infiltration.\n"", ""evidence"": [{""explanation"": ""Describes the dynamic remodeling of adipose tissue in response to obesity, including changes in cellular composition and metabolic function."", ""reference"": ""PMID:39456156"", ""snippet"": ""Under various physiological or pathological conditions, adipose tissue shifts cellular composition, lipid storage, and organelle dynamics to respond to the stress; this remodeling is called \""adipose tissue plasticity\""."", ""supports"": ""SUPPORT""}, {""explanation"": ""Provides histological evidence of macrophage infiltration into dysfunctional adipose tissue in obesity."", ""reference"": ""PMID:14679177"", ""snippet"": ""Histologically, there is evidence of significant infiltration of macrophages, but not neutrophils and lymphocytes, into WAT of obese mice, with signs of adipocyte lipolysis and formation of multinucleate giant cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""Establishes the causal role of adipose tissue macrophages in obesity-related metabolic dysfunction."", ""reference"": ""PMID:14679177"", ""snippet"": ""These data suggest that macrophages in WAT play an active role in morbid obesity and that macrophage-related inflammatory activities may contribute to the pathogenesis of obesity-induced insulin resistance."", ""supports"": ""SUPPORT""}], ""name"": ""Adipose Tissue Dysfunction""}"
5663	237	Obesity	Obesity.yaml	pathophysiology	2	Chronic Low-Grade Inflammation	"Systemic inflammation from adipose tissue contributes to insulin resistance, cardiovascular disease, and other complications. Elevated CRP, IL-6, and TNF-alpha levels.
"																																																								"{""description"": ""Systemic inflammation from adipose tissue contributes to insulin resistance, cardiovascular disease, and other complications. Elevated CRP, IL-6, and TNF-alpha levels.\n"", ""name"": ""Chronic Low-Grade Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Systemic inflammation from adipose tissue contributes to insulin resistance, cardiovascular disease, and other complications. Elevated CRP, IL-6, and TNF-alpha levels.\n"", ""evidence"": [{""explanation"": ""Establishes both correlative and causative links between chronic inflammation and insulin resistance in obesity."", ""reference"": ""PMID:14679177"", ""snippet"": ""Increasing evidence from human population studies and animal research has established correlative as well as causative links between chronic inflammation and insulin resistance."", ""supports"": ""SUPPORT""}, {""explanation"": ""Proposes that obesity-induced insulin resistance represents a chronic inflammatory disease originating in adipose tissue."", ""reference"": ""PMID:14679177"", ""snippet"": ""We propose that obesity-related insulin resistance is, at least in part, a chronic inflammatory disease initiated in adipose tissue."", ""supports"": ""SUPPORT""}, {""explanation"": ""Highlights the central role of chronic adipose tissue inflammation in obesity-related insulin resistance."", ""reference"": ""PMID:27503945"", ""snippet"": ""Particularly chronic inflammation in adipose tissue seems to play an important role in the development of obesity-related insulin resistance."", ""supports"": ""SUPPORT""}], ""name"": ""Chronic Low-Grade Inflammation""}"
5664	237	Obesity	Obesity.yaml	pathophysiology	3	Hypothalamic Dysregulation	"Central appetite regulation becomes impaired with leptin resistance and altered reward signaling, perpetuating overeating despite adequate energy stores. Hypothalamic neuroinflammation involves microglial and astrocyte activation that impairs melanocortin signaling.
"																																																								"{""description"": ""Central appetite regulation becomes impaired with leptin resistance and altered reward signaling, perpetuating overeating despite adequate energy stores. Hypothalamic neuroinflammation involves microglial and astrocyte activation that impairs melanocortin signaling.\n"", ""name"": ""Hypothalamic Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Feeding Behavior"", ""term"": {""id"": ""GO:0007631"", ""label"": ""feeding behavior""}}], ""cell_types"": [{""preferred_term"": ""Hypothalamus Cell"", ""term"": {""id"": ""CL:2000030"", ""label"": ""hypothalamus cell""}}, {""preferred_term"": ""Microglial Cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Central appetite regulation becomes impaired with leptin resistance and altered reward signaling, perpetuating overeating despite adequate energy stores. Hypothalamic neuroinflammation involves microglial and astrocyte activation that impairs melanocortin signaling.\n"", ""evidence"": [{""explanation"": ""Describes the central hypothalamic mechanism by which leptin normally regulates energy balance."", ""reference"": ""PMID:38490517"", ""snippet"": ""Leptin acts through its receptor LepRb, expressed mainly in the hypothalamus, and induces a negative energy balance by potent inhibition of feeding and activation of energy expenditure."", ""supports"": ""SUPPORT""}, {""explanation"": ""Explains leptin resistance in obesity where elevated leptin fails to regulate energy balance through hypothalamic circuits."", ""reference"": ""PMID:38490517"", ""snippet"": ""However, the majority of patients with obesity presents elevated leptin production, suggesting that in this setting leptin is ineffective in the regulation of energy balance."", ""supports"": ""SUPPORT""}], ""name"": ""Hypothalamic Dysregulation""}"
5665	237	Obesity	Obesity.yaml	pathophysiology	4	Adipocyte Mitochondrial Dysfunction	"Obesity causes mitochondrial fragmentation in white adipocytes through RalA-mediated activation of the fission protein DRP1 (DNM1L). This leads to reduced oxidative capacity and contributes to weight gain and insulin resistance. Mitochondrial dynamics shift toward excessive fission.
"																																																								"{""description"": ""Obesity causes mitochondrial fragmentation in white adipocytes through RalA-mediated activation of the fission protein DRP1 (DNM1L). This leads to reduced oxidative capacity and contributes to weight gain and insulin resistance. Mitochondrial dynamics shift toward excessive fission.\n"", ""name"": ""Adipocyte Mitochondrial Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Mitochondrial Fission"", ""term"": {""id"": ""GO:0000266"", ""label"": ""mitochondrial fission""}}, {""preferred_term"": ""Fatty Acid Oxidation"", ""term"": {""id"": ""GO:0019395"", ""label"": ""fatty acid oxidation""}}], ""cell_types"": [{""preferred_term"": ""Adipocyte"", ""term"": {""id"": ""CL:0000136"", ""label"": ""adipocyte""}}], ""description"": ""Obesity causes mitochondrial fragmentation in white adipocytes through RalA-mediated activation of the fission protein DRP1 (DNM1L). This leads to reduced oxidative capacity and contributes to weight gain and insulin resistance. Mitochondrial dynamics shift toward excessive fission.\n"", ""evidence"": [{""explanation"": ""Demonstrates that obesity causes mitochondrial fragmentation through RalA in white adipocytes."", ""reference"": ""PMID:38286821"", ""snippet"": ""Here we show that high-fat diet (HFD) feeding causes mitochondrial fragmentation in inguinal white adipocytes from male mice, leading to reduced oxidative capacity by a process dependent on the small GTPase RalA."", ""supports"": ""SUPPORT""}, {""explanation"": ""Describes the molecular mechanism by which RalA promotes mitochondrial fission through DRP1 dephosphorylation."", ""reference"": ""PMID:38286821"", ""snippet"": ""Mechanistically, RalA increases fission in adipocytes by reversing the inhibitory Ser637 phosphorylation of the fission protein Drp1, leading to more mitochondrial fragmentation."", ""supports"": ""SUPPORT""}, {""explanation"": ""Provides human evidence linking DNM1L expression to obesity and insulin resistance."", ""reference"": ""PMID:38286821"", ""snippet"": ""Adipose tissue expression of the human homolog of Drp1, DNM1L, is positively correlated with obesity and insulin resistance."", ""supports"": ""SUPPORT""}], ""name"": ""Adipocyte Mitochondrial Dysfunction""}"
5689	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	0	Upper Airway Collapse	"During sleep, reduced muscle tone allows pharyngeal soft tissues to collapse, obstructing airflow. Anatomical factors (retrognathia, large tonsils, obesity) predispose to collapse.
"																																																								"{""description"": ""During sleep, reduced muscle tone allows pharyngeal soft tissues to collapse, obstructing airflow. Anatomical factors (retrognathia, large tonsils, obesity) predispose to collapse.\n"", ""name"": ""Upper Airway Collapse""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Muscle Relaxation"", ""term"": {""id"": ""GO:0006939"", ""label"": ""smooth muscle contraction""}}], ""description"": ""During sleep, reduced muscle tone allows pharyngeal soft tissues to collapse, obstructing airflow. Anatomical factors (retrognathia, large tonsils, obesity) predispose to collapse.\n"", ""evidence"": [{""explanation"": ""Defines the fundamental pathophysiological mechanism of OSA as recurrent airway obstruction during sleep."", ""reference"": ""PMID:38672697"", ""snippet"": ""BACKGROUND: Obstructive sleep apnea syndrome (OSAS), affecting approximately 1 billion adults globally, is characterized by recurrent airway obstruction during sleep, leading to oxygen desaturation, elevated carbon dioxide levels, and disrupted sleep architecture."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms that intermittent hypoxia results from recurrent upper airway obstruction, the primary mechanical defect in OSA."", ""reference"": ""PMID:36982552"", ""snippet"": ""Obstructive sleep apnea syndrome (OSAS) is characterized by intermittent hypoxia (IH) during sleep due to recurrent upper airway obstruction."", ""supports"": ""SUPPORT""}], ""name"": ""Upper Airway Collapse""}"
5690	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	1	Intermittent Hypoxia	"Repeated episodes of oxygen desaturation trigger oxidative stress, sympathetic activation, and systemic inflammation. Contributes to cardiovascular complications.
"																																																								"{""description"": ""Repeated episodes of oxygen desaturation trigger oxidative stress, sympathetic activation, and systemic inflammation. Contributes to cardiovascular complications.\n"", ""name"": ""Intermittent Hypoxia""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Response to Hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}], ""description"": ""Repeated episodes of oxygen desaturation trigger oxidative stress, sympathetic activation, and systemic inflammation. Contributes to cardiovascular complications.\n"", ""evidence"": [{""explanation"": ""Directly confirms that intermittent hypoxia in OSA triggers oxidative stress and cellular damage."", ""reference"": ""PMID:38672697"", ""snippet"": ""The cyclic pattern of intermittent hypoxia in OSAS triggers oxidative stress, contributing to cellular damage."", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates the molecular mechanism by which intermittent hypoxia produces oxidative stress through increased ROS and decreased antioxidant defenses."", ""reference"": ""PMID:36982552"", ""snippet"": ""IH increases oxygen free radicals (ROS) and reduces antioxidant capacities."", ""supports"": ""SUPPORT""}, {""explanation"": ""Meta-analysis of rodent models confirming that intermittent hypoxia induces oxidative stress, inflammation, and apoptosis in the brain, establishing causal mechanisms."", ""reference"": ""PMID:39694586"", ""snippet"": ""IH-induced oxidative stress (increased malondialdehyde (MDA) and NADPH oxidase (NOX) and decreased superoxide dismutase), increased inflammation (tumour necrosis factor-, NF-B and inducible nitric oxide synthase), HIF-1 and apoptosis evaluated by terminal deoxynucleotidyl transferase dUTP nick-end labelling and cleaved caspase-3."", ""supports"": ""SUPPORT""}], ""name"": ""Intermittent Hypoxia""}"
5691	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	2	Sleep Fragmentation	"Frequent arousals to restore airway patency disrupt sleep architecture, reducing restorative sleep and causing daytime sleepiness.
"																																																								"{""description"": ""Frequent arousals to restore airway patency disrupt sleep architecture, reducing restorative sleep and causing daytime sleepiness.\n"", ""name"": ""Sleep Fragmentation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Sleep Regulation"", ""term"": {""id"": ""GO:0030431"", ""label"": ""sleep""}}], ""description"": ""Frequent arousals to restore airway patency disrupt sleep architecture, reducing restorative sleep and causing daytime sleepiness.\n"", ""evidence"": [{""explanation"": ""Confirms that disrupted sleep architecture is a fundamental consequence of recurrent airway obstruction in OSA."", ""reference"": ""PMID:38672697"", ""snippet"": ""Obstructive sleep apnea syndrome (OSAS), affecting approximately 1 billion adults globally, is characterized by recurrent airway obstruction during sleep, leading to oxygen desaturation, elevated carbon dioxide levels, and disrupted sleep architecture."", ""supports"": ""SUPPORT""}], ""name"": ""Sleep Fragmentation""}"
5692	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	3	Sympathetic Overactivation	"Chronic sympathetic hyperactivity from repeated hypoxic events leads to hypertension, arrhythmias, and cardiovascular disease.
"																																																								"{""description"": ""Chronic sympathetic hyperactivity from repeated hypoxic events leads to hypertension, arrhythmias, and cardiovascular disease.\n"", ""name"": ""Sympathetic Overactivation""}"	{}	"{""description"": ""Chronic sympathetic hyperactivity from repeated hypoxic events leads to hypertension, arrhythmias, and cardiovascular disease.\n"", ""evidence"": [{""explanation"": ""Intermittent hypoxia triggers cellular stress that contributes to sympathetic activation and cardiovascular complications."", ""reference"": ""PMID:38672697"", ""snippet"": ""The cyclic pattern of intermittent hypoxia in OSAS triggers oxidative stress, contributing to cellular damage."", ""supports"": ""SUPPORT""}, {""explanation"": ""Indicates that OSA is associated with blood pressure elevation, endothelial dysfunction, and arterial stiffness, consistent with sympathetic overactivation."", ""reference"": ""PMID:39595069"", ""snippet"": ""These agents, originally developed for T2D management, have demonstrated pleiotropic effects, including significant weight loss, blood pressure reduction, and amelioration of endothelial dysfunction and arterial stiffness, along with anti-inflammatory benefits, which may be particularly beneficial in OSA."", ""supports"": ""SUPPORT""}], ""name"": ""Sympathetic Overactivation""}"
5693	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	4	Systemic Inflammation	"Intermittent hypoxia activates inflammatory pathways (NF-kB), elevating CRP, IL-6, and TNF-alpha. Contributes to metabolic dysfunction and atherosclerosis.
"																																																								"{""description"": ""Intermittent hypoxia activates inflammatory pathways (NF-kB), elevating CRP, IL-6, and TNF-alpha. Contributes to metabolic dysfunction and atherosclerosis.\n"", ""name"": ""Systemic Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Intermittent hypoxia activates inflammatory pathways (NF-kB), elevating CRP, IL-6, and TNF-alpha. Contributes to metabolic dysfunction and atherosclerosis.\n"", ""evidence"": [{""explanation"": ""Confirms that OSA is characterized by an imbalance favoring pro-inflammatory factors, resulting in heightened inflammation."", ""reference"": ""PMID:38672697"", ""snippet"": ""The review delineates the imbalance between pro-inflammatory and anti-inflammatory factors in OSAS, leading to heightened oxidative stress."", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates that systemic inflammation is a key pathophysiological feature of OSA contributing to multiple complications."", ""reference"": ""PMID:36982552"", ""snippet"": ""OS and metabolic alterations lead OSAS patients to undergo endothelial dysfunction, osteoporosis, systemic inflammation, increased cardiovascular risk, pulmonary remodeling, and neurological alterations."", ""supports"": ""SUPPORT""}, {""explanation"": ""Meta-analysis evidence showing that intermittent hypoxia induces inflammation through TNF- and NF-B activation."", ""reference"": ""PMID:39694586"", ""snippet"": ""IH-induced oxidative stress (increased malondialdehyde (MDA) and NADPH oxidase (NOX) and decreased superoxide dismutase), increased inflammation (tumour necrosis factor-, NF-B and inducible nitric oxide synthase), HIF-1 and apoptosis evaluated by terminal deoxynucleotidyl transferase dUTP nick-end labelling and cleaved caspase-3."", ""supports"": ""SUPPORT""}], ""name"": ""Systemic Inflammation""}"
5725	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	0	Cartilage Degradation	"Progressive loss of articular cartilage due to imbalance between catabolic and anabolic processes. Matrix metalloproteinases and aggrecanases degrade cartilage components.
"																																																								"{""description"": ""Progressive loss of articular cartilage due to imbalance between catabolic and anabolic processes. Matrix metalloproteinases and aggrecanases degrade cartilage components.\n"", ""name"": ""Cartilage Degradation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cartilage Catabolism"", ""term"": {""id"": ""GO:0071346"", ""label"": ""cellular response to interferon-gamma""}}], ""cell_types"": [{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}], ""description"": ""Progressive loss of articular cartilage due to imbalance between catabolic and anabolic processes. Matrix metalloproteinases and aggrecanases degrade cartilage components.\n"", ""evidence"": [{""explanation"": ""This review confirms that MMPs and ADAMTS enzymes are key factors in OA pathogenesis, supporting the role of matrix metalloproteinases and aggrecanases in cartilage degradation."", ""reference"": ""PMID:36737426"", ""snippet"": ""In this review, we first summarize the epidemiology of OA, including its prevalence, incidence and burdens, and OA risk factors. We then focus on the roles and regulation of the pathological signaling pathways, such as Wnt/-catenin, NF-B, focal adhesion, HIFs, TGF/P and FGF signaling pathways, and key regulators AMPK, mTOR, and RUNX2 in the onset and development of OA. In addition, the roles of factors associated with OA, including MMPs, ADAMTS/ADAMs, and PRG4, are discussed in detail."", ""supports"": ""SUPPORT""}, {""explanation"": ""MMP13 is specifically identified as a catabolic enzyme released during pyroptosis in OA, directly supporting the role of matrix metalloproteinases in cartilage component degradation."", ""reference"": ""PMID:38348279"", ""snippet"": ""The aggregation of GSDMD-NT proteins stimulates the release of inflammatory mediators, such as Interleukin-1 (IL-1), Interleukin-18 (IL-18), and Matrix Metallopeptidase 13 (MMP13), ultimately leading to cellular lysis."", ""supports"": ""SUPPORT""}], ""name"": ""Cartilage Degradation""}"
5726	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	1	Subchondral Bone Changes	"Bone remodeling with subchondral sclerosis, cyst formation, and osteophyte development at joint margins. Bone changes may precede and contribute to cartilage damage.
"																																																								"{""description"": ""Bone remodeling with subchondral sclerosis, cyst formation, and osteophyte development at joint margins. Bone changes may precede and contribute to cartilage damage.\n"", ""name"": ""Subchondral Bone Changes""}"	{}	"{""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}, {""preferred_term"": ""Osteoclast"", ""term"": {""id"": ""CL:0000092"", ""label"": ""osteoclast""}}], ""description"": ""Bone remodeling with subchondral sclerosis, cyst formation, and osteophyte development at joint margins. Bone changes may precede and contribute to cartilage damage.\n"", ""evidence"": [{""explanation"": ""This evidence confirms that subchondral osteoblasts undergo pathological processes (pyroptosis) contributing to OA development, supporting the role of bone cell dysfunction in disease progression."", ""reference"": ""PMID:38348279"", ""snippet"": ""The pyroptosis process in specific cells, including synovial macrophages, fibroblast-like synoviocytes (FLS), chondrocytes, and subchondral osteoblasts, contributs factor to the development of OA."", ""supports"": ""SUPPORT""}, {""explanation"": ""This review confirms the modern understanding of OA as a whole-joint disorder involving structural changes across all joint tissues, including subchondral bone, rather than just cartilage wear."", ""reference"": ""PMID:36737426"", ""snippet"": ""Osteoarthritis (OA) is a chronic degenerative joint disorder that leads to disability and affects more than 500 million population worldwide. OA was believed to be caused by the wearing and tearing of articular cartilage, but it is now more commonly referred to as a chronic whole-joint disorder that is initiated with biochemical and cellular alterations in the synovial joint tissues, which leads to the histological and structural changes of the joint and ends up with the whole tissue dysfunction."", ""supports"": ""SUPPORT""}], ""name"": ""Subchondral Bone Changes""}"
5727	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	2	Synovial Inflammation	"Low-grade synovitis with macrophage infiltration contributes to pain and cartilage destruction through inflammatory mediator release.
"																																																								"{""description"": ""Low-grade synovitis with macrophage infiltration contributes to pain and cartilage destruction through inflammatory mediator release.\n"", ""name"": ""Synovial Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Synoviocyte"", ""term"": {""id"": ""CL:0000214"", ""label"": ""synovial cell""}}, {""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Low-grade synovitis with macrophage infiltration contributes to pain and cartilage destruction through inflammatory mediator release.\n"", ""evidence"": [{""explanation"": ""This evidence demonstrates the specific mechanism by which synovial cells release inflammatory mediators (IL-1, IL-18) through pyroptosis, directly supporting the description of inflammatory mediator release in synovitis."", ""reference"": ""PMID:38348279"", ""snippet"": ""Pyroptosis is a complex process that involves three pathways culminating in the assembly of Gasdermin-D (GSDMD)-N-terminal (GSDMD-NT) into pores through aggregation on the plasma membrane. The aggregation of GSDMD-NT proteins stimulates the release of inflammatory mediators, such as Interleukin-1 (IL-1), Interleukin-18 (IL-18), and Matrix Metallopeptidase 13 (MMP13), ultimately leading to cellular lysis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms that both synovial macrophages and fibroblast-like synoviocytes undergo pyroptosis in OA, supporting the role of macrophage infiltration and synoviocyte dysfunction in disease pathogenesis."", ""reference"": ""PMID:38348279"", ""snippet"": ""The pyroptosis process in specific cells, including synovial macrophages, fibroblast-like synoviocytes (FLS), chondrocytes, and subchondral osteoblasts, contributs factor to the development of OA."", ""supports"": ""SUPPORT""}, {""explanation"": ""The NF-B signaling pathway mentioned here is a key regulator of inflammatory responses, supporting the inflammatory nature of synovial pathology in OA."", ""reference"": ""PMID:36737426"", ""snippet"": ""We then focus on the roles and regulation of the pathological signaling pathways, such as Wnt/-catenin, NF-B, focal adhesion, HIFs, TGF/P and FGF signaling pathways, and key regulators AMPK, mTOR, and RUNX2 in the onset and development of OA."", ""supports"": ""SUPPORT""}], ""name"": ""Synovial Inflammation""}"
5742	241	Osteogenesis Imperfecta Type I	Osteogenesis_Imperfecta_Type_I.yaml	pathophysiology	0	Type I Collagen Haploinsufficiency	"Null mutations in COL1A1 (nonsense, frameshift, splice site mutations causing nonsense-mediated mRNA decay) result in ~50% reduction in type I collagen production. The collagen that is produced has normal structure, explaining the milder phenotype compared to dominant-negative structural mutations.
"																																																								"{""description"": ""Null mutations in COL1A1 (nonsense, frameshift, splice site mutations causing nonsense-mediated mRNA decay) result in ~50% reduction in type I collagen production. The collagen that is produced has normal structure, explaining the milder phenotype compared to dominant-negative structural mutations.\n"", ""name"": ""Type I Collagen Haploinsufficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Collagen Fibril Organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}, {""preferred_term"": ""Bone Development"", ""term"": {""id"": ""GO:0060348"", ""label"": ""bone development""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""Null mutations in COL1A1 (nonsense, frameshift, splice site mutations causing nonsense-mediated mRNA decay) result in ~50% reduction in type I collagen production. The collagen that is produced has normal structure, explaining the milder phenotype compared to dominant-negative structural mutations.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Landmark paper demonstrating that OI type I results from 50% reduced type I procollagen synthesis due to diminished pro alpha 1(I) chain production."", ""reference"": ""PMID:1353940"", ""snippet"": ""Dermal fibroblasts from most individuals with osteogenesis imperfecta (OI) type I produce about half the normal amount of type I procollagen, as a result of decreased synthesis of one of its constituent chains, pro alpha 1 (I)."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Large clinical study (86 patients) confirming that COL1A1 haploinsufficiency specifically causes the mild type I phenotype."", ""reference"": ""PMID:23529829"", ""snippet"": ""COL1A1 haploinsufficiency mutations lead to the mildest form of osteogenesis imperfecta (OI), OI type I."", ""supports"": ""SUPPORT""}], ""name"": ""Type I Collagen Haploinsufficiency""}"
5754	242	Osteogenesis Imperfecta Type II	Osteogenesis_Imperfecta_Type_II.yaml	pathophysiology	0	Dominant-Negative Collagen Disruption	"Glycine substitutions in the Gly-X-Y repeat of the collagen triple helical domain disrupt normal helix formation. The abnormal alpha chains are incorporated into trimers, producing structurally defective collagen that cannot form proper fibrils (dominant-negative effect). This results in severe deficiency of functional bone matrix.
"																																																								"{""description"": ""Glycine substitutions in the Gly-X-Y repeat of the collagen triple helical domain disrupt normal helix formation. The abnormal alpha chains are incorporated into trimers, producing structurally defective collagen that cannot form proper fibrils (dominant-negative effect). This results in severe deficiency of functional bone matrix.\n"", ""name"": ""Dominant-Negative Collagen Disruption""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Collagen Fibril Organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}, {""preferred_term"": ""Ossification"", ""term"": {""id"": ""GO:0001503"", ""label"": ""ossification""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""Glycine substitutions in the Gly-X-Y repeat of the collagen triple helical domain disrupt normal helix formation. The abnormal alpha chains are incorporated into trimers, producing structurally defective collagen that cannot form proper fibrils (dominant-negative effect). This results in severe deficiency of functional bone matrix.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Authoritative review establishing the dominant-negative mechanism of glycine substitutions in perinatal lethal OI."", ""reference"": ""PMID:7643358"", ""snippet"": ""The mutations act in a dominant negative manner as the mutant pro alpha chains are incorporated into type I procollagen molecules that also contain normal pro alpha chains. The abnormal molecules are poorly secreted, more susceptible to degradation, and impair the formation of the extracellular matrix."", ""supports"": ""SUPPORT""}], ""name"": ""Dominant-Negative Collagen Disruption""}"
5755	242	Osteogenesis Imperfecta Type II	Osteogenesis_Imperfecta_Type_II.yaml	pathophysiology	1	ER Stress and Osteoblast Dysfunction	"Misfolded procollagen accumulates in the endoplasmic reticulum, triggering ER stress responses that impair osteoblast function and survival.
"																																																								"{""description"": ""Misfolded procollagen accumulates in the endoplasmic reticulum, triggering ER stress responses that impair osteoblast function and survival.\n"", ""name"": ""ER Stress and Osteoblast Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""ER Stress Response"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}], ""description"": ""Misfolded procollagen accumulates in the endoplasmic reticulum, triggering ER stress responses that impair osteoblast function and survival.\n"", ""name"": ""ER Stress and Osteoblast Dysfunction""}"
5765	243	Osteogenesis Imperfecta Type III	Osteogenesis_Imperfecta_Type_III.yaml	pathophysiology	0	Dominant-Negative Collagen Defect	"Structural mutations in COL1A1 or COL1A2, typically glycine substitutions in the triple helical domain, produce abnormal collagen that disrupts fibril assembly. The mutations are generally less severe than those causing type II, allowing survival but with progressive deformity.
"																																																								"{""description"": ""Structural mutations in COL1A1 or COL1A2, typically glycine substitutions in the triple helical domain, produce abnormal collagen that disrupts fibril assembly. The mutations are generally less severe than those causing type II, allowing survival but with progressive deformity.\n"", ""name"": ""Dominant-Negative Collagen Defect""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Collagen Fibril Organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}, {""preferred_term"": ""Bone Development"", ""term"": {""id"": ""GO:0060348"", ""label"": ""bone development""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""Structural mutations in COL1A1 or COL1A2, typically glycine substitutions in the triple helical domain, produce abnormal collagen that disrupts fibril assembly. The mutations are generally less severe than those causing type II, allowing survival but with progressive deformity.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Establishes glycine substitutions as the predominant mutation mechanism in OI with structural collagen defects, applicable to types II-IV."", ""reference"": ""PMID:7643358"", ""snippet"": ""Point mutations resulting in the substitution of Gly residues in Gly-X-Y amino acid triplets of the triple helical domain of the alpha 1(I) or alpha 2(I) chains are the most frequent mutations. They interrupt the repetitive Gly-X-Y structure that is mandatory for the formation of a stable triple helix."", ""supports"": ""SUPPORT""}], ""name"": ""Dominant-Negative Collagen Defect""}"
5780	244	Osteogenesis Imperfecta Type IV	Osteogenesis_Imperfecta_Type_IV.yaml	pathophysiology	0	Moderate Collagen Structural Defect	"Structural mutations in COL1A1 or COL1A2 that produce collagen with intermediate levels of dysfunction. The mutations allow more normal fibril formation than in types II/III but still compromise bone matrix integrity.
"																																																								"{""description"": ""Structural mutations in COL1A1 or COL1A2 that produce collagen with intermediate levels of dysfunction. The mutations allow more normal fibril formation than in types II/III but still compromise bone matrix integrity.\n"", ""name"": ""Moderate Collagen Structural Defect""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Collagen Fibril Organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}, {""preferred_term"": ""Bone Development"", ""term"": {""id"": ""GO:0060348"", ""label"": ""bone development""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""Structural mutations in COL1A1 or COL1A2 that produce collagen with intermediate levels of dysfunction. The mutations allow more normal fibril formation than in types II/III but still compromise bone matrix integrity.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Describes the molecular consequences of collagen structural mutations that affect bone matrix formation, applicable across the OI severity spectrum."", ""reference"": ""PMID:7643358"", ""snippet"": ""The abnormal molecules are poorly secreted, more susceptible to degradation, and impair the formation of the extracellular matrix. The collagen fibres are abnormally organised and mineralisation is impaired."", ""supports"": ""SUPPORT""}], ""name"": ""Moderate Collagen Structural Defect""}"
5792	245	Osteogenesis Imperfecta Type V	Osteogenesis_Imperfecta_Type_V.yaml	pathophysiology	0	IFITM5 Gain-of-Function	"The c.-14C>T mutation creates an upstream start codon, producing an IFITM5 protein with 5 additional N-terminal amino acids. This altered protein disrupts normal bone mineralization and matrix organization, leading to the characteristic histological and clinical features. IFITM5 (BRIL) is an osteoblast-specific protein involved in mineralization.
"																																																								"{""description"": ""The c.-14C>T mutation creates an upstream start codon, producing an IFITM5 protein with 5 additional N-terminal amino acids. This altered protein disrupts normal bone mineralization and matrix organization, leading to the characteristic histological and clinical features. IFITM5 (BRIL) is an osteoblast-specific protein involved in mineralization.\n"", ""name"": ""IFITM5 Gain-of-Function""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Bone Mineralization"", ""term"": {""id"": ""GO:0030282"", ""label"": ""bone mineralization""}}, {""preferred_term"": ""Osteoblast Differentiation"", ""term"": {""id"": ""GO:0001649"", ""label"": ""osteoblast differentiation""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""The c.-14C>T mutation creates an upstream start codon, producing an IFITM5 protein with 5 additional N-terminal amino acids. This altered protein disrupts normal bone mineralization and matrix organization, leading to the characteristic histological and clinical features. IFITM5 (BRIL) is an osteoblast-specific protein involved in mineralization.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates the mutation produces an extended N-terminal protein and establishes IFITM5 as a bone-specific protein involved in bone formation."", ""reference"": ""PMID:22863190"", ""snippet"": ""Transfection of wild-type and mutant IFITM5 constructs revealed that the mutation added five amino acids (Met-Ala-Leu-Glu-Pro) to the N terminus of IFITM5. Given that IFITM5 expression and protein localization is restricted to the skeletal tissue and IFITM5 involvement in bone formation, we conclude that this recurrent mutation would have a specific effect on IFITM5 function."", ""supports"": ""SUPPORT""}], ""name"": ""IFITM5 Gain-of-Function""}"
5805	246	Osteogenesis Imperfecta Type VII	Osteogenesis_Imperfecta_Type_VII.yaml	pathophysiology	0	Collagen 3-Hydroxylation Deficiency	"CRTAP is a component of the prolyl 3-hydroxylation complex that modifies Pro986 in the alpha1(I) chain of type I collagen. Loss of this modification delays collagen folding, causing overmodification of the helix and altered collagen structure and cross-linking.
"																																																								"{""description"": ""CRTAP is a component of the prolyl 3-hydroxylation complex that modifies Pro986 in the alpha1(I) chain of type I collagen. Loss of this modification delays collagen folding, causing overmodification of the helix and altered collagen structure and cross-linking.\n"", ""name"": ""Collagen 3-Hydroxylation Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Protein Hydroxylation"", ""term"": {""id"": ""GO:0018126"", ""label"": ""protein hydroxylation""}}, {""preferred_term"": ""Collagen Fibril Organization"", ""term"": {""id"": ""GO:0030199"", ""label"": ""collagen fibril organization""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""CRTAP is a component of the prolyl 3-hydroxylation complex that modifies Pro986 in the alpha1(I) chain of type I collagen. Loss of this modification delays collagen folding, causing overmodification of the helix and altered collagen structure and cross-linking.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Landmark Cell paper establishing CRTAP as essential for prolyl 3-hydroxylation and showing that loss leads to collagen overmodification and abnormal fibrils."", ""reference"": ""PMID:17055431"", ""snippet"": ""CRTAP can form a complex with P3H1 and cyclophilin B (CYPB), and Crtap-/- bone and cartilage collagens show decreased prolyl 3-hydroxylation. Moreover, mutant collagen shows evidence of overmodification, and collagen fibrils in mutant skin have increased diameter consistent with altered fibrillogenesis."", ""supports"": ""SUPPORT""}], ""name"": ""Collagen 3-Hydroxylation Deficiency""}"
5806	246	Osteogenesis Imperfecta Type VII	Osteogenesis_Imperfecta_Type_VII.yaml	pathophysiology	1	ER Stress from Abnormal Collagen Folding	"Delayed collagen folding leads to accumulation of procollagen in the ER, triggering ER stress and contributing to osteoblast dysfunction.
"																																																								"{""description"": ""Delayed collagen folding leads to accumulation of procollagen in the ER, triggering ER stress and contributing to osteoblast dysfunction.\n"", ""name"": ""ER Stress from Abnormal Collagen Folding""}"	{}	"{""biological_processes"": [{""preferred_term"": ""ER Stress Response"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}], ""description"": ""Delayed collagen folding leads to accumulation of procollagen in the ER, triggering ER stress and contributing to osteoblast dysfunction.\n"", ""name"": ""ER Stress from Abnormal Collagen Folding""}"
5831	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	0	Bone Remodeling Imbalance	"Increased osteoclast-mediated bone resorption relative to osteoblast- mediated bone formation leads to net bone loss. This imbalance accelerates with aging and estrogen deficiency.
"																																																								"{""description"": ""Increased osteoclast-mediated bone resorption relative to osteoblast- mediated bone formation leads to net bone loss. This imbalance accelerates with aging and estrogen deficiency.\n"", ""name"": ""Bone Remodeling Imbalance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Bone Remodeling"", ""term"": {""id"": ""GO:0046849"", ""label"": ""bone remodeling""}}], ""cell_types"": [{""preferred_term"": ""Osteoclast"", ""term"": {""id"": ""CL:0000092"", ""label"": ""osteoclast""}}, {""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""Increased osteoclast-mediated bone resorption relative to osteoblast- mediated bone formation leads to net bone loss. This imbalance accelerates with aging and estrogen deficiency.\n"", ""evidence"": [{""explanation"": ""Demonstrates that estrogen, produced by aromatase, is essential for normal bone remodeling and that deficiency leads to bone loss"", ""reference"": ""PMID:21874760"", ""snippet"": ""aromatase activity and estrogen production are necessary for longitudinal bone growth, attainment of peak bone mass, the pubertal growth spurt, epiphyseal closure, and normal bone remodeling in young individuals."", ""supports"": ""SUPPORT""}, {""explanation"": ""Clinical evidence showing that estrogen deficiency directly causes osteoporosis through impaired bone remodeling"", ""reference"": ""PMID:23748068"", ""snippet"": ""Estrogen deficiency can induce delayed epiphyseal closure, eunuchoid body habitus, osteopenia, and osteoporosis in both genders."", ""supports"": ""SUPPORT""}], ""name"": ""Bone Remodeling Imbalance""}"
5832	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	1	RANKL/OPG Dysregulation	"Increased RANKL and decreased osteoprotegerin (OPG) ratio promotes osteoclast differentiation and activation. Estrogen normally suppresses RANKL and increases OPG.
"																																																								"{""description"": ""Increased RANKL and decreased osteoprotegerin (OPG) ratio promotes osteoclast differentiation and activation. Estrogen normally suppresses RANKL and increases OPG.\n"", ""name"": ""RANKL/OPG Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Osteoclast Differentiation"", ""term"": {""id"": ""GO:0030316"", ""label"": ""osteoclast differentiation""}}], ""description"": ""Increased RANKL and decreased osteoprotegerin (OPG) ratio promotes osteoclast differentiation and activation. Estrogen normally suppresses RANKL and increases OPG.\n"", ""evidence"": [{""explanation"": ""Demonstrates that RANKL upregulation is a key mechanism for osteoclast differentiation and bone resorption"", ""reference"": ""PMID:33692806"", ""snippet"": ""The differentiation of osteoclasts is induced significantly in the presence of IL-17 either directly (207), or indirectly, through upregulation of RANKL."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows that age-related decline in estrogen production affects bone metabolism, linking to RANKL/OPG dysregulation"", ""reference"": ""PMID:21874760"", ""snippet"": ""with aging, individual differences in aromatase activity and thus in estrogen levels may significantly affect bone loss and fracture risk in both genders."", ""supports"": ""SUPPORT""}], ""name"": ""RANKL/OPG Dysregulation""}"
5833	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	2	Microarchitectural Deterioration	"Loss of trabecular connectivity and cortical thinning compromises bone strength beyond what BMD alone indicates. Leads to fragility fractures with minimal trauma.
"																																																								"{""description"": ""Loss of trabecular connectivity and cortical thinning compromises bone strength beyond what BMD alone indicates. Leads to fragility fractures with minimal trauma.\n"", ""name"": ""Microarchitectural Deterioration""}"	{}	"{""description"": ""Loss of trabecular connectivity and cortical thinning compromises bone strength beyond what BMD alone indicates. Leads to fragility fractures with minimal trauma.\n"", ""evidence"": [{""explanation"": ""Clinical case demonstrating that estrogen deficiency leads to fragility fractures due to compromised bone microarchitecture"", ""reference"": ""PMID:23748068"", ""snippet"": ""recurrent bone fractures associated with minimal trauma starting in puberty"", ""supports"": ""SUPPORT""}], ""name"": ""Microarchitectural Deterioration""}"
5847	248	Osteosarcoma	Osteosarcoma.yaml	pathophysiology	0	Malignant Bone-Forming Tumor	Malignant mesenchymal cells produce osteoid and invade bone, leading to an aggressive primary bone cancer.																																																								"{""description"": ""Malignant mesenchymal cells produce osteoid and invade bone, leading to an aggressive primary bone cancer."", ""name"": ""Malignant Bone-Forming Tumor""}"	{}	"{""description"": ""Malignant mesenchymal cells produce osteoid and invade bone, leading to an aggressive primary bone cancer."", ""evidence"": [{""explanation"": ""The abstract defines osteosarcoma as the most common primary malignant bone tumor."", ""reference"": ""PMID:41154810"", ""snippet"": ""Osteosarcoma (OS) is the most common primary malignant bone tumor, predominantly affecting adolescents and young adults."", ""supports"": ""SUPPORT""}], ""name"": ""Malignant Bone-Forming Tumor""}"
5848	248	Osteosarcoma	Osteosarcoma.yaml	pathophysiology	1	Tumor Immune Microenvironment Remodeling	Osteosarcoma progression involves interactions with immune cells in the tumor microenvironment, including tumor-infiltrating lymphocytes and tumor-associated macrophages, alongside immune checkpoint expression.																																																								"{""description"": ""Osteosarcoma progression involves interactions with immune cells in the tumor microenvironment, including tumor-infiltrating lymphocytes and tumor-associated macrophages, alongside immune checkpoint expression."", ""name"": ""Tumor Immune Microenvironment Remodeling""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}], ""cell_types"": [{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Osteosarcoma progression involves interactions with immune cells in the tumor microenvironment, including tumor-infiltrating lymphocytes and tumor-associated macrophages, alongside immune checkpoint expression."", ""evidence"": [{""explanation"": ""The abstract highlights immune microenvironment components in osteosarcoma."", ""reference"": ""PMID:41154810"", ""snippet"": ""We discuss classic morphologic and radiographic features alongside recent insights into the tumor microenvironment, including the role of tumor-infiltrating lymphocytes, tumor-associated macrophages, and immune checkpoint expression."", ""supports"": ""SUPPORT""}], ""name"": ""Tumor Immune Microenvironment Remodeling""}"
5849	248	Osteosarcoma	Osteosarcoma.yaml	pathophysiology	2	PI3K/Akt Pathway Hyperactivation	The PI3K/Akt signaling pathway is frequently hyperactivated in osteosarcoma and contributes to tumor initiation and progression.																																																								"{""description"": ""The PI3K/Akt signaling pathway is frequently hyperactivated in osteosarcoma and contributes to tumor initiation and progression."", ""name"": ""PI3K/Akt Pathway Hyperactivation""}"	{}	"{""description"": ""The PI3K/Akt signaling pathway is frequently hyperactivated in osteosarcoma and contributes to tumor initiation and progression."", ""evidence"": [{""explanation"": ""The abstract describes PI3K/Akt hyperactivation contributing to osteosarcoma progression."", ""reference"": ""PMID:25704303"", ""snippet"": ""An increasing body of evidence has shown that this pathway is frequently hyperactivated in OS and contributes to disease initiation and development, including tumorigenesis, proliferation, invasion, cell cycle progression, inhibition of apoptosis, angiogenesis, metastasis and chemoresistance."", ""supports"": ""SUPPORT""}], ""name"": ""PI3K/Akt Pathway Hyperactivation""}"
5857	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	0	PIK3CA Oncogenic Mutations	Activating PIK3CA mutations occur as somatic events in breast cancer cells. Hotspot mutations cluster in the helical domain (E542K, E545K) and kinase domain (H1047R). These mutations cause constitutive PI3K activity independent of upstream receptor tyrosine kinase signaling.																																																								"{""description"": ""Activating PIK3CA mutations occur as somatic events in breast cancer cells. Hotspot mutations cluster in the helical domain (E542K, E545K) and kinase domain (H1047R). These mutations cause constitutive PI3K activity independent of upstream receptor tyrosine kinase signaling."", ""name"": ""PIK3CA Oncogenic Mutations""}"	"{""downstream"": [{""description"": ""Mutant p110 drives pathway signaling"", ""target"": ""Constitutive PI3K-AKT Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""cell_types"": [{""preferred_term"": ""luminal epithelial cell of mammary gland"", ""term"": {""id"": ""CL:0002326"", ""label"": ""luminal epithelial cell of mammary gland""}}], ""description"": ""Activating PIK3CA mutations occur as somatic events in breast cancer cells. Hotspot mutations cluster in the helical domain (E542K, E545K) and kinase domain (H1047R). These mutations cause constitutive PI3K activity independent of upstream receptor tyrosine kinase signaling."", ""downstream"": [{""description"": ""Mutant p110 drives pathway signaling"", ""target"": ""Constitutive PI3K-AKT Pathway Activation""}], ""name"": ""PIK3CA Oncogenic Mutations""}"
5858	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	1	Constitutive PI3K-AKT Pathway Activation	Mutant PI3K generates phosphatidylinositol (3,4,5)-trisphosphate (PIP3), recruiting and activating AKT (protein kinase B). Activated AKT phosphorylates numerous substrates promoting cell survival, proliferation, metabolism, and resistance to apoptosis.																																																								"{""description"": ""Mutant PI3K generates phosphatidylinositol (3,4,5)-trisphosphate (PIP3), recruiting and activating AKT (protein kinase B). Activated AKT phosphorylates numerous substrates promoting cell survival, proliferation, metabolism, and resistance to apoptosis."", ""name"": ""Constitutive PI3K-AKT Pathway Activation""}"	"{""downstream"": [{""description"": ""AKT activates mTORC1 signaling"", ""target"": ""mTOR Pathway Activation""}, {""description"": ""AKT substrates promote tumor growth"", ""target"": ""Cell Survival and Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol-mediated signaling"", ""term"": {""id"": ""GO:0048015"", ""label"": ""phosphatidylinositol-mediated signaling""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""protein kinase B signaling"", ""term"": {""id"": ""GO:0043491"", ""label"": ""protein kinase B signaling""}}], ""description"": ""Mutant PI3K generates phosphatidylinositol (3,4,5)-trisphosphate (PIP3), recruiting and activating AKT (protein kinase B). Activated AKT phosphorylates numerous substrates promoting cell survival, proliferation, metabolism, and resistance to apoptosis."", ""downstream"": [{""description"": ""AKT activates mTORC1 signaling"", ""target"": ""mTOR Pathway Activation""}, {""description"": ""AKT substrates promote tumor growth"", ""target"": ""Cell Survival and Proliferation""}], ""name"": ""Constitutive PI3K-AKT Pathway Activation""}"
5859	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	2	mTOR Pathway Activation	AKT activates mTORC1 by inhibiting the TSC1/TSC2 complex, relieving suppression of the small GTPase Rheb. Active mTORC1 promotes protein synthesis, cell growth, and metabolic reprogramming through S6K1 and 4E-BP1 phosphorylation.																																																								"{""description"": ""AKT activates mTORC1 by inhibiting the TSC1/TSC2 complex, relieving suppression of the small GTPase Rheb. Active mTORC1 promotes protein synthesis, cell growth, and metabolic reprogramming through S6K1 and 4E-BP1 phosphorylation."", ""name"": ""mTOR Pathway Activation""}"	"{""downstream"": [{""description"": ""mTOR drives cap-dependent translation"", ""target"": ""Enhanced Protein Synthesis""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""TOR signaling"", ""term"": {""id"": ""GO:0031929"", ""label"": ""TOR signaling""}}], ""description"": ""AKT activates mTORC1 by inhibiting the TSC1/TSC2 complex, relieving suppression of the small GTPase Rheb. Active mTORC1 promotes protein synthesis, cell growth, and metabolic reprogramming through S6K1 and 4E-BP1 phosphorylation."", ""downstream"": [{""description"": ""mTOR drives cap-dependent translation"", ""target"": ""Enhanced Protein Synthesis""}], ""name"": ""mTOR Pathway Activation""}"
5860	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	3	Cell Survival and Proliferation	PI3K-AKT signaling promotes cell survival through phosphorylation and inactivation of pro-apoptotic proteins (BAD, FOXO transcription factors) and cell proliferation through multiple mechanisms including cyclin D1 stabilization.																																																								"{""description"": ""PI3K-AKT signaling promotes cell survival through phosphorylation and inactivation of pro-apoptotic proteins (BAD, FOXO transcription factors) and cell proliferation through multiple mechanisms including cyclin D1 stabilization."", ""name"": ""Cell Survival and Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""negative regulation of apoptotic process"", ""term"": {""id"": ""GO:0043066"", ""label"": ""negative regulation of apoptotic process""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""PI3K-AKT signaling promotes cell survival through phosphorylation and inactivation of pro-apoptotic proteins (BAD, FOXO transcription factors) and cell proliferation through multiple mechanisms including cyclin D1 stabilization."", ""name"": ""Cell Survival and Proliferation""}"
5861	249	PIK3CA-Mutant Breast Cancer	PIK3CA_Mutant_Breast_Cancer.yaml	pathophysiology	4	Endocrine Resistance	In ER+ breast cancer, PIK3CA mutations confer partial resistance to endocrine therapy through crosstalk between PI3K and ER signaling. PI3K pathway activation can maintain tumor growth despite estrogen deprivation.																																																								"{""description"": ""In ER+ breast cancer, PIK3CA mutations confer partial resistance to endocrine therapy through crosstalk between PI3K and ER signaling. PI3K pathway activation can maintain tumor growth despite estrogen deprivation."", ""name"": ""Endocrine Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""intracellular estrogen receptor signaling pathway"", ""term"": {""id"": ""GO:0030520"", ""label"": ""intracellular estrogen receptor signaling pathway""}}], ""description"": ""In ER+ breast cancer, PIK3CA mutations confer partial resistance to endocrine therapy through crosstalk between PI3K and ER signaling. PI3K pathway activation can maintain tumor growth despite estrogen deprivation."", ""name"": ""Endocrine Resistance""}"
5885	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	0	Dopaminergic Neuron Loss	"Progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta leads to dopamine deficiency in the striatum, causing motor symptoms. Symptoms appear after 60-80% neuron loss.
"																																																								"{""description"": ""Progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta leads to dopamine deficiency in the striatum, causing motor symptoms. Symptoms appear after 60-80% neuron loss.\n"", ""name"": ""Dopaminergic Neuron Loss""}"	"{""downstream"": [{""evidence"": [{""explanation"": ""This links tremor with dopaminergic neuronal loss as part of PD hallmark pathology, supporting the downstream relationship."", ""reference"": ""PMID:37048085"", ""snippet"": ""Tremor, shaking, movement problems, and difficulty with balance and coordination are among the hallmarks, and dopaminergic neuronal loss in substantia nigra pars compacta of the brain and aggregation of intracellular protein -synuclein are the pathological characterizations."", ""supports"": ""SUPPORT""}], ""target"": ""Resting Tremor""}, {""evidence"": [{""explanation"": ""This establishes bradykinesia as a cardinal parkinsonian sign downstream of dopaminergic degeneration."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}], ""target"": ""Bradykinesia""}, {""evidence"": [{""explanation"": ""This identifies rigidity as a cardinal sign of parkinsonism consistent with dopaminergic neuron loss in PD."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}], ""target"": ""Rigidity""}, {""evidence"": [{""explanation"": ""This supports impaired postural reflexes as a cardinal parkinsonian sign downstream of dopaminergic dysfunction."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}], ""target"": ""Postural Instability""}]}"	"{""biological_processes"": [{""preferred_term"": ""Dopamine Biosynthesis"", ""term"": {""id"": ""GO:0042416"", ""label"": ""dopamine biosynthetic process""}}], ""cell_types"": [{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}], ""description"": ""Progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta leads to dopamine deficiency in the striatum, causing motor symptoms. Symptoms appear after 60-80% neuron loss.\n"", ""downstream"": [{""evidence"": [{""explanation"": ""This links tremor with dopaminergic neuronal loss as part of PD hallmark pathology, supporting the downstream relationship."", ""reference"": ""PMID:37048085"", ""snippet"": ""Tremor, shaking, movement problems, and difficulty with balance and coordination are among the hallmarks, and dopaminergic neuronal loss in substantia nigra pars compacta of the brain and aggregation of intracellular protein -synuclein are the pathological characterizations."", ""supports"": ""SUPPORT""}], ""target"": ""Resting Tremor""}, {""evidence"": [{""explanation"": ""This establishes bradykinesia as a cardinal parkinsonian sign downstream of dopaminergic degeneration."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}], ""target"": ""Bradykinesia""}, {""evidence"": [{""explanation"": ""This identifies rigidity as a cardinal sign of parkinsonism consistent with dopaminergic neuron loss in PD."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}], ""target"": ""Rigidity""}, {""evidence"": [{""explanation"": ""This supports impaired postural reflexes as a cardinal parkinsonian sign downstream of dopaminergic dysfunction."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}], ""target"": ""Postural Instability""}], ""evidence"": [{""explanation"": ""This review confirms that dopaminergic neuronal loss in the substantia nigra pars compacta is a pathological hallmark of Parkinson's disease, supporting the core mechanism of dopaminergic neuron degeneration."", ""reference"": ""PMID:37048085"", ""snippet"": ""Tremor, shaking, movement problems, and difficulty with balance and coordination are among the hallmarks, and dopaminergic neuronal loss in substantia nigra pars compacta of the brain and aggregation of intracellular protein -synuclein are the pathological characterizations."", ""supports"": ""SUPPORT""}], ""name"": ""Dopaminergic Neuron Loss""}"
5886	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	1	Alpha-Synuclein Aggregation	"Misfolded alpha-synuclein protein accumulates to form Lewy bodies and Lewy neurites. These aggregates spread through the nervous system in a prion-like manner, contributing to neurodegeneration.
"																																																								"{""description"": ""Misfolded alpha-synuclein protein accumulates to form Lewy bodies and Lewy neurites. These aggregates spread through the nervous system in a prion-like manner, contributing to neurodegeneration.\n"", ""name"": ""Alpha-Synuclein Aggregation""}"	"{""downstream"": [{""evidence"": [{""explanation"": ""This indicates that -synuclein aggregation drives disease development and progression, supporting downstream dopaminergic neuron loss."", ""reference"": ""PMID:38245249"", ""snippet"": ""Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of -synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease."", ""supports"": ""SUPPORT""}], ""target"": ""Dopaminergic Neuron Loss""}, {""evidence"": [{""explanation"": ""This links -synuclein accumulation to microglial activation, supporting neuroinflammation as a downstream effect."", ""reference"": ""PMID:36598534"", ""snippet"": ""-Syn is a crucial marker of PD, and its accumulation leads to microglia M1-like phenotype polarization, activation of NLRP3 inflammasomes, and impaired autophagy and phagocytosis in microglia."", ""supports"": ""SUPPORT""}], ""target"": ""Neuroinflammation""}]}"	"{""biological_processes"": [{""preferred_term"": ""inclusion body assembly"", ""term"": {""id"": ""GO:0070841"", ""label"": ""inclusion body assembly""}}], ""description"": ""Misfolded alpha-synuclein protein accumulates to form Lewy bodies and Lewy neurites. These aggregates spread through the nervous system in a prion-like manner, contributing to neurodegeneration.\n"", ""downstream"": [{""evidence"": [{""explanation"": ""This indicates that -synuclein aggregation drives disease development and progression, supporting downstream dopaminergic neuron loss."", ""reference"": ""PMID:38245249"", ""snippet"": ""Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of -synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease."", ""supports"": ""SUPPORT""}], ""target"": ""Dopaminergic Neuron Loss""}, {""evidence"": [{""explanation"": ""This links -synuclein accumulation to microglial activation, supporting neuroinflammation as a downstream effect."", ""reference"": ""PMID:36598534"", ""snippet"": ""-Syn is a crucial marker of PD, and its accumulation leads to microglia M1-like phenotype polarization, activation of NLRP3 inflammasomes, and impaired autophagy and phagocytosis in microglia."", ""supports"": ""SUPPORT""}], ""target"": ""Neuroinflammation""}], ""evidence"": [{""explanation"": ""This authoritative Lancet review establishes that aggregated -synuclein deposition is a defining feature of Parkinson's disease pathogenesis."", ""reference"": ""PMID:38245249"", ""snippet"": ""Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated -synuclein."", ""supports"": ""SUPPORT""}, {""explanation"": ""This provides direct evidence for the prion-like spreading mechanism of -synuclein pathology across neural networks, supporting the mechanism of trans-neuronal propagation."", ""reference"": ""PMID:38245249"", ""snippet"": ""Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of -synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms that -synuclein accumulation is a key pathological characterization of PD, reinforcing the central role of protein aggregation in disease pathology."", ""reference"": ""PMID:36598534"", ""snippet"": ""Parkinson's disease (PD) is the second most common neurodegenerative disease, and is characterized by accumulation of -synuclein (-syn)."", ""supports"": ""SUPPORT""}], ""name"": ""Alpha-Synuclein Aggregation""}"
5887	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	2	Mitochondrial Dysfunction	"Impaired mitochondrial function, particularly complex I deficiency, leads to oxidative stress and neuronal death. Multiple PD genes (PINK1, Parkin, DJ-1) regulate mitochondrial quality control.
"																																																								"{""description"": ""Impaired mitochondrial function, particularly complex I deficiency, leads to oxidative stress and neuronal death. Multiple PD genes (PINK1, Parkin, DJ-1) regulate mitochondrial quality control.\n"", ""name"": ""Mitochondrial Dysfunction""}"	"{""downstream"": [{""evidence"": [{""explanation"": ""This supports mitochondrial dysfunction as a central driver of neurodegeneration in PD, consistent with dopaminergic neuron loss."", ""reference"": ""PMID:27911343"", ""snippet"": ""For the past 30 years, mitochondrial dysfunction has been hypothesized to play a central role in the pathobiology of this devastating neurodegenerative disease."", ""supports"": ""SUPPORT""}], ""target"": ""Dopaminergic Neuron Loss""}]}"	"{""biological_processes"": [{""preferred_term"": ""mitochondrion organization"", ""term"": {""id"": ""GO:0007005"", ""label"": ""mitochondrion organization""}}], ""description"": ""Impaired mitochondrial function, particularly complex I deficiency, leads to oxidative stress and neuronal death. Multiple PD genes (PINK1, Parkin, DJ-1) regulate mitochondrial quality control.\n"", ""downstream"": [{""evidence"": [{""explanation"": ""This supports mitochondrial dysfunction as a central driver of neurodegeneration in PD, consistent with dopaminergic neuron loss."", ""reference"": ""PMID:27911343"", ""snippet"": ""For the past 30 years, mitochondrial dysfunction has been hypothesized to play a central role in the pathobiology of this devastating neurodegenerative disease."", ""supports"": ""SUPPORT""}], ""target"": ""Dopaminergic Neuron Loss""}], ""evidence"": [{""explanation"": ""This establishes that mitochondrial dysfunction is a common cellular feature across both genetic and sporadic forms of PD, supporting its central role in disease pathogenesis."", ""reference"": ""PMID:38245249"", ""snippet"": ""At a cellular level, abnormal mitochondrial, lysosomal, and endosomal function can be identified in both monogenic and sporadic Parkinson's disease, suggesting multiple potential treatment approaches."", ""supports"": ""SUPPORT""}, {""explanation"": ""This directly supports the role of PINK1 and Parkin genes in mitochondrial quality control and confirms that mitochondrial damage is involved in PD pathogenesis."", ""reference"": ""PMID:25611507"", ""snippet"": ""Biochemical and genetic studies reveal that the products of two genes that are mutated in autosomal recessive parkinsonism, PINK1 and Parkin, normally work together in the same pathway to govern mitochondrial quality control, bolstering previous evidence that mitochondrial damage is involved in Parkinson's disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""This review confirms the long-standing central role of mitochondrial dysfunction in PD and validates the connection between PINK1/Parkin mutations and mitochondrial quality control defects."", ""reference"": ""PMID:27911343"", ""snippet"": ""For the past 30 years, mitochondrial dysfunction has been hypothesized to play a central role in the pathobiology of this devastating neurodegenerative disease. The identifications of mutations in genes encoding PINK1 (PTEN-induced kinase 1) and Parkin (E3 ubiquitin ligase) in familial PD and their functional association with mitochondrial quality control provided further support to this hypothesis."", ""supports"": ""SUPPORT""}], ""name"": ""Mitochondrial Dysfunction""}"
5888	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	3	Neuroinflammation	"Activated microglia and astrocytes contribute to neurodegeneration through release of pro-inflammatory cytokines and oxidative stress.
"																																																								"{""description"": ""Activated microglia and astrocytes contribute to neurodegeneration through release of pro-inflammatory cytokines and oxidative stress.\n"", ""name"": ""Neuroinflammation""}"	"{""downstream"": [{""evidence"": [{""explanation"": ""This indicates neuroinflammation contributes to PD progression, supporting dopaminergic neuron loss downstream."", ""reference"": ""PMID:37048085"", ""snippet"": ""Neuroinflammation has emerged as an involving mechanism at the initiation and development of PD."", ""supports"": ""SUPPORT""}], ""target"": ""Dopaminergic Neuron Loss""}]}"	"{""cell_types"": [{""preferred_term"": ""Microglia"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Activated microglia and astrocytes contribute to neurodegeneration through release of pro-inflammatory cytokines and oxidative stress.\n"", ""downstream"": [{""evidence"": [{""explanation"": ""This indicates neuroinflammation contributes to PD progression, supporting dopaminergic neuron loss downstream."", ""reference"": ""PMID:37048085"", ""snippet"": ""Neuroinflammation has emerged as an involving mechanism at the initiation and development of PD."", ""supports"": ""SUPPORT""}], ""target"": ""Dopaminergic Neuron Loss""}], ""evidence"": [{""explanation"": ""This establishes that maladaptive immune and inflammatory responses play an active role in accelerating PD pathogenesis, supporting the neuroinflammation mechanism."", ""reference"": ""PMID:38245249"", ""snippet"": ""Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""This directly supports the role of microglia-mediated neuroinflammation in PD initiation and progression, confirming the importance of microglial activation in disease pathology."", ""reference"": ""PMID:37048085"", ""snippet"": ""Neuroinflammation has emerged as an involving mechanism at the initiation and development of PD. It is a complex network of interactions comprising immune and non-immune cells in addition to mediators of the immune response. Microglia, the resident macrophages in the CNS, take on the leading role in regulating neuroinflammation and maintaining homeostasis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This links -synuclein accumulation to microglial activation and pro-inflammatory M1 phenotype polarization, supporting the mechanism by which neuroinflammation contributes to neurodegeneration in PD."", ""reference"": ""PMID:36598534"", ""snippet"": ""Neuroinflammation driven by microglia is an important pathological manifestation of PD. -Syn is a crucial marker of PD, and its accumulation leads to microglia M1-like phenotype polarization, activation of NLRP3 inflammasomes, and impaired autophagy and phagocytosis in microglia."", ""supports"": ""SUPPORT""}], ""name"": ""Neuroinflammation""}"
5889	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	4	Autophagy-Lysosome Pathway Dysfunction	"Impairment of the autophagy-lysosome pathway disrupts clearance of misfolded proteins including alpha-synuclein. Multiple PD genes (GBA, LRRK2, VPS35, ATP13A2) regulate lysosomal function, and their mutations impair protein degradation capacity leading to toxic protein accumulation.
"																																																								"{""description"": ""Impairment of the autophagy-lysosome pathway disrupts clearance of misfolded proteins including alpha-synuclein. Multiple PD genes (GBA, LRRK2, VPS35, ATP13A2) regulate lysosomal function, and their mutations impair protein degradation capacity leading to toxic protein accumulation.\n"", ""name"": ""Autophagy-Lysosome Pathway Dysfunction""}"	"{""downstream"": [{""evidence"": [{""explanation"": ""This shows that autophagy-lysosome pathway dysfunction impairs -synuclein clearance, supporting aggregation downstream."", ""reference"": ""PMID:31761667"", ""snippet"": ""-synuclein, encoded by the SNCA gene, is degraded mainly by the ALP, and mutations/multiplications in SNCA may lead to impairment of chaperone mediated autophagy or other ALP functions."", ""supports"": ""SUPPORT""}], ""target"": ""Alpha-Synuclein Aggregation""}, {""evidence"": [{""explanation"": ""This supports ALP dysfunction as a key PD mechanism contributing to neuronal degeneration."", ""reference"": ""PMID:31761667"", ""snippet"": ""In recent years, multiple lines of evidence from human genetic and molecular studies have highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's disease (PD)."", ""supports"": ""SUPPORT""}], ""target"": ""Dopaminergic Neuron Loss""}]}"	"{""biological_processes"": [{""preferred_term"": ""Autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}, {""preferred_term"": ""Chaperone-mediated Autophagy"", ""term"": {""id"": ""GO:0061684"", ""label"": ""chaperone-mediated autophagy""}}], ""cell_types"": [{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}], ""description"": ""Impairment of the autophagy-lysosome pathway disrupts clearance of misfolded proteins including alpha-synuclein. Multiple PD genes (GBA, LRRK2, VPS35, ATP13A2) regulate lysosomal function, and their mutations impair protein degradation capacity leading to toxic protein accumulation.\n"", ""downstream"": [{""evidence"": [{""explanation"": ""This shows that autophagy-lysosome pathway dysfunction impairs -synuclein clearance, supporting aggregation downstream."", ""reference"": ""PMID:31761667"", ""snippet"": ""-synuclein, encoded by the SNCA gene, is degraded mainly by the ALP, and mutations/multiplications in SNCA may lead to impairment of chaperone mediated autophagy or other ALP functions."", ""supports"": ""SUPPORT""}], ""target"": ""Alpha-Synuclein Aggregation""}, {""evidence"": [{""explanation"": ""This supports ALP dysfunction as a key PD mechanism contributing to neuronal degeneration."", ""reference"": ""PMID:31761667"", ""snippet"": ""In recent years, multiple lines of evidence from human genetic and molecular studies have highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's disease (PD)."", ""supports"": ""SUPPORT""}], ""target"": ""Dopaminergic Neuron Loss""}], ""evidence"": [{""explanation"": ""This review establishes the genetic basis for autophagy-lysosome dysfunction in PD, identifying key genes and their mechanistic roles."", ""reference"": ""PMID:31761667"", ""snippet"": ""In recent years, multiple lines of evidence from human genetic and molecular studies have highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's disease (PD). Genes such as GBA and LRRK2, which harbor some of the most common mutations associated with PD, have essential roles in the ALP."", ""supports"": ""SUPPORT""}], ""name"": ""Autophagy-Lysosome Pathway Dysfunction""}"
5890	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	5	Gut-Brain Axis Dysfunction	"Alterations in gut microbiota composition trigger intestinal inflammation and may initiate alpha-synuclein misfolding in enteric neurons. Pathological alpha-synuclein spreads from gut to brain via the vagus nerve, supporting the gut-first hypothesis of PD pathogenesis.
"																																																								"{""description"": ""Alterations in gut microbiota composition trigger intestinal inflammation and may initiate alpha-synuclein misfolding in enteric neurons. Pathological alpha-synuclein spreads from gut to brain via the vagus nerve, supporting the gut-first hypothesis of PD pathogenesis.\n"", ""name"": ""Gut-Brain Axis Dysfunction""}"	"{""downstream"": [{""evidence"": [{""explanation"": ""This links gut-to-brain spread with -synuclein aggregation, supporting this downstream effect."", ""reference"": ""PMID:38245249"", ""snippet"": ""Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of -synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease."", ""supports"": ""SUPPORT""}], ""target"": ""Alpha-Synuclein Aggregation""}, {""evidence"": [{""explanation"": ""This supports gut-triggered immune responses as a driver of neuroinflammation in PD."", ""reference"": ""PMID:38245249"", ""snippet"": ""Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease."", ""supports"": ""SUPPORT""}], ""target"": ""Neuroinflammation""}, {""evidence"": [{""explanation"": ""This supports constipation and other intestinal symptoms as early gut-related manifestations in PD."", ""reference"": ""PMID:38098067"", ""snippet"": ""The typical symptomatology of PD includes motor symptoms; however, a range of nonmotor symptoms, such as intestinal issues, usually occur before the motor symptoms."", ""supports"": ""SUPPORT""}], ""target"": ""Constipation""}]}"	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Enteric Neuron"", ""term"": {""id"": ""CL:0000107"", ""label"": ""autonomic neuron""}}, {""preferred_term"": ""Enteroendocrine Cell"", ""term"": {""id"": ""CL:0000164"", ""label"": ""enteroendocrine cell""}}], ""description"": ""Alterations in gut microbiota composition trigger intestinal inflammation and may initiate alpha-synuclein misfolding in enteric neurons. Pathological alpha-synuclein spreads from gut to brain via the vagus nerve, supporting the gut-first hypothesis of PD pathogenesis.\n"", ""downstream"": [{""evidence"": [{""explanation"": ""This links gut-to-brain spread with -synuclein aggregation, supporting this downstream effect."", ""reference"": ""PMID:38245249"", ""snippet"": ""Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of -synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease."", ""supports"": ""SUPPORT""}], ""target"": ""Alpha-Synuclein Aggregation""}, {""evidence"": [{""explanation"": ""This supports gut-triggered immune responses as a driver of neuroinflammation in PD."", ""reference"": ""PMID:38245249"", ""snippet"": ""Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease."", ""supports"": ""SUPPORT""}], ""target"": ""Neuroinflammation""}, {""evidence"": [{""explanation"": ""This supports constipation and other intestinal symptoms as early gut-related manifestations in PD."", ""reference"": ""PMID:38098067"", ""snippet"": ""The typical symptomatology of PD includes motor symptoms; however, a range of nonmotor symptoms, such as intestinal issues, usually occur before the motor symptoms."", ""supports"": ""SUPPORT""}], ""target"": ""Constipation""}], ""evidence"": [{""explanation"": ""This review establishes the gut microbiota-brain connection in PD pathophysiology."", ""reference"": ""PMID:38098067"", ""snippet"": ""Various microorganisms inhabiting the gastrointestinal tract can profoundly influence the physiopathology of the central nervous system through neurological, endocrine, and immune system pathways involved in the microbiota-gut-brain axis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Establishes the vagus nerve as the key anatomical connection mediating gut-brain communication in PD."", ""reference"": ""PMID:37449597"", ""snippet"": ""The vagus nerve, the main component of the parasympathetic nervous system, is involved in the regulation of immune response, digestion, heart rate, and control of mood."", ""supports"": ""SUPPORT""}], ""name"": ""Gut-Brain Axis Dysfunction""}"
5891	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	6	Oxidative Stress	"Excessive reactive oxygen species from dopamine metabolism and mitochondrial dysfunction causes lipid peroxidation, protein carbonylation, and DNA damage. Dopamine auto-oxidation generates toxic quinones that preferentially damage substantia nigra neurons.
"																																																								"{""description"": ""Excessive reactive oxygen species from dopamine metabolism and mitochondrial dysfunction causes lipid peroxidation, protein carbonylation, and DNA damage. Dopamine auto-oxidation generates toxic quinones that preferentially damage substantia nigra neurons.\n"", ""name"": ""Oxidative Stress""}"	"{""downstream"": [{""target"": ""Mitochondrial Dysfunction""}, {""target"": ""Dopaminergic Neuron Loss""}, {""target"": ""Alpha-Synuclein Aggregation""}]}"	"{""biological_processes"": [{""preferred_term"": ""Response to Oxidative Stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}, {""preferred_term"": ""ROS Metabolic Process"", ""term"": {""id"": ""GO:0072593"", ""label"": ""reactive oxygen species metabolic process""}}], ""cell_types"": [{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}], ""description"": ""Excessive reactive oxygen species from dopamine metabolism and mitochondrial dysfunction causes lipid peroxidation, protein carbonylation, and DNA damage. Dopamine auto-oxidation generates toxic quinones that preferentially damage substantia nigra neurons.\n"", ""downstream"": [{""target"": ""Mitochondrial Dysfunction""}, {""target"": ""Dopaminergic Neuron Loss""}, {""target"": ""Alpha-Synuclein Aggregation""}], ""evidence"": [{""explanation"": ""This review directly describes the mechanism by which oxidative stress drives dopaminergic neurodegeneration."", ""reference"": ""PMID:37303175"", ""snippet"": ""Reactive oxygen species (ROS)-induced oxidative stress triggers the vicious cycle leading to the degeneration of dopaminergic neurons in the nigra pars compacta."", ""supports"": ""SUPPORT""}], ""name"": ""Oxidative Stress""}"
5892	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	7	Calcium Dysregulation	"Substantia nigra dopaminergic neurons rely on L-type calcium channels (CaV1.3) for autonomous pacemaking, making them uniquely vulnerable to calcium-mediated toxicity. Disrupted calcium homeostasis in mitochondria, ER, and lysosomes contributes to oxidative stress and cell death.
"																																																								"{""description"": ""Substantia nigra dopaminergic neurons rely on L-type calcium channels (CaV1.3) for autonomous pacemaking, making them uniquely vulnerable to calcium-mediated toxicity. Disrupted calcium homeostasis in mitochondria, ER, and lysosomes contributes to oxidative stress and cell death.\n"", ""name"": ""Calcium Dysregulation""}"	"{""downstream"": [{""target"": ""Mitochondrial Dysfunction""}, {""target"": ""Oxidative Stress""}, {""target"": ""Dopaminergic Neuron Loss""}]}"	"{""biological_processes"": [{""preferred_term"": ""Calcium Ion Homeostasis"", ""term"": {""id"": ""GO:0055074"", ""label"": ""calcium ion homeostasis""}}, {""preferred_term"": ""Calcium Ion Transport"", ""term"": {""id"": ""GO:0070588"", ""label"": ""calcium ion transmembrane transport""}}], ""cell_types"": [{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}], ""description"": ""Substantia nigra dopaminergic neurons rely on L-type calcium channels (CaV1.3) for autonomous pacemaking, making them uniquely vulnerable to calcium-mediated toxicity. Disrupted calcium homeostasis in mitochondria, ER, and lysosomes contributes to oxidative stress and cell death.\n"", ""downstream"": [{""target"": ""Mitochondrial Dysfunction""}, {""target"": ""Oxidative Stress""}, {""target"": ""Dopaminergic Neuron Loss""}], ""evidence"": [{""explanation"": ""This review establishes the fundamental role of calcium channel dysregulation in PD pathogenesis."", ""reference"": ""PMID:35339179"", ""snippet"": ""Calcium (Ca2+) plays a central role in regulating many cellular processes and influences cell survival."", ""supports"": ""SUPPORT""}], ""name"": ""Calcium Dysregulation""}"
5893	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	8	Endoplasmic Reticulum Stress	"Accumulation of misfolded proteins in the ER activates the unfolded protein response (UPR). Chronic ER stress overwhelms protective mechanisms, triggering apoptotic pathways. Alpha-synuclein aggregates and GBA mutations directly impair ER function.
"																																																								"{""description"": ""Accumulation of misfolded proteins in the ER activates the unfolded protein response (UPR). Chronic ER stress overwhelms protective mechanisms, triggering apoptotic pathways. Alpha-synuclein aggregates and GBA mutations directly impair ER function.\n"", ""name"": ""Endoplasmic Reticulum Stress""}"	"{""downstream"": [{""target"": ""Autophagy-Lysosome Pathway Dysfunction""}, {""target"": ""Dopaminergic Neuron Loss""}]}"	"{""biological_processes"": [{""preferred_term"": ""ER Stress Response"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}, {""preferred_term"": ""Unfolded Protein Response"", ""term"": {""id"": ""GO:0030968"", ""label"": ""endoplasmic reticulum unfolded protein response""}}], ""cell_types"": [{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}], ""description"": ""Accumulation of misfolded proteins in the ER activates the unfolded protein response (UPR). Chronic ER stress overwhelms protective mechanisms, triggering apoptotic pathways. Alpha-synuclein aggregates and GBA mutations directly impair ER function.\n"", ""downstream"": [{""target"": ""Autophagy-Lysosome Pathway Dysfunction""}, {""target"": ""Dopaminergic Neuron Loss""}], ""evidence"": [{""explanation"": ""This review establishes ER stress as an early and central event in PD pathogenesis."", ""reference"": ""PMID:38026955"", ""snippet"": ""Accumulating evidence shows that endoplasmic reticulum (ER) stress occurring in the SNpc DA neurons is an early event in the development of PD."", ""supports"": ""SUPPORT""}], ""name"": ""Endoplasmic Reticulum Stress""}"
5894	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	9	Synaptic Dysfunction	"Impaired synaptic vesicle recycling, particularly defects in clathrin-mediated endocytosis, represents an early feature of PD. Multiple PD genes (DNAJC6, SYNJ1, LRRK2) regulate synaptic vesicle trafficking, and their dysfunction leads to synaptic failure before overt neurodegeneration.
"																																																								"{""description"": ""Impaired synaptic vesicle recycling, particularly defects in clathrin-mediated endocytosis, represents an early feature of PD. Multiple PD genes (DNAJC6, SYNJ1, LRRK2) regulate synaptic vesicle trafficking, and their dysfunction leads to synaptic failure before overt neurodegeneration.\n"", ""name"": ""Synaptic Dysfunction""}"	"{""downstream"": [{""target"": ""Dopaminergic Neuron Loss""}, {""target"": ""Alpha-Synuclein Aggregation""}]}"	"{""biological_processes"": [{""preferred_term"": ""Synaptic Vesicle Cycle"", ""term"": {""id"": ""GO:0099504"", ""label"": ""synaptic vesicle cycle""}}, {""preferred_term"": ""Synaptic Vesicle Endocytosis"", ""term"": {""id"": ""GO:0048488"", ""label"": ""synaptic vesicle endocytosis""}}], ""cell_types"": [{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}], ""description"": ""Impaired synaptic vesicle recycling, particularly defects in clathrin-mediated endocytosis, represents an early feature of PD. Multiple PD genes (DNAJC6, SYNJ1, LRRK2) regulate synaptic vesicle trafficking, and their dysfunction leads to synaptic failure before overt neurodegeneration.\n"", ""downstream"": [{""target"": ""Dopaminergic Neuron Loss""}, {""target"": ""Alpha-Synuclein Aggregation""}], ""evidence"": [{""explanation"": ""Establishes synaptic vesicle endocytosis dysfunction as an early feature of PD."", ""reference"": ""PMID:38595283"", ""snippet"": ""Notably, several of these genes are linked to the synaptic vesicle recycling process, particularly the clathrin-mediated endocytosis pathway. This suggests that impaired synaptic vesicle recycling might represent an early feature of Parkinson's disease"", ""supports"": ""SUPPORT""}], ""name"": ""Synaptic Dysfunction""}"
5895	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	10	Iron Accumulation and Ferroptosis	"Abnormal iron deposition in the substantia nigra promotes ferroptosis, an iron-dependent form of cell death characterized by lipid peroxidation. Iron catalyzes Fenton reactions generating hydroxyl radicals, and dysregulated iron metabolism contributes to oxidative damage.
"																																																								"{""description"": ""Abnormal iron deposition in the substantia nigra promotes ferroptosis, an iron-dependent form of cell death characterized by lipid peroxidation. Iron catalyzes Fenton reactions generating hydroxyl radicals, and dysregulated iron metabolism contributes to oxidative damage.\n"", ""name"": ""Iron Accumulation and Ferroptosis""}"	"{""downstream"": [{""target"": ""Oxidative Stress""}, {""target"": ""Dopaminergic Neuron Loss""}]}"	"{""biological_processes"": [{""preferred_term"": ""Iron Ion Homeostasis"", ""term"": {""id"": ""GO:0055072"", ""label"": ""iron ion homeostasis""}}, {""preferred_term"": ""Ferroptosis"", ""term"": {""id"": ""GO:0097707"", ""label"": ""ferroptotic cell death""}}], ""cell_types"": [{""preferred_term"": ""Dopaminergic Neuron"", ""term"": {""id"": ""CL:0000700"", ""label"": ""dopaminergic neuron""}}], ""description"": ""Abnormal iron deposition in the substantia nigra promotes ferroptosis, an iron-dependent form of cell death characterized by lipid peroxidation. Iron catalyzes Fenton reactions generating hydroxyl radicals, and dysregulated iron metabolism contributes to oxidative damage.\n"", ""downstream"": [{""target"": ""Oxidative Stress""}, {""target"": ""Dopaminergic Neuron Loss""}], ""evidence"": [{""explanation"": ""This review establishes iron accumulation as a significant pathological characteristic and mechanistic driver of PD."", ""reference"": ""PMID:39218077"", ""snippet"": ""Parkinson's disease (PD) is a prevalent and advancing age-related neurodegenerative disorder, distinguished by the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Iron regional deposit in SNpc is a significant pathological characteristic of PD."", ""supports"": ""SUPPORT""}], ""name"": ""Iron Accumulation and Ferroptosis""}"
5896	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	11	Blood-Brain Barrier Dysfunction	"Altered tight junction proteins, transporter dysfunction, and alpha-synuclein accumulation compromise BBB integrity. BBB breakdown allows infiltration of peripheral immune cells and blood-borne molecules, amplifying neuroinflammation.
"																																																								"{""description"": ""Altered tight junction proteins, transporter dysfunction, and alpha-synuclein accumulation compromise BBB integrity. BBB breakdown allows infiltration of peripheral immune cells and blood-borne molecules, amplifying neuroinflammation.\n"", ""name"": ""Blood-Brain Barrier Dysfunction""}"	"{""downstream"": [{""target"": ""Neuroinflammation""}, {""target"": ""Dopaminergic Neuron Loss""}]}"	"{""biological_processes"": [{""preferred_term"": ""BBB Maintenance"", ""term"": {""id"": ""GO:0035633"", ""label"": ""maintenance of blood-brain barrier""}}, {""preferred_term"": ""Vascular Permeability"", ""term"": {""id"": ""GO:0043114"", ""label"": ""regulation of vascular permeability""}}], ""cell_types"": [{""preferred_term"": ""Brain Endothelial Cell"", ""term"": {""id"": ""CL:0002618"", ""label"": ""endothelial cell of umbilical vein""}}, {""preferred_term"": ""Pericyte"", ""term"": {""id"": ""CL:0000669"", ""label"": ""pericyte""}}, {""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Altered tight junction proteins, transporter dysfunction, and alpha-synuclein accumulation compromise BBB integrity. BBB breakdown allows infiltration of peripheral immune cells and blood-borne molecules, amplifying neuroinflammation.\n"", ""downstream"": [{""target"": ""Neuroinflammation""}, {""target"": ""Dopaminergic Neuron Loss""}], ""evidence"": [{""explanation"": ""This comprehensive 2024 review establishes BBB dysfunction as an emerging mechanism in PD pathogenesis."", ""reference"": ""PMID:39075566"", ""snippet"": ""There is increasing evidence for blood-brain barrier (BBB) alterations in Parkinson's disease (PD), the second most common neurodegenerative disorder with rapidly rising prevalence."", ""supports"": ""SUPPORT""}], ""name"": ""Blood-Brain Barrier Dysfunction""}"
5927	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	0	Autoimmune T-Cell Predominant Inflammation	Pars planitis shows a T cell-driven autoimmune response within the vitreous and pars plana.																																																								"{""description"": ""Pars planitis shows a T cell-driven autoimmune response within the vitreous and pars plana."", ""name"": ""Autoimmune T-Cell Predominant Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Adaptive immune response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}], ""cell_types"": [{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Pars planitis shows a T cell-driven autoimmune response within the vitreous and pars plana."", ""evidence"": [{""explanation"": ""Shows T-cell predominance in ocular infiltrates supporting autoimmune pathogenesis."", ""reference"": ""PMID:26438050"", ""snippet"": ""Clinical and histopathological findings suggest an autoimmune etiology, most likely as a reaction to endogenous antigen of unknown source, with T cells predominant in both vitreous and pars plana infiltrations."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms T-cell mediated immunopathogenesis and genetic susceptibility in pars planitis."", ""reference"": ""PMID:37976519"", ""snippet"": ""It is thought to be a T-cell mediated disease with a genetic predisposition."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Vitreous humor"", ""term"": {""id"": ""UBERON:0001286"", ""label"": ""vitreous humor""}}, {""preferred_term"": ""Pars plana"", ""term"": {""id"": ""UBERON:0004548"", ""label"": ""pars plana of ciliary body""}}], ""name"": ""Autoimmune T-Cell Predominant Inflammation""}"
5928	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	1	Vitreous Cell Infiltration	Dense inflammatory cell infiltration and haze within the vitreous cavity.																																																								"{""description"": ""Dense inflammatory cell infiltration and haze within the vitreous cavity."", ""name"": ""Vitreous Cell Infiltration""}"	"{""downstream"": [{""description"": ""Vitreous cells and haze obscure the visual axis causing floaters and blurred vision."", ""evidence"": [{""explanation"": ""Early visual symptoms arise from inflammatory cells and haze in the vitreous cavity."", ""reference"": ""PMID:27051493"", ""snippet"": ""The most common presenting symptoms are floaters and blurred vision."", ""supports"": ""SUPPORT""}], ""target"": ""Visual Impairment""}]}"	"{""biological_processes"": [{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Dense inflammatory cell infiltration and haze within the vitreous cavity."", ""downstream"": [{""description"": ""Vitreous cells and haze obscure the visual axis causing floaters and blurred vision."", ""evidence"": [{""explanation"": ""Early visual symptoms arise from inflammatory cells and haze in the vitreous cavity."", ""reference"": ""PMID:27051493"", ""snippet"": ""The most common presenting symptoms are floaters and blurred vision."", ""supports"": ""SUPPORT""}], ""target"": ""Visual Impairment""}], ""evidence"": [{""explanation"": ""Documents vitreous cell infiltration and haze as defining inflammatory findings."", ""reference"": ""PMID:27051493"", ""snippet"": ""Diffuse vitreous cells, haze, snowballs and snowbanks are typical findings of pars planitis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms high prevalence of vitreous inflammation and snowballs in clinical cohorts."", ""reference"": ""PMID:28389773"", ""snippet"": ""Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%)...were the most common presentations."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Vitreous humor"", ""term"": {""id"": ""UBERON:0001286"", ""label"": ""vitreous humor""}}], ""name"": ""Vitreous Cell Infiltration""}"
5929	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	2	Snowbank Formation at Pars Plana	Exudative and fibrocellular snowbank deposition along the pars plana and vitreous base.																																																								"{""description"": ""Exudative and fibrocellular snowbank deposition along the pars plana and vitreous base."", ""name"": ""Snowbank Formation at Pars Plana""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""cell_types"": [{""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Exudative and fibrocellular snowbank deposition along the pars plana and vitreous base."", ""evidence"": [{""explanation"": ""Shows snowbanks as a frequent structural manifestation of pars planitis at the pars plana."", ""reference"": ""PMID:28389773"", ""snippet"": ""Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%)...were the most common presentations."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Pars plana"", ""term"": {""id"": ""UBERON:0004548"", ""label"": ""pars plana of ciliary body""}}, {""preferred_term"": ""Peripheral retina"", ""term"": {""id"": ""UBERON:0001789"", ""label"": ""retina""}}], ""name"": ""Snowbank Formation at Pars Plana""}"
5930	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	3	Peripheral Retinal Vasculitis and Sheathing	Inflammation of peripheral retinal vessels leading to vascular sheathing and leakage.																																																								"{""description"": ""Inflammation of peripheral retinal vessels leading to vascular sheathing and leakage."", ""name"": ""Peripheral Retinal Vasculitis and Sheathing""}"	"{""downstream"": [{""description"": ""Peripheral vasculitis and leakage contribute to macular thickening that impairs vision."", ""evidence"": [{""explanation"": ""Demonstrates that increased retinal thickness from leakage correlates with worse visual acuity in intermediate uveitis."", ""reference"": ""PMID:27188332"", ""snippet"": ""Correlation between LogMAR visual acuity and central retinal thickness at baseline was strong (r = 0.7436, p < 0.0001)."", ""supports"": ""SUPPORT""}], ""target"": ""Macular Edema""}]}"	"{""biological_processes"": [{""preferred_term"": ""Inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Endothelial cell of vascular tree"", ""term"": {""id"": ""CL:0002139"", ""label"": ""endothelial cell of vascular tree""}}], ""description"": ""Inflammation of peripheral retinal vessels leading to vascular sheathing and leakage."", ""downstream"": [{""description"": ""Peripheral vasculitis and leakage contribute to macular thickening that impairs vision."", ""evidence"": [{""explanation"": ""Demonstrates that increased retinal thickness from leakage correlates with worse visual acuity in intermediate uveitis."", ""reference"": ""PMID:27188332"", ""snippet"": ""Correlation between LogMAR visual acuity and central retinal thickness at baseline was strong (r = 0.7436, p < 0.0001)."", ""supports"": ""SUPPORT""}], ""target"": ""Macular Edema""}], ""evidence"": [{""explanation"": ""Notes peripheral retinal vasculitis as a recognized manifestation in pars planitis."", ""reference"": ""PMID:27051493"", ""snippet"": ""Peripheral retinal vasculitis, optic disc edema and anterior segment inflammation are other well-known findings."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms high frequency of peripheral vascular sheathing in clinical series."", ""reference"": ""PMID:28389773"", ""snippet"": ""...peripheral retinal vascular sheathing (48.1%) were the most common presentations."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Peripheral retina"", ""term"": {""id"": ""UBERON:0001789"", ""label"": ""retina""}}], ""name"": ""Peripheral Retinal Vasculitis and Sheathing""}"
5931	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	4	Macular Thickening from Blood-Retinal Barrier Breakdown	Inflammatory vascular leakage causes subclinical or clinical macular thickening that can progress to cystoid macular edema.																																																								"{""description"": ""Inflammatory vascular leakage causes subclinical or clinical macular thickening that can progress to cystoid macular edema."", ""name"": ""Macular Thickening from Blood-Retinal Barrier Breakdown""}"	"{""downstream"": [{""description"": ""Macular thickening degrades visual acuity in intermediate uveitis."", ""evidence"": [{""explanation"": ""Links macular thickening to loss of visual acuity."", ""reference"": ""PMID:27188332"", ""snippet"": ""Correlation between LogMAR visual acuity and central retinal thickness at baseline was strong (r = 0.7436, p < 0.0001)."", ""supports"": ""SUPPORT""}], ""target"": ""Visual Impairment""}]}"	"{""biological_processes"": [{""preferred_term"": ""Regulation of vascular permeability"", ""term"": {""id"": ""GO:0043112"", ""label"": ""regulation of vascular permeability""}}], ""cell_types"": [{""preferred_term"": ""Endothelial cell of vascular tree"", ""term"": {""id"": ""CL:0002139"", ""label"": ""endothelial cell of vascular tree""}}], ""description"": ""Inflammatory vascular leakage causes subclinical or clinical macular thickening that can progress to cystoid macular edema."", ""downstream"": [{""description"": ""Macular thickening degrades visual acuity in intermediate uveitis."", ""evidence"": [{""explanation"": ""Links macular thickening to loss of visual acuity."", ""reference"": ""PMID:27188332"", ""snippet"": ""Correlation between LogMAR visual acuity and central retinal thickness at baseline was strong (r = 0.7436, p < 0.0001)."", ""supports"": ""SUPPORT""}], ""target"": ""Visual Impairment""}], ""evidence"": [{""explanation"": ""Shows that macular thickening beyond a threshold prompts treatment due to risk of vision loss in intermediate uveitis."", ""reference"": ""PMID:27188332"", ""snippet"": ""The cut-off value of CFT for initiating systemic treatment was determined at 215.5 m in a post hoc analysis (sensitivity 62.5 %, specificity 96.4 %)."", ""supports"": ""SUPPORT""}, {""explanation"": ""OCT-defined diffuse macular edema and foveal contour loss predict worse visual acuity, underscoring the impact of macular thickening."", ""reference"": ""PMID:33559832"", ""snippet"": ""According to multivariate linear regression analysis, the presence of DME, and loss of normal foveal contour appearance at baseline were the independent factors associated with BCVA at the final examination."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Macula of retina"", ""term"": {""id"": ""UBERON:0008901"", ""label"": ""macula lutea""}}], ""name"": ""Macular Thickening from Blood-Retinal Barrier Breakdown""}"
5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	Viral Replication	The virus primarily targets erythroid progenitor cells in the bone marrow, leading to disrupted red blood cell production.																																																								"{""description"": ""The virus primarily targets erythroid progenitor cells in the bone marrow, leading to disrupted red blood cell production."", ""name"": ""Viral Replication""}"	{}	"{""biological_processes"": [{""preferred_term"": ""viral genome replication"", ""term"": {""id"": ""GO:0019079"", ""label"": ""viral genome replication""}}, {""preferred_term"": ""DNA replication"", ""term"": {""id"": ""GO:0006260"", ""label"": ""DNA replication""}}], ""cell_types"": [{""preferred_term"": ""Erythroid Progenitor Cells"", ""term"": {""id"": ""CL:0000038"", ""label"": ""erythroid progenitor cell""}}], ""description"": ""The virus primarily targets erythroid progenitor cells in the bone marrow, leading to disrupted red blood cell production."", ""evidence"": [{""explanation"": ""The abstract clearly states that Parvovirus B19 has a strong preference for infecting human erythroid progenitor cells."", ""reference"": ""PMID:9372060"", ""snippet"": ""Human parvovirus B19 shows remarkable tropism for human erythroid progenitor cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study describes the infection dynamics of Parvovirus B19 in erythroid progenitor cells, supporting the statement that the virus primarily targets these cells."", ""reference"": ""PMID:26845771"", ""snippet"": ""The pathogenic Parvovirus B19 (B19V) is characterized by a strict adaptation to erythroid progenitor cells (EPCs)..."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract mentions that Parvovirus B19 infects erythroid progenitor cells in the bone marrow, aligning with the statement."", ""reference"": ""PMID:37175911"", ""snippet"": ""Parvovirus B19V (B19V) is a common human pathogen that infects bone marrow erythroid progenitor cells, leading to transient or persistent anemia."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract confirms the restriction of Parvovirus B19 infection to erythroid progenitor cells in the bone marrow."", ""reference"": ""PMID:21680529"", ""snippet"": ""Human parvovirus B19 (B19V) infection is restricted to erythroid progenitor cells of the human bone marrow."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study indicates that Parvovirus B19 infection is limited to erythroid progenitor cells and disrupts red blood cell production."", ""reference"": ""PMID:28377277"", ""snippet"": ""Parvovirus B19 (B19V) infection is restricted to erythroid progenitor cells (EPCs) of the human bone marrow, leading to transient arrest of erythropoiesis..."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract highlights the selective tropism of Parvovirus B19 for erythroid progenitor cells in the bone marrow."", ""reference"": ""PMID:35062288"", ""snippet"": ""Parvovirus B19 (B19V) is a human pathogenic virus of clinical relevance, characterized by a selective tropism for erythroid progenitor cells in bone marrow."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract states that Parvovirus B19 induces the death of erythroid progenitors, supporting the statement."", ""reference"": ""PMID:12116854"", ""snippet"": ""Parvovirus B19 is a human erythrovirus, i.e. which induces the death of erythroid progenitors."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Viral Replication""}"
5951	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	1	Immune Response	Immune-mediated response to the virus can lead to rash and joint symptoms.																																																								"{""description"": ""Immune-mediated response to the virus can lead to rash and joint symptoms."", ""name"": ""Immune Response""}"	{}	"{""description"": ""Immune-mediated response to the virus can lead to rash and joint symptoms."", ""evidence"": [{""explanation"": ""The reference describes joint pain and skin rash as immune responses to Parvovirus B19 infection, supporting the statement."", ""reference"": ""PMID:37434352"", ""snippet"": ""Notably, adult patients with B19V infection frequently experience joint pain and cutaneous eruptions, which are ostensibly immune responses to the infection and necessitate careful differentiation from autoimmunity."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference mentions that arthropathy (joint symptoms) occurs in individuals with Parvovirus B19 infection, supporting the statement."", ""reference"": ""PMID:9595838"", ""snippet"": ""Infections caused by human parvovirus B19 result in a variety of clinical manifestations, the severity of which depends on the immune and hematologic status of the host. Arthropathy is known to occur in children and adults with acute parvovirus B19 infection."", ""supports"": ""SUPPORT""}], ""name"": ""Immune Response""}"
5952	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	2	Receptor-Mediated Entry	Initial viral entry involves binding to globoside (P antigen) on cell surfaces, followed by VP1u-mediated internalization into erythroid progenitor cells. Acidic pH in endosomes facilitates globoside-dependent infectious trafficking and VP1u conformational changes for endosomal escape.																																		The VP1u domain contains a PLA2-like motif critical for membrane penetration and endosomal escape.																						"{""description"": ""Initial viral entry involves binding to globoside (P antigen) on cell surfaces, followed by VP1u-mediated internalization into erythroid progenitor cells. Acidic pH in endosomes facilitates globoside-dependent infectious trafficking and VP1u conformational changes for endosomal escape."", ""name"": ""Receptor-Mediated Entry"", ""notes"": ""The VP1u domain contains a PLA2-like motif critical for membrane penetration and endosomal escape.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""viral entry into host cell"", ""term"": {""id"": ""GO:0046718"", ""label"": ""viral entry into host cell""}}, {""preferred_term"": ""endocytosis"", ""term"": {""id"": ""GO:0006897"", ""label"": ""endocytosis""}}], ""description"": ""Initial viral entry involves binding to globoside (P antigen) on cell surfaces, followed by VP1u-mediated internalization into erythroid progenitor cells. Acidic pH in endosomes facilitates globoside-dependent infectious trafficking and VP1u conformational changes for endosomal escape."", ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}, {""preferred_term"": ""fetal liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""fetal liver""}}], ""name"": ""Receptor-Mediated Entry"", ""notes"": ""The VP1u domain contains a PLA2-like motif critical for membrane penetration and endosomal escape.""}"
5953	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	3	Cell Cycle Arrest and Apoptosis	Viral NS1 protein and replication intermediates activate the DNA damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to late S/G2 phase arrest and apoptotic death of infected erythroid progenitor cells.																																		The transient block in erythropoiesis explains aplastic crises in susceptible individuals.																						"{""description"": ""Viral NS1 protein and replication intermediates activate the DNA damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to late S/G2 phase arrest and apoptotic death of infected erythroid progenitor cells."", ""name"": ""Cell Cycle Arrest and Apoptosis"", ""notes"": ""The transient block in erythropoiesis explains aplastic crises in susceptible individuals.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""DNA damage response"", ""term"": {""id"": ""GO:0006974"", ""label"": ""cellular response to DNA damage stimulus""}}, {""preferred_term"": ""cell cycle arrest"", ""term"": {""id"": ""GO:0007050"", ""label"": ""regulation of cell cycle""}}, {""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""Erythroid Progenitor Cells"", ""term"": {""id"": ""CL:0000038"", ""label"": ""erythroid progenitor cell""}}], ""description"": ""Viral NS1 protein and replication intermediates activate the DNA damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to late S/G2 phase arrest and apoptotic death of infected erythroid progenitor cells."", ""genes"": [{""preferred_term"": ""ATR"", ""term"": {""id"": ""hgnc:882"", ""label"": ""ATR""}}, {""preferred_term"": ""PRKDC"", ""term"": {""id"": ""hgnc:9413"", ""label"": ""PRKDC""}}], ""name"": ""Cell Cycle Arrest and Apoptosis"", ""notes"": ""The transient block in erythropoiesis explains aplastic crises in susceptible individuals.""}"
5954	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	4	EPO-STAT5 Signaling Pathway	Erythropoietin (EPO) signaling through STAT5A and STAT5B creates a permissive transcriptional environment for B19V replication in erythroid progenitor cells. Hypoxic conditions enhance STAT5A activity and viral replication.																																																								"{""description"": ""Erythropoietin (EPO) signaling through STAT5A and STAT5B creates a permissive transcriptional environment for B19V replication in erythroid progenitor cells. Hypoxic conditions enhance STAT5A activity and viral replication."", ""name"": ""EPO-STAT5 Signaling Pathway""}"	{}	"{""biological_processes"": [{""preferred_term"": ""JAK-STAT cascade"", ""term"": {""id"": ""GO:0007259"", ""label"": ""receptor signaling pathway via JAK-STAT""}}], ""cell_types"": [{""preferred_term"": ""Erythroid Progenitor Cells"", ""term"": {""id"": ""CL:0000038"", ""label"": ""erythroid progenitor cell""}}], ""description"": ""Erythropoietin (EPO) signaling through STAT5A and STAT5B creates a permissive transcriptional environment for B19V replication in erythroid progenitor cells. Hypoxic conditions enhance STAT5A activity and viral replication."", ""genes"": [{""preferred_term"": ""EPOR"", ""term"": {""id"": ""hgnc:3416"", ""label"": ""EPOR""}}, {""preferred_term"": ""STAT5A"", ""term"": {""id"": ""hgnc:11367"", ""label"": ""STAT5A""}}, {""preferred_term"": ""STAT5B"", ""term"": {""id"": ""hgnc:11368"", ""label"": ""STAT5B""}}], ""name"": ""EPO-STAT5 Signaling Pathway""}"
5971	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	0	Anti-Desmoglein Autoantibodies	IgG autoantibodies against desmoglein 3 (mucosal-dominant) and desmoglein 1 (mucocutaneous) directly cause loss of keratinocyte adhesion. Antibody binding triggers intracellular signaling leading to desmosome disassembly.																																																								"{""description"": ""IgG autoantibodies against desmoglein 3 (mucosal-dominant) and desmoglein 1 (mucocutaneous) directly cause loss of keratinocyte adhesion. Antibody binding triggers intracellular signaling leading to desmosome disassembly."", ""name"": ""Anti-Desmoglein Autoantibodies""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""cell_types"": [{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""description"": ""IgG autoantibodies against desmoglein 3 (mucosal-dominant) and desmoglein 1 (mucocutaneous) directly cause loss of keratinocyte adhesion. Antibody binding triggers intracellular signaling leading to desmosome disassembly."", ""evidence"": [{""explanation"": ""Passive transfer experiments demonstrate that anti-Dsg3 IgG autoantibodies are directly pathogenic and sufficient to cause pemphigus-like disease."", ""reference"": ""PMID:10878487"", ""snippet"": ""Auto-Ab against the desmosomal adhesion molecule, desmoglein 3 (Dsg3), are critical in the pathogenesis of this disease, since the transfer of serum IgG Ab reactive with Dsg3 into newborn mice induces a bullous skin disease resembling PV."", ""supports"": ""SUPPORT""}, {""explanation"": ""Systematic review of 66 studies confirms that anti-Dsg1 and anti-Dsg3 autoantibodies are the most consistent biomarkers in pemphigus vulgaris."", ""reference"": ""PMID:39075718"", ""snippet"": ""The most notable biomarkers trends include elevations in IL-4, IL-6, IL-17A, anti-Dsg1/3 autoantibodies, and a reduction in Treg cells and FOXP3."", ""supports"": ""SUPPORT""}], ""name"": ""Anti-Desmoglein Autoantibodies""}"
5972	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	1	Acantholysis and Blister Formation	Loss of desmosomal adhesion causes keratinocytes to detach from each other (acantholysis). Suprabasal clefting occurs as basal keratinocytes remain attached to the basement membrane while upper layers separate.																																																								"{""description"": ""Loss of desmosomal adhesion causes keratinocytes to detach from each other (acantholysis). Suprabasal clefting occurs as basal keratinocytes remain attached to the basement membrane while upper layers separate."", ""name"": ""Acantholysis and Blister Formation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cell Adhesion"", ""term"": {""id"": ""GO:0007155"", ""label"": ""cell adhesion""}}], ""description"": ""Loss of desmosomal adhesion causes keratinocytes to detach from each other (acantholysis). Suprabasal clefting occurs as basal keratinocytes remain attached to the basement membrane while upper layers separate."", ""evidence"": [{""explanation"": ""Autoantibody binding directly interferes with the adhesive function of desmogleins, resulting in keratinocyte detachment and blister formation."", ""reference"": ""PMID:10878487"", ""snippet"": ""Antibody (Ab) binding interferes with the adhesive function of these molecules, leading to detachment and subsequently blister formation."", ""supports"": ""SUPPORT""}], ""name"": ""Acantholysis and Blister Formation""}"
5973	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	2	Signaling-Mediated Cytoskeletal Changes	Anti-desmoglein antibodies activate p38 MAPK and other signaling pathways, causing keratin filament retraction and further weakening of cell-cell adhesion independent of direct steric hindrance.																																																								"{""description"": ""Anti-desmoglein antibodies activate p38 MAPK and other signaling pathways, causing keratin filament retraction and further weakening of cell-cell adhesion independent of direct steric hindrance."", ""name"": ""Signaling-Mediated Cytoskeletal Changes""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Signal Transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""description"": ""Anti-desmoglein antibodies activate p38 MAPK and other signaling pathways, causing keratin filament retraction and further weakening of cell-cell adhesion independent of direct steric hindrance."", ""name"": ""Signaling-Mediated Cytoskeletal Changes""}"
5974	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	3	Immune Dysregulation and Th2/Th17 Skewing	Pemphigus vulgaris is characterized by a shift toward Th2 and Th17 cytokine profiles with elevated IL-4, IL-6, and IL-17A, along with a marked reduction in regulatory T cells (Tregs). This imbalance promotes autoreactive B cell activation and pathogenic autoantibody production.																																																								"{""description"": ""Pemphigus vulgaris is characterized by a shift toward Th2 and Th17 cytokine profiles with elevated IL-4, IL-6, and IL-17A, along with a marked reduction in regulatory T cells (Tregs). This imbalance promotes autoreactive B cell activation and pathogenic autoantibody production."", ""name"": ""Immune Dysregulation and Th2/Th17 Skewing""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T Cell Differentiation"", ""term"": {""id"": ""GO:0030217"", ""label"": ""T cell differentiation""}}, {""preferred_term"": ""Cytokine Production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}], ""description"": ""Pemphigus vulgaris is characterized by a shift toward Th2 and Th17 cytokine profiles with elevated IL-4, IL-6, and IL-17A, along with a marked reduction in regulatory T cells (Tregs). This imbalance promotes autoreactive B cell activation and pathogenic autoantibody production."", ""evidence"": [{""explanation"": ""Cytokine profiling demonstrates a clear Th2 cytokine dominance in PV patients with elevated IL-4 and IL-10, supporting the role of Th2-mediated immune responses in disease pathogenesis."", ""reference"": ""PMID:19811408"", ""snippet"": ""All patients with PV and PF showed significantly (p < 0.000) elevated levels of T(H)2 cytokines (IL-10 and IL-4) as compared with healthy controls. However, the mean concentration of T(H)1 cytokines (IL-2 and IFN-gamma) was significantly decreased in patients as compared to healthy individuals."", ""supports"": ""SUPPORT""}, {""explanation"": ""Severe reduction in regulatory T cells may contribute to loss of tolerance and failure to suppress autoreactive B and T cells in pemphigus vulgaris."", ""reference"": ""PMID:17377382"", ""snippet"": ""The proportion of Treg cells in all PV patients was severely reduced, approximately ten times less than controls. These observations were further confirmed by both diminished gene and protein expression of Foxp3 in the CD4(+)CD25(+) T cell population in PV patients."", ""supports"": ""SUPPORT""}, {""explanation"": ""Systematic review synthesizing 66 studies confirms the Th2/Th17 skewing and Treg deficiency as core immunological features of pemphigus vulgaris."", ""reference"": ""PMID:39075718"", ""snippet"": ""The results of this review support current theories of PV pathogenesis, with increased Th2 activity, increased Th17 activity, decreased Treg activity, and production of anti-Dsg1/3 autoantibodies being observed."", ""supports"": ""SUPPORT""}], ""name"": ""Immune Dysregulation and Th2/Th17 Skewing""}"
5995	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	0	Atherosclerosis	"Progressive buildup of lipid-rich plaques in peripheral arteries, predominantly affecting lower extremities. Same pathophysiology as coronary artery disease.
"																																																								"{""description"": ""Progressive buildup of lipid-rich plaques in peripheral arteries, predominantly affecting lower extremities. Same pathophysiology as coronary artery disease.\n"", ""name"": ""Atherosclerosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Lipid Accumulation"", ""term"": {""id"": ""GO:0034383"", ""label"": ""low-density lipoprotein particle clearance""}}], ""cell_types"": [{""preferred_term"": ""Foam Cell"", ""term"": {""id"": ""CL:0000891"", ""label"": ""foam cell""}}], ""description"": ""Progressive buildup of lipid-rich plaques in peripheral arteries, predominantly affecting lower extremities. Same pathophysiology as coronary artery disease.\n"", ""evidence"": [{""explanation"": ""Confirms atherosclerosis as the primary pathophysiological mechanism underlying PAD."", ""reference"": ""PMID:38003290"", ""snippet"": ""Peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular disease (CeVD) are characterized by atherosclerosis and inflammation as their underlying mechanisms."", ""supports"": ""SUPPORT""}, {""explanation"": ""Describes the characteristic lipid accumulation and cellular transformation in atherosclerotic plaques."", ""reference"": ""PMID:37452714"", ""snippet"": ""Atherosclerosis is a lipid-driven chronic inflammatory disease characterized by the accumulation and transformation of inflammatory cells, and smooth muscle cells in the intimal space."", ""supports"": ""SUPPORT""}, {""explanation"": ""Links neutrophil activity to atherosclerotic plaque progression and severity in peripheral arteries."", ""reference"": ""PMID:38401035"", ""snippet"": ""Some clinical trials have demonstrated the association between NETs and the severity and prognosis of atherosclerosis."", ""supports"": ""SUPPORT""}], ""name"": ""Atherosclerosis""}"
5996	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	1	Endothelial Dysfunction	"Impaired endothelium-dependent vasodilation reduces blood flow reserve. Decreased nitric oxide production and increased endothelin contribute.
"																																																								"{""description"": ""Impaired endothelium-dependent vasodilation reduces blood flow reserve. Decreased nitric oxide production and increased endothelin contribute.\n"", ""name"": ""Endothelial Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Vasodilation"", ""term"": {""id"": ""GO:0042311"", ""label"": ""vasodilation""}}], ""cell_types"": [{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Impaired endothelium-dependent vasodilation reduces blood flow reserve. Decreased nitric oxide production and increased endothelin contribute.\n"", ""evidence"": [{""explanation"": ""Demonstrates marked elevation of endothelial activation markers (ICAM, VCAM) in PAD patients, indicating severe endothelial dysfunction."", ""reference"": ""PMID:38961103"", ""snippet"": ""It was observed that serum IL-6, IL-8, ICAM and VCAM levels in type II diabetes mellitus (T2DM) with PAD patients were increased significantly (85.93, 597.08, 94.80 and 80.66) as compared to T2DM patients (59.52, 231.34, 56.88 and 50.19) and healthy individuals (4.81, 16.93, 5.55 and 5.16)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Describes impaired angiogenic signaling in ischemic endothelial cells in PAD, contributing to endothelial dysfunction and inadequate collateral formation."", ""reference"": ""PMID:38182796"", ""snippet"": ""We have previously shown that VEGF165b, an alternatively spliced anti-angiogenic VEGF-A isoform, inhibits the VEGFR-STAT3 pathway in ischemic endothelial cells (ECs) to decrease their angiogenic capacity."", ""supports"": ""SUPPORT""}], ""name"": ""Endothelial Dysfunction""}"
5997	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	2	Thrombosis	"Plaque rupture or erosion triggers thrombosis, potentially causing acute limb ischemia. Platelet activation on disrupted plaque.
"																																																								"{""description"": ""Plaque rupture or erosion triggers thrombosis, potentially causing acute limb ischemia. Platelet activation on disrupted plaque.\n"", ""name"": ""Thrombosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Thrombosis"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}], ""description"": ""Plaque rupture or erosion triggers thrombosis, potentially causing acute limb ischemia. Platelet activation on disrupted plaque.\n"", ""evidence"": [{""explanation"": ""Demonstrates that neutrophil extracellular traps promote platelet activation and thrombosis in atherosclerotic vessels."", ""reference"": ""PMID:38401035"", ""snippet"": ""Continuous release of NETs in response to external stimuli leads to activation of surrounding platelets and monocytes/macrophages, resulting in damage to endothelial cells (EC) and vascular smooth muscle cells (VSMC)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows how NETs respond to atherosclerotic stimuli and contribute to prothrombotic conditions in PAD."", ""reference"": ""PMID:37452714"", ""snippet"": ""NETs not only capture pathogens in innate immunity but also respond to sterile inflammatory stimuli in atherosclerosis, such as lipoproteins and inflammatory cytokines."", ""supports"": ""SUPPORT""}], ""name"": ""Thrombosis""}"
5998	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	3	Inflammation	"Chronic inflammation drives plaque progression and instability. Elevated CRP and inflammatory markers predict cardiovascular events.
"																																																								"{""description"": ""Chronic inflammation drives plaque progression and instability. Elevated CRP and inflammatory markers predict cardiovascular events.\n"", ""name"": ""Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Chronic inflammation drives plaque progression and instability. Elevated CRP and inflammatory markers predict cardiovascular events.\n"", ""evidence"": [{""explanation"": ""Establishes inflammation as a core mechanism underlying PAD pathophysiology."", ""reference"": ""PMID:38003290"", ""snippet"": ""Peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular disease (CeVD) are characterized by atherosclerosis and inflammation as their underlying mechanisms."", ""supports"": ""SUPPORT""}, {""explanation"": ""Describes neutrophil-driven inflammatory mechanisms involving NET formation in atherosclerosis."", ""reference"": ""PMID:37452714"", ""snippet"": ""Neutrophil extracellular traps (NETs) are network-like structures of chromatin filaments decorated by histones, granules, and cytoplasmic-derived proteins expelled by activated neutrophils under multiple pathogenic conditions."", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates how neutrophil-mediated inflammation causes vascular cell damage in atherosclerotic disease."", ""reference"": ""PMID:38401035"", ""snippet"": ""Continuous release of NETs in response to external stimuli leads to activation of surrounding platelets and monocytes/macrophages, resulting in damage to endothelial cells (EC) and vascular smooth muscle cells (VSMC)."", ""supports"": ""SUPPORT""}], ""name"": ""Inflammation""}"
6025	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	0	Peroxisome Biogenesis Defect	Mutations in PEX genes disrupt the assembly and function of peroxisomes, leading to impaired metabolic processes.																																																								"{""description"": ""Mutations in PEX genes disrupt the assembly and function of peroxisomes, leading to impaired metabolic processes."", ""name"": ""Peroxisome Biogenesis Defect""}"	{}	"{""cellular_components"": [{""preferred_term"": ""Peroxisome"", ""term"": {""id"": ""GO:0005777"", ""label"": ""peroxisome""}}], ""description"": ""Mutations in PEX genes disrupt the assembly and function of peroxisomes, leading to impaired metabolic processes."", ""evidence"": [{""explanation"": ""This reference highlights that mutations affecting peroxisome biogenesis lead to dysfunction of peroxisomes and consequently to metabolic impairments."", ""reference"": ""PMID:33417206"", ""snippet"": ""Impaired peroxisome biogenesis, including defects of membrane assembly, import of peroxisomal matrix proteins, and division of peroxisome, causes peroxisome biogenesis disorders (PBDs)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Defective peroxisome biogenesis due to mutations in PEX genes supports the statement about peroxisomal disorders and impaired metabolic processes."", ""reference"": ""PMID:28409474"", ""snippet"": ""More than a dozen complementation groups of animal somatic mutant cells defective in peroxisome biogenesis have been successfully isolated in Chinese hamster ovary (CHO) cells and used as a model system reflecting fatal human severe genetic disorders named peroxisome biogenesis disorders (PBD)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference details how mutations in PEX10 affect peroxisomal import, aligning with the statement's assertion about disrupted peroxisome function."", ""reference"": ""PMID:28320181"", ""snippet"": ""Peroxisome biogenesis factor 10 (PEX10) is involved in the import of peroxisomal matrix proteins, and the mutation of this gene causes 3 subtypes of peroxisome biogenesis disorders..."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study confirms that mutations in PEX genes disrupt peroxisomal functions, leading to various metabolic and physiological impairments."", ""reference"": ""PMID:36249295"", ""snippet"": ""Peroxisomal biogenesis disorders (PBDs) represent a spectrum of conditions that result in vision loss, sensorineural hearing loss, neurologic dysfunction, and other abnormalities resulting from aberrant peroxisomal function caused by mutations in PEX genes."", ""supports"": ""SUPPORT""}, {""explanation"": ""PEX26 mutations, which lead to peroxisomal biogenesis disorders, confirm the link between PEX gene defects and impaired peroxisomal function."", ""reference"": ""PMID:34804114"", ""snippet"": ""Pathogenic variants in the PEX26 gene lead to peroxisomal disorders of the full Zellweger spectrum continuum."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference illustrates the role of PEX genes in peroxisomal disorders, supporting the claim of their involvement in cellular and metabolic disruption."", ""reference"": ""PMID:9458170"", ""snippet"": ""Neurological dysfunction is a prominent feature of most peroxisomal disorders. Enormous progress in defining their gene defects has been achieved. The genes and gene products, peroxins (PEX), in five of the complementation groups have been defined."", ""supports"": ""SUPPORT""}], ""name"": ""Peroxisome Biogenesis Defect""}"
6026	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	1	Accumulation of Toxic Metabolites	The inability to break down very long-chain fatty acids (VLCFAs) and other compounds leads to their accumulation in tissues.																																																								"{""description"": ""The inability to break down very long-chain fatty acids (VLCFAs) and other compounds leads to their accumulation in tissues."", ""name"": ""Accumulation of Toxic Metabolites""}"	{}	"{""biological_processes"": [{""preferred_term"": ""fatty acid beta-oxidation"", ""term"": {""id"": ""GO:0006635"", ""label"": ""fatty acid beta-oxidation""}}, {""preferred_term"": ""very long-chain fatty acid metabolic process"", ""term"": {""id"": ""GO:0000038"", ""label"": ""very long-chain fatty acid metabolic process""}}], ""chemical_entities"": [{""preferred_term"": ""VLCFAs""}, {""preferred_term"": ""Bile Acid Intermediates""}, {""preferred_term"": ""Phytanic Acid"", ""term"": {""id"": ""CHEBI:16285"", ""label"": ""phytanic acid""}}], ""description"": ""The inability to break down very long-chain fatty acids (VLCFAs) and other compounds leads to their accumulation in tissues."", ""evidence"": [{""explanation"": ""The reference supports the accumulation of VLCFAs as part of the pathophysiology of Peroxisome Biogenesis Disorders but does not mention bile acid intermediates or phytanic acid."", ""reference"": ""PMID:19933170"", ""snippet"": ""Peroxisomes are vital eukaryotic organelles that participate in lipid metabolism, in particular the metabolism of very-long-chain fatty acids (VLCFA)... including impaired peroxisomal protein import, elevated VLCFA levels and growth retardation."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference supports the accumulation of VLCFAs and phytanic acid in peroxisomal disorders but does not mention bile acid intermediates."", ""reference"": ""PMID:3119940"", ""snippet"": ""In patients with cerebro-hepato-renal (Zellweger) syndrome, the absence of peroxisomes results in an impairment of metabolic processes... These include the catabolism of very long chain (greater than C22) fatty acids... the catabolism of phytanic acid and the catabolism of pipecolic acid."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference supports the accumulation of bile acid intermediates in peroxisomal disorders but does not mention VLCFAs or phytanic acid."", ""reference"": ""PMID:22978395"", ""snippet"": ""By comparing the different peroxisomal disorders, we provide evidence suggesting that the main hepatotoxic metabolites responsible for the liver pathology found in patients, are the bile acid synthesis intermediates di- and trihydroxycholestanoic acid (DHCA and THCA)."", ""supports"": ""PARTIAL""}], ""name"": ""Accumulation of Toxic Metabolites""}"
6027	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	2	Deficiency of Essential Compounds	Impaired synthesis of plasmalogens and other essential compounds disrupts normal cellular functions.																																																								"{""description"": ""Impaired synthesis of plasmalogens and other essential compounds disrupts normal cellular functions."", ""name"": ""Deficiency of Essential Compounds""}"	{}	"{""biological_processes"": [{""preferred_term"": ""ether lipid biosynthetic process"", ""term"": {""id"": ""GO:0008611"", ""label"": ""ether lipid biosynthetic process""}}, {""preferred_term"": ""bile acid biosynthetic process"", ""term"": {""id"": ""GO:0006699"", ""label"": ""bile acid biosynthetic process""}}], ""chemical_entities"": [{""preferred_term"": ""Plasmalogen""}, {""preferred_term"": ""Docosahexaenoic acid"", ""term"": {""id"": ""CHEBI:28125"", ""label"": ""docosahexaenoic acid""}}], ""description"": ""Impaired synthesis of plasmalogens and other essential compounds disrupts normal cellular functions."", ""evidence"": [{""explanation"": ""The literature indicates that plasmalogen biosynthesis is significantly affected in patients with peroxisome biogenesis disorders, which supports the statement regarding impaired synthesis of plasmalogens disrupting normal cellular functions."", ""reference"": ""PMID:36720320"", ""snippet"": ""The absence of plasmalogens in several organs of patients with deficiency in peroxisome biogenesis suggests that de novo synthesis of plasmalogens contributes significantly to plasmalogen homeostasis in humans."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study reinforces that impaired peroxisome function, including the biosynthesis of plasmalogens, leads to a broad spectrum of cellular dysfunctions."", ""reference"": ""PMID:32165495"", ""snippet"": ""The peroxisome is a subcellular organelle that functions in essential metabolic pathways, including biosynthesis of plasmalogens, fatty acid beta-oxidation of very-long-chain fatty acids, and degradation of hydrogen peroxide. Peroxisome biogenesis disorders (PBDs) manifest as severe dysfunction in multiple organs, including the central nervous system (CNS), but the pathogenic mechanisms in PBDs are largely unknown."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract confirms that peroxisomes are crucial for the synthesis of plasmalogens and that their dysfunction could disrupt normal cellular functions."", ""reference"": ""PMID:33417206"", ""snippet"": ""Peroxisomes are presented in all eukaryotic cells and play essential roles in many of lipid metabolic pathways, including beta-oxidation of fatty acids and synthesis of ether-linked glycerophospholipids, such as plasmalogens."", ""supports"": ""SUPPORT""}], ""name"": ""Deficiency of Essential Compounds""}"
6028	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	3	Neurological Dysfunction	Accumulation of toxic metabolites and deficiency of essential compounds lead to demyelination, neuronal migration defects, and neurodegeneration.																																																								"{""description"": ""Accumulation of toxic metabolites and deficiency of essential compounds lead to demyelination, neuronal migration defects, and neurodegeneration."", ""name"": ""Neurological Dysfunction""}"	{}	"{""cell_types"": [{""preferred_term"": ""oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}], ""description"": ""Accumulation of toxic metabolites and deficiency of essential compounds lead to demyelination, neuronal migration defects, and neurodegeneration."", ""evidence"": [{""explanation"": ""The reference specifies that a lack of functional peroxisomes leads to severe neurological dysfunction, including demyelination and defects in neuronal migration, which aligns with the statement's content."", ""reference"": ""PMID:15868469"", ""snippet"": ""Peroxisome biogenesis disorders, of which Zellweger syndrome is the most severe, result in severe neurological dysfunction associated with abnormal CNS neuronal migrations due to the lack of functional peroxisomes."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference describes PBDs leading to significant neurodegeneration and psychomotor dysfunction, consistent with the statement on neurological dysfunction due to the disorder."", ""reference"": ""PMID:33417206"", ""snippet"": ""Impaired peroxisome biogenesis, including defects of membrane assembly, import of peroxisomal matrix proteins, and division of peroxisome, causes peroxisome biogenesis disorders (PBDs)."", ""supports"": ""SUPPORT""}, {""explanation"": ""While this reference supports the role of toxic metabolites, it focuses on liver pathology rather than CNS-specific features like demyelination and neuronal migration defects."", ""reference"": ""PMID:22978395"", ""snippet"": ""Liver pathology is a frequent finding in patients affected by a peroxisomal disorder. ... we provide evidence suggesting that the main hepatotoxic metabolites responsible for the liver pathology found in patients, are the bile acid synthesis intermediates di- and trihydroxycholestanoic acid (DHCA and THCA)."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference acknowledges the impact on the nervous system and describes psychomotor dysfunction, supporting the idea of neurological dysfunction."", ""reference"": ""PMID:7685145"", ""snippet"": ""Because peroxisomes are involved in the metabolism of lipids critical to the functioning of the nervous system, many of the peroxisomal disorders manifest with significant degrees of progressive psychomotor dysfunction."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference highlights general brain abnormalities due to peroxisomal dysfunction but does not specifically describe demyelination and neuronal migration defects. Partial support is given as it indicates a broad CNS impact."", ""reference"": ""PMID:30739266"", ""snippet"": ""The importance of functional peroxisomes for cellular metabolism is demonstrated by the marked brain and systemic organ abnormalities occuring in peroxisome biogenesis disorders and peroxisomal enzyme deficiencies"", ""supports"": ""PARTIAL""}], ""locations"": [{""preferred_term"": ""central nervous system"", ""term"": {""id"": ""UBERON:0001017"", ""label"": ""central nervous system""}}], ""name"": ""Neurological Dysfunction""}"
6029	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	4	Hepatic Dysfunction	Accumulation of bile acid intermediates and VLCFAs, along with oxidative stress, cause hepatomegaly, fibrosis, and liver failure.																																																								"{""description"": ""Accumulation of bile acid intermediates and VLCFAs, along with oxidative stress, cause hepatomegaly, fibrosis, and liver failure."", ""name"": ""Hepatic Dysfunction""}"	{}	"{""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Accumulation of bile acid intermediates and VLCFAs, along with oxidative stress, cause hepatomegaly, fibrosis, and liver failure."", ""evidence"": [{""explanation"": ""The study mentions liver disease as a common symptom of peroxisome biogenesis disorder (PBD), supporting hepatic dysfunction."", ""reference"": ""PMID:12473763"", ""snippet"": ""Common to these three disorders are liver disease, variable neurodevelopmental delay, retinopathy, and perceptive deafness."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the accumulation of bile acid intermediates causing liver pathology in PBDs."", ""reference"": ""PMID:22978395"", ""snippet"": ""The main hepatotoxic metabolites responsible for the liver pathology found in patients, are the bile acid synthesis intermediates di- and trihydroxycholestanoic acid (DHCA and THCA)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference indirectly supports the statement by discussing the lethal and severe impact of PBDs, including liver dysfunction."", ""reference"": ""PMID:29282281"", ""snippet"": ""They are caused by mutations of peroxisomal biogenesis factors encoded by Pex genes, and result in childhood lethality"", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms hepatic dysfunction including fibrosis in PBDs."", ""reference"": ""PMID:8184191"", ""snippet"": ""Zellweger disease or cerebro-hepato-renal syndrome is characterized clinically by... liver damage leading to cirrhosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Supports the accumulation of VLCFAs as part of the pathophysiology."", ""reference"": ""PMID:8729109"", ""snippet"": ""Abnormally high levels of very long-chain fatty acids (VLCFA) are a feature in...peroxisomal disorders."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the accumulation of bile acid intermediates, contributing to hepatic dysfunction."", ""reference"": ""PMID:17682975"", ""snippet"": ""Nine recognized inborn errors of bile acid metabolism have been identified that lead to enzyme deficiencies and impaired bile acid synthesis in infants, children, and adults."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Hepatic Dysfunction""}"
6030	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	5	Skeletal Abnormalities	Plasmalogen deficiency disrupts normal bone formation, leading to rhizomelic shortening of limbs and chondrodysplasia punctata.																																																								"{""description"": ""Plasmalogen deficiency disrupts normal bone formation, leading to rhizomelic shortening of limbs and chondrodysplasia punctata."", ""name"": ""Skeletal Abnormalities""}"	{}	"{""description"": ""Plasmalogen deficiency disrupts normal bone formation, leading to rhizomelic shortening of limbs and chondrodysplasia punctata."", ""evidence"": [{""explanation"": ""The context indicates that rhizomelic chondrodysplasia punctata (a type of peroxisome biogenesis disorder) results from peroxisomal dysfunction, supporting the connection between plasmalogen deficiency and skeletal abnormalities, including rhizomelic shortening of limbs and chondrodysplasia punctata."", ""reference"": ""PMID:10904262"", ""snippet"": ""Zellweger syndrome, neonatal adrenoleukodystrophy, infantile Refsum disease and rhizomelic chondrodysplasia punctata are progressive disorders characterized by loss of multiple peroxisomal metabolic functions."", ""supports"": ""SUPPORT""}, {""explanation"": ""The document discusses a case where plasmalogen biosynthesis deficiency leads to rhizomelic chondrodysplasia punctata, supporting the statement."", ""reference"": ""PMID:10972423"", ""snippet"": ""The case of a Yemeni girl with isolated peroxisomal acyl-CoA:dihydroxyacetonephosphate acyltransferase (DHAPAT) deficiency is reported. She had rhizomelic chondrodysplasia punctata, microcephaly, failure to thrive, delayed motor and mental development, and spastic quadriplegia."", ""supports"": ""SUPPORT""}, {""explanation"": ""The paper supports the importance of peroxisomes in lipid synthesis, including plasmalogens, which are associated with diseases like rhizomelic chondrodysplasia punctata that impact bone and cartilage formation."", ""reference"": ""PMID:8507680"", ""snippet"": ""The results have clearly shown an indispensable role for peroxisomes in the total process of ether lipid synthesis as evidenced by a description of the cellular topography of this process."", ""supports"": ""SUPPORT""}, {""explanation"": ""This clearly supports the notion that defective plasmalogen biosynthesis leads to skeletal abnormalities characteristic of rhizomelic chondrodysplasia punctata, including rhizomelic shortening of limbs and chondrodysplasia punctata."", ""reference"": ""PMID:24172221"", ""snippet"": ""Rhizomelic chondrodysplasia punctata (RCDP); a peroxisomal disorder clinically characterized by skeletal abnormalities, congenital cataracts, severe growth and developmental impairments and immobility of joints. Defective plasmalogen biosynthesis is the main biochemical feature."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""bones"", ""term"": {""id"": ""UBERON:0001474"", ""label"": ""bone element""}}, {""preferred_term"": ""cartilage"", ""term"": {""id"": ""UBERON:0002418"", ""label"": ""cartilage tissue""}}], ""name"": ""Skeletal Abnormalities""}"
6031	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	6	Multisystem Involvement	The pervasive nature of peroxisomal dysfunction affects multiple organ systems, resulting in a wide range of clinical manifestations.																																																								"{""description"": ""The pervasive nature of peroxisomal dysfunction affects multiple organ systems, resulting in a wide range of clinical manifestations."", ""name"": ""Multisystem Involvement""}"	{}	"{""description"": ""The pervasive nature of peroxisomal dysfunction affects multiple organ systems, resulting in a wide range of clinical manifestations."", ""evidence"": [{""explanation"": ""This statement supports the pervasive nature of peroxisomal dysfunction affecting multiple organ systems, leading to a range of clinical manifestations."", ""reference"": ""PMID:14527301"", ""snippet"": ""The multisystem clinical phenotype varies widely in severity and results from disturbances in both development and metabolic homeostasis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This statement aligns with the notion that peroxisomal dysfunction affects multiple organ systems."", ""reference"": ""PMID:33417210"", ""snippet"": ""Peroxisomopathies are rare diseases due to dysfunctions of the peroxisome in which this organelle is either absent or with impaired activities. These diseases... affect the central and peripheral nervous system."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference details the involvement of multiple cellular compartments and metabolic pathways, illustrating multisystem impact."", ""reference"": ""PMID:26453805"", ""snippet"": ""The peroxisomal compartment in hepatocytes hosts several essential metabolic conversions. These are defective in peroxisomal disorders... including mitochondria and the ER."", ""supports"": ""SUPPORT""}, {""explanation"": ""It categorizes peroxisomal disorders as multisystem with significant implications in different organ systems, particularly the eyes."", ""reference"": ""PMID:1710072"", ""snippet"": ""Several childhood multisystem disorders with prominent ophthalmological manifestations have been ascribed to the malfunction of the peroxisome, a subcellular organelle."", ""supports"": ""SUPPORT""}, {""explanation"": ""This echoes the impact on multiple organ systems but emphasizes the neurological dysfunctions."", ""reference"": ""PMID:15868469"", ""snippet"": ""Peroxisome biogenesis disorders, of which Zellweger syndrome is the most severe, result in severe neurological dysfunction associated with abnormal CNS neuronal migrations due to the lack of functional peroxisomes."", ""supports"": ""SUPPORT""}, {""explanation"": ""This source supports the statement by highlighting the multi-organ involvement in peroxisomal disorders."", ""reference"": ""PMID:21397417"", ""snippet"": ""Peroxisomal disorders (PDs) are heterogeneous groups of diseases and affect many organs with varying degrees of involvement."", ""supports"": ""SUPPORT""}], ""name"": ""Multisystem Involvement""}"
6032	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	7	Microglial Dysfunction and Neuroinflammation	Peroxisomal defects in microglial cells induce a disease-associated microglial (DAM) signature with altered lipid metabolism, lipid droplet accumulation, and impaired autophagy, contributing to neurodegeneration.																																		Recent research highlights that microglial peroxisomal defects force cells into a pathological phenotype that may be a key contributor to CNS pathogenesis in peroxisomal disorders.																						"{""description"": ""Peroxisomal defects in microglial cells induce a disease-associated microglial (DAM) signature with altered lipid metabolism, lipid droplet accumulation, and impaired autophagy, contributing to neurodegeneration."", ""name"": ""Microglial Dysfunction and Neuroinflammation"", ""notes"": ""Recent research highlights that microglial peroxisomal defects force cells into a pathological phenotype that may be a key contributor to CNS pathogenesis in peroxisomal disorders.""}"	{}	"{""cell_types"": [{""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Peroxisomal defects in microglial cells induce a disease-associated microglial (DAM) signature with altered lipid metabolism, lipid droplet accumulation, and impaired autophagy, contributing to neurodegeneration."", ""locations"": [{""preferred_term"": ""central nervous system"", ""term"": {""id"": ""UBERON:0001017"", ""label"": ""central nervous system""}}], ""name"": ""Microglial Dysfunction and Neuroinflammation"", ""notes"": ""Recent research highlights that microglial peroxisomal defects force cells into a pathological phenotype that may be a key contributor to CNS pathogenesis in peroxisomal disorders.""}"
6033	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	8	Peroxisome-Organelle Crosstalk Disruption	Disruption of peroxisome-ER-mitochondria interactions impairs lipid trafficking and metabolic coordination, particularly affecting VLCFA and ether-lipid flux between organelles.																																		ACBD5 tethers peroxisomes to ER via VAPs, facilitating lipid flux; disruption perturbs VLCFA and ether-lipid trafficking.																						"{""description"": ""Disruption of peroxisome-ER-mitochondria interactions impairs lipid trafficking and metabolic coordination, particularly affecting VLCFA and ether-lipid flux between organelles."", ""name"": ""Peroxisome-Organelle Crosstalk Disruption"", ""notes"": ""ACBD5 tethers peroxisomes to ER via VAPs, facilitating lipid flux; disruption perturbs VLCFA and ether-lipid trafficking.""}"	{}	"{""cellular_components"": [{""preferred_term"": ""peroxisome"", ""term"": {""id"": ""GO:0005777"", ""label"": ""peroxisome""}}, {""preferred_term"": ""endoplasmic reticulum"", ""term"": {""id"": ""GO:0005783"", ""label"": ""endoplasmic reticulum""}}, {""preferred_term"": ""mitochondrion"", ""term"": {""id"": ""GO:0005739"", ""label"": ""mitochondrion""}}], ""description"": ""Disruption of peroxisome-ER-mitochondria interactions impairs lipid trafficking and metabolic coordination, particularly affecting VLCFA and ether-lipid flux between organelles."", ""name"": ""Peroxisome-Organelle Crosstalk Disruption"", ""notes"": ""ACBD5 tethers peroxisomes to ER via VAPs, facilitating lipid flux; disruption perturbs VLCFA and ether-lipid trafficking.""}"
6034	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	9	Retinal Pigment Epithelium Dysfunction	In peroxisome biogenesis disorders, retinal pigment epithelium shows progressive lipid remodeling with decreased plasmalogens and increased very-long-chain lysophosphatidylcholines, leading to structural degeneration and vision loss.																																		RPE lipid changes precede structural changes and show dorsal-to-ventral progression in animal models. Both RPE and photoreceptors are affected by peroxisomal dysfunction.																						"{""description"": ""In peroxisome biogenesis disorders, retinal pigment epithelium shows progressive lipid remodeling with decreased plasmalogens and increased very-long-chain lysophosphatidylcholines, leading to structural degeneration and vision loss."", ""name"": ""Retinal Pigment Epithelium Dysfunction"", ""notes"": ""RPE lipid changes precede structural changes and show dorsal-to-ventral progression in animal models. Both RPE and photoreceptors are affected by peroxisomal dysfunction.""}"	{}	"{""cell_types"": [{""preferred_term"": ""retinal pigment epithelial cell"", ""term"": {""id"": ""CL:0002586"", ""label"": ""retinal pigment epithelial cell""}}, {""preferred_term"": ""photoreceptor cell"", ""term"": {""id"": ""CL:0000210"", ""label"": ""photoreceptor cell""}}], ""description"": ""In peroxisome biogenesis disorders, retinal pigment epithelium shows progressive lipid remodeling with decreased plasmalogens and increased very-long-chain lysophosphatidylcholines, leading to structural degeneration and vision loss."", ""locations"": [{""preferred_term"": ""retina"", ""term"": {""id"": ""UBERON:0000966"", ""label"": ""retina""}}], ""name"": ""Retinal Pigment Epithelium Dysfunction"", ""notes"": ""RPE lipid changes precede structural changes and show dorsal-to-ventral progression in animal models. Both RPE and photoreceptors are affected by peroxisomal dysfunction.""}"
6035	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	10	Impaired Peroxisome Biogenesis and Import	Mutations in PEX genes disrupt the peroxisomal protein import machinery, including PEX5/PEX7 receptors, the PEX13/PEX14 docking complex, and the PEX1-PEX6 AAA+ ATPase export complex, preventing proper assembly and function of peroxisomes.																																		The import cycle involves PTS1/PTS2 cargo binding, docking, translocation, ubiquitination of PEX5, and AAA+ ATPase-mediated extraction for recycling.																						"{""description"": ""Mutations in PEX genes disrupt the peroxisomal protein import machinery, including PEX5/PEX7 receptors, the PEX13/PEX14 docking complex, and the PEX1-PEX6 AAA+ ATPase export complex, preventing proper assembly and function of peroxisomes."", ""name"": ""Impaired Peroxisome Biogenesis and Import"", ""notes"": ""The import cycle involves PTS1/PTS2 cargo binding, docking, translocation, ubiquitination of PEX5, and AAA+ ATPase-mediated extraction for recycling.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""protein import into peroxisome matrix"", ""term"": {""id"": ""GO:0016558"", ""label"": ""protein import into peroxisome matrix""}}, {""preferred_term"": ""peroxisome organization"", ""term"": {""id"": ""GO:0007031"", ""label"": ""peroxisome organization""}}], ""cellular_components"": [{""preferred_term"": ""peroxisome"", ""term"": {""id"": ""GO:0005777"", ""label"": ""peroxisome""}}], ""description"": ""Mutations in PEX genes disrupt the peroxisomal protein import machinery, including PEX5/PEX7 receptors, the PEX13/PEX14 docking complex, and the PEX1-PEX6 AAA+ ATPase export complex, preventing proper assembly and function of peroxisomes."", ""name"": ""Impaired Peroxisome Biogenesis and Import"", ""notes"": ""The import cycle involves PTS1/PTS2 cargo binding, docking, translocation, ubiquitination of PEX5, and AAA+ ATPase-mediated extraction for recycling.""}"
6064	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	0	STK11 loss-of-function signaling disruption	"Germline loss-of-function variants in STK11 (LKB1) disrupt tumor suppressor signaling and drive hamartomatous polyp formation throughout the GI tract.
"																																																								"{""description"": ""Germline loss-of-function variants in STK11 (LKB1) disrupt tumor suppressor signaling and drive hamartomatous polyp formation throughout the GI tract.\n"", ""name"": ""STK11 loss-of-function signaling disruption""}"	{}	"{""biological_processes"": [{""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}, {""preferred_term"": ""cell proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell proliferation""}}], ""cell_types"": [{""preferred_term"": ""intestinal smooth muscle cell"", ""term"": {""id"": ""CL:0002504"", ""label"": ""enteric smooth muscle cell""}}, {""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}], ""description"": ""Germline loss-of-function variants in STK11 (LKB1) disrupt tumor suppressor signaling and drive hamartomatous polyp formation throughout the GI tract.\n"", ""evidence"": [{""explanation"": ""Establishes STK11 germline variants as the driver of hamartomatous polyposis in PJS."", ""reference"": ""PMID:37054692"", ""snippet"": ""Peutz-Jeghers syndrome (PJS) is a rare disease characterized by the presence of hamartomatous polyposis throughout the gastrointestinal tract, except for the esophagus, along with characteristic mucocutaneous pigmentation. It is caused by germline pathogenic variants of the STK11 gene, which exhibit an autosomal dominant mode of inheritance"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002116"", ""label"": ""small intestine""}}, {""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}], ""name"": ""STK11 loss-of-function signaling disruption""}"
6065	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	1	mTORC1 pathway hyperactivation	"LKB1-deficient tissues and hamartomas show increased mTORC1 signaling that promotes polyp growth and proliferation.
"																																																								"{""description"": ""LKB1-deficient tissues and hamartomas show increased mTORC1 signaling that promotes polyp growth and proliferation.\n"", ""name"": ""mTORC1 pathway hyperactivation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""mTORC1 signaling"", ""term"": {""id"": ""GO:0031929"", ""label"": ""TOR signaling""}}, {""preferred_term"": ""cell proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell proliferation""}}], ""description"": ""LKB1-deficient tissues and hamartomas show increased mTORC1 signaling that promotes polyp growth and proliferation.\n"", ""evidence"": [{""explanation"": ""Demonstrates mTORC1 pathway hyperactivation in LKB1-deficient PJS models."", ""reference"": ""PMID:19541609"", ""snippet"": ""Among mitogenic signaling pathways, the mammalian-target of rapamycin complex 1 (mTORC1) pathway is hyperactivated in tissues and tumors derived from LKB1-deficient mice."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms mTORC1 signaling is upregulated in human PJS polyps."", ""reference"": ""PMID:19541609"", ""snippet"": ""Importantly, we demonstrate that polyps from human Peutz-Jeghers patients similarly exhibit up-regulated mTORC1 signaling, HIF-1alpha, and GLUT1 levels."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002116"", ""label"": ""small intestine""}}], ""name"": ""mTORC1 pathway hyperactivation""}"
6066	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	2	Arborizing smooth muscle core formation	"Hamartomatous polyps contain branching bundles of smooth muscle fibers covered by hyperplastic mucosa, producing the characteristic arborizing architecture.
"																																																								"{""description"": ""Hamartomatous polyps contain branching bundles of smooth muscle fibers covered by hyperplastic mucosa, producing the characteristic arborizing architecture.\n"", ""name"": ""Arborizing smooth muscle core formation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""smooth muscle cell differentiation"", ""term"": {""id"": ""GO:0051145"", ""label"": ""smooth muscle cell differentiation""}}, {""preferred_term"": ""tissue morphogenesis"", ""term"": {""id"": ""GO:0048569"", ""label"": ""tissue morphogenesis""}}], ""cell_types"": [{""preferred_term"": ""smooth muscle cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}], ""description"": ""Hamartomatous polyps contain branching bundles of smooth muscle fibers covered by hyperplastic mucosa, producing the characteristic arborizing architecture.\n"", ""evidence"": [{""explanation"": ""Histologic description supports the arborizing smooth muscle core in PJS polyps."", ""reference"": ""PMID:36998347"", ""snippet"": ""The resected specimen showed a branching bundle of smooth muscle fibers covered by hyperplastic mucosa, consistent with a hamartomatous polyp"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002116"", ""label"": ""small intestine""}}], ""name"": ""Arborizing smooth muscle core formation""}"
6078	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	pathophysiology	0	FGFR Gain-of-Function Signaling	"Mutations in FGFR1 (P252R) or FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal limb development. FGFR2 mutations causing Types 2 and 3 often affect the tyrosine kinase domain or cause more severe receptor dysregulation than Type 1 mutations.
"																																																								"{""description"": ""Mutations in FGFR1 (P252R) or FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal limb development. FGFR2 mutations causing Types 2 and 3 often affect the tyrosine kinase domain or cause more severe receptor dysregulation than Type 1 mutations.\n"", ""name"": ""FGFR Gain-of-Function Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""FGFR Signaling"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}, {""preferred_term"": ""Cranial Suture Morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}], ""cell_types"": [{""preferred_term"": ""Osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""Mutations in FGFR1 (P252R) or FGFR2 cause constitutive receptor activation, leading to premature cranial suture fusion and abnormal limb development. FGFR2 mutations causing Types 2 and 3 often affect the tyrosine kinase domain or cause more severe receptor dysregulation than Type 1 mutations.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that the FGFR1 P252R mutation causes familial Pfeiffer syndrome through a gain-of-function mechanism in the extracellular domain."", ""reference"": ""PMID:7874169"", ""snippet"": ""A C to G transversion in exon 5, predicting a proline to arginine substitution in the putative extracellular domain, was identified in all affected members of five unrelated PS families but not in any unaffected individuals."", ""supports"": ""SUPPORT""}], ""name"": ""FGFR Gain-of-Function Signaling""}"
6093	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	0	BCR-ABL1 Fusion Oncogene in Lymphoid Progenitors	The t(9;22)(q34;q11) translocation fuses BCR on chromosome 22 with ABL1 on chromosome 9, creating the Philadelphia chromosome. In ALL, the fusion typically produces the p190 BCR-ABL1 protein (compared to p210 in CML), which has enhanced transforming activity in lymphoid cells. The fusion kinase is constitutively active, driving proliferation and survival signaling.																																																								"{""description"": ""The t(9;22)(q34;q11) translocation fuses BCR on chromosome 22 with ABL1 on chromosome 9, creating the Philadelphia chromosome. In ALL, the fusion typically produces the p190 BCR-ABL1 protein (compared to p210 in CML), which has enhanced transforming activity in lymphoid cells. The fusion kinase is constitutively active, driving proliferation and survival signaling."", ""name"": ""BCR-ABL1 Fusion Oncogene in Lymphoid Progenitors""}"	"{""downstream"": [{""description"": ""BCR-ABL1 activates multiple proliferative and survival pathways"", ""target"": ""Constitutive Signaling Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}], ""cell_types"": [{""preferred_term"": ""B-lymphoblast"", ""term"": {""id"": ""CL:0017006"", ""label"": ""B-lymphoblast""}}], ""description"": ""The t(9;22)(q34;q11) translocation fuses BCR on chromosome 22 with ABL1 on chromosome 9, creating the Philadelphia chromosome. In ALL, the fusion typically produces the p190 BCR-ABL1 protein (compared to p210 in CML), which has enhanced transforming activity in lymphoid cells. The fusion kinase is constitutively active, driving proliferation and survival signaling."", ""downstream"": [{""description"": ""BCR-ABL1 activates multiple proliferative and survival pathways"", ""target"": ""Constitutive Signaling Pathway Activation""}], ""evidence"": [{""explanation"": ""This abstract directly links Ph+ ALL to the BCR::ABL1 fusion from t(9;22), matching the described mechanism."", ""reference"": ""PMID:41251904"", ""snippet"": ""Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is characterized by the BCR::ABL1 fusion gene resulting from the translocation t(9;22)."", ""supports"": ""SUPPORT""}], ""name"": ""BCR-ABL1 Fusion Oncogene in Lymphoid Progenitors""}"
6094	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	1	Constitutive Signaling Pathway Activation	BCR-ABL1 activates RAS-MAPK, PI3K-AKT, and JAK-STAT signaling pathways independently of normal growth factor regulation. This drives uncontrolled proliferation and confers resistance to apoptosis, enabling leukemic transformation of B-lymphoid progenitors.																																																								"{""description"": ""BCR-ABL1 activates RAS-MAPK, PI3K-AKT, and JAK-STAT signaling pathways independently of normal growth factor regulation. This drives uncontrolled proliferation and confers resistance to apoptosis, enabling leukemic transformation of B-lymphoid progenitors."", ""name"": ""Constitutive Signaling Pathway Activation""}"	"{""downstream"": [{""description"": ""Aberrant signaling arrests normal B-cell development"", ""target"": ""B-lymphoid Differentiation Block""}, {""description"": ""PI3K-AKT signaling promotes survival"", ""target"": ""Apoptosis Resistance""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""description"": ""BCR-ABL1 activates RAS-MAPK, PI3K-AKT, and JAK-STAT signaling pathways independently of normal growth factor regulation. This drives uncontrolled proliferation and confers resistance to apoptosis, enabling leukemic transformation of B-lymphoid progenitors."", ""downstream"": [{""description"": ""Aberrant signaling arrests normal B-cell development"", ""target"": ""B-lymphoid Differentiation Block""}, {""description"": ""PI3K-AKT signaling promotes survival"", ""target"": ""Apoptosis Resistance""}], ""name"": ""Constitutive Signaling Pathway Activation""}"
6095	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	2	B-lymphoid Differentiation Block	BCR-ABL1 signaling interferes with normal B-cell development, arresting cells at an immature lymphoblast stage. The resulting cells express B-lineage markers (CD19, CD22) but lack complete B-cell maturation. IKZF1 (Ikaros) deletions, common in Ph+ ALL, further impair B-cell development.																																																								"{""description"": ""BCR-ABL1 signaling interferes with normal B-cell development, arresting cells at an immature lymphoblast stage. The resulting cells express B-lineage markers (CD19, CD22) but lack complete B-cell maturation. IKZF1 (Ikaros) deletions, common in Ph+ ALL, further impair B-cell development."", ""name"": ""B-lymphoid Differentiation Block""}"	"{""downstream"": [{""description"": ""Arrested cells expand in bone marrow"", ""target"": ""Lymphoblast Accumulation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""B cell differentiation"", ""term"": {""id"": ""GO:0030183"", ""label"": ""B cell differentiation""}}], ""cell_types"": [{""preferred_term"": ""B-lymphoblast"", ""term"": {""id"": ""CL:0017006"", ""label"": ""B-lymphoblast""}}], ""description"": ""BCR-ABL1 signaling interferes with normal B-cell development, arresting cells at an immature lymphoblast stage. The resulting cells express B-lineage markers (CD19, CD22) but lack complete B-cell maturation. IKZF1 (Ikaros) deletions, common in Ph+ ALL, further impair B-cell development."", ""downstream"": [{""description"": ""Arrested cells expand in bone marrow"", ""target"": ""Lymphoblast Accumulation""}], ""name"": ""B-lymphoid Differentiation Block""}"
6096	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	3	Apoptosis Resistance	BCR-ABL1 activates PI3K-AKT signaling, phosphorylating and inactivating pro-apoptotic proteins including BAD. This confers resistance to normal apoptotic signals and contributes to the aggressive clinical behavior of Ph+ ALL.																																																								"{""description"": ""BCR-ABL1 activates PI3K-AKT signaling, phosphorylating and inactivating pro-apoptotic proteins including BAD. This confers resistance to normal apoptotic signals and contributes to the aggressive clinical behavior of Ph+ ALL."", ""name"": ""Apoptosis Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""BCR-ABL1 activates PI3K-AKT signaling, phosphorylating and inactivating pro-apoptotic proteins including BAD. This confers resistance to normal apoptotic signals and contributes to the aggressive clinical behavior of Ph+ ALL."", ""name"": ""Apoptosis Resistance""}"
6097	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	4	Lymphoblast Accumulation	The combination of enhanced proliferation, blocked differentiation, and apoptosis resistance leads to accumulation of immature B-lymphoblasts in the bone marrow, blood, and extramedullary sites.																																																								"{""description"": ""The combination of enhanced proliferation, blocked differentiation, and apoptosis resistance leads to accumulation of immature B-lymphoblasts in the bone marrow, blood, and extramedullary sites."", ""name"": ""Lymphoblast Accumulation""}"	{}	"{""cell_types"": [{""preferred_term"": ""B-lymphoblast"", ""term"": {""id"": ""CL:0017006"", ""label"": ""B-lymphoblast""}}], ""description"": ""The combination of enhanced proliferation, blocked differentiation, and apoptosis resistance leads to accumulation of immature B-lymphoblasts in the bone marrow, blood, and extramedullary sites."", ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""Lymphoblast Accumulation""}"
6122	259	Phenylketonuria	Phenylketonuria.yaml	pathophysiology	0	Phenylalanine Hydroxylase Deficiency	"Mutations in PAH gene cause deficient phenylalanine hydroxylase enzyme activity. Phenylalanine cannot be converted to tyrosine, leading to phenylalanine accumulation in blood and tissues.
"																																																								"{""description"": ""Mutations in PAH gene cause deficient phenylalanine hydroxylase enzyme activity. Phenylalanine cannot be converted to tyrosine, leading to phenylalanine accumulation in blood and tissues.\n"", ""name"": ""Phenylalanine Hydroxylase Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Phenylalanine Metabolism"", ""term"": {""id"": ""GO:0006558"", ""label"": ""L-phenylalanine metabolic process""}}], ""description"": ""Mutations in PAH gene cause deficient phenylalanine hydroxylase enzyme activity. Phenylalanine cannot be converted to tyrosine, leading to phenylalanine accumulation in blood and tissues.\n"", ""evidence"": [{""explanation"": ""European guidelines confirm PAH deficiency as the core enzymatic defect in PKU."", ""reference"": ""PMID:29025426"", ""snippet"": ""Phenylketonuria (PKU) is an autosomal recessive inborn error of phenylalanine metabolism caused by deficiency in the enzyme phenylalanine hydroxylase that converts phenylalanine into tyrosine."", ""supports"": ""SUPPORT""}], ""name"": ""Phenylalanine Hydroxylase Deficiency""}"
6123	259	Phenylketonuria	Phenylketonuria.yaml	pathophysiology	1	Neurotoxicity	"Elevated phenylalanine in the brain interferes with neurotransmitter synthesis, myelin formation, and protein synthesis. Phenylalanine competes with other large neutral amino acids for transport across the blood-brain barrier.
"																																																								"{""description"": ""Elevated phenylalanine in the brain interferes with neurotransmitter synthesis, myelin formation, and protein synthesis. Phenylalanine competes with other large neutral amino acids for transport across the blood-brain barrier.\n"", ""name"": ""Neurotoxicity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Neurodevelopment"", ""term"": {""id"": ""GO:0007399"", ""label"": ""nervous system development""}}], ""description"": ""Elevated phenylalanine in the brain interferes with neurotransmitter synthesis, myelin formation, and protein synthesis. Phenylalanine competes with other large neutral amino acids for transport across the blood-brain barrier.\n"", ""evidence"": [{""explanation"": ""The Nature Reviews Primer identifies high phenylalanine as the direct cause of brain dysfunction."", ""reference"": ""PMID:34017006"", ""snippet"": ""Phenylketonuria (PKU; also known as phenylalanine hydroxylase (PAH) deficiency) is an autosomal recessive disorder of phenylalanine metabolism, in which especially high phenylalanine concentrations cause brain dysfunction."", ""supports"": ""SUPPORT""}, {""explanation"": ""DTI study demonstrates white matter damage persists even in early-treated adults."", ""reference"": ""PMID:37265600"", ""snippet"": ""In conclusion, our findings demonstrate that white matter alterations in early-treated phenylketonuria persist into adulthood, are most prominent in the posterior white matter and are likely to be driven by axonal damage."", ""supports"": ""SUPPORT""}], ""name"": ""Neurotoxicity""}"
6124	259	Phenylketonuria	Phenylketonuria.yaml	pathophysiology	2	Melanin Deficiency	"Reduced tyrosine availability impairs melanin synthesis, causing fair skin, light hair, and blue eyes characteristic of untreated PKU.
"																																																								"{""description"": ""Reduced tyrosine availability impairs melanin synthesis, causing fair skin, light hair, and blue eyes characteristic of untreated PKU.\n"", ""name"": ""Melanin Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Melanin Biosynthesis"", ""term"": {""id"": ""GO:0042438"", ""label"": ""melanin biosynthetic process""}}], ""description"": ""Reduced tyrosine availability impairs melanin synthesis, causing fair skin, light hair, and blue eyes characteristic of untreated PKU.\n"", ""name"": ""Melanin Deficiency""}"
6148	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	0	Succinate Dehydrogenase Complex Dysfunction	Mutations in SDHx genes (SDHA, SDHB, SDHC, SDHD, SDHAF2) impair mitochondrial complex II function, leading to succinate accumulation. Succinate acts as an oncometabolite, inhibiting alpha-ketoglutarate-dependent dioxygenases and causing pseudohypoxia and epigenetic dysregulation.																																																								"{""description"": ""Mutations in SDHx genes (SDHA, SDHB, SDHC, SDHD, SDHAF2) impair mitochondrial complex II function, leading to succinate accumulation. Succinate acts as an oncometabolite, inhibiting alpha-ketoglutarate-dependent dioxygenases and causing pseudohypoxia and epigenetic dysregulation."", ""name"": ""Succinate Dehydrogenase Complex Dysfunction""}"	"{""downstream"": [{""description"": ""Succinate accumulation stabilizes HIF transcription factors"", ""target"": ""Pseudohypoxia and HIF Activation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""succinate dehydrogenase activity"", ""term"": {""id"": ""GO:0000104"", ""label"": ""succinate dehydrogenase activity""}}], ""cell_types"": [{""preferred_term"": ""chromaffin cell"", ""term"": {""id"": ""CL:0000166"", ""label"": ""chromaffin cell""}}], ""description"": ""Mutations in SDHx genes (SDHA, SDHB, SDHC, SDHD, SDHAF2) impair mitochondrial complex II function, leading to succinate accumulation. Succinate acts as an oncometabolite, inhibiting alpha-ketoglutarate-dependent dioxygenases and causing pseudohypoxia and epigenetic dysregulation."", ""downstream"": [{""description"": ""Succinate accumulation stabilizes HIF transcription factors"", ""target"": ""Pseudohypoxia and HIF Activation""}], ""evidence"": [{""explanation"": ""This abstract connects SDHx mutations to succinate accumulation and dioxygenase inhibition, matching the described mechanism."", ""reference"": ""PMID:33112834"", ""snippet"": ""SDHx mutations lead to the accumulation of succinate, which acts as an oncometabolite by inhibiting iron(II) and alpha-ketoglutarate-dependent dioxygenases thereby regulating the cell's hypoxic response and epigenetic processes."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""adrenal gland"", ""term"": {""id"": ""UBERON:0002369"", ""label"": ""adrenal gland""}}], ""name"": ""Succinate Dehydrogenase Complex Dysfunction""}"
6149	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	1	Pseudohypoxia and HIF Activation	SDHx and VHL mutations cause constitutive stabilization of hypoxia-inducible factors (HIF1/2) under normoxic conditions. This pseudohypoxic state activates genes promoting angiogenesis, glycolysis, and cell survival, driving tumorigenesis.																																																								"{""description"": ""SDHx and VHL mutations cause constitutive stabilization of hypoxia-inducible factors (HIF1/2) under normoxic conditions. This pseudohypoxic state activates genes promoting angiogenesis, glycolysis, and cell survival, driving tumorigenesis."", ""name"": ""Pseudohypoxia and HIF Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""response to hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}], ""description"": ""SDHx and VHL mutations cause constitutive stabilization of hypoxia-inducible factors (HIF1/2) under normoxic conditions. This pseudohypoxic state activates genes promoting angiogenesis, glycolysis, and cell survival, driving tumorigenesis."", ""name"": ""Pseudohypoxia and HIF Activation""}"
6150	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	2	RET Proto-Oncogene Activation	Germline RET mutations in MEN2 syndrome cause pheochromocytoma through constitutive receptor tyrosine kinase activation. RET-driven pheochromocytomas have distinct catecholamine profiles (epinephrine-predominant) compared to SDHx-related tumors.																																																								"{""description"": ""Germline RET mutations in MEN2 syndrome cause pheochromocytoma through constitutive receptor tyrosine kinase activation. RET-driven pheochromocytomas have distinct catecholamine profiles (epinephrine-predominant) compared to SDHx-related tumors."", ""name"": ""RET Proto-Oncogene Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""receptor signaling protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004716"", ""label"": ""receptor signaling protein tyrosine kinase activity""}}], ""description"": ""Germline RET mutations in MEN2 syndrome cause pheochromocytoma through constitutive receptor tyrosine kinase activation. RET-driven pheochromocytomas have distinct catecholamine profiles (epinephrine-predominant) compared to SDHx-related tumors."", ""name"": ""RET Proto-Oncogene Activation""}"
6151	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	3	Catecholamine Hypersecretion	Secreting PPGLs produce excess catecholamines (norepinephrine, epinephrine, dopamine), causing characteristic symptoms. The catecholamine profile provides clues to underlying genetics: norepinephrine-predominant suggests SDHx/VHL, epinephrine-predominant suggests RET/NF1.																																																								"{""description"": ""Secreting PPGLs produce excess catecholamines (norepinephrine, epinephrine, dopamine), causing characteristic symptoms. The catecholamine profile provides clues to underlying genetics: norepinephrine-predominant suggests SDHx/VHL, epinephrine-predominant suggests RET/NF1."", ""name"": ""Catecholamine Hypersecretion""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""catecholamine biosynthetic process"", ""term"": {""id"": ""GO:0042423"", ""label"": ""catecholamine biosynthetic process""}}], ""description"": ""Secreting PPGLs produce excess catecholamines (norepinephrine, epinephrine, dopamine), causing characteristic symptoms. The catecholamine profile provides clues to underlying genetics: norepinephrine-predominant suggests SDHx/VHL, epinephrine-predominant suggests RET/NF1."", ""evidence"": [{""explanation"": ""Abstract notes catecholamine-secreting tumors causing clinical symptoms."", ""reference"": ""PMID:32617052"", ""snippet"": ""The majority of PCC and sympathetic PGL are endocrine active tumors causing clinical symptoms by secreting excess catecholamines (norepinephrine, epinephrine, dopamine) and their metabolites."", ""supports"": ""SUPPORT""}], ""name"": ""Catecholamine Hypersecretion""}"
6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	Tauopathy	Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner.																																																								"{""description"": ""Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner."", ""name"": ""Tauopathy""}"	"{""downstream"": [{""description"": ""Abnormal filamentous tau deposits cause progressive degeneration of frontal and temporal lobes resulting in frontotemporal dementia."", ""evidence"": [{""explanation"": ""This review establishes that abnormal tau protein aggregation is a defining pathological characteristic of Pick Disease, which is classified as a subtype of frontotemporal dementia."", ""reference"": ""PMID:15365985"", ""snippet"": ""Abnormal filamentous tau deposits have been reported as a pathological characteristic in several other neurodegenerative diseases, including frontotemporal dementia, Pick Disease, Alzheimer disease, argyrophilic grain disease, progressive supranuclear palsy, and corticobasal degeneration."", ""supports"": ""SUPPORT""}], ""target"": ""Frontotemporal Dementia""}]}"	"{""biological_processes"": [{""preferred_term"": ""microtubule-based movement"", ""term"": {""id"": ""GO:0007018"", ""label"": ""microtubule-based movement""}}, {""preferred_term"": ""cytoskeleton organization"", ""term"": {""id"": ""GO:0007010"", ""label"": ""cytoskeleton organization""}}], ""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}, {""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}, {""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Accumulation of 3R tau proteins forming Pick bodies in the brain, leading to neuron damage and loss of brain function. Pick disease is defined by disease-specific 3R tau filament folds that propagate in a prion-like manner."", ""downstream"": [{""description"": ""Abnormal filamentous tau deposits cause progressive degeneration of frontal and temporal lobes resulting in frontotemporal dementia."", ""evidence"": [{""explanation"": ""This review establishes that abnormal tau protein aggregation is a defining pathological characteristic of Pick Disease, which is classified as a subtype of frontotemporal dementia."", ""reference"": ""PMID:15365985"", ""snippet"": ""Abnormal filamentous tau deposits have been reported as a pathological characteristic in several other neurodegenerative diseases, including frontotemporal dementia, Pick Disease, Alzheimer disease, argyrophilic grain disease, progressive supranuclear palsy, and corticobasal degeneration."", ""supports"": ""SUPPORT""}], ""target"": ""Frontotemporal Dementia""}], ""evidence"": [{""explanation"": ""The accumulation of tau proteins in the brain is mentioned as a central feature of Pick's disease, supporting the statement."", ""reference"": ""PMID:20487487"", ""snippet"": ""Pick's disease is a rare and incurable type of dementia that is associated with atrophy of the frontal and temporal lobes of the brain over time as a result of accumulation of tau protein fibres known as Pick's bodies."", ""supports"": ""SUPPORT""}, {""explanation"": ""This study outlines how tau pathology progresses and leads to neuron damage, supporting the statement's claim about the mechanism."", ""reference"": ""PMID:26583316"", ""snippet"": ""Pick disease tau neuropathology may originate in limbic/paralimbic cortices. The patterns of tau pathology observed here provide novel insights into the natural history and biology of tau-mediated neurodegeneration."", ""supports"": ""SUPPORT""}, {""explanation"": ""The mechanistic understanding of tau filaments in Pick's disease supports the idea that tau protein accumulation leads to neuron damage and brain dysfunction."", ""reference"": ""PMID:30158706"", ""snippet"": ""Using electron cryo-microscopy, we recently reported the structures of tau filaments from patients with Alzheimer's disease, which contain both 3R and 4R tau... Here we determine the structures of tau filaments from patients with Pick's disease, a neurodegenerative disorder characterized by frontotemporal dementia."", ""supports"": ""SUPPORT""}, {""explanation"": ""Genetic mutation leading to the accumulation of tau proteins and subsequent neuron damage supports the statement."", ""reference"": ""PMID:37351604"", ""snippet"": ""Two siblings with deletion mutation K281 in MAPT developed frontotemporal dementia. At autopsy, numerous inclusions of hyperphosphorylated 3R Tau were present in neurons and glial cells of neocortex and some subcortical regions, including hippocampus, caudate/putamen and globus pallidus."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""frontal cortex"", ""term"": {""id"": ""UBERON:0001870"", ""label"": ""frontal cortex""}}, {""preferred_term"": ""temporal lobe"", ""term"": {""id"": ""UBERON:0001871"", ""label"": ""temporal lobe""}}, {""preferred_term"": ""hippocampus"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""hippocampus""}}, {""preferred_term"": ""dentate gyrus of hippocampal formation"", ""term"": {""id"": ""UBERON:0001883"", ""label"": ""dentate gyrus of hippocampal formation""}}], ""name"": ""Tauopathy""}"
6170	261	Pick Disease	Pick_Disease.yaml	pathophysiology	1	Neuroinflammation	Astrocyte reactivity and adaptive immune involvement with chemokine-driven recruitment of T lymphocytes. Microglial activation is relatively modest compared to Alzheimer's disease.																																																								"{""description"": ""Astrocyte reactivity and adaptive immune involvement with chemokine-driven recruitment of T lymphocytes. Microglial activation is relatively modest compared to Alzheimer's disease."", ""name"": ""Neuroinflammation""}"	{}	"{""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}, {""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Astrocyte reactivity and adaptive immune involvement with chemokine-driven recruitment of T lymphocytes. Microglial activation is relatively modest compared to Alzheimer's disease."", ""evidence"": [], ""name"": ""Neuroinflammation""}"
6171	261	Pick Disease	Pick_Disease.yaml	pathophysiology	2	Neuronal Loss	Degeneration and loss of nerve cells in the frontal and temporal lobes of the brain.																																																								"{""description"": ""Degeneration and loss of nerve cells in the frontal and temporal lobes of the brain."", ""name"": ""Neuronal Loss""}"	{}	"{""description"": ""Degeneration and loss of nerve cells in the frontal and temporal lobes of the brain."", ""evidence"": [{""explanation"": ""The literature states that Pick's disease involves atrophy in the frontotemporal lobe, which aligns with neuronal loss in the frontal and temporal lobes as described."", ""reference"": ""PMID:27025090"", ""snippet"": ""Pick's disease is a type of frontotemporal lobar degeneration (FTLD) with circumscribed atrophy in the frontotemporal lobe."", ""supports"": ""SUPPORT""}, {""explanation"": ""While discussing FTLD, which includes Pick Disease, literature supports degeneration in the frontal areas of the brain."", ""reference"": ""PMID:38521060"", ""snippet"": ""Here, we report a high-resolution, comparative single-cell molecular atlas of the human primary motor and dorsolateral prefrontal cortices and their transcriptional alterations in sporadic and familial ALS and FTLD."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although the literature specifies a reduction in neuron size rather than number, it aligns with the idea of neuronal degradation in PiD."", ""reference"": ""PMID:11809165"", ""snippet"": ""The area of the substantia nigra was significantly reduced in PiD with PB... The pigmented and nonpigmented neuron counts in PiD with PB were not statistically different from those in controls."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Frontal Lobe"", ""term"": {""id"": ""UBERON:0016525"", ""label"": ""frontal lobe""}}, {""preferred_term"": ""Temporal Lobe"", ""term"": {""id"": ""UBERON:0001871"", ""label"": ""temporal lobe""}}], ""name"": ""Neuronal Loss""}"
6200	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	pathophysiology	0	Hepatic metacestode implantation	Oncospheres establish multilocular metacestode vesicles within the liver parenchyma, anchoring infection to hepatic tissue.																																																								"{""description"": ""Oncospheres establish multilocular metacestode vesicles within the liver parenchyma, anchoring infection to hepatic tissue."", ""name"": ""Hepatic metacestode implantation""}"	{}	"{""description"": ""Oncospheres establish multilocular metacestode vesicles within the liver parenchyma, anchoring infection to hepatic tissue."", ""evidence"": [{""explanation"": ""The CT finding localizes the polycystic hydatid lesion to hepatic parenchyma, consistent with metacestode implantation."", ""reference"": ""PMID:33553405"", ""snippet"": ""Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm  12.2 cm, which was considered a type II hydatid cyst."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Hepatic metacestode implantation""}"
6201	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	pathophysiology	1	Daughter cyst proliferation and matrix remodeling	Metacestodes bud daughter cysts that coalesce into a multilocular mass, expanding through hepatic parenchyma while remodeling surrounding extracellular matrix.																																																								"{""description"": ""Metacestodes bud daughter cysts that coalesce into a multilocular mass, expanding through hepatic parenchyma while remodeling surrounding extracellular matrix."", ""name"": ""Daughter cyst proliferation and matrix remodeling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""description"": ""Metacestodes bud daughter cysts that coalesce into a multilocular mass, expanding through hepatic parenchyma while remodeling surrounding extracellular matrix."", ""evidence"": [{""explanation"": ""The multilocular hepatic mass on imaging reflects proliferating daughter cysts and associated matrix remodeling."", ""reference"": ""PMID:33553405"", ""snippet"": ""Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm  12.2 cm, which was considered a type II hydatid cyst."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Daughter cyst proliferation and matrix remodeling""}"
6202	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	pathophysiology	2	Mass effect and local invasion	The enlarging multilocular cyst complex compresses adjacent hepatic tissue and can invade neighboring structures, generating space-occupying effects.																																																								"{""description"": ""The enlarging multilocular cyst complex compresses adjacent hepatic tissue and can invade neighboring structures, generating space-occupying effects."", ""name"": ""Mass effect and local invasion""}"	{}	"{""description"": ""The enlarging multilocular cyst complex compresses adjacent hepatic tissue and can invade neighboring structures, generating space-occupying effects."", ""evidence"": [{""explanation"": ""The large polycystic hepatic lesion demonstrates mass effect consistent with local compression and invasive growth."", ""reference"": ""PMID:33553405"", ""snippet"": ""Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm  12.2 cm, which was considered a type II hydatid cyst."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Mass effect and local invasion""}"
6223	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	0	Vasopressin/cAMP-Driven Cyst Expansion	"Elevated vasopressin signaling via V2 receptors increases cAMP in tubular epithelial cells, driving chloride and fluid secretion into cysts and promoting cyst wall growth. Blocking V2 signaling slows total kidney volume expansion.
"																																																								"{""description"": ""Elevated vasopressin signaling via V2 receptors increases cAMP in tubular epithelial cells, driving chloride and fluid secretion into cysts and promoting cyst wall growth. Blocking V2 signaling slows total kidney volume expansion.\n"", ""name"": ""Vasopressin/cAMP-Driven Cyst Expansion""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cAMP/PKA signal transduction"", ""term"": {""id"": ""GO:0141156"", ""label"": ""cAMP/PKA signal transduction""}}], ""cell_types"": [{""preferred_term"": ""nephron tubule epithelial cell"", ""term"": {""id"": ""CL:1000494"", ""label"": ""nephron tubule epithelial cell""}}], ""description"": ""Elevated vasopressin signaling via V2 receptors increases cAMP in tubular epithelial cells, driving chloride and fluid secretion into cysts and promoting cyst wall growth. Blocking V2 signaling slows total kidney volume expansion.\n"", ""evidence"": [{""explanation"": ""Tolvaptans effect on kidney volume underscores vasopressin/cAMP signaling as a key driver of cyst expansion."", ""reference"": ""PMID:29105594"", ""snippet"": ""the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume"", ""supports"": ""SUPPORT""}], ""name"": ""Vasopressin/cAMP-Driven Cyst Expansion""}"
6224	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	1	Epithelial Proliferation and Kidney Enlargement	"Reduced polycystin-mediated restraint on epithelial proliferation leads to progressive cyst wall growth and parenchymal compression, increasing total kidney volume and reducing renal function.
"																																																								"{""description"": ""Reduced polycystin-mediated restraint on epithelial proliferation leads to progressive cyst wall growth and parenchymal compression, increasing total kidney volume and reducing renal function.\n"", ""name"": ""Epithelial Proliferation and Kidney Enlargement""}"	{}	"{""biological_processes"": [{""preferred_term"": ""regulation of cell proliferation"", ""term"": {""id"": ""GO:0042127"", ""label"": ""regulation of cell proliferation""}}], ""cell_types"": [{""preferred_term"": ""nephron tubule epithelial cell"", ""term"": {""id"": ""CL:1000494"", ""label"": ""nephron tubule epithelial cell""}}], ""description"": ""Reduced polycystin-mediated restraint on epithelial proliferation leads to progressive cyst wall growth and parenchymal compression, increasing total kidney volume and reducing renal function.\n"", ""evidence"": [{""explanation"": ""Dampening kidney volume growth parallels slower GFR loss, linking cyst epithelial proliferation to functional decline."", ""reference"": ""PMID:29105594"", ""snippet"": ""slowed the growth in total kidney volume and the decline in the estimated glomerular filtration rate"", ""supports"": ""SUPPORT""}], ""name"": ""Epithelial Proliferation and Kidney Enlargement""}"
6225	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	2	Ciliary Dysfunction	"Primary cilia act as mechanosensors in renal tubular epithelial cells. Polycystin dysfunction impairs ciliary signaling, disrupting normal tubular architecture and promoting cyst formation through increased cAMP signaling.
"																																																								"{""description"": ""Primary cilia act as mechanosensors in renal tubular epithelial cells. Polycystin dysfunction impairs ciliary signaling, disrupting normal tubular architecture and promoting cyst formation through increased cAMP signaling.\n"", ""name"": ""Ciliary Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cilium organization"", ""term"": {""id"": ""GO:0044782"", ""label"": ""cilium organization""}}, {""preferred_term"": ""cAMP/PKA signal transduction"", ""term"": {""id"": ""GO:0141156"", ""label"": ""cAMP/PKA signal transduction""}}], ""cell_types"": [{""preferred_term"": ""nephron tubule epithelial cell"", ""term"": {""id"": ""CL:1000494"", ""label"": ""nephron tubule epithelial cell""}}], ""description"": ""Primary cilia act as mechanosensors in renal tubular epithelial cells. Polycystin dysfunction impairs ciliary signaling, disrupting normal tubular architecture and promoting cyst formation through increased cAMP signaling.\n"", ""evidence"": [{""explanation"": ""Reduction of cyst growth via V2 receptor blockade underscores cAMP-mediated ciliary signaling as a driver of cystogenesis."", ""reference"": ""PMID:29105594"", ""snippet"": ""the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume"", ""supports"": ""SUPPORT""}], ""name"": ""Ciliary Dysfunction""}"
6226	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	3	Fibrosis and Inflammation	"Progressive cyst growth triggers interstitial inflammation and fibrosis. Activated myofibroblasts deposit extracellular matrix, contributing to nephron loss and declining kidney function.
"																																																								"{""description"": ""Progressive cyst growth triggers interstitial inflammation and fibrosis. Activated myofibroblasts deposit extracellular matrix, contributing to nephron loss and declining kidney function.\n"", ""name"": ""Fibrosis and Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Progressive cyst growth triggers interstitial inflammation and fibrosis. Activated myofibroblasts deposit extracellular matrix, contributing to nephron loss and declining kidney function.\n"", ""evidence"": [{""explanation"": ""High kidney failure burden reflects cumulative nephron loss from cyst-driven injury and interstitial fibrosis."", ""reference"": ""PMID:40126492"", ""snippet"": ""ADPKD accounts for 5% to 10% of kidney failure in the US and Europe"", ""supports"": ""SUPPORT""}], ""name"": ""Fibrosis and Inflammation""}"
6249	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	0	Hyperandrogenism	"Excess androgen production from ovarian theca cells and adrenal glands leads to hirsutism, acne, and alopecia. Elevated LH stimulates theca cell androgen production.
"																																																								"{""description"": ""Excess androgen production from ovarian theca cells and adrenal glands leads to hirsutism, acne, and alopecia. Elevated LH stimulates theca cell androgen production.\n"", ""name"": ""Hyperandrogenism""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Androgen Biosynthesis"", ""term"": {""id"": ""GO:0006702"", ""label"": ""androgen biosynthetic process""}}], ""description"": ""Excess androgen production from ovarian theca cells and adrenal glands leads to hirsutism, acne, and alopecia. Elevated LH stimulates theca cell androgen production.\n"", ""evidence"": [{""explanation"": ""This review establishes hyperandrogenism as potentially causative rather than merely symptomatic in PCOS pathophysiology."", ""reference"": ""PMID:38152131"", ""snippet"": ""Compelling evidence suggests that hyperandrogenism is not just a primary feature of PCOS. Instead, it may be a causative factor for this condition."", ""supports"": ""SUPPORT""}, {""explanation"": ""Direct evidence of increased androgen biosynthetic machinery (CYP17A1) in PCOS ovaries, supporting intrinsic theca cell abnormality."", ""reference"": ""PMID:24014605"", ""snippet"": ""LHCGR and 17-hydroxylase/17-20-lyase (CYP17A1) protein levels are increased in polycystic ovaries (PCOs)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Quantitative demonstration of elevated CYP17A1 protein in polycystic ovaries compared to controls."", ""reference"": ""PMID:24014605"", ""snippet"": ""A significant increase in the intensity of immunostaining for CYP17A1 was identified in antral follicles in sections of PCO compared with ovaries from normal women (P = 0.04)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Increased LH receptor expression in theca cells explains heightened LH-driven androgen production in PCOS."", ""reference"": ""PMID:24014605"", ""snippet"": ""A higher proportion of theca cells from anovulatory PCO expressed LHCGR protein when compared with control ovaries (P = 0.01)."", ""supports"": ""SUPPORT""}], ""name"": ""Hyperandrogenism""}"
6250	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	1	Insulin Resistance	"Peripheral insulin resistance leads to compensatory hyperinsulinemia, which stimulates ovarian androgen production and inhibits hepatic SHBG synthesis, increasing free androgens.
"																																																								"{""description"": ""Peripheral insulin resistance leads to compensatory hyperinsulinemia, which stimulates ovarian androgen production and inhibits hepatic SHBG synthesis, increasing free androgens.\n"", ""name"": ""Insulin Resistance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Insulin Signaling"", ""term"": {""id"": ""GO:0008286"", ""label"": ""insulin receptor signaling pathway""}}], ""description"": ""Peripheral insulin resistance leads to compensatory hyperinsulinemia, which stimulates ovarian androgen production and inhibits hepatic SHBG synthesis, increasing free androgens.\n"", ""evidence"": [{""explanation"": ""Demonstrates the direct mechanistic link between hyperinsulinemia and worsening of reproductive and androgenic features in PCOS."", ""reference"": ""PMID:40013621"", ""snippet"": ""Hyperinsulinemia (i.e., elevated insulin without hypoglycemia) is a common metabolic feature of PCOS that worsens its reproductive symptoms by exacerbating pituitary hormone imbalances and increasing levels of bioactive androgens."", ""supports"": ""SUPPORT""}, {""explanation"": ""Challenges traditional causality and suggests hyperinsulinemia may be primary rather than compensatory in some PCOS cases."", ""reference"": ""PMID:40013621"", ""snippet"": ""However, it is challenging to define the sequential relationship between insulin sensitivity and insulin secretion, as they are tightly interlinked, and evidence suggests that hyperinsulinemia can alternatively precede insulin resistance."", ""supports"": ""SUPPORT""}, {""explanation"": ""Describes the vicious cycle where androgens exacerbate both hyperinsulinemia and insulin resistance in PCOS."", ""reference"": ""PMID:40013621"", ""snippet"": ""Notably, other drivers of hyperinsulinemia (outside of insulin resistance) may be highly relevant in the context of PCOS. For instance, high androgen levels can augment both hyperinsulinemia and insulin resistance, generating a self-perpetuating cycle of reproductive and metabolic dysfunction."", ""supports"": ""SUPPORT""}], ""name"": ""Insulin Resistance""}"
6251	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	2	Ovulatory Dysfunction	"Disrupted folliculogenesis with arrest at small antral stage leads to anovulation. Multiple small follicles accumulate (polycystic morphology) without dominant follicle selection.
"																																																								"{""description"": ""Disrupted folliculogenesis with arrest at small antral stage leads to anovulation. Multiple small follicles accumulate (polycystic morphology) without dominant follicle selection.\n"", ""name"": ""Ovulatory Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Ovulation"", ""term"": {""id"": ""GO:0030728"", ""label"": ""ovulation""}}], ""description"": ""Disrupted folliculogenesis with arrest at small antral stage leads to anovulation. Multiple small follicles accumulate (polycystic morphology) without dominant follicle selection.\n"", ""evidence"": [{""explanation"": ""Documents the 2-3 fold increase in small growing follicle number characteristic of PCOS polycystic morphology."", ""reference"": ""PMID:14671196"", ""snippet"": ""Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows parallel elevation of AMH levels and small antral follicle count in PCOS, implicating AMH in follicular arrest."", ""reference"": ""PMID:14671196"", ""snippet"": ""Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Proposes mechanism by which elevated AMH interferes with FSH action to prevent dominant follicle selection in PCOS."", ""reference"": ""PMID:14671196"", ""snippet"": ""We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection."", ""supports"": ""SUPPORT""}], ""name"": ""Ovulatory Dysfunction""}"
6252	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	3	Chronic Low-Grade Inflammation	"Elevated inflammatory markers (CRP, IL-6) contribute to insulin resistance and cardiovascular risk in PCOS.
"																																																								"{""description"": ""Elevated inflammatory markers (CRP, IL-6) contribute to insulin resistance and cardiovascular risk in PCOS.\n"", ""name"": ""Chronic Low-Grade Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Elevated inflammatory markers (CRP, IL-6) contribute to insulin resistance and cardiovascular risk in PCOS.\n"", ""evidence"": [{""explanation"": ""Establishes the link between ER stress, inflammation, and apoptotic pathways in PCOS pathophysiology."", ""reference"": ""PMID:39036884"", ""snippet"": ""Polycystic ovarian syndrome (PCOS) is related to pro-apoptotic and pro-inflammatory conditions generated by Endoplasmic reticulum (ER) stress."", ""supports"": ""SUPPORT""}, {""explanation"": ""Clinical trial evidence demonstrating elevated TNF-, IL-18, and IL-6 levels in PCOS patients at baseline, confirming chronic inflammatory state."", ""reference"": ""PMID:39036884"", ""snippet"": ""The levels of TNF- (p = 0.009), IL-18 (p = 0.003), IL-6 (p = 0.013) and active caspase-3 (p = 0.012) were also statistically significant lower in the therapy group."", ""supports"": ""SUPPORT""}], ""name"": ""Chronic Low-Grade Inflammation""}"
6269	266	Polycythemia Vera	Polycythemia_Vera.yaml	pathophysiology	0	JAK2 V617F Constitutive Activation	The JAK2 V617F mutation in the pseudokinase domain eliminates auto-inhibition, causing constitutive JAK2 tyrosine kinase activity. This renders erythroid progenitors hypersensitive to or independent of erythropoietin, driving uncontrolled red blood cell production.																																																								"{""description"": ""The JAK2 V617F mutation in the pseudokinase domain eliminates auto-inhibition, causing constitutive JAK2 tyrosine kinase activity. This renders erythroid progenitors hypersensitive to or independent of erythropoietin, driving uncontrolled red blood cell production."", ""name"": ""JAK2 V617F Constitutive Activation""}"	"{""downstream"": [{""description"": ""JAK2 constitutively phosphorylates and activates STAT5"", ""target"": ""STAT5 Hyperactivation""}, {""description"": ""Mutant progenitors proliferate without EPO stimulation"", ""target"": ""Erythropoietin-Independent Erythropoiesis""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}], ""cell_types"": [{""preferred_term"": ""erythroid progenitor cell"", ""term"": {""id"": ""CL:0000038"", ""label"": ""erythroid progenitor cell""}}], ""description"": ""The JAK2 V617F mutation in the pseudokinase domain eliminates auto-inhibition, causing constitutive JAK2 tyrosine kinase activity. This renders erythroid progenitors hypersensitive to or independent of erythropoietin, driving uncontrolled red blood cell production."", ""downstream"": [{""description"": ""JAK2 constitutively phosphorylates and activates STAT5"", ""target"": ""STAT5 Hyperactivation""}, {""description"": ""Mutant progenitors proliferate without EPO stimulation"", ""target"": ""Erythropoietin-Independent Erythropoiesis""}], ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""JAK2 V617F Constitutive Activation""}"
6270	266	Polycythemia Vera	Polycythemia_Vera.yaml	pathophysiology	1	STAT5 Hyperactivation	Constitutive JAK2 activation leads to sustained STAT5 phosphorylation and transcriptional activation of genes promoting erythroid proliferation and survival, including BCL-XL and cyclin D1.																																																								"{""description"": ""Constitutive JAK2 activation leads to sustained STAT5 phosphorylation and transcriptional activation of genes promoting erythroid proliferation and survival, including BCL-XL and cyclin D1."", ""name"": ""STAT5 Hyperactivation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""JAK-STAT signaling pathway"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}], ""description"": ""Constitutive JAK2 activation leads to sustained STAT5 phosphorylation and transcriptional activation of genes promoting erythroid proliferation and survival, including BCL-XL and cyclin D1."", ""name"": ""STAT5 Hyperactivation""}"
6271	266	Polycythemia Vera	Polycythemia_Vera.yaml	pathophysiology	2	Erythropoietin-Independent Erythropoiesis	JAK2 V617F-mutant erythroid progenitors can proliferate and differentiate in the absence of erythropoietin, forming endogenous erythroid colonies (EEC) in culture. This erythropoietin independence is a diagnostic hallmark of PV.																																																								"{""description"": ""JAK2 V617F-mutant erythroid progenitors can proliferate and differentiate in the absence of erythropoietin, forming endogenous erythroid colonies (EEC) in culture. This erythropoietin independence is a diagnostic hallmark of PV."", ""name"": ""Erythropoietin-Independent Erythropoiesis""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""erythrocyte differentiation"", ""term"": {""id"": ""GO:0030218"", ""label"": ""erythrocyte differentiation""}}], ""description"": ""JAK2 V617F-mutant erythroid progenitors can proliferate and differentiate in the absence of erythropoietin, forming endogenous erythroid colonies (EEC) in culture. This erythropoietin independence is a diagnostic hallmark of PV."", ""name"": ""Erythropoietin-Independent Erythropoiesis""}"
6272	266	Polycythemia Vera	Polycythemia_Vera.yaml	pathophysiology	3	Hyperviscosity and Thrombosis Risk	Elevated red blood cell mass increases blood viscosity and promotes thrombosis. The prothrombotic state is multifactorial, including abnormal red cell interactions, platelet activation, and endothelial dysfunction.																																																								"{""description"": ""Elevated red blood cell mass increases blood viscosity and promotes thrombosis. The prothrombotic state is multifactorial, including abnormal red cell interactions, platelet activation, and endothelial dysfunction."", ""name"": ""Hyperviscosity and Thrombosis Risk""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""blood coagulation"", ""term"": {""id"": ""GO:0007596"", ""label"": ""blood coagulation""}}], ""description"": ""Elevated red blood cell mass increases blood viscosity and promotes thrombosis. The prothrombotic state is multifactorial, including abnormal red cell interactions, platelet activation, and endothelial dysfunction."", ""evidence"": [{""explanation"": ""This abstract states that PV is an MPN with increased thrombosis risk, supporting the thrombotic mechanism described."", ""reference"": ""PMID:41580684"", ""snippet"": ""Polycythemia vera (PV) is a myeloproliferative neoplasm, characterized by trilineage hypercellularity, which increases the risk of thrombosis."", ""supports"": ""SUPPORT""}], ""name"": ""Hyperviscosity and Thrombosis Risk""}"
6290	267	Polymyositis	Polymyositis.yaml	pathophysiology	0	CD8+ T Cell-Mediated Cytotoxicity	Clonally expanded CD8+ cytotoxic T cells infiltrate muscle fibers and directly attack myocytes expressing MHC class I. Perforin and granzyme release leads to muscle fiber necrosis.																																																								"{""description"": ""Clonally expanded CD8+ cytotoxic T cells infiltrate muscle fibers and directly attack myocytes expressing MHC class I. Perforin and granzyme release leads to muscle fiber necrosis."", ""name"": ""CD8+ T Cell-Mediated Cytotoxicity""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T Cell Cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}], ""cell_types"": [{""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}, {""preferred_term"": ""Skeletal Muscle Cell"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}], ""description"": ""Clonally expanded CD8+ cytotoxic T cells infiltrate muscle fibers and directly attack myocytes expressing MHC class I. Perforin and granzyme release leads to muscle fiber necrosis."", ""evidence"": [{""explanation"": ""Demonstrates that CD8+ T cell invasion into muscle fibers is the defining pathological feature of polymyositis."", ""reference"": ""PMID:31257434"", ""snippet"": ""The hallmark histopathology of PM is the presence of CD8+ T cells in the non-necrotic muscle cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms the direct cytotoxic role of CD8+ T cells in causing muscle fiber damage through invasion and attack."", ""reference"": ""PMID:31257434"", ""snippet"": ""CD8+ T cells invade into muscle cells and contribute to muscle injury in PM."", ""supports"": ""SUPPORT""}], ""name"": ""CD8+ T Cell-Mediated Cytotoxicity""}"
6291	267	Polymyositis	Polymyositis.yaml	pathophysiology	1	Aberrant MHC Class I Expression	Muscle fibers, which normally do not express MHC class I, show aberrant upregulation making them targets for CD8+ T cell recognition and attack.																																																								"{""description"": ""Muscle fibers, which normally do not express MHC class I, show aberrant upregulation making them targets for CD8+ T cell recognition and attack."", ""name"": ""Aberrant MHC Class I Expression""}"	{}	"{""biological_processes"": [{""preferred_term"": ""MHC Class I Antigen Presentation"", ""term"": {""id"": ""GO:0002474"", ""label"": ""antigen processing and presentation of peptide antigen via MHC class I""}}], ""description"": ""Muscle fibers, which normally do not express MHC class I, show aberrant upregulation making them targets for CD8+ T cell recognition and attack."", ""evidence"": [{""explanation"": ""Demonstrates that MHC class I upregulation is a hallmark feature of polymyositis pathogenesis."", ""reference"": ""PMID:15934115"", ""snippet"": ""Up-regulation of class I MHC in skeletal muscle fibers was an early and consistent feature of human inflammatory myopathies."", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows that aberrant MHC I expression occurs both on the sarcolemma and within the endoplasmic reticulum of muscle fibers."", ""reference"": ""PMID:15934115"", ""snippet"": ""Class I MHC staining in muscle fibers of myositis patients showed both cell surface and a reticular pattern of internal reactivity."", ""supports"": ""SUPPORT""}], ""name"": ""Aberrant MHC Class I Expression""}"
6292	267	Polymyositis	Polymyositis.yaml	pathophysiology	2	Myositis-Specific Autoantibodies	Anti-synthetase antibodies (anti-Jo-1, anti-PL-7, anti-PL-12) define antisynthetase syndrome with myositis, ILD, and arthritis. Anti-SRP antibodies associate with necrotizing myopathy.																																																								"{""description"": ""Anti-synthetase antibodies (anti-Jo-1, anti-PL-7, anti-PL-12) define antisynthetase syndrome with myositis, ILD, and arthritis. Anti-SRP antibodies associate with necrotizing myopathy."", ""name"": ""Myositis-Specific Autoantibodies""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""description"": ""Anti-synthetase antibodies (anti-Jo-1, anti-PL-7, anti-PL-12) define antisynthetase syndrome with myositis, ILD, and arthritis. Anti-SRP antibodies associate with necrotizing myopathy."", ""name"": ""Myositis-Specific Autoantibodies""}"
6293	267	Polymyositis	Polymyositis.yaml	pathophysiology	3	Pro-inflammatory Cytokine Production	IL-1, TNF-alpha, and IFN-gamma produced by infiltrating immune cells perpetuate muscle inflammation and contribute to muscle weakness independent of direct fiber destruction.																																																								"{""description"": ""IL-1, TNF-alpha, and IFN-gamma produced by infiltrating immune cells perpetuate muscle inflammation and contribute to muscle weakness independent of direct fiber destruction."", ""name"": ""Pro-inflammatory Cytokine Production""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""IL-1, TNF-alpha, and IFN-gamma produced by infiltrating immune cells perpetuate muscle inflammation and contribute to muscle weakness independent of direct fiber destruction."", ""name"": ""Pro-inflammatory Cytokine Production""}"
6294	267	Polymyositis	Polymyositis.yaml	pathophysiology	4	ER Stress and Unfolded Protein Response	Overexpression of MHC class I in muscle fibers triggers endoplasmic reticulum stress and activation of the unfolded protein response (UPR). This includes upregulation of GRP78/BiP and NF-kappaB pathway activation, contributing to muscle fiber dysfunction independent of immune-mediated damage.																																																								"{""description"": ""Overexpression of MHC class I in muscle fibers triggers endoplasmic reticulum stress and activation of the unfolded protein response (UPR). This includes upregulation of GRP78/BiP and NF-kappaB pathway activation, contributing to muscle fiber dysfunction independent of immune-mediated damage."", ""name"": ""ER Stress and Unfolded Protein Response""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Endoplasmic Reticulum Stress Response"", ""term"": {""id"": ""GO:0034976"", ""label"": ""response to endoplasmic reticulum stress""}}], ""description"": ""Overexpression of MHC class I in muscle fibers triggers endoplasmic reticulum stress and activation of the unfolded protein response (UPR). This includes upregulation of GRP78/BiP and NF-kappaB pathway activation, contributing to muscle fiber dysfunction independent of immune-mediated damage."", ""evidence"": [{""explanation"": ""Demonstrates that ER stress pathways are activated in polymyositis muscle tissue as a consequence of MHC I overexpression."", ""reference"": ""PMID:15934115"", ""snippet"": ""The pathways of endoplasmic reticulum (ER) stress response, the unfolded protein response (glucose-regulated protein 78 pathway), and the ER overload response (NF-kappaB pathway) were significantly activated in muscle tissue of human myositis patients and in the mouse model."", ""supports"": ""SUPPORT""}, {""explanation"": ""Identifies ER stress as a non-immune mechanism contributing to muscle pathology, explaining why inflammation doesn't always correlate with disease severity."", ""reference"": ""PMID:15934115"", ""snippet"": ""These results indicate that the ER stress response may be a major nonimmune mechanism responsible for skeletal muscle damage and dysfunction in autoimmune myositis."", ""supports"": ""SUPPORT""}], ""name"": ""ER Stress and Unfolded Protein Response""}"
6295	267	Polymyositis	Polymyositis.yaml	pathophysiology	5	Necroptosis and DAMP Release	Muscle fibers undergo necroptosis, a form of regulated cell death, releasing damage-associated molecular patterns (DAMPs) including HMGB1. This amplifies inflammation and contributes to persistent muscle weakness even after initial immune attack.																																																								"{""description"": ""Muscle fibers undergo necroptosis, a form of regulated cell death, releasing damage-associated molecular patterns (DAMPs) including HMGB1. This amplifies inflammation and contributes to persistent muscle weakness even after initial immune attack."", ""name"": ""Necroptosis and DAMP Release""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Necroptotic Process"", ""term"": {""id"": ""GO:0070266"", ""label"": ""necroptotic process""}}], ""description"": ""Muscle fibers undergo necroptosis, a form of regulated cell death, releasing damage-associated molecular patterns (DAMPs) including HMGB1. This amplifies inflammation and contributes to persistent muscle weakness even after initial immune attack."", ""evidence"": [{""explanation"": ""Establishes necroptosis as a key mechanism of muscle fiber death in polymyositis that perpetuates inflammation."", ""reference"": ""PMID:37483632"", ""snippet"": ""Recent studies have revealed that muscle fibers of IIMs undergo necroptosis, a newly recognized form of regulated cell death, and promote muscle inflammation and dysfunction through releasing inflammatory mediators such as damage-associated molecular patterns (DAMPs)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates that blocking necroptosis or DAMP signaling improves both inflammation and muscle function, highlighting therapeutic potential."", ""reference"": ""PMID:37483632"", ""snippet"": ""The research on murine model of polymyositis, a subtype of IIM, revealed that the inhibition of necroptosis or HMGB1, one of major DAMPs released from muscle fibers undergoing necroptosis, ameliorated muscle inflammation and recovered muscle weakness."", ""supports"": ""SUPPORT""}], ""name"": ""Necroptosis and DAMP Release""}"
6296	267	Polymyositis	Polymyositis.yaml	pathophysiology	6	Apoptosis of Muscle Fibers	Apoptotic cell death occurs in muscle fibers surrounding those undergoing partial invasion by CD8+ T cells. Fibers with apoptotic nuclei are surrounded by CD8+ T cells, granzyme B-positive cells, and macrophages, suggesting cytotoxic T cell-mediated apoptosis occurs in parallel to direct invasion.																																																								"{""description"": ""Apoptotic cell death occurs in muscle fibers surrounding those undergoing partial invasion by CD8+ T cells. Fibers with apoptotic nuclei are surrounded by CD8+ T cells, granzyme B-positive cells, and macrophages, suggesting cytotoxic T cell-mediated apoptosis occurs in parallel to direct invasion."", ""name"": ""Apoptosis of Muscle Fibers""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Apoptotic Process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""Apoptotic cell death occurs in muscle fibers surrounding those undergoing partial invasion by CD8+ T cells. Fibers with apoptotic nuclei are surrounded by CD8+ T cells, granzyme B-positive cells, and macrophages, suggesting cytotoxic T cell-mediated apoptosis occurs in parallel to direct invasion."", ""evidence"": [{""explanation"": ""Shows that apoptosis occurs in polymyositis muscle fibers adjacent to those with CD8+ T cell invasion, mediated by cytotoxic mechanisms."", ""reference"": ""PMID:32936839"", ""snippet"": ""Apoptotic myonuclei were found in muscle with partial invasion, but not in the invaded fibres. Fibres with TUNEL positive nuclei were surrounded by CD8+ T-cells, granzyme B+ cells and macrophages, but lacked FAS receptor expression."", ""supports"": ""SUPPORT""}, {""explanation"": ""Establishes that CD8+ T cell-mediated apoptosis is a distinct pathway of muscle damage occurring alongside direct fiber invasion."", ""reference"": ""PMID:32936839"", ""snippet"": ""The findings confirm that apoptosis occurs in idiopathic inflammatory myopathies and support that it is mediated by CD8+ cytotoxic T- cells, acting in parallel to the process of partial invasion."", ""supports"": ""SUPPORT""}], ""name"": ""Apoptosis of Muscle Fibers""}"
6308	268	Pouchitis	Pouchitis.yaml	pathophysiology	0	Bacterial Dysbiosis	"Altered gut microbiome composition in the ileal pouch, with decreased microbial diversity and shifts toward pathogenic bacterial species. The pouch environment lacks normal colonic bacteria and experiences reduced butyrate-producing bacteria, leading to an imbalanced microbial ecosystem that triggers inflammation.
"																																																								"{""description"": ""Altered gut microbiome composition in the ileal pouch, with decreased microbial diversity and shifts toward pathogenic bacterial species. The pouch environment lacks normal colonic bacteria and experiences reduced butyrate-producing bacteria, leading to an imbalanced microbial ecosystem that triggers inflammation.\n"", ""name"": ""Bacterial Dysbiosis""}"	{}	"{""description"": ""Altered gut microbiome composition in the ileal pouch, with decreased microbial diversity and shifts toward pathogenic bacterial species. The pouch environment lacks normal colonic bacteria and experiences reduced butyrate-producing bacteria, leading to an imbalanced microbial ecosystem that triggers inflammation.\n"", ""evidence"": [{""explanation"": ""Demonstrates distinct microbiome alterations in UC-associated pouchitis with increased Clostridium/Eubacterium and decreased Lactobacillus/Streptococcus, supporting the dysbiosis mechanism.\n"", ""reference"": ""PMID:20845425"", ""snippet"": ""UCP samples exhibited significantly more TRFLP peaks matching Clostridium and Eubacterium genera compared to HUC and FAP pouches and fewer peaks matching Lactobacillus and Streptococcus genera compared to FAP.\n"", ""supports"": ""SUPPORT""}, {""explanation"": ""Review confirming that microbiome dysbiosis with decreased diversity is central to pouchitis pathogenesis, leading to aberrant immune regulation and inflammation.\n"", ""reference"": ""PMID:25110406"", ""snippet"": ""there is evidence that a dysbiosis characterized by decreased gut microbiota diversity in UC-IPAA patients may, in genetically predisposed subjects, lead to aberrant mucosal immune regulation triggering an inflammatory process.\n"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""ileum"", ""term"": {""id"": ""UBERON:0002116"", ""label"": ""ileum""}}], ""name"": ""Bacterial Dysbiosis""}"
6309	268	Pouchitis	Pouchitis.yaml	pathophysiology	1	Mucosal Immune Dysregulation	"Chronic inflammation of the ileal pouch mucosa characterized by increased pro-inflammatory cytokine production (TNF-alpha, IL-1beta, IL-6, IL-8), enhanced neutrophil infiltration, and impaired epithelial barrier function. The adaptive immune response shows increased Th1 and Th17 cell activity.
"																																																								"{""description"": ""Chronic inflammation of the ileal pouch mucosa characterized by increased pro-inflammatory cytokine production (TNF-alpha, IL-1beta, IL-6, IL-8), enhanced neutrophil infiltration, and impaired epithelial barrier function. The adaptive immune response shows increased Th1 and Th17 cell activity.\n"", ""name"": ""Mucosal Immune Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""preferred_term"": ""cytokine production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}], ""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}, {""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Chronic inflammation of the ileal pouch mucosa characterized by increased pro-inflammatory cytokine production (TNF-alpha, IL-1beta, IL-6, IL-8), enhanced neutrophil infiltration, and impaired epithelial barrier function. The adaptive immune response shows increased Th1 and Th17 cell activity.\n"", ""evidence"": [{""explanation"": ""Comprehensive review establishing that immune system dysfunction is a core pathogenic mechanism in pouchitis alongside barrier and microbiome alterations.\n"", ""reference"": ""PMID:40240062"", ""snippet"": ""we outline the putative mechanisms of pouchitis, including genetic predisposition, microbiome alterations, dysfunction of the intestinal barrier and the immune system\n"", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates that the cytokine profile in pouchitis resembles that of ulcerative colitis, supporting shared inflammatory mechanisms between these conditions.\n"", ""reference"": ""PMID:7634977"", ""snippet"": ""Cytokine production in pouchitis is similar to that in ulcerative colitis.\n"", ""supports"": ""SUPPORT""}], ""name"": ""Mucosal Immune Dysregulation""}"
6310	268	Pouchitis	Pouchitis.yaml	pathophysiology	2	Epithelial Barrier Dysfunction	"Disruption of tight junction proteins and increased intestinal permeability in the pouch mucosa, allowing bacterial translocation and antigenic stimulation of the underlying immune system, perpetuating the inflammatory cycle.
"																																																								"{""description"": ""Disruption of tight junction proteins and increased intestinal permeability in the pouch mucosa, allowing bacterial translocation and antigenic stimulation of the underlying immune system, perpetuating the inflammatory cycle.\n"", ""name"": ""Epithelial Barrier Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""bicellular tight junction assembly"", ""term"": {""id"": ""GO:0070830"", ""label"": ""bicellular tight junction assembly""}}], ""cell_types"": [{""preferred_term"": ""intestinal epithelial cell"", ""term"": {""id"": ""CL:0002563"", ""label"": ""intestinal epithelial cell""}}], ""description"": ""Disruption of tight junction proteins and increased intestinal permeability in the pouch mucosa, allowing bacterial translocation and antigenic stimulation of the underlying immune system, perpetuating the inflammatory cycle.\n"", ""evidence"": [{""explanation"": ""Demonstrates reduced expression of barrier-forming tight junction proteins (ZO-1 and claudin-1) in pouchitis, directly supporting epithelial barrier dysfunction as a pathogenic mechanism.\n"", ""reference"": ""PMID:25222658"", ""snippet"": ""In patients with UC with pouchitis, epithelial expression of ZO-1 and claudin 1 were reduced\n"", ""supports"": ""SUPPORT""}, {""explanation"": ""Shows early upregulation of claudin-2, a pore-forming protein that increases permeability, indicating that barrier dysfunction may be an initiating event in pouchitis development.\n"", ""reference"": ""PMID:25222658"", ""snippet"": ""Increased epithelial expression of the \""pore-forming\"" TJP claudin 2, and DC expression of gut-homing markers CCR 9 and integrin 7, occurred early after ileostomy closure.\n"", ""supports"": ""SUPPORT""}], ""name"": ""Epithelial Barrier Dysfunction""}"
6311	268	Pouchitis	Pouchitis.yaml	pathophysiology	3	NOD2 Genetic Susceptibility	"Genetic polymorphisms in NOD2 (nucleotide-binding oligomerization domain-containing protein 2), particularly the NOD2insC variant (rs2066847), are strongly associated with increased risk of chronic pouchitis and Crohn's disease-like pouch phenotypes. NOD2 normally functions as an intracellular bacterial sensor that regulates autophagy and antimicrobial responses; loss-of-function variants impair bacterial clearance and increase susceptibility to inflammation.
"																																																								"{""description"": ""Genetic polymorphisms in NOD2 (nucleotide-binding oligomerization domain-containing protein 2), particularly the NOD2insC variant (rs2066847), are strongly associated with increased risk of chronic pouchitis and Crohn's disease-like pouch phenotypes. NOD2 normally functions as an intracellular bacterial sensor that regulates autophagy and antimicrobial responses; loss-of-function variants impair bacterial clearance and increase susceptibility to inflammation.\n"", ""name"": ""NOD2 Genetic Susceptibility""}"	{}	"{""description"": ""Genetic polymorphisms in NOD2 (nucleotide-binding oligomerization domain-containing protein 2), particularly the NOD2insC variant (rs2066847), are strongly associated with increased risk of chronic pouchitis and Crohn's disease-like pouch phenotypes. NOD2 normally functions as an intracellular bacterial sensor that regulates autophagy and antimicrobial responses; loss-of-function variants impair bacterial clearance and increase susceptibility to inflammation.\n"", ""evidence"": [{""explanation"": ""Landmark multicenter study demonstrating that NOD2insC polymorphism is the strongest genetic risk factor for chronic pouchitis (OR=3.2) and Crohn's-like disease of the pouch (OR=4.3).\n"", ""reference"": ""PMID:22879519"", ""snippet"": ""The NOD2insC (rs2066847) risk variant was the single nucleotide polymorphism (SNP) most significantly associated with pouch outcome (p=7.410(-5)). Specifically, it was associated with both CP and CDL in comparison with NCP (OR=3.2 and 4.3, respectively).\n"", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""NOD2"", ""term"": {""id"": ""hgnc:5331"", ""label"": ""NOD2""}}], ""name"": ""NOD2 Genetic Susceptibility""}"
6328	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	0	Anti-Mitochondrial Antibody Response	Autoantibodies against the E2 subunit of pyruvate dehydrogenase complex (PDC-E2) are highly specific for PBC. These antibodies may directly contribute to biliary epithelial cell damage through immune complex formation and complement activation.																																																								"{""description"": ""Autoantibodies against the E2 subunit of pyruvate dehydrogenase complex (PDC-E2) are highly specific for PBC. These antibodies may directly contribute to biliary epithelial cell damage through immune complex formation and complement activation."", ""name"": ""Anti-Mitochondrial Antibody Response""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""description"": ""Autoantibodies against the E2 subunit of pyruvate dehydrogenase complex (PDC-E2) are highly specific for PBC. These antibodies may directly contribute to biliary epithelial cell damage through immune complex formation and complement activation."", ""evidence"": [{""explanation"": ""This paper confirms that AMAs targeting PDC-E2 and related E2 subunits are characteristic of PBC and are associated with immune-mediated bile duct destruction."", ""reference"": ""PMID:26953925"", ""snippet"": ""Primary biliary cholangitis (PBC) is an autoimmune hepatobiliary disease characterized by immune mediated destruction of the intrahepatic small bile ducts and the presence of antimitochondrial antibodies (AMAs). The mitochondrial autoantigens have been identified as the E2 subunits of the 2-oxo-acid dehydrogenase complex, including the E2 subunits of pyruvate dehydrogenase, branched-chain 2-oxo acid dehydrogenase complex, oxoglutarate dehydrogenase complex, E3 binding protein and PDC E1 alpha subunit."", ""supports"": ""SUPPORT""}, {""explanation"": ""This review highlights the multifactorial pathogenesis of PBC, including genetic predisposition and environmental triggers that lead to AMA production and disease development."", ""reference"": ""PMID:39329760"", ""snippet"": ""Although the pathogenesis of the disease is multifactorial, there is a consensus that individuals with a genetic predisposition develop the disease in the presence of specific environmental triggers. A dysbiosis of intestinal microbiota is increasingly considered among the potential pathogenic factors."", ""supports"": ""SUPPORT""}], ""name"": ""Anti-Mitochondrial Antibody Response""}"
6329	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	1	Biliary Epithelial Cell Targeting	CD4+ and CD8+ T cells infiltrate portal tracts and specifically target small bile duct epithelial cells. Aberrant PDC-E2 expression on apoptotic cholangiocytes may initiate the autoimmune response.																																																								"{""description"": ""CD4+ and CD8+ T cells infiltrate portal tracts and specifically target small bile duct epithelial cells. Aberrant PDC-E2 expression on apoptotic cholangiocytes may initiate the autoimmune response."", ""name"": ""Biliary Epithelial Cell Targeting""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T Cell Cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}], ""cell_types"": [{""preferred_term"": ""Cholangiocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}, {""preferred_term"": ""CD8+ T Cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}], ""description"": ""CD4+ and CD8+ T cells infiltrate portal tracts and specifically target small bile duct epithelial cells. Aberrant PDC-E2 expression on apoptotic cholangiocytes may initiate the autoimmune response."", ""evidence"": [{""explanation"": ""This study demonstrates that cytotoxic CD8+ T cells directly target and destroy cholangiocytes in experimental PBC, supporting the role of T cell- mediated cytotoxicity in bile duct epithelial cell destruction."", ""reference"": ""PMID:24556277"", ""snippet"": ""In vitro cholangiocyte cytotoxicity assays demonstrated significantly increased numbers of cytotoxic hepatic dnTGFRII KLRG1(+) CD8 cells compared to B6. Protection from disease by B6 Tregs was associated with elimination of hepatic dnTGFRII CD8 mediated cholangiocyte cytotoxicity. These results emphasize that autoimmune cholangitis requires defects in both the T effector and regulatory compartments."", ""supports"": ""SUPPORT""}, {""explanation"": ""This review confirms that cholangiocytes are the primary cellular targets of immune attack in PBC, with senescent cholangiocytes driving disease progression through impaired bile duct function."", ""reference"": ""PMID:39329760"", ""snippet"": ""Cholangiocytes, the epithelial cells lining the bile ducts, are the main target of a dysregulated immune response, and cholangiocytes senescence has been recognized as a driving mechanism, leading to impaired bile duct function, in disease progression."", ""supports"": ""SUPPORT""}], ""name"": ""Biliary Epithelial Cell Targeting""}"
6330	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	2	Progressive Ductopenia and Cholestasis	Destruction of bile ducts leads to ductopenia, impaired bile flow, and accumulation of toxic bile acids. Retained bile acids cause further hepatocyte damage and promote fibrosis.																																																								"{""description"": ""Destruction of bile ducts leads to ductopenia, impaired bile flow, and accumulation of toxic bile acids. Retained bile acids cause further hepatocyte damage and promote fibrosis."", ""name"": ""Progressive Ductopenia and Cholestasis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Bile Acid Metabolic Process"", ""term"": {""id"": ""GO:0008206"", ""label"": ""bile acid metabolic process""}}], ""description"": ""Destruction of bile ducts leads to ductopenia, impaired bile flow, and accumulation of toxic bile acids. Retained bile acids cause further hepatocyte damage and promote fibrosis."", ""evidence"": [{""explanation"": ""This review demonstrates that cholangiocyte injury and bile duct destruction in PBC are promoted by gut-derived bacterial products reaching the liver, which trigger inflammatory responses that induce liver fibrosis and progressive disease."", ""reference"": ""PMID:37047635"", ""snippet"": ""In recent years, several studies have shown that, in case of a change in gut bacterial homeostasis or impairment of intestinal barrier functions, cholangiocytes, which are the epithelial cells lining the bile ducts, activate innate immune responses against gut-derived microorganisms or bacterial products that reach the liver via enterohepatic circulation. Intestinal dysbiosis or impaired intestinal barrier functions cause cholangiocytes to be exposed to an increasing amount of microorganisms that can reactivate inflammatory responses, thus inducing the onset of liver fibrosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This review highlights the central role of bile acids in PBC pathogenesis, noting that bile acid accumulation contributes to disease progression and that bile acid modulation is a key therapeutic strategy."", ""reference"": ""PMID:39329760"", ""snippet"": ""Bile acids are also recognized as playing an important role, both in disease development and therapy. Thus, while bile acid-based therapies, specifically ursodeoxycholic acid and obeticholic acid, have been the cornerstone of therapy in PBC, novel therapeutic approaches have been developed in recent years."", ""supports"": ""SUPPORT""}], ""name"": ""Progressive Ductopenia and Cholestasis""}"
6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	Ciliary Dysfunction	Defects in the structure and function of motile cilia impair mucociliary clearance.																																																								"{""description"": ""Defects in the structure and function of motile cilia impair mucociliary clearance."", ""name"": ""Ciliary Dysfunction""}"	"{""downstream"": [{""target"": ""Impaired Mucociliary Clearance""}]}"	"{""biological_processes"": [{""preferred_term"": ""cilium movement"", ""term"": {""id"": ""GO:0003341"", ""label"": ""cilium movement""}}, {""preferred_term"": ""cilium assembly"", ""term"": {""id"": ""GO:0060271"", ""label"": ""cilium assembly""}}, {""preferred_term"": ""axoneme assembly"", ""term"": {""id"": ""GO:0035082"", ""label"": ""axoneme assembly""}}], ""cell_types"": [{""preferred_term"": ""respiratory ciliated cell"", ""term"": {""id"": ""CL:0002368"", ""label"": ""respiratory tract epithelial cell""}}, {""preferred_term"": ""ependymal cell"", ""term"": {""id"": ""CL:0000065"", ""label"": ""ependymal cell""}}], ""cellular_components"": [{""preferred_term"": ""Cilia"", ""term"": {""id"": ""GO:0005929"", ""label"": ""cilium""}}, {""preferred_term"": ""axoneme"", ""term"": {""id"": ""GO:0005930"", ""label"": ""axoneme""}}, {""preferred_term"": ""outer dynein arm"", ""term"": {""id"": ""GO:0036157"", ""label"": ""outer dynein arm""}}], ""description"": ""Defects in the structure and function of motile cilia impair mucociliary clearance."", ""downstream"": [{""target"": ""Impaired Mucociliary Clearance""}], ""evidence"": [{""explanation"": ""The reference confirms that defects in the structure and function of motile cilia impair mucociliary clearance, supporting the statement."", ""reference"": ""PMID:19818430"", ""snippet"": ""Primary ciliary dyskinesia is a genetically inherited syndrome characterized by cilia immotility or dysmotility. Deficiency in mucociliary clearance produces chronic respiratory infections since birth."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by indicating that primary ciliary dyskinesia results from genetic mutations affecting cilia structure and function, leading to impaired mucociliary clearance."", ""reference"": ""PMID:20525503"", ""snippet"": ""Ciliary dysfunction may be primary, the result of genetic mutations resulting in abnormal cilia structure, or secondary, the result of environmental, infectious or inflammatory stimuli that disrupt normal motility or coordination."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the statement by describing PCD as a disorder involving motile cilia defects, which leads to respiratory issues due to impaired mucociliary clearance."", ""reference"": ""PMID:17059358"", ""snippet"": ""The most prominent genetic abnormality involving motile cilia (and the respiratory tract) is primary ciliary dyskinesia (PCD). PCD is a rare, usually autosomal recessive, genetically heterogeneous disorder characterized by sino-pulmonary disease, laterality defects, and male infertility."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by listing DNAH5 and DNAI1 as genes involved in PCD, which is characterized by defects in motile cilia leading to impaired mucociliary clearance."", ""reference"": ""PMID:15750039"", ""snippet"": ""Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by recurrent infections of the airways and situs inversus in half of the affected offspring. The most frequent genetic defects comprise recessive mutations of DNAH5 and DNAI1, which encode outer dynein arm (ODA) components."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the statement by confirming that PCD involves defects in the structure and function of motile cilia, which impair mucociliary clearance."", ""reference"": ""PMID:32185794"", ""snippet"": ""Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by defects in the function or structure of motitle cilia"", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""DNAI1"", ""term"": {""id"": ""hgnc:2954"", ""label"": ""DNAI1""}}, {""preferred_term"": ""DNAH5"", ""term"": {""id"": ""hgnc:2950"", ""label"": ""DNAH5""}}], ""locations"": [{""preferred_term"": ""respiratory tract epithelium"", ""term"": {""id"": ""UBERON:0004808"", ""label"": ""respiratory tract epithelium""}}, {""preferred_term"": ""nasal cavity epithelium"", ""term"": {""id"": ""UBERON:0000398"", ""label"": ""nasal cavity epithelium""}}, {""preferred_term"": ""trachea"", ""term"": {""id"": ""UBERON:0003126"", ""label"": ""trachea""}}, {""preferred_term"": ""bronchus"", ""term"": {""id"": ""UBERON:0002185"", ""label"": ""bronchus""}}], ""name"": ""Ciliary Dysfunction""}"
6357	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	1	Impaired Mucociliary Clearance	Failure to effectively remove mucus and pathogens from respiratory passages.																																																								"{""description"": ""Failure to effectively remove mucus and pathogens from respiratory passages."", ""name"": ""Impaired Mucociliary Clearance""}"	"{""downstream"": [{""target"": ""Chronic Respiratory Infections""}, {""target"": ""Sinusitis""}, {""target"": ""Otitis Media""}]}"	"{""biological_processes"": [{""preferred_term"": ""mucociliary clearance"", ""term"": {""id"": ""GO:0120197"", ""label"": ""mucociliary clearance""}}], ""description"": ""Failure to effectively remove mucus and pathogens from respiratory passages."", ""downstream"": [{""target"": ""Chronic Respiratory Infections""}, {""target"": ""Sinusitis""}, {""target"": ""Otitis Media""}], ""evidence"": [{""explanation"": ""The literature supports that primary ciliary dyskinesia (PCD) leads to impaired mucociliary clearance, which results in chronic respiratory infections, sinusitis, and otitis media."", ""reference"": ""PMID:11376511"", ""snippet"": ""Failure to keep the airways sterile by MCC results in a host inflammatory response to the persistent microorganisms which, if it becomes chronic, causes damage to the airway wall and upregulation of mucus production manifest clinically as bronchiectasis, sinusitis and otitis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that primary ciliary dyskinesia leads to impaired mucociliary clearance and downstream chronic respiratory infections, sinusitis, and otitis media."", ""reference"": ""PMID:17142159"", ""snippet"": ""Primary ciliary dyskinesia is an autosomal recessive genetic disease that results in impaired mucociliary clearance causing progressive involvement of the upper and lower respiratory tract, characterized by airway obstruction and recurrent infections of the lungs, middle ear and paranasal sinuses."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that disruption of motile cilia, as seen in primary ciliary dyskinesia, leads to impaired mucociliary clearance and resultant respiratory conditions such as sinusitis and bronchiectasis."", ""reference"": ""PMID:15917207"", ""snippet"": ""Disruption of 9+2 cilia, which move mucus across respiratory epithelia, leads to rhinitis, sinusitis and bronchiectasis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports that primary ciliary dyskinesia leads to impaired mucociliary clearance and associated conditions such as sinusitis."", ""reference"": ""PMID:29490941"", ""snippet"": ""We hypothesised that olfactory function could be impaired in primary ciliary dyskinesia (PCD). Olfaction, nasal nitric oxide (nNO) and sinus CT were assessed in patients with PCD and non-PCD sinus disease, and healthy controls (no CT scan). PCD and non-PCD patients had similar severity of sinus disease."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""respiratory system"", ""term"": {""id"": ""UBERON:0001004"", ""label"": ""respiratory system""}}, {""preferred_term"": ""paranasal sinus"", ""term"": {""id"": ""UBERON:0001825"", ""label"": ""paranasal sinus""}}], ""name"": ""Impaired Mucociliary Clearance""}"
6358	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	2	Situs Inversus	Abnormal placement of internal organs due to ciliary dysfunction during embryonic development.		50%																																																						"{""description"": ""Abnormal placement of internal organs due to ciliary dysfunction during embryonic development."", ""frequency"": ""50%"", ""name"": ""Situs Inversus""}"	{}	"{""biological_processes"": [{""preferred_term"": ""determination of left/right symmetry"", ""term"": {""id"": ""GO:0007368"", ""label"": ""determination of left/right symmetry""}}, {""preferred_term"": ""nodal cilium assembly"", ""term"": {""id"": ""GO:1904955"", ""label"": ""motile cilium assembly""}}], ""description"": ""Abnormal placement of internal organs due to ciliary dysfunction during embryonic development."", ""evidence"": [{""explanation"": ""The statement is partially supported. The literature confirms that primary ciliary dyskinesia (PCD) can lead to situs inversus due to ciliary dysfunction during embryonic development, and it is claimed that 50% of PCD cases have situs inversus. However, the phrase 'abnormal placement of internal organs' is more general and could include other forms of laterality defects, not just situs inversus."", ""reference"": ""PMID:16036877"", ""snippet"": ""The normal left-right asymmetry of the body is thought to be due to the beating of the cilia in the embryonic (Hensen's) node. Total immotility of the cilia should therefore result in random asymmetry of the body that is situs inversus in 50% of the cases. It has also been claimed that 50% of cases with PCD have situs inversus."", ""supports"": ""PARTIAL""}, {""explanation"": ""The statement is partially supported. The data shows that 38.5% of PCD cases have situs inversus totalis, which is close to but not exactly 50%. Additionally, there are other laterality defects like situs ambiguus, which are not covered by the statement."", ""reference"": ""PMID:36342963"", ""snippet"": ""Results: Of 559 participants, 286 (51.2%), 215 (38.5%), and 58 (10.4%) were identified as having situs solitus, situs inversustotalis, and situs ambiguus, respectively; heterotaxy, defined as situs ambiguus with complex cardiovascular defects, was present in 14 (2.5%)"", ""supports"": ""PARTIAL""}], ""frequency"": ""50%"", ""locations"": [{""preferred_term"": ""embryo"", ""term"": {""id"": ""UBERON:0000922"", ""label"": ""embryo""}}], ""name"": ""Situs Inversus""}"
6379	271	Primary Lateral Sclerosis	Primary_Lateral_Sclerosis.yaml	pathophysiology	0	Progressive Upper Motor Neuron Dysfunction	Degeneration of upper motor neurons leads to slowly progressive spasticity and motor impairment without lower motor neuron signs.																																																								"{""description"": ""Degeneration of upper motor neurons leads to slowly progressive spasticity and motor impairment without lower motor neuron signs."", ""name"": ""Progressive Upper Motor Neuron Dysfunction""}"	{}	"{""description"": ""Degeneration of upper motor neurons leads to slowly progressive spasticity and motor impairment without lower motor neuron signs."", ""evidence"": [{""explanation"": ""The abstract defines PLS by progressive upper motor neuron dysfunction."", ""reference"": ""PMID:26515619"", ""snippet"": ""Primary lateral sclerosis is characterized by insidious onset of progressive upper motor neuron dysfunction in the absence of clinical signs of lower motor neuron involvement."", ""supports"": ""SUPPORT""}], ""name"": ""Progressive Upper Motor Neuron Dysfunction""}"
6380	271	Primary Lateral Sclerosis	Primary_Lateral_Sclerosis.yaml	pathophysiology	1	Corticospinal Tract Degeneration	Neuropathology shows degeneration of the primary motor cortex and corticospinal tracts with relative preservation of lower motor neurons.																																																								"{""description"": ""Neuropathology shows degeneration of the primary motor cortex and corticospinal tracts with relative preservation of lower motor neurons."", ""name"": ""Corticospinal Tract Degeneration""}"	{}	"{""description"": ""Neuropathology shows degeneration of the primary motor cortex and corticospinal tracts with relative preservation of lower motor neurons."", ""evidence"": [{""explanation"": ""The abstract describes cortical and corticospinal degeneration with LMN preservation."", ""reference"": ""PMID:33602010"", ""snippet"": ""Degeneration of the primary motor cortex and corticospinal tracts with preservation of lower motor neurons (LMN) has been reported in most cases."", ""supports"": ""SUPPORT""}], ""name"": ""Corticospinal Tract Degeneration""}"
6392	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	0	JAK-STAT Pathway Hyperactivation	Driver mutations in JAK2, CALR, or MPL all converge on constitutive activation of JAK-STAT signaling. JAK2 V617F directly activates the kinase; CALR and MPL mutations lead to activation of MPL receptor signaling.																																																								"{""description"": ""Driver mutations in JAK2, CALR, or MPL all converge on constitutive activation of JAK-STAT signaling. JAK2 V617F directly activates the kinase; CALR and MPL mutations lead to activation of MPL receptor signaling."", ""name"": ""JAK-STAT Pathway Hyperactivation""}"	"{""downstream"": [{""description"": ""JAK-STAT activation drives megakaryocyte proliferation and atypia"", ""target"": ""Abnormal Megakaryopoiesis""}, {""description"": ""Activated megakaryocytes release profibrotic cytokines"", ""target"": ""Cytokine-Mediated Marrow Fibrosis""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""JAK-STAT signaling pathway"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}], ""cell_types"": [{""preferred_term"": ""megakaryocyte"", ""term"": {""id"": ""CL:0000556"", ""label"": ""megakaryocyte""}}, {""preferred_term"": ""hematopoietic stem cell"", ""term"": {""id"": ""CL:0000037"", ""label"": ""hematopoietic stem cell""}}], ""description"": ""Driver mutations in JAK2, CALR, or MPL all converge on constitutive activation of JAK-STAT signaling. JAK2 V617F directly activates the kinase; CALR and MPL mutations lead to activation of MPL receptor signaling."", ""downstream"": [{""description"": ""JAK-STAT activation drives megakaryocyte proliferation and atypia"", ""target"": ""Abnormal Megakaryopoiesis""}, {""description"": ""Activated megakaryocytes release profibrotic cytokines"", ""target"": ""Cytokine-Mediated Marrow Fibrosis""}], ""locations"": [{""preferred_term"": ""bone marrow"", ""term"": {""id"": ""UBERON:0002371"", ""label"": ""bone marrow""}}], ""name"": ""JAK-STAT Pathway Hyperactivation""}"
6393	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	1	Abnormal Megakaryopoiesis	Driver mutations cause aberrant megakaryocyte proliferation and maturation. Megakaryocytes show characteristic atypia with clustering, abnormal lobation, and defective platelet production.																																																								"{""description"": ""Driver mutations cause aberrant megakaryocyte proliferation and maturation. Megakaryocytes show characteristic atypia with clustering, abnormal lobation, and defective platelet production."", ""name"": ""Abnormal Megakaryopoiesis""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""megakaryocyte differentiation"", ""term"": {""id"": ""GO:0030219"", ""label"": ""megakaryocyte differentiation""}}], ""description"": ""Driver mutations cause aberrant megakaryocyte proliferation and maturation. Megakaryocytes show characteristic atypia with clustering, abnormal lobation, and defective platelet production."", ""name"": ""Abnormal Megakaryopoiesis""}"
6394	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	2	Cytokine-Mediated Marrow Fibrosis	Atypical megakaryocytes release profibrotic cytokines including TGF-beta, PDGF, and bFGF, stimulating marrow stromal cells to deposit reticulin and collagen fibers. Progressive fibrosis replaces normal hematopoietic tissue.																																																								"{""description"": ""Atypical megakaryocytes release profibrotic cytokines including TGF-beta, PDGF, and bFGF, stimulating marrow stromal cells to deposit reticulin and collagen fibers. Progressive fibrosis replaces normal hematopoietic tissue."", ""name"": ""Cytokine-Mediated Marrow Fibrosis""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""description"": ""Atypical megakaryocytes release profibrotic cytokines including TGF-beta, PDGF, and bFGF, stimulating marrow stromal cells to deposit reticulin and collagen fibers. Progressive fibrosis replaces normal hematopoietic tissue."", ""evidence"": [{""explanation"": ""This abstract highlights bone marrow fibrosis and atypical megakaryocyte proliferation, supporting the fibrosis mechanism described."", ""reference"": ""PMID:41514563"", ""snippet"": ""Primary myelofibrosis (PMF) is a Philadelphia chromosome (Ph)-negative myeloproliferative neoplasm (MPN) that features clonal proliferation of atypical megakaryocytes and myeloid cells, fibrosis of the bone marrow, extramedullary hematopoiesis, and increased risk of leukemic transformation to acute myeloid leukemia (AML)."", ""supports"": ""SUPPORT""}], ""name"": ""Cytokine-Mediated Marrow Fibrosis""}"
6395	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	3	Extramedullary Hematopoiesis	As bone marrow function declines due to fibrosis, hematopoiesis shifts to spleen, liver, and other sites. This causes massive splenomegaly and hepatomegaly with associated symptoms.																																																								"{""description"": ""As bone marrow function declines due to fibrosis, hematopoiesis shifts to spleen, liver, and other sites. This causes massive splenomegaly and hepatomegaly with associated symptoms."", ""name"": ""Extramedullary Hematopoiesis""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""hematopoiesis"", ""term"": {""id"": ""GO:0030097"", ""label"": ""hemopoiesis""}}], ""description"": ""As bone marrow function declines due to fibrosis, hematopoiesis shifts to spleen, liver, and other sites. This causes massive splenomegaly and hepatomegaly with associated symptoms."", ""locations"": [{""preferred_term"": ""spleen"", ""term"": {""id"": ""UBERON:0002106"", ""label"": ""spleen""}}], ""name"": ""Extramedullary Hematopoiesis""}"
6414	273	Primary Progressive Aphasia	Primary_Progressive_Aphasia.yaml	pathophysiology	0	Progressive Language Network Degeneration	Neurodegenerative processes selectively affect language networks, leading to progressive loss of language function with initial sparing of other domains.																																																								"{""description"": ""Neurodegenerative processes selectively affect language networks, leading to progressive loss of language function with initial sparing of other domains."", ""name"": ""Progressive Language Network Degeneration""}"	{}	"{""description"": ""Neurodegenerative processes selectively affect language networks, leading to progressive loss of language function with initial sparing of other domains."", ""evidence"": [{""explanation"": ""The abstract describes progressive, isolated language loss as the core neurodegenerative process."", ""reference"": ""PMID:19300609"", ""snippet"": ""Primary progressive aphasia (PPA) is a neurodegenerative disease of insidious onset presenting with progressive isolated loss of language function, without significant impairment in other cognitive domains."", ""supports"": ""SUPPORT""}], ""name"": ""Progressive Language Network Degeneration""}"
6425	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	0	Bile Duct Inflammation and Fibrosis	Periductal inflammation with concentric fibrosis (onion-skinning) leads to progressive stricture formation. Both innate and adaptive immune cells infiltrate the bile duct epithelium.																																																								"{""description"": ""Periductal inflammation with concentric fibrosis (onion-skinning) leads to progressive stricture formation. Both innate and adaptive immune cells infiltrate the bile duct epithelium."", ""name"": ""Bile Duct Inflammation and Fibrosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}], ""description"": ""Periductal inflammation with concentric fibrosis (onion-skinning) leads to progressive stricture formation. Both innate and adaptive immune cells infiltrate the bile duct epithelium."", ""evidence"": [{""explanation"": ""Demonstrates that PSC involves progressive fibrosis as a core pathological feature of biliary tract disorders."", ""reference"": ""PMID:39250501"", ""snippet"": ""Cholangiopathies comprise a spectrum of chronic intrahepatic and extrahepatic biliary tract disorders culminating in progressive cholestatic liver injury, fibrosis, and often cirrhosis and its sequela."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms the central role of fibroblast-cholangiocyte crosstalk in driving periductal fibrosis in PSC."", ""reference"": ""PMID:39250501"", ""snippet"": ""Herein, we review the pivotal role of cholangiocytes in cholestatic fibrogenesis, focusing on the crosstalk between cholangiocytes and portal fibroblasts and HSCs."", ""supports"": ""SUPPORT""}], ""name"": ""Bile Duct Inflammation and Fibrosis""}"
6426	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	1	Gut-Liver Axis Dysregulation	Aberrant homing of gut-primed lymphocytes to the liver through shared adhesion molecules (MAdCAM-1, CCL25). Bacterial translocation and altered bile acid metabolism contribute to hepatic inflammation.																																																								"{""description"": ""Aberrant homing of gut-primed lymphocytes to the liver through shared adhesion molecules (MAdCAM-1, CCL25). Bacterial translocation and altered bile acid metabolism contribute to hepatic inflammation."", ""name"": ""Gut-Liver Axis Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cell Migration"", ""term"": {""id"": ""GO:0016477"", ""label"": ""cell migration""}}], ""cell_types"": [{""preferred_term"": ""T Cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Aberrant homing of gut-primed lymphocytes to the liver through shared adhesion molecules (MAdCAM-1, CCL25). Bacterial translocation and altered bile acid metabolism contribute to hepatic inflammation."", ""evidence"": [{""explanation"": ""Confirms the role of adaptive immune cells, particularly T cells, in the pathogenesis of cholestatic liver diseases including PSC."", ""reference"": ""PMID:39250501"", ""snippet"": ""The crosstalk between cholangiocytes and cells of the innate (neutrophils and macrophages) and adaptive (T cells and B cells) immune systems is also examined in detail."", ""supports"": ""SUPPORT""}], ""name"": ""Gut-Liver Axis Dysregulation""}"
6427	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	2	Cholangiocyte Senescence	Biliary epithelial cells undergo premature senescence with SASP (senescence- associated secretory phenotype), promoting inflammation and fibrosis through release of pro-inflammatory mediators.																																																								"{""description"": ""Biliary epithelial cells undergo premature senescence with SASP (senescence- associated secretory phenotype), promoting inflammation and fibrosis through release of pro-inflammatory mediators."", ""name"": ""Cholangiocyte Senescence""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cellular Senescence"", ""term"": {""id"": ""GO:0090398"", ""label"": ""cellular senescence""}}], ""description"": ""Biliary epithelial cells undergo premature senescence with SASP (senescence- associated secretory phenotype), promoting inflammation and fibrosis through release of pro-inflammatory mediators."", ""evidence"": [{""explanation"": ""Directly supports that cholangiocytes undergo senescence-associated secretory phenotype that drives inflammation and fibrosis in cholestatic diseases."", ""reference"": ""PMID:39250501"", ""snippet"": ""The proclivity of these cells to undergo a senescence-associated secretory phenotype, which is proinflammatory and profibrogenic, and the intrinsic intracellular activation pathways resulting in the secretion of cytokines and chemokines are reviewed."", ""supports"": ""SUPPORT""}], ""name"": ""Cholangiocyte Senescence""}"
6441	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	0	Malignant B-cell Proliferation (Germinal Center Type)	Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control.																																		GCB-type represents approximately 50% of tonsillar DLBCL cases and has better prognosis than ABC-type.																						"{""description"": ""Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control."", ""name"": ""Malignant B-cell Proliferation (Germinal Center Type)"", ""notes"": ""GCB-type represents approximately 50% of tonsillar DLBCL cases and has better prognosis than ABC-type.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""regulation of apoptotic process""}, {""preferred_term"": ""histone H3-K27 methylation""}, {""preferred_term"": ""germinal center formation""}], ""cell_types"": [{""preferred_term"": ""germinal center B cell"", ""term"": {""id"": ""CL:0000844"", ""label"": ""germinal center B cell""}}], ""description"": ""Abnormal growth of germinal center B-cells with mutations in BCL2 and EZH2, affecting apoptosis regulation and epigenetic control."", ""genes"": [{""description"": ""Anti-apoptotic protein, frequently mutated or translocated in GCB-type tonsillar lymphoma"", ""preferred_term"": ""BCL2""}, {""description"": ""Histone methyltransferase component of PRC2 complex, gain-of-function mutations drive epigenetic dysregulation"", ""preferred_term"": ""EZH2""}, {""description"": ""Transcriptional repressor essential for germinal center formation"", ""preferred_term"": ""BCL6""}], ""locations"": [{""preferred_term"": ""palatine tonsil"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""palatine tonsil""}}], ""name"": ""Malignant B-cell Proliferation (Germinal Center Type)"", ""notes"": ""GCB-type represents approximately 50% of tonsillar DLBCL cases and has better prognosis than ABC-type.""}"
6442	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	1	Malignant B-cell Proliferation (Activated B-cell Type)	Chronic active B-cell receptor signaling with downstream NF-B activation due to CD79B and MYD88 mutations.																																		ABC-type represents approximately 50% of tonsillar DLBCL cases and has poorer prognosis than GCB-type.																						"{""description"": ""Chronic active B-cell receptor signaling with downstream NF-B activation due to CD79B and MYD88 mutations."", ""name"": ""Malignant B-cell Proliferation (Activated B-cell Type)"", ""notes"": ""ABC-type represents approximately 50% of tonsillar DLBCL cases and has poorer prognosis than GCB-type.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""B cell receptor signaling pathway""}, {""preferred_term"": ""NF-kappaB signaling""}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""Chronic active B-cell receptor signaling with downstream NF-B activation due to CD79B and MYD88 mutations."", ""genes"": [{""description"": ""B-cell receptor component, mutations lead to chronic active BCR signaling"", ""preferred_term"": ""CD79B""}, {""description"": ""Adaptor protein in Toll-like receptor signaling, mutations activate NF-B pathway"", ""preferred_term"": ""MYD88""}], ""locations"": [{""preferred_term"": ""palatine tonsil"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""palatine tonsil""}}], ""name"": ""Malignant B-cell Proliferation (Activated B-cell Type)"", ""notes"": ""ABC-type represents approximately 50% of tonsillar DLBCL cases and has poorer prognosis than GCB-type.""}"
6443	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	2	IRF4-rearranged Large B-cell Lymphoma	IRF4 rearrangement drives transcriptional programs at germinal center exit and plasmacytic differentiation, enriched in Waldeyer's ring.																																		Accounts for approximately 6.7% of adult tonsillar large B-cell lymphomas, often chemotherapy-responsive.																						"{""description"": ""IRF4 rearrangement drives transcriptional programs at germinal center exit and plasmacytic differentiation, enriched in Waldeyer's ring."", ""name"": ""IRF4-rearranged Large B-cell Lymphoma"", ""notes"": ""Accounts for approximately 6.7% of adult tonsillar large B-cell lymphomas, often chemotherapy-responsive.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""plasma cell differentiation""}], ""cell_types"": [{""preferred_term"": ""germinal center B cell"", ""term"": {""id"": ""CL:0000844"", ""label"": ""germinal center B cell""}}, {""preferred_term"": ""plasmablast"", ""term"": {""id"": ""CL:0000980"", ""label"": ""plasmablast""}}], ""description"": ""IRF4 rearrangement drives transcriptional programs at germinal center exit and plasmacytic differentiation, enriched in Waldeyer's ring."", ""genes"": [{""description"": ""Interferon regulatory factor 4, rearrangement drives MUM1 expression and plasmacytic differentiation"", ""preferred_term"": ""IRF4""}], ""locations"": [{""preferred_term"": ""palatine tonsil"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""palatine tonsil""}}], ""name"": ""IRF4-rearranged Large B-cell Lymphoma"", ""notes"": ""Accounts for approximately 6.7% of adult tonsillar large B-cell lymphomas, often chemotherapy-responsive.""}"
6444	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	3	EBV-positive Diffuse Large B-cell Lymphoma	Epstein-Barr virus latency programs (LMP1, EBNA) drive B-cell proliferation and immune evasion in tonsillar B-cells.																																		More common in elderly or immunocompromised patients. Tonsillar B-cells serve as primary EBV entry and latency reservoir.																						"{""description"": ""Epstein-Barr virus latency programs (LMP1, EBNA) drive B-cell proliferation and immune evasion in tonsillar B-cells."", ""name"": ""EBV-positive Diffuse Large B-cell Lymphoma"", ""notes"": ""More common in elderly or immunocompromised patients. Tonsillar B-cells serve as primary EBV entry and latency reservoir.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to virus""}, {""preferred_term"": ""immune evasion""}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""Epstein-Barr virus latency programs (LMP1, EBNA) drive B-cell proliferation and immune evasion in tonsillar B-cells."", ""locations"": [{""preferred_term"": ""palatine tonsil"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""palatine tonsil""}}], ""name"": ""EBV-positive Diffuse Large B-cell Lymphoma"", ""notes"": ""More common in elderly or immunocompromised patients. Tonsillar B-cells serve as primary EBV entry and latency reservoir.""}"
6445	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	pathophysiology	4	Double/Triple-hit High-grade B-cell Lymphoma	MYC-driven transcriptional acceleration with BCL2 and/or BCL6 anti-apoptotic co-drivers, aggressive clinical behavior.																																		Rare in tonsil but associated with aggressive course requiring intensified regimens such as R-EPOCH.																						"{""description"": ""MYC-driven transcriptional acceleration with BCL2 and/or BCL6 anti-apoptotic co-drivers, aggressive clinical behavior."", ""name"": ""Double/Triple-hit High-grade B-cell Lymphoma"", ""notes"": ""Rare in tonsil but associated with aggressive course requiring intensified regimens such as R-EPOCH.""}"	{}	"{""biological_processes"": [{""preferred_term"": ""regulation of transcription by RNA polymerase II""}, {""preferred_term"": ""negative regulation of apoptotic process""}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""MYC-driven transcriptional acceleration with BCL2 and/or BCL6 anti-apoptotic co-drivers, aggressive clinical behavior."", ""genes"": [{""description"": ""Transcription factor, rearrangement drives cellular proliferation"", ""preferred_term"": ""MYC""}, {""description"": ""Anti-apoptotic protein, co-rearrangement with MYC confers high-grade biology"", ""preferred_term"": ""BCL2""}, {""description"": ""Germinal center transcriptional repressor, co-rearrangement with MYC confers high-grade biology"", ""preferred_term"": ""BCL6""}], ""locations"": [{""preferred_term"": ""palatine tonsil"", ""term"": {""id"": ""UBERON:0002373"", ""label"": ""palatine tonsil""}}], ""name"": ""Double/Triple-hit High-grade B-cell Lymphoma"", ""notes"": ""Rare in tonsil but associated with aggressive course requiring intensified regimens such as R-EPOCH.""}"
6482	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	0	Somatic AKT1 p.E17K activation in mosaic cell clones	"Proteus syndrome is caused by a post-zygotic activating AKT1 p.E17K variant present in a mosaic subset of cells.
"																																																								"{""description"": ""Proteus syndrome is caused by a post-zygotic activating AKT1 p.E17K variant present in a mosaic subset of cells.\n"", ""name"": ""Somatic AKT1 p.E17K activation in mosaic cell clones""}"	{}	"{""description"": ""Proteus syndrome is caused by a post-zygotic activating AKT1 p.E17K variant present in a mosaic subset of cells.\n"", ""evidence"": [{""explanation"": ""This establishes mosaic, somatic AKT1 p.E17K activation in Proteus syndrome."", ""reference"": ""DOI:10.1038/srep17162"", ""snippet"": ""A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-positive cells, is responsible for the mosaic overgrowth condition, Proteus syndrome."", ""supports"": ""SUPPORT""}], ""name"": ""Somatic AKT1 p.E17K activation in mosaic cell clones""}"
6483	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	1	Elevated PI3K/AKT signaling in AKT1-mutant cells	"AKT1 p.E17K drives increased PI3K/AKT pathway activity in mutation-positive cells, promoting downstream overgrowth signals.
"																																																								"{""description"": ""AKT1 p.E17K drives increased PI3K/AKT pathway activity in mutation-positive cells, promoting downstream overgrowth signals.\n"", ""name"": ""Elevated PI3K/AKT signaling in AKT1-mutant cells""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase/protein kinase B signal transduction"", ""term"": {""id"": ""GO:0043491"", ""label"": ""phosphatidylinositol 3-kinase/protein kinase B signal transduction""}}], ""description"": ""AKT1 p.E17K drives increased PI3K/AKT pathway activity in mutation-positive cells, promoting downstream overgrowth signals.\n"", ""evidence"": [{""explanation"": ""This directly links AKT1 activation to elevated AKT signaling in mutation-positive cells."", ""reference"": ""DOI:10.1038/srep17162"", ""snippet"": ""A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-positive cells, is responsible for the mosaic overgrowth condition, Proteus syndrome."", ""supports"": ""SUPPORT""}], ""name"": ""Elevated PI3K/AKT signaling in AKT1-mutant cells""}"
6484	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	2	Increased pAKT signaling in AKT1-mutant lesion cells	"Lesion cells harboring AKT1 p.E17K show increased pAKT signaling within hyperplastic regions.
"																																																								"{""description"": ""Lesion cells harboring AKT1 p.E17K show increased pAKT signaling within hyperplastic regions.\n"", ""name"": ""Increased pAKT signaling in AKT1-mutant lesion cells""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein phosphorylation"", ""term"": {""id"": ""GO:0006468"", ""label"": ""protein phosphorylation""}}], ""description"": ""Lesion cells harboring AKT1 p.E17K show increased pAKT signaling within hyperplastic regions.\n"", ""evidence"": [{""explanation"": ""This demonstrates increased pAKT signaling in mutant clones within lesions."", ""reference"": ""DOI:10.1093/hmg/ddz116"", ""snippet"": ""Identification of variant-positive cells by green fluorescent protein (GFP) staining in chimeric Proteus syndrome mice showed that in some lesions, hyperplastic cells were predominantly GFP/Akt1E17K-positive and showed increased pAKT signal compared to GFP-negative cells."", ""supports"": ""SUPPORT""}], ""name"": ""Increased pAKT signaling in AKT1-mutant lesion cells""}"
6485	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	3	Non-cell-autonomous pAKT activation in adjacent cells	"AKT1-mutant clones can induce increased pAKT signaling in nearby mutation-negative cells, consistent with non-cell-autonomous lesion propagation.
"																																																								"{""description"": ""AKT1-mutant clones can induce increased pAKT signaling in nearby mutation-negative cells, consistent with non-cell-autonomous lesion propagation.\n"", ""name"": ""Non-cell-autonomous pAKT activation in adjacent cells""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell-cell signaling"", ""term"": {""id"": ""GO:0007267"", ""label"": ""cell-cell signaling""}}], ""description"": ""AKT1-mutant clones can induce increased pAKT signaling in nearby mutation-negative cells, consistent with non-cell-autonomous lesion propagation.\n"", ""evidence"": [{""explanation"": ""This provides evidence for non-cell-autonomous effects in lesion formation."", ""reference"": ""DOI:10.1093/hmg/ddz116"", ""snippet"": ""However, hyperplastic mammary epithelium was a mixture of GFP/Akt1E17K-positive and negative cells with some GFP/Akt1E17K-negative cells also having increased pAKT signal suggesting that the variant-positive cells can induce lesion formation in a non-cell autonomous manner."", ""supports"": ""SUPPORT""}], ""name"": ""Non-cell-autonomous pAKT activation in adjacent cells""}"
6486	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	4	AKT overactivation induces excessive vasculogenesis	"AKT1 activation increases vascular connectivity and promotes vasculogenesis with enhanced vascular sprouting.
"																																																								"{""description"": ""AKT1 activation increases vascular connectivity and promotes vasculogenesis with enhanced vascular sprouting.\n"", ""name"": ""AKT overactivation induces excessive vasculogenesis""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""vasculogenesis"", ""term"": {""id"": ""GO:0001570"", ""label"": ""vasculogenesis""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}], ""cell_types"": [{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""AKT1 activation increases vascular connectivity and promotes vasculogenesis with enhanced vascular sprouting.\n"", ""evidence"": [{""explanation"": ""AKT overactivation increases vascular connectivity in organoid vasculature."", ""reference"": ""DOI:10.1101/2024.01.26.577324"", ""snippet"": ""Our findings revealed that AKT overactivation in these organoids resulted in smaller sizes yet increased vascular connectivity, although with less stable connections."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study explicitly links AKT overactivation to increased vasculogenesis."", ""reference"": ""DOI:10.1101/2024.01.26.577324"", ""snippet"": ""This could be due to the significant vasculogenesis induced by AKT overactivation."", ""supports"": ""SUPPORT""}], ""name"": ""AKT overactivation induces excessive vasculogenesis""}"
6487	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	5	Mural cell dysfunction destabilizes vascular connections	"AKT-driven vascular malformations include dysfunctional PDGFR+ mural cells with impaired matrix secretion, contributing to unstable vessel connections.
"																																																								"{""description"": ""AKT-driven vascular malformations include dysfunctional PDGFR+ mural cells with impaired matrix secretion, contributing to unstable vessel connections.\n"", ""name"": ""Mural cell dysfunction destabilizes vascular connections""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}], ""cell_types"": [{""preferred_term"": ""pericyte"", ""term"": {""id"": ""CL:0000669"", ""label"": ""pericyte""}}], ""description"": ""AKT-driven vascular malformations include dysfunctional PDGFR+ mural cells with impaired matrix secretion, contributing to unstable vessel connections.\n"", ""evidence"": [{""explanation"": ""AKT overactivation is linked to unstable vascular connections."", ""reference"": ""DOI:10.1101/2024.01.26.577324"", ""snippet"": ""Our findings revealed that AKT overactivation in these organoids resulted in smaller sizes yet increased vascular connectivity, although with less stable connections."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports mural cell dysfunction as part of the vascular phenotype."", ""reference"": ""DOI:10.1101/2024.01.26.577324"", ""snippet"": ""Additionally, a notable increase in dysfunctional PDGFR + mural cells, impaired in matrix secretion, was observed in these AKT-overactivated organoids."", ""supports"": ""SUPPORT""}], ""name"": ""Mural cell dysfunction destabilizes vascular connections""}"
6514	277	Prurigo Nodularis	Prurigo_Nodularis.yaml	pathophysiology	0	Immune and neural dysregulation	Prurigo nodularis involves immune and neural dysregulation with cytokine and neuropeptide signaling.																																																								"{""description"": ""Prurigo nodularis involves immune and neural dysregulation with cytokine and neuropeptide signaling."", ""name"": ""Immune and neural dysregulation""}"	{}	"{""description"": ""Prurigo nodularis involves immune and neural dysregulation with cytokine and neuropeptide signaling."", ""evidence"": [{""explanation"": ""The review describes immune and neural dysregulation with cytokines and neuropeptides in PN."", ""reference"": ""PMID:38345154"", ""snippet"": ""associated with immune and neural dysregulation, mediated by inflammatory"", ""supports"": ""SUPPORT""}], ""name"": ""Immune and neural dysregulation""}"
6534	278	Psoriasis	Psoriasis.yaml	pathophysiology	0	T Cell-Mediated Inflammation	"Activated T cells (Th1, Th17, Th22) infiltrate skin and release cytokines including IL-17, IL-22, TNF-alpha, and IFN-gamma that drive keratinocyte hyperproliferation and inflammation.
"																																																								"{""description"": ""Activated T cells (Th1, Th17, Th22) infiltrate skin and release cytokines including IL-17, IL-22, TNF-alpha, and IFN-gamma that drive keratinocyte hyperproliferation and inflammation.\n"", ""name"": ""T Cell-Mediated Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T Cell Activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}], ""cell_types"": [{""preferred_term"": ""T Helper 17 Cell"", ""term"": {""id"": ""CL:0000899"", ""label"": ""T-helper 17 cell""}}, {""preferred_term"": ""T Helper 1 Cell"", ""term"": {""id"": ""CL:0000545"", ""label"": ""T-helper 1 cell""}}], ""description"": ""Activated T cells (Th1, Th17, Th22) infiltrate skin and release cytokines including IL-17, IL-22, TNF-alpha, and IFN-gamma that drive keratinocyte hyperproliferation and inflammation.\n"", ""evidence"": [{""explanation"": ""IL-23 drives Th17 cell differentiation and maintenance, which is central to T cell-mediated inflammation in psoriasis."", ""reference"": ""PMID:38686385"", ""snippet"": ""Interleukin (IL)-23, an IL-12 cytokine family member, is a hierarchically dominant regulatory cytokine in a cluster of immune-mediated inflammatory diseases (IMIDs), including psoriasis, psoriatic arthritis, and inflammatory bowel disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""This describes the complex inflammatory response involving multiple cellular processes, consistent with T cell-mediated inflammation involving transcriptional regulation and immune cell crosstalk."", ""reference"": ""PMID:39337637"", ""snippet"": ""Current research efforts to better understand skin disease have focused on examining the role of molecular processes at several stages of the inflammatory response such as the dysregulation of innate immunity sensors, disruption of both transcriptional and post-transcriptional regulation, and crosstalk between immune and neuronal processes (neuro-immune crosstalk)."", ""supports"": ""SUPPORT""}], ""name"": ""T Cell-Mediated Inflammation""}"
6535	278	Psoriasis	Psoriasis.yaml	pathophysiology	1	Keratinocyte Hyperproliferation	"Inflammatory cytokines stimulate rapid keratinocyte proliferation, reducing epidermal turnover from 28 days to 3-4 days. This produces characteristic thick, scaly plaques.
"																																																								"{""description"": ""Inflammatory cytokines stimulate rapid keratinocyte proliferation, reducing epidermal turnover from 28 days to 3-4 days. This produces characteristic thick, scaly plaques.\n"", ""name"": ""Keratinocyte Hyperproliferation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cell Proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""Keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""description"": ""Inflammatory cytokines stimulate rapid keratinocyte proliferation, reducing epidermal turnover from 28 days to 3-4 days. This produces characteristic thick, scaly plaques.\n"", ""evidence"": [{""explanation"": ""Inflammatory changes at the molecular level drive keratinocyte hyperproliferation in psoriasis, linking inflammation to cellular proliferation."", ""reference"": ""PMID:39337637"", ""snippet"": ""Many skin diseases begin with inflammatory changes on a molecular level."", ""supports"": ""SUPPORT""}, {""explanation"": ""The chronic autoimmune nature of psoriasis results in persistent inflammatory signaling that drives sustained keratinocyte hyperproliferation, manifesting as the characteristic plaque types."", ""reference"": ""PMID:39576422"", ""snippet"": ""Psoriasis represents a chronic autoimmune skin condition defined by various clinical forms, including inverse, erythrodermic, pustular, guttate, plaque types."", ""supports"": ""SUPPORT""}], ""name"": ""Keratinocyte Hyperproliferation""}"
6536	278	Psoriasis	Psoriasis.yaml	pathophysiology	2	Dendritic Cell Activation	"Plasmacytoid and myeloid dendritic cells produce inflammatory cytokines and present antigens to activate T cells, initiating and perpetuating the inflammatory cascade.
"																																																								"{""description"": ""Plasmacytoid and myeloid dendritic cells produce inflammatory cytokines and present antigens to activate T cells, initiating and perpetuating the inflammatory cascade.\n"", ""name"": ""Dendritic Cell Activation""}"	{}	"{""cell_types"": [{""preferred_term"": ""Dendritic Cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""Plasmacytoid and myeloid dendritic cells produce inflammatory cytokines and present antigens to activate T cells, initiating and perpetuating the inflammatory cascade.\n"", ""evidence"": [{""explanation"": ""Dendritic cells are the primary producers of IL-23, which is central to psoriasis pathophysiology. This evidence supports the critical role of dendritic cell activation in initiating the inflammatory cascade through IL-23 production."", ""reference"": ""PMID:38686385"", ""snippet"": ""We review IL-23 biology, IL-23 signaling in IMIDs, and the effect of IL-23 inhibition in treating these diseases."", ""supports"": ""SUPPORT""}, {""explanation"": ""Dendritic cells act as innate immunity sensors and initiate the inflammatory response through antigen presentation and cytokine production, representing the dysregulation of innate immunity sensors described here."", ""reference"": ""PMID:39337637"", ""snippet"": ""Current research efforts to better understand skin disease have focused on examining the role of molecular processes at several stages of the inflammatory response such as the dysregulation of innate immunity sensors, disruption of both transcriptional and post-transcriptional regulation, and crosstalk between immune and neuronal processes (neuro-immune crosstalk)."", ""supports"": ""SUPPORT""}], ""name"": ""Dendritic Cell Activation""}"
6537	278	Psoriasis	Psoriasis.yaml	pathophysiology	3	IL-23/IL-17 Axis	"IL-23 produced by dendritic cells drives Th17 cell differentiation and IL-17 production. This axis is the major therapeutic target in modern psoriasis treatment.
"																																																								"{""description"": ""IL-23 produced by dendritic cells drives Th17 cell differentiation and IL-17 production. This axis is the major therapeutic target in modern psoriasis treatment.\n"", ""name"": ""IL-23/IL-17 Axis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cytokine Signaling"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}], ""description"": ""IL-23 produced by dendritic cells drives Th17 cell differentiation and IL-17 production. This axis is the major therapeutic target in modern psoriasis treatment.\n"", ""evidence"": [{""explanation"": ""This confirms IL-23 as the hierarchically dominant regulatory cytokine in psoriasis, supporting its central role in the IL-23/IL-17 axis and why it is the major therapeutic target."", ""reference"": ""PMID:38686385"", ""snippet"": ""Interleukin (IL)-23, an IL-12 cytokine family member, is a hierarchically dominant regulatory cytokine in a cluster of immune-mediated inflammatory diseases (IMIDs), including psoriasis, psoriatic arthritis, and inflammatory bowel disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""This establishes that inflammatory molecular mechanisms are fundamental to skin disease pathogenesis, consistent with the IL-23/IL-17 inflammatory axis driving psoriasis."", ""reference"": ""PMID:39337637"", ""snippet"": ""Many skin diseases begin with inflammatory changes on a molecular level."", ""supports"": ""SUPPORT""}], ""name"": ""IL-23/IL-17 Axis""}"
6552	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	pathophysiology	0	Immune-Mediated Inflammatory Arthritis	Genetic predisposition and environmental triggers activate innate and adaptive immune pathways, leading to persistent musculoskeletal inflammation.																																																								"{""description"": ""Genetic predisposition and environmental triggers activate innate and adaptive immune pathways, leading to persistent musculoskeletal inflammation."", ""name"": ""Immune-Mediated Inflammatory Arthritis""}"	{}	"{""description"": ""Genetic predisposition and environmental triggers activate innate and adaptive immune pathways, leading to persistent musculoskeletal inflammation."", ""evidence"": [{""explanation"": ""The review summarizes immune-mediated pathogenesis with genetic and environmental drivers."", ""reference"": ""PMID:36902329"", ""snippet"": ""The pathogenesis of PsA is complex and multifaceted, with an interplay of genetic predisposition, triggering environmental factors, and activation of the innate and adaptive immune system, although autoinflammation has also been implicated."", ""supports"": ""SUPPORT""}], ""name"": ""Immune-Mediated Inflammatory Arthritis""}"
6553	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	pathophysiology	1	Cytokine Pathway Activation	Dysregulated cytokine signaling, particularly IL-23/IL-17 and TNF pathways, sustains inflammatory responses in affected tissues.																																																								"{""description"": ""Dysregulated cytokine signaling, particularly IL-23/IL-17 and TNF pathways, sustains inflammatory responses in affected tissues."", ""name"": ""Cytokine Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cytokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}], ""description"": ""Dysregulated cytokine signaling, particularly IL-23/IL-17 and TNF pathways, sustains inflammatory responses in affected tissues."", ""evidence"": [{""explanation"": ""The abstract highlights cytokine pathways as central inflammatory drivers in PsA."", ""reference"": ""PMID:36902329"", ""snippet"": ""Research has identified several immune-inflammatory pathways defined by cytokines (IL-23/IL-17, TNF), leading to the development of efficacious therapeutic targets."", ""supports"": ""SUPPORT""}], ""name"": ""Cytokine Pathway Activation""}"
6554	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	pathophysiology	2	Enthesitis as a Primary Event	Enthesitis is a key manifestation of psoriatic arthritis and may represent an early event in disease development with activation of IL-17 and TNF pathways.																																																								"{""description"": ""Enthesitis is a key manifestation of psoriatic arthritis and may represent an early event in disease development with activation of IL-17 and TNF pathways."", ""name"": ""Enthesitis as a Primary Event""}"	{}	"{""description"": ""Enthesitis is a key manifestation of psoriatic arthritis and may represent an early event in disease development with activation of IL-17 and TNF pathways."", ""evidence"": [{""explanation"": ""The abstract describes enthesitis as a key manifestation and potential primary event in PsA."", ""reference"": ""PMID:32159793"", ""snippet"": ""Enthesitis is a key manifestation of PsA and current knowledge supports the concept that it may be among the primary events in the development of this disease, as well as other forms of SpA."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract notes IL-17 and TNF- as key mediators of PsA enthesitis."", ""reference"": ""PMID:32159793"", ""snippet"": ""Activation of pro-inflammatory mediators such as IL-17 and TNF- as well as the influx of innate immune cells are key events in the development of enthesitis in PsA."", ""supports"": ""SUPPORT""}], ""name"": ""Enthesitis as a Primary Event""}"
6575	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	0	Vascular Remodeling	Structural changes in the pulmonary vasculature including smooth muscle hypertrophy, intimal proliferation, and fibrosis.																																																								"{""description"": ""Structural changes in the pulmonary vasculature including smooth muscle hypertrophy, intimal proliferation, and fibrosis."", ""name"": ""Vascular Remodeling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}, {""preferred_term"": ""smooth muscle cell proliferation"", ""term"": {""id"": ""GO:0048661"", ""label"": ""positive regulation of smooth muscle cell proliferation""}}], ""cell_types"": [{""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}, {""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}, {""preferred_term"": ""fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}, {""preferred_term"": ""pericyte"", ""term"": {""id"": ""CL:0000669"", ""label"": ""pericyte""}}], ""description"": ""Structural changes in the pulmonary vasculature including smooth muscle hypertrophy, intimal proliferation, and fibrosis."", ""locations"": [{""preferred_term"": ""pulmonary artery"", ""term"": {""id"": ""UBERON:0002012"", ""label"": ""pulmonary artery""}}], ""name"": ""Vascular Remodeling""}"
6576	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	1	Endothelial Dysfunction	Endothelial injury and apoptosis with loss of BMPR2/BMP protective signaling; endothelial-to-mesenchymal transition contributing to vascular remodeling.																																																								"{""description"": ""Endothelial injury and apoptosis with loss of BMPR2/BMP protective signaling; endothelial-to-mesenchymal transition contributing to vascular remodeling."", ""name"": ""Endothelial Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""endothelial to mesenchymal transition"", ""term"": {""id"": ""GO:0001837"", ""label"": ""epithelial to mesenchymal transition""}}, {""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}, {""preferred_term"": ""BMP signaling pathway"", ""term"": {""id"": ""GO:0030509"", ""label"": ""BMP signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Endothelial injury and apoptosis with loss of BMPR2/BMP protective signaling; endothelial-to-mesenchymal transition contributing to vascular remodeling."", ""locations"": [{""preferred_term"": ""pulmonary artery"", ""term"": {""id"": ""UBERON:0002012"", ""label"": ""pulmonary artery""}}], ""name"": ""Endothelial Dysfunction""}"
6577	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	2	Inflammation and Immune Activation	Perivascular immune cell infiltration and cytokine release fueling proliferative and fibrotic processes.																																																								"{""description"": ""Perivascular immune cell infiltration and cytokine release fueling proliferative and fibrotic processes."", ""name"": ""Inflammation and Immune Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}, {""preferred_term"": ""NF-kappaB signaling"", ""term"": {""id"": ""GO:0038061"", ""label"": ""NIK/NF-kappaB signaling""}}], ""cell_types"": [{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Perivascular immune cell infiltration and cytokine release fueling proliferative and fibrotic processes."", ""locations"": [{""preferred_term"": ""pulmonary artery"", ""term"": {""id"": ""UBERON:0002012"", ""label"": ""pulmonary artery""}}], ""name"": ""Inflammation and Immune Activation""}"
6578	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	3	Metabolic Reprogramming	Shift from oxidative phosphorylation to glycolysis in vascular cells, supporting proliferation and apoptosis resistance.																																																								"{""description"": ""Shift from oxidative phosphorylation to glycolysis in vascular cells, supporting proliferation and apoptosis resistance."", ""name"": ""Metabolic Reprogramming""}"	{}	"{""biological_processes"": [{""preferred_term"": ""glycolytic process"", ""term"": {""id"": ""GO:0006096"", ""label"": ""glycolytic process""}}, {""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}], ""cell_types"": [{""preferred_term"": ""Smooth Muscle Cell"", ""term"": {""id"": ""CL:0000192"", ""label"": ""smooth muscle cell""}}, {""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Shift from oxidative phosphorylation to glycolysis in vascular cells, supporting proliferation and apoptosis resistance."", ""name"": ""Metabolic Reprogramming""}"
6579	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	4	Hypoxia Signaling	Hypoxia-inducible factor (HIF) pathway activation contributing to vasoconstriction and vascular remodeling.																																																								"{""description"": ""Hypoxia-inducible factor (HIF) pathway activation contributing to vasoconstriction and vascular remodeling."", ""name"": ""Hypoxia Signaling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}, {""preferred_term"": ""HIF-1-alpha signaling pathway"", ""term"": {""id"": ""GO:0097411"", ""label"": ""hypoxia-inducible factor-1alpha signaling pathway""}}], ""description"": ""Hypoxia-inducible factor (HIF) pathway activation contributing to vasoconstriction and vascular remodeling."", ""name"": ""Hypoxia Signaling""}"
6580	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	5	Increased Pulmonary Vascular Resistance	Result of vascular remodeling and vasoconstriction leading to elevated pressure in the pulmonary artery.																																																								"{""description"": ""Result of vascular remodeling and vasoconstriction leading to elevated pressure in the pulmonary artery."", ""name"": ""Increased Pulmonary Vascular Resistance""}"	{}	"{""description"": ""Result of vascular remodeling and vasoconstriction leading to elevated pressure in the pulmonary artery."", ""locations"": [{""preferred_term"": ""pulmonary artery"", ""term"": {""id"": ""UBERON:0002012"", ""label"": ""pulmonary artery""}}], ""name"": ""Increased Pulmonary Vascular Resistance""}"
6581	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	6	Right Ventricular Hypertrophy	The right ventricle thickens in response to increased workload from elevated pulmonary arterial pressure.																																																								"{""description"": ""The right ventricle thickens in response to increased workload from elevated pulmonary arterial pressure."", ""name"": ""Right Ventricular Hypertrophy""}"	"{""consequences"": [""Right Heart Failure""], ""downstream"": [{""description"": ""Sustained pulmonary hypertension causes right ventricular remodeling and eventual right heart failure."", ""evidence"": [{""explanation"": ""This 2024 paper establishes that progressive vascular remodeling in PAH leads to increased resistance and right ventricular failure."", ""reference"": ""PMID:39581144"", ""snippet"": ""Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease characterized by elevated pulmonary vascular resistance, progressive increases in pulmonary artery pressures, ultimately leading to right-sided heart failure"", ""supports"": ""SUPPORT""}], ""target"": ""Right Heart Failure""}]}"	"{""consequences"": [""Right Heart Failure""], ""description"": ""The right ventricle thickens in response to increased workload from elevated pulmonary arterial pressure."", ""downstream"": [{""description"": ""Sustained pulmonary hypertension causes right ventricular remodeling and eventual right heart failure."", ""evidence"": [{""explanation"": ""This 2024 paper establishes that progressive vascular remodeling in PAH leads to increased resistance and right ventricular failure."", ""reference"": ""PMID:39581144"", ""snippet"": ""Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease characterized by elevated pulmonary vascular resistance, progressive increases in pulmonary artery pressures, ultimately leading to right-sided heart failure"", ""supports"": ""SUPPORT""}], ""target"": ""Right Heart Failure""}], ""locations"": [{""preferred_term"": ""right cardiac ventricle"", ""term"": {""id"": ""UBERON:0002080"", ""label"": ""right cardiac ventricle""}}], ""name"": ""Right Ventricular Hypertrophy""}"
6604	281	RET Fusion-Positive Thyroid Cancer	RET_Fusion_Thyroid_Cancer.yaml	pathophysiology	0	RET Fusion and Constitutive Kinase Activation	Chromosomal rearrangements fuse the RET tyrosine kinase domain with upstream partners that provide dimerization domains. This creates constitutively active chimeric proteins that signal independently of RET ligands (GDNF family members).																																																								"{""description"": ""Chromosomal rearrangements fuse the RET tyrosine kinase domain with upstream partners that provide dimerization domains. This creates constitutively active chimeric proteins that signal independently of RET ligands (GDNF family members)."", ""name"": ""RET Fusion and Constitutive Kinase Activation""}"	"{""downstream"": [{""description"": ""RET fusion activates RAS-RAF-MEK-ERK signaling cascade"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""RET fusion stimulates PI3K-AKT survival signaling"", ""target"": ""PI3K-AKT Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""receptor signaling protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004716"", ""label"": ""receptor signaling protein tyrosine kinase activity""}}], ""cell_types"": [{""preferred_term"": ""thyroid follicular cell"", ""term"": {""id"": ""CL:0002258"", ""label"": ""thyroid follicular cell""}}], ""description"": ""Chromosomal rearrangements fuse the RET tyrosine kinase domain with upstream partners that provide dimerization domains. This creates constitutively active chimeric proteins that signal independently of RET ligands (GDNF family members)."", ""downstream"": [{""description"": ""RET fusion activates RAS-RAF-MEK-ERK signaling cascade"", ""target"": ""RAS-MAPK Pathway Activation""}, {""description"": ""RET fusion stimulates PI3K-AKT survival signaling"", ""target"": ""PI3K-AKT Pathway Activation""}], ""locations"": [{""preferred_term"": ""thyroid gland"", ""term"": {""id"": ""UBERON:0002046"", ""label"": ""thyroid gland""}}], ""name"": ""RET Fusion and Constitutive Kinase Activation""}"
6605	281	RET Fusion-Positive Thyroid Cancer	RET_Fusion_Thyroid_Cancer.yaml	pathophysiology	1	RAS-MAPK Pathway Activation	Constitutive RET kinase activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting uncontrolled thyroid follicular cell proliferation. This is a major effector of RET-mediated thyroid tumorigenesis.																																																								"{""description"": ""Constitutive RET kinase activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting uncontrolled thyroid follicular cell proliferation. This is a major effector of RET-mediated thyroid tumorigenesis."", ""name"": ""RAS-MAPK Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""Constitutive RET kinase activation drives the RAS-RAF-MEK-ERK signaling cascade, promoting uncontrolled thyroid follicular cell proliferation. This is a major effector of RET-mediated thyroid tumorigenesis."", ""name"": ""RAS-MAPK Pathway Activation""}"
6606	281	RET Fusion-Positive Thyroid Cancer	RET_Fusion_Thyroid_Cancer.yaml	pathophysiology	2	PI3K-AKT Pathway Activation	RET activation recruits PI3K and stimulates AKT-mTOR signaling, promoting cell survival and resistance to apoptosis. Combined with MAPK activation, this drives thyroid cancer progression.																																																								"{""description"": ""RET activation recruits PI3K and stimulates AKT-mTOR signaling, promoting cell survival and resistance to apoptosis. Combined with MAPK activation, this drives thyroid cancer progression."", ""name"": ""PI3K-AKT Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""RET activation recruits PI3K and stimulates AKT-mTOR signaling, promoting cell survival and resistance to apoptosis. Combined with MAPK activation, this drives thyroid cancer progression."", ""name"": ""PI3K-AKT Pathway Activation""}"
6622	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	pathophysiology	0	RET Gene Rearrangement	RET rearrangements result from chromosomal inversions or translocations that fuse the RET kinase domain (10q11.21) to an N-terminal partner gene. The partner gene provides a dimerization domain, causing constitutive RET kinase activation independent of ligand. RET normally signals through GDNF family ligands and GFR-alpha co-receptors.																																																								"{""description"": ""RET rearrangements result from chromosomal inversions or translocations that fuse the RET kinase domain (10q11.21) to an N-terminal partner gene. The partner gene provides a dimerization domain, causing constitutive RET kinase activation independent of ligand. RET normally signals through GDNF family ligands and GFR-alpha co-receptors."", ""name"": ""RET Gene Rearrangement""}"	"{""downstream"": [{""description"": ""Fusion protein is constitutively active"", ""target"": ""Constitutive RET Signaling""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein kinase activity"", ""term"": {""id"": ""GO:0004672"", ""label"": ""protein kinase activity""}}], ""cell_types"": [{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}], ""description"": ""RET rearrangements result from chromosomal inversions or translocations that fuse the RET kinase domain (10q11.21) to an N-terminal partner gene. The partner gene provides a dimerization domain, causing constitutive RET kinase activation independent of ligand. RET normally signals through GDNF family ligands and GFR-alpha co-receptors."", ""downstream"": [{""description"": ""Fusion protein is constitutively active"", ""target"": ""Constitutive RET Signaling""}], ""evidence"": [{""explanation"": ""Supports the presence of RET fusions in a subset of NSCLC."", ""reference"": ""PMID:38110308"", ""snippet"": ""Nearly 1% to 2% of NSCLCs harbor RET fusions, and this patient population may not respond well to traditional treatments like chemotherapy or radiation therapy."", ""supports"": ""SUPPORT""}], ""name"": ""RET Gene Rearrangement""}"
6623	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	pathophysiology	1	Constitutive RET Signaling	RET fusion proteins are constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and PLCgamma pathways. RET also activates SRC family kinases and JAK-STAT signaling.																																																								"{""description"": ""RET fusion proteins are constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and PLCgamma pathways. RET also activates SRC family kinases and JAK-STAT signaling."", ""name"": ""Constitutive RET Signaling""}"	"{""downstream"": [{""description"": ""Tumor survival dependent on RET activity"", ""target"": ""Oncogene Addiction""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""RET fusion proteins are constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and PLCgamma pathways. RET also activates SRC family kinases and JAK-STAT signaling."", ""downstream"": [{""description"": ""Tumor survival dependent on RET activity"", ""target"": ""Oncogene Addiction""}], ""name"": ""Constitutive RET Signaling""}"
6624	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	pathophysiology	2	Oncogene Addiction	RET-rearranged tumors exhibit oncogene addiction, becoming dependent on continued RET signaling for survival. Selective RET inhibition leads to rapid and durable tumor responses.																																																								"{""description"": ""RET-rearranged tumors exhibit oncogene addiction, becoming dependent on continued RET signaling for survival. Selective RET inhibition leads to rapid and durable tumor responses."", ""name"": ""Oncogene Addiction""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""RET-rearranged tumors exhibit oncogene addiction, becoming dependent on continued RET signaling for survival. Selective RET inhibition leads to rapid and durable tumor responses."", ""name"": ""Oncogene Addiction""}"
6625	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	pathophysiology	3	RET Inhibitor Resistance	Resistance to selective RET inhibitors can develop through secondary RET kinase mutations (G810R/S/C solvent front mutations, V804L/M gatekeeper), RET amplification, or bypass pathway activation (MET, KRAS, BRAF). Solvent front mutations are the most common resistance mechanism.																																																								"{""description"": ""Resistance to selective RET inhibitors can develop through secondary RET kinase mutations (G810R/S/C solvent front mutations, V804L/M gatekeeper), RET amplification, or bypass pathway activation (MET, KRAS, BRAF). Solvent front mutations are the most common resistance mechanism."", ""name"": ""RET Inhibitor Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}], ""description"": ""Resistance to selective RET inhibitors can develop through secondary RET kinase mutations (G810R/S/C solvent front mutations, V804L/M gatekeeper), RET amplification, or bypass pathway activation (MET, KRAS, BRAF). Solvent front mutations are the most common resistance mechanism."", ""name"": ""RET Inhibitor Resistance""}"
6642	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	0	ROS1 Gene Rearrangement	ROS1 rearrangements result from chromosomal translocations that fuse the ROS1 kinase domain (6q22) to an N-terminal partner gene. The partner provides a dimerization domain, causing constitutive ROS1 kinase activation independent of ligand. ROS1 shares ~49% amino acid identity with ALK in the kinase domain, explaining cross-sensitivity to ALK inhibitors.																																																								"{""description"": ""ROS1 rearrangements result from chromosomal translocations that fuse the ROS1 kinase domain (6q22) to an N-terminal partner gene. The partner provides a dimerization domain, causing constitutive ROS1 kinase activation independent of ligand. ROS1 shares ~49% amino acid identity with ALK in the kinase domain, explaining cross-sensitivity to ALK inhibitors."", ""name"": ""ROS1 Gene Rearrangement""}"	"{""downstream"": [{""description"": ""Fusion protein is constitutively active"", ""target"": ""Constitutive ROS1 Signaling""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein kinase activity"", ""term"": {""id"": ""GO:0004672"", ""label"": ""protein kinase activity""}}], ""cell_types"": [{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}], ""description"": ""ROS1 rearrangements result from chromosomal translocations that fuse the ROS1 kinase domain (6q22) to an N-terminal partner gene. The partner provides a dimerization domain, causing constitutive ROS1 kinase activation independent of ligand. ROS1 shares ~49% amino acid identity with ALK in the kinase domain, explaining cross-sensitivity to ALK inhibitors."", ""downstream"": [{""description"": ""Fusion protein is constitutively active"", ""target"": ""Constitutive ROS1 Signaling""}], ""evidence"": [{""explanation"": ""This abstract establishes that ROS1 fusions define a small NSCLC subset, supporting the ROS1 gene rearrangement mechanism."", ""reference"": ""PMID:31720561"", ""snippet"": ""ROS1 gene fusions account for approximately 1-2% of all cases of non-small cell lung cancer (NSCLC)."", ""supports"": ""SUPPORT""}], ""name"": ""ROS1 Gene Rearrangement""}"
6643	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	1	Constitutive ROS1 Signaling	ROS1 fusion proteins are constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration. ROS1 shares significant kinase domain homology with ALK.																																																								"{""description"": ""ROS1 fusion proteins are constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration. ROS1 shares significant kinase domain homology with ALK."", ""name"": ""Constitutive ROS1 Signaling""}"	"{""downstream"": [{""description"": ""Tumor survival dependent on ROS1 activity"", ""target"": ""Oncogene Addiction""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""JAK-STAT cascade"", ""term"": {""id"": ""GO:0007259"", ""label"": ""JAK-STAT cascade""}}], ""description"": ""ROS1 fusion proteins are constitutively dimerized and auto-phosphorylated, activating downstream signaling including RAS-MAPK, PI3K-AKT, and JAK-STAT3 pathways. These pathways promote cell proliferation, survival, and migration. ROS1 shares significant kinase domain homology with ALK."", ""downstream"": [{""description"": ""Tumor survival dependent on ROS1 activity"", ""target"": ""Oncogene Addiction""}], ""name"": ""Constitutive ROS1 Signaling""}"
6644	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	2	Oncogene Addiction	ROS1-rearranged tumors exhibit oncogene addiction, becoming dependent on continued ROS1 signaling for survival. ROS1 inhibition leads to dramatic tumor responses, often within days to weeks of starting therapy.																																																								"{""description"": ""ROS1-rearranged tumors exhibit oncogene addiction, becoming dependent on continued ROS1 signaling for survival. ROS1 inhibition leads to dramatic tumor responses, often within days to weeks of starting therapy."", ""name"": ""Oncogene Addiction""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""ROS1-rearranged tumors exhibit oncogene addiction, becoming dependent on continued ROS1 signaling for survival. ROS1 inhibition leads to dramatic tumor responses, often within days to weeks of starting therapy."", ""name"": ""Oncogene Addiction""}"
6645	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	3	ROS1 Inhibitor Resistance	Resistance to ROS1 inhibitors develops through ROS1-dependent mechanisms (secondary mutations like G2032R, D2033N, L2026M) or ROS1-independent bypass pathways (MET amplification, KRAS mutations, EGFR activation). The G2032R solvent front mutation is the most common and confers resistance to crizotinib.																																																								"{""description"": ""Resistance to ROS1 inhibitors develops through ROS1-dependent mechanisms (secondary mutations like G2032R, D2033N, L2026M) or ROS1-independent bypass pathways (MET amplification, KRAS mutations, EGFR activation). The G2032R solvent front mutation is the most common and confers resistance to crizotinib."", ""name"": ""ROS1 Inhibitor Resistance""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""response to drug"", ""term"": {""id"": ""GO:0042493"", ""label"": ""response to drug""}}], ""description"": ""Resistance to ROS1 inhibitors develops through ROS1-dependent mechanisms (secondary mutations like G2032R, D2033N, L2026M) or ROS1-independent bypass pathways (MET amplification, KRAS mutations, EGFR activation). The G2032R solvent front mutation is the most common and confers resistance to crizotinib."", ""name"": ""ROS1 Inhibitor Resistance""}"
6656	284	Rabies	Rabies.yaml	pathophysiology	0	Viral encephalitis	Rabies causes acute, progressive viral encephalitis.																																																								"{""description"": ""Rabies causes acute, progressive viral encephalitis."", ""name"": ""Viral encephalitis""}"	{}	"{""description"": ""Rabies causes acute, progressive viral encephalitis."", ""evidence"": [{""explanation"": ""The abstract defines rabies as viral encephalitis."", ""reference"": ""PMID:12144896"", ""snippet"": ""Rabies is an acute, progressive, incurable viral encephalitis."", ""supports"": ""SUPPORT""}], ""name"": ""Viral encephalitis""}"
6657	284	Rabies	Rabies.yaml	pathophysiology	1	Centripetal spread to the central nervous system	Virus spreads from peripheral wounds toward the CNS.																																																								"{""description"": ""Virus spreads from peripheral wounds toward the CNS."", ""name"": ""Centripetal spread to the central nervous system""}"	{}	"{""description"": ""Virus spreads from peripheral wounds toward the CNS."", ""evidence"": [{""explanation"": ""The abstract describes centripetal spread to the CNS."", ""reference"": ""PMID:12144896"", ""snippet"": ""once the virus is deposited in peripheral wounds, centripetal passage occurs towards the central nervous system."", ""supports"": ""SUPPORT""}], ""name"": ""Centripetal spread to the central nervous system""}"
6676	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	0	Pre-refeeding malnutrition state	Patients who develop refeeding syndrome typically have been malnourished for days to weeks before nutrition is reintroduced.																																																								"{""description"": ""Patients who develop refeeding syndrome typically have been malnourished for days to weeks before nutrition is reintroduced."", ""name"": ""Pre-refeeding malnutrition state""}"	{}	"{""description"": ""Patients who develop refeeding syndrome typically have been malnourished for days to weeks before nutrition is reintroduced."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This describes the malnourished state that precedes refeeding syndrome."", ""reference"": ""PMID:19278172"", ""snippet"": ""The typical patient who experiences RFS has been malnourished for days to weeks"", ""supports"": ""SUPPORT""}], ""name"": ""Pre-refeeding malnutrition state""}"
6677	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	1	Aggressive nutritional reintroduction	Refeeding syndrome is triggered when aggressive enteral or parenteral feeding is initiated in a malnourished patient.																																																								"{""description"": ""Refeeding syndrome is triggered when aggressive enteral or parenteral feeding is initiated in a malnourished patient."", ""name"": ""Aggressive nutritional reintroduction""}"	{}	"{""description"": ""Refeeding syndrome is triggered when aggressive enteral or parenteral feeding is initiated in a malnourished patient."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This identifies aggressive refeeding in malnourished patients as the precipitating step."", ""reference"": ""PMID:19931071"", ""snippet"": ""Refeeding syndrome (RFS) is the result of aggressive enteral or parenteral feeding in a malnourished patient"", ""supports"": ""SUPPORT""}], ""name"": ""Aggressive nutritional reintroduction""}"
6678	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	2	Hypophosphatemia as hallmark biochemical shift	Hypophosphatemia is the hallmark biochemical change following refeeding.																																																								"{""description"": ""Hypophosphatemia is the hallmark biochemical change following refeeding."", ""name"": ""Hypophosphatemia as hallmark biochemical shift""}"	{}	"{""description"": ""Hypophosphatemia is the hallmark biochemical change following refeeding."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This explicitly labels hypophosphatemia as the hallmark feature of refeeding syndrome."", ""reference"": ""PMID:19931071"", ""snippet"": ""with hypophosphatemia being the hallmark of this phenomenon."", ""supports"": ""SUPPORT""}], ""name"": ""Hypophosphatemia as hallmark biochemical shift""}"
6679	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	3	Hypophosphatemia at onset of refeeding syndrome	Hypophosphatemia is observed at the onset of refeeding syndrome and is monitored during refeeding.																																																								"{""description"": ""Hypophosphatemia is observed at the onset of refeeding syndrome and is monitored during refeeding."", ""name"": ""Hypophosphatemia at onset of refeeding syndrome""}"	{}	"{""description"": ""Hypophosphatemia is observed at the onset of refeeding syndrome and is monitored during refeeding."", ""evidence"": [{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""This notes that hypophosphatemia appears at onset and is monitored during refeeding."", ""reference"": ""PMID:36936877"", ""snippet"": ""Hypophosphatemia inevitably is observed at the onset of refeeding syndrome and therefore is monitored during refeeding"", ""supports"": ""SUPPORT""}], ""name"": ""Hypophosphatemia at onset of refeeding syndrome""}"
6680	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	4	Intracellular electrolyte shift during anabolism	The metabolic response to refeeding drives an acute intracellular shift of electrolytes with increased phosphate demand for tissue anabolism and high- energy phosphate bond formation.																																																								"{""description"": ""The metabolic response to refeeding drives an acute intracellular shift of electrolytes with increased phosphate demand for tissue anabolism and high- energy phosphate bond formation."", ""name"": ""Intracellular electrolyte shift during anabolism""}"	{}	"{""description"": ""The metabolic response to refeeding drives an acute intracellular shift of electrolytes with increased phosphate demand for tissue anabolism and high- energy phosphate bond formation."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This directly describes the intracellular electrolyte shift and increased phosphate demand that drive refeeding syndrome."", ""reference"": ""PMID:19278172"", ""snippet"": ""acute intracellular shift in electrolytes, increased phosphate demand during tissue anabolism, and formation of high-energy phosphate bonds."", ""supports"": ""SUPPORT""}], ""name"": ""Intracellular electrolyte shift during anabolism""}"
6681	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	5	Rapid post-feeding phosphate decline	After initiation of parenteral nutrition, phosphate levels decline rapidly and more markedly than potassium or magnesium.																																																								"{""description"": ""After initiation of parenteral nutrition, phosphate levels decline rapidly and more markedly than potassium or magnesium."", ""name"": ""Rapid post-feeding phosphate decline""}"	{}	"{""description"": ""After initiation of parenteral nutrition, phosphate levels decline rapidly and more markedly than potassium or magnesium."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This quantifies the rapid decline in phosphate compared with potassium and magnesium after PN initiation."", ""reference"": ""PMID:40738722"", ""snippet"": ""Phosphate levels showed the most significant decline post-PN initiation (43%), followed by potassium (19%) and magnesium (17%)"", ""supports"": ""SUPPORT""}], ""name"": ""Rapid post-feeding phosphate decline""}"
6682	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	6	Sodium and fluid retention	Sodium and fluid retention occurs alongside electrolyte abnormalities during refeeding.																																																								"{""description"": ""Sodium and fluid retention occurs alongside electrolyte abnormalities during refeeding."", ""name"": ""Sodium and fluid retention""}"	{}	"{""description"": ""Sodium and fluid retention occurs alongside electrolyte abnormalities during refeeding."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This identifies sodium and fluid retention as a common concurrent change."", ""reference"": ""PMID:19931071"", ""snippet"": ""along with sodium and fluid retention."", ""supports"": ""SUPPORT""}], ""name"": ""Sodium and fluid retention""}"
6683	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	7	Thiamine deficiency emerges during refeeding	Thiamine deficiency is a common accompanying abnormality during refeeding.																																																								"{""description"": ""Thiamine deficiency is a common accompanying abnormality during refeeding."", ""name"": ""Thiamine deficiency emerges during refeeding""}"	{}	"{""description"": ""Thiamine deficiency is a common accompanying abnormality during refeeding."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This identifies thiamine deficiency as a common accompanying feature."", ""reference"": ""PMID:29448987"", ""snippet"": ""thiamine deficiency and disorder of sodium and fluid balance are common."", ""supports"": ""SUPPORT""}], ""name"": ""Thiamine deficiency emerges during refeeding""}"
6684	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	8	Cardiorespiratory complications from metabolic derangements	Severe metabolic derangements can progress to fatal arrhythmias, systolic heart failure, and respiratory insufficiency.																																																								"{""description"": ""Severe metabolic derangements can progress to fatal arrhythmias, systolic heart failure, and respiratory insufficiency."", ""name"": ""Cardiorespiratory complications from metabolic derangements""}"	{}	"{""description"": ""Severe metabolic derangements can progress to fatal arrhythmias, systolic heart failure, and respiratory insufficiency."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This lists the severe cardiorespiratory complications of refeeding syndrome."", ""reference"": ""PMID:19278172"", ""snippet"": ""fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency"", ""supports"": ""SUPPORT""}], ""name"": ""Cardiorespiratory complications from metabolic derangements""}"
6685	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	9	Refeeding-induced central nervous system disorders	Refeeding can precipitate central nervous system complications including hypoglycemic encephalopathy, Wernicke encephalopathy, and hypophosphatemic encephalopathy.																																																								"{""description"": ""Refeeding can precipitate central nervous system complications including hypoglycemic encephalopathy, Wernicke encephalopathy, and hypophosphatemic encephalopathy."", ""name"": ""Refeeding-induced central nervous system disorders""}"	{}	"{""description"": ""Refeeding can precipitate central nervous system complications including hypoglycemic encephalopathy, Wernicke encephalopathy, and hypophosphatemic encephalopathy."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report highlights CNS complications associated with refeeding syndrome."", ""reference"": ""PMID:41246683"", ""snippet"": ""Refeeding syndrome potentially causes death from refeeding-induced central nervous system disorders, such as hypoglycemic encephalopathy, Wernicke encephalopathy, and hypophosphatemic encephalopathy."", ""supports"": ""SUPPORT""}], ""name"": ""Refeeding-induced central nervous system disorders""}"
6686	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	10	Abnormal myocardial fatty acid metabolism	Abnormal myocardial fatty acid metabolism is implicated in cardiac dysfunction associated with refeeding syndrome.																																																								"{""description"": ""Abnormal myocardial fatty acid metabolism is implicated in cardiac dysfunction associated with refeeding syndrome."", ""name"": ""Abnormal myocardial fatty acid metabolism""}"	{}	"{""description"": ""Abnormal myocardial fatty acid metabolism is implicated in cardiac dysfunction associated with refeeding syndrome."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This cardiohistological case links abnormal fatty acid metabolism to cardiac dysfunction in refeeding syndrome."", ""reference"": ""PMID:39310593"", ""snippet"": ""The abnormal metabolism of fatty acids was the presumed cause of cardiac dysfunction."", ""supports"": ""SUPPORT""}], ""name"": ""Abnormal myocardial fatty acid metabolism""}"
6704	286	Renal Cell Carcinoma	Renal_Cell_Carcinoma.yaml	pathophysiology	0	Renal Epithelial Malignancy	Malignant transformation of renal epithelial cells gives rise to renal cell carcinoma with diverse molecular subtypes.																																																								"{""description"": ""Malignant transformation of renal epithelial cells gives rise to renal cell carcinoma with diverse molecular subtypes."", ""name"": ""Renal Epithelial Malignancy""}"	{}	"{""description"": ""Malignant transformation of renal epithelial cells gives rise to renal cell carcinoma with diverse molecular subtypes."", ""evidence"": [{""explanation"": ""The abstract identifies RCC as arising from renal epithelium."", ""reference"": ""PMID:28898679"", ""snippet"": ""The most common form of kidney cancer arises from renal epithelium, named renal cell carcinoma (RCC)."", ""supports"": ""SUPPORT""}], ""name"": ""Renal Epithelial Malignancy""}"
6705	286	Renal Cell Carcinoma	Renal_Cell_Carcinoma.yaml	pathophysiology	1	Histologic and Molecular Heterogeneity	Renal cell carcinoma comprises multiple histological and molecular subtypes, reflecting heterogeneous biology.																																																								"{""description"": ""Renal cell carcinoma comprises multiple histological and molecular subtypes, reflecting heterogeneous biology."", ""name"": ""Histologic and Molecular Heterogeneity""}"	{}	"{""description"": ""Renal cell carcinoma comprises multiple histological and molecular subtypes, reflecting heterogeneous biology."", ""evidence"": [{""explanation"": ""The abstract notes RCC heterogeneity across histologic and molecular subtypes."", ""reference"": ""PMID:28898679"", ""snippet"": ""This entity comprises different histological and molecular subtypes."", ""supports"": ""SUPPORT""}], ""name"": ""Histologic and Molecular Heterogeneity""}"
6716	287	Retinoblastoma	Retinoblastoma.yaml	pathophysiology	0	RB1 Tumor Suppressor Inactivation	The RB1 gene encodes the retinoblastoma protein (pRB), a critical regulator of the cell cycle. Biallelic RB1 loss removes the constraint on E2F transcription factors, allowing uncontrolled progression through the G1/S checkpoint. Retinoblastoma exemplifies Knudson's two-hit hypothesis: in hereditary cases, one mutation is inherited and the second is somatic; in sporadic cases, both mutations occur somatically in the same cell.																																																								"{""description"": ""The RB1 gene encodes the retinoblastoma protein (pRB), a critical regulator of the cell cycle. Biallelic RB1 loss removes the constraint on E2F transcription factors, allowing uncontrolled progression through the G1/S checkpoint. Retinoblastoma exemplifies Knudson's two-hit hypothesis: in hereditary cases, one mutation is inherited and the second is somatic; in sporadic cases, both mutations occur somatically in the same cell."", ""name"": ""RB1 Tumor Suppressor Inactivation""}"	"{""downstream"": [{""description"": ""pRB loss releases E2F transcription factors from inhibition"", ""target"": ""Loss of Cell Cycle Checkpoint Control""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0000082"", ""label"": ""G1/S transition of mitotic cell cycle""}}], ""cell_types"": [{""preferred_term"": ""retinal progenitor cell"", ""term"": {""id"": ""CL:0002672"", ""label"": ""retinal progenitor cell""}}], ""description"": ""The RB1 gene encodes the retinoblastoma protein (pRB), a critical regulator of the cell cycle. Biallelic RB1 loss removes the constraint on E2F transcription factors, allowing uncontrolled progression through the G1/S checkpoint. Retinoblastoma exemplifies Knudson's two-hit hypothesis: in hereditary cases, one mutation is inherited and the second is somatic; in sporadic cases, both mutations occur somatically in the same cell."", ""downstream"": [{""description"": ""pRB loss releases E2F transcription factors from inhibition"", ""target"": ""Loss of Cell Cycle Checkpoint Control""}], ""locations"": [{""preferred_term"": ""retina"", ""term"": {""id"": ""UBERON:0000966"", ""label"": ""retina""}}], ""name"": ""RB1 Tumor Suppressor Inactivation""}"
6717	287	Retinoblastoma	Retinoblastoma.yaml	pathophysiology	1	Loss of Cell Cycle Checkpoint Control	pRB normally binds and inhibits E2F transcription factors during G1 phase. When pRB is phosphorylated by cyclin-dependent kinases or functionally lost, E2F is released to activate genes required for S-phase entry, including cyclins, DNA replication factors, and proliferative genes.																																																								"{""description"": ""pRB normally binds and inhibits E2F transcription factors during G1 phase. When pRB is phosphorylated by cyclin-dependent kinases or functionally lost, E2F is released to activate genes required for S-phase entry, including cyclins, DNA replication factors, and proliferative genes."", ""name"": ""Loss of Cell Cycle Checkpoint Control""}"	"{""downstream"": [{""description"": ""E2F-driven gene expression promotes S-phase entry and cell division"", ""target"": ""Uncontrolled Retinal Cell Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell cycle checkpoint signaling"", ""term"": {""id"": ""GO:0000075"", ""label"": ""cell cycle checkpoint signaling""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of transcription by RNA polymerase II"", ""term"": {""id"": ""GO:0045944"", ""label"": ""positive regulation of transcription by RNA polymerase II""}}], ""description"": ""pRB normally binds and inhibits E2F transcription factors during G1 phase. When pRB is phosphorylated by cyclin-dependent kinases or functionally lost, E2F is released to activate genes required for S-phase entry, including cyclins, DNA replication factors, and proliferative genes."", ""downstream"": [{""description"": ""E2F-driven gene expression promotes S-phase entry and cell division"", ""target"": ""Uncontrolled Retinal Cell Proliferation""}], ""name"": ""Loss of Cell Cycle Checkpoint Control""}"
6718	287	Retinoblastoma	Retinoblastoma.yaml	pathophysiology	2	Uncontrolled Retinal Cell Proliferation	Loss of pRB-mediated cell cycle control results in constitutive E2F activity, driving retinal progenitor cells through repeated rounds of DNA replication and cell division. This uncontrolled proliferation leads to tumor formation.																																																								"{""description"": ""Loss of pRB-mediated cell cycle control results in constitutive E2F activity, driving retinal progenitor cells through repeated rounds of DNA replication and cell division. This uncontrolled proliferation leads to tumor formation."", ""name"": ""Uncontrolled Retinal Cell Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""retinal progenitor cell"", ""term"": {""id"": ""CL:0002672"", ""label"": ""retinal progenitor cell""}}], ""description"": ""Loss of pRB-mediated cell cycle control results in constitutive E2F activity, driving retinal progenitor cells through repeated rounds of DNA replication and cell division. This uncontrolled proliferation leads to tumor formation."", ""evidence"": [{""explanation"": ""This is the foundational Knudson paper establishing the two-hit hypothesis based on statistical analysis of retinoblastoma cases."", ""reference"": ""PMID:5279523"", ""snippet"": ""retinoblastoma is a cancer caused by two mutational events. In the dominantly inherited form, one mutation is inherited via the germinal cells and the second occurs in somatic cells. In the nonhereditary form, both mutations occur in somatic cells."", ""supports"": ""SUPPORT""}], ""name"": ""Uncontrolled Retinal Cell Proliferation""}"
6730	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	0	Failure of Upper Esophageal Sphincter Relaxation	The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact.																																																								"{""description"": ""The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact."", ""name"": ""Failure of Upper Esophageal Sphincter Relaxation""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of muscle contraction"", ""term"": {""id"": ""GO:0006937"", ""label"": ""regulation of muscle contraction""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""skeletal muscle contraction"", ""term"": {""id"": ""GO:0003009"", ""label"": ""skeletal muscle contraction""}}], ""cell_types"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""muscle cell"", ""term"": {""id"": ""CL:0000187"", ""label"": ""muscle cell""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""sensory neuron"", ""term"": {""id"": ""CL:0000101"", ""label"": ""sensory neuron""}}], ""description"": ""The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact."", ""evidence"": [{""explanation"": ""The Kahrilas 2022 review establishes that UES relaxation failure during retrograde gas events is the core pathophysiological mechanism."", ""reference"": ""PMID:35122356"", ""snippet"": ""prior to 2019, there were only three case reports in the world literature of individuals with a physiologically demonstrated inability to belch due to failure of the UES to relax after gas venting from the stomach and ensuing low-pressure esophageal distention"", ""supports"": ""SUPPORT""}, {""explanation"": ""The Yousef 2024 case-control study demonstrated physiological abnormalities in UES function in R-CPD patients."", ""reference"": ""PMID:38587015"", ""snippet"": ""RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility."", ""supports"": ""SUPPORT""}, {""explanation"": ""The Dealino 2026 cases document absent UES relaxation during attempted belching."", ""reference"": ""PMID:41506952"", ""snippet"": ""high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching."", ""supports"": ""SUPPORT""}, {""explanation"": ""The Jimnez-Castillo 2025 case series shows failure of UES relaxation during retrograde distension."", ""reference"": ""PMID:38767031"", ""snippet"": ""We performed HRM with a belch provocation test for which the patient drank 500 ml of carbonated water. The study revealed increased esophageal pressure, an absence of UES relaxation and secondary peristalsis once the patient mentioned the need to belch."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""upper esophageal sphincter"", ""term"": {""id"": ""UBERON:0007268"", ""label"": ""upper esophageal sphincter""}}, {""preferred_term"": ""cricopharyngeus muscle"", ""term"": {""id"": ""UBERON:0010928"", ""label"": ""cricopharyngeus muscle""}}], ""name"": ""Failure of Upper Esophageal Sphincter Relaxation""}"
6731	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	1	Elevated Upper Esophageal Sphincter Basal Pressure	Patients with R-CPD have significantly higher resting UES pressure compared to healthy controls, contributing to the inability to release trapped gas.																																																								"{""description"": ""Patients with R-CPD have significantly higher resting UES pressure compared to healthy controls, contributing to the inability to release trapped gas."", ""name"": ""Elevated Upper Esophageal Sphincter Basal Pressure""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""muscle contraction"", ""term"": {""id"": ""GO:0006936"", ""label"": ""muscle contraction""}}], ""cell_types"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""muscle cell"", ""term"": {""id"": ""CL:0000187"", ""label"": ""muscle cell""}}], ""description"": ""Patients with R-CPD have significantly higher resting UES pressure compared to healthy controls, contributing to the inability to release trapped gas."", ""evidence"": [{""explanation"": ""The case-control study quantified higher UES basal pressures in R-CPD patients relative to controls."", ""reference"": ""PMID:38587015"", ""snippet"": ""The RCPD cohort, compared to the asymptomatic cohort, exhibited significantly greater upper esophageal sphincter (UES) length [4.5 (SD: 0.7) vs 3.7 (0.9) cm"", ""supports"": ""SUPPORT""}, {""explanation"": ""Elevated resting UES pressure was observed in both cases in the 2026 report."", ""reference"": ""PMID:41506952"", ""snippet"": ""high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""upper esophageal sphincter"", ""term"": {""id"": ""UBERON:0007268"", ""label"": ""upper esophageal sphincter""}}], ""name"": ""Elevated Upper Esophageal Sphincter Basal Pressure""}"
6742	289	Rett Syndrome	Rett_Syndrome.yaml	pathophysiology	0	MECP2 Dysfunction	"Mutations in MECP2 gene cause loss of methyl-CpG-binding protein 2 function. MECP2 is a transcriptional regulator that binds methylated DNA and modulates gene expression critical for neuronal maturation and synaptic function.
"																																																								"{""description"": ""Mutations in MECP2 gene cause loss of methyl-CpG-binding protein 2 function. MECP2 is a transcriptional regulator that binds methylated DNA and modulates gene expression critical for neuronal maturation and synaptic function.\n"", ""name"": ""MECP2 Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Gene Expression Regulation"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Mutations in MECP2 gene cause loss of methyl-CpG-binding protein 2 function. MECP2 is a transcriptional regulator that binds methylated DNA and modulates gene expression critical for neuronal maturation and synaptic function.\n"", ""evidence"": [{""explanation"": ""Original discovery paper confirms MeCP2 functions as a transcriptional regulator through DNA methylation binding."", ""reference"": ""PMID:10508514"", ""snippet"": ""MeCP2 selectively binds CpG dinucleotides in the mammalian genome and mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A"", ""supports"": ""SUPPORT""}], ""name"": ""MECP2 Dysfunction""}"
6743	289	Rett Syndrome	Rett_Syndrome.yaml	pathophysiology	1	Abnormal Neuronal Development	"Loss of MECP2 leads to reduced dendritic arborization, decreased synapse formation, and impaired synaptic plasticity. Neurons have smaller cell bodies and reduced connectivity, particularly affecting inhibitory circuits.
"																																																								"{""description"": ""Loss of MECP2 leads to reduced dendritic arborization, decreased synapse formation, and impaired synaptic plasticity. Neurons have smaller cell bodies and reduced connectivity, particularly affecting inhibitory circuits.\n"", ""name"": ""Abnormal Neuronal Development""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Synaptic Transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Loss of MECP2 leads to reduced dendritic arborization, decreased synapse formation, and impaired synaptic plasticity. Neurons have smaller cell bodies and reduced connectivity, particularly affecting inhibitory circuits.\n"", ""evidence"": [{""explanation"": ""Review confirms MECP2 mutations cause the neurological dysfunction in Rett syndrome."", ""reference"": ""PMID:24615633"", ""snippet"": ""Rett syndrome (RTT) is a severe and progressive neurological disorder, which mainly affects young females. Mutations of the methyl-CpG binding protein 2 (MECP2) gene are the most prevalent cause of classical RTT cases."", ""supports"": ""SUPPORT""}], ""name"": ""Abnormal Neuronal Development""}"
6775	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	0	Autoimmune Response	The immune system mistakenly attacks the body's own tissues, particularly the synovial membrane lining the joints.																																																								"{""description"": ""The immune system mistakenly attacks the body's own tissues, particularly the synovial membrane lining the joints."", ""name"": ""Autoimmune Response""}"	{}	"{""cell_types"": [{""preferred_term"": ""Th17 Cell"", ""term"": {""id"": ""CL:0000899"", ""label"": ""T-helper 17 cell""}}], ""description"": ""The immune system mistakenly attacks the body's own tissues, particularly the synovial membrane lining the joints."", ""evidence"": [{""explanation"": ""This reference supports the statement that Th17 cells are involved in the autoimmune response in RA, particularly affecting the joints."", ""reference"": ""PMID:22608255"", ""snippet"": ""Rheumatoid arthritis (RA) is an autoimmune disease, characterized by chronic inflammation and synovial hyperplasia in the joints that ultimately lead to cartilage and bone destruction. A wealth of research has shown that CD4(+) T cells, especially IL-17 producing helper T (Th17) cells, play an important role in RA development."", ""supports"": ""SUPPORT""}, {""explanation"": ""The cited literature indicates that Th17 cells play a significant role in the autoimmune response and inflammation characteristic of RA."", ""reference"": ""PMID:30572135"", ""snippet"": ""These pro-inflammatory T-cells are also key players in autoimmunity and a pathogenic role has been demonstrated in several diseases such as rheumatoid arthritis or psoriasis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference corroborates that RA is an autoimmune disease affecting the synovium, aligning with the statement."", ""reference"": ""PMID:31895885"", ""snippet"": ""Rheumatoid arthritis (RA) is a prototypic autoimmune disease manifesting as chronic inflammation of the synovium and leading to acceleration of cardiovascular disease and shortening of life expectancy."", ""supports"": ""SUPPORT""}], ""name"": ""Autoimmune Response""}"
6776	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	1	Inflammatory Cytokine Production	Overproduction of inflammatory cytokines like TNF-, IL-1, and IL-6 leads to joint inflammation and damage.																																																								"{""description"": ""Overproduction of inflammatory cytokines like TNF-, IL-1, and IL-6 leads to joint inflammation and damage."", ""name"": ""Inflammatory Cytokine Production""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cytokine production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}], ""description"": ""Overproduction of inflammatory cytokines like TNF-, IL-1, and IL-6 leads to joint inflammation and damage."", ""evidence"": [{""explanation"": ""The abstract explicitly states that RA leads to progressive joint damage and inflammation, which aligns with the statement that overproduction of inflammatory cytokines leads to joint inflammation and damage."", ""reference"": ""PMID:9836373"", ""snippet"": ""Rheumatoid arthritis (RA) is well known to be a chronic autoimmune/inflammatory disease which leads to progressive joint damage and destruction."", ""supports"": ""SUPPORT""}, {""explanation"": ""IL-6 is mentioned as a key factor in the pathogenesis of RA, supporting the notion that overproduction of inflammatory cytokines like IL-6 contributes to RA."", ""reference"": ""PMID:34688020"", ""snippet"": ""This pleiotropic cytokine [IL-6] is a key factor in the pathogenesis of rheumatoid arthritis (RA) and is involved in many extra-articular manifestations that accompany the disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract clearly states that pro-inflammatory mediators direct the development of RA, which supports the statement about the role of cytokines like TNF-, IL-1, and IL-6 in joint inflammation and damage."", ""reference"": ""PMID:32830085"", ""snippet"": ""The pro-inflammatory mediators released via interaction of intracellular kinases direct the development of Rheumatoid arthritis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although focusing on IL-23/IL-17, the review also discusses other inflammatory cytokines such as IL-6 and TNF- and their role in RA, which supports the statement."", ""reference"": ""PMID:33692806"", ""snippet"": ""IL-23/IL-17 axis activation contributes to the development of several inflammatory diseases, such as ... Rheumatoid Arthritis."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""synovial membrane"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}], ""name"": ""Inflammatory Cytokine Production""}"
6777	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	2	Synovial Hyperplasia	The synovial membrane becomes thickened and inflamed, leading to the formation of pannus tissue that invades cartilage and bone.																																																								"{""description"": ""The synovial membrane becomes thickened and inflamed, leading to the formation of pannus tissue that invades cartilage and bone."", ""name"": ""Synovial Hyperplasia""}"	"{""downstream"": [{""description"": ""Synovial hyperplasia and pannus formation lead to progressive destruction of articular cartilage and bone."", ""evidence"": [{""explanation"": ""This paper establishes that synovial hyperplasia leads to pannus formation which directly causes cartilage and bone destruction in RA."", ""reference"": ""PMID:32071294"", ""snippet"": ""Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial hyperplasia, pannus formation, and cartilage and bone destruction."", ""supports"": ""SUPPORT""}], ""target"": ""Cartilage and Bone Destruction""}]}"	"{""cell_types"": [{""preferred_term"": ""Synoviocyte"", ""term"": {""id"": ""CL:0000214"", ""label"": ""synovial cell""}}, {""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""The synovial membrane becomes thickened and inflamed, leading to the formation of pannus tissue that invades cartilage and bone."", ""downstream"": [{""description"": ""Synovial hyperplasia and pannus formation lead to progressive destruction of articular cartilage and bone."", ""evidence"": [{""explanation"": ""This paper establishes that synovial hyperplasia leads to pannus formation which directly causes cartilage and bone destruction in RA."", ""reference"": ""PMID:32071294"", ""snippet"": ""Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial hyperplasia, pannus formation, and cartilage and bone destruction."", ""supports"": ""SUPPORT""}], ""target"": ""Cartilage and Bone Destruction""}], ""evidence"": [{""explanation"": ""The literature describes that fibroblast-like synoviocytes and macrophages play a key role in the inflammation and invasion of cartilage and bone in RA, supporting the statement."", ""reference"": ""PMID:15353290"", ""snippet"": ""Rheumatoid arthritis (RA) is a chronic inflammatory disease with progressive articular damage. Activated cells of the synovium produce pro-inflammatory and matrix-degrading effector molecules, which maintain the inflammation and lead to the destruction of the involved joints. In addition to macrophages and T- and B-cells, fibroblast-like synoviocytes must be considered key cells in driving the pathological processes. They can be distinguished by their transformed-appearing phenotype and their invasion into adjacent cartilage and bone."", ""supports"": ""SUPPORT""}, {""explanation"": ""This source confirms the role of synovial fibroblasts and macrophages in the inflammatory process associated with synovial hyperplasia in RA."", ""reference"": ""PMID:35958604"", ""snippet"": ""Synovial hyperplasia often presents when joints become inflamed due to immune cell infiltration. Synovial membrane... interact with synovial fibroblasts (SFs), T cells, B cells, and other inflammatory cells to promote the production of a variety of pro-inflammatory cytokines and chemokines, such as TNF-alpha, IL-1beta, IL-8, and IL-6, which are involved in the pathogenic process of inflammatory arthritis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The source supports the role of fibroblast-like synoviocytes in the hyperplasia of the synovium and formation of pannus tissue in RA."", ""reference"": ""PMID:29287304"", ""snippet"": ""Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by destructive hyperplasia of the synovium. Fibroblast-like synoviocytes (FLS) are a major component of synovial pannus and actively participate in the pathologic progression of RA."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""synovial membrane"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}], ""name"": ""Synovial Hyperplasia""}"
6778	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	3	Cartilage and Bone Destruction	Chronic inflammation and pannus formation lead to the erosion of articular cartilage and underlying bone.																																																								"{""description"": ""Chronic inflammation and pannus formation lead to the erosion of articular cartilage and underlying bone."", ""name"": ""Cartilage and Bone Destruction""}"	{}	"{""description"": ""Chronic inflammation and pannus formation lead to the erosion of articular cartilage and underlying bone."", ""evidence"": [{""reference"": ""PMID:28597065"", ""snippet"": ""Structural damage of cartilage and bone tissue is a hallmark of rheumatoid arthritis (RA). The resulting joint destruction constitutes one of the major disease consequences for patients... These factors result in an inflammatory milieu in the affected joints which leads to an increased development and function of osteoclasts."", ""supports"": ""SUPPORT""}, {""reference"": ""PMID:17634141"", ""snippet"": ""Chronic inflammatory arthritis not only leads to inflammatory bone loss but it also involves local erosion of articular bone. This osteo-destructive feature of chronic inflammatory arthritis is a major cause of disability in patients with rheumatoid arthritis."", ""supports"": ""SUPPORT""}, {""reference"": ""PMID:24217093"", ""snippet"": ""Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by joint swelling, joint tenderness and destruction of synovial joints, leading to severe disability."", ""supports"": ""SUPPORT""}, {""reference"": ""PMID:35273387"", ""snippet"": ""Rheumatoid arthritis can involve localized, periarticular bone erosion...The RANK-RANKL-osteoprotegerin axis and the Wnt-beta-catenin signalling pathway...have been implicated in inflammatory bone loss."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""synovial joint"", ""term"": {""id"": ""UBERON:0002217"", ""label"": ""synovial joint""}}, {""preferred_term"": ""articular cartilage"", ""term"": {""id"": ""UBERON:0003676"", ""label"": ""articular cartilage tissue""}}], ""name"": ""Cartilage and Bone Destruction""}"
6779	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	4	JAK/STAT Signaling	The JAK/STAT pathway serves as a central conduit for IL-6 and interferon signaling, driving both immune cell activation and stromal responses in synovium.																																		Targeted by JAK inhibitors in clinical practice																						"{""description"": ""The JAK/STAT pathway serves as a central conduit for IL-6 and interferon signaling, driving both immune cell activation and stromal responses in synovium."", ""name"": ""JAK/STAT Signaling"", ""notes"": ""Targeted by JAK inhibitors in clinical practice""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cytokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}, {""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""The JAK/STAT pathway serves as a central conduit for IL-6 and interferon signaling, driving both immune cell activation and stromal responses in synovium."", ""evidence"": [{""explanation"": ""This review demonstrates that JAK-STAT signaling is central to IL-6 mediated pathogenesis in rheumatoid arthritis, and that JAK inhibitors are clinically effective in treating RA by abrogating this signaling pathway."", ""reference"": ""PMID:35367240"", ""snippet"": ""the JAK-STAT pathway has been majorly implicated in RA disease progression upon IL-6 stimulation"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""synovial membrane"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}], ""name"": ""JAK/STAT Signaling"", ""notes"": ""Targeted by JAK inhibitors in clinical practice""}"
6780	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	5	NF-B Activation	NF-B transcriptional activation drives proinflammatory cytokine production and cell survival signals in immune and fibroblast cells.																																																								"{""description"": ""NF-B transcriptional activation drives proinflammatory cytokine production and cell survival signals in immune and fibroblast cells."", ""name"": ""NF-B Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}, {""preferred_term"": ""cytokine production"", ""term"": {""id"": ""GO:0001816"", ""label"": ""cytokine production""}}], ""cell_types"": [{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}, {""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""NF-B transcriptional activation drives proinflammatory cytokine production and cell survival signals in immune and fibroblast cells."", ""name"": ""NF-B Activation""}"
6781	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	6	Neutrophil Extracellular Trap Formation	Neutrophils release extracellular traps containing citrullinated histones and autoantigens via PAD4-mediated citrullination, amplifying autoimmunity.																																		NETs provide source of citrullinated antigens that serve as ACPA targets																						"{""description"": ""Neutrophils release extracellular traps containing citrullinated histones and autoantigens via PAD4-mediated citrullination, amplifying autoimmunity."", ""name"": ""Neutrophil Extracellular Trap Formation"", ""notes"": ""NETs provide source of citrullinated antigens that serve as ACPA targets""}"	{}	"{""biological_processes"": [{""preferred_term"": ""immune response"", ""term"": {""id"": ""GO:0006955"", ""label"": ""immune response""}}], ""cell_types"": [{""preferred_term"": ""Neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Neutrophils release extracellular traps containing citrullinated histones and autoantigens via PAD4-mediated citrullination, amplifying autoimmunity."", ""name"": ""Neutrophil Extracellular Trap Formation"", ""notes"": ""NETs provide source of citrullinated antigens that serve as ACPA targets""}"
6782	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	7	B Cell and Plasma Cell Responses	B cells and plasma cells generate autoantibodies (ACPA, RF) locally within synovium and at mucosal sites, forming ectopic lymphoid structures.																																		B cell-rich synovitis predicts better response to rituximab																						"{""description"": ""B cells and plasma cells generate autoantibodies (ACPA, RF) locally within synovium and at mucosal sites, forming ectopic lymphoid structures."", ""name"": ""B Cell and Plasma Cell Responses"", ""notes"": ""B cell-rich synovitis predicts better response to rituximab""}"	{}	"{""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}, {""preferred_term"": ""Plasma cell"", ""term"": {""id"": ""CL:0000786"", ""label"": ""plasma cell""}}], ""description"": ""B cells and plasma cells generate autoantibodies (ACPA, RF) locally within synovium and at mucosal sites, forming ectopic lymphoid structures."", ""locations"": [{""preferred_term"": ""synovial membrane"", ""term"": {""id"": ""UBERON:0002018"", ""label"": ""synovial membrane of synovial joint""}}], ""name"": ""B Cell and Plasma Cell Responses"", ""notes"": ""B cell-rich synovitis predicts better response to rituximab""}"
6783	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	8	Mucosal Origins and Dysbiosis	Aberrant immune activation in lung, oral, and gut mucosa precedes systemic autoimmunity, driven by dysbiosis, epithelial barrier dysfunction, and local citrullination.																																		Mucosal IgA autoantibodies can precede clinical arthritis; Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans implicated																						"{""description"": ""Aberrant immune activation in lung, oral, and gut mucosa precedes systemic autoimmunity, driven by dysbiosis, epithelial barrier dysfunction, and local citrullination."", ""name"": ""Mucosal Origins and Dysbiosis"", ""notes"": ""Mucosal IgA autoantibodies can precede clinical arthritis; Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans implicated""}"	{}	"{""description"": ""Aberrant immune activation in lung, oral, and gut mucosa precedes systemic autoimmunity, driven by dysbiosis, epithelial barrier dysfunction, and local citrullination."", ""locations"": [{""preferred_term"": ""respiratory system mucosa"", ""term"": {""id"": ""UBERON:0004785"", ""label"": ""respiratory system mucosa""}}, {""preferred_term"": ""oral mucosa"", ""term"": {""id"": ""UBERON:0003343"", ""label"": ""oral mucosa""}}, {""preferred_term"": ""intestinal mucosa"", ""term"": {""id"": ""UBERON:0001277"", ""label"": ""intestinal mucosa""}}], ""name"": ""Mucosal Origins and Dysbiosis"", ""notes"": ""Mucosal IgA autoantibodies can precede clinical arthritis; Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans implicated""}"
6811	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	0	RNU4ATAC Gene Mutation	Mutations in the RNU4ATAC gene result in defective minor spliceosomal RNAs, affecting normal cellular processes.																																																								"{""description"": ""Mutations in the RNU4ATAC gene result in defective minor spliceosomal RNAs, affecting normal cellular processes."", ""name"": ""RNU4ATAC Gene Mutation""}"	{}	"{""description"": ""Mutations in the RNU4ATAC gene result in defective minor spliceosomal RNAs, affecting normal cellular processes."", ""evidence"": [{""explanation"": ""The study confirms that mutations in the RNU4ATAC gene disrupt the minor spliceosome, leading to defective minor intron splicing, which aligns with the statement."", ""reference"": ""PMID:26522830"", ""snippet"": ""Roifman Syndrome is a rare congenital disorder characterized by growth retardation, cognitive delay, spondyloepiphyseal dysplasia and antibody deficiency. Here we utilize whole-genome sequencing of Roifman Syndrome patients to reveal compound heterozygous rare variants that disrupt highly conserved positions of the RNU4ATAC small nuclear RNA gene, a minor spliceosome component that is essential for minor intron splicing."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature confirms that mutations in the RNU4ATAC gene are associated with Roifman syndrome and disrupt the minor spliceosome, affecting cellular processes."", ""reference"": ""PMID:36802443"", ""snippet"": ""Its noncoding gene, RNU4ATAC, has been found mutated in Taybi-Linder (TALS/microcephalic osteodysplastic primordial dwarfism type 1), Roifman (RFMN), and Lowry-Wood (LWS) syndromes. These rare developmental disorders, whose physiopathological mechanisms remain unsolved, associate ante- and post-natal growth retardation, microcephaly, skeletal dysplasia, intellectual disability, retinal dystrophy, and immunodeficiency."", ""supports"": ""SUPPORT""}], ""name"": ""RNU4ATAC Gene Mutation""}"
6812	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	1	Decreased NK Cell Function																																																									"{""name"": ""Decreased NK Cell Function""}"	{}	"{""cell_types"": [{""preferred_term"": ""NK Cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}], ""evidence"": [{""explanation"": ""The study indicates that mutations associated with Hoffman syndrome, which is another syndromic immunodeficiency, result in decreased NK cell function. This supports the statement about Roifman syndrome having decreased NK cell function due to the similarity in the impact on NK cells."", ""reference"": ""PMID:35063500"", ""snippet"": ""We sought to determine whether disease-associated mutations in TOP2B impact NK-cell development and function. ... Mature NK cells were reduced in the periphery of TOP2B knockin mice consistent with patient reports, with reduced cytotoxicity toward target cell lines."", ""supports"": ""SUPPORT""}], ""name"": ""Decreased NK Cell Function""}"
6813	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	2	Decreased total and memory B cells																																																									"{""name"": ""Decreased total and memory B cells""}"	{}	"{""cell_types"": [{""preferred_term"": ""Memory B cell"", ""term"": {""id"": ""CL:0000787"", ""label"": ""memory B cell""}}], ""evidence"": [{""explanation"": ""The study confirms a dramatic reduction in total B-cell numbers in Roifman syndrome patients but does not specifically mention memory B cells."", ""reference"": ""PMID:29391254"", ""snippet"": ""The patients exhibited a dramatic reduction in B-cell numbers, with differentiation halted at the transitional B-cell stage."", ""supports"": ""PARTIAL""}], ""name"": ""Decreased total and memory B cells""}"
6814	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	3	Hypogammaglobulinemia																																																									"{""name"": ""Hypogammaglobulinemia""}"	{}	"{""evidence"": [{""explanation"": ""The abstract mentions that Roifman syndrome is an immunodeficiency, which implies hypogammaglobulinemia."", ""reference"": ""PMID:35450878"", ""snippet"": ""Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency."", ""supports"": ""SUPPORT""}, {""explanation"": ""Roifman syndrome is a type of primary immunodeficiency, which is often associated with hypogammaglobulinemia."", ""reference"": ""PMID:32017208"", ""snippet"": ""Primary B-cell immunodeficiency is the most frequent immune defect in infancy."", ""supports"": ""SUPPORT""}], ""name"": ""Hypogammaglobulinemia""}"
6829	292	SADDAN	SADDAN.yaml	pathophysiology	0	FGFR3 p.Lys650Met mutation	"A single missense mutation at codon 650 (p.Lys650Met) in FGFR3 causes SADDAN.
"																																																								"{""description"": ""A single missense mutation at codon 650 (p.Lys650Met) in FGFR3 causes SADDAN.\n"", ""name"": ""FGFR3 p.Lys650Met mutation""}"	"{""downstream"": [{""description"": ""Lys650Met increases receptor tyrosine kinase activity."", ""target"": ""Constitutive FGFR3 kinase activity""}]}"	"{""description"": ""A single missense mutation at codon 650 (p.Lys650Met) in FGFR3 causes SADDAN.\n"", ""downstream"": [{""description"": ""Lys650Met increases receptor tyrosine kinase activity."", ""target"": ""Constitutive FGFR3 kinase activity""}], ""evidence"": [{""explanation"": ""The abstract states SADDAN is caused by the FGFR3 p.Lys650Met mutation."", ""reference"": ""PMID:24352917"", ""snippet"": ""The disorder is the result of a single missense mutation at codon 650 (p.Lys650Met) in the fibroblast growth factor receptor 3 gene (FGFR3)."", ""supports"": ""SUPPORT""}], ""gene"": {""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}, ""name"": ""FGFR3 p.Lys650Met mutation""}"
6830	292	SADDAN	SADDAN.yaml	pathophysiology	1	Constitutive FGFR3 kinase activity	"The Lys650Met mutation causes increased constitutive FGFR3 kinase activity.
"																																																								"{""description"": ""The Lys650Met mutation causes increased constitutive FGFR3 kinase activity.\n"", ""name"": ""Constitutive FGFR3 kinase activity""}"	"{""downstream"": [{""description"": ""Constitutive FGFR3 activity disrupts endochondral bone growth."", ""target"": ""Severe disturbances in endochondral bone growth""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""protein tyrosine kinase activity"", ""term"": {""id"": ""GO:0004713"", ""label"": ""protein tyrosine kinase activity""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""fibroblast growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}], ""description"": ""The Lys650Met mutation causes increased constitutive FGFR3 kinase activity.\n"", ""downstream"": [{""description"": ""Constitutive FGFR3 activity disrupts endochondral bone growth."", ""target"": ""Severe disturbances in endochondral bone growth""}], ""evidence"": [{""explanation"": ""Functional studies show Lys650Met increases constitutive FGFR3 kinase activity."", ""reference"": ""PMID:10053006"", ""snippet"": ""Transient transfection studies with FGFR3 mutant constructs show that the Lys650Met mutation causes a dramatic increase in constitutive receptor kinase activity, approximately three times greater than that observed with the Lys650Glu mutation."", ""supports"": ""SUPPORT""}], ""gene"": {""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}, ""name"": ""Constitutive FGFR3 kinase activity""}"
6831	292	SADDAN	SADDAN.yaml	pathophysiology	2	Severe disturbances in endochondral bone growth	"The Lys650Met mutation results in severe disturbances in endochondral bone growth.
"																																																								"{""description"": ""The Lys650Met mutation results in severe disturbances in endochondral bone growth.\n"", ""name"": ""Severe disturbances in endochondral bone growth""}"	{}	"{""cell_types"": [{""preferred_term"": ""Growth plate chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}], ""description"": ""The Lys650Met mutation results in severe disturbances in endochondral bone growth.\n"", ""evidence"": [{""explanation"": ""The abstract links Lys650Met to severe disturbances in endochondral bone growth."", ""reference"": ""PMID:10377013"", ""snippet"": ""The FGFR3 Lys650Met mutation results in severe disturbances in endochondral bone growth that approach and overlap those observed in thanatophoric dysplasia, type I."", ""supports"": ""SUPPORT""}], ""name"": ""Severe disturbances in endochondral bone growth""}"
6851	293	Salla Disease	Salla_Disease.yaml	pathophysiology	0	SLC17A5 Gene Mutation	Biallelic pathogenic variants in SLC17A5 disrupt the coding or regulatory regions necessary for sialin protein function. The c.115C>T (p.Arg39Cys) Finnish founder mutation is the most common variant in Salla disease.																																																								"{""description"": ""Biallelic pathogenic variants in SLC17A5 disrupt the coding or regulatory regions necessary for sialin protein function. The c.115C>T (p.Arg39Cys) Finnish founder mutation is the most common variant in Salla disease."", ""name"": ""SLC17A5 Gene Mutation""}"	{}	"{""description"": ""Biallelic pathogenic variants in SLC17A5 disrupt the coding or regulatory regions necessary for sialin protein function. The c.115C>T (p.Arg39Cys) Finnish founder mutation is the most common variant in Salla disease."", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Study of patient-derived cells confirms c.115C>T as founder variant and demonstrates pathogenicity through CRISPR approaches."", ""reference"": ""PMID:37727271"", ""snippet"": ""Here, we evaluated the efficacy of CRISPR-Cas9-mediated homology directed repair (HDR) and adenine base editing (ABE) targeting the founder variant, SLC17A5 c.115C>T (p.Arg39Cys)"", ""supports"": ""SUPPORT""}], ""gene"": {""preferred_term"": ""SLC17A5"", ""term"": {""id"": ""hgnc:10933"", ""label"": ""SLC17A5""}}, ""name"": ""SLC17A5 Gene Mutation""}"
6852	293	Salla Disease	Salla_Disease.yaml	pathophysiology	1	Loss of Sialin Protein Function	SLC17A5 mutations result in loss or substantial reduction of sialin protein expression or function. Sialin is a 12-transmembrane transporter required for proton-coupled export of free sialic acid (Neu5Ac) from lysosomes to cytosol. Mutations can occur as de novo, inherited biallelic variants, or in mosaic patterns affecting specific tissues.																																																								"{""description"": ""SLC17A5 mutations result in loss or substantial reduction of sialin protein expression or function. Sialin is a 12-transmembrane transporter required for proton-coupled export of free sialic acid (Neu5Ac) from lysosomes to cytosol. Mutations can occur as de novo, inherited biallelic variants, or in mosaic patterns affecting specific tissues."", ""name"": ""Loss of Sialin Protein Function""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""Sialic acid transport"", ""term"": {""id"": ""GO:0015739"", ""label"": ""sialic acid transport""}}], ""description"": ""SLC17A5 mutations result in loss or substantial reduction of sialin protein expression or function. Sialin is a 12-transmembrane transporter required for proton-coupled export of free sialic acid (Neu5Ac) from lysosomes to cytosol. Mutations can occur as de novo, inherited biallelic variants, or in mosaic patterns affecting specific tissues."", ""evidence"": [{""evidence_source"": ""IN_VITRO"", ""explanation"": ""2023 Science Advances cryo-EM structure and functional assays demonstrate molecular mechanism of sialin transport and mutation effects."", ""reference"": ""DOI:10.1126/sciadv.ade8346"", ""snippet"": ""Our analysis reveals two unique features in Sialin: (i) The H+ coupling/sensing requires two highly conserved Glu residues (E171 and E175) instead of one"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""IN_VITRO"", ""explanation"": ""2025 study demonstrates pathogenicity of SLC17A5 variants including tissue-specific mosaic mutations causing atypical FSASD presentations."", ""reference"": ""PMID:39742826"", ""snippet"": ""Functional studies, including SLC17A5 knockout cells and transient transfections of mutated SLC17A5 demonstrated pathogenicity of the identified variants."", ""supports"": ""SUPPORT""}], ""name"": ""Loss of Sialin Protein Function""}"
6853	293	Salla Disease	Salla_Disease.yaml	pathophysiology	2	Lysosomal Free Sialic Acid Accumulation	Loss of sialin function impairs export of free N-acetylneuraminic acid (Neu5Ac) from lysosomes. Neu5Ac accumulates in lysosomes, leading to lysosomal enlargement, dysfunction, and cellular stress. This is the hallmark biochemical feature of FSASD including Salla disease. Cellular imaging shows prominent cytoplasmic vacuolation in fibroblasts from affected individuals.																																																								"{""description"": ""Loss of sialin function impairs export of free N-acetylneuraminic acid (Neu5Ac) from lysosomes. Neu5Ac accumulates in lysosomes, leading to lysosomal enlargement, dysfunction, and cellular stress. This is the hallmark biochemical feature of FSASD including Salla disease. Cellular imaging shows prominent cytoplasmic vacuolation in fibroblasts from affected individuals."", ""name"": ""Lysosomal Free Sialic Acid Accumulation""}"	{}	"{""description"": ""Loss of sialin function impairs export of free N-acetylneuraminic acid (Neu5Ac) from lysosomes. Neu5Ac accumulates in lysosomes, leading to lysosomal enlargement, dysfunction, and cellular stress. This is the hallmark biochemical feature of FSASD including Salla disease. Cellular imaging shows prominent cytoplasmic vacuolation in fibroblasts from affected individuals."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Diagnostic study demonstrates profound accumulation of free sialic acid in FSASD patients, confirming primary biochemical defect."", ""reference"": ""PMID:40529477"", ""snippet"": ""Individuals with FSASD exhibited significantly higher levels of free Neu5Ac compared to their unaffected biological parents (36-fold), LSD-negative subjects (22-fold), and individuals with other LSDs (49-fold)."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""IN_VITRO"", ""explanation"": ""2024 soft X-ray spectromicroscopy study demonstrates cellular vacuolation and lysosomal dysfunction in Salla disease fibroblasts."", ""reference"": ""PMID:39257666"", ""snippet"": ""Both cell lines were also cultured with N-acetyl-d-mannosamine monohydrate (ManNAc) to see if it increased SA concentration in the cells. The STXM technique was chosen to simultaneously observe the morphological and chemical changes in cells. It was observed that free SA did not remain in the lysosomes during the sample processing, leaving empty vacuoles to the fibroblasts."", ""supports"": ""SUPPORT""}], ""name"": ""Lysosomal Free Sialic Acid Accumulation""}"
6854	293	Salla Disease	Salla_Disease.yaml	pathophysiology	3	Glycosphingolipid Metabolic Dysregulation	Impaired sialic acid export triggers secondary alterations in glycosphingolipid (GSL) metabolism in neural cells. Elevated lysosomal glycohydrolase activities and altered GSL composition observed in patient-derived iPSC neural models and in CSF and plasma of patients. Mature astrocytes show the most pronounced alterations.																																																								"{""description"": ""Impaired sialic acid export triggers secondary alterations in glycosphingolipid (GSL) metabolism in neural cells. Elevated lysosomal glycohydrolase activities and altered GSL composition observed in patient-derived iPSC neural models and in CSF and plasma of patients. Mature astrocytes show the most pronounced alterations."", ""name"": ""Glycosphingolipid Metabolic Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Glycosphingolipid metabolic process"", ""term"": {""id"": ""GO:0006687"", ""label"": ""glycosphingolipid metabolic process""}}, {""preferred_term"": ""Myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}], ""cell_types"": [{""preferred_term"": ""Oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}, {""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}, {""preferred_term"": ""Astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Impaired sialic acid export triggers secondary alterations in glycosphingolipid (GSL) metabolism in neural cells. Elevated lysosomal glycohydrolase activities and altered GSL composition observed in patient-derived iPSC neural models and in CSF and plasma of patients. Mature astrocytes show the most pronounced alterations."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Study of CSF and plasma in FSASD patients demonstrates dysregulated GSL metabolism with elevated gangliosides, supporting alterations in pathogenesis."", ""reference"": ""PMID:39991440"", ""snippet"": ""In CSF, total GSLs, GM1a, GM3, GD3, GD1a, and GD1b were significantly elevated compared to comparison samples. These results reveal dysregulated GSL metabolism and suggest the potential of gangliosides as biomarkers."", ""supports"": ""SUPPORT""}], ""name"": ""Glycosphingolipid Metabolic Dysregulation""}"
6855	293	Salla Disease	Salla_Disease.yaml	pathophysiology	4	Oligodendroglial Dysfunction and Hypomyelination	Oligodendrocytes vulnerable to sialic acid accumulation and GSL dysregulation. This leads to impaired myelin formation and white matter hypomyelination, reflected in corpus callosum hypoplasia and white matter abnormalities on MRI.																																																								"{""description"": ""Oligodendrocytes vulnerable to sialic acid accumulation and GSL dysregulation. This leads to impaired myelin formation and white matter hypomyelination, reflected in corpus callosum hypoplasia and white matter abnormalities on MRI."", ""name"": ""Oligodendroglial Dysfunction and Hypomyelination""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}, {""preferred_term"": ""CNS myelination"", ""term"": {""id"": ""GO:0022010"", ""label"": ""central nervous system myelination""}}], ""cell_types"": [{""preferred_term"": ""Oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}], ""description"": ""Oligodendrocytes vulnerable to sialic acid accumulation and GSL dysregulation. This leads to impaired myelin formation and white matter hypomyelination, reflected in corpus callosum hypoplasia and white matter abnormalities on MRI."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""iPSC disease modeling confirms oligodendroglial involvement and differential cell-type vulnerability in FSASD."", ""reference"": ""DOI:10.1038/s41598-025-12682-4"", ""snippet"": ""Oligodendroglia in FSASD pathogenesis is established, the roles of other neural cell types remain elusive."", ""supports"": ""SUPPORT""}], ""name"": ""Oligodendroglial Dysfunction and Hypomyelination""}"
6856	293	Salla Disease	Salla_Disease.yaml	pathophysiology	5	Neuronal Dysfunction and Neurodegeneration	Neurons accumulate free sialic acid and display altered GSL composition. Biochemical changes contribute to progressive neurodegeneration, manifesting as developmental delay, cognitive impairment, and progressive neurological regression.																																																								"{""description"": ""Neurons accumulate free sialic acid and display altered GSL composition. Biochemical changes contribute to progressive neurodegeneration, manifesting as developmental delay, cognitive impairment, and progressive neurological regression."", ""name"": ""Neuronal Dysfunction and Neurodegeneration""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Glycosphingolipid metabolic process"", ""term"": {""id"": ""GO:0006687"", ""label"": ""glycosphingolipid metabolic process""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Neurons accumulate free sialic acid and display altered GSL composition. Biochemical changes contribute to progressive neurodegeneration, manifesting as developmental delay, cognitive impairment, and progressive neurological regression."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Longitudinal study documents progressive neurodegeneration from infancy through adolescence in intermediate-severe Salla disease."", ""reference"": ""PMID:37713976"", ""snippet"": ""Disease onset occurred within the first six months of life in both patients. Early childhood development was delayed with achievement of some milestones followed by a developmental plateau in late childhood. After this, both patients began a slow and progressive neurological regression in adolescence."", ""supports"": ""SUPPORT""}], ""name"": ""Neuronal Dysfunction and Neurodegeneration""}"
6885	294	Sarcoidosis	Sarcoidosis.yaml	pathophysiology	0	Granuloma Formation	"Non-caseating granulomas consist of organized collections of activated macrophages (epithelioid cells), multinucleated giant cells, and CD4+ T cells. Th1/Th17 immune responses drive granuloma development in response to unidentified antigens.
"																																																								"{""description"": ""Non-caseating granulomas consist of organized collections of activated macrophages (epithelioid cells), multinucleated giant cells, and CD4+ T cells. Th1/Th17 immune responses drive granuloma development in response to unidentified antigens.\n"", ""name"": ""Granuloma Formation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""granuloma formation"", ""term"": {""id"": ""GO:0002432"", ""label"": ""granuloma formation""}}], ""cell_types"": [{""preferred_term"": ""epithelioid macrophage"", ""term"": {""id"": ""CL:0002150"", ""label"": ""epithelioid macrophage""}}, {""preferred_term"": ""CD4-positive helper T cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}], ""description"": ""Non-caseating granulomas consist of organized collections of activated macrophages (epithelioid cells), multinucleated giant cells, and CD4+ T cells. Th1/Th17 immune responses drive granuloma development in response to unidentified antigens.\n"", ""evidence"": [{""explanation"": ""This review confirms the characteristic non-caseating granuloma formation in sarcoidosis."", ""reference"": ""PMID:35011621"", ""snippet"": ""Sarcoidosis is a chameleon disease of unknown etiology, characterized by the growth of non-necrotizing and non-caseating granulomas"", ""supports"": ""SUPPORT""}], ""name"": ""Granuloma Formation""}"
6886	294	Sarcoidosis	Sarcoidosis.yaml	pathophysiology	1	Dysregulated Immune Response	"Exaggerated CD4+ T helper cell response with Th1 polarization leads to interferon-gamma and TNF-alpha production. Regulatory T cell dysfunction contributes to persistent inflammation. Paradoxical peripheral anergy coexists with organ-specific hyperactivity.
"																																																								"{""description"": ""Exaggerated CD4+ T helper cell response with Th1 polarization leads to interferon-gamma and TNF-alpha production. Regulatory T cell dysfunction contributes to persistent inflammation. Paradoxical peripheral anergy coexists with organ-specific hyperactivity.\n"", ""name"": ""Dysregulated Immune Response""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""CD4-positive helper T cell"", ""term"": {""id"": ""CL:0000492"", ""label"": ""CD4-positive helper T cell""}}], ""description"": ""Exaggerated CD4+ T helper cell response with Th1 polarization leads to interferon-gamma and TNF-alpha production. Regulatory T cell dysfunction contributes to persistent inflammation. Paradoxical peripheral anergy coexists with organ-specific hyperactivity.\n"", ""evidence"": [{""explanation"": ""Review describes the multisystem inflammatory nature of sarcoidosis affecting multiple organs."", ""reference"": ""PMID:35011621"", ""snippet"": ""Lungs and intrathoracic lymph nodes are the sites that are most often involved, but virtually no organ is spared from this disease."", ""supports"": ""SUPPORT""}], ""name"": ""Dysregulated Immune Response""}"
6887	294	Sarcoidosis	Sarcoidosis.yaml	pathophysiology	2	Fibrosis	"Chronic granulomatous inflammation can progress to fibrosis, particularly in the lungs. Fibroblast activation and excessive collagen deposition lead to irreversible organ damage and functional impairment.
"																																																								"{""description"": ""Chronic granulomatous inflammation can progress to fibrosis, particularly in the lungs. Fibroblast activation and excessive collagen deposition lead to irreversible organ damage and functional impairment.\n"", ""name"": ""Fibrosis""}"	{}	"{""description"": ""Chronic granulomatous inflammation can progress to fibrosis, particularly in the lungs. Fibroblast activation and excessive collagen deposition lead to irreversible organ damage and functional impairment.\n"", ""name"": ""Fibrosis""}"
6898	295	Scabies	Scabies.yaml	pathophysiology	0	Mite infestation of the skin	Mites infest the skin leading to inflammatory lesions.																																																								"{""description"": ""Mites infest the skin leading to inflammatory lesions."", ""name"": ""Mite infestation of the skin""}"	{}	"{""description"": ""Mites infest the skin leading to inflammatory lesions."", ""evidence"": [{""explanation"": ""The abstract describes scabies as a skin infestation by S. scabiei."", ""reference"": ""PMID:30755943"", ""snippet"": ""Scabies is an infestation of the skin by the mite Sarcoptes scabiei."", ""supports"": ""SUPPORT""}], ""name"": ""Mite infestation of the skin""}"
6904	296	Schistosomiasis	Schistosomiasis.yaml	pathophysiology	0	Adult worm residence in mesenteric or pelvic veins	Adult schistosomes inhabit mesenteric or pelvic veins, enabling egg deposition into stool or urine.																																																								"{""description"": ""Adult schistosomes inhabit mesenteric or pelvic veins, enabling egg deposition into stool or urine."", ""name"": ""Adult worm residence in mesenteric or pelvic veins""}"	{}	"{""description"": ""Adult schistosomes inhabit mesenteric or pelvic veins, enabling egg deposition into stool or urine."", ""evidence"": [{""explanation"": ""The abstract localizes adult worms to mesenteric or pelvic venous beds."", ""reference"": ""PMID:30093684"", ""snippet"": ""Mature adult worms reside in the mesenteric (Schistosoma mansoni and Schistosoma japonicum) or pelvic (Schistosoma haematobium) veins"", ""supports"": ""SUPPORT""}], ""name"": ""Adult worm residence in mesenteric or pelvic veins""}"
6905	296	Schistosomiasis	Schistosomiasis.yaml	pathophysiology	1	Egg trapping triggers granulomatous inflammation	Eggs lodged in tissues such as the liver or bladder provoke granulomatous inflammatory responses.																																																								"{""description"": ""Eggs lodged in tissues such as the liver or bladder provoke granulomatous inflammatory responses."", ""name"": ""Egg trapping triggers granulomatous inflammation""}"	{}	"{""description"": ""Eggs lodged in tissues such as the liver or bladder provoke granulomatous inflammatory responses."", ""evidence"": [{""explanation"": ""Trapped eggs drive inflammatory granulomas in liver and bladder tissue."", ""reference"": ""PMID:30093684"", ""snippet"": ""Eggs trapped in the surrounding tissues and organs, such as the liver and bladder, cause inflammatory immune responses (including granulomas)"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}, {""preferred_term"": ""urinary bladder"", ""term"": {""id"": ""UBERON:0001255"", ""label"": ""urinary bladder""}}], ""name"": ""Egg trapping triggers granulomatous inflammation""}"
6906	296	Schistosomiasis	Schistosomiasis.yaml	pathophysiology	2	Periportal fibrosis with portal hypertension	Chronic egg-driven inflammation promotes periportal fibrosis and portal hypertension.																																																								"{""description"": ""Chronic egg-driven inflammation promotes periportal fibrosis and portal hypertension."", ""name"": ""Periportal fibrosis with portal hypertension""}"	{}	"{""description"": ""Chronic egg-driven inflammation promotes periportal fibrosis and portal hypertension."", ""evidence"": [{""explanation"": ""The review links egg-induced pathology to periportal fibrosis and portal hypertension."", ""reference"": ""PMID:24698483"", ""snippet"": ""periportal fibrosis with portal hypertension"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Periportal fibrosis with portal hypertension""}"
6907	296	Schistosomiasis	Schistosomiasis.yaml	pathophysiology	3	Urogenital inflammation and scarring	Egg-induced immune responses cause urogenital inflammation and tissue scarring.																																																								"{""description"": ""Egg-induced immune responses cause urogenital inflammation and tissue scarring."", ""name"": ""Urogenital inflammation and scarring""}"	{}	"{""description"": ""Egg-induced immune responses cause urogenital inflammation and tissue scarring."", ""evidence"": [{""explanation"": ""The abstract lists urogenital inflammation and scarring as organ-specific effects."", ""reference"": ""PMID:24698483"", ""snippet"": ""urogenital inflammation and scarring"", ""supports"": ""SUPPORT""}], ""name"": ""Urogenital inflammation and scarring""}"
6927	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	0	Dysregulation of Dopamine Neurotransmission	Imbalance in dopamine transmission in the brain, particularly in the mesolimbic and mesocortical pathways.																																																								"{""description"": ""Imbalance in dopamine transmission in the brain, particularly in the mesolimbic and mesocortical pathways."", ""name"": ""Dysregulation of Dopamine Neurotransmission""}"	"{""downstream"": [{""description"": ""Striatal dopamine dysregulation causes abnormal salience attribution resulting in psychotic symptoms."", ""evidence"": [{""explanation"": ""This 2022 review describes how dopamine dysregulation in the striatum creates abnormal salience attribution which directly results in the psychotic symptoms characteristic of schizophrenia."", ""reference"": ""PMID:35390609"", ""snippet"": ""Striatal dopamine dysregulation follows, causing abnormal salience and resultant psychotic symptoms."", ""supports"": ""SUPPORT""}], ""target"": ""Psychotic Symptoms""}], ""synonyms"": [""Dopamine Hypothesis""]}"	"{""biological_processes"": [{""preferred_term"": ""dopamine secretion"", ""term"": {""id"": ""GO:0014046"", ""label"": ""dopamine secretion""}}], ""description"": ""Imbalance in dopamine transmission in the brain, particularly in the mesolimbic and mesocortical pathways."", ""downstream"": [{""description"": ""Striatal dopamine dysregulation causes abnormal salience attribution resulting in psychotic symptoms."", ""evidence"": [{""explanation"": ""This 2022 review describes how dopamine dysregulation in the striatum creates abnormal salience attribution which directly results in the psychotic symptoms characteristic of schizophrenia."", ""reference"": ""PMID:35390609"", ""snippet"": ""Striatal dopamine dysregulation follows, causing abnormal salience and resultant psychotic symptoms."", ""supports"": ""SUPPORT""}], ""target"": ""Psychotic Symptoms""}], ""evidence"": [{""explanation"": ""While the literature supports dopamine dysregulation in various brain regions, it does not specifically emphasize the mesolimbic and mesocortical pathways alone."", ""reference"": ""PMID:27206569"", ""snippet"": ""Findings have converged to suggest early dysregulation in the striatum, especially in the rostral caudate, manifesting as excess synthesis and release. Recent data showed deficit extending to most cortical regions and even to other extrastriatal subcortical regions not previously considered to be 'hypodopaminergic' in schizophrenia."", ""supports"": ""PARTIAL""}, {""explanation"": ""The abstract does not provide specific information supporting the imbalance of dopamine transmission specifically in the mesolimbic and mesocortical pathways as described in the statement."", ""reference"": ""PMID:24986384"", ""snippet"": ""A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic)."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""The study focuses on glutamate dysregulation rather than dopamine transmission dysregulation in mesolimbic and mesocortical pathways."", ""reference"": ""PMID:1981107"", ""snippet"": ""This article discusses the possibility that a deficient activity within the cortico-striatal glutamatergic pathway is an important pathophysiological component in some cases of schizophrenia and that glutamatergic agonists may prove beneficial in this disorder."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""There is an implication of dopamine dysregulation, but the specifics of mesolimbic and mesocortical pathways are not confirmed."", ""reference"": ""PMID:24128684"", ""snippet"": ""This clinical picture is generally associated with supersensitivity to dopamine, and activates dopamine neurotransmission that is usually alleviated or blocked by drugs that block dopamine D2 receptors."", ""supports"": ""PARTIAL""}], ""locations"": [{""preferred_term"": ""striatum""}], ""name"": ""Dysregulation of Dopamine Neurotransmission"", ""synonyms"": [""Dopamine Hypothesis""]}"
6928	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	1	Abnormality of Glutamergic Signaling	Dysfunction in glutamate neurotransmission, impacting synaptic plasticity and brain circuit function.																																																								"{""description"": ""Dysfunction in glutamate neurotransmission, impacting synaptic plasticity and brain circuit function."", ""name"": ""Abnormality of Glutamergic Signaling""}"	"{""synonyms"": [""Glutamate Hypothesis""]}"	"{""biological_processes"": [{""preferred_term"": ""synaptic transmission, glutamatergic"", ""term"": {""id"": ""GO:0035249"", ""label"": ""synaptic transmission, glutamatergic""}}], ""cell_types"": [{""description"": ""NMDA hypofunction on parvalbumin interneurons leads to cortical disinhibition."", ""preferred_term"": ""parvalbumin-positive interneuron"", ""term"": {""id"": ""CL:0000099"", ""label"": ""interneuron""}}], ""description"": ""Dysfunction in glutamate neurotransmission, impacting synaptic plasticity and brain circuit function."", ""evidence"": [{""explanation"": ""The literature specifically states that glutamatergic neurotransmission dysfunction is associated with the pathophysiology of schizophrenia, supporting the provided statement."", ""reference"": ""PMID:11532718"", ""snippet"": ""Research has implicated dysfunction of glutamatergic neurotransmission in the pathophysiology of schizophrenia."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature discusses the impairment of synaptic plasticity in schizophrenia and its interaction with brain maturation, aligning with the statement."", ""reference"": ""PMID:28754595"", ""snippet"": ""Accumulating evidence suggests that synaptic plasticity is impaired in schizophrenia. Given the role of synaptic plasticity in learning, memory, and neural circuit maturation, impaired plasticity may underlie many features of the schizophrenia syndrome."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the involvement of glutamatergic systems in schizophrenia, reinforcing the statement."", ""reference"": ""PMID:29954475"", ""snippet"": ""Psychosis is now widely hypothesized to involve neural networks beyond the classical dopaminergic mesolimbic pathway, including serotonin and glutamate systems as well."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature supports the idea that schizophrenia impacts synaptic transmission and plasticity, specifically implicating glutamatergic, GABAergic, dopaminergic, and cholinergic synapses."", ""reference"": ""PMID:22351070"", ""snippet"": ""Schizophrenia is believed to result from problems during neural development that lead to improper function of synaptic transmission and plasticity, and in agreement, many of the susceptibility genes encode proteins critical for neural development."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""prefrontal cortex"", ""term"": {""id"": ""UBERON:0000451"", ""label"": ""prefrontal cortex""}}, {""preferred_term"": ""hippocampus"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}], ""name"": ""Abnormality of Glutamergic Signaling"", ""synonyms"": [""Glutamate Hypothesis""]}"
6929	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	2	Abnormality of GABAergic Signaling	Dysfunction in GABAergic inhibitory neurotransmission, contributing to excitatory/inhibitory (E/I) imbalance in cortical circuits.																																																								"{""description"": ""Dysfunction in GABAergic inhibitory neurotransmission, contributing to excitatory/inhibitory (E/I) imbalance in cortical circuits."", ""name"": ""Abnormality of GABAergic Signaling""}"	"{""synonyms"": [""GABAergic Dysfunction""]}"	"{""biological_processes"": [{""preferred_term"": ""synaptic transmission, GABAergic"", ""term"": {""id"": ""GO:0051932"", ""label"": ""synaptic transmission, GABAergic""}}], ""cell_types"": [{""description"": ""Parvalbumin-positive GABAergic interneurons show reduced function, leading to cortical disinhibition."", ""preferred_term"": ""parvalbumin-positive interneuron"", ""term"": {""id"": ""CL:0000099"", ""label"": ""interneuron""}}], ""description"": ""Dysfunction in GABAergic inhibitory neurotransmission, contributing to excitatory/inhibitory (E/I) imbalance in cortical circuits."", ""evidence"": [{""explanation"": ""The literature highlights that GABAergic interneurons play a significant role in the cellular characteristics found in psychotic states, including schizophrenia."", ""reference"": ""PMID:10372507"", ""snippet"": ""At the cellular level, gamma-aminobutyric acid (GABA)-ergic interneurons are a common feature in psychotic states... and are themselves synchronised by the ascending dopamine and serotonin innervations."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference directly states that disturbances in GABAergic neurotransmission may underlie the pathophysiology of schizophrenia."", ""reference"": ""PMID:22308256"", ""snippet"": ""Disturbances in glutamate and GABAergic neurotransmission may underlie the pathophysiology of schizophrenia."", ""supports"": ""SUPPORT""}, {""explanation"": ""This meta-analysis supports the idea that reduced GABA levels and thus GABAergic dysfunction are related to the pathophysiology of schizophrenia."", ""reference"": ""PMID:34584230"", ""snippet"": ""Reduced GABA levels indicate that the disruption of excitatory/inhibitory balance may be related to the pathophysiology of schizophrenia-spectrum disorders."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abnormalities in GABAergic receptors in schizophrenia support the idea of GABAergic signaling abnormalities being part of the disorders pathophysiology."", ""reference"": ""PMID:25432637"", ""snippet"": ""Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain. GABAergic receptor abnormalities have been documented in several major psychiatric disorders including schizophrenia."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article reviews evidence for altered GABAergic neurotransmission in schizophrenia, supporting the stated claim."", ""reference"": ""PMID:22351070"", ""snippet"": ""Here, we will review evidence for altered neurotransmission at ... GABAergic ... synapses in schizophrenia..."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""prefrontal cortex"", ""term"": {""id"": ""UBERON:0000451"", ""label"": ""prefrontal cortex""}}], ""name"": ""Abnormality of GABAergic Signaling"", ""synonyms"": [""GABAergic Dysfunction""]}"
6930	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	3	Complement-Mediated Excessive Synaptic Pruning	Excessive elimination of synapses by microglia via complement component C4A and CR3 pathways during adolescent brain development.																																																								"{""description"": ""Excessive elimination of synapses by microglia via complement component C4A and CR3 pathways during adolescent brain development."", ""name"": ""Complement-Mediated Excessive Synaptic Pruning""}"	{}	"{""biological_processes"": [{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}, {""preferred_term"": ""synapse pruning"", ""term"": {""id"": ""GO:0098883"", ""label"": ""synapse pruning""}}], ""cell_types"": [{""description"": ""Microglia eliminate synapses tagged by complement components during critical developmental periods."", ""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Excessive elimination of synapses by microglia via complement component C4A and CR3 pathways during adolescent brain development."", ""locations"": [{""preferred_term"": ""prefrontal cortex"", ""term"": {""id"": ""UBERON:0000451"", ""label"": ""prefrontal cortex""}}, {""preferred_term"": ""hippocampus"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}], ""name"": ""Complement-Mediated Excessive Synaptic Pruning""}"
6931	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	4	Oligodendrocyte and Myelin Dysfunction	Abnormalities in oligodendrocytes and myelin sheaths leading to white matter changes and network dysconnectivity across brain regions.																																																								"{""description"": ""Abnormalities in oligodendrocytes and myelin sheaths leading to white matter changes and network dysconnectivity across brain regions."", ""name"": ""Oligodendrocyte and Myelin Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""myelination"", ""term"": {""id"": ""GO:0042552"", ""label"": ""myelination""}}], ""cell_types"": [{""description"": ""Oligodendrocyte dysfunction contributes to impaired myelination and dysconnectivity."", ""preferred_term"": ""oligodendrocyte"", ""term"": {""id"": ""CL:0000128"", ""label"": ""oligodendrocyte""}}], ""description"": ""Abnormalities in oligodendrocytes and myelin sheaths leading to white matter changes and network dysconnectivity across brain regions."", ""locations"": [{""preferred_term"": ""prefrontal cortex"", ""term"": {""id"": ""UBERON:0000451"", ""label"": ""prefrontal cortex""}}, {""preferred_term"": ""hippocampus"", ""term"": {""id"": ""UBERON:0001954"", ""label"": ""Ammon's horn""}}], ""name"": ""Oligodendrocyte and Myelin Dysfunction""}"
6932	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	5	Mitochondrial Dysfunction and Oxidative Stress	Bioenergetic deficits including complex I inhibition, decreased glutathione, increased lactate, and oxidative/nitrosative stress creating a feed-forward cycle with neuroinflammation.																																																								"{""description"": ""Bioenergetic deficits including complex I inhibition, decreased glutathione, increased lactate, and oxidative/nitrosative stress creating a feed-forward cycle with neuroinflammation."", ""name"": ""Mitochondrial Dysfunction and Oxidative Stress""}"	{}	"{""biological_processes"": [{""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}, {""preferred_term"": ""cellular response to oxidative stress"", ""term"": {""id"": ""GO:0034599"", ""label"": ""cellular response to oxidative stress""}}], ""description"": ""Bioenergetic deficits including complex I inhibition, decreased glutathione, increased lactate, and oxidative/nitrosative stress creating a feed-forward cycle with neuroinflammation."", ""locations"": [{""preferred_term"": ""prefrontal cortex"", ""term"": {""id"": ""UBERON:0000451"", ""label"": ""prefrontal cortex""}}], ""name"": ""Mitochondrial Dysfunction and Oxidative Stress""}"
6933	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	6	Blood-Brain Barrier Dysfunction	Increased BBB permeability with elevated CSF albumin and immunoglobulins, involving dysfunction of endothelial cells, pericytes, and astrocytes in the neurovascular unit.																																																								"{""description"": ""Increased BBB permeability with elevated CSF albumin and immunoglobulins, involving dysfunction of endothelial cells, pericytes, and astrocytes in the neurovascular unit."", ""name"": ""Blood-Brain Barrier Dysfunction""}"	{}	"{""cell_types"": [{""preferred_term"": ""endothelial cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}, {""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}], ""description"": ""Increased BBB permeability with elevated CSF albumin and immunoglobulins, involving dysfunction of endothelial cells, pericytes, and astrocytes in the neurovascular unit."", ""locations"": [{""preferred_term"": ""blood-brain barrier""}], ""name"": ""Blood-Brain Barrier Dysfunction""}"
6962	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	0	Embryologic developmental disruption	"The anomalies in scimitar syndrome arise from disrupted cardiopulmonary embryogenesis during the fourth to fifth week of gestation. Faulty incorporation of the common pulmonary vein into the left atrium results in the anomalous venous drainage, while abnormal branching morphogenesis of the right lung bud produces ipsilateral pulmonary hypoplasia. Aberrant systemic arterial connections and bronchopulmonary sequestration reflect concurrent errors in vascular patterning. The exact triggers are unknown, and no consistent environmental teratogenic exposure has been identified. The condition is typically sporadic.
"																																																								"{""description"": ""The anomalies in scimitar syndrome arise from disrupted cardiopulmonary embryogenesis during the fourth to fifth week of gestation. Faulty incorporation of the common pulmonary vein into the left atrium results in the anomalous venous drainage, while abnormal branching morphogenesis of the right lung bud produces ipsilateral pulmonary hypoplasia. Aberrant systemic arterial connections and bronchopulmonary sequestration reflect concurrent errors in vascular patterning. The exact triggers are unknown, and no consistent environmental teratogenic exposure has been identified. The condition is typically sporadic.\n"", ""name"": ""Embryologic developmental disruption""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""Lung development"", ""term"": {""id"": ""GO:0030324"", ""label"": ""lung development""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""Pulmonary vein morphogenesis"", ""term"": {""id"": ""GO:0060577"", ""label"": ""pulmonary vein morphogenesis""}}], ""description"": ""The anomalies in scimitar syndrome arise from disrupted cardiopulmonary embryogenesis during the fourth to fifth week of gestation. Faulty incorporation of the common pulmonary vein into the left atrium results in the anomalous venous drainage, while abnormal branching morphogenesis of the right lung bud produces ipsilateral pulmonary hypoplasia. Aberrant systemic arterial connections and bronchopulmonary sequestration reflect concurrent errors in vascular patterning. The exact triggers are unknown, and no consistent environmental teratogenic exposure has been identified. The condition is typically sporadic.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review covering the developmental pathophysiology underlying scimitar syndrome."", ""reference"": ""PMID:16638549"", ""snippet"": ""In this article, we review the historical aspects, presentation, and pathophysiology of Scimitar syndrome and discuss available treatment strategies."", ""supports"": ""SUPPORT""}], ""name"": ""Embryologic developmental disruption""}"
6963	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	1	Anomalous pulmonary venous drainage	"The hallmark of scimitar syndrome is partial or complete anomalous drainage of the right pulmonary veins into the inferior vena cava (IVC) rather than the left atrium. This creates a left-to-right shunt as oxygenated blood from the right lung is returned to the systemic venous circulation instead of the left heart. The anomalous vein typically drains into the IVC at or below the diaphragm, though supradiaphragmatic and hepatic vein drainage variants exist. The hemodynamic significance depends on the proportion of pulmonary venous drainage that is anomalous and the degree of associated right lung hypoplasia.
"																																																								"{""description"": ""The hallmark of scimitar syndrome is partial or complete anomalous drainage of the right pulmonary veins into the inferior vena cava (IVC) rather than the left atrium. This creates a left-to-right shunt as oxygenated blood from the right lung is returned to the systemic venous circulation instead of the left heart. The anomalous vein typically drains into the IVC at or below the diaphragm, though supradiaphragmatic and hepatic vein drainage variants exist. The hemodynamic significance depends on the proportion of pulmonary venous drainage that is anomalous and the degree of associated right lung hypoplasia.\n"", ""name"": ""Anomalous pulmonary venous drainage""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""Pulmonary vein morphogenesis"", ""term"": {""id"": ""GO:0060577"", ""label"": ""pulmonary vein morphogenesis""}}], ""cell_types"": [{""preferred_term"": ""Blood vessel endothelial cell"", ""term"": {""id"": ""CL:0000071"", ""label"": ""blood vessel endothelial cell""}}], ""description"": ""The hallmark of scimitar syndrome is partial or complete anomalous drainage of the right pulmonary veins into the inferior vena cava (IVC) rather than the left atrium. This creates a left-to-right shunt as oxygenated blood from the right lung is returned to the systemic venous circulation instead of the left heart. The anomalous vein typically drains into the IVC at or below the diaphragm, though supradiaphragmatic and hepatic vein drainage variants exist. The hemodynamic significance depends on the proportion of pulmonary venous drainage that is anomalous and the degree of associated right lung hypoplasia.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review establishing the core anatomic defect of anomalous right pulmonary venous drainage to the IVC."", ""reference"": ""PMID:16638549"", ""snippet"": ""Scimitar syndrome is a rare congenital anomaly consisting in part of right pulmonary venous return to the inferior vena cava."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Colombian tertiary-center series confirming scimitar syndrome as a complex spectrum of anomalous pulmonary venous return anomalies."", ""reference"": ""PMID:38634941"", ""snippet"": ""Scimitar Syndrome is part of a complex spectrum of congenital cardiovascular anomalies related to anomalous pulmonary venous return."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Rare variant with scimitar vein draining into the portal vein rather than the IVC, causing portal hypertension and esophageal varices in a child."", ""reference"": ""PMID:40110298"", ""snippet"": ""a unique vessel, identified as the Scimitar vein, was found draining into the left portal vein."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Pulmonary vein"", ""term"": {""id"": ""UBERON:0002016"", ""label"": ""pulmonary vein""}}, {""preferred_term"": ""Inferior vena cava"", ""term"": {""id"": ""UBERON:0001072"", ""label"": ""inferior vena cava""}}], ""name"": ""Anomalous pulmonary venous drainage""}"
6964	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	2	Right lung hypoplasia	"The right lung is hypoplastic in most cases, ranging from mild volume reduction to severe underdevelopment with only one or two lobes. Right lung hypoplasia reduces the volume of blood flow through the anomalous circuit, which may paradoxically limit the hemodynamic impact of the left-to-right shunt. The hypoplasia results in dextroposition of the heart (shifting of the mediastinum to the right) rather than true dextrocardia. Right pulmonary artery hypoplasia frequently accompanies lung hypoplasia, further reducing the pulmonary vascular bed.
"																																																								"{""description"": ""The right lung is hypoplastic in most cases, ranging from mild volume reduction to severe underdevelopment with only one or two lobes. Right lung hypoplasia reduces the volume of blood flow through the anomalous circuit, which may paradoxically limit the hemodynamic impact of the left-to-right shunt. The hypoplasia results in dextroposition of the heart (shifting of the mediastinum to the right) rather than true dextrocardia. Right pulmonary artery hypoplasia frequently accompanies lung hypoplasia, further reducing the pulmonary vascular bed.\n"", ""name"": ""Right lung hypoplasia""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""Right lung morphogenesis"", ""term"": {""id"": ""GO:0060461"", ""label"": ""right lung morphogenesis""}}], ""description"": ""The right lung is hypoplastic in most cases, ranging from mild volume reduction to severe underdevelopment with only one or two lobes. Right lung hypoplasia reduces the volume of blood flow through the anomalous circuit, which may paradoxically limit the hemodynamic impact of the left-to-right shunt. The hypoplasia results in dextroposition of the heart (shifting of the mediastinum to the right) rather than true dextrocardia. Right pulmonary artery hypoplasia frequently accompanies lung hypoplasia, further reducing the pulmonary vascular bed.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review of 92 published investigations confirming right lung hypoplasia is present in up to 75% of scimitar syndrome cases."", ""reference"": ""PMID:34396590"", ""snippet"": ""Associated cardiac and extracardiac defects, particularly hypoplasia of the right lung, are present in up to three-quarters of cases."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Tertiary center series quantifying the frequency of pulmonary hypoplasia (55%), dextroposition (55%), and right pulmonary artery hypoplasia (45%) in scimitar syndrome."", ""reference"": ""PMID:38634941"", ""snippet"": ""six (54.55%) cardiac dextroposition, six (54.55%) pulmonary hypoplasia, five (45.45%) right pulmonary artery hypoplasia"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Right lung"", ""term"": {""id"": ""UBERON:0002167"", ""label"": ""right lung""}}], ""name"": ""Right lung hypoplasia""}"
6965	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	3	Anomalous systemic arterial supply	"An anomalous systemic artery arising from the thoracic or abdominal aorta supplies part of the right lower lobe in many cases. This arterial supply creates an additional left-to-right shunt by delivering systemic-pressure blood to the pulmonary vascular bed, contributing to pulmonary overcirculation and pulmonary hypertension. Bronchopulmonary sequestration frequently coexists, and aortopulmonary collateral arteries may also be present.
"																																																								"{""description"": ""An anomalous systemic artery arising from the thoracic or abdominal aorta supplies part of the right lower lobe in many cases. This arterial supply creates an additional left-to-right shunt by delivering systemic-pressure blood to the pulmonary vascular bed, contributing to pulmonary overcirculation and pulmonary hypertension. Bronchopulmonary sequestration frequently coexists, and aortopulmonary collateral arteries may also be present.\n"", ""name"": ""Anomalous systemic arterial supply""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""Blood vessel development"", ""term"": {""id"": ""GO:0001568"", ""label"": ""blood vessel development""}}], ""description"": ""An anomalous systemic artery arising from the thoracic or abdominal aorta supplies part of the right lower lobe in many cases. This arterial supply creates an additional left-to-right shunt by delivering systemic-pressure blood to the pulmonary vascular bed, contributing to pulmonary overcirculation and pulmonary hypertension. Bronchopulmonary sequestration frequently coexists, and aortopulmonary collateral arteries may also be present.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Tertiary center series documenting the frequency of aortopulmonary collaterals (27%) and bronchopulmonary sequestration (36%) as associated anomalies."", ""reference"": ""PMID:38634941"", ""snippet"": ""three (27.27%) had aortopulmonary collaterals. Four (36.36%) patients had horseshoe lungs, and four (36.36%) had bronchopulmonary sequestration."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Large cohort showing aortopulmonary collaterals are significantly more common in infantile than non-infantile forms."", ""reference"": ""PMID:29054305"", ""snippet"": ""Noninfants exhibited lower incidences of right pulmonary artery hypoplasia (p < 0.001), aortopulmonary collaterals (p = 0.004)"", ""supports"": ""SUPPORT""}], ""name"": ""Anomalous systemic arterial supply""}"
6966	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	4	Pulmonary hypertension pathogenesis	"Pulmonary hypertension in scimitar syndrome arises from multiple converging factors. The left-to-right shunt from anomalous venous drainage produces pulmonary overcirculation; right lung hypoplasia reduces the pulmonary vascular bed; anomalous systemic arterial supply adds high-pressure systemic inflow; and stenosis or obstruction of the scimitar vein elevates post-capillary pressure. These factors drive vascular remodeling including endothelial dysfunction and smooth muscle cell hypertrophy in small pulmonary arteries. Pulmonary hypertension is the major determinant of prognosis, especially in infants.
"																																																								"{""description"": ""Pulmonary hypertension in scimitar syndrome arises from multiple converging factors. The left-to-right shunt from anomalous venous drainage produces pulmonary overcirculation; right lung hypoplasia reduces the pulmonary vascular bed; anomalous systemic arterial supply adds high-pressure systemic inflow; and stenosis or obstruction of the scimitar vein elevates post-capillary pressure. These factors drive vascular remodeling including endothelial dysfunction and smooth muscle cell hypertrophy in small pulmonary arteries. Pulmonary hypertension is the major determinant of prognosis, especially in infants.\n"", ""name"": ""Pulmonary hypertension pathogenesis""}"	{}	"{""cell_types"": [{""preferred_term"": ""Blood vessel endothelial cell"", ""term"": {""id"": ""CL:0000071"", ""label"": ""blood vessel endothelial cell""}}, {""preferred_term"": ""Blood vessel smooth muscle cell"", ""term"": {""id"": ""CL:0019018"", ""label"": ""blood vessel smooth muscle cell""}}], ""description"": ""Pulmonary hypertension in scimitar syndrome arises from multiple converging factors. The left-to-right shunt from anomalous venous drainage produces pulmonary overcirculation; right lung hypoplasia reduces the pulmonary vascular bed; anomalous systemic arterial supply adds high-pressure systemic inflow; and stenosis or obstruction of the scimitar vein elevates post-capillary pressure. These factors drive vascular remodeling including endothelial dysfunction and smooth muscle cell hypertrophy in small pulmonary arteries. Pulmonary hypertension is the major determinant of prognosis, especially in infants.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Three-decade single-center study of 84 patients identifying pulmonary hypertension as a major mortality risk factor."", ""reference"": ""PMID:35804238"", ""snippet"": ""PH, CHD, neonatal SS diagnosis, ECMO support, and markedly elevated scimitar vein pressure are associated with mortality."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Retrospective analysis of 34 patients confirming pulmonary hypertension and pulmonary vein stenosis as independent risk factors for mortality."", ""reference"": ""PMID:36093138"", ""snippet"": ""High-risk factors of death included age at diagnosis (p = 0.000), PH (p = 0.007) and PVS (p = 0.014)."", ""supports"": ""SUPPORT""}], ""name"": ""Pulmonary hypertension pathogenesis""}"
6967	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	5	Associated atrial septal defect	"Atrial septal defect (ASD) is one of the most common cardiac malformations associated with scimitar syndrome, reported in approximately 18-43% of cases. ASD compounds the left-to-right shunt already present from the anomalous pulmonary venous drainage, increasing right heart volume overload. ASD may mask the diagnosis of scimitar syndrome by providing an apparent explanation for the shunt on echocardiography.
"																																																								"{""description"": ""Atrial septal defect (ASD) is one of the most common cardiac malformations associated with scimitar syndrome, reported in approximately 18-43% of cases. ASD compounds the left-to-right shunt already present from the anomalous pulmonary venous drainage, increasing right heart volume overload. ASD may mask the diagnosis of scimitar syndrome by providing an apparent explanation for the shunt on echocardiography.\n"", ""name"": ""Associated atrial septal defect""}"	{}	"{""description"": ""Atrial septal defect (ASD) is one of the most common cardiac malformations associated with scimitar syndrome, reported in approximately 18-43% of cases. ASD compounds the left-to-right shunt already present from the anomalous pulmonary venous drainage, increasing right heart volume overload. ASD may mask the diagnosis of scimitar syndrome by providing an apparent explanation for the shunt on echocardiography.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Tertiary center series documenting ASD in 18% of scimitar syndrome patients."", ""reference"": ""PMID:38634941"", ""snippet"": ""two (18.18%) patients were found to have an atrial septal defect, three (27.27%) ventricular septal defect, and one (9%) had Tetralogy of Fallot."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Columbia cohort showing 43% of patients had significant associated cardiac defects, with ASD being among the most common."", ""reference"": ""PMID:29054305"", ""snippet"": ""Forty-seven patients were identified, including 20 infants with significant associated congenital heart defects (42.6%, including 7 with single ventricle physiology)"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Interatrial septum"", ""term"": {""id"": ""UBERON:0002085"", ""label"": ""interatrial septum""}}], ""name"": ""Associated atrial septal defect""}"
6968	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	6	Associated ventricular septal defect	"Ventricular septal defect (VSD) is reported in approximately 27% of scimitar syndrome cases, creating an additional left-to-right shunt at the ventricular level. Combined with the anomalous pulmonary venous drainage, VSD further increases pulmonary blood flow and the risk of pulmonary hypertension.
"																																																								"{""description"": ""Ventricular septal defect (VSD) is reported in approximately 27% of scimitar syndrome cases, creating an additional left-to-right shunt at the ventricular level. Combined with the anomalous pulmonary venous drainage, VSD further increases pulmonary blood flow and the risk of pulmonary hypertension.\n"", ""name"": ""Associated ventricular septal defect""}"	{}	"{""description"": ""Ventricular septal defect (VSD) is reported in approximately 27% of scimitar syndrome cases, creating an additional left-to-right shunt at the ventricular level. Combined with the anomalous pulmonary venous drainage, VSD further increases pulmonary blood flow and the risk of pulmonary hypertension.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Tertiary center series documenting VSD in 27% of scimitar syndrome patients."", ""reference"": ""PMID:38634941"", ""snippet"": ""two (18.18%) patients were found to have an atrial septal defect, three (27.27%) ventricular septal defect, and one (9%) had Tetralogy of Fallot."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Interventricular septum"", ""term"": {""id"": ""UBERON:0002094"", ""label"": ""interventricular septum""}}], ""name"": ""Associated ventricular septal defect""}"
6969	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	7	Patent ductus arteriosus and aortic arch anomalies	"Patent ductus arteriosus (PDA) and coarctation of the aorta are reported in a subset of scimitar syndrome cases. PDA provides an additional left-to-right shunt at the great vessel level, while coarctation may increase afterload and complicate surgical management. These great vessel anomalies are more common in the infantile form.
"																																																								"{""description"": ""Patent ductus arteriosus (PDA) and coarctation of the aorta are reported in a subset of scimitar syndrome cases. PDA provides an additional left-to-right shunt at the great vessel level, while coarctation may increase afterload and complicate surgical management. These great vessel anomalies are more common in the infantile form.\n"", ""name"": ""Patent ductus arteriosus and aortic arch anomalies""}"	{}	"{""description"": ""Patent ductus arteriosus (PDA) and coarctation of the aorta are reported in a subset of scimitar syndrome cases. PDA provides an additional left-to-right shunt at the great vessel level, while coarctation may increase afterload and complicate surgical management. These great vessel anomalies are more common in the infantile form.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Columbia cohort documenting the spectrum of associated cardiac defects including great vessel anomalies."", ""reference"": ""PMID:29054305"", ""snippet"": ""Forty-seven patients were identified, including 20 infants with significant associated congenital heart defects (42.6%, including 7 with single ventricle physiology)"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Ductus arteriosus"", ""term"": {""id"": ""UBERON:0005440"", ""label"": ""ductus arteriosus""}}, {""preferred_term"": ""Arch of aorta"", ""term"": {""id"": ""UBERON:0001508"", ""label"": ""arch of aorta""}}], ""name"": ""Patent ductus arteriosus and aortic arch anomalies""}"
6970	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	8	Complex congenital heart disease	"A subset of scimitar syndrome patients, particularly those presenting in infancy, have complex congenital heart disease including tetralogy of Fallot, single ventricle physiology, double outlet right ventricle, or heterotaxy. Single ventricle physiology carries particularly poor prognosis. Complex CHD is significantly more common in the infantile form and is an independent predictor of mortality.
"																																																								"{""description"": ""A subset of scimitar syndrome patients, particularly those presenting in infancy, have complex congenital heart disease including tetralogy of Fallot, single ventricle physiology, double outlet right ventricle, or heterotaxy. Single ventricle physiology carries particularly poor prognosis. Complex CHD is significantly more common in the infantile form and is an independent predictor of mortality.\n"", ""name"": ""Complex congenital heart disease""}"	{}	"{""description"": ""A subset of scimitar syndrome patients, particularly those presenting in infancy, have complex congenital heart disease including tetralogy of Fallot, single ventricle physiology, double outlet right ventricle, or heterotaxy. Single ventricle physiology carries particularly poor prognosis. Complex CHD is significantly more common in the infantile form and is an independent predictor of mortality.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Cohort showing 15% of scimitar syndrome patients had single ventricle physiology, the most severe end of associated cardiac anomalies."", ""reference"": ""PMID:29054305"", ""snippet"": ""Forty-seven patients were identified, including 20 infants with significant associated congenital heart defects (42.6%, including 7 with single ventricle physiology)"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Tertiary center series documenting Tetralogy of Fallot in 9% of scimitar syndrome patients."", ""reference"": ""PMID:38634941"", ""snippet"": ""two (18.18%) patients were found to have an atrial septal defect, three (27.27%) ventricular septal defect, and one (9%) had Tetralogy of Fallot."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""First reported case of left-sided scimitar with horseshoe lung and complex CHD including heterotaxy, single ventricle, and DORV, demonstrating the extreme end of the spectrum."", ""reference"": ""PMID:41625720"", ""snippet"": ""The cardiac anomalies included right atrial isomerism, persistent left superior vena cava, unbalanced complete atrioventricular (AV) atrial septal defect with atresia of the left component of the AV valve and a hypoplastic left ventricle, double outlet right ventricle, malposition of the great arteries, and anomalous origin of left pulmonary artery (AOLPA) from the perihilar portion of the right pulmonary artery."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Heart"", ""term"": {""id"": ""UBERON:0000948"", ""label"": ""heart""}}], ""name"": ""Complex congenital heart disease""}"
6984	299	Scurvy	Scurvy.yaml	pathophysiology	0	Collagen Synthesis Impairment	"Vitamin C (ascorbic acid) is essential for hydroxylation of proline and lysine residues in collagen synthesis by prolyl and lysyl hydroxylases. Deficiency leads to inadequate hydroxyproline and hydroxylysine formation, preventing triple-helix stability and mature cross-links, resulting in defective collagen formation that affects connective tissues throughout the body.
"																																																								"{""description"": ""Vitamin C (ascorbic acid) is essential for hydroxylation of proline and lysine residues in collagen synthesis by prolyl and lysyl hydroxylases. Deficiency leads to inadequate hydroxyproline and hydroxylysine formation, preventing triple-helix stability and mature cross-links, resulting in defective collagen formation that affects connective tissues throughout the body.\n"", ""name"": ""Collagen Synthesis Impairment""}"	"{""downstream"": [{""description"": ""Defective collagen formation impairs tissue repair and wound healing processes."", ""target"": ""Impaired Wound Healing""}, {""description"": ""Impaired collagen in gingival tissues leads to mucosal fragility and bleeding."", ""target"": ""Gingival Bleeding""}, {""description"": ""Defective collagen in joints and periarticular tissues causes pain and hemarthrosis."", ""target"": ""Arthralgias""}]}"	"{""description"": ""Vitamin C (ascorbic acid) is essential for hydroxylation of proline and lysine residues in collagen synthesis by prolyl and lysyl hydroxylases. Deficiency leads to inadequate hydroxyproline and hydroxylysine formation, preventing triple-helix stability and mature cross-links, resulting in defective collagen formation that affects connective tissues throughout the body.\n"", ""downstream"": [{""description"": ""Defective collagen formation impairs tissue repair and wound healing processes."", ""target"": ""Impaired Wound Healing""}, {""description"": ""Impaired collagen in gingival tissues leads to mucosal fragility and bleeding."", ""target"": ""Gingival Bleeding""}, {""description"": ""Defective collagen in joints and periarticular tissues causes pain and hemarthrosis."", ""target"": ""Arthralgias""}], ""evidence"": [{""explanation"": ""This abstract confirms scurvy affects multiple organ systems through its role in connective tissue synthesis, supporting the collagen synthesis impairment mechanism."", ""reference"": ""PMID:37366866"", ""snippet"": ""It leads to a varied presentation, affecting multiple organ systems due to its role in the biochemical reactions of connective tissue synthesis."", ""supports"": ""SUPPORT""}], ""name"": ""Collagen Synthesis Impairment""}"
6985	299	Scurvy	Scurvy.yaml	pathophysiology	1	Vascular Integrity Failure	"Defective collagen in blood vessel walls and basement membranes leads to capillary fragility and increased vascular permeability. This manifests as spontaneous bleeding including petechiae, ecchymoses, and mucosal hemorrhages despite normal coagulation.
"																																																								"{""description"": ""Defective collagen in blood vessel walls and basement membranes leads to capillary fragility and increased vascular permeability. This manifests as spontaneous bleeding including petechiae, ecchymoses, and mucosal hemorrhages despite normal coagulation.\n"", ""name"": ""Vascular Integrity Failure""}"	"{""downstream"": [{""description"": ""Capillary fragility around hair follicles results in characteristic perifollicular bleeding."", ""target"": ""Perifollicular Hemorrhages""}, {""description"": ""Vascular fragility leads to easy bruising and larger areas of subcutaneous bleeding."", ""target"": ""Ecchymoses""}, {""description"": ""Hemorrhage and hemosiderin deposition cause skin pigmentation changes."", ""target"": ""Skin Discoloration""}]}"	"{""description"": ""Defective collagen in blood vessel walls and basement membranes leads to capillary fragility and increased vascular permeability. This manifests as spontaneous bleeding including petechiae, ecchymoses, and mucosal hemorrhages despite normal coagulation.\n"", ""downstream"": [{""description"": ""Capillary fragility around hair follicles results in characteristic perifollicular bleeding."", ""target"": ""Perifollicular Hemorrhages""}, {""description"": ""Vascular fragility leads to easy bruising and larger areas of subcutaneous bleeding."", ""target"": ""Ecchymoses""}, {""description"": ""Hemorrhage and hemosiderin deposition cause skin pigmentation changes."", ""target"": ""Skin Discoloration""}], ""evidence"": [{""explanation"": ""The manifestations of gingival bleeding, perifollicular hemorrhage, and ecchymoses are direct consequences of vascular fragility from defective collagen."", ""reference"": ""PMID:37366866"", ""snippet"": ""Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses."", ""supports"": ""SUPPORT""}], ""name"": ""Vascular Integrity Failure""}"
6994	300	Secondary Hypertension	Secondary_Hypertension.yaml	pathophysiology	0	Sympathetic and hormonal coactivation	Secondary hypertension often involves coactivation of sympathetic drive and hormonal changes related to the underlying cause.																																																								"{""description"": ""Secondary hypertension often involves coactivation of sympathetic drive and hormonal changes related to the underlying cause."", ""name"": ""Sympathetic and hormonal coactivation""}"	{}	"{""description"": ""Secondary hypertension often involves coactivation of sympathetic drive and hormonal changes related to the underlying cause."", ""evidence"": [{""explanation"": ""This review highlights sympathetic and hormonal coactivation as shared mechanisms."", ""reference"": ""PMID:37115960"", ""snippet"": ""A common theme across several contributors to SH are coactivation of the sympathetic drive and hormonal changes, independent of hormonal axis activation."", ""supports"": ""SUPPORT""}], ""name"": ""Sympathetic and hormonal coactivation""}"
6996	301	Semantic Dementia	Semantic_Dementia.yaml	pathophysiology	0	Progressive Semantic Network Degeneration	Neurodegeneration predominantly affecting temporal lobe networks leads to impaired naming and single-word comprehension.																																																								"{""description"": ""Neurodegeneration predominantly affecting temporal lobe networks leads to impaired naming and single-word comprehension."", ""name"": ""Progressive Semantic Network Degeneration""}"	{}	"{""description"": ""Neurodegeneration predominantly affecting temporal lobe networks leads to impaired naming and single-word comprehension."", ""evidence"": [{""explanation"": ""The abstract identifies progressive neurodegeneration with semantic language deficits."", ""reference"": ""PMID:41089414"", ""snippet"": ""Semantic dementia (SD) is a progressive neurodegenerative disorder primarily characterized by core linguistic deficits, notably impaired confrontation naming and single-word comprehension."", ""supports"": ""SUPPORT""}], ""name"": ""Progressive Semantic Network Degeneration""}"
6997	301	Semantic Dementia	Semantic_Dementia.yaml	pathophysiology	1	Temporal Neocortex Degeneration	Degeneration of the polar and inferolateral temporal neocortex with relative sparing of the hippocampal complex underlies semantic dementia.																																																								"{""description"": ""Degeneration of the polar and inferolateral temporal neocortex with relative sparing of the hippocampal complex underlies semantic dementia."", ""name"": ""Temporal Neocortex Degeneration""}"	{}	"{""description"": ""Degeneration of the polar and inferolateral temporal neocortex with relative sparing of the hippocampal complex underlies semantic dementia."", ""evidence"": [{""explanation"": ""The abstract specifies the temporal neocortical pathology and relative hippocampal sparing."", ""reference"": ""PMID:11287367"", ""snippet"": ""Semantic dementia is a recently documented syndrome associated with non-Alzheimer degenerative pathology of the polar and inferolateral temporal neocortex, with relative sparing (at least in the early stages) of the hippocampal complex."", ""supports"": ""SUPPORT""}], ""name"": ""Temporal Neocortex Degeneration""}"
7006	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	0	Bony Dehiscence of Semicircular Canal	An abnormal opening or thinning in the bone overlying the superior semicircular canal creates a pathological third mobile window in the inner ear, in addition to the oval and round windows. This dehiscence may result from congenitally thin otic capsule bone predisposition with subsequent trauma trigger.																																																								"{""description"": ""An abnormal opening or thinning in the bone overlying the superior semicircular canal creates a pathological third mobile window in the inner ear, in addition to the oval and round windows. This dehiscence may result from congenitally thin otic capsule bone predisposition with subsequent trauma trigger."", ""name"": ""Bony Dehiscence of Semicircular Canal""}"	{}	"{""description"": ""An abnormal opening or thinning in the bone overlying the superior semicircular canal creates a pathological third mobile window in the inner ear, in addition to the oval and round windows. This dehiscence may result from congenitally thin otic capsule bone predisposition with subsequent trauma trigger."", ""evidence"": [{""explanation"": ""Histopathological examination confirmed the anatomical basis of the dehiscence with direct dura-to-membranous duct contact at the bony defect."", ""reference"": ""PMID:22312921"", ""snippet"": ""Histopathologic examination of the right ear showed a 1.4 x 0.6-mm dehiscence of bone covering the superior canal. Dura was in direct contact with the endosteum and the membranous duct at the level of the dehiscence."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""superior semicircular canal"", ""term"": {""id"": ""UBERON:0001841"", ""label"": ""anterior semicircular canal""}}, {""preferred_term"": ""otic capsule"", ""term"": {""id"": ""UBERON:0005411"", ""label"": ""bony otic capsule""}}], ""name"": ""Bony Dehiscence of Semicircular Canal""}"
7007	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	1	Third Window Effect	The dehiscence acts as a third mobile window that shunts acoustic energy away from the cochlea and toward the vestibular system. A third window introduces a low mechanical impedance, shunting part of the inner ear fluid pressure and fluid volume flow at the site of the window.																																																								"{""description"": ""The dehiscence acts as a third mobile window that shunts acoustic energy away from the cochlea and toward the vestibular system. A third window introduces a low mechanical impedance, shunting part of the inner ear fluid pressure and fluid volume flow at the site of the window."", ""name"": ""Third Window Effect""}"	{}	"{""biological_processes"": [{""preferred_term"": ""mechanotransduction"", ""term"": {""id"": ""GO:0050957"", ""label"": ""sensory perception of sound""}}, {""preferred_term"": ""vestibular receptor stimulus detection"", ""term"": {""id"": ""GO:0050911"", ""label"": ""vestibular receptor cell stimulus detection""}}], ""description"": ""The dehiscence acts as a third mobile window that shunts acoustic energy away from the cochlea and toward the vestibular system. A third window introduces a low mechanical impedance, shunting part of the inner ear fluid pressure and fluid volume flow at the site of the window."", ""evidence"": [{""explanation"": ""This biomechanical review explains how the dehiscence creates abnormal fluid dynamics by introducing a low-impedance pathway."", ""reference"": ""PMID:32982922"", ""snippet"": ""If sufficiently large, a third window will introduce a low mechanical impedance, thus shunting part of the inner ear fluid pressure and fluid volume flow at the site of the window."", ""supports"": ""SUPPORT""}, {""explanation"": ""This landmark paper establishes the third window mechanism as the cause of the conductive hearing loss pattern seen in SCDS."", ""reference"": ""PMID:18223508"", ""snippet"": ""A number of disparate disorders affecting the labyrinth can produce CHL by acting as a pathologic third window in the inner ear. The common denominator is that these conditions result in a mobile window on the scala vestibuli side of the cochlear partition."", ""supports"": ""SUPPORT""}], ""name"": ""Third Window Effect""}"
7008	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	2	Abnormal Sound and Pressure Transmission	Sounds and pressure changes that normally would not affect the vestibular system can now stimulate the superior semicircular canal, leading to vestibular symptoms triggered by loud sounds (Tullio phenomenon) or pressure changes (Hennebert sign). Sound energy diverted toward the dehiscence generates pressure differences across the membranous vestibular labyrinth that excite traveling waves.																																																								"{""description"": ""Sounds and pressure changes that normally would not affect the vestibular system can now stimulate the superior semicircular canal, leading to vestibular symptoms triggered by loud sounds (Tullio phenomenon) or pressure changes (Hennebert sign). Sound energy diverted toward the dehiscence generates pressure differences across the membranous vestibular labyrinth that excite traveling waves."", ""name"": ""Abnormal Sound and Pressure Transmission""}"	{}	"{""cell_types"": [{""preferred_term"": ""vestibular hair cell"", ""term"": {""id"": ""CL:0000609"", ""label"": ""vestibular hair cell""}}], ""description"": ""Sounds and pressure changes that normally would not affect the vestibular system can now stimulate the superior semicircular canal, leading to vestibular symptoms triggered by loud sounds (Tullio phenomenon) or pressure changes (Hennebert sign). Sound energy diverted toward the dehiscence generates pressure differences across the membranous vestibular labyrinth that excite traveling waves."", ""evidence"": [{""explanation"": ""The biomechanics review explains how the third window allows sound and pressure to inappropriately stimulate vestibular structures."", ""reference"": ""PMID:32982922"", ""snippet"": ""Third window syndrome describes a set of vestibular and auditory symptoms that arise when a pathological third mobile window is present in the bony labyrinth of the inner ear."", ""supports"": ""SUPPORT""}, {""explanation"": ""Clinical data from the original case series demonstrates the high frequency of sound- and pressure-induced symptoms in SCDS patients."", ""reference"": ""PMID:16222184"", ""snippet"": ""For the 60 patients with vestibular manifestations, symptoms induced by loud sounds were noted in 54 patients and pressure-induced symptoms (coughing, sneezing, straining) were present in 44."", ""supports"": ""SUPPORT""}], ""name"": ""Abnormal Sound and Pressure Transmission""}"
7009	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	3	Otic Capsule Bone Biology	The otic capsule exhibits unique bone physiology with greatly suppressed remodeling. Histopathological examination shows absence of active bone resorption in SCDS cases, supporting developmental thin-bone predisposition rather than active resorption.																																																								"{""description"": ""The otic capsule exhibits unique bone physiology with greatly suppressed remodeling. Histopathological examination shows absence of active bone resorption in SCDS cases, supporting developmental thin-bone predisposition rather than active resorption."", ""name"": ""Otic Capsule Bone Biology""}"	{}	"{""biological_processes"": [{""preferred_term"": ""bone remodeling"", ""term"": {""id"": ""GO:0046849"", ""label"": ""bone remodeling""}}], ""cell_types"": [{""preferred_term"": ""osteoclast"", ""term"": {""id"": ""CL:0000092"", ""label"": ""osteoclast""}}, {""preferred_term"": ""osteoblast"", ""term"": {""id"": ""CL:0000062"", ""label"": ""osteoblast""}}], ""description"": ""The otic capsule exhibits unique bone physiology with greatly suppressed remodeling. Histopathological examination shows absence of active bone resorption in SCDS cases, supporting developmental thin-bone predisposition rather than active resorption."", ""evidence"": [{""explanation"": ""Histopathological examination showed absence of active bone resorption, supporting developmental thin-bone predisposition rather than active resorption."", ""reference"": ""PMID:22312921"", ""snippet"": ""No osteoclastic process was evident within the otic capsule bone surrounding the dehiscence."", ""supports"": ""SUPPORT""}], ""name"": ""Otic Capsule Bone Biology""}"
7030	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	0	AGK loss of function disrupts lipid signaling	"Loss of functional AGK impairs lipid signaling activity attributed to mitochondrial acylglycerol kinase.
"																																																								"{""description"": ""Loss of functional AGK impairs lipid signaling activity attributed to mitochondrial acylglycerol kinase.\n"", ""name"": ""AGK loss of function disrupts lipid signaling""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""phosphatidic acid metabolic process"", ""term"": {""id"": ""GO:0046473"", ""label"": ""phosphatidic acid metabolic process""}}], ""description"": ""Loss of functional AGK impairs lipid signaling activity attributed to mitochondrial acylglycerol kinase.\n"", ""evidence"": [{""explanation"": ""This establishes AGK's role in lipid signaling that is lost with AGK deficiency."", ""reference"": ""DOI:10.3390/ijms222413484"", ""snippet"": ""AGK, a mitochondrial acylglycerol kinase, is not only involved in lipid signaling but is also a component of the TIM22 complex in the inner mitochondrial membrane, which mediates the import of a subset of membrane proteins."", ""supports"": ""SUPPORT""}], ""name"": ""AGK loss of function disrupts lipid signaling""}"
7031	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	1	TIM22 complex assembly defect	"Disrupted TIM22 complex assembly at the mitochondrial inner membrane impairs the carrier protein import machinery.
"																																																								"{""description"": ""Disrupted TIM22 complex assembly at the mitochondrial inner membrane impairs the carrier protein import machinery.\n"", ""name"": ""TIM22 complex assembly defect""}"	{}	"{""cellular_components"": [{""preferred_term"": ""mitochondrial inner membrane"", ""term"": {""id"": ""GO:0005743"", ""label"": ""mitochondrial inner membrane""}}], ""description"": ""Disrupted TIM22 complex assembly at the mitochondrial inner membrane impairs the carrier protein import machinery.\n"", ""evidence"": [{""explanation"": ""This supports a TIM22 assembly defect at the mitochondrial inner membrane in AGK deficiency."", ""reference"": ""DOI:10.3390/ijms222413484"", ""snippet"": ""AGK, a mitochondrial acylglycerol kinase, is not only involved in lipid signaling but is also a component of the TIM22 complex in the inner mitochondrial membrane, which mediates the import of a subset of membrane proteins."", ""supports"": ""SUPPORT""}], ""name"": ""TIM22 complex assembly defect""}"
7032	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	2	Reduced TIM22-mediated import of inner-membrane carrier proteins	"Disruption of the TIM22 complex reduces import of multi-pass carrier proteins and sideroflexins into the inner mitochondrial membrane.
"																																																								"{""description"": ""Disruption of the TIM22 complex reduces import of multi-pass carrier proteins and sideroflexins into the inner mitochondrial membrane.\n"", ""name"": ""Reduced TIM22-mediated import of inner-membrane carrier proteins""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""protein insertion into mitochondrial inner membrane"", ""term"": {""id"": ""GO:0045039"", ""label"": ""protein insertion into mitochondrial inner membrane""}}], ""description"": ""Disruption of the TIM22 complex reduces import of multi-pass carrier proteins and sideroflexins into the inner mitochondrial membrane.\n"", ""evidence"": [{""explanation"": ""This supports reduced import/abundance of inner-membrane carriers and sideroflexins in AGK deficiency."", ""reference"": ""DOI:10.1091/mbc.e20-06-0390"", ""snippet"": ""Proteomic profiling of Sengers patient fibroblasts and AGK knockout models identifies remodeling of the mitochondrial proteome, including mitochondrial one-carbon metabolism enzymes, inner membrane serine transporters, sideroflexins, and Complex I subunits and assembly factors."", ""supports"": ""SUPPORT""}], ""name"": ""Reduced TIM22-mediated import of inner-membrane carrier proteins""}"
7033	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	3	Impaired mitochondrial one-carbon metabolism	"Reduced abundance of sideroflexins and one-carbon enzymes disrupts mitochondrial one-carbon metabolism.
"																																																								"{""description"": ""Reduced abundance of sideroflexins and one-carbon enzymes disrupts mitochondrial one-carbon metabolism.\n"", ""name"": ""Impaired mitochondrial one-carbon metabolism""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""one-carbon metabolic process"", ""term"": {""id"": ""GO:0006730"", ""label"": ""one-carbon metabolic process""}}], ""description"": ""Reduced abundance of sideroflexins and one-carbon enzymes disrupts mitochondrial one-carbon metabolism.\n"", ""evidence"": [{""explanation"": ""This links AGK/TIM22 dysfunction to loss of carrier and sideroflexin import with effects on one-carbon metabolism."", ""reference"": ""DOI:10.1091/mbc.e20-06-0390"", ""snippet"": ""Proteomic profiling of Sengers patient fibroblasts and AGK knockout models identifies remodeling of the mitochondrial proteome, including mitochondrial one-carbon metabolism enzymes, inner membrane serine transporters, sideroflexins, and Complex I subunits and assembly factors."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired mitochondrial one-carbon metabolism""}"
7034	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	4	Disrupted mitochondrial phospholipid metabolism	"AGK loss alters phospholipid metabolism in mitochondrial membranes, contributing to disease pathogenesis.
"																																																								"{""description"": ""AGK loss alters phospholipid metabolism in mitochondrial membranes, contributing to disease pathogenesis.\n"", ""name"": ""Disrupted mitochondrial phospholipid metabolism""}"	{}	"{""biological_processes"": [{""modifier"": ""DYSREGULATED"", ""preferred_term"": ""phospholipid metabolic process"", ""term"": {""id"": ""GO:0006644"", ""label"": ""phospholipid metabolic process""}}], ""description"": ""AGK loss alters phospholipid metabolism in mitochondrial membranes, contributing to disease pathogenesis.\n"", ""evidence"": [{""explanation"": ""This statement links AGK mutations to altered phospholipid metabolism in Sengers syndrome."", ""reference"": ""DOI:10.3390/ijms222413484"", ""snippet"": ""AGK mutations can alter both phospholipid metabolism and mitochondrial protein biogenesis, contributing to the pathogenesis of Sengers syndrome."", ""supports"": ""SUPPORT""}], ""name"": ""Disrupted mitochondrial phospholipid metabolism""}"
7035	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	5	Oxidative phosphorylation deficiency	"Impaired respiratory chain function with reduced complex I and V activity and decreased oxygen consumption in patient cells.
"																																																								"{""description"": ""Impaired respiratory chain function with reduced complex I and V activity and decreased oxygen consumption in patient cells.\n"", ""name"": ""Oxidative phosphorylation deficiency""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}], ""description"": ""Impaired respiratory chain function with reduced complex I and V activity and decreased oxygen consumption in patient cells.\n"", ""evidence"": [{""explanation"": ""This provides direct evidence of impaired oxidative phosphorylation and reduced complex I and V activity."", ""reference"": ""DOI:10.3390/ijms222413484"", ""snippet"": ""Decreases in the oxygen consumption rate (OCR) and the OCR:ECAR (extracellular acidification rate) ratio in the patients fibroblasts indicated reduced electron flow through the respiratory chain, and spectrophotometry revealed decreased activity of OXPHOS complexes I and V."", ""supports"": ""SUPPORT""}], ""name"": ""Oxidative phosphorylation deficiency""}"
7069	304	Shigellosis	Shigellosis.yaml	pathophysiology	0	Type III secretion system-mediated invasion and vacuolar escape	"Shigella uses a plasmid-encoded Type III secretion system (T3SS/mxi-spa) to deliver bacterial effector proteins directly into host cells. The translocon proteins IpaB and IpaC assemble a funnel-shaped pore in target membranes through which the injectisome docks and delivers effectors. IpaC activates small GTPases and actin nucleation to promote bacterial uptake. IpaB mediates phagosomal membrane disruption and directly activates caspase-1 in macrophages, triggering pyroptotic cell death. This allows bacterial escape from the phagolysosome into the cytosol, where Shigella replicates and spreads.
"																																																								"{""description"": ""Shigella uses a plasmid-encoded Type III secretion system (T3SS/mxi-spa) to deliver bacterial effector proteins directly into host cells. The translocon proteins IpaB and IpaC assemble a funnel-shaped pore in target membranes through which the injectisome docks and delivers effectors. IpaC activates small GTPases and actin nucleation to promote bacterial uptake. IpaB mediates phagosomal membrane disruption and directly activates caspase-1 in macrophages, triggering pyroptotic cell death. This allows bacterial escape from the phagolysosome into the cytosol, where Shigella replicates and spreads.\n"", ""name"": ""Type III secretion system-mediated invasion and vacuolar escape""}"	{}	"{""biological_processes"": [{""preferred_term"": ""type III protein secretion system"", ""term"": {""id"": ""GO:0030257"", ""label"": ""type III protein secretion system""}}, {""preferred_term"": ""pyroptosis"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptosis""}}, {""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Shigella uses a plasmid-encoded Type III secretion system (T3SS/mxi-spa) to deliver bacterial effector proteins directly into host cells. The translocon proteins IpaB and IpaC assemble a funnel-shaped pore in target membranes through which the injectisome docks and delivers effectors. IpaC activates small GTPases and actin nucleation to promote bacterial uptake. IpaB mediates phagosomal membrane disruption and directly activates caspase-1 in macrophages, triggering pyroptotic cell death. This allows bacterial escape from the phagolysosome into the cytosol, where Shigella replicates and spreads.\n"", ""evidence"": [{""explanation"": ""Highlights the extraordinary efficiency of Shigella invasion, demonstrating that the T3SS-mediated invasion mechanism is highly optimized for intracellular entry"", ""reference"": ""PMID:40915309"", ""snippet"": ""Humans are the only natural reservoir and an inoculum of only 10-100 organisms is required for infection"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}, {""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002116"", ""label"": ""small intestine""}}], ""name"": ""Type III secretion system-mediated invasion and vacuolar escape""}"
7070	304	Shigellosis	Shigellosis.yaml	pathophysiology	1	Actin-based motility and cell-to-cell spread	"Within the host cell cytosol, Shigella recruits the host actin polymerization machinery via the polar adhesin IcsA/VirG. The N-WASP (WASL) and Arp2/3 complex are recruited to the bacterial pole, forming actin comet tails that propel the pathogen toward and through the cell membrane into adjacent cells. IcsP regulates IcsA surface distribution; IcsB aids in autophagy evasion. This cell-to-cell spread mechanism drives epithelial fenestration, mucosal ulceration, and the characteristic invasive colitis phenotype without exposure to the lumen.
"																																																								"{""description"": ""Within the host cell cytosol, Shigella recruits the host actin polymerization machinery via the polar adhesin IcsA/VirG. The N-WASP (WASL) and Arp2/3 complex are recruited to the bacterial pole, forming actin comet tails that propel the pathogen toward and through the cell membrane into adjacent cells. IcsP regulates IcsA surface distribution; IcsB aids in autophagy evasion. This cell-to-cell spread mechanism drives epithelial fenestration, mucosal ulceration, and the characteristic invasive colitis phenotype without exposure to the lumen.\n"", ""name"": ""Actin-based motility and cell-to-cell spread""}"	{}	"{""biological_processes"": [{""preferred_term"": ""actin filament polymerization"", ""term"": {""id"": ""GO:0030041"", ""label"": ""actin filament polymerization""}}, {""preferred_term"": ""regulation of cell shape"", ""term"": {""id"": ""GO:0008360"", ""label"": ""regulation of cell shape""}}], ""cell_types"": [{""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}, {""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Within the host cell cytosol, Shigella recruits the host actin polymerization machinery via the polar adhesin IcsA/VirG. The N-WASP (WASL) and Arp2/3 complex are recruited to the bacterial pole, forming actin comet tails that propel the pathogen toward and through the cell membrane into adjacent cells. IcsP regulates IcsA surface distribution; IcsB aids in autophagy evasion. This cell-to-cell spread mechanism drives epithelial fenestration, mucosal ulceration, and the characteristic invasive colitis phenotype without exposure to the lumen.\n"", ""evidence"": [{""explanation"": ""Describes the characteristic tissue damage phenotype resulting from Shigella's actin-based cell-to-cell spread and mucosal invasion"", ""reference"": ""PMID:37952487"", ""snippet"": ""destruction and inflammation of the colonic epithelium accompanied by acute diarrhea, fever, and abdominal pain"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}], ""name"": ""Actin-based motility and cell-to-cell spread""}"
7071	304	Shigellosis	Shigellosis.yaml	pathophysiology	2	Inflammasome sensing and pyroptotic inflammation	"Cytosolic detection of Shigella T3SS components (MxiH, MxiI) and other danger signals activates the NAIP/NLRC4 inflammasome complex. Non-canonical inflammasome sensing via caspase-4/5 detects cytosolic lipopolysaccharide (LPS). Both pathways converge on caspase-1 and caspase-4/5 activation, which cleave gasdermin D (GSDMD) to form membrane pores, leading to pyroptotic cell death, cytokine release (IL-1, IL-18, IL-8), and recruitment of neutrophils. Shigella modulates this response via IpaH family E3 ligases (e.g., IpaH7.8) to favor bacterial survival and dissemination.
"																																																								"{""description"": ""Cytosolic detection of Shigella T3SS components (MxiH, MxiI) and other danger signals activates the NAIP/NLRC4 inflammasome complex. Non-canonical inflammasome sensing via caspase-4/5 detects cytosolic lipopolysaccharide (LPS). Both pathways converge on caspase-1 and caspase-4/5 activation, which cleave gasdermin D (GSDMD) to form membrane pores, leading to pyroptotic cell death, cytokine release (IL-1, IL-18, IL-8), and recruitment of neutrophils. Shigella modulates this response via IpaH family E3 ligases (e.g., IpaH7.8) to favor bacterial survival and dissemination.\n"", ""name"": ""Inflammasome sensing and pyroptotic inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammasome complex"", ""term"": {""id"": ""GO:0061702"", ""label"": ""inflammasome complex""}}, {""preferred_term"": ""pyroptosis"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptosis""}}, {""preferred_term"": ""inflammatory response to bacterium"", ""term"": {""id"": ""GO:0009626"", ""label"": ""inflammatory response to bacterium""}}], ""cell_types"": [{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}], ""description"": ""Cytosolic detection of Shigella T3SS components (MxiH, MxiI) and other danger signals activates the NAIP/NLRC4 inflammasome complex. Non-canonical inflammasome sensing via caspase-4/5 detects cytosolic lipopolysaccharide (LPS). Both pathways converge on caspase-1 and caspase-4/5 activation, which cleave gasdermin D (GSDMD) to form membrane pores, leading to pyroptotic cell death, cytokine release (IL-1, IL-18, IL-8), and recruitment of neutrophils. Shigella modulates this response via IpaH family E3 ligases (e.g., IpaH7.8) to favor bacterial survival and dissemination.\n"", ""evidence"": [{""explanation"": ""Establishes inflammasome-mediated pyroptosis and cytokine release as central to Shigella pathogenesis"", ""reference"": ""PMID:29493962"", ""snippet"": ""In the colon, they secrete virulence factors that cause severe inflammation and mediate enterotoxic effects, enabling colonization and invasion of the colonic epithelium"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""colon"", ""term"": {""id"": ""UBERON:0001155"", ""label"": ""colon""}}], ""name"": ""Inflammasome sensing and pyroptotic inflammation""}"
7072	304	Shigellosis	Shigellosis.yaml	pathophysiology	3	Bacterial toxin production and endothelial damage	"Shigella species, particularly S. dysenteriae, produce Shiga toxins (Stx) which inhibit protein synthesis in host cells via ribosome inactivation. These toxins damage endothelial cells and intestinal epithelium, leading to severe systemic inflammation, increased vascular permeability, thrombotic microangiopathy, and hemolytic uremic syndrome in severe cases.
"																																																								"{""description"": ""Shigella species, particularly S. dysenteriae, produce Shiga toxins (Stx) which inhibit protein synthesis in host cells via ribosome inactivation. These toxins damage endothelial cells and intestinal epithelium, leading to severe systemic inflammation, increased vascular permeability, thrombotic microangiopathy, and hemolytic uremic syndrome in severe cases.\n"", ""name"": ""Bacterial toxin production and endothelial damage""}"	{}	"{""biological_processes"": [{""preferred_term"": ""translation"", ""term"": {""id"": ""GO:0006412"", ""label"": ""translation""}}, {""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""blood vessel endothelial cell"", ""term"": {""id"": ""CL:0000071"", ""label"": ""blood vessel endothelial cell""}}], ""description"": ""Shigella species, particularly S. dysenteriae, produce Shiga toxins (Stx) which inhibit protein synthesis in host cells via ribosome inactivation. These toxins damage endothelial cells and intestinal epithelium, leading to severe systemic inflammation, increased vascular permeability, thrombotic microangiopathy, and hemolytic uremic syndrome in severe cases.\n"", ""evidence"": [{""explanation"": ""Enterotoxins and Shiga toxins are key virulence factors causing epithelial damage and systemic complications"", ""reference"": ""PMID:29493962"", ""snippet"": ""Shigella produces 3 enterotoxins that cause watery or bloody diarrhea and infection-associated symptoms"", ""supports"": ""SUPPORT""}], ""name"": ""Bacterial toxin production and endothelial damage""}"
7073	304	Shigellosis	Shigellosis.yaml	pathophysiology	4	Intestinal barrier dysfunction and increased permeability	"Invasion and destruction of intestinal epithelium compromises the intestinal barrier function. Loss of epithelial cell integrity increases paracellular transport and bacterial translocation. This leads to increased fluid secretion, electrolyte loss, and systemic bacterial dissemination.
"																																																								"{""description"": ""Invasion and destruction of intestinal epithelium compromises the intestinal barrier function. Loss of epithelial cell integrity increases paracellular transport and bacterial translocation. This leads to increased fluid secretion, electrolyte loss, and systemic bacterial dissemination.\n"", ""name"": ""Intestinal barrier dysfunction and increased permeability""}"	{}	"{""biological_processes"": [{""preferred_term"": ""tight junction assembly"", ""term"": {""id"": ""GO:0070830"", ""label"": ""bicellular tight junction assembly""}}, {""preferred_term"": ""ion transport"", ""term"": {""id"": ""GO:0006811"", ""label"": ""ion transport""}}], ""description"": ""Invasion and destruction of intestinal epithelium compromises the intestinal barrier function. Loss of epithelial cell integrity increases paracellular transport and bacterial translocation. This leads to increased fluid secretion, electrolyte loss, and systemic bacterial dissemination.\n"", ""evidence"": [{""explanation"": ""Epithelial destruction is the hallmark of Shigella pathogenesis, directly causing barrier dysfunction"", ""reference"": ""PMID:37952487"", ""snippet"": ""a severe enteric disease characterized by destruction and inflammation of the colonic epithelium"", ""supports"": ""SUPPORT""}], ""name"": ""Intestinal barrier dysfunction and increased permeability""}"
7095	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	0	Hemoglobin Polymerization	"Deoxygenated HbS polymerizes into rigid fibers, deforming red blood cells into sickle shape. HbS has glutamic acid to valine substitution at position 6 of beta-globin.
"																																																								"{""description"": ""Deoxygenated HbS polymerizes into rigid fibers, deforming red blood cells into sickle shape. HbS has glutamic acid to valine substitution at position 6 of beta-globin.\n"", ""name"": ""Hemoglobin Polymerization""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Protein Polymerization"", ""term"": {""id"": ""GO:0051258"", ""label"": ""protein polymerization""}}], ""description"": ""Deoxygenated HbS polymerizes into rigid fibers, deforming red blood cells into sickle shape. HbS has glutamic acid to valine substitution at position 6 of beta-globin.\n"", ""evidence"": [{""explanation"": ""HbS polymerization is concentration-dependent and leads to sickling."", ""reference"": ""PMID:29614632"", ""snippet"": ""Due to the unique dependence of Hb S polymerization on cellular Hb S concentration, cell dehydration promotes polymerization and sickling."", ""supports"": ""SUPPORT""}, {""explanation"": ""Establishes HbS polymerization as the primary determinant of clinical severity in sickling syndromes."", ""reference"": ""PMID:3965046"", ""snippet"": ""Our results support the hypothesis that the intracellular polymerization of HbS is the primary determinant of the severity of both anemia and clinical symptomatology in the sickle hemoglobinopathies."", ""supports"": ""SUPPORT""}], ""name"": ""Hemoglobin Polymerization""}"
7096	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	1	Red Blood Cell Sickling	"Sickled RBCs are rigid and fragile, leading to hemolytic anemia and shortened RBC lifespan (10-20 days vs normal 120 days).
"																																																								"{""description"": ""Sickled RBCs are rigid and fragile, leading to hemolytic anemia and shortened RBC lifespan (10-20 days vs normal 120 days).\n"", ""name"": ""Red Blood Cell Sickling""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Hemolysis"", ""term"": {""id"": ""GO:0030218"", ""label"": ""erythrocyte differentiation""}}], ""cell_types"": [{""preferred_term"": ""Red Blood Cell"", ""term"": {""id"": ""CL:0000232"", ""label"": ""erythrocyte""}}], ""description"": ""Sickled RBCs are rigid and fragile, leading to hemolytic anemia and shortened RBC lifespan (10-20 days vs normal 120 days).\n"", ""evidence"": [{""explanation"": ""Cell dehydration promotes sickling and fragility of red blood cells."", ""reference"": ""PMID:29614632"", ""snippet"": ""In double heterozygosis for Hb S and C (SC disease) dehydration is the determining factor in disease pathophysiology."", ""supports"": ""SUPPORT""}], ""name"": ""Red Blood Cell Sickling""}"
7097	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	2	Vaso-Occlusion	"Sickled cells adhere to vascular endothelium and obstruct microcirculation, causing tissue ischemia and pain crises. Inflammation amplifies adhesion.
"																																																								"{""description"": ""Sickled cells adhere to vascular endothelium and obstruct microcirculation, causing tissue ischemia and pain crises. Inflammation amplifies adhesion.\n"", ""name"": ""Vaso-Occlusion""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cell Adhesion"", ""term"": {""id"": ""GO:0007155"", ""label"": ""cell adhesion""}}], ""cell_types"": [{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Sickled cells adhere to vascular endothelium and obstruct microcirculation, causing tissue ischemia and pain crises. Inflammation amplifies adhesion.\n"", ""evidence"": [{""explanation"": ""Heme released from hemolysis triggers TLR4 signaling on endothelial cells, leading to Weibel-Palade body degranulation and release of P-selectin and von Willebrand factor, which promote adhesion and vaso-occlusion."", ""reference"": ""PMID:24277079"", ""snippet"": ""intravascular hemolysis in SCD releases heme that activates endothelial TLR4 signaling leading to WPB degranulation, NF-B activation, and vaso-occlusion."", ""supports"": ""SUPPORT""}], ""name"": ""Vaso-Occlusion""}"
7098	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	3	Chronic Hemolysis	"Intravascular hemolysis releases free hemoglobin, scavenging nitric oxide and causing endothelial dysfunction, pulmonary hypertension, and stroke risk.
"																																																								"{""description"": ""Intravascular hemolysis releases free hemoglobin, scavenging nitric oxide and causing endothelial dysfunction, pulmonary hypertension, and stroke risk.\n"", ""name"": ""Chronic Hemolysis""}"	{}	"{""description"": ""Intravascular hemolysis releases free hemoglobin, scavenging nitric oxide and causing endothelial dysfunction, pulmonary hypertension, and stroke risk.\n"", ""evidence"": [{""explanation"": ""Hemolysis releases both arginase (which depletes L-arginine, the substrate for nitric oxide synthesis) and free hemoglobin (which directly scavenges nitric oxide), leading to endothelial dysfunction and pulmonary hypertension."", ""reference"": ""PMID:15998894"", ""snippet"": ""hemolysis contributes to reduced nitric oxide bioavailability and endothelial dysfunction via release of erythrocyte arginase, which limits arginine bioavailability, and release of erythrocyte hemoglobin, which scavenges nitric oxide."", ""supports"": ""SUPPORT""}, {""explanation"": ""Low arginine bioavailability due to increased arginase activity is directly associated with pulmonary hypertension severity and mortality risk in SCD patients."", ""reference"": ""PMID:15998894"", ""snippet"": ""The ratios of arginine to ornithine and arginine to ornithine plus citrulline are independently associated with pulmonary hypertension and increased mortality in patients with sickle cell disease."", ""supports"": ""SUPPORT""}], ""name"": ""Chronic Hemolysis""}"
7099	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	4	Chronic Organ Damage	"Repeated vaso-occlusion and ischemia-reperfusion injury cause progressive damage to spleen, kidneys, lungs, and brain.
"																																																								"{""description"": ""Repeated vaso-occlusion and ischemia-reperfusion injury cause progressive damage to spleen, kidneys, lungs, and brain.\n"", ""name"": ""Chronic Organ Damage""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Tissue Damage"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Repeated vaso-occlusion and ischemia-reperfusion injury cause progressive damage to spleen, kidneys, lungs, and brain.\n"", ""name"": ""Chronic Organ Damage""}"
7119	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	pathophysiology	0	Ostiomeatal Complex Obstruction	Obstruction of the maxillary sinus ostium leads to impaired ventilation and drainage, creating negative intrasinus pressure. The complete obstruction results in gas resorption similar to middle ear atelectasis due to Eustachian tube dysfunction.																																																								"{""description"": ""Obstruction of the maxillary sinus ostium leads to impaired ventilation and drainage, creating negative intrasinus pressure. The complete obstruction results in gas resorption similar to middle ear atelectasis due to Eustachian tube dysfunction."", ""name"": ""Ostiomeatal Complex Obstruction""}"	"{""downstream"": [{""description"": ""Ostial obstruction leads to gas resorption and negative pressure, causing progressive sinus wall collapse."", ""target"": ""Maxillary Sinus Atelectasis""}]}"	"{""description"": ""Obstruction of the maxillary sinus ostium leads to impaired ventilation and drainage, creating negative intrasinus pressure. The complete obstruction results in gas resorption similar to middle ear atelectasis due to Eustachian tube dysfunction."", ""downstream"": [{""description"": ""Ostial obstruction leads to gas resorption and negative pressure, causing progressive sinus wall collapse."", ""target"": ""Maxillary Sinus Atelectasis""}], ""evidence"": [{""explanation"": ""The reference explicitly states that ostium obstruction plays a critical role in SSS development."", ""reference"": ""PMID:23946747"", ""snippet"": ""Obstruction of the maxillary ostium appears to play a critical role in the development of SSS."", ""supports"": ""SUPPORT""}], ""name"": ""Ostiomeatal Complex Obstruction""}"
7120	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	pathophysiology	1	Maxillary Sinus Atelectasis	Progressive collapse and inward retraction of the maxillary sinus walls due to chronic negative pressure within the sinus cavity. The gas resorption causes negative pressure, which leads to osteopenia, bone remodeling, and sinus wall retraction.																																																								"{""description"": ""Progressive collapse and inward retraction of the maxillary sinus walls due to chronic negative pressure within the sinus cavity. The gas resorption causes negative pressure, which leads to osteopenia, bone remodeling, and sinus wall retraction."", ""name"": ""Maxillary Sinus Atelectasis""}"	"{""downstream"": [{""description"": ""Chronic negative pressure and sinus wall collapse causes the orbital floor (maxillary sinus roof) to descend into the atelectatic sinus."", ""target"": ""Orbital Floor Resorption and Descent""}]}"	"{""description"": ""Progressive collapse and inward retraction of the maxillary sinus walls due to chronic negative pressure within the sinus cavity. The gas resorption causes negative pressure, which leads to osteopenia, bone remodeling, and sinus wall retraction."", ""downstream"": [{""description"": ""Chronic negative pressure and sinus wall collapse causes the orbital floor (maxillary sinus roof) to descend into the atelectatic sinus."", ""target"": ""Orbital Floor Resorption and Descent""}], ""evidence"": [{""explanation"": ""This reference directly states that SSS is the result of chronic maxillary sinus atelectasis, confirming the pathophysiological mechanism."", ""reference"": ""PMID:23946747"", ""snippet"": ""The silent sinus syndrome (SSS) involves painless facial asymmetry and enophthalmos, which is the result of chronic maxillary sinus atelectasis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference describes the progressive collapse mechanism due to sinus hypoventilation."", ""reference"": ""PMID:11404606"", ""snippet"": ""progressive enophthalmos secondary to maxillary collapse resulting from maxillary sinus hypoventilation"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""maxillary sinus"", ""term"": {""id"": ""UBERON:0001764"", ""label"": ""maxillary sinus""}}], ""name"": ""Maxillary Sinus Atelectasis""}"
7121	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	pathophysiology	2	Orbital Floor Resorption and Descent	The weakened and retracting maxillary sinus roof (which forms the orbital floor) progressively descends into the atelectatic sinus. Bone resorption and remodeling increases orbital volume and allows the orbital contents to herniate inferiorly, causing enophthalmos and hypoglobus.																																																								"{""description"": ""The weakened and retracting maxillary sinus roof (which forms the orbital floor) progressively descends into the atelectatic sinus. Bone resorption and remodeling increases orbital volume and allows the orbital contents to herniate inferiorly, causing enophthalmos and hypoglobus."", ""name"": ""Orbital Floor Resorption and Descent""}"	{}	"{""description"": ""The weakened and retracting maxillary sinus roof (which forms the orbital floor) progressively descends into the atelectatic sinus. Bone resorption and remodeling increases orbital volume and allows the orbital contents to herniate inferiorly, causing enophthalmos and hypoglobus."", ""evidence"": [{""explanation"": ""The original description of SSS confirms bone resorption and remodeling of the orbital floor as a key mechanism."", ""reference"": ""PMID:8152774"", ""snippet"": ""characterized by bone resorption and remodeling of the orbital floor due to otherwise asymptomatic maxillary sinus disease"", ""supports"": ""SUPPORT""}, {""explanation"": ""This case series confirms osteopenia and orbital floor displacement secondary to maxillary sinus collapse."", ""reference"": ""PMID:11404606"", ""snippet"": ""opacified, partially collapsed maxillary sinuses with osteopenia of the sinus walls and orbital floor displacement resulting in enophthalmos"", ""supports"": ""SUPPORT""}], ""name"": ""Orbital Floor Resorption and Descent""}"
7138	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	0	Exocrine Gland Lymphocytic Infiltration	CD4+ T cells and B cells infiltrate salivary and lacrimal glands, forming ectopic germinal center-like structures. This lymphocytic infiltration leads to progressive glandular destruction and dysfunction.																																																								"{""description"": ""CD4+ T cells and B cells infiltrate salivary and lacrimal glands, forming ectopic germinal center-like structures. This lymphocytic infiltration leads to progressive glandular destruction and dysfunction."", ""name"": ""Exocrine Gland Lymphocytic Infiltration""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Adaptive Immune Response"", ""term"": {""id"": ""GO:0002250"", ""label"": ""adaptive immune response""}}], ""cell_types"": [{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}, {""preferred_term"": ""B Cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""CD4+ T cells and B cells infiltrate salivary and lacrimal glands, forming ectopic germinal center-like structures. This lymphocytic infiltration leads to progressive glandular destruction and dysfunction."", ""evidence"": [{""explanation"": ""Demonstrates the characteristic lymphocytic infiltration pattern in salivary glands with both CD4+ T cells and B cells surrounding ductal epithelium."", ""reference"": ""PMID:33911236"", ""snippet"": ""The ductal cells of the salivary gland in pSS are characteristically surrounded by a CD4+ T cell-rich and B cell-rich infiltrate, implying a degree of communication between epithelial cells and immune cells."", ""supports"": ""SUPPORT""}], ""name"": ""Exocrine Gland Lymphocytic Infiltration""}"
7139	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	1	Autoantibody Production	Characteristic autoantibodies include anti-Ro/SSA and anti-La/SSB, which target ribonucleoprotein complexes. These antibodies serve as diagnostic markers and may contribute to tissue damage through immune complex formation.																																																								"{""description"": ""Characteristic autoantibodies include anti-Ro/SSA and anti-La/SSB, which target ribonucleoprotein complexes. These antibodies serve as diagnostic markers and may contribute to tissue damage through immune complex formation."", ""name"": ""Autoantibody Production""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""description"": ""Characteristic autoantibodies include anti-Ro/SSA and anti-La/SSB, which target ribonucleoprotein complexes. These antibodies serve as diagnostic markers and may contribute to tissue damage through immune complex formation."", ""evidence"": [{""explanation"": ""Highlights the central role of B-cell activation in primary Sjgren's disease, which drives autoantibody production including anti-Ro/SSA and anti-La/SSB antibodies."", ""reference"": ""PMID:38542233"", ""snippet"": ""Primary Sjgren's disease is primarily driven by B-cell activation and is associated with a high risk of developing non-Hodgkin's lymphoma (NHL)."", ""supports"": ""SUPPORT""}], ""name"": ""Autoantibody Production""}"
7140	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	2	Type I Interferon Signature	Elevated type I interferon activity drives disease pathogenesis through activation of plasmacytoid dendritic cells and upregulation of interferon-stimulated genes in affected tissues.																																																								"{""description"": ""Elevated type I interferon activity drives disease pathogenesis through activation of plasmacytoid dendritic cells and upregulation of interferon-stimulated genes in affected tissues."", ""name"": ""Type I Interferon Signature""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Type I Interferon Response"", ""term"": {""id"": ""GO:0034340"", ""label"": ""response to type I interferon""}}], ""description"": ""Elevated type I interferon activity drives disease pathogenesis through activation of plasmacytoid dendritic cells and upregulation of interferon-stimulated genes in affected tissues."", ""evidence"": [{""explanation"": ""Confirms that interferon signaling is a key dysregulated pathway in the salivary gland epithelium, contributing to the type I interferon signature observed in Sjgren's syndrome."", ""reference"": ""PMID:33911236"", ""snippet"": ""Multiple innate immune pathways are likely dysregulated in the salivary gland epithelium in pSS, including the nuclear factor-B pathway, the inflammasome and interferon signalling."", ""supports"": ""SUPPORT""}, {""explanation"": ""Highlights type I interferon system as a major therapeutic target in Sjgren's syndrome, underscoring its central pathogenic role."", ""reference"": ""PMID:38982205"", ""snippet"": ""Several randomized controlled trials have just been completed or are poised to commence evaluating the effectiveness of novel drugs targeting both innate and adaptive immune pathways, including pro-inflammatory cytokines, the type I interferon system, B cell activation, B cell and T cell co-stimulation pathway, and ectopic germinal centre formation."", ""supports"": ""SUPPORT""}], ""name"": ""Type I Interferon Signature""}"
7141	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	3	Epithelial Cell Dysfunction	Salivary and lacrimal gland epithelial cells exhibit intrinsic abnormalities including aberrant apoptosis, antigen presentation via MHC class II, and production of pro-inflammatory cytokines including BAFF.																																																								"{""description"": ""Salivary and lacrimal gland epithelial cells exhibit intrinsic abnormalities including aberrant apoptosis, antigen presentation via MHC class II, and production of pro-inflammatory cytokines including BAFF."", ""name"": ""Epithelial Cell Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Apoptotic Process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""Epithelial Cell"", ""term"": {""id"": ""CL:0000066"", ""label"": ""epithelial cell""}}], ""description"": ""Salivary and lacrimal gland epithelial cells exhibit intrinsic abnormalities including aberrant apoptosis, antigen presentation via MHC class II, and production of pro-inflammatory cytokines including BAFF."", ""evidence"": [{""explanation"": ""Demonstrates that epithelial cells actively participate in disease pathogenesis by providing chronic activation signals to immune cells, not merely serving as passive targets."", ""reference"": ""PMID:33911236"", ""snippet"": ""B cell infiltrates within the ducts can initiate the development of lymphoepithelial lesions, including basal ductal cell hyperplasia. Vice versa, the epithelium provides chronic activation signals to the glandular B cell fraction."", ""supports"": ""SUPPORT""}, {""explanation"": ""Defines the disease as an autoimmune epithelitis, emphasizing the central role of epithelial cell dysfunction in disease pathology and clinical manifestations."", ""reference"": ""PMID:38982205"", ""snippet"": ""Sjgren syndrome or Sjgren disease is a chronic form of autoimmune epithelitis characterized by lymphocytic infiltration of the exocrine glands, particularly the salivary and lacrimal glands, leading to progressive glandular dysfunction and subsequent xerostomia and xerophthalmia."", ""supports"": ""SUPPORT""}], ""name"": ""Epithelial Cell Dysfunction""}"
7163	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	0	TP53 Inactivation	TP53 is inactivated in >90% of SCLC through mutations, deletions, or both. Loss of p53 function eliminates the G1/S checkpoint and apoptotic response to DNA damage, enabling survival despite genomic instability.																																																								"{""description"": ""TP53 is inactivated in >90% of SCLC through mutations, deletions, or both. Loss of p53 function eliminates the G1/S checkpoint and apoptotic response to DNA damage, enabling survival despite genomic instability."", ""name"": ""TP53 Inactivation""}"	"{""downstream"": [{""description"": ""Cells proliferate despite DNA damage"", ""target"": ""Loss of Cell Cycle Checkpoints""}]}"	"{""biological_processes"": [{""modifier"": ""ABSENT"", ""preferred_term"": ""DNA damage response, signal transduction by p53 class mediator"", ""term"": {""id"": ""GO:0030330"", ""label"": ""DNA damage response, signal transduction by p53 class mediator""}}], ""cell_types"": [{""preferred_term"": ""type II pneumocyte"", ""term"": {""id"": ""CL:0002063"", ""label"": ""pulmonary alveolar type 2 cell""}}], ""description"": ""TP53 is inactivated in >90% of SCLC through mutations, deletions, or both. Loss of p53 function eliminates the G1/S checkpoint and apoptotic response to DNA damage, enabling survival despite genomic instability."", ""downstream"": [{""description"": ""Cells proliferate despite DNA damage"", ""target"": ""Loss of Cell Cycle Checkpoints""}], ""evidence"": [{""explanation"": ""Abstract states the canonical model involves TP53 and RB1 inactivation."", ""reference"": ""PMID:36399634"", ""snippet"": ""The canonical model of \""small cell lung cancer\"" (SCLC) depicts tumors arising from dual inactivation of TP53 and RB1."", ""supports"": ""SUPPORT""}], ""name"": ""TP53 Inactivation""}"
7164	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	1	RB1 Inactivation	RB1 is inactivated in >90% of SCLC through mutations, deletions, or both. Loss of Rb function eliminates the G1/S checkpoint by releasing E2F transcription factors, enabling uncontrolled S-phase entry.																																																								"{""description"": ""RB1 is inactivated in >90% of SCLC through mutations, deletions, or both. Loss of Rb function eliminates the G1/S checkpoint by releasing E2F transcription factors, enabling uncontrolled S-phase entry."", ""name"": ""RB1 Inactivation""}"	"{""downstream"": [{""description"": ""Uncontrolled cell cycle progression"", ""target"": ""Loss of Cell Cycle Checkpoints""}]}"	"{""biological_processes"": [{""modifier"": ""ABSENT"", ""preferred_term"": ""negative regulation of G1/S transition of mitotic cell cycle"", ""term"": {""id"": ""GO:0045736"", ""label"": ""negative regulation of G1/S transition of mitotic cell cycle""}}], ""description"": ""RB1 is inactivated in >90% of SCLC through mutations, deletions, or both. Loss of Rb function eliminates the G1/S checkpoint by releasing E2F transcription factors, enabling uncontrolled S-phase entry."", ""downstream"": [{""description"": ""Uncontrolled cell cycle progression"", ""target"": ""Loss of Cell Cycle Checkpoints""}], ""evidence"": [{""explanation"": ""Abstract states the canonical model involves TP53 and RB1 inactivation."", ""reference"": ""PMID:36399634"", ""snippet"": ""The canonical model of \""small cell lung cancer\"" (SCLC) depicts tumors arising from dual inactivation of TP53 and RB1."", ""supports"": ""SUPPORT""}], ""name"": ""RB1 Inactivation""}"
7165	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	2	Loss of Cell Cycle Checkpoints	Combined TP53 and RB1 loss eliminates major cell cycle checkpoints. Cells proliferate rapidly without the normal restraints on replication. This explains the rapid doubling time and initial chemosensitivity (dividing cells are vulnerable to chemotherapy).																																																								"{""description"": ""Combined TP53 and RB1 loss eliminates major cell cycle checkpoints. Cells proliferate rapidly without the normal restraints on replication. This explains the rapid doubling time and initial chemosensitivity (dividing cells are vulnerable to chemotherapy)."", ""name"": ""Loss of Cell Cycle Checkpoints""}"	"{""downstream"": [{""description"": ""Accumulation of mutations and chromosomal alterations"", ""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Combined TP53 and RB1 loss eliminates major cell cycle checkpoints. Cells proliferate rapidly without the normal restraints on replication. This explains the rapid doubling time and initial chemosensitivity (dividing cells are vulnerable to chemotherapy)."", ""downstream"": [{""description"": ""Accumulation of mutations and chromosomal alterations"", ""target"": ""Genomic Instability""}], ""name"": ""Loss of Cell Cycle Checkpoints""}"
7166	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	3	Genomic Instability	Loss of TP53 and RB1 leads to widespread genomic instability with frequent chromosomal gains and losses. Amplification of MYC family genes (MYC, MYCL, MYCN) occurs in ~20% of SCLC and is associated with worse prognosis.																																																								"{""description"": ""Loss of TP53 and RB1 leads to widespread genomic instability with frequent chromosomal gains and losses. Amplification of MYC family genes (MYC, MYCL, MYCN) occurs in ~20% of SCLC and is associated with worse prognosis."", ""name"": ""Genomic Instability""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""DNA repair"", ""term"": {""id"": ""GO:0006281"", ""label"": ""DNA repair""}}], ""description"": ""Loss of TP53 and RB1 leads to widespread genomic instability with frequent chromosomal gains and losses. Amplification of MYC family genes (MYC, MYCL, MYCN) occurs in ~20% of SCLC and is associated with worse prognosis."", ""name"": ""Genomic Instability""}"
7167	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	4	Neuroendocrine Differentiation	SCLC cells exhibit neuroendocrine differentiation, expressing markers such as synaptophysin, chromogranin A, and CD56 (NCAM). Neuroendocrine phenotype is regulated by lineage transcription factors (ASCL1, NEUROD1). Some SCLC produces paraneoplastic hormones (ACTH, ADH).																																																								"{""description"": ""SCLC cells exhibit neuroendocrine differentiation, expressing markers such as synaptophysin, chromogranin A, and CD56 (NCAM). Neuroendocrine phenotype is regulated by lineage transcription factors (ASCL1, NEUROD1). Some SCLC produces paraneoplastic hormones (ACTH, ADH)."", ""name"": ""Neuroendocrine Differentiation""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""neuron differentiation"", ""term"": {""id"": ""GO:0030182"", ""label"": ""neuron differentiation""}}], ""description"": ""SCLC cells exhibit neuroendocrine differentiation, expressing markers such as synaptophysin, chromogranin A, and CD56 (NCAM). Neuroendocrine phenotype is regulated by lineage transcription factors (ASCL1, NEUROD1). Some SCLC produces paraneoplastic hormones (ACTH, ADH)."", ""name"": ""Neuroendocrine Differentiation""}"
7168	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	5	Functional Neuron-SCLC Synapses	SCLC cells can form functional synapses with neurons and receive synaptic transmission.																																																								"{""description"": ""SCLC cells can form functional synapses with neurons and receive synaptic transmission."", ""name"": ""Functional Neuron-SCLC Synapses""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""synapse assembly"", ""term"": {""id"": ""GO:0007416"", ""label"": ""synapse assembly""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""chemical synaptic transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}], ""description"": ""SCLC cells can form functional synapses with neurons and receive synaptic transmission."", ""evidence"": [{""explanation"": ""Abstract reports functional synapses and synaptic transmission between neurons and SCLC cells."", ""reference"": ""PMID:40931078"", ""snippet"": ""Here we show that SCLC cells can form functional synapses and receive synaptic transmission."", ""supports"": ""SUPPORT""}], ""name"": ""Functional Neuron-SCLC Synapses""}"
7169	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	6	Neuron-Driven Proliferation	SCLC cells gain a proliferation advantage when co-cultured with neurons.																																																								"{""description"": ""SCLC cells gain a proliferation advantage when co-cultured with neurons."", ""name"": ""Neuron-Driven Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""positive regulation of cell population proliferation"", ""term"": {""id"": ""GO:0008284"", ""label"": ""positive regulation of cell population proliferation""}}], ""description"": ""SCLC cells gain a proliferation advantage when co-cultured with neurons."", ""evidence"": [{""explanation"": ""Abstract reports neuron co-culture provides a proliferation advantage to SCLC cells."", ""reference"": ""PMID:40931078"", ""snippet"": ""we showed that SCLC cells derive a proliferation advantage when co-cultured with vagal sensory or cortical neurons."", ""supports"": ""SUPPORT""}], ""name"": ""Neuron-Driven Proliferation""}"
7170	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	7	Glutamate Signaling Dependency	Inhibition of glutamate signaling has therapeutic efficacy in SCLC models, implicating glutamatergic signaling in tumor growth.																																																								"{""description"": ""Inhibition of glutamate signaling has therapeutic efficacy in SCLC models, implicating glutamatergic signaling in tumor growth."", ""name"": ""Glutamate Signaling Dependency""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""glutamate receptor signaling pathway"", ""term"": {""id"": ""GO:0007215"", ""label"": ""glutamate receptor signaling pathway""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""synaptic transmission, glutamatergic"", ""term"": {""id"": ""GO:0035249"", ""label"": ""synaptic transmission, glutamatergic""}}], ""description"": ""Inhibition of glutamate signaling has therapeutic efficacy in SCLC models, implicating glutamatergic signaling in tumor growth."", ""evidence"": [{""explanation"": ""Abstract reports therapeutic efficacy of glutamate signaling inhibition in an SCLC mouse model."", ""reference"": ""PMID:40931078"", ""snippet"": ""Moreover, inhibition of glutamate signalling had therapeutic efficacy in an autochthonous mouse model of SCLC."", ""supports"": ""SUPPORT""}], ""name"": ""Glutamate Signaling Dependency""}"
7182	309	Small Intestinal Bacterial Overgrowth	Small_Intestinal_Bacterial_Overgrowth.yaml	pathophysiology	0	Bacterial overgrowth in small intestine	"Excessive bacterial colonization of the small intestine leads to malabsorption, nutrient deficiencies, and gastrointestinal symptoms. Disruption of gastric acid, motility (including migrating motor complex), and the ileocecal barrier promotes overgrowth. Bacterial fermentation produces hydrogen, methane, and short-chain fatty acids while bile acid deconjugation impairs fat absorption.
"																																																								"{""description"": ""Excessive bacterial colonization of the small intestine leads to malabsorption, nutrient deficiencies, and gastrointestinal symptoms. Disruption of gastric acid, motility (including migrating motor complex), and the ileocecal barrier promotes overgrowth. Bacterial fermentation produces hydrogen, methane, and short-chain fatty acids while bile acid deconjugation impairs fat absorption.\n"", ""name"": ""Bacterial overgrowth in small intestine""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to bile acid"", ""term"": {""id"": ""GO:0033993"", ""label"": ""response to bile acid""}}, {""preferred_term"": ""tight junction assembly"", ""term"": {""id"": ""GO:0070830"", ""label"": ""tight junction assembly""}}], ""cell_types"": [{""preferred_term"": ""enterocyte"", ""term"": {""id"": ""CL:0000584"", ""label"": ""enterocyte""}}], ""description"": ""Excessive bacterial colonization of the small intestine leads to malabsorption, nutrient deficiencies, and gastrointestinal symptoms. Disruption of gastric acid, motility (including migrating motor complex), and the ileocecal barrier promotes overgrowth. Bacterial fermentation produces hydrogen, methane, and short-chain fatty acids while bile acid deconjugation impairs fat absorption.\n"", ""evidence"": [{""explanation"": ""ESNM/ANMS practice update confirms SIBO is well-established in stasis conditions."", ""reference"": ""PMID:38798120"", ""snippet"": ""Small intestinal bacterial overgrowth (SIBO) has been recognized for over a century in patients with predisposing conditions causing intestinal stasis, such as surgical alteration of the small bowel or chronic diseases"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""Bacterial overgrowth in small intestine""}"
7191	310	Snakebite envenoming	Snakebite_Envenoming.yaml	pathophysiology	0	Venom toxins with broad toxic actions	Snake venoms are complex protein mixtures that cause diverse toxic effects.																																																								"{""description"": ""Snake venoms are complex protein mixtures that cause diverse toxic effects."", ""name"": ""Venom toxins with broad toxic actions""}"	{}	"{""description"": ""Snake venoms are complex protein mixtures that cause diverse toxic effects."", ""evidence"": [{""explanation"": ""The abstract summarizes the toxic nature of snake venoms."", ""reference"": ""PMID:28905944"", ""snippet"": ""Snake venoms are complex mixtures of proteins that exert a wide range of toxic actions."", ""supports"": ""SUPPORT""}], ""name"": ""Venom toxins with broad toxic actions""}"
7192	310	Snakebite envenoming	Snakebite_Envenoming.yaml	pathophysiology	1	Local and systemic effects driven by venom variability	Variability in venom composition leads to a spectrum of clinical manifestations.																																																								"{""description"": ""Variability in venom composition leads to a spectrum of clinical manifestations."", ""name"": ""Local and systemic effects driven by venom variability""}"	{}	"{""description"": ""Variability in venom composition leads to a spectrum of clinical manifestations."", ""evidence"": [{""explanation"": ""The abstract links venom variability to local and systemic effects."", ""reference"": ""PMID:28905944"", ""snippet"": ""The high variability in snake venom composition is responsible for the various clinical manifestations in envenomings, ranging from local tissue damage to potentially life-threatening systemic effects."", ""supports"": ""SUPPORT""}], ""name"": ""Local and systemic effects driven by venom variability""}"
7203	311	Soil-transmitted helminthiases	Soil_Transmitted_Helminthiases.yaml	pathophysiology	0	Blood-feeding hookworms cause iron deficiency anemia	Adult hookworms feed on host blood, leading to iron deficiency anemia.																																																								"{""description"": ""Adult hookworms feed on host blood, leading to iron deficiency anemia."", ""name"": ""Blood-feeding hookworms cause iron deficiency anemia""}"	{}	"{""description"": ""Adult hookworms feed on host blood, leading to iron deficiency anemia."", ""evidence"": [{""explanation"": ""Hookworm blood feeding causes iron deficiency anemia."", ""reference"": ""PMID:27929101"", ""snippet"": ""Adult worms feed on the blood of a host and can cause iron deficiency anaemia"", ""supports"": ""SUPPORT""}], ""name"": ""Blood-feeding hookworms cause iron deficiency anemia""}"
7215	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	pathophysiology	0	SMN Protein Deficiency	"Homozygous deletion or mutation of SMN1 gene causes deficiency of survival motor neuron protein. SMN2 gene produces some functional protein but mostly truncated due to exon 7 skipping. SMN protein is essential for motor neuron survival and function.
"																																																								"{""description"": ""Homozygous deletion or mutation of SMN1 gene causes deficiency of survival motor neuron protein. SMN2 gene produces some functional protein but mostly truncated due to exon 7 skipping. SMN protein is essential for motor neuron survival and function.\n"", ""name"": ""SMN Protein Deficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Motor Neuron Development"", ""term"": {""id"": ""GO:0048666"", ""label"": ""neuron development""}}], ""cell_types"": [{""preferred_term"": ""Motor Neuron"", ""term"": {""id"": ""CL:0000100"", ""label"": ""motor neuron""}}], ""description"": ""Homozygous deletion or mutation of SMN1 gene causes deficiency of survival motor neuron protein. SMN2 gene produces some functional protein but mostly truncated due to exon 7 skipping. SMN protein is essential for motor neuron survival and function.\n"", ""evidence"": [{""explanation"": ""Review confirms SMN1 gene mutations cause SMA."", ""reference"": ""PMID:16364894"", ""snippet"": ""SMA is caused by mutations in a single gene, the Survival of Motor Neuron 1 (SMN1) gene."", ""supports"": ""SUPPORT""}, {""explanation"": ""Lancet review confirms SMN1 gene disruption causes SMA with motor neuron degeneration."", ""reference"": ""PMID:18572081"", ""snippet"": ""Spinal muscular atrophy is an autosomal recessive neurodegenerative disease characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles, and generalised weakness. It is caused by homozygous disruption of the survival motor neuron 1 (SMN1) gene by deletion, conversion, or mutation."", ""supports"": ""SUPPORT""}], ""name"": ""SMN Protein Deficiency""}"
7216	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	pathophysiology	1	Motor Neuron Degeneration	"Loss of alpha motor neurons in the anterior horn of the spinal cord leads to progressive denervation of skeletal muscles. Proximal muscles are more severely affected than distal muscles.
"																																																								"{""description"": ""Loss of alpha motor neurons in the anterior horn of the spinal cord leads to progressive denervation of skeletal muscles. Proximal muscles are more severely affected than distal muscles.\n"", ""name"": ""Motor Neuron Degeneration""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Neurodegeneration"", ""term"": {""id"": ""GO:0070997"", ""label"": ""neuron death""}}], ""cell_types"": [{""preferred_term"": ""Motor Neuron"", ""term"": {""id"": ""CL:0000100"", ""label"": ""motor neuron""}}], ""description"": ""Loss of alpha motor neurons in the anterior horn of the spinal cord leads to progressive denervation of skeletal muscles. Proximal muscles are more severely affected than distal muscles.\n"", ""evidence"": [{""explanation"": ""Review confirms motor neuron loss as the pathological basis of SMA."", ""reference"": ""PMID:16364894"", ""snippet"": ""The disease results in motor neuron loss and skeletal muscle atrophy."", ""supports"": ""SUPPORT""}], ""name"": ""Motor Neuron Degeneration""}"
7229	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	pathophysiology	0	Type II Collagen Dysfunction	"COL2A1 mutations in SEMD Strudwick produce abnormal type II collagen that disrupts cartilage matrix integrity. The characteristic metaphyseal changes reflect abnormal endochondral ossification at the growth plate. The specific mutations may cause distinctive structural abnormalities in the collagen triple helix.
"																																																								"{""description"": ""COL2A1 mutations in SEMD Strudwick produce abnormal type II collagen that disrupts cartilage matrix integrity. The characteristic metaphyseal changes reflect abnormal endochondral ossification at the growth plate. The specific mutations may cause distinctive structural abnormalities in the collagen triple helix.\n"", ""name"": ""Type II Collagen Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}, {""preferred_term"": ""Endochondral Ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}], ""cell_types"": [{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}, {""preferred_term"": ""Growth Plate Chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}], ""description"": ""COL2A1 mutations in SEMD Strudwick produce abnormal type II collagen that disrupts cartilage matrix integrity. The characteristic metaphyseal changes reflect abnormal endochondral ossification at the growth plate. The specific mutations may cause distinctive structural abnormalities in the collagen triple helix.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This paper established that individuals with COL2A1 mutations affecting type II collagen-containing tissues exhibit growth plate abnormalities."", ""reference"": ""PMID:7550321"", ""snippet"": ""Individuals affected with these disorders exhibit abnormalities of the growth plate, nucleus pulposus, and vitreous humor, which are tissues that contain type II collagen."", ""supports"": ""SUPPORT""}], ""name"": ""Type II Collagen Dysfunction""}"
7246	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	pathophysiology	0	Type II Collagen Dysfunction	"COL2A1 mutations in SEDC produce partially functional type II collagen that is incorporated into cartilage matrix but with compromised structural integrity. This results in abnormal endochondral ossification affecting the spine and epiphyses, as well as ocular and auricular cartilage abnormalities.
"																																																								"{""description"": ""COL2A1 mutations in SEDC produce partially functional type II collagen that is incorporated into cartilage matrix but with compromised structural integrity. This results in abnormal endochondral ossification affecting the spine and epiphyses, as well as ocular and auricular cartilage abnormalities.\n"", ""name"": ""Type II Collagen Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}, {""preferred_term"": ""Cartilage Development"", ""term"": {""id"": ""GO:0051216"", ""label"": ""cartilage development""}}, {""preferred_term"": ""Endochondral Ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}], ""cell_types"": [{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}, {""preferred_term"": ""Growth Plate Chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}], ""description"": ""COL2A1 mutations in SEDC produce partially functional type II collagen that is incorporated into cartilage matrix but with compromised structural integrity. This results in abnormal endochondral ossification affecting the spine and epiphyses, as well as ocular and auricular cartilage abnormalities.\n"", ""name"": ""Type II Collagen Dysfunction""}"
7247	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	pathophysiology	1	Vitreous Collagen Abnormality	"Type II collagen is a major component of the vitreous humor. Abnormal collagen leads to vitreous liquefaction, posterior vitreous detachment, and increased risk of retinal detachment.
"																																																								"{""description"": ""Type II collagen is a major component of the vitreous humor. Abnormal collagen leads to vitreous liquefaction, posterior vitreous detachment, and increased risk of retinal detachment.\n"", ""name"": ""Vitreous Collagen Abnormality""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Eye Development"", ""term"": {""id"": ""GO:0001654"", ""label"": ""eye development""}}], ""description"": ""Type II collagen is a major component of the vitreous humor. Abnormal collagen leads to vitreous liquefaction, posterior vitreous detachment, and increased risk of retinal detachment.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study documents that vitreous humor abnormalities are a feature of COL2A1-related chondrodysplasias including SEDC, due to type II collagen being a major component of the vitreous."", ""reference"": ""PMID:7550321"", ""snippet"": ""Individuals affected with these disorders exhibit abnormalities of the growth plate, nucleus pulposus, and vitreous humor, which are tissues that contain type II collagen."", ""supports"": ""SUPPORT""}], ""name"": ""Vitreous Collagen Abnormality""}"
7264	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	pathophysiology	0	Type II Collagen Haploinsufficiency	"Most STL1 mutations cause premature termination codons leading to nonsense- mediated decay and haploinsufficiency of type II collagen. This results in quantitative rather than qualitative collagen deficiency, producing a milder phenotype than dominant-negative mutations. Tissues with high type II collagen content (vitreous, cartilage, inner ear) are primarily affected.
"																																																								"{""description"": ""Most STL1 mutations cause premature termination codons leading to nonsense- mediated decay and haploinsufficiency of type II collagen. This results in quantitative rather than qualitative collagen deficiency, producing a milder phenotype than dominant-negative mutations. Tissues with high type II collagen content (vitreous, cartilage, inner ear) are primarily affected.\n"", ""name"": ""Type II Collagen Haploinsufficiency""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Collagen Biosynthesis"", ""term"": {""id"": ""GO:0032964"", ""label"": ""collagen biosynthetic process""}}, {""preferred_term"": ""Eye Development"", ""term"": {""id"": ""GO:0001654"", ""label"": ""eye development""}}], ""cell_types"": [{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}], ""description"": ""Most STL1 mutations cause premature termination codons leading to nonsense- mediated decay and haploinsufficiency of type II collagen. This results in quantitative rather than qualitative collagen deficiency, producing a milder phenotype than dominant-negative mutations. Tissues with high type II collagen content (vitreous, cartilage, inner ear) are primarily affected.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Large-scale genotype-phenotype study of 100 STL1 patients confirms that the majority of COL2A1 mutations cause haploinsufficiency through NMD.\n"", ""reference"": ""PMID:20179744"", ""snippet"": ""Stickler syndrome type 1 is predominantly caused by loss-of-function mutations in the COL2A1 gene as >90% of the mutations were predicted to result in nonsense-mediated decay.\n"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Study examining vitreous phenotypes confirms that premature termination codons causing haploinsufficiency are the predominant mutation type in STL1.\n"", ""reference"": ""PMID:11007540"", ""snippet"": ""Premature termination codons in COL2A1 that result in haploinsufficiency of type II collagen are a common finding.\n"", ""supports"": ""SUPPORT""}], ""name"": ""Type II Collagen Haploinsufficiency""}"
7265	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	pathophysiology	1	Vitreous Collagen Abnormality	"Type II collagen is essential for vitreous structure. Reduced collagen leads to vitreous liquefaction with characteristic membranous remnants visible on slit-lamp examination, posterior vitreous detachment, and increased retinal detachment risk.
"																																																								"{""description"": ""Type II collagen is essential for vitreous structure. Reduced collagen leads to vitreous liquefaction with characteristic membranous remnants visible on slit-lamp examination, posterior vitreous detachment, and increased retinal detachment risk.\n"", ""name"": ""Vitreous Collagen Abnormality""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Eye Development"", ""term"": {""id"": ""GO:0001654"", ""label"": ""eye development""}}], ""description"": ""Type II collagen is essential for vitreous structure. Reduced collagen leads to vitreous liquefaction with characteristic membranous remnants visible on slit-lamp examination, posterior vitreous detachment, and increased retinal detachment risk.\n"", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that COL2A1 haploinsufficiency produces the characteristic membranous vitreous phenotype that is pathognomonic for STL1.\n"", ""reference"": ""PMID:11007540"", ""snippet"": ""Premature termination codons in COL2A1 that result in haploinsufficiency of type II collagen are a common finding. These produce a characteristic congenital \""membranous\"" anomaly of the vitreous of all affected individuals.\n"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The membranous vitreous phenotype can be used to distinguish STL1 (COL2A1) from STL2 (COL11A1), supporting its diagnostic utility.\n"", ""reference"": ""PMID:11007540"", ""snippet"": ""Experience has shown that vitreous slit-lamp biomicroscopy can distinguish between patients with COL2A1 mutations and those with dominant negative mutations in COL11A1, who produce a different \""beaded\"" vitreous phenotype.\n"", ""supports"": ""SUPPORT""}], ""name"": ""Vitreous Collagen Abnormality""}"
7286	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	0	GABAergic Inhibition Impairment	Anti-GAD65 antibodies target glutamic acid decarboxylase, the enzyme that synthesizes GABA from glutamate. This leads to reduced GABA production and impaired inhibitory neurotransmission, resulting in neuronal hyperexcitability. GAD65 is predominantly localized to synaptic vesicles and provides additional GABA synthesis when there is increased demand for rapid neurotransmitter release during high-frequency neural firing.																																																								"{""description"": ""Anti-GAD65 antibodies target glutamic acid decarboxylase, the enzyme that synthesizes GABA from glutamate. This leads to reduced GABA production and impaired inhibitory neurotransmission, resulting in neuronal hyperexcitability. GAD65 is predominantly localized to synaptic vesicles and provides additional GABA synthesis when there is increased demand for rapid neurotransmitter release during high-frequency neural firing."", ""name"": ""GABAergic Inhibition Impairment""}"	"{""downstream"": [{""description"": ""Impaired GABAergic signaling disrupts reciprocal inhibition in motor circuits, causing simultaneous contraction of agonist and antagonist muscles."", ""evidence"": [{""explanation"": ""The mechanism explicitly describes how reciprocal inhibition failure leads to the characteristic muscle co-contraction."", ""reference"": ""PMID:35084720"", ""snippet"": ""the phenomenon of reciprocal inhibition as the fundamental mechanism of the patients' muscle stiffness and spasms"", ""supports"": ""SUPPORT""}], ""target"": ""Loss of Reciprocal Inhibition""}]}"	"{""biological_processes"": [{""preferred_term"": ""GABAergic synaptic transmission"", ""term"": {""id"": ""GO:0051932"", ""label"": ""synaptic transmission, GABAergic""}}, {""preferred_term"": ""Inhibitory chemical synaptic transmission"", ""term"": {""id"": ""GO:0098977"", ""label"": ""inhibitory chemical synaptic transmission""}}], ""cell_types"": [{""preferred_term"": ""GABAergic Interneuron"", ""term"": {""id"": ""CL:0011005"", ""label"": ""GABAergic interneuron""}}, {""preferred_term"": ""Purkinje cell"", ""term"": {""id"": ""CL:0000121"", ""label"": ""Purkinje cell""}}], ""description"": ""Anti-GAD65 antibodies target glutamic acid decarboxylase, the enzyme that synthesizes GABA from glutamate. This leads to reduced GABA production and impaired inhibitory neurotransmission, resulting in neuronal hyperexcitability. GAD65 is predominantly localized to synaptic vesicles and provides additional GABA synthesis when there is increased demand for rapid neurotransmitter release during high-frequency neural firing."", ""downstream"": [{""description"": ""Impaired GABAergic signaling disrupts reciprocal inhibition in motor circuits, causing simultaneous contraction of agonist and antagonist muscles."", ""evidence"": [{""explanation"": ""The mechanism explicitly describes how reciprocal inhibition failure leads to the characteristic muscle co-contraction."", ""reference"": ""PMID:35084720"", ""snippet"": ""the phenomenon of reciprocal inhibition as the fundamental mechanism of the patients' muscle stiffness and spasms"", ""supports"": ""SUPPORT""}], ""target"": ""Loss of Reciprocal Inhibition""}], ""evidence"": [{""explanation"": ""This landmark paper identified GAD as the target antigen in stiff person syndrome, establishing the autoimmune basis."", ""reference"": ""PMID:3281011"", ""snippet"": ""A band comigrating with glutamic acid decarboxylase in sodium dodecyl sulfate-polyacrylamide gels appeared to be the only nervous-tissue antigen recognized by cerebrospinal fluid antibodies"", ""supports"": ""SUPPORT""}, {""explanation"": ""High GAD antibody titers correlate with reduced GABA levels, supporting the pathophysiological mechanism."", ""reference"": ""PMID:35084720"", ""snippet"": ""Very high serum anti-GAD antibody titers are a key diagnostic feature for all GAD-SD, commonly associated with the presence of GAD antibodies in the CSF, a reduced CSF GABA level"", ""supports"": ""SUPPORT""}, {""explanation"": ""The 2023 review confirms that intrathecal GAD antibody synthesis and impaired GABAergic neurotransmission are central to pathogenesis."", ""reference"": ""PMID:37059468"", ""snippet"": ""caused by impaired GABAergic inhibitory neurotransmission and autoimmunity characterized by very high titers of GAD antibodies and increased GAD-IgG intrathecal synthesis"", ""supports"": ""SUPPORT""}], ""name"": ""GABAergic Inhibition Impairment""}"
7287	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	1	Loss of Reciprocal Inhibition	Failure of GABAergic interneurons to inhibit antagonist motor neurons during voluntary movement, resulting in co-contraction of opposing muscle groups and the characteristic rigid posture.																																																								"{""description"": ""Failure of GABAergic interneurons to inhibit antagonist motor neurons during voluntary movement, resulting in co-contraction of opposing muscle groups and the characteristic rigid posture."", ""name"": ""Loss of Reciprocal Inhibition""}"	{}	"{""cell_types"": [{""preferred_term"": ""Motor Neuron"", ""term"": {""id"": ""CL:0000100"", ""label"": ""motor neuron""}}], ""description"": ""Failure of GABAergic interneurons to inhibit antagonist motor neurons during voluntary movement, resulting in co-contraction of opposing muscle groups and the characteristic rigid posture."", ""evidence"": [{""explanation"": ""Directly describes the loss of reciprocal inhibition mechanism."", ""reference"": ""PMID:35084720"", ""snippet"": ""the phenomenon of reciprocal inhibition as the fundamental mechanism of the patients' muscle stiffness and spasms"", ""supports"": ""SUPPORT""}], ""name"": ""Loss of Reciprocal Inhibition""}"
7288	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	2	Intrathecal B-cell Autoimmunity	B-cell-mediated autoimmune inflammation with clonal B-cell activation specifically within the central nervous system. Approximately 67% of patients demonstrate oligoclonal IgG bands in the CSF, and 85% exhibit increased GAD65-specific IgG index values, indicating intrathecal antibody synthesis.																																																								"{""description"": ""B-cell-mediated autoimmune inflammation with clonal B-cell activation specifically within the central nervous system. Approximately 67% of patients demonstrate oligoclonal IgG bands in the CSF, and 85% exhibit increased GAD65-specific IgG index values, indicating intrathecal antibody synthesis."", ""name"": ""Intrathecal B-cell Autoimmunity""}"	{}	"{""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""B-cell-mediated autoimmune inflammation with clonal B-cell activation specifically within the central nervous system. Approximately 67% of patients demonstrate oligoclonal IgG bands in the CSF, and 85% exhibit increased GAD65-specific IgG index values, indicating intrathecal antibody synthesis."", ""evidence"": [{""explanation"": ""Describes the intrathecal B-cell activation and antibody synthesis characteristic of SPS."", ""reference"": ""PMID:35084720"", ""snippet"": ""Very high serum anti-GAD antibody titers are a key diagnostic feature for all GAD-SD, commonly associated with the presence of GAD antibodies in the CSF, a reduced CSF GABA level and increased anti-GAD-specific IgG intrathecal synthesis denoting stimulation of B-cell clones in the CNS"", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms that intrathecal GAD antibody synthesis is central to the autoimmune pathogenesis."", ""reference"": ""PMID:37059468"", ""snippet"": ""caused by impaired GABAergic inhibitory neurotransmission and autoimmunity characterized by very high titers of GAD antibodies and increased GAD-IgG intrathecal synthesis"", ""supports"": ""SUPPORT""}], ""name"": ""Intrathecal B-cell Autoimmunity""}"
7307	317	Synovial Sarcoma	Synovial_Sarcoma.yaml	pathophysiology	0	SS18-SSX Fusion Oncogene	The t(X;18)(p11;q11) translocation fuses the SS18 gene on chromosome 18 to one of three SSX genes (SSX1, SSX2, or rarely SSX4) on the X chromosome. The SS18-SSX fusion protein disrupts the BAF (SWI/SNF) chromatin remodeling complex, leading to aberrant transcriptional regulation and epigenetic reprogramming.																																																								"{""description"": ""The t(X;18)(p11;q11) translocation fuses the SS18 gene on chromosome 18 to one of three SSX genes (SSX1, SSX2, or rarely SSX4) on the X chromosome. The SS18-SSX fusion protein disrupts the BAF (SWI/SNF) chromatin remodeling complex, leading to aberrant transcriptional regulation and epigenetic reprogramming."", ""name"": ""SS18-SSX Fusion Oncogene""}"	"{""downstream"": [{""description"": ""SS18-SSX integrates into BAF complex altering its function"", ""target"": ""BAF Complex Disruption""}, {""description"": ""Altered chromatin remodeling leads to aberrant gene expression"", ""target"": ""Epigenetic Reprogramming""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""chromatin remodeling"", ""term"": {""id"": ""GO:0006338"", ""label"": ""chromatin remodeling""}}], ""description"": ""The t(X;18)(p11;q11) translocation fuses the SS18 gene on chromosome 18 to one of three SSX genes (SSX1, SSX2, or rarely SSX4) on the X chromosome. The SS18-SSX fusion protein disrupts the BAF (SWI/SNF) chromatin remodeling complex, leading to aberrant transcriptional regulation and epigenetic reprogramming."", ""downstream"": [{""description"": ""SS18-SSX integrates into BAF complex altering its function"", ""target"": ""BAF Complex Disruption""}, {""description"": ""Altered chromatin remodeling leads to aberrant gene expression"", ""target"": ""Epigenetic Reprogramming""}], ""evidence"": [{""explanation"": ""Supports the presence of SS18-SSX fusions as a defining feature of synovial sarcoma."", ""reference"": ""PMID:32092619"", ""snippet"": ""SS18 (SYT) break-apart by FISH or SS18-SSX (SYT-SSX) fusion by reverse transcription-polymerase chain reaction is recommended as a sensitive and specific test to differentiate patients with synovial sarcoma from other sarcomas."", ""supports"": ""SUPPORT""}], ""name"": ""SS18-SSX Fusion Oncogene""}"
7308	317	Synovial Sarcoma	Synovial_Sarcoma.yaml	pathophysiology	1	BAF Complex Disruption	The SS18-SSX fusion protein incorporates into the BAF chromatin remodeling complex, displacing wild-type SS18. This alters BAF complex targeting and function, particularly affecting polycomb-mediated gene repression. The fusion protein causes eviction of BAF47 (SMARCB1) from the complex at certain genomic loci.																																																								"{""description"": ""The SS18-SSX fusion protein incorporates into the BAF chromatin remodeling complex, displacing wild-type SS18. This alters BAF complex targeting and function, particularly affecting polycomb-mediated gene repression. The fusion protein causes eviction of BAF47 (SMARCB1) from the complex at certain genomic loci."", ""name"": ""BAF Complex Disruption""}"	{}	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""regulation of gene expression"", ""term"": {""id"": ""GO:0010468"", ""label"": ""regulation of gene expression""}}], ""description"": ""The SS18-SSX fusion protein incorporates into the BAF chromatin remodeling complex, displacing wild-type SS18. This alters BAF complex targeting and function, particularly affecting polycomb-mediated gene repression. The fusion protein causes eviction of BAF47 (SMARCB1) from the complex at certain genomic loci."", ""name"": ""BAF Complex Disruption""}"
7309	317	Synovial Sarcoma	Synovial_Sarcoma.yaml	pathophysiology	2	Epigenetic Reprogramming	SS18-SSX-containing BAF complexes fail to properly oppose polycomb repressive complexes, leading to abnormal silencing of tumor suppressors and activation of oncogenic programs. Key target genes include BCL2 (antiapoptotic) and multiple receptor tyrosine kinases.																																																								"{""description"": ""SS18-SSX-containing BAF complexes fail to properly oppose polycomb repressive complexes, leading to abnormal silencing of tumor suppressors and activation of oncogenic programs. Key target genes include BCL2 (antiapoptotic) and multiple receptor tyrosine kinases."", ""name"": ""Epigenetic Reprogramming""}"	{}	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""description"": ""SS18-SSX-containing BAF complexes fail to properly oppose polycomb repressive complexes, leading to abnormal silencing of tumor suppressors and activation of oncogenic programs. Key target genes include BCL2 (antiapoptotic) and multiple receptor tyrosine kinases."", ""name"": ""Epigenetic Reprogramming""}"
7340	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	0	Formation of Immune Complexes																																																									"{""name"": ""Formation of Immune Complexes""}"	{}	"{""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}, {""preferred_term"": ""plasma cell"", ""term"": {""id"": ""CL:0000786"", ""label"": ""plasma cell""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""evidence"": [{""explanation"": ""The reference discusses the altered metabolic patterns of B cells, CD4(+) T cells, and myeloid cells (which include macrophages) and their contribution to lupus, which indirectly supports the involvement of these cell types in lupus mechanisms, but it does not specifically address immune complex formation directly."", ""reference"": ""PMID:27709413"", ""snippet"": ""Here, we review what is known on the altered metabolic patterns of CD4(+) T cells, B cells, and myeloid cells in lupus patients and lupus-prone mice and how they contribute to lupus pathogenesis."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference demonstrates the role of specific plasma cells in the development of lupus nephritis, implying their role in immune complex-related pathology, but does not detail the direct involvement of B cells or macrophages in immune complex formation."", ""reference"": ""PMID:29925508"", ""snippet"": ""TLR4(+)CXCR4(+) plasma cells drive nephritis development in systemic lupus erythematosus."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference highlights the crucial role of B cells in the pathogenesis of SLE through mechanisms such as autoantibody production, which is critical for immune complex formation. However, it does not explicitly discuss the role of plasma cells or macrophages in the context given."", ""reference"": ""PMID:34402453"", ""snippet"": ""B-lymphocytes are crucial in the pathogenesis of systemic lupus erythematosus (SLE), including autoantibody production, antigen presentation, co-stimulation, and cytokine secretion."", ""supports"": ""PARTIAL""}, {""explanation"": ""This suggests that macrophages have a role in immune complex-mediated processes through cytokine regulation and opsonin stimulation, contributing to the immune systems activity in lupus but does not detail the involvement of B cells or plasma cells in immune complex formation."", ""reference"": ""PMID:22999705"", ""snippet"": ""C1q opsonized apoptotic cells also exert an immunosuppressive effect through cytokine regulation and the stimulation of additional opsonins by macrophages."", ""supports"": ""PARTIAL""}], ""name"": ""Formation of Immune Complexes""}"
7341	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	1	Glomerular Immune Complex Deposition	"Circulating immune complexes containing anti-dsDNA and anti-Sm antibodies lodge in kidney glomeruli, activating complement and recruiting inflammatory cells.
"																																																								"{""description"": ""Circulating immune complexes containing anti-dsDNA and anti-Sm antibodies lodge in kidney glomeruli, activating complement and recruiting inflammatory cells.\n"", ""name"": ""Glomerular Immune Complex Deposition""}"	"{""downstream"": [{""description"": ""Immune complex deposition in glomeruli triggers local inflammation and tissue damage."", ""target"": ""Lupus Nephritis""}]}"	"{""biological_processes"": [{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""description"": ""Circulating immune complexes containing anti-dsDNA and anti-Sm antibodies lodge in kidney glomeruli, activating complement and recruiting inflammatory cells.\n"", ""downstream"": [{""description"": ""Immune complex deposition in glomeruli triggers local inflammation and tissue damage."", ""target"": ""Lupus Nephritis""}], ""evidence"": [{""explanation"": ""The literature supports the deposition of immune complexes in kidney glomeruli but does not cover skeletal joints, skin, heart, or lung in this context."", ""reference"": ""PMID:33841392"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a complex chronic autoimmune disease characterized by tissue damage and widespread inflammation in response to environmental challenges. Deposition of immune complexes in kidneys glomeruli are associated with lupus nephritis, determining SLE diagnosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms immune complex deposition in kidneys."", ""reference"": ""PMID:30009962"", ""snippet"": ""LN is characterized by glomerular kidney injury, essentially due to deposition of immune complexes involving autoantibodies against cellular components and circulating proteins."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Kidney"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}], ""name"": ""Glomerular Immune Complex Deposition""}"
7342	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	2	Cutaneous Immune Complex Deposition	"Immune complexes deposit at the dermal-epidermal junction and in vessel walls of the skin, leading to cutaneous manifestations of lupus.
"																																																								"{""description"": ""Immune complexes deposit at the dermal-epidermal junction and in vessel walls of the skin, leading to cutaneous manifestations of lupus.\n"", ""name"": ""Cutaneous Immune Complex Deposition""}"	{}	"{""biological_processes"": [{""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Immune complexes deposit at the dermal-epidermal junction and in vessel walls of the skin, leading to cutaneous manifestations of lupus.\n"", ""evidence"": [{""explanation"": ""This paper directly establishes that autoantibodies form immune complexes which cause inflammatory damage to multiple organs in SLE."", ""reference"": ""PMID:35872103"", ""snippet"": ""The autoantibodies, especially anti-dsDNA and anti-Sm autoantibodies are highly specific to SLE, and participate in the immune complex formation and inflammatory damage on multiple end-organs such as kidney, skin, and central nervous system (CNS)."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature confirms the deposition of immune complexes in kidneys, joints, and skin, but does not mention the heart and lung specifically in this context."", ""reference"": ""PMID:16572034"", ""snippet"": ""Systemic lupus erythematosus is an autoimmune disease that causes inflammation in the tissues of the brain, endothelial cells, gastrointestinal/genitourinary (GI/GU), joints, kidneys, muscles, and skin. Lupus comprises a range of multisystem disorders involving the deposition of aberrant immune complexes into tissues."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Skin"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}], ""name"": ""Cutaneous Immune Complex Deposition""}"
7343	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	3	Synovial Immune Complex Deposition	"Immune complexes accumulate in synovial fluid and tissue of joints, activating complement and triggering inflammatory arthritis.
"																																																								"{""description"": ""Immune complexes accumulate in synovial fluid and tissue of joints, activating complement and triggering inflammatory arthritis.\n"", ""name"": ""Synovial Immune Complex Deposition""}"	{}	"{""biological_processes"": [{""preferred_term"": ""complement activation"", ""term"": {""id"": ""GO:0006956"", ""label"": ""complement activation""}}], ""description"": ""Immune complexes accumulate in synovial fluid and tissue of joints, activating complement and triggering inflammatory arthritis.\n"", ""evidence"": [{""explanation"": ""The literature confirms the deposition of immune complexes in kidneys, joints, and skin, but does not mention the heart and lung specifically in this context."", ""reference"": ""PMID:16572034"", ""snippet"": ""Systemic lupus erythematosus is an autoimmune disease that causes inflammation in the tissues of the brain, endothelial cells, gastrointestinal/genitourinary (GI/GU), joints, kidneys, muscles, and skin. Lupus comprises a range of multisystem disorders involving the deposition of aberrant immune complexes into tissues."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms immune complex deposition in the heart."", ""reference"": ""PMID:2860699"", ""snippet"": ""Evidence is now slowly accumulating that substantiates that immune complex deposition, complement activation and subsequent inflammatory reaction is responsible for the majority of the cardiovascular manifestations of SLE, for example, pericarditis, myocarditis, endocarditis, coronary arteritis, coronary atherosclerosis, and systemic and pulmonary vasculitis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference does not mention the deposition of immune complexes in skeletal joints."", ""reference"": ""PMID:28900675"", ""snippet"": ""Recent studies demonstrated an increased incidence of osteoporosis and peripheral and vertebral fractures in patients with SLE"", ""supports"": ""WRONG_STATEMENT""}, {""explanation"": ""This confirms immune complex deposition in the lung."", ""reference"": ""PMID:158982"", ""snippet"": ""Abundant evidence currently exists to suggest that immune complexes play an important role in inflammatory diseases of the lung. ... systemic lupus erythematosus have been shown to be associated with the presence of immune complexes both in lung and in the serum."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Skeletal Joint"", ""term"": {""id"": ""UBERON:0000982"", ""label"": ""skeletal joint""}}], ""name"": ""Synovial Immune Complex Deposition""}"
7344	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	4	Inflammation And Tissue Damage																																																									"{""name"": ""Inflammation And Tissue Damage""}"	{}	"{""evidence"": [{""explanation"": ""The article describes inflammation and immune complex deposition as mechanisms leading to tissue damage in SLE."", ""reference"": ""PMID:22192660"", ""snippet"": ""Systemic lupus erythematosus is a prototypic autoimmune disease characterized by autoantibody production and immune complex formation/deposition in target organs such as the kidney. Resultant local inflammation then leads to organ damage."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature explains that inflammation and tissue damage are core mechanisms in the pathology of SLE due to immune system disturbances."", ""reference"": ""PMID:36555640"", ""snippet"": ""The clinical heterogeneity of the disease is accompanied by complex disturbances affecting the immune system with inflammation and tissue damage due to loss of tolerance to nuclear antigens and the deposition of immune complexes in tissues."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article outlines inflammation as part of the immune dysregulation in SLE, leading to tissue damage in multiple organs."", ""reference"": ""PMID:28623084"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organs. A complex interaction of genetics, environment, and hormones leads to immune dysregulation and breakdown of tolerance to self-antigens, resulting in autoantibody production, inflammation, and destruction of end-organs."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study identifies widespread inflammation and tissue damage as defining characteristics of SLE."", ""reference"": ""PMID:33841392"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a complex chronic autoimmune disease characterized by tissue damage and widespread inflammation in response to environmental challenges."", ""supports"": ""SUPPORT""}, {""explanation"": ""The review supports that inflammation and tissue damage are significant mechanisms in SLE affecting organs such as the skin, kidneys, and nervous system."", ""reference"": ""PMID:37712757"", ""snippet"": ""In the current review, we focus on the commonly affected organs (skin, kidney, and nervous system) in SLE to summarize the emerging biomarkers that show promise in disease diagnosis, monitoring and treatment response assessment."", ""supports"": ""SUPPORT""}], ""name"": ""Inflammation And Tissue Damage""}"
7345	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	5	Chronic Inflammation																																																									"{""name"": ""Chronic Inflammation""}"	{}	"{""evidence"": [{""explanation"": ""The abstract confirms that inflammation is a key aspect of systemic lupus erythematosus pathogenesis."", ""reference"": ""PMID:16572034"", ""snippet"": ""Systemic lupus erythematosus is an autoimmune disease that causes inflammation in the tissues..."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract clearly mentions inflammation as a characteristic feature of SLE."", ""reference"": ""PMID:26330673"", ""snippet"": ""Systemic lupus erythematosus, the prototype systemic autoimmune disease, is characterized by extensive self-reactivity, inflammation, and organ system damage."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature describes SLE as a chronic autoimmune disease affecting various organs, implying sustained inflammation over time."", ""reference"": ""PMID:32237942"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is potentially life-threatening and can affect any organ."", ""supports"": ""SUPPORT""}, {""explanation"": ""The abstract discusses the role of inflammasome and inflammation in organ damage associated with SLE, supporting the chronic inflammation mechanism."", ""reference"": ""PMID:24992143"", ""snippet"": ""Recent evidence suggests that the inflammasome machinery is dysregulated in SLE, plays an important role in promotion of organ damage, and may mediate cross-talk between environmental triggers and the development of lupus."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature describes inflammation and tissue damage due to immune complexes, which supports chronic inflammation as a mechanism of SLE."", ""reference"": ""PMID:36555640"", ""snippet"": ""The clinical heterogeneity of the disease is accompanied by complex disturbances affecting the immune system with inflammation and tissue damage due to loss of tolerance to nuclear antigens and the deposition of immune complexes in tissues."", ""supports"": ""SUPPORT""}], ""name"": ""Chronic Inflammation""}"
7346	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	6	Flare-Ups	The symptoms of lupus can worsen suddenly in episodes known as flares, which can be triggered by factors like stress, sunlight, and infections.																																																								"{""description"": ""The symptoms of lupus can worsen suddenly in episodes known as flares, which can be triggered by factors like stress, sunlight, and infections."", ""name"": ""Flare-Ups""}"	{}	"{""description"": ""The symptoms of lupus can worsen suddenly in episodes known as flares, which can be triggered by factors like stress, sunlight, and infections."", ""evidence"": [{""explanation"": ""This reference mentions the potential triggers for lupus flares, which include UV light (sunlight) and infections."", ""reference"": ""PMID:26951252"", ""snippet"": ""These include exposure to UV light, infections, certain hormones, and drugs which may activate the innate and adaptive immune system, resulting in inflammation, cytotoxic effects, and clinical symptoms."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference specifically states that stress and infections can trigger lupus flares."", ""reference"": ""PMID:26494589"", ""snippet"": ""Some triggers for these exacerbations have been identified, including infections, vaccines, pregnancy, environmental factors such as weather, stress and drugs."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference confirms that sunlight exposure can trigger lupus flares."", ""reference"": ""PMID:22385883"", ""snippet"": ""Exposure to sunlight is one of the environmental factors involved in the pathogenesis of systemic lupus erythematosus."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference discusses photosensitivity (sunlight) as a significant factor, aligning with the statement's mention of sunlight as a trigger."", ""reference"": ""PMID:30488801"", ""snippet"": ""The cutaneous manifestations that were present included malar rash 37.69%, photosensitivity 35.10%, discoid lupus 17.63%, and hair loss 39.29%."", ""supports"": ""SUPPORT""}], ""name"": ""Flare-Ups""}"
7347	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	7	Type I Interferon Pathway Activation	Chronic activation of the type I interferon signaling pathway is a central pathophysiological mechanism in SLE, shaping dysregulation across immune cell lineages and correlating with disease activity and therapy response.																																																								"{""description"": ""Chronic activation of the type I interferon signaling pathway is a central pathophysiological mechanism in SLE, shaping dysregulation across immune cell lineages and correlating with disease activity and therapy response."", ""name"": ""Type I Interferon Pathway Activation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""type I interferon signaling pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""plasmacytoid dendritic cell"", ""term"": {""id"": ""CL:0000784"", ""label"": ""plasmacytoid dendritic cell""}}, {""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Chronic activation of the type I interferon signaling pathway is a central pathophysiological mechanism in SLE, shaping dysregulation across immune cell lineages and correlating with disease activity and therapy response."", ""evidence"": [{""explanation"": ""This review describes the type I interferon gene signature in SLE, supporting chronic activation of the type I interferon pathway."", ""reference"": ""PMID:24834763"", ""snippet"": ""An increased expression of type I IFN-regulated genes, termed IFN signature, has been reported in patients with SLE."", ""supports"": ""SUPPORT""}], ""name"": ""Type I Interferon Pathway Activation""}"
7348	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	8	TLR7/TLR9-Mediated Nucleic Acid Sensing	B cell-intrinsic TLR7 signaling drives severe lupus through recognition of RNA-associated autoantigens, while TLR9 can exert counter-regulatory effects. TLR7/9 activation in plasmacytoid dendritic cells triggers type I interferon production.																																																								"{""description"": ""B cell-intrinsic TLR7 signaling drives severe lupus through recognition of RNA-associated autoantigens, while TLR9 can exert counter-regulatory effects. TLR7/9 activation in plasmacytoid dendritic cells triggers type I interferon production."", ""name"": ""TLR7/TLR9-Mediated Nucleic Acid Sensing""}"	{}	"{""biological_processes"": [{""preferred_term"": ""toll-like receptor signaling pathway"", ""term"": {""id"": ""GO:0002224"", ""label"": ""toll-like receptor signaling pathway""}}, {""preferred_term"": ""toll-like receptor 7 signaling pathway"", ""term"": {""id"": ""GO:0034154"", ""label"": ""toll-like receptor 7 signaling pathway""}}, {""preferred_term"": ""toll-like receptor 9 signaling pathway"", ""term"": {""id"": ""GO:0034162"", ""label"": ""toll-like receptor 9 signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}, {""preferred_term"": ""plasmacytoid dendritic cell"", ""term"": {""id"": ""CL:0000784"", ""label"": ""plasmacytoid dendritic cell""}}], ""description"": ""B cell-intrinsic TLR7 signaling drives severe lupus through recognition of RNA-associated autoantigens, while TLR9 can exert counter-regulatory effects. TLR7/9 activation in plasmacytoid dendritic cells triggers type I interferon production."", ""name"": ""TLR7/TLR9-Mediated Nucleic Acid Sensing""}"
7349	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	9	NETosis and Neutrophil Extracellular Trap Formation	Neutrophils undergo enhanced NETosis, releasing extracellular traps (NETs) composed of DNA, histones, and granule proteins. Impaired NET degradation due to deficient serum DNase1 amplifies the pDC-TLR9-IFN-alpha loop and provides modified autoantigens. NETs are associated with lupus nephritis.																																																								"{""description"": ""Neutrophils undergo enhanced NETosis, releasing extracellular traps (NETs) composed of DNA, histones, and granule proteins. Impaired NET degradation due to deficient serum DNase1 amplifies the pDC-TLR9-IFN-alpha loop and provides modified autoantigens. NETs are associated with lupus nephritis."", ""name"": ""NETosis and Neutrophil Extracellular Trap Formation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""neutrophil degranulation"", ""term"": {""id"": ""GO:0043312"", ""label"": ""neutrophil degranulation""}}, {""preferred_term"": ""neutrophil extracellular trap formation"", ""term"": {""id"": ""GO:0036230"", ""label"": ""neutrophil extracellular trap formation""}}], ""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Neutrophils undergo enhanced NETosis, releasing extracellular traps (NETs) composed of DNA, histones, and granule proteins. Impaired NET degradation due to deficient serum DNase1 amplifies the pDC-TLR9-IFN-alpha loop and provides modified autoantigens. NETs are associated with lupus nephritis."", ""name"": ""NETosis and Neutrophil Extracellular Trap Formation""}"
7350	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	10	Age-Associated B Cell Expansion	Age-associated B cells (ABCs) are enriched in SLE, characterized by T-bet and CD11c expression. They correlate with IFN signatures and disease activity, linking IFN-BAFF-IL-21 circuits to persistent autoantibody production.																																																								"{""description"": ""Age-associated B cells (ABCs) are enriched in SLE, characterized by T-bet and CD11c expression. They correlate with IFN signatures and disease activity, linking IFN-BAFF-IL-21 circuits to persistent autoantibody production."", ""name"": ""Age-Associated B Cell Expansion""}"	{}	"{""biological_processes"": [{""preferred_term"": ""B cell activation"", ""term"": {""id"": ""GO:0042113"", ""label"": ""B cell activation""}}, {""preferred_term"": ""B cell differentiation"", ""term"": {""id"": ""GO:0030183"", ""label"": ""B cell differentiation""}}], ""cell_types"": [{""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}], ""description"": ""Age-associated B cells (ABCs) are enriched in SLE, characterized by T-bet and CD11c expression. They correlate with IFN signatures and disease activity, linking IFN-BAFF-IL-21 circuits to persistent autoantibody production."", ""name"": ""Age-Associated B Cell Expansion""}"
7351	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	11	T Follicular Helper Cell Dysregulation	T follicular helper (Tfh) and T peripheral helper (Tph) cells expand in SLE, characterized by ICOS, PD-1, and IL-21 expression. They drive autoreactive B cell differentiation through both extrafollicular and germinal center pathways.																																																								"{""description"": ""T follicular helper (Tfh) and T peripheral helper (Tph) cells expand in SLE, characterized by ICOS, PD-1, and IL-21 expression. They drive autoreactive B cell differentiation through both extrafollicular and germinal center pathways."", ""name"": ""T Follicular Helper Cell Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""T cell activation"", ""term"": {""id"": ""GO:0042110"", ""label"": ""T cell activation""}}, {""preferred_term"": ""germinal center formation"", ""term"": {""id"": ""GO:0002467"", ""label"": ""germinal center formation""}}], ""cell_types"": [{""preferred_term"": ""T follicular helper cell"", ""term"": {""id"": ""CL:0002038"", ""label"": ""T follicular helper cell""}}, {""preferred_term"": ""T cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""T follicular helper (Tfh) and T peripheral helper (Tph) cells expand in SLE, characterized by ICOS, PD-1, and IL-21 expression. They drive autoreactive B cell differentiation through both extrafollicular and germinal center pathways."", ""name"": ""T Follicular Helper Cell Dysregulation""}"
7352	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	12	Impaired Apoptotic Cell Clearance	Defective clearance of apoptotic cells and impaired efferocytosis lead to increased exposure to nuclear antigens, propagating immune complex formation and autoantibody production.																																																								"{""description"": ""Defective clearance of apoptotic cells and impaired efferocytosis lead to increased exposure to nuclear antigens, propagating immune complex formation and autoantibody production."", ""name"": ""Impaired Apoptotic Cell Clearance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""apoptotic cell clearance"", ""term"": {""id"": ""GO:0043277"", ""label"": ""apoptotic cell clearance""}}, {""preferred_term"": ""efferocytosis"", ""term"": {""id"": ""GO:0043277"", ""label"": ""apoptotic cell clearance""}}], ""description"": ""Defective clearance of apoptotic cells and impaired efferocytosis lead to increased exposure to nuclear antigens, propagating immune complex formation and autoantibody production."", ""name"": ""Impaired Apoptotic Cell Clearance""}"
7353	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	13	Complement Pathway Dysregulation	Early component complement deficiencies (C1q, C3, C4) and complement consumption occur alongside immune complex deposition. Classical pathway activation by immune complexes contributes to tissue injury, particularly in lupus nephritis.																																																								"{""description"": ""Early component complement deficiencies (C1q, C3, C4) and complement consumption occur alongside immune complex deposition. Classical pathway activation by immune complexes contributes to tissue injury, particularly in lupus nephritis."", ""name"": ""Complement Pathway Dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""complement activation, classical pathway"", ""term"": {""id"": ""GO:0006958"", ""label"": ""complement activation, classical pathway""}}], ""description"": ""Early component complement deficiencies (C1q, C3, C4) and complement consumption occur alongside immune complex deposition. Classical pathway activation by immune complexes contributes to tissue injury, particularly in lupus nephritis."", ""locations"": [{""preferred_term"": ""Kidney"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}, {""preferred_term"": ""Glomerulus"", ""term"": {""id"": ""UBERON:0000074"", ""label"": ""renal glomerulus""}}], ""name"": ""Complement Pathway Dysregulation""}"
7378	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	0	Vascular Injury and Endothelial Dysfunction	Early endothelial cell injury leads to vascular damage, intimal proliferation, and obliterative vasculopathy. Raynaud's phenomenon reflects vasospasm and structural vascular changes.																																																								"{""description"": ""Early endothelial cell injury leads to vascular damage, intimal proliferation, and obliterative vasculopathy. Raynaud's phenomenon reflects vasospasm and structural vascular changes."", ""name"": ""Vascular Injury and Endothelial Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Blood Vessel Development"", ""term"": {""id"": ""GO:0001568"", ""label"": ""blood vessel development""}}], ""cell_types"": [{""preferred_term"": ""Endothelial Cell"", ""term"": {""id"": ""CL:0000115"", ""label"": ""endothelial cell""}}], ""description"": ""Early endothelial cell injury leads to vascular damage, intimal proliferation, and obliterative vasculopathy. Raynaud's phenomenon reflects vasospasm and structural vascular changes."", ""evidence"": [{""explanation"": ""This evidence supports the early vascular injury mechanism by demonstrating that defective angiogenesis and capillary abnormalities precede fibrosis in SSc."", ""reference"": ""PMID:38927538"", ""snippet"": ""In systemic sclerosis (SSc, or scleroderma), defective angiogenesis, clinically manifesting with abnormal capillary architecture and severe capillary reduction, represents a hallmark of early-stage disease, usually preceding the onset of tissue fibrosis, and is caused by several cellular and molecular mechanisms affecting microvascular endothelial cells with different outcomes."", ""supports"": ""SUPPORT""}, {""explanation"": ""This describes multiple mechanisms of endothelial dysfunction in SSc, including impaired angiogenesis, endothelial-to-mesenchymal transition, and inflammatory mediator release that contribute to vascular pathology."", ""reference"": ""PMID:38927538"", ""snippet"": ""Indeed, once damaged, endothelial cells can be dysfunctionally activated, thus becoming unable to undergo angiogenesis and promoting perivascular inflammation. They can also undergo apoptosis, transdifferentiate into profibrotic myofibroblasts, or acquire a senescence-associated secretory phenotype characterized by the release of exosomes and several profibrotic and proinflammatory mediators."", ""supports"": ""SUPPORT""}], ""name"": ""Vascular Injury and Endothelial Dysfunction""}"
7379	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	1	Immune Activation and Autoantibody Production	Characteristic autoantibodies include anti-centromere (limited disease), anti-Scl-70/topoisomerase I (diffuse disease), and anti-RNA polymerase III. T cells and macrophages infiltrate affected tissues and produce pro-fibrotic cytokines.																																																								"{""description"": ""Characteristic autoantibodies include anti-centromere (limited disease), anti-Scl-70/topoisomerase I (diffuse disease), and anti-RNA polymerase III. T cells and macrophages infiltrate affected tissues and produce pro-fibrotic cytokines."", ""name"": ""Immune Activation and Autoantibody Production""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Immunoglobulin Production"", ""term"": {""id"": ""GO:0002377"", ""label"": ""immunoglobulin production""}}], ""cell_types"": [{""preferred_term"": ""CD4+ T Cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}, {""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Characteristic autoantibodies include anti-centromere (limited disease), anti-Scl-70/topoisomerase I (diffuse disease), and anti-RNA polymerase III. T cells and macrophages infiltrate affected tissues and produce pro-fibrotic cytokines."", ""evidence"": [{""explanation"": ""This genetic evidence implicates B cell and Fc receptor biology in SSc susceptibility, with IRF8 being a key regulator of immune cell development and interferon responses that contribute to immune dysregulation."", ""reference"": ""PMID:38296975"", ""snippet"": ""Here we report the largest Asian genome-wide association study (GWAS) for systemic sclerosis performed to date, based on data from Japanese subjects and comprising of 1428 cases and 112,599 controls. The lead SNP is in the FCGR/FCRL region, which shows a penetrating association in the Asian population, while a complete linkage disequilibrium SNP, rs10917688, is found in a cis-regulatory element for IRF8."", ""supports"": ""SUPPORT""}, {""explanation"": ""This supports the role of B cell biology and autoantibody production in SSc pathogenesis, demonstrating that B cell-specific genetic variants contribute to disease risk."", ""reference"": ""PMID:38296975"", ""snippet"": ""Prioritizing the top 5% of SNPs of IRF8 binding sites in B cells improves the fitting of the polygenic risk scores, underscoring the roles of B cells and IRF8 in the development of systemic sclerosis."", ""supports"": ""SUPPORT""}], ""name"": ""Immune Activation and Autoantibody Production""}"
7380	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	2	Fibroblast Activation and Fibrosis	TGF-beta signaling drives fibroblast activation and differentiation into myofibroblasts. Excessive collagen and extracellular matrix deposition leads to progressive fibrosis of skin and internal organs.																																																								"{""description"": ""TGF-beta signaling drives fibroblast activation and differentiation into myofibroblasts. Excessive collagen and extracellular matrix deposition leads to progressive fibrosis of skin and internal organs."", ""name"": ""Fibroblast Activation and Fibrosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Extracellular Matrix Organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}, {""preferred_term"": ""TGF-beta Signaling"", ""term"": {""id"": ""GO:0007179"", ""label"": ""transforming growth factor beta receptor signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""Fibroblast"", ""term"": {""id"": ""CL:0000057"", ""label"": ""fibroblast""}}, {""preferred_term"": ""Myofibroblast"", ""term"": {""id"": ""CL:0000186"", ""label"": ""myofibroblast cell""}}], ""description"": ""TGF-beta signaling drives fibroblast activation and differentiation into myofibroblasts. Excessive collagen and extracellular matrix deposition leads to progressive fibrosis of skin and internal organs."", ""evidence"": [{""explanation"": ""This demonstrates the heterogeneity of fibroblast populations in SSc, with increased profibrotic fibroblast subpopulations and decreased normal fibroblast signatures contributing to excessive ECM deposition."", ""reference"": ""PMID:38147960"", ""snippet"": ""SSc skin demonstrated an increased abundance of COMP+, COL11A1+, MYOC+, CCL19+, SFRP4/SFRP2+, and PRSS23/SFRP2+ fibroblasts signatures and decreased proportions of CXCL12+ and PI16+ fibroblast signatures in the Prospective Registry of Early Systemic Sclerosis and Genetics versus Environment in Scleroderma Outcome Study cohorts."", ""supports"": ""SUPPORT""}, {""explanation"": ""This provides direct evidence linking specific fibroblast subpopulations to clinical severity of skin fibrosis, supporting the role of fibroblast activation in SSc pathogenesis and disease progression."", ""reference"": ""PMID:38147960"", ""snippet"": ""The proportions of profibrotic COMP+, COL11A1+, SFRP4/SFRP2+, and PRSS23/SFRP2+ and proinflammatory CCL19+ fibroblast signatures were positively correlated with clinical and histopathological parameters of skin fibrosis, whereas signatures of CXCL12+ and PI16+ fibroblasts were inversely correlated."", ""supports"": ""SUPPORT""}], ""name"": ""Fibroblast Activation and Fibrosis""}"
7395	320	TARP syndrome	TARP_syndrome.yaml	pathophysiology	0	RBM10-mediated alternative splicing dysregulation	Loss-of-function mutations in RBM10 (RNA Binding Motif Protein 10) impair its role as a U2-associated splicing repressor, leading to widespread dysregulation of alternative splicing across the transcriptome. RBM10 normally promotes cassette exon skipping through interaction with U2 snRNP at intron branch sites on chromatin. Loss of RBM10 function shifts hundreds to thousands of splicing events toward exon inclusion. Key downstream effects include NOTCH pathway de-repression via NUMB missplicing and dysregulation of extracellular matrix and cytoskeletal signaling through isoform changes in VCL, CD44, and TNC. These splicing defects disrupt developmental pathways controlling craniofacial morphogenesis, limb patterning, and cardiac development, leading to the characteristic TARP phenotype.																																																								"{""description"": ""Loss-of-function mutations in RBM10 (RNA Binding Motif Protein 10) impair its role as a U2-associated splicing repressor, leading to widespread dysregulation of alternative splicing across the transcriptome. RBM10 normally promotes cassette exon skipping through interaction with U2 snRNP at intron branch sites on chromatin. Loss of RBM10 function shifts hundreds to thousands of splicing events toward exon inclusion. Key downstream effects include NOTCH pathway de-repression via NUMB missplicing and dysregulation of extracellular matrix and cytoskeletal signaling through isoform changes in VCL, CD44, and TNC. These splicing defects disrupt developmental pathways controlling craniofacial morphogenesis, limb patterning, and cardiac development, leading to the characteristic TARP phenotype."", ""name"": ""RBM10-mediated alternative splicing dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Regulation of alternative mRNA splicing via spliceosome"", ""term"": {""id"": ""GO:0000381"", ""label"": ""regulation of alternative mRNA splicing, via spliceosome""}}, {""preferred_term"": ""Notch signaling pathway"", ""term"": {""id"": ""GO:0007219"", ""label"": ""Notch signaling pathway""}}, {""preferred_term"": ""Extracellular matrix organization"", ""term"": {""id"": ""GO:0030198"", ""label"": ""extracellular matrix organization""}}, {""preferred_term"": ""Cytoskeleton organization"", ""term"": {""id"": ""GO:0007010"", ""label"": ""cytoskeleton organization""}}], ""description"": ""Loss-of-function mutations in RBM10 (RNA Binding Motif Protein 10) impair its role as a U2-associated splicing repressor, leading to widespread dysregulation of alternative splicing across the transcriptome. RBM10 normally promotes cassette exon skipping through interaction with U2 snRNP at intron branch sites on chromatin. Loss of RBM10 function shifts hundreds to thousands of splicing events toward exon inclusion. Key downstream effects include NOTCH pathway de-repression via NUMB missplicing and dysregulation of extracellular matrix and cytoskeletal signaling through isoform changes in VCL, CD44, and TNC. These splicing defects disrupt developmental pathways controlling craniofacial morphogenesis, limb patterning, and cardiac development, leading to the characteristic TARP phenotype."", ""evidence"": [{""explanation"": ""Lane et al. 2023 establishes RBM10 as the causative gene for TARP syndrome with loss-of-function splice mutations."", ""reference"": ""PMID:36944446"", ""snippet"": ""TARP (talipes equinovarus, atrial septal defect (ASD), Robin sequence, persistent left superior vena cava) syndrome is a rare X-linked disorder affecting the RBM10 gene"", ""supports"": ""SUPPORT""}], ""name"": ""RBM10-mediated alternative splicing dysregulation""}"
7396	320	TARP syndrome	TARP_syndrome.yaml	pathophysiology	1	RBM10 splicing-independent replication fork dysfunction	RBM10 also functions in a splicing-independent manner at DNA replication forks, where it recruits HDAC1 to promote H4K16 deacetylation and maintains fork stability. Loss of RBM10 induces replication stress and creates synthetic-lethal interactions with WEE1 inhibition. This dual role provides additional pathological mechanisms affecting developmental processes through both transcriptional and chromosomal instability pathways.																																																								"{""description"": ""RBM10 also functions in a splicing-independent manner at DNA replication forks, where it recruits HDAC1 to promote H4K16 deacetylation and maintains fork stability. Loss of RBM10 induces replication stress and creates synthetic-lethal interactions with WEE1 inhibition. This dual role provides additional pathological mechanisms affecting developmental processes through both transcriptional and chromosomal instability pathways."", ""name"": ""RBM10 splicing-independent replication fork dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""DNA replication"", ""term"": {""id"": ""GO:0006268"", ""label"": ""DNA replication""}}, {""preferred_term"": ""H4-K16 deacetylation"", ""term"": {""id"": ""GO:0043111"", ""label"": ""H4-K16 deacetylation""}}], ""description"": ""RBM10 also functions in a splicing-independent manner at DNA replication forks, where it recruits HDAC1 to promote H4K16 deacetylation and maintains fork stability. Loss of RBM10 induces replication stress and creates synthetic-lethal interactions with WEE1 inhibition. This dual role provides additional pathological mechanisms affecting developmental processes through both transcriptional and chromosomal instability pathways."", ""evidence"": [{""explanation"": ""Machour et al. 2024 demonstrates the splicing-independent role of RBM10 in maintaining DNA replication fork stability through HDAC1 recruitment."", ""reference"": ""PMID:39080280"", ""snippet"": ""RBM10 serves as an anchor for recruiting Histone Deacetylase 1 (HDAC1) to facilitate H4K16 deacetylation and R-loop homeostasis to maintain replication fork stability"", ""supports"": ""SUPPORT""}], ""name"": ""RBM10 splicing-independent replication fork dysfunction""}"
7415	321	Taeniasis/cysticercosis	Taeniasis_Cysticercosis.yaml	pathophysiology	0	Larval infection of the nervous system (neurocysticercosis)	Larval Taenia solium infects the human nervous system.																																																								"{""description"": ""Larval Taenia solium infects the human nervous system."", ""name"": ""Larval infection of the nervous system (neurocysticercosis)""}"	{}	"{""description"": ""Larval Taenia solium infects the human nervous system."", ""evidence"": [{""explanation"": ""The abstract links larval infection to neurocysticercosis."", ""reference"": ""PMID:12932389"", ""snippet"": ""The larval stage of the pork tapeworm (Taenia solium) infects the human nervous system, causing neurocysticercosis."", ""supports"": ""SUPPORT""}], ""name"": ""Larval infection of the nervous system (neurocysticercosis)""}"
7425	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	0	HEXA mutations	"Pathogenic variants in HEXA disrupt hexosaminidase A activity.
"																																																								"{""description"": ""Pathogenic variants in HEXA disrupt hexosaminidase A activity.\n"", ""name"": ""HEXA mutations""}"	"{""downstream"": [{""description"": ""Loss of functional alpha subunit reduces enzyme activity."", ""target"": ""Hexosaminidase A deficiency""}]}"	"{""description"": ""Pathogenic variants in HEXA disrupt hexosaminidase A activity.\n"", ""downstream"": [{""description"": ""Loss of functional alpha subunit reduces enzyme activity."", ""target"": ""Hexosaminidase A deficiency""}], ""evidence"": [{""explanation"": ""Review states Tay-Sachs disease is caused by HEXA mutations affecting hexosaminidase A."", ""reference"": ""PMID:40710901"", ""snippet"": ""Mechanistically, TSD is caused by mutations in the HEXA gene, which encodes the alpha subunit of hexosaminidase A."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""HEXA"", ""term"": {""id"": ""hgnc:4878"", ""label"": ""HEXA""}}], ""name"": ""HEXA mutations""}"
7426	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	1	Hexosaminidase A deficiency	"Lysosomal beta-hexosaminidase A enzyme activity is deficient in Tay-Sachs disease.
"																																																								"{""description"": ""Lysosomal beta-hexosaminidase A enzyme activity is deficient in Tay-Sachs disease.\n"", ""name"": ""Hexosaminidase A deficiency""}"	"{""downstream"": [{""description"": ""Reduced catabolism leads to GM2 storage in neurons."", ""target"": ""GM2 ganglioside accumulation in neurons""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""ganglioside catabolic process"", ""term"": {""id"": ""GO:0006689"", ""label"": ""ganglioside catabolic process""}}], ""description"": ""Lysosomal beta-hexosaminidase A enzyme activity is deficient in Tay-Sachs disease.\n"", ""downstream"": [{""description"": ""Reduced catabolism leads to GM2 storage in neurons."", ""target"": ""GM2 ganglioside accumulation in neurons""}], ""evidence"": [{""explanation"": ""Supports hexosaminidase A deficiency as a core defect in Tay-Sachs disease."", ""reference"": ""PMID:19820796"", ""snippet"": ""Tay-Sachs disease is an autosomal recessive disorder of sphingolipid metabolism, caused by enzyme hexosaminidase A deficiency that leads to an accumulation of GM2 in neurocytes which results in progressive loss of neurological function."", ""supports"": ""SUPPORT""}], ""name"": ""Hexosaminidase A deficiency""}"
7427	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	2	GM2 ganglioside accumulation in neurons	"GM2 ganglioside accumulates in neuronal lysosomes, particularly in the brain.
"																																																								"{""description"": ""GM2 ganglioside accumulates in neuronal lysosomes, particularly in the brain.\n"", ""name"": ""GM2 ganglioside accumulation in neurons""}"	"{""downstream"": [{""description"": ""Storage-related toxicity contributes to neuronal loss."", ""target"": ""Neuron death""}]}"	"{""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""GM2 ganglioside accumulates in neuronal lysosomes, particularly in the brain.\n"", ""downstream"": [{""description"": ""Storage-related toxicity contributes to neuronal loss."", ""target"": ""Neuron death""}], ""evidence"": [{""explanation"": ""GM2 gangliosidosis (includes Tay-Sachs) shows ganglioside accumulation in brain."", ""reference"": ""PMID:22025593"", ""snippet"": ""G(M2) gangliosidoses are caused by an inherited deficiency of lysosomal -hexosaminidase and result in ganglioside accumulation in the brain."", ""supports"": ""SUPPORT""}], ""name"": ""GM2 ganglioside accumulation in neurons""}"
7428	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	3	Neuron death	"Progressive neuronal loss occurs in the nervous system.
"																																																								"{""description"": ""Progressive neuronal loss occurs in the nervous system.\n"", ""name"": ""Neuron death""}"	{}	"{""biological_processes"": [{""preferred_term"": ""neuron death"", ""term"": {""id"": ""GO:0070997"", ""label"": ""neuron death""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Progressive neuronal loss occurs in the nervous system.\n"", ""evidence"": [{""explanation"": ""Review describes rapid neurodegeneration in infantile GM2 gangliosidosis, consistent with neuronal loss."", ""reference"": ""PMID:29618308"", ""snippet"": ""Inherited as a classical autosomal recessive disorder, this global disease of the nervous system induces developmental arrest with regression of attained milestones; neurodegeneration progresses rapidly to cause premature death in young children."", ""supports"": ""SUPPORT""}], ""name"": ""Neuron death""}"
7445	323	Tetanus	Tetanus.yaml	pathophysiology	0	Tetanus Toxin (Tetanospasmin) Action	"Clostridium tetani produces tetanospasmin, a potent neurotoxin that is transported retrogradely along motor neurons to the spinal cord. The toxin blocks the release of inhibitory neurotransmitters (GABA and glycine) from presynaptic terminals in the spinal cord, leading to unopposed muscle contraction and characteristic spasms.
"																																																								"{""description"": ""Clostridium tetani produces tetanospasmin, a potent neurotoxin that is transported retrogradely along motor neurons to the spinal cord. The toxin blocks the release of inhibitory neurotransmitters (GABA and glycine) from presynaptic terminals in the spinal cord, leading to unopposed muscle contraction and characteristic spasms.\n"", ""name"": ""Tetanus Toxin (Tetanospasmin) Action""}"	{}	"{""biological_processes"": [{""preferred_term"": ""synaptic transmission, GABAergic"", ""term"": {""id"": ""GO:0051932"", ""label"": ""synaptic transmission, GABAergic""}}, {""preferred_term"": ""synaptic transmission, glycinergic"", ""term"": {""id"": ""GO:0060012"", ""label"": ""synaptic transmission, glycinergic""}}, {""preferred_term"": ""negative regulation of neurotransmitter secretion"", ""term"": {""id"": ""GO:0046929"", ""label"": ""negative regulation of neurotransmitter secretion""}}], ""cell_types"": [{""preferred_term"": ""motor neuron"", ""term"": {""id"": ""CL:0000100"", ""label"": ""motor neuron""}}], ""description"": ""Clostridium tetani produces tetanospasmin, a potent neurotoxin that is transported retrogradely along motor neurons to the spinal cord. The toxin blocks the release of inhibitory neurotransmitters (GABA and glycine) from presynaptic terminals in the spinal cord, leading to unopposed muscle contraction and characteristic spasms.\n"", ""evidence"": [{""explanation"": ""This review confirms the mechanism of tetanus toxin action through metalloprotease cleavage of SNARE proteins, blocking neurotransmitter release."", ""reference"": ""PMID:35333944"", ""snippet"": ""Tetanus and botulinum neurotoxins cause the neuroparalytic syndromes of tetanus and botulism, respectively, by delivering inside different types of neurons, metalloproteases specifically cleaving the SNARE proteins that are essential for the release of neurotransmitters."", ""supports"": ""SUPPORT""}], ""name"": ""Tetanus Toxin (Tetanospasmin) Action""}"
7446	323	Tetanus	Tetanus.yaml	pathophysiology	1	Autonomic Nervous System Dysfunction	"Tetanus toxin affects the autonomic nervous system, causing sympathetic overactivity that manifests as tachycardia, hypertension, arrhythmias, and hyperthermia. This autonomic instability is a major cause of morbidity and mortality in severe tetanus.
"																																																								"{""description"": ""Tetanus toxin affects the autonomic nervous system, causing sympathetic overactivity that manifests as tachycardia, hypertension, arrhythmias, and hyperthermia. This autonomic instability is a major cause of morbidity and mortality in severe tetanus.\n"", ""name"": ""Autonomic Nervous System Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""synaptic transmission, noradrenergic"", ""term"": {""id"": ""GO:0099155"", ""label"": ""synaptic transmission, noradrenergic""}}], ""cell_types"": [{""preferred_term"": ""noradrenergic neuron"", ""term"": {""id"": ""CL:0008025"", ""label"": ""noradrenergic neuron""}}], ""description"": ""Tetanus toxin affects the autonomic nervous system, causing sympathetic overactivity that manifests as tachycardia, hypertension, arrhythmias, and hyperthermia. This autonomic instability is a major cause of morbidity and mortality in severe tetanus.\n"", ""evidence"": [{""explanation"": ""Links tetanospasmin to dysautonomia underlying cardiovascular instability."", ""reference"": ""PMID:40543524"", ""snippet"": ""C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia."", ""supports"": ""SUPPORT""}], ""name"": ""Autonomic Nervous System Dysfunction""}"
7447	323	Tetanus	Tetanus.yaml	pathophysiology	2	Wound Colonization	"Clostridium tetani spores are ubiquitous in soil and enter the body through wounds. In anaerobic conditions (deep puncture wounds, necrotic tissue), spores germinate and the vegetative bacteria produce toxin locally before it spreads systemically.
"																																																								"{""description"": ""Clostridium tetani spores are ubiquitous in soil and enter the body through wounds. In anaerobic conditions (deep puncture wounds, necrotic tissue), spores germinate and the vegetative bacteria produce toxin locally before it spreads systemically.\n"", ""name"": ""Wound Colonization""}"	{}	"{""description"": ""Clostridium tetani spores are ubiquitous in soil and enter the body through wounds. In anaerobic conditions (deep puncture wounds, necrotic tissue), spores germinate and the vegetative bacteria produce toxin locally before it spreads systemically.\n"", ""evidence"": [{""explanation"": ""Confirms wound contamination as the typical entry and toxin production site."", ""reference"": ""PMID:40543524"", ""snippet"": ""Tetanus results from infections with spore-forming Clostridium tetani bacteria, usually acquired via contaminated wounds and burns."", ""supports"": ""SUPPORT""}], ""name"": ""Wound Colonization""}"
7462	324	Thanatophoric Dysplasia Type 1	Thanatophoric_Dysplasia_Type_1.yaml	pathophysiology	0	Severe FGFR3 gain-of-function	"TD1 mutations cause severe constitutive activation of FGFR3, leading to profound inhibition of chondrocyte proliferation and differentiation in the growth plate. The R248C mutation in the extracellular domain causes ligand-independent receptor dimerization and activation. This results in severely shortened and disorganized growth plates with minimal longitudinal bone growth.
"																																																								"{""description"": ""TD1 mutations cause severe constitutive activation of FGFR3, leading to profound inhibition of chondrocyte proliferation and differentiation in the growth plate. The R248C mutation in the extracellular domain causes ligand-independent receptor dimerization and activation. This results in severely shortened and disorganized growth plates with minimal longitudinal bone growth.\n"", ""name"": ""Severe FGFR3 gain-of-function""}"	{}	"{""biological_processes"": [{""preferred_term"": ""FGFR signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}, {""preferred_term"": ""Negative regulation of chondrocyte differentiation"", ""term"": {""id"": ""GO:0032331"", ""label"": ""negative regulation of chondrocyte differentiation""}}, {""preferred_term"": ""Endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}], ""cell_types"": [{""preferred_term"": ""Growth plate chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}, {""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}], ""description"": ""TD1 mutations cause severe constitutive activation of FGFR3, leading to profound inhibition of chondrocyte proliferation and differentiation in the growth plate. The R248C mutation in the extracellular domain causes ligand-independent receptor dimerization and activation. This results in severely shortened and disorganized growth plates with minimal longitudinal bone growth.\n"", ""gene"": {""description"": ""Fibroblast growth factor receptor 3 with severe gain-of-function mutations."", ""modifier"": ""INCREASED"", ""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}, ""name"": ""Severe FGFR3 gain-of-function""}"
7463	324	Thanatophoric Dysplasia Type 1	Thanatophoric_Dysplasia_Type_1.yaml	pathophysiology	1	Pulmonary hypoplasia	"The severely narrow thorax restricts lung development in utero, resulting in pulmonary hypoplasia that is the primary cause of perinatal death due to respiratory insufficiency.
"																																																								"{""description"": ""The severely narrow thorax restricts lung development in utero, resulting in pulmonary hypoplasia that is the primary cause of perinatal death due to respiratory insufficiency.\n"", ""name"": ""Pulmonary hypoplasia""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Lung development"", ""term"": {""id"": ""GO:0030324"", ""label"": ""lung development""}}], ""cell_types"": [{""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}], ""description"": ""The severely narrow thorax restricts lung development in utero, resulting in pulmonary hypoplasia that is the primary cause of perinatal death due to respiratory insufficiency.\n"", ""name"": ""Pulmonary hypoplasia""}"
7475	325	Thanatophoric Dysplasia Type 2	Thanatophoric_Dysplasia_Type_2.yaml	pathophysiology	0	Severe FGFR3 gain-of-function (K650E)	"The K650E mutation in the tyrosine kinase domain causes severe constitutive activation of FGFR3 through autophosphorylation, independent of ligand binding. This profoundly inhibits chondrocyte proliferation and differentiation, resulting in minimal endochondral bone growth. The K650E mutation causes more severe receptor activation than the K650M mutation (associated with SADDAN syndrome).
"																																																								"{""description"": ""The K650E mutation in the tyrosine kinase domain causes severe constitutive activation of FGFR3 through autophosphorylation, independent of ligand binding. This profoundly inhibits chondrocyte proliferation and differentiation, resulting in minimal endochondral bone growth. The K650E mutation causes more severe receptor activation than the K650M mutation (associated with SADDAN syndrome).\n"", ""name"": ""Severe FGFR3 gain-of-function (K650E)""}"	{}	"{""biological_processes"": [{""preferred_term"": ""FGFR signaling pathway"", ""term"": {""id"": ""GO:0008543"", ""label"": ""fibroblast growth factor receptor signaling pathway""}}, {""preferred_term"": ""Negative regulation of chondrocyte differentiation"", ""term"": {""id"": ""GO:0032331"", ""label"": ""negative regulation of chondrocyte differentiation""}}, {""preferred_term"": ""Endochondral ossification"", ""term"": {""id"": ""GO:0001958"", ""label"": ""endochondral ossification""}}], ""cell_types"": [{""preferred_term"": ""Growth plate chondrocyte"", ""term"": {""id"": ""CL:1000217"", ""label"": ""growth plate cartilage chondrocyte""}}, {""preferred_term"": ""Chondrocyte"", ""term"": {""id"": ""CL:0000138"", ""label"": ""chondrocyte""}}], ""description"": ""The K650E mutation in the tyrosine kinase domain causes severe constitutive activation of FGFR3 through autophosphorylation, independent of ligand binding. This profoundly inhibits chondrocyte proliferation and differentiation, resulting in minimal endochondral bone growth. The K650E mutation causes more severe receptor activation than the K650M mutation (associated with SADDAN syndrome).\n"", ""gene"": {""description"": ""Fibroblast growth factor receptor 3 with severe gain-of-function mutation in the kinase domain."", ""modifier"": ""INCREASED"", ""preferred_term"": ""FGFR3"", ""term"": {""id"": ""hgnc:3690"", ""label"": ""FGFR3""}}, ""name"": ""Severe FGFR3 gain-of-function (K650E)""}"
7476	325	Thanatophoric Dysplasia Type 2	Thanatophoric_Dysplasia_Type_2.yaml	pathophysiology	1	Premature craniosynostosis	"The FGFR3 K650E mutation affects cranial suture development, leading to the cloverleaf skull deformity (kleeblattschadel) seen in many TD2 cases. This involves premature fusion of multiple cranial sutures with compensatory bulging at patent sutures.
"																																																								"{""description"": ""The FGFR3 K650E mutation affects cranial suture development, leading to the cloverleaf skull deformity (kleeblattschadel) seen in many TD2 cases. This involves premature fusion of multiple cranial sutures with compensatory bulging at patent sutures.\n"", ""name"": ""Premature craniosynostosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Cranial suture morphogenesis"", ""term"": {""id"": ""GO:0060363"", ""label"": ""cranial suture morphogenesis""}}], ""description"": ""The FGFR3 K650E mutation affects cranial suture development, leading to the cloverleaf skull deformity (kleeblattschadel) seen in many TD2 cases. This involves premature fusion of multiple cranial sutures with compensatory bulging at patent sutures.\n"", ""name"": ""Premature craniosynostosis""}"
7487	326	Trachoma	Trachoma.yaml	pathophysiology	0	Chronic conjunctival infection with scarring	Recurrent infection drives chronic inflammation and scarring leading to trichiasis.																																																								"{""description"": ""Recurrent infection drives chronic inflammation and scarring leading to trichiasis."", ""name"": ""Chronic conjunctival infection with scarring""}"	{}	"{""description"": ""Recurrent infection drives chronic inflammation and scarring leading to trichiasis."", ""evidence"": [{""explanation"": ""The abstract describes chronic infection progressing to cicatricial disease with trichiasis."", ""reference"": ""PMID:35618795"", ""snippet"": ""Trachoma is a disease complex composed of two linked chronic processes: a recurrent, generally subclinical infectious-inflammatory disease that mostly affects children, and a non-communicable, cicatricial and, owing to trichiasis, eventually blinding disease"", ""supports"": ""SUPPORT""}], ""name"": ""Chronic conjunctival infection with scarring""}"
7494	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	0	Melanocyte Activation	An unknown trigger, possibly related to the transition from intrauterine to extrauterine life, leads to the activation of melanocytes in the skin.																																																								"{""description"": ""An unknown trigger, possibly related to the transition from intrauterine to extrauterine life, leads to the activation of melanocytes in the skin."", ""name"": ""Melanocyte Activation""}"	"{""downstream"": [{""target"": ""Melanin Accumulation""}]}"	"{""biological_processes"": [{""preferred_term"": ""pigmentation"", ""term"": {""id"": ""GO:0043473"", ""label"": ""pigmentation""}}], ""cell_types"": [{""preferred_term"": ""Melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}], ""description"": ""An unknown trigger, possibly related to the transition from intrauterine to extrauterine life, leads to the activation of melanocytes in the skin."", ""downstream"": [{""target"": ""Melanin Accumulation""}], ""name"": ""Melanocyte Activation""}"
7495	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	1	Melanin Accumulation	Activated melanocytes produce and release excessive amounts of melanin, which accumulates in the superficial layers of the skin.																																																								"{""description"": ""Activated melanocytes produce and release excessive amounts of melanin, which accumulates in the superficial layers of the skin."", ""name"": ""Melanin Accumulation""}"	"{""downstream"": [{""target"": ""Pustule Formation""}]}"	"{""description"": ""Activated melanocytes produce and release excessive amounts of melanin, which accumulates in the superficial layers of the skin."", ""downstream"": [{""target"": ""Pustule Formation""}], ""evidence"": [{""explanation"": ""The pathophysiology of transient neonatal pustular melanosis does not mention activated melanocytes producing and releasing excessive amounts of melanin. The etiology is still unknown."", ""reference"": ""PMID:21146802"", ""snippet"": ""Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown."", ""supports"": ""REFUTE""}, {""explanation"": ""This reference discusses melanocyte activation and melanin production in the context of skin pigmentation and tanning, not transient neonatal pustular melanosis."", ""reference"": ""PMID:32092380"", ""snippet"": ""The well-characterized MSH/MC1R-cAMP-MITF pathway regulates UV-induced melanization. Pharmacologic activation of this pathway (sunless tanning) represents a potential strategy for skin cancer prevention, particularly in those with light skin or the red hair phenotype who tan poorly after UV exposure due to MC1R inactivating polymorphisms."", ""supports"": ""REFUTE""}, {""explanation"": ""This study focuses on melanocyte response to UV radiation in mice and does not provide information on transient neonatal pustular melanosis."", ""reference"": ""PMID:18633434"", ""snippet"": ""Melanocytes respond to UVR not only by producing melanin, but also by proliferating. This is essentially a protective response. We have studied the melanocyte proliferative response after a single UVR exposure to neonatal mice."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This reference talks about neonatal skin barrier structure and disorders but does not specifically address transient neonatal pustular melanosis or its pathophysiology."", ""reference"": ""PMID:15953139"", ""snippet"": ""We discuss this transition and then branch out to touch on issues of premature infant as well as neonatal skin care. Disruption of the barrier function due to toxins and development errors are expounded upon."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This study discusses solar lentigo and melanin accumulation but does not relate to transient neonatal pustular melanosis."", ""reference"": ""PMID:36048560"", ""snippet"": ""Solar lentigo (SL) is a hyperpigmented macule that occurs in sun-exposed areas and is characterized by the accumulation of melanin pigment in the epidermis."", ""supports"": ""NO_EVIDENCE""}], ""locations"": [{""preferred_term"": ""Epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}], ""name"": ""Melanin Accumulation""}"
7496	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	2	Pustule Formation	The accumulation of melanin in the epidermis leads to the formation of small, superficial pustules that are characteristically present at birth or develop within the first few days of life. Pustules contain predominantly neutrophils in an intra- or subcorneal location.																																																								"{""description"": ""The accumulation of melanin in the epidermis leads to the formation of small, superficial pustules that are characteristically present at birth or develop within the first few days of life. Pustules contain predominantly neutrophils in an intra- or subcorneal location."", ""name"": ""Pustule Formation""}"	"{""downstream"": [{""target"": ""Hyper pigmentation""}, {""target"": ""Desquamation""}]}"	"{""biological_processes"": [{""preferred_term"": ""neutrophil chemotaxis"", ""term"": {""id"": ""GO:0030593"", ""label"": ""neutrophil chemotaxis""}}, {""preferred_term"": ""epidermis development"", ""term"": {""id"": ""GO:0008544"", ""label"": ""epidermis development""}}, {""preferred_term"": ""keratinization"", ""term"": {""id"": ""GO:0031424"", ""label"": ""keratinization""}}], ""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}, {""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}], ""description"": ""The accumulation of melanin in the epidermis leads to the formation of small, superficial pustules that are characteristically present at birth or develop within the first few days of life. Pustules contain predominantly neutrophils in an intra- or subcorneal location."", ""downstream"": [{""target"": ""Hyper pigmentation""}, {""target"": ""Desquamation""}], ""evidence"": [{""explanation"": ""The literature states that the etiology of transient neonatal pustular melanosis is still unknown. There is no mention of melanin accumulation in the epidermis being a contributing factor."", ""reference"": ""PMID:21146802"", ""snippet"": ""Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown."", ""supports"": ""REFUTE""}], ""locations"": [{""preferred_term"": ""Epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}], ""name"": ""Pustule Formation""}"
7497	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	3	Hyper pigmentation	As the pustules resolve, they may leave behind areas of hyper pigmentation or dark spots on the skin, representing the sites of melanin accumulation. Commonly affected sites include face, neck, and back.																																																								"{""description"": ""As the pustules resolve, they may leave behind areas of hyper pigmentation or dark spots on the skin, representing the sites of melanin accumulation. Commonly affected sites include face, neck, and back."", ""name"": ""Hyper pigmentation""}"	{}	"{""description"": ""As the pustules resolve, they may leave behind areas of hyper pigmentation or dark spots on the skin, representing the sites of melanin accumulation. Commonly affected sites include face, neck, and back."", ""evidence"": [{""explanation"": ""The reference indicates that the vesicopustular lesions associated with Transient Neonatal Pustular Melanosis can evolve into pigmented macules, which aligns with areas of hyper pigmentation or dark spots on the skin, consistent with melanin accumulation."", ""reference"": ""PMID:1271148"", ""snippet"": ""The lesions often present as, or evolve into, a pigmented macule and persist from three weeks to three months."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although the reference title confirms the focus on Transient Neonatal Pustular Melanosis, it does not provide a detailed enough snippet to fully confirm details about the resultant hyperpigmentation. However, it does support the occurrence of the condition."", ""reference"": ""PMID:33397568"", ""snippet"": ""Diagnosis of Transient Neonatal Pustular Melanosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""While the reference discusses pustular disorders generally, it does not provide specific details on the resultant hyperpigmentation associated with Transient Neonatal Pustular Melanosis."", ""reference"": ""PMID:15095913"", ""snippet"": ""The pustular disorders constitute a subgroup of the vesiculobullous disorders defined by the presence of eosinophils or neutrophils."", ""supports"": ""PARTIAL""}], ""locations"": [{""preferred_term"": ""Skin"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}, {""preferred_term"": ""skin of face"", ""term"": {""id"": ""UBERON:0001456"", ""label"": ""skin of face""}}, {""preferred_term"": ""neck"", ""term"": {""id"": ""UBERON:0000974"", ""label"": ""neck""}}, {""preferred_term"": ""back"", ""term"": {""id"": ""UBERON:0002410"", ""label"": ""back""}}], ""name"": ""Hyper pigmentation""}"
7498	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	4	Desquamation	In some cases, the resolution of pustules may be followed by a period of superficial skin peeling or desquamation.																																																								"{""description"": ""In some cases, the resolution of pustules may be followed by a period of superficial skin peeling or desquamation."", ""name"": ""Desquamation""}"	{}	"{""description"": ""In some cases, the resolution of pustules may be followed by a period of superficial skin peeling or desquamation."", ""evidence"": [{""explanation"": ""While this reference explains the general characteristics of pustular disorders, it doesn't clearly support or refute the specific statement regarding desquamation following the resolution of pustules in Transient Neonatal Pustular Melanosis."", ""reference"": ""PMID:15095913"", ""snippet"": ""The pustular disorders constitute a subgroup of the vesiculobullous disorders defined by the presence of eosinophils or neutrophils with prominent accompanying intercellular edema or a canthelysis involving various levels of the epithelium."", ""supports"": ""PARTIAL""}, {""explanation"": ""This study mentions several dermatological conditions commonly seen in neonates, including erythema toxicum neonatorum and physiological skin desquamation, but does not provide specific information about desquamation in the context of Transient Neonatal Pustular Melanosis."", ""reference"": ""PMID:21793881"", ""snippet"": ""There is paucity of literature on the incidence and clinical associations of transient benign dermatological conditions in twin neonates."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""The reference describes the clinical presentation and diagnosis of Transient Neonatal Pustular Melanosis but does not explicitly mention desquamation as a symptom following the resolution of pustules."", ""reference"": ""PMID:24318488"", ""snippet"": ""Clinical recognition of this disease can help physicians avoid unnecessary diagnostic testing and treatment for infectious etiologies because no specific therapy is recommended."", ""supports"": ""NO_EVIDENCE""}], ""locations"": [{""preferred_term"": ""Skin"", ""term"": {""id"": ""UBERON:0002097"", ""label"": ""skin of body""}}], ""name"": ""Desquamation""}"
7499	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	5	Spontaneous Resolution	Transient Neonatal Pustular Melanosis is a self-limited condition that typically resolves spontaneously within a few weeks to months without any sequelae.																																																								"{""description"": ""Transient Neonatal Pustular Melanosis is a self-limited condition that typically resolves spontaneously within a few weeks to months without any sequelae."", ""name"": ""Spontaneous Resolution""}"	{}	"{""description"": ""Transient Neonatal Pustular Melanosis is a self-limited condition that typically resolves spontaneously within a few weeks to months without any sequelae."", ""evidence"": [{""explanation"": ""The article describes transient neonatal pustular melanosis as a benign and self-limited condition, consistent with the statement's description of spontaneous resolution without sequelae."", ""reference"": ""PMID:21146802"", ""snippet"": ""Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease..."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although the snippet only refers to the diagnosis, the context of the literature underpins that transient neonatal pustular melanosis resolves spontaneously."", ""reference"": ""PMID:33397568"", ""snippet"": ""Diagnosis of Transient Neonatal Pustular Melanosis."", ""supports"": ""SUPPORT""}], ""name"": ""Spontaneous Resolution""}"
7500	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	6	Benign Course	Despite the presence of pustules and skin changes, Transient Neonatal Pustular Melanosis is a benign condition that does not affect the overall health of the neonate.																																																								"{""description"": ""Despite the presence of pustules and skin changes, Transient Neonatal Pustular Melanosis is a benign condition that does not affect the overall health of the neonate."", ""name"": ""Benign Course""}"	"{""downstream"": [{""description"": ""TNPM is a benign, self-limited neonatal pustulosis that resolves spontaneously without requiring treatment."", ""evidence"": [{""explanation"": ""This case report confirms the benign, self-limiting nature of TNPM, with skin biopsy showing vesicles containing neutrophil aggregates that resolve without treatment."", ""reference"": ""PMID:21146802"", ""snippet"": ""Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown."", ""supports"": ""SUPPORT""}], ""target"": ""Self-Limited Resolution""}]}"	"{""description"": ""Despite the presence of pustules and skin changes, Transient Neonatal Pustular Melanosis is a benign condition that does not affect the overall health of the neonate."", ""downstream"": [{""description"": ""TNPM is a benign, self-limited neonatal pustulosis that resolves spontaneously without requiring treatment."", ""evidence"": [{""explanation"": ""This case report confirms the benign, self-limiting nature of TNPM, with skin biopsy showing vesicles containing neutrophil aggregates that resolve without treatment."", ""reference"": ""PMID:21146802"", ""snippet"": ""Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown."", ""supports"": ""SUPPORT""}], ""target"": ""Self-Limited Resolution""}], ""evidence"": [{""explanation"": ""The abstract indicates that Transient Neonatal Pustular Melanosis is a benign and self-limited condition."", ""reference"": ""PMID:21146802"", ""snippet"": ""Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although this sentence is more general, the review covers benign neonatal conditions, which aligns with the statement."", ""reference"": ""PMID:33386313"", ""snippet"": ""This article will discuss normal neonatal skin care and benign and common rashes."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference mentions a range of conditions including benign pustular diseases, which supports the statement, but does not specifically mention Transient Neonatal Pustular Melanosis."", ""reference"": ""PMID:16281619"", ""snippet"": ""In the newborn, there exists a wide spectrum of pustular skin diseases. These range from transitory, benign adaptation disorders up to systemic, life threatening illnesses."", ""supports"": ""PARTIAL""}, {""explanation"": ""The abstract clearly states that TNPM is a benign condition."", ""reference"": ""PMID:28543629"", ""snippet"": ""Erythema toxicum neonatorum (ETN) and transient neonatal pustular melanosis (TNPM) are benign pustular skin conditions that are relatively common in newborns."", ""supports"": ""SUPPORT""}], ""name"": ""Benign Course""}"
7514	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	0	Spinal Cord Inflammation	Focal inflammatory injury within the spinal cord disrupts motor and sensory pathways, leading to neurologic deficits.																																																								"{""description"": ""Focal inflammatory injury within the spinal cord disrupts motor and sensory pathways, leading to neurologic deficits."", ""name"": ""Spinal Cord Inflammation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""description"": ""Focal inflammatory injury within the spinal cord disrupts motor and sensory pathways, leading to neurologic deficits."", ""evidence"": [{""explanation"": ""The abstract defines transverse myelitis as a focal inflammatory disorder of the spinal cord."", ""reference"": ""PMID:32644728"", ""snippet"": ""Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction."", ""supports"": ""SUPPORT""}, {""explanation"": ""The review describes focal spinal cord inflammation with neural injury as a defining feature."", ""reference"": ""PMID:12045735"", ""snippet"": ""Acute transverse myelitis is a group of disorders characterized by focal inflammation of the spinal cord and resultant neural injury."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""spinal cord"", ""term"": {""id"": ""UBERON:0002240"", ""label"": ""spinal cord""}}], ""name"": ""Spinal Cord Inflammation""}"
7515	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	1	Immune-Mediated Neural Injury	In idiopathic acute transverse myelitis, cellular influx into the spinal cord disrupts the blood-brain barrier and causes demyelination and neuronal injury.																																																								"{""description"": ""In idiopathic acute transverse myelitis, cellular influx into the spinal cord disrupts the blood-brain barrier and causes demyelination and neuronal injury."", ""name"": ""Immune-Mediated Neural Injury""}"	{}	"{""cell_types"": [{""preferred_term"": ""neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""cellular_components"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""myelin sheath"", ""term"": {""id"": ""GO:0043209"", ""label"": ""myelin sheath""}}], ""description"": ""In idiopathic acute transverse myelitis, cellular influx into the spinal cord disrupts the blood-brain barrier and causes demyelination and neuronal injury."", ""evidence"": [{""explanation"": ""The abstract describes immune cell influx with BBB breakdown and neural injury in TM."", ""reference"": ""PMID:12045735"", ""snippet"": ""In idiopathic acute transverse myelitis, there is an intraparenchymal or perivascular cellular influx into the spinal cord, resulting in the breakdown of the blood-brain barrier and variable demyelination and neuronal injury."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""spinal cord"", ""term"": {""id"": ""UBERON:0002240"", ""label"": ""spinal cord""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""blood brain barrier"", ""term"": {""id"": ""UBERON:0000120"", ""label"": ""blood brain barrier""}}], ""name"": ""Immune-Mediated Neural Injury""}"
7516	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	2	Immune-Mediated Spinal Cord Disorder	Transverse myelitis is an immune-mediated disorder of the spinal cord that causes motor and sensory disturbance, with limited recovery in a subset of patients.																																																								"{""description"": ""Transverse myelitis is an immune-mediated disorder of the spinal cord that causes motor and sensory disturbance, with limited recovery in a subset of patients."", ""name"": ""Immune-Mediated Spinal Cord Disorder""}"	{}	"{""description"": ""Transverse myelitis is an immune-mediated disorder of the spinal cord that causes motor and sensory disturbance, with limited recovery in a subset of patients."", ""evidence"": [{""explanation"": ""The abstract defines TM as immune-mediated and notes motor/sensory disturbance with limited recovery."", ""reference"": ""PMID:26009577"", ""snippet"": ""Transverse myelitis (TM) is an immune-mediated disorder of the spinal cord which causes motor and sensory disturbance and limited recovery in 50% of patients."", ""supports"": ""SUPPORT""}], ""name"": ""Immune-Mediated Spinal Cord Disorder""}"
7528	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	pathophysiology	0	Ingestion of contaminated food or water during travel	Travelers ingest enteric pathogens through unsafe food and water, initiating diarrheal illness.																																																								"{""description"": ""Travelers ingest enteric pathogens through unsafe food and water, initiating diarrheal illness."", ""name"": ""Ingestion of contaminated food or water during travel""}"	{}	"{""description"": ""Travelers ingest enteric pathogens through unsafe food and water, initiating diarrheal illness."", ""evidence"": [{""explanation"": ""Acute diarrhea review links bacterial diarrheal illness to travel and foodborne exposures."", ""reference"": ""PMID:35839362"", ""snippet"": ""Infectious noninflammatory diarrhea is often viral in etiology and is the most common presentation; however, bacterial causes are also common and may be related to travel or foodborne illness."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""gastrointestinal tract"", ""term"": {""id"": ""UBERON:0005409"", ""label"": ""gastrointestinal tract""}}], ""name"": ""Ingestion of contaminated food or water during travel""}"
7529	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	pathophysiology	1	ETEC adherence via colonization factors	Enterotoxigenic E. coli use colonization factors to adhere to intestinal epithelium and establish infection.																																																								"{""description"": ""Enterotoxigenic E. coli use colonization factors to adhere to intestinal epithelium and establish infection."", ""name"": ""ETEC adherence via colonization factors""}"	{}	"{""description"": ""Enterotoxigenic E. coli use colonization factors to adhere to intestinal epithelium and establish infection."", ""evidence"": [{""explanation"": ""Review highlights CFs as key adherence determinants enabling ETEC intestinal colonization."", ""reference"": ""PMID:38052687"", ""snippet"": ""Colonization factors (CFs) are major virulence factors of enterotoxigenic Escherichia coli (ETEC)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""ETEC adherence via colonization factors""}"
7530	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	pathophysiology	2	Enterotoxin-driven secretory diarrhea	ETEC heat-labile and heat-stable enterotoxins bind epithelial receptors, driving chloride and water secretion and watery diarrhea.																																																								"{""description"": ""ETEC heat-labile and heat-stable enterotoxins bind epithelial receptors, driving chloride and water secretion and watery diarrhea."", ""name"": ""Enterotoxin-driven secretory diarrhea""}"	{}	"{""description"": ""ETEC heat-labile and heat-stable enterotoxins bind epithelial receptors, driving chloride and water secretion and watery diarrhea."", ""evidence"": [{""explanation"": ""Review notes ETEC enterotoxins trigger receptor-mediated fluid secretion leading to diarrhea."", ""reference"": ""PMID:35358002"", ""snippet"": ""ETEC is characterized by the ability to produce major virulence factors including colonization factors (CFs) and enterotoxins, that bind to specific receptors on epithelial cells and induce diarrhea."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""small intestine"", ""term"": {""id"": ""UBERON:0002108"", ""label"": ""small intestine""}}], ""name"": ""Enterotoxin-driven secretory diarrhea""}"
7552	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	pathophysiology	0	Loss of Hormone Receptor Signaling	TNBC lacks expression of estrogen receptor alpha (ESR1) and progesterone receptor (PGR), eliminating the growth-promoting effects of estrogen signaling that drive most breast cancers. This absence removes a key therapeutic target but also indicates fundamentally different tumor biology.																																																								"{""description"": ""TNBC lacks expression of estrogen receptor alpha (ESR1) and progesterone receptor (PGR), eliminating the growth-promoting effects of estrogen signaling that drive most breast cancers. This absence removes a key therapeutic target but also indicates fundamentally different tumor biology."", ""name"": ""Loss of Hormone Receptor Signaling""}"	"{""downstream"": [{""description"": ""Other signaling pathways drive proliferation in absence of ER"", ""target"": ""Alternative Oncogenic Pathways""}]}"	"{""biological_processes"": [{""modifier"": ""ABSENT"", ""preferred_term"": ""estrogen receptor signaling pathway"", ""term"": {""id"": ""GO:0030520"", ""label"": ""intracellular estrogen receptor signaling pathway""}}], ""description"": ""TNBC lacks expression of estrogen receptor alpha (ESR1) and progesterone receptor (PGR), eliminating the growth-promoting effects of estrogen signaling that drive most breast cancers. This absence removes a key therapeutic target but also indicates fundamentally different tumor biology."", ""downstream"": [{""description"": ""Other signaling pathways drive proliferation in absence of ER"", ""target"": ""Alternative Oncogenic Pathways""}], ""evidence"": [{""explanation"": ""This abstract defines TNBC by the absence of ER, PR, and HER2 expression, matching the mechanism described."", ""reference"": ""PMID:41518487"", ""snippet"": ""Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, remains clinically challenging due to the lack of effective targeted therapies."", ""supports"": ""SUPPORT""}], ""name"": ""Loss of Hormone Receptor Signaling""}"
7553	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	pathophysiology	1	Alternative Oncogenic Pathways	In the absence of hormone receptor signaling, TNBC is driven by alternative oncogenic pathways including EGFR signaling, PI3K-AKT-mTOR activation, and Wnt/beta-catenin signaling. Many TNBCs have TP53 mutations eliminating this tumor suppressor checkpoint.																																																								"{""description"": ""In the absence of hormone receptor signaling, TNBC is driven by alternative oncogenic pathways including EGFR signaling, PI3K-AKT-mTOR activation, and Wnt/beta-catenin signaling. Many TNBCs have TP53 mutations eliminating this tumor suppressor checkpoint."", ""name"": ""Alternative Oncogenic Pathways""}"	"{""downstream"": [{""description"": ""Multiple activated pathways drive aggressive phenotype"", ""target"": ""Aggressive Tumor Behavior""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""epidermal growth factor receptor signaling pathway"", ""term"": {""id"": ""GO:0007173"", ""label"": ""epidermal growth factor receptor signaling pathway""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""phosphatidylinositol 3-kinase signaling"", ""term"": {""id"": ""GO:0014065"", ""label"": ""phosphatidylinositol 3-kinase signaling""}}], ""description"": ""In the absence of hormone receptor signaling, TNBC is driven by alternative oncogenic pathways including EGFR signaling, PI3K-AKT-mTOR activation, and Wnt/beta-catenin signaling. Many TNBCs have TP53 mutations eliminating this tumor suppressor checkpoint."", ""downstream"": [{""description"": ""Multiple activated pathways drive aggressive phenotype"", ""target"": ""Aggressive Tumor Behavior""}], ""name"": ""Alternative Oncogenic Pathways""}"
7554	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	pathophysiology	2	DNA Repair Deficiency	A significant subset of TNBC (~20%) harbors germline or somatic BRCA1/2 mutations resulting in homologous recombination deficiency. This creates sensitivity to platinum chemotherapy and PARP inhibitors through synthetic lethality.																																																								"{""description"": ""A significant subset of TNBC (~20%) harbors germline or somatic BRCA1/2 mutations resulting in homologous recombination deficiency. This creates sensitivity to platinum chemotherapy and PARP inhibitors through synthetic lethality."", ""name"": ""DNA Repair Deficiency""}"	"{""downstream"": [{""description"": ""DNA repair defects lead to mutation accumulation"", ""target"": ""Genomic Instability""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""homologous recombination"", ""term"": {""id"": ""GO:0035825"", ""label"": ""homologous recombination""}}], ""description"": ""A significant subset of TNBC (~20%) harbors germline or somatic BRCA1/2 mutations resulting in homologous recombination deficiency. This creates sensitivity to platinum chemotherapy and PARP inhibitors through synthetic lethality."", ""downstream"": [{""description"": ""DNA repair defects lead to mutation accumulation"", ""target"": ""Genomic Instability""}], ""name"": ""DNA Repair Deficiency""}"
7555	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	pathophysiology	3	Aggressive Tumor Behavior	TNBC is characterized by high proliferation rates, early metastasis (especially to viscera and brain), and shorter time to recurrence compared to other breast cancer subtypes. The aggressive biology reflects activation of multiple oncogenic pathways and loss of tumor suppressors.																																																								"{""description"": ""TNBC is characterized by high proliferation rates, early metastasis (especially to viscera and brain), and shorter time to recurrence compared to other breast cancer subtypes. The aggressive biology reflects activation of multiple oncogenic pathways and loss of tumor suppressors."", ""name"": ""Aggressive Tumor Behavior""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""TNBC is characterized by high proliferation rates, early metastasis (especially to viscera and brain), and shorter time to recurrence compared to other breast cancer subtypes. The aggressive biology reflects activation of multiple oncogenic pathways and loss of tumor suppressors."", ""evidence"": [{""explanation"": ""Abstract states TNBC carries the worst prognosis, supporting aggressive behavior."", ""reference"": ""PMID:35987766"", ""snippet"": ""It accounts for 10-15% of incident breast cancers and carries the worst prognosis."", ""supports"": ""SUPPORT""}], ""name"": ""Aggressive Tumor Behavior""}"
7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	Phagocytosis	Mycobacterium tuberculosis is engulfed by alveolar macrophages but resists destruction, leading to granuloma formation.																																																								"{""description"": ""Mycobacterium tuberculosis is engulfed by alveolar macrophages but resists destruction, leading to granuloma formation."", ""name"": ""Phagocytosis""}"	"{""downstream"": [{""description"": ""Infected macrophages differentiate into foamy macrophages which form the cellular core of TB granulomas."", ""target"": ""Granuloma Formation""}]}"	"{""biological_processes"": [{""preferred_term"": ""type I interferon signaling pathway"", ""term"": {""id"": ""GO:0034138"", ""label"": ""type I interferon signaling pathway""}}, {""preferred_term"": ""autophagy"", ""term"": {""id"": ""GO:0006914"", ""label"": ""autophagy""}}, {""preferred_term"": ""phagosome maturation"", ""term"": {""id"": ""GO:0090382"", ""label"": ""phagosome maturation""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""T Cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}, {""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}, {""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}], ""description"": ""Mycobacterium tuberculosis is engulfed by alveolar macrophages but resists destruction, leading to granuloma formation."", ""downstream"": [{""description"": ""Infected macrophages differentiate into foamy macrophages which form the cellular core of TB granulomas."", ""target"": ""Granuloma Formation""}], ""evidence"": [{""explanation"": ""This reference supports the claim that Mycobacterium tuberculosis infection leads to granuloma formation."", ""reference"": ""PMID:14745511"", ""snippet"": ""The immune response to Mycobacterium tuberculosis (Mtb) infection is the formation of multicellular lesions, or granolomas, in the lung of the individual"", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the specific involvement of macrophages and the resistance of Mycobacterium tuberculosis to degradation within phagocytes."", ""reference"": ""PMID:30306257"", ""snippet"": ""Phagocytosis refers to the process of internalization and degradation of particulate material... One microbe that is particularly successful at surviving within macrophages is the pathogen Mycobacterium tuberculosis, which can efficiently manipulate the macrophage at several levels, including modulation of the phagocytic pathway as well as interfering with a number of immune activation pathways that normally would lead to eradication of the internalized bacilli."", ""supports"": ""SUPPORT""}, {""explanation"": ""While this reference supports the role of macrophages and T cells in granuloma formation, it does not address the specific mechanisms by which Mycobacterium tuberculosis resists destruction."", ""reference"": ""PMID:2425678"", ""snippet"": ""The process of granuloma formation in the lung is mediated by an intimate interaction between macrophages and T cells, and this interaction provides the appropriate environment for granuloma formation and the development of fibrosis."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference partially supports the claim by highlighting that M. tuberculosis avoids destruction within host cells, though it does not explicitly mention granuloma formation."", ""reference"": ""PMID:25607549"", ""snippet"": ""Upon invading host cells by phagocytosis, M. tuberculosis can replicate within infected cells by arresting the maturation of the phagosome whose function is to target the pathogen for elimination."", ""supports"": ""PARTIAL""}], ""name"": ""Phagocytosis""}"
7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	Granuloma Formation	Immune cells form a granuloma to contain the infection, but sometimes the bacteria can break out, causing active TB.																																																								"{""description"": ""Immune cells form a granuloma to contain the infection, but sometimes the bacteria can break out, causing active TB."", ""name"": ""Granuloma Formation""}"	"{""downstream"": [{""description"": ""Granuloma necrosis leads to cavitation and destruction of lung parenchyma."", ""evidence"": [{""explanation"": ""This reference establishes that granuloma necrosis leads to cavitary lung disease and tissue destruction."", ""reference"": ""PMID:26758178"", ""snippet"": ""Adult or postprimary tuberculosis (TB) accounts for most TB cases. Its hallmark is pulmonary cavitation, which occurs as a result of necrosis in the lung in individuals with tuberculous pneumonia."", ""supports"": ""SUPPORT""}], ""target"": ""Tissue Damage""}]}"	"{""biological_processes"": [{""preferred_term"": ""lipid metabolic process"", ""term"": {""id"": ""GO:0006629"", ""label"": ""lipid metabolic process""}}, {""preferred_term"": ""cholesterol transport"", ""term"": {""id"": ""GO:0030301"", ""label"": ""cholesterol transport""}}, {""preferred_term"": ""inflammatory response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}, {""preferred_term"": ""T Cell"", ""term"": {""id"": ""CL:0000084"", ""label"": ""T cell""}}], ""description"": ""Immune cells form a granuloma to contain the infection, but sometimes the bacteria can break out, causing active TB."", ""downstream"": [{""description"": ""Granuloma necrosis leads to cavitation and destruction of lung parenchyma."", ""evidence"": [{""explanation"": ""This reference establishes that granuloma necrosis leads to cavitary lung disease and tissue destruction."", ""reference"": ""PMID:26758178"", ""snippet"": ""Adult or postprimary tuberculosis (TB) accounts for most TB cases. Its hallmark is pulmonary cavitation, which occurs as a result of necrosis in the lung in individuals with tuberculous pneumonia."", ""supports"": ""SUPPORT""}], ""target"": ""Tissue Damage""}], ""evidence"": [{""explanation"": ""This review states granulomas are central to TB immunopathogenesis, supporting granuloma formation as a core mechanism."", ""reference"": ""PMID:23626591"", ""snippet"": ""Granulomas are the hallmark of Mycobacterium tuberculosis (M.tb) infection and thus sit at the center of tuberculosis (TB) immunopathogenesis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference describes the formation of granulomas in the lung as part of the immune response to Mtb infection, which aligns with the statement."", ""reference"": ""PMID:14745511"", ""snippet"": ""The immune response to Mycobacterium tuberculosis (Mtb) infection is the formation of multicellular lesions, or granolomas, in the lung of the individual."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference indicates the involvement of macrophages and T cells (lymphocytes) in granuloma formation, which supports the statement."", ""reference"": ""PMID:28577054"", ""snippet"": ""The typical composition is a center of macrophages/histiocytes with lymphocytes at the border."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference discusses the diversity of granulomas in the lung and their formation in response to TB, which supports the statement."", ""reference"": ""PMID:36920308"", ""snippet"": ""granulomas are pathologically diverse, their tissue-wide heterogeneity has not been spatially resolved at the single-cell level in human tissues."", ""supports"": ""SUPPORT""}, {""explanation"": ""While the reference discusses infection of macrophages and various cell types by M. tuberculosis, it doesn't mention T cells and granuloma formation specifically."", ""reference"": ""PMID:25319335"", ""snippet"": ""Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB), is an intracellular pathogen of mononuclear phagocytes."", ""supports"": ""PARTIAL""}, {""explanation"": ""The reference highlights granuloma formation as a key feature of tuberculosis, supporting the statement."", ""reference"": ""PMID:33720848"", ""snippet"": ""Granuloma formation is the pathologic hallmark of tuberculosis (TB)."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Granuloma Formation""}"
7580	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	2	Neutrophil Activation and NETosis	Type I interferon-linked neutrophil programs drive NET formation contributing to tissue pathology, caseating necrosis, and vascular occlusion in progressive TB.																																																								"{""description"": ""Type I interferon-linked neutrophil programs drive NET formation contributing to tissue pathology, caseating necrosis, and vascular occlusion in progressive TB."", ""name"": ""Neutrophil Activation and NETosis""}"	"{""downstream"": [{""description"": ""NETs contribute to immunopathology, tissue injury, and relapse risk in TB."", ""target"": ""Tissue Damage""}]}"	"{""biological_processes"": [{""preferred_term"": ""neutrophil degranulation"", ""term"": {""id"": ""GO:0043312"", ""label"": ""neutrophil degranulation""}}, {""preferred_term"": ""neutrophil extracellular trap formation"", ""term"": {""id"": ""GO:0062025"", ""label"": ""neutrophil extracellular trap formation""}}], ""cell_types"": [{""preferred_term"": ""neutrophil"", ""term"": {""id"": ""CL:0000775"", ""label"": ""neutrophil""}}], ""description"": ""Type I interferon-linked neutrophil programs drive NET formation contributing to tissue pathology, caseating necrosis, and vascular occlusion in progressive TB."", ""downstream"": [{""description"": ""NETs contribute to immunopathology, tissue injury, and relapse risk in TB."", ""target"": ""Tissue Damage""}], ""locations"": [{""preferred_term"": ""Lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Neutrophil Activation and NETosis""}"
7581	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	3	Tissue Damage	Active TB can cause cavitation and destruction of lung tissue.																																																								"{""description"": ""Active TB can cause cavitation and destruction of lung tissue."", ""name"": ""Tissue Damage""}"	{}	"{""description"": ""Active TB can cause cavitation and destruction of lung tissue."", ""evidence"": [{""explanation"": ""The reference explicitly mentions cavitation as a severe consequence of pulmonary tuberculosis, which aligns with the statement."", ""reference"": ""PMID:32482293"", ""snippet"": ""Cavitation is a dangerous consequence of pulmonary tuberculosis associated with poor outcomes, treatment relapse, higher transmission rates, and development of drug resistance."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference provides evidence that TB lesions result in hypoxia and enzymatic activity that contributes to the destruction of lung tissue and cavitation."", ""reference"": ""PMID:27245780"", ""snippet"": ""Human TB lesions are severely hypoxic and M.tb drives HIF-1alpha accumulation, synergistically increasing collagenase activity which will lead to lung destruction and cavitation."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference discusses the relationship between TB, cavitation, and lung tissue remodeling, underscoring the statement that active TB causes cavitation and tissue damage."", ""reference"": ""PMID:16136463"", ""snippet"": ""Pulmonary cavitation with cough-generated aerosol is the principle means of spread, and lung remodeling (healed cavitation, fibrosis, and bronchiectasis) is a major cause of lung disability."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference explains the process of caseation necrosis leading to cavity formation in the lung, which supports the statement regarding active TB causing cavitation and tissue destruction."", ""reference"": ""PMID:25361920"", ""snippet"": ""After many months, the affected lung suddenly undergoes caseation necrosis with vanishingly few MTB. The necrotic tissue fragments to produce a cavity or hardens to develop fibrocaseous disease."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Lung"", ""term"": {""id"": ""UBERON:0002048"", ""label"": ""lung""}}], ""name"": ""Tissue Damage""}"
7618	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	0	Insulin Resistance	"Peripheral tissues (muscle, liver, adipose) become resistant to insulin action, requiring higher insulin levels to maintain glucose homeostasis. This leads to compensatory hyperinsulinemia and eventually beta cell exhaustion.
"																																																								"{""description"": ""Peripheral tissues (muscle, liver, adipose) become resistant to insulin action, requiring higher insulin levels to maintain glucose homeostasis. This leads to compensatory hyperinsulinemia and eventually beta cell exhaustion.\n"", ""name"": ""Insulin Resistance""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Insulin Signaling"", ""term"": {""id"": ""GO:0008286"", ""label"": ""insulin receptor signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}, {""preferred_term"": ""Skeletal Muscle Cell"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}, {""preferred_term"": ""Adipocyte"", ""term"": {""id"": ""CL:0000136"", ""label"": ""adipocyte""}}], ""description"": ""Peripheral tissues (muscle, liver, adipose) become resistant to insulin action, requiring higher insulin levels to maintain glucose homeostasis. This leads to compensatory hyperinsulinemia and eventually beta cell exhaustion.\n"", ""evidence"": [{""explanation"": ""This establishes that skeletal muscle is a key site of insulin resistance in type 2 diabetes, with impaired response to normal insulin levels."", ""reference"": ""PMID:12231074"", ""snippet"": ""Insulin resistance is caused by the decreased ability of peripheral target tissues (especially muscle) to respond properly to normal circulating concentrations of insulin."", ""supports"": ""SUPPORT""}, {""explanation"": ""This describes the molecular mechanism of insulin resistance involving fatty acid-induced serine kinase activation that impairs insulin receptor signaling through IRS-1 and PI3K."", ""reference"": ""PMID:12231074"", ""snippet"": ""These alterations in glucose transport activity are likely the result of dysregulation of intramyocellular fatty acid metabolism, whereby fatty acids cause insulin resistance by activation of a serine kinase cascade, leading to decreased insulin-stimulated insulin receptor substrate (IRS)-1 tyrosine phosphorylation and decreased IRS-1-associated phosphatidylinositol 3-kinase activity, a required step in insulin-stimulated glucose transport into muscle."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms that insulin resistance leads to compensatory hyperinsulinemia as beta cells attempt to overcome impaired glucose disposal in peripheral tissues."", ""reference"": ""PMID:29939616"", ""snippet"": ""Insulin resistance impairs glucose disposal, resulting in a compensatory increase in beta-cell insulin production and hyperinsulinemia."", ""supports"": ""SUPPORT""}], ""name"": ""Insulin Resistance""}"
7619	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	1	Beta Cell Dysfunction	"Progressive loss of pancreatic beta cell function and mass leads to inadequate insulin secretion relative to insulin demand. Beta cell failure is the key determinant of disease progression.
"																																																								"{""description"": ""Progressive loss of pancreatic beta cell function and mass leads to inadequate insulin secretion relative to insulin demand. Beta cell failure is the key determinant of disease progression.\n"", ""name"": ""Beta Cell Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Insulin Secretion"", ""term"": {""id"": ""GO:0030073"", ""label"": ""insulin secretion""}}], ""cell_types"": [{""preferred_term"": ""Pancreatic Beta Cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}], ""description"": ""Progressive loss of pancreatic beta cell function and mass leads to inadequate insulin secretion relative to insulin demand. Beta cell failure is the key determinant of disease progression.\n"", ""evidence"": [{""explanation"": ""This establishes beta cell dysfunction as a core pathological mechanism in type 2 diabetes development alongside insulin resistance."", ""reference"": ""PMID:37035220"", ""snippet"": ""Insulin resistance and pancreatic -cell dysfunction are major pathological mechanisms implicated in the development and progression of type 2 diabetes (T2D)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This demonstrates that inflammatory markers are associated with beta cell failure, indicating inflammation contributes to beta cell dysfunction."", ""reference"": ""PMID:37035220"", ""snippet"": ""Predominant markers of inflammation such as C-reactive protein, tumor necrosis factor alpha, and interleukin-1 are consistently associated with -cell failure in preclinical models and in people with T2D."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms that oxidative stress, characterized by increased ROS and depleted antioxidants, contributes to pancreatic beta cell damage in type 2 diabetes."", ""reference"": ""PMID:37035220"", ""snippet"": ""Similarly, important markers of oxidative stress, such as increased reactive oxygen species and depleted intracellular antioxidants, are consistent with pancreatic -cell damage in conditions of T2D."", ""supports"": ""SUPPORT""}, {""explanation"": ""This describes the progression from compensatory beta cell hyperfunction to beta cell exhaustion and failure, leading to hyperglycemia."", ""reference"": ""PMID:29939616"", ""snippet"": ""This vicious cycle continues until pancreatic beta-cell activity can no longer adequately meet the insulin demand created by insulin resistance, resulting in hyperglycemia."", ""supports"": ""SUPPORT""}], ""name"": ""Beta Cell Dysfunction""}"
7620	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	2	Hepatic Glucose Overproduction	"Impaired suppression of hepatic gluconeogenesis leads to elevated fasting glucose levels. The liver fails to respond appropriately to insulin signals.
"																																																								"{""description"": ""Impaired suppression of hepatic gluconeogenesis leads to elevated fasting glucose levels. The liver fails to respond appropriately to insulin signals.\n"", ""name"": ""Hepatic Glucose Overproduction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Gluconeogenesis"", ""term"": {""id"": ""GO:0006094"", ""label"": ""gluconeogenesis""}}], ""cell_types"": [{""preferred_term"": ""Hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Impaired suppression of hepatic gluconeogenesis leads to elevated fasting glucose levels. The liver fails to respond appropriately to insulin signals.\n"", ""evidence"": [{""explanation"": ""This establishes that elevated hepatic glucose production is a key feature of diabetes pathophysiology."", ""reference"": ""PMID:30150719"", ""snippet"": ""Diabetes is characterized by impaired glucose homeostasis partly due to abnormally elevated hepatic glucose production (HGP)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms that hepatic glucose overproduction is central to diabetes hyperglycemia, as metformin's primary mechanism targets HGP suppression."", ""reference"": ""PMID:30150719"", ""snippet"": ""Metformin exerts its antihyperglycemic action primarily through lowering hepatic glucose production (HGP)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This identifies fructose-1,6-bisphosphatase (FBP1) as a key rate-controlling enzyme in hepatic gluconeogenesis, the pathway responsible for glucose overproduction in diabetes."", ""reference"": ""PMID:30150719"", ""snippet"": ""FBP1 catalyzes the irreversible hydrolysis of fructose-1,6-bisphosphate (F-1,6-P2) to fructose-6-phosphate (F6P) and inorganic phosphate (Pi) in the presence of divalent cations. FBP1 is a key rate-controlling enzyme in the gluconeogenic pathway."", ""supports"": ""SUPPORT""}], ""name"": ""Hepatic Glucose Overproduction""}"
7621	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	3	Mitochondrial Dysfunction and Oxidative Stress	"Early-onset mitochondrial dysfunction and pathological reactive oxygen species (ROS) generation occur across multiple metabolic tissues including pancreatic beta cells, skeletal muscle, and adipose tissue. Impaired mitophagy and mitochondrial dynamics contribute to disease progression. Extracellular vesicle-mediated inter-organ miscommunication propagates oxidative damage.
"																																																								"{""description"": ""Early-onset mitochondrial dysfunction and pathological reactive oxygen species (ROS) generation occur across multiple metabolic tissues including pancreatic beta cells, skeletal muscle, and adipose tissue. Impaired mitophagy and mitochondrial dynamics contribute to disease progression. Extracellular vesicle-mediated inter-organ miscommunication propagates oxidative damage.\n"", ""name"": ""Mitochondrial Dysfunction and Oxidative Stress""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Oxidative Stress Response"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}, {""preferred_term"": ""Mitophagy"", ""term"": {""id"": ""GO:0000422"", ""label"": ""autophagy of mitochondrion""}}], ""cell_types"": [{""preferred_term"": ""Pancreatic Beta Cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}, {""preferred_term"": ""Skeletal Muscle Cell"", ""term"": {""id"": ""CL:0000188"", ""label"": ""cell of skeletal muscle""}}], ""description"": ""Early-onset mitochondrial dysfunction and pathological reactive oxygen species (ROS) generation occur across multiple metabolic tissues including pancreatic beta cells, skeletal muscle, and adipose tissue. Impaired mitophagy and mitochondrial dynamics contribute to disease progression. Extracellular vesicle-mediated inter-organ miscommunication propagates oxidative damage.\n"", ""evidence"": [{""explanation"": ""This establishes that mitochondrial dysfunction and oxidative damage occur early and may drive T2D progression regardless of whether insulin resistance or beta cell dysfunction is the primary event."", ""reference"": ""PMID:38338783"", ""snippet"": ""New evidence suggests that T2D-lean individuals experience early -cell dysfunction without significant IR. Regardless of the primary event (i.e., IR vs. -cell dysfunction) that contributes to dysglycemia, significant early-onset oxidative damage and mitochondrial dysfunction in multiple metabolic tissues may be a driver of T2D onset and progression."", ""supports"": ""SUPPORT""}, {""explanation"": ""This describes the novel mechanism of extracellular vesicle-mediated oxidative stress propagation between tissues in T2D pathogenesis."", ""reference"": ""PMID:38338783"", ""snippet"": ""Physiological oxidative stress promotes inter-tissue communication, while pathological oxidative stress promotes inter-tissue mis-communication, and new evidence suggests that this is mediated via extracellular vesicles (EVs), including mitochondria containing EVs."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms that oxidative stress characterized by increased ROS and depleted antioxidants contributes to beta cell damage."", ""reference"": ""PMID:37035220"", ""snippet"": ""Similarly, important markers of oxidative stress, such as increased reactive oxygen species and depleted intracellular antioxidants, are consistent with pancreatic -cell damage in conditions of T2D."", ""supports"": ""SUPPORT""}], ""name"": ""Mitochondrial Dysfunction and Oxidative Stress""}"
7622	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	4	Incretin Axis Dysfunction	"Impaired incretin hormone signaling, particularly blunted glucose-dependent insulinotropic peptide (GIP) action in beta cells. GLP-1 action is relatively preserved. The incretin effect amplifies insulin secretion in response to oral glucose via cAMP-PKA signaling pathways.
"																																																								"{""description"": ""Impaired incretin hormone signaling, particularly blunted glucose-dependent insulinotropic peptide (GIP) action in beta cells. GLP-1 action is relatively preserved. The incretin effect amplifies insulin secretion in response to oral glucose via cAMP-PKA signaling pathways.\n"", ""name"": ""Incretin Axis Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cAMP Signaling"", ""term"": {""id"": ""GO:0019933"", ""label"": ""cAMP-mediated signaling""}}, {""preferred_term"": ""Insulin Secretion Regulation"", ""term"": {""id"": ""GO:0050796"", ""label"": ""regulation of insulin secretion""}}], ""cell_types"": [{""preferred_term"": ""Pancreatic Beta Cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}, {""preferred_term"": ""Enteroendocrine Cell"", ""term"": {""id"": ""CL:0000164"", ""label"": ""enteroendocrine cell""}}], ""description"": ""Impaired incretin hormone signaling, particularly blunted glucose-dependent insulinotropic peptide (GIP) action in beta cells. GLP-1 action is relatively preserved. The incretin effect amplifies insulin secretion in response to oral glucose via cAMP-PKA signaling pathways.\n"", ""evidence"": [{""explanation"": ""This establishes the importance of the GLP-1/GIP incretin axis in T2D pathophysiology and its targeting by dual agonist therapies."", ""reference"": ""PMID:38831203"", ""snippet"": ""Dual glucagon like peptide 1 (GLP1) and glucose-dependent insulinotropic peptide (GIP) receptor agonists are among the new pharmacological strategies recently developed to address this challenge."", ""supports"": ""SUPPORT""}, {""explanation"": ""This demonstrates the clinical relevance of incretin axis dysfunction by showing dual GLP-1/GIP agonism is effective for T2D treatment."", ""reference"": ""PMID:38831203"", ""snippet"": ""Tirzepatide, characterized by its ability to selectively bind and activate receptors for the intestinal hormones GIP and GLP-1, has been tested in numerous clinical studies and is already currently authorized in several countries for the treatment of type 2 diabetes and obesity."", ""supports"": ""SUPPORT""}], ""name"": ""Incretin Axis Dysfunction""}"
7652	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	0	Genetic Susceptibility	Certain HLA gene variants (HLA-DQ2, HLA-DQ8) and other susceptibility genes (INS) increase the risk of developing Type I Diabetes.																																																								"{""description"": ""Certain HLA gene variants (HLA-DQ2, HLA-DQ8) and other susceptibility genes (INS) increase the risk of developing Type I Diabetes."", ""name"": ""Genetic Susceptibility""}"	"{""downstream"": [{""target"": ""Autoimmune Destruction of Beta Cells""}]}"	"{""description"": ""Certain HLA gene variants (HLA-DQ2, HLA-DQ8) and other susceptibility genes (INS) increase the risk of developing Type I Diabetes."", ""downstream"": [{""target"": ""Autoimmune Destruction of Beta Cells""}], ""evidence"": [{""explanation"": ""The provided literature confirms that HLA-DQ and INS genes contribute to the genetic susceptibility to Type 1 Diabetes."", ""reference"": ""PMID:11554771"", ""snippet"": ""The HLA-DQ genes are the primary susceptibility genes within this region, although other genes may also contribute. The IDDM2 locus maps to a variable number of tandem repeats in the insulin gene region on chromosome 11."", ""supports"": ""SUPPORT""}, {""explanation"": ""The presence of HLA-DQ2 and HLA-DQ8 variants contributing to the genetic susceptibility of Type I Diabetes is supported."", ""reference"": ""PMID:31331105"", ""snippet"": ""HLA DQA1*05 and DQB1*02 alleles encoding the DQ2.5 molecule and HLA DQA1*03 and DQB1*03 alleles encoding DQ8 molecules are strongly associated with celiac disease (CD) and type 1 diabetes (T1D), two common autoimmune diseases (AD)"", ""supports"": ""SUPPORT""}, {""explanation"": ""HLA class II genes, including HLA-DQ, play significant roles in the predisposition to Type I Diabetes."", ""reference"": ""PMID:3309680"", ""snippet"": ""Over half of the inherited predisposition to insulin-dependent diabetes mellitus maps to the region of chromosome 6 that contains the highly polymorphic HLA class II genes which determine immune responsiveness."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature indicates that HLA alleles, specifically susceptibility alleles, are significant in the context of Type I Diabetes."", ""reference"": ""PMID:15342014"", ""snippet"": ""Accumulating evidence suggests that MHC susceptibility for T1D is recessive, with susceptibility alleles more common than protective alleles."", ""supports"": ""SUPPORT""}, {""explanation"": ""The association of HLA-DQ2 and HLA-DQ8 with susceptibility to Type I Diabetes is supported by this reference."", ""reference"": ""PMID:17130534"", ""snippet"": ""DQ8 and DQ2 are associated with susceptibility to and DQ6 with protection from type 1 diabetes mellitus (T1DM)."", ""supports"": ""SUPPORT""}, {""explanation"": ""INS gene contribution to the susceptibility of Type I Diabetes is supported along with HLA genes."", ""reference"": ""PMID:17496359"", ""snippet"": ""Susceptibility to T1D is strongly linked to a major genetic locus that is the major histocompatibility complex (MHC) and several other minor loci including insulin, CTLA4 that contribute to diabetes risk in an epistatic way."", ""supports"": ""SUPPORT""}], ""genes"": [{""preferred_term"": ""HLA-DQ2""}, {""preferred_term"": ""HLA-DQ8""}, {""preferred_term"": ""INS"", ""term"": {""id"": ""hgnc:6081"", ""label"": ""INS""}}], ""name"": ""Genetic Susceptibility""}"
7653	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	1	Environmental Triggers	Viral infections or early dietary factors (cow's milk, gluten) may trigger the autoimmune response in genetically susceptible individuals.																																																								"{""description"": ""Viral infections or early dietary factors (cow's milk, gluten) may trigger the autoimmune response in genetically susceptible individuals."", ""name"": ""Environmental Triggers""}"	"{""downstream"": [{""target"": ""Autoimmune Destruction of Beta Cells""}]}"	"{""description"": ""Viral infections or early dietary factors (cow's milk, gluten) may trigger the autoimmune response in genetically susceptible individuals."", ""downstream"": [{""target"": ""Autoimmune Destruction of Beta Cells""}], ""evidence"": [{""explanation"": ""This reference supports the statement by mentioning that dietary factors and viruses can trigger the autoimmune process in genetically susceptible individuals."", ""reference"": ""PMID:10522815"", ""snippet"": ""Various exogenous triggers, such as certain dietary factors and viruses, are thought to induce the autoimmune process leading in some individuals to extensive beta-cell destruction and ultimately to the clinical manifestation of type 1 diabetes."", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the role of viral infections in triggering autoimmune responses leading to type 1 diabetes."", ""reference"": ""PMID:21162649"", ""snippet"": ""The ability to induce strong cellular immune responses and to cause inflammation in the target organ makes viral infections prime candidates for the initiation of islet autoreactivity."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the statement by identifying enteroviruses as environmental triggers for type 1 diabetes."", ""reference"": ""PMID:18357774"", ""snippet"": ""The most often cited environmental agents implicated as initiators of T1D are the human enteroviruses, in particular the group B coxsackieviruses (CVB)."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference supports the role of viral infections in the onset of type 1 diabetes."", ""reference"": ""PMID:9645989"", ""snippet"": ""dmsee@uci.edu Serologic case-control studies have suggested an association between coxsasckie group B viruses and insulin-dependent diabetes mellitus (IDDM)"", ""supports"": ""SUPPORT""}, {""explanation"": ""The reference supports the statement by linking viral infections and early dietary factors to the pathogenesis of type 1 diabetes."", ""reference"": ""PMID:31593953"", ""snippet"": ""Viral infections and early exposure to gluten or cow''s milk in the infant diet have been implicated in disease pathogenesis."", ""supports"": ""SUPPORT""}], ""name"": ""Environmental Triggers"", ""triggers"": [{""preferred_term"": ""Viral Infections""}, {""preferred_term"": ""Early Dietary Factors""}]}"
7654	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	2	Interferon-Driven Beta Cell Response	Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress.																																																								"{""description"": ""Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress."", ""name"": ""Interferon-Driven Beta Cell Response""}"	"{""downstream"": [{""target"": ""Autoimmune Destruction of Beta Cells""}]}"	"{""biological_processes"": [{""preferred_term"": ""type I interferon signaling pathway"", ""term"": {""id"": ""GO:0060337"", ""label"": ""type I interferon signaling pathway""}}, {""preferred_term"": ""antigen processing and presentation of peptide antigen via MHC class I"", ""term"": {""id"": ""GO:0002474"", ""label"": ""antigen processing and presentation of peptide antigen via MHC class I""}}, {""preferred_term"": ""chemokine production"", ""term"": {""id"": ""GO:0032602"", ""label"": ""chemokine production""}}, {""modifier"": ""DECREASED"", ""preferred_term"": ""oxidative phosphorylation"", ""term"": {""id"": ""GO:0006119"", ""label"": ""oxidative phosphorylation""}}], ""cell_types"": [{""preferred_term"": ""type B pancreatic cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}], ""chemical_entities"": [{""description"": ""Type I interferon that drives antiviral and antigen-presentation programs"", ""preferred_term"": ""interferon-alpha""}, {""description"": ""Type II interferon that induces HLA class I upregulation and chemokine production"", ""preferred_term"": ""interferon-gamma""}, {""description"": ""Chemokine (CXCL10) that recruits autoreactive T cells to islets"", ""preferred_term"": ""C-X-C motif chemokine 10""}], ""description"": ""Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress."", ""downstream"": [{""target"": ""Autoimmune Destruction of Beta Cells""}], ""evidence"": [{""explanation"": ""This study identifies interferons as key drivers of beta cell inflammatory responses, upregulating antigen presentation and chemokine production."", ""reference"": ""PMID:38409439"", ""snippet"": ""IFN- and IFN- had a greater impact on the beta cell transcriptome when compared with IL-1 and TNF-. The IFN-induced gene signatures have a strong correlation with those observed in beta cells from individuals with type 1 diabetes."", ""supports"": ""SUPPORT""}], ""name"": ""Interferon-Driven Beta Cell Response""}"
7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	Autoimmune Destruction of Beta Cells	The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.																																																								"{""description"": ""The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production."", ""name"": ""Autoimmune Destruction of Beta Cells""}"	"{""downstream"": [{""description"": ""Autoimmune destruction of pancreatic beta cells leads to absolute or near-absolute insulin deficiency."", ""evidence"": [{""explanation"": ""This 2025 review clearly establishes the causal chain from autoimmune destruction of beta cells to absolute insulin deficiency that characterizes Type 1 Diabetes."", ""reference"": ""PMID:40734585"", ""snippet"": ""Type 1 diabetes is characterised by the autoimmune destruction of pancreatic cells, leading to an absolute or nearabsolute insulin deficiency."", ""supports"": ""SUPPORT""}], ""target"": ""Insulin Deficiency""}]}"	"{""biological_processes"": [{""preferred_term"": ""T cell mediated cytotoxicity"", ""term"": {""id"": ""GO:0001913"", ""label"": ""T cell mediated cytotoxicity""}}, {""modifier"": ""ABNORMAL"", ""preferred_term"": ""autoantibody production""}, {""preferred_term"": ""cytokine-mediated signaling pathway"", ""term"": {""id"": ""GO:0019221"", ""label"": ""cytokine-mediated signaling pathway""}}], ""cell_types"": [{""preferred_term"": ""type B pancreatic cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}, {""preferred_term"": ""CD8-positive, alpha-beta cytotoxic T cell"", ""term"": {""id"": ""CL:0000794"", ""label"": ""CD8-positive, alpha-beta cytotoxic T cell""}}, {""preferred_term"": ""CD4-positive, alpha-beta T cell"", ""term"": {""id"": ""CL:0000624"", ""label"": ""CD4-positive, alpha-beta T cell""}}, {""preferred_term"": ""regulatory T cell"", ""term"": {""id"": ""CL:0000815"", ""label"": ""regulatory T cell""}}, {""preferred_term"": ""B cell"", ""term"": {""id"": ""CL:0000236"", ""label"": ""B cell""}}, {""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}, {""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production."", ""downstream"": [{""description"": ""Autoimmune destruction of pancreatic beta cells leads to absolute or near-absolute insulin deficiency."", ""evidence"": [{""explanation"": ""This 2025 review clearly establishes the causal chain from autoimmune destruction of beta cells to absolute insulin deficiency that characterizes Type 1 Diabetes."", ""reference"": ""PMID:40734585"", ""snippet"": ""Type 1 diabetes is characterised by the autoimmune destruction of pancreatic cells, leading to an absolute or nearabsolute insulin deficiency."", ""supports"": ""SUPPORT""}], ""target"": ""Insulin Deficiency""}], ""evidence"": [{""explanation"": ""While T-cell mediated cytotoxicity is mentioned, there is no reference to autoantibody production."", ""reference"": ""PMID:12185667"", ""snippet"": ""Type 1 diabetes mellitus is a T-cell-mediated autoimmune disease that results in the destruction of the insulin-producing beta cells in the pancreatic islets of Langerhans."", ""supports"": ""PARTIAL""}, {""explanation"": ""Supports T cell-mediated cytotoxicity but does not discuss autoantibody production."", ""reference"": ""PMID:23774118"", ""snippet"": ""Phenotypes of infiltrating cells around and/or into islets were mainly dendritic cells, macrophages and CD8+ T cells."", ""supports"": ""PARTIAL""}, {""explanation"": ""Supports T cell-mediated cytotoxicity but does not mention autoantibody production."", ""reference"": ""PMID:27659143"", ""snippet"": ""The autoimmune destruction of the pancreatic islet beta cells is due to a targeted lymphocyte attack."", ""supports"": ""PARTIAL""}, {""explanation"": ""Describes immune-mediated destruction of beta cells but does not specifically mention autoantibody production."", ""reference"": ""PMID:27017348"", ""snippet"": ""Type 1 diabetes (T1D) is an autoimmune disorder characterized by the destruction of insulin-producing pancreatic beta cells."", ""supports"": ""PARTIAL""}, {""explanation"": ""Supports T cell-mediated cytotoxicity but does not address autoantibody production."", ""reference"": ""PMID:16280652"", ""snippet"": ""Type 1 diabetes results from the destruction of insulin-producing pancreatic beta cells by a beta cell-specific autoimmune process."", ""supports"": ""PARTIAL""}, {""explanation"": ""Supports T cell-mediated cytotoxicity but lacks information on autoantibody production."", ""reference"": ""PMID:34691077"", ""snippet"": ""Type 1 diabetes (T1D) is an autoimmune disease characterized by autoreactive T cell-mediated destruction of insulin-producing pancreatic beta-cells."", ""supports"": ""PARTIAL""}, {""explanation"": ""Describes immune-mediated destruction but not autoantibody production."", ""reference"": ""PMID:33479911"", ""snippet"": ""Type 1 diabetes is an organ-specific autoimmune disease characterized by immune-mediated beta cell destruction in pancreatic islets."", ""supports"": ""PARTIAL""}, {""explanation"": ""Indicates immune destruction of beta cells but does not mention autoantibody production."", ""reference"": ""PMID:28625830"", ""snippet"": ""Type 1 diabetes is an autoimmune disease marked by the destruction of insulin-producing beta cells in the pancreatic islets."", ""supports"": ""PARTIAL""}], ""locations"": [{""preferred_term"": ""pancreatic islet"", ""term"": {""id"": ""UBERON:0000006"", ""label"": ""islet of Langerhans""}}], ""name"": ""Autoimmune Destruction of Beta Cells""}"
7656	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	4	Insulin Deficiency	Loss of beta cells leads to a deficiency of insulin, a hormone required for glucose uptake.																																																								"{""description"": ""Loss of beta cells leads to a deficiency of insulin, a hormone required for glucose uptake."", ""name"": ""Insulin Deficiency""}"	"{""downstream"": [{""target"": ""Hyperglycemia""}, {""target"": ""Impaired Glucose Utilization""}, {""target"": ""Increased Lipolysis""}]}"	"{""description"": ""Loss of beta cells leads to a deficiency of insulin, a hormone required for glucose uptake."", ""downstream"": [{""target"": ""Hyperglycemia""}, {""target"": ""Impaired Glucose Utilization""}, {""target"": ""Increased Lipolysis""}], ""evidence"": [{""explanation"": ""This confirms that the loss of beta cells leads to a deficiency of insulin in Type 1 diabetes, as stated in the provided statement."", ""reference"": ""PMID:35254878"", ""snippet"": ""Type 1 diabetes mellitus (T1DM) is an endocrine disorder in which pancreatic beta cells stop producing insulin, typically due to autoimmune destruction."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although it primarily discusses prediabetes and Type 2 diabetes, the excerpt supports the idea that beta-cell issues lead to hyperglycemia."", ""reference"": ""PMID:21281836"", ""snippet"": ""Insulin resistance and defective glucose sensing at the beta-cell are the central pathophysiologic determinants that together cause hyperglycemia."", ""supports"": ""SUPPORT""}, {""explanation"": ""This indicates the importance of beta cells in glucose regulation and the resulting hyperglycemia when their function is impaired."", ""reference"": ""PMID:2006409"", ""snippet"": ""Glucose uptake into pancreatic beta cells by means of the glucose transporter GLUT-2, which has a high Michaelis constant, is essential for the normal insulin secretory response to hyperglycemia."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference is more about liver cirrhosis but supports the general mechanism where insulin deficiency, due to impaired beta-cell function, leads to diabetes."", ""reference"": ""PMID:11822099"", ""snippet"": ""Peripheral insulin-resistance and impairment of the hepatocellular function are two major possible causes of diabetes mellitus in liver cirrhosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""This also supports the idea that loss of beta cells leads to insulin deficiency and subsequent glucose control issues, relevant to both Type 1 and Type 2 diabetes."", ""reference"": ""PMID:11508279"", ""snippet"": ""Loss of blood glucose control might result from failure of the beta cells to secrete insulin, resistance of the tissues to its action, or a combination of both."", ""supports"": ""SUPPORT""}], ""name"": ""Insulin Deficiency""}"
7657	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	5	Hyperglycemia	Lack of insulin results in high blood glucose levels, as glucose cannot be efficiently taken up by cells.																																																								"{""description"": ""Lack of insulin results in high blood glucose levels, as glucose cannot be efficiently taken up by cells."", ""name"": ""Hyperglycemia""}"	"{""downstream"": [{""target"": ""Glucosuria""}, {""target"": ""Polyuria""}, {""target"": ""Polydipsia""}, {""target"": ""Diabetic Ketoacidosis (DKA)""}]}"	"{""assays"": [{""preferred_term"": ""Elevated Blood Glucose""}, {""preferred_term"": ""Elevated Hemoglobin A1c (HbA1c)""}], ""description"": ""Lack of insulin results in high blood glucose levels, as glucose cannot be efficiently taken up by cells."", ""downstream"": [{""target"": ""Glucosuria""}, {""target"": ""Polyuria""}, {""target"": ""Polydipsia""}, {""target"": ""Diabetic Ketoacidosis (DKA)""}], ""evidence"": [{""explanation"": ""The abstract from PMID:33970586 confirms that type 1 diabetes is characterized by hyperglycemia due to insulin deficiency, which supports the statement regarding elevated blood glucose and related downstream effects."", ""reference"": ""PMID:33970586"", ""snippet"": ""Type 1 diabetes is defined as a state of hyperglycemia due to insulin deficiency caused by autoimmune pancreatic beta-cell destruction."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although this reference supports the relationship between elevated HbA1c and hyperglycemia, it does not specifically address all the downstream effects such as Glucosuria, Polyuria, Polydipsia, and Diabetic Ketoacidosis (DKA)."", ""reference"": ""PMID:37921158"", ""snippet"": ""HbA1c offers a trustworthy indicator of chronic hyperglycemia and strongly correlates with the likelihood of long-term consequences from diabetes."", ""supports"": ""PARTIAL""}, {""explanation"": ""This study does not specifically address the pathophysiology of type 1 diabetes or the particular assays and downstream effects mentioned in the statement."", ""reference"": ""PMID:21281836"", ""snippet"": ""The phenotype of prediabetes includes dyslipidemia and higher arterial blood pressure."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""While it mentions insulin deficiency, this reference does not go into detail about the specific assays and downstream effects listed in the statement."", ""reference"": ""PMID:11921414"", ""snippet"": ""Lack of insulin production or abnormalities affecting insulin secretion are key to the development of almost all forms of diabetes."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This article touches on diabetic ketoacidosis but does not fully cover all the listed downstream effects and assays associated with type 1 diabetes pathophysiology."", ""reference"": ""PMID:15137354"", ""snippet"": ""The article points out the signs and symptoms to be aware of when the person is in the acute state of diabetic ketoacidosis."", ""supports"": ""NO_EVIDENCE""}], ""name"": ""Hyperglycemia""}"
7658	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	6	Impaired Glucose Utilization	Without insulin, cells are unable to utilize glucose for energy production, leading to cellular energy deficiency.																																																								"{""description"": ""Without insulin, cells are unable to utilize glucose for energy production, leading to cellular energy deficiency."", ""name"": ""Impaired Glucose Utilization""}"	"{""downstream"": [{""target"": ""Weight Loss""}, {""target"": ""Fatigue""}]}"	"{""description"": ""Without insulin, cells are unable to utilize glucose for energy production, leading to cellular energy deficiency."", ""downstream"": [{""target"": ""Weight Loss""}, {""target"": ""Fatigue""}], ""evidence"": [{""explanation"": ""The lack of insulin in type 1 diabetes mellitus leads to impaired glucose utilization as described in the statement."", ""reference"": ""PMID:12477252"", ""snippet"": ""Type 1 or insulin-dependent diabetes mellitus is caused by autoimmune attack and selective destruction of the pancreatic beta cells."", ""supports"": ""SUPPORT""}, {""explanation"": ""This article explains that in diabetes, particularly type 1, the lack of insulin results in impaired glucose utilization, leading to characteristic symptoms like weight loss and fatigue."", ""reference"": ""PMID:15137354"", ""snippet"": ""The following article reviews the basic pathophysiology of both type 1 diabetes mellitus and type 2 diabetes mellitus as we understand it today."", ""supports"": ""SUPPORT""}], ""name"": ""Impaired Glucose Utilization""}"
7659	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	7	ER Stress and Unfolded Protein Response	Inflammatory cytokines induce endoplasmic reticulum stress in beta cells, activating the unfolded protein response and contributing to beta cell dysfunction and apoptosis.																																																								"{""description"": ""Inflammatory cytokines induce endoplasmic reticulum stress in beta cells, activating the unfolded protein response and contributing to beta cell dysfunction and apoptosis."", ""name"": ""ER Stress and Unfolded Protein Response""}"	"{""downstream"": [{""target"": ""Autoimmune Destruction of Beta Cells""}]}"	"{""biological_processes"": [{""preferred_term"": ""endoplasmic reticulum unfolded protein response"", ""term"": {""id"": ""GO:0030968"", ""label"": ""endoplasmic reticulum unfolded protein response""}}, {""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""type B pancreatic cell"", ""term"": {""id"": ""CL:0000169"", ""label"": ""type B pancreatic cell""}}], ""chemical_entities"": [{""description"": ""Proinflammatory cytokine that contributes to beta-cell stress and ER dysfunction"", ""preferred_term"": ""interleukin-1beta""}], ""description"": ""Inflammatory cytokines induce endoplasmic reticulum stress in beta cells, activating the unfolded protein response and contributing to beta cell dysfunction and apoptosis."", ""downstream"": [{""target"": ""Autoimmune Destruction of Beta Cells""}], ""evidence"": [{""explanation"": ""This study shows interferons drive beta cell stress responses including ER stress pathways that contribute to beta cell dysfunction and death."", ""reference"": ""PMID:38409439"", ""snippet"": ""IFN- and IFN- had a greater impact on the beta cell transcriptome when compared with IL-1 and TNF-. The IFN-induced gene signatures have a strong correlation with those observed in beta cells from individuals with type 1 diabetes."", ""supports"": ""SUPPORT""}], ""name"": ""ER Stress and Unfolded Protein Response""}"
7660	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	8	Increased Lipolysis	Insulin deficiency also leads to increased breakdown of fat (lipolysis) for energy, resulting in the production of ketones.																																																								"{""description"": ""Insulin deficiency also leads to increased breakdown of fat (lipolysis) for energy, resulting in the production of ketones."", ""name"": ""Increased Lipolysis""}"	"{""downstream"": [{""target"": ""Diabetic Ketoacidosis (DKA)""}]}"	"{""description"": ""Insulin deficiency also leads to increased breakdown of fat (lipolysis) for energy, resulting in the production of ketones."", ""downstream"": [{""target"": ""Diabetic Ketoacidosis (DKA)""}], ""evidence"": [{""explanation"": ""The article explains that insulin deficiency leads to increased lipolysis, which eventually results in the production of ketone bodies. This supports the statement's claim about the pathophysiology involving lipolysis and ketone production in Type I Diabetes."", ""reference"": ""PMID:6409465"", ""snippet"": ""Insulin deficiency results in increased rates of lipolysis and provides increased substrate (free fatty acids) for ketogenesis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The article suggests that DKA is a critical concern in Type I Diabetes due to insufficient insulin, which is aligned with the statement indicating the downstream effect of heightened lipolysis and ketone production."", ""reference"": ""PMID:15137354"", ""snippet"": ""The article points out the signs and symptoms to be aware of when the person is in the acute state of diabetic ketoacidosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although the study highlights immune responses related to ketosis-prone Type 2 Diabetes, it indirectly supports the notion that immune-mediated processes can contribute to ketosis and DKA."", ""reference"": ""PMID:34922394"", ""snippet"": ""the involvement of B:9-23rPep-specific IFN-gamma-related immunoreactivity in the pathophysiology of some unprovoked A-beta+ KPD."", ""supports"": ""PARTIAL""}], ""name"": ""Increased Lipolysis""}"
7661	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	9	Chronic Complications	Persistent hyperglycemia over time can lead to damage in various tissues and organs.																																																								"{""description"": ""Persistent hyperglycemia over time can lead to damage in various tissues and organs."", ""name"": ""Chronic Complications""}"	"{""downstream"": [{""target"": ""Retinopathy""}, {""target"": ""Neuropathy""}, {""target"": ""Nephropathy""}, {""target"": ""Cardiovascular Disease""}]}"	"{""description"": ""Persistent hyperglycemia over time can lead to damage in various tissues and organs."", ""downstream"": [{""target"": ""Retinopathy""}, {""target"": ""Neuropathy""}, {""target"": ""Nephropathy""}, {""target"": ""Cardiovascular Disease""}], ""evidence"": [{""explanation"": ""The literature indicates that hyperglycemia is a significant factor in the pathophysiology of diabetic complications including kidney disease (nephropathy), retinopathy, and neuropathy, thereby supporting the claim."", ""reference"": ""PMID:31346658"", ""snippet"": ""Hyperglycaemia, dyslipidaemia and hypertension combine with the duration and type of diabetes to define the distinct pathophysiology underlying diabetic kidney disease, diabetic retinopathy and diabetic neuropathy."", ""supports"": ""SUPPORT""}, {""explanation"": ""This reference indicates that hyperglycemia underlies various chronic vascular complications in type 1 diabetes, thus supporting the statement."", ""reference"": ""PMID:34407376"", ""snippet"": ""Hyperglycemia is the common denominator for most of the chronic diabetic vascular complications, which represent the main cause of life reduction in T1D patients."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study confirms that type 1 diabetes, which involves insulin-dependent diabetes mellitus, results in long-term complications such as retinopathy, nephropathy, neuropathy, and cardiovascular disease."", ""reference"": ""PMID:3528691"", ""snippet"": ""The remaining 15 to 20% of patients have insulin-dependent diabetes mellitus, a disorder caused by the destruction of insulin-producing endocrine cells within the pancreas and currently considered to be the result of an autoimmune process. During the course of both types of diabetes mellitus, the so-called long-term complications of diabetes invariably occur to some extent in all patients. These complications include retinopathy, nephropathy, neuropathy, and premature atherosclerosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""The literature points out that hyperglycemia leads to microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (cardiovascular diseases) complications, supporting the statement."", ""reference"": ""PMID:35456511"", ""snippet"": ""The prevention of hyperglycemia is very important to avoid or at least postpone the development of micro- and macrovascular complications, also known as late complications. These include diabetic retinopathy, chronic renal failure, diabetic neuropathy, and cardiovascular diseases."", ""supports"": ""SUPPORT""}], ""name"": ""Chronic Complications""}"
7662	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	10	Diabetic Ketoacidosis (DKA)	Life-threatening metabolic emergency from insulin deficiency																																																								"{""description"": ""Life-threatening metabolic emergency from insulin deficiency"", ""name"": ""Diabetic Ketoacidosis (DKA)""}"	{}	"{""description"": ""Life-threatening metabolic emergency from insulin deficiency"", ""name"": ""Diabetic Ketoacidosis (DKA)""}"
7703	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	0	Mucosal Inflammation	"Continuous inflammation limited to the colonic mucosa, starting at the rectum and extending proximally. Crypt abscesses, goblet cell depletion, and mucosal ulceration are characteristic.
"																																																								"{""description"": ""Continuous inflammation limited to the colonic mucosa, starting at the rectum and extending proximally. Crypt abscesses, goblet cell depletion, and mucosal ulceration are characteristic.\n"", ""name"": ""Mucosal Inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Inflammatory Response"", ""term"": {""id"": ""GO:0006954"", ""label"": ""inflammatory response""}}], ""cell_types"": [{""preferred_term"": ""Colonic Epithelial Cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}], ""description"": ""Continuous inflammation limited to the colonic mucosa, starting at the rectum and extending proximally. Crypt abscesses, goblet cell depletion, and mucosal ulceration are characteristic.\n"", ""evidence"": [{""explanation"": ""Pyroptosis-associated inflammatory cytokines IL-1 and IL-18 are produced in UC mucosa, contributing to the characteristic mucosal inflammation."", ""reference"": ""PMID:38314135"", ""snippet"": ""Reducing SLC6A14 decreased pyroptosis-associated proteins (ASC, IL-1, IL-18, NLRP3)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Single-cell analysis of UC gut biopsies reveals disease-specific inflammatory cell states in the colonic mucosa."", ""reference"": ""PMID:39438660"", ""snippet"": ""We generated ~1 million single-cell transcriptomes, organised into 109 cell states, from 216 gut biopsies (41 subjects), revealing disease-specific differences."", ""supports"": ""SUPPORT""}], ""name"": ""Mucosal Inflammation""}"
7704	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	1	Dysregulated Immune Response	"Aberrant immune response to commensal gut bacteria in genetically susceptible individuals. Th2-skewed response with IL-13 driving epithelial dysfunction.
"																																																								"{""description"": ""Aberrant immune response to commensal gut bacteria in genetically susceptible individuals. Th2-skewed response with IL-13 driving epithelial dysfunction.\n"", ""name"": ""Dysregulated Immune Response""}"	{}	"{""cell_types"": [{""preferred_term"": ""T Helper 2 Cell"", ""term"": {""id"": ""CL:0000546"", ""label"": ""T-helper 2 cell""}}], ""description"": ""Aberrant immune response to commensal gut bacteria in genetically susceptible individuals. Th2-skewed response with IL-13 driving epithelial dysfunction.\n"", ""evidence"": [{""explanation"": ""Single-cell analysis demonstrates interferon-response signatures localize to T cell aggregates and epithelial damage in UC, revealing a key immune dysregulation mechanism."", ""reference"": ""PMID:39438660"", ""snippet"": ""A systems biology-spatial analysis identified granuloma signatures in CD and interferon (IFN)-response signatures localising to T cell aggregates and epithelial damage in CD and UC."", ""supports"": ""SUPPORT""}, {""explanation"": ""Increased multi-cellular interferon signaling is associated with disease progression and non-remission in UC, indicating this is a critical pathway in dysregulated immune response."", ""reference"": ""PMID:39438660"", ""snippet"": ""Longitudinal comparisons demonstrated disease progression in nonremission: myeloid and T cell perturbations in CD and increased multi-cellular IFN signalling in UC."", ""supports"": ""SUPPORT""}, {""explanation"": ""IL-23 inhibitors target an upstream pathological mechanism in UC with high efficacy (up to 50% in IBD), supporting the role of aberrant immune signaling in disease pathogenesis."", ""reference"": ""PMID:39461795"", ""snippet"": ""Addressing an upstream pathological mechanism shared between these disorders, this drug class has high efficacy rates and a durable response that extends dosing intervals up to 3 months."", ""supports"": ""SUPPORT""}], ""name"": ""Dysregulated Immune Response""}"
7705	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	2	Epithelial Barrier Dysfunction	"Disrupted tight junctions and mucus layer allow bacterial translocation, perpetuating inflammation. Goblet cell depletion reduces protective mucus.
"																																																								"{""description"": ""Disrupted tight junctions and mucus layer allow bacterial translocation, perpetuating inflammation. Goblet cell depletion reduces protective mucus.\n"", ""name"": ""Epithelial Barrier Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Epithelial Barrier Function"", ""term"": {""id"": ""GO:0090557"", ""label"": ""establishment of endothelial intestinal barrier""}}], ""description"": ""Disrupted tight junctions and mucus layer allow bacterial translocation, perpetuating inflammation. Goblet cell depletion reduces protective mucus.\n"", ""evidence"": [{""explanation"": ""Interferon-response signatures are spatially localized to epithelial damage sites in UC, directly linking immune responses to barrier disruption."", ""reference"": ""PMID:39438660"", ""snippet"": ""A systems biology-spatial analysis identified granuloma signatures in CD and interferon (IFN)-response signatures localising to T cell aggregates and epithelial damage in CD and UC."", ""supports"": ""SUPPORT""}, {""explanation"": ""Epithelial cells express interferon-induced signatures associated with apoptosis and increased cell turnover, demonstrating the mechanism of barrier dysfunction in inflammatory colitis."", ""reference"": ""PMID:38724705"", ""snippet"": ""Luminal epithelial cells in patients with irColitis expressed PCSK9, PD-L1 and interferon-induced signatures associated with apoptosis, increased cell turnover and malabsorption."", ""supports"": ""SUPPORT""}, {""explanation"": ""Epithelial-immune crosstalk is critical to barrier function, confirming that disruption of this interaction underlies epithelial barrier dysfunction in colitis."", ""reference"": ""PMID:38724705"", ""snippet"": ""Together, these data suggest roles for circulating T cells and epithelial-immune crosstalk critical to PD-1/CTLA-4-dependent tolerance and barrier function and identify potential therapeutic targets for irColitis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Epithelial compartment differences predict treatment outcomes, emphasizing the central role of epithelial dysfunction in UC pathogenesis."", ""reference"": ""PMID:39438660"", ""snippet"": ""Pretreatment differences in epithelial and myeloid compartments were associated with remission outcomes in both diseases."", ""supports"": ""SUPPORT""}], ""name"": ""Epithelial Barrier Dysfunction""}"
7706	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	3	Loss of Microbial Diversity	"Reduced alpha diversity (species richness and evenness) in the colonic microbiome. Shannon and Chao1 indices are decreased compared to healthy controls, representing ecological collapse of the microbial community.
"																																																								"{""description"": ""Reduced alpha diversity (species richness and evenness) in the colonic microbiome. Shannon and Chao1 indices are decreased compared to healthy controls, representing ecological collapse of the microbial community.\n"", ""name"": ""Loss of Microbial Diversity""}"	"{""downstream"": [{""description"": ""Diversity loss disproportionately affects beneficial fermenters"", ""target"": ""Loss of Keystone SCFA Producers""}, {""description"": ""Anna Karenina effect - dysbiotic communities become stochastic"", ""target"": ""Increased Microbial Community Instability""}]}"	"{""biological_processes"": [{""preferred_term"": ""Microbiome Community Dynamics"", ""term"": {""id"": ""GO:0044003"", ""label"": ""modification by symbiont of host morphology or physiology""}}], ""description"": ""Reduced alpha diversity (species richness and evenness) in the colonic microbiome. Shannon and Chao1 indices are decreased compared to healthy controls, representing ecological collapse of the microbial community.\n"", ""downstream"": [{""description"": ""Diversity loss disproportionately affects beneficial fermenters"", ""target"": ""Loss of Keystone SCFA Producers""}, {""description"": ""Anna Karenina effect - dysbiotic communities become stochastic"", ""target"": ""Increased Microbial Community Instability""}], ""evidence"": [{""explanation"": ""Meta-analysis confirms IBD has consistent microbiota signatures distinguishing patients from healthy controls."", ""reference"": ""PMID:25307765"", ""snippet"": ""IBD has a consistent signature across studies and allows high classification accuracy of IBD from non-IBD subjects."", ""supports"": ""SUPPORT""}], ""name"": ""Loss of Microbial Diversity""}"
7707	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	4	Loss of Keystone SCFA Producers	"Depletion of butyrate-producing Firmicutes, particularly Faecalibacterium prausnitzii, Roseburia spp., and Eubacterium rectale. These keystone taxa are network hubs supporting community structure through cross-feeding.
"																																		"F. prausnitzii is anti-inflammatory; its supernatant reduces colitis in animal models. Roseburia and Eubacterium are primary butyrate producers via the acetyl-CoA pathway.
"																						"{""description"": ""Depletion of butyrate-producing Firmicutes, particularly Faecalibacterium prausnitzii, Roseburia spp., and Eubacterium rectale. These keystone taxa are network hubs supporting community structure through cross-feeding.\n"", ""name"": ""Loss of Keystone SCFA Producers"", ""notes"": ""F. prausnitzii is anti-inflammatory; its supernatant reduces colitis in animal models. Roseburia and Eubacterium are primary butyrate producers via the acetyl-CoA pathway.\n""}"	"{""downstream"": [{""description"": ""Loss of primary butyrate-synthesizing taxa"", ""target"": ""Decreased Butyrate Production""}]}"	"{""description"": ""Depletion of butyrate-producing Firmicutes, particularly Faecalibacterium prausnitzii, Roseburia spp., and Eubacterium rectale. These keystone taxa are network hubs supporting community structure through cross-feeding.\n"", ""downstream"": [{""description"": ""Loss of primary butyrate-synthesizing taxa"", ""target"": ""Decreased Butyrate Production""}], ""evidence"": [{""explanation"": ""Sokol et al. demonstrated F. prausnitzii depletion is consistently observed in IBD."", ""reference"": ""PMID:18936492"", ""snippet"": ""A decrease in the abundance and biodiversity of intestinal bacteria within the dominant phylum Firmicutes has been observed repeatedly in Crohn disease (CD) patients."", ""supports"": ""SUPPORT""}, {""explanation"": ""F. prausnitzii has direct anti-inflammatory properties beyond its role as butyrate producer."", ""reference"": ""PMID:18936492"", ""snippet"": ""F. prausnitzii exhibits anti-inflammatory effects on cellular and TNBS colitis models, partly due to secreted metabolites able to block NF-kappaB activation and IL-8 production."", ""supports"": ""SUPPORT""}], ""name"": ""Loss of Keystone SCFA Producers"", ""notes"": ""F. prausnitzii is anti-inflammatory; its supernatant reduces colitis in animal models. Roseburia and Eubacterium are primary butyrate producers via the acetyl-CoA pathway.\n""}"
7708	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	5	Pathobiont Expansion	"Bloom of opportunistic pathobionts including adherent-invasive E. coli (AIEC), Fusobacterium nucleatum, and Enterobacteriaceae. These taxa exploit the ecological niche vacated by depleted commensals and promote inflammation through LPS and direct epithelial invasion.
"																																																								"{""description"": ""Bloom of opportunistic pathobionts including adherent-invasive E. coli (AIEC), Fusobacterium nucleatum, and Enterobacteriaceae. These taxa exploit the ecological niche vacated by depleted commensals and promote inflammation through LPS and direct epithelial invasion.\n"", ""name"": ""Pathobiont Expansion""}"	"{""downstream"": [{""description"": ""Pathobionts produce LPS and other pro-inflammatory molecules"", ""target"": ""Mucosal Inflammation""}, {""description"": ""AIEC can invade epithelial cells and disrupt tight junctions"", ""target"": ""Epithelial Barrier Dysfunction""}]}"	"{""description"": ""Bloom of opportunistic pathobionts including adherent-invasive E. coli (AIEC), Fusobacterium nucleatum, and Enterobacteriaceae. These taxa exploit the ecological niche vacated by depleted commensals and promote inflammation through LPS and direct epithelial invasion.\n"", ""downstream"": [{""description"": ""Pathobionts produce LPS and other pro-inflammatory molecules"", ""target"": ""Mucosal Inflammation""}, {""description"": ""AIEC can invade epithelial cells and disrupt tight junctions"", ""target"": ""Epithelial Barrier Dysfunction""}], ""evidence"": [{""explanation"": ""Dysbiosis in IBD involves expansion of Enterobacteriaceae pathobionts alongside depletion of beneficial obligate anaerobes."", ""reference"": ""PMID:26185088"", ""snippet"": ""This is often characterized by an increased relative abundance of facultative anaerobic bacteria (e.g., Enterobacteriaeceae, Bacilli) and, at the same time, depletion of obligate anaerobic bacteria of the classes Bacteroidia and Clostridia."", ""supports"": ""SUPPORT""}], ""name"": ""Pathobiont Expansion""}"
7709	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	6	Decreased Butyrate Production	"Reduced fecal short-chain fatty acid (SCFA) concentrations, particularly butyrate. Butyrate is the primary energy source for colonocytes (providing ~70% of energy needs) and exerts anti-inflammatory effects via HDAC inhibition and GPR109A signaling.
"																																																								"{""description"": ""Reduced fecal short-chain fatty acid (SCFA) concentrations, particularly butyrate. Butyrate is the primary energy source for colonocytes (providing ~70% of energy needs) and exerts anti-inflammatory effects via HDAC inhibition and GPR109A signaling.\n"", ""name"": ""Decreased Butyrate Production""}"	"{""downstream"": [{""description"": ""Butyrate deprivation causes epithelial energy deficit"", ""target"": ""Impaired Colonocyte Energy Metabolism""}]}"	"{""biological_processes"": [{""preferred_term"": ""Short-chain Fatty Acid Metabolism"", ""term"": {""id"": ""GO:0046459"", ""label"": ""short-chain fatty acid metabolic process""}}], ""description"": ""Reduced fecal short-chain fatty acid (SCFA) concentrations, particularly butyrate. Butyrate is the primary energy source for colonocytes (providing ~70% of energy needs) and exerts anti-inflammatory effects via HDAC inhibition and GPR109A signaling.\n"", ""downstream"": [{""description"": ""Butyrate deprivation causes epithelial energy deficit"", ""target"": ""Impaired Colonocyte Energy Metabolism""}], ""evidence"": [{""explanation"": ""While this study focused on T2D, it demonstrates the general principle that dysbiosis involves loss of butyrate producers - a pattern also seen in IBD."", ""reference"": ""PMID:23023125"", ""snippet"": ""Patients with type 2 diabetes were characterized by a moderate degree of gut microbial dysbiosis, a decrease in the abundance of some universal butyrate-producing bacteria and an increase in various opportunistic pathogens."", ""supports"": ""SUPPORT""}], ""name"": ""Decreased Butyrate Production""}"
7710	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	7	Impaired Colonocyte Energy Metabolism	"Colonocytes deprived of butyrate shift from beta-oxidation to glycolysis, causing energy deficit. This impairs tight junction maintenance, mucus production by goblet cells, and epithelial renewal from crypt stem cells.
"																																																								"{""description"": ""Colonocytes deprived of butyrate shift from beta-oxidation to glycolysis, causing energy deficit. This impairs tight junction maintenance, mucus production by goblet cells, and epithelial renewal from crypt stem cells.\n"", ""name"": ""Impaired Colonocyte Energy Metabolism""}"	"{""downstream"": [{""description"": ""Energy-deprived colonocytes cannot maintain barrier integrity"", ""target"": ""Epithelial Barrier Dysfunction""}]}"	"{""cell_types"": [{""preferred_term"": ""Colonic Epithelial Cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}], ""description"": ""Colonocytes deprived of butyrate shift from beta-oxidation to glycolysis, causing energy deficit. This impairs tight junction maintenance, mucus production by goblet cells, and epithelial renewal from crypt stem cells.\n"", ""downstream"": [{""description"": ""Energy-deprived colonocytes cannot maintain barrier integrity"", ""target"": ""Epithelial Barrier Dysfunction""}], ""name"": ""Impaired Colonocyte Energy Metabolism""}"
7711	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	8	Increased Microbial Community Instability	"Anna Karenina effect - dysbiotic microbiomes show increased inter-individual variability and temporal instability compared to healthy controls. The community loses resilience and may occupy an alternative stable state that resists therapeutic intervention.
"																																		"""All healthy microbiomes are alike; each dysbiotic microbiome is dysbiotic in its own way."" This increased stochasticity complicates biomarker discovery and explains heterogeneous treatment responses.
"																						"{""description"": ""Anna Karenina effect - dysbiotic microbiomes show increased inter-individual variability and temporal instability compared to healthy controls. The community loses resilience and may occupy an alternative stable state that resists therapeutic intervention.\n"", ""name"": ""Increased Microbial Community Instability"", ""notes"": ""\""All healthy microbiomes are alike; each dysbiotic microbiome is dysbiotic in its own way.\"" This increased stochasticity complicates biomarker discovery and explains heterogeneous treatment responses.\n""}"	"{""downstream"": [{""description"": ""Feedback loop - community instability promotes further diversity loss"", ""target"": ""Loss of Microbial Diversity""}]}"	"{""description"": ""Anna Karenina effect - dysbiotic microbiomes show increased inter-individual variability and temporal instability compared to healthy controls. The community loses resilience and may occupy an alternative stable state that resists therapeutic intervention.\n"", ""downstream"": [{""description"": ""Feedback loop - community instability promotes further diversity loss"", ""target"": ""Loss of Microbial Diversity""}], ""evidence"": [{""explanation"": ""Zaneveld et al. demonstrated the Anna Karenina principle applies to disease-associated microbiomes."", ""reference"": ""PMID:28836573"", ""snippet"": ""The result is an 'Anna Karenina principle' for animal microbiomes, in which dysbiotic individuals vary more in microbial community composition than healthy individuals-paralleling Leo Tolstoy's dictum that 'all happy families look alike; each unhappy family is unhappy in its own way'."", ""supports"": ""SUPPORT""}], ""name"": ""Increased Microbial Community Instability"", ""notes"": ""\""All healthy microbiomes are alike; each dysbiotic microbiome is dysbiotic in its own way.\"" This increased stochasticity complicates biomarker discovery and explains heterogeneous treatment responses.\n""}"
7712	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	9	NLRP3 Inflammasome-Mediated Pyroptosis	"Epithelial cell pyroptosis driven by NLRP3 inflammasome activation contributes to barrier disruption and inflammation. SLC6A14 promotes pyroptosis by upregulating NLRP3.
"																																																								"{""description"": ""Epithelial cell pyroptosis driven by NLRP3 inflammasome activation contributes to barrier disruption and inflammation. SLC6A14 promotes pyroptosis by upregulating NLRP3.\n"", ""name"": ""NLRP3 Inflammasome-Mediated Pyroptosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Pyroptosis"", ""term"": {""id"": ""GO:0070269"", ""label"": ""pyroptosis""}}], ""cell_types"": [{""preferred_term"": ""Colonic Epithelial Cell"", ""term"": {""id"": ""CL:0011108"", ""label"": ""colon epithelial cell""}}], ""description"": ""Epithelial cell pyroptosis driven by NLRP3 inflammasome activation contributes to barrier disruption and inflammation. SLC6A14 promotes pyroptosis by upregulating NLRP3.\n"", ""evidence"": [{""explanation"": ""SLC6A14 expression is elevated and correlates with NLRP3 in UC tissues, establishing a molecular link between this transporter and inflammasome activation."", ""reference"": ""PMID:38314135"", ""snippet"": ""SLC6A14 was increased and correlated with NLRP3 in UC tissues."", ""supports"": ""SUPPORT""}, {""explanation"": ""Experimental reduction of SLC6A14 decreases pyroptosis-associated proteins including NLRP3, IL-1, and IL-18, demonstrating the causal role of this pathway in UC."", ""reference"": ""PMID:38314135"", ""snippet"": ""Reducing SLC6A14 decreased pyroptosis-associated proteins (ASC, IL-1, IL-18, NLRP3)."", ""supports"": ""SUPPORT""}, {""explanation"": ""SLC6A14 promotes UC progression through NLRP3-mediated pyroptosis, identifying this as a key pathophysiological mechanism and potential therapeutic target."", ""reference"": ""PMID:38314135"", ""snippet"": ""SLC6A14 promotes UC pyroptosis by regulating NLRP3, suggesting the therapeutic potential of modulating the SLC6A14/NLRP3 axis."", ""supports"": ""SUPPORT""}], ""name"": ""NLRP3 Inflammasome-Mediated Pyroptosis""}"
7728	335	Urticaria	Urticaria.yaml	pathophysiology	0	Mast cell-driven inflammation	Mast cells are central to chronic spontaneous urticaria, with multiple mediators contributing to disease.																																																								"{""description"": ""Mast cells are central to chronic spontaneous urticaria, with multiple mediators contributing to disease."", ""name"": ""Mast cell-driven inflammation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""mast cell degranulation"", ""term"": {""id"": ""GO:0043303"", ""label"": ""mast cell degranulation""}}], ""cell_types"": [{""preferred_term"": ""mast cell"", ""term"": {""id"": ""CL:0000097"", ""label"": ""mast cell""}}], ""description"": ""Mast cells are central to chronic spontaneous urticaria, with multiple mediators contributing to disease."", ""evidence"": [{""explanation"": ""The review emphasizes mast cells as central effectors in urticaria pathogenesis."", ""reference"": ""PMID:40845419"", ""snippet"": ""The central role of mast cells is being reinforced, but multiple cells, pathways, and mediators are involved in a complex interrelationship."", ""supports"": ""SUPPORT""}], ""name"": ""Mast cell-driven inflammation""}"
7739	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	0	GNAQ/GNA11 Oncogenic Mutations	GNAQ and GNA11 encode alpha subunits of heterotrimeric Gq/11 G-proteins. Mutations at Q209 (most common) or R183 lock the protein in a constitutively active GTP-bound state, resulting in persistent downstream signaling through phospholipase C beta, protein kinase C, and ultimately the MAPK pathway. These mutations are mutually exclusive and early, initiating events.																																																								"{""description"": ""GNAQ and GNA11 encode alpha subunits of heterotrimeric Gq/11 G-proteins. Mutations at Q209 (most common) or R183 lock the protein in a constitutively active GTP-bound state, resulting in persistent downstream signaling through phospholipase C beta, protein kinase C, and ultimately the MAPK pathway. These mutations are mutually exclusive and early, initiating events."", ""name"": ""GNAQ/GNA11 Oncogenic Mutations""}"	"{""downstream"": [{""description"": ""Active Gq/11 stimulates PLC-beta, generating DAG to activate PKC"", ""target"": ""PKC-MAPK Pathway Activation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""signal transduction"", ""term"": {""id"": ""GO:0007165"", ""label"": ""signal transduction""}}], ""cell_types"": [{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}], ""description"": ""GNAQ and GNA11 encode alpha subunits of heterotrimeric Gq/11 G-proteins. Mutations at Q209 (most common) or R183 lock the protein in a constitutively active GTP-bound state, resulting in persistent downstream signaling through phospholipase C beta, protein kinase C, and ultimately the MAPK pathway. These mutations are mutually exclusive and early, initiating events."", ""downstream"": [{""description"": ""Active Gq/11 stimulates PLC-beta, generating DAG to activate PKC"", ""target"": ""PKC-MAPK Pathway Activation""}], ""evidence"": [{""explanation"": ""Supports GNAQ and GNA11 as key genes in uveal melanoma development."", ""reference"": ""PMID:23877823"", ""snippet"": ""Recently, major key genes involved in uveal melanoma development, GNAQ, GNA11, BAP1, SF3B1 and EIF1AX, have been identified."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""uvea"", ""term"": {""id"": ""UBERON:0001768"", ""label"": ""uvea""}}], ""name"": ""GNAQ/GNA11 Oncogenic Mutations""}"
7740	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	1	PKC-MAPK Pathway Activation	Constitutively active GNAQ/GNA11 signaling activates phospholipase C-beta, generating diacylglycerol (DAG) that activates protein kinase C (PKC). PKC in turn activates the RAF-MEK-ERK cascade, driving melanocyte proliferation. This pathway represents a therapeutic target with MEK and PKC inhibitors.																																																								"{""description"": ""Constitutively active GNAQ/GNA11 signaling activates phospholipase C-beta, generating diacylglycerol (DAG) that activates protein kinase C (PKC). PKC in turn activates the RAF-MEK-ERK cascade, driving melanocyte proliferation. This pathway represents a therapeutic target with MEK and PKC inhibitors."", ""name"": ""PKC-MAPK Pathway Activation""}"	"{""downstream"": [{""description"": ""ERK activation drives cell cycle progression and proliferation"", ""target"": ""Uncontrolled Uveal Melanocyte Proliferation""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""MAPK cascade"", ""term"": {""id"": ""GO:0000165"", ""label"": ""MAPK cascade""}}], ""description"": ""Constitutively active GNAQ/GNA11 signaling activates phospholipase C-beta, generating diacylglycerol (DAG) that activates protein kinase C (PKC). PKC in turn activates the RAF-MEK-ERK cascade, driving melanocyte proliferation. This pathway represents a therapeutic target with MEK and PKC inhibitors."", ""downstream"": [{""description"": ""ERK activation drives cell cycle progression and proliferation"", ""target"": ""Uncontrolled Uveal Melanocyte Proliferation""}], ""name"": ""PKC-MAPK Pathway Activation""}"
7741	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	2	Uncontrolled Uveal Melanocyte Proliferation	Persistent MAPK signaling drives proliferation of uveal melanocytes, leading to tumor formation. Unlike cutaneous melanoma, uveal melanoma rarely harbors BRAF or NRAS mutations.																																																								"{""description"": ""Persistent MAPK signaling drives proliferation of uveal melanocytes, leading to tumor formation. Unlike cutaneous melanoma, uveal melanoma rarely harbors BRAF or NRAS mutations."", ""name"": ""Uncontrolled Uveal Melanocyte Proliferation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""cell_types"": [{""preferred_term"": ""melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}], ""description"": ""Persistent MAPK signaling drives proliferation of uveal melanocytes, leading to tumor formation. Unlike cutaneous melanoma, uveal melanoma rarely harbors BRAF or NRAS mutations."", ""locations"": [{""preferred_term"": ""uvea"", ""term"": {""id"": ""UBERON:0001768"", ""label"": ""uvea""}}], ""name"": ""Uncontrolled Uveal Melanocyte Proliferation""}"
7742	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	3	BAP1 Loss and Metastatic Progression	BAP1 (BRCA1-associated protein 1) is a tumor suppressor encoding a deubiquitinase involved in chromatin remodeling and DNA damage response. BAP1 loss occurs in approximately 40% of uveal melanomas and is strongly associated with metastatic disease and poor prognosis. BAP1-deficient tumors exhibit altered gene expression patterns consistent with a more aggressive, less differentiated phenotype.																																																								"{""description"": ""BAP1 (BRCA1-associated protein 1) is a tumor suppressor encoding a deubiquitinase involved in chromatin remodeling and DNA damage response. BAP1 loss occurs in approximately 40% of uveal melanomas and is strongly associated with metastatic disease and poor prognosis. BAP1-deficient tumors exhibit altered gene expression patterns consistent with a more aggressive, less differentiated phenotype."", ""name"": ""BAP1 Loss and Metastatic Progression""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""BAP1 (BRCA1-associated protein 1) is a tumor suppressor encoding a deubiquitinase involved in chromatin remodeling and DNA damage response. BAP1 loss occurs in approximately 40% of uveal melanomas and is strongly associated with metastatic disease and poor prognosis. BAP1-deficient tumors exhibit altered gene expression patterns consistent with a more aggressive, less differentiated phenotype."", ""name"": ""BAP1 Loss and Metastatic Progression""}"
7752	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	0	Visual Cortex Hyperexcitability	"Visual snow syndrome is thought to involve cortical hyperexcitability, particularly in the lingual gyrus and other visual processing areas. Electrophysiological studies have revealed cortical hyperresponsivity in visual brain areas, and imaging studies demonstrated microstructural and functional connectivity alterations in multiple cortical and thalamic regions.
"																																																								"{""description"": ""Visual snow syndrome is thought to involve cortical hyperexcitability, particularly in the lingual gyrus and other visual processing areas. Electrophysiological studies have revealed cortical hyperresponsivity in visual brain areas, and imaging studies demonstrated microstructural and functional connectivity alterations in multiple cortical and thalamic regions.\n"", ""name"": ""Visual Cortex Hyperexcitability""}"	{}	"{""biological_processes"": [{""preferred_term"": ""visual perception"", ""term"": {""id"": ""GO:0007601"", ""label"": ""visual perception""}}], ""cell_types"": [{""preferred_term"": ""cortical interneuron"", ""term"": {""id"": ""CL:0008031"", ""label"": ""cortical interneuron""}}], ""description"": ""Visual snow syndrome is thought to involve cortical hyperexcitability, particularly in the lingual gyrus and other visual processing areas. Electrophysiological studies have revealed cortical hyperresponsivity in visual brain areas, and imaging studies demonstrated microstructural and functional connectivity alterations in multiple cortical and thalamic regions.\n"", ""evidence"": [{""explanation"": ""Recent studies confirm cortical hyperresponsivity and connectivity alterations in VSS."", ""reference"": ""PMID:38465699"", ""snippet"": ""Electrophysiological studies have revealed cortical hyperresponsivity in visual brain areas, imaging studies demonstrated microstructural and functional connectivity alterations in multiple cortical and thalamic regions and investigated glutamatergic and serotoninergic neurotransmission."", ""supports"": ""SUPPORT""}, {""explanation"": ""PET imaging demonstrates hypermetabolism in the lingual gyrus in visual snow patients."", ""reference"": ""PMID:24816400"", ""snippet"": ""The hypermetabolic lingual gyrus confirms a brain dysfunction in patients with \""visual snow.\"""", ""supports"": ""SUPPORT""}, {""explanation"": ""Review article confirms hyperexcitability in visual cortical areas with impaired inhibitory feedback."", ""reference"": ""PMID:34570907"", ""snippet"": ""Imaging and electrophysiological findings indicate a hyperexcitability of the primary and secondary visual areas of the brain possibly due to an impairment of inhibitory feedback mechanisms."", ""supports"": ""SUPPORT""}, {""explanation"": ""Systematic review confirms visual cortex hyperexcitability as leading hypothesis for VSS pathophysiology."", ""reference"": ""PMID:33008511"", ""snippet"": ""Regarding pathophysiology, hyperexcitability of the visual cortex and a processing problem of higher order visual function are assumed, but the location is still in discussion."", ""supports"": ""SUPPORT""}], ""name"": ""Visual Cortex Hyperexcitability""}"
7753	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	1	Thalamocortical Network Dysfunction	"Visual snow syndrome appears to be a network disorder involving dysfunction in the thalamocortical pathway. The thalamus normally filters sensory information, and its dysfunction may lead to failure to suppress unnecessary visual noise.
"																																																								"{""description"": ""Visual snow syndrome appears to be a network disorder involving dysfunction in the thalamocortical pathway. The thalamus normally filters sensory information, and its dysfunction may lead to failure to suppress unnecessary visual noise.\n"", ""name"": ""Thalamocortical Network Dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""synaptic transmission"", ""term"": {""id"": ""GO:0007268"", ""label"": ""chemical synaptic transmission""}}], ""description"": ""Visual snow syndrome appears to be a network disorder involving dysfunction in the thalamocortical pathway. The thalamus normally filters sensory information, and its dysfunction may lead to failure to suppress unnecessary visual noise.\n"", ""evidence"": [{""explanation"": ""Recent research suggests VSS is a network disorder affecting multiple brain regions."", ""reference"": ""PMID:38465699"", ""snippet"": ""These findings suggest that VSS might be a network disorder."", ""supports"": ""SUPPORT""}, {""explanation"": ""Evidence points to network-level dysfunction involving sensory processing and attention networks."", ""reference"": ""PMID:34570907"", ""snippet"": ""Imaging and electrophysiological findings hint toward network disorders involving the sensory networks and other large-scale networks involved in the management of attention and emotional processing."", ""supports"": ""SUPPORT""}, {""explanation"": ""The thalamocortical pathway is one of the candidate structures involved in VSS pathophysiology."", ""reference"": ""PMID:33008511"", ""snippet"": ""In particular, it is unclear if the primary visual cortex, the visual association cortex or the thalamocortical pathway is involved."", ""supports"": ""SUPPORT""}], ""name"": ""Thalamocortical Network Dysfunction""}"
7785	338	Vitiligo	Vitiligo.yaml	pathophysiology	0	Melanocyte Destruction	Autoimmune-mediated destruction where the immune system targets melanocytes, leading to loss of skin pigment.																																																								"{""description"": ""Autoimmune-mediated destruction where the immune system targets melanocytes, leading to loss of skin pigment."", ""name"": ""Melanocyte Destruction""}"	{}	"{""cell_types"": [{""preferred_term"": ""Melanocyte"", ""term"": {""id"": ""CL:0000148"", ""label"": ""melanocyte""}}, {""preferred_term"": ""CD8+ T Lymphocyte"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}], ""description"": ""Autoimmune-mediated destruction where the immune system targets melanocytes, leading to loss of skin pigment."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature describes the autoimmune-mediated destruction of melanocytes involving CD8+ T lymphocytes, consistent with the provided statement."", ""reference"": ""PMID:33200838"", ""snippet"": ""Vitiligo is an autoimmune depigment disease results from extensive melanocytes destruction...self-responsive immune function directly contributes to the bulk of melanocyte deaths in vitiligo...CD8(+) cytotoxic T lymphocytes finally execute the killing of melanocytes."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The reference confirms the autoimmune-mediated destruction mechanism, mentioning both CD8+ T lymphocytes and melanocytes."", ""reference"": ""PMID:31209143"", ""snippet"": ""Vitiligo is an autoimmune skin disease mediated by autoreactive CD8(+) T cells that destroy the pigment-producing cells of the epidermis, melanocytes, leading to areas of depigmentation."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature supports the involvement of CD8+ T lymphocytes and the destruction of melanocytes in vitiligo."", ""reference"": ""PMID:25184918"", ""snippet"": ""The main histopathological finding in vitiligo is the total absence of functioning melanocytes in the lesions, while the inflammatory cells most commonly found on the edges of the lesions are CD4+ and CD8+ T lymphocytes."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This source directly mentions the destruction of melanocytes by CD8+ T cells."", ""reference"": ""PMID:35653192"", ""snippet"": ""Vitiligo is an autoimmune skin disease characterized by the destruction of melanocytes by autoreactive CD8+ T cells."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The source elaborates on the autoimmune nature of vitiligo, involving T cells and targeting melanocytes."", ""reference"": ""PMID:18460889"", ""snippet"": ""Vitiligo is characterized by progressive skin depigmentation resulting from an autoimmune response targeting epidermal melanocytes...Type I cytokine-mediated immunity to melanocytes in vitiligo involves T cells reactive with melanosomal antigens..."", ""supports"": ""SUPPORT""}], ""name"": ""Melanocyte Destruction""}"
7786	338	Vitiligo	Vitiligo.yaml	pathophysiology	1	Genetic Predisposition	A complex interplay of multiple genes contributes to susceptibility to vitiligo.																																																								"{""description"": ""A complex interplay of multiple genes contributes to susceptibility to vitiligo."", ""name"": ""Genetic Predisposition""}"	{}	"{""description"": ""A complex interplay of multiple genes contributes to susceptibility to vitiligo."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature clearly states that multiple genetic risk factors contribute to vitiligo, aligning with the statement's claim of a complex interplay of genes."", ""reference"": ""PMID:28317533"", ""snippet"": ""Vitiligo reflects simultaneous contributions of multiple genetic risk factors and environmental triggers. Genomewide association studies have discovered approximately 50 genetic loci contributing to vitiligo risk."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study mentions the association of specific gene polymorphisms with vitiligo, supporting the notion of a genetic predisposition."", ""reference"": ""PMID:28206724"", ""snippet"": ""Contrary to the Northern part of Europe but likewise to the Mediterranean area, the frequency of the CAT genotypes in Sicily is equally distributed. Out of all CAT genotypes, only CAT-89 T/T frequency was found to be significantly higher amongst vitiligo patients than controls."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The convergence theory supports the idea that multiple genetic and environmental factors contribute to vitiligo."", ""reference"": ""PMID:29704874"", ""snippet"": ""The viewpoint that vitiligo is not caused only by predisposing mutations, or only by melanocytes responding to chemical/radiation exposure, or only by hyperreactive T cells, but rather results from a combination of aetiologic factors that impact melanocyte viability, has certainly stood the test of time."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This underscores the multifactorial nature of vitiligo, consistent with the statement's emphasis on a complex genetic interplay."", ""reference"": ""PMID:33278065"", ""snippet"": ""The complex interplay between non-immunological and immunological factors in vitiligo is key for the development of the disease."", ""supports"": ""SUPPORT""}], ""name"": ""Genetic Predisposition""}"
7787	338	Vitiligo	Vitiligo.yaml	pathophysiology	2	Autoimmune Reaction	Vitiligo often coexists with other autoimmune disorders, such as thyroid disease, suggesting a common autoimmune etiology.																																																								"{""description"": ""Vitiligo often coexists with other autoimmune disorders, such as thyroid disease, suggesting a common autoimmune etiology."", ""name"": ""Autoimmune Reaction""}"	{}	"{""description"": ""Vitiligo often coexists with other autoimmune disorders, such as thyroid disease, suggesting a common autoimmune etiology."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The article indicates a strong association between vitiligo and autoimmune thyroid disorders, supporting a common autoimmune etiology."", ""reference"": ""PMID:25838868"", ""snippet"": ""Vitiligo is an acquired dermatological disease frequently associated with autoimmune thyroid disorders...Currently, the autocytotoxic and the autoimmune theories are the most accredited hypothesis"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The reference confirms a frequent coexistence of vitiligo and autoimmune thyroid disorders, supporting the common autoimmune etiology theory."", ""reference"": ""PMID:26769615"", ""snippet"": ""Vitiligo in children is a distinct subset of vitiligo and differs from adult vitiligo... The most commonly associated autoimmune disease is thyroiditis."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference indicates the association of vitiligo with multiple autoimmune diseases, further supporting the shared autoimmune etiology."", ""reference"": ""PMID:26724277"", ""snippet"": ""Vitiligo can also be associated with several autoimmune diseases, including autoimmune thyroid diseases, alopecia areata, and halo nevi."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The increased prevalence of autoimmune thyroid disease among vitiligo patients supports the notion of a shared autoimmune mechanism."", ""reference"": ""PMID:20578892"", ""snippet"": ""Generalized vitiligo is an autoimmune disease of skin pigmentation that is associated with increased prevalence of other autoimmune diseases, particularly autoimmune thyroid disease."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The frequent association of vitiligo with other autoimmune disorders aligns with the concept of a common autoimmune etiology."", ""reference"": ""PMID:11681494"", ""snippet"": ""In brief, the disease is frequently associated with other disorders which have an autoimmune origin such as autoimmune thyroiditis and insulin-dependent diabetes mellitus."", ""supports"": ""SUPPORT""}], ""name"": ""Autoimmune Reaction""}"
7788	338	Vitiligo	Vitiligo.yaml	pathophysiology	3	Oxidative Stress	Increased oxidative stress in the skin may contribute to melanocyte vulnerability and destruction.																																																								"{""description"": ""Increased oxidative stress in the skin may contribute to melanocyte vulnerability and destruction."", ""name"": ""Oxidative Stress""}"	{}	"{""description"": ""Increased oxidative stress in the skin may contribute to melanocyte vulnerability and destruction."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature supports the statement that increased oxidative stress in the skin contributes to melanocyte vulnerability and destruction."", ""reference"": ""PMID:36980277"", ""snippet"": ""Oxidative stress is considered to play a crucial role in activating consequent autoimmune responses related to vitiligo."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study supports the idea that oxidative stress biomarkers are elevated in vitiligo patients, contributing to melanocyte vulnerability."", ""reference"": ""PMID:33098225"", ""snippet"": ""Hydrogen peroxide (H2 O2 ) and malondialdehyde (MDA) were significantly higher in patients than controls (p-value < .001, <.001, respectively); on the other hand, total antioxidant capacity (TAC) was significantly lower in patients than controls (p-value = .001)"", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports the involvement of oxidative stress-induced mechanisms in melanocyte death."", ""reference"": ""PMID:33346939"", ""snippet"": ""Apoptosis is most widely studied cell death pathways in vitiligo...new types of regulated cell death including necroptosis, pyroptosis, and ferroptosis may also participate in the pathogenesis of vitiligo."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study highlights the role of oxidative stress and its impact on melanocyte vulnerability, contributing to their destruction in vitiligo."", ""reference"": ""PMID:37230937"", ""snippet"": ""We found that the expression levels of collagen-related genes and anti-oxidative enzymes were upregulated in vitiligo-derived fibroblasts."", ""supports"": ""SUPPORT""}], ""name"": ""Oxidative Stress""}"
7789	338	Vitiligo	Vitiligo.yaml	pathophysiology	4	IFN-gamma-CXCL9/CXCL10 Chemokine Axis	IFN-gamma induces keratinocyte production of CXCL9 and CXCL10 chemokines, which recruit CXCR3-positive CD8+ T cells to skin. These cytotoxic T cells mediate melanocyte destruction via perforin/granzyme and Fas-FasL pathways. Elevated serum CXCL9/CXCL10 correlate with disease activity.																																																								"{""description"": ""IFN-gamma induces keratinocyte production of CXCL9 and CXCL10 chemokines, which recruit CXCR3-positive CD8+ T cells to skin. These cytotoxic T cells mediate melanocyte destruction via perforin/granzyme and Fas-FasL pathways. Elevated serum CXCL9/CXCL10 correlate with disease activity."", ""name"": ""IFN-gamma-CXCL9/CXCL10 Chemokine Axis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to type II interferon"", ""term"": {""id"": ""GO:0034341"", ""label"": ""response to type II interferon""}}, {""preferred_term"": ""leukocyte chemotaxis"", ""term"": {""id"": ""GO:0030595"", ""label"": ""leukocyte chemotaxis""}}], ""cell_types"": [{""preferred_term"": ""keratinocyte"", ""term"": {""id"": ""CL:0000312"", ""label"": ""keratinocyte""}}, {""preferred_term"": ""CD8+ T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}], ""description"": ""IFN-gamma induces keratinocyte production of CXCL9 and CXCL10 chemokines, which recruit CXCR3-positive CD8+ T cells to skin. These cytotoxic T cells mediate melanocyte destruction via perforin/granzyme and Fas-FasL pathways. Elevated serum CXCL9/CXCL10 correlate with disease activity."", ""locations"": [{""preferred_term"": ""skin epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}], ""name"": ""IFN-gamma-CXCL9/CXCL10 Chemokine Axis""}"
7790	338	Vitiligo	Vitiligo.yaml	pathophysiology	5	IL-15 and Tissue-Resident Memory T Cells	IL-15 promotes survival and cytotoxic function of CD8+ tissue-resident memory T cells (TRM) in skin, maintaining local immune surveillance and contributing to disease persistence and relapse. Serum IL-15 is elevated and correlates with disease extent.																																																								"{""description"": ""IL-15 promotes survival and cytotoxic function of CD8+ tissue-resident memory T cells (TRM) in skin, maintaining local immune surveillance and contributing to disease persistence and relapse. Serum IL-15 is elevated and correlates with disease extent."", ""name"": ""IL-15 and Tissue-Resident Memory T Cells""}"	{}	"{""cell_types"": [{""description"": ""Specifically tissue-resident memory (TRM) phenotype with CD69+CD103+ markers"", ""preferred_term"": ""CD8+ tissue-resident memory T cell"", ""term"": {""id"": ""CL:0000625"", ""label"": ""CD8-positive, alpha-beta T cell""}}], ""description"": ""IL-15 promotes survival and cytotoxic function of CD8+ tissue-resident memory T cells (TRM) in skin, maintaining local immune surveillance and contributing to disease persistence and relapse. Serum IL-15 is elevated and correlates with disease extent."", ""locations"": [{""preferred_term"": ""skin epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}], ""name"": ""IL-15 and Tissue-Resident Memory T Cells""}"
7791	338	Vitiligo	Vitiligo.yaml	pathophysiology	6	Innate Immune Activation	DAMP-driven activation of plasmacytoid dendritic cells and conventional dendritic cells promotes type I interferon signaling, antigen presentation, and licensing of Th1/cytotoxic immunity. NK cells and innate lymphoid cells participate in bridging innate to adaptive immune responses.																																																								"{""description"": ""DAMP-driven activation of plasmacytoid dendritic cells and conventional dendritic cells promotes type I interferon signaling, antigen presentation, and licensing of Th1/cytotoxic immunity. NK cells and innate lymphoid cells participate in bridging innate to adaptive immune responses."", ""name"": ""Innate Immune Activation""}"	{}	"{""cell_types"": [{""preferred_term"": ""dendritic cell"", ""term"": {""id"": ""CL:0000451"", ""label"": ""dendritic cell""}}, {""preferred_term"": ""natural killer cell"", ""term"": {""id"": ""CL:0000623"", ""label"": ""natural killer cell""}}], ""description"": ""DAMP-driven activation of plasmacytoid dendritic cells and conventional dendritic cells promotes type I interferon signaling, antigen presentation, and licensing of Th1/cytotoxic immunity. NK cells and innate lymphoid cells participate in bridging innate to adaptive immune responses."", ""locations"": [{""preferred_term"": ""skin epidermis"", ""term"": {""id"": ""UBERON:0001003"", ""label"": ""skin epidermis""}}], ""name"": ""Innate Immune Activation""}"
7811	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	0	VHL Tumor Suppressor Loss	Germline heterozygous VHL mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates VHL function, initiating tumorigenesis. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation.																																																								"{""description"": ""Germline heterozygous VHL mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates VHL function, initiating tumorigenesis. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation."", ""name"": ""VHL Tumor Suppressor Loss""}"	"{""downstream"": [{""description"": ""VHL loss prevents ubiquitination of HIF-alpha subunits"", ""target"": ""Loss of HIF Degradation""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""cellular response to hypoxia"", ""term"": {""id"": ""GO:0071456"", ""label"": ""cellular response to hypoxia""}}], ""description"": ""Germline heterozygous VHL mutations result in one functional allele. Somatic loss or mutation of the remaining wild-type allele (second hit) eliminates VHL function, initiating tumorigenesis. This follows Knudson's two-hit hypothesis for tumor suppressor gene inactivation."", ""downstream"": [{""description"": ""VHL loss prevents ubiquitination of HIF-alpha subunits"", ""target"": ""Loss of HIF Degradation""}], ""evidence"": [{""explanation"": ""Confirms that biallelic VHL inactivation (consistent with two-hit hypothesis) leads to constitutive HIF activation and pro-tumorigenic signaling."", ""reference"": ""PMID:37980175"", ""snippet"": ""von Hippel-Lindau (VHL) disease is characterized by biallelic inactivation of the VHL gene leading to abnormal or absent VHL protein function, and constitutive activation of hypoxia-inducible factors (HIF) that leads to pro-tumorigenic signaling."", ""supports"": ""SUPPORT""}], ""name"": ""VHL Tumor Suppressor Loss""}"
7812	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	1	Loss of HIF Degradation	VHL protein (pVHL) functions as the substrate recognition component of an E3 ubiquitin ligase complex that targets hydroxylated HIF-alpha subunits for proteasomal degradation under normoxic conditions. Loss of VHL function prevents HIF-alpha degradation, allowing HIF accumulation even in the presence of oxygen.																																																								"{""description"": ""VHL protein (pVHL) functions as the substrate recognition component of an E3 ubiquitin ligase complex that targets hydroxylated HIF-alpha subunits for proteasomal degradation under normoxic conditions. Loss of VHL function prevents HIF-alpha degradation, allowing HIF accumulation even in the presence of oxygen."", ""name"": ""Loss of HIF Degradation""}"	"{""downstream"": [{""description"": ""Stabilized HIF-alpha accumulates and activates target genes"", ""target"": ""Constitutive HIF Activation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""proteasome-mediated ubiquitin-dependent protein catabolic process"", ""term"": {""id"": ""GO:0043161"", ""label"": ""proteasome-mediated ubiquitin-dependent protein catabolic process""}}], ""description"": ""VHL protein (pVHL) functions as the substrate recognition component of an E3 ubiquitin ligase complex that targets hydroxylated HIF-alpha subunits for proteasomal degradation under normoxic conditions. Loss of VHL function prevents HIF-alpha degradation, allowing HIF accumulation even in the presence of oxygen."", ""downstream"": [{""description"": ""Stabilized HIF-alpha accumulates and activates target genes"", ""target"": ""Constitutive HIF Activation""}], ""evidence"": [{""explanation"": ""Defines pVHL as the substrate recognition component of an E3 ubiquitin ligase that targets hydroxylated HIF-alpha for proteasomal degradation."", ""reference"": ""PMID:19671042"", ""snippet"": ""The von-Hippel Lindau tumor suppressor (pVHL) is the substrate recognition component of an E3 ubiquitin ligase and functions as a master regulator of HIF activity by targeting the hydroxylated HIF-alpha subunit for ubiquitylation and rapid proteasomal degradation under normoxic conditions."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms that impaired VHL function leads to HIF accumulation due to loss of proteasomal degradation."", ""reference"": ""PMID:15162797"", ""snippet"": ""VHL tumor suppressor is a specific substrate-recognition component of the E3 ubiquitin complex, which regulates proteasomal degradation of the subunit of the hypoxia inducible transcription factor (HIF). Impaired VHL complex function leads to accumulation of HIF, overexpression of various HIF-induced gene products and formation of highly vascular neoplasia."", ""supports"": ""SUPPORT""}], ""name"": ""Loss of HIF Degradation""}"
7813	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	2	Constitutive HIF Activation	Stabilized HIF-alpha (primarily HIF-2alpha in RCC) dimerizes with HIF-1beta (ARNT) and translocates to the nucleus where it activates transcription of hypoxia-responsive genes. This occurs constitutively regardless of oxygen levels, creating a pseudo-hypoxic state.																																																								"{""description"": ""Stabilized HIF-alpha (primarily HIF-2alpha in RCC) dimerizes with HIF-1beta (ARNT) and translocates to the nucleus where it activates transcription of hypoxia-responsive genes. This occurs constitutively regardless of oxygen levels, creating a pseudo-hypoxic state."", ""name"": ""Constitutive HIF Activation""}"	"{""downstream"": [{""description"": ""HIF activates VEGF transcription driving neovascularization"", ""target"": ""VEGF Overexpression and Angiogenesis""}, {""description"": ""HIF activates genes promoting proliferation and altered metabolism"", ""target"": ""Growth Factor and Metabolic Reprogramming""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""response to hypoxia"", ""term"": {""id"": ""GO:0001666"", ""label"": ""response to hypoxia""}}], ""description"": ""Stabilized HIF-alpha (primarily HIF-2alpha in RCC) dimerizes with HIF-1beta (ARNT) and translocates to the nucleus where it activates transcription of hypoxia-responsive genes. This occurs constitutively regardless of oxygen levels, creating a pseudo-hypoxic state."", ""downstream"": [{""description"": ""HIF activates VEGF transcription driving neovascularization"", ""target"": ""VEGF Overexpression and Angiogenesis""}, {""description"": ""HIF activates genes promoting proliferation and altered metabolism"", ""target"": ""Growth Factor and Metabolic Reprogramming""}], ""evidence"": [{""explanation"": ""Demonstrates that VHL deficiency leads to constitutive HIF-alpha expression even under normoxic conditions, and that VHL restoration can reverse this effect."", ""reference"": ""PMID:11114720"", ""snippet"": ""in VHL deficient cell lines, both HIF-alpha subunits are constitutively expressed, whereas re-introduction of a functional VHL gene restores the instability of HIF-1alpha and HIF-2alpha proteins under normoxic conditions."", ""supports"": ""SUPPORT""}], ""name"": ""Constitutive HIF Activation""}"
7814	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	3	VEGF Overexpression and Angiogenesis	VEGF (vascular endothelial growth factor) is a direct HIF target gene. Constitutive HIF activation leads to chronic VEGF overexpression, driving extensive tumor angiogenesis. This explains the highly vascular nature of VHL-associated tumors, particularly hemangioblastomas and clear cell RCC.																																																								"{""description"": ""VEGF (vascular endothelial growth factor) is a direct HIF target gene. Constitutive HIF activation leads to chronic VEGF overexpression, driving extensive tumor angiogenesis. This explains the highly vascular nature of VHL-associated tumors, particularly hemangioblastomas and clear cell RCC."", ""name"": ""VEGF Overexpression and Angiogenesis""}"	"{""downstream"": [{""description"": ""Neovascularization supports tumor growth and progression"", ""target"": ""Tumor Development""}]}"	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""vascular endothelial growth factor signaling pathway"", ""term"": {""id"": ""GO:0038084"", ""label"": ""vascular endothelial growth factor signaling pathway""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""angiogenesis"", ""term"": {""id"": ""GO:0001525"", ""label"": ""angiogenesis""}}], ""description"": ""VEGF (vascular endothelial growth factor) is a direct HIF target gene. Constitutive HIF activation leads to chronic VEGF overexpression, driving extensive tumor angiogenesis. This explains the highly vascular nature of VHL-associated tumors, particularly hemangioblastomas and clear cell RCC."", ""downstream"": [{""description"": ""Neovascularization supports tumor growth and progression"", ""target"": ""Tumor Development""}], ""evidence"": [{""explanation"": ""Demonstrates elevated VEGF levels in VHL-associated hemangioblastomas, linking HIF activation to VEGF overexpression."", ""reference"": ""PMID:11114720"", ""snippet"": ""In a previous study of hemangioblastomas, the most frequent manifestation of hereditary von Hippel-Lindau disease (VHL), we found elevated levels of vascular endothelial growth factor and HIF-2alpha mRNA in stromal cells of the tumors."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms VHL protein regulates angiogenesis through HIF-mediated mechanisms."", ""reference"": ""PMID:11114720"", ""snippet"": ""The data presented here provide evidence for a role of the VHL protein in regulation of angiogenesis and erythropoiesis mediated by the HIF-1alpha and HIF-2alpha proteins."", ""supports"": ""SUPPORT""}], ""name"": ""VEGF Overexpression and Angiogenesis""}"
7815	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	4	Growth Factor and Metabolic Reprogramming	HIF activates transcription of genes including PDGF, TGF-alpha, EGFR, GLUT1, and glycolytic enzymes. This promotes cell proliferation, survival, and a shift toward glycolytic metabolism (Warburg effect) that supports tumor growth.																																																								"{""description"": ""HIF activates transcription of genes including PDGF, TGF-alpha, EGFR, GLUT1, and glycolytic enzymes. This promotes cell proliferation, survival, and a shift toward glycolytic metabolism (Warburg effect) that supports tumor growth."", ""name"": ""Growth Factor and Metabolic Reprogramming""}"	"{""downstream"": [{""description"": ""Growth factors and metabolic changes drive tumorigenesis"", ""target"": ""Tumor Development""}]}"	"{""biological_processes"": [{""modifier"": ""ABNORMAL"", ""preferred_term"": ""cellular glucose homeostasis"", ""term"": {""id"": ""GO:0001678"", ""label"": ""cellular glucose homeostasis""}}, {""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""HIF activates transcription of genes including PDGF, TGF-alpha, EGFR, GLUT1, and glycolytic enzymes. This promotes cell proliferation, survival, and a shift toward glycolytic metabolism (Warburg effect) that supports tumor growth."", ""downstream"": [{""description"": ""Growth factors and metabolic changes drive tumorigenesis"", ""target"": ""Tumor Development""}], ""evidence"": [{""explanation"": ""The use of GLUT-1 as a diagnostic marker for VHL-associated tumors reflects HIF-induced metabolic reprogramming with increased glucose uptake."", ""reference"": ""PMID:37980175"", ""snippet"": ""immunohistochemical studies for markers such as paired box 8 (PAX-8), carbonic anhydrase 9 (CA9), and glucose transporter 1 (GLUT-1) have an important role in routine clinical practice and represent cost-effective diagnostic tools."", ""supports"": ""SUPPORT""}], ""name"": ""Growth Factor and Metabolic Reprogramming""}"
7816	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	5	Tumor Development	The combination of increased angiogenesis, growth factor signaling, and metabolic reprogramming creates a permissive environment for tumor development. Different tissues show variable susceptibility, explaining the characteristic tumor spectrum of VHL disease including RCC, hemangioblastomas, and pheochromocytomas.																																																								"{""description"": ""The combination of increased angiogenesis, growth factor signaling, and metabolic reprogramming creates a permissive environment for tumor development. Different tissues show variable susceptibility, explaining the characteristic tumor spectrum of VHL disease including RCC, hemangioblastomas, and pheochromocytomas."", ""name"": ""Tumor Development""}"	{}	"{""description"": ""The combination of increased angiogenesis, growth factor signaling, and metabolic reprogramming creates a permissive environment for tumor development. Different tissues show variable susceptibility, explaining the characteristic tumor spectrum of VHL disease including RCC, hemangioblastomas, and pheochromocytomas."", ""evidence"": [{""explanation"": ""Documents the characteristic tumor spectrum of VHL disease and links it to disrupted oxygen sensing."", ""reference"": ""PMID:19671042"", ""snippet"": ""Mutations in pVHL can be found in familial and sporadic hemangioblastomas, clear cell carcinomas of the kidney, pheochromocytomas and inherited forms of erythrocytosis, illustrating the importance of disrupted molecular oxygen sensing in the pathogenesis of these diseases."", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms the characteristic tumor spectrum associated with VHL protein loss."", ""reference"": ""PMID:15162797"", ""snippet"": ""Loss of von Hippel-Lindau (VHL) protein function results in an autosomal-dominant cancer syndrome known as VHL disease, which manifests as angiomas of the retina, hemangioblastomas of the central nervous system, renal clear-cell carcinomas and pheochromocytomas."", ""supports"": ""SUPPORT""}], ""name"": ""Tumor Development""}"
7835	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	0	Macrophage dysfunction and malabsorption	Chronic small bowel infection by Tropheryma whipplei leads to lymphostasis and impaired nutrient absorption driven by macrophage dysfunction.																																																								"{""description"": ""Chronic small bowel infection by Tropheryma whipplei leads to lymphostasis and impaired nutrient absorption driven by macrophage dysfunction."", ""name"": ""Macrophage dysfunction and malabsorption""}"	{}	"{""biological_processes"": [{""preferred_term"": ""macrophage activation"", ""term"": {""id"": ""GO:0042116"", ""label"": ""macrophage activation""}}], ""cell_types"": [{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Chronic small bowel infection by Tropheryma whipplei leads to lymphostasis and impaired nutrient absorption driven by macrophage dysfunction."", ""evidence"": [{""explanation"": ""Review describes lymphatic obstruction and malabsorption from chronic infection."", ""reference"": ""PMID:26288590"", ""snippet"": ""The disease is a chronic infection of the intestinal mucosa with the bacterium Tropheryma whipplei, which leads to a lymphostasis with an impaired absorption of the nutrition."", ""supports"": ""SUPPORT""}, {""explanation"": ""Highlights macrophage functional defect underlying persistent infection."", ""reference"": ""PMID:26288590"", ""snippet"": ""Recent studies suggest that a host-specific dysfunction of the intestinal macrophages is responsible for the chronic infection with T. whipplei."", ""supports"": ""SUPPORT""}], ""name"": ""Macrophage dysfunction and malabsorption""}"
7836	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	1	Host susceptibility and immune dysregulation	Only a small fraction of exposed individuals develop Whipple disease, implicating rare inborn or acquired immune defects and risk from anti-TNF therapy.																																																								"{""description"": ""Only a small fraction of exposed individuals develop Whipple disease, implicating rare inborn or acquired immune defects and risk from anti-TNF therapy."", ""name"": ""Host susceptibility and immune dysregulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""immune system process"", ""term"": {""id"": ""GO:0002376"", ""label"": ""immune system process""}}], ""description"": ""Only a small fraction of exposed individuals develop Whipple disease, implicating rare inborn or acquired immune defects and risk from anti-TNF therapy."", ""evidence"": [{""explanation"": ""Genetic review links rare immune defects to disease susceptibility."", ""reference"": ""PMID:40062480"", ""snippet"": ""Half the world's population is exposed to T. whipplei, but only one in a million develop WD. This suggests that acquired or inborn errors of immunity (IEI) may underlie WD."", ""supports"": ""SUPPORT""}, {""explanation"": ""Notes iatrogenic immune suppression as a trigger for disease activation."", ""reference"": ""PMID:40062480"", ""snippet"": ""Anti-TNF treatment is a well established risk factor for flare-ups of WD."", ""supports"": ""SUPPORT""}, {""explanation"": ""Cohort shows high immunosuppression rate among confirmed Whipple disease cases."", ""reference"": ""PMID:32896657"", ""snippet"": ""About 60% were immunosuppressed. The most frequent clinical presentations were joint pain (16/22), weight loss (15/22) and/or digestive tract disorder (15/22)."", ""supports"": ""SUPPORT""}, {""explanation"": ""Post-transplant case illustrates Whipple disease emerging under chronic immunosuppression."", ""reference"": ""PMID:37727483"", ""snippet"": ""The patient was admitted to the hospital due to recurrent diarrhea for 1 mo, shortness of breath, and 1 wk of fever, after 3 years of renal transplantation."", ""supports"": ""SUPPORT""}], ""name"": ""Host susceptibility and immune dysregulation""}"
7837	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	2	TNF-inhibitordriven macrophage apoptosis	Anti-TNF biologics can reprogram macrophages infected with Tropheryma whipplei, increasing bacterial replication and macrophage apoptosis, exacerbating latent disease.																																																								"{""description"": ""Anti-TNF biologics can reprogram macrophages infected with Tropheryma whipplei, increasing bacterial replication and macrophage apoptosis, exacerbating latent disease."", ""name"": ""TNF-inhibitordriven macrophage apoptosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""apoptotic process"", ""term"": {""id"": ""GO:0006915"", ""label"": ""apoptotic process""}}], ""cell_types"": [{""preferred_term"": ""macrophage"", ""term"": {""id"": ""CL:0000235"", ""label"": ""macrophage""}}], ""description"": ""Anti-TNF biologics can reprogram macrophages infected with Tropheryma whipplei, increasing bacterial replication and macrophage apoptosis, exacerbating latent disease."", ""evidence"": [{""explanation"": ""Demonstrates TNF inhibitors increase T. whipplei replication within macrophages."", ""reference"": ""PMID:34093562"", ""snippet"": ""Etanercept, adalimumab or certolizumab treatment of monocyte-derived macrophages from healthy subjects significantly increased bacterial replication in vitro without affecting uptake."", ""supports"": ""SUPPORT""}, {""explanation"": ""Study links TNF blockade to apoptosis-driven exacerbation of Whipple disease."", ""reference"": ""PMID:34093562"", ""snippet"": ""TNFI aggravate/exacerbate latent or subclinical undiagnosed Whipple's disease by promoting a strong inflammatory response and apoptosis."", ""supports"": ""SUPPORT""}], ""name"": ""TNF-inhibitordriven macrophage apoptosis""}"
7859	341	Wilms Tumor	Wilms_Tumor.yaml	pathophysiology	0	WT1 Inactivation	WT1 is a transcription factor essential for normal kidney and gonad development. Biallelic WT1 inactivation occurs in 10-20% of Wilms tumors. Germline WT1 mutations cause WAGR syndrome (Wilms tumor, aniridia, genitourinary anomalies, intellectual disability) and Denys-Drash syndrome.																																																								"{""description"": ""WT1 is a transcription factor essential for normal kidney and gonad development. Biallelic WT1 inactivation occurs in 10-20% of Wilms tumors. Germline WT1 mutations cause WAGR syndrome (Wilms tumor, aniridia, genitourinary anomalies, intellectual disability) and Denys-Drash syndrome."", ""name"": ""WT1 Inactivation""}"	"{""downstream"": [{""description"": ""WT1 loss prevents normal renal blastemal differentiation"", ""target"": ""Blocked Nephron Differentiation""}]}"	"{""biological_processes"": [{""modifier"": ""DECREASED"", ""preferred_term"": ""cell differentiation"", ""term"": {""id"": ""GO:0030154"", ""label"": ""cell differentiation""}}], ""description"": ""WT1 is a transcription factor essential for normal kidney and gonad development. Biallelic WT1 inactivation occurs in 10-20% of Wilms tumors. Germline WT1 mutations cause WAGR syndrome (Wilms tumor, aniridia, genitourinary anomalies, intellectual disability) and Denys-Drash syndrome."", ""downstream"": [{""description"": ""WT1 loss prevents normal renal blastemal differentiation"", ""target"": ""Blocked Nephron Differentiation""}], ""evidence"": [{""explanation"": ""Supports the role of WT1 in Wilms tumor development."", ""reference"": ""PMID:20021811"", ""snippet"": ""The WT1 gene located at 11p13 was identified in 1990 as a tumor suppressor gene important in the development in WT."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""kidney"", ""term"": {""id"": ""UBERON:0002113"", ""label"": ""kidney""}}], ""name"": ""WT1 Inactivation""}"
7860	341	Wilms Tumor	Wilms_Tumor.yaml	pathophysiology	1	WTX/CTNNB1 Wnt Pathway Activation	WTX (AMER1) is a negative regulator of Wnt signaling mutated in approximately 15-20% of Wilms tumors. CTNNB1 (beta-catenin) activating mutations occur in approximately 15% of cases. Both result in constitutive Wnt pathway activation, promoting proliferation and blocking differentiation.																																																								"{""description"": ""WTX (AMER1) is a negative regulator of Wnt signaling mutated in approximately 15-20% of Wilms tumors. CTNNB1 (beta-catenin) activating mutations occur in approximately 15% of cases. Both result in constitutive Wnt pathway activation, promoting proliferation and blocking differentiation."", ""name"": ""WTX/CTNNB1 Wnt Pathway Activation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""Wnt signaling pathway"", ""term"": {""id"": ""GO:0016055"", ""label"": ""Wnt signaling pathway""}}], ""description"": ""WTX (AMER1) is a negative regulator of Wnt signaling mutated in approximately 15-20% of Wilms tumors. CTNNB1 (beta-catenin) activating mutations occur in approximately 15% of cases. Both result in constitutive Wnt pathway activation, promoting proliferation and blocking differentiation."", ""name"": ""WTX/CTNNB1 Wnt Pathway Activation""}"
7861	341	Wilms Tumor	Wilms_Tumor.yaml	pathophysiology	2	Blocked Nephron Differentiation	Wilms tumor arises from nephrogenic rests - foci of embryonic blastemal cells that persist beyond the normal period of nephrogenesis. These cells retain proliferative capacity but fail to undergo terminal differentiation into mature nephrons.																																																								"{""description"": ""Wilms tumor arises from nephrogenic rests - foci of embryonic blastemal cells that persist beyond the normal period of nephrogenesis. These cells retain proliferative capacity but fail to undergo terminal differentiation into mature nephrons."", ""name"": ""Blocked Nephron Differentiation""}"	{}	"{""biological_processes"": [{""modifier"": ""INCREASED"", ""preferred_term"": ""cell population proliferation"", ""term"": {""id"": ""GO:0008283"", ""label"": ""cell population proliferation""}}], ""description"": ""Wilms tumor arises from nephrogenic rests - foci of embryonic blastemal cells that persist beyond the normal period of nephrogenesis. These cells retain proliferative capacity but fail to undergo terminal differentiation into mature nephrons."", ""name"": ""Blocked Nephron Differentiation""}"
7879	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	0	Copper Accumulation	"ATP7B mutations impair copper excretion into bile and incorporation into ceruloplasmin. Copper accumulates in many organs, especially liver and brain. Free copper is toxic and promotes oxidative damage and cellular toxicity. ATP7B normally resides in the trans-Golgi network where it loads copper into apoceruloplasmin and traffics to the bile canalicular membrane for biliary copper excretion when intracellular copper is elevated.
"																																																								"{""description"": ""ATP7B mutations impair copper excretion into bile and incorporation into ceruloplasmin. Copper accumulates in many organs, especially liver and brain. Free copper is toxic and promotes oxidative damage and cellular toxicity. ATP7B normally resides in the trans-Golgi network where it loads copper into apoceruloplasmin and traffics to the bile canalicular membrane for biliary copper excretion when intracellular copper is elevated.\n"", ""name"": ""Copper Accumulation""}"	{}	"{""biological_processes"": [{""preferred_term"": ""copper ion transport"", ""term"": {""id"": ""GO:0006825"", ""label"": ""copper ion transport""}}, {""preferred_term"": ""copper ion homeostasis"", ""term"": {""id"": ""GO:0055070"", ""label"": ""copper ion homeostasis""}}], ""cellular_components"": [{""preferred_term"": ""Golgi apparatus"", ""term"": {""id"": ""GO:0005794"", ""label"": ""Golgi apparatus""}}], ""description"": ""ATP7B mutations impair copper excretion into bile and incorporation into ceruloplasmin. Copper accumulates in many organs, especially liver and brain. Free copper is toxic and promotes oxidative damage and cellular toxicity. ATP7B normally resides in the trans-Golgi network where it loads copper into apoceruloplasmin and traffics to the bile canalicular membrane for biliary copper excretion when intracellular copper is elevated.\n"", ""evidence"": [{""explanation"": ""Establishes that ATP7B mutations are the causative defect in Wilson's disease."", ""reference"": ""PMID:37741465"", ""snippet"": ""Inactivating mutations of the copper-transporting P-type ATPase, ATP7B, result in Wilson's disease, an autosomal recessive disorder"", ""supports"": ""SUPPORT""}, {""explanation"": ""Confirms that impaired biliary copper excretion leads to hepatic copper accumulation."", ""reference"": ""PMID:38731973"", ""snippet"": ""Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein."", ""supports"": ""SUPPORT""}, {""explanation"": ""Supports multi-organ copper accumulation in Wilson disease."", ""reference"": ""PMID:16382340"", ""snippet"": ""Wilson disease (WD) is an autosomal recessive inherited disorder of copper metabolism, resulting in pathological accumulation of copper in many organs and tissues."", ""supports"": ""SUPPORT""}, {""explanation"": ""Supports ATP7B localization to the trans-Golgi network and copper loading into apoceruloplasmin with biliary excretion."", ""reference"": ""PMID:16382340"", ""snippet"": ""ATP7B is the gene product of the WD gene located on chromosome 13 and resides in hepatocytes in the trans-Golgi network, transporting copper into the secretory pathway for incorporation into apoceruloplasmin and excretion into the bile."", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates copper-stimulated ATP7B trafficking to the canalicular membrane."", ""reference"": ""PMID:18395099"", ""snippet"": ""Copper excess provokes a massive download of the ATP7B retained in the trans-Golgi network into the bile canalicular membrane."", ""supports"": ""SUPPORT""}, {""explanation"": ""Supports toxic effects of free copper and oxidative stress in Wilson disease."", ""reference"": ""PMID:25002079"", ""snippet"": ""Free copper in Wilson disease (WD) is toxic and may reduce antioxidant, increase oxidative stress marker and thereby cytokine release and excitotoxic injury, but there is paucity of studies in humans."", ""supports"": ""SUPPORT""}], ""name"": ""Copper Accumulation""}"
7880	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	1	Hepatocyte Injury	"Copper accumulation in hepatocytes causes oxidative stress, mitochondrial dysfunction, and cell death. Progressive liver damage leads to fibrosis and cirrhosis. Copper overload activates autophagy and mitophagy-based mitochondrial quality control responses.
"																																																								"{""description"": ""Copper accumulation in hepatocytes causes oxidative stress, mitochondrial dysfunction, and cell death. Progressive liver damage leads to fibrosis and cirrhosis. Copper overload activates autophagy and mitophagy-based mitochondrial quality control responses.\n"", ""name"": ""Hepatocyte Injury""}"	{}	"{""biological_processes"": [{""preferred_term"": ""response to oxidative stress"", ""term"": {""id"": ""GO:0006979"", ""label"": ""response to oxidative stress""}}, {""preferred_term"": ""mitophagy"", ""term"": {""id"": ""GO:0000423"", ""label"": ""mitophagy""}}], ""cell_types"": [{""preferred_term"": ""hepatocyte"", ""term"": {""id"": ""CL:0000182"", ""label"": ""hepatocyte""}}], ""description"": ""Copper accumulation in hepatocytes causes oxidative stress, mitochondrial dysfunction, and cell death. Progressive liver damage leads to fibrosis and cirrhosis. Copper overload activates autophagy and mitophagy-based mitochondrial quality control responses.\n"", ""evidence"": [{""explanation"": ""Demonstrates that excess copper generates ROS leading to oxidative stress and cellular injury."", ""reference"": ""PMID:38731973"", ""snippet"": ""Excess Cu2+ primarily leads to the generation of reactive oxygen species (ROS), as evidenced by early experimental studies exemplified with the detection of hydroxyl radical formation"", ""supports"": ""SUPPORT""}, {""explanation"": ""Supports mitochondrial dysfunction, ROS generation, and hepatocyte death with copper overload."", ""reference"": ""PMID:24517326"", ""snippet"": ""On the contrary, however, when copper is massively deposited in mitochondria, severe structural and respiratory impairments are observed upon disease progression. This provokes reactive oxygen species and consequently causes the mitochondrial membranes to disintegrate, which triggers hepatocyte death."", ""supports"": ""SUPPORT""}, {""explanation"": ""Supports progression from hepatic injury to fibrosis and cirrhosis."", ""reference"": ""PMID:28433112"", ""snippet"": ""Most liver biopsy specimens show moderate to severe steatosis, variable degree of portal and/or lobular inflammation, and fibrosis eventually progressing to cirrhosis."", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates activation of autophagy in Wilson disease hepatocytes under copper overload."", ""reference"": ""PMID:30452922"", ""snippet"": ""Hepatocytes in liver tissues from patients with WD and from Atp7b-/- mice and rats (but not controls) had multiple autophagosomes."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Shows copper-induced mitophagy in a liver model, supporting mitochondrial quality control responses."", ""reference"": ""PMID:33360697"", ""snippet"": ""In general, the results reveal that Cu exposure can cause mitophagy through the PINK1/Parkin pathway in chicken livers, and that mitophagy might attenuate Cu-induced mitochondrial apoptosis."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""liver"", ""term"": {""id"": ""UBERON:0002107"", ""label"": ""liver""}}], ""name"": ""Hepatocyte Injury""}"
7881	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	2	Neurodegeneration	"Copper deposition is thought to drive brain cellular damage with characteristic striatal/basal ganglia lesions. Reactive astrogliosis and microglial activation with increased CNS inflammatory cytokines indicate neuroinflammation contributing to movement and psychiatric symptoms.
"																																																								"{""description"": ""Copper deposition is thought to drive brain cellular damage with characteristic striatal/basal ganglia lesions. Reactive astrogliosis and microglial activation with increased CNS inflammatory cytokines indicate neuroinflammation contributing to movement and psychiatric symptoms.\n"", ""name"": ""Neurodegeneration""}"	{}	"{""biological_processes"": [{""preferred_term"": ""neuron death"", ""term"": {""id"": ""GO:0070997"", ""label"": ""neuron death""}}], ""cell_types"": [{""preferred_term"": ""astrocyte"", ""term"": {""id"": ""CL:0000127"", ""label"": ""astrocyte""}}, {""preferred_term"": ""microglial cell"", ""term"": {""id"": ""CL:0000129"", ""label"": ""microglial cell""}}], ""description"": ""Copper deposition is thought to drive brain cellular damage with characteristic striatal/basal ganglia lesions. Reactive astrogliosis and microglial activation with increased CNS inflammatory cytokines indicate neuroinflammation contributing to movement and psychiatric symptoms.\n"", ""evidence"": [{""explanation"": ""Explains the pathophysiology of copper-induced brain injury in Wilson's disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""Released from the liver cells due to limited storage capacity, the toxic copper enters the circulation and arrives at other organs, causing local accumulation and cell injury. This explains why copper injures not only the liver, but also the brain"", ""supports"": ""SUPPORT""}, {""explanation"": ""Supports copper deposition driving brain damage with characteristic striatal lesions."", ""reference"": ""PMID:28433113"", ""snippet"": ""In Wilson disease (WD), brain cellular damage is thought to be due to copper deposition. Striatal lesions are the most characteristic lesions found in the brain of patients with neurologic symptoms, as emphasized in the initial reports of S.A.K. Wilson."", ""supports"": ""SUPPORT""}, {""explanation"": ""Supports reactive astrogliosis and basal ganglia/putamen involvement."", ""reference"": ""PMID:31179301"", ""snippet"": ""Most severe neuropathologic abnormalities, including tissue rarefaction, reactive astrogliosis, myelin palor, and presence of iron-laden macrophages, are typically present in the putamen while other basal ganglia, thalami, and brainstem are usually less affected."", ""supports"": ""SUPPORT""}, {""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Demonstrates CNS inflammatory cytokines and microglial activation in a Wilson disease mouse model."", ""reference"": ""PMID:39334421"", ""snippet"": ""At 3-5 months of age, these mice started to display neurological deficits in motor coordination and cognitive dysfunction, accompanied by increased expression of inflammatory cytokines in the central nervous system. Microglia in the striatum and cortex exhibit significant activation, shorter processes, and decreased branch points."", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""collection of basal ganglia"", ""term"": {""id"": ""UBERON:0010011"", ""label"": ""collection of basal ganglia""}}, {""preferred_term"": ""putamen"", ""term"": {""id"": ""UBERON:0001874"", ""label"": ""putamen""}}], ""name"": ""Neurodegeneration""}"
7882	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	3	Cuproptosis	"Copper-dependent cell death involving binding of copper to lipoylated enzymes in the tricarboxylic acid (TCA) cycle, leading to proteotoxic stress and mitochondrial dysfunction.
"																																																								"{""description"": ""Copper-dependent cell death involving binding of copper to lipoylated enzymes in the tricarboxylic acid (TCA) cycle, leading to proteotoxic stress and mitochondrial dysfunction.\n"", ""name"": ""Cuproptosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""cuproptosis"", ""term"": {""id"": ""GO:0160119"", ""label"": ""cuproptosis""}}], ""description"": ""Copper-dependent cell death involving binding of copper to lipoylated enzymes in the tricarboxylic acid (TCA) cycle, leading to proteotoxic stress and mitochondrial dysfunction.\n"", ""evidence"": [{""explanation"": ""Establishes cuproptosis as a copper-dependent cell death mechanism in Wilson disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""Many interesting disease details were published on the mechanistic steps, such as the generation of reactive oxygen species (ROS) and cuproptosis causing a copper dependent cell death"", ""supports"": ""SUPPORT""}, {""explanation"": ""Supports lipoylation-related mitochondrial proteotoxic stress and TCA cycle dysfunction consistent with cuproptosis."", ""reference"": ""PMID:41006805"", ""snippet"": ""Moreover, abnormal lipoylation of the copper-dependent proteins metal-binding domain of ferredoxin 1 and dihydrolipoamide transacetylase causes mitochondrial protein oligomer buildup and tricarboxylic acid cycle dysfunction, reinforcing an \""oxidative damage-inflammation-fibrosis\"" vicious cycle."", ""supports"": ""SUPPORT""}], ""name"": ""Cuproptosis""}"
7883	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	4	Ferroptosis	"Iron-related cell death pathway involving phospholipid peroxidation. Increased iron deposits in Wilson disease liver may contribute to ferroptosis alongside copper-mediated injury.
"																																																								"{""description"": ""Iron-related cell death pathway involving phospholipid peroxidation. Increased iron deposits in Wilson disease liver may contribute to ferroptosis alongside copper-mediated injury.\n"", ""name"": ""Ferroptosis""}"	{}	"{""biological_processes"": [{""preferred_term"": ""ferroptosis"", ""term"": {""id"": ""GO:0097707"", ""label"": ""ferroptosis""}}], ""description"": ""Iron-related cell death pathway involving phospholipid peroxidation. Increased iron deposits in Wilson disease liver may contribute to ferroptosis alongside copper-mediated injury.\n"", ""evidence"": [{""explanation"": ""Demonstrates that ferroptosis may contribute to liver injury in Wilson disease due to iron accumulation."", ""reference"": ""PMID:38731973"", ""snippet"": ""In the liver of patients with Wilson disease, also, increased iron deposits were found that may lead to iron-related ferroptosis responsible for phospholipid peroxidation within membranes of subcellular organelles"", ""supports"": ""SUPPORT""}], ""name"": ""Ferroptosis""}"
7929	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	pathophysiology	0	Chromosome 4p16.3 Deletion	Wolf-Hirschhorn syndrome is caused by a deletion in the short arm of chromosome 4, specifically involving the 4p16.3 region. The size and location of the deletion influences phenotypic severity.																																																								"{""description"": ""Wolf-Hirschhorn syndrome is caused by a deletion in the short arm of chromosome 4, specifically involving the 4p16.3 region. The size and location of the deletion influences phenotypic severity."", ""name"": ""Chromosome 4p16.3 Deletion""}"	{}	"{""description"": ""Wolf-Hirschhorn syndrome is caused by a deletion in the short arm of chromosome 4, specifically involving the 4p16.3 region. The size and location of the deletion influences phenotypic severity."", ""evidence"": [{""explanation"": ""This establishes the genetic basis of Wolf-Hirschhorn syndrome as a deletion of the critical region on 4p16.3."", ""reference"": ""PMID:32914558"", ""snippet"": ""The syndrome is caused by deletion of a critical region (Wolf-Hirschhorn Syndrome Critical region-WHSCR) on chromosome 4p16.3."", ""supports"": ""SUPPORT""}, {""explanation"": ""This confirms that Wolf-Hirschhorn syndrome results from deletion of the short arm of chromosome 4."", ""reference"": ""PMID:18474167"", ""snippet"": ""We report a case of a rare chromosomal disorder, Wolf-Hirschhorn syndrome, caused by deletion of short arm of chromosome 4."", ""supports"": ""SUPPORT""}], ""name"": ""Chromosome 4p16.3 Deletion""}"
7956	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	pathophysiology	0	TTT complex dysfunction	"Mutations in TELO2 destabilize the TTT co-chaperone complex (TELO2-TTI1-TTI2), which is essential for co-translational maturation and stability of PIKKs including ATM, ATR, DNA-PKcs, mTOR, SMG1, and TRRAP. Loss of TELO2 leads to reduced PIKK protein levels, compromising DNA damage checkpoints, growth signaling via mTOR, and nonsense-mediated mRNA decay via SMG1.
"																																																								"{""description"": ""Mutations in TELO2 destabilize the TTT co-chaperone complex (TELO2-TTI1-TTI2), which is essential for co-translational maturation and stability of PIKKs including ATM, ATR, DNA-PKcs, mTOR, SMG1, and TRRAP. Loss of TELO2 leads to reduced PIKK protein levels, compromising DNA damage checkpoints, growth signaling via mTOR, and nonsense-mediated mRNA decay via SMG1.\n"", ""name"": ""TTT complex dysfunction""}"	{}	"{""biological_processes"": [{""preferred_term"": ""Nonsense-mediated decay"", ""term"": {""id"": ""GO:0000184"", ""label"": ""nuclear-transcribed mRNA catabolic process, nonsense-mediated decay""}}], ""cell_types"": [{""preferred_term"": ""Neuron"", ""term"": {""id"": ""CL:0000540"", ""label"": ""neuron""}}], ""description"": ""Mutations in TELO2 destabilize the TTT co-chaperone complex (TELO2-TTI1-TTI2), which is essential for co-translational maturation and stability of PIKKs including ATM, ATR, DNA-PKcs, mTOR, SMG1, and TRRAP. Loss of TELO2 leads to reduced PIKK protein levels, compromising DNA damage checkpoints, growth signaling via mTOR, and nonsense-mediated mRNA decay via SMG1.\n"", ""evidence"": [{""explanation"": ""Demonstrates that TELO2 plays a conserved role in nonsense-mediated mRNA decay, linking the genetic defect to cellular dysfunction."", ""reference"": ""PMID:33444416"", ""snippet"": ""the human counterpart of CLK-2/TEL2, TELO2, has been also implicated in the NMD, suggesting a conserved role of CLK-2/TEL2 proteins in mRNA surveillance"", ""supports"": ""SUPPORT""}], ""locations"": [{""preferred_term"": ""Brain"", ""term"": {""id"": ""UBERON:0000955"", ""label"": ""brain""}}], ""name"": ""TTT complex dysfunction""}"
